,Original Text,Wakati Text,BoW_oh+SVC,BoW_oh+SVC_Neg,BoW_oh+SVC_Pos,TFIDF+RID,TFIDF+RID_Neg,TFIDF+RID_Pos,TFIDF+LGB,TFIDF+LGB_Neg,TFIDF+LGB_Pos,Emb_tohoku_tfidf+MLP2,Emb_tohoku_tfidf+MLP2_Neg,Emb_tohoku_tfidf+MLP2_Pos,MEDBERT3,MEDBERT3_Neg,MEDBERT3_Pos,UTHBERT2,UTHBERT2_Neg,UTHBERT2_Pos,Ensumble Prediction,Negative Scores,Positive Scores,Label
0,患者はmethylprednisolone(静脈内、1 g、1日1回、使用理由:有害事象)、prednisolone(経口、50 mg、1日1回、使用理由:有害事象)、bisoprolol(投与量・投与回数:不明、使用理由:有害事象)、spironolactone(投与量・投与回数:不明、使用理由:有害事象)、enalapril(投与量・投与回数:不明、使用理由:有害事象)及びamiodarone(投与量・投与回数:不明、使用理由:有害事象)による治療を受けた。,患者 methylprednisolone 静脈 内 0 g 0 日 0回 使用 理由 有害事象 prednisolone 経口 0 mg 0 日 0回 使用 理由 有害事象 bisoprolol 投与 量 投与 回数 不明 使用 理由 有害事象 spironolactone 投与 量 投与 回数 不明 使用 理由 有害事象 enalapril 投与 量 投与 回数 不明 使用 理由 有害事象 amiodarone 投与 量 投与 回数 不明 使用 理由 有害事象 治療 受ける た,0,0.9845739590597158,0.015426040940284273,0,4.920932317684803e-05,0.9999507906768231,0,0.976134944610248,0.023865055389751987,1,0.4401768428335965,0.5598231571664035,0,0.8093244433403015,0.150737002491951,0,0.7353788614273071,0.20400866866111755,1,0.8799363488151155,0.12006365118488449,0
1,ラフチジン錠10mg「サワイ」(2錠、分2、朝食、夕食後、28日間、)、ベイスンOD錠0.3 0.3mg(1錠、分1、朝食直前、28日間)、フェブリク錠10mg(1錠、分1、朝食後、28日間)、アダラートCR錠20mg(1錠、分1、夕食後、28日間)、スピロノラクトン錠25mg「トーワ」(0.5錠)、ラシックス錠10mg(1錠、分1、朝食後、28日間)、ノイエルカプセル200mg(2カプセル、分2、朝食と夕食後、28日間)。,ラフチジン 錠 0m g サワイ 0 錠 0 朝食 夕食 後 0 日間 ベイスン OD 錠 0 0 0 0m g 0 錠 0 朝食 直前 0 日間 フェブリク 錠 0m g 0 錠 0 朝食 後 0 日間 アダラート CR 錠 0m g 0 錠 0 夕食 後 0 日間 スピロノラクトン 錠 0m g TOWA 0 0 錠 ラシックス 錠 0m g 0 錠 0 朝食 後 0 日間 ノイエル カプセル 0m g 0 カプセル 0 朝食 夕食 後 0 日間,1,0.10401580830014436,0.8959841916998558,0,0.00012966429453074274,0.9998703357054692,1,0.4120070811255634,0.5879929188744366,1,0.003495559246316393,0.9965044407536836,0,0.8320513963699341,0.2354583889245987,0,0.5622096657752991,0.49520906805992126,1,0.09136257853657526,0.9086374214634247,0
2,患者はfamotidine(静脈内、20 mg、2021年)、chlorphenamine maleate (Chlorpheniramine C)(静脈内、5 mg、2021年)、metoclopramide(静脈内、10 mg、2021年)、methylprednisolon(静脈内、80 mg、2021年)及びadrenaline(Epinephrine、筋肉内、0.3 mg、2021年)による治療を受けた。,患者 famotidine 静脈 内 0 mg 0 年 chlorphenamine maleate Chlorpheniramine C 静脈 内 0 mg 0 年 metoclopramide 静脈 内 0 mg 0 年 methylprednisolon 静脈 内 0 mg 0 年 adrenaline Epinephrine 筋肉 内 0 0 mg 0 年 治療 受ける た,0,0.9857316857265387,0.014268314273461303,0,7.864348105261922e-05,0.9999213565189474,0,0.936854783450263,0.06314521654973708,1,0.41408370788237947,0.5859162921176205,0,0.8977357745170593,0.103299580514431,0,0.6289874315261841,0.3525850772857666,1,0.8512370049640896,0.1487629950359104,0
3,Seeplex RV15ワンステップACE検出測定キットを用いた喀痰及び咽頭スワブのマルチプレックスPCRは、アデノウイルス、コロナウイルス229E/NL63、パラインフルエンザウイルス1/2/3/4、ボカウイルス1/2/3/4、エンテロウイルス、インフルエンザA/Bウイルス、メタニューモウイルス、コロナウイルスOC43、呼吸器合胞体ウイルスA/B及びヒトライノウイルスA/B/Cにおいて陰性であった。,Seeplex RV 0 ワンステップ ACE 検出 測定 キット 用いる た 喀痰 咽頭 スワブ マルチプレックス PCR アデノウイルス コロナウイルス 0 E NL 0 パラインフルエンザウイルス 0 0 0 0 ボカウイルス 0 0 0 0 エンテロウイルス インフルエンザA B ウイルス メタニューモウイルス コロナウイルス OC 0 呼吸 器 合 胞体 ウイルス A B ヒト ライノウイルス A B C 陰性 だ ある た,0,0.5901639197645026,0.4098360802354974,0,8.905579420284305e-05,0.9999109442057972,0,0.5476747463740661,0.45232525362593395,1,0.21378848848521714,0.7862115115147829,0,0.8416582942008972,0.15797600150108337,0,0.6124930381774902,0.3367222547531128,1,0.41651056860555247,0.5834894313944475,0
4,ウイルス検査:(陰性)重症急性呼吸器症候群コロナウイルス2型、並びにエンテロウイルス、アデノウイルス、パルボウイルス、インフルエンザウイルス、サイトメガロウイルス及びヘルペスウイルスなどの心筋炎誘発ウイルスを含む178個のヒトウイルスゲノムを検出可能なポリメラーゼ連鎖反応(PCR)検査。,ウイルス検査 陰性 重症 急性呼吸 器 症候群 コロナウイルス 0 型 エンテロウイルス アデノウイルス パルボウイルス インフルエンザウイルス サイトメガロウイルス ヘルペスウイルス 心筋炎 誘発 ウイルス 含む 0 個 ヒトウイルスゲノム 検出 可能 だ ポリメラーゼ連鎖反応 PCR 検査,0,0.9751276098675982,0.024872390132401948,0,8.211661949134316e-05,0.9999178833805087,0,0.6674570723773211,0.3325429276226789,0,0.9675022910460542,0.0324977089539458,0,0.7582228779792786,0.32705995440483093,0,0.5830225944519043,0.38945046067237854,0,0.8635476061831975,0.1364523938168024,0
5,他のウイルス性心筋炎の鑑別のためパルボウイルス、アデノウイルス、エンテロウイルス(70、71型)、コクサッキーウイルス(A16、B1、3、4型)についてIgMまたはペア血清による有意な変化があるか調査したが、これら他のウイルスの関与は否定的である結果となった。,他 ウイルス性 心筋炎 鑑別 ため パルボウイルス アデノウイルス エンテロウイルス 0 0 型 コクサッキーウイルス A 0 B 0 0 0 型 IgM ペア 血清 有意 だ 変化 ある 調査 する た これら 他 ウイルス 関与 否定 的 だ ある 結果 なる た,0,0.9402470672762959,0.059752932723704244,0,9.418245306546644e-05,0.9999058175469345,0,0.7039749437524709,0.296025056247529,1,0.21722212733040125,0.7827778726695988,0,0.8830521702766418,0.14435264468193054,0,0.6485137343406677,0.3334910273551941,1,0.684989788308675,0.31501021169132504,0
6,2022/06/02、トロポニンT、CK(血中クレアチンホスホキナーゼ)、CK-MB(血中クレアチンホスホキナーゼMB)、CRP(Cー反応性蛋白)、D-ダイマー(フィブリンDダイマー)を受けたが結果は上昇なしであった。,0 0 0 トロポニン T CK 血 中 クレアチンホスホキナーゼ CK MB 血 中 クレアチンホスホキナーゼ MB CRP C ー 反応 性 蛋白 D ダイマー フィブリン D ダイマー 受ける た 結果 上昇 ない だ ある た,0,0.902397683238547,0.09760231676145323,0,0.00016055844424170564,0.9998394415557583,1,0.07995132999694643,0.9200486700030536,1,0.40642134558518483,0.5935786544148152,0,0.839939534664154,0.17891614139080048,0,0.7205798029899597,0.27584484219551086,1,0.47093784186716514,0.5290621581328349,0
7,患者はprednisolone(15 mg、1日1回、使用理由:亜急性甲状腺炎)及びpotassium chloride (静脈内、80 mEq、1日1回、使用理由:低カリウム血症)による治療を受けた。,患者 prednisolone 0 mg 0 日 0回 使用 理由 亜急性 甲状腺炎 potassium chloride 静脈 内 0 mEq 0 日 0回 使用 理由 低カリウム血症 治療 受ける た,0,0.9880835356945241,0.011916464305475813,0,7.879094277255532e-05,0.9999212090572275,0,0.8334187583314437,0.16658124166855623,1,0.4615450372697326,0.5384549627302674,0,0.8192651867866516,0.20506154000759125,0,0.6848477721214294,0.31136438250541687,1,0.8254819583520294,0.17451804164797058,0
8,患者はmethylprednisolone(静脈内、1 g、1日1回)、prednisolone(経口、50 mg、1日1回)及びcolchicine(1 mg、1日1回)による治療を受けた。,患者 methylprednisolone 静脈 内 0 g 0 日 0回 prednisolone 経口 0 mg 0 日 0回 colchicine 0 mg 0 日 0回 治療 受ける た,0,0.9965402036887565,0.003459796311243493,0,6.960867109575873e-05,0.9999303913289043,0,0.9406528411933281,0.0593471588066718,1,0.4858515279154003,0.5141484720845997,0,0.9106003642082214,0.09165889024734497,0,0.7847588658332825,0.20121294260025024,1,0.9045397016282104,0.09546029837178961,0
9,マルチウイルスリアルタイムポリメラーゼ連鎖反応(PCR)システムではEMB検体全ての心筋で重症急性呼吸器症候群コロナウイルス2(SARS-CoV-2)を含むウイルスゲノム検出されなかった。,マルチ ウイルス リアルタイム ポリメラーゼ連鎖反応 PCR システム EMB 検体 全て 心筋 だ 重症 急性呼吸 器 症候群 コロナウイルス 0 SARS CoV 0 含む ウイルス ゲノム 検出 する れる ない た,0,0.9655049999194054,0.03449500008059452,0,7.112677682420568e-05,0.9999288732231758,0,0.6603352103574789,0.33966478964252106,0,0.6325887429846988,0.36741125701530114,0,0.9320319294929504,0.0784815102815628,0,0.798906683921814,0.1508299857378006,0,0.8827389920666754,0.11726100793332463,0
10,オランザピン(15mg)、ブレクスピプラゾール(2mg)、ルラシドン(80mg)など、ほとんどすべての非定型的抗精神病薬が、症状の治療には効果がなかったか、あるいは忍容性が低かった。,オランザピン 0m g ブレクスピプラゾール 0m g ルラシドン 0m g すべて 非定型的 抗精神病 薬 症状 治療 効果 ない た 忍容性 低い た,0,0.9845581511195362,0.015441848880463854,0,8.534385071964094e-05,0.9999146561492803,0,0.9218738535752824,0.07812614642471764,0,0.6342636321191066,0.36573636788089336,0,0.9175679683685303,0.07956168800592422,0,0.8042886257171631,0.19345803558826447,0,0.9262456041000011,0.07375439589999894,0
11,治療翌日より自覚症状は改善傾向を示し、10日目には視力、視野は共にほぽ正常に回復した(右眼1.0、左眼1.5)、後療法については行わずに経過を見る方針とし、15日目に自宅退院した。,治療 翌日 自覚症状 改善 傾向 示す 0 日 目 視力 視野 ほる ぽい 正常 回復 した 右 眼 0 0 左 眼 0 0 後 療法 行う ぬ 経過 見る 方針 する 0 日 目 自宅 退院 する た,0,0.9845736876395381,0.015426312360461842,0,8.452121512787317e-05,0.9999154787848721,0,0.9340514063717305,0.06594859362826959,1,0.3070200875009469,0.6929799124990531,0,0.9249377250671387,0.11154031753540039,0,0.7583077549934387,0.19574300944805145,1,0.8614542744687269,0.138545725531273,0
12,2022/04/05-2022/04/07(ワクチン接種後20日-22日)、大動脈バルーンパンピングおよび人工心肺(経皮的心肺補助(PCPS))を導入し循環サポートを行った。,0 0 0 0 0 0 ワクチン接種 後 0 日 0 日 大動脈 バルーンパンピング 人工心肺 経 皮 的 心肺 補助 PCPS 導入 する 循環 サポート 行う た,0,0.963341521750312,0.03665847824968813,0,0.00015019919059531726,0.9998498008094047,1,0.3740784295625532,0.6259215704374468,1,0.3837012823112774,0.6162987176887226,0,0.8988374471664429,0.1201368197798729,0,0.7316775321960449,0.25643831491470337,1,0.6674074829745601,0.3325925170254399,0
13,接種後35日目より2週間連続でpulse methylprednisolone 1 gを3日連続投与し、その後prednisolone 60 mgを2日おきに投与した。,接種 後 0 日 目 0 週間 連続 PULSE methylprednisolone 0 g 0 日 連続 投与 する その後 prednisolone 0 mg 0 日 おき 投与 する た,0,0.9877773107597673,0.01222268924023271,0,8.40425219799649e-05,0.9999159574780201,0,0.9339079447176226,0.06609205528237744,1,0.19933212635491349,0.8006678736450865,0,0.908135175704956,0.09484163671731949,0,0.8144040703773499,0.1736096441745758,1,0.845049672770052,0.15495032722994792,0
14,CK-MB(心筋帯)、トロポニンT、トロポニンI、ESR(赤血球沈降速度)、Dダイマー、その他、心筋/心膜組織の病理組織検査、心磁気共鳴、心エコーは実施されなかった。,CK MB 心筋 帯 トロポニン T トロポニン I ESR 赤血球沈降速度 D ダイマー その他 心筋 心膜 組織 病理 組織 検査 心 磁気 共鳴 心 エコー 実施 する れる ない た,0,0.9932433586051983,0.006756641394801711,0,5.950261263935902e-05,0.9999404973873607,0,0.8469718913422447,0.1530281086577553,0,0.6618690323287308,0.33813096767126916,0,0.9258794784545898,0.07331360131502151,0,0.7950852513313293,0.15423905849456787,0,0.9239803987520001,0.07601960124799984,0
15,投与開始1週間後には病棟内歩行器歩行、訓練にも取り組んで、2週間後には2本杖で70m、独歩10m、3週間後には2本杖100m、病室内独歩と徐々に歩行距離を伸ばした。,投与 開始 0 週間 後 病棟 内 歩行器歩行 訓練 取り組む 0 週間 後 0本 杖 0m 独歩 0m 0 週間 後 0本 杖 0m 病室内 独歩 歩行距離 伸ばす た,0,0.9845603775217484,0.015439622478251494,0,8.488121434745208e-05,0.9999151187856525,0,0.6951569364588461,0.3048430635411538,1,0.25155718816951256,0.7484428118304874,0,0.8867204785346985,0.1461459845304489,0,0.789326012134552,0.17667940258979797,1,0.7713482528688324,0.2286517471311677,0
16,搬送手段、搬送中の有害事象(AE)の経過および処置内容、病院到着日時、到着時の身体所見、処置の詳細、検査(血液/生化学検査、感染症関連検査、画像検査等)はなかった。,搬送 手段 搬送 中 有害事象 AE 経過 お呼び 処置 内容 病院 到着 日 時 到着 時 身体所見 処置 詳細 検査 血液 生化学 検査 感染症関連 検査 画像 検査 等 ない た,0,0.9822657313962856,0.01773426860371436,0,8.13348439854338e-05,0.9999186651560146,0,0.8953750626961392,0.10462493730386081,0,0.5818296769079447,0.41817032309205526,0,0.9400057196617126,0.06714150309562683,0,0.7970876693725586,0.15762858092784882,0,0.9191925841170736,0.08080741588292635,0
17,症状改善が不十分であったため、第21病日よりIVIg(0.4g/kg/日、5日間)施行、シクロスポリン内服を開始し、症状改善したため第37病日に退院となった。,症状改善 不十分 だ ある た ため 0 病 日 IVIg 0 0g kg 日 0 日間 施行 シクロスポリン 内服 開始 する 症状改善 する た ため 0 病 日 退院 なる た,0,0.9805244764258075,0.019475523574192556,0,0.00011751279356874312,0.9998824872064312,0,0.6341898605933499,0.3658101394066501,1,0.15840155042101034,0.8415984495789897,0,0.9224939942359924,0.0941300168633461,0,0.7404065132141113,0.23355838656425476,1,0.7071700105063978,0.2928299894936021,0
18,2022年7月15日19時10分BP:106/64、P74、SPO2 99 %会話良好、気分不快なし、症状改善、Dr診察にて帰宅許可あり、独歩に帰宅される。,0 年 0 月 0 日 0時 0分 BP 0 0 P 0 SPO 0 0 % 会話 良好 気分 不快なし 症状改善 Dr 診察 帰宅 許可 ある 独歩 帰宅 する れる,0,0.9159090731556976,0.0840909268443025,0,0.00010904377984841944,0.9998909562201516,0,0.8206554117966613,0.17934458820333865,0,0.5741393645304627,0.4258606354695374,0,0.5721055865287781,0.5647517442703247,0,0.7570624947547913,0.24511343240737915,0,0.7578501070071442,0.2421498929928559,0
19,トロポニンT:methylprednisoloneの静脈内投与から3?日後、著明に減少した、入院時15.000 ng/mL及び退院時0.034 ng/mL。,トロポニン T methylprednisolone 静脈 内 投与 0 日後 著 明 減少 する た 入院 時 0 0 NG mL 退院 時 0 0 NG mL,0,0.9938171611868993,0.006182838813100583,0,8.170014540372714e-05,0.9999182998545962,0,0.7795425417648023,0.22045745823519775,0,0.5195482961797382,0.48045170382026176,0,0.5636226534843445,0.453587144613266,0,0.7563576698303223,0.22984568774700165,0,0.7725079293071175,0.22749207069288252,0
20,その後、およそ3か月の間、定期的に来院したが、最終的に疼痛は消え、耳介の発赤は消え、顔面神経麻痺は柳原法で40点と客観的には麻痺を認識できないほど改善した。,その後 0 か月 間 定期的 来院 する た 最終的 疼痛 消える 耳介 発赤 消える 顔面神経 麻痺 柳原 法 0点 客観的 麻痺 認識 できる ない 改善 する た,0,0.9845667204722632,0.015433279527736779,0,0.00010428166897984278,0.9998957183310202,0,0.770510879762191,0.229489120237809,1,0.41963104473982527,0.5803689552601747,0,0.871187686920166,0.1985870748758316,0,0.74839848279953,0.20435038208961487,1,0.8272518694909204,0.17274813050907947,0
21,連日の血小板輸血に不応で第7病日まで血小板数0.2- 0.5万/μLで経過したが、第8病日以降Plt数回復し、第18病日elthrombopag終了した。,連日 血小板輸血 不応 0 病 日 血小板 数 0 0 0 0 万 μ L 経過 する た 0 病 日 以降 Plt 数 回復 0 病 日 elthrombopag 終了 する た,0,0.9801763254522051,0.019823674547794885,0,0.00011561941915880867,0.9998843805808412,0,0.6787497772500619,0.3212502227499381,1,0.41021330041190585,0.5897866995880942,0,0.9003224968910217,0.09642684459686279,0,0.7307077050209045,0.24387212097644806,1,0.8067830710941536,0.19321692890584638,0
22,患者の血糖値は、強化インスリン療法(夕食前、デグルデク9U;朝食前、リスプロ24U;昼食前、5U;及び夕食前、15U)により最終的にコントロールされた。,患者 血糖 値 強化 インスリン 療法 夕食 前 デグルデク 0 U 朝食 前 リス プロ 0 U 昼食 前 0 U 夕食 前 0 U 最終的 コントロール する れる た,0,0.9585399015112471,0.04146009848875276,0,0.00011321076207102759,0.999886789237929,1,0.35400105133058624,0.6459989486694138,1,0.2856178611416893,0.7143821388583107,0,0.8863558173179626,0.10081958770751953,0,0.7923440337181091,0.18901969492435455,1,0.6423100583996658,0.3576899416003343,0
23,入院12日後、3日間の静脈メチルプレドニゾロンパルス療法(1000 mg/日)を開始し、その後プレドニゾロン1mg/kgを毎日(70 mg/日)行った。,入院 0 日 後 0 日間 静脈 メチルプレドニゾロン パルス 療法 0 mg 日 開始 する その後 プレドニゾロン 0m g kg 毎日 0 mg 日 行う た,0,0.9845951550576181,0.015404844942381861,0,0.00011180031237488744,0.9998881996876251,0,0.7565868912075643,0.2434131087924357,1,0.3532799350878849,0.6467200649121151,0,0.889604926109314,0.14997470378875732,0,0.7999635338783264,0.197709321975708,1,0.8221572575980136,0.17784274240198647,0
24,翌日、患者は完全寛解し、初回接種から56日後の2回目接種において、prednisoloneの経口投与治療中であったが、事象再発は見られなかった。,翌日 患者 完全寛解 初回 接種 0 日 後 0回目 接種 prednisolone 経口 投与 治療 中 だ ある た 事象 再発 見る られる ない た,0,0.9845624630572684,0.015437536942731698,0,7.509313781952186e-05,0.9999249068621805,0,0.8146981655632153,0.18530183443678475,0,0.9344860468889618,0.06551395311103826,0,0.9348169565200806,0.07168754190206528,0,0.8122866153717041,0.1464986503124237,0,0.9524185184970301,0.04758148150297002,0
25,ワクチンの予診票(基礎疾患、アレルギー、最近一か月以内の予防接種や病気、服薬中の薬、過去の副作用歴、発育状況等)に関して考慮される点はなかった。,ワクチン 予診 票 基礎疾患 アレルギー 最近 一 か月 以内 予防接種 病気 服薬 中 薬 過去 副作用 歴 発育 状況 等 考慮 する れる 点 ない た,0,0.9845697875711206,0.015430212428879549,0,6.359570584787527e-05,0.9999364042941521,0,0.9228286985930506,0.07717130140694939,0,0.6176923504953431,0.3823076495046569,0,0.9347744584083557,0.06848032027482986,0,0.8073926568031311,0.14221274852752686,0,0.9296799165553207,0.07032008344467933,0
26,患者はレミエール症候群の疑いで抗生剤の静脈内投与を受けたが、扁桃炎は認めず、口腔感染は陰性であったため、レミエール症候群の可能性は除外された。,患者 レミエール症候群 疑い だ 抗生剤 静脈 内 投与 受ける た 扁桃炎 認める ぬ 口腔感染 陰性 だ ある た ため レミエール症候群 の 可能性 除外 する れる た,0,0.9845747421323529,0.015425257867647157,0,8.936723280935475e-05,0.9999106327671906,0,0.7637137471625597,0.23628625283744034,1,0.05205735598551098,0.947942644014489,0,0.8754827976226807,0.18617244064807892,0,0.7800759673118591,0.1975902020931244,1,0.7053002479151631,0.2946997520848368,0
27,唇のしびれは残存しており(腫脹は消失)、ベタメタゾン(HlSTABLOCKとして報告)、トラネキサム酸(トランサミンとして報告)が処方された。,唇 しびれ 残存 する おる 腫脹 消失 ベタメタゾン HlSTABLOCK 報告 トラネキサム 酸 トランサミン 報告 処方 する れる た,0,0.9813788149544137,0.01862118504558638,0,8.91666630522664e-05,0.9999108333369477,0,0.7833201534229286,0.21667984657707137,1,0.16480758635725545,0.8351924136427445,0,0.8512898087501526,0.19966484606266022,0,0.6550235748291016,0.39265745878219604,1,0.6842089346158591,0.315791065384141,0
28,診断結果(可能であれば括弧内に正常範囲を示す):日付不明血管造影:磁気共鳴血管造影では、アテローム性動脈硬化症の変化や異常は認められなかった。,診断 結果 可能 だ ある 括弧 内 正常範囲 示す 日付 不明 血管造影 磁気 共鳴 血管造影 だ アテローム性 動脈硬化症 変化 異常 認める られる ない た,0,0.9845759235389979,0.015424076461002056,0,9.279977544731974e-05,0.9999072002245527,1,0.4046771622859162,0.5953228377140838,0,0.6934273089478338,0.3065726910521662,0,0.9381603598594666,0.0638708844780922,0,0.8195112943649292,0.15259650349617004,1,0.84641435417258,0.15358564582742004,0
29,免疫学的検査:陰性(陰性)抗糸球体基底膜抗体は陰性、2 U/mL未満、抗糸球体基底膜抗体は2 U/mL未満及び顕著な免疫複合体沈着は認めず。,免疫学 的 検査 陰性 陰性 糸球体 基底膜 抗体 陰性 0 U mL 未満 糸球体 基底膜 抗体 0 U mL 未満 顕著 だ 免疫複合体 沈着 認める ぬ,0,0.9827186305935264,0.017281369406473717,0,5.8378424406675076e-05,0.9999416215755933,0,0.8924610916907265,0.10753890830927343,0,0.720211473404481,0.279788526595519,1,0.3493155837059021,0.7912530303001404,1,0.24513640999794006,0.8331714272499084,1,0.540145070728161,0.45985492927183896,0
30,ワクチン予診票(基礎疾患、アレルギー、最近1ヶ月以内のワクチン接種や病気、服用中の薬、過去の副作用歴、発育状況等)に留意すべき点はなかった。,ワクチン 予診 票 基礎疾患 アレルギー 最近 0 ヶ月 以内 ワクチン接種 病気 服用 中 薬 過去 副作用 歴 発育 状況 等 留意 する べし 点 ない た,0,0.9845683979964899,0.015431602003510047,0,6.388010251169459e-05,0.9999361198974883,0,0.9430900002950806,0.0569099997049194,0,0.6411528188323821,0.35884718116761793,0,0.9349335432052612,0.08586017042398453,0,0.8039882779121399,0.1442328691482544,0,0.9337998242156301,0.06620017578436976,0
31,患者は、リモデリング防止のため、ibuprofen(抗炎症作用のため)及びアンジオテンシン変換酵素阻害剤(ACE-I)による治療を受けた。,患者 リモデリング 防止 ため ibuprofen 抗炎症作用 ため アンジオテンシン 変換 酵素阻害剤 ACE I 治療 受ける た,1,0.4129098611466957,0.5870901388533043,1,0.00019854675742276691,0.9998014532425772,1,0.3191999174576685,0.6808000825423315,0,0.576639837175267,0.42336016282473293,0,0.8275038003921509,0.24676911532878876,0,0.7460764646530151,0.3071240484714508,1,0.41037470772807044,0.5896252922719295,0
32,脳性ナトリウム利尿ペプチド前駆体N端フラグメント(0 pg/mL-125 pg/mL):99.4 pg/mL(正常)99.4 pg/mL。,脳性 ナトリウム利尿 ペプチド 前駆体 N 端 FRAGMENT 0 PG mL 0 PG mL 0 0 PG mL 正常 0 0 PG mL,0,0.9890800812425569,0.01091991875744305,0,0.00012037129286314453,0.9998796287071369,0,0.5579276429185207,0.44207235708147935,0,0.5195482961797382,0.48045170382026176,0,0.6875212788581848,0.3529905676841736,1,0.42239832878112793,0.7106841206550598,1,0.544779126488831,0.455220873511169,0
33,コンピュータ断層撮影:(2022/05/26)異常所見なし、メモ:報告病院実施の左肩X線、左肩CTでは、特記すべき異常所見は示さなかった。,コンピュータ断層撮影 0 0 0 異常所見なし メモ 報告 病院 実施 左肩 X線 左肩 CT 特記 する べし 異常所見 示す ない た,0,0.9699767385282427,0.030023261471757226,0,7.883553565682453e-05,0.9999211644643432,0,0.7340389870279485,0.2659610129720515,0,0.818095531680015,0.181904468319985,0,0.9392843842506409,0.07203463464975357,0,0.7733334898948669,0.23036102950572968,0,0.9208973643169691,0.07910263568303097,0
34,患者は経口抗アレルギー薬(抗ヒスタミン薬)及び外用ステロイド(副腎皮質ステロイド外用薬)を処方され、治療期間は53日以上と報告された。,患者 経口 抗アレルギー 薬 抗ヒスタミン薬 外用 ステロイド 腎皮質 ステロイド外用薬 処方 する れる 治療 期間 0 日 以上 報告 する れる た,0,0.7255705892479449,0.27442941075205507,0,9.450296443410842e-05,0.9999054970355659,0,0.881081867612263,0.11891813238773699,1,0.1794766612176134,0.8205233387823866,0,0.689046323299408,0.423998087644577,0,0.8033984899520874,0.17692138254642487,1,0.6139561596074274,0.38604384039257256,0
35,IADの原因として腫瘍随伴性機序が報告されているため、胸部及び腹部CTスキャンを実施したが、胸腺腫を含む悪性病変は認められなかった。,IAD 原因 する 腫瘍 随伴性 機序 報告 する れる いる ため 胸部 腹部 CTスキャン 実施 する た 胸腺腫 含む 悪性病変 認める られる ない た,0,0.982488677248965,0.017511322751034942,0,9.176290117327314e-05,0.9999082370988267,1,0.28024735884190666,0.7197526411580933,0,0.9235885374664843,0.07641146253351577,0,0.9301854968070984,0.069447360932827,0,0.7717387676239014,0.19452589750289917,1,0.8594565622781902,0.14054343772180983,0
36,エキスパートオピニオンに則って、アシクロビル10 mg/kg 8時間毎14日間とメチルプレドニゾロン1 mg/kgを5日間静脈投与。,エキスパート オピニオン 則る アシクロビル 0 mg kg 0時 間 毎 0 日間 メチルプレドニゾロン 0 mg kg 0 日間 静脈 投与,0,0.5442035811353038,0.45579641886469635,0,9.921251487617503e-05,0.9999007874851238,0,0.9197187149169355,0.08028128508306448,1,0.001380248717954946,0.998619751282045,0,0.8897200226783752,0.17075642943382263,0,0.7557448744773865,0.25491055846214294,1,0.5375793553403078,0.46242064465969224,0
37,"白血球数(3,300-8,600):5,700 mcL(正常) 5,700 mcL及び5,700 mcL(正常)5,700 mcL。",白血球 数 0 0 0 0 0 0 mcL 正常 0 0 mcL 0 0 mcL 正常 0 0 mcL,0,0.9879592013728525,0.012040798627147312,0,0.00014129054579995961,0.9998587094542001,0,0.9820634835998474,0.017936516400152612,0,0.5195482961797382,0.48045170382026176,0,0.7367711663246155,0.31531623005867004,1,0.23687061667442322,0.8452813625335693,1,0.6883611696438273,0.31163883035617274,0
38,補助循環によるサポートで循環不全は改善、心機能も改善し、ECMO導入4日目にECMO離脱、Impellaは導入7日目に離脱できた。,補助循環 サポート だ 循環不全 改善 心 機能 改善 する ECMO 導入 0 日 目 ECMO 離脱 Impella 導入 0 日 目 離脱 できる た,0,0.9917312513278965,0.00826874867210348,0,6.0566020272777254e-05,0.9999394339797272,0,0.96800083378708,0.03199916621291999,0,0.5927105076531816,0.4072894923468185,0,0.926616907119751,0.0803731307387352,0,0.7760852575302124,0.19662538170814514,0,0.9262668565729678,0.07373314342703216,0
39,患者は、これまでに、けいれん(ひきつけ)や、薬または食品に対する重いアレルギー反応(アナフィラキシーなど)を起こした事はなかった。,患者 これ けいれん ひきつけ 薬 食品 重い アレルギー反応 アナフィラキシー 起こす た 事 ない た,0,0.9375772307584805,0.062422769241519536,0,9.293667562869976e-05,0.9999070633243713,0,0.9389708718986982,0.06102912810130174,0,0.9593375819088918,0.040662418091108196,0,0.9120969772338867,0.09184902161359787,0,0.8119931817054749,0.15848411619663239,0,0.9587395193278785,0.041260480672121576,0
40,2021/09/04核酸検出検査(PCR法、LAMP法)にて、COVID-19病原体(SARS-CoV-2)検査を実施し、陰性。,0 0 0 核酸 検出 検査 PCR法 LAMP法 COVID 0 病原体 SARS CoV 0 検査 実施 する 陰性,0,0.9914280429159369,0.008571957084063088,0,9.852838628243031e-05,0.9999014716137176,0,0.9548784402326544,0.04512155976734555,0,0.9987722055743089,0.0012277944256910607,0,0.8924190402030945,0.12390141934156418,0,0.7775787115097046,0.21822679042816162,0,0.9615143474536434,0.03848565254635674,0
41,CKD合併症の管理として利尿薬、アルカリ化薬、リン吸着薬、球形吸着炭の投与を行いつつ、血液透析又は腹膜透析の導入を検討していた。,CKD 合併症 管理 利尿 薬 アルカリ化 薬 リン 吸着 薬 球形吸着炭 投与 行う 血液 透析 腹膜透析 導入 検討 する いる た,0,0.9846218681913741,0.015378131808625859,0,6.308778611412136e-05,0.9999369122138859,0,0.960307402956114,0.039692597043886,1,0.3162972526223571,0.6837027473776429,0,0.8914803266525269,0.12557026743888855,0,0.6160910129547119,0.43257594108581543,1,0.8133618468498001,0.18663815315019996,0
42,駆出率(60-80):(不明日)、20%から50%まで回復した、(不明日)70%、(2021/07/22)24%、注:心エコー。,駆け出し 率 0 0 明日 0% 0% 回復 した 明日 0% 0 0 0 0% 注 心 エコー,0,0.9384088486133588,0.06159115138664118,1,0.00017028526057573062,0.9998297147394243,1,0.4920317266030174,0.5079682733969826,1,0.002426335131949342,0.9975736648680507,0,0.8127070069313049,0.2939039170742035,0,0.7751790881156921,0.257515549659729,1,0.47565452179192075,0.5243454782080792,0
43,SARS-CoV-2 PCRは陰性で、エンテロウイルス、インフルエンザウイルス、サイトメガロウイルスも血清学的に陰性であった。,SARS CoV 0 PCR 陰性 エンテロウイルス インフルエンザウイルス サイトメガロウイルス 血清 学的 陰性 だ ある た,0,0.9933974931087851,0.006602506891214903,0,5.5348229771540844e-05,0.9999446517702285,0,0.9729090421195872,0.02709095788041281,0,0.588718520275707,0.4112814797242929,0,0.9143697023391724,0.06993154436349869,0,0.8136159777641296,0.17024841904640198,0,0.9307305938926491,0.06926940610735083,0
44,ソルメドロール1g 3日間投与後、プレドニゾロン60 mg/日を開始し、50 mg/日、40 mg/日、35 mg/日と漸減。,ソルメドロール 0g 0 日間 投与 後 プレドニゾロン 0 mg 日 開始 する 0 mg 日 0 mg 日 0 mg 日 漸減,0,0.9845452064043283,0.015454793595671673,0,7.589234084162288e-05,0.9999241076591584,0,0.9384077781782656,0.06159222182173438,0,0.9999996266570385,3.733429615281662e-07,0,0.9004545211791992,0.12184251844882965,0,0.7996517419815063,0.21640844643115997,0,0.9611309479665703,0.038869052033429795,0
45,血液検査と左潰瘍の生検により、患者は外用4% lidocaine軟膏及びacetaminophenを使用するよう指示を受けた。,血液検査 左潰瘍 生検 患者 外用 0% lidocaine 軟膏 acetaminophen 使用 する よう 指示 受ける た,1,0.45088435692823636,0.5491156430717636,0,0.0001432138025720804,0.9998567861974279,1,0.4646363370596339,0.5353636629403661,0,0.6745146684307692,0.3254853315692307,0,0.754767894744873,0.4082847833633423,0,0.6687912940979004,0.40899863839149475,1,0.44685968043033464,0.5531403195696654,0
46,"2021/08/07-2021/08/10 3日間、メチルプレドニゾロン1,000 mg/日のステロイドパルス療法実施。",0 0 0 0 0 0 0 日間 メチルプレドニゾロン 0 0 mg 日 ステロイド パルス 療法 実施,0,0.9845402830239736,0.015459716976026374,0,0.00012873274260324726,0.9998712672573967,0,0.8256364682852027,0.1743635317147973,0,0.5870998151610756,0.4129001848389245,0,0.9129152894020081,0.09576231241226196,1,0.4407058358192444,0.6541005373001099,1,0.8019566922503147,0.19804330774968523,0
47,インデラル(10) 3T、ヨウ化カリウム(50) 1T、メルカゾール(5) 3Tの治療で、事象の転帰は提供されなかった。,インデラル 0 0 T ヨウ化カリウム 0 0 T メルカゾール 0 0 T 治療 事象 転帰 提供 する れる ない た,0,0.993230095119606,0.006769904880393959,0,9.819822459334247e-05,0.9999018017754067,0,0.8240385207967666,0.1759614792032334,0,0.912007846128921,0.08799215387107893,0,0.9412551522254944,0.05568481981754303,0,0.8089698553085327,0.15633651614189148,0,0.9524362832047083,0.047563716795291616,0
48,心エコー検査では有意所見を認めず、ホルター心電図では頻脈発作をとらえられなかったため、症状時再診の方針となり一旦終診。,心 エコー 検査 有意所見 認める ぬ ホルター心電図 頻脈 発作 とらえる られる ない た ため 症状 時 再診 方針 なる 終 診る,0,0.9845877474502427,0.015412252549757324,0,0.00011331887143997381,0.99988668112856,1,0.4404698614971543,0.5595301385028457,0,0.9988449877376088,0.0011550122623911838,0,0.9130432605743408,0.14841940999031067,0,0.7790449261665344,0.16995824873447418,1,0.9021850617581664,0.09781493824183371,0
49,神経学的検査、全血球計算、電解質および抗体価を含む血液化学検査、脳磁気共鳴画像(MRI)では、目立った所見はなかった。,神経学 的 検査 全血 球 計算 電解質 抗体価 含む 血液 化学 検査 脳 磁気 共鳴 画像 MRI だ 目立つ た 所見 ない た,0,0.9785080197406446,0.021491980259355437,0,7.446768426459411e-05,0.9999255323157354,0,0.862940780210044,0.137059219789956,0,0.8759982793625327,0.12400172063746723,0,0.9225378632545471,0.07231085002422333,0,0.7989083528518677,0.16242899000644684,0,0.9489111778512553,0.051088822148744654,0
50,併用薬は、不明に対するトラネキサム酸、遺伝性血管浮腫3型に対する乾燥濃縮人C1ーインアクチベーター(ベリナートP)。,併用 薬 不明 トラネキサム 酸 遺伝性 血管浮腫 0 型 乾燥 濃縮 人 C 0 ーインアクチベーター ベリナート P,0,0.9695885443804101,0.030411455619590015,0,9.872265942218234e-05,0.9999012773405778,0,0.8713723800851911,0.12862761991480884,0,0.5195482961797382,0.48045170382026176,0,0.8677861094474792,0.16499702632427216,0,0.6217677593231201,0.41272249817848206,0,0.8365870614783235,0.16341293852167654,0
51,酸素投与、集中治療室(ICU)への入室、人工呼吸器の使用、体外式膜型人工肺装置(ECMO)の使用は実施されなかった。,酸素 投与 集中治療室 ICU 入室 人工呼吸器 使用 体外 式 膜型人工肺 装置 ECMO 使用 実施 する れる ない た,0,0.9922178976934848,0.0077821023065152714,0,6.5948398589603e-05,0.9999340516014104,0,0.9261640662942384,0.07383593370576154,0,0.8390645116731856,0.16093548832681442,0,0.9474800229072571,0.05808355286717415,0,0.8204386830329895,0.14860832691192627,0,0.9559024513294235,0.04409754867057657,0
52,(2022/05/26)異常所見なし、メモ:報告病院実施の左肩X線、左肩CTでは、特記すべき異常所見は示さなかった。,0 0 0 異常所見なし メモ 報告 病院 実施 左肩 X線 左肩 CT 特記 する べし 異常所見 示す ない た,0,0.987268659684149,0.01273134031585097,0,7.296513303250835e-05,0.9999270348669675,0,0.7017282575797571,0.2982717424202429,0,0.8650227331970358,0.13497726680296415,0,0.9410820603370667,0.0654221922159195,0,0.7949573993682861,0.20638135075569153,0,0.9290654223470565,0.07093457765294361,0
53,2022/04/27外来で血液検査、レントゲン等行い、炎症反応は治まっているため症状がある時に再受診するよう指示。,0 0 0 外来 血液検査 レントゲン 等 行い 炎症反応 治まる いる ため 症状 ある時 受診 する よう 指示,0,0.9845650654736594,0.015434934526340576,0,0.0001241849197908063,0.9998758150802092,1,0.3037371459951934,0.6962628540048066,0,0.999452755051512,0.0005472449484879869,0,0.8988370299339294,0.15536320209503174,0,0.7548377513885498,0.24086850881576538,1,0.8621426599781643,0.13785734002183572,0
54,基礎疾患のない患者ではあったが、発症約2週間前に本剤を接種されており、直接的な証拠はないもののその関与が疑われた。,基礎疾患 ない 患者 ある た 発症 0 週間 前 本 剤 接種 する れる おる 直接的 だ 証拠 ない 関与 疑う れる た,0,0.9845797995713048,0.015420200428695104,0,0.00011265588299854846,0.9998873441170014,0,0.7994119858142326,0.2005880141857674,1,0.1594357444312302,0.8405642555687698,1,0.4045809805393219,0.7521316409111023,0,0.8055500388145447,0.19954808056354523,1,0.5363188387988141,0.4636811612011858,0
55,経胸壁心エコー像による左心室駆出率(LVEF)は正常値の68%であり、重大な弁疾患や心嚢液貯留は見つからなかった。,経 胸壁 心 エコー 像 左心室 駆け出し 率 LVEF 正常 値 0% だ ある 重大 だ 弁疾患 心嚢液 貯留 見つかる ない た,0,0.9814244753608515,0.01857552463914847,0,8.692817888549065e-05,0.9999130718211146,0,0.8401269661643606,0.15987303383563947,0,0.6860740006463188,0.3139259993536811,0,0.9344013929367065,0.07313523441553116,0,0.7943428754806519,0.16748346388339996,0,0.9243903354776292,0.0756096645223707,0
56,治療にはステロイドが一番効くと言われたため、血液サラサラの薬に加えてステロイド(薬剤の名前は未聴取)も飲み始めた。,治療 ステロイド 一番 効く 言う れる た ため 血液サラサラ 薬 加える ステロイド 薬剤 名前 聴取 飲む 始める た,0,0.9845738782495993,0.015426121750400786,0,9.197814237634423e-05,0.9999080218576236,0,0.9573454767291592,0.042654523270840884,1,0.307862462511707,0.692137537488293,0,0.7768065333366394,0.2932160496711731,0,0.7122780084609985,0.336851567029953,1,0.7955588258793257,0.2044411741206743,0
57,免疫組織化学的染色にて、HIV1型、サイトメガロウイルス及びエプスタイン・バーウイルスが存在しないことを確認した。,免疫 組織 化学 的 染色 HIV 0 型 サイトメガロウイルス エプスタイン・バーウイルス 存在 する ない こと 確認 する た,0,0.8791945222054874,0.12080547779451258,0,0.000114932783998434,0.9998850672160016,0,0.7514979478679196,0.24850205213208038,1,0.3428340601362049,0.6571659398637951,0,0.9144213795661926,0.11551949381828308,0,0.823897123336792,0.1702110320329666,1,0.8021634020213791,0.19783659797862088,0
58,グルタミン酸脱炭酸酵素に対する膵島関連自己抗体、抗IA-2抗体、及び亜鉛輸送体-8のテスト結果は、陰性であった。,グルタミン酸 脱炭酸 酵素 膵島 関連 自己抗体 IA 0 抗体 亜鉛 輸送 体 0 テスト 結果 陰性 だ ある た,0,0.9802655677348161,0.019734432265183836,0,9.076605332876818e-05,0.9999092339466712,0,0.5296176208768058,0.47038237912319425,1,0.31411277148849515,0.6858872285115049,0,0.8544918298721313,0.12483685463666916,0,0.7823925614356995,0.19278916716575623,1,0.724607309562985,0.27539269043701503,0
59,報告時、好酸球増加及び全身症状を伴う薬疹(allopurinolによる薬剤誘発性過敏症症候群)は未回復であった。,報告 時 好酸球 増加 及ぶ 全身症状 伴う 薬疹 allopurinol 薬剤 誘発性 過敏症 症候群 回復 だ ある た,0,0.9845673542493525,0.015432645750647556,0,0.00010249437609652806,0.9998975056239034,0,0.6488587950839234,0.3511412049160766,1,0.3322833915970824,0.6677166084029176,0,0.9338414669036865,0.08038728684186935,1,0.25162774324417114,0.7909700870513916,1,0.5611266854908458,0.43887331450915434,0
60,X-1年11月下旬に娘の生体腎移植ドナーとして左腎を摘出し、その後sCr 1.5mg/dL前後で推移していた。,X 0 年 0 月 下旬 娘 生体 腎移植ドナー 左 腎 摘出 する その後 sCr 0 0m g dL 前後 推移 する いる た,0,0.9504722537579972,0.04952774624200298,0,0.00011580304859734258,0.9998841969514026,1,0.47124067413558457,0.5287593258644154,1,0.3224547310498955,0.6775452689501045,0,0.7814390063285828,0.2902710437774658,1,0.43388164043426514,0.6573499441146851,1,0.43936651489926726,0.5606334851007326,0
61,心機能の低下は無く、CK645から81、トロポニン12.0から0.01、CRP2.3から0.05未満であった。,心 機能 低下 無い CK 0 0 トロポニン 0 0 0 0 CRP 0 0 0 0 未満 だ ある た,0,0.9914216347098931,0.008578365290106972,0,0.00012415861925378513,0.9998758413807463,1,0.16010122543093108,0.8398987745690689,1,0.3270398982547419,0.6729601017452581,1,0.22633053362369537,0.8404368758201599,0,0.7027938961982727,0.3324364125728607,1,0.21646700749390838,0.7835329925060918,0
62,MRI検査、血管造影検査、肺換気血流シンチグラフィー、外科的処置、病理学的検査、VQスキャンは実施しなかった。,MRI 検査 血管造影 検査 肺換気 血流 シンチグラフィー 外科 的 処置 病理学的検査 VQ スキャン 実施 する ない た,0,0.9878212427533853,0.012178757246614576,0,8.861215139249076e-05,0.9999113878486076,0,0.8864175823924042,0.11358241760759578,0,0.8541053202645073,0.14589467973549278,0,0.9373512864112854,0.06672998517751694,0,0.8001713752746582,0.1455031782388687,0,0.9517614078373734,0.04823859216262666,0
63,抗体検査:(不詳日)抗AQP抗体の自己抗体は検出されなかった、(不詳日)MOG抗体の自己抗体は検出されなかった,抗体検査 不詳 日 AQP 抗体 自己抗体 検出 する れる ない た 不詳 日 MOG 抗体 自己抗体 検出 する れる ない た,0,0.9933860725512983,0.00661392744870182,0,8.203890735186084e-05,0.9999179610926482,0,0.978560711524732,0.021439288475268024,0,0.9912812092772375,0.008718790722762456,0,0.935289204120636,0.07462925463914871,0,0.8262017965316772,0.15323670208454132,0,0.9695352072607001,0.030464792739299907,0
64,1週間のみヒドロコルチゾンの点滴投与し、輸液と電解質補正で事象は改善したため、2022/07/22に退院した。,0 週間 ヒドロコルチゾン 点滴 投与 する 輸液 電解質補正 事象 改善 する た ため 0 0 0 退院 する た,0,0.9966304578063557,0.0033695421936443723,0,6.702356325233644e-05,0.9999329764367476,0,0.9223704430513245,0.07762955694867547,0,0.8800056339629381,0.11999436603706187,0,0.9467663168907166,0.07971864938735962,0,0.7865082621574402,0.18784746527671814,0,0.9553769563169101,0.04462304368308992,0
65,"メチルプレドニゾロン1,000mg/日を3日間投与後、プレドニゾロン40mg/内服へ変更し、漸減・中止した。",メチルプレドニゾロン 0 0m g 日 0 日間 投与 後 プレドニゾロン 0m g 内服 変更 漸減 中止 する た,0,0.9845453892564003,0.015454610743599554,0,7.625882026205378e-05,0.9999237411797379,0,0.833809811468893,0.166190188531107,1,0.25176199398627475,0.7482380060137253,0,0.9358952641487122,0.07742916792631149,0,0.8123493790626526,0.17551060020923615,1,0.8369478647018995,0.16305213529810042,0
66,濃縮F13の投与(1200単位/日、5日間)の投与で、患者の症状は著明に改善し、74日目に、患者は退院した。,濃縮 F 0 投与 0 単位 日 0 日間 投与 患者 症状 著い 明 改善 する 0 日 目 患者 退院 する た,0,0.9950996145112853,0.004900385488714629,0,6.298380413652633e-05,0.9999370161958635,0,0.9885356817926177,0.0114643182073822,1,0.2848018514938926,0.7151981485061074,0,0.930294394493103,0.07339932769536972,0,0.7790226936340332,0.1964750587940216,1,0.8783014690668854,0.12169853093311452,0
67,2020年06月、被験者はイカチバント酢酸塩(Icatibant)(皮下)(30 mg、頓用)を開始した。,0 年 0 月 被験者 イカチバント 酢酸塩 Icatibant 皮下 0 mg 頓 用 開始 する た,0,0.9830776833120627,0.016922316687937203,0,7.936230637140031e-05,0.9999206376936286,0,0.6227174160207388,0.3772825839792612,1,0.25233296834547625,0.7476670316545238,0,0.907063364982605,0.1294698715209961,0,0.799858570098877,0.2537025809288025,1,0.7388817148552298,0.2611182851447702,0
68,2022/05/02後療法として、40 mg/日で投与開始し、ステップダウンしてPSL 20 mgへ漸減。,0 0 0 後 療法 0 mg 日 投与 開始 する ステップ ダウン する PSL 0 mg 漸減,0,0.9885651800855534,0.011434819914446451,0,8.131191872815828e-05,0.9999186880812718,0,0.9595796184223019,0.040420381577698165,0,0.9999999980155787,1.9844213394241465e-09,0,0.8924960494041443,0.13921314477920532,0,0.8031795620918274,0.20524302124977112,0,0.962589356934714,0.03741064306528608,0
69,インターフェロガンマ遊離試験:陰性(陰性)、結核特異的インターフェロンガンマ遊離試験の結果は陰性であった。,インターフェロガンマ 遊離 試験 陰性 陰性 結核 特異的 インターフェロンガンマ 遊離 試験 結果 陰性 だ ある た,0,0.9845709058688901,0.015429094131109865,0,8.073656821504157e-05,0.9999192634317849,0,0.967152118612919,0.03284788138708095,1,0.32034528913266946,0.6796547108673305,0,0.9281291961669922,0.07526317238807678,0,0.8342958688735962,0.1710275560617447,1,0.8869975216003213,0.1130024783996787,0
70,ステントグラフトエンドリーク:採取したSGは無傷であり、ステント破損、狭窄、接合部漏出は認められなかった。,ステント グラフ ト エンドリーク 採取 する た SG 無傷 だ ある ステント 破損 狭窄 接合 部 漏出 認める られる ない た,1,0.27311734407220123,0.7268826559277989,1,0.0001819006855618898,0.9998180993144381,1,0.15810829837484575,0.8418917016251543,0,0.8779814672044659,0.12201853279553414,0,0.9451358318328857,0.06553549319505692,0,0.771243155002594,0.20394958555698395,1,0.5164120841072647,0.48358791589273525,0
71,回復後の心エコーでは、心機能良好で肥大型心筋症、拡張型心筋症、不整脈源性右室心筋症の何れも否定的であった。,回復 後 心 エコー だ 心 機能 良好 だ 肥大型心筋症 拡張型心筋症 不整脈源性 右室心筋症 何れ 否定 的 だ ある た,0,0.9845737028436038,0.015426297156396184,0,5.858510283654045e-05,0.9999414148971635,0,0.9827733702977886,0.017226629702211407,1,0.38489230652789796,0.615107693472102,0,0.932111382484436,0.09156143665313721,0,0.7904601097106934,0.19153152406215668,1,0.8951137580222521,0.1048862419777478,0
72,患者はリモデリング防止のため、アンジオテンシン変換酵素阻害剤(ACE-I)(詳細不明)による治療を受けた。,患者 リモデリング 防止 ため アンジオテンシン 変換 酵素阻害剤 ACE I 詳細不明 治療 受ける た,1,0.5,0.5,1,0.00016769620458178495,0.9998323037954182,1,0.3191999174576685,0.6808000825423315,0,0.7340362590962941,0.26596374090370584,0,0.9053183197975159,0.1361570954322815,0,0.747112512588501,0.28980517387390137,1,0.5825563389983919,0.41744366100160807,0
73,入院中、ステロイドパルスを行い複視は改善傾向であったが、不十分であったため2回目のステロイドパルスを実施。,入院 中 ステロイド パルス 行う 複視 改善 傾向 だ ある た 不十分 だ ある た ため 0回目 ステロイド パルス 実施,0,0.9845499842315361,0.015450015768463842,0,8.6079669959292e-05,0.9999139203300407,0,0.9657774528017068,0.03422254719829318,0,0.943454060979358,0.056545939020642005,0,0.92742919921875,0.10663697868585587,0,0.5780844688415527,0.5051025152206421,0,0.9359266945167348,0.06407330548326508,0
74,患者は入院中し、酸素投与は受けず、ICUへは入室せず、人工呼吸器の使用はせず、ECMOの使用はしなかった。,患者 入院 中 する 酸素 投与 受ける ぬ ICU 入室 する ぬ 人工呼吸器 使用 する ぬ ECMO 使用 する ない た,0,0.9920098230734287,0.00799017692657129,0,8.021420261031812e-05,0.9999197857973897,0,0.8852298101743087,0.11477018982569132,0,0.8301990741493985,0.16980092585060141,0,0.9538393616676331,0.06789129227399826,0,0.8066828846931458,0.1330406814813614,0,0.9514146582603704,0.04858534173962947,0
75,その後、prednisoloneは60 mg隔日投与に減量し、維持用量の30 mg隔日投与まで漸減した。,その後 prednisolone 0 mg 隔日 投与 減量 する 維持 用量 0 mg 隔日 投与 漸減 する た,0,0.9845715402276503,0.015428459772349691,0,7.284494681144455e-05,0.9999271550531885,0,0.9847875550433831,0.015212444956616937,1,0.34165281651107726,0.6583471834889227,0,0.9142394661903381,0.08835256099700928,0,0.8059324026107788,0.19839651882648468,1,0.8865114713108063,0.11348852868919368,0
76,2021/11/02、2021/11/09、クリニック受診し、徐々に粘膜所見は改善していたことを認めた。,0 0 0 0 0 0 クリニック 受診 する 粘膜所見 改善 する いる た こと 認める た,0,0.9845581753303881,0.015441824669611815,0,0.00014305353895379392,0.9998569464610462,0,0.724413612159273,0.275586387840727,1,0.01624309523437628,0.9837569047656237,0,0.9356101155281067,0.07856471091508865,0,0.7543367743492126,0.2508701980113983,1,0.6923710906984165,0.30762890930158343,0
77,胸部レントゲン検査:(2022/07/28)うっ血がある程度解除されていた、注記:マスク5Lに切り替えた,胸部 レントゲン 検査 0 0 0 うっ血 解除 する れる いる た 注記 マスク 0 L 切り替える た,0,0.9779926326894622,0.022007367310537818,0,9.407318827704473e-05,0.999905926811723,0,0.540261177091655,0.459738822908345,0,0.9987660340643676,0.0012339659356324461,0,0.9154783487319946,0.15050499141216278,0,0.8121920824050903,0.18270394206047058,0,0.9189890094475736,0.0810109905524265,0
78,時間経過と共に、左肩の疼痛と筋力低下は改善し、11月2日の診察時点で、左母指のしびれを残すのみとなった。,時間 経過 左肩 疼痛 筋力低下 改善 する 0 月 0 日 診察 時点 左 母 指 しびれ 残す なる た,0,0.9845560418623739,0.01544395813762608,0,0.0001579297787692393,0.9998420702212307,0,0.593442237476766,0.4065577625232339,1,0.18076585511392962,0.8192341448860704,0,0.8678963780403137,0.1971743404865265,0,0.7372879981994629,0.26593002676963806,1,0.6592433467753459,0.34075665322465415,0
79,SARS-CoV-2検査:陰性(陰性)入院時のSARS-CoV- 2に対する鼻咽頭PCRの結果は陰性。,SARS CoV 0 検査 陰性 陰性 入院 時 SARS CoV 0 鼻 咽頭 PCR 結果 陰性,0,0.9869073431198577,0.013092656880142375,0,5.963622259051311e-05,0.9999403637774095,0,0.9443029350155712,0.055697064984428814,0,1.0,7.911843501076207e-20,0,0.8798572421073914,0.1247112900018692,0,0.8136735558509827,0.1799463927745819,0,0.9627238516256726,0.03727614837432744,0
80,クロピドグレル(75)1錠分1、ネキシウム(20)1錠分1、アトルバスタチン(10)1錠分1を投与中。,クロピドグレル 0 0 錠 分 0 ネキシウム 0 0 錠 分 0 アトルバスタチン 0 0 錠 分 0 投与 中,0,0.9845734148935978,0.015426585106402125,0,0.00013565004950763282,0.9998643499504923,1,0.4596681026117675,0.5403318973882325,1,0.3584291768184885,0.6415708231815115,0,0.8670656681060791,0.15298345685005188,0,0.7978322505950928,0.24616873264312744,1,0.705028277880759,0.29497172211924116,0
81,左室収縮正常、三尖弁軽度閉鎖不全は2020年と変化なく、左室拡大、肺高血圧、心嚢液貯留を認めなかった。,左室収縮正常 三 尖る 弁軽度閉鎖不全 0 年 変化 ない 左室拡大 肺高血圧 心嚢液 貯留 認める ない た,0,0.9845760186064784,0.015423981393521637,0,8.696444294305492e-05,0.9999130355570569,0,0.9405101479853825,0.05948985201461755,0,0.9262380584678074,0.07376194153219263,0,0.6835640668869019,0.38963082432746887,0,0.7492652535438538,0.24542440474033356,0,0.92418362419117,0.07581637580883005,0
82,単純血漿交換を計6回施行、mPSLパルス療法施行後PSL 15mgまで漸増し、第13病日に抜管できた。,単純 血漿交換 0回 施行 mPSL パルス 療法 施行 後 PSL 0m g 漸増 0 病 日 抜管 できる た,0,0.9739309578904466,0.026069042109553506,0,9.815450893030493e-05,0.9999018454910696,0,0.746618001824985,0.25338199817501506,0,0.5750229307375266,0.42497706926247336,0,0.9247106313705444,0.07656875252723694,0,0.7258184552192688,0.2527122497558594,0,0.8713096366415986,0.12869036335840145,0
83,日付不明特発性心室細動の可能性を疑ったが、回復後の心電図では、QT延長やJ波などの心電図異常は認めず。,日付 不明 特発性 心室細動 の 可能性 疑う た 回復 後 心電図 QT 延長 J 波 心電図異常 認める ぬ,0,0.9654054311515944,0.03459456884840571,1,0.00020648087533625873,0.9997935191246637,1,0.17062764107481176,0.8293723589251882,0,0.7924836132757195,0.2075163867242805,1,0.15420691668987274,0.9069706797599792,1,0.19982947409152985,0.8534385561943054,1,0.17524136720301206,0.824758632796988,0
84,脳脊髄液検査では、蛋白105 mg/dL、細胞数24/μLで、細菌培養及びウイルス検査は異常なかった。,脳脊髄液 検査 蛋白 0 mg dL 細胞 数 0 μ L 細菌 培養 ウイルス検査 異常 ない た,0,0.9909355381886932,0.009064461811306853,0,7.193997518773897e-05,0.9999280600248123,0,0.9089259068250767,0.09107409317492332,0,0.8827136084104885,0.11728639158951149,0,0.9252922534942627,0.08678098767995834,0,0.8145015239715576,0.16612987220287323,0,0.954876416700781,0.04512358329921899,0
85,鑑別診断に、臨床症状/所見を説明可能なその他の疾患(例:心筋梗塞、肺塞栓症、縦隔炎)が否定されている。,鑑別 診断 臨床症状 所見 説明 可能 だ その他 疾患 例 心筋梗塞 肺塞栓症 縦隔炎 否定 する れる いる,0,0.8699755672737546,0.13002443272624525,0,0.00010342930267699266,0.999896570697323,1,0.2654556735120901,0.7345443264879099,1,0.4893375021397812,0.5106624978602188,0,0.7638024091720581,0.30057018995285034,0,0.7399932742118835,0.2196395993232727,1,0.5580693426175743,0.44193065738242565,0
86,2022/01/19 COVID-19病原体(SARS-CoV-2)検査を抗原検査にて実施し、陰性。,0 0 0 COVID 0 病原体 SARS CoV 0 検査 抗原検査 実施 する 陰性,0,0.9935292005042775,0.006470799495722462,0,0.00010080322809159837,0.9998991967719084,0,0.9821584935369414,0.017841506463058546,0,0.9999920390275354,7.960972464560354e-06,0,0.9206055998802185,0.09650756418704987,0,0.7096156477928162,0.3401557505130768,0,0.9587159656472365,0.04128403435276348,0
87,PSL 50 mg開始後6週の経過でCr 1.98から1.4 mg/dLまで改善しC3は正常化した。,PSL 0 mg 開始 後 0 週 経過 Cr 0 0 0 0 mg dL 改善 する C 0 正常 化 する た,0,0.9997825504330343,0.00021744956696571291,0,5.186920728306129e-05,0.9999481307927169,0,0.9728347593821809,0.027165240617819105,0,0.5604091760222716,0.4395908239777285,0,0.9284601807594299,0.07063566893339157,0,0.7569630146026611,0.2256460040807724,0,0.9209480379974712,0.07905196200252894,0
88,SARS-CoV-2ポリメラーゼ連鎖反応(PCR)及び上咽頭スワブによる迅速抗原検査は陰性であった。,SARS CoV 0 ポリメラーゼ連鎖反応 PCR 上 咽頭 スワブ 迅速 抗原検査 陰性 だ ある た,0,0.924671155744395,0.07532884425560518,0,0.00012598341778242273,0.9998740165822175,0,0.7360022112137607,0.26399778878623925,0,0.6505937951288701,0.3494062048711299,0,0.9155195355415344,0.09503769874572754,0,0.8101076483726501,0.17768973112106323,0,0.8885174335790922,0.11148256642090777,0
89,心臓MRI検査、胸部CT検査、直近の冠動脈検査、胸部X線検査とその他の画像検査は、実施されなかった。,心臓 MRI 検査 胸部 CT検査 直近 冠動脈 検査 胸部 X線 検査 その他 画像 検査 実施 する れる ない た,0,0.9992415679667448,0.0007584320332552947,0,6.204565585415864e-05,0.9999379543441459,0,0.9839765117354545,0.01602348826454548,0,0.8725253845954717,0.12747461540452826,0,0.9463004469871521,0.06469171494245529,0,0.8166568279266357,0.1470690369606018,0,0.9631306163763322,0.036869383623667644,0
90,2022/01/27抗原検査にてCOVID-19病原体(SARS-CoV-2)検査を実施し、陰性。,0 0 0 抗原検査 COVID 0 病原体 SARS CoV 0 検査 実施 する 陰性,0,0.9935292005042775,0.006470799495722462,0,0.00010080322809159837,0.9998991967719084,0,0.9821584935369414,0.017841506463058546,0,0.9999921962382123,7.8037617876823e-06,0,0.9237699508666992,0.08902958035469055,0,0.7735710144042969,0.24935382604599,0,0.9647879147774322,0.03521208522256773,0
91,血液検査、髄液検査、MRI検査、神経伝導検査、体性感覚誘導電位を行ったが、異常所見は認めなかった。,血液検査 髄液 検査 MRI 検査 神経 伝導 検査 体性感覚 誘導 電位 行う た 異常所見 認める ない た,0,0.9629282794072501,0.037071720592749935,0,0.00013518292488056015,0.9998648170751194,0,0.5287461360859135,0.4712538639140865,0,0.9246212079582885,0.0753787920417115,0,0.9327877759933472,0.09205344319343567,0,0.8054869771003723,0.1673501580953598,0,0.9098440911730379,0.09015590882696216,0
92,接種時及び/又は有害事象発生時に、処方薬、市販薬、栄養補助食品、又は漢方薬は服用されていなかった。,接種 時 有害事象発生 時 処方 薬 市販薬 栄養 補助 食品 漢方薬 服用 する れる いる ない た,0,0.987604871193827,0.012395128806173073,0,5.8983301687383904e-05,0.9999410166983126,0,0.9518069314421644,0.04819306855783553,0,0.8014675355187796,0.19853246448122044,0,0.9481706619262695,0.05841924995183945,0,0.8089011907577515,0.14115123450756073,0,0.9543217232795809,0.045678276720419145,0
93,事象は酸素投与、集中治療室(ICU)、人工呼吸器、体外式膜型人工肺(ECMO)は必要としなかった。,事象 酸素 投与 集中治療室 ICU 人工呼吸器 体外 式 膜型人工肺 ECMO 必要 する ない た,0,0.9946629436534974,0.005337056346502687,0,5.4646001079907185e-05,0.99994535399892,0,0.9610178201533126,0.03898217984668736,0,0.9695570069457689,0.03044299305423117,0,0.9467411041259766,0.05963171645998955,0,0.8037598133087158,0.14606186747550964,0,0.9675602183872761,0.032439781612723866,0
94,調査担当医師は、本事象を有害事象と判断したが、被験者は入院しなかったため、重篤ではないと判断した。,調査 担当 医師 事象 有害事象 判断 する た 被験者 入院 する ない た ため 重篤 ない 判断 する た,0,0.9845467442313811,0.015453255768618892,0,7.167943754898114e-05,0.9999283205624511,0,0.9508286980544272,0.049171301945572884,0,0.9330857121763219,0.06691428782367814,0,0.8625199198722839,0.2330925613641739,0,0.8154926896095276,0.14662127196788788,0,0.9541464453994822,0.04585355460051776,0
95,2022/04/07-2022/04/08トロポニンI、CK/CK-MBの採血実施し、経過観察。,0 0 0 0 0 0 トロポニン I CK CK MB 採血 実施 する 経過 観察,0,0.9955637755177649,0.00443622448223507,0,0.00010078832964011585,0.9998992116703599,0,0.8802722677412674,0.11972773225873254,0,0.6855469202581216,0.3144530797418784,0,0.864369809627533,0.13993263244628906,0,0.693939208984375,0.2934124171733856,0,0.9044719587765575,0.09552804122344243,0
96,2022/05/06症状の増悪なく改善傾向であり、プレドニン30 mgまで減量したところで退院。,0 0 0 症状 増悪 ない 改善 傾向 だ ある プレドニン 0 mg 減量 する た ところ 退院,0,0.9989962793400385,0.0010037206599615186,0,3.820159060315979e-05,0.9999617984093968,0,0.9979558294345244,0.0020441705654756052,0,0.9999999997746565,2.253434685625273e-10,0,0.9385743737220764,0.06801731884479523,0,0.7878221273422241,0.19249127805233002,0,0.9695240822490793,0.030475917750920792,0
97,その為、入院翌日よりmethylprednisolone (20 mg/日)の投与が追加された。,為 入院 翌日 methylprednisolone 0 mg 日 投与 追加 する れる た,0,0.9845645218773059,0.015435478122694163,0,0.00010544185167847805,0.9998945581483215,0,0.8616869128141407,0.13831308718585927,1,0.2879099435959467,0.7120900564040533,0,0.8774287104606628,0.1663520485162735,0,0.7169873714447021,0.3601694107055664,1,0.7919019569504748,0.20809804304952517,0
98,2022/05/06、画像検査(磁気共鳴画像(MRI):実施、その他:部位:脳、所見:異常なし。,0 0 0 画像 検査 磁気 共鳴 画像 MRI 実施 その他 部位 脳 所見 異常 ない,0,0.9854579575332767,0.014542042466723339,0,7.089668126285886e-05,0.9999291033187372,0,0.9468277403509174,0.05317225964908253,0,0.8819767982548629,0.11802320174513713,0,0.9326596856117249,0.06359834969043732,0,0.8040919303894043,0.17489326000213623,0,0.9579898848032088,0.0420101151967913,0
99,2022/04/28症状安定したため、一旦退院とし、今後は外来にて継続加療とする方針となった。,0 0 0 症状 安定 する た ため 退院 する 今後 外来 継続 加療 する 方針 なる た,0,0.9845698695435857,0.015430130456414207,0,8.58067234979404e-05,0.9999141932765021,0,0.970658553163162,0.029341446836838078,0,0.520326171786841,0.47967382821315896,0,0.9397023320198059,0.08078771829605103,0,0.7739817500114441,0.20072990655899048,0,0.9155563340990642,0.08444366590093573,0
100,経胸壁心エコーにて、心室壁厚正常、心室の大きさ正常、収縮機能正常及び心嚢液貯留量正常を認めた。,経 胸壁 心 エコー 心室 壁 厚い 正常 心室 大きい さ 正常 収縮 機能正常 心嚢液 貯留 量 正常 認める た,0,0.9845488956413335,0.015451104358666631,0,9.223066448495934e-05,0.9999077693355151,0,0.6942342732241154,0.3057657267758847,1,0.12442975043263382,0.8755702495673662,0,0.8654889464378357,0.13703128695487976,1,0.28595277667045593,0.8166325688362122,1,0.4512523826300261,0.5487476173699739,0
101,抗生剤、心血管作動薬、ヒドロコルチゾンを静脈内投与した後、血行動態及び炎症マーカーが改善した。,抗生剤 心血 管 作動薬 ヒドロコルチゾン 静脈 内 投与 する た 後 血行動態 炎症 マーカー 改善 する た,0,0.9846032249987668,0.015396775001233173,0,6.939077794181546e-05,0.9999306092220582,0,0.9225709894326062,0.07742901056739383,0,0.6499068299595387,0.3500931700404613,0,0.9308449625968933,0.08966979384422302,0,0.7975097298622131,0.18106846511363983,0,0.9290322104001988,0.07096778959980116,0
102,一回目接種時、被験者にはアレルギー歴、既往歴、進行中の病歴はなく、治療薬は服用していなかった。,1回目 接種 時 被験者 アレルギー歴 既往 歴 進行中 病歴 ない 治療薬 服用 する いる ない た,0,0.9845818804170919,0.01541811958290808,0,5.7137231548077185e-05,0.9999428627684519,0,0.9865152915354047,0.013484708464595221,0,0.9852994765016786,0.014700523498321445,0,0.9433550238609314,0.0667528584599495,0,0.8296089768409729,0.145974799990654,0,0.96991389649907,0.03008610350093006,0
103,2022/04/04-2022/04/12通院にてステロイド点滴治療を行ったが、右聾は不変。,0 0 0 0 0 0 通院 ステロイド 点滴 治療 行う た 右 聾 不変,0,0.9845469551522714,0.015453044847728605,0,0.00013794531388148276,0.9998620546861186,1,0.3469451637681822,0.6530548362318178,0,0.9999880305615546,1.1969438445439324e-05,0,0.8943505883216858,0.124545618891716,0,0.5514674186706543,0.49600985646247864,1,0.8158528319215841,0.18414716807841588,0
104,prednisoloneによる治療は2週間毎に用量を5 mgずつ減量し、6週間後に中止した。,prednisolone 治療 0 週間 毎 用量 0 mg 減量 する 0 週間 後 中止 する た,0,0.9783956776077519,0.021604322392248097,0,0.00010314814930839709,0.9998968518506915,0,0.8177681879537854,0.18223181204621466,0,0.5352701038624772,0.46472989613752275,0,0.9347913265228271,0.06906626373529434,0,0.8268269896507263,0.16394422948360443,0,0.8995000661915674,0.10049993380843265,0
105,ステロイド投与後から肝障害は改善傾向を示し、プレドニゾロン(20 mg)まで減量し退院した。,ステロイド 投与 後 肝障害 改善 傾向 示す プレドニゾロン 0 mg 減量 する 退院 する た,0,0.9989807526746994,0.001019247325300529,0,4.3786905526604753e-05,0.9999562130944734,0,0.9992804232039706,0.0007195767960294415,0,0.7367374272438754,0.2632625727561247,0,0.9396753907203674,0.06953113526105881,0,0.783449649810791,0.18178848922252655,0,0.9498787938524573,0.05012120614754264,0
106,患者はacetaminophen(投与量・投与回数不明、使用理由:発熱)による治療を受けた。,患者 acetaminophen 投与 量 投与 回数 不明 使用 理由 発熱 治療 受ける た,0,0.984561181900098,0.015438818099901969,0,7.663066657700684e-05,0.999923369333423,0,0.6695413461941884,0.3304586538058117,0,0.7424287735672901,0.25757122643270985,0,0.9130772948265076,0.15381334722042084,0,0.7443599104881287,0.24270480871200562,0,0.8863647624780279,0.11363523752197224,0
107,合併症にはリンパ浮腫(4年間のリンパ浮腫、浮腫に対して特に治療は受けていない)などがあった。,合併症 リンパ浮腫 0 年間 リンパ浮腫 浮腫 治療 受ける いる ない ある た,0,0.9845664819515426,0.01543351804845732,0,9.396266851668714e-05,0.9999060373314833,0,0.8684654782064287,0.13153452179357122,0,0.5009429413361182,0.4990570586638819,0,0.8757696747779846,0.11229010671377182,0,0.7048089504241943,0.3196476399898529,0,0.8649210264055793,0.13507897359442061,0
108,糸球体毛細血管内腔は良好に管理され、糸球体間質の細胞成分の増加や基底膜の肥厚は認めなかった。,糸球体 毛細血管 内 腔 良好 管理 する れる 糸球体 間質 細い 胞成分 増加 基底膜 肥厚 認める ない た,0,0.9845706343411988,0.015429365658801191,0,0.00011378641418328391,0.9998862135858168,0,0.636895489653036,0.363104510346964,0,0.651229287614911,0.34877071238508905,0,0.8739814162254333,0.15693487226963043,0,0.757621705532074,0.21911373734474182,0,0.8582916524711948,0.14170834752880532,0
109,メトトレキサート(メソトレキセート) 3 - 4 mg経口、開始日及び終了日は不明であった。,メトトレキサート メソトレキセート 0 0 mg 経口 開始 日 終了 日 不明 だ ある た,0,0.9960410035018632,0.003958996498136797,0,5.8694272893051334e-05,0.9999413057271069,0,0.8539990474179697,0.1460009525820303,0,0.6320861956757514,0.3679138043242486,0,0.9389185309410095,0.06185062974691391,0,0.8457046747207642,0.17906875908374786,0,0.9247058816217774,0.0752941183782226,0
110,他の疾患など、その他に可能性のある要因はなかった(死因となる疾患/外因は見つからなかった)。,他 疾患 その他 可能性 の ある 要因 ない た 死因 なる 疾患 外因 見つかる ない た,0,0.9845622911154407,0.0154377088845594,0,7.61479384364005e-05,0.9999238520615636,0,0.9749653848947389,0.02503461510526109,0,0.9914201435596088,0.008579856440391186,0,0.9363498091697693,0.05994754657149315,0,0.81038898229599,0.14441072940826416,0,0.9690645500380869,0.030935449961913202,0
111,CTでは出血なし、MRIでは明らかな異常信号なし、胸部XPでは縦隔拡大なし、肺うっ血なし。,CT 出血 ない MRI 明らか だ 異常信号 ない 胸部 XP 縦 隔 拡大 ない 肺うっ血 ない,0,0.9907338257061568,0.009266174293843212,0,5.1995074195414596e-05,0.9999480049258046,0,0.9929029725920788,0.007097027407921229,0,0.9987504937917122,0.0012495062082878061,0,0.888419508934021,0.1380317509174347,0,0.819226086139679,0.17717118561267853,0,0.9663437626013581,0.03365623739864194,0
112,mPSL 500mgを3日間静注投与後、後療法はPSL40mg/日で開始し、以降漸減した。,mPSL 0m g 0 日間 静 投与 後 後 療法 PSL 0m g 日 開始 する 以降 漸減 する た,0,0.9851192654600849,0.014880734539915176,0,0.00010285651533297588,0.9998971434846671,0,0.863822148287234,0.13617785171276595,1,0.4545489292808007,0.5454510707191993,0,0.911535918712616,0.08951099961996078,0,0.8217189311981201,0.17245560884475708,1,0.8887933565649715,0.11120664343502853,0
113,アラニンアミノトランスフェラーゼ:18 IU/L、18 IU/L(入院時の臨床検査結果)。,アラニンアミノトランスフェラーゼ 0 IU L 0 IU L 入院 時 臨床検査 結果,0,0.8341993229115293,0.16580067708847088,0,0.00014399229975582188,0.9998560077002442,1,0.1531908087327244,0.8468091912672756,0,0.9999999771068027,2.2893197307545975e-08,0,0.6550498604774475,0.4064282178878784,0,0.5583404302597046,0.5578488707542419,1,0.5558118007288184,0.4441881992711816,0
114,その後心電図で不完全右脚ブロックは消失し、経胸壁心臓超音波検査で壁運動低下は改善していた。,その後 心電図 だ 不完全右脚ブロック 消失 する 経 胸壁 心臓 超音波 検査 だ 壁運動低下 改善 する いる た,0,0.9845586748259536,0.015441325174046491,0,6.788310383274752e-05,0.9999321168961672,0,0.9759559293221618,0.024044070677838168,0,0.5666389505882985,0.4333610494117015,0,0.9244526624679565,0.09497299790382385,0,0.8220590353012085,0.18457555770874023,0,0.9256289030957848,0.07437109690421531,0
115,患者は10年前にMRAを受けており、VAに異常は認められず、解離性病変は描出されなかった。,患者 0 年 前 MRA 受ける おる VA 異常 認める られる ぬ 解離 性病変 描出 する れる ない た,0,0.9835065197671178,0.016493480232882305,0,8.74826248307099e-05,0.9999125173751693,0,0.9478439747222085,0.05215602527779152,0,0.9511311263944737,0.04886887360552631,0,0.9351570010185242,0.08304416388273239,0,0.7424447536468506,0.23320500552654266,0,0.9579723343762809,0.04202766562371897,0
116,"経過観察ののちに過換気負荷試験や運動負荷試験を行い,問題のないことを確認した上で退院した。",経過 観察 のち 過換気 負荷 試験 運動負荷 試験 行い 問題 ない こと 確認 する た 上 退院 する た,0,0.9845723994563854,0.015427600543614467,0,7.439737093738568e-05,0.9999256026290626,0,0.9099967175432901,0.0900032824567098,1,0.485439913217969,0.514560086782031,0,0.9447010159492493,0.07823599129915237,0,0.7853569388389587,0.2108813375234604,1,0.9003489189766737,0.09965108102332626,0
117,診断後に高用量ステロイド、タクロリムス、シクロフォスファミドパルス療法により治療を行った。,診断 後 用量 ステロイド タクロリムス シクロフォスファミドパルス 療法 治療 行う た,1,0.41553996077445743,0.5844600392255427,1,0.0002116435450316391,0.9997883564549683,1,0.12627746049944955,0.8737225395005505,1,0.3344585191202655,0.6655414808797345,0,0.8943555355072021,0.10499819368124008,0,0.6870472431182861,0.38999390602111816,1,0.23855570823128527,0.7614442917687148,0
118,普段と同程度の血圧96/64 mmHg、心拍数104/分となり、動悸時の頓用内服薬を処方。,普段 程度 血圧 0 0 mmHg 心拍数 0 分 なる 動悸時 頓 用 内服薬 処方,0,0.9670395920159133,0.032960407984086795,0,0.00011002989835366515,0.9998899701016464,1,0.3321355774035565,0.6678644225964435,0,0.9998269267796838,0.00017307322031621171,1,0.4751930832862854,0.7186560034751892,0,0.6537167429924011,0.4745100140571594,1,0.630408122702541,0.36959187729745907,0
119,MRI検査、血管造影検査、肺換気血流シンチグラフィーおよびその他の検査は実施されなかった。,MRI 検査 血管造影 検査 肺換気 血流 シンチグラフィー その他 検査 実施 する れる ない た,0,0.9992578642933472,0.0007421357066527861,0,7.090915675703289e-05,0.999929090843243,0,0.9858429147595702,0.014157085240429832,0,0.946294354559191,0.053705645440809004,0,0.9411313533782959,0.06285557150840759,0,0.8070204257965088,0.14034676551818848,0,0.9679499465787822,0.032050053421217826,0
120,心臓超音波検査は、2022/10/25(報告の通り)実施され、結果は異常所見なしであった。,心臓 超音波 検査 0 0 0 報告 通り 実施 する れる 結果 異常所見なし だ ある た,0,0.9845568403041837,0.015443159695816487,0,5.9658303683782443e-05,0.9999403416963162,0,0.9174008669009321,0.08259913309906783,0,0.7694976009892597,0.23050239901074032,0,0.9362444281578064,0.05921941250562668,0,0.8173896074295044,0.16213956475257874,0,0.9466120858431191,0.0533879141568809,0
121,2022/07/16、経鼻カニューラによる治療を終了し、バリシチニブによる治療を終了した。,0 0 0 経 鼻 カニューラ 治療 終了 する バリシチニブ 治療 終了 する た,0,0.9845581487696189,0.01544185123038107,0,7.634977103517125e-05,0.9999236502289648,0,0.7008487875044016,0.29915121249559845,0,0.8618439517876998,0.13815604821230024,0,0.9384552240371704,0.07431735098361969,0,0.8180344104766846,0.16899871826171875,0,0.9313636829978531,0.06863631700214678,0
122,2021/09/30カシリビマブ・イムデビマブ(ロナプリーブ)11.1mlの治療を受けた。,0 0 0 カシリビマブ・イムデビマブ ロナプリーブ 0 0ml 治療 受ける た,0,0.9845780513118725,0.015421948688127405,0,0.00011618899025762143,0.9998838110097423,0,0.692930689541263,0.3070693104587369,0,0.9347596997282357,0.06524030027176435,0,0.9296964406967163,0.08828677237033844,0,0.8002771735191345,0.205368772149086,0,0.9346910724992781,0.06530892750072205,0
123,"sugar qualitative(urine): (-),基準値範囲: (-)-(+-)",SUGAR qualitative urine 基準値 範囲,0,0.9682305915895116,0.03176940841048831,0,9.525840565382303e-05,0.9999047415943462,1,0.4563792597309324,0.5436207402690676,0,0.9999999999999999,5.868860357294611e-17,0,0.8114619255065918,0.25604018568992615,0,0.7993931770324707,0.19637200236320496,1,0.8816191440938608,0.1183808559061393,0
124,臨床症状/所見を説明可能なその他の疾患が否定されている(例:心筋梗塞、肺塞栓症、縦隔炎)。,臨床症状 所見 説明 可能 だ その他 疾患 否定 する れる いる 例 心筋梗塞 肺塞栓症 縦隔炎,0,0.9845491711879716,0.015450828812028479,0,8.478348778436455e-05,0.9999152165122156,0,0.7988042860643054,0.20119571393569458,0,0.9664511699763375,0.03354883002366254,1,0.3011091351509094,0.7671958804130554,0,0.739133358001709,0.2180219441652298,1,0.8256064225942363,0.1743935774057638,0
125,2022/04/08(ワクチン接種12日後)、肝機能はほぼ正常化し、経過観察は完了した。,0 0 0 ワクチン接種 0 日 後 機能 正常 化 する 経過 観察 完了 する た,0,0.9803384844077583,0.019661515592241836,0,7.393778241364813e-05,0.9999260622175864,0,0.9064808386856671,0.09351916131433287,0,0.9792279976695847,0.0207720023304153,0,0.9421491026878357,0.06700307130813599,0,0.8109627962112427,0.15779119729995728,0,0.9630507281715123,0.036949271828487756,0
126,22日、32日、40日、55日目に、リツキシマブ375 mg/m2を週4回にて治療した。,0 日 0 日 0 日 0 日 目 リツキシマブ 0 mg m 0 週 0回 治療 する た,0,0.9845681334723996,0.015431866527600424,0,0.00013527670716075265,0.9998647232928393,0,0.7599004581514054,0.24009954184859464,1,0.17913362999401317,0.8208663700059868,0,0.9032331705093384,0.08330772817134857,0,0.8042408227920532,0.19981035590171814,1,0.7810560076986436,0.2189439923013565,0
127,PSLパルスでは症状改善せず、全血漿交換を開始し、臨床症状と検査所見が改善傾向となった。,PSL パルス 症状改善 する ぬ 血漿交換 開始 する 臨床症状 検査 所見 改善 傾向 なる た,0,0.9811382129949171,0.01886178700508292,0,8.42313911681076e-05,0.9999157686088319,0,0.9966951962895058,0.003304803710494272,0,0.5016018872327848,0.49839811276721524,0,0.9402036666870117,0.07358742505311966,0,0.7857328653335571,0.19880495965480804,0,0.9177818166114121,0.08221818338858797,0
128,アシクロビルで腎機能障害、精神運動興奮、幻視、振戦、ミオクローヌスなど副作用はなかった。,アシクロビル だ 腎機能障害 精神運動興奮 幻視 振戦 ミオクローヌス 副作用 ない た,0,0.984596325741939,0.01540367425806089,0,7.957922277807217e-05,0.9999204207772219,0,0.8420755823785357,0.15792441762146428,0,0.881663423681732,0.118336576318268,0,0.925169825553894,0.06867914646863937,0,0.8189157843589783,0.15424251556396484,0,0.9496929631115121,0.05030703688848783,0
129,アスパラギン酸アミノトランスフェラーゼ(13- 30):33 IU/L、33 IU/L。,アスパラギン酸 アミノトランスフェラーゼ 0 0 0 IU L 0 IU L,0,0.8755111088840029,0.12448889111599698,1,0.00018388481303544568,0.9998161151869646,1,0.35873972300322543,0.6412602769967746,0,0.5195482961797382,0.48045170382026176,0,0.7635973691940308,0.23988759517669678,1,0.447347491979599,0.6429886221885681,1,0.4591002575626316,0.5408997424373684,0
130,プレドニン10 mgまで漸減困難と判断し、TPO-RA(レボレード12.5 mg)開始。,プレドニン 0 mg 漸減困難 判断 する TPO RA レボレード 0 0 mg 開始,0,0.9902181609135473,0.00978183908645261,0,8.078609346166527e-05,0.9999192139065384,0,0.8243047183856584,0.1756952816143416,0,0.9983568382700719,0.0016431617299280442,0,0.8545305132865906,0.14979621767997742,0,0.6848167777061462,0.3510480523109436,0,0.9348944616954554,0.06510553830454466,0
131,胸部レントゲン検査でうっ血がある程度解除されていることを確認し、マスク5Lに切り替えた。,胸部 レントゲン 検査 だ うっ血 解除 する れる いる こと 確認 する マスク 0 L 切り替える た,0,0.9810693414246949,0.01893065857530509,0,6.827216386369425e-05,0.9999317278361363,0,0.7485183902437623,0.2514816097562377,0,0.9154752201844287,0.08452477981557123,0,0.9300654530525208,0.14317086338996887,0,0.8200681805610657,0.20637351274490356,0,0.9364846609176953,0.06351533908230463,0
132,診断結果(正常範囲が得られている場合は括弧内に記載):日付不明、体温:正常(正常)正常。,診断 結果 正常範囲 得る られる いる 場合 括弧 内 記載 日付 不明 体温 正常 正常 正常,0,0.9845487944419836,0.015451205558016391,0,5.31938219198382e-05,0.9999468061780802,0,0.9342356832219642,0.06576431677803582,0,1.0,1.770089705822296e-32,0,0.9273713231086731,0.08166820555925369,0,0.8109795451164246,0.16802722215652466,0,0.96532114767739,0.034678852322609935,0
133,患者の臨床経過:クロザピン:0日目12.5mg、その後、25および50mgまで増量した。,患者 臨床 経過 クロザピン 0 日 目 0 0m g その後 0 お呼び 0m g 増量 する た,0,0.9845767475002456,0.015423252499754453,0,0.00011699009025962282,0.9998830099097403,1,0.4074070579986626,0.5925929420013374,1,0.1844315301927275,0.8155684698072725,0,0.9049929976463318,0.10000378638505936,0,0.793328046798706,0.19462934136390686,1,0.6357008147943256,0.36429918520567445,0
134,2022/02/28呼吸状態は大きな問題はなかったが、意識状態は改善なく気管切開実施。,0 0 0 呼吸 状態 問題 ない た 意識状態 改善 ない 気管切開 実施,0,0.9994243614391791,0.000575638560820963,0,4.6963445027612205e-05,0.9999530365549724,0,0.9838554516969984,0.016144548303001556,0,0.9942803105878898,0.005719689412110231,0,0.949082612991333,0.06413823366165161,0,0.7471267580986023,0.2691655158996582,0,0.9650452220799707,0.03495477792002938,0
135,2022/04/01血行動態の安定を確認、ヘパリンを中止し、アピキサバンの内服を開始。,0 0 0 血行動態 安定 確認 ヘパリン 中止 する アピキサバン 内服 開始,0,0.9845655747301043,0.015434425269895613,0,6.107269938028803e-05,0.9999389273006197,0,0.6789830224437967,0.32101697755620334,0,0.981964689180224,0.01803531081977609,0,0.9235392808914185,0.08017218112945557,0,0.8075077533721924,0.1849394142627716,0,0.9403121917834592,0.05968780821654082,0
136,アドレナリン筋注後に症状は改善し、入院時には症状は消失、バイタルサインも安定していた。,アドレナリン 筋 注 後 症状 改善 する 入院 時 症状 消失 バイタルサイン 安定 する いる た,0,0.9925772821853424,0.00742271781465764,0,6.202996451713982e-05,0.9999379700354829,0,0.982887363647311,0.01711263635268902,0,0.5309768412386775,0.46902315876132256,0,0.939825713634491,0.0709068700671196,0,0.7953858971595764,0.1768866628408432,0,0.9241716165339473,0.07582838346605277,0
137,患者は抗ヒスタミン薬と外用副腎皮質ステロイドによる治療を受け、これら治療から離脱した。,患者 抗ヒスタミン薬 外用 腎皮質 ステロイド 治療 受ける これら 治療 離脱 する た,0,0.9845723293873444,0.015427670612655544,0,7.724267439974349e-05,0.9999227573256002,0,0.7666156599330533,0.23338434006694678,1,0.3440571426820155,0.6559428573179845,0,0.9316090941429138,0.07389778643846512,0,0.823218584060669,0.17556610703468323,1,0.8450127072466906,0.15498729275330933,0
138,非侵襲的陽圧換気(NPPV)による呼吸管理とニトログリセリン、利尿薬による治療を開始。,侵襲 的 陽圧換気 NPPV 呼吸 管理 ニトログリセリン 利尿 薬 治療 開始,0,0.983060263912157,0.016939736087843174,0,0.00010239170382647043,0.9998976082961736,0,0.8997097012037043,0.10029029879629574,1,0.302361826973056,0.697638173026944,0,0.8964639902114868,0.14568474888801575,0,0.6538347005844116,0.37021198868751526,1,0.8029555976416946,0.19704440235830553,0
139,プレドニゾロンによる副腎皮質ステロイド治療を再開したが、明確な改善は認められなかった。,プレドニゾロン 腎皮質 ステロイド 治療 再開 する た 明確 だ 改善 認める られる ない た,0,0.9985062335017325,0.0014937664982675354,0,4.9099017479182854e-05,0.9999509009825208,0,0.973850582059133,0.02614941794086701,0,0.9731219172763004,0.02687808272369968,0,0.9507029056549072,0.05852075293660164,0,0.8321785926818848,0.15998400747776031,0,0.9693927341589801,0.030607265841019936,0
140,酸素投与、ICU入室、人工呼吸器または体外式膜型人工肺(ECMO)は必要としなかった。,酸素 投与 ICU 入室 人工呼吸器 体外 式 膜型人工肺 ECMO 必要 する ない た,0,0.9936533691098107,0.006346630890189369,0,6.906162152487991e-05,0.9999309383784751,0,0.9553878132270275,0.04461218677297247,0,0.9761955746662413,0.023804425333758674,0,0.9508951902389526,0.059534911066293716,0,0.8262197971343994,0.1477031409740448,0,0.9683387541035552,0.03166124589644472,0
141,2022/07/15、レムデシビル、リクシアナ、セフトリアキソンによる治療を終了した。,0 0 0 レムデシビル リクシアナ セフトリアキソン 治療 終了 する た,0,0.9845755684985465,0.015424431501453477,0,7.805940261838326e-05,0.9999219405973816,0,0.5203447634246715,0.4796552365753285,0,0.692974337574277,0.307025662425723,0,0.9324654936790466,0.07277490943670273,0,0.8197823166847229,0.17557109892368317,0,0.8698742374852748,0.1301257625147253,0
142,2022/03/15時点で、事象「抗MDA5抗体陽性間質性肺炎」の転帰は軽快していた。,0 0 0時 点 事象 MDA 0 抗体陽性 間質性 肺炎 転帰 軽快 する いる た,0,0.5688062515797562,0.4311937484202438,0,0.00015942022916189794,0.9998405797708381,1,0.3521767608558245,0.6478232391441755,0,0.5752496409162982,0.42475035908370185,0,0.9173991680145264,0.09159045666456223,1,0.4911714494228363,0.6145732402801514,1,0.4243823226654663,0.5756176773345336,0
143,2022/04/02(ワクチン接種6日後)、血液検査での改善により、退院が認められた。,0 0 0 ワクチン接種 0 日 後 血液検査 改善 退院 認める られる た,0,0.9845845858222472,0.015415414177752934,0,0.0001071994121904215,0.9998928005878096,0,0.9789099373066281,0.021090062693371936,1,0.3554742856230425,0.6445257143769575,0,0.9341377019882202,0.07716778665781021,0,0.8101261854171753,0.17634963989257812,1,0.893680391686493,0.10631960831350706,0
144,Magnetic resonance imaging:(2022/05/17)異常なし,Magnetic resonance imaging 0 0 0 異常 ない,0,0.9870013708602893,0.01299862913971071,0,9.047512404808054e-05,0.999909524875952,0,0.9355206966322281,0.06447930336777186,0,0.9266103102485732,0.07338968975142673,0,0.9345995187759399,0.07862363755702972,0,0.8244726657867432,0.16365143656730652,0,0.9614038791918043,0.03859612080819581,0
145,中心静脈カテーテル、高カロリー輸液、アルブミン投与、利尿剤、抗菌薬投与の治療を受けた。,中心静脈 カテーテル カロリー 輸液 アルブミン 投与 利尿剤 抗菌薬 投与 治療 受ける た,0,0.984546825376627,0.015453174623372985,0,9.000547317796815e-05,0.999909994526822,0,0.9494600432753242,0.05053995672467576,0,0.5616221838934683,0.43837781610653165,0,0.8814399242401123,0.11453375220298767,0,0.7578160762786865,0.2126023769378662,0,0.9091712815937425,0.0908287184062574,0
146,薬が弱いから強いのに変えましょうとの事で、強めの薬に変えたが、あまり効き目がなかった。,薬 弱い 強い の 変える ます う 事 だ 強める 薬 変える た 効き目 ない た,0,0.9845846290559025,0.015415370944097468,0,8.896760758747017e-05,0.9999110323924125,0,0.9510672882022938,0.04893271179770616,0,0.9402416804400773,0.05975831955992271,0,0.9289417862892151,0.09656967222690582,0,0.6992313861846924,0.41254130005836487,0,0.9463954894877429,0.0536045105122571,0
147,皮膚科に受診を指示するも、C反応性タンパク(CRP)陰性であり、蜂窩織炎は否定された。,皮膚科 受診 指示 する C 反応 性 タンパク CRP 陰性 だ ある 蜂窩織炎 否定 する れる た,0,0.9541689616707748,0.04583103832922529,0,0.00010903318780867398,0.9998909668121914,0,0.703244948225225,0.29675505177477507,1,0.19604414758162214,0.8039558524183779,0,0.9166756272315979,0.0987062156200409,0,0.8051860928535461,0.18717177212238312,1,0.7582516316916421,0.2417483683083578,0
148,2022/05/11、受診時に左眼の眼瞼下垂が半分程度改善し、挙上できるようになった。,0 0 0 受診 時 左 眼 眼瞼下垂 半分 程度 改善 する 挙 上 できる よう なる た,0,0.7964560432443919,0.203543956755608,0,0.00015533145484703813,0.999844668545153,0,0.7708678571736767,0.2291321428263233,1,0.3384722059139733,0.6615277940860267,0,0.9004052877426147,0.15300652384757996,1,0.4944130778312683,0.5876383185386658,1,0.6144546731758583,0.3855453268241418,0
149,2022/06/07から半夏白朮天麻湯を服用したが、2022/06/09に中止した。,0 0 0 半夏白朮天麻湯 服用 する た 0 0 0 中止 する た,0,0.9845637600371199,0.015436239962880082,0,0.00010601423644806075,0.9998939857635519,1,0.4882958218733673,0.5117041781266327,0,0.8305975815421427,0.16940241845785728,0,0.9282637238502502,0.09469601511955261,0,0.8115200400352478,0.20889851450920105,1,0.8852704517918237,0.1147295482081764,0
150,2022/06/25-2022/06/27 m-PSL 500 mgにてパルス施行。,0 0 0 0 0 0 m PSL 0 mg パルス 施行,0,0.981109175290989,0.01889082470901097,0,0.00013893330535358039,0.9998610666946465,0,0.8362630310206329,0.16373696897936701,0,0.9975750981484738,0.0024249018515262338,0,0.8837282061576843,0.1483982503414154,1,0.27179545164108276,0.8397545218467712,1,0.8578496268783489,0.1421503731216511,0
151,患者にCOVID-19感染症の罹患歴はなく、初回ワクチン接種時の発熱は認めなかった。,患者 COVID 0 感染症 の 罹患歴 ない 初回 ワクチン接種 時 発熱 認める ない た,0,0.9593567782078791,0.04064322179212075,0,7.877625062295385e-05,0.9999212237493771,0,0.9433457397091682,0.0566542602908318,0,0.9967090695284117,0.003290930471588323,0,0.9271653294563293,0.1017145961523056,0,0.8357885479927063,0.15227250754833221,0,0.9647004526725365,0.03529954732746349,0
152,プリンペランで点滴を受け、入院を勧められたが、自宅で様子をみたいとのことで帰宅した。,プリンペラン だ 点滴 受ける 入院 勧める られる た 自宅 だ 様子 みる たい こと 帰宅 する た,0,0.9845741746839355,0.015425825316064389,0,0.00010267677664271838,0.9998973232233572,0,0.6295041118147013,0.37049588818529866,1,0.17388479056485417,0.8261152094351458,0,0.7545876502990723,0.3284604251384735,0,0.6071621179580688,0.42847564816474915,1,0.5451132793252792,0.45488672067472075,0
153,「花粉症」(継続中)、注記:ビラノア錠20mgを花粉症のために経口投与(継続中)。,花粉症 継続 中 注記 ビラ ノア 錠 0m g 花粉症 ため 経口 投与 継続 中,0,0.9845935019254193,0.015406498074580648,0,0.00010839189699182203,0.9998916081030081,0,0.7397357275897793,0.2602642724102207,0,0.9473274461192346,0.052672553880765395,0,0.8693044781684875,0.12924034893512726,0,0.6510599255561829,0.48592832684516907,0,0.9045405739840552,0.09545942601594477,0
154,2022/05/07心臓超音波検査では、左室駆出率67.1%であり、異常所見なし。,0 0 0 心臓 超音波 検査 左 室 駆け出し 率 0 0% だ ある 異常所見なし,0,0.984564147299108,0.015435852700892013,0,0.00012277720448635,0.9998772227955136,0,0.6701751685558537,0.3298248314441463,0,0.9940257873166353,0.0059742126833647845,0,0.8743076920509338,0.15367551147937775,0,0.7989572286605835,0.245633065700531,0,0.9290199989709597,0.07098000102904045,0
155,検査したいずれの臓器にも血栓症や心筋炎などの顕著な病理学的変化は認められなかった。,検査 する た いずれ 臓器 血栓症 心筋炎 顕著 だ 病理学 的 変化 認める られる ない た,0,0.9845564148149517,0.015443585185048304,0,0.00011419165742333358,0.9998858083425767,0,0.7112954606786086,0.2887045393213914,0,0.9617684967715785,0.03823150322842145,0,0.9350439310073853,0.08728539943695068,0,0.7858285307884216,0.15914183855056763,0,0.9421283751384997,0.05787162486150034,0
156,心臓MRI検査、胸部CT検査、直近の冠動脈検査、その他の画像検査は未実施であった。,心臓 MRI 検査 胸部 CT検査 直近 冠動脈 検査 その他 画像 検査 実施 だ ある た,0,0.9571283579856436,0.04287164201435647,0,7.530283696909333e-05,0.9999246971630309,0,0.972401757821004,0.027598242178995928,0,0.6926893932169582,0.30731060678304173,0,0.9404792189598083,0.08221270143985748,0,0.8144238591194153,0.1741258054971695,0,0.9395255581163763,0.06047444188362373,0
157,Echocardiogram:(2022/05/17)特記なし、注記:他院にて施行,Echocardiogram 0 0 0 特記 ない 注記 院 施行,0,0.9937244112211119,0.0062755887788880586,0,7.260495730148934e-05,0.9999273950426986,0,0.9755083033144996,0.024491696685500438,0,0.9999935435237257,6.456476274332035e-06,0,0.9316493272781372,0.09334195405244827,0,0.8112356066703796,0.19406288862228394,0,0.9675189389502533,0.032481061049746705,0
158,16:00、嘔気・嘔吐なく、リハビリテーション(立上り訓練、歩行訓練)を実施した。,0 0 嘔気 嘔吐 ない リハビリテーション 立上り 訓練 歩行 訓練 実施 する た,0,0.984543585124427,0.015456414875573185,0,8.563125011209505e-05,0.9999143687498879,0,0.7648652482347995,0.23513475176520052,1,0.21860257723841747,0.7813974227615825,0,0.9150600433349609,0.10247036069631577,0,0.8138059377670288,0.17155395448207855,1,0.800757543198713,0.1992424568012871,0
159,2022/05/02心臓超音波検査にて、心嚢液は生理範囲内であり、異常所見なし。,0 0 0 心臓 超音波 検査 心嚢液 生理 範囲 内 だ ある 異常所見なし,0,0.9845694603847743,0.015430539615225745,0,9.242790202411415e-05,0.9999075720979759,0,0.7227718109882195,0.2772281890117805,0,0.9949143972244622,0.005085602775537861,0,0.9300627708435059,0.08014494925737381,0,0.8151143789291382,0.19180315732955933,0,0.9467443519891731,0.053255648010827085,0
160,2022年7月9日8:00に電話連絡をしたところ「痛みはよくなった」と確認した。,0 年 0 月 0 日 0 0 電話 連絡 する た ところ 痛み なる た 確認 する た,0,0.9845625010556551,0.015437498944344912,1,0.0001777023015165299,0.9998222976984835,1,0.2851142889912387,0.7148857110087613,1,0.13988820928163315,0.8601117907183669,0,0.6274858713150024,0.5565221905708313,0,0.7922329902648926,0.25994768738746643,1,0.35956201844840374,0.6404379815515963,0
161,緊急治療室にてコンピュータ断層撮影:頭部コンピュータ断層撮影にて特異的所見なし。,緊急 治療 室 コンピュータ断層撮影 頭部 コンピュータ断層撮影 特異的 所見 ない,0,0.9845912337410836,0.01540876625891651,0,0.00012410587310658327,0.9998758941268934,0,0.9118379851663942,0.08816201483360572,0,0.9120477413412096,0.08795225865879043,0,0.9209728837013245,0.09343166649341583,0,0.8348326683044434,0.17920039594173431,0,0.9569082364316631,0.043091763568336855,0
162,元々酒好きであり、家族の前では飲酒をやめていたが隠れて飲酒していた形跡があった。,酒 好き だ ある 家族 出端 飲酒 やめる いる た 隠れる 飲酒 する いる た 形跡 ある た,1,0.13211689918957334,0.8678831008104265,0,0.0001614836367382643,0.9998385163632617,1,0.2588623315909422,0.7411376684090578,0,0.8735205548507267,0.12647944514927334,1,0.16997815668582916,0.8849847912788391,1,0.26754119992256165,0.8159735798835754,1,0.06098998490657227,0.9390100150934279,0
163,脳神経系、運動系、感覚系に異常はなく、四肢腱反射正常で病的反射は両側陰性だった。,脳神経 系 運動系 感覚 系 異常 ない 四肢腱反射正常 だ 病的 反射 両側 陰性 だ た,0,0.9845998885517132,0.015400111448286798,0,7.612273093969847e-05,0.9999238772690603,0,0.8665192462849053,0.13348075371509474,0,0.6767644781803146,0.3232355218196854,0,0.843205988407135,0.13653060793876648,0,0.7626869082450867,0.2018398493528366,0,0.9107999688230785,0.08920003117692149,0
164,報告時、心原性ショック(心原性ショック)及び心筋炎(急性心筋炎)は軽快していた。,報告 時 心原性ショック 心原性ショック 及ぶ 心筋炎 急性心筋炎 軽快 する いる た,0,0.9845800418880593,0.015419958111940886,0,0.00010138367142241939,0.9998986163285776,0,0.8134490467996813,0.18655095320031867,0,0.542862277696712,0.457137722303288,0,0.9371653199195862,0.0855155661702156,0,0.7160236239433289,0.27786073088645935,0,0.8778041207584623,0.1221958792415376,0
165,被験者は初回接種時に継続中の病歴、アレルギー、過去の病歴、治療薬などはなかった。,被験者 初回 接種 時 継続 中 病歴 アレルギー 過去 病歴 治療薬 ない た,0,0.987619199776432,0.012380800223568108,0,6.305744211271165e-05,0.9999369425578873,0,0.9066816309225071,0.09331836907749294,0,0.9472267210345938,0.05277327896540613,0,0.9494306445121765,0.06069456785917282,0,0.8400614857673645,0.14096635580062866,0,0.9634208674393989,0.03657913256060103,0
166,抗AQP抗体、MOG抗体の自己抗体は検出されず、他原因となりうる結果はなかった。,AQP 抗体 MOG 抗体 自己抗体 検出 する れる ぬ 原因 なる うる 結果 ない た,0,0.9867759876801413,0.01322401231985863,0,6.61391391361167e-05,0.9999338608608639,0,0.921802460726536,0.07819753927346393,0,0.9514418613724839,0.04855813862751611,0,0.9371483325958252,0.08142516016960144,0,0.8142390847206116,0.14874598383903503,0,0.9623624589304631,0.03763754106953681,0
167,1回目ワクチン接種時に入手した情報は次の通りである:合併症(予診票)はなかった。,0回目 ワクチン接種 入手 する た 情報 次 通り だ ある 合併症 予診 票 ない た,0,0.9845756973949701,0.015424302605029909,0,7.688057295289198e-05,0.9999231194270471,0,0.8785438730292374,0.12145612697076259,0,0.9383704849962196,0.06162951500378049,0,0.9465241432189941,0.0742252916097641,0,0.84611976146698,0.14914877712726593,0,0.9597824705066663,0.04021752949333372,0
168,ヒト免疫不全ウイルス抗体、B型肝炎表面抗原、C型肝炎ウイルス抗体は陰性であった。,ヒト 免疫不全 ウイルス 抗体 B型 肝炎 表面 抗原 C型 肝炎 ウイルス 抗体 陰性 だ ある た,0,0.984055006384443,0.015944993615556975,0,7.488422315185276e-05,0.9999251157768482,0,0.816686172040069,0.183313827959931,1,0.31183547551045565,0.6881645244895443,0,0.9159361124038696,0.06414345651865005,0,0.8240497708320618,0.16687627136707306,1,0.8499576875617819,0.15004231243821806,0
169,経口プレドニゾロン30 mg日内服を開始、プレドニゾロン20 mg日へ減量した。,経口 プレドニゾロン 0 mg 日 内服 開始 プレドニゾロン 0 mg 日 減量 する た,0,0.9845524323320487,0.015447567667951294,0,8.194646544190532e-05,0.9999180535345581,0,0.9332372616980555,0.06676273830194449,1,0.2054669444476276,0.7945330555523724,0,0.9276258945465088,0.07244415581226349,0,0.817107617855072,0.1799972504377365,1,0.8505560970444881,0.1494439029555119,0
170,死亡時画像診断が行われたかどうか、および死亡時画像診断結果の有無は不明であった。,死亡 時 画像 診断 行う れる た およぶ 死亡 時 画像 診断 結果 有無 不明 だ ある た,1,0.21637246202821583,0.7836275379717844,1,0.0002099263891192203,0.9997900736108808,1,0.07188752790557307,0.9281124720944269,1,0.4611841694500828,0.5388158305499172,0,0.8912168741226196,0.17861483991146088,0,0.7938661575317383,0.18983004987239838,1,0.2343241155673478,0.7656758844326523,0
171,プレドニゾロン5mgを含む新たな薬剤/その他の治療/処置を開始する必要があった。,プレドニゾロン 0m g 含む 新た だ 薬剤 その他 治療 処置 開始 する 必要 ある た,0,0.9845785837951536,0.015421416204846378,0,8.979652523449799e-05,0.9999102034747654,1,0.4882539075048328,0.5117460924951672,0,0.6635950610967385,0.3364049389032615,0,0.926846444606781,0.1114267036318779,1,0.5175665616989136,0.6028212308883667,1,0.7316872262057272,0.2683127737942728,0
172,入院3日目には、心筋逸脱酵素はpeak outし、1週間の安静後に退院となった。,入院 0 日 目 心筋逸脱酵素 peak out する 0 週間 安静 後 退院 なる た,0,0.9845720532478276,0.015427946752172421,0,0.00010935667433918062,0.9998906433256608,0,0.7947319855646695,0.20526801443533052,1,0.49364338755150305,0.506356612448497,0,0.8702074289321899,0.19758333265781403,0,0.8037458658218384,0.18427520990371704,1,0.8627366705587307,0.13726332944126926,0
173,患者は軽度の認知症、慢性心不全の基礎疾患を有するが、症状は安定した状態であった。,患者 軽度 認知症 慢性心不全 の 基礎疾患 有する 症状 安定 する た 状態 だ ある た,1,0.44733471217702614,0.5526652878229737,0,0.00015941163509914185,0.9998405883649009,1,0.09807150630236272,0.9019284936976373,1,0.46547981115768644,0.5345201888423136,0,0.7761450409889221,0.2796637713909149,0,0.7974730730056763,0.197697713971138,1,0.29283545969533237,0.7071645403046676,0
174,Interferon gamma release assay: negative,Interferon gamma release assay negative,0,0.9803944042962197,0.019605595703780256,0,9.257617430023098e-05,0.9999074238256997,1,0.4563792597309324,0.5436207402690676,0,1.0,4.269635874741179e-28,0,0.858494758605957,0.20047950744628906,1,0.39771580696105957,0.7395210862159729,1,0.7667307717115474,0.2332692282884527,0
175,2022/02/13(3回目ワクチン接種後、日付不明)、症状悪化なく回復した。,0 0 0 0回目 ワクチン接種 後 日付 不明 症状悪化 ない 回復 する た,0,0.9976497293546899,0.002350270645310045,0,6.797358060966855e-05,0.9999320264193904,0,0.9472802368410447,0.052719763158955345,0,0.759430023443714,0.240569976556286,0,0.9342626333236694,0.06086011603474617,0,0.8345217108726501,0.16094188392162323,0,0.9505386971688153,0.049461302831184516,0
176,2022/03/04心臓超音波検査では、左室駆出率58%であり、異常所見なし。,0 0 0 心臓 超音波 検査 左 室 駆け出し 率 0% だ ある 異常所見なし,0,0.984564147299108,0.015435852700892013,0,0.00011749165977323715,0.9998825083402267,0,0.6735673084391418,0.3264326915608582,0,0.9967529789352835,0.0032470210647165616,0,0.9002043008804321,0.11800190061330795,0,0.8055525422096252,0.2302326112985611,0,0.9350830254526857,0.06491697454731425,0
177,3ヶ所の病院に受診できるか問い合わせたが、コロナ蔓延を理由に断られたとのこと。,0 ヶ所 病院 受診 できる 問い合わせる た コロナ 蔓延 理由 断る れる た こと,0,0.9845721272866678,0.01542787271333232,0,0.00012316566416097392,0.9998768343358391,1,0.23703458259408494,0.7629654174059151,0,0.9999999141831413,8.581685877400818e-08,0,0.8561242818832397,0.21306367218494415,0,0.7438040971755981,0.27672094106674194,1,0.8254335576743571,0.17456644232564278,0
178,3週間後のCAGでは一部の冠動脈は修復傾向にありステロイドの効果が認められた。,0 週間 後 CAG 一部 冠動脈 修復 傾向 ある ステロイド 効果 認める られる た,0,0.9659207819709106,0.03407921802908943,0,0.00013533378489853786,0.9998646662151015,1,0.30686917236469424,0.6931308276353058,1,0.08992669881985305,0.910073301180147,0,0.8699485063552856,0.17774228751659393,0,0.7678639888763428,0.27098485827445984,1,0.47871021111871565,0.5212897888812844,0
179,prednisoloneによる治療開始から2日後、心電図所見はほぼ正常化した。,prednisolone 治療 開始 0 日 後 心電図 所見 正常 化 する た,0,0.9845726221648515,0.015427377835148493,0,7.085327408228352e-05,0.9999291467259177,0,0.9965094087995965,0.003490591200403473,0,0.6916981408440538,0.3083018591559462,0,0.940128743648529,0.06615622341632843,0,0.8301473259925842,0.16736432909965515,0,0.9469724076287508,0.05302759237124916,0
180,イカチバント酢酸塩(Icatibant)(皮下)について取られた処置は、なし。,イカチバント 酢酸塩 Icatibant 皮下 取る れる た 処置 ない,0,0.9890876591815456,0.010912340818454295,0,8.368844264648684e-05,0.9999163115573535,0,0.8758037892736436,0.12419621072635648,0,0.9689575101806667,0.031042489819333347,0,0.9440263509750366,0.09843040257692337,0,0.8321022987365723,0.19587856531143188,0,0.9588963071811527,0.04110369281884732,0
181,ステロイドパルスを3回施行し、血尿、蛋白尿、尿中NAG、血清Creは改善した。,ステロイド パルス 0回 施行 する 血尿 蛋白尿 尿 中 NAG 血清 Cre 改善 する た,0,0.9936328952595922,0.0063671047404076685,0,7.376934842183346e-05,0.9999262306515782,0,0.9899656457044307,0.010034354295569273,0,0.828509512431458,0.171490487568542,0,0.9106032252311707,0.12159709632396698,0,0.7542016506195068,0.24666962027549744,0,0.948870068451074,0.05112993154892589,0
182,患者に甲状腺疾患、低カリウム血症及び周期性四肢麻痺の家族歴又は病歴はなかった。,患者 甲状腺疾患 低カリウム血症 周期性四肢麻痺 家族 歴 病歴 ない た,0,0.9845681163428776,0.015431883657122317,0,8.57843650844618e-05,0.9999142156349156,0,0.9317477421091691,0.06825225789083086,0,0.9705635194215745,0.029436480578425562,0,0.8928638100624084,0.12867651879787445,0,0.8204895257949829,0.1645003855228424,0,0.9606119007187444,0.03938809928125567,0
183,経口摂取のリハビリテーション後、患者はリハビリテーション病院回復に退院した)。,経口摂取 リハビリテーション 後 患者 リハビリテーション 病院 回復 退院 する た,0,0.9985133866715844,0.0014866133284155028,0,5.64142170249955e-05,0.999943585782975,0,0.9731056195494223,0.026894380450577696,1,0.3653276709804367,0.6346723290195633,0,0.940879225730896,0.06676450371742249,0,0.8108409643173218,0.18794849514961243,1,0.8976161345891153,0.10238386541088468,0
184,血行動態は保たれていたため、消炎鎮痛剤投与下に、慎重に経過観察することとした。,血行動態 保つ れる いる た ため 消炎鎮痛剤 投与 下 慎重 経過 観察 する こと する た,0,0.9845573347852031,0.015442665214796836,0,0.00010706417247089929,0.9998929358275291,0,0.6243050528476706,0.3756949471523295,1,0.38696157564271005,0.61303842435729,0,0.9268043637275696,0.10740126669406891,0,0.7939620614051819,0.21466311812400818,1,0.8006822824685919,0.19931771753140806,0
185,入院1カ月前に、ポジトロン放出断層撮影で腫瘍の転移又は再発は認められなかった。,入院 0 カ月 前 ポジトロン 放出 断層 撮影 だ 腫瘍 の 転移 再発 認める られる ない た,1,0.13706907436626345,0.8629309256337366,0,0.0001439323752457657,0.9998560676247542,1,0.1573475961007207,0.8426524038992793,0,0.7918762334082919,0.20812376659170806,0,0.943806529045105,0.0632644072175026,0,0.8242661952972412,0.16862459480762482,1,0.42777311739009094,0.5722268826099091,0
186,2022/01/17、COVIDー19抗原検査は実施され、結果は陰性であった。,0 0 0 COVID ー 0 抗原検査 実施 する れる 結果 陰性 だ ある た,0,0.9882682203229004,0.011731779677099744,0,9.949515871472818e-05,0.9999005048412852,0,0.9744835735389181,0.025516426461081886,0,0.8364422689588338,0.1635577310411662,0,0.9282413721084595,0.06640751659870148,0,0.8134077191352844,0.17967112362384796,0,0.9566511060899411,0.04334889391005888,0
187,初回ワクチン接種に関する報告:被験者は、合併症、アレルギー、治療薬はなかった。,初回 ワクチン接種 報告 被験者 合併症 アレルギー 治療薬 ない た,0,0.9907526118051744,0.009247388194825654,0,6.087659631883389e-05,0.9999391234036812,0,0.9840699862117276,0.015930013788272367,0,0.9873128164745135,0.012687183525486475,0,0.9541859030723572,0.05297398567199707,0,0.8305802345275879,0.14437684416770935,0,0.9710218786181266,0.028978121381873417,0
188,患者は、特定の製品に対するアレルギーの既往歴やアレルギーを示す症状はなかった。,患者 特定 製品 アレルギー 既往 歴 アレルギー 示す 症状 ない た,0,0.9845836145901017,0.015416385409898314,0,8.874415540611975e-05,0.9999112558445938,0,0.8729256190659631,0.12707438093403683,0,0.9244960472791209,0.07550395272087902,0,0.94246506690979,0.06161851808428764,0,0.8307167887687683,0.15017013251781464,0,0.9579356999391028,0.04206430006089709,0
189,事象は未回復で、ヒジファーゲン配合静注投与1管/日を4日間継続の治療を行った。,事象 回復 だ ヒジファーゲン 配合 静 投与 0 管 日 0 日間 継続 治療 行う た,0,0.9709118042155052,0.02908819578449481,0,7.343267521887578e-05,0.9999265673247811,0,0.9369346514049016,0.06306534859509838,1,0.2901959622635698,0.7098040377364302,0,0.9417567849159241,0.06514258682727814,0,0.8244679570198059,0.1646903157234192,1,0.8735395218744747,0.12646047812552522,0
190,心筋炎ウイルス検出のための生検組織のポリメラーゼ連鎖反応は陰性と報告された。,心筋炎 ウイルス検出 ため 生検 組織 ポリメラーゼ連鎖反応 陰性 報告 する れる た,0,0.9845671291181005,0.015432870881899508,0,0.00011002678119713054,0.9998899732188029,0,0.7941406467749357,0.20585935322506438,1,0.2578395168304841,0.7421604831695159,0,0.8796422481536865,0.1528043895959854,0,0.7796547412872314,0.20072723925113678,1,0.7988432035102233,0.20115679648977672,0
191,2022/05/20顔は少し動くようになり、眼がシャンプーでしみなくなった。,0 0 0 顔 動く よう なる 眼 シャンプー だ しみ なくなる た,0,0.9845683893128698,0.01543161068713027,0,0.00014097458633745435,0.9998590254136626,1,0.31044122463823454,0.6895587753617655,0,0.9469626067524309,0.053037393247569106,1,0.4807390570640564,0.6002269387245178,1,0.2238323986530304,0.8545570373535156,1,0.4338927584394415,0.5661072415605585,0
192,陰性(陰性)、血清CRPが陰性化したため、副腎皮質ステロイド療法を漸減した。,陰性 陰性 血清 CRP 陰性化 する た ため 腎皮質 ステロイド 療法 漸減 する た,0,0.9918626693961039,0.008137330603896112,0,4.7594264270139286e-05,0.9999524057357299,0,0.9565259251224256,0.04347407487757439,0,0.9409690221677335,0.05903097783226647,0,0.9415140748023987,0.062398314476013184,0,0.8102234601974487,0.18938840925693512,0,0.9636929655064135,0.03630703449358645,0
193,寛解し安定しているが、慢性炎症性脱髄性多発ニューロパチーで通院中の被接種者。,寛解 する 安定 する いる 慢性炎症性 脱髄性 多発ニューロパチー 通院 中 接種 者,0,0.9845715730367044,0.015428426963295595,0,6.946268167879117e-05,0.9999305373183212,0,0.5691477551551732,0.43085224484482676,0,0.9999993772413747,6.227586253386938e-07,1,0.4852365255355835,0.7134994268417358,0,0.6945309638977051,0.3778252601623535,1,0.76781585351595,0.23218414648405003,0
194,血液検査、髄液顕微鏡検査、培養などから神経梅毒、結核、真菌感染症はなかった。,血液検査 髄液 顕微鏡 検査 培養 神経梅毒 結核 真菌 感染症 ない た,0,0.9845765167687364,0.0154234832312638,0,8.599435648322277e-05,0.9999140056435167,0,0.8578238020293806,0.14217619797061942,0,0.8654928439423707,0.1345071560576293,0,0.9396591782569885,0.053902462124824524,0,0.8352411985397339,0.15814264118671417,0,0.9516077657510761,0.04839223424892402,0
195,接種3週間前のMRIにて頭蓋内出血はなく、明らかな合併症も認められなかった。,接種 0 週間 前 MRI 頭蓋内出血 ない 明らか だ 合併症 認める られる ない た,0,0.8884429388044996,0.11155706119550024,0,5.6240762944816736e-05,0.9999437592370551,0,0.9937370589280091,0.0062629410719909,0,0.9968339549703751,0.0031660450296248847,0,0.9411197900772095,0.06250988692045212,0,0.8275274038314819,0.1522323191165924,0,0.9648397341430577,0.03516026585694233,0
196,挿管直前に施行できた塩酸エドロホニウム試験では著明な呼吸状態の改善を認めた。,挿管 直前 施行 できる た 塩酸 エドロホニウム 試験 著い 明 だ 呼吸 状態 改善 認める た,0,0.9845626824808528,0.01543731751914732,0,9.639160043954737e-05,0.9999036083995605,0,0.5154908546600354,0.48450914533996464,1,0.09354884044453948,0.9064511595554605,0,0.8946484923362732,0.11727917939424515,0,0.7900327444076538,0.23696547746658325,1,0.6266411714105055,0.37335882858949454,0
197,(日付不明)徐々に改善、注釈:徐々に改善し、4日目にはST低下はなくなった。,日付 不明 徐々 改善 注釈 徐々 改善 する 0 日 目 ST 低下 なくなる た,0,0.9838716802097153,0.016128319790284736,0,7.008232823627307e-05,0.9999299176717638,0,0.8689233389861017,0.1310766610138983,0,0.844969767128362,0.155030232871638,0,0.9307821393013,0.07094256579875946,0,0.7733616828918457,0.22195330262184143,0,0.9430485003547576,0.05695149964524239,0
198,2021/10/29から、心電図検査が実施され、結果は異常所見なしであった。,0 0 0 心電図 検査 実施 する れる 結果 異常所見なし だ ある た,0,0.9845651269680195,0.015434873031980509,0,6.65835228729429e-05,0.9999334164771271,0,0.9285399948320272,0.07146000516797282,0,0.9000335390097344,0.09996646099026563,0,0.9372485876083374,0.05640696361660957,0,0.8120163679122925,0.17436975240707397,0,0.9587072462608237,0.0412927537391763,0
199,ワクチン接種前の状態は良好であり、COVID-19感染を疑う症状はなかった。,ワクチン接種 前 状態 良好 だ ある COVID 0 感染 疑う症状 ない た,0,0.9875956500439258,0.012404349956074156,0,6.715463387404546e-05,0.9999328453661259,0,0.9769187455115123,0.023081254488487732,0,0.9469208703038333,0.05307912969616669,0,0.9365866780281067,0.061642955988645554,0,0.8428617119789124,0.15583887696266174,0,0.967231538639754,0.03276846136024596,0
200,被験者は酸素吸入(高流量式やECMOを含む)や人工呼吸器は必要としなかった。,被験者 酸素吸入 流量 式 ECMO 含む 人工呼吸器 必要 する ない た,0,0.9897098416210611,0.010290158378938923,0,7.561832074701843e-05,0.999924381679253,0,0.8960011840169555,0.10399881598304445,0,0.9776394710425999,0.02236052895740015,0,0.957545816898346,0.05461600050330162,0,0.8274899125099182,0.1447579264640808,0,0.9648556294318619,0.03514437056813815,0
201,被験者は有害事象のために追加治療(薬理学のまたは非薬理学の)を受けなかった。,被験者 有害事象 ため 追加 治療 薬理学 薬理学 受ける ない た,0,0.9973725856148541,0.0026274143851458026,0,8.503237649559151e-05,0.9999149676235044,0,0.788157760958663,0.211842239041337,0,0.9285843141327663,0.07141568586723371,0,0.9586833715438843,0.05537725239992142,0,0.8256533145904541,0.1480952948331833,0,0.9529908717872843,0.04700912821271562,0
202,ロセフィン(セフトリアキソンナトリウム水和物)1gの抗生物質の点滴を受けた。,ロセフィン セフトリアキソン ナトリウム 水和物 0g 抗生物質 点滴 受ける た,0,0.7419133336707812,0.25808666632921906,0,0.00012796011519894578,0.999872039884801,0,0.5861886354114016,0.4138113645885984,0,0.7414057977169857,0.2585942022830143,0,0.9177706241607666,0.1057608500123024,0,0.7663261890411377,0.27130958437919617,0,0.8094280128318234,0.19057198716817653,0
203,患者は気分が良くなり、非常に低用量(50 mg)のクロザピンで幻覚が回復した,患者 気分 良い なる 非常 用量 0 mg クロザピン だ 幻覚 回復 する た,0,0.9845713155028907,0.015428684497109407,0,6.704984019747284e-05,0.9999329501598025,0,0.851750487896052,0.148249512103948,1,0.3117306811870276,0.6882693188129724,0,0.938321053981781,0.0954473614692688,0,0.8065586090087891,0.17174382507801056,1,0.8549454200051558,0.1450545799948441,0
204,2022/07/04(ワクチン接種後17日目)、事象は軽快し、ほぼ下熱した。,0 0 0 ワクチン接種 後 0 日 目 事象 軽快 する 下熱 する た,0,0.9845838726571223,0.015416127342877643,0,9.517892041381415e-05,0.9999048210795862,0,0.8202700344758997,0.17972996552410025,0,0.570385386678506,0.42961461332149403,0,0.9104378819465637,0.1030123308300972,0,0.7973928451538086,0.16662472486495972,0,0.8992449023190328,0.10075509768096728,0
205,11:00経過観察を行い、症状が完全に消失し、回復したことを確認して帰宅。,0 0 経過 観察 行う 症状 完全 消失 する 回復 する た こと 確認 する 帰宅,0,0.9976136362015149,0.0023863637984851706,0,5.0266634100709145e-05,0.9999497333658993,0,0.9769418035333844,0.023058196466615513,0,0.9954702910370459,0.004529708962954141,0,0.9337266087532043,0.07642245292663574,0,0.8049867749214172,0.1714526116847992,0,0.9686591462567723,0.03134085374322769,0
206,2021/12/08加療を継続したが、呼吸状態の改善なく、気管切開を施行。,0 0 0 加療 継続 する た 呼吸 状態 改善 ない 気管切開 施行,0,0.9976080890459422,0.0023919109540576637,0,6.699331861798658e-05,0.999933006681382,0,0.9843827914752248,0.015617208524775252,0,0.9998717205897567,0.00012827941024330257,0,0.9394757151603699,0.0655931755900383,1,0.47428786754608154,0.5511360764503479,1,0.9405256346506331,0.05947436534936677,0
207,2021年10月4日神経内科整形外科にて精査するも特別異常は見当たらない。,0 年 0 月 0 日 神経内科 整形外科 精査 する 特別 異常 見当たる ない,0,0.9845845439307375,0.015415456069262486,0,0.00011056091562976003,0.9998894390843702,0,0.7236613196811499,0.27633868031885006,0,0.6301368707507342,0.3698631292492658,0,0.8807151913642883,0.20321880280971527,0,0.7901548743247986,0.16577130556106567,0,0.8785602835870184,0.12143971641298162,0
208,カロナール、メリスロン、アデホス、ラックビー、補中益気湯を処方され、内服。,カロナール メリスロン アデホス ラックビー 補中益気湯 処方 する れる 内服,0,0.9845659636606306,0.015434036339369399,0,9.283762161779687e-05,0.9999071623783822,0,0.647399553501461,0.35260044649853906,0,0.980937124722756,0.01906287527724405,0,0.8689141273498535,0.1986222118139267,0,0.716744601726532,0.3305791914463043,0,0.9074129440531267,0.09258705594687341,0
209,"甲状腺機能も1ヶ月後には正常化した.その後,甲状腺炎の再発は懃めていない。",甲状腺機能 0 ヶ月 後 正常 化 する た その後 甲状腺炎 再発 懃 馬手 いない,0,0.98457525191158,0.015424748088419947,0,9.305368799944667e-05,0.9999069463120005,0,0.7194449610185742,0.2805550389814258,0,0.9994994103306758,0.0005005896693241821,0,0.891595184803009,0.1984553337097168,1,0.2801074683666229,0.7791576385498047,1,0.8322020991462791,0.16779790085372084,0
210,酸素投与に加え、メチルプレドニゾロン、ヘパリン、セフトリアキソン投与開始。,酸素 投与 加える メチルプレドニゾロン ヘパリン セフトリアキソン 投与 開始,0,0.9845804391377876,0.015419560862212267,0,8.57076044464556e-05,0.9999142923955535,0,0.949353495776695,0.050646504223304994,0,0.9660265540102113,0.033973445989788645,0,0.9081689715385437,0.11218921095132828,0,0.6664438247680664,0.4073449671268463,0,0.9455853642342026,0.054414635765797366,0
211,心室壁厚正常、心室の大きさ正常、収縮機能正常及び心嚢液貯留量正常を認めた。,心室 壁 厚い 正常 心室 大きい さ 正常 収縮 機能正常 心嚢液 貯留 量 正常 認める た,0,0.9845695105085209,0.015430489491479047,0,8.991253033517247e-05,0.9999100874696648,0,0.6942342732241154,0.3057657267758847,1,0.1009952588679256,0.8990047411320744,0,0.8501833081245422,0.1630915105342865,1,0.29712367057800293,0.82036292552948,1,0.43134405376020907,0.568655946239791,0
212,退院前の心エコーでわずかに残存しており、循環器外来でフォロー予定とされた。,退院前 心 エコー 残存 する おる 循環器外来 フォロー 予定 する れる た,0,0.9845910033822374,0.01540899661776273,0,9.12901153535724e-05,0.9999087098846464,0,0.5883198617940923,0.4116801382059077,1,0.25048000784414404,0.749519992155856,0,0.9405235052108765,0.08265478163957596,0,0.7694317698478699,0.2593194246292114,1,0.7339868550352905,0.2660131449647095,0
213,日付不明術後、新たな神経症状の悪化はないが、左不全麻痺及び空間無視が残存。,日付 不明 術後 新た だ 神経症状 の 悪化 ない 左不全麻痺 空間 無視 残存,0,0.984563106836196,0.015436893163804125,0,8.408829463930567e-05,0.9999159117053606,0,0.5093675440559795,0.49063245594402055,0,0.999998800850748,1.1991492519864085e-06,0,0.8744759559631348,0.181998610496521,0,0.5594696402549744,0.49555402994155884,0,0.8512476223528821,0.14875237764711788,0
214,腹部超音波検査では、腎臓の大きさは正常で、尿路閉塞の所見は見られなかった。,腹部超音波 検査 腎臓 大きい さ 正常 だ 尿路閉塞 所見 見る られる ない た,0,0.9727283468772209,0.027271653122779172,0,8.268549643942299e-05,0.9999173145035606,0,0.8684233322486312,0.13157666775136884,0,0.9119381555566158,0.08806184444338414,0,0.943108856678009,0.06135433539748192,0,0.8262738585472107,0.1624942421913147,0,0.9548635866938141,0.0451364133061858,0
215,入院、酸素投与、ICUでの投与、人工呼吸器使用、ECMO使用はしなかった。,入院 酸素 投与 ICU 投与 人工呼吸器 使用 ECMO 使用 する ない た,0,0.9958021318885409,0.0041978681114589285,0,7.614879657179487e-05,0.9999238512034282,0,0.9315739417923533,0.06842605820764669,0,0.9858047514390871,0.014195248560912872,0,0.9474591612815857,0.05477743223309517,0,0.8255539536476135,0.1478142887353897,0,0.9676086197641768,0.0323913802358233,0
216,有害事象が確認されなかったため、根本原因またはCAPAも特定されなかった。,有害事象 確認 する れる ない た ため 根本 原因 CAPA 特定 する れる ない た,0,0.9915052770881015,0.008494722911898402,0,6.507542156968984e-05,0.9999349245784304,0,0.9825222578397758,0.01747774216022427,0,0.9989859631788948,0.001014036821105259,0,0.9566587805747986,0.061426792293787,0,0.8204651474952698,0.1448262631893158,0,0.9711684040541989,0.02883159594580113,0
217,2022/05/06、MRI(磁気共鳴画像法)を受け、結果は正常であった。,0 0 0 MRI 磁気 共鳴 画像 法 受ける 結果 正常 だ ある た,0,0.995055517649927,0.004944482350073135,0,7.441727428077419e-05,0.9999255827257192,0,0.9479272187133368,0.0520727812866631,0,0.8267767956820182,0.1732232043179818,0,0.9345483779907227,0.06281433999538422,0,0.7863065004348755,0.22303684055805206,0,0.9514166681081516,0.048583331891848394,0
218,2022/07/13から、経鼻カニューラに変更し、デキサメタゾン終了した。,0 0 0 経 鼻 カニューラ 変更 デキサメタゾン 終了 する た,0,0.9656996440891162,0.03430035591088374,0,8.46297881427637e-05,0.9999153702118573,1,0.3533345469092234,0.6466654530907766,0,0.5268353562809975,0.4731646437190025,0,0.9478487968444824,0.07558471709489822,0,0.8014959692955017,0.19398009777069092,1,0.7634500492763584,0.23654995072364154,0
219,2022/07/14から、リクシアナ投与し、ヘパリンによる治療を終了した。,0 0 0 リクシアナ 投与 する ヘパリン 治療 終了 する た,0,0.997104520544202,0.0028954794557979383,0,6.281873729019013e-05,0.9999371812627098,0,0.9622334190415921,0.03776658095840786,0,0.9830977558033884,0.01690224419661152,0,0.9405618906021118,0.06726612150669098,0,0.8253222703933716,0.1700560301542282,0,0.9681256119247386,0.031874388075261516,0
220,保存サンプルの確認:参考品で確認する項目がなかったため、該当無しであった。,保存 サンプル 確認 参考 品 確認 する 項目 ない た ため 該当 無い だ ある た,0,0.9311109783392764,0.06888902166072362,0,9.648940641937887e-05,0.9999035105935806,1,0.400724666477978,0.599275333522022,1,0.49096690219665795,0.509033097803342,0,0.9487292170524597,0.07713663578033447,0,0.8281987309455872,0.15812422335147858,1,0.766287403918446,0.23371259608155395,0
221,スピロノラクトン錠25mg、ラシックス、リピディル錠80mgは休止された。,スピロノラクトン 錠 0m g ラシックス リピディル 錠 0m g 休止 する れる た,1,0.43615049954064306,0.563849500459357,0,0.00013439445885699407,0.999865605541143,1,0.44628298360787977,0.5537170163921202,1,0.17655812290917383,0.8234418770908262,0,0.9186811447143555,0.07784131914377213,0,0.8230372667312622,0.21540415287017822,1,0.39334454936798835,0.6066554506320115,0
222,患者は、事象の報告前に他の疾患に対して最近ワクチン接種は受けていなかった。,患者 事象 報告 前 他 疾患 最近 ワクチン接種 受ける いる ない た,0,0.9979199388509296,0.002080061149070471,0,5.026869389571227e-05,0.9999497313061043,0,0.9927455082375829,0.007254491762417157,0,0.9907671130711573,0.009232886928842771,0,0.9509376287460327,0.05140865221619606,0,0.8183083534240723,0.14905837178230286,0,0.9715776287314827,0.02842237126851725,0
223,報告者(医師)の意見は次の通り:血栓症のリスクとなる既往や内服はなかった。,報告 者 医師 意見 次 通り 血栓症 リスク なる 既往 内服 ない た,0,0.8830949886959273,0.11690501130407267,0,8.277477821048679e-05,0.9999172252217895,0,0.825219713062502,0.17478028693749806,0,0.8958767102232061,0.10412328977679391,0,0.9336491823196411,0.07329758256673813,0,0.8326426148414612,0.14906193315982819,0,0.9400532951117583,0.05994670488824175,0
224,追記にて、患者は他複数の医療機関を受診しており、内服薬の処方を受けていた。,追記 患者 複数 医療機関 受診 する おる 内服薬 処方 受ける いる た,0,0.8792998272936868,0.12070017270631332,0,0.0001271275381104232,0.9998728724618896,1,0.39774944781350463,0.6022505521864954,0,0.8070469156018168,0.19295308439818315,1,0.17035609483718872,0.8681325912475586,0,0.7281480431556702,0.3887999653816223,1,0.4526468954672921,0.547353104532708,0
225,2022/04/14処方薬をlongに増量し、躁症状は速やかに改善した。,0 0 0 処方 薬 long 増量 する 躁症状 速やか 改善 する た,0,0.9964337929338994,0.0035662070661006597,0,8.144110455834833e-05,0.9999185588954417,0,0.9816040733925342,0.018395926607465807,0,0.808008584742866,0.191991415257134,0,0.9333782196044922,0.07623808830976486,0,0.7856432199478149,0.22924579679965973,0,0.9519281749966254,0.0480718250033746,0
226,2022/06/14、臨床検査結果は改善傾向を認め、輸液投与は終了した。,0 0 0 臨床検査 結果 改善 傾向 認める 輸液 投与 終了 する た,0,0.9905478423334315,0.00945215766656846,0,5.678174027829647e-05,0.9999432182597217,0,0.9806775139207823,0.01932248607921771,0,0.6982701144631156,0.30172988553688435,0,0.9447096586227417,0.06893384456634521,0,0.8073440194129944,0.18120917677879333,0,0.944852382485013,0.05514761751498697,0
227,アンビューバッグ人工呼吸、心臓マッサージ続け、ボスミン1/2A筋肉注射。,アンビューバッグ 人工呼吸 心臓マッサージ 続ける ボス ミン 0 0 A 筋肉 注射,0,0.964353699560469,0.03564630043953101,0,0.00010953787121215106,0.9998904621287878,1,0.4563792597309324,0.5436207402690676,0,0.9999720432511267,2.7956748873400782e-05,0,0.8534022569656372,0.22950807213783264,0,0.6890564560890198,0.25406548380851746,1,0.8699497161500659,0.13005028384993414,0
228,疾患は単相パターンであり、症状のナディアから最低3か月以内の再発がない。,疾患 単相 パターン だ ある 症状 NADIA 最低 0 か月 以内 再発 ない,0,0.988705955469375,0.011294044530624955,0,7.522066474260104e-05,0.9999247793352574,0,0.6653475009703959,0.33465249902960414,0,0.8928409565496401,0.10715904345035984,0,0.9301962852478027,0.12849344313144684,0,0.8120042681694031,0.16274918615818024,0,0.9272299545770736,0.07277004542292644,0
229,術後MRIにて内部トラッピング術の明らかな合併症及び異常は認めなかった。,術後 MRI 内部 トラッピング 術 明らか だ 合併症 異常 認める ない た,0,0.9849426556905967,0.015057344309403246,0,7.92624698345084e-05,0.9999207375301655,0,0.7761796978394073,0.22382030216059273,0,0.9559405737037001,0.044059426296299865,0,0.9462968111038208,0.05201162397861481,0,0.8122736215591431,0.16660888493061066,0,0.9513964511106751,0.04860354888932498,0
230,内部トラッピング後の左右VA血管造影術では解離性病変は描出されなかった。,内部 トラッピング 後 左右 VA 血管造影 術 解離 性病変 描出 する れる ない た,0,0.9853393768180342,0.014660623181965877,0,8.22238971746756e-05,0.9999177761028253,0,0.8301175218216562,0.16988247817834376,0,0.9033338476465267,0.09666615235347327,0,0.940092921257019,0.06934355199337006,0,0.8136765956878662,0.18454541265964508,0,0.949675413086432,0.05032458691356789,0
231,両側耳内、外耳道、鼓膜に明らかな異常所見はなく、頭位眼振も認めなかった。,両側 耳 内 外耳道 鼓膜 明らか だ 異常所見 ない 頭位眼振 認める ない た,0,0.9845816430530907,0.015418356946909333,0,9.539629371544832e-05,0.9999046037062845,0,0.9567678058427784,0.04323219415722157,0,0.9812313015751638,0.01876869842483618,0,0.9054951667785645,0.17102652788162231,0,0.7975150942802429,0.17355160415172577,0,0.9609764436117495,0.03902355638825051,0
232,COVIDー19病原体(SAR S-CoV-2)検査は実施されなかった。,COVID ー 0 病原体 SAR S CoV 0 検査 実施 する れる ない た,0,0.9998667092582327,0.0001332907417672007,0,6.237133582141808e-05,0.9999376286641786,0,0.9721905766516865,0.027809423348313517,0,0.9974592018065649,0.0025407981934351368,0,0.9550119042396545,0.06706707179546356,0,0.81304532289505,0.14599297940731049,0,0.9705209999649255,0.029479000035074657,0
233,酸素吸入(高流量又はECMOを含む)または人工呼吸器は必要としなかった。,酸素吸入 流量 ECMO 含む 人工呼吸器 必要 する ない た,0,0.9978157692792003,0.002184230720799561,0,7.17282888472856e-05,0.9999282717111527,0,0.928686000798546,0.07131399920145401,0,0.9905747493644901,0.009425250635509877,0,0.9528987407684326,0.05164290964603424,0,0.8228421807289124,0.14403992891311646,0,0.9681501519101702,0.03184984808982979,0
234,検査(血液/生化学検査、感染症関連検査、画像検査等)は実施されなかった。,検査 血液 生化学 検査 感染症関連 検査 画像 検査 等 実施 する れる ない た,0,0.999640715699065,0.0003592843009350687,0,6.35947106328557e-05,0.9999364052893671,0,0.9630933854837598,0.03690661451624022,0,0.9074388342482383,0.09256116575176164,0,0.9512190818786621,0.05909828841686249,0,0.8264726996421814,0.14314594864845276,0,0.9649709609758472,0.03502903902415282,0
235,患者は、薬物、食物、他の製品に対するアレルギーおよび基礎疾患はなかった。,患者 薬物 食物 他 製品 アレルギー 基礎疾患 ない た,0,0.9850483099422447,0.01495169005775541,0,6.213180502242417e-05,0.9999378681949775,0,0.974539195961596,0.025460804038404047,0,0.984515192678903,0.015484807321097008,0,0.9453158378601074,0.053587764501571655,0,0.838290274143219,0.1518941968679428,0,0.9697180581548426,0.03028194184515752,0
236,2021/09/25、血液検査、臨床化学検査と炎症マーカーは実施された。,0 0 0 血液検査 臨床 化学 検査 炎症 マーカー 実施 する れる た,0,0.9845761037559702,0.015423896244029865,0,0.00010598720201908935,0.999894012797981,0,0.8603861768270731,0.13961382317292695,1,0.2938301776356179,0.7061698223643821,0,0.8740653395652771,0.1604422926902771,0,0.7948271632194519,0.21586903929710388,1,0.8278374972630367,0.17216250273696326,0
237,SARS-CoV-2検査等により、COVID-19の可能性は否定された。,SARS CoV 0 検査 等 COVID 0 可能性 否定 する れる た,0,0.9857514720083344,0.01424852799166561,0,8.690408098223121e-05,0.9999130959190178,0,0.8693915032912908,0.13060849670870925,1,0.4133938988327802,0.5866061011672198,0,0.9409408569335938,0.06592003256082535,0,0.8128132820129395,0.17451390624046326,1,0.8860049747929396,0.11399502520706037,0
238,ワクチン接種以降、患者はCOVID-19について検査を受けていなかった。,ワクチン接種 以降 患者 COVID 0 検査 受ける いる ない た,0,0.9997560766808316,0.00024392331916855273,0,6.193561241214657e-05,0.9999380643875878,0,0.9949987144963258,0.005001285503674186,0,0.9990211241583978,0.0009788758416021857,0,0.9529900550842285,0.05585739389061928,0,0.8347166776657104,0.14804142713546753,0,0.9726546772296731,0.027345322770326905,0
239,心筋炎調査票の経過は、以下の通り:病理組織学的検査は、実施されなかった。,心筋炎 調査 票 経過 以下 通り 病理 組織 学 的 検査 実施 する れる ない た,0,0.9916977764701106,0.008302223529889298,0,6.376135534144605e-05,0.9999362386446585,0,0.9627300306549135,0.037269969345086515,0,0.9613771783602683,0.03862282163973175,0,0.9578475952148438,0.05655159056186676,0,0.8335195779800415,0.1431162804365158,0,0.9684290184261526,0.03157098157384733,0
240,2022/07/19(ワクチン接種10日後)、事象の転帰は軽快であった。,0 0 0 ワクチン接種 0 日 後 事象 転帰 軽快 だ ある た,0,0.9909090920545854,0.00909090794541466,0,0.00010164892322718476,0.9998983510767728,0,0.984960627217017,0.015039372782982981,0,0.9071886797743213,0.09281132022567869,0,0.9436327219009399,0.07398204505443573,0,0.8152997493743896,0.15283355116844177,0,0.9643751507003696,0.03562484929963043,0
241,COVID-19病原体(SARS-CoV-2)検査は、実施されなかった。,COVID 0 病原体 SARS CoV 0 検査 実施 する れる ない た,0,0.9999391315342866,6.086846571342738e-05,0,5.345197145450253e-05,0.9999465480285455,0,0.9876968616885643,0.01230313831143566,0,0.9985135253882867,0.0014864746117133033,0,0.9549412727355957,0.06135265529155731,0,0.820534348487854,0.14681673049926758,0,0.9717968245073023,0.028203175492697657,0
242,各肝炎ウイルス、EBV、サイトメガロウイルス、各自己抗体は陰性であった。,肝炎 ウイルス EBV サイトメガロウイルス 自己抗体 陰性 だ ある た,0,0.9931864039035909,0.006813596096409028,0,6.317904142255657e-05,0.9999368209585774,0,0.9814137205752579,0.01858627942474215,0,0.7861394292322261,0.2138605707677739,0,0.9115416407585144,0.08034893125295639,0,0.8398564457893372,0.16818787157535553,0,0.9536672936391496,0.04633270636085047,0
243,高感度CRP、ESR(1時間値)およびD-ダイマーは、実施されなかった。,感度 CRP ESR 0時 間 値 D ダイマー 実施 する れる ない た,0,0.9966361704194642,0.0033638295805358156,0,7.315610103233563e-05,0.9999268438989677,0,0.9697913314347542,0.030208668565245882,0,0.9923456957106092,0.007654304289390809,0,0.9422160387039185,0.0661962628364563,0,0.8368396759033203,0.16573026776313782,0,0.9696701001591768,0.030329899840823238,0
244,2021/10/15、胸X線検査は実施され、心拡大の所見を示さなかった。,0 0 0 胸 X線検査 実施 する れる 心拡大 所見 示す ない た,0,0.9979662264029019,0.0020337735970980667,0,0.00010171028896469398,0.9998982897110353,0,0.9790757483117978,0.020924251688202177,0,0.9884104984193677,0.011589501580632268,0,0.94122713804245,0.06464378535747528,0,0.8176844716072083,0.16163526475429535,0,0.9696382928376812,0.030361707162318723,0
245,心膜炎調査票では以下の通り報告された:組織病理試験は、実施されなかった。,心膜炎 調査 票 以下 通り 報告 する れる た 組織 病理 試験 実施 する れる ない た,0,0.9972731813892854,0.002726818610714599,0,5.246448452340697e-05,0.9999475355154765,0,0.9399802426408146,0.06001975735918537,0,0.9731121271370556,0.026887872862944327,0,0.9547456502914429,0.06237317994236946,0,0.8301752805709839,0.14284522831439972,0,0.967721362201338,0.032278637798662024,0
246,報告病院実施の左肩X線、左肩CTでは、特記すべき異常所見は示さなかった。,報告 病院 実施 左肩 X線 左肩 CT 特記 する べし 異常所見 示す ない た,0,0.9902347810707356,0.009765218929264484,0,9.339983561980323e-05,0.9999066001643802,0,0.9051193426799521,0.09488065732004788,0,0.9436601585594948,0.05633984144050517,0,0.9509279727935791,0.0698656365275383,0,0.8077398538589478,0.18135759234428406,0,0.9602910557033187,0.039708944296681245,0
247,培養:未検出、備考:バクテリア、真菌または異型ミコバクテリウムのいずれも,培養 未検出 備考 バクテリア 真菌 異型 ミコバクテリウム いずれ,0,0.9845838385368136,0.015416161463186228,0,0.00010757652228011087,0.9998924234777199,1,0.4563792597309324,0.5436207402690676,0,0.9954810389837593,0.0045189610162407025,0,0.9046603441238403,0.1177344024181366,0,0.803758442401886,0.23158442974090576,1,0.9031043414396358,0.0968956585603643,0
248,2022/03/28ヘパリンによる効果不十分のためアルガトロバン開始。,0 0 0 ヘパリン 効果不十分 ため アルガトロバン 開始,0,0.6229026630082738,0.3770973369917263,1,0.00016899625419222435,0.9998310037458078,1,0.19986115219031975,0.8001388478096803,0,0.976470246604889,0.023529753395111007,0,0.9046987891197205,0.11401786655187607,1,0.41059914231300354,0.6995127201080322,1,0.5251221928320244,0.4748778071679755,0
249,2022/04/24左脇胸部の違和感・軽い痛み、肩痛/上背部痛が回復。,0 0 0 左脇 胸部 違和感 軽い 痛み 肩痛 上背部痛 回復,0,0.9845746385352471,0.01542536146475283,0,0.00014833088030743462,0.9998516691196926,0,0.7564837688028636,0.24351623119713633,0,0.942150653760498,0.05784934623950202,0,0.7830938696861267,0.29643845558166504,1,0.19310830533504486,0.8626102805137634,1,0.76564260757773,0.23435739242227002,0
250,2022/05/29利尿薬と血管拡張薬の内服を継続する方針とし、退院。,0 0 0 利尿 薬 血管拡張薬 内服 継続 する 方針 する 退院,0,0.9921212397079382,0.00787876029206188,0,7.282633748050364e-05,0.9999271736625195,0,0.9929369053685334,0.007063094631466647,0,0.9999999999743246,2.567530118922737e-11,0,0.9392773509025574,0.07768869400024414,0,0.8053337335586548,0.21308796107769012,0,0.9684491782499879,0.03155082175001214,0
251,2日目に患者の症状は無くなり、トロポニンIとCRPはそれぞれ改善した。,0 日 目 患者 症状 無くなる トロポニン I CRP それぞれ 改善 する た,0,0.996074519124507,0.003925480875493038,0,7.074389147943217e-05,0.9999292561085206,0,0.9825072846038935,0.017492715396106553,0,0.6171259468678276,0.3828740531321724,0,0.9376621842384338,0.06727307289838791,0,0.8183044791221619,0.16271455585956573,0,0.9380535086730771,0.06194649132692293,0
252,バイタルサイン測定:バイタルサインはすべて一貫して正常範囲内であった。,バイタルサイン 測定 バイタルサイン すべて 一貫 する 正常範囲 内 だ ある た,0,0.9580331545140838,0.041966845485916275,0,9.67292690384086e-05,0.9999032707309616,1,0.3991479158940743,0.6008520841059257,1,0.4150007404178907,0.5849992595821093,0,0.9087017774581909,0.14806632697582245,0,0.8322592973709106,0.1766364723443985,1,0.723285023216959,0.27671497678304097,0
253,各種検体検査・画像検査を実施したが、原因となる病巣は認められなかった。,各種 検体検査 画像 検査 実施 する た 原因 なる 病巣 認める られる ない た,0,0.9264771581063085,0.07352284189369164,0,0.00011384226474440637,0.9998861577352556,0,0.8075756818515096,0.19242431814849031,0,0.9676326650897807,0.03236733491021923,0,0.946184515953064,0.058651600033044815,0,0.8031455874443054,0.14946013689041138,0,0.9500179558366137,0.04998204416338614,0
254,患者はDiHS発現時にカルバマゼピンを継続中であり、49日間内服した。,患者 DiHS 発現 カルバマゼピン 継続 中 だ ある 0 日間 内服 する た,0,0.9686037178188708,0.031396282181129255,0,0.0001331854155297011,0.9998668145844704,1,0.2696348542088828,0.7303651457911172,1,0.37517017436756994,0.6248298256324301,0,0.8210737109184265,0.25896844267845154,0,0.8273975253105164,0.1824464052915573,1,0.6068618877598324,0.3931381122401676,0
255,抗AQP4抗体(ELISA及びCBA法)、抗MOG抗体は陰性であった。,AQP 0 抗体 ELISA CBA 法 MOG 抗体 陰性 だ ある た,0,0.9994712317391855,0.0005287682608145024,0,5.9203133766266546e-05,0.9999407968662337,0,0.9936458227510115,0.006354177248988403,0,0.8212731198934535,0.17872688010654653,0,0.865699052810669,0.13459272682666779,0,0.8347679376602173,0.19253909587860107,0,0.9526749460209383,0.047325053979061685,0
256,抗好中球細胞質プロテイナーゼ3抗体(PR3-ANCA)は陰性であった。,好中球 細胞 質 プロテイナーゼ 0 抗体 PR 0 ANCA 陰性 だ ある た,0,0.993092401537041,0.006907598462959072,0,8.688037524335369e-05,0.9999131196247566,0,0.8790921536678005,0.1209078463321995,0,0.6526276180494692,0.34737238195053083,0,0.9227886199951172,0.07506700605154037,0,0.8291812539100647,0.1791081428527832,0,0.9274116324306745,0.07258836756932559,0
257,歯性感染、上歯移動、ニコルスキー徴候及びその他病変は認められなかった。,歯性感染 上 歯 移動 ニコル スキー 徴候 その他 病変 認める られる ない た,0,0.9845503741673232,0.015449625832676747,0,0.00010302807035045917,0.9998969719296495,0,0.5506096166182782,0.44939038338172177,0,0.8114950046519648,0.18850499534803522,0,0.9208794832229614,0.08242513984441757,0,0.8191211223602295,0.15678846836090088,0,0.8997367545903604,0.10026324540963963,0
258,同日に、ベクルリー、ヘパリンおよびメロペネム(MEPM)が開始された。,同日 ベクルリー ヘパリン お呼び メロペネム MEPM 開始 する れる た,0,0.9763032787148711,0.023696721285129008,0,0.00011067825129241296,0.9998893217487076,0,0.6636440002549948,0.3363559997450052,1,0.28607657192592817,0.7139234280740718,0,0.9091477394104004,0.10385046154260635,0,0.7365609407424927,0.348784863948822,1,0.7398795121332422,0.2601204878667579,0
259,日付不明本剤接種後である訴えを重視して少量のプレドニンを内服し、軽快。,日付 不明 本 剤 接種 後 だ ある 訴え 重視 する 少量 プレドニン 内服 する 軽快,0,0.9845580501445474,0.015441949855452603,0,9.736187400602344e-05,0.999902638125994,0,0.8077701012047172,0.1922298987952829,1,0.34106473455305886,0.6589352654469411,0,0.9351651072502136,0.09315206855535507,0,0.7896612882614136,0.2536567151546478,1,0.838213883896344,0.16178611610365592,0
260,複数病原体ポリメラーゼ連鎖反応(PCR)検査:ウイルスゲノム検出なし。,複数 病原体 ポリメラーゼ連鎖反応 PCR 検査 ウイルス ゲノム 検出 ない,0,0.9939042145128631,0.0060957854871368095,0,6.227330004450318e-05,0.9999377266999555,0,0.9095213986040933,0.09047860139590674,0,0.9999666570343634,3.33429656366388e-05,0,0.936421275138855,0.06840575486421585,0,0.8229938745498657,0.1536250114440918,0,0.9659174703554757,0.03408252964452423,0
261,免疫抑制療法により、心筋障害は効果的に軽減し、患者は臨床的に改善した。,免疫抑制 療法 心筋障害 効果 的 軽減 患者 臨床 的 改善 する た,0,0.9845893134646508,0.01541068653534921,0,9.369417183669865e-05,0.9999063058281633,0,0.9004292372225146,0.09957076277748543,1,0.43635083445898293,0.5636491655410171,0,0.922703742980957,0.08207526057958603,0,0.8013955354690552,0.16900941729545593,1,0.8924429090743972,0.10755709092560291,0
262,両上下肢の感覚障害、構音障害はなく、全身状態は一晩でほぼ改善し、退院。,上下 肢 感覚障害 構音障害 ない 全身 状態 一晩 改善 する 退院,0,0.9959012620953126,0.0040987379046873796,0,6.863485777998535e-05,0.99993136514222,0,0.9895069605349411,0.010493039465058827,0,0.9999999981280913,1.8719087890699526e-09,0,0.9391024708747864,0.08777385205030441,0,0.8093456029891968,0.20370039343833923,0,0.9685660311192933,0.031433968880706646,0
263,ステロイド、シクロホスファミド、メポリズマブ投与により症状は改善した。,ステロイド シクロホスファミド メポリズマブ 投与 症状 改善 する た,0,0.9993414767924614,0.00065852320753846,0,6.549240655341001e-05,0.9999345075934466,0,0.9975061682297516,0.0024938317702484186,0,0.6665472697252535,0.33345273027474653,0,0.9297517538070679,0.06938276439905167,0,0.809444010257721,0.17136543989181519,0,0.9440313875818304,0.05596861241816974,0
264,COVIDー19病原体(SARS-CoV-2)検査は実施されなかった。,COVID ー 0 病原体 SARS CoV 0 検査 実施 する れる ない た,0,0.9998667092582327,0.0001332907417672007,0,6.237133582141808e-05,0.9999376286641786,0,0.9721905766516865,0.027809423348313517,0,0.9974592018065649,0.0025407981934351368,0,0.9558224081993103,0.06381396949291229,0,0.813435971736908,0.14562177658081055,0,0.9706587432507124,0.02934125674928758,0
265,COVID-19病原体(SARS-CoV-2)検査は実施されなかった。,COVID 0 病原体 SARS CoV 0 検査 実施 する れる ない た,0,0.9999391315342866,6.086846571342738e-05,0,5.345197145450253e-05,0.9999465480285455,0,0.9876968616885643,0.01230313831143566,0,0.9985135253882867,0.0014864746117133033,0,0.9549412727355957,0.06135265529155731,0,0.820534348487854,0.14681673049926758,0,0.9717968245073023,0.028203175492697657,0
266,ワクチン接種後、患者はCOVID-19のための検査を受けていなかった。,ワクチン接種 後 患者 COVID 0 ため 検査 受ける いる ない た,0,0.9965133174666853,0.0034866825333147,0,9.156060008559098e-05,0.9999084393999144,0,0.9938746103815972,0.0061253896184028,0,0.9993089867428192,0.0006910132571808172,0,0.9509482383728027,0.055482957512140274,0,0.8323692083358765,0.14958889782428741,0,0.9722889704343031,0.02771102956569692,0
267,事象に対する、新たな薬剤/その他の治療/処置を開始する必要はなかった。,事象 新た だ 薬剤 その他 治療 処置 開始 する 必要 ない た,0,0.9990288467894273,0.0009711532105727348,0,4.580359008400474e-05,0.999954196409916,0,0.9799917325668623,0.020008267433137675,0,0.9929291736958843,0.007070826304115678,0,0.9538055062294006,0.05554940924048424,0,0.8271422386169434,0.15197567641735077,0,0.9711792032997109,0.02882079670028917,0
268,臨床情報は以下の通り:2022/06/21、事象の転帰は軽快であった。,臨床 情報 以下 通り 0 0 0 事象 転帰 軽快 だ ある た,0,0.9924416131570747,0.007558386842925225,0,7.764430214123417e-05,0.9999223556978588,0,0.8087685047413289,0.19123149525867106,0,0.7716656243045312,0.22833437569546883,0,0.9426665902137756,0.06404430419206619,0,0.8203545808792114,0.16086357831954956,0,0.93607709319966,0.06392290680034005,0
269,ワクチン接種後、COVID-19の検査を受けたかどうかは不明であった。,ワクチン接種 後 COVID 0 検査 受ける た 不明 だ ある た,0,0.9964299004316486,0.0035700995683513917,0,7.881496263901414e-05,0.9999211850373609,0,0.981614279047408,0.01838572095259207,0,0.9967895841375904,0.0032104158624095894,0,0.9407966732978821,0.06557895988225937,0,0.8326985239982605,0.1824350208044052,0,0.9699769350145139,0.03002306498548613,0
270,2021/08/11、他院にて血液検査、胸部X線と胸部CTが実行された,0 0 0 院 血液検査 胸部 X線 胸部 C，T 実行 する れる た,0,0.8501202079554158,0.14987979204458407,0,0.00012759826727086796,0.9998724017327292,0,0.5262785223631529,0.47372147763684713,1,0.34801581757366773,0.6519841824263323,0,0.6602602005004883,0.4190601110458374,1,0.18625611066818237,0.8723941445350647,1,0.26975742344895004,0.73024257655105,0
271,2021/08/23カロナール1000-1500 mg/日投与終了。,0 0 0 カロナール 0 0 mg 日 投与 終了,0,0.9979623713645971,0.0020376286354029144,0,6.991741738520469e-05,0.9999300825826148,0,0.981539596339383,0.018460403660616947,0,0.9999999999687729,3.122718606755324e-11,0,0.9381874799728394,0.07454744726419449,0,0.8185632824897766,0.18504630029201508,0,0.9694184889968944,0.030581511003105515,0
272,2021/09/02、丘疹性皮疹(丘疹小水疱性皮疹)は回復していた。,0 0 0 丘疹性 皮疹 丘疹 水疱性 皮疹 回復 する いる た,0,0.9845659406895243,0.01543405931047563,0,0.00010804872204140013,0.9998919512779586,0,0.8423477228268648,0.15765227717313518,0,0.5654275232836576,0.4345724767163423,0,0.9289374351501465,0.07963625341653824,0,0.7784675359725952,0.2089720517396927,0,0.9005808449872678,0.09941915501273224,0
273,2022/02/05 09:00頃車椅子にて10 mLほど水分摂取。,0 0 0 0 0 頃 車椅子 0 mL 水分摂取,0,0.9772953632030452,0.022704636796954926,1,0.0001677709331928116,0.9998322290668072,1,0.24931105935462838,0.7506889406453716,0,0.7038417876544247,0.2961582123455752,1,0.45271602272987366,0.6878277063369751,1,0.2891146242618561,0.8126751184463501,1,0.289576817794147,0.710423182205853,0
274,2022/06/03-2022/06/04発熱、頭痛、頸部痛が消失。,0 0 0 0 0 0 発 熱 頭痛 頸部痛 消失,0,0.9845601670265753,0.015439832973424541,0,0.00015388011723580124,0.9998461198827642,0,0.740298071641539,0.259701928358461,0,0.9885396255718342,0.011460374428165864,1,0.1590557098388672,0.9063540697097778,1,0.4095970094203949,0.6970941424369812,1,0.5968381786202714,0.40316182137972856,0
275,35歳時の最終再発(53回目)後、36歳でプレドニゾロンを終了した。,0歳 時 最終 再発 0回目 後 0歳 プレドニゾロン 終了 する た,0,0.9845700258370169,0.015429974162983051,0,0.00011896741562164542,0.9998810325843783,0,0.5440090587419881,0.4559909412580118,1,0.3709423056835701,0.6290576943164299,0,0.938683271408081,0.0936521366238594,0,0.8356406688690186,0.1730579435825348,1,0.7869930420101123,0.21300695798988764,0
276,7日目に潰瘍及び生検創はほぼ完全に治癒し、患者の摂食障害は軽減した。,0 日 目 潰瘍 生検 創 完全 治癒 患者 摂食障害 軽減 する た,0,0.984567775667062,0.01543222433293785,0,0.00010183820176052571,0.9998981617982394,1,0.4302166255107459,0.5697833744892541,1,0.22156270388448973,0.7784372961155103,0,0.9312865138053894,0.08776753395795822,0,0.7997542023658752,0.17502987384796143,1,0.6772453537187939,0.32275464628120604,0
277,COVID-19病原体(SARS-CoV-2)検査は実施しなかった。,COVID 0 病原体 SARS CoV 0 検査 実施 する ない た,0,0.9999262237072276,7.377629277225176e-05,0,4.6773844289915766e-05,0.99995322615571,0,0.995153048081881,0.004846951918118993,0,0.9992514083460255,0.0007485916539743981,0,0.9529802799224854,0.05610694736242294,0,0.8113088607788086,0.1524752378463745,0,0.9719267114612966,0.028073288538703382,0
278,フォローアップではなんとか再開通が維持されており、再出血もなかった。,フォローアップ 再開通 維持 する れる おる 再出血 ない た,0,0.9895947366581669,0.010405263341833138,0,8.932761222460576e-05,0.9999106723877754,0,0.8866843527778852,0.11331564722211483,0,0.9449272840901497,0.05507271590985032,0,0.9425819516181946,0.05505138263106346,0,0.8325388431549072,0.1544496715068817,0,0.961142110472834,0.038857889527165866,0
279,事象に対する新たな薬剤/その他の治療/処置を開始する必要はなかった。,事象 新た だ 薬剤 その他 治療 処置 開始 する 必要 ない た,0,0.9990288467894273,0.0009711532105727348,0,4.580359008400474e-05,0.999954196409916,0,0.9799917325668623,0.020008267433137675,0,0.9929291736958843,0.007070826304115678,0,0.9538055062294006,0.05554940924048424,0,0.8271422386169434,0.15197567641735077,0,0.9711792032997109,0.02882079670028917,0
280,前医を受診し頭部から腰椎のMRIを撮影したが異常は指摘されなかった。,医 受診 する 頭部 腰椎 MRI 撮影 する た 異常 指摘 する れる ない た,0,0.9720379403754518,0.02796205962454835,0,0.00014698535075658353,0.9998530146492434,0,0.8090563574161778,0.19094364258382218,0,0.9797338146718587,0.020266185328141315,0,0.9396581053733826,0.07229582965373993,0,0.75051349401474,0.22975192964076996,0,0.9483421916109708,0.05165780838902927,0
281,退院時にβ遮断薬、Ca拮抗剤(ヘルベッサーR)の薬剤中止および減量。,退院 時 遮断 薬 Ca 拮抗 剤 ヘルベッサー R 薬剤 中止 お呼び 減量,0,0.993084718471724,0.006915281528276077,0,6.0448896579455895e-05,0.9999395511034206,0,0.9776024968354349,0.0223975031645651,0,0.9999924046588329,7.595341167171411e-06,0,0.9092537760734558,0.11996503919363022,0,0.8129616379737854,0.2323402613401413,0,0.964817502947909,0.03518249705209098,0
282,日付不明血清HIV(ヒト免疫不全ウイルス)検査:特記すべき所見なし。,日付 不明 血清 HIV ヒト 免疫不全 ウイルス 検査 特記 する べし 所見 ない,0,0.987351522272612,0.012648477727388032,0,5.948726520305599e-05,0.9999405127347969,0,0.9058403149860417,0.09415968501395838,0,0.8523219168294587,0.14767808317054135,0,0.949905514717102,0.07553426176309586,0,0.8323575258255005,0.16161324083805084,0,0.9541856992793982,0.0458143007206019,0
283,非ステロイド性抗炎症薬(NSAIDs)と抗生剤は入院前に投与された。,ステロイド性 抗炎症 薬 NSAIDs 抗生剤 入院 前 投与 する れる た,0,0.9750513169674463,0.024948683032553768,0,9.356742683778942e-05,0.9999064325731623,0,0.8772846046703907,0.12271539532960929,1,0.2551598455892635,0.7448401544107365,0,0.936250627040863,0.08840496838092804,0,0.812779426574707,0.22468343377113342,1,0.8390424074941718,0.1609575925058283,0
284,併用薬及び治療薬の使用に関しての情報は、報告者より提供されなかった。,併用 薬 治療薬 使用 情報 報告 者 提供 する れる ない た,0,0.9977890026896507,0.0022109973103493306,0,5.38948837544156e-05,0.9999461051162456,0,0.9869042543442862,0.0130957456557138,0,0.985499980927236,0.014500019072763983,0,0.9527706503868103,0.06515663862228394,0,0.8316956758499146,0.1452847719192505,0,0.9710980726416046,0.028901927358395425,0
285,免疫抑制療法は心筋損傷を効果的に減少させ、患者の臨床経過は改善した。,免疫抑制 療法 心筋損傷 効果的 減少 する せる 患者 臨床 経過 改善 する た,0,0.9845693163336339,0.015430683666366221,0,9.692053940777807e-05,0.9999030794605922,0,0.8692743568548724,0.13072564314512752,0,0.671930181715252,0.328069818284748,0,0.9242565631866455,0.0799764022231102,0,0.7950913906097412,0.15500357747077942,0,0.926634779931764,0.07336522006823584,0
286,酸素吸入(高流量又はECMOを含む)または人工呼吸器は要さなかった。,酸素吸入 流量 ECMO 含む 人工呼吸器 要す ない た,0,0.9900438269401343,0.009956173059865845,0,0.0001132172655785602,0.9998867827344214,0,0.9266823476495376,0.07331765235046236,0,0.9794269206096763,0.02057307939032373,0,0.9496039152145386,0.05519283562898636,0,0.8234630227088928,0.14320321381092072,0,0.9666636918933793,0.03333630810662074,0
287,電解質やアミノトランスフェラーゼの異常はなく、腎機能は正常であった。,電解質 アミノトランスフェラーゼ 異常 ない 腎 機能 正常 だ ある た,0,0.9980953673659746,0.0019046326340254774,0,5.662844296221196e-05,0.9999433715570378,0,0.978619586194032,0.021380413805967977,0,0.7918402193400127,0.2081597806599873,0,0.9316902160644531,0.05640548840165138,0,0.8264878392219543,0.16520054638385773,0,0.9557988055163662,0.04420119448363387,0
288,SARS-COV2 PCR検査、開始日および転帰は提供されなかった。,SARS COV 0 PCR検査 開始 日 転帰 提供 する れる ない た,0,0.9976588155938747,0.002341184406125315,0,7.360737874043379e-05,0.9999263926212596,0,0.9889807010164428,0.01101929898355722,0,0.997897586343767,0.0021024136562329348,0,0.9483469724655151,0.062233708798885345,0,0.8329710960388184,0.14735865592956543,0,0.9718306519432833,0.028169348056716628,0
289,病理組織学的検査、高感度CRP、ESR(1時間値)は実施しなかった。,病理 組織 学 的 検査 感度 CRP ESR 0時 間 値 実施 する ない た,0,0.9880429178499464,0.011957082150053604,0,7.46849846805776e-05,0.9999253150153194,0,0.9613672146513975,0.03863278534860246,0,0.9803502241871128,0.019649775812887234,0,0.9446813464164734,0.06551550328731537,0,0.8234480023384094,0.14788666367530823,0,0.9681514681480182,0.0318485318519818,0
290,他要因(他の疾患や関連する病歴等)の可能性はなかった(報告の通り)。,要因 他 疾患 関連 する 病歴 等 可能性 ない た 報告 通り,0,0.9904454098060288,0.00955459019397122,0,5.882826352354812e-05,0.9999411717364765,0,0.9747113496190285,0.025288650380971528,0,0.9999877248819016,1.2275118098411333e-05,0,0.945349931716919,0.061091627925634384,0,0.836427628993988,0.1639404445886612,0,0.9703199889882635,0.02968001101173638,0
291,培養は実施されず、結果は陽性ではなく、血清型判定は実施されなかった。,培養 実施 する れる ぬ 結果 陽性 ない 血清型 判定 実施 する れる ない た,0,0.9495999281083014,0.05040007189169869,0,7.866046469089576e-05,0.9999213395353092,0,0.9564618331231219,0.04353816687687803,0,0.9939482940771306,0.006051705922869385,0,0.9535143971443176,0.06363564729690552,0,0.8356251120567322,0.14390790462493896,0,0.9671300271382004,0.03286997286179959,0
292,血小板数、ヘモグロビン、ヘマトクリット、Dダイマーは異常なしであった,血小板 数 ヘモグロビン ヘマトクリット D ダイマー 異常 ない だ ある た,0,0.982785539522624,0.01721446047737593,0,9.503630763051625e-05,0.9999049636923695,0,0.8949766892347512,0.10502331076524883,0,0.754578378203315,0.245421621796685,0,0.9235795736312866,0.06764577329158783,0,0.8359898328781128,0.167708620429039,0,0.9420832111233207,0.05791678887667928,0
293,コンピューター断層撮影では、感染性病変を示す所見は認められなかった。,コンピューター 断層 撮影 感染性病変 示す 所見 認める られる ない た,0,0.9845639631788208,0.015436036821179172,0,0.00011426636801683714,0.9998857336319832,0,0.7375923860132922,0.26240761398670776,0,0.9698522935892673,0.03014770641073268,0,0.9429731369018555,0.06326018273830414,0,0.8238996267318726,0.17849527299404144,0,0.9483073535634107,0.051692646436589294,0
294,COVID-19病原体(SARS-CoV-2)検査を実施しなかった。,COVID 0 病原体 SARS CoV 0 検査 実施 する ない た,0,0.9999262237072276,7.377629277225176e-05,0,4.6773844289915766e-05,0.99995322615571,0,0.995153048081881,0.004846951918118993,0,0.9992514083460255,0.0007485916539743981,0,0.9529802799224854,0.05610694736242294,0,0.8113088607788086,0.1524752378463745,0,0.9719267114612966,0.028073288538703382,0
295,physical examination:顕著な異常は認めなかった。,physical examination 顕著 だ 異常 認める ない た,0,0.9845752640950645,0.015424735904935536,0,8.521017482903732e-05,0.999914789825171,0,0.7415833442169735,0.25841665578302647,0,0.9834896062829143,0.016510393717085722,0,0.9476765394210815,0.07073027640581131,0,0.8230159878730774,0.15948237478733063,0,0.9507314985454328,0.04926850145456727,0
296,血小板減少症を伴う血栓塞栓事象が発現している場合の検査は、なかった。,血小板減少症 伴う 血栓 塞栓 事象 発現 する いる 場合 検査 ない た,0,0.9845525112388949,0.015447488761105226,0,0.00011357514186029232,0.9998864248581397,0,0.6515431508517404,0.3484568491482596,0,0.9860693449542152,0.013930655045784888,0,0.9331603050231934,0.07392657548189163,0,0.7748866081237793,0.1671038419008255,0,0.9377061347052046,0.062293865294795484,0
297,2021/06/17、胸部X線検査にて血栓/塞栓症の所見はなかった。,0 0 0 胸部 X線検査 血栓 塞栓症 所見 ない た,0,0.9945216488129827,0.005478351187017395,0,0.00010684554229104566,0.999893154457709,0,0.9867094127058308,0.013290587294169258,0,0.9791199772206579,0.020880022779342124,0,0.9293951392173767,0.06691286712884903,0,0.8069314956665039,0.17350685596466064,0,0.9682261690361978,0.031773830963802145,0
298,2021/09/15、COVID-19PCR検査、結果は陰性であった,0 0 0 COVID 0 PCR検査 結果 陰性 だ ある た,0,0.9963497792276104,0.003650220772389638,0,9.957726402227007e-05,0.9999004227359777,0,0.969886449179084,0.03011355082091601,0,0.9628039086428173,0.03719609135718272,0,0.9363132119178772,0.06655861437320709,0,0.8243635296821594,0.17819400131702423,0,0.966888532811188,0.03311146718881196,0
299,ICUでの数日間の経過観察後、患者は重大な合併症もなく自宅退院した。,ICU 数 日間 経過 観察 後 患者 重大 だ 合併症 ない 自宅 退院 する た,0,0.9911416153124942,0.008858384687505879,0,4.83297214135979e-05,0.9999516702785864,0,0.9926345171784163,0.007365482821583724,1,0.41515460809848426,0.5848453919015157,0,0.9419070482254028,0.06111523136496544,0,0.8014430999755859,0.15856322646141052,1,0.9106526396883969,0.08934736031160295,0
300,事象の報告前に他の何らかの疾患に対し最近ワクチン接種は受けなかった。,事象 報告 前 他 疾患 最近 ワクチン接種 受ける ない た,0,0.9985910778969049,0.001408922103095017,0,5.4860832797849894e-05,0.9999451391672022,0,0.9924277268411023,0.0075722731588977205,0,0.9953363480048941,0.0046636519951059165,0,0.9468708038330078,0.051075708121061325,0,0.8197928071022034,0.14507557451725006,0,0.9718958761999374,0.02810412380006253,0
301,利尿薬静脈注射、降圧薬内服にて、高血圧は改善し頭痛、嘔気も消失した。,利尿 薬 静脈 注射 降圧 薬 内服 高血圧 改善 する 頭痛 嘔気 消失 する た,0,0.9845643273477095,0.015435672652290603,0,5.982338728963683e-05,0.9999401766127104,0,0.9774396854998193,0.022560314500180704,1,0.262349043811694,0.737650956188306,0,0.93581622838974,0.0811043381690979,0,0.7804035544395447,0.18332307040691376,1,0.8699614702480261,0.130038529751974,0
302,2021/**/**、免疫性心筋炎(免疫性心筋炎)は回復していた。,0 免疫性 心筋炎 免疫性 心筋炎 回復 する いる た,0,0.9419481190105408,0.05805188098945921,0,0.00013747867518832437,0.9998625213248117,0,0.803528169787372,0.1964718302126281,0,0.5897237917797808,0.4102762082202191,0,0.9253256320953369,0.07315445691347122,0,0.7334697246551514,0.2481810301542282,0,0.8816485571642854,0.11835144283571462,0
303,2022/03/22、NEAR法で検査を受け、結果は陽性であった。,0 0 0 NEAR 法 検査 受ける 結果 陽性 だ ある た,0,0.8577124983005531,0.14228750169944704,1,0.0002509544142877872,0.9997490455857122,0,0.5719498800871723,0.42805011991282765,0,0.8785125719360412,0.12148742806395886,1,0.20019260048866272,0.8786239624023438,1,0.3451240360736847,0.8065798878669739,1,0.3721427290313939,0.6278572709686062,0
304,2022/04/08再度下肢静脈エコーにて可動性血栓の消失を確認。,0 0 0 下肢 静脈 エコー にる 可動性 血栓 消失 確認,0,0.7992900115959116,0.20070998840408855,0,0.00012158005385566851,0.9998784199461443,0,0.7264737555475693,0.27352624445243073,1,0.30291137288249326,0.6970886271175067,0,0.7288074493408203,0.3717425763607025,0,0.7523407936096191,0.21574914455413818,1,0.6344255431414348,0.3655744568585651,0
305,2022/05/30歩行が可能となってきた為、リハビリ病院へ転院。,0 0 0 歩行 可能 なる くる た 為 リハビリ 病院 転院,0,0.9845519052671435,0.015448094732856339,0,0.00010489763919857258,0.9998951023608015,1,0.30496027235159473,0.6950397276484053,0,0.9995051390488838,0.0004948609511161793,0,0.8859663009643555,0.2072094976902008,0,0.7822890877723694,0.21299083530902863,1,0.8613202996859882,0.13867970031401175,0
306,2022/06/27採血、心電図所見が改善し、症状の回復を認めた。,0 0 0 採血 心電図 所見 改善 する 症状 回復 認める た,0,0.9970837565038978,0.0029162434961021036,0,7.41351307700618e-05,0.99992586486923,0,0.9947663790966402,0.0052336209033597945,0,0.5684264583736298,0.4315735416263702,0,0.9367321729660034,0.06625960767269135,0,0.8173507452011108,0.17858938872814178,0,0.9327634968318468,0.06723650316815324,0
307,IVIg後、急速に症状は改善し臨床所見、検査所見とも正常となった。,IVIg 後 急速 症状 改善 する 臨床 所見 検査 所見 正常 なる た,0,0.998392365190116,0.0016076348098840408,0,5.947347712867868e-05,0.9999405265228714,0,0.9901726333579852,0.009827366642014756,0,0.5753025996984242,0.42469740030157577,0,0.9408296346664429,0.05854718014597893,0,0.8195165991783142,0.1884310245513916,0,0.9334679083770551,0.06653209162294502,0
308,PCRによるSARS-CoV-2検査等よりCOVID-19は否定。,PCR SARS CoV 0 検査 等 COVID 0 否定,0,0.9901808683845256,0.009819131615474371,0,6.204660787661369e-05,0.9999379533921234,0,0.8513974275658374,0.14860257243416267,0,0.9999999998730549,1.2694513696884826e-10,0,0.9227362275123596,0.16081668436527252,0,0.7687296271324158,0.25503334403038025,0,0.9506822820317912,0.04931771796820882,0
309,"アセリオ1,000 mg点滴し、ロキソプロフェン頓服を処方し帰宅。",アセリオ 0 0 mg 点滴 ロキソプロフェン 頓服 処方 する 帰宅,0,0.9845720827921406,0.015427917207859411,0,8.094950613223257e-05,0.9999190504938678,0,0.7967061774408625,0.20329382255913755,0,0.6848833743962706,0.3151166256037294,0,0.9150317907333374,0.1108175590634346,0,0.7810153365135193,0.3257305920124054,0,0.8995273714097557,0.10047262859024421,0
310,下肢脱力が軽減したため、患者は7日後に退院し、外来受診を継続した。,下肢脱力 軽減 する た ため 患者 0 日 後 退院 する 外来 受診 継続 する た,0,0.9845720462377516,0.015427953762248342,0,9.448396015349009e-05,0.9999055160398466,0,0.8884976399907505,0.11150236000924948,0,0.9632436956909719,0.03675630430902805,0,0.9262951016426086,0.12759633362293243,0,0.8029187917709351,0.18017324805259705,0,0.9566553555684072,0.04334464443159274,0
311,頚動脈エコー、心機能検査、頭部MRI/MRAも特記所見はなかった。,頚動脈 エコー 心 機能 検査 頭部 MRI MRA 特記 所見 ない た,0,0.998409152758965,0.0015908472410348746,0,5.673339062099647e-05,0.999943266609379,0,0.9828424298945826,0.017157570105417436,0,0.9826396538363648,0.01736034616363522,0,0.9511512517929077,0.06471382826566696,0,0.809461236000061,0.15581464767456055,0,0.9697628410677213,0.03023715893227874,0
312,口唇の痺れは入院時に軽快し、両手の痺れはPSL開始5日で軽快した。,口唇 痺れ 入院 時 軽快 する 両手 痺れ PSL 開始 0 日 軽快 する た,0,0.9651234488199054,0.034876551180094556,0,0.00011366313152942674,0.9998863368684706,0,0.9744851333385514,0.025514866661448653,0,0.6530295607528389,0.34697043924716103,0,0.8639854788780212,0.19798840582370758,0,0.7424126863479614,0.252274751663208,0,0.9122673218097374,0.08773267819026265,0
313,治療薬としてアンジオテンシン変換酵素(ACE)阻害薬が報告された。,治療薬 アンジオテンシン 変換 酵素 ACE 阻害 薬 報告 する れる た,0,0.9837181694765335,0.016281830523466597,0,0.00010332581699289057,0.9998966741830071,0,0.8807838917318993,0.1192161082681007,1,0.24553756691217155,0.7544624330878285,0,0.9157218337059021,0.09549614787101746,0,0.7960538864135742,0.2581701874732971,1,0.8289771322117216,0.17102286778827827,0
314,除外した疾患は、ヘパリン起因性血小板減少症、抗リン脂質抗体症候群。,除外 する た 疾患 ヘパリン起因性 血小板減少症 抗リン脂質抗体症候群,0,0.9845611403704927,0.015438859629507227,0,0.00011046371502852657,0.9998895362849715,0,0.5650592113665174,0.4349407886334826,0,0.9999983681599792,1.6318400207290344e-06,0,0.5764188766479492,0.4540465474128723,0,0.7561898827552795,0.1924142837524414,0,0.8563877502822168,0.14361224971778325,0
315,上下部消化管内視鏡検査、造影CT検査まで施行したが、異常所見なし。,上下 部 消化 管 内視鏡検査 造影 CT検査 施行 する た 異常所見なし,0,0.9873266788958666,0.012673321104133547,0,0.00010043418072016145,0.9998995658192799,0,0.6822119203626031,0.31778807963739686,0,0.9921655487437905,0.007834451256209482,0,0.9215893745422363,0.06131189316511154,0,0.7949935793876648,0.2472480833530426,0,0.9388675814864847,0.061132418513515266,0
316,心筋生検では、心筋組織に明らかな炎症細胞の浸潤は認められなかった。,心筋生検 だ 心筋 組織 明らか だ 炎症細胞 浸潤 認める られる ない た,0,0.9845777872195239,0.015422212780475992,0,9.893218209381547e-05,0.9999010678179062,0,0.864161023879539,0.13583897612046097,0,0.9661026355111578,0.033897364488842174,0,0.9253012537956238,0.10289733111858368,0,0.8026867508888245,0.18452568352222443,0,0.9556570655340392,0.0443429344659608,0
317,退院時、ポララミン2 mg 2錠分2で3日間内服、有事再診を指示。,退院 時 ポララミン 0 mg 0 錠 分 0 0 日間 内服 有事 再診 指示,0,0.9845522851772307,0.015447714822769397,0,7.464508656870609e-05,0.9999253549134313,0,0.9461079140412594,0.05389208595874059,0,0.955363581423025,0.044636418576975,0,0.9053575992584229,0.1357729583978653,0,0.7918582558631897,0.2212424874305725,0,0.9574012332089483,0.04259876679105165,0
318,同時に冠動脈造影を施行したが、両冠動脈に有意の狭窄病変はなかった。,冠動脈造影 施行 する た 冠動脈 有意 狭窄病変 ない た,0,0.9986663568525017,0.0013336431474983593,0,6.167534055789075e-05,0.9999383246594421,0,0.9704780444505922,0.029521955549407862,0,0.9532544245933641,0.046745575406635896,0,0.9409577250480652,0.05583367124199867,0,0.8179599046707153,0.17578920722007751,0,0.9668248340770796,0.0331751659229204,0
319,病理組織学的検査、心臓MRI検査、その他の画像検査は受けなかった。,病理 組織 学 的 検査 心臓 MRI 検査 その他 画像 検査 受ける ない た,0,0.9853840923378376,0.01461590766216222,0,6.753916149053735e-05,0.9999324608385095,0,0.9904494830605548,0.00955051693944525,0,0.9830674262877875,0.016932573712212455,0,0.9425547122955322,0.057884443551301956,0,0.8098019361495972,0.13833114504814148,0,0.9699411461736713,0.030058853826328686,0
320,患者は、現在、疾患のための治療(薬物などでの)は受けていなかった。,患者 現在 疾患 ため 治療 薬物 受ける いる ない た,0,0.9986572994978471,0.0013427005021530278,0,7.01691656208083e-05,0.9999298308343791,0,0.9843382370221191,0.015661762977880925,0,0.9967880395171136,0.003211960482886452,0,0.953415036201477,0.049484316259622574,0,0.8210374116897583,0.14820899069309235,0,0.9717077350547001,0.02829226494529999,0
321,2021/07/16、血液検査データが改善傾向にて患者は退院した。,0 0 0 血液検査 データ 改善 傾向 患者 退院 する た,0,0.9997021841877649,0.00029781581223514025,0,3.962988436447701e-05,0.9999603701156355,0,0.9991461272830819,0.0008538727169180542,0,0.6862990112774826,0.3137009887225174,0,0.939864993095398,0.06630963087081909,0,0.7978474497795105,0.19483014941215515,0,0.945160632209884,0.05483936779011604,0
322,2022/06/17、その他事象の転帰は軽快であった(報告通り)。,0 0 0 その他 事象 転帰 軽快 だ ある た 報告 通り,0,0.998274889295792,0.0017251107042079163,0,6.494420965620229e-05,0.9999350557903438,0,0.9860090093136664,0.013990990686333554,0,0.9999992386122603,7.613877397663988e-07,0,0.9367420077323914,0.06562500447034836,0,0.798661470413208,0.1572224646806717,0,0.9701496036353063,0.029850396364693627,0
323,新生児は事象により追加治療(薬物療法、非薬物療法)を受けなかった。,新生児 事象 よる 追加 治療 薬物 療法 薬物 療法 受ける ない た,0,0.9983271125354335,0.0016728874645666862,0,7.236324254027817e-05,0.9999276367574598,0,0.9032284986619075,0.09677150133809256,0,0.9110242929761238,0.08897570702387621,0,0.9567093253135681,0.05398763343691826,0,0.8004551529884338,0.1402134746313095,0,0.960390382871289,0.03960961712871107,0
324,2022/06/22、COVID-19 PCR検査は陰性であった。,0 0 0 COVID 0 PCR検査 陰性 だ ある た,0,0.9984349471328579,0.0015650528671420818,0,9.40610997648423e-05,0.9999059389002352,0,0.9688785079421657,0.031121492057834276,0,0.9819272973798706,0.01807270262012944,0,0.9345833659172058,0.06553806364536285,0,0.8242226243019104,0.18076004087924957,0,0.968052039865822,0.03194796013417794,0
325,患者は、事象により救急救命室または医療機関に訪れる必要はなかった。,患者 事象 救急救命室 医療機関 訪れる 必要 ない た,0,0.9976360656453824,0.002363934354617426,0,7.144350901681663e-05,0.9999285564909832,0,0.9437039756263039,0.05629602437369605,0,0.9887431026676959,0.011256897332304018,0,0.9518791437149048,0.051915690302848816,0,0.8229533433914185,0.14999350905418396,0,0.9687271432848232,0.03127285671517674,0
326,心膜炎調査票の情報は以下の通り:病理組織学的検査は未実施であった。,心膜炎 調査 票 情報 以下 通り 病理 組織 学 的 検査 実施 だ ある た,0,0.9514202064243221,0.04857979357567776,0,7.53453926621219e-05,0.9999246546073379,0,0.6082089265919903,0.3917910734080097,0,0.5810895384658331,0.4189104615341669,0,0.9429803490638733,0.06583502143621445,0,0.8397637009620667,0.16524046659469604,0,0.8621492231841661,0.13785077681583385,0
327,「2022/06/01、頭部MRIが実施され、異常所見はなかった。,0 0 0 頭部 MRI 実施 する れる 異常所見 ない た,0,0.997801647824599,0.002198352175401065,0,8.069999443584515e-05,0.9999193000055642,0,0.9807404023790062,0.019259597620993777,0,0.9939599772763611,0.006040022723638883,0,0.9467864036560059,0.05883174017071724,0,0.8104216456413269,0.16208596527576447,0,0.9701554999747324,0.02984450002526752,0
328,患者には、悪性疾患や自己免疫不全の根拠はなく、薬物服用もなかった。,患者 悪性疾患 自己免疫 不全 根拠 ない 薬物 服用 ない た,0,0.9932282625534663,0.006771737446533785,0,6.67630134613416e-05,0.9999332369865387,0,0.9753239656634761,0.024676034336523857,0,0.9943376547530945,0.0056623452469054085,0,0.9479663372039795,0.05056670680642128,0,0.8329230546951294,0.14257672429084778,0,0.9710739275840518,0.0289260724159482,0
329,臨床経過の詳細は以下の通り:ワクチン接種の前の体温は不明であった。,臨床 経過 詳細 以下 通り ワクチン接種 前 体温 不明 だ ある た,0,0.9845825863076538,0.01541741369234635,0,6.756237509700908e-05,0.999932437624903,0,0.7519822770288266,0.24801772297117342,0,0.7234399171957787,0.2765600828042213,0,0.9364083409309387,0.0588969849050045,0,0.7285597920417786,0.34015101194381714,0,0.8989911289830942,0.10100887101690581,0
330,熱が出たわけではなく慢性的なものであり、あまり気にしていなかった。,熱 出る た わけ だ ない 慢性 的 だ もの だ ある 気 する いる ない た,0,0.9845751017371774,0.015424898262822537,0,8.452750272678304e-05,0.9999154724972732,0,0.963755732500589,0.03624426749941098,0,0.9983156342973967,0.0016843657026033544,0,0.9359535574913025,0.115827277302742,0,0.8151745796203613,0.20723406970500946,0,0.9651600350875514,0.034839964912448534,0
331,2021/11/25抗菌薬をセフェピム、メトロニダゾールに変更。,0 0 0 抗菌薬 セフェピム メトロニダゾール 変更,0,0.9845840861440316,0.01541591385596836,0,0.00011859699601210091,0.9998814030039879,1,0.35873972300322543,0.6412602769967746,0,0.9999999815300744,1.8469925633156207e-08,0,0.9002162218093872,0.09807021170854568,0,0.7760970592498779,0.2490890622138977,1,0.8824707891503661,0.11752921084963391,0
332,2022/04/20上室性頻拍に対するアブレーション治療を施行。,0 0 0 上室性 頻拍 アブレーション 治療 施行,0,0.9845710725530025,0.015428927446997554,0,0.00015200248334715712,0.9998479975166529,0,0.7573625450867356,0.24263745491326438,0,0.9965702518021149,0.003429748197885094,0,0.6250865459442139,0.36586129665374756,0,0.6436768770217896,0.45566216111183167,0,0.8726451491664707,0.12735485083352918,0
333,6月6日に受診し抗アレルギー薬の内服とステロイド外用を使用した。,0 月 0 日 受診 する 抗アレルギー 薬 内服 ステロイド 外用 使用 する た,0,0.9845573039498914,0.015442696050108668,0,9.340732246903424e-05,0.999906592677531,0,0.9439471660056435,0.05605283399435642,0,0.9053601125329807,0.09463988746701932,0,0.8892613053321838,0.1474619209766388,0,0.769740641117096,0.23495550453662872,0,0.9500029221851977,0.0499970778148023,0
334,ゼルヤンツとサラゾスルファピリジンの開始日と終了日が追加された。,ゼルヤンツ サラゾスルファピリジン 開始 日 終了 日 追加 する れる た,0,0.9845552047207837,0.015444795279216245,0,8.350967057805148e-05,0.999916490329422,0,0.8336805267008265,0.1663194732991735,1,0.29039797688748736,0.7096020231125126,0,0.9052662253379822,0.09614297747612,0,0.8255141973495483,0.21899022161960602,1,0.8365913580201527,0.16340864197984717,0
335,その後、徐々に意識障害は改善が見られたが、左上下肢全麻痺は継続。,その後 意識障害 改善 見る られる た 左上 下肢 全麻痺 継続,0,0.9845889055350382,0.015411094464961913,0,0.0001136844655329405,0.999886315534467,0,0.9270384177973134,0.07296158220268656,0,0.949190430745637,0.050809569254363016,0,0.8739957809448242,0.20216982066631317,0,0.7012122869491577,0.35414421558380127,0,0.9393892072265894,0.06061079277341068,0
336,ポリメラーゼ連鎖反応:陰性(陰性)、COVID-19感染症陰性。,ポリメラーゼ連鎖反応 陰性 陰性 COVID 0 感染症陰性,0,0.9899013086387046,0.010098691361295415,0,6.33822507616948e-05,0.9999366177492383,0,0.9748863304620521,0.02511366953794793,0,0.999967722371222,3.2277628778050944e-05,0,0.8826116919517517,0.11496046185493469,0,0.8113645315170288,0.19093254208564758,0,0.9650317571388781,0.034968242861121865,0
337,胸痛は約10日で消失し、ECGのST部分の上昇は正常に変化した。,胸痛 0 日 消失 する ECG ST 部分 上昇 正常 変化 する た,0,0.9819332102720388,0.018066789727961226,0,8.686107575508072e-05,0.9999131389242449,0,0.9155965469985148,0.0844034530014852,0,0.8746078888145076,0.12539211118549243,0,0.8726112246513367,0.16612571477890015,0,0.7525544166564941,0.2852194011211395,0,0.9380961189603156,0.06190388103968441,0
338,持続的血液透析(CHD)とニカルジピン塩酸塩持続静注を施行した。,持続的 血液 透析 CHD ニカルジピン 塩酸 塩 持続 静 注 施行 する た,0,0.9801713129711411,0.019828687028858878,0,0.00010725687706937496,0.9998927431229306,0,0.6619087705960044,0.3380912294039956,1,0.20048058224131138,0.7995194177586886,0,0.8548895716667175,0.18046535551548004,0,0.7772269248962402,0.2789298892021179,1,0.7022545665019149,0.29774543349808513,0
339,状態が安定し、消化管症状改善、呼吸器所見改善していることを確認。,状態 安定 する 消化 管 症状改善 呼吸 器 所見 改善 する いる こと 確認,0,0.9845605385914802,0.01543946140851972,0,7.760744150630733e-05,0.9999223925584937,0,0.8724293243837724,0.12757067561622762,0,0.9942878055875215,0.005712194412478542,0,0.9293862581253052,0.09920187294483185,0,0.7965452671051025,0.20472198724746704,0,0.9579009101579324,0.04209908984206757,0
340,日付不明発症4か月後の心臓MRIでも炎症所見の改善が認められた。,日付 不明 発症 0 か月 後 心臓 MRI 炎症所見 改善 認める られる た,0,0.9664804161234023,0.03351958387659753,0,0.00011485228409875117,0.9998851477159012,0,0.8293321266101912,0.17066787338980888,1,0.20874413652617352,0.7912558634738265,0,0.9348584413528442,0.07318726181983948,0,0.7757050395011902,0.21690087020397186,1,0.8068730206635811,0.19312697933641898,0
341,尿所見は残存するも腎機能障害は改善したため、外来加療継続とする。,尿 所見 残存 する 腎機能障害 改善 する た ため 外来 加療 継続 する,0,0.9845731735655517,0.01542682643444814,0,7.878657601823037e-05,0.9999212134239818,0,0.9749236726010645,0.02507632739893554,0,0.9128563108358807,0.08714368916411931,0,0.9442618489265442,0.08840446919202805,0,0.7916459441184998,0.18797729909420013,0,0.9609991435611674,0.03900085643883248,0
342,トロポニンT、高感度CRP、その他の画像検査は実施されなかった。,トロポニン T 感度 CRP その他 画像 検査 実施 する れる ない た,0,0.9999106480482202,8.935195177982096e-05,0,3.913935558562399e-05,0.9999608606444144,0,0.9955214742581786,0.0044785257418214425,0,0.9959561666923533,0.0040438333076467095,0,0.9426295161247253,0.05859995633363724,0,0.8267472386360168,0.14472545683383942,0,0.9720477219266982,0.02795227807330193,0
343,心臓カテーテル検査は行わなかった(厳密な虚血は否定されていた)。,心臓カテーテル検査 行う ない た 厳密 だ 虚血 否定 する れる いる た,0,0.9947074619567663,0.005292538043233647,0,6.849873851625831e-05,0.9999315012614838,0,0.9670029503537347,0.03299704964626524,1,0.23594154040577853,0.7640584595942215,0,0.9429547190666199,0.062095269560813904,0,0.8197636008262634,0.16179034113883972,1,0.8737216900324035,0.12627830996759654,0
344,ワクチン接種前または併用したCOVIDー19感染のデータはない。,ワクチン接種 前 併用 する た COVID ー 0 感染 データ ない,0,0.977304192958982,0.022695807041017927,0,9.826191209739756e-05,0.9999017380879026,0,0.9634794576129516,0.03652054238704835,0,0.9998172198542229,0.00018278014577715582,0,0.9502931237220764,0.061908625066280365,0,0.8406876921653748,0.14843887090682983,0,0.9695879296128973,0.03041207038710263,0
345,頭部コンピューター断層画像:(2022/04/25)特記所見なし,頭部 コンピューター 断層 画像 0 0 0 特記 所見 ない,0,0.9956661381379953,0.004333861862004642,0,6.7023243448114e-05,0.9999329767565519,0,0.9150126552617461,0.0849873447382539,0,0.9560874248808577,0.04391257511914226,0,0.9145934581756592,0.1925247311592102,0,0.8147820234298706,0.1534489393234253,0,0.9575913306627376,0.0424086693372625,0
346,心電図:(日付不明)変化なし注:心機能異常及び心電図変化は認めず,心電図 日付 不明 変化 ない 心機能異常 心電図変化 認める ぬ,0,0.9885232913218183,0.011476708678181763,0,8.890103683429792e-05,0.9999110989631657,0,0.9597265296135112,0.04027347038648878,0,0.9042894052528075,0.09571059474719247,1,0.5616897940635681,0.6867731809616089,1,0.33226048946380615,0.7454068064689636,1,0.7626071302895948,0.23739286971040516,0
347,2022/02/19、事象の転帰は軽快であった(報告のとおり)。,0 0 0 事象 転帰 軽快 だ ある た 報告 とおり,0,0.9986362425398946,0.001363757460105342,0,7.18666787190789e-05,0.9999281333212809,0,0.9827873663350757,0.017212633664924364,0,0.9999999997368678,2.631321747820732e-10,0,0.9412879943847656,0.0666298046708107,0,0.8082513809204102,0.16462235152721405,0,0.9701503565063946,0.02984964349360538,0
348,COVID-19に対する追加療法を受けたかどうかは不明であった。,COVID 0 追加 療法 受ける た 不明 だ ある た,0,0.9989219801029195,0.0010780198970804732,0,5.974216921429612e-05,0.9999402578307857,0,0.9889474344901454,0.011052565509854553,0,0.9851450279932973,0.014854972006702764,0,0.9480786919593811,0.06653352826833725,0,0.8265179991722107,0.19061291217803955,0,0.969634103081459,0.030365896918541,0
349,2022/06/08、頭部MRIが実施され、異常所見はなかった。,0 0 0 頭部 MRI 実施 する れる 異常所見 ない た,0,0.997801647824599,0.002198352175401065,0,8.069999443584515e-05,0.9999193000055642,0,0.9807404023790062,0.019259597620993777,0,0.9939599772763611,0.006040022723638883,0,0.9467864036560059,0.05883174017071724,0,0.8104216456413269,0.16208596527576447,0,0.9701554999747324,0.02984450002526752,0
350,2022/06/22受診後、患者は再来せず、回復等不明であった。,0 0 0 受診 後 患者 再来 する ぬ 回復 不明 だ ある た,0,0.9845961287302404,0.015403871269759544,0,7.015847701955717e-05,0.9999298415229805,0,0.9070415395699385,0.09295846043006156,0,0.8655006993835618,0.13449930061643822,0,0.9428663849830627,0.07818423211574554,0,0.8054492473602295,0.20249667763710022,0,0.9517566677693244,0.04824333223067547,0
351,クロザピン中止から間もなく、炎症反応は回復し、細胞数は回復した。,クロザピン 中止 炎症反応 回復 細胞 数 回復 する た,0,0.9930414300192673,0.006958569980732703,0,3.911073019217704e-05,0.9999608892698079,0,0.9852015749728615,0.014798425027138436,0,0.7669662169153603,0.23303378308463973,0,0.9347595572471619,0.06219291314482689,0,0.7994303107261658,0.16909568011760712,0,0.9522749750482359,0.04772502495176426,0
352,その後も症状の再燃はなく、患者は2021/12/29に退院した。,その後 症状 再燃 ない 患者 0 0 0 退院 する た,0,0.9998410056759834,0.00015899432401639117,0,6.359090446131629e-05,0.9999364090955387,0,0.9884413716704273,0.011558628329572659,0,0.6784566101823313,0.3215433898176688,0,0.9389951229095459,0.08090225607156754,0,0.8240260481834412,0.16501957178115845,0,0.9453550878670606,0.05464491213293944,0
353,心筋/心膜組織の病理組織検査と心臓磁気共鳴検査は未実施であった。,心筋 心膜 組織 病理 組織 検査 心臓 磁気 共鳴 検査 実施 だ ある た,0,0.9845726726556312,0.015427327344368823,0,8.004748604192341e-05,0.999919952513958,0,0.8643978086576414,0.13560219134235857,0,0.516113464363893,0.48388653563610695,0,0.9392327666282654,0.07842936366796494,0,0.8317179083824158,0.1653309166431427,0,0.9052970851380461,0.09470291486195383,0
354,2021/09/11、嚥下障害、構音障害と呼吸筋障害は改善した。,0 0 0 嚥下障害 構音障害 呼吸 筋障害 改善 する た,0,0.9845859746158869,0.015414025384113194,0,0.00012738250647362963,0.9998726174935264,0,0.9523250769696939,0.0476749230303061,0,0.6309847864454041,0.3690152135545958,0,0.9282501935958862,0.10318154096603394,0,0.7387139201164246,0.2656995952129364,0,0.9193930921405219,0.08060690785947806,0
355,2022/06/15、摂氏38度の発熱は軽快した(報告の通り)。,0 0 0 摂氏 0度 発熱 軽快 した 報告 通り,0,0.9845930861066928,0.015406913893307311,0,0.00011373750127816893,0.9998862624987218,0,0.7937174485455234,0.20628255145447663,0,0.9999994362445679,5.6375543213115e-07,0,0.9330411553382874,0.07662538439035416,0,0.8068699240684509,0.21567291021347046,0,0.9527752175828923,0.04722478241710773,0
356,COVID-19病原体(SARS-CoV-2)検査は実施された。,COVID 0 病原体 SARS CoV 0 検査 実施 する れる た,0,0.9907723033174464,0.009227696682553651,0,0.000113728170190724,0.9998862718298093,0,0.9672692905284369,0.03273070947156304,0,0.5077857463892764,0.4922142536107236,0,0.9242088794708252,0.1223379448056221,0,0.7743006348609924,0.24824121594429016,0,0.9054935861442686,0.09450641385573136,0
357,COVIDー19病原体(SARS-CoV-2)検査は実施された。,COVID ー 0 病原体 SARS CoV 0 検査 実施 する れる た,0,0.9876668792596011,0.012333120740398981,0,0.00011912067819360986,0.9998808793218064,0,0.9432217448922057,0.056778255107794294,1,0.442457481479687,0.557542518520313,0,0.9255049228668213,0.1267387419939041,0,0.7695683240890503,0.23041631281375885,1,0.8894218018740252,0.11057819812597484,0
358,Echocardiogram: (2022/06/10)改善傾向,Echocardiogram 0 0 0 改善 傾向,0,0.9998220067729655,0.0001779932270343733,0,5.8025102672610717e-05,0.9999419748973274,0,0.99352727046285,0.0064727295371499365,0,0.999999999999994,6.028309536464617e-15,0,0.9291444420814514,0.08695333451032639,0,0.8008736968040466,0.21421833336353302,0,0.9681904136914093,0.031809586308590605,0
359,その他の全ての事象の転帰は軽快(2022/05/17)であった。,その他 全て 事象 転帰 軽快 0 0 0 だ ある た,0,0.9975906045335388,0.0024093954664611557,0,7.712261569624203e-05,0.9999228773843037,0,0.985202454041563,0.014797545958436962,0,0.8393443052707715,0.1606556947292285,0,0.8871796131134033,0.12343443185091019,0,0.8073546886444092,0.15867573022842407,0,0.9550774745318802,0.044922525468119846,0
360,患者は10年前にMRIを受けており、VAに異常は見られなかった。,患者 0 年 前 MRI 受ける おる VA 異常 見る られる ない た,0,0.991635104043888,0.008364895956111932,0,8.258934466944193e-05,0.9999174106553306,0,0.9703869101181944,0.02961308988180557,0,0.9877674108210068,0.012232589178993208,0,0.945824921131134,0.055543385446071625,0,0.8234028816223145,0.14777708053588867,0,0.9696944854882049,0.03030551451179505,0
361,血液、唾液、尿の培養とインターフェロンγ遊離試験は陰性であった。,血液 唾液 尿 培養 インターフェロンγ遊離試験 陰性 だ ある た,0,0.9845578784792403,0.015442121520759777,0,8.901559567715959e-05,0.9999109844043228,0,0.9150774999595124,0.08492250004048761,0,0.6839332328462264,0.3160667671537735,0,0.935866117477417,0.06202251836657524,0,0.8508982062339783,0.18518206477165222,0,0.9374311048137187,0.06256889518628135,0
362,組織標本:いずれの組織標本でも異常な好酸球濾過は認められなかった,組織 標本 いずれ 組織 標本 異常 だ 好酸球 濾過 認める られる ない た,0,0.9845774073574625,0.01542259264253756,0,9.372302761835894e-05,0.9999062769723817,1,0.3224679403848556,0.6775320596151444,0,0.7935719828327722,0.20642801716722778,0,0.9400159120559692,0.06867071986198425,0,0.8311657905578613,0.15979203581809998,1,0.8512122928012504,0.14878770719874965,0
363,報告者はかかりつけ医ではないため、合併症などの情報は不明である。,報告 者 かかりつけ医 ない ため 合併症 情報 不明 だ ある,0,0.9923752894444912,0.0076247105555089035,0,6.477283267794378e-05,0.9999352271673221,0,0.9426620093222466,0.05733799067775332,0,0.722376943606093,0.277623056393907,0,0.9508017301559448,0.07372786849737167,0,0.8017754554748535,0.17776107788085938,0,0.943536800022318,0.056463199977682135,0
364,2021/10/12退院後2回目の外来時、心電図所見も正常化。,0 0 0 退院後 0回目 外来 時 心電図 所見 正常化,0,0.9900618230152878,0.009938176984712343,0,5.702897116574349e-05,0.9999429710288342,0,0.7267319629964726,0.2732680370035275,0,0.9999999999999731,2.690506481409978e-14,0,0.9315251111984253,0.07849150151014328,0,0.8198856115341187,0.19732819497585297,0,0.948303898979056,0.05169610102094404,0
365,2021/11/01、麻疹様発疹(麻疹様発疹)は回復していた。,0 0 0 麻疹 様 発疹 麻疹 様 発疹 回復 する いる た,0,0.9845627350157663,0.015437264984233692,0,0.00010888639611381932,0.9998911136038862,0,0.7061762877965746,0.2938237122034254,1,0.30285126422388464,0.6971487357761154,0,0.9172802567481995,0.07983411848545074,0,0.7964351773262024,0.18715359270572662,1,0.8075433912545298,0.19245660874547027,0
366,2021年12月13日SARS-CoV-2検査:(陰性)陰性。,0 年 0 月 0 日 SARS CoV 0 検査 陰性 陰性,0,0.9836503194609142,0.0163496805390858,0,8.332355609075671e-05,0.9999166764439092,0,0.9781457763071714,0.021854223692828613,0,1.0,1.1832368184858775e-25,0,0.9165593981742859,0.08070298284292221,0,0.818236231803894,0.20140144228935242,0,0.966960378988364,0.03303962101163609,0
367,2022/03入院後、安静により症状、採血所見の改善を認めた。,0 0 入院 後 安静 症状 採血 所見 改善 認める た,0,0.9845961476587148,0.01540385234128519,0,0.00013173376414265636,0.9998682662358573,0,0.967342231369003,0.03265776863099702,0,0.5379957304869791,0.4620042695130209,0,0.9252952337265015,0.07655631005764008,0,0.7732570767402649,0.20866017043590546,0,0.9163278106838546,0.08367218931614537,0
368,2022/05/16一日中動悸が治まらなかったが、一日で回復。,0 0 0 一 日中動悸 治まる ない た 一日 回復,0,0.9894076904039724,0.010592309596027727,0,7.326593042458958e-05,0.9999267340695754,0,0.922142903263157,0.07785709673684307,0,0.9999887329770434,1.1267022956653118e-05,0,0.9281477928161621,0.0850968286395073,0,0.78333979845047,0.255311518907547,0,0.9606193793217275,0.039380620678272464,0
369,アラニンアミノトランスフェラーゼ:31 U/L、31 U/L。,アラニンアミノトランスフェラーゼ 0 U L 0 U L,0,0.8674303108541146,0.13256968914588546,0,0.0001225511041999987,0.9998774488958,1,0.35873972300322543,0.6412602769967746,0,0.5195482961797382,0.48045170382026176,0,0.7842774391174316,0.19807679951190948,1,0.4258928894996643,0.6729605197906494,1,0.4578042944783657,0.5421957055216343,0
370,クロザピンの中止後すぐに、炎症反応は解消し、細胞数は回復した。,クロザピン 中止 後 炎症反応 解消 する 細胞 数 回復 する た,0,0.9845709838911062,0.015429016108893766,0,7.076773287464816e-05,0.9999292322671254,0,0.9334372884018297,0.06656271159817027,0,0.7836774138069456,0.21632258619305447,0,0.9400762915611267,0.06551656126976013,0,0.8051466345787048,0.16751258075237274,0,0.9486174355544701,0.051382564445529855,0
371,ロキソニンやカロナールなどの非ステロイド性抗炎症薬と点滴投与。,ロキソニン カロナール ステロイド性 抗炎症 薬 点滴 投与,0,0.9925106389768895,0.007489361023110456,0,7.778792305207979e-05,0.9999222120769479,0,0.940847802094617,0.059152197905382925,0,0.9943458614008176,0.005654138599182403,0,0.8916445374488831,0.140553817152977,0,0.7498815059661865,0.2854595184326172,0,0.9556838034774909,0.04431619652250903,0
372,開始後は速やかに解熱、炎症反応の改善を認めプレドニゾロン漸減。,開始 後 速やか 解熱 炎症反応 改善 認める プレドニゾロン 漸減,0,0.9915214489079832,0.008478551092016803,0,6.556408386919663e-05,0.9999344359161308,0,0.8885773549786056,0.1114226450213944,0,0.9999999997677677,2.3223239613322674e-10,0,0.9264867305755615,0.10501132905483246,0,0.7895823121070862,0.20504814386367798,0,0.9595476914545019,0.04045230854549806,0
373,血圧は80 mmHg台ではあったが、カテコラミン未使用で経過。,血圧 0 mmHg 台 ある た カテコラミン 未使用 経過,0,0.9053779724711521,0.09462202752884778,0,0.0001434878715960619,0.999856512128404,1,0.3285985167051432,0.6714014832948568,0,0.9999565693772521,4.343062274787823e-05,0,0.9239442348480225,0.08255627751350403,0,0.8092617988586426,0.21954171359539032,1,0.8698078778983543,0.13019212210164569,0
374,抗甲状腺抗体(不明-5.1未満):4.2 IU/mL(陰性)。,甲状腺抗体 不明 0 0 未満 0 0 IU mL 陰性,0,0.9967603695766569,0.003239630423343142,0,7.321158082085317e-05,0.9999267884191791,0,0.967006846359078,0.032993153640922014,0,0.9987712887773663,0.0012287112226336814,0,0.9090679287910461,0.09612823277711868,0,0.7663399577140808,0.24165259301662445,0,0.9631321415154216,0.036867858484578284,0
375,心血管造影:冠動脈コンピュータ断層撮影(CCT)陰性(陰性)。,心 血管造影 冠動脈 コンピュータ断層撮影 CCT 陰性 陰性,0,0.9900183327432137,0.009981667256786264,0,7.23928043830861e-05,0.9999276071956169,0,0.9772201720599405,0.02277982794005947,0,1.0,5.445043671911788e-22,0,0.9270614981651306,0.06994879990816116,0,0.8067747354507446,0.2186855971813202,0,0.9670679887775061,0.032932011222493875,0
376,心電図変化も現在認めない状態であり、今後のフォローは必要なし。,心電図変化 現在 認める ない 状態 だ ある 今後 フォロー 必要 ない,0,0.984583709791304,0.015416290208696027,0,5.562697626270742e-05,0.9999443730237373,0,0.9534695857577726,0.04653041424222733,0,0.9892841462817237,0.010715853718276332,0,0.9568605422973633,0.06393467634916306,0,0.8064383268356323,0.17406727373600006,0,0.9670762498100405,0.03292375018995959,0
377,入院2日目より、インスリンを静脈内投与から皮下注射に変更した。,入院 0 日 目 インスリン 静脈 内 投与 皮下注 射る 変更 する た,0,0.9845606275928105,0.01543937240718964,0,7.880239856640031e-05,0.9999211976014336,0,0.5640355359649997,0.43596446403500033,1,0.33595634008237707,0.6640436599176229,0,0.9305241107940674,0.0877438634634018,0,0.8044631481170654,0.20697815716266632,1,0.7702153969468025,0.2297846030531975,0
378,ワクチン接種以降、患者にCOVIDー19の検査はされなかった。,ワクチン接種 以降 患者 COVID ー 0 検査 する れる ない た,0,0.997141991762235,0.00285800823776513,0,9.217098324171338e-05,0.9999078290167582,0,0.987973582687587,0.012026417312413072,0,0.9974542991290428,0.002545700870957133,0,0.9550451040267944,0.0613737553358078,0,0.8322328925132751,0.1383650302886963,0,0.9721550395301592,0.027844960469840762,0
379,抗血小板第4因子抗体および抗HIT抗体検査は実施されなかった。,抗血小板 0 因子 抗体 HIT 抗体検査 実施 する れる ない た,0,0.9989401153832179,0.0010598846167821268,0,6.514516043817838e-05,0.9999348548395618,0,0.9869511731580486,0.013048826841951435,0,0.9907856270938019,0.009214372906198075,0,0.9441903233528137,0.05724172294139862,0,0.8344098925590515,0.1439051330089569,0,0.9715553316026142,0.028444668397385846,0
380,事象に対して、関連する他の診断検査や確認検査の結果はなかった。,事象 関連 する 他 診断 検査 確認 検査 結果 ない た,0,0.9941790532747488,0.005820946725251231,0,7.202507706044624e-05,0.9999279749229395,0,0.9909611441709222,0.009038855829077786,0,0.9970182765337288,0.0029817234662712607,0,0.9530691504478455,0.05431170389056206,0,0.8190537095069885,0.13656385242938995,0,0.9719607007555006,0.028039299244499397,0
381,今は基礎疾患がないため、血圧、肺機能も通常は問題なしであった。,今 基礎疾患 ない ため 血圧 肺 機能 通常 問題なし だ ある た,0,0.9231933733686138,0.07680662663138622,0,9.289772628772851e-05,0.9999071022737123,0,0.6581082816649699,0.3418917183350301,0,0.6783838573428596,0.32161614265714045,0,0.9427044987678528,0.05845467001199722,0,0.8326693773269653,0.18227273225784302,0,0.8863716496840983,0.11362835031590163,0
382,1回目ワクチン接種時:合併症、アレルギー、基礎疾患はなかった。,0回目 ワクチン接種 時 合併症 アレルギー 基礎疾患 ない た,0,0.9948916620925956,0.005108337907404489,0,6.991201927492836e-05,0.999930087980725,0,0.9911654464229694,0.008834553577030604,0,0.9886078538848508,0.01139214611514919,0,0.9443748593330383,0.05910627171397209,0,0.8381785154342651,0.1457725167274475,0,0.9714503181335893,0.028549681866410794,0
383,事象に対して、関連する他の診断結果や確認検査の結果は無かった。,事象 関連 する 他 診断 結果 確認 検査 結果 無い た,0,0.8850801085881307,0.11491989141186923,0,9.03080198427722e-05,0.9999096919801572,1,0.398191930509766,0.601808069490234,0,0.9995996729325496,0.0004003270674504246,0,0.9204112887382507,0.12033291906118393,0,0.8140466213226318,0.14094537496566772,1,0.8848419650077219,0.11515803499227806,0
384,心電図所見は徐々に改善し、入院4日後にはST低下はなくなった。,心電図 所見 改善 する 入院 0 日 後 ST 低下 なくなる た,0,0.9804340180215929,0.019565981978406987,0,0.00011805963113902642,0.999881940368861,0,0.8321273579046131,0.16787264209538694,0,0.9899623340103806,0.01003766598961947,0,0.9167750477790833,0.08717519044876099,0,0.8143808245658875,0.1796737015247345,0,0.9556208097146487,0.04437919028535135,0
385,2022/05/24、事象の転帰は軽快であった(報告の通り)。,0 0 0 事象 転帰 軽快 だ ある た 報告 通り,0,0.9990098538689165,0.0009901461310835014,0,6.649156772121297e-05,0.9999335084322788,0,0.9853703872512933,0.014629612748706692,0,0.999999827931009,1.7206899095897213e-07,0,0.9373418688774109,0.06478088349103928,0,0.8054470419883728,0.1588902771472931,0,0.9703447104699887,0.02965528953001132,0
386,事象に対して関連する他の診断または確認検査の結果は不明である。,事象 関連 する 他 診断 確認 検査 結果 不明 だ ある,0,0.9845601655662408,0.015439834433759242,0,8.509289002054846e-05,0.9999149071099794,0,0.9625022450119891,0.03749775498801089,0,0.9540178125941833,0.04598218740581674,0,0.9398376941680908,0.09164801239967346,0,0.8165965676307678,0.16188760101795197,0,0.9646077707604187,0.03539222923958121,0
387,2022/02/01、COVID-19抗原検査は陰性であった。,0 0 0 COVID 0 抗原検査 陰性 だ ある た,0,0.995337213500098,0.0046627864999019344,0,0.00011559554923235821,0.9998844044507676,0,0.9668133996143495,0.03318660038565043,0,0.9276022213796363,0.07239777862036369,0,0.9335657954216003,0.059929437935352325,0,0.8308096528053284,0.17961952090263367,0,0.9645850290931669,0.035414970906833154,0
388,2022/02/23、PCR検査を実施し、結果は陰性であった。,0 0 0 PCR検査 実施 する 結果 陰性 だ ある た,0,0.9983563522027668,0.0016436477972332315,0,6.281616127014238e-05,0.9999371838387299,0,0.9856052440522897,0.014394755947710386,0,0.967142744216647,0.032857255783352975,0,0.9349483251571655,0.06453683227300644,0,0.8295509219169617,0.17277735471725464,0,0.9686144597574627,0.031385540242537174,0
389,フォローの採血検査では心筋酵素、炎症反応共に改善傾向にあった。,フォロー 採血 検査 心筋 酵素 炎症反応共 改善 傾向 ある た,0,0.984599156313313,0.015400843686687081,0,6.58377944652044e-05,0.9999341622055348,0,0.9930421927623465,0.006957807237653489,0,0.727578418539405,0.272421581460595,0,0.9400233626365662,0.06556828320026398,0,0.8271698355674744,0.20175206661224365,0,0.9483603157880108,0.051639684211989105,0
390,ミドドリン、ミグシスとレバミピドで加療するも、改善しなかった。,ミドドリン ミグシス レバミピド 加療 する 改善 する ない た,0,0.9991738533026325,0.0008261466973674393,0,7.38620606841472e-05,0.9999261379393158,0,0.977588331100495,0.02241166889950497,0,0.9847772542158741,0.015222745784125833,0,0.9472631216049194,0.05414487421512604,0,0.7112659811973572,0.28771182894706726,0,0.9623084463377458,0.03769155366225411,0
391,患者は、薬物、食物または他の製品に対するアレルギーはなかった。,患者 薬物 食物 他 製品 アレルギー ない た,0,0.9925274510093796,0.007472548990620341,0,6.355033455758164e-05,0.9999364496654424,0,0.974539195961596,0.025460804038404047,0,0.9926020141633367,0.00739798583666328,0,0.9446370005607605,0.05287298187613487,0,0.8413812518119812,0.15285664796829224,0,0.9706807418285713,0.029319258171428796,0
392,胸部X線: (2021/10/15)異常なし/心拡大の所見なし,胸部 X線 0 0 0 異常 ない 心拡大 所見 ない,0,0.987797033089719,0.012202966910280924,0,5.195788615845822e-05,0.9999480421138416,0,0.9960558646096112,0.0039441353903888485,0,0.9999800280302645,1.9971969735468533e-05,0,0.9353243708610535,0.07706625014543533,0,0.8328230977058411,0.15439903736114502,0,0.9708141755493498,0.029185824450650107,0
393,SARS-CoV-2検査により、COVID-19は否定された。,SARS CoV 0 検査 COVID 0 否定 する れる た,0,0.9936549435559745,0.006345056444025536,0,7.248710935302806e-05,0.999927512890647,0,0.9196911243797253,0.0803088756202747,0,0.7169662678521576,0.28303373214784244,0,0.9372146129608154,0.0667826235294342,0,0.8085301518440247,0.18562372028827667,0,0.9401449391581518,0.059855060841848176,0
394,レムデシビルを投与したところ、低酸素血症と肺の画像は改善した。,レムデシビル 投与 する た ところ 低酸素血症 肺 画像 改善 する た,0,0.9866404182853403,0.013359581714659691,0,8.35232874240367e-05,0.999916476712576,0,0.9844220494983511,0.015577950501648882,0,0.956991280941374,0.043008719058626,0,0.929146409034729,0.06954662501811981,0,0.7961598634719849,0.20112456381320953,0,0.9648011846861776,0.03519881531382242,0
395,ワクチン接種前に、患者はCOVID-19の診断はされなかった。,ワクチン接種 前 患者 COVID 0 診断 する れる ない た,0,0.9696546785241646,0.030345321475835244,0,0.0001254520635717576,0.9998745479364283,0,0.9693110691687382,0.030688930831261767,0,0.9984485931452388,0.0015514068547612379,0,0.9475989937782288,0.0613066740334034,0,0.8351690173149109,0.14207594096660614,0,0.9693640173312765,0.030635982668723503,0
396,血液検査:(日付不明)炎症所見はなし、注釈:先行感染もなかった,血液検査 日付 不明 炎症所見 ない 注釈 先行感染 ない た,0,0.9876677624775417,0.012332237522458185,0,5.983436055300961e-05,0.999940165639447,0,0.9922302672106986,0.007769732789301359,0,0.9991226281534804,0.0008773718465195422,0,0.9415557980537415,0.05868106707930565,0,0.8431909084320068,0.14987242221832275,0,0.9716496026272505,0.028350397372749588,0
397,現状、患者は回復しているらしいので4回目接種を検討中であった。,現状 患者 回復 する いる らしい 0回目 接種 検討 中 だ ある た,0,0.9845615412061701,0.01543845879382972,0,8.277602600822301e-05,0.9999172239739917,0,0.9162888525320424,0.08371114746795758,0,0.6584418198923276,0.3415581801076723,0,0.9423146843910217,0.09101320058107376,0,0.8137701749801636,0.19342468678951263,0,0.9302409807650251,0.0697590192349749,0
398,被験者にSARS-CoV2感染中に悪化した基礎疾患はなかった。,被験者 SARS CoV 0 感染中 悪化 する た 基礎疾患 ない た,0,0.9796026253193763,0.020397374680623827,0,8.047053579864816e-05,0.9999195294642014,0,0.9641797707210672,0.035820229278932775,0,0.9954836200369208,0.004516379963079181,0,0.9450914263725281,0.0595836266875267,0,0.811606228351593,0.1632152646780014,0,0.9680957490322568,0.03190425096774314,0
399,Transaminases: no abnormalities,Transaminases N・O abnormalities,0,0.8147384146363513,0.18526158536364878,0,0.00013302490709065382,0.9998669750929093,1,0.4563792597309324,0.5436207402690676,0,1.0,1.316253539458348e-19,0,0.7748222351074219,0.29847827553749084,0,0.6659526824951172,0.409397155046463,1,0.7816658884933229,0.2183341115066771,0
400,2022/03/20症状の改善を認め、エピペン指導し、退院。,0 0 0 症状 改善 認める エピペン 指導 する 退院,0,0.9894709177364349,0.010529082263565132,0,8.751180940271866e-05,0.9999124881905973,0,0.9922481819768847,0.007751818023115303,0,0.9999999999944477,5.552293613419499e-12,0,0.9334849119186401,0.08147229999303818,0,0.8208021521568298,0.1971113532781601,0,0.9689109377157444,0.03108906228425559,0
401,2022/05/31、自覚症状、検査所見とも改善し退院した。,0 0 0 自覚症状 検査 所見 改善 する 退院 する た,0,0.9998872845669582,0.00011271543304195662,0,5.213277819695158e-05,0.9999478672218031,0,0.9979742549394102,0.002025745060589798,0,0.9887286622646595,0.011271337735340479,0,0.9391686320304871,0.06584025919437408,0,0.8000630140304565,0.188984215259552,0,0.9694597017062896,0.030540298293710477,0
402,アシクロビル、メチルプレドニゾロン投与終了したが、著変なし。,アシクロビル メチルプレドニゾロン 投与 終了 する た 著変 ない,0,0.9995880144077639,0.0004119855922359815,0,4.116808326008557e-05,0.99995883191674,0,0.98213089302853,0.017869106971470084,0,0.9837447356567693,0.01625526434323067,0,0.9496669769287109,0.05305410176515579,0,0.8401080369949341,0.19524452090263367,0,0.9698946924285202,0.030105307571479705,0
403,インスリン及び生食の持続静脈内投与に反応し、血糖は低下した。,インスリン 生食 持続 静脈 内 投与 反応 する 血糖 低下 する た,0,0.9845538690529153,0.015446130947084748,0,0.000103784001062396,0.9998962159989376,0,0.7261742703511799,0.2738257296488201,1,0.3818186494441933,0.6181813505558067,1,0.34500089287757874,0.7626758217811584,0,0.7540366649627686,0.28076303005218506,1,0.5599353916445363,0.4400646083554636,0
404,インフルエンザ、COVID-19抗原検査実施し、陰性を確認。,インフルエンザ COVID 0 抗原検査 実施 する 陰性 確認,0,0.9977228552191533,0.0022771447808467306,0,6.017671774251178e-05,0.9999398232822575,0,0.9808562712937201,0.01914372870627985,0,0.999998979164746,1.0208352540427479e-06,0,0.9206021428108215,0.10984799265861511,0,0.8120039105415344,0.19121567904949188,0,0.967353266510768,0.032646733489232034,0
405,コンピュータ断層多層血管造影では冠状動脈疾患は認めなかった。,コンピュータ 断層 多層 血管造影 冠状動脈疾患 認める ない た,0,0.9845947843723367,0.015405215627663206,0,0.00010043310436499065,0.999899566895635,0,0.5980856214867061,0.401914378513294,0,0.959857787058173,0.040142212941827,0,0.934680700302124,0.05806833878159523,0,0.8275172710418701,0.1651640683412552,0,0.9324056026782972,0.06759439732170282,0
406,"ニトログリセリン舌下錠を投与し,胸痛・心電図変化は改善した。",ニトログリセリン 舌下錠 投与 する 胸痛 心電図変化 改善 する た,0,0.9866325616776481,0.013367438322351747,0,7.545546122803816e-05,0.999924544538772,0,0.9587786283755074,0.041221371624492575,0,0.9146132241142556,0.08538677588574443,0,0.9255191087722778,0.074639692902565,0,0.8364660739898682,0.20620837807655334,0,0.9608845542911796,0.039115445708820515,0
407,ロキソプロフェンNa 60 mg 3錠分3内服にて治療開始。,ロキソプロフェン Na 0 mg 0 錠 分 0 内服 治療 開始,0,0.9922578640920707,0.007742135907929279,0,8.296200680309397e-05,0.9999170379931969,0,0.9892394486827515,0.010760551317248563,0,0.6551861868317841,0.34481381316821585,0,0.8768195509910583,0.1265885978937149,0,0.8038402199745178,0.23863857984542847,0,0.9301480338676608,0.06985196613233932,0
408,頚動脈デュプレックス超音波検査:頚動脈プラーク又は狭窄なし。,頚動脈 デュプレックス 超音波 検査 頚動脈プラーク 狭窄 ない,0,0.9794177295617956,0.020582270438204358,0,0.00010324311370382951,0.9998967568862962,0,0.9095213986040933,0.09047860139590674,0,0.999003984012099,0.0009960159879009779,0,0.9395055174827576,0.07569726556539536,0,0.830482542514801,0.16413627564907074,0,0.9646425067157652,0.03535749328423488,0
409,採血、心電図、造影CTで原因を指摘できず、経過観察となった。,採血 心電図 造影 CT だ 原因 指摘 できる ぬ 経過 観察 なる た,0,0.9756510034121706,0.024348996587829384,0,0.00014980476226005842,0.99985019523774,0,0.527386602390805,0.47261339760919496,1,0.29840466841578217,0.7015953315842178,0,0.92540442943573,0.12189529836177826,0,0.7734105587005615,0.200215145945549,1,0.727086131785497,0.272913868214503,0
410,採血、頸椎のレントゲン撮影を行なったが、異常は認めなかった。,採血 頸椎 レントゲン 撮影 行なう た 異常 認める ない た,0,0.9230140894141294,0.07698591058587068,0,0.00011487395114650618,0.9998851260488535,0,0.598709600453658,0.40129039954634205,0,0.9688476014573865,0.03115239854261355,0,0.9402657151222229,0.06552958488464355,0,0.8294058442115784,0.1693630963563919,0,0.9252663517898835,0.07473364821011648,0
411,治療開始後、速やかに解熱、意識レベルとDIC状態が改善した。,治療 開始 後 速やか 解熱 意識レベル DIC 状態 改善 する た,0,0.9970982425423264,0.0029017574576737266,0,6.368549069667743e-05,0.9999363145093033,0,0.9730053654484248,0.02699463455157522,0,0.7135660874389993,0.28643391256100076,0,0.9308851361274719,0.07430100440979004,0,0.797158420085907,0.17840740084648132,0,0.944945409615446,0.05505459038455396,0
412,術後6ヵ月目に初回mRNAワクチン(商品名不明)を接種した。,術後 0 ヵ月 目 初回 mRNA ワクチン 商品名 不明 接種 する た,0,0.9874520499699498,0.012547950030050117,0,8.962259280332744e-05,0.9999103774071967,0,0.691761863708771,0.30823813629122904,1,0.25021855970491513,0.7497814402950849,0,0.9156872630119324,0.10829979181289673,0,0.8238992094993591,0.16949822008609772,1,0.7893202048539597,0.2106797951460403,0
413,心尖部血栓を認めなかったため直接経口抗凝固薬による治療終了。,心尖部血栓 認める ない た ため 直接 経口 抗凝固 薬 治療 終了,0,0.985441864693647,0.014558135306352969,0,8.085950240969058e-05,0.9999191404975903,0,0.7643650354053342,0.23563496459466576,0,0.9999999998895416,1.1045841753278434e-10,0,0.9457549452781677,0.06486622244119644,0,0.8172684907913208,0.17832989990711212,0,0.9534519018296137,0.0465480981703864,0
414,副腎皮質ステロイドは、血清CRP値が陰性になるまで漸減した。,腎皮質 ステロイド 血清 CRP 値 陰性 なる 漸減 する た,0,0.9811223897399639,0.018877610260036128,0,7.284496639777513e-05,0.9999271550336022,0,0.9841664746139707,0.015833525386029296,0,0.7536325870262528,0.2463674129737472,0,0.9316908121109009,0.058814410120248795,0,0.8231036067008972,0.1753823310136795,0,0.950667734211584,0.04933226578841592,0
415,併用薬には乳癌第4期のためのdocetaxelなどがあった。,併用 薬 乳癌 0 期 ため docetaxel ある た,0,0.7331571610373516,0.26684283896264843,1,0.00019586356685619128,0.9998041364331438,0,0.809091173915662,0.190908826084338,0,0.584434003274431,0.41556599672556904,0,0.8646427392959595,0.1557265967130661,0,0.7331196069717407,0.3258671462535858,1,0.7973680370334656,0.20263196296653446,0
416,心臓MRI検査、心臓超音波検査、心電図検査は未実施であった。,心臓 MRI 検査 心臓 超音波 検査 心電図 検査 実施 だ ある た,0,0.9695533445097255,0.03044665549027435,0,0.00010417933488808708,0.999895820665112,0,0.9594529814392194,0.04054701856078052,0,0.7432889442990216,0.25671105570097835,0,0.9430469274520874,0.0682467371225357,0,0.828362762928009,0.17322151362895966,0,0.946583542436752,0.05341645756324786,0
417,10月の健康診断で血糖値は正常で、糖尿病は指摘されなかった。,0 月 健康 診断 だ 血糖 値 正常 だ 糖尿病 指摘 する れる ない た,0,0.9845839870966101,0.015416012903389916,0,9.174099207697194e-05,0.999908259007923,0,0.7599335544109707,0.24006644558902937,0,0.9680872016938015,0.03191279830619854,0,0.9416678547859192,0.05660754069685936,0,0.7608438730239868,0.2704782485961914,0,0.9427200602478417,0.05727993975215822,0
418,2022/05/04(ワクチン接種3日後)、患者は退院した。,0 0 0 ワクチン接種 0 日 後 患者 退院 する た,0,0.9845552406455506,0.01544475935444947,0,0.00012975202794256722,0.9998702479720575,0,0.9850422726854934,0.014957727314506621,0,0.8766686763723368,0.12333132362766323,0,0.93790602684021,0.08161034435033798,0,0.8039366602897644,0.18877995014190674,0,0.9594663315249886,0.040533668475011324,0
419,患者に薬物、食物または他の製品に対するアレルギーはなかった。,患者 薬物 食物 他 製品 アレルギー ない た,0,0.9925274510093796,0.007472548990620341,0,6.355033455758164e-05,0.9999364496654424,0,0.974539195961596,0.025460804038404047,0,0.9926020141633367,0.00739798583666328,0,0.9446370005607605,0.05287298187613487,0,0.8413812518119812,0.15285664796829224,0,0.9706807418285713,0.029319258171428796,0
420,2022/06/27、症状は消失し、患者は症状から寛解した。,0 0 0 症状 消失 する 患者 症状 寛解 する た,0,0.9989319839701405,0.0010680160298594794,0,7.087198498460235e-05,0.9999291280150154,0,0.9142532181488167,0.08574678185118335,0,0.89462290928047,0.10537709071953004,0,0.9204680323600769,0.07799125462770462,0,0.823052167892456,0.17082194983959198,0,0.957322356453667,0.04267764354633309,0
421,頭部磁気共鳴画像:(不明日)転移や梗塞部位は認められなかった,頭部 磁気 共鳴 画像 明日 転移 梗塞 部位 認める られる ない た,0,0.984568901605147,0.01543109839485311,0,8.842344937049346e-05,0.9999115765506295,0,0.7858906004786703,0.21410939952132962,0,0.9456412759506797,0.05435872404932034,0,0.9409216046333313,0.06435899436473846,0,0.8359878659248352,0.16868242621421814,0,0.9514894109550702,0.04851058904492973,0
422,それ以外は、患者はワクチン接種後、重篤な有害事象はなかった。,それ 以外 患者 ワクチン接種 後 重篤 だ 有害事象 ない た,0,0.9875655167563078,0.012434483243692276,0,6.093823503787464e-05,0.9999390617649622,0,0.9361605730522524,0.06383942694774762,0,0.9925813356496294,0.007418664350370614,0,0.9479463696479797,0.05487716197967529,0,0.8429253697395325,0.1503470540046692,0,0.9682741744769008,0.03172582552309932,0
423,2022/04/25、病院初診時には症状は完全回復していた。,0 0 0 病院 初診 時 症状 完全 回復 する いる た,0,0.9920811302591324,0.007918869740867673,0,7.414688911686503e-05,0.9999258531108831,0,0.954590726753475,0.04540927324652494,0,0.7580638334172363,0.24193616658276368,0,0.93359375,0.07401463389396667,0,0.8178388476371765,0.1885683834552765,0,0.9477707148337973,0.052229285166202746,0
424,Blood culture:(2022/06/03)特記なし,BLOOD culture 0 0 0 特記 ない,0,0.997962186692085,0.0020378133079148207,0,7.306426302314771e-05,0.9999269357369769,0,0.9453015381125173,0.05469846188748271,0,0.9984900672039726,0.0015099327960274057,0,0.9499857425689697,0.07232533395290375,0,0.8168132305145264,0.16460208594799042,0,0.9681245697622581,0.03187543023774189,0
425,ワクチン接種日周辺に解熱剤を使用したかどうかは不明であった。,ワクチン接種 日 周辺 解熱 剤 使用 する た 不明 だ ある た,0,0.9845703909204953,0.015429609079504608,0,7.437362646027846e-05,0.9999256263735398,0,0.9831965038357176,0.01680349616428249,0,0.8349611984531479,0.16503880154685216,0,0.936024010181427,0.06002592667937279,0,0.832328200340271,0.1828741431236267,0,0.9581557950400655,0.04184420495993445,0
426,血小板値は死後血では正確な値を反映しないため測定しなかった。,血小板 値 死後 血 正確 だ 値 反映 する ない ため 測定 する ない た,0,0.9845698101628203,0.01543018983717965,0,8.857858343826583e-05,0.9999114214165618,0,0.8548100431786825,0.14518995682131747,0,0.9788105819025219,0.021189418097478083,0,0.937576949596405,0.07585182785987854,0,0.8101691603660583,0.14852994680404663,0,0.9592979151651381,0.040702084834861985,0
427,心機能は駆出率(EF)70%まで改善を認め、患者は退院した。,心 機能 駆け出し 率 EF 0% 改善 認める 患者 退院 する た,0,0.9868484824288105,0.01315151757118945,0,8.256364796791073e-05,0.9999174363520321,0,0.9198850596758914,0.08011494032410858,0,0.569492934169987,0.43050706583001297,0,0.93105149269104,0.07627329230308533,0,0.7848496437072754,0.19344379007816315,0,0.9167359146050359,0.08326408539496406,0
428,その後に硬膜外ブラッドパッチを施行、頭痛はほとんど消失した。,その後 硬膜外 ブラ ッドパッチ 施行 頭痛 消失 する た,0,0.9845769990085329,0.015423000991467026,0,8.446804972601374e-05,0.9999155319502739,0,0.935676222299411,0.06432377770058899,1,0.3013422837281545,0.6986577162718455,0,0.943438708782196,0.08380156010389328,0,0.809698224067688,0.18417450785636902,1,0.8730856056286121,0.1269143943713879,0
429,呼吸器病原体検出キットによる検査: (2022年)すべて陰性,呼吸 器 病原体 検出 キット 検査 0 年 すべて 陰性,0,0.9074332613429922,0.09256673865700775,0,8.669617339070385e-05,0.9999133038266093,0,0.7868674355059367,0.21313256449406323,0,0.9999997937905436,2.0620945645403364e-07,0,0.9275076985359192,0.10310955345630646,0,0.8120602965354919,0.18335843086242676,0,0.944897136345329,0.05510286365467111,0
430,ケトン体(尿中ケトン体):陰性、注記:基準値は(-)であった,ケトン体 尿 中 ケトン体 陰性 注記 基準値 だ ある た,0,0.9845902240053809,0.01540977599461929,0,9.064074145671148e-05,0.9999093592585433,0,0.5436511919071236,0.4563488080928763,1,0.39214965662831924,0.6078503433716808,0,0.8600892424583435,0.18377742171287537,0,0.8277226090431213,0.20018193125724792,1,0.7585627510292658,0.24143724897073407,0
431,1ヵ月の追跡調査時、血清トロポニンTは正常範囲内であった。,0 ヵ月 追跡調査 時 血清 トロポニン T 正常範囲 内 だ ある た,0,0.9950470552757864,0.004952944724213531,0,5.408747385253731e-05,0.9999459125261475,0,0.8440431593496163,0.15595684065038376,0,0.7919373582262552,0.20806264177374484,0,0.9345498085021973,0.06782861053943634,0,0.8302744626998901,0.15781550109386444,0,0.9427483800775678,0.05725161992243227,0
432,2021/08/25心臓MRI検査を実施し、異常所見なし。,0 0 0 心臓 MRI 検査 実施 する 異常所見なし,0,0.9978334606859113,0.0021665393140887666,0,5.482654567428249e-05,0.9999451734543258,0,0.9543783582188167,0.045621641781183365,0,0.999999959883476,4.011652404565775e-08,0,0.9199663996696472,0.0662652850151062,0,0.8115381598472595,0.20840176939964294,0,0.9664752175126733,0.03352478248732682,0
433,2022/03/26安静・臥床での経過観察にて症状は改善。,0 0 0 安静 臥床 経過 観察 症状 改善,0,0.9990672857732183,0.0009327142267816385,0,8.331319712025621e-05,0.9999166868028797,0,0.9920109921652451,0.007989007834754912,0,0.9998799850959064,0.0001200149040936495,0,0.9132525324821472,0.07901278883218765,0,0.8052604794502258,0.18473747372627258,0,0.9688364267236989,0.031163573276301034,0
434,その他の神経所見に異常はなく、髄膜刺激徴候も認めなかった。,その他 神経所見 異常 ない 髄膜刺激 徴候 認める ない た,0,0.9845893742414977,0.015410625758502374,0,7.490829622409859e-05,0.9999250917037759,0,0.9865426891698883,0.01345731083011169,0,0.9954079099556541,0.004592090044345954,0,0.9357456564903259,0.09402153640985489,0,0.8324129581451416,0.17198427021503448,0,0.9687922149324653,0.031207785067534705,0
435,トラネキサム酸は効果がないため内服を中止した(薬効欠如)。,トラネキサム 酸 効果 ない ため 内服 中止 する た 薬効 欠如,0,0.9845551686879008,0.01544483131209911,0,7.062364245030745e-05,0.9999293763575496,0,0.6680671007194301,0.3319328992805699,0,0.9999999917098275,8.290172568449358e-09,0,0.9387407302856445,0.06833970546722412,0,0.7844460010528564,0.27197954058647156,0,0.9363299266953052,0.0636700733046947,0
436,患者にCOVID-19及びその他合併症の罹患歴はなかった。,患者 COVID 0 その他 合併症 の 罹患歴 ない た,0,0.9949967449635098,0.005003255036490391,0,7.43056897106549e-05,0.9999256943102893,0,0.992467120242747,0.007532879757253048,0,0.9841170012403546,0.015882998759645335,0,0.9391185641288757,0.06048949807882309,0,0.8292471766471863,0.15436430275440216,0,0.9705972182635506,0.029402781736449383,0
437,患者はCOVID-19と診断/陽性となったことはなかった。,患者 COVID 0 診断 陽性 なる た こと ない た,0,0.9056953257951968,0.09430467420480314,1,0.00025683539092302,0.999743164609077,0,0.8145116923682977,0.18548830763170232,0,0.9999466434600163,5.335653998372112e-05,0,0.9359820485115051,0.0626787319779396,0,0.8442100286483765,0.15389379858970642,1,0.9527743329371333,0.047225667062866634,0
438,心臓超音波検査では、左室駆出率70%であり、異常所見なし。,心臓 超音波 検査 左 室 駆け出し 率 0% だ ある 異常所見なし,0,0.9845689259385169,0.01543107406148309,0,0.00010469565267332756,0.9998953043473267,0,0.794569997582314,0.20543000241768603,0,0.9987411717330783,0.0012588282669217128,0,0.9220921397209167,0.07988414913415909,0,0.8112807273864746,0.2683950662612915,0,0.9498394082819842,0.05016059171801583,0
439,人工呼吸器または体外膜酸素化(ECMO)の使用はなかった。,人工呼吸器 体外 膜 酸素化 ECMO 使用 ない た,0,0.9944465751796047,0.00555342482039538,0,7.542489597546563e-05,0.9999245751040245,0,0.9266823476495376,0.07331765235046236,0,0.9966581844951651,0.003341815504834974,0,0.9474228620529175,0.05407420173287392,0,0.8350127935409546,0.1500253826379776,0,0.968141102232519,0.031858897767480944,0
440,全身状態は良好で、アスピリン300mgを1日3回処方した。,全身 状態 良好 だ アスピリン 0m g 0 日 0回 処方 する た,0,0.9846033450502013,0.015396654949798635,0,8.074514194311044e-05,0.9999192548580569,0,0.877504240885333,0.12249575911466704,1,0.4298612421097455,0.5701387578902545,0,0.9351585507392883,0.07770907133817673,0,0.8186429142951965,0.1746353805065155,1,0.8894913672517232,0.11050863274827681,0
441,追跡調査を試みたが、報告者の協力が得られず、追跡調査不能。,追跡調査 試みる た 報告 者 協力 得る られる ぬ 追跡調査 不能,0,0.9845618878877623,0.015438112112237543,0,7.904192918526129e-05,0.9999209580708147,1,0.31802560916603007,0.6819743908339699,0,0.9998303144605193,0.00016968553948067957,0,0.9218289852142334,0.1361590176820755,0,0.8097601532936096,0.16878476738929749,1,0.8840791598510541,0.11592084014894588,0
442,日付不明ステロイドパルス療法施行後、神経症状は徐々に改善。,日付 不明 ステロイド パルス 療法 施行 後 神経症状 改善,0,0.9988361944849358,0.0011638055150641946,0,5.119697606769143e-05,0.9999488030239323,0,0.9975394624652554,0.0024605375347446,0,0.9999476649032587,5.233509674131858e-05,0,0.9224120378494263,0.09333737939596176,0,0.7982190251350403,0.20282219350337982,0,0.9682384062348777,0.031761593765122415,0
443,日付不明リハビリ病院で加療後、当科外来で術後のフォロー中。,日付 不明 リハビリ 病院 加療 後 科 外来 術後 フォロー 中,0,0.9845664289460756,0.015433571053924545,0,7.365383666795869e-05,0.9999263461633321,0,0.7562237644096942,0.24377623559030584,0,0.9949498637709075,0.005050136229092478,0,0.9438571929931641,0.08571770787239075,0,0.8229421377182007,0.1934112161397934,0,0.9507010945935226,0.049298905406477425,0
444,発症約2ヵ月後には矯正視力右1.0、左1.2まで回復した。,発症 0 ヵ月 後 矯正 視力 右 0 0 左 0 0 回復 する た,0,0.9845564461703973,0.015443553829602776,1,0.00017574191848384468,0.9998242580815162,0,0.5196689099319769,0.48033109006802316,1,0.4599017109924758,0.5400982890075242,0,0.9241009950637817,0.11840973794460297,0,0.7922045588493347,0.2099948674440384,1,0.7885999030653894,0.21140009693461048,0
445,併用薬には痛風のためのallopurinolなどがあった。,併用 薬 痛風 ため allopurinol ある た,0,0.9845427696642787,0.015457230335721349,0,0.00012433163105188153,0.9998756683689481,0,0.7516701802173489,0.24832981978265115,1,0.3959544508982714,0.6040455491017286,0,0.919670581817627,0.14171798527240753,0,0.792711079120636,0.269959419965744,1,0.8271107975868113,0.17288920241318864,0
446,ワクチン接種以後、COVIDー19検査は実施されなかった。,ワクチン接種 以後 COVID ー 0 検査 実施 する れる ない た,0,0.9995718634433853,0.0004281365566146218,0,6.796253472805564e-05,0.9999320374652719,0,0.9839205035744605,0.016079496425539495,0,0.9963990603494643,0.0036009396505356246,0,0.955045759677887,0.060832858085632324,0,0.8272911310195923,0.1397026628255844,0,0.9718518064360145,0.028148193563985364,0
447,心臓MRI検査および直近の冠動脈検査は、実施されなかった。,心臓 MRI 検査 直近 冠動脈 検査 実施 する れる ない た,0,0.99980824673881,0.00019175326119003224,0,5.731376356455063e-05,0.9999426862364355,0,0.9920679920501543,0.00793200794984572,0,0.9941621002553152,0.005837899744684801,0,0.9524933695793152,0.05643056333065033,0,0.8354592323303223,0.14337655901908875,0,0.9723566316377374,0.027643368362262576,0
448,ESR(1時間値)およびD-ダイマーは、実施されなかった。,ESR 0時 間 値 D ダイマー 実施 する れる ない た,0,0.998466917459143,0.0015330825408569923,0,7.204250505672093e-05,0.9999279574949432,0,0.9722669604800569,0.027733039519943107,0,0.9958680908804189,0.0041319091195811,0,0.943193256855011,0.056979142129421234,0,0.8368101119995117,0.14748318493366241,0,0.9709396345551385,0.029060365444861513,0
449,人工呼吸器または体外膜酸素化(ECMO)を使用しなかった。,人工呼吸器 体外 膜 酸素化 ECMO 使用 する ない た,0,0.9955068594747967,0.004493140525203243,0,7.961220323346651e-05,0.9999203877967665,0,0.928686000798546,0.07131399920145401,0,0.9920624407379492,0.0079375592620507,0,0.9516990780830383,0.056630898267030716,0,0.8335828185081482,0.14472301304340363,0,0.968219250391542,0.03178074960845793,0
450,4日目、退院となり、1か月以内に再発の症状は認めていない。,0 日 目 退院 なる 0 か月 以内 再発 症状 認める いる ない,0,0.984570499915137,0.015429500084862985,0,6.599911296594189e-05,0.9999340008870341,0,0.871372531110004,0.12862746888999593,0,0.9406323801104561,0.05936761988954383,0,0.9264429211616516,0.13605475425720215,0,0.7970801591873169,0.17029358446598053,0,0.9530443348519678,0.04695566514803212,0
451,患者は安静時、重度の全身疾患を示す臨床徴候は示さなかった。,患者 安静 時 重度 全身 疾患 示す 臨床徴候 示す ない た,0,0.9845916254264281,0.015408374573571809,0,0.0001177250516319122,0.9998822749483681,0,0.922460817217705,0.07753918278229503,0,0.925924886117337,0.07407511388266298,0,0.953193724155426,0.07424457371234894,0,0.8181058764457703,0.15640594065189362,0,0.9610908385531087,0.038909161446891286,0
452,補液による保存的加療後、改善傾向にて、患者は一旦退院した。,補液 保存 的 加療 後 改善 傾向 患者 退院 する た,0,0.9940046215634831,0.005995378436516877,0,7.50604048989994e-05,0.999924939595101,0,0.9988897084353541,0.0011102915646459411,1,0.4644357686718311,0.5355642313281689,0,0.9376652836799622,0.06613318622112274,0,0.7824416160583496,0.19322948157787323,1,0.9149441207760863,0.08505587922391362,0
453,人工呼吸器も体外式膜型人工肺(ECMO)の使用もなかった。,人工呼吸器 体外 式 膜型人工肺 ECMO 使用 ない た,0,0.9958451221723513,0.004154877827648751,0,6.120246184090982e-05,0.9999387975381591,0,0.9624138043385085,0.037586195661491476,0,0.9977171168378974,0.0022828831621025812,0,0.9497802257537842,0.05633328855037689,0,0.8405463695526123,0.15630966424942017,0,0.9703949481452041,0.029605051854795957,0
454,被験者に合併症、アレルギー、既往歴または治療薬はなかった。,被験者 合併症 アレルギー 既往 歴 治療薬 ない た,0,0.9925941386616138,0.007405861338386155,0,7.342392073233252e-05,0.9999265760792677,0,0.9891442186069256,0.010855781393074365,0,0.9922063898496133,0.007793610150386685,0,0.9490091800689697,0.054731473326683044,0,0.8244629502296448,0.14625418186187744,0,0.9712660985892813,0.02873390141071872,0
455,2022年には、プレドニゾロン5 mgまで減量できていた。,0 年 プレドニゾロン 0 mg 減量 できる いる た,0,0.9845730354458501,0.015426964554149946,0,0.00011618735569982123,0.9998838126443002,0,0.7793437546540152,0.22065624534598485,0,0.9360486042945577,0.06395139570544224,0,0.9386890530586243,0.062351685017347336,0,0.8254866003990173,0.20767681300640106,0,0.9475644579294551,0.05243554207054501,0
456,SARS-CoV- 2感染中に悪化した基礎疾患はなかった。,SARS CoV 0 感染中 悪化 する た 基礎疾患 ない た,0,0.9895177954360513,0.010482204563948678,0,7.656634319656786e-05,0.9999234336568035,0,0.9536107232604573,0.04638927673954275,0,0.9981842075322577,0.0018157924677422907,0,0.9416555166244507,0.05945175886154175,0,0.8095899224281311,0.17222534120082855,0,0.9677778020160592,0.03222219798394075,0
457,初回および2回目接種時に妊娠あるいは授乳の疑いはなかった。,初回 0回目 接種 時 妊娠 授乳 疑い ない た,0,0.9845863684487633,0.01541363155123651,0,8.056164712210408e-05,0.9999194383528779,0,0.8741072158462264,0.12589278415377356,0,0.9540006689391567,0.04599933106084327,0,0.9337322115898132,0.0727999284863472,0,0.8375102281570435,0.14961223304271698,0,0.9598586827132176,0.040141317286782344,0
458,人工呼吸器も体外式膜型人工肺(ECMO)も使用しなかった。,人工呼吸器 体外 式 膜型人工肺 ECMO 使用 する ない た,0,0.9967256732938733,0.003274326706126764,0,6.491472227763726e-05,0.9999350852777223,0,0.9634794576129516,0.03652054238704835,0,0.9940114428619431,0.005988557138056857,0,0.9531979560852051,0.05595593899488449,0,0.836226761341095,0.1545410007238388,0,0.9703297400039861,0.029670259996013876,0
459,頭部磁気共鳴画像: (2022/06/08)異常所見なし。,頭部 磁気 共鳴 画像 0 0 0 異常所見なし,0,0.9845614404313927,0.015438559568607329,0,7.351296244420045e-05,0.9999264870375558,0,0.5846297631957111,0.41537023680428886,0,0.9999972670828368,2.73291716325998e-06,0,0.8988973498344421,0.07643591612577438,0,0.8103406429290771,0.20592725276947021,0,0.9286012322117922,0.07139876778820779,0
460,Chest X-ray: (2022/06/04)異常なし,CHEST X-RAY 0 0 0 異常 ない,0,0.9927498463723333,0.007250153627666629,0,7.528733154847039e-05,0.9999247126684515,0,0.9840786066824166,0.01592139331758336,0,0.9999999765315247,2.3468475224907915e-08,0,0.920263409614563,0.10806360840797424,0,0.8312055468559265,0.15754428505897522,0,0.9689215349718352,0.03107846502816472,0
461,IVIG投与後は、症状はわずかではあるが改善傾向であった。,IVIG 投与 後 症状 だ ある 改善 傾向 だ ある た,0,0.9997713982084117,0.00022860179158840232,0,4.333517306688954e-05,0.9999566648269331,0,0.999386416943873,0.0006135830561270236,0,0.9990948088277185,0.0009051911722815496,0,0.9445102214813232,0.06946725398302078,0,0.8354060053825378,0.1873825043439865,0,0.9712419640083677,0.028758035991632323,0
462,クロザピンの血中濃度は、施設で測定することができなかった。,クロザピン 血中濃度 施設 測定 する こと できる ない た,0,0.9912281374642934,0.008771862535706597,0,7.316500365091548e-05,0.999926834996349,0,0.8896714986966349,0.11032850130336515,0,0.983897300810768,0.016102699189232034,0,0.9492430686950684,0.05563634634017944,0,0.8354472517967224,0.18458449840545654,0,0.9635333754156594,0.03646662458434064,0
463,ステロイドに反応するが、病前のADLを得ることはできない。,ステロイド 反応 する 病 前 ADL 得る こと できる ない,0,0.8662627505352255,0.1337372494647743,0,9.127027059911103e-05,0.9999087297294009,0,0.9831738861532484,0.016826113846751638,0,0.8676484171215348,0.13235158287846513,0,0.9473994374275208,0.07532920688390732,0,0.8319113254547119,0.16684658825397491,0,0.9512692832868943,0.04873071671310569,0
464,患者はワクチン接種の2週以内にその他薬剤を服用しなかった。,患者 ワクチン接種 0 週 以内 その他 薬剤 服用 する ない た,0,0.9986706507298575,0.0013293492701423949,0,5.265070655732999e-05,0.9999473492934426,0,0.9662336578856998,0.03376634211430021,0,0.9913859273886813,0.00861407261131872,0,0.9428324103355408,0.05379835516214371,0,0.8301244974136353,0.14524084329605103,0,0.9703041848380858,0.029695815161914208,0
465,事象右室不全の転帰は回復(2022年、日付不明)であった。,事象 右室不全 転帰 回復 0 年 日付 不明 だ ある た,0,0.998239990856976,0.0017600091430239149,0,6.680412674144781e-05,0.9999331958732586,0,0.9713131608819104,0.02868683911808957,0,0.8668624975290348,0.13313750247096523,0,0.9365708231925964,0.08773469924926758,0,0.6511175632476807,0.3869772255420685,0,0.9419113772753592,0.05808862272464088,0
466,追加報告の試みは以上であり、これ以上の情報は期待できない。,追加 報告 試み 以上 だ ある これ 以上 情報 期待 できる ない,0,0.984564896675456,0.015435103324544038,0,7.511812102896418e-05,0.999924881878971,0,0.8337928277262069,0.16620717227379309,0,0.9306129737674541,0.06938702623254585,0,0.9521719217300415,0.07834596186876297,0,0.8182690739631653,0.16655422747135162,0,0.9536304148592831,0.04636958514071691,0
467,Lipemic index score: negative,Lipemic INDEX SCO Re: negative,0,0.9744285557358504,0.02557144426414959,0,7.766987460101972e-05,0.999922330125399,1,0.4563792597309324,0.5436207402690676,0,1.0,2.1216141726876757e-35,0,0.5898372530937195,0.44495460391044617,1,0.39771580696105957,0.7395210862159729,1,0.6603486584787807,0.33965134152121934,0
468,13:15、経口挿管が実施され、ドーパミンが開始された。,0 0 経口 挿管 実施 する れる ドーパミン 開始 する れる た,0,0.984576184430696,0.015423815569303953,0,9.94482669877369e-05,0.9999005517330123,0,0.8233544382395325,0.17664556176046753,0,0.6608481374263091,0.33915186257369095,0,0.9168154001235962,0.15628845989704132,1,0.45166656374931335,0.651923418045044,1,0.8172799515743686,0.18272004842563133,0
469,2022/03/17施行2日目より、対麻痺改善を認めた。,0 0 0 施行 0 日 目 対麻痺 改善 認める た,0,0.984579973654066,0.01542002634593398,0,9.576634730360709e-05,0.9999042336526964,0,0.9075047253136095,0.09249527468639057,1,0.24697593175448707,0.7530240682455129,0,0.9352778196334839,0.07504428178071976,0,0.813427209854126,0.20854143798351288,1,0.8511224819431568,0.1488775180568433,0
470,2022/04/04再検にて心筋トロポニンI陰性を確認。,0 0 0 再検 心筋 トロポニン I 陰性 確認,0,0.9965719925784229,0.003428007421577183,0,7.923235401291415e-05,0.9999207676459871,0,0.9705064665746779,0.02949353342532217,0,0.9999917526014607,8.247398539322425e-06,0,0.8389176726341248,0.1867893487215042,0,0.8106107115745544,0.18260785937309265,0,0.9613737095358764,0.03862629046412364,0
471,2022/05/26、患者はトレッドミル心電図を受けた。,0 0 0 患者 トレッドミル 心電図 受ける た,0,0.9845427811470292,0.015457218852970753,0,0.00012923972326871587,0.9998707602767313,0,0.5147609264047455,0.48523907359525453,0,0.9850645027483125,0.01493549725168753,0,0.8509207367897034,0.20956288278102875,0,0.7684347629547119,0.2693479061126709,0,0.8918172792047083,0.10818272079529163,0
472,アドレナリン注0.1% 1/2 Aを右大腿部に筋肉注射。,アドレナリン 0 0% 0 0 A 右 大腿 部 筋肉 注射,1,0.02310201487672344,0.9768979851232765,1,0.00041977879712327753,0.9995802212028767,1,0.061943353374357635,0.9380566466256424,0,0.9999954010880802,4.598911919818387e-06,0,0.6508713960647583,0.49095526337623596,0,0.7210752964019775,0.2834811210632324,1,0.22590700271996775,0.7740929972800323,0
473,胸部症状や発熱の再燃がないことから、第6病日に退院した。,胸部症状 発熱 再燃 ない こと 0 病 日 退院 する た,0,0.9951997610006077,0.004800238999392177,0,7.143796375795327e-05,0.999928562036242,0,0.927212921906593,0.07278707809340705,1,0.4960500690326417,0.5039499309673583,0,0.9357886910438538,0.06739934533834457,0,0.8119626641273499,0.1856023520231247,1,0.9114781362396448,0.08852186376035526,0
474,治療開始後の症状改善乏しく、血漿交換療法を予定している。,治療 開始 後 症状改善 乏しい 血漿交換 療法 予定 する いる,0,0.9845796587801773,0.01542034121982273,0,0.00010525075314797505,0.9998947492468521,0,0.7869242575125456,0.21307574248745445,0,0.7378242946456227,0.2621757053543773,0,0.9213893413543701,0.11864583939313889,1,0.5133106112480164,0.667124330997467,1,0.8412818436906345,0.1587181563093655,0
475,心臓生検:組織標本にウイルスゲノムの所見を認めなかった。,心臓 生検 組織 標本 ウイルス ゲノム 所見 認める ない た,0,0.984576183835818,0.015423816164181875,0,7.357403501262467e-05,0.9999264259649874,0,0.7287857132438114,0.2712142867561886,0,0.9723708456794848,0.027629154320515135,0,0.9421657919883728,0.06368397921323776,0,0.8210051655769348,0.14777101576328278,0,0.9489876776722775,0.05101232232772236,0
476,心電図検査も正常洞調律で症状もなく、症状の回復を認めた。,心電図 検査 正常洞調律 症状 ない 症状 回復 認める た,0,0.9997033092912114,0.0002966907087885151,0,7.094287825974977e-05,0.9999290571217403,0,0.9714357056039014,0.028564294396098616,1,0.39817065133924523,0.6018293486607548,0,0.9325675964355469,0.05871432647109032,0,0.8227483630180359,0.17134571075439453,1,0.9058527859197418,0.0941472140802581,0
477,接種3日後、心エコー図にて局所壁運動異常は認めなかった。,接種 0 日 後 心 エコー 図 局所壁運動異常 認める ない た,0,0.9845635677345196,0.015436432265480448,0,0.00011098218637599229,0.999889017813624,0,0.7604502586007319,0.23954974139926807,0,0.9860955079955982,0.013904492004401805,0,0.9256439805030823,0.0871795266866684,0,0.8300747871398926,0.15954303741455078,0,0.9512669293046366,0.0487330706953634,0
478,当院に転院し、そして、ワソラン投与その後徴候は改善した。,院 転院 する ワソラン 投与 その後 徴候 改善 する た,0,0.9966506194411469,0.0033493805588530705,0,7.268792038102721e-05,0.9999273120796189,0,0.9806475206630056,0.019352479336994327,0,0.8708643133126146,0.12913568668738537,0,0.9392558932304382,0.07159219682216644,0,0.7813131213188171,0.1975598782300949,0,0.9588253917053358,0.0411746082946643,0
479,搬送時、SARS-CoV-2抗原定性検査は検出感度以下。,搬送 時 SARS CoV 0 抗原 定性 検査 検出感度以下,0,0.965114358734534,0.03488564126546602,0,0.00012035706147844981,0.9998796429385215,0,0.760431213286078,0.23956878671392204,0,0.999998930562052,1.0694379480229854e-06,0,0.873852014541626,0.21168152987957,0,0.802015483379364,0.19681181013584137,0,0.9381213369156711,0.06187866308432883,0
480,報告時、微少病変糸球体腎炎(微小変化群)は回復していた。,報告 時 微少 病変 糸球体腎炎 微小変化群 回復 する いる た,0,0.9845732192786026,0.01542678072139745,0,7.648788203730809e-05,0.9999235121179627,0,0.9531643315056624,0.046835668494337596,0,0.6107389770900298,0.38926102290997017,0,0.9402442574501038,0.0710848793387413,0,0.8216232061386108,0.16485686600208282,0,0.9323292347513961,0.06767076524860391,0
481,報告時、蜂巣炎(リンパ浮腫部位の蜂巣炎)は回復していた。,報告 時 蜂巣炎 リンパ 浮腫部位 の 蜂巣炎 回復 する いる た,0,0.9550842898558105,0.0449157101441895,0,0.00015621606513470024,0.9998437839348653,0,0.7647710277377311,0.23522897226226896,0,0.502163250276596,0.4978367497234039,0,0.9342316389083862,0.07542698830366135,0,0.7927561402320862,0.170324444770813,0,0.8727600418506276,0.12723995814937233,0
482,来院後、TRC法でSARS-CoV-2検査実施し、陰性。,来院 後 TRC 法 SARS CoV 0 検査 実施 する 陰性,0,0.9951238922351214,0.00487610776487846,0,7.890382851307153e-05,0.999921096171487,0,0.9675119591490893,0.032488040850910685,0,0.9999999964174018,3.582598249035286e-09,0,0.9182671308517456,0.09334808588027954,0,0.7920464277267456,0.2751104533672333,0,0.9632892648576532,0.0367107351423468,0
483,家族歴は、ワクチン関連の特記すべき事項の報告はなかった。,家族 歴 ワクチン 関連 特記 する べし 事項 報告 ない た,0,0.9916049384737453,0.008395061526254665,0,6.886477216108457e-05,0.9999311352278389,0,0.9531220009529239,0.04687799904707609,0,0.9860362380490181,0.01396376195098188,0,0.9578390717506409,0.06991811841726303,0,0.8360212445259094,0.17136459052562714,0,0.9681466708196531,0.03185332918034697,0
484,再調査の試みは完了し、これ以上の追加情報は期待できない。,再調査 試み 完了 する これ 以上 追加 情報 期待 できる ない,0,0.9910068816416855,0.008993118358314364,0,4.757071461229246e-05,0.9999524292853877,0,0.8900247608895075,0.10997523911049249,0,0.9217468328874515,0.0782531671125485,0,0.9567208886146545,0.07143665105104446,0,0.8131521940231323,0.15889105200767517,0,0.9587190712043223,0.041280928795677685,0
485,その他の疾患など、他に考えられる本事象の原因はなかった。,その他 疾患 他 考える られる 事象 原因 ない た,0,0.9937054733014372,0.006294526698562889,0,7.749811314037642e-05,0.9999225018868596,0,0.9889939316772202,0.011006068322779793,0,0.9661749948654291,0.033825005134570846,0,0.9370768666267395,0.06101994588971138,0,0.8244611024856567,0.15085582435131073,0,0.9691584704451875,0.030841529554812404,0
486,臨床症状、所見を説明可能なその他の疾患は否定されている。,臨床症状 所見 説明 可能 だ その他 疾患 否定 する れる いる,0,0.984561699130812,0.015438300869187927,0,6.4237801630871e-05,0.9999357621983691,0,0.9130277767872834,0.08697222321271664,0,0.8029387633256713,0.19706123667432873,0,0.9450648427009583,0.06257248669862747,0,0.8331912755966187,0.1684430092573166,0,0.950189024016606,0.049810975983393936,0
487,冠動脈造影検査:(2021/11/03)有意病変はなし。,冠動脈造影 検査 0 0 0 有意 病変 ない,0,0.9970352133761002,0.002964786623899746,0,6.473055875618596e-05,0.9999352694412438,0,0.9587706140472985,0.04122938595270159,0,0.9999779093263671,2.209067363292528e-05,0,0.9350671768188477,0.07751090079545975,0,0.8186211585998535,0.168436661362648,0,0.9683065199793638,0.031693480020636114,0
488,薬剤、食物、または他の製品に対してアレルギーはなかった。,薬剤 食物 他 製品 対す アレルギー ない た,0,0.9928314647509713,0.007168535249028815,0,6.225228401920702e-05,0.9999377477159808,0,0.9620102512237333,0.03798974877626673,0,0.9796835632616699,0.020316436738330036,0,0.9436668753623962,0.054379478096961975,0,0.8437814116477966,0.1547173708677292,0,0.9691572899436177,0.030842710056382255,0
489,2022/04/27、体温管理療法および抜管は完了した。,0 0 0 体温 管理 療法 抜管 完了 する た,0,0.9845869690519867,0.015413030948013341,0,8.003105633365614e-05,0.9999199689436663,1,0.48710059809420747,0.5128994019057925,0,0.8961972409691162,0.10380275903088376,0,0.9328702092170715,0.07370646297931671,0,0.8145605325698853,0.19231486320495605,1,0.9017957973099899,0.09820420269001007,0
490,患者には、関連する病歴(接種時の病気を含む)はなかった。,患者 関連 する 病歴 接種 時 病気 含む ない た,0,0.994611569670497,0.005388430329503005,0,6.455988402991992e-05,0.9999354401159701,0,0.9811427631900509,0.018857236809949128,0,0.9826886289175071,0.01731137108249287,0,0.9508612155914307,0.06034615635871887,0,0.836064338684082,0.1506425440311432,0,0.9704865627509122,0.029513437249087945,0
491,コンピュータ断層撮影:(2021/07/19)異常なし。,コンピュータ断層撮影 0 0 0 異常 ない,0,0.9760777571339991,0.023922242866000892,0,0.0001039791822960811,0.9998960208177039,0,0.9597775112735767,0.04022248872642334,0,0.9998686870776907,0.000131312922309242,0,0.924800455570221,0.07654444873332977,0,0.8340485095977783,0.1594870537519455,0,0.9675313661139799,0.032468633886020046,0
492,初回および2回目接種時に妊娠および授乳の疑いはなかった。,初回 0回目 接種 時 妊娠 授乳 疑い ない た,0,0.9845863684487633,0.01541363155123651,0,8.056164712210408e-05,0.9999194383528779,0,0.8741072158462264,0.12589278415377356,0,0.9540006689391567,0.04599933106084327,0,0.9337322115898132,0.0727999284863472,0,0.8375102281570435,0.14961223304271698,0,0.9598586827132176,0.040141317286782344,0
493,SARS- CoV2感染中に悪化した基礎疾患はなかった。,SARS CoV 0 感染中 悪化 する た 基礎疾患 ない た,0,0.9895177954360513,0.010482204563948678,0,7.656634319656786e-05,0.9999234336568035,0,0.9536107232604573,0.04638927673954275,0,0.9981842075322577,0.0018157924677422907,0,0.9416555166244507,0.05945175886154175,0,0.8095899224281311,0.17222534120082855,0,0.9677778020160592,0.03222219798394075,0
494,SARS-CoV-2感染中に悪化した基礎疾患はなかった。,SARS CoV 0 感染中 悪化 する た 基礎疾患 ない た,0,0.9895177954360513,0.010482204563948678,0,7.656634319656786e-05,0.9999234336568035,0,0.9536107232604573,0.04638927673954275,0,0.9981842075322577,0.0018157924677422907,0,0.9416555166244507,0.05945175886154175,0,0.8095899224281311,0.17222534120082855,0,0.9677778020160592,0.03222219798394075,0
495,ワクチン接種に関連した副反応の可能性も否定できなかった。,ワクチン接種 関連 する た 副反応 可能性 否定 できる ない た,0,0.9923738472984037,0.007626152701596229,0,6.924239343864902e-05,0.9999307576065614,0,0.9840732384459445,0.01592676155405548,0,0.9949625170561157,0.005037482943884329,0,0.9451007843017578,0.054646555334329605,0,0.7888177037239075,0.21458280086517334,0,0.9679426645469633,0.03205733545303662,0
496,ワクチン接種日周辺に解熱剤が使用されたかは不明であった。,ワクチン接種 日 周辺 解熱 剤 使用 する れる た 不明 だ ある た,0,0.9581299685774771,0.0418700314225229,0,7.987868325967193e-05,0.9999201213167404,0,0.9803721787618064,0.01962782123819366,0,0.8009711872080943,0.19902881279190565,0,0.9325257539749146,0.06537873297929764,0,0.8259016871452332,0.18752151727676392,0,0.9518750772468932,0.04812492275310681,0
497,患者は、基礎疾患および合併症は無かった(報告のとおり)。,患者 基礎疾患 合併症 無い た 報告 とおり,0,0.9845528242686825,0.015447175731317434,0,6.75679918471198e-05,0.9999324320081528,0,0.6547951274052601,0.3452048725947399,0,0.999999999851808,1.4819203613747413e-10,0,0.9446845650672913,0.09056100249290466,0,0.8134952187538147,0.17336934804916382,0,0.9412036896001781,0.058796310399822,0
498,患者本人いわく、第1、2回目接種の際は特に問題なかった。,患者 本人 いわく 0 0回目 接種 際 問題 ない た,0,0.9845737818598934,0.015426218140106505,0,9.866717912167097e-05,0.9999013328208783,0,0.8973697427234012,0.10263025727659876,0,0.9780399513064213,0.02196004869357867,0,0.950522780418396,0.06649963557720184,0,0.8224567174911499,0.20550839602947235,0,0.9616219516222582,0.03837804837774181,0
499,血液検査:(202206/10)特筆すべき所見はなかった,血液検査 0 0 特筆 する べし 所見 ない た,0,0.9915235665022252,0.008476433497774796,0,0.00010109313995975539,0.9998989068600402,0,0.9732172265883408,0.026782773411659296,0,0.9873175909995816,0.012682409000418367,0,0.9484857320785522,0.056757599115371704,0,0.8357208371162415,0.15615390241146088,0,0.9699858929565022,0.030014107043497724,0
500,血液検査で血栓性素因なく、血栓を誘発する内服はなかった。,血液検査 だ 血栓性素因 ない 血栓 誘発 する 内服 ない た,0,0.9939368756143653,0.006063124385634679,0,5.731590066607488e-05,0.999942684099334,0,0.9956102493384352,0.004389750661564721,0,0.9985087538563318,0.0014912461436682957,0,0.9452314972877502,0.0591856874525547,0,0.8452123403549194,0.15518149733543396,0,0.9721398695536088,0.027860130446391206,0
501,血液検査等は各種伝染病と膠原病に対して否定可能であった。,血液検査 等 各種 伝染病 膠原病 否定 可能 だ ある た,0,0.8288447334860443,0.1711552665139557,0,8.528501680629605e-05,0.9999147149831937,0,0.6525896991346708,0.3474103008653292,0,0.6362065803391581,0.3637934196608419,0,0.9417322278022766,0.0603383406996727,0,0.8180518746376038,0.17790742218494415,0,0.8528323954433948,0.14716760455660519,0
502,呼吸器、心血管系、皮膚/粘膜を含む多臓器障害はなかった。,呼吸 器 心 血管系 皮膚 粘膜 含む 多臓器障害 ない た,0,0.984570559204063,0.015429440795937046,0,8.045498405683363e-05,0.9999195450159432,0,0.835692725669096,0.16430727433090397,0,0.9222802580018234,0.07771974199817659,0,0.931373655796051,0.0791788250207901,0,0.7960530519485474,0.16278202831745148,0,0.951233402046962,0.04876659795303805,0
503,SARS-CoV2感染中に、悪化した基礎疾患はなかった。,SARS CoV 0 感染中 悪化 する た 基礎疾患 ない た,0,0.9895177954360513,0.010482204563948678,0,7.656634319656786e-05,0.9999234336568035,0,0.9536107232604573,0.04638927673954275,0,0.9981842075322577,0.0018157924677422907,0,0.9416555166244507,0.05945175886154175,0,0.8095899224281311,0.17222534120082855,0,0.9677778020160592,0.03222219798394075,0
504,その後、内服は徐々に減らされ、後遺症はほとんどなかった。,その後 内服 徐々 減らす れる 後遺症 ない た,0,0.9845664595109858,0.015433540489014262,0,8.134886195298206e-05,0.999918651138047,0,0.9768269873075187,0.023173012692481277,0,0.9735312400821724,0.02646875991782759,0,0.9531155228614807,0.058143336325883865,0,0.8229774832725525,0.16974548995494843,0,0.9682690132469856,0.03173098675301434,0
505,医師は一般開業医なので、その病院でのことは知らなかった。,医師 一般 開業医 だ 病院 こと 知る ない た,0,0.9948994597639219,0.0051005402360781585,0,6.221745266466007e-05,0.9999377825473353,0,0.9188770006865576,0.08112299931344234,0,0.9620097152760126,0.037990284723987335,0,0.9445239305496216,0.06404446810483932,0,0.8330675363540649,0.16605445742607117,0,0.9644009894287937,0.0355990105712063,0
506,患者は3回予防接種を受けており、すべて熱などはなかった。,患者 0回 予防接種 受ける おる すべて 熱 ない た,0,0.997595751276128,0.0024042487238720737,0,6.831595115784952e-05,0.9999316840488421,0,0.9679211531229813,0.032078846877018626,0,0.9700659889797725,0.029934011020227472,0,0.9283520579338074,0.087933748960495,0,0.8353384137153625,0.14612489938735962,0,0.9677337199139172,0.03226628008608276,0
507,呼吸困難および胸痛に対して受けた治療は「なし」とされた。,呼吸困難 胸痛 受ける た 治療 なし する れる た,0,0.9845844599406367,0.01541554005936333,0,0.00014442812104645378,0.9998555718789536,1,0.4487883224666904,0.5512116775333096,1,0.10634499208568604,0.893655007914314,0,0.9402774572372437,0.09634784609079361,0,0.7596048712730408,0.26088958978652954,1,0.6040500627954877,0.3959499372045123,0
508,抗GAD抗体:(不明日)陰性化、注記:3か月後に再検した,GAD 抗体 明日 陰性化 注記 0 か月 後 再検 する た,0,0.9905139623819456,0.00948603761805448,0,7.933818017699697e-05,0.999920661819823,0,0.7294261338655496,0.27057386613445045,1,0.4167664484312995,0.5832335515687005,0,0.9365639090538025,0.06447417289018631,0,0.8237982988357544,0.2105007916688919,1,0.853079235491723,0.14692076450827687,0
509,心エコーでは心収縮は良好で、asynergyはなかった。,心 エコー 心収縮 良好 だ asynergy ない た,0,0.9995960720247219,0.0004039279752781208,0,5.859231542526988e-05,0.9999414076845747,0,0.9841889220850335,0.015811077914966453,0,0.9782042991030829,0.02179570089691703,0,0.9472674131393433,0.06042589619755745,0,0.8333738446235657,0.17796072363853455,0,0.9697150216007203,0.030284978399279756,0
510,入院時の心エコーでは壁運動の局所的な低下は認めなかった。,入院 時 心 エコー 壁 運動 局所的 低下 認める ない た,0,0.9845597332395444,0.015440266760455715,0,0.00011970558822642724,0.9998802944117736,0,0.6421977304293387,0.35780226957066136,0,0.9800785104909133,0.01992148950908671,0,0.940451443195343,0.08052237331867218,0,0.803174614906311,0.17895707488059998,0,0.9369119518543093,0.06308804814569063,0
511,2022/05/20、皮下植込み型除細動器が挿入された。,0 0 0 皮下 植込み 型 除 細動 器 挿入 する れる た,0,0.9845810964344985,0.015418903565501596,0,0.00011953419467221365,0.9998804658053277,1,0.31885326053051444,0.6811467394694856,1,0.15891966579238093,0.8410803342076191,0,0.8282210826873779,0.258944034576416,0,0.7939102649688721,0.22337517142295837,1,0.5161841582443314,0.4838158417556686,0
512,2022/04/09胸部症状はほぼ完解したため、退院。,0 0 0 胸部症状 完 解す た ため 退院,0,0.9845456710751619,0.01545432892483816,0,9.299244083064868e-05,0.9999070075591694,0,0.9013759282453354,0.09862407175466463,0,0.9999999999950684,4.931630753179073e-12,0,0.9320500493049622,0.1015472412109375,0,0.8157617449760437,0.19078092277050018,0,0.9618566066098081,0.03814339339019188,0
513,11月現在sCr 2.85mg/dLまで改善している。,0 月 現在 sCr 0 0m g dL 改善 する いる,0,0.9929667946557806,0.007033205344219373,0,8.497446743452163e-05,0.9999150255325655,0,0.9713049766963772,0.02869502330362285,0,0.8585263652920885,0.14147363470791147,0,0.9351802468299866,0.07525335252285004,0,0.8254691958427429,0.1898527592420578,0,0.9585649250499212,0.041435074950078796,0
514,2022/04/23発熱、ふらつき、手指等しびれなし。,0 0 0 発 熱 ふらつき 手 指 等 しびれ ない,1,0.2566820648350007,0.7433179351649991,1,0.00017857047033237436,0.9998214295296676,0,0.7318571473213339,0.2681428526786661,1,0.13061207150387655,0.8693879284961235,1,0.35090115666389465,0.8207052946090698,1,0.22013992071151733,0.8526943922042847,1,0.05397750811300846,0.9460224918869915,0
515,2022/04診療の結果、潰瘍性大腸炎ではないと診断。,0 0 診療 結果 潰瘍性大 腸炎 だ ない 診断,0,0.9845918021402958,0.015408197859704067,0,9.592136814619218e-05,0.9999040786318538,0,0.7326148628803772,0.2673851371196228,0,0.9612388953205936,0.03876110467940639,0,0.7614485025405884,0.29411837458610535,0,0.8004463315010071,0.24018460512161255,0,0.9156511918190183,0.08434880818098164,0
516,2022/05/26状態が改善し、人工呼吸管理を離脱。,0 0 0 状態 改善 する 人工呼吸 管理 離脱,0,0.9958166788443774,0.004183321155622528,0,7.445036216059084e-05,0.9999255496378394,0,0.9356952389777593,0.06430476102224073,0,0.9999999985475464,1.452453594312821e-09,0,0.921699047088623,0.08770044147968292,0,0.7910338044166565,0.19964295625686646,0,0.9640343353253431,0.03596566467465692,0
517,2022/07/01現在もステロイド治療を行っている。,0 0 0 現在 ステロイド 治療 行う いる,0,0.9686526752692961,0.03134732473070384,0,0.00012850079872425162,0.9998714992012757,0,0.9448082514608694,0.05519174853913051,0,0.8321574011801605,0.1678425988198395,0,0.9289702773094177,0.08840113878250122,0,0.7609327435493469,0.31721311807632446,0,0.9413530354562569,0.058646964543743,0
518,9日目以降も無熱が続いたため、12日目に退院となった。,0 日 目 以降 熱 続く た ため 0 日 目 退院 なる た,0,0.9845573756328212,0.015442624367178814,0,0.00014182236743438137,0.9998581776325656,0,0.9262940946422201,0.07370590535777984,0,0.5397957147197083,0.4602042852802917,0,0.8974614143371582,0.1857731193304062,0,0.6550488471984863,0.33334991335868835,0,0.8737979794614418,0.1262020205385582,0
519,その後、プレドニン60 mgから内服開始し、漸減した。,その後 プレドニン 0 mg 内服 開始 する 漸減 する た,0,0.9974016494884206,0.00259835051157943,0,5.732220843830621e-05,0.9999426777915617,0,0.9885421362731258,0.01145786372687416,0,0.9858411124068894,0.014158887593110594,0,0.918844997882843,0.08802618086338043,0,0.8079574108123779,0.20681719481945038,0,0.9669346009875682,0.03306539901243169,0
520,ヒト免疫不全ウイルス(HIV)抗原:陰性(陰性)陰性。,ヒト 免疫不全 ウイルス HIV 抗原 陰性 陰性 陰性,0,0.8938715192448218,0.10612848075517801,0,5.4287475662811606e-05,0.9999457125243372,0,0.9748863304620521,0.02511366953794793,0,1.0,4.101068538484409e-39,0,0.9247937202453613,0.06983952224254608,0,0.8269773125648499,0.18960082530975342,0,0.9619461042244231,0.038053895775576954,0
521,患者にその他の症状/事象があるかどうかは不明であった。,患者 その他 症状 事象 ある 不明 だ ある た,0,0.9993145752668148,0.000685424733185157,0,6.725956285774293e-05,0.9999327404371423,0,0.9981667240055305,0.001833275994469486,0,0.9959611975924555,0.004038802407544487,0,0.9407414793968201,0.07761217653751373,0,0.7767111659049988,0.20545943081378937,0,0.9683667023328804,0.03163329766711971,0
522,患者に自己免疫性又は自己炎症性疾患の既往歴はなかった。,患者 自己免疫性 自己 炎症 性疾患 既往 歴 ない た,0,0.9845586233630518,0.015441376636948294,0,8.046924511933538e-05,0.9999195307548807,0,0.9317477421091691,0.06825225789083086,0,0.9690273351421782,0.030972664857821762,0,0.9474990367889404,0.06009068712592125,0,0.8395199775695801,0.164699524641037,0,0.9655456173915301,0.03445438260846977,0
523,患者の自覚症状は翌日までに回復し、予後良好で退院した。,患者 自覚症状 翌日 回復 予後 良好 退院 する た,0,0.9960519062747187,0.003948093725281358,0,5.1109597028176044e-05,0.9999488904029719,0,0.9869824282070302,0.013017571792969843,0,0.667755576383659,0.332244423616341,0,0.9411853551864624,0.06887726485729218,0,0.7742630243301392,0.17674559354782104,0,0.9411165854096313,0.05888341459036872,0
524,患者は7日目に合併症なく退院し、退院後症状はなかった。,患者 0 日 目 合併症 ない 退院 する 退院後症状 ない た,0,0.9997599602997599,0.00024003970024018539,0,3.7329218649818074e-05,0.9999626707813501,0,0.9984456695600215,0.001554330439978533,0,0.9988751652285991,0.0011248347714009307,0,0.9528683423995972,0.054798759520053864,0,0.8237207531929016,0.1544847935438156,0,0.9723890028198956,0.027610997180104416,0
525,感覚障害に関してはしびれ感は改善傾向も感覚鈍麻は残存。,感覚障害 しびれ感 改善 傾向 感覚鈍麻 残存,0,0.9845701814207932,0.015429818579206807,0,8.493140457545422e-05,0.9999150685954246,0,0.993431238531231,0.006568761468768977,0,0.9999999992496058,7.503941599463206e-10,0,0.9143645167350769,0.10917699337005615,0,0.6862818002700806,0.4458910822868347,0,0.9526531659054688,0.04734683409453119,0
526,心臓超音波検査で左室駆出率58%であり、異常所見なし。,心臓 超音波 検査 左 室 駆け出し 率 0% だ ある 異常所見なし,0,0.9845689259385169,0.01543107406148309,0,0.00010469565267332756,0.9998953043473267,0,0.794569997582314,0.20543000241768603,0,0.9987411717330783,0.0012588282669217128,0,0.9220921397209167,0.07988414913415909,0,0.8112807273864746,0.2683950662612915,0,0.9498394082819842,0.05016059171801583,0
527,全身状態は安定し、現在リハビリテーション継続中である。,全身 状態 安定 する 現在 リハビリテーション 継続 中 だ ある,0,0.984553365599471,0.015446634400529057,0,7.594513849882046e-05,0.9999240548615012,0,0.7032635122438141,0.2967364877561859,0,0.6728910998201026,0.32710890017989736,0,0.9517862200737,0.06718174368143082,0,0.7984241247177124,0.187503844499588,0,0.9017739658063195,0.09822603419368045,0
528,臨床経過は良好で翌日症状は消失し入院7日後に退院した。,臨床 経過 良好 だ 翌日症状 消失 する 入院 0 日 後 退院 する た,0,0.9446067969219728,0.05539320307802718,0,5.372356625447623e-05,0.9999462764337456,0,0.9773488085866886,0.022651191413311417,0,0.8370704797606606,0.16292952023933935,0,0.9407958388328552,0.09417641907930374,0,0.8146793246269226,0.1694909781217575,0,0.953022394098661,0.04697760590133911,0
529,ワクチン接種以降、COVID-19の検査はしなかった。,ワクチン接種 以降 COVID 0 検査 する ない た,0,0.9990481064173662,0.0009518935826339099,0,7.620371808695963e-05,0.9999237962819131,0,0.9921753466782673,0.007824653321732652,0,0.9994686088819107,0.0005313911180893263,0,0.951968789100647,0.055073801428079605,0,0.8306158781051636,0.14378048479557037,0,0.9724888414195156,0.027511158580484273,0
530,事象に対して関連する他の診断検査や確認検査はなかった。,事象 関連 する 他 診断 検査 確認 検査 ない た,0,0.9970395651644361,0.002960434835563868,0,6.899755299522184e-05,0.9999310024470047,0,0.9931896655721427,0.0068103344278572795,0,0.9994765413855191,0.000523458614480855,0,0.9535931348800659,0.05451479181647301,0,0.8209697604179382,0.13611991703510284,0,0.9724409325064951,0.027559067493504924,0
531,事象について、他要因(他の疾患等)の可能性はなかった。,事象 要因 他 疾患 等 可能性 ない た,0,0.9993407588445111,0.0006592411554889661,0,4.756699397442902e-05,0.9999524330060255,0,0.993089103022664,0.006910896977336053,0,0.9927234281742753,0.0072765718257247385,0,0.9459103345870972,0.05419921875,0,0.8249131441116333,0.14573729038238525,0,0.9718400009050175,0.028159999094982357,0
532,ワクチン接種以降、COVID-19の検査はしていない。,ワクチン接種 以降 COVID 0 検査 する いる ない,0,0.9932130212650185,0.006786978734981451,0,7.28156364396565e-05,0.9999271843635603,0,0.9841306878278271,0.015869312172172873,0,0.9810338327845293,0.018966167215470692,0,0.948316216468811,0.06921181082725525,0,0.8190268874168396,0.1637319177389145,0,0.9692698884715476,0.030730111528452432,0
533,プレドニゾロン内服にて、溶血性貧血は改善傾向であった。,プレドニゾロン 内服 溶血性 貧血 改善 傾向 だ ある た,0,0.996313440255498,0.003686559744501916,0,6.298053054924895e-05,0.9999370194694508,0,0.9983150874162771,0.001684912583722927,0,0.8554479398326656,0.14455206016733432,0,0.9371596574783325,0.06478945165872574,0,0.8246249556541443,0.18308986723423004,0,0.9613645781403368,0.038635421859663226,0
534,2022/01/10、経過良好にて、被験者は退院した。,0 0 0 経過 良好 被験者 退院 する た,0,0.9971993465085763,0.002800653491423614,0,5.859770588476331e-05,0.9999414022941152,0,0.9963547686265267,0.0036452313734732424,0,0.8264004628311895,0.17359953716881046,0,0.9419609904289246,0.078041672706604,0,0.8031514286994934,0.19071051478385925,0,0.9575636376150389,0.04243636238496116,0
535,2回目のCOVID-19ワクチン接種:体調不良はなし。,0回目 COVID 0 ワクチン接種 体調不良 ない,0,0.9433928339620475,0.05660716603795244,0,0.00013576074507640188,0.9998642392549236,0,0.961060472864768,0.03893952713523196,0,0.9986777520475758,0.0013222479524241395,0,0.9284437298774719,0.09645450115203857,0,0.8146167397499084,0.20016878843307495,0,0.9627797182506003,0.037220281749399675,0
536,(2021/06/22)結果なし、メモ:ワクチン接種後,0 0 0 結果 ない メモ ワクチン接種 後,0,0.9929809798855387,0.007019020114461322,0,0.00012568903605551953,0.9998743109639445,0,0.9398122099622583,0.06018779003774165,0,0.9999999999904232,9.576834255495722e-12,0,0.9366559982299805,0.07453279197216034,0,0.8374022841453552,0.16479958593845367,0,0.9677221464933815,0.03227785350661849,0
537,当院のカルテ情報にはワクチンメーカーの記載はなかった。,院 カルテ 情報 ワクチン メーカー 記載 ない た,0,0.9845906589227311,0.015409341077268946,0,8.988970023610253e-05,0.9999101102997638,0,0.8310460710546428,0.16895392894535718,0,0.986273410452091,0.013726589547909002,0,0.9506675601005554,0.056076779961586,0,0.8371291756629944,0.1789274513721466,0,0.9591755350386212,0.04082446496137889,0
538,ワクチン接種以来、COVID-19の検査はしていない。,ワクチン接種 以来 COVID 0 検査 する いる ない,0,0.9916970095332769,0.008302990466723094,0,7.704948519122349e-05,0.9999229505148087,0,0.9842331966709358,0.015766803329064223,0,0.9723139625435363,0.027686037456463714,0,0.9450461864471436,0.0741671547293663,0,0.8120849132537842,0.1618768572807312,0,0.9682540555671018,0.03174594443289819,0
539,第90病日に測定した抗MOG抗体の結果は陰性であった。,0 病 日 測定 する た MOG 抗体 結果 陰性 だ ある た,0,0.9927174719957094,0.0072825280042905,0,6.230611972213955e-05,0.9999376938802779,0,0.9915957086818453,0.008404291318154665,0,0.7441577772170156,0.25584222278298446,0,0.9266836047172546,0.0665203332901001,0,0.8349992036819458,0.16980312764644623,0,0.9517738420363296,0.048226157963670406,0
540,2022/06/17、ステロイド治療は継続中であった。,0 0 0 ステロイド 治療 継続 中 だ ある た,0,0.9958059352026261,0.004194064797374062,0,8.872788473481344e-05,0.9999112721152652,0,0.9858488306255786,0.014151169374421423,0,0.9568096766373582,0.04319032336264182,0,0.9381306767463684,0.058741819113492966,0,0.8269845843315125,0.21526919305324554,0,0.9666961296751376,0.033303870324862296,0
541,患者は、事象発現前2週以内に投与した併用薬はなかった。,患者 事象 発現 0 週 以内 投与 する た 併用 薬 ない た,0,0.9964476824787518,0.0035523175212482188,0,6.140224948173424e-05,0.9999385977505183,0,0.9893033964087962,0.010696603591203856,0,0.9981714755127525,0.001828524487247516,0,0.9513658285140991,0.05736666917800903,0,0.8249868154525757,0.141324982047081,0,0.9719585368955281,0.028041463104471934,0
542,2022/06/24、臨床検査データに異常はなかった。,0 0 0 臨床検査 データ 異常 ない た,0,0.9962308463779652,0.0037691536220348697,0,7.844862849809594e-05,0.9999215513715018,0,0.9434741657459477,0.0565258342540523,0,0.9946537260501804,0.005346273949819582,0,0.9272826910018921,0.06309500336647034,0,0.8280198574066162,0.16407163441181183,0,0.9676109685412638,0.03238903145873615,0
543,SARS-CoV2感染中に悪化した基礎疾患はなかった。,SARS CoV 0 感染中 悪化 する た 基礎疾患 ない た,0,0.9895177954360513,0.010482204563948678,0,7.656634319656786e-05,0.9999234336568035,0,0.9536107232604573,0.04638927673954275,0,0.9981842075322577,0.0018157924677422907,0,0.9416555166244507,0.05945175886154175,0,0.8095899224281311,0.17222534120082855,0,0.9677778020160592,0.03222219798394075,0
544,バイタルサイン測定:(2022/07/14)異常なし。,バイタルサイン 測定 0 0 0 異常 ない,0,0.9939702249644122,0.006029775035587826,0,7.140708781481722e-05,0.9999285929121852,0,0.9453015381125173,0.05469846188748271,0,0.9914995280306866,0.008500471969313344,0,0.9334057569503784,0.07696876674890518,0,0.823614239692688,0.16377735137939453,0,0.9670085619540658,0.03299143804593416,0
545,メコバラミンとカリシノゲナーゼ内服を行い経過観察した。,メコバラミン カリシノゲナーゼ 内服 行い 経過 観察 する た,0,0.9277157899808498,0.07228421001915002,0,0.00010781547969302153,0.9998921845203069,0,0.886059468337508,0.1139405316624919,1,0.25669507343041553,0.7433049265695845,0,0.9408729672431946,0.07370159029960632,0,0.7654291987419128,0.22711636126041412,1,0.8244279871944832,0.17557201280551687,0
546,リハビリテーションとアセトアミノフェン療法を継続した。,リハビリテーション アセトアミノフェン 療法 継続 する た,0,0.9845840814272088,0.015415918572791234,0,9.911490149761092e-05,0.9999008850985024,0,0.7038610037434254,0.29613899625657464,0,0.8756566902336407,0.12434330976635935,0,0.9478764533996582,0.059272415935993195,0,0.8047404289245605,0.20227546989917755,0,0.9321042217115583,0.06789577828844175,0
547,ワクチン接種前の問診時、患者の全身状態は良好であった。,ワクチン接種 前 問診 時 患者 全身 状態 良好 だ ある た,0,0.984565673559985,0.015434326440014981,0,7.66875441226296e-05,0.9999233124558774,0,0.9175741138626432,0.0824258861373568,0,0.8590021083239413,0.14099789167605872,0,0.938161313533783,0.07042425125837326,0,0.8378127217292786,0.17526422441005707,0,0.9548999289293703,0.045100071070629674,0
548,塩酸ジラゼフが投与されたが、症状は改善を示さなかった。,塩酸 ジラゼフ 投与 する れる た 症状 改善 示す ない た,0,0.9997748366978032,0.00022516330219680462,0,5.2872163239798975e-05,0.9999471278367602,0,0.993361367753225,0.006638632246774987,0,0.993873162820499,0.006126837179500984,0,0.9472876191139221,0.05900838226079941,0,0.8053874969482422,0.18413126468658447,0,0.9702192523902914,0.029780747609708495,0
549,入院時にはすでに症状は消失しており、経過観察となった。,入院 時 症状 消失 する おる 経過 観察 なる た,0,0.9845791455420282,0.015420854457971764,0,8.656742699134381e-05,0.9999134325730087,0,0.9673075506187936,0.032692449381206364,0,0.5016909321145459,0.49830906788545415,0,0.945521354675293,0.07015351951122284,0,0.7779445052146912,0.1937408745288849,0,0.9142681774273218,0.0857318225726782,0
550,被験者は体外式模型人工肺(ECMO)を使用しなかった。,被験者 体外 式 模型 人工 肺 ECMO 使用 する ない た,0,0.9850681792485345,0.014931820751465567,0,8.844095103123478e-05,0.9999115590489688,0,0.8866130827643285,0.11338691723567151,0,0.9706134857569704,0.029386514243029647,0,0.9545738697052002,0.06063137575984001,0,0.8371966481208801,0.15924814343452454,0,0.9629116006148696,0.03708839938513036,0
551,2022/05/17、降圧薬内服を終了し同日退院した。,0 0 0 降圧 薬 内服 終了 する 同日 退院 する た,0,0.9996196190810726,0.0003803809189273991,0,5.388534188889985e-05,0.9999461146581111,0,0.9974475097039861,0.00255249029601389,0,0.9267578633494722,0.07324213665052783,0,0.9439133405685425,0.07870849967002869,0,0.8146885633468628,0.19332696497440338,0,0.9655877439051072,0.03441225609489293,0
552,事象の転帰は、ステロイドパルス療法により回復であった。,事象 転帰 ステロイド パルス 療法 回復 だ ある た,0,0.999446395824859,0.0005536041751410747,0,4.9253487575512704e-05,0.9999507465124244,0,0.9965440947151696,0.0034559052848304544,0,0.9393271503270686,0.060672849672931434,0,0.9449116587638855,0.05746328458189964,0,0.8236289620399475,0.16805440187454224,0,0.968131711619792,0.031868288380208026,0
553,事象好酸球性心筋炎、トロポニンT上昇と発熱は回復した。,事象 好酸球性 心筋炎 トロポニン T 上昇 発熱 回復 する た,1,0.36576569013244387,0.6342343098675561,0,0.00012788824301810382,0.9998721117569819,1,0.28398599606528785,0.7160140039347122,0,0.6812414793462581,0.3187585206537419,0,0.5731302499771118,0.5038907527923584,1,0.21583840250968933,0.8622966408729553,1,0.12842278486139058,0.8715772151386094,0
554,絶食、輸液で治療開始し、腹痛と嘔気は改善傾向であった。,絶食 輸液 治療 開始 する 腹痛 嘔気 改善 傾向 だ ある た,0,0.9845760040888435,0.01542399591115645,0,8.590326988856433e-05,0.9999140967301114,0,0.9951725763821687,0.004827423617831312,0,0.7511021016261787,0.24889789837382129,0,0.9390987157821655,0.06921429932117462,0,0.7962443828582764,0.21111948788166046,0,0.9486747161748247,0.0513252838251753,0
555,頭部CTは異常所見なく、頭痛の器質的疾患は否定された。,頭部 C，T 異常所 見る ない 頭痛 の 器質的疾患 否定 する れる た,0,0.9497028619755385,0.050297138024461355,0,9.095402806650081e-05,0.9999090459719335,0,0.7002843484750718,0.29971565152492824,1,0.2736723334453106,0.7263276665546894,0,0.8489802479743958,0.19523152709007263,0,0.8001002669334412,0.1785428524017334,1,0.754509039153377,0.24549096084662303,0
556,被験者は安静時重度の全身疾患を示す臨床徴候はなかった。,被験者 安静 時 重度 全身 疾患 示す 臨床徴候 ない た,0,0.9406186699504298,0.05938133004957001,0,9.700460211967046e-05,0.9999029953978803,0,0.940055567575723,0.05994443242427703,0,0.9633167306086934,0.036683269391306575,0,0.9480437636375427,0.06449385732412338,0,0.826310932636261,0.15326647460460663,0,0.9624847357343245,0.03751526426567547,0
557,嚥下障害、眼瞼下垂および筋力低下の転帰は軽快であった。,嚥下障害 眼瞼下垂 筋力低下 転帰 軽快 だ ある た,0,0.9845666577067683,0.015433342293231716,0,9.713451953774065e-05,0.9999028654804623,0,0.9877656796820304,0.012234320317969602,0,0.8795138486022928,0.12048615139770726,0,0.9382113814353943,0.07919009774923325,0,0.7952547669410706,0.19042569398880005,0,0.9596019481033702,0.04039805189662991,0
558,解熱剤(薬剤名は未聴取)を飲んでも熱が下がらなかった。,解熱 剤 薬剤 名 聴取 飲む 熱 下がる ない た,0,0.9845727900064574,0.01542720999354265,0,8.89956652057377e-05,0.9999110043347943,0,0.8798144764902329,0.12018552350976702,0,0.9269201390660187,0.07307986093398132,0,0.9432134032249451,0.07001221925020218,0,0.8393345475196838,0.16666775941848755,0,0.958059613999807,0.041940386000193,0
559,Renal function test: normal,Renal function test normal,0,0.6011114830894531,0.39888851691054716,0,0.00015066424574511407,0.9998493357542548,1,0.4563792597309324,0.5436207402690676,0,0.9999999999994225,5.775438756008197e-13,1,0.3365212678909302,0.7946407794952393,1,0.5098938345909119,0.6303535103797913,1,0.38620412441666324,0.6137958755833368,0
560,2021/07と2021/08にワクチン接種を受けた。,0 0 0 0 ワクチン接種 受ける た,0,0.9845890515400206,0.015410948459979323,1,0.00020165354365193121,0.999798346456348,0,0.5787161895479949,0.42128381045200514,0,0.999414741248163,0.0005852587518370355,0,0.8410816192626953,0.19731637835502625,0,0.7979605197906494,0.18071548640727997,1,0.9158193115951055,0.08418068840489445,0
561,2021/**/**、心血管造影:狭窄なし(正常)。,0 心 血管造影 狭窄 ない 正常,0,0.9998954381285617,0.0001045618714382817,0,4.6494412584500675e-05,0.9999535055874155,0,0.9916240778304536,0.008375922169546437,0,0.9999999999999993,6.208403486379223e-16,0,0.9433618187904358,0.060603637248277664,0,0.8320909142494202,0.1783621609210968,0,0.9712408626337887,0.02875913736621134,0
562,2021/09/21、冠動脈検査(直近)が行われた。,0 0 0 冠動脈 検査 直近 行う れる た,0,0.781315765632384,0.21868423436761608,1,0.00018866051094126168,0.9998113394890588,0,0.6306905924772029,0.36930940752279706,1,0.49028546857569966,0.5097145314243003,1,0.4873832166194916,0.721062421798706,0,0.8090862035751343,0.23873783648014069,1,0.5353484656345288,0.46465153436547124,0
563,2022/03/07対症療法で経過良好のため、退院。,0 0 0 対症療法 経過 良好 ため 退院,0,0.984550220565222,0.01544977943477811,0,8.618546618355454e-05,0.9999138145338164,0,0.9858581508734741,0.01414184912652597,0,0.9999999999999967,3.3832397044076134e-15,0,0.9456779360771179,0.08861743658781052,0,0.7409626841545105,0.24405546486377716,0,0.9642553946262494,0.03574460537375056,0
564,2022/05/17、心臓磁気共鳴画像が実施された。,0 0 0 心臓 磁気 共鳴 画像 実施 する れる た,0,0.9845679347830859,0.015432065216914136,0,0.00011404509491398322,0.999885954905086,0,0.8247031494835586,0.1752968505164414,1,0.39009721296220823,0.6099027870377918,0,0.8553677797317505,0.23173661530017853,0,0.8193902969360352,0.2007635235786438,1,0.8377012312107508,0.16229876878924926,0
565,20分後、症状が回復したため、医師の許可により帰宅。,0分 後 症状 回復 する た ため 医師 許可 帰宅,0,0.9845871424694798,0.015412857530520227,0,8.950647185027967e-05,0.9999104935281498,0,0.8830685029304431,0.11693149706955681,0,0.9999967083955662,3.2916044338144114e-06,0,0.9390286803245544,0.09653989970684052,0,0.8081642389297485,0.20479051768779755,0,0.9601262365552437,0.03987376344475637,0
566,COVID-19に対する追加療法は受けていなかった。,COVID 0 追加 療法 受ける いる ない た,0,0.9998710901621649,0.00012890983783496124,0,4.57422455559377e-05,0.999954257754444,0,0.9960294275083009,0.003970572491699072,0,0.999336335956248,0.000663664043751958,0,0.9587345719337463,0.05136055871844292,0,0.8252152800559998,0.15201371908187866,0,0.9726455568412617,0.02735444315873837,0
567,WBC数6900 / uLに増加し、幻覚は減少した。,WBC 数 0 uL 増加 する 幻覚 減少 する た,1,0.016877566223523224,0.9831224337764766,1,0.0003621573847174397,0.9996378426152825,1,0.280960819939426,0.719039180060574,0,0.9095685175626923,0.09043148243730767,1,0.12126104533672333,0.92628014087677,0,0.6411956548690796,0.46795520186424255,1,0.09830153547473158,0.9016984645252684,0
568,アムロジピン、メコバラミン、フスコデ配合錠投与中止。,アムロジピン メコバラミン フスコデ 配合 錠 投与 中止,0,0.984565263349388,0.015434736650611949,0,8.082560259248245e-05,0.9999191743974075,0,0.7963334554148771,0.20366654458512296,0,0.9999999975156887,2.4843113406077352e-09,0,0.9011611342430115,0.10974590480327606,0,0.7704076170921326,0.3539164066314697,0,0.9410255240136303,0.0589744759863696,0
569,アルブミン投与を複数回行うも循環動態安定しなかった。,アルブミン 投与 複数 回 行う 循環動態 安定 する ない た,0,0.9961157229318204,0.003884277068179716,0,0.00010291807385140644,0.9998970819261486,0,0.9541648070408048,0.045835192959195276,0,0.9739161058629225,0.02608389413707751,0,0.9481024742126465,0.05296105891466141,0,0.7634697556495667,0.21591316163539886,0,0.9641290409356962,0.03587095906430385,0
570,過ヨウ素酸シッフ染色にて真菌感染は認められなかった。,過ヨウ素酸 シッフ 染色 真菌感染 認める られる ない た,0,0.9845551331542235,0.015444866845776426,0,0.00010731015542370474,0.9998926898445762,0,0.7704913901745609,0.22950860982543914,0,0.9696024782663286,0.030397521733671336,0,0.9413882493972778,0.05677510425448418,0,0.8292893171310425,0.1645481139421463,0,0.9525229141391346,0.04747708586086536,0
571,患者には喫煙歴又はアルコール飲料の摂取歴はなかった。,患者 喫煙 歴 アルコール飲料 摂取 歴 ない た,0,0.9972950887644942,0.0027049112355056848,0,7.874826266793711e-05,0.999921251737332,0,0.9317477421091691,0.06825225789083086,0,0.9798589647956475,0.02014103520435247,0,0.9422719478607178,0.07045575231313705,0,0.8415840268135071,0.16122554242610931,0,0.9667580545957184,0.033241945404281555,0
572,患者は血行動態が安定し、機械的循環補助から離脱した。,患者 血行動態 安定 する 機械的 循環 補助 離脱 する た,0,0.9845972845081845,0.015402715491815417,0,7.602078265950861e-05,0.9999239792173404,0,0.6150706672849001,0.3849293327150999,0,0.7368933992692555,0.26310660073074454,0,0.9385722875595093,0.07427798211574554,0,0.8188133239746094,0.17059169709682465,0,0.8989662321432809,0.10103376785671901,0
573,患者は抗生物質の経口投与による治療を受け、回復した。,患者 抗生物質 経口 投与 治療 受ける 回復 する た,0,0.9989804522750223,0.001019547724977748,0,5.898841872943215e-05,0.9999410115812706,0,0.9911651682903658,0.00883483170963421,0,0.8471937681400389,0.15280623185996112,0,0.941404402256012,0.06413643807172775,0,0.8136870861053467,0.16327892243862152,0,0.9609272301555342,0.03907276984446579,0
574,血漿グルコース及びHbA1cを4週間ごとに検査した。,血漿 Glucose HbA 0 c 0 週間 ごと 検査 する た,0,0.9738862941965716,0.026113705803428432,0,0.00015308214274027538,0.9998469178572598,0,0.7381023531368462,0.2618976468631537,1,0.42852969237804617,0.5714703076219538,0,0.9216129779815674,0.08095888048410416,0,0.7961673140525818,0.17899829149246216,1,0.8505810963809798,0.14941890361902027,0
575,献血ヴェノグロブリンIHの投与は、問題なく終了した。,献血 ヴェノグロブリン IH 投与 問題 ない 終了 する た,0,0.9997591562907082,0.00024084370929183382,0,4.509484190075994e-05,0.9999549051580993,0,0.98213089302853,0.017869106971470084,0,0.8111675687274519,0.1888324312725481,0,0.9482707381248474,0.06432447582483292,0,0.812908947467804,0.23231962323188782,0,0.9548145073538159,0.04518549264618411,0
576,抗原定性検査でSARS-CoV-2検査実施し、陰性。,抗原 定性 検査 SARS CoV 0 検査 実施 する 陰性,0,0.9983587264609075,0.001641273539092465,0,6.293160435788745e-05,0.9999370683956421,0,0.9901944736981197,0.00980552630188028,0,0.9999982142137259,1.7857862740793681e-06,0,0.9308638572692871,0.0836998000741005,0,0.8238625526428223,0.23462480306625366,0,0.9681278170281851,0.031872182971815065,0
577,事象に対する追加治療(薬物療法、非薬物療法):なし。,事象 追加 治療 薬物 療法 薬物 療法 ない,0,0.9995004616924333,0.0004995383075666001,0,6.295215920289891e-05,0.9999370478407971,0,0.9593855956150127,0.04061440438498731,0,0.9999999252876764,7.471232352718498e-08,0,0.9511542916297913,0.061355043202638626,0,0.7703668475151062,0.17088328301906586,0,0.9679281972313089,0.03207180276869119,0
578,生理食塩水で輸液ルート確保し、救急外来に診療を依頼。,生理 食塩水 だ 輸液 ルート 確保 する 救急外来 診療 依頼,0,0.9845606856354802,0.015439314364519886,0,0.00010791214808154898,0.9998920878519184,1,0.4563792597309324,0.5436207402690676,0,0.998784725610905,0.0012152743890949263,1,0.481524258852005,0.656150221824646,0,0.7623388767242432,0.31469929218292236,1,0.7599998682854866,0.24000013171451337,0
579,足背動脈両側触知、胸部X-P骨折なし、肺野異状なし。,足 背 動脈 両側 触知 胸部 X P 骨折 ない 肺 野 異状なし,0,0.9609955096229451,0.03900449037705479,0,0.00014684608014903846,0.999853153919851,0,0.765316497951962,0.23468350204803798,0,0.9951220216342832,0.0048779783657168455,0,0.8399417996406555,0.18949095904827118,0,0.7896575331687927,0.22054047882556915,0,0.9347912539967158,0.06520874600328432,0
580,転院後、全身状態は改善し、MRIや血小板も改善した。,転院 後 全身 状態 改善 する MRI 血小板 改善 する た,0,0.9969606829133782,0.00303931708662169,0,6.354946423531626e-05,0.9999364505357646,0,0.9631443269742159,0.03685567302578409,0,0.9694684353654838,0.030531564634516183,0,0.9414641857147217,0.06357074528932571,0,0.8069893717765808,0.16908666491508484,0,0.9669162653024672,0.03308373469753283,0
581,日付不明血液検査:ワクチン接種2日後の施行にて正常。,日付 不明 血液検査 ワクチン接種 0 日 後 施行 正常,0,0.9907781694289525,0.009221830571047489,0,6.67694078950413e-05,0.9999332305921049,0,0.9950319511943831,0.004968048805616863,0,0.9999999999999917,8.376545066739895e-15,0,0.9431135058403015,0.07558702677488327,0,0.8254445195198059,0.200208842754364,0,0.9696611007172882,0.03033889928271173,0
582,肺炎マイコプラズマの血清学的マーカーは陰性であった。,肺炎 マイコプラズマ の 血清 学的 マーカー 陰性 だ ある た,0,0.8100688168383698,0.18993118316163002,0,0.00012154408860002337,0.9998784559114,0,0.5390449129847537,0.4609550870152464,0,0.7273056028467959,0.27269439715320415,0,0.9317643046379089,0.0585453175008297,0,0.8358034491539001,0.1765189915895462,0,0.8436426877879537,0.1563573122120462,0
583,鼻咽頭ポリメラーゼ連鎖反応は陰性であった(入院時)。,鼻 咽頭 ポリメラーゼ連鎖反応 陰性 だ ある た 入院 時,0,0.9845457471134751,0.015454252886524794,0,8.227886898829379e-05,0.9999177211310117,0,0.9590980185865473,0.040901981413452665,0,0.7733941681630285,0.2266058318369715,0,0.9295635223388672,0.09132444113492966,0,0.8330226540565491,0.17729204893112183,0,0.9492234748875119,0.050776525112488244,0
584,報告時、免疫性心筋炎(免疫性心筋炎)は回復していた。,報告 時 免疫性 心筋炎 免疫性 心筋炎 回復 する いる た,0,0.988589960624087,0.011410039375912883,0,0.00010684299073703925,0.999893157009263,0,0.8858616395794673,0.11413836042053267,0,0.565368106960388,0.434631893039612,0,0.9392728209495544,0.07327362895011902,0,0.8080691695213318,0.16004087030887604,0,0.916359476173964,0.08364052382603605,0
585,本剤接種に伴う心筋炎も否定はできず、経過観察を継続。,本 剤 接種 伴う 心筋炎 否定 できる ぬ 経過 観察 継続,0,0.9845709468383818,0.015429053161618187,0,0.00011531501768514732,0.9998846849823149,0,0.7630203749379617,0.23697962506203832,0,0.941163223849116,0.05883677615088405,0,0.9296765327453613,0.10900992155075073,0,0.7631205916404724,0.269074410200119,0,0.9365798123227406,0.06342018767725943,0
586,炎症マーカー検査: (2022/01/27)結果なし,炎症 マーカー 検査 0 0 0 結果 ない,0,0.9952401564183101,0.004759843581689834,0,9.358588532577651e-05,0.9999064141146742,0,0.9598492028056285,0.04015079719437157,0,0.998968722357132,0.001031277642867993,0,0.9396378993988037,0.06076711788773537,0,0.8376789093017578,0.15938085317611694,0,0.969689219088283,0.03031078091171715,0
587,薬物、食物、その他製品に対するアレルギーはなかった。,薬物 食物 その他 製品 アレルギー ない た,0,0.9902701998444324,0.00972980015556761,0,6.72881581012359e-05,0.9999327118418988,0,0.981754615377876,0.01824538462212405,0,0.9941167160907519,0.005883283909248129,0,0.9377160668373108,0.05296739935874939,0,0.8461859822273254,0.1523958295583725,0,0.9709979111145031,0.02900208888549697,0
588,肝機能および腎機能検査では特記すべき事項はなかった。,機能 腎 機能 検査 特記 する べし 事項 ない た,0,0.997918080082318,0.0020819199176821306,0,7.798140500239727e-05,0.9999220185949976,0,0.9389652226882174,0.06103477731178261,0,0.9874571544146815,0.012542845585318478,0,0.9534096121788025,0.06519147753715515,0,0.8251953125,0.15760169923305511,0,0.967849500864078,0.03215049913592201,0
589,事象に関して他要因(他の疾患等)の可能性はなかった。,事象 要因 他 疾患 等 可能性 ない た,0,0.9993407588445111,0.0006592411554889661,0,4.756699397442902e-05,0.9999524330060255,0,0.993089103022664,0.006910896977336053,0,0.9927234281742753,0.0072765718257247385,0,0.9459103345870972,0.05419921875,0,0.8249131441116333,0.14573729038238525,0,0.9718400009050175,0.028159999094982357,0
590,事象について他要因(他の疾患等)の可能性はなかった。,事象 要因 他 疾患 等 可能性 ない た,0,0.9993407588445111,0.0006592411554889661,0,4.756699397442902e-05,0.9999524330060255,0,0.993089103022664,0.006910896977336053,0,0.9927234281742753,0.0072765718257247385,0,0.9459103345870972,0.05419921875,0,0.8249131441116333,0.14573729038238525,0,0.9718400009050175,0.028159999094982357,0
591,CSF oligoclonal band:データなし,CSF oligoclonal band データ ない,0,0.9920963876932104,0.007903612306789808,0,7.477135674463963e-05,0.9999252286432554,0,0.9508470662576923,0.04915293374230766,0,0.9978654313568275,0.002134568643172492,0,0.9497752785682678,0.07435808330774307,0,0.8506403565406799,0.16895927488803864,0,0.968897348266426,0.031102651733573967,0
592,副腎皮質ホルモン(プレドニン)の治療で軽快であった。,腎皮質 ホルモン プレドニン 治療 軽快 だ ある た,0,0.9957037976989854,0.004296202301014621,0,6.59723300950062e-05,0.999934027669905,0,0.8697327373420145,0.13026726265798555,0,0.8658468005741339,0.13415319942586615,0,0.9372592568397522,0.06255041807889938,0,0.8305631279945374,0.17114128172397614,0,0.952430679505739,0.04756932049426091,0
593,血液検査:(2021/11/02)大きな異常値はなし,血液検査 0 0 0 異常値 ない,0,0.987017200309572,0.012982799690428024,0,0.00010614088782115416,0.9998938591121789,0,0.9564049712076866,0.04359502879231336,0,0.9965278434842862,0.003472156515713751,0,0.9398671984672546,0.062328439205884933,0,0.8380701541900635,0.1595003306865692,0,0.9688175507198373,0.031182449280162776,0
594,患者は、事象発現前2週以内に併用薬剤投与はなかった。,患者 事象 発現 0 週 以内 併用 薬剤 投与 ない た,0,0.9881999477266434,0.011800052273356619,0,6.662640633587491e-05,0.9999333735936641,0,0.8909698255475306,0.10903017445246942,0,0.9894472303198252,0.01055276968017478,0,0.9469228982925415,0.05453702062368393,0,0.8179545402526855,0.14615394175052643,0,0.9644820745677641,0.03551792543223579,0
595,SARS-CoV2感染時に悪化した既往症はなかった。,SARS CoV 0 感染 時 悪化 する た 既往症 ない た,0,0.99305282895684,0.006947171043159902,0,8.81842283014253e-05,0.9999118157716985,0,0.9827804921247429,0.01721950787525702,0,0.9906147238736824,0.00938527612631758,0,0.9504956603050232,0.059366680681705475,0,0.825921893119812,0.16715480387210846,0,0.9701992680832394,0.029800731916760515,0
596,被験者はワクチン接種日周辺で解熱剤を使用しなかった。,被験者 ワクチン接種 日 周辺 だ 解熱 剤 使用 する ない た,0,0.9967347425688772,0.0032652574311228364,0,6.107913732063562e-05,0.9999389208626793,0,0.9795520342931913,0.020447965706808683,0,0.9951881719567683,0.004811828043231616,0,0.9524522423744202,0.055031366646289825,0,0.8419225215911865,0.14724211394786835,0,0.9716721584128488,0.028327841587151074,0
597,有害事象内容は調査により確認することができなかった。,有害事象 内容 調査 確認 する こと できる ない た,0,0.9973087459040015,0.0026912540959984914,0,5.542578905026285e-05,0.9999445742109497,0,0.9610783034800167,0.03892169651998333,0,0.9952776890940112,0.0047223109059888226,0,0.9571556448936462,0.059553083032369614,0,0.8343212008476257,0.16542625427246094,0,0.9699370552794188,0.03006294472058123,0
598,(不明日)陰性、注:血小板減少(報告通り)はなかった,明日 陰性 注 血小板減少 報告 通り ない た,0,0.9995804232889232,0.0004195767110767657,0,5.530656510482247e-05,0.9999446934348952,0,0.9874619207703177,0.012538079229682335,0,0.9952884263141041,0.0047115736858959105,0,0.9498711824417114,0.05050230398774147,0,0.8492099642753601,0.1876949816942215,0,0.9714090111941905,0.028590988805809514,0
599,2021/11/01、D-ダイマーの結果は上昇なし。,0 0 0 D ダイマー 結果 上昇 ない,0,0.9811318466813598,0.018868153318640248,0,0.00011653195957521135,0.9998834680404248,0,0.8663651919161173,0.1336348080838827,0,0.812252201583038,0.18774779841696204,0,0.9216839671134949,0.10651405155658722,0,0.8206539154052734,0.16552512347698212,0,0.9421346939785408,0.057865306021459194,0
600,2022/07/07にECG所見正常化が確認された。,0 0 0 ECG 所見 正常化 確認 する れる た,0,0.9724923369045788,0.027507663095421176,0,8.26207787596489e-05,0.9999173792212404,0,0.5782834500675282,0.4217165499324718,0,0.5243076805861738,0.47569231941382617,0,0.9406117796897888,0.06841734796762466,0,0.8221694231033325,0.175568088889122,0,0.8414595186317068,0.15854048136829316,0
601,ワクチン接種前に、COVIDー19の診断はなかった。,ワクチン接種 前 COVID ー 0 診断 ない た,0,0.961481615729184,0.038518384270815914,0,0.00011517963166221863,0.9998848203683378,0,0.9504757449441574,0.049524255055842625,0,0.9983728619978173,0.0016271380021826978,0,0.9458273649215698,0.053741805255413055,0,0.8365349173545837,0.14814281463623047,0,0.9677472759096081,0.03225272409039187,0
602,ワクチン接種前の体温は不明であった(報告のとおり)。,ワクチン接種 前 体温 不明 だ ある た 報告 とおり,0,0.9954741159458326,0.004525884054167428,0,6.228413561361305e-05,0.9999377158643864,0,0.9754542384394217,0.024545761560578264,0,0.9999999998686867,1.3131326052004928e-10,0,0.9405478239059448,0.07562528550624847,0,0.7591989636421204,0.3600827753543854,0,0.9610601931590657,0.03893980684093435,0
603,安静時、重度の全身疾患を示す臨床徴候は示さなかった。,安静 時 重度 全身 疾患 示す 臨床徴候 示す ない た,0,0.9845731492672352,0.015426850732764893,0,0.0001206401148984228,0.9998793598851016,0,0.9343529395601358,0.06564706043986418,0,0.9303833477809004,0.06961665221909963,0,0.9538830518722534,0.07389286160469055,0,0.8244985342025757,0.16097447276115417,0,0.9623981287970202,0.03760187120297978,0
604,肝機能異常、倦怠感に対して治療処置は取られなかった。,肝機能異常 倦怠感 治療 処置 取る れる ない た,0,0.9845717307905586,0.01542826920944142,0,0.00012112680135998838,0.99987887319864,0,0.8458182542024573,0.15418174579754268,0,0.9935058368414036,0.00649416315859646,0,0.9458391070365906,0.055535804480314255,0,0.7702258229255676,0.15831556916236877,0,0.9589184710530324,0.041081528946967504,0
605,接種後の観察期間(約15分)には特に変化はなかった。,接種 後 観察 期間 0分 変化 ない た,0,0.9845641134585514,0.015435886541448672,0,8.159006622263095e-05,0.9999184099337773,0,0.9802738848169525,0.019726115183047507,0,0.9973154365964351,0.002684563403564937,0,0.9446219205856323,0.0650472566485405,0,0.8386160731315613,0.15328167378902435,0,0.9703840574644924,0.02961594253550756,0
606,追加報告(2021/08/24):再調査は完了した。,追加 報告 0 0 0 再調査 完了 する た,0,0.9845792198080644,0.0154207801919355,0,7.397015168472007e-05,0.9999260298483152,0,0.5229409814367061,0.47705901856329386,0,0.9814018415681087,0.01859815843189129,0,0.945486307144165,0.07834542542695999,0,0.8204007148742676,0.1921786367893219,0,0.9222526674042792,0.0777473325957208,0
607,点滴解熱剤投与にて炎症反応は値下し、発熱が消失した。,点滴 解熱 剤 投与 炎症反応 値下げ する 発熱 消失 する た,0,0.9845807294382376,0.015419270561762474,0,7.14759377781279e-05,0.9999285240622219,0,0.8097230055361548,0.1902769944638452,1,0.461667075721217,0.538332924278783,0,0.9369773268699646,0.06787186861038208,0,0.7786687612533569,0.1771964281797409,1,0.8789646856996787,0.12103531430032131,0
608,被験者は、事前のワクチン接種後の有害事象はなかった。,被験者 事前 ワクチン接種 後 有害事象 ない た,0,0.99408368975356,0.0059163102464399285,0,6.756865601674337e-05,0.9999324313439832,0,0.968253672491632,0.03174632750836802,0,0.997957406037035,0.002042593962964996,0,0.9534449577331543,0.053800635039806366,0,0.8491549491882324,0.1468956470489502,0,0.9713248006557541,0.028675199344245922,0
609,有害事象発生後も薬剤投与は継続された(報告の通り)。,有害事象発 生後 薬剤 投与 継続 する れる た 報告 通り,0,0.9845544082936352,0.015445591706364854,0,7.701663954071858e-05,0.9999229833604593,0,0.8608407859372709,0.1391592140627291,0,0.9999746035103161,2.539648968390992e-05,0,0.8853845000267029,0.18740354478359222,0,0.7810675501823425,0.1680036187171936,0,0.9526616256841225,0.04733837431587738,0
610,2021/10/29、高感度CRPの結果は上昇なし。,0 0 0 感度 CRP 結果 上昇 ない,0,0.9829113300414202,0.01708866995857992,0,0.00012937821810637149,0.9998706217818937,0,0.8663651919161173,0.1336348080838827,0,0.9165288270879853,0.08347117291201465,0,0.9038631319999695,0.16230463981628418,0,0.825099527835846,0.1765492558479309,0,0.9489222661611357,0.05107773383886428,0
611,28週目の診察で明らかな皮疹の悪化は見られなかった。,0 週 目 診察 明らか だ 皮疹 の 悪化 見る られる ない た,0,0.9845691741431402,0.015430825856859839,0,8.837803094877241e-05,0.9999116219690513,0,0.7871125850631924,0.21288741493680768,0,0.9714182030108602,0.028581796989139773,0,0.950920045375824,0.07283198088407516,0,0.8368872404098511,0.17471197247505188,0,0.953763226817991,0.046236773182008924,0
612,アドレナリン1mg×2Aで患者の自己心拍は再開した。,アドレナリン 0m g 0 A 患者 自己 心拍 再開 する た,0,0.9829477725592107,0.017052227440789252,0,9.214636557563015e-05,0.9999078536344244,0,0.5364323091829462,0.4635676908170538,0,0.6674897532984276,0.3325102467015724,0,0.9358412623405457,0.08573790639638901,0,0.7695105671882629,0.25049278140068054,0,0.8510734374337485,0.1489265625662515,0
613,冠動脈造影検査も行われたが、有意病変は認めなかった。,冠動脈造影 検査 行う れる た 有意 病変 認める ない た,0,0.9845916407554464,0.015408359244553648,0,9.645489138709724e-05,0.9999035451086129,0,0.9147541350790378,0.0852458649209622,0,0.9778572048042973,0.022142795195702697,0,0.9482161998748779,0.05774030089378357,0,0.8203058838844299,0.16238988935947418,0,0.9645312691461565,0.035468730853843555,0
614,抗核抗体:(不明日)陰性化、注記:3か月後に再検した,抗核抗体 明日 陰性化 注記 0 か月 後 再検 する た,0,0.984569096248679,0.015430903751321053,0,8.894711364806051e-05,0.999911052886352,1,0.46908510374761503,0.530914896252385,1,0.38569115311939084,0.6143088468806092,0,0.9416991472244263,0.06758052110671997,0,0.8247550129890442,0.20805925130844116,1,0.7630877095841253,0.23691229041587464,0
615,症状は、接種医にも近隣の開業医にも報告されなかった。,症状 接種 医 近隣 開業医 報告 する れる ない た,0,0.9845673508376087,0.01543264916239127,0,9.17369556994763e-05,0.9999082630443005,0,0.9329247268759823,0.06707527312401775,0,0.9885104567113258,0.011489543288674199,0,0.9551612138748169,0.05787421390414238,0,0.8369795083999634,0.14291492104530334,0,0.96781499010336,0.03218500989663999,0
616,尿蛋白:陰性、備考:2年前より健康診断時に蛋白尿なし,尿蛋白 陰性 備考 0 年 前 健康 診断 蛋白尿 ない,0,0.9845530157849699,0.015446984215030006,0,9.157467478850916e-05,0.9999084253252115,0,0.7328026939243119,0.26719730607568815,0,0.9749074817506339,0.02509251824936606,0,0.925380527973175,0.07218475639820099,0,0.8278481960296631,0.20291750133037567,0,0.945978411718951,0.054021588281049034,0
617,"Casts urinary hyaline, (-)",Casts urinary hyaline,0,0.9397970239824307,0.06020297601756942,0,0.00011621578651607767,0.9998837842134839,1,0.4563792597309324,0.5436207402690676,0,1.0,2.2690290686134706e-24,0,0.9109088778495789,0.1299820989370346,0,0.6659526824951172,0.409397155046463,1,0.8617697446158114,0.13823025538418865,0
618,患者は、風邪薬、葛根湯、熱を下げる薬を処方された。,患者 風邪 薬 葛根湯 熱 下げる 薬 処方 する れる た,0,0.9845693153726525,0.015430684627347575,0,8.302787058151548e-05,0.9999169721294184,0,0.9401268183314321,0.05987318166856795,1,0.22031111066883713,0.7796888893311629,0,0.8472481966018677,0.28854650259017944,0,0.7320335507392883,0.3338140845298767,1,0.7767977491911939,0.22320225080880596,0
619,1ヵ月後の外来検査において、心電図は正常であった。,0 ヵ月 後 外来 検査 心電図 正常 だ ある た,0,0.9924978118480211,0.007502188151978917,0,5.566805946132592e-05,0.9999443319405387,0,0.9976083325212003,0.002391667478799762,0,0.9428335493705042,0.05716645062949571,0,0.9391985535621643,0.0622120276093483,0,0.8394241333007812,0.16036731004714966,0,0.9683861030219983,0.03161389697800158,0
620,2021/07/19リリカ25 mg経口投与開始。,0 0 0 リリカ 0 mg 経口 投与 開始,0,0.993633009864222,0.0063669901357779075,0,8.694019190506296e-05,0.999913059808095,0,0.9826549509729932,0.017345049027006846,0,0.9826290583892989,0.01737094161070105,0,0.8991199135780334,0.10267774015665054,0,0.7690587639808655,0.23700065910816193,0,0.9625474367306115,0.0374525632693884,0
621,2021/09/16、心臓超音波検査が実施された。,0 0 0 心臓 超音波 検査 実施 する れる た,0,0.9875173339106355,0.012482666089364559,0,0.00012565045059447923,0.9998743495494056,0,0.9560410822766854,0.04395891772331461,1,0.42396705778268085,0.5760329422173192,0,0.91847825050354,0.11083907634019852,0,0.8277836441993713,0.1827116757631302,1,0.8991679334245631,0.10083206657543689,0
622,2021/12/13インフルエンザワクチンを接種。,0 0 0 インフルエンザ ワクチン 接種,0,0.9845696479806604,0.015430352019339516,0,0.00014971117476609267,0.9998502888252339,1,0.35873972300322543,0.6412602769967746,0,0.9999910893554829,8.910644517165198e-06,0,0.7743065357208252,0.32705795764923096,0,0.7923822999000549,0.20882534980773926,1,0.847833102010128,0.15216689798987207,0
623,2022/02/16症状の消失および回復を認めた。,0 0 0 症状 消失 回復 認める た,0,0.9993335344638193,0.0006664655361806731,0,6.38697234173554e-05,0.9999361302765827,0,0.9852019921352435,0.014798007864756503,0,0.9824951241900953,0.017504875809904622,0,0.9345480799674988,0.06606557965278625,0,0.8224066495895386,0.202509343624115,0,0.9684024707535527,0.03159752924644736,0
624,2022/06/01薬物鎮静で症状の軽快を認めた。,0 0 0 薬物 鎮静 症状 軽快 認める た,0,0.9845853447299446,0.015414655270055365,0,0.00010905769834776629,0.9998909423016522,0,0.9037110393101919,0.09628896068980813,1,0.25227838635812316,0.7477216136418768,0,0.9364279508590698,0.0687997043132782,0,0.8066093325614929,0.19244033098220825,1,0.8536055991667333,0.14639440083326674,0
625,2022年6月2日心電図は心拍62に回復していた。,0 年 0 月 0 日 心電図 心拍 0 回復 する いる た,0,0.984560886024691,0.015439113975309055,0,0.00012800598631869525,0.9998719940136813,0,0.925532637989186,0.0744673620108141,0,0.7453670285910012,0.25463297140899877,0,0.9380223155021667,0.06838614493608475,0,0.826037585735321,0.18620355427265167,0,0.9437814217896978,0.05621857821030229,0
626,6月13日の再診で皮疹は軽快し治療は終了となった。,0 月 0 日 再診 だ 皮疹 軽快 する 治療 終了 なる た,0,0.9873806432725637,0.01261935672743629,0,6.439607445854378e-05,0.9999356039255415,0,0.8442330711384356,0.15576692886156446,0,0.9482467638117877,0.05175323618821227,0,0.9410861730575562,0.07106853276491165,0,0.8285034894943237,0.17260564863681793,0,0.956301740971725,0.04369825902827493,0
627,MRIや神経伝達速度などの精査の結果では異常なし。,MRI 神経伝達速度 精査 結果 異常 ない,0,0.989251887937091,0.010748112062908993,0,7.694659346566114e-05,0.9999230534065343,0,0.9474188310581418,0.05258116894185812,0,0.9985296952380746,0.0014703047619255003,0,0.945425271987915,0.06397037208080292,0,0.8225228786468506,0.1621098518371582,0,0.9680905260977632,0.03190947390223668,0
628,カロナール1000-1500 mg/日で投与開始。,カロナール 0 0 mg 日 投与 開始,0,0.9961589113990653,0.0038410886009347064,0,7.800445351410536e-05,0.9999219955464859,0,0.9908725298931557,0.00912747010684436,0,0.9992934116442549,0.0007065883557450959,0,0.9138679504394531,0.10404860228300095,0,0.8304839730262756,0.18447145819664001,0,0.9685876416612131,0.031412358338786875,0
629,その他の症状/事象が発現したかどうかは不明である。,その他 症状 事象 発現 する た 不明 だ ある,0,0.9715777300246639,0.0284222699753362,0,9.714891486195231e-05,0.9999028510851381,0,0.8743342627705462,0.1256657372294538,0,0.9995347275160255,0.00046527248397456,0,0.8847872018814087,0.18556223809719086,0,0.6656914353370667,0.2886156141757965,0,0.9408879089369043,0.05911209106309566,0
630,患者にはCOVID-19感染症の罹患歴はなかった。,患者 COVID 0 感染症 の 罹患歴 ない た,0,0.9916596557511523,0.008340344248847747,0,9.110138264960418e-05,0.9999088986173504,0,0.9674601227815672,0.03253987721843279,0,0.9871628889334334,0.01283711106656657,0,0.9394835233688354,0.06595509499311447,0,0.8410274386405945,0.15988364815711975,0,0.9691540990364107,0.030845900963589315,0
631,患者の既往歴、合併症、危険因子、アレルギーはなし。,患者 既往 歴 合併症 危険因子 アレルギー ない,0,0.9905726995537184,0.009427300446281527,0,6.351506811496316e-05,0.999936484931885,0,0.9866752667788438,0.013324733221156218,0,0.998049042472543,0.0019509575274570447,0,0.945152997970581,0.07939383387565613,0,0.8250813484191895,0.15762896835803986,0,0.97022712911418,0.02977287088582005,0
632,患者はCOVID-19と診断されたことはなかった。,患者 COVID 0 診断 する れる た こと ない た,0,0.9950713963674005,0.004928603632599496,0,0.00010580921903973167,0.9998941907809603,0,0.9533681500081258,0.046631849991874245,0,0.9999978989387611,2.10106123890065e-06,0,0.9442017078399658,0.06499899178743362,0,0.834094762802124,0.14742982387542725,0,0.9696151220934095,0.030384877906590474,0
633,血管造影:冠動脈造影にて冠動脈疾患は認めなかった。,血管造影 冠動脈造影 にる 冠動脈疾患 認める ない た,0,0.9845640584776179,0.015435941522382122,0,8.874407931641946e-05,0.9999112559206835,0,0.8948317344082177,0.10516826559178222,0,0.9829575449268433,0.017042455073156736,0,0.9437779784202576,0.052813317626714706,0,0.8408071994781494,0.17189839482307434,0,0.9639021900384153,0.03609780996158472,0
634,献血ヴェノグロブリンIH投与は、問題なく終了した。,献血 ヴェノグロブリン IH 投与 問題 ない 終了 する た,0,0.9997591562907082,0.00024084370929183382,0,4.509484190075994e-05,0.9999549051580993,0,0.98213089302853,0.017869106971470084,0,0.8111675687274519,0.1888324312725481,0,0.9482707381248474,0.06432447582483292,0,0.812908947467804,0.23231962323188782,0,0.9548145073538159,0.04518549264618411,0
635,抗環状シトルリン化ペプチド抗体:陰性(陰性)陰性。,抗環状シトルリン化ペプチド抗体 陰性 陰性 陰性,0,0.9914928236197131,0.008507176380286873,0,5.3374569123825826e-05,0.9999466254308762,0,0.9748863304620521,0.02511366953794793,0,1.0,3.2546171171408733e-59,0,0.9147686958312988,0.0748915895819664,0,0.8081223368644714,0.18326601386070251,0,0.9676293977219523,0.03237060227804769,0
636,抗凝固薬のエダラボン、エリキュースによる治療開始。,抗凝固 薬 エダラボン エリキュース 治療 開始,0,0.9817383002570471,0.018261699742952858,0,0.00010629504603338832,0.9998937049539666,0,0.9673451501152561,0.03265484988474392,0,0.7989084169885035,0.20109158301149654,0,0.8928754925727844,0.10929645597934723,0,0.7649697065353394,0.3240601122379303,0,0.9382362381508569,0.06176376184914303,0
637,合併症、既往歴及び併用薬の情報は報告されていない。,合併症 既往 歴 併用 薬 情報 報告 する れる いる ない,0,0.9969008826500932,0.0030991173499067383,0,5.325318248143525e-05,0.9999467468175186,0,0.991808947793838,0.008191052206162005,0,0.9611705477799762,0.03882945222002379,0,0.9552984833717346,0.06654486805200577,0,0.8056181073188782,0.16992300748825073,0,0.9684558876957347,0.03154411230426528,0
638,事象発現前の2週間以内に投与した併用薬はなかった。,事象 発現 前 0 週間 以内 投与 する た 併用 薬 ない た,0,0.9971793304188243,0.0028206695811755973,0,6.00774397082425e-05,0.9999399225602917,0,0.9908025356666958,0.009197464333304112,0,0.998063812549904,0.0019361874500960945,0,0.9517346024513245,0.05441347137093544,0,0.828333854675293,0.14193595945835114,0,0.9722379483695738,0.02776205163042621,0
639,心エコーでは左室駆出率61%であり、異常所見なし。,心 エコー 左 室 駆け出し 率 0% だ ある 異常所見なし,0,0.8882732001351609,0.11172679986483906,0,0.00010754320509061642,0.9998924567949093,0,0.5346791796459822,0.46532082035401773,0,0.9994709524592567,0.0005290475407433878,0,0.925769567489624,0.07711983472108841,0,0.8040972352027893,0.29175397753715515,0,0.9007919125264509,0.09920808747354905,0
640,心臓超音波検査にて左室駆出率61%、異常所見なし。,心臓 超音波 検査 左 室 駆け出し 率 0% 異常所見なし,0,0.9845577378185986,0.0154422621814016,0,0.00010955777671227845,0.9998904422232877,0,0.7587335652418392,0.24126643475816073,0,0.9997963868982038,0.00020361310179620537,0,0.917748212814331,0.06914625316858292,0,0.7376217246055603,0.3773254156112671,0,0.9367483086471119,0.06325169135288816,0
641,心嚢液から有意な細菌やウイルスは検出されなかった。,心嚢液 有意 だ 細菌 ウイルス 検出 する れる ない た,0,0.9946121042978116,0.005387895702188395,0,5.973479851008069e-05,0.9999402652014899,0,0.9353148895834881,0.06468511041651191,0,0.9884701564218572,0.011529843578142742,0,0.9529087543487549,0.05693677440285683,0,0.8375681638717651,0.14788340032100677,0,0.9684025217437333,0.03159747825626667,0
642,新型コロナウイルス感染のPCR検査は陰性であった。,新型コロナ ウイルス感染 PCR検査 陰性 だ ある た,0,0.9942824346892379,0.00571756531076209,0,8.402214215727387e-05,0.9999159778578427,0,0.9842473603721523,0.015752639627847682,0,0.9207376291170031,0.07926237088299688,0,0.937138020992279,0.061971794813871384,0,0.8410919904708862,0.1742183268070221,0,0.9658003849044114,0.03419961509558858,0
643,接種3日後、心エコー図にて拡張機能は正常であった。,接種 0 日 後 心 エコー 図 拡張機能 正常 だ ある た,0,0.9845572521263267,0.01544274787367335,0,8.492864987323778e-05,0.9999150713501268,0,0.9750819012288412,0.024918098771158758,0,0.8567432875478066,0.14325671245219337,0,0.9337931275367737,0.06114872545003891,0,0.8442477583885193,0.16105209290981293,0,0.9604096612613742,0.0395903387386258,0
644,第3病日には心電図変化は改善、自覚症状は消失した。,0 病 日 心電図変化 改善 自覚症状 消失 する た,0,0.9994452721448228,0.0005547278551772309,0,5.386049215305786e-05,0.9999461395078469,0,0.9884673971996261,0.011532602800373935,0,0.5295021566282502,0.4704978433717498,0,0.9396913647651672,0.06502874195575714,0,0.8209459781646729,0.177344411611557,0,0.9277883042316826,0.07221169576831739,0
645,日付不明接種約2週間後から両下肢に紅い皮疹が出現。,日付 不明 接種 0 週間 後 下肢 紅い 皮疹 出現,0,0.9845649174125082,0.015435082587491813,1,0.00016476357580926394,0.9998352364241907,1,0.17707036164500078,0.8229296383549992,0,0.8586891123961131,0.14131088760388683,1,0.09218362718820572,0.9473876357078552,1,0.19145597517490387,0.8570834994316101,1,0.18544959015790238,0.8145504098420976,0
646,入院時、鼻咽頭ポリメラーゼ連鎖反応は陰性であった。,入院 時 鼻 咽頭 ポリメラーゼ連鎖反応 陰性 だ ある た,0,0.9845457471134751,0.015454252886524794,0,8.227886898829379e-05,0.9999177211310117,0,0.9590980185865473,0.040901981413452665,0,0.8106390720523681,0.18936092794763193,0,0.9374338388442993,0.06331878900527954,0,0.8292569518089294,0.17252732813358307,0,0.9543303055407447,0.045669694459255256,0
647,免疫蛍光抗体分析では顕著な免疫複合体沈着は認めず。,免疫 蛍光 抗体 分析 顕著 だ 免疫複合体 沈着 認める ぬ,0,0.9845600437093435,0.015439956290656457,0,0.00011759303469838609,0.9998824069653016,0,0.6181739596284088,0.38182604037159124,0,0.7082402709086473,0.2917597290913528,1,0.12197566777467728,0.9128395915031433,1,0.2149920016527176,0.8453150987625122,1,0.31023876596331157,0.6897612340366884,0
648,薬物療法および非薬物療法の追加治療を受けなかった。,薬物 療法 薬物 療法 の 追加 治療 受ける ない た,0,0.9991177144797235,0.0008822855202765741,0,7.723333836453138e-05,0.9999227666616355,0,0.9531823538273242,0.04681764617267577,0,0.9668402243296671,0.033159775670332854,0,0.9556366205215454,0.049351826310157776,0,0.8062265515327454,0.1477101594209671,0,0.9678055227903842,0.03219447720961566,0
649,ワクチン接種日周辺には解熱剤は使用していなかった。,ワクチン接種 日 周辺 解熱 剤 使用 する いる ない た,0,0.998148133273797,0.0018518667262029571,0,6.148055262360209e-05,0.9999385194473764,0,0.9936160959395925,0.006383904060407475,0,0.9964772299019238,0.00352277009807622,0,0.950531005859375,0.05013977736234665,0,0.8385720252990723,0.14619950950145721,0,0.9725983940458742,0.027401605954125743,0
650,CSF immunoglobulin:データなし。,CSF immunoglobulin データ ない,0,0.9958428225937039,0.004157177406296019,0,6.666623398755119e-05,0.9999333337660125,0,0.9584064201532027,0.04159357984679737,0,0.9999999223708852,7.762911476396412e-08,0,0.9538034796714783,0.06678342074155807,0,0.8525751829147339,0.17276766896247864,0,0.9699813862877424,0.030018613712257478,0
651,再調査は完了し、これ以上の追加情報は期待できない。,再調査 完了 する これ 以上 追加 情報 期待 できる ない,0,0.9948093131723601,0.005190686827639846,0,4.528466030754981e-05,0.9999547153396925,0,0.9116471306921917,0.08835286930780828,0,0.9191444974991023,0.08085550250089762,0,0.9575306177139282,0.07242780178785324,0,0.8127833008766174,0.15931613743305206,0,0.9604509952538088,0.03954900474619111,0
652,その他疾患等、他に考えられる事象の原因はなかった。,その他 疾患 等 他 考える られる 事象 原因 ない た,0,0.9906983976207498,0.009301602379250117,0,7.328134888888605e-05,0.9999267186511112,0,0.9746673766242873,0.02533262337571269,0,0.9637701562215697,0.03622984377843029,0,0.9398288726806641,0.06041834130883217,0,0.8191301822662354,0.15443643927574158,0,0.9677832828847496,0.03221671711525033,0
653,事象の原因に他要因(他疾患等)の可能性はなかった。,事象 原因 要因 疾患 等 可能性 ない た,0,0.9989808809234082,0.0010191190765918346,0,5.0000650435331804e-05,0.9999499993495646,0,0.9793607573364271,0.02063924266357285,0,0.9914121176780918,0.008587882321908172,0,0.9388318657875061,0.05462953448295593,0,0.8212014436721802,0.14962604641914368,0,0.9705561798283063,0.029443820171693783,0
654,2022/04/11、本試験の観察期間は完了した。,0 0 0 試験 観察 期間 完了 する た,0,0.9845656896066085,0.015434310393391477,0,0.00011471578934590197,0.9998852842106541,0,0.5793300642063699,0.4206699357936301,0,0.984343501744451,0.015656498255549062,0,0.9428765773773193,0.0746181458234787,0,0.8321154117584229,0.17526176571846008,0,0.9322527449417335,0.0677472550582664,0
655,2022/06/27、検査結果により軽快であった。,0 0 0 検査結果 軽快 だ ある た,0,0.997436374821207,0.0025636251787929643,0,7.245093916045551e-05,0.9999275490608396,0,0.981139573628423,0.01886042637157701,0,0.983902827836784,0.01609717216321609,0,0.9399511218070984,0.06793057918548584,0,0.8264415860176086,0.16664963960647583,0,0.9694366912618102,0.030563308738189823,0
656,2022/04/11(月曜日)、鼻症状は改善した。,0 0 0 月曜日 鼻症状 改善 する た,0,0.9966605117451228,0.0033394882548770915,0,7.993796795632679e-05,0.9999200620320436,0,0.9523250769696939,0.0476749230303061,0,0.8322180118489942,0.16778198815100576,0,0.9290276765823364,0.06943335384130478,0,0.825077474117279,0.1824321746826172,0,0.9554174866618451,0.04458251333815481,0
657,患者はワクチン接種日周辺に解熱剤を使用しなかった。,患者 ワクチン接種 日 周辺 解熱 剤 使用 する ない た,0,0.9986946914236452,0.0013053085763548686,0,6.651821286693206e-05,0.999933481787133,0,0.992952856627143,0.0070471433728569,0,0.9969383738809668,0.003061626119033108,0,0.9512891173362732,0.05173192545771599,0,0.8292660117149353,0.144635871052742,0,0.972387671678946,0.027612328321054112,0
658,予定通りリサンキズマブを投与し、発疹は改善された。,予定通り リサンキズマブ 投与 する 発疹 改善 する れる た,0,0.9884355910963388,0.011564408903661106,0,8.48379511942436e-05,0.9999151620488057,0,0.9837580688639469,0.016241931136053114,1,0.4318361332201309,0.5681638667798691,0,0.9271234273910522,0.08570047467947006,0,0.8104533553123474,0.19752921164035797,1,0.9057298391099571,0.09427016089004304,0
659,2022/04/25(月曜日)、倦怠感は改善した。,0 0 0 月曜日 倦怠感 改善 する た,0,0.9845558489065492,0.015444151093450853,0,8.801450095657913e-05,0.9999119854990435,0,0.8453305706180843,0.15466942938191572,0,0.9321621456135117,0.06783785438648826,0,0.9319193959236145,0.06738580018281937,0,0.8175522685050964,0.20083017647266388,0,0.9528232776013575,0.047176722398642415,0
660,心エコー検査結果は、機能障害の残存を示さなかった。,心 エコー 検査結果 機 能障害 の 残存 示す ない た,0,0.9845806517480009,0.01541934825199921,0,9.055530837343199e-05,0.9999094446916266,0,0.7950453945402046,0.20495460545979538,0,0.9691088324056222,0.030891167594377857,0,0.9564918875694275,0.05786030367016792,0,0.8433521389961243,0.16535302996635437,0,0.9558193305999766,0.04418066940002343,0
661,症状(1)は、2022/03/16現在、改善した。,症状 0 0 0 0 現在 改善 する た,0,0.9987529641025972,0.0012470358974029025,0,8.830295285639918e-05,0.9999116970471436,0,0.9847062935252507,0.015293706474749246,0,0.9798071729799559,0.0201928270200441,0,0.9355074167251587,0.06870004534721375,0,0.8237677216529846,0.17863163352012634,0,0.9688909389505799,0.031109061049420163,0
662,有害事象後の本剤の投与は中止であった(報告通り)。,有害事象 後 本 剤 投与 中止 だ ある た 報告 通り,0,0.9891991047983884,0.010800895201611597,0,6.3945538272894e-05,0.9999360544617271,0,0.9680634461103526,0.0319365538896474,0,0.9999973741791137,2.6258208863170886e-06,0,0.9434203505516052,0.08679403364658356,0,0.7895534038543701,0.18247506022453308,0,0.9670211015798127,0.03297889842018732,0
663,2022/03/15、継続していた咳嗽は回復した。,0 0 0 継続 する いる た 咳嗽 回復 する た,0,0.983129182757019,0.01687081724298099,0,8.888724390416869e-05,0.9999111127560958,0,0.9754362559115665,0.024563744088433575,0,0.9812761686370988,0.01872383136290128,0,0.9206892848014832,0.08554107695817947,0,0.8136203289031982,0.19546730816364288,0,0.9655491127921472,0.03445088720785289,0
664,スクリーニングCTでは、内出血は見つからなかった。,スクリーニング CT 内出血 見つかる ない た,0,0.9932093952356584,0.006790604764341636,0,8.823802779695864e-05,0.999911761972203,0,0.9640365464408378,0.03596345355916219,0,0.8690310279105702,0.1309689720894298,0,0.9416190385818481,0.05850480496883392,0,0.8256056904792786,0.16757437586784363,0,0.9606031673668531,0.0393968326331469,0
665,また、CAGを実施した結果、冠動脈は正常であった。,CAG 実施 する た 結果 冠動脈 正常 だ ある た,0,0.9970648169416471,0.002935183058352899,0,5.356713456197864e-05,0.999946432865438,0,0.9876731059443609,0.012326894055639115,0,0.9838430376778854,0.016156962322114613,0,0.9442172050476074,0.056447822600603104,0,0.8260453939437866,0.1717711091041565,0,0.9700933872052075,0.02990661279479236,0
666,ロキソニンとロピオンによる解熱剤使用にて軽快した。,ロキソニン ロピオン 解熱 剤 使用 軽快 する た,0,0.9967268391165811,0.003273160883418835,0,6.220466906601127e-05,0.999937795330934,0,0.8361938966169544,0.16380610338304558,0,0.6228932303397354,0.3771067696602646,0,0.9349161386489868,0.0688989907503128,0,0.8070746660232544,0.19105537235736847,0,0.9163524392642349,0.08364756073576507,0
667,患者に化粧品など医薬品以外のアレルギーはなかった。,患者 化粧品 医 薬品 以外 アレルギー ない た,0,0.9845501490185893,0.015449850981410811,0,7.98649478625775e-05,0.9999201350521374,0,0.8973697427234012,0.10263025727659876,0,0.9818866075564856,0.018113392443514394,0,0.9506500959396362,0.05381281301379204,0,0.8512014150619507,0.15688364207744598,0,0.9650724676708853,0.03492753232911483,0
668,死亡時画像診断が実施されたかどうかは不明であった。,死亡 時 画像 診断 実施 する れる た 不明 だ ある た,0,0.7706886989809328,0.22931130101906708,0,0.00011288757073189091,0.9998871124292681,0,0.9137976124302802,0.08620238756971976,0,0.9013037470789095,0.09869625292109055,0,0.9389591813087463,0.07901501655578613,0,0.8168141841888428,0.16870974004268646,0,0.935827386281998,0.06417261371800188,0
669,全身状態は良好で、2022/06/09に退院した。,全身 状態 良好 だ 0 0 0 退院 する た,0,0.9953842938581673,0.00461570614183272,0,6.085635537991886e-05,0.9999391436446201,0,0.9901976114213997,0.009802388578600286,0,0.6949776410087496,0.3050223589912504,0,0.9406086802482605,0.07945626229047775,0,0.818063497543335,0.19036604464054108,0,0.9453233697601134,0.054676630239886566,0
670,被験者は事前のワクチン接種後の有害事象はなかった。,被験者 事前 ワクチン接種 後 有害事象 ない た,0,0.99408368975356,0.0059163102464399285,0,6.756865601674337e-05,0.9999324313439832,0,0.968253672491632,0.03174632750836802,0,0.997957406037035,0.002042593962964996,0,0.9534449577331543,0.053800635039806366,0,0.8491549491882324,0.1468956470489502,0,0.9713248006557541,0.028675199344245922,0
671,有害事象後の本剤の投与は継続であった(報告通り)。,有害事象 後 本 剤 投与 継続 だ ある た 報告 通り,0,0.9845682287208193,0.015431771279180662,0,7.740652944903939e-05,0.999922593470551,0,0.9707827269791094,0.029217273020890566,0,0.9999982654735583,1.7345264416963356e-06,0,0.9414474964141846,0.09276091307401657,0,0.8094374537467957,0.17011821269989014,0,0.9676688596965611,0.032331140303438755,0
672,2021/10/29、CK-MBの結果は上昇なし。,0 0 0 CK MB 結果 上昇 ない,0,0.9884886431495218,0.011511356850478379,0,0.00013676753074053888,0.9998632324692595,0,0.949389905417836,0.05061009458216408,0,0.9959969416736065,0.004003058326393461,0,0.9222899675369263,0.10544463992118835,0,0.8212735652923584,0.17087897658348083,0,0.9656189724980963,0.03438102750190371,0
673,COVID-19感染に対す追加療法を受けなかった。,COVID 0 感染 対す 追加 療法 受ける ない た,0,0.9986500002609242,0.0013499997390759371,0,7.238115000884668e-05,0.9999276188499912,0,0.9935331353412217,0.006466864658778345,0,0.9974758874887691,0.0025241125112308925,0,0.9587472677230835,0.05356379970908165,0,0.8215804100036621,0.14916175603866577,0,0.9722685507104984,0.027731449289501588,0
674,X-ray:(2022/06/23)異常所見なし。,X-RAY 0 0 0 異常所見なし,0,0.9890472300880613,0.010952769911938835,0,6.969008117482307e-05,0.9999303099188251,1,0.3741492743921715,0.6258507256078285,0,0.9999996495486204,3.5045137955964286e-07,0,0.9226931929588318,0.07195603102445602,0,0.7592048645019531,0.24079778790473938,1,0.8904821908440183,0.10951780915598178,0
675,その後は患者様自身が2期目以降の接種を避けている。,その後 患者 様 自身 0 期 目 以降 接種 避ける いる,0,0.9845701789832871,0.015429821016712957,0,9.792635636826125e-05,0.9999020736436317,1,0.4795691971592325,0.5204308028407675,0,0.9144078713139604,0.08559212868603956,0,0.9311216473579407,0.09270137548446655,0,0.814738929271698,0.18012173473834991,1,0.9029400921950659,0.09705990780493422,0
676,患者が関連する検査を受けたかどうかは不明であった。,患者 関連 する 検査 受ける た 不明 だ ある た,0,0.9956706093595274,0.004329390640472563,0,6.266095067923272e-05,0.9999373390493208,0,0.9929711374240363,0.007028862575963637,0,0.9927894742870548,0.007210525712945212,0,0.9371187090873718,0.07583297789096832,0,0.8219404220581055,0.16431017220020294,0,0.9701684669937229,0.029831533006277014,0
677,胸部CT結果:VIPパターン、急性増悪の所見なし。,胸部 CT 結果 VIP パターン 急性増悪 所見 ない,0,0.996352255823868,0.003647744176132121,0,7.662929030094951e-05,0.999923370709699,0,0.9892117183244562,0.010788281675543788,0,0.9811030183647608,0.018896981635239254,0,0.9336735010147095,0.08207721263170242,0,0.8304376006126404,0.18228107690811157,0,0.9687273733143764,0.031272626685623583,0
678,搬送中の事象臨床経過および処置内容は不明であった。,搬送 中 事象 臨床 経過 お呼び 処置 内容 不明 だ ある た,0,0.9585821660082575,0.041417833991742425,0,7.946197779375322e-05,0.9999205380222063,1,0.4519278824556917,0.5480721175443083,0,0.7782874688318071,0.22171253116819292,0,0.9300034642219543,0.08467340469360352,0,0.8319534063339233,0.165325328707695,1,0.868722700412792,0.1312772995872079,0
679,胸痛、炎症反応、トロポニンI値は低下傾向であった。,胸痛 炎症反応 トロポニン I 値 低下 傾向 だ ある た,0,0.9671899097471792,0.0328100902528207,0,0.00013446380471288482,0.9998655361952871,0,0.927329601463051,0.07267039853694901,0,0.880140936128909,0.11985906387109099,1,0.5250954031944275,0.5622828602790833,0,0.821614682674408,0.1931656152009964,1,0.8948107780533485,0.1051892219466515,0
680,患者は食欲を徐々に回復し、活動量も徐々に増加した。,患者 食欲 回復 活動量 増加 する た,0,0.9845670685764912,0.015432931423508694,0,8.88002165893313e-05,0.9999111997834107,0,0.9027942779653121,0.09720572203468794,1,0.44055271227366344,0.5594472877263366,0,0.8754780292510986,0.1732276976108551,0,0.7928401827812195,0.18719232082366943,1,0.8769548245483676,0.12304517545163234,0
681,新型コロナウイルスのPCR検査では陰性であった。,新型コロナウイルス PCR検査 陰性 だ ある た,0,0.9945824102559025,0.005417589744097371,0,9.200256748167396e-05,0.9999079974325183,0,0.984800132466641,0.01519986753335898,0,0.9823690403857691,0.01763095961423087,0,0.9311097264289856,0.06335210800170898,0,0.8525380492210388,0.17643019556999207,0,0.9697503086485623,0.03024969135143767,0
682,1ヵ月の経過観察時、患者は完全に無症状であった。,0 ヵ月 経過 観察 時 患者 完全 無症状 だ ある た,0,0.9845541976264316,0.015445802373568485,0,6.633941666030854e-05,0.9999336605833397,0,0.7375687514181286,0.26243124858187145,0,0.7879354444160545,0.2120645555839455,0,0.9348767399787903,0.08148209750652313,0,0.8331782817840576,0.16987651586532593,0,0.92669161697591,0.0733083830240901,0
683,1か月後の外来検査においてTnTは正常であった。,0 か月 後 外来 検査 TnT 正常 だ ある た,0,0.9990648439804727,0.000935156019527271,0,3.8685528011208086e-05,0.9999613144719888,0,0.9980490682824428,0.001950931717557236,0,0.9570054367171329,0.04299456328286708,0,0.9383502006530762,0.06216150149703026,0,0.8390634059906006,0.15852166712284088,0,0.9696767054094095,0.030323294590590348,0
684,2021/10/27症状はないが、治療を継続中。,0 0 0 症状 ない 治療 継続 中,0,0.9996767144132982,0.00032328558670169675,0,6.454265919498783e-05,0.999935457340805,0,0.9905061234998056,0.009493876500194391,0,0.9999929009808377,7.099019162322908e-06,0,0.9426464438438416,0.05932450294494629,0,0.812534749507904,0.2056790590286255,0,0.9698412761146128,0.030158723885387134,0
685,2021/11/27インフルエンザワクチン接種。,0 0 0 インフルエンザ ワクチン接種,0,0.8998619828460095,0.10013801715399061,0,0.0001507913202872009,0.9998492086797128,1,0.35873972300322543,0.6412602769967746,1,0.24550731801073378,0.7544926819892662,0,0.8780785202980042,0.13074196875095367,0,0.7820810079574585,0.22808289527893066,1,0.5768496956949404,0.4231503043050596,0
686,2022/04/05 PCR検査の結果は、陰性。,0 0 0 PCR検査 結果 陰性,0,0.9961446721737349,0.0038553278262650277,0,9.781679576747114e-05,0.9999021832042325,0,0.9578490428835932,0.042150957116406866,0,1.0,9.110605460378342e-18,0,0.9254327416419983,0.07487025111913681,0,0.8151273131370544,0.19413352012634277,0,0.9670653044216834,0.03293469557831666,0
687,2022/04/12症状の軽快を認め、自宅退院。,0 0 0 症状 軽快 認める 自宅 退院,0,0.9986309403347051,0.0013690596652949066,0,7.058071861093118e-05,0.9999294192813891,0,0.9903231320021829,0.009676867997817069,0,0.9999999999999998,2.1774972665631606e-16,0,0.9370817542076111,0.08666744828224182,0,0.7958238124847412,0.20138630270957947,0,0.9684126364805646,0.031587363519435335,0
688,2022/05/28経過観察で改善を認め、退院。,0 0 0 経過 観察 改善 認める 退院,0,0.9995837533029734,0.00041624669702647587,0,5.951022412360896e-05,0.9999404897758764,0,0.9843621563897311,0.015637843610268914,0,0.9999999999999994,5.296595174426594e-16,0,0.9370011687278748,0.06997132301330566,0,0.7832106947898865,0.19032351672649384,0,0.9685660409838778,0.031433959016122164,0
689,2022/06/13症状改善なく、利尿薬を増量。,0 0 0 症状改善 ない 利尿 薬 増量,0,0.989181015233908,0.010818984766092101,0,8.249336107913126e-05,0.9999175066389209,0,0.9856212125790927,0.014378787420907209,0,0.9978552541209087,0.0021447458790912893,0,0.9180920720100403,0.06981108337640762,0,0.7372307181358337,0.31757092475891113,0,0.9613362112494529,0.0386637887505472,0
690,2022/07/05ステロイドパルス療法を開始。,0 0 0 ステロイド パルス 療法 開始,0,0.9823786460656488,0.01762135393435108,0,0.00010849536256716017,0.9998915046374328,0,0.9506580124249306,0.04934198757506931,0,0.9999827399703454,1.726002965467893e-05,0,0.9126490950584412,0.08821234852075577,0,0.5585718750953674,0.5340244770050049,0,0.9379199505443542,0.062080049455645936,0
691,6か月の追跡診察時、患者は完全に無症状であった。,0 か月 追跡 診察 時 患者 完全 無症状 だ ある た,0,0.9845717765403522,0.015428223459647691,0,7.872766203467734e-05,0.9999212723379654,0,0.7167144686396525,0.28328553136034745,0,0.6965851533405238,0.3034148466594762,0,0.9258557558059692,0.09000343829393387,0,0.835206925868988,0.17308233678340912,0,0.9083686768507883,0.09163132314921178,0
692,COVID-19に対する追加療法は受けなかった。,COVID 0 追加 療法 受ける ない た,0,0.9998957941596764,0.00010420584032361574,0,4.932371563587622e-05,0.9999506762843641,0,0.9933650634627259,0.006634936537274067,0,0.999875047939496,0.00012495206050404977,0,0.9575533866882324,0.05043021962046623,0,0.8132649064064026,0.15190540254116058,0,0.9722088528786684,0.027791147121331534,0
693,COVIDー19に対する追加療法は受けなかった。,COVID ー 0 追加 療法 受ける ない た,0,0.9996887939897793,0.00031120601022066114,0,5.877216106388955e-05,0.9999412278389361,0,0.9944243538781717,0.005575646121828235,0,0.999568948943998,0.0004310510560020605,0,0.9587623476982117,0.053484175354242325,0,0.8095852136611938,0.1484495997428894,0,0.9721829678308673,0.027817032169132713,0
694,MRAにて右VAの解離性病変は描出されなかった。,MRA 右 VA 解離 性病変 描出 する れる ない た,0,0.9908671722547565,0.009132827745243476,0,9.992795657318272e-05,0.9999000720434268,0,0.9063583018034859,0.09364169819651412,0,0.9920494565750204,0.007950543424979598,0,0.9393526315689087,0.06064462289214134,0,0.815727949142456,0.19857317209243774,0,0.9635475266956421,0.03645247330435775,0
695,prednisolone投与後に改善がみられた。,prednisolone 投与 後 改善 みる られる た,0,0.9937430468256534,0.0062569531743466,0,7.217461910506183e-05,0.999927825380895,0,0.9790169665370788,0.020983033462921182,0,0.9644639040802268,0.0355360959197733,0,0.9190554618835449,0.09955238550901413,0,0.8007200956344604,0.19990770518779755,0,0.9642536994473174,0.03574630055268248,0
696,ST上昇の改善を認めた(無治療にて経過観察中)。,ST 上昇 改善 認める た 治療 経過 観察 中,0,0.9894237651352051,0.010576234864794854,0,0.00010808405446752891,0.9998919159455325,0,0.8309184219449406,0.16908157805505944,0,0.9999813118173777,1.8688182622332947e-05,0,0.9374173879623413,0.06535518169403076,0,0.7895065546035767,0.2013692557811737,0,0.9569365579190744,0.04306344208092559,0
697,シロスタゾールについて、投与量に変更はなかった。,シロスタゾール 投与 量 変更 ない た,0,0.9997354349027778,0.0002645650972220651,0,5.922974409796534e-05,0.999940770255902,0,0.986438752351077,0.013561247648923015,0,0.9986547447911545,0.0013452552088455718,0,0.9398353099822998,0.05083495005965233,0,0.844711184501648,0.17966067790985107,0,0.9713581744338529,0.028641825566147142,0
698,ステロイド(プレドニン)60 mgを投与し治療。,ステロイド プレドニン 0 mg 投与 する 治療,0,0.9985194362030124,0.0014805637969876044,0,4.680419190353095e-05,0.9999531958080965,0,0.9980358400402899,0.0019641599597101014,0,0.9999995399450934,4.6005490664885106e-07,0,0.9043014049530029,0.09626184403896332,0,0.7660444974899292,0.3581620752811432,0,0.9611762351402121,0.0388237648597879,0
699,その後、ステロイド内服を継続し、血尿は消失した。,その後 ステロイド 内服 継続 する 血尿 消失 する た,0,0.995773891476692,0.00422610852330814,0,6.628179038389825e-05,0.9999337182096161,0,0.9948240975798258,0.00517590242017419,0,0.7924724810663281,0.2075275189336719,0,0.9452017545700073,0.07537935674190521,0,0.7874124050140381,0.1796032041311264,0,0.9545186618237338,0.04548133817626629,0
700,ロキソプロフェン60mg 1日3回が処方された。,ロキソプロフェン 0m g 0 日 0回 処方 する れる た,0,0.9845886901226011,0.015411309877398981,0,0.0001032012120876238,0.9998967987879124,0,0.6076105222677324,0.3923894777322676,1,0.3906976629294858,0.6093023370705142,0,0.9167760610580444,0.10872597247362137,0,0.8241699934005737,0.20366796851158142,1,0.8013179922204331,0.19868200777956704,0
701,異常な心嚢液貯留、心膜の炎症所見は認めなかった。,異常 だ 心嚢液 貯留 心膜 炎症所見 認める ない た,0,0.9845593686827252,0.015440631317274953,0,0.000131199002793577,0.9998688009972064,0,0.8912118474736106,0.10878815252638936,0,0.9827079382174585,0.017292061782541546,0,0.9361991882324219,0.07843954861164093,0,0.7983412146568298,0.19904136657714844,0,0.959854840575664,0.04014515942433614,0
702,外科的処置および病理学的検査は実施されなかった。,外科 的 処置 お呼び 病理学的検査 実施 する れる ない た,0,0.9968586350630111,0.003141364936988821,0,8.182817544399133e-05,0.999918171824556,0,0.9471407148224068,0.052859285177593196,0,0.9896402027815668,0.010359797218433187,0,0.9525255560874939,0.05370379611849785,0,0.829432487487793,0.1423828899860382,0,0.9693298212099106,0.030670178790089247,0
703,患者の関連した病歴と併用薬は、報告されなかった。,患者 関連 する た 病歴 併用 薬 報告 する れる ない た,0,0.9996336460479486,0.0003663539520515884,0,6.487259896052435e-05,0.9999351274010395,0,0.9900731066822333,0.009926893317766783,0,0.9972823716684902,0.002717628331509799,0,0.9549403786659241,0.056938767433166504,0,0.8414729237556458,0.14025379717350006,0,0.9727037100885891,0.027296289911410827,0
704,患者の関連する病歴及び併用薬は報告されなかった。,患者 関連 する 病歴 併用 薬 報告 する れる ない た,0,0.9996336460479486,0.0003663539520515884,0,6.752182264868872e-05,0.9999324781773513,0,0.9953012756829719,0.004698724317028163,0,0.9964222194791854,0.0035777805208145933,0,0.9535135626792908,0.055654726922512054,0,0.8387539982795715,0.14033491909503937,0,0.9728572462111419,0.027142753788858078,0
705,患者は、ワクチン接種部位に副作用を来さなかった。,患者 ワクチン接種 部位 副作用 来す ない た,0,0.9979816673871359,0.0020183326128640757,0,6.887590401885512e-05,0.9999311240959812,0,0.9655526154238976,0.03444738457610245,0,0.9845698210720186,0.015430178927981344,0,0.9489374756813049,0.05649664252996445,0,0.8513109087944031,0.1538386046886444,0,0.9702942601049779,0.029705739895022197,0
706,患者はCOVID-19感染症の罹患歴を否定した。,患者 COVID 0 感染症 の 罹患歴 否定 する た,0,0.7713648949361362,0.22863510506386373,0,9.629344301844244e-05,0.9999037065569816,0,0.543894953824736,0.456105046175264,1,0.344280356347054,0.655719643652946,0,0.9357470273971558,0.073817178606987,0,0.8341209888458252,0.15832263231277466,1,0.7020337390576475,0.29796626094235257,0
707,患者はPCR検査でCOVID-19陰性であった。,患者 PCR検査 COVID 0 陰性 だ ある た,0,0.9982144597286698,0.001785540271330272,0,5.64288943470099e-05,0.999943571105653,0,0.9882095604896448,0.011790439510355204,0,0.9996717424362283,0.0003282575637717437,0,0.9240289330482483,0.08182098716497421,0,0.8423094749450684,0.16744932532310486,0,0.9703838667945521,0.029616133205447807,0
708,緊急冠動脈造影では、冠状動脈異常を示さなかった。,緊急 冠動脈造影 だ 冠状 動脈異常 示す ない た,0,0.9845642607401014,0.015435739259898522,0,7.645978293087362e-05,0.9999235402170691,0,0.915966497924704,0.08403350207529602,0,0.9744285108929419,0.025571489107058087,0,0.9435014128684998,0.05728983134031296,0,0.8362829685211182,0.1782081127166748,0,0.9642347453809766,0.03576525461902342,0
709,血清学的検査にて全身性ウイルス感染は否定された。,血清 学的 検査 身性 ウイルス感染 否定 する れる た,0,0.9845702409587963,0.015429759041203576,0,7.053523562499268e-05,0.999929464764375,0,0.8540516387575247,0.14594836124247532,1,0.28373091639155723,0.7162690836084428,0,0.9401422142982483,0.0664433017373085,0,0.8073455691337585,0.16896311938762665,1,0.8528244994134415,0.14717550058655846,0
710,現在、外来にて患者の状態を注意深く観察している。,現在 外来 患者 状態 注意深い 観察 する いる,0,0.98457483668839,0.015425163311610035,0,8.046104359096551e-05,0.9999195389564091,0,0.756521014833246,0.24347898516675406,0,0.509741290136575,0.490258709863425,0,0.9435973763465881,0.11686287820339203,0,0.7563665509223938,0.28077057003974915,0,0.8586552649732766,0.14134473502672346,0
711,甲状腺機能亢進症、亜急性甲状腺炎は回復していた。,甲状腺機能亢進症 亜急性 甲状腺炎 回復 する いる た,0,0.9845767565028675,0.015423243497132458,0,8.337711050825334e-05,0.9999166228894918,0,0.9336596210665729,0.06634037893342713,0,0.7060714297754352,0.29392857022456476,0,0.9176925420761108,0.06251301616430283,0,0.806610107421875,0.17415310442447662,0,0.9391417420598175,0.06085825794018242,0
712,事象発現前の2週間以内に併用薬の投与はなかった。,事象 発現 前 0 週間 以内 併用 薬 投与 ない た,0,0.9967936070765611,0.0032063929234390355,0,5.871070980943245e-05,0.9999412892901905,0,0.9908025356666958,0.009197464333304112,0,0.9917237128907672,0.00827628710923283,0,0.9495941996574402,0.05315927788615227,0,0.820131242275238,0.14950384199619293,0,0.971413550147693,0.02858644985230691,0
713,心臓超音波検査・胸部X線検査では、異常所見なし。,心臓 超音波 検査 胸部 X線検査 異常所見なし,0,0.9951904566575145,0.00480954334248553,0,6.102820419390538e-05,0.999938971795806,0,0.8925354135998649,0.10746458640013518,0,0.999971439154932,2.8560845067932187e-05,0,0.9152871966362,0.06839916855096817,0,0.7960819005966187,0.2057141810655594,0,0.9613121070805754,0.038687892919424725,0
714,肺炎クラミジアの血清学的マーカーは陰性であった。,肺炎クラミジア の 血清 学的 マーカー 陰性 だ ある た,0,0.9845731269497313,0.015426873050268741,0,7.955549642743436e-05,0.9999204445035725,0,0.8944329971855655,0.10556700281443458,0,0.7634351358845716,0.23656486411542846,0,0.936169445514679,0.059040989726781845,0,0.8447766304016113,0.18217211961746216,0,0.9440000064596783,0.05599999354032161,0
715,治療内容と検査実施の有無については不明であった。,治療 内容 検査 実施 有無 不明 だ ある た,0,0.9977849093584258,0.00221509064157429,0,4.882791820241627e-05,0.9999511720817976,0,0.9903899199987577,0.009610080001242348,0,0.9332614845482874,0.0667385154517126,0,0.9462231397628784,0.058025259524583817,0,0.8493205308914185,0.1783958375453949,0,0.9677698782704108,0.03223012172958927,0
716,心エコー:(日付不明)変化なし注:以前の検査より,心 エコー 日付 不明 変化 ない 以前 検査,0,0.9768299726947434,0.02317002730525658,0,6.467362088850667e-05,0.9999353263791115,0,0.9703094996170554,0.029690500382944573,0,0.9999999994234889,5.765110159486389e-10,0,0.9422398805618286,0.060724887996912,0,0.82840895652771,0.20765326917171478,0,0.9676005835700974,0.032399416429902586,0
717,感染を診断/評価するための検査は実施しなかった。,感染 診断 評価 する ため 検査 実施 する ない た,0,0.9845812388826407,0.015418761117359276,0,0.00011195417981069679,0.9998880458201893,0,0.9307478589547942,0.06925214104520583,0,0.9968641744082197,0.003135825591780282,0,0.9561854004859924,0.05790158361196518,0,0.8277790546417236,0.15105067193508148,0,0.967692740177324,0.032307259822676036,0
718,精査: (2021/11)異常は認められなかった,精査 0 0 異常 認める られる ない た,0,0.9845620932964586,0.015437906703541471,0,0.00012392419178206197,0.9998760758082179,0,0.908054084487762,0.09194591551223796,0,0.9938566342317913,0.006143365768208682,0,0.9442178606987,0.062233731150627136,0,0.8107807636260986,0.17345640063285828,0,0.9641706863806988,0.03582931361930116,0
719,D-ダイマーを含む血液凝固系は検査されなかった。,D ダイマー 含む 血液 凝固 系 検査 する れる ない た,0,0.9978745527098917,0.0021254472901082204,0,6.74389421601279e-05,0.9999325610578399,0,0.9659247141209425,0.034075285879057456,0,0.9886443795347513,0.011355620465248722,0,0.9463112354278564,0.05827070027589798,0,0.8256967067718506,0.13962532579898834,0,0.9700882041469537,0.029911795853046264,0
720,追加調査は完了し、これ以上の情報は期待できない。,追加 調査 完了 する これ 以上 情報 期待 できる ない,0,0.9920672370860023,0.007932762913997641,0,4.693903625210913e-05,0.9999530609637479,0,0.9116471306921917,0.08835286930780828,0,0.9193253965953475,0.08067460340465246,0,0.9564997553825378,0.07737880200147629,0,0.8173418045043945,0.1569630354642868,0,0.9602915577926394,0.03970844220736046,0
721,その他の末梢神経障害の原因になる病態はなかった。,その他 末梢神経障害 の 原因 なる 病態 ない た,0,0.9845739235155317,0.015426076484468176,0,0.00010299718115071696,0.9998970028188493,0,0.9532323614021391,0.046767638597860914,0,0.953793750594172,0.046206249405827966,0,0.931601345539093,0.06058110296726227,0,0.8306388258934021,0.16113141179084778,0,0.9652408135325777,0.03475918646742223,0
722,被験者(母親)は、他のワクチンの接種はなかった。,被験者 母親 他 ワクチン 接種 ない た,0,0.9963677069596109,0.0036322930403891373,0,7.725676767345109e-05,0.9999227432323265,0,0.9878312547831744,0.012168745216825662,0,0.9953392615579993,0.004660738442000671,0,0.9506247043609619,0.05401905998587608,0,0.8337090015411377,0.14479902386665344,0,0.9719344790192012,0.028065520980798838,0
723,2022/06/06、腹部エコー検査:特記なし。,0 0 0 腹部 エコー 検査 特記 ない,0,0.9975513415232939,0.0024486584767060855,0,7.778927088539121e-05,0.9999222107291146,0,0.9635819041208851,0.03641809587911498,0,0.9998928525183989,0.00010714748160106972,0,0.9409883618354797,0.07141818106174469,0,0.8191335201263428,0.1611662209033966,0,0.969223542690408,0.030776457309591904,0
724,ワクチン投与による副作用、心内膜炎は否定された。,ワクチン 投与 副作用 心内膜炎 否定 する れる た,0,0.9877359556531276,0.012264044346872454,0,7.5293554205511e-05,0.9999247064457945,0,0.9757651095003264,0.0242348904996736,1,0.29182823000339586,0.7081717699966041,0,0.9392890334129333,0.06479719281196594,0,0.8286426663398743,0.15930382907390594,1,0.8864156113858866,0.11358438861411349,0
725,患者が関連した病歴と併用薬は、報告されなかった。,患者 関連 する た 病歴 併用 薬 報告 する れる ない た,0,0.9996336460479486,0.0003663539520515884,0,6.487259896052435e-05,0.9999351274010395,0,0.9900731066822333,0.009926893317766783,0,0.9972823716684902,0.002717628331509799,0,0.9549403786659241,0.056938767433166504,0,0.8414729237556458,0.14025379717350006,0,0.9727037100885891,0.027296289911410827,0
726,その後7か月の経過観察中に再発はみられなかった。,その後 0 か月 経過 観察 中 再発 みる られる ない た,0,0.9845993294446119,0.015400670555388105,0,6.535892364719967e-05,0.9999346410763528,0,0.843044183926879,0.15695581607312104,0,0.9851189686583367,0.014881031341663265,0,0.9554888010025024,0.05844584107398987,0,0.8141465783119202,0.16534028947353363,0,0.9597477632924797,0.04025223670752033,0
727,患者は、いかなる関連する検査も受けていなかった。,患者 関連 する 検査 受ける いる ない た,0,0.9998621406219221,0.00013785937807801008,0,4.7250808721929434e-05,0.9999527491912781,0,0.997508212120435,0.002491787879565101,0,0.9995860089308325,0.0004139910691674588,0,0.9524964094161987,0.05239143967628479,0,0.8260115385055542,0.14143434166908264,0,0.9728456819532267,0.02715431804677335,0
728,2021/08までの採血では特に問題はなかった。,0 0 採血 問題 ない た,0,0.9984582563017693,0.0015417436982307928,0,6.767197751486751e-05,0.9999323280224851,0,0.9573747651903916,0.04262523480960841,0,0.9992224847284384,0.0007775152715615859,0,0.9420061111450195,0.057648103684186935,0,0.8448445200920105,0.16140900552272797,0,0.9700564370794209,0.029943562920578995,0
729,心膜炎調査票:病理組織学的検査は未実施であった。,心膜炎 調査 票 病理 組織 学 的 検査 実施 だ ある た,0,0.9845832211944434,0.015416778805556565,0,7.56444460478458e-05,0.9999243555539522,0,0.9287673864750035,0.07123261352499655,0,0.7790334509935949,0.22096654900640508,0,0.9520484209060669,0.07427037507295609,0,0.8417395353317261,0.16357240080833435,0,0.9498299430002334,0.05017005699976663,0
730,有害事象に関連した家族歴は特記事項なしであった。,有害事象 関連 する た 家族 歴 特記 事項 ない だ ある た,0,0.9945136705785586,0.005486329421441423,0,5.346046385935721e-05,0.9999465395361407,0,0.9434516942819696,0.056548305718030406,0,0.7355498831717249,0.2644501168282751,0,0.954208254814148,0.07959955930709839,0,0.83201664686203,0.15648405253887177,0,0.947711749624512,0.05228825037548807,0
731,アレルギー、継続中の病歴または既往歴はなかった。,アレルギー 継続 中 病歴 既往 歴 ない た,0,0.9982122117742882,0.001787788225711746,0,5.673267648655145e-05,0.9999432673235135,0,0.9839548416862315,0.016045158313768494,0,0.9925824154752615,0.0074175845247384875,0,0.9460179805755615,0.056176528334617615,0,0.848188579082489,0.1622883677482605,0,0.9714006238311556,0.028599376168844434,0
732,体外式膜型人工肺(ECMO)は使用されなかった。,体外 式 膜型人工肺 ECMO 使用 する れる ない た,0,0.9937191473428002,0.0062808526571997555,0,7.524717319951017e-05,0.9999247528268005,0,0.9650817667220792,0.03491823327792075,0,0.9953897720770819,0.004610227922918096,0,0.9563691020011902,0.06078986078500748,0,0.848644495010376,0.15355482697486877,0,0.9706650203491451,0.029334979650854943,0
733,心筋炎調査票:病理組織学的検査は未実施であった。,心筋炎 調査 票 病理 組織 学 的 検査 実施 だ ある た,0,0.984575926679788,0.015424073320211978,0,7.90382494400708e-05,0.9999209617505599,0,0.8871672900723936,0.1128327099276064,0,0.7967869965628219,0.20321300343717807,0,0.9516333341598511,0.07728661596775055,0,0.8417612314224243,0.16474676132202148,0,0.9472789942667772,0.05272100573322287,0
734,心膜炎調査票:病理組織学的検査:未実施であった。,心膜炎 調査 票 病理 組織 学 的 検査 実施 だ ある た,0,0.9845832211944434,0.015416778805556565,0,7.56444460478458e-05,0.9999243555539522,0,0.9287673864750035,0.07123261352499655,0,0.7790334509935949,0.22096654900640508,0,0.9520484209060669,0.07427037507295609,0,0.8417395353317261,0.16357240080833435,0,0.9498299430002334,0.05017005699976663,0
735,問診では、患者は接種に関して問題なしと言われた。,問診 患者 接種 問題なし 言う れる た,0,0.7737569855771729,0.22624301442282707,0,9.213369505768931e-05,0.9999078663049423,1,0.35075040890996034,0.6492495910900397,1,0.26918817395694083,0.7308118260430592,0,0.9411330819129944,0.05734888091683388,0,0.833128809928894,0.17782984673976898,1,0.5809461336606376,0.41905386633936226,0
736,2022/06//17、症状軽快のため退院した。,0 0 0 症状 軽快 ため 退院 する た,0,0.9990159749566417,0.0009840250433584305,0,6.819070061470401e-05,0.9999318092993853,0,0.9939410695241622,0.006058930475837868,0,0.9401816158839074,0.059818384116092596,0,0.9427460432052612,0.07482496649026871,0,0.7944839000701904,0.1987629234790802,0,0.9654456297837546,0.034554370216245335,0
737,Anti-thyroid antibody:なし,Anti thyroid antibody ない,0,0.9945433932477357,0.0054566067522644765,0,8.131826565402601e-05,0.999918681734346,0,0.9584064201532027,0.04159357984679737,0,0.9999999999101773,8.982270193530195e-11,0,0.9362127780914307,0.0637165829539299,0,0.8119086027145386,0.19242145121097565,0,0.9676433999218688,0.032356600078131306,0
738,アレルギー検査:(2022/04/14)異常なし,アレルギー 検査 0 0 0 異常 ない,0,0.9912014781734908,0.008798521826509054,0,7.538826600798745e-05,0.999924611733992,0,0.9744363447819243,0.02556365521807564,0,0.999876433217839,0.00012356678216098288,0,0.9281790852546692,0.07027116417884827,0,0.8404148817062378,0.15688666701316833,0,0.9698984708688314,0.03010152913116855,0
739,リウマチの悪化もなく患者は順調に回復中であった。,リウマチ の 悪化 ない 患者 順調 回復 中 だ ある た,0,0.9983097349372179,0.0016902650627820019,0,6.480205871108758e-05,0.9999351979412889,0,0.9399229075956868,0.06007709240431323,0,0.8038320985496717,0.19616790145032822,0,0.9447135925292969,0.0648534968495369,0,0.8215043544769287,0.18191200494766235,0,0.9527415200479303,0.04725847995206962,0
740,視力の右眼は改善したが、左眼は改善を得なかった。,視力 右 眼 改善 する た 左 眼 改善 得る ない た,0,0.9962710543275661,0.0037289456724337177,0,7.68187417060372e-05,0.9999231812582939,0,0.9521837831096591,0.04781621689034089,0,0.9871060600250694,0.012893939974930586,0,0.9507889151573181,0.05720483884215355,0,0.7993449568748474,0.21688517928123474,0,0.9660169426652481,0.033983057334752056,0
741,事象の転帰は2022/06/23に軽快していた。,事象 転帰 0 0 0 軽快 する いる た,0,0.9972134337771938,0.0027865662228061905,0,7.286803396881093e-05,0.9999271319660312,0,0.980980412527451,0.019019587472548935,0,0.8783099116892485,0.12169008831075145,0,0.9460061192512512,0.06606785207986832,0,0.8086567521095276,0.1618599146604538,0,0.9623080602566562,0.03769193974334376,0
742,疼痛がやや落ち着いたため、外来療養に切り替えた。,疼痛 落ち着く た ため 外来 療養 切り替える た,0,0.9845567743278201,0.015443225672179968,0,0.0001244785214652775,0.9998755214785348,0,0.5372774359139274,0.46272256408607254,0,0.9962680553126739,0.0037319446873260364,0,0.8069837093353271,0.32929369807243347,0,0.7935270667076111,0.18930211663246155,0,0.892675717657935,0.10732428234206497,0
743,上記診断にて通院でのステロイド点滴加療を行った。,上記 診断 通院 ステロイド 点滴 加療 行う た,0,0.9845948678888073,0.015405132111192642,0,0.00011576071799063338,0.9998842392820093,1,0.09027663069131775,0.9097233693086823,1,0.055063108570263086,0.9449368914297369,0,0.8773581385612488,0.16916048526763916,1,0.30093586444854736,0.8268867135047913,1,0.1739837618385841,0.8260162381614158,0
744,2021/07/16抗ウイルス薬点滴治療終了。,0 0 0 抗ウイルス薬 点滴 治療 終了,0,0.9917230920607484,0.008276907939251569,0,7.5417152192594e-05,0.9999245828478074,0,0.6226348045656038,0.3773651954343961,0,0.9999999999999911,8.93382813721055e-15,0,0.9427194595336914,0.07332392036914825,0,0.8119252324104309,0.18700337409973145,0,0.9383808982137699,0.06161910178623014,0
745,2021/08/31、症状が改善されなかった。,0 0 0 症状 改善 する れる ない た,0,0.9999908604233928,9.139576607292646e-06,0,3.955003831604534e-05,0.999960449961684,0,0.9931554386083788,0.006844561391621106,0,0.9989488418847472,0.0010511581152528482,0,0.9492247104644775,0.05421403422951698,0,0.8308431506156921,0.1616349071264267,0,0.9720363650377917,0.02796363496220835,0
746,2021年12月20日扁桃周囲膿瘍は回復した。,0 年 0 月 0 日 扁桃周囲膿瘍 回復 する た,0,0.9845651001744926,0.01543489982550742,0,0.0001088593471151103,0.9998911406528849,0,0.931992555553132,0.068007444446868,0,0.737847758480059,0.262152241519941,0,0.934804379940033,0.08700811117887497,0,0.7959645986557007,0.20626769959926605,0,0.9397166085030692,0.060283391496930884,0
747,2022/03/29会社が連絡するも応答なし。,0 0 0 会社 連絡 する 応答 ない,0,0.9942705632973285,0.0057294367026713665,0,7.347390720633476e-05,0.9999265260927936,0,0.848465402537224,0.15153459746277595,0,0.992300203884363,0.007699796115636994,0,0.9470429420471191,0.0771566778421402,0,0.8150646686553955,0.20101013779640198,0,0.9590723280525263,0.04092767194747376,0
748,2022/06/28 PSL 20 mg継続。,0 0 0 PSL 0 mg 継続,0,0.9690518801168336,0.03094811988316634,0,0.00011341691545127625,0.9998865830845487,0,0.8087244490735253,0.19127555092647477,0,0.9999999963588783,3.6411217306935392e-09,0,0.911207377910614,0.09990012645721436,0,0.735618531703949,0.2458098977804184,0,0.9456740207157864,0.054325979284213476,0
749,3日間イブプロフェン(頓用)内服を3日間継続。,0 日間 イブプロフェン 頓 用 内服 0 日間 継続,0,0.9845590375044193,0.0154409624955806,0,0.00012086247102025327,0.9998791375289797,0,0.5926429767389879,0.4073570232610121,0,0.8124331271551355,0.18756687284486454,0,0.9056829214096069,0.11254282295703888,0,0.8197682499885559,0.22168110311031342,0,0.8975909397416474,0.10240906025835261,0
750,EIA法によって抗HIT抗体検査を行い、陰性。,EIA 法 HIT 抗体検査 行う 陰性,0,0.979190551903161,0.02080944809683904,0,0.00010450923622672614,0.9998954907637733,0,0.9748863304620521,0.02511366953794793,0,0.9999999971938143,2.806185692193885e-09,0,0.9272115230560303,0.09252854436635971,0,0.7745530605316162,0.32077881693840027,0,0.9607144326476179,0.03928556735238203,0
751,SARS-CoV2 PCR(near法)陰性。,SARS CoV 0 PCR near 法 陰性,0,0.9982764484525476,0.0017235515474524894,0,5.582783666004921e-05,0.99994417216334,0,0.9748863304620521,0.02511366953794793,0,0.9999999999999922,7.753496680490752e-15,0,0.9108983874320984,0.11254226416349411,0,0.8268465399742126,0.20772650837898254,0,0.9665575040294949,0.03344249597050521,0
752,ステロイドの内服治療を開始し、症状は軽快した。,ステロイド 内服 治療 開始 する 症状 軽快 する た,0,0.9988368748234387,0.0011631251765613934,0,4.568109531398315e-05,0.999954318904686,0,0.9991715260221992,0.0008284739778008254,0,0.9697243095974863,0.030275690402513693,0,0.9415069222450256,0.068959079682827,0,0.807461142539978,0.17788627743721008,0,0.9688615849437885,0.031138415056211472,0
753,ステロイドパルス療法2コースにて症状軽快した。,ステロイド パルス 療法 0 コース 症状 軽快 する た,0,0.9971905957103544,0.0028094042896454605,0,6.941875212412618e-05,0.9999305812478759,0,0.9981686775190791,0.0018313224809208776,1,0.4969712686880552,0.5030287313119448,0,0.9392359256744385,0.06314931064844131,0,0.8108071684837341,0.1794666051864624,1,0.9235951111330114,0.07640488886698861,0
754,メチコバール、セレコキシブ、リリカの投与終了。,メチコバール セレコキシブ リリカ 投与 終了,0,0.9845519868236128,0.01544801317638714,0,7.663880093990063e-05,0.9999233611990601,0,0.8079751475642252,0.19202485243577477,0,0.9999999998205505,1.7944941890770843e-10,0,0.9369915723800659,0.07596469670534134,0,0.8091743588447571,0.24563634395599365,0,0.9530136653965516,0.0469863346034483,0
755,一過性の心電図変化であり、心電図異常は正常化。,一過性 心電図変化 だ ある 心電図異常 正常化,0,0.9845460467456604,0.015453953254339627,0,8.093674770452672e-05,0.9999190632522955,0,0.6702185656181219,0.3297814343818781,0,0.9999999999998906,1.0934413760315441e-13,0,0.9153003692626953,0.10187121480703354,0,0.7844284176826477,0.31220948696136475,0,0.9305610143863933,0.0694389856136068,0
756,患者に関連する病歴と併用薬は報告されなかった。,患者 関連 する 病歴 併用 薬 報告 する れる ない た,0,0.9996336460479486,0.0003663539520515884,0,6.752182264868872e-05,0.9999324781773513,0,0.9953012756829719,0.004698724317028163,0,0.9964222194791854,0.0035777805208145933,0,0.9535135626792908,0.055654726922512054,0,0.8387539982795715,0.14033491909503937,0,0.9728572462111419,0.027142753788858078,0
757,患者の関連した病歴と併用薬は報告されなかった。,患者 関連 する た 病歴 併用 薬 報告 する れる ない た,0,0.9996336460479486,0.0003663539520515884,0,6.487259896052435e-05,0.9999351274010395,0,0.9900731066822333,0.009926893317766783,0,0.9972823716684902,0.002717628331509799,0,0.9549403786659241,0.056938767433166504,0,0.8414729237556458,0.14025379717350006,0,0.9727037100885891,0.027296289911410827,0
758,患者の関連する病歴と併用薬は報告されなかった。,患者 関連 する 病歴 併用 薬 報告 する れる ない た,0,0.9996336460479486,0.0003663539520515884,0,6.752182264868872e-05,0.9999324781773513,0,0.9953012756829719,0.004698724317028163,0,0.9964222194791854,0.0035777805208145933,0,0.9535135626792908,0.055654726922512054,0,0.8387539982795715,0.14033491909503937,0,0.9728572462111419,0.027142753788858078,0
759,患者は、その他いずれの併用薬も投与しなかった。,患者 その他 いずれ 併用 薬 投与 する ない た,0,0.9999415611933489,5.843880665123207e-05,0,5.186855226695133e-05,0.9999481314477331,0,0.9979024524659847,0.002097547534015236,0,0.9963972825676465,0.003602717432353566,0,0.9499852061271667,0.05149054899811745,0,0.8183121085166931,0.15167361497879028,0,0.9721782066345653,0.02782179336543452,0
760,患者は以前より糖尿病にて内服治療を受けていた。,患者 以前 糖尿病 内服 治療 受ける いる た,0,0.9845498199318192,0.015450180068180747,0,0.00010923751628707051,0.9998907624837129,0,0.9495343579245172,0.05046564207548272,0,0.9631169005653822,0.03688309943461771,0,0.7656813859939575,0.24607452750205994,0,0.7430156469345093,0.31443390250205994,0,0.9395059554506532,0.06049404454934682,0
761,関連する病歴および併用薬は、報告されなかった。,関連 する 病歴 お呼び 併用 薬 報告 する れる ない た,0,0.9991097885197541,0.0008902114802460437,0,7.497573988359933e-05,0.9999250242601164,0,0.9936271501328832,0.006372849867116877,0,0.9947350554096995,0.005264944590300471,0,0.9544413685798645,0.05854623764753342,0,0.8439611792564392,0.14023876190185547,0,0.9727403999376891,0.0272596000623109,0
762,凝固異常なく、血小板減少症を伴う血栓症は否定。,凝固異常 ない 血小板減少症 伴う 血栓症 否定,0,0.9845778208682924,0.015422179131707571,0,7.932506707708964e-05,0.9999206749329229,0,0.9108879724583641,0.08911202754163589,0,0.9999994322438105,5.677561894873984e-07,0,0.7979736924171448,0.3532123863697052,0,0.8104798793792725,0.18980461359024048,0,0.9456550245157379,0.0543449754842621,0
763,血清学的検査:全身性ウイルス感染は否定された。,血清 学的 検査 身性 ウイルス感染 否定 する れる た,0,0.9845702409587963,0.015429759041203576,0,7.053523562499268e-05,0.999929464764375,0,0.8540516387575247,0.14594836124247532,1,0.28373091639155723,0.7162690836084428,0,0.9401422142982483,0.0664433017373085,0,0.8073455691337585,0.16896311938762665,1,0.8528244994134415,0.14717550058655846,0
764,抗ウイルス剤投与、鎮痛剤投与、軟膏処置を実施。,ウイルス 剤 投与 鎮痛 剤 投与 軟膏 処置 実施,0,0.9845623583023726,0.015437641697627484,0,8.171816058075744e-05,0.9999182818394192,0,0.9139381936871069,0.08606180631289301,0,0.8483391194745384,0.1516608805254615,0,0.9269298911094666,0.140075221657753,0,0.7632178068161011,0.2866486608982086,0,0.940322430305245,0.05967756969475512,0
765,磁気共鳴血管造影:頚動脈プラーク又は狭窄なし。,磁気 共鳴 血管造影 頚動脈プラーク 狭窄 ない,0,0.984691093000764,0.01530890699923608,0,8.300459258898716e-05,0.999916995407411,0,0.892143225061961,0.10785677493803905,0,0.9999749946156996,2.5005384300378692e-05,0,0.9357914924621582,0.07141752541065216,0,0.8228939175605774,0.17169775068759918,0,0.9633624049042839,0.03663759509571603,0
766,症状軽快、採血所見、心電図所見の改善があった。,症状 軽快 採血 所見 心電図 所見 改善 ある た,0,0.9992433337804542,0.0007566662195458143,0,4.705721114656759e-05,0.9999529427888534,0,0.9916207534389361,0.008379246561063885,0,0.9489795390438173,0.05102046095618274,0,0.9386805891990662,0.060558151453733444,0,0.8257014155387878,0.17404231429100037,0,0.9680020666995645,0.03199793330043563,0
767,組織標本にウイルスゲノムの所見は認めなかった。,組織 標本 ウイルス ゲノム 所見 認める ない た,0,0.9950117805099987,0.00498821949000125,0,6.080685869201107e-05,0.999939193141308,0,0.9535107239785406,0.046489276021459344,0,0.986288094136441,0.013711905863558955,0,0.9467833042144775,0.05831306055188179,0,0.8180842995643616,0.14479856193065643,0,0.9686745792730603,0.03132542072693975,0
768,点滴、内服加療受けるも、症状は改善しなかった。,点滴 内服 加療 受ける 症状 改善 する ない た,0,0.9999506395550278,4.9360444972068817e-05,0,3.7985182853975976e-05,0.999962014817146,0,0.9981855508656498,0.001814449134350201,0,0.9968832725808642,0.0031167274191357887,0,0.9477174282073975,0.05062856525182724,0,0.775646984577179,0.21498438715934753,0,0.9691674470980319,0.030832552901968145,0
769,到着時、右手の麻痺と呂律が回らない症状は回復。,到着 時 右手 麻痺 呂律 回らない症状 回復,0,0.9845751977868898,0.01542480221311009,0,9.437407532629323e-05,0.9999056259246737,0,0.9339758597054119,0.06602414029458815,0,0.9999974445170265,2.555482973399414e-06,0,0.9161741733551025,0.11497286707162857,1,0.23060324788093567,0.8289448022842407,1,0.8849480832751482,0.1150519167248519,0
770,併用薬及び投与に関する情報は報告されなかった。,併用 薬 投与 情報 報告 する れる ない た,0,0.9999713204389628,2.867956103733564e-05,0,3.775724999766724e-05,0.9999622427500023,0,0.9967024993640331,0.0032975006359668756,0,0.9973127145318528,0.0026872854681471835,0,0.9546603560447693,0.05513985455036163,0,0.8331772089004517,0.1453678011894226,0,0.9727580809957529,0.027241919004247068,0
771,上記以外の薬剤、サプリメント、飲酒はなかった。,上記 以外 薬剤 サプリメント 飲酒 ない た,0,0.996488165410667,0.0035118345893329897,0,6.446614058228158e-05,0.9999355338594177,0,0.8931848342047265,0.1068151657952735,0,0.9781261069085718,0.021873893091428204,0,0.9491215944290161,0.05045221745967865,0,0.8442655205726624,0.18069426715373993,0,0.9643590276465698,0.03564097235343027,0
772,2022/02/04現在、事象は軽快していた。,0 0 0 現在 事象 軽快 する いる た,0,0.9963257355096528,0.003674264490347242,0,5.765632530008908e-05,0.9999423436746999,0,0.980980412527451,0.019019587472548935,0,0.8930219564561388,0.10697804354386123,0,0.947403073310852,0.07348035275936127,0,0.8272925019264221,0.16099002957344055,0,0.9637711013661491,0.03622889863385088,0
773,ECG、胸部X線(胸部X線撮影)、結果:正常。,ECG 胸部 X線 胸部 X線撮影 結果 正常,0,0.9969449988354114,0.003055001164588654,0,7.606200381264504e-05,0.9999239379961874,0,0.9953397011525896,0.004660298847410426,0,0.9999999999999925,7.523892966454747e-15,0,0.9411919116973877,0.07462051510810852,0,0.815200924873352,0.22620061039924622,0,0.9689403419496921,0.031059658050307856,0
774,体外式膜型人工肺(ECMO)の使用はなかった。,体外 式 膜型人工肺 ECMO 使用 ない た,0,0.9942669082974048,0.005733091702595223,0,6.520239578579993e-05,0.9999347976042142,0,0.9640365464408378,0.03596345355916219,0,0.9988713885104621,0.0011286114895379562,0,0.9527201056480408,0.058988478034734726,0,0.8447980284690857,0.16176718473434448,0,0.9704375639222813,0.02956243607771853,0
775,事象の他要因(他の疾患等)の可能性はなかった。,事象 他 要因 他 疾患 等 可能性 ない た,0,0.9993407588445111,0.0006592411554889661,0,5.2701485085111886e-05,0.9999472985149149,0,0.9854556916733505,0.014544308326649555,0,0.9828182256449094,0.017181774355090586,0,0.9481346607208252,0.05471254512667656,0,0.822921872138977,0.14985623955726624,0,0.9707395805238291,0.02926041947617083,0
776,画像検査:心臓MRI検査は、実施されなかった。,画像 検査 心臓 MRI 検査 実施 する れる ない た,0,0.9999490823650821,5.091763491792004e-05,0,4.841747929107427e-05,0.9999515825207089,0,0.9929524728090213,0.0070475271909787125,0,0.9974901080648272,0.0025098919351728482,0,0.9507753252983093,0.053935833275318146,0,0.8297727704048157,0.14007766544818878,0,0.9725462472461711,0.027453752753828893,0
777,再調査は完了し、これ以上の情報は期待できない。,再調査 完了 する これ 以上 情報 期待 できる ない,0,0.9945842618112783,0.005415738188721714,0,4.6309172818292086e-05,0.9999536908271817,0,0.8502768278020432,0.1497231721979568,0,0.9201685732121129,0.07983142678788716,0,0.9573198556900024,0.07426988333463669,0,0.8207278847694397,0.16228248178958893,0,0.9557079562348855,0.04429204376511446,0
778,患者には基礎疾患や、既存の疾患などはなかった。,患者 基礎疾患 既存 疾患 ない た,0,0.9989066665259312,0.0010933334740688455,0,6.698869094033418e-05,0.9999330113090596,0,0.9858510513344676,0.014148948665532384,0,0.9955664914858721,0.004433508514127982,0,0.9464515447616577,0.05665433406829834,0,0.8353724479675293,0.1475122720003128,0,0.9717619301034848,0.0282380698965152,0
779,ワクチン接種前後に投与された解熱剤はなかった。,ワクチン接種 前後 投与 する れる た 解熱 剤 ない た,0,0.9997481417254261,0.00025185827457381636,0,4.764702033636464e-05,0.9999523529796637,0,0.9945122711875704,0.005487728812429652,0,0.9991068770090181,0.0008931229909818303,0,0.9470088481903076,0.05472908541560173,0,0.8411639332771301,0.14455582201480865,0,0.9727670697570632,0.027232930242936756,0
780,解剖が実施されたかについては報告されなかった。,解剖 実施 する れる た 報告 する れる ない た,0,0.9999496298991771,5.0370100822853213e-05,0,7.061486529115361e-05,0.9999293851347089,0,0.9638956653750332,0.03610433462496677,0,0.9979446641455016,0.0020553358544983537,0,0.9539745450019836,0.05455803498625755,0,0.8187591433525085,0.14458420872688293,0,0.9706112076001019,0.02938879239989807,0
781,体外式膜型人工肺(ECMO)は使用しなかった。,体外 式 膜型人工肺 ECMO 使用 する ない た,0,0.9959078422554929,0.004092157744507253,0,6.959968859788041e-05,0.9999304003114021,0,0.9650578617391792,0.03494213826082077,0,0.9966737054590551,0.003326294540944875,0,0.9562168121337891,0.059282220900058746,0,0.8433610796928406,0.1588689088821411,0,0.9705978602566516,0.029402139743348394,0
782,約15分間の観察時間中には特に変化はなかった。,0分 間 観察 時間 中 変化 ない た,0,0.9931855814823024,0.006814418517697574,0,7.9039062876421e-05,0.9999209609371236,0,0.979631453663119,0.020368546336880962,0,0.9958073900603142,0.0041926099396858135,0,0.9379336833953857,0.06072211638092995,0,0.8406458497047424,0.16120971739292145,0,0.970518131215521,0.029481868784479077,0
783,事象自己免疫性溶血性貧血の転帰は軽快であった。,事象 自己免疫性 溶血性 貧血 転帰 軽快 だ ある た,0,0.9845504729804045,0.015449527019595377,0,0.00010919163650952071,0.9998908083634904,0,0.8998216040875804,0.10017839591241966,0,0.8388735630562802,0.16112643694371978,0,0.9360316395759583,0.06570004671812057,0,0.8150020241737366,0.16945813596248627,0,0.9508549381658153,0.04914506183418464,0
784,血圧上昇に対して治療的な処置は施されなかった。,血圧 上昇 治療 的 だ 処置 施す れる ない た,0,0.9845532779074103,0.015446722092589737,0,0.0001194204229092809,0.9998805795770908,0,0.8462590985394329,0.1537409014605671,0,0.9949333968617947,0.005066603138205282,0,0.9455683827400208,0.05726677179336548,0,0.8115658164024353,0.14912226796150208,0,0.9609273302064018,0.03907266979359825,0
785,本症例に追加された新たな安全性情報はなかった。,症例 追加 する れる た 新た だ 安全性 情報 ない た,0,0.994044741694149,0.005955258305850829,0,7.75485316980117e-05,0.9999224514683019,0,0.9543048367010265,0.04569516329897348,0,0.9977648919681051,0.002235108031894857,0,0.9569488763809204,0.05878444388508797,0,0.8227929472923279,0.15122026205062866,0,0.9695905706958134,0.030409429304186518,0
786,産科歴:該当なし父親の情報は該当なしであった。,産科 歴 該当 ない 父親 情報 該当 ない だ ある た,0,0.9969764517219875,0.0030235482780125934,0,5.275130226565768e-05,0.9999472486977343,0,0.9434774339049006,0.05652256609509948,1,0.4350352076569264,0.5649647923430736,0,0.9465240240097046,0.06363163888454437,0,0.8476828336715698,0.1617499738931656,1,0.9105125209405619,0.08948747905943823,0
787,培養: (2022年)有意菌は検出されなかった,培養 0 年 有意菌 検出 する れる ない た,0,0.9913809395398169,0.008619060460183056,0,9.08815444384687e-05,0.9999091184555615,0,0.9650817667220792,0.03491823327792075,0,0.993823436788545,0.006176563211454981,0,0.9505952000617981,0.055907391011714935,0,0.8408862352371216,0.15125645697116852,0,0.9702600144485357,0.029739985551464194,0
788,家族の病歴に関連する特記すべきことはなかった。,家族 病歴 関連 する 特記 する べし こと ない た,0,0.9908753308601519,0.009124669139848069,0,7.426289999320094e-05,0.9999257371000068,0,0.9689008241466943,0.031099175853305686,0,0.9966241515954285,0.0033758484045714548,0,0.9598345160484314,0.07069844007492065,0,0.8402831554412842,0.15214653313159943,0,0.9704082667790997,0.02959173322090024,0
789,体外式膜型人工肺(ECMO)を使用しなかった。,体外 式 膜型人工肺 ECMO 使用 する ない た,0,0.9959078422554929,0.004092157744507253,0,6.959968859788041e-05,0.9999304003114021,0,0.9650578617391792,0.03494213826082077,0,0.9966737054590551,0.003326294540944875,0,0.9562168121337891,0.059282220900058746,0,0.8433610796928406,0.1588689088821411,0,0.9705978602566516,0.029402139743348394,0
790,2022/06/24、採血にて正常化していた。,0 0 0 採血 正常 化 する いる た,0,0.9845489181012218,0.015451081898778299,0,8.214165776003817e-05,0.99991785834224,0,0.9841760836584527,0.015823916341547388,0,0.9046230617380762,0.09537693826192378,0,0.9415892958641052,0.0621575228869915,0,0.8285687565803528,0.16869045794010162,0,0.9639513176984726,0.036048682301527295,0
791,事象の転帰は提供されなかった(報告のとおり)。,事象 転帰 提供 する れる ない た 報告 とおり,0,0.9992378817145185,0.0007621182854814387,0,6.152283933123404e-05,0.9999384771606687,0,0.9737581473868576,0.026241852613142425,0,0.9999999998978375,1.0216246725935062e-10,0,0.9535524845123291,0.05897927284240723,0,0.7987544536590576,0.14624349772930145,0,0.9704936473118888,0.029506352688111127,0
792,心エコー図: (2022/06/17)異常なし,心 エコー 図 0 0 0 異常 ない,0,0.9922427170555154,0.007757282944484637,0,8.173939686110128e-05,0.9999182606031389,0,0.9502444084129436,0.04975559158705643,0,0.9870005090095973,0.0129994909904026,0,0.9252725839614868,0.07378873974084854,0,0.8274329304695129,0.15368212759494781,0,0.9672125798175828,0.032787420182417155,0
793,"HbA1c: 5.4 %,注記:上昇はなかった",HbA 0 c 0 0 % 注記 上昇 ない た,0,0.9805396726971187,0.019460327302881223,0,0.0001473786276816988,0.9998526213723183,0,0.8115043530863592,0.18849564691364082,0,0.9928744974942278,0.00712550250577218,0,0.9313753247261047,0.0786099061369896,0,0.8301230072975159,0.16788934171199799,0,0.9562752249666101,0.04372477503338995,0
794,2021/09/21、やや改善も症状は残った。,0 0 0 改善 症状 残る た,0,0.9976247126316456,0.0023752873683542705,0,0.00015837265786339177,0.9998416273421367,0,0.9847062935252507,0.015293706474749246,0,0.8729703136089331,0.127029686391067,0,0.9352160096168518,0.06259127706289291,0,0.8253127932548523,0.1895262897014618,0,0.9615552773903239,0.03844472260967611,0
795,2021/10/29、CRPの結果は上昇なし。,0 0 0 CRP 結果 上昇 ない,0,0.9884886431495218,0.011511356850478379,0,0.00013676753074053888,0.9998632324692595,0,0.949389905417836,0.05061009458216408,0,0.9959969416736065,0.004003058326393461,0,0.9262096881866455,0.11245542764663696,0,0.8290537595748901,0.16784614324569702,0,0.9658744139466582,0.03412558605334184,0
796,ワクチン接種日周辺で、解熱剤を使用しなかった。,ワクチン接種 日 周辺 解熱 剤 使用 する ない た,0,0.9988139505982556,0.001186049401744376,0,6.741693513857085e-05,0.9999325830648614,0,0.993038945534271,0.006961054465729,0,0.9974156812150733,0.0025843187849267507,0,0.9485096335411072,0.050342436879873276,0,0.8288263082504272,0.14388835430145264,0,0.9723953208897125,0.02760467911028758,0
797,ワクチン接種日周辺に、解熱剤を使用しなかった。,ワクチン接種 日 周辺 解熱 剤 使用 する ない た,0,0.9988139505982556,0.001186049401744376,0,6.741693513857085e-05,0.9999325830648614,0,0.993038945534271,0.006961054465729,0,0.9974156812150733,0.0025843187849267507,0,0.9485096335411072,0.050342436879873276,0,0.8288263082504272,0.14388835430145264,0,0.9723953208897125,0.02760467911028758,0
798,患者が併用薬を使用したかどうかは不明であった。,患者 併用 薬 使用 する た 不明 だ ある た,0,0.9985757142996117,0.0014242857003883903,0,6.223200544738936e-05,0.9999377679945526,0,0.9948203459431602,0.005179654056839866,0,0.9838926343492215,0.016107365650778544,0,0.945670485496521,0.060787227004766464,0,0.8288651704788208,0.1695922166109085,0,0.9706552602907422,0.02934473970925774,0
799,患者はヘパリン療法中で、全身状態良好であった。,患者 ヘパリン 療法 中 全身 状態 良好 だ ある た,0,0.9932411923398499,0.006758807660150246,0,6.0468619724422615e-05,0.9999395313802756,0,0.933258406401364,0.06674159359863595,0,0.8952622004335896,0.10473779956641034,0,0.9399315714836121,0.06699348986148834,0,0.845079243183136,0.17228750884532928,0,0.9604324514309849,0.039567548569015176,0
800,頭部CT:(2021/09/22)特に問題なし,頭部 C，T 0 0 0 問題なし,0,0.9670949470224727,0.0329050529775273,0,0.00010100325323428373,0.9998989967467657,0,0.5557375229169158,0.4442624770830842,0,0.9893286579883086,0.01067134201169139,0,0.9355235695838928,0.07686875015497208,0,0.7985354661941528,0.17973946034908295,0,0.9242801650235262,0.07571983497647375,0
801,本報告時点では、外来フォローを継続中であった。,報告 時点 外来 フォロー 継続 中 だ ある た,0,0.9975331170420952,0.002466882957904884,0,5.246159385641104e-05,0.9999475384061436,0,0.9185499869695318,0.08145001303046819,0,0.8677048215324908,0.13229517846750918,0,0.9503653645515442,0.061083756387233734,0,0.8170433640480042,0.17916403710842133,0,0.9566794684541534,0.043320531545846544,0
802,(2022/06/10)壁運動は良好であった。,0 0 0 壁 運動 良好 だ ある た,0,0.9845597544460302,0.015440245553969844,0,8.941166289826737e-05,0.9999105883371018,0,0.8901628793547298,0.10983712064527015,0,0.964941729823375,0.035058270176625,0,0.9474722146987915,0.06095036864280701,0,0.8385029435157776,0.19204802811145782,0,0.9613013904867039,0.038698609513296,0
803,2021/08/07、患者は病院から退院した。,0 0 0 患者 病院 退院 する た,0,0.9845524803797745,0.01544751962022545,0,9.215800952894188e-05,0.9999078419904711,0,0.987470630216285,0.01252936978371504,0,0.9467009051013447,0.05329909489865525,0,0.9340015649795532,0.08414113521575928,0,0.8124752640724182,0.21368373930454254,0,0.9639552726412923,0.036044727358707646,0
804,2022/01/28、PCR検査で陰性を確認。,0 0 0 PCR検査 陰性 確認,0,0.9962214621369235,0.0037785378630765284,0,8.918058111696099e-05,0.999910819418883,0,0.9566003223203415,0.04339967767965849,0,0.9999999999999624,3.764126381072836e-14,0,0.9122527241706848,0.10322829335927963,0,0.8141512870788574,0.18513081967830658,0,0.9659034221201295,0.03409657787987064,0
805,2022/02/24、患者は病院より退院した。,0 0 0 患者 病院 退院 する た,0,0.9845524803797745,0.01544751962022545,0,9.215800952894188e-05,0.9999078419904711,0,0.987470630216285,0.01252936978371504,0,0.9467009051013447,0.05329909489865525,0,0.9340015649795532,0.08414113521575928,0,0.8124752640724182,0.21368373930454254,0,0.9639552726412923,0.036044727358707646,0
806,レントゲン:(2022/04/14)異常なし。,レントゲン 0 0 0 異常 ない,0,0.9944688764316585,0.005531123568341565,0,7.16527188606858e-05,0.9999283472811393,0,0.9597775112735767,0.04022248872642334,0,0.9998777635081343,0.00012223649186574257,0,0.9322109222412109,0.0652470588684082,0,0.8286077976226807,0.18294309079647064,0,0.9683550484385387,0.03164495156146128,0
807,血液培養では、細菌または真菌は見られなかった。,血液 培養 細菌 真菌 見る られる ない た,0,0.991634111265188,0.008365888734812083,0,7.083915988035195e-05,0.9999291608401196,0,0.8618177305418544,0.1381822694581456,0,0.9818242847865142,0.01817571521348582,0,0.9449039697647095,0.05331319198012352,0,0.8448235392570496,0.16239213943481445,0,0.9624827786132873,0.037517221386712755,0
808,身体的に回復した(例えば、通常活動への復帰)。,身体的 回復 した 通常 活動 復帰,0,0.9845558305738233,0.015444169426176543,0,8.445149174357774e-05,0.9999155485082564,0,0.8928390791275373,0.10716092087246262,0,0.9999999999989159,1.0841019261253353e-12,0,0.9341632127761841,0.07847093790769577,0,0.784216582775116,0.21420322358608246,0,0.960100123912135,0.039899876087865056,0
809,脳梁膨大部の病変は29日目に完全に改善された。,脳梁 膨大 部 病変 0 日 目 完全 改善 する れる た,0,0.9241174851066113,0.0758825148933888,0,0.00012092767323190163,0.9998790723267681,0,0.9276998589398749,0.07230014106012503,1,0.32151701644476116,0.6784829835552388,0,0.9341596364974976,0.08262164890766144,0,0.8253068923950195,0.17348210513591766,1,0.8641591943554456,0.13584080564455442,0
810,肺画像検査:(2022/01/05)異常なし。,肺 画像 検査 0 0 0 異常 ない,0,0.9845842341375304,0.01541576586246961,0,8.836314813828623e-05,0.9999116368518617,0,0.9712082335577037,0.028791766442296314,0,0.997149009237833,0.0028509907621670104,0,0.9240627884864807,0.07946095615625381,0,0.8198056221008301,0.1579490602016449,0,0.9680934737960739,0.031906526203926096,0
811,発熱、関節痛のための治療処置は施されなかった。,発熱 関節痛 ため 治療 処置 施す れる ない た,0,0.9845783201195308,0.015421679880469186,0,0.00016149673745747788,0.9998385032625425,0,0.8280864126327837,0.1719135873672163,0,0.9950997376109976,0.004900262389002399,0,0.9452545046806335,0.06054861098527908,0,0.810735285282135,0.16396969556808472,0,0.9588031273596241,0.04119687264037586,0
812,Culture urine: Negative,Culture urine Negative,0,0.9717857773393365,0.028214222660663694,0,7.852612662116665e-05,0.9999214738733788,1,0.4563792597309324,0.5436207402690676,0,0.5195482961797382,0.48045170382026176,0,0.840715765953064,0.24058471620082855,0,0.6659526824951172,0.409397155046463,1,0.6796731839349673,0.32032681606503277,0
813,また左眼の上下転もわずかにできるようになった。,左 眼 上下 転 できる よう なる た,0,0.9845732137514012,0.015426786248598914,1,0.00019010830969883082,0.9998098916903012,1,0.3831850891458667,0.6168149108541333,0,0.6687284938611531,0.331271506138847,0,0.757987380027771,0.4214797914028168,0,0.7220717668533325,0.3328670561313629,1,0.6897746774568528,0.3102253225431471,0
814,2020/12、両側扁桃摘出術が施行された。,0 0 両側 扁桃 摘出 術 施行 する れる た,0,0.984560080919243,0.015439919080757002,0,0.00011006007000225824,0.9998899399299978,0,0.6057708902997936,0.3942291097002064,1,0.29387067660163857,0.7061293233983614,0,0.8971996903419495,0.1441182643175125,0,0.776149332523346,0.2857019603252411,1,0.7334411296965055,0.26655887030349434,0
815,2021/07/21モンテルカスト投与中止。,0 0 0 モンテルカスト 投与 中止,0,0.984593306347179,0.01540669365282102,0,8.262395508383956e-05,0.9999173760449162,0,0.9047601863611796,0.09523981363882042,0,0.9999999999999999,9.356965572085826e-17,0,0.9169602394104004,0.07910505682229996,0,0.8035962581634521,0.22812822461128235,0,0.9605395195302087,0.039460480469791406,0
816,2021/09/02 PCR検査結果は陰性。,0 0 0 PCR検査 結果 陰性,0,0.9961446721737349,0.0038553278262650277,0,9.781679576747114e-05,0.9999021832042325,0,0.9578490428835932,0.042150957116406866,0,1.0,9.110605460378342e-18,0,0.9254327416419983,0.07487025111913681,0,0.8151273131370544,0.19413352012634277,0,0.9670653044216834,0.03293469557831666,0
817,2022/02/26、症状が消失、回復した。,0 0 0 症状 消失 回復 する た,0,0.9999281883399649,7.181166003514037e-05,0,3.9494043708938987e-05,0.999960505956291,0,0.9964038187091612,0.0035961812908388746,0,0.9876963674626312,0.012303632537368776,0,0.9353498816490173,0.06811429560184479,0,0.8296101689338684,0.17123916745185852,0,0.9705091940675765,0.029490805932423432,0
818,2022/03/20症状の回復を認め、退院。,0 0 0 症状 回復 認める 退院,0,0.9993603658432225,0.000639634156777425,0,7.063640175726918e-05,0.9999293635982427,0,0.9933106042508706,0.006689395749129369,0,1.0,8.975652568848062e-19,0,0.9352657198905945,0.07813286036252975,0,0.7963941097259521,0.2095966339111328,0,0.9686112424657999,0.03138875753420006,0
819,2022/03/24これらの症状は完治した。,0 0 0 これら 症状 完 治す た,0,0.9845784659283557,0.015421534071644327,0,0.00010951774811218006,0.9998904822518878,1,0.37790060427998895,0.622099395720011,0,0.9929817032570911,0.007018296742908904,0,0.92439204454422,0.07510421425104141,0,0.7970361113548279,0.19850419461727142,1,0.8965031221842988,0.10349687781570116,0
820,2022/03胸痛は改善し、トロポニン低下。,0 0 胸痛 改善 する トロポニン 低下,0,0.9845915339648827,0.015408466035117339,0,0.00010582468760688447,0.9998941753123931,0,0.8961297624423417,0.10387023755765837,0,0.9995948116742653,0.00040518832573469476,0,0.8789753913879395,0.17111143469810486,0,0.7614796161651611,0.27078041434288025,0,0.9507062121699567,0.049293787830043415,0
821,2022/04/21合併症なく経過し、退院。,0 0 0 合併症 ない 経過 する 退院,0,0.9998198902962318,0.0001801097037683148,0,4.451862833023474e-05,0.9999554813716698,0,0.9969319798357213,0.003068020164278634,0,1.0,1.117768373948264e-18,0,0.940975546836853,0.0661354660987854,0,0.8000614047050476,0.18782801926136017,0,0.9701326308616022,0.029867369138397878,0
822,2022/05/20症状の軽快を認め、退院。,0 0 0 症状 軽快 認める 退院,0,0.9990780069911136,0.0009219930088865498,0,7.557226805738663e-05,0.9999244277319426,0,0.9903231320021829,0.009676867997817069,0,1.0,2.289350565929637e-17,0,0.9382225871086121,0.08076336234807968,0,0.8001272678375244,0.20054584741592407,0,0.9688106975286755,0.031189302471324388,0
823,2022/06/03顔面神経麻痺はほぼ回復。,0 0 0 顔面神経 麻痺 回復,0,0.9907332138340799,0.009266786165920256,0,0.00011473564512087223,0.9998852643548791,0,0.9758996728966532,0.024100327103346794,0,0.9999999330056302,6.699436981011266e-08,0,0.9038566946983337,0.08447650074958801,0,0.7938936352729797,0.20652367174625397,0,0.9657839481994521,0.034216051800547855,0
824,2週間以内に併用薬の投与は受けていなかった。,0 週間 以内 併用 薬 投与 受ける いる ない た,0,0.9999405707811448,5.942921885517482e-05,0,4.2982149986057045e-05,0.9999570178500139,0,0.99807319385208,0.0019268061479200038,0,0.9966956625305694,0.003304337469430555,0,0.9507672190666199,0.05056670680642128,0,0.8348143100738525,0.1490868479013443,0,0.9727595199159391,0.027240480084060933,0
825,ECGは正常洞調律でST変化を認めなかった。,ECG 正常洞調律 ST 変化 認める ない た,0,0.9815145747021777,0.01848542529782227,0,0.00010666972410473686,0.9998933302758952,0,0.9077711813421644,0.0922288186578356,0,0.9969632124584396,0.0030367875415604944,0,0.9358091354370117,0.06902876496315002,0,0.8195067644119263,0.16503462195396423,0,0.964221151693016,0.03577884830698408,0
826,SARS-Cov- 2抗原検査を行い、陰性。,SARS Cov 0 抗原検査 行う 陰性,0,0.9847515202531701,0.015248479746830003,0,0.00012878056289078273,0.9998712194371092,0,0.9643152920515782,0.035684707948421795,0,0.9999999999996948,3.052421963245601e-13,0,0.9353311061859131,0.07596521824598312,0,0.7973520755767822,0.258823424577713,0,0.9643011692076188,0.035698830792381224,0
827,アンチトロンビンIII:特記すべき所見なし。,トロンビン III 特記 する べし 所見 ない,0,0.9976789445760823,0.0023210554239176395,0,6.508871790872296e-05,0.9999349112820913,0,0.9804551161082906,0.019544883891709438,0,0.9698831307551451,0.030116869244854926,0,0.9483186602592468,0.08792591094970703,0,0.834713339805603,0.18212580680847168,0,0.9679891150450103,0.03201088495498984,0
828,ステロイドパルス点滴施行し、症状は軽快した。,ステロイド パルス 点滴 施行 する 症状 軽快 する た,0,0.9995292225225131,0.00047077747748694215,0,5.2012897716476205e-05,0.9999479871022835,0,0.9978910230508642,0.0021089769491357845,0,0.9190210144209627,0.08097898557903731,0,0.9402137994766235,0.06553242355585098,0,0.7912238240242004,0.18520326912403107,0,0.964895432210463,0.035104567789537036,0
829,その他の病歴、合併症又は危険因子はなかった。,その他 病歴 合併症 危険因子 ない た,0,0.9971609715992575,0.002839028400742344,0,6.206229243966845e-05,0.9999379377075603,0,0.9918197842930029,0.008180215706997151,0,0.9530490536263404,0.046950946373659555,0,0.943267822265625,0.058902084827423096,0,0.8311815857887268,0.15464189648628235,0,0.9690843512564739,0.03091564874352621,0
830,フィブリンDダイマー:正常(正常)正常範囲。,フィブリン D ダイマー 正常 正常 正常範囲,0,0.9919763910425817,0.008023608957418302,0,5.376583716101907e-05,0.999946234162839,0,0.9923758882265481,0.0076241117734518575,0,1.0,3.085090245410815e-20,0,0.9242437481880188,0.07790344208478928,0,0.8248299360275269,0.21866238117218018,0,0.9683642332607136,0.03163576673928639,0
831,リハビリ介入にて短距離の歩行可能までに回復。,リハビリ 介入 短距離 歩行可能 回復,0,0.9845514393423832,0.015448560657616784,0,7.157266863308843e-05,0.9999284273313669,0,0.8928390791275373,0.10716092087246262,0,0.9999669593984721,3.3040601527812074e-05,0,0.9200456142425537,0.09349532425403595,0,0.7571520805358887,0.2764632999897003,0,0.9553019320487823,0.04469806795121772,0
832,冠動脈造影では冠動脈疾患は認められなかった。,冠動脈造影 冠動脈疾患 認める られる ない た,0,0.9845525654973325,0.015447434502667605,0,7.846265438979319e-05,0.9999215373456102,0,0.948032790186748,0.05196720981325202,0,0.9923509712013913,0.007649028798608701,0,0.9471970200538635,0.05127078294754028,0,0.8393728137016296,0.16829045116901398,0,0.9682327980138613,0.03176720198613876,0
833,患者の血圧は109/58 mmHgであった。,患者 血圧 0 0 mmHg だ ある た,0,0.9396562896257309,0.060343710374269055,0,0.00014635024324144706,0.9998536497567585,0,0.8404080352052307,0.15959196479476936,0,0.9915880927960793,0.008411907203920677,0,0.8987439274787903,0.1778290718793869,0,0.8352729678153992,0.18265703320503235,0,0.9486866852337233,0.051313314766276735,0
834,患者の他の病歴はなかった(病歴の追加なし)。,患者 他 病歴 ない た 病歴 追加 ない,0,0.9994498106675791,0.0005501893324209702,0,4.385767036772792e-05,0.9999561423296323,0,0.997750957576487,0.002249042423512989,0,0.999598419403326,0.00040158059667397814,0,0.9546459913253784,0.06715650111436844,0,0.8445529341697693,0.18881261348724365,0,0.9717200836892943,0.028279916310705762,0
835,関連した病歴及び併用薬は、報告されなかった。,関連 する た 病歴 併用 薬 報告 する れる ない た,0,0.9997065276568812,0.0002934723431188344,0,6.567529851265467e-05,0.9999343247014874,0,0.9897064036167993,0.01029359638320074,0,0.9980383494803116,0.001961650519688434,0,0.9543623328208923,0.05548310652375221,0,0.8409210443496704,0.14019472897052765,0,0.9727384897791354,0.02726151022086474,0
836,関連する病歴および併用薬は報告されなかった。,関連 する 病歴 お呼び 併用 薬 報告 する れる ない た,0,0.9991097885197541,0.0008902114802460437,0,7.497573988359933e-05,0.9999250242601164,0,0.9936271501328832,0.006372849867116877,0,0.9947350554096995,0.005264944590300471,0,0.9544413685798645,0.05854623764753342,0,0.8439611792564392,0.14023876190185547,0,0.9727403999376891,0.0272596000623109,0
837,基底膜には融解様変化や断裂像は認めなかった。,基底膜 融解 様 変化 断裂 像 認める ない た,0,0.9845442642176426,0.015455735782357479,0,9.25935211529204e-05,0.9999074064788471,0,0.581482301603442,0.418517698396558,0,0.9543683684114216,0.04563163158857842,0,0.935804009437561,0.08001530170440674,0,0.8214686512947083,0.20048199594020844,0,0.9253768596282663,0.07462314037173375,0
838,駆出率:入院時15%及び退院時50%へ改善。,駆け出し 率 入院 時 0% 退院 時 0% 改善,0,0.9876537166895654,0.012346283310434686,0,9.014650236474831e-05,0.9999098534976353,0,0.9796427304873954,0.020357269512604602,0,0.9997803968859842,0.0002196031140157594,0,0.8798055648803711,0.1975628137588501,0,0.8137274980545044,0.17635762691497803,0,0.96281466962234,0.03718533037766012,0
839,血清は血管炎関連自己抗体に対し陰性であった。,血清 血管炎関連 自己抗体 陰性 だ ある た,0,0.9894055728612464,0.010594427138753559,0,7.597042409518087e-05,0.9999240295759049,0,0.9814697853394488,0.018530214660551114,0,0.8190435479374394,0.18095645206256067,0,0.9252670407295227,0.062349993735551834,0,0.8415107727050781,0.1794860064983368,0,0.9570957096040621,0.04290429039593795,0
840,午後、その他の症状も改善してきたため、退院。,午後 その他 症状 改善 する くる た ため 退院,0,0.9963985552653398,0.003601444734660154,0,7.110755970262842e-05,0.9999288924402974,0,0.9955363407975022,0.004463659202497805,0,0.9999999999999472,5.2806382070888454e-14,0,0.9308596849441528,0.0838153287768364,0,0.8052976727485657,0.18988697230815887,0,0.9691256060967233,0.03087439390327684,0
841,口腔外の眼、皮膚又は外陰部に異常はなかった。,口腔 外 眼 皮膚 外 陰部 異常 ない た,0,0.9845786265185552,0.015421373481444803,0,9.850039643735398e-05,0.9999014996035627,0,0.8420755823785357,0.15792441762146428,0,0.866847389964402,0.13315261003559797,0,0.9185199737548828,0.07818308472633362,0,0.8248304128646851,0.15439940989017487,0,0.947745900932683,0.052254099067317004,0
842,合併症、アレルギー、治療薬の服用はなかった。,合併症 アレルギー 治療薬 服用 ない た,0,0.9996574292807471,0.0003425707192529388,0,5.327333386006159e-05,0.9999467266661399,0,0.9858185192757318,0.014181480724268173,0,0.9971566287288496,0.0028433712711504362,0,0.9463911652565002,0.047602612525224686,0,0.8357288837432861,0.15311165153980255,0,0.9719898246432258,0.028010175356774192,0
843,今後の方針としてアブレーション治療を勧めた。,今後 方針 アブレーション 治療 勧める た,0,0.7348592477868237,0.2651407522131765,0,0.0001272132728898313,0.9998727867271102,1,0.4148259742226219,0.5851740257773781,0,0.8912545653476782,0.10874543465232175,0,0.931504487991333,0.08875206112861633,0,0.750088095664978,0.27765265107154846,1,0.8017585662515029,0.19824143374849718,0
844,市販の痛み止めは1日2回ほど使うことがある。,市販 痛み 止め 0 日 0回 使う こと ある,0,0.9845672999054985,0.015432700094501392,0,0.00014599119444171565,0.9998540088055583,1,0.225087121192173,0.774912878807827,0,0.9453240767368062,0.05467592326319379,0,0.922099769115448,0.1281866878271103,0,0.6229482889175415,0.5242207646369934,1,0.7690384254570573,0.23096157454294275,0
845,心臓超音波検査、心臓カテーテルでは異常なし。,心臓 超音波 検査 心臓 カテーテル 異常 ない,0,0.9875241067464661,0.012475893253534015,0,7.72322024120782e-05,0.9999227677975879,0,0.9592754145591779,0.040724585440822136,0,0.973706895620302,0.026293104379698024,0,0.935118556022644,0.06543459743261337,0,0.8206490278244019,0.16697868704795837,0,0.9665771589118898,0.03342284108811016,0
846,心内膜心筋生検、心臓超音波検査では異常なし。,心内膜 心筋生検 心臓 超音波 検査 異常 ない,0,0.984579028328982,0.015420971671017948,0,8.693022163378895e-05,0.9999130697783662,0,0.9759565561506006,0.024043443849399434,0,0.9931584414940385,0.00684155850596146,0,0.9331282377243042,0.06741020083427429,0,0.8354741334915161,0.1614706963300705,0,0.9691500220685418,0.030849977931458234,0
847,接種の2週間以内に投与した併用薬はなかった。,接種 0 週間 以内 投与 する た 併用 薬 ない た,0,0.9997645767223378,0.00023542327766210738,0,5.281114088588381e-05,0.9999471888591142,0,0.9966194650502493,0.003380534949750602,0,0.9995778715501311,0.00042212844986891113,0,0.9499598145484924,0.051703181117773056,0,0.8427661657333374,0.14159053564071655,0,0.9731810578501402,0.026818942149859644,0
848,素因は不明であった、培養は実施されなかった。,素因 不明 だ ある た 培養 実施 する れる ない た,0,0.9999047256677444,9.52743322557582e-05,0,3.653342880216671e-05,0.9999634665711978,0,0.9503706710212669,0.04962932897873303,0,0.9973254095613131,0.002674590438686873,0,0.9555721879005432,0.05086550861597061,0,0.8494002223014832,0.1519424021244049,0,0.9706148182510399,0.02938518174896012,0
849,他院に受診指示も軽快したのでと行かなかった。,院 受診 指示 軽快 する た 行く ない た,0,0.997605047633917,0.0023949523660831236,0,6.236259828472303e-05,0.9999376374017153,0,0.9834778350358019,0.016522164964198116,0,0.9296122904993281,0.07038770950067183,0,0.9360746741294861,0.07395550608634949,0,0.8135135769844055,0.16346535086631775,0,0.9655664141435516,0.03443358585644836,0
850,日付不明、免疫組織化学的検査:陰性(陰性)。,日付 不明 免疫 組織 化学 的 検査 陰性 陰性,0,0.9849720081900777,0.015027991809922316,0,5.415509607811846e-05,0.9999458449039219,0,0.9855307620520938,0.01446923794790624,0,1.0,5.255405359470871e-20,0,0.9304512739181519,0.062399473041296005,0,0.8387419581413269,0.17617441713809967,0,0.9698727030455352,0.03012729695446469,0
851,日付不明プレドニゾロン漸減中に再燃なく経過。,日付 不明 プレドニゾロン 漸減 中 再燃 ない 経過,0,0.9955368709117682,0.004463129088231639,0,5.586994752147709e-05,0.9999441300524785,0,0.9597966441552017,0.040203355844798234,0,0.9873505259857669,0.012649474014233112,0,0.9362306594848633,0.062081314623355865,0,0.8454698324203491,0.16370424628257751,0,0.9689734749655918,0.03102652503440811,0
852,発熱の発症前に上気道感染症の症状はなかった。,発熱 の 発症 前 上気道感染症 症状 ない た,0,0.984588495068324,0.015411504931675882,0,0.00012545407312084954,0.9998745459268792,0,0.8609090251094864,0.13909097489051364,0,0.9099908433087185,0.09000915669128154,0,0.9350219368934631,0.07824971526861191,0,0.8168345093727112,0.18513274192810059,0,0.952560645379541,0.047439354620458965,0
853,皮疹、高熱及び肝機能障害は6週間で緩和した。,皮疹 高熱 肝機能障害 0 週間 緩和 する た,0,0.9845507032840389,0.01544929671596091,1,0.00018880088724128333,0.9998111991127587,0,0.5403879646573917,0.45961203534260825,0,0.6775705836899397,0.32242941631006033,0,0.9120274782180786,0.11412709206342697,0,0.5640251040458679,0.4893095791339874,1,0.7821111875741901,0.21788881242580987,0
854,輸液ライン確保し、ボスミン1/2A静脈注射。,輸液 ライン 確保 する ボス ミン 0 0 A 静脈 注射,0,0.971469320352112,0.028530679647888038,0,9.915033943984246e-05,0.9999008496605601,1,0.4068323482018076,0.5931676517981924,0,0.9999999975495771,2.4504228947588347e-09,0,0.891167402267456,0.20361419022083282,0,0.7518778443336487,0.23698362708091736,1,0.8764516607582783,0.12354833924172162,0
855,身体的検査および血清学的検査は正常であった。,身体的 検査 血清 学的 検査 正常 だ ある た,0,0.9887564010305757,0.011243598969424324,0,7.502540964693238e-05,0.9999249745903531,0,0.9946620260795264,0.005337973920473643,0,0.8917632827539169,0.1082367172460831,0,0.9372595548629761,0.05672721564769745,0,0.8378575444221497,0.15759694576263428,0,0.9648146568186659,0.03518534318133412,0
856,一般/家族歴に関する詳細は報告されなかった。,一般 家族 歴 詳細 報告 する れる ない た,0,0.9981152274042923,0.0018847725957078,0,5.8487316607528766e-05,0.9999415126833925,0,0.9773507777781711,0.022649222221828864,0,0.993714129395979,0.0062858706040209164,0,0.9518712162971497,0.056513115763664246,0,0.8393585681915283,0.15216229856014252,0,0.9712802948196848,0.02871970518031527,0
857,X線、心電図および心エコーに異常はなかった。,X線 心電図 お呼び 心 エコー 異常 ない た,0,0.9955276492127235,0.004472350787276502,0,8.528202480142708e-05,0.9999147179751986,0,0.962383553731402,0.037616446268598,0,0.984740273347191,0.015259726652808924,0,0.9396543502807617,0.06244324892759323,0,0.831038236618042,0.15837594866752625,0,0.9687911366117179,0.031208863388282205,0
858,他の要因(他の疾患など)の可能性はなかった。,他 要因 他 疾患 可能性 ない た,0,0.999312277103124,0.0006877228968760903,0,6.372962504954702e-05,0.9999362703749505,0,0.9908441572432939,0.009155842756706124,0,0.9817762658804283,0.018223734119571722,0,0.9391061663627625,0.056137219071388245,0,0.836941123008728,0.15417557954788208,0,0.970963278181026,0.029036721818973956,0
859,血液検査やCT所見に異常は認められなかった。,血液検査 C，T 所見 異常 認める られる ない た,0,0.9827288394278378,0.01727116057216201,0,0.00010124755425686657,0.9998987524457431,0,0.977870044875155,0.022129955124844895,0,0.9935493538451843,0.006450646154815694,0,0.945573091506958,0.06264840811491013,0,0.8285139799118042,0.15891386568546295,0,0.9695581979092647,0.03044180209073529,0
860,他疾患等、他要因の可能性は報告されなかった。,疾患 等 要因 の 可能性 報告 する れる ない た,0,0.9937690883452308,0.006230911654769209,0,7.784173142268588e-05,0.9999221582685773,0,0.9639754746040278,0.03602452539597218,0,0.9941980188118708,0.005801981188129284,0,0.9484245181083679,0.05725812166929245,0,0.8209361433982849,0.14654457569122314,0,0.9698102745973899,0.03018972540261009,0
861,症状は安静により改善、患者は独歩帰宅できた。,症状 安静 改善 患者 独歩 帰宅 できる た,0,0.9994918504560381,0.0005081495439619098,0,4.92160996681437e-05,0.9999507839003319,0,0.9928932456685078,0.00710675433149222,0,0.9616814540617693,0.03831854593823075,0,0.9338842630386353,0.06614218652248383,0,0.8210507035255432,0.1915576308965683,0,0.9678749464648521,0.03212505353514799,0
862,COVID-19のPCR検査は陰性であった。,COVID 0 PCR検査 陰性 だ ある た,0,0.9984349471328579,0.0015650528671420818,0,5.374826877628585e-05,0.9999462517312238,0,0.964470997544302,0.03552900245569807,0,0.9999784288040572,2.1571195942766197e-05,0,0.9396675825119019,0.060956306755542755,0,0.84317547082901,0.17440283298492432,0,0.9699202060436546,0.030079793956345486,0
863,酸素飽和度:(2022/01/27)結果なし,酸素飽和度 0 0 0 結果 ない,0,0.9976855158252762,0.002314484174723858,0,8.62100454866304e-05,0.9999137899545134,0,0.9556728136814235,0.04432718631857645,0,0.999971077661545,2.892233845501191e-05,0,0.9503161311149597,0.06395900994539261,0,0.8245255947113037,0.1653023362159729,0,0.9693029788006692,0.03069702119933071,0
864,血液検査:(不特定日)異常は認められなかった,血液検査 不特定 日 異常 認める られる ない た,0,0.9845696662364324,0.015430333763567606,0,0.00010698111900416007,0.9998930188809958,0,0.9631116616036378,0.03688833839636215,0,0.9921485325268594,0.007851467473140592,0,0.9438997507095337,0.07116644084453583,0,0.8313552141189575,0.15296481549739838,0,0.9686593611216081,0.03134063887839195,0
865,基礎疾患は不明であるが、服薬薬剤はなかった。,基礎疾患 不明 だ ある 服薬 薬剤 ない た,0,0.9998358918932535,0.00016410810674640687,0,4.236870973260133e-05,0.9999576312902674,0,0.9412930455099383,0.058706954490061705,0,0.9984175969384133,0.0015824030615867865,0,0.9413962960243225,0.04939156025648117,0,0.8392072319984436,0.15901431441307068,0,0.9692721333192227,0.03072786668077742,0
866,肺画像検査:(2022/01/27)所見なし,肺 画像 検査 0 0 0 所見 ない,0,0.9965444134620397,0.003455586537960249,0,7.680339783455015e-05,0.9999231966021654,0,0.9862207906232742,0.013779209376725833,0,0.9990109807991363,0.0009890192008636528,0,0.9306941628456116,0.06965594738721848,0,0.8375915884971619,0.15452346205711365,0,0.9709092378300161,0.029090762169983877,0
867,患者は市販の軟膏を使用し、褐色はなくなった。,患者 市販 軟膏 使用 する 褐色 なくなる た,0,0.7418810397291212,0.258118960270879,0,0.00011188474782447434,0.9998881152521756,1,0.48021634188129947,0.5197836581187005,0,0.8218760124662785,0.17812398753372144,0,0.9461923241615295,0.07635708898305893,0,0.8283311128616333,0.19237782061100006,1,0.831172389721805,0.168827610278195,0
868,ADAMTS13活性測定: (2021)正常,ADAMTS 0 活性 測定 0 正常,0,0.9934494210675774,0.006550578932422617,0,7.813669498187368e-05,0.9999218633050181,0,0.980855994784636,0.019144005215364017,0,0.9999999999999523,4.7704761410021805e-14,0,0.9258235692977905,0.08268368989229202,0,0.8098841309547424,0.19855806231498718,0,0.967805423547861,0.03219457645213893,0
869,ワクチン接種日周辺に解熱剤を使用しなかった。,ワクチン接種 日 周辺 解熱 剤 使用 する ない た,0,0.9988139505982556,0.001186049401744376,0,6.741693513857085e-05,0.9999325830648614,0,0.993038945534271,0.006961054465729,0,0.9974156812150733,0.0025843187849267507,0,0.9485096335411072,0.050342436879873276,0,0.8288263082504272,0.14388835430145264,0,0.9723953208897125,0.02760467911028758,0
870,ワクチン接種日周辺で解熱剤を使用しなかった。,ワクチン接種 日 周辺 だ 解熱 剤 使用 する ない た,0,0.9986646722232387,0.0013353277767612923,0,5.724700269688636e-05,0.9999427529973031,0,0.9932401232406283,0.006759876759371736,0,0.9970466703326696,0.0029533296673304606,0,0.9501862525939941,0.052320439368486404,0,0.8308203816413879,0.14471085369586945,0,0.972401108318534,0.02759889168146598,0
871,肝機能の数値は1ヵ月後には正常範囲に戻った。,機能 数値 0 ヵ月 後 正常範囲 戻る た,0,0.7648599179772522,0.2351400820227477,0,0.0001358357944568083,0.9998641642055431,1,0.42919369837831944,0.5708063016216806,0,0.9923538274972656,0.007646172502734316,0,0.9321682453155518,0.06780674308538437,0,0.8158606886863708,0.18117119371891022,1,0.8667054168760093,0.13329458312399067,0
872,2021/07/29、症状は少し軽減された。,0 0 0 症状 軽減 する れる た,0,0.8692110685172559,0.13078893148274406,0,0.00015011813447196964,0.999849881865528,0,0.6858277356321616,0.31417226436783835,0,0.5366232386110577,0.46337676138894235,0,0.9363808631896973,0.06888359785079956,0,0.8145884871482849,0.1849239021539688,0,0.8430086051999024,0.1569913948000976,0
873,2週間ビタミン剤を内服したが改善しなかった。,0 週間 ビタミン剤 内服 する た 改善 する ない た,0,0.9999889847462333,1.1015253766637378e-05,0,4.790311441806255e-05,0.999952096885582,0,0.9948125311595809,0.005187468840419087,0,0.9985064619941032,0.0014935380058968054,0,0.9482657313346863,0.05573700740933418,0,0.7946588397026062,0.20392437279224396,0,0.9698212854441937,0.03017871455580623,0
874,ワクチン接種との関連は否定も断定もできない。,ワクチン接種 関連 否定 断定 できる ない,0,0.9934532997564021,0.006546700243597995,0,6.076780299942814e-05,0.9999392321970005,0,0.9804021003489015,0.01959789965109849,0,0.8012445198166058,0.19875548018339423,0,0.9495428204536438,0.0639292299747467,0,0.8335331678390503,0.1817530244588852,0,0.9563831514857313,0.04361684851426881,0
875,患者に関連する病歴はなく、喫煙歴はなかった。,患者 関連 する 病歴 ない 喫煙 歴 ない た,0,0.9979504851760471,0.0020495148239529095,0,3.941144791907871e-05,0.9999605885520809,0,0.9942095389934152,0.00579046100658475,0,0.9991466211394385,0.0008533788605614544,0,0.950458288192749,0.058844611048698425,0,0.8454963564872742,0.15113258361816406,0,0.9725797307395612,0.027420269260438977,0
876,備考:採血ではCRPの軽度上昇のみで特記なし,備考 採血 CRP 軽度 上昇 特記 ない,0,0.9777975906186661,0.022202409381333874,0,0.00011123696610059342,0.9998887630338994,0,0.7478921877053994,0.2521078122946006,0,0.9950157846995207,0.004984215300479303,0,0.9096844792366028,0.1658364236354828,0,0.8266557455062866,0.17814113199710846,0,0.9444855095529607,0.05551449044703917,0
877,有害事象(AE)に関連する家族歴はなかった。,有害事象 AE 関連 する 家族 歴 ない た,0,0.9986210576037077,0.0013789423962924472,0,5.572690182018485e-05,0.9999442730981798,0,0.9803456809168571,0.019654319083142826,0,0.9970656034222104,0.002934396577789548,0,0.9506953954696655,0.061097487807273865,0,0.8340741991996765,0.1632351577281952,0,0.9710445269711003,0.028955473028899628,0
878,2021/06/23、画像検査は実行された。,0 0 0 画像 検査 実行 する れる た,0,0.984550866609292,0.015449133390707843,0,0.00011485143934433537,0.9998851485606557,0,0.7237063415911362,0.2762936584088637,0,0.6022811223350132,0.3977188776649868,0,0.9255858659744263,0.12603028118610382,0,0.8325608968734741,0.18235881626605988,0,0.8880587806908727,0.11194121930912734,0
879,右心機能は回復したが左心機能低下は残存した。,右 心 機能 回復 する た 左心機能低下 残存 する た,0,0.9845942423381904,0.015405757661809575,0,8.59963837192665e-05,0.9999140036162807,0,0.8818097478313962,0.11819025216860381,0,0.971515267352339,0.02848473264766108,0,0.9317207336425781,0.08279118686914444,1,0.37093299627304077,0.7496383786201477,1,0.8953163966706187,0.10468360332938118,0
880,患者のSARS-CoV-2抗原は陰性だった。,患者 SARS CoV 0 抗原 陰性 だ た,0,0.9972377847997844,0.0027622152002156207,0,5.82216118253716e-05,0.9999417783881747,0,0.9863292045656743,0.013670795434325696,0,0.9738719131388682,0.026128086861131827,0,0.9217529296875,0.06696812808513641,0,0.8467274308204651,0.163801372051239,0,0.9693117104432063,0.030688289556793747,0
881,患者は原疾患または合併症を持っていなかった。,患者 疾患 合併症 持つ いる ない た,0,0.9994327414342665,0.0005672585657335151,0,5.9481617729178555e-05,0.9999405183822708,0,0.9937441325569143,0.006255867443085699,0,0.9911081305756337,0.00889186942436628,0,0.952156126499176,0.049225881695747375,0,0.8254911303520203,0.14677694439888,0,0.9720864743206619,0.027913525679338216,0
882,患者は妊娠しておらず、授乳もしていなかった。,患者 妊娠 する おる ぬ 授乳 する いる ない た,0,0.9984914000803394,0.0015085999196604437,0,6.192320760500159e-05,0.999938076792395,0,0.9731140766702665,0.026885923329733486,0,0.992972994720378,0.007027005279621996,0,0.9441935420036316,0.06287317723035812,0,0.8319775462150574,0.14186245203018188,0,0.9707081418100049,0.029291858189995214,0
883,血液検査:(2020/01/09)異常なし。,血液検査 0 0 0 異常 ない,0,0.9870861692853976,0.012913830714602396,0,8.423163192987829e-05,0.9999157683680702,0,0.9830044285363864,0.01699557146361367,0,0.9999973855657023,2.614434297738087e-06,0,0.934623658657074,0.0685984417796135,0,0.833692729473114,0.1642383635044098,0,0.9699920058687697,0.030007994131230453,0
884,抗体検査:明らかな抗体価の上昇は認めていない,抗体検査 明らか だ 抗体価 上昇 認める いる ない,0,0.9845881384591583,0.015411861540841853,0,9.9661838373018e-05,0.9999003381616269,0,0.7862901264868557,0.21370987351314427,0,0.9195784594934785,0.08042154050652146,0,0.9341160655021667,0.12766437232494354,0,0.8148425221443176,0.2432938665151596,0,0.9404259660796057,0.05957403392039431,0
885,心エコー像:(2021/10/29)異常なし,心 エコー 像 0 0 0 異常 ない,0,0.9845872459036663,0.015412754096333697,0,0.0001065605654556689,0.9998934394345443,0,0.9502444084129436,0.04975559158705643,0,0.9925530248025374,0.0074469751974626745,0,0.926456093788147,0.07637390494346619,0,0.8343079686164856,0.15474475920200348,0,0.9672206491192756,0.03277935088072428,0
886,心嚢液貯留を示唆する身体検査所見はなかった。,心嚢液 貯留 示唆 する 身体検査 所見 ない た,0,0.9963772656617752,0.003622734338224622,0,8.981818876898537e-05,0.999910181811231,0,0.9844783482714147,0.015521651728585321,0,0.986300625528443,0.013699374471557014,0,0.9347288608551025,0.06707839667797089,0,0.8380690217018127,0.16598215699195862,0,0.9699455571369808,0.030054442863019285,0
887,Urine analysis: normal,Urine analysis normal,0,0.777402814226526,0.22259718577347395,0,0.00013146725106263405,0.9998685327489374,1,0.4563792597309324,0.5436207402690676,0,0.9999999999999989,1.102058814144053e-15,0,0.7385144233703613,0.32725146412849426,0,0.6659526824951172,0.409397155046463,1,0.7568792634554098,0.2431207365445902,0
888,15:35医師診察し、症状の回復を認めた。,0 0 医師 診察 症状 回復 認める た,0,0.9706054377615143,0.02939456223848576,0,0.000125713548697073,0.9998742864513029,0,0.9631439711767228,0.03685602882327716,0,0.7336616565856462,0.26633834341435386,0,0.9306008219718933,0.06875355541706085,0,0.8101672530174255,0.19109857082366943,0,0.9435337759035443,0.05646622409645568,0
889,1日3回に分けて熱冷ましの薬が与えられた。,0 日 0回 分ける 熱 冷ます 薬 与える られる た,0,0.9845752626371289,0.015424737362871001,0,9.43966363666523e-05,0.9999056033636333,0,0.8262610753985113,0.17373892460148868,1,0.1858425939582261,0.8141574060417739,0,0.8731866478919983,0.25180524587631226,0,0.7802550792694092,0.2634604573249817,1,0.7561566736807988,0.24384332631920122,0
890,2021/07/12経過良好であり、退院。,0 0 0 経過 良好 だ ある 退院,0,0.9987849427502311,0.0012150572497688908,0,5.1104055146175153e-05,0.9999488959448538,0,0.9975435813319755,0.002456418668024508,0,1.0,3.0416592501926227e-18,0,0.9458824992179871,0.0705403983592987,0,0.8107081651687622,0.19218046963214874,0,0.9703049216013072,0.02969507839869267,0
891,2021/08/27合併症なく、軽快退院。,0 0 0 合併症 ない 軽快 退院,0,0.9999942463778873,5.753622112696227e-06,0,2.091470776258404e-05,0.9999790852922374,0,0.9980837701942302,0.0019162298057697632,0,1.0,2.6099292557513255e-18,0,0.9422515034675598,0.06996380537748337,0,0.7930185198783875,0.16872987151145935,0,0.9704814729101324,0.02951852708986754,0
892,2021/09/02朝、体温36.2°C。,0 0 0 朝 体温 0 0 C,0,0.8943164752490141,0.10568352475098601,1,0.00019393630726196446,0.9998060636927381,1,0.3741492743921715,0.6258507256078285,0,0.5195482961797382,0.48045170382026176,0,0.7813372611999512,0.21147270500659943,0,0.5853533744812012,0.4472278356552124,1,0.5706260954250517,0.42937390457494834,0
893,2021/12/09、頭部CT:異常なし。,0 0 0 頭部 C，T 異常 ない,0,0.9923545859987873,0.0076454140012126946,0,7.6244093990248e-05,0.9999237559060098,0,0.9874530292103105,0.012546970789689494,0,0.9993857489248237,0.0006142510751763675,0,0.927467942237854,0.08258762955665588,0,0.8160852193832397,0.1719992309808731,0,0.9691566627090665,0.03084333729093344,0
894,2021/12フマル酸ジメチルの内服開始。,0 0 フマル酸ジメチル 内服 開始,0,0.984568069182651,0.015431930817349036,0,0.00010022546303487419,0.9998997745369651,0,0.9269150502276918,0.07308494977230813,0,0.9999967379737061,3.262026293880722e-06,0,0.9087195992469788,0.09892652183771133,0,0.8114923238754272,0.256010502576828,0,0.9603967412393302,0.03960325876066985,0
895,2022/01/11、心エコー:異常なし。,0 0 0 心 エコー 異常 ない,0,0.9953916432119136,0.004608356788086405,0,8.763181399841777e-05,0.9999123681860016,0,0.9603865177922778,0.03961348220772217,0,0.9999591210504044,4.0878949595567046e-05,0,0.9224198460578918,0.06755853444337845,0,0.8129017353057861,0.17159201204776764,0,0.9679480645219465,0.03205193547805339,0
896,2022/03/25皮膚症状改善し、退院。,0 0 0 皮膚症状 改善 する 退院,0,0.999811704909398,0.0001882950906020439,0,6.29305675152175e-05,0.9999370694324848,0,0.9946701138225618,0.00532988617743822,0,0.9999999999999988,1.2342789216886118e-15,0,0.937321662902832,0.07759055495262146,0,0.798200249671936,0.18352460861206055,0,0.969631088697606,0.030368911302394035,0
897,2022/05/03症状消失のため、退院。,0 0 0 症状消失 ため 退院,0,0.9877255638496919,0.012274436150308037,0,8.900571744200281e-05,0.999910994282558,0,0.9183198282655191,0.08168017173448097,0,1.0,2.099635068016125e-17,0,0.9368736147880554,0.09904856234788895,0,0.8100510239601135,0.1924339234828949,0,0.9633043416055551,0.03669565839444504,0
898,2022/06/14歩行可能となり、退院。,0 0 0 歩行可能 なる 退院,0,0.9845532842567462,0.015446715743253856,0,0.0001047615186427829,0.9998952384813572,0,0.9482490754151687,0.05175092458483131,0,0.9999999999999992,7.740279587069009e-16,0,0.9021187424659729,0.1234477162361145,0,0.8101234436035156,0.19602496922016144,0,0.9629803353531853,0.03701966464681461,0
899,SARSーCoVー2検査を実施しなかった。,SARS ー CoV ー 0 検査 実施 する ない た,0,0.9999393788183697,6.0621181630384365e-05,0,6.840742168160414e-05,0.9999315925783184,0,0.9832267659164285,0.016773234083571426,0,0.9951142336405477,0.0048857663594523105,0,0.9554082751274109,0.05917636677622795,0,0.8205621838569641,0.1473720222711563,0,0.9714218849346838,0.028578115065316212,0
900,けいれん重積は持続したため抗痙攣薬を処方。,けいれん 重積 持続 する た ため 抗痙攣 薬 処方,0,0.9845556946599664,0.015444305340033541,0,0.00012373559786590198,0.9998762644021341,0,0.856508766684094,0.14349123331590594,0,0.9999398927841332,6.010721586683696e-05,0,0.6836493015289307,0.5403647422790527,1,0.40359392762184143,0.7177277207374573,1,0.8192696225156462,0.18073037748435386,0
901,セフトリアキソン、アジスロマイシンを投与。,セフトリアキソン アジスロマイシン 投与,0,0.9845552244501115,0.015444775549888505,0,8.297405169582444e-05,0.9999170259483042,0,0.9371363224023153,0.06286367759768478,0,0.9999999999930613,6.93868043418703e-12,0,0.915972888469696,0.0830569863319397,0,0.7751520872116089,0.3055371046066284,0,0.9587539818152206,0.041246018184779444,0
902,加療としてオランザピン5 mgを内服開始。,加療 オランザピン 0 mg 内服 開始,0,0.98457881493671,0.01542118506329007,0,8.425779584746888e-05,0.9999157422041526,0,0.9925123206597941,0.007487679340205844,0,0.9999941754965994,5.824503400615231e-06,0,0.8934710025787354,0.14290839433670044,0,0.7036161422729492,0.4192184507846832,0,0.9520883633325545,0.04791163666744539,0
903,過去に実施歴なく、新規の所見かどうか不明。,過去 実施 歴る ない 新規 所見 不明,0,0.9995713740752942,0.0004286259247057746,0,5.599842771579266e-05,0.9999440015722842,0,0.9638973443566301,0.03610265564336989,0,0.9971812781128484,0.0028187218871516193,0,0.9270061254501343,0.08257420361042023,0,0.8293418884277344,0.2103709727525711,0,0.9672265758207557,0.032773424179244205,0
904,患者の関連病歴と併用薬は報告されなかった。,患者 関連 病歴 併用 薬 報告 する れる ない た,0,0.9996336460479486,0.0003663539520515884,0,6.138709272814103e-05,0.9999386129072718,0,0.995811259937741,0.004188740062258962,0,0.996934565522858,0.003065434477141974,0,0.9561632871627808,0.056308627128601074,0,0.8322551250457764,0.1459483802318573,0,0.9726429587908604,0.027357041209139645,0
905,患者の合併症及び併用薬の情報は不明である。,患者 合併症 併用 薬 情報 不明 だ ある,0,0.9987986560992066,0.0012013439007933545,0,5.879961734309649e-05,0.9999412003826569,0,0.9970693329513011,0.002930667048698916,0,0.9978075671012486,0.002192432898751363,0,0.9468383193016052,0.0634414553642273,0,0.8133559226989746,0.1788349449634552,0,0.9708406450072866,0.029159354992713372,0
906,関連した病歴と併用薬は、報告されなかった。,関連 する た 病歴 併用 薬 報告 する れる ない た,0,0.9997065276568812,0.0002934723431188344,0,6.567529851265467e-05,0.9999343247014874,0,0.9897064036167993,0.01029359638320074,0,0.9980383494803116,0.001961650519688434,0,0.9543623328208923,0.05548310652375221,0,0.8409210443496704,0.14019472897052765,0,0.9727384897791354,0.02726151022086474,0
907,関連する病歴と併用薬は、報告されなかった。,関連 する 病歴 併用 薬 報告 する れる ない た,0,0.9997065276568812,0.0002934723431188344,0,6.8421829627194e-05,0.9999315781703728,0,0.9923975604483977,0.007602439551602304,0,0.9968670649044176,0.003132935095582461,0,0.9534828066825867,0.05459258332848549,0,0.8391259908676147,0.14156286418437958,0,0.9727356533935675,0.02726434660643261,0
908,局所的疼痛以外に、副作用は起こらなかった。,局所的 疼痛 以外 副作用 起こる ない た,0,0.9845525319907665,0.01544746800923342,0,7.855997635908213e-05,0.9999214400236409,0,0.9113676594962061,0.08863234050379382,0,0.8825084375143181,0.11749156248568196,0,0.9471005797386169,0.06253683567047119,0,0.8358023762702942,0.1805502325296402,0,0.9567618071111201,0.043238192888879895,0
909,駆出率:入院時46%、退院時71%に改善。,駆け出し 率 入院 時 0% 退院 時 0% 改善,0,0.9876537166895654,0.012346283310434686,0,9.014650236474831e-05,0.9999098534976353,0,0.9796427304873954,0.020357269512604602,0,0.9997803968859842,0.0002196031140157594,0,0.8798055648803711,0.1975628137588501,0,0.8137274980545044,0.17635762691497803,0,0.96281466962234,0.03718533037766012,0
910,血液培養:レミエール症候群は陰性(陰性)。,血液 培養 レミエール症候群 陰性 陰性,0,0.9939686659249353,0.006031334075064616,0,5.5172964400946274e-05,0.9999448270355991,0,0.9748863304620521,0.02511366953794793,0,1.0,7.432131122022225e-25,0,0.9336621761322021,0.06273289024829865,0,0.8291193246841431,0.1909584254026413,0,0.9691388721772572,0.03086112782274275,0
911,症状および心機能は改善し、患者は退院した。,症状 お呼び 心 機能 改善 する 患者 退院 する た,0,0.9997722675690318,0.00022773243096819534,0,4.741988734970619e-05,0.9999525801126503,0,0.9966272684776997,0.00337273152230034,0,0.97757948710442,0.022420512895579957,0,0.934860110282898,0.06827425956726074,0,0.7967945337295532,0.1826595813035965,0,0.9685917826727082,0.03140821732729187,0
912,心血管造影:磁気共鳴画像(MRI)は陰性。,心 血管造影 磁気 共鳴 画像 MRI 陰性,0,0.9835713389048903,0.016428661095109615,0,7.564269451598975e-05,0.999924357305484,0,0.9797027645419796,0.020297235458020455,0,0.9998462609696094,0.00015373903039060194,0,0.9275963306427002,0.06348612904548645,0,0.841383159160614,0.17926833033561707,0,0.9693090907387362,0.030690909261263964,0
913,心内膜心筋生検では心筋組織の炎症所見なし。,心内膜 心筋生検 心筋 組織 炎症所見 ない,0,0.9933873788748426,0.0066126211251572005,0,7.7429120003013e-05,0.999922570879997,0,0.962876283265576,0.03712371673442402,0,0.9910111964816065,0.008988803518393484,0,0.9300174713134766,0.11677108705043793,0,0.7689220905303955,0.20598915219306946,0,0.963416337740792,0.03658366225920796,0
914,診察時には意識清明、バイタル安定していた。,診察 時 意識清明 バイタル 安定 する いる た,0,0.9971189865042882,0.0028810134957117516,0,5.858479813199039e-05,0.999941415201868,0,0.6519871278226939,0.3480128721773061,0,0.7640479947268763,0.23595200527312366,0,0.9108346104621887,0.10565415769815445,0,0.8132182359695435,0.23334315419197083,0,0.9012757742829128,0.09872422571708717,0
915,接種の2週間以内に投与した薬剤は無かった。,接種 0 週間 以内 投与 する た 薬剤 無い た,0,0.9866874677145007,0.01331253228549922,0,5.70183152118678e-05,0.9999429816847881,0,0.943137915640481,0.056862084359519,0,0.9999920560266996,7.943973300357675e-06,0,0.9353879690170288,0.06142202764749527,0,0.8415427803993225,0.1502227485179901,0,0.9684778423617871,0.031522157638213,0
916,他に考えうる事象の原因は報告されていない。,他 考える うる 事象 原因 報告 する れる いる ない,0,0.9860218094322359,0.013978190567764219,0,8.006628379809309e-05,0.9999199337162019,0,0.9383249020661724,0.06167509793382758,0,0.961748036222594,0.038251963777406014,0,0.9350360631942749,0.08988907933235168,0,0.7820356488227844,0.16259898245334625,0,0.9622007292932346,0.037799270706765316,0
917,日付不明ステロイドパルスを行うも反応なし。,日付 不明 ステロイド パルス 行う 反応 ない,0,0.980711821312542,0.019288178687457934,0,8.166471861315016e-05,0.9999183352813868,0,0.987827529442496,0.012172470557504008,1,0.06448117284900357,0.9355188271509964,0,0.9482276439666748,0.06612282246351242,0,0.8124295473098755,0.2000306397676468,1,0.8264549380573222,0.17354506194267785,0
918,日付不明プロテインC:特記すべき所見なし。,日付 不明 プロテイン C 特記 する べし 所見 ない,0,0.996281116093134,0.0037188839068660598,0,5.743991184446388e-05,0.9999425600881555,0,0.9795278437994736,0.020472156200526427,0,0.947407888463664,0.052592111536336035,0,0.9433018565177917,0.08478835970163345,0,0.8424146175384521,0.1675923466682434,0,0.967069922263048,0.03293007773695203,0
919,日付不明プロテインS:特記すべき所見なし。,日付 不明 プロテイン S 特記 する べし 所見 ない,0,0.996281116093134,0.0037188839068660598,0,5.743991184446388e-05,0.9999425600881555,0,0.9795278437994736,0.020472156200526427,0,0.947407888463664,0.052592111536336035,0,0.9438254237174988,0.10593909025192261,0,0.8424146175384521,0.1675923466682434,0,0.9664066695834637,0.03359333041653622,0
920,入院2日後、CRPは正常及び正常(正常)。,入院 0 日 後 CRP 正常 正常 正常,0,0.9845895546309749,0.015410445369025114,0,5.914842730503222e-05,0.999940851572695,0,0.9653945928965717,0.03460540710342832,0,1.0,3.257776756235084e-81,0,0.9329270124435425,0.08601408451795578,0,0.837384045124054,0.17760854959487915,0,0.967915601635734,0.032084398364266,0
921,発作が起きた時に神経伝達の検査をする予定。,発作 起きる た 時 神経 伝達 検査 する 予定,0,0.9845813329220925,0.01541866707790754,0,0.00012464134642081327,0.9998753586535792,0,0.6971190631518349,0.30288093684816514,0,0.9999998634202184,1.3657978159582468e-07,0,0.8855135440826416,0.24958449602127075,0,0.6892096996307373,0.3499538004398346,0,0.9120426526074811,0.08795734739251894,0
922,剖検:大動脈破裂や心筋梗塞を疑う所見なし。,剖検 大動脈破裂 心筋梗塞 疑う 所見 ない,0,0.9845750686782377,0.015424931321762115,0,0.00010181428891605999,0.9998981857110839,0,0.8658036360101258,0.13419636398987428,0,0.9651210564092639,0.03487894359073608,0,0.9166269898414612,0.10133124887943268,0,0.8108757734298706,0.18030160665512085,0,0.955937062139098,0.044062937860902034,0
923,慢性又は長期の健康状態は報告されなかった。,慢性 長期 健康状態 報告 する れる ない た,0,0.9962532476453165,0.0037467523546836374,0,8.229718071832313e-05,0.9999177028192817,0,0.9324062607157114,0.06759373928428858,0,0.9894127899060668,0.010587210093933142,0,0.9518803954124451,0.05584022030234337,0,0.8294390439987183,0.14588198065757751,0,0.9681979691607812,0.031802030839218835,0
924,他の要因(他の疾患等)の可能性はなかった。,他 要因 他 疾患 等 可能性 ない た,0,0.9990116131379752,0.0009883868620249375,0,6.11029910032284e-05,0.9999388970089967,0,0.9816240709413052,0.018375929058694805,0,0.9862249421494672,0.013775057850532785,0,0.9446061253547668,0.05523984506726265,0,0.8328276872634888,0.15625406801700592,0,0.9706816044992899,0.029318395500710033,0
925,継続している病歴は(問診票では)なかった。,継続 する いる 病歴 問診 票 ない た,0,0.9986931701356744,0.0013068298643256785,0,5.443042852062859e-05,0.9999455695714794,0,0.9791564784855368,0.020843521514463188,0,0.9945852549700039,0.005414745029996106,0,0.9555383324623108,0.06169288232922554,0,0.8443525433540344,0.14730824530124664,0,0.971691284395111,0.028308715604888898,0
926,他の疾患など、他の要因の可能性はなかった。,他 疾患 他 要因 の 可能性 ない た,0,0.9973064041972258,0.0026935958027742178,0,7.636495341112085e-05,0.9999236350465889,0,0.9708688104335139,0.0291311895664861,0,0.9844858664952388,0.015514133504761171,0,0.944955587387085,0.053146619349718094,0,0.8351460695266724,0.15612466633319855,0,0.9700060107068332,0.029993989293166844,0
927,有害事象に関連した家族歴の特記はなかった。,有害事象 関連 する た 家族 歴 特記 ない た,0,0.9990336556927762,0.0009663443072237393,0,4.736584717903129e-05,0.999952634152821,0,0.9657630330053317,0.03423696699466823,0,0.9996956173098015,0.0003043826901985497,0,0.9527477025985718,0.06889217346906662,0,0.8306323289871216,0.15905259549617767,0,0.9702439368427407,0.02975606315725936,0
928,他要因(他の疾患など)の可能性はなかった。,要因 他 疾患 可能性 ない た,0,0.999312277103124,0.0006877228968760903,0,5.669903273677285e-05,0.9999433009672632,0,0.9922267094511983,0.007773290548801709,0,0.9911310422270931,0.008868957772906888,0,0.9405307769775391,0.05517417937517166,0,0.8390992879867554,0.15269246697425842,0,0.9717283532942909,0.02827164670570904,0
929,他の疾患など可能性のある他要因はなかった。,他 疾患 可能性 の ある 他 要因 ない た,0,0.9861486058929585,0.013851394107041459,0,8.494704681645002e-05,0.9999150529531835,0,0.9251553683740122,0.07484463162598771,0,0.9771710444726661,0.022828955527333925,0,0.9465407133102417,0.05095047876238823,0,0.8347164392471313,0.1538160741329193,0,0.9662228685510071,0.03377713144899281,0
930,ワクチン以外の発症前エピソードはなかった。,ワクチン 以外 発症 エピソード ない た,0,0.9845887227535557,0.015411277246444309,0,9.949181819362875e-05,0.9999005081818064,0,0.9256817070624574,0.07431829293754252,0,0.9401061933794443,0.059893806620555615,0,0.9488029479980469,0.05032417178153992,0,0.845853328704834,0.17619314789772034,0,0.9633531005876474,0.03664689941235268,0
931,ワクチン接種前の体温は、提供されなかった。,ワクチン接種 前 体温 提供 する れる ない た,0,0.9981453873213268,0.0018546126786731956,0,5.5070495687300626e-05,0.9999449295043127,0,0.9704171274384936,0.029582872561506372,0,0.9973251683398355,0.002674831660164502,0,0.9446579813957214,0.055174294859170914,0,0.8396614193916321,0.1410067081451416,0,0.971252171541093,0.028747828458906884,0
932,以前のワクチン接種後の有害事象はなかった。,以前 ワクチン接種 後 有害事象 ない た,0,0.9845921745326859,0.015407825467313977,0,7.07884301409228e-05,0.999929211569859,0,0.9741827841769427,0.025817215823057262,0,0.9991862988449016,0.0008137011550983272,0,0.9478447437286377,0.052495770156383514,0,0.8517709374427795,0.15868544578552246,0,0.9708154961377066,0.029184503862293557,0
933,事前のワクチン接種後の有害事象はなかった。,事前 ワクチン接種 後 有害事象 ない た,0,0.9976140540216504,0.0023859459783496057,0,6.250872231251921e-05,0.9999374912776875,0,0.9741827841769427,0.025817215823057262,0,0.9988349711153318,0.0011650288846681343,0,0.9512838125228882,0.05272505804896355,0,0.8511082530021667,0.15302519500255585,0,0.9717506955251243,0.02824930447487577,0
934,尿検査:(2022/01/27)結果なし。,尿検査 0 0 0 結果 ない,0,0.9967148939953193,0.0032851060046806373,0,8.490024709285555e-05,0.9999150997529072,0,0.9519733284288264,0.04802667157117359,0,0.9999344061645776,6.559383542234679e-05,0,0.9466919302940369,0.0691804587841034,0,0.8466427326202393,0.17558656632900238,0,0.9691111099364927,0.0308888900635073,0
935,死亡に対する治療的処置は実施されなかった。,死亡 治療 的 処置 実施 する れる ない た,0,0.9903968360913413,0.009603163908658629,0,0.00013231870255096795,0.9998676812974491,0,0.9710292290355184,0.02897077096448169,0,0.9977348931185834,0.0022651068814165255,0,0.9526558518409729,0.05144868791103363,0,0.817907989025116,0.14687903225421906,0,0.9704255155851461,0.029574484414853813,0
936,事象の製造販売業者への情報提供は無かった。,事象 製造 販売 業者 情報提供 無い た,0,0.9845677497184615,0.015432250281538438,0,6.75055627381614e-05,0.9999324944372618,1,0.481076531168824,0.518923468831176,0,0.9991400748993422,0.000859925100657854,0,0.9459449648857117,0.05755075439810753,0,0.8303725719451904,0.1601475179195404,1,0.9233191529008699,0.07668084709913021,0
937,関節痛、発熱は一般的副作用で軽快していた。,関節痛 発熱 一般的 副作用 軽快 する いる た,0,0.9845629901011632,0.015437009898836786,0,8.477509483146665e-05,0.9999152249051685,1,0.26173140281483276,0.7382685971851672,0,0.723487108342517,0.276512891657483,0,0.9417142868041992,0.059752557426691055,0,0.8179662823677063,0.17397688329219818,1,0.8124004401527255,0.18759955984727444,0
938,集中治療室(ICU)入室は行われなかった。,集中治療室 ICU 入室 行う れる ない た,0,0.9912046578404218,0.008795342159578213,0,9.281350446789143e-05,0.9999071864955321,0,0.9615130790445598,0.03848692095544011,0,0.9973406432324653,0.0026593567675346538,0,0.9546669721603394,0.05559120699763298,0,0.820458710193634,0.14310985803604126,0,0.9700182785602047,0.02998172143979527,0
939,胸部X線:(2021/10/29)所見なし,胸部 X線 0 0 0 所見 ない,0,0.999290483946967,0.000709516053033067,0,6.192025128583643e-05,0.9999380797487142,0,0.9948101187688879,0.005189881231112119,0,0.9999939879405559,6.012059444073046e-06,0,0.9343235492706299,0.059455398470163345,0,0.8433358073234558,0.16082489490509033,0,0.9719602587964508,0.028039741203549205,0
940,事前のワクチン接種後に有害事象はなかった。,事前 ワクチン接種 後 有害事象 ない た,0,0.9976140540216504,0.0023859459783496057,0,6.250872231251921e-05,0.9999374912776875,0,0.9741827841769427,0.025817215823057262,0,0.9988349711153318,0.0011650288846681343,0,0.9512838125228882,0.05272505804896355,0,0.8511082530021667,0.15302519500255585,0,0.9717506955251243,0.02824930447487577,0
941,HC(15 mg/日)の補充は継続された。,HC 0 mg 日 補充 継続 する れる た,0,0.9838250192683095,0.016174980731690623,0,9.69191855336222e-05,0.9999030808144663,0,0.8857310949672926,0.11426890503270741,0,0.513555679810273,0.4864443201897271,0,0.9387631416320801,0.07039009779691696,0,0.8267301917076111,0.16750232875347137,0,0.9083804268187012,0.09161957318129868,0
942,COVID-19抗原定性検査は陰性だった。,COVID 0 抗原 定性 検査 陰性 だ た,0,0.9968151316478996,0.0031848683521003254,0,6.350280187965293e-05,0.9999364971981204,0,0.9846331932035042,0.01536680679649584,0,0.9869896976443583,0.013010302355641728,0,0.9341826438903809,0.06300697475671768,0,0.8476775884628296,0.17394189536571503,0,0.9701687757334595,0.029831224266540404,0
943,約2時間後、症状は軽快し、患者は帰宅した。,0時 間 後 症状 軽快 する 患者 帰宅 する た,0,0.98964615062457,0.01035384937543001,0,8.723942374192514e-05,0.9999127605762581,0,0.9956637794428652,0.004336220557134764,0,0.900482034293689,0.099517965706311,0,0.9351457357406616,0.0772523432970047,0,0.8255253434181213,0.17040860652923584,0,0.963902569566222,0.036097430433777944,0
944,抗GQ1b抗体は陰性、8.先行感染はなし。,GQ 0 b 抗体 陰性 0 先行感染 ない,0,0.9996704786276663,0.0003295213723337008,0,5.636392161931369e-05,0.9999436360783807,0,0.9907996783827733,0.009200321617226762,0,0.9738002909355986,0.026199709064401437,0,0.9267289638519287,0.0788276344537735,0,0.8324757814407349,0.17598217725753784,0,0.9687215714173814,0.03127842858261876,0
945,2022/02/09、聴力検査:左右差なし,0 0 0 聴力 検査 左右 差 ない,0,0.9845562821714472,0.015443717828552873,0,0.00012976289361856346,0.9998702371063815,0,0.9569208805209524,0.04307911947904769,0,0.9898374613926857,0.0101625386073143,0,0.8876532316207886,0.12070057541131973,0,0.8246725797653198,0.1713542938232422,0,0.9638465498049517,0.03615345019504843,0
946,前回のワクチン接種後、有害事象はなかった。,前回 ワクチン接種 後 有害事象 ない た,0,0.9975953981386214,0.002404601861378473,0,7.437881175108814e-05,0.9999256211882489,0,0.9674531832640656,0.03254681673593442,0,0.9987043695666526,0.0012956304333473353,0,0.9500144720077515,0.05277365446090698,0,0.8487663865089417,0.1605399250984192,0,0.9710588309526745,0.028941169047325594,0
947,Urine antigen test:正常,Urine antigen test 正常,0,0.9906971056429736,0.009302894357026421,0,8.906270063293974e-05,0.9999109372993671,0,0.9923758882265481,0.0076241117734518575,0,1.0,7.073747944216904e-21,0,0.9301046133041382,0.08342903107404709,0,0.8071967363357544,0.20873652398586273,0,0.9680607724204392,0.031939227579560824,0
948,相対的リンパ球減少は現在も改善していない。,相対的 リンパ球減少 現在 改善 する いる ない,0,0.9996333444844341,0.00036665551556584015,0,5.613161059935498e-05,0.9999438683894006,0,0.9805126851833554,0.019487314816644535,0,0.9638240993081978,0.03617590069180222,0,0.9417862892150879,0.06156495213508606,0,0.8040398359298706,0.18348824977874756,0,0.9673534717220219,0.03264652827797799,0
949,前回の報告以降、この患者の受診はなかった。,前回 報告 以降 患者 受診 ない た,0,0.9942971912672482,0.005702808732751732,0,9.495465106142867e-05,0.9999050453489385,0,0.9712539181841462,0.028746081815853818,0,0.991836192967892,0.00816380703210798,0,0.9498111009597778,0.05927750840783119,0,0.8092705011367798,0.16138218343257904,0,0.9693319707370032,0.030668029262996853,0
950,臨床化学:(2022/01/05)異常なし,臨床 化学 0 0 0 異常 ない,0,0.9845512965838864,0.01544870341611358,0,7.60480796990197e-05,0.999923951920301,0,0.9453015381125173,0.05469846188748271,0,0.9928955330543496,0.007104466945650368,0,0.9292532801628113,0.07021967321634293,0,0.8303812742233276,0.1577104777097702,0,0.9669892219918435,0.03301077800815656,0
951,DVT(深静脈(静脈)血栓症)はなかった。,DVT 深い 静脈 静脈 血栓症 ない た,0,0.9982980277566299,0.0017019722433700279,0,6.976332116018852e-05,0.9999302366788398,0,0.9266823476495376,0.07331765235046236,0,0.8227069649495534,0.17729303505044658,0,0.9308180809020996,0.05660213157534599,0,0.8312478065490723,0.15812154114246368,0,0.9544731139777323,0.0455268860222676,0
952,患者は治療を受けなかった(報告のとおり)。,患者 治療 受ける ない た 報告 とおり,0,0.9999312990808865,6.870091911352248e-05,0,5.5647940736856264e-05,0.9999443520592631,0,0.995112943779115,0.004887056220885054,0,0.9999999999998304,1.6967689737252676e-13,0,0.9559024572372437,0.06207985058426857,0,0.8319740295410156,0.17013777792453766,0,0.971964797644238,0.028035202355762,0
953,(2022年)陰影は著明な改善が認められた,0 年 陰影 著い 明 だ 改善 認める られる た,0,0.9845842698642857,0.015415730135714248,0,0.00010215219571688913,0.9998978478042831,0,0.865622230646429,0.1343777693535711,1,0.20846756582028136,0.7915324341797186,0,0.9389420747756958,0.07321537286043167,0,0.7734695076942444,0.2712404727935791,1,0.815403116638281,0.18459688336171895,0
954,バイタルサイン測定:正常、注記:身体検査。,バイタルサイン 測定 正常 注記 身体検査,0,0.9923566176761582,0.007643382323841809,0,6.784239008333626e-05,0.9999321576099167,0,0.9923758882265481,0.0076241117734518575,0,0.9999902229927538,9.777007246298721e-06,0,0.9291149377822876,0.10769908130168915,0,0.7961184978485107,0.19395746290683746,0,0.9674900213684733,0.0325099786315267,0
955,人工呼吸器またはECMOを使用しなかった。,人工呼吸器 ECMO 使用 する ない た,0,0.9998232726863061,0.000176727313693852,0,5.0203342670162665e-05,0.9999497966573299,0,0.9933914285537546,0.006608571446245387,0,0.9995950730149293,0.0004049269850706125,0,0.949370265007019,0.053820524364709854,0,0.8338790535926819,0.15117721259593964,0,0.9724541633406668,0.02754583665933321,0
956,(不明日)陰性化、注記:3か月後に再検した,明日 陰性化 注記 0 か月 後 再検 する た,0,0.9845701284460016,0.015429871553998498,0,9.251614841976895e-05,0.9999074838515802,1,0.46908510374761503,0.530914896252385,1,0.4682502897568612,0.5317497102431388,0,0.9398448467254639,0.06892795115709305,0,0.7970552444458008,0.26150476932525635,1,0.7773800757391867,0.22261992426081323,0
957,2022/07/04、患者は退院となった。,0 0 0 患者 退院 なる た,0,0.995293910604969,0.00470608939503087,0,9.927190456547697e-05,0.9999007280954345,0,0.9820438790849554,0.017956120915044584,0,0.9999444750856846,5.552491431534781e-05,0,0.932319164276123,0.07823629677295685,0,0.809847891330719,0.20045271515846252,0,0.9682697772138085,0.03173022278619145,0
958,患者が検査を受けたかどうかは不明であった。,患者 検査 受ける た 不明 だ ある た,0,0.9989808472524451,0.0010191527475548914,0,5.4928391419022194e-05,0.9999450716085809,0,0.9946080775276092,0.005391922472390839,0,0.9997544032791903,0.00024559672080967095,0,0.9377618432044983,0.0642818957567215,0,0.8346522450447083,0.16337880492210388,0,0.9715722512613103,0.028427748738689588,0
959,患者は、本日、具合の悪いところはなかった。,患者 本日 具合 悪い ところ ない た,0,0.9859382183110594,0.014061781688940551,0,9.712665459480113e-05,0.9999028733454052,0,0.9296582144564108,0.07034178554358918,0,0.9879667342419527,0.01203326575804726,0,0.9483900666236877,0.0595189593732357,0,0.8225991129875183,0.18658588826656342,0,0.9655172550005666,0.03448274499943341,0
960,期待どおり、WBC数は数日後に正常化した。,期待 どおり WBC 数 数 日 後 正常 化 する た,0,0.9869600332717144,0.013039966728285465,0,0.00010986127889756532,0.9998901387211024,0,0.8060125699449033,0.19398743005509664,0,0.5054921741525622,0.4945078258474378,0,0.9437012672424316,0.07696108520030975,0,0.8206477761268616,0.175893172621727,0,0.8917405014208968,0.10825949857910329,0
961,事象発現の正確な日付と時刻は不明であった。,事象 発現 正確 だ 日付 時刻 不明 だ ある た,0,0.9845839046701352,0.015416095329864855,0,0.00010355920724588715,0.9998964407927541,0,0.5174658061048705,0.4825341938951296,0,0.9384534248352476,0.06154657516475234,0,0.9419755935668945,0.10252846032381058,0,0.7919933199882507,0.22402581572532654,0,0.9079308276790283,0.09206917232097157,0
962,尿検査:(2020/01/09)異常なし。,尿検査 0 0 0 異常 ない,0,0.9845608737386101,0.015439126261389822,0,8.275021313328052e-05,0.9999172497868667,0,0.9564049712076866,0.04359502879231336,0,0.9996492355242954,0.00035076447570456866,0,0.9289461970329285,0.07448557019233704,0,0.8471432328224182,0.16592717170715332,0,0.9682338490181042,0.03176615098189569,0
963,反応はまだ製造販売業者へ報告されていない。,反応 製造 販売 業者 報告 する れる いる ない,0,0.9880537293574849,0.011946270642515041,0,7.327385666847416e-05,0.9999267261433316,0,0.9040848221871609,0.09591517781283906,0,0.9665175380838045,0.03348246191619555,0,0.9451614022254944,0.07376931607723236,0,0.8304839730262756,0.19452184438705444,0,0.9617574288117329,0.038242571188267085,0
964,報告者の病院には、まだ受診されていなかった,報告 者 病院 受診 する れる いる ない た,0,0.9884375200946968,0.011562479905303326,0,7.8900271561444e-05,0.9999210997284386,0,0.9587366100599357,0.041263389940064336,0,0.9975619294935137,0.002438070506486208,0,0.9502333998680115,0.05774226039648056,0,0.8237264752388,0.1487317532300949,0,0.9694426413637874,0.03055735863621261,0
965,本事象は救急外来を受診する必要はなかった。,事象 救急外来 受診 する 必要 ない た,0,0.9941500709911741,0.005849929008825795,0,8.775395771441234e-05,0.9999122460422856,0,0.9771479926699467,0.02285200733005328,0,0.9986584660055927,0.001341533994407311,0,0.9418251514434814,0.07149028778076172,0,0.8200805187225342,0.16312569379806519,0,0.9697451926308794,0.0302548073691206,0
966,入院時からステロイドパルス療法を施行した。,入院 時 ステロイド パルス 療法 施行 する た,0,0.98456546860432,0.015434531395679992,0,8.978368882486495e-05,0.9999102163111752,0,0.9026492125278328,0.09735078747216722,0,0.712694601325081,0.28730539867491905,0,0.925940215587616,0.11029817909002304,1,0.5638896226882935,0.5692821145057678,1,0.8818688266767898,0.11813117332321016,0
967,(不明日)36.5-36.9度、注記:平熱,明日 0 0 0 0度 注記 平熱,0,0.9845518071102404,0.015448192889759656,0,0.00010717146832468239,0.9998928285316753,1,0.35873972300322543,0.6412602769967746,0,0.9999999839056417,1.6094358244753227e-08,0,0.6428591012954712,0.5340390205383301,0,0.7264371514320374,0.4612938165664673,1,0.7428359057641684,0.25716409423583164,0
968,内視鏡で確認したが、喉頭浮腫なしであった。,内視鏡 確認 する た 喉頭浮腫 ない だ ある た,0,0.9951338885840949,0.0048661114159051656,0,7.551024018232013e-05,0.9999244897598176,0,0.8802226253604211,0.11977737463957892,0,0.7379556398358709,0.2620443601641291,0,0.9128607511520386,0.12405404448509216,0,0.8414567112922668,0.1673247367143631,0,0.9364169558341363,0.0635830441658638,0
969,Viral test:陰性、注記:入院時。,Viral test 陰性 注記 入院 時,0,0.9760072972360514,0.023992702763948548,0,0.00011551987864125391,0.9998844801213588,0,0.9406007118246903,0.059399288175309706,0,0.9986234323214197,0.0013765676785803377,0,0.7648860812187195,0.3918362855911255,0,0.8303006291389465,0.19407117366790771,0,0.9447980631124264,0.055201936887573556,0
970,19:40、解熱剤(ラックル)を内服した。,0 0 解熱 剤 ラックル 内服 する た,0,0.9845495440284904,0.015450455971509687,0,9.57867658997936e-05,0.9999042132341002,0,0.9495715112005189,0.05042848879948112,1,0.467273965527491,0.532726034472509,0,0.9306071996688843,0.11891833692789078,0,0.7545042634010315,0.34759530425071716,1,0.8830442275340729,0.1169557724659273,0
971,患者は以前ペニシリンアレルギーを経験した。,患者 以前 ペニシリンアレルギー 経験 する た,1,0.05458257428594081,0.9454174257140592,1,0.00021706591143813946,0.9997829340885619,1,0.48021634188129947,0.5197836581187005,1,0.15689871740416061,0.8431012825958394,1,0.34921807050704956,0.806531548500061,1,0.3864063322544098,0.7682986855506897,1,0.030608926519828175,0.9693910734801718,0
972,(2021/09/26) negative,0 0 0 negative,0,0.9845634143284934,0.015436585671506705,0,0.00010764164164531549,0.9998923583583547,1,0.35873972300322543,0.6412602769967746,0,1.0,4.2259553859901435e-17,0,0.7359415292739868,0.3834224343299866,1,0.5098938345909119,0.6303535103797913,1,0.7148140422155942,0.2851859577844058,0
973,SARS-CoV-2検査:陰性(陰性)。,SARS CoV 0 検査 陰性 陰性,0,0.9982471437202612,0.00175285627973874,0,4.2768803658495e-05,0.9999572311963415,0,0.9860468973744586,0.01395310262554141,0,1.0,6.91215904429231e-51,0,0.9305198788642883,0.07080040127038956,0,0.8341232538223267,0.19461888074874878,0,0.9697604223897207,0.03023957761027926,0
974,血算や生化学検査では特記すべき所見なし。,血算 生化学 検査 特記 する べし 所見 ない,0,0.996800934601299,0.0031990653987008797,0,6.359399464703552e-05,0.9999364060053529,0,0.9780547978535973,0.021945202146402762,0,0.9034263725946781,0.09657362740532197,0,0.9398587942123413,0.08671364188194275,0,0.8357751965522766,0.19931267201900482,0,0.9625398971742419,0.037460102825758054,0
975,1か月後の外来検査においてCRPは正常。,0 か月 後 外来 検査 CRP 正常,0,0.9998538896332058,0.0001461103667944314,0,4.0377439375281495e-05,0.9999596225606248,0,0.9977362633091987,0.0022637366908013186,0,0.9999999999978483,2.1517396583501327e-12,0,0.9310166239738464,0.08195779472589493,0,0.8184224367141724,0.1824411302804947,0,0.97012205168877,0.029877948311230147,0
976,2021/07/12ゾルピデム投与中止。,0 0 0 ゾルピデム 投与 中止,0,0.984593306347179,0.01540669365282102,0,8.262395508383956e-05,0.9999173760449162,0,0.9047601863611796,0.09523981363882042,0,0.9999999999999927,7.373618424580394e-15,0,0.9246484637260437,0.08931878954172134,0,0.8000012040138245,0.2211582362651825,0,0.9605717030222064,0.0394282969777935,0
977,2021/07/22症状の回復を認めた。,0 0 0 症状 回復 認める た,0,0.9893250523332535,0.010674947666746417,0,0.00013088862851911404,0.9998691113714809,0,0.9672732785305521,0.03272672146944792,0,0.9895883286080458,0.010411671391954227,0,0.9308914542198181,0.06509068608283997,0,0.8027011752128601,0.22175443172454834,0,0.9657554298583119,0.03424457014168823,0
978,2021/08/11改善したため、退院。,0 0 0 改善 する た ため 退院,0,0.9994308581365974,0.0005691418634027843,0,6.381336284471431e-05,0.9999361866371553,0,0.9919812199328425,0.008018780067157475,0,1.0,4.232204419400391e-23,0,0.9384986758232117,0.078730508685112,0,0.7821320295333862,0.20352961122989655,0,0.9683643073094276,0.03163569269057241,0
979,2021/12/27全身状態は改善せず。,0 0 0 全身 状態 改善 する ぬ,0,0.9912367263054646,0.0087632736945354,0,9.323760223591358e-05,0.9999067623977641,0,0.9421673522510031,0.05783264774899692,0,0.8494259349042407,0.15057406509575932,0,0.9399399757385254,0.08193843811750412,0,0.7910359501838684,0.19297365844249725,0,0.9535542047043151,0.04644579529568507,0
980,2022/03/01人工呼吸器より離脱。,0 0 0 人工呼吸器 離脱,0,0.9845681883607816,0.015431811639218465,0,0.0001070405982533725,0.9998929594017466,1,0.35873972300322543,0.6412602769967746,0,1.0,6.492854315102096e-18,0,0.8729018568992615,0.1280938982963562,0,0.7837136387825012,0.23795975744724274,1,0.8784028457632841,0.1215971542367159,0
981,2022/03/03症状の軽快を認めた。,0 0 0 症状 軽快 認める た,0,0.9845526757928758,0.015447324207124339,0,0.00013957498029676038,0.9998604250197033,0,0.9216380253184914,0.07836197468150861,0,0.8222821901368766,0.1777178098631233,0,0.9397403001785278,0.0659029632806778,0,0.8050299286842346,0.2099282592535019,0,0.9491247621880327,0.05087523781196734,0
982,2022/03/16心エコー検査を施行。,0 0 0 心 エコー 検査 施行,0,0.9845520639658729,0.01544793603412697,0,0.0001170422752624177,0.9998829577247376,0,0.857719616846948,0.14228038315305203,0,0.9999995996794705,4.0032052953019105e-07,0,0.840346097946167,0.2035890370607376,0,0.7828935980796814,0.2417992502450943,0,0.9459677841031288,0.05403221589687129,0
983,2022/03/26尿道カテーテル抜去。,0 0 0 尿道カテーテル 抜去,0,0.8466714995873456,0.15332850041265417,0,0.00016175516735493725,0.999838244832645,1,0.35873972300322543,0.6412602769967746,0,1.0,3.3090715583226448e-19,0,0.886885404586792,0.12039057165384293,0,0.8209326267242432,0.19180412590503693,1,0.8589709601485058,0.14102903985149418,0
984,2022/03/31胃部問題なく、退院。,0 0 0 胃 部 問題 ない 退院,0,0.9981134440875691,0.0018865559124308382,0,7.243045648300863e-05,0.999927569543517,0,0.9687465396527251,0.031253460347274886,0,0.9999999999999475,5.2541309757398154e-14,0,0.9344199895858765,0.06473623961210251,0,0.8426193594932556,0.1679031401872635,0,0.9700629696059532,0.029937030394046903,0
985,2022/05/21 IVIG投与終了。,0 0 0 IVIG 投与 終了,0,0.9964078656487952,0.0035921343512047726,0,5.57813606344948e-05,0.9999442186393656,0,0.8970232567278718,0.10297674327212823,0,1.0,3.640955023721721e-20,0,0.9356818795204163,0.06869159638881683,0,0.8276867866516113,0.19351530075073242,0,0.9640195408918975,0.03598045910810257,0
986,COVIDー19病原体検査が実施された。,COVID ー 0 病原体 検査 実施 する れる た,0,0.9876668792596011,0.012333120740398981,0,0.00011192451246537968,0.9998880754875347,0,0.9548630582306838,0.045136941769316104,1,0.4377599672636475,0.5622400327363525,0,0.9371128678321838,0.10857177525758743,0,0.8064594268798828,0.19209294021129608,1,0.9005822865597751,0.09941771344022482,0
987,カルジオリピン抗体:特記すべき所見なし。,カルジオリピン 抗体 特記 する べし 所見 ない,0,0.9983815207933489,0.0016184792066510799,0,6.0918462838746335e-05,0.9999390815371613,0,0.9928124176641389,0.007187582335861121,0,0.9430993879686819,0.056900612031318104,0,0.9484775066375732,0.07738961279392242,0,0.8400577306747437,0.1818929761648178,0,0.9676407550391436,0.03235924496085632,0
988,コクサッキーウイルス検査:陰性(陰性)。,コクサッキーウイルス 検査 陰性 陰性,0,0.9953324501310539,0.00466754986894597,0,5.5477064343330486e-05,0.9999445229356567,0,0.9830269590625047,0.016973040937495267,0,1.0,4.6314508015477475e-36,0,0.9334671497344971,0.06600160896778107,0,0.8251913189888,0.19212694466114044,0,0.9694498659205057,0.030550134079494255,0
989,しかし、大事には至らず、患者は軽快した。,大事 至る ぬ 患者 軽快 する た,0,0.9845712234441844,0.015428776555815657,0,8.57708929557549e-05,0.9999142291070442,0,0.9814998313838529,0.018500168616147113,0,0.641881421639973,0.35811857836002703,0,0.9419553875923157,0.07129543274641037,0,0.7992246747016907,0.15805543959140778,0,0.9386533504547784,0.06134664954522171,0
990,ステロイド投与は依然として漸減していた。,ステロイド 投与 漸減 する いる た,0,0.9976826663278827,0.0023173336721172837,0,5.009772717036943e-05,0.9999499022728296,0,0.9952711852472784,0.0047288147527216225,0,0.9753467997391004,0.024653200260899552,0,0.9374164342880249,0.057613782584667206,0,0.8314602375030518,0.20835444331169128,0,0.968919771744872,0.031080228255127927,0
991,なおPBCの典型的な所見は認めなかった。,PBC 典型 的 だ 所見 認める ない た,0,0.9816092604187946,0.018390739581205445,0,0.00015578940733825805,0.9998442105926617,0,0.9372671009247258,0.06273289907527423,0,0.996157501517434,0.0038424984825660255,0,0.9337758421897888,0.10327594727277756,0,0.8370597958564758,0.16722148656845093,0,0.9654676993175718,0.0345323006824283,0
992,モデルナアームのような症状は治っている。,モデルナアーム よう 症状 治る いる,0,0.9845626252923899,0.015437374707610004,0,0.0001053233439921206,0.9998946766560078,0,0.5442181794647485,0.4557818205352515,0,0.9999998924775465,1.0752245352640925e-07,0,0.9406000375747681,0.06890048086643219,0,0.6369459629058838,0.5721489787101746,0,0.8801940012907274,0.11980599870927248,0
993,患者の併用薬については報告されなかった。,患者 併用 薬 報告 する れる ない た,0,0.9999691584964517,3.084150354823304e-05,0,5.1834468120064636e-05,0.9999481655318799,0,0.9974125885044414,0.002587411495558632,0,0.9984648780096508,0.0015351219903492169,0,0.9572455883026123,0.05549032986164093,0,0.8317983150482178,0.14673791825771332,0,0.9728436525985352,0.027156347401464765,0
994,患者は修正ランキンスケール1で退院した。,患者 修正 ランキンスケール 0 退院 する た,0,0.9845866909164628,0.015413309083537234,0,8.410401221940112e-05,0.9999158959877806,0,0.9543667641482938,0.04563323585170617,0,0.6478986118094603,0.35210138819053965,0,0.9388593435287476,0.08702508360147476,0,0.820378303527832,0.18545302748680115,0,0.9346632645870968,0.06533673541290329,0
995,患者は補体阻害薬を投与されていなかった。,患者 補 体 阻害 薬 投与 する れる いる ない た,0,0.9996084502773526,0.000391549722647343,0,5.754803246371318e-05,0.9999424519675363,0,0.9928037147251603,0.007196285274839764,0,0.9880399397573272,0.011960060242672859,0,0.9547629952430725,0.04907044395804405,0,0.8305060863494873,0.1439296454191208,0,0.9721665417491899,0.027833458250809982,0
996,関連した病歴と併用薬は報告されなかった。,関連 する た 病歴 併用 薬 報告 する れる ない た,0,0.9997065276568812,0.0002934723431188344,0,6.567529851265467e-05,0.9999343247014874,0,0.9897064036167993,0.01029359638320074,0,0.9980383494803116,0.001961650519688434,0,0.9543623328208923,0.05548310652375221,0,0.8409210443496704,0.14019472897052765,0,0.9727384897791354,0.02726151022086474,0
997,関連する病歴、併用薬は報告されなかった。,関連 する 病歴 併用 薬 報告 する れる ない た,0,0.9997065276568812,0.0002934723431188344,0,6.8421829627194e-05,0.9999315781703728,0,0.9923975604483977,0.007602439551602304,0,0.9968670649044176,0.003132935095582461,0,0.9534828066825867,0.05459258332848549,0,0.8391259908676147,0.14156286418437958,0,0.9727356533935675,0.02726434660643261,0
998,血液検査は血小板数正常で、特記事項なし。,血液検査 血小板 数 正常 だ 特記 事項 ない,0,0.9991664344989267,0.0008335655010732636,0,4.9329135902075754e-05,0.999950670864098,0,0.9902974765577632,0.009702523442236767,0,0.9996767660268335,0.0003232339731665234,0,0.9507526159286499,0.06202736869454384,0,0.8413053750991821,0.18665508925914764,0,0.9713004819181047,0.02869951808189534,0
999,磁気共鳴画像(MRI):頭蓋内出血なし。,磁気 共鳴 画像 MRI 頭蓋内出血 ない,0,0.9927541620349747,0.007245837965025429,0,7.37568512446041e-05,0.9999262431487554,0,0.9579591332538753,0.042040866746124755,0,0.9721911452913766,0.027808854708623355,0,0.941950798034668,0.061390943825244904,0,0.8318384289741516,0.1584864854812622,0,0.9677004157400056,0.03229958425999442,0
1000,心嚢液貯留を疑う身体診察所見:なかった。,心嚢液 貯留 疑う 身体 診察 所見 ない た,0,0.9845880627628757,0.015411937237124246,0,0.00012593262762521375,0.9998740673723748,0,0.9590619564932594,0.040938043506740615,0,0.9718633376771657,0.028136662322834304,0,0.9146168828010559,0.09577254951000214,0,0.8367182016372681,0.1688982993364334,0,0.9650392514937124,0.03496074850628758,0
1001,接種2週以内に他の併用薬使用はなかった。,接種 0 週 以内 他 併用 薬 使用 ない た,0,0.9980187293337452,0.0019812706662548606,0,6.210234939523049e-05,0.9999378976506048,0,0.9960495718921998,0.003950428107800262,0,0.9978342020187728,0.002165797981227169,0,0.9458062052726746,0.054862476885318756,0,0.841041088104248,0.14589616656303406,0,0.9726156647746159,0.027384335225383975,0
1002,接種日周辺にて、解熱剤の使用はなかった。,接種 日 周辺 解熱 剤 使用 ない た,0,0.9975352255354777,0.0024647744645223653,0,6.122486995468368e-05,0.9999387751300454,0,0.9934220063371529,0.006577993662847089,0,0.9992688568508893,0.0007311431491107557,0,0.950579047203064,0.056632500141859055,0,0.8432843089103699,0.1489526331424713,0,0.972584618273262,0.027415381726737853,0
1003,他要因(他の疾患等の可能性)はなかった。,要因 他 疾患 等 可能性 ない た,0,0.9990116131379752,0.0009883868620249375,0,5.586478276168347e-05,0.9999441352172384,0,0.991250609396377,0.008749390603622996,0,0.9943988032693094,0.005601196730690543,0,0.9429233074188232,0.053256891667842865,0,0.8358714580535889,0.1565704047679901,0,0.9717608727255096,0.02823912727449039,0
1004,他要因(他の疾患等の可能性)は無かった。,要因 他 疾患 等 可能性 無い た,0,0.9845598193220059,0.015440180677994048,0,6.622656593561616e-05,0.9999337734340644,0,0.7700177937574298,0.22998220624257018,0,0.9982350863723305,0.00176491362766948,0,0.9377920627593994,0.05987480655312538,0,0.8329342007637024,0.1605410873889923,0,0.9550437871518089,0.04495621284819093,0
1005,日付不明心エコー図:特記すべき所見なし。,日付 不明 心 エコー 図 特記 する べし 所見 ない,0,0.9897200677484199,0.010279932251580028,0,5.403953896416697e-05,0.9999459604610358,0,0.9671760955407737,0.032823904459226345,0,0.9059311565995578,0.09406884340044222,0,0.9503211975097656,0.06883174926042557,0,0.8390336632728577,0.15272554755210876,0,0.9642072286244168,0.035792771375583274,0
1006,"白血球数(WBC):6,500(正常)。",白血球 数 WBC 0 0 正常,0,0.9879592013728525,0.012040798627147312,0,0.0001216006974370132,0.999878399302563,0,0.980855994784636,0.019144005215364017,0,0.9999999999999496,5.045789884058799e-14,0,0.8592404127120972,0.1929483413696289,0,0.8033604621887207,0.23627768456935883,0,0.9597378534809685,0.04026214651903137,0
1007,併用薬及び治療薬情報は提供されなかった。,併用 薬 治療薬 情報 提供 する れる ない た,0,0.9996941039444098,0.0003058960555902704,0,5.924128193737817e-05,0.9999407587180626,0,0.9923998853935267,0.007600114606473214,0,0.9953989524159695,0.004601047584030491,0,0.9528725743293762,0.06564383953809738,0,0.8313245177268982,0.14582428336143494,0,0.9720185564518359,0.027981443548164057,0
1008,報告時、心筋炎(心筋炎)は回復していた。,報告 時 心筋炎 心筋炎 回復 する いる た,0,0.9967069665873617,0.0032930334126383236,0,7.680465264126263e-05,0.9999231953473587,0,0.9284863760109392,0.07151362398906078,0,0.7237229492382411,0.27627705076175885,0,0.937118649482727,0.0589657686650753,0,0.8345456719398499,0.17175410687923431,0,0.9447436648217512,0.055256335178248656,0
1009,家族歴:出血素因を有する血縁家族はなし。,家族 歴 出血素因 有する 血縁 家族 ない,0,0.9606933337250845,0.039306666274915386,0,0.00012219713459314741,0.9998778028654068,0,0.8701519374210215,0.1298480625789785,0,0.9227451549519461,0.07725484504805388,0,0.8779791593551636,0.15749377012252808,0,0.8095294237136841,0.19679424166679382,0,0.9448331341592932,0.055166865840706784,0
1010,治療内容及び関連する検査は不明であった。,治療 内容 関連 する 検査 不明 だ ある た,0,0.9855425978455642,0.014457402154435755,0,6.849033208380277e-05,0.9999315096679162,0,0.9915747977215302,0.008425202278469799,0,0.9545951312759432,0.04540486872405679,0,0.9397259950637817,0.06045646220445633,0,0.8433783650398254,0.17394885420799255,0,0.9680855346093309,0.0319144653906691,0
1011,無力症に対して治療措置は取られなかった。,無力症 治療 措置 取る れる ない た,0,0.9845821768600819,0.015417823139918236,0,0.00010638181341226216,0.9998936181865877,0,0.9608178164564157,0.03918218354358428,0,0.9918794537765442,0.008120546223455845,0,0.9530196785926819,0.05498479679226875,0,0.8344448208808899,0.14907442033290863,0,0.9694740610609426,0.030525938939057386,0
1012,ESR(1時間値)は、実施されなかった。,ESR 0時 間 値 実施 する れる ない た,0,0.9993051191700428,0.0006948808299571392,0,7.704149229120765e-05,0.9999229585077088,0,0.9727294593728371,0.027270540627162932,0,0.9977607881449374,0.0022392118550625647,0,0.9467201828956604,0.0577952116727829,0,0.8357359170913696,0.14597207307815552,0,0.9712077356048101,0.028792264395189848,0
1013,検診:(不明日)、異常は認められなかった,検診 明日 異常 認める られる ない た,0,0.9845767929553371,0.01542320704466299,0,9.721669725510016e-05,0.9999027833027448,0,0.9539152845075243,0.04608471549247577,0,0.9934754156800917,0.006524584319908355,0,0.9444188475608826,0.055296652019023895,0,0.8457300066947937,0.16988028585910797,0,0.9686017487298602,0.03139825127013991,0
1014,有害事象後の被験薬の処置は不明であった。,有害事象 後 被験 薬 処置 不明 だ ある た,0,0.9960994717593171,0.0039005282406829153,0,6.750367949324998e-05,0.9999324963205067,0,0.9888518879685863,0.011148112031413695,0,0.8951394297186558,0.1048605702813442,0,0.9413696527481079,0.07441174983978271,0,0.8483906984329224,0.17328669130802155,0,0.9645103170611921,0.03548968293880795,0
1015,ワクチン接種前後、とくに異常はなかった。,ワクチン接種 前後 異常 ない た,0,0.9968638577806074,0.003136142219392633,0,6.774411902129188e-05,0.9999322558809787,0,0.9762142247222021,0.023785775277797884,0,0.9863591065795568,0.013640893420443204,0,0.9353753328323364,0.05088406801223755,0,0.8496731519699097,0.1576317399740219,0,0.9705606746814922,0.029439325318507806,0
1016,病気治療のため3回目接種は受けなかった。,病気 治療 ため 0回目 接種 受ける ない た,0,0.9924432886498736,0.007556711350126274,0,0.00010541197267214371,0.9998945880273279,0,0.9764360575287094,0.023563942471290573,0,0.9985946572536474,0.001405342746352611,0,0.9469890594482422,0.0569046288728714,0,0.8350269198417664,0.14472757279872894,0,0.9711267829204252,0.028873217079574902,0
1017,製造販売業者へ報告された反応は無かった。,製造 販売 業者 報告 する れる た 反応 無い た,0,0.9845726798070413,0.015427320192958727,0,8.235638267044837e-05,0.9999176436173296,1,0.4984153621544455,0.5015846378455545,0,0.9797954651232367,0.020204534876763346,0,0.9375432133674622,0.0627652034163475,0,0.8350809812545776,0.16291315853595734,1,0.9222040802359318,0.07779591976406816,0
1018,胸部X線検査:実施、心拡大の所見:なし。,胸部 X線検査 実施 心拡大 所見 ない,0,0.9998677373946416,0.00013226260535826456,0,4.7772631255624524e-05,0.9999522273687443,0,0.9976444096406343,0.0023555903593657375,0,0.9987998194004338,0.0012001805995661221,0,0.9452049732208252,0.05670017749071121,0,0.8379095792770386,0.17650894820690155,0,0.9718765462447122,0.02812345375528781,0
1019,経過はよく2週間程度で回復し、退院した。,経過 0 週間 程度 だ 回復 退院 する た,0,0.9995553746060831,0.000444625393916824,0,4.0941780076416514e-05,0.9999590582199236,0,0.9984064131769278,0.0015935868230722162,0,0.9249182265149662,0.07508177348503375,0,0.9421233534812927,0.07407184690237045,0,0.784573495388031,0.1905091255903244,0,0.964700802992461,0.035299197007539015,0
1020,基礎疾患としての自己免疫疾患はなかった。,基礎疾患 自己免疫疾患 ない た,0,0.996603663371164,0.0033963366288360156,0,8.35186897726354e-05,0.9999164813102274,0,0.9741827841769427,0.025817215823057262,0,0.9668963037080939,0.033103696291906126,0,0.9434187412261963,0.054284773766994476,0,0.8451462984085083,0.15569570660591125,0,0.9693536844245283,0.030646315575471702,0
1021,血液検査の結果、異常は認められなかった。,血液検査 結果 異常 認める られる ない た,0,0.9463381873999456,0.05366181260005443,0,0.00012334111434485787,0.9998766588856551,0,0.9665703877036201,0.0334296122963799,0,0.9938185987462642,0.006181401253735738,0,0.9502811431884766,0.05840938910841942,0,0.838665783405304,0.17865154147148132,0,0.9666115612730787,0.033388438726921245,0
1022,剖検は、遺族の意思により行われなかった。,剖検 遺族 意思 行う れる ない た,0,0.9845900899056076,0.015409910094392387,0,8.730373598536423e-05,0.9999126962640147,0,0.9139629226681906,0.08603707733180943,0,0.9912502692893078,0.008749730710692235,0,0.9489353895187378,0.05777430906891823,0,0.8183865547180176,0.15255361795425415,0,0.9656690927969693,0.03433090720303066,0
1023,ワクチン接種前後に解熱剤を使わなかった。,ワクチン接種 前後 解熱 剤 使う ない た,0,0.9990371094871774,0.0009628905128226775,0,5.9609503525974725e-05,0.999940390496474,0,0.9705590779676064,0.029440922032393554,0,0.9963056837563269,0.003694316243673114,0,0.9128758907318115,0.07796771079301834,0,0.8325212597846985,0.16958516836166382,0,0.9686219939303231,0.031378006069676896,0
1024,X線:(2021/10/29)異常なし。,X線 0 0 0 異常 ない,0,0.9927498463723333,0.007250153627666629,0,7.528733154847039e-05,0.9999247126684515,0,0.9840786066824166,0.01592139331758336,0,0.9999999765315247,2.3468475224907915e-08,0,0.9394532442092896,0.0607866533100605,0,0.8355115056037903,0.15299221873283386,0,0.9711113768957702,0.02888862310422988,0
1025,(2022/07/07)ECG所見正常化,0 0 0 ECG 所見 正常化,0,0.9865701859004941,0.013429814099505914,0,7.481448706238479e-05,0.9999251855129376,0,0.5735527926910237,0.42644720730897634,0,1.0,7.277646439017494e-25,0,0.9334509372711182,0.07339683920145035,0,0.7879835367202759,0.22876189649105072,0,0.9268765532549975,0.0731234467450026,0
1026,心筋炎調査票:病理組織学的検査:未実施。,心筋炎 調査 票 病理 組織 学 的 検査 実施,0,0.9845883391834602,0.015411660816539911,0,8.560793807712823e-05,0.9999143920619229,0,0.8889170823100294,0.11108291768997063,0,0.8798666078777416,0.12013339212225838,0,0.886260986328125,0.23563137650489807,0,0.8059033751487732,0.21321742236614227,0,0.9399263853217636,0.06007361467823639,0
1027,2022/02/05、被験者は退院した。,0 0 0 被験者 退院 する た,0,0.9845878496906348,0.015412150309365151,0,9.608085381068508e-05,0.9999039191461894,0,0.9776090998008131,0.022390900199186905,0,0.9535217882969065,0.04647821170309355,0,0.9372878074645996,0.08656022697687149,0,0.816888153553009,0.19861562550067902,0,0.9644504083944698,0.03554959160553026,0
1028,3回目投与の解剖学的部位は不明であった。,0回目 投与 解剖学的 部位 不明 だ ある た,0,0.9929213320448154,0.007078667955184708,0,7.855392034915347e-05,0.9999214460796508,0,0.9917333371315913,0.008266662868408738,0,0.8838556549814715,0.11614434501852852,0,0.937857449054718,0.07083959877490997,0,0.8229306936264038,0.19231481850147247,0,0.9621234827907826,0.03787651720921726,0
1029,患者の原疾患、合併症の有無は不明である。,患者 疾患 合併症 有無 不明 だ ある,0,0.9906511260757304,0.009348873924269762,0,7.12452219575079e-05,0.9999287547780424,0,0.9936177061498628,0.006382293850137215,0,0.9556333164604516,0.04436668353954841,0,0.9452231526374817,0.06887155026197433,0,0.82110595703125,0.17237165570259094,0,0.967861449652341,0.03213855034765906,0
1030,胸水は改善乏しく人工呼吸器設定変更した。,胸水 改善 乏しい 人工呼吸器 設定 変更 する た,0,0.9908961090006508,0.009103890999349221,0,7.905873295377477e-05,0.9999209412670462,0,0.9597879441034481,0.04021205589655186,0,0.5949806951513509,0.4050193048486491,0,0.9329426288604736,0.06994891166687012,1,0.40358659625053406,0.7017307877540588,1,0.8397456946538636,0.16025430534613644,0
1031,事象は緊急治療室受診する必要はなかった。,事象 緊急 治療 室 受診 する 必要 ない た,0,0.989833599312244,0.010166400687756158,0,9.449890227876897e-05,0.9999055010977212,0,0.961147572840128,0.03885242715987206,0,0.9976762217422988,0.0023237782577012625,0,0.9474321603775024,0.06382143497467041,0,0.8229642510414124,0.15077288448810577,0,0.9693295761899943,0.03067042381000573,0
1032,培養が実施されたかどうかは不明であった。,培養 実施 する れる た 不明 だ ある た,0,0.9986705763820571,0.001329423617942984,0,5.943042938406926e-05,0.999940569570616,0,0.9864413978177932,0.01355860218220688,0,0.9963724130622331,0.003627586937766906,0,0.9421377778053284,0.05955740436911583,0,0.8405044674873352,0.17317794263362885,0,0.9710552502057612,0.02894474979423873,0
1033,搬送中の経過及び処置内容は不明であった。,搬送 中 経過 処置 内容 不明 だ ある た,0,0.9845619397415236,0.015438060258476265,0,9.110903323831588e-05,0.9999088909667617,0,0.9751245208797773,0.02487547912022267,0,0.9283828010013404,0.07161719899865965,0,0.9364610910415649,0.061446476727724075,0,0.8453720808029175,0.1753988116979599,0,0.9651526312837757,0.03484736871622421,0
1034,Blood test:(不明日)結果不明,BLOOD test 明日 結果 不明,0,0.9902679136581045,0.009732086341895468,0,7.473927986911236e-05,0.9999252607201309,0,0.8833087917580037,0.11669120824199632,0,0.9999999999665637,3.343620013930659e-11,0,0.9397256970405579,0.08402427285909653,0,0.7942184209823608,0.2983994483947754,0,0.9568441806598765,0.04315581934012355,0
1035,患者は、他のワクチンを受けていなかった。,患者 他 ワクチン 受ける いる ない た,0,0.999913367042258,8.663295774210799e-05,0,4.999084066802849e-05,0.999950009159332,0,0.9971684922792866,0.0028315077207133567,0,0.9991896020290096,0.0008103979709904169,0,0.9535568952560425,0.051755692809820175,0,0.8340092897415161,0.14470382034778595,0,0.9729790372928535,0.027020962707146524,0
1036,血清抗アクアポリン4抗体は陰性であった。,血清 アクアポリン 0 抗体 陰性 だ ある た,0,0.9975204881333014,0.0024795118666984866,0,6.70469659417718e-05,0.9999329530340583,0,0.994781950020736,0.005218049979263981,0,0.8734350044109338,0.12656499558906614,0,0.9260510802268982,0.07105188816785812,0,0.8418393135070801,0.18174056708812714,0,0.9625545999168282,0.037445400083171675,0
1037,使用薬剤はカロナール500mgであった。,使用 薬剤 カロナール 0m g だ ある た,0,0.9845833436433246,0.015416656356675325,0,0.00010051581726022803,0.9998994841827398,0,0.8495130869850815,0.15048691301491843,0,0.8902702480657613,0.10972975193423871,0,0.9319710731506348,0.0797983705997467,0,0.8529525399208069,0.17117968201637268,0,0.9517946799369664,0.04820532006303364,0
1038,磁気共鳴画像:(2021/06)結果不明,磁気 共鳴 画像 0 0 結果 不明,0,0.9845670026934646,0.015432997306535254,0,9.235280704371625e-05,0.9999076471929563,0,0.8410412959446487,0.15895870405535126,0,0.999999984521882,1.5478117997889994e-08,0,0.9203833937644958,0.08616016805171967,0,0.8160614967346191,0.22569477558135986,0,0.955891471057567,0.04410852894243299,0
1039,被験者は観察期間中に授乳していなかった。,被験者 観察 期間中 授乳 する いる ない た,0,0.9979586014657863,0.0020413985342137525,0,6.039678665901356e-05,0.999939603213341,0,0.9821885319990133,0.017811468000986652,0,0.9955856611345176,0.004414338865482323,0,0.9502881765365601,0.06580138206481934,0,0.8376320004463196,0.14649875462055206,0,0.9714520400662199,0.028547959933780207,0
1040,2022/07/04、他院転院となった。,0 0 0 院 転院 なる た,0,0.9845715591860574,0.015428440813942679,1,0.00020071368757759828,0.9997992863124224,1,0.28344052026821775,0.7165594797317822,0,0.9028340487295415,0.09716595127045846,0,0.6066927909851074,0.4445042610168457,0,0.7971333265304565,0.2362964153289795,1,0.743667600732936,0.256332399267064,0
1041,2022/05/17、患者は再受診した。,0 0 0 患者 受診 する た,0,0.7158542216305223,0.2841457783694781,1,0.00029908718469306533,0.9997009128153069,1,0.489952062983263,0.510047937016737,1,0.18923930563377644,0.8107606943662236,1,0.09081149101257324,0.9397461414337158,1,0.4195103943347931,0.753226101398468,1,0.08378776794574198,0.9162122320542581,0
1042,12日目、血清カリウムは正常であった。,0 日 目 血清 カリウム 正常 だ ある た,0,0.9926107906463478,0.007389209353652092,0,7.220446757090521e-05,0.999927795532429,0,0.9952822689808869,0.004717731019113155,0,0.8863753008102356,0.11362469918976441,0,0.9359788298606873,0.06023474037647247,0,0.8435163497924805,0.1681976020336151,0,0.9644200262473669,0.03557997375263303,0
1043,2021/12/18風疹ワクチン接種。,0 0 0 風疹 ワクチン接種,0,0.5935590486819298,0.40644095131807045,1,0.00022785423765834343,0.9997721457623416,1,0.35873972300322543,0.6412602769967746,1,0.13926809226925385,0.8607319077307461,0,0.8377899527549744,0.20435504615306854,0,0.778789758682251,0.24480406939983368,1,0.3432171818716831,0.6567828181283168,0
1044,2022/03/07症状軽快し、退院。,0 0 0 症状 軽快 する 退院,0,0.9997960884099439,0.00020391159005600786,0,4.577236100009929e-05,0.9999542276389999,0,0.9984672625842125,0.0015327374157875732,0,1.0,8.52801191528686e-20,0,0.9369260668754578,0.07629933208227158,0,0.8014118671417236,0.18585358560085297,0,0.9699039544070311,0.030096045592968856,0
1045,2022/06/16、内服は終了した。,0 0 0 内服 終了 する た,0,0.9905611235418559,0.009438876458144245,0,7.280649991634821e-05,0.9999271935000836,0,0.8850764024200877,0.11492359757991234,0,0.9943485300039083,0.0056514699960916875,0,0.9429823756217957,0.06848637014627457,0,0.8361210227012634,0.1968345195055008,0,0.9628130094285633,0.03718699057143673,0
1046,2022/06/16歩行訓練まで回復。,0 0 0 歩行 訓練 回復,0,0.9924979750497511,0.0075020249502489155,0,8.223999017255844e-05,0.9999177600098275,0,0.9147004300548427,0.08529956994515735,0,0.9999999990386054,9.613946111223842e-10,0,0.927124559879303,0.06824007630348206,0,0.777880847454071,0.2073417454957962,0,0.9624563650090365,0.037543634990963394,0
1047,2022/06/24、症状は消失した。,0 0 0 症状 消失 する た,0,0.99657420993234,0.0034257900676600635,0,8.473010301905078e-05,0.999915269896981,0,0.9363765232310574,0.06362347676894262,0,0.9269954322911385,0.07300456770886157,0,0.9402814507484436,0.06789594143629074,0,0.8233787417411804,0.1771208643913269,0,0.9622651213879748,0.03773487861202514,0
1048,2022/06/28現在も経過観察中。,0 0 0 現在 経過 観察 中,0,0.9845849620980799,0.01541503790192018,0,0.00010768413418958447,0.9998923158658104,0,0.8312685256426806,0.16873147435731933,0,0.9999986677435975,1.3322564024931667e-06,0,0.9278461933135986,0.06783349812030792,0,0.7892979383468628,0.23909243941307068,0,0.9544418798274421,0.04555812017255793,0
1049,2022/07/01症状再燃なく退院。,0 0 0 症状再燃 ない 退院,0,0.9998197784120009,0.00018022158799924524,0,5.856426091942921e-05,0.9999414357390806,0,0.9855043613746776,0.014495638625322492,0,0.9999999999999999,6.83357188248864e-17,0,0.938474714756012,0.06785282492637634,0,0.8321593999862671,0.17299260199069977,0,0.9707035308419744,0.02929646915802564,0
1050,5月、維持療法のプレドニンは終了した。,0 月 維持 療法 プレドニン 終了 する た,0,0.9845914693197014,0.015408530680298611,0,6.725031279451766e-05,0.9999327496872055,0,0.6056317871588066,0.39436821284119344,0,0.900347807702474,0.09965219229752595,0,0.9372208118438721,0.06417273730039597,0,0.8391395807266235,0.18939965963363647,0,0.9244262744865237,0.07557372551347616,0
1051,COVID-19は発症していなかった。,COVID 0 発症 する いる ない た,0,0.9805672342141424,0.01943276578585763,0,9.913919457148569e-05,0.9999008608054285,0,0.9720109270913136,0.0279890729086863,0,0.999623257033049,0.0003767429669509903,0,0.9469928741455078,0.06319883465766907,0,0.8321499824523926,0.16765674948692322,0,0.9693171618839274,0.030682838116072593,0
1052,CTにてすべての結石排石が確認された。,C，T すべて 結石 排石 確認 する れる た,0,0.9368715178344192,0.06312848216558083,0,0.0001148701681266054,0.9998851298318734,1,0.4692617135814625,0.5307382864185375,1,0.30628516527253136,0.6937148347274686,0,0.8493589758872986,0.17220699787139893,0,0.8179847002029419,0.20958289504051208,1,0.670538212674767,0.32946178732523296,0
1053,HC補充開始1週間後、症状は消失した。,HC 補充 開始 0 週間 後 症状 消失 する た,0,0.9962855480004686,0.0037144519995311546,0,6.696311799069048e-05,0.9999330368820093,0,0.9786622639897908,0.02133773601020915,1,0.43019079484630585,0.5698092051536942,0,0.9422507882118225,0.07338564842939377,0,0.829382061958313,0.1589413434267044,1,0.9129117304429973,0.08708826955700275,0
1054,SARS-CoV-2 PCR検査陰性。,SARS CoV 0 PCR検査 陰性,0,0.9969848216024887,0.0030151783975113427,0,4.968625258889994e-05,0.9999503137474111,0,0.9566003223203415,0.04339967767965849,0,1.0,4.435482889524018e-22,0,0.9281108975410461,0.08258571475744247,0,0.8145492076873779,0.2055244743824005,0,0.9664897579447689,0.033510242055231176,0
1055,アシクロビル750 mg/日投与開始。,アシクロビル 0 mg 日 投与 開始,0,0.9967942870126333,0.003205712987366616,0,6.206457519208838e-05,0.9999379354248079,0,0.9950031987017084,0.004996801298291586,0,0.998820902093337,0.0011790979066630943,0,0.9217294454574585,0.08958391100168228,0,0.822719395160675,0.20501159131526947,0,0.9686659437211682,0.03133405627883172,0
1056,その後は、動悸ある日とない日があった。,その後 動悸 ある日 ない 日 ある た,0,0.9798405326126683,0.020159467387331532,0,0.00011100804974189207,0.9998889919502582,0,0.7999337173899989,0.20006628261000117,0,0.888281250570583,0.11171874942941695,1,0.33184435963630676,0.7489334940910339,1,0.3760297894477844,0.7506873607635498,1,0.6328786642245149,0.3671213357754851,0
1057,ハプトグロビン:正常(正常)正常範囲。,ハプトグロビン 正常 正常 正常範囲,0,0.9961123192953878,0.003887680704612227,0,5.638042794398634e-05,0.999943619572056,0,0.9923758882265481,0.0076241117734518575,0,1.0,1.0522631782319064e-23,0,0.9098625779151917,0.09095341712236404,0,0.8233869075775146,0.21846498548984528,0,0.9677332832838916,0.032266716716108264,0
1058,ヘパリンの投与歴なし(報告のとおり)。,ヘパリン 投与歴なし 報告 とおり,0,0.9845945204158743,0.015405479584125685,0,9.246618879974951e-05,0.9999075338112002,1,0.47051884239184383,0.5294811576081562,0,0.9999999999833439,1.665611881034448e-11,0,0.9353085160255432,0.0605095811188221,0,0.8372623920440674,0.27209192514419556,1,0.9129645114529907,0.08703548854700925,0
1059,遺伝子検査などを実施したが、原因不明。,遺伝子検査 実施 する た 原因 不明,0,0.9968935963273777,0.0031064036726223157,0,7.205957183014455e-05,0.9999279404281699,0,0.9617657470316893,0.03823425296831077,0,0.9993185790765569,0.0006814209234431117,0,0.9293280243873596,0.07556170970201492,0,0.786486804485321,0.20251771807670593,0,0.9662302055134543,0.03376979448654577,0
1060,一方、心電図ではSTに変化はなかった。,心電図 ST 変化 ない た,0,0.9987219262880501,0.0012780737119497845,0,5.503282882666304e-05,0.9999449671711733,0,0.9872581054821963,0.012741894517803708,0,0.9996550668574663,0.00034493314253371564,0,0.9353808760643005,0.053573619574308395,0,0.8492763042449951,0.16690917313098907,0,0.9716826522600428,0.028317347739957154,0
1061,右瞳孔散大の程度は改善傾向が見られた。,右瞳孔散大 程度 改善 傾向 見る られる た,0,0.9890748373235773,0.010925162676422831,0,8.300723778871606e-05,0.9999169927622112,0,0.9870295895160052,0.012970410483994811,0,0.625448367836763,0.37455163216323695,0,0.9289535880088806,0.0918586477637291,0,0.7673776745796204,0.31578901410102844,0,0.9235759220513585,0.07642407794864152,0
1062,患者の健忘症状は12時間後に改善した。,患者 健忘症状 0時 間 後 改善 する た,0,0.9815167840273273,0.018483215972672704,0,0.00010660861701198814,0.999893391382988,0,0.9614759592338245,0.0385240407661756,0,0.8753702479681954,0.12462975203180462,0,0.9321366548538208,0.09193410724401474,0,0.8281391263008118,0.15832668542861938,0,0.9587885404403231,0.04121145955967691,0
1063,患者の病歴と併用薬は報告されなかった。,患者 病歴 併用 薬 報告 する れる ない た,0,0.9998806863752753,0.00011931362472460758,0,6.0545302723149435e-05,0.9999394546972769,0,0.9966495222950178,0.003350477704982181,0,0.9978817134866208,0.002118286513379196,0,0.9572451114654541,0.055237773805856705,0,0.829555094242096,0.1443023532629013,0,0.9727799750829536,0.027220024917046403,0
1064,患者は会社へ提出する診断書を希望した。,患者 会社 提出 する 診断 書 希望 する た,0,0.984576959400796,0.01542304059920399,0,0.00012253649452932398,0.9998774635054707,1,0.11078557214837481,0.8892144278516252,0,0.770374837043216,0.229625162956784,0,0.9151351451873779,0.12475401908159256,0,0.7115719318389893,0.4263222813606262,1,0.6915446432285693,0.30845535677143066,0
1065,患者は他に併存疾患を有していなかった。,患者 他 併存疾患 有す いる ない た,0,0.9988333696710772,0.0011666303289227292,0,6.937433015065816e-05,0.9999306256698494,0,0.9886589693568544,0.011341030643145645,0,0.9934123214353427,0.006587678564657275,0,0.9550607204437256,0.049034688621759415,0,0.8207648992538452,0.14948447048664093,0,0.9717842787370484,0.028215721262951625,0
1066,患者は発熱及び頭痛は来していなかった。,患者 発熱 頭痛 来す いる ない た,0,0.9845632932522903,0.015436706747709743,0,9.721172886359853e-05,0.9999027882711364,0,0.9013490716032654,0.09865092839673459,0,0.9918302870709057,0.008169712929094297,0,0.9509456157684326,0.07136218249797821,0,0.8282482028007507,0.16670982539653778,0,0.9643189215319584,0.0356810784680417,0
1067,胸骨圧迫、気管挿管、アドレナリン投与。,胸骨圧迫 気管挿管 アドレナリン 投与,0,0.9845660322241997,0.015433967775800316,0,0.00010006345632230618,0.9998999365436777,0,0.9371363224023153,0.06286367759768478,0,0.9967918070502046,0.003208192949795338,0,0.8718553781509399,0.17501693964004517,1,0.49350792169570923,0.5197030305862427,1,0.9246890363236704,0.07531096367632957,0
1068,胸部X線:急性肺疾患は認めず(正常)。,胸部 X線 急性 肺疾患 認める ぬ 正常,0,0.9979156868305635,0.002084313169436415,0,0.00011334184020853839,0.9998866581597915,0,0.970630313897302,0.029369686102698012,0,0.99999999999898,1.0199700943048978e-12,0,0.9383370876312256,0.1032835990190506,0,0.7263333797454834,0.392964243888855,0,0.9571289482026516,0.04287105179734835,0
1069,胸部X線検査で血栓・塞栓症の所見なし。,胸部 X線検査 だ 血栓 塞栓症 所見 ない,0,0.9964074380278369,0.003592561972163053,0,7.911656613328182e-05,0.9999208834338668,0,0.9900359907479899,0.009964009252010136,0,0.9995080700471655,0.0004919299528345358,0,0.9385830163955688,0.06459798663854599,0,0.8519539833068848,0.16530795395374298,0,0.9716037866214383,0.028396213378561574,0
1070,経過観察後10分ほどで意識レベル回復。,経過 観察 後 0分 だ 意識レベル 回復,0,0.9885372004145488,0.011462799585451178,0,5.93803644923346e-05,0.9999406196355076,0,0.9833283424380704,0.0166716575619296,0,0.9999999818414511,1.815854891465525e-08,0,0.9286098480224609,0.08862251043319702,0,0.8143242597579956,0.22567157447338104,0,0.966833623927984,0.03316637607201599,0
1071,幸いに、心膜炎の再発は発生していない。,心膜炎 再発 発生 する いる ない,0,0.9845654732775668,0.01543452672243321,0,9.20478313167522e-05,0.9999079521686832,0,0.9680992472547998,0.031900752745200225,0,0.9144929990975689,0.08550700090243116,0,0.9442598223686218,0.0731605812907219,0,0.7843055129051208,0.2164904922246933,0,0.9598214419103926,0.04017855808960739,0
1072,左室造影検査ではたこつぼ心筋症を否定。,左 室 造影 検査 たこつぼ 心筋症 否定,0,0.9845442407719589,0.015455759228041249,0,0.0001295241619406042,0.9998704758380594,0,0.879439001015042,0.12056099898495795,0,0.9992967143812794,0.0007032856187206114,0,0.8978670835494995,0.13438835740089417,0,0.6037774085998535,0.4579170346260071,0,0.9331527075811561,0.06684729241884392,0
1073,左心室(LV)収縮機能は保たれていた。,左心室 LV 収縮 機能 保つ れる いる た,0,0.7118682343621157,0.2881317656378845,0,0.00012414499485081492,0.9998758550051492,1,0.41536261573246913,0.5846373842675309,0,0.7416871249119101,0.2583128750880899,0,0.7427718639373779,0.4244421720504761,0,0.8002227544784546,0.20909523963928223,1,0.6564562196436416,0.3435437803563584,0
1074,治験薬に関する情報は報告されなかった。,治験 薬 情報 報告 する れる ない た,0,0.99987929696592,0.00012070303407983632,0,5.474220980424811e-05,0.9999452577901957,0,0.9931120127654899,0.0068879872345100936,0,0.9959223999358597,0.004077600064140228,0,0.947810173034668,0.052840836346149445,0,0.8348687887191772,0.14567604660987854,0,0.9724039587089477,0.02759604129105219,0
1075,診察で症状は改善されたため終診とした。,診察 症状 改善 する れる た ため 終 診る する た,0,0.9845872743544809,0.015412725645519128,0,8.072636060333849e-05,0.9999192736393967,0,0.9358348570742988,0.06416514292570123,1,0.33696650394661765,0.6630334960533824,0,0.9474746584892273,0.0814950168132782,0,0.8118466734886169,0.1953045129776001,1,0.8805301915194852,0.11946980848051475,0
1076,接種から6日後(初回)にMRIは陰性。,接種 0 日 後 初回 MRI 陰性,0,0.98745089591364,0.012549104086360091,0,7.779628919234376e-05,0.9999222037108076,0,0.9649726850788849,0.03502731492111513,0,0.9999999021858292,9.781417080922497e-08,0,0.9155511856079102,0.08833543956279755,0,0.8288145661354065,0.1749667376279831,0,0.9672662181976879,0.032733781802312185,0
1077,接種後15分間の経過観察時も異常なし。,接種 後 0分 間 経過 観察 時 異常 ない,0,0.9778510537790467,0.022148946220953276,0,7.042354213565657e-05,0.9999295764578643,0,0.9934503349382129,0.0065496650617871514,0,0.9809525836970694,0.01904741630293066,0,0.9408960938453674,0.077888123691082,0,0.8292496204376221,0.14883585274219513,0,0.9691735475927601,0.030826452407239954,0
1078,接種後26日目、蛋白尿は未治療で回復。,接種 後 0 日 目 蛋白尿 治療 だ 回復,0,0.9845611862461503,0.015438813753849739,0,8.125879111588062e-05,0.9999187412088841,0,0.9565447541034298,0.043455245896570266,0,0.9999999769566282,2.3043371714355112e-08,0,0.9324895739555359,0.08767148107290268,0,0.7621853351593018,0.3296157717704773,0,0.9592916535948541,0.04070834640514581,0
1079,点滴、内服加療受けるも改善しなかった。,点滴 内服 加療 受ける 改善 する ない た,0,0.9999748139431754,2.518605682461574e-05,0,3.630735618162171e-05,0.9999636926438183,0,0.9973432794792001,0.002656720520799916,0,0.9979105590460914,0.002089440953908584,0,0.9480043649673462,0.05225132778286934,0,0.7591348886489868,0.24722693860530853,0,0.9676479488136602,0.03235205118633979,0
1080,日付不明頭部MRI検査では病変認めず。,日付 不明 頭部 MRI 検査 病変 認める ぬ,0,0.9717671861884695,0.028232813811530443,0,0.00012644880601948855,0.9998735511939805,0,0.8481923623412707,0.1518076376587293,0,0.9997346222936284,0.00026537770637158657,0,0.7343235015869141,0.43362295627593994,1,0.5431121587753296,0.6312147378921509,1,0.8643897970576152,0.13561020294238482,0
1081,壁運動スコア指数:局所壁運動異常なし。,壁 運動 スコア 指数 局所壁運動 異常 ない,0,0.9845696362085922,0.015430363791407813,0,8.301792137266438e-05,0.9999169820786273,0,0.8454964221087805,0.15450357789121946,0,0.9072055929463729,0.09279440705362708,0,0.9298628568649292,0.08542823791503906,0,0.8187944293022156,0.17889179289340973,0,0.9506893182514986,0.049310681748501416,0
1082,報告者の協力が得られず、追跡調査不能。,報告 者 協力 得る られる ぬ 追跡調査 不能,0,0.9845791088027596,0.015420891197240433,0,8.666647718116223e-05,0.9999133335228189,1,0.45342053495279067,0.5465794650472093,0,0.9922026326608208,0.007797367339179246,0,0.9310958981513977,0.11770641058683395,0,0.8065922856330872,0.17649702727794647,1,0.9092129459412378,0.09078705405876224,0
1083,臨床検査データ/結果は得られていない。,臨床検査 データ 結果 得る られる いる ない,0,0.9845667582098208,0.015433241790179339,0,7.67029835472436e-05,0.9999232970164528,0,0.9442576256198851,0.0557423743801149,0,0.8840813020665265,0.11591869793347356,0,0.9536591172218323,0.07002580165863037,0,0.8229151964187622,0.1697436273097992,0,0.959408943909906,0.04059105609009399,0
1084,(日付不明)変化なし注:以前の検査より,日付 不明 変化 ない 以前 検査,0,0.9845735990936275,0.01542640090637248,0,5.873487872334034e-05,0.9999412651212767,0,0.9848097765941376,0.01519022340586235,0,0.9999999999996838,3.1621774779402245e-13,0,0.9394738674163818,0.06185077503323555,0,0.8295853137969971,0.2035912424325943,0,0.9690067273526439,0.03099327264735612,0
1085,他疾患など、他要因の可能性はなかった。,疾患 要因 の 可能性 ない た,0,0.9963850491082689,0.003614950891731146,0,7.849333467341135e-05,0.9999215066653266,0,0.975389400900256,0.024610599099743974,0,0.992549118645351,0.007450881354648942,0,0.9417458772659302,0.05427755415439606,0,0.83879554271698,0.1541263610124588,0,0.9707145495638144,0.029285450436185648,0
1086,症状は自然に経過して、正常化していた。,症状 自然 経過 する 正常 化 する いる た,0,0.9891260589220835,0.010873941077916399,0,7.644507369195593e-05,0.999923554926308,0,0.995206750321333,0.0047932496786669615,0,0.8843237767471348,0.11567622325286514,0,0.9490976333618164,0.05807797983288765,0,0.8411809206008911,0.17486119270324707,0,0.964250176344457,0.03574982365554302,0
1087,集中治療室(ICU)の入室はなかった。,集中治療室 ICU 入室 ない た,0,0.998396339063708,0.0016036609362921198,0,6.497005578474601e-05,0.9999350299442152,0,0.9762142247222021,0.023785775277797884,0,0.9965874752952463,0.0034125247047537824,0,0.9478930234909058,0.05341053009033203,0,0.8363939523696899,0.15175983309745789,0,0.9712973341604331,0.02870266583956691,0
1088,有害事象発症時の内服薬は不明であった。,有害事象 発症 時 内服薬 不明 だ ある た,0,0.9857131740126928,0.014286825987307298,0,6.406400009633695e-05,0.9999359359999037,0,0.9688847961571054,0.03111520384289461,0,0.9453939481644485,0.05460605183555149,0,0.9339712858200073,0.07136361300945282,0,0.8390057682991028,0.16135577857494354,0,0.9657880574424175,0.03421194255758259,0
1089,人工呼吸器とECMOは使用しなかった。,人工呼吸器 ECMO 使用 する ない た,0,0.9998232726863061,0.000176727313693852,0,5.0203342670162665e-05,0.9999497966573299,0,0.9933914285537546,0.006608571446245387,0,0.9995950730149293,0.0004049269850706125,0,0.949370265007019,0.053820524364709854,0,0.8338790535926819,0.15117721259593964,0,0.9724541633406668,0.02754583665933321,0
1090,病理組織学的検査は、実施されなかった。,病理 組織 学 的 検査 実施 する れる ない た,0,0.9996269936204221,0.00037300637957785385,0,5.626576066660986e-05,0.9999437342393334,0,0.9874451847732418,0.01255481522675814,0,0.9959182098308872,0.0040817901691128245,0,0.9498389363288879,0.05805223807692528,0,0.8226318359375,0.13859331607818604,0,0.9718572326901334,0.02814276730986673,0
1091,直近の冠動脈検査は、実施されなかった。,直近 冠動脈 検査 実施 する れる ない た,0,0.9999466134315369,5.338656846315325e-05,0,5.0926568599954176e-05,0.9999490734314,0,0.9860224267302892,0.013977573269710813,0,0.9976814597675561,0.0023185402324439742,0,0.9549008011817932,0.0602075420320034,0,0.8370323777198792,0.15392734110355377,0,0.97194687595726,0.028053124042739883,0
1092,ワクチン接種時点の体温は不明であった。,ワクチン接種 時点 体温 不明 だ ある た,0,0.9984205568782086,0.0015794431217913902,0,6.08968340135818e-05,0.9999391031659864,0,0.9865641045560012,0.013435895443998772,0,0.9443647434920392,0.05563525650796078,0,0.9341821074485779,0.05903840810060501,0,0.8500714302062988,0.19556955993175507,0,0.9673421237671612,0.032657876232838896,0
1093,ワクチン接種後、特に変わりはなかった。,ワクチン接種 後 変わる ない た,0,0.998298595906325,0.0017014040936748937,0,6.321657932908522e-05,0.9999367834206709,0,0.9837495366257796,0.016250463374220408,0,0.9978346508907426,0.0021653491092573506,0,0.9462368488311768,0.05031450092792511,0,0.8526111245155334,0.15721891820430756,0,0.972110156953872,0.027889843046127828,0
1094,集中治療室(ICU)入室はしなかった。,集中治療室 ICU 入室 する ない た,0,0.99903380836061,0.0009661916393900329,0,7.102170482446845e-05,0.9999289782951756,0,0.982763423464673,0.017236576535326953,0,0.998169350649827,0.001830649350172955,0,0.9535841345787048,0.057090066373348236,0,0.833687961101532,0.14837166666984558,0,0.971856331329767,0.028143668670232998,0
1095,2022/03、MRI検査:異常なし。,0 0 MRI 検査 異常 ない,0,0.995711510991209,0.004288489008790961,0,5.806407308237309e-05,0.9999419359269176,0,0.9930424838959437,0.006957516104056214,0,0.9999999999971794,2.820587504120793e-12,0,0.9350486993789673,0.058868952095508575,0,0.8363511562347412,0.1653207242488861,0,0.9713861803379913,0.028613819662008686,0
1096,ESR(1時間値)は実施されなかった。,ESR 0時 間 値 実施 する れる ない た,0,0.9993051191700428,0.0006948808299571392,0,7.704149229120765e-05,0.9999229585077088,0,0.9727294593728371,0.027270540627162932,0,0.9977607881449374,0.0022392118550625647,0,0.9467201828956604,0.0577952116727829,0,0.8357359170913696,0.14597207307815552,0,0.9712077356048101,0.028792264395189848,0
1097,患者は病理組織学的検査を受けなかった。,患者 病理 組織 学 的 検査 受ける ない た,0,0.9973981837082927,0.0026018162917072125,0,6.442741027283765e-05,0.9999355725897272,0,0.991896321781996,0.008103678218003958,0,0.9988638606679954,0.0011361393320046319,0,0.950577437877655,0.05341610684990883,0,0.8232435584068298,0.14137864112854004,0,0.9722255646876424,0.027774435312357543,0
1098,合併症、アレルギー、既往歴はなかった。,合併症 アレルギー 既往 歴 ない た,0,0.9983866565200719,0.0016133434799280595,0,6.054807380813628e-05,0.9999394519261918,0,0.9908703085539522,0.009129691446047762,0,0.9954448754163169,0.0045551245836831025,0,0.9470398426055908,0.051217611879110336,0,0.8471864461898804,0.15726938843727112,0,0.9722199537249364,0.02778004627506352,0
1099,ワクチン接種の影響は否定できなかった。,ワクチン接種 影響 否定 できる ない た,0,0.9991264986596585,0.0008735013403415431,0,5.754227956820246e-05,0.9999424577204318,0,0.9832561732161861,0.01674382678381389,0,0.9984098190217084,0.0015901809782915286,0,0.9434416890144348,0.05276131629943848,0,0.7886024713516235,0.27507659792900085,0,0.9666218642806559,0.033378135719344094,0
1100,一次感染部位および素因は不明であった。,一 次感染 部位 素因 不明 だ ある た,0,0.9845556619559713,0.015444338044028791,0,7.483032462742e-05,0.9999251696753726,0,0.8622345698387102,0.13776543016128978,0,0.8088575304059613,0.19114246959403872,0,0.9336303472518921,0.08203893154859543,0,0.8366686701774597,0.17955385148525238,0,0.9437551045241973,0.05624489547580282,0
1101,画像検査:心臓MRIは未実施であった。,画像 検査 心臓 MRI 実施 だ ある た,0,0.9777399466748804,0.022260053325119728,0,7.232197320863717e-05,0.9999276780267914,0,0.9880771408311765,0.011922859168823526,0,0.9886155015915963,0.011384498408403703,0,0.9442819356918335,0.05818840488791466,0,0.8443355560302734,0.17406117916107178,0,0.9696864431001616,0.030313556899838334,0
1102,アレルギーおよび過去の病歴はなかった。,アレルギー 過去 病歴 ない た,0,0.9970379376113809,0.002962062388619043,0,6.834517904447344e-05,0.9999316548209555,0,0.9741827841769427,0.025817215823057262,0,0.9987154879066638,0.0012845120933362047,0,0.9449670910835266,0.0539034865796566,0,0.8561970591545105,0.16404537856578827,0,0.97134139901706,0.02865860098294002,0
1103,日付不明喀痰培養:正常細菌叢(正常)。,日付 不明 喀痰 培養 正常細菌叢 正常,0,0.984546359658842,0.015453640341158027,0,7.886345772916111e-05,0.9999211365422709,0,0.9839321766016474,0.016067823398352533,0,0.9999999999997111,2.8885597791524004e-13,0,0.9295498132705688,0.07452768087387085,0,0.8286891579627991,0.17694911360740662,0,0.9690480134168572,0.030951986583142667,0
1104,2022/06/22、患者は退院した。,0 0 0 患者 退院 する た,0,0.9947928439057093,0.005207156094290764,0,8.547088323567997e-05,0.9999145291167644,0,0.9882658987270558,0.011734101272944135,0,0.9992366647918358,0.0007633352081641496,0,0.9357202053070068,0.07339093834161758,0,0.8088247776031494,0.20047923922538757,0,0.9687938472360068,0.031206152763993196,0
1105,"2021/10/28,患者は退院した。",0 0 0 患者 退院 する た,0,0.9947928439057093,0.005207156094290764,0,8.547088323567997e-05,0.9999145291167644,0,0.9882658987270558,0.011734101272944135,0,0.9992366647918358,0.0007633352081641496,0,0.9357202053070068,0.07339093834161758,0,0.8088247776031494,0.20047923922538757,0,0.9687938472360068,0.031206152763993196,0
1106,心膜炎調査票の病理組織学検査:未実施。,心膜炎 調査 票 病理 組織 学 検査 実施,0,0.984565293304819,0.015434706695180897,0,7.128332369048045e-05,0.9999287166763096,0,0.9395639337057744,0.06043606629422555,0,0.9229527956728055,0.07704720432719445,0,0.9123054146766663,0.16371960937976837,0,0.8071516156196594,0.2193409502506256,0,0.953942073881703,0.04605792611829696,0
1107,患者は他のワクチン接種を受けなかった。,患者 他 ワクチン接種 受ける ない た,0,0.9998871703699111,0.00011282963008892152,0,5.3007560872233134e-05,0.9999469924391278,0,0.9972817124487706,0.0027182875512293788,0,0.999836698069526,0.000163301930473953,0,0.9497140645980835,0.05285709723830223,0,0.8386891484260559,0.14322000741958618,0,0.9730497669829083,0.026950233017091735,0
1108,血圧測定:血圧低下は観察されなかった。,血圧 測定 血圧低下 観察 する れる ない た,0,0.9912698006095054,0.008730199390494523,0,6.703592179540587e-05,0.9999329640782046,0,0.9767170597020278,0.023282940297972166,0,0.996321346715909,0.003678653284090993,0,0.9573948979377747,0.05751597136259079,0,0.8248542547225952,0.16454528272151947,0,0.9703713888079518,0.029628611192048196,0
1109,同日の頭部CTでは特記所見はなかった。,同日 頭部 CT 特記 所見 ない た,0,0.999534636147416,0.0004653638525839491,0,4.930780779463282e-05,0.9999506921922053,0,0.9939045867220778,0.0060954132779221844,0,0.9974215950125338,0.0025784049874662497,0,0.9528740048408508,0.064993716776371,0,0.8063694834709167,0.18579895794391632,0,0.9704096803716,0.029590319628399905,0
1110,今日の予防接種について質問はなかった。,今日 予防接種 質問 ない た,0,0.9957308550064649,0.004269144993535211,0,7.794821871984e-05,0.9999220517812801,0,0.9624138043385085,0.037586195661491476,0,0.9972039586042993,0.0027960413957006875,0,0.9494574069976807,0.06149463355541229,0,0.8315944671630859,0.24053624272346497,0,0.9673865737615716,0.03261342623842847,0
1111,その他の事象の転帰は報告されなかった。,その他 事象 転帰 報告 する れる ない た,0,0.9996963912122866,0.0003036087877133545,0,5.958265268155344e-05,0.9999404173473184,0,0.9907852026929654,0.009214797307034554,0,0.9977754494007871,0.0022245505992128708,0,0.9528658390045166,0.05455531179904938,0,0.8124553561210632,0.14289286732673645,0,0.9719279230197081,0.028072076980291946,0
1112,心筋炎調査票、病理組織学検査:未実施。,心筋炎 調査 票 病理 組織 学 検査 実施,0,0.9845790904848674,0.015420909515132558,0,7.45062919970283e-05,0.999925493708003,0,0.8889170823100294,0.11108291768997063,0,0.9412820878666435,0.05871791213335654,0,0.8938992619514465,0.19940336048603058,0,0.8076449036598206,0.22132964432239532,0,0.9483638728524528,0.05163612714754716,0
1113,さらなる以上の追加情報は期待できない。,以上 追加 情報 期待 できる ない,0,0.984570621752121,0.015429378247879056,0,7.475265975749833e-05,0.9999252473402425,0,0.9737266127202857,0.026273387279714327,0,0.9494479945097912,0.050552005490208746,0,0.9544537663459778,0.0702870562672615,0,0.8067448735237122,0.17000871896743774,0,0.9656613886795533,0.0343386113204467,0
1114,事象は救急救命室受診の必要はなかった。,事象 救急救命室 受診 必要 ない た,0,0.9951938528743502,0.004806147125649887,0,7.193886994525704e-05,0.9999280611300547,0,0.9504903345372023,0.04950966546279766,0,0.9963383257017968,0.0036616742982031624,0,0.9494109749794006,0.0546736977994442,0,0.8233785033226013,0.1520872861146927,0,0.969237623264968,0.030762376735032106,0
1115,活性化部分トロンボプラスチン時間:正常,活性化部分トロンボプラスチン時間 正常,0,0.9933513892246802,0.006648610775319758,0,7.446679498737774e-05,0.9999255332050127,0,0.9923758882265481,0.0076241117734518575,0,1.0,2.239585986061056e-20,0,0.9142754673957825,0.07127628475427628,0,0.7937011122703552,0.28709399700164795,0,0.965149306898531,0.034850693101469106,0
1116,アレルギーや有害事象の病歴はなかった。,アレルギー 有害事象 病歴 ない た,0,0.9989056358611942,0.001094364138805657,0,5.0092724499372944e-05,0.9999499072755006,0,0.9741827841769427,0.025817215823057262,0,0.9991818651689041,0.0008181348310959886,0,0.9505111575126648,0.055920105427503586,0,0.8547744750976562,0.16133052110671997,0,0.9716033306139389,0.028396669386061116,0
1117,副作用歴があるかどうかは不明であった。,副作用 歴 ある 不明 だ ある た,0,0.9983988265134576,0.0016011734865423765,0,7.755216140700372e-05,0.999922447838593,0,0.9913526279184829,0.008647372081517113,0,0.9970037682684196,0.0029962317315803985,0,0.9473034739494324,0.06933549046516418,0,0.8333616852760315,0.19964540004730225,0,0.970268040482471,0.029731959517529147,0
1118,2022/01/23に事象は回復した。,0 0 0 事象 回復 する た,0,0.998518058738517,0.0014819412614830575,0,5.677558971083843e-05,0.9999432244102892,0,0.9861653265762715,0.013834673423728508,0,0.9929502406270058,0.007049759372994241,0,0.9360530376434326,0.07062216103076935,0,0.8270081281661987,0.15963710844516754,0,0.9703496545657546,0.029650345434245474,0
1119,IVCY療法は計4回投与後に完了した。,IVCY 療法 0回 投与 後 完了 する た,0,0.9956440040576094,0.004355995942390525,0,5.8226543678254856e-05,0.9999417734563217,0,0.964667572986765,0.03533242701323498,0,0.9951422086382022,0.004857791361797811,0,0.9461029767990112,0.06823716312646866,0,0.8299708366394043,0.17370444536209106,0,0.9690863602734808,0.030913639726519122,0
1120,SARS-CoV-2検査は実施された。,SARS CoV 0 検査 実施 する れる た,0,0.9951239070289998,0.004876092971000125,0,9.2264306786873e-05,0.9999077356932131,0,0.973163324338542,0.026836675661457938,0,0.990753425250073,0.00924657474992698,0,0.932911217212677,0.10799425840377808,0,0.8276199698448181,0.18838448822498322,0,0.9671505218282126,0.032849478171787315,0
1121,インチュニブ内服のみ退院後再開された。,インチュニブ 内服 退院後 再開 する れる た,0,0.9845911036767675,0.015408896323232493,0,8.186070141460518e-05,0.9999181392985854,0,0.8861310416374177,0.11386895836258225,1,0.47117821733202403,0.528821782667976,0,0.9407650232315063,0.06777135282754898,0,0.8212496638298035,0.19221241772174835,1,0.8989848215332502,0.10101517846674979,0
1122,クロザピンのための処置は不明であった。,クロザピン ため 処置 不明 だ ある た,0,0.9845660063931235,0.015433993606876332,0,0.00010509115796134644,0.9998949088420387,0,0.9484124433494461,0.051587556650553944,0,0.9674885669873425,0.03251143301265742,0,0.9387406706809998,0.0622757263481617,0,0.8295128345489502,0.22257372736930847,0,0.9638949046326527,0.03610509536734736,0
1123,患者はステロイド後に症状から回復した。,患者 ステロイド 後 症状 回復 する た,0,0.9993297423911855,0.0006702576088144822,0,4.750504646328801e-05,0.9999524949535367,0,0.99902562976416,0.0009743702358400105,0,0.9874351729707304,0.012564827029269613,0,0.9382120370864868,0.05399153754115105,0,0.8343932628631592,0.16903533041477203,0,0.971286512448848,0.028713487551151932,0
1124,血圧、SpO2の低下はみられなかった。,血圧 SpO 0 低下 みる られる ない た,0,0.9736302429194891,0.026369757080510862,0,0.00015353253002805105,0.999846467469972,0,0.8976298360939591,0.1023701639060409,0,0.9945290358736103,0.005470964126389709,0,0.9374327063560486,0.07799345999956131,0,0.8316658139228821,0.1862802803516388,0,0.9621926104367133,0.03780738956328659,0
1125,心血管造影:(日付不明)有意な狭窄なし,心 血管造影 日付 不明 有意 だ 狭窄 ない,0,0.9974224538855349,0.0025775461144651474,0,6.444736274598398e-05,0.999935552637254,0,0.9626625243283149,0.03733747567168513,0,0.9997039036734777,0.00029609632652229497,0,0.9438051581382751,0.07168198376893997,0,0.8417876958847046,0.171847864985466,0,0.9695802053574228,0.030419794642577127,0
1126,洞調律は復帰し心不全改善傾向となった。,洞調律 復帰 する 心不全 改善 傾向 なる た,0,0.998282128203507,0.0017178717964928915,0,6.0964615807405964e-05,0.9999390353841926,0,0.9901575110463623,0.009842488953637714,0,0.6709736239598685,0.3290263760401315,0,0.9419028759002686,0.06546728312969208,0,0.8091637492179871,0.1956273466348648,0,0.9431559692424866,0.056844030757513306,0
1127,被験者は集中治療室に収容されなかった。,被験者 集中治療室 収容 する れる ない た,0,0.9966184883586775,0.003381511641322464,0,7.982402451244333e-05,0.9999201759754875,0,0.9664774410145305,0.033522558985469554,0,0.9964582606780524,0.003541739321947524,0,0.9560292363166809,0.06778084486722946,0,0.8329554200172424,0.1422571986913681,0,0.9706369276732578,0.02936307232674218,0
1128,Full blood count:正常,Full BLOOD count 正常,0,0.9937986811208961,0.0062013188791038894,0,8.942937807527989e-05,0.9999105706219247,0,0.9923758882265481,0.0076241117734518575,0,1.0,1.1037087477507394e-24,0,0.925300121307373,0.09404873102903366,0,0.8071967363357544,0.20873652398586273,0,0.9677744550624393,0.03222554493756067,0
1129,SARS-CoV-2検査は陰性だった。,SARS CoV 0 検査 陰性 だ た,0,0.9988707044066474,0.0011292955933525752,0,3.85849234510802e-05,0.9999614150765489,0,0.982538992550709,0.017461007449290997,0,0.9999999593247245,4.067527546182844e-08,0,0.9270765781402588,0.06177464872598648,0,0.846363365650177,0.1690487563610077,0,0.9708442249849891,0.029155775015010814,0
1130,患者は観察期間中に授乳していなかった。,患者 観察 期間中 授乳 する いる ない た,0,0.999130749649174,0.0008692503508260603,0,5.5691868083231504e-05,0.9999443081319168,0,0.9836463926044897,0.01635360739551033,0,0.9965953937317157,0.0034046062682843406,0,0.9515321850776672,0.06229731813073158,0,0.840094804763794,0.1547810584306717,0,0.9716234454938488,0.02837655450615121,0
1131,患者は関連した病歴を持っていなかった。,患者 関連 する た 病歴 持つ いる ない た,0,0.9975286482575773,0.002471351742422614,0,6.891947476506344e-05,0.9999310805252349,0,0.9585928290216212,0.04140717097837874,0,0.9966519858119166,0.0033480141880833873,0,0.9540157318115234,0.05693221837282181,0,0.8408495187759399,0.14532139897346497,0,0.9706392577429482,0.029360742257051757,0
1132,体位性低血圧の明らかな症状はなかった。,体位 性低血圧 明らか だ 症状 ない た,0,0.9992254580721569,0.0007745419278429469,0,6.850509781799187e-05,0.999931494902182,0,0.9792046724255885,0.020795327574411472,0,0.9789006433714642,0.02109935662853579,0,0.9353904724121094,0.06241690367460251,0,0.8424093723297119,0.1705457717180252,0,0.9695172030076862,0.030482796992313717,0
1133,兆候の消失(日付不明)注:退院2ヵ月後,兆候 消失 日付 不明 注 退院 0 ヵ月 後,0,0.9935509920013706,0.006449007998629495,0,5.6855386894274874e-05,0.9999431446131057,0,0.9897315750422544,0.010268424957745657,0,0.9999999659430304,3.4056969557708573e-08,0,0.933959424495697,0.09544385969638824,0,0.8046937584877014,0.176189586520195,0,0.9687412591491402,0.03125874085085966,0
1134,内服薬は中止され、肝庇護薬を投与した。,内服薬 中止 する れる 庇護 薬 投与 する た,0,0.9987724415685003,0.0012275584314998234,0,5.8277498994203086e-05,0.9999417225010058,0,0.9918409346925865,0.008159065307413473,1,0.4846086314902128,0.5153913685097872,0,0.9385841488838196,0.07312069088220596,0,0.8092317581176758,0.2304326891899109,1,0.9164316859961915,0.08356831400380843,0
1135,日付不明、尿中ブドウ糖:陰性(陰性)。,日付 不明 尿 中 ブドウ糖 陰性 陰性,0,0.985798588908221,0.01420141109177908,0,6.459783605993028e-05,0.9999354021639401,0,0.9789029141695574,0.021097085830442532,0,1.0,1.76249784054471e-25,0,0.9091110825538635,0.0785219669342041,0,0.8332745432853699,0.19773541390895844,0,0.9675686379483535,0.032431362051646595,0
1136,本剤の処置は不明であった(報告通り)。,本 剤 処置 不明 だ ある た 報告 通り,0,0.9880247029910045,0.011975297008995614,0,0.00010354470696758267,0.9998964552930324,0,0.9628009482279373,0.0371990517720627,0,0.9999999202693454,7.973065464429184e-08,0,0.9445371031761169,0.09099353849887848,0,0.8376100063323975,0.2133052498102188,0,0.9670642599278918,0.0329357400721083,0
1137,片頭痛、2004/12/01から継続中,片頭痛 0 0 0 継続 中,0,0.9845567879575507,0.01544321204244912,0,0.0001100087518611577,0.9998899912481388,1,0.4504611047123629,0.5495388952876371,0,0.9817072757697833,0.018292724230216672,0,0.8462602496147156,0.17349421977996826,0,0.7725839018821716,0.3084200918674469,1,0.8776755653383934,0.12232443466160654,0
1138,平熱は、36.5-36.9度であった。,平熱 0 0 0 0度 だ ある た,0,0.9845556143101549,0.015444385689845033,0,9.724276434725434e-05,0.9999027572356527,0,0.6650961478368196,0.33490385216318047,0,0.7908444828951362,0.20915551710486383,0,0.8127307891845703,0.2934524714946747,0,0.8079500794410706,0.2840360701084137,0,0.872625987446273,0.12737401255372707,0
1139,両足趾を挙上し、仰臥位で経過観察した。,両足 趾 挙 上し 仰臥位 経過 観察 する た,0,0.9845932032630403,0.015406796736959756,0,8.544768762264743e-05,0.9999145523123774,1,0.45226125843102893,0.5477387415689711,1,0.20588828911033108,0.7941117108896689,0,0.9262029528617859,0.12915337085723877,0,0.7911233305931091,0.2854229509830475,1,0.6429994068722888,0.3570005931277112,0
1140,異常の出現はなく、会場を独歩退出した。,異常 出現 ない 会場 独歩 退出 する た,0,0.9845756802826502,0.015424319717349928,0,8.80245461468792e-05,0.9999119754538531,0,0.7053441255190327,0.29465587448096725,0,0.6608407600740643,0.33915923992593566,1,0.43804651498794556,0.7009239196777344,0,0.8141470551490784,0.19117051362991333,1,0.7430336742647382,0.25696632573526174,0
1141,"U- ketone body, (-)",U ketone BODY,0,0.6900391963545341,0.30996080364546597,0,0.0001274820233761314,0.9998725179766239,1,0.4563792597309324,0.5436207402690676,0,0.5195482961797382,0.48045170382026176,0,0.7702581882476807,0.37801608443260193,0,0.6659526824951172,0.409397155046463,1,0.4952466681647315,0.5047533318352685,0
1142,"Bacteria urine, (-)",BACTERIA urine,0,0.9717857773393365,0.028214222660663694,0,7.852612662116665e-05,0.9999214738733788,1,0.4563792597309324,0.5436207402690676,0,0.999999999998984,1.0159840098517063e-12,0,0.7893078923225403,0.3040286898612976,0,0.7354044914245605,0.33487778902053833,1,0.8509780888981123,0.1490219111018878,0
1143,15分間の経過観察中は著変なかった。,0分 間 経過 観察 中 著変 ない た,0,0.9971768212219339,0.0028231787780660786,0,5.922159191735396e-05,0.9999407784080826,0,0.9840229507024386,0.015977049297561368,0,0.9941740825707212,0.005825917429278901,0,0.9403123259544373,0.053811777383089066,0,0.8242115378379822,0.15667365491390228,0,0.9708269977928866,0.029173002207113347,0
1144,1回目接種時点での併用薬はなかった。,0回目 接種 時点 併用 薬 ない た,0,0.9992099863070143,0.0007900136929858393,0,6.9568237652424e-05,0.9999304317623475,0,0.9922276636064545,0.007772336393545467,0,0.9993974264937044,0.0006025735062955973,0,0.9494602680206299,0.05264173075556755,0,0.8517636656761169,0.14428631961345673,0,0.9730408989262831,0.02695910107371694,0
1145,2022/03/04 PCPS抜去。,0 0 0 PCPS 抜去,0,0.906376084375231,0.09362391562476885,0,0.00015479994160559098,0.9998452000583944,1,0.35873972300322543,0.6412602769967746,0,0.9999986437776636,1.356222336476446e-06,0,0.9052315354347229,0.09620220959186554,0,0.7702702283859253,0.20330952107906342,1,0.870628644310907,0.12937135568909292,0
1146,2022/03/08一般病棟へ転出。,0 0 0 一般 病棟 転出,0,0.9845717072428406,0.015428292757159477,0,0.00011029556471000399,0.99988970443529,1,0.35873972300322543,0.6412602769967746,0,0.9999999985249902,1.4750097506751328e-09,0,0.8453555703163147,0.19438129663467407,0,0.7850804328918457,0.2525038421154022,1,0.8665038961883932,0.1334961038116069,0
1147,2022/04/09ステロイド開始。,0 0 0 ステロイド 開始,0,0.984583429153105,0.015416570846895038,0,0.00010782446398027243,0.9998921755360197,0,0.9238020820587826,0.0761979179412174,0,0.9999999999926542,7.345774400674606e-12,0,0.9194839000701904,0.07965987175703049,0,0.8002755641937256,0.23578180372714996,0,0.9616281773235004,0.03837182267649953,0
1148,2022/04/15自宅退院となる。,0 0 0 自宅 退院 なる,0,0.9846837780024117,0.015316221997588312,0,9.655623732807484e-05,0.9999034437626719,0,0.9482490754151687,0.05175092458483131,0,0.9999999053284245,9.467157543467477e-08,0,0.92057865858078,0.10091671347618103,0,0.7923277616500854,0.22035656869411469,0,0.9629485240161737,0.0370514759838263,0
1149,B型肝炎表面抗原:陰性(陰性)陰性。,B型 肝炎 表面 抗原 陰性 陰性 陰性,0,0.9893720000863172,0.010627999913682797,0,5.5132212264242546e-05,0.9999448677877357,0,0.9748863304620521,0.02511366953794793,0,1.0,5.761928733851554e-48,0,0.9191227555274963,0.06081266328692436,0,0.828060507774353,0.189678356051445,0,0.9684865198768787,0.03151348012312127,0
1150,B型肝炎表面抗体:陰性(陰性)陰性。,B型 肝炎 表面 抗体 陰性 陰性 陰性,0,0.9970175357184364,0.002982464281563539,0,4.6873396957079224e-05,0.9999531266030429,0,0.9918597849167566,0.008140215083243404,0,1.0,5.816166515052312e-50,0,0.9151580929756165,0.06386459618806839,0,0.8266153931617737,0.18624061346054077,0,0.9698078693919239,0.030192130608076167,0
1151,アミオダロン、βblocker導入。,アミオダロン blocker 導入,0,0.9845709865647443,0.015429013435255759,0,0.00010590246231577487,0.9998940975376842,1,0.4563792597309324,0.5436207402690676,0,0.9999999804777665,1.952223348022209e-08,0,0.841830849647522,0.19055022299289703,0,0.6247245073318481,0.5041748285293579,1,0.8394231875206415,0.1605768124793586,0
1152,ステロイドについては少し様子を見た。,ステロイド 様子 見る た,0,0.9845671237151312,0.015432876284868854,0,0.00010097700638461607,0.9998990229936154,0,0.8426875841974217,0.1573124158025782,0,0.99387295498776,0.006127045012240019,0,0.9292305111885071,0.06286121904850006,0,0.7340601086616516,0.2990098297595978,0,0.9499732921499742,0.05002670785002585,0
1153,その他の画像検査は実施されなかった。,その他 画像 検査 実施 する れる ない た,0,0.9999781421200031,2.1857879996811763e-05,0,3.958733023211042e-05,0.9999604126697679,0,0.9966415069250014,0.00335849307499856,0,0.9985274657948028,0.001472534205197167,0,0.9482524394989014,0.056617993861436844,0,0.8311830759048462,0.1473340541124344,0,0.9725046209680971,0.02749537903190302,0
1154,トレポネーマ検査:陰性(陰性)陰性。,トレポネーマ 検査 陰性 陰性 陰性,0,0.9950571668208634,0.004942833179136432,0,5.175233554788462e-05,0.9999482476644521,0,0.9799639453345924,0.02003605466540755,0,1.0,7.545312485748645e-56,0,0.9283798336982727,0.06413137912750244,0,0.8408843874931335,0.1979692131280899,0,0.9694483752796766,0.030551624720323387,0
1155,冠動脈検査を実施し、有意狭窄はなし。,冠動脈 検査 実施 する 有意狭窄 ない,0,0.9995162781416155,0.00048372185838451516,0,6.989423918608612e-05,0.9999301057608139,0,0.9820288759630366,0.01797112403696342,0,0.9971933136077631,0.0028066863922369557,0,0.9488986730575562,0.06285807490348816,0,0.8339323997497559,0.18225301802158356,0,0.9705547927334063,0.02944520726659368,0
1156,患者のDダイマー値に変化はなかった。,患者 D ダイマー 値 変化 ない た,0,0.9902340374393642,0.009765962560635867,0,6.103494293817854e-05,0.9999389650570618,0,0.9784327650700544,0.021567234929945635,0,0.996280772788813,0.0037192272111869996,0,0.9332443475723267,0.05857937037944794,0,0.8444307446479797,0.15197494626045227,0,0.970606226791253,0.029393773208747014,0
1157,患者の体温は摂氏36.9度であった。,患者 体温 摂氏 0 0度 だ ある た,0,0.9845796526529469,0.01542034734705312,0,0.00013548264133961973,0.9998645173586603,0,0.8893268546379658,0.11067314536203417,0,0.7754490843854238,0.2245509156145762,0,0.8527300953865051,0.21034948527812958,0,0.8367117047309875,0.19447533786296844,0,0.929798559263621,0.07020144073637898,0
1158,頚と肩こりのため湿布を使用し、軽快。,頚 肩こり ため 湿布 使用 する 軽快,0,0.9845688056348446,0.015431194365155403,0,9.821639852234774e-05,0.9999017836014776,0,0.5490801355880511,0.45091986441194887,0,0.7797294059239369,0.22027059407606306,0,0.927969217300415,0.14221392571926117,0,0.5780695080757141,0.5647428631782532,0,0.8062827808972259,0.19371721910277406,0
1159,現在はステロイドによる治療を継続中。,現在 ステロイド 治療 継続 中,0,0.9918457001504838,0.008154299849516279,0,7.530532642103418e-05,0.9999246946735789,0,0.9498795843318393,0.05012041566816077,0,0.999999345674157,6.543258429562759e-07,0,0.9325177669525146,0.06301737576723099,0,0.7431367039680481,0.3746030330657959,0,0.9577763551786129,0.04222364482138703,0
1160,抗アレルギー薬を1錠内服させ、帰宅。,抗アレルギー 薬 0 錠 内服 する せる 帰宅,0,0.9845763150064717,0.015423684993528431,0,7.69628259887452e-05,0.9999230371740112,0,0.9925601543567302,0.007439845643269809,0,0.9896663584188662,0.010333641581133807,0,0.9298651218414307,0.08790736645460129,0,0.755402684211731,0.3479090929031372,0,0.9601975634357812,0.039802436564218786,0
1161,抗リン脂質抗体:特記すべき所見なし。,リン脂質 抗体 特記 する べし 所見 ない,0,0.9983815207933489,0.0016184792066510799,0,6.0918462838746335e-05,0.9999390815371613,0,0.9928124176641389,0.007187582335861121,0,0.9441377106753076,0.05586228932469243,0,0.9482405185699463,0.07379848510026932,0,0.8410355448722839,0.17872297763824463,0,0.9679393415280918,0.032060658471908275,0
1162,採血にてトロポニンT上昇はなかった。,採血 トロポニン T 上昇 ない た,0,0.9965468974915528,0.003453102508447307,0,6.947852805303397e-05,0.9999305214719469,0,0.9616546902150209,0.03834530978497906,0,0.9939726562117719,0.0060273437882281565,0,0.9277970194816589,0.0601351298391819,0,0.8389014005661011,0.1778358370065689,0,0.9687266111647299,0.03127338883527013,0
1163,上記薬剤以外の処置・診断はなかった。,上記 薬剤 以外 処置 診断 ない た,0,0.9845685652681906,0.015431434731809374,0,8.065332291650446e-05,0.9999193466770835,0,0.9119111417143011,0.08808885828569889,0,0.9949287969617735,0.005071203038226461,0,0.945356011390686,0.05343751981854439,0,0.8440013527870178,0.1565445512533188,0,0.9665070494684624,0.033492950531537426,0
1164,心電図、心エコーは改善傾向であった。,心電図 心 エコー 改善 傾向 だ ある た,0,0.9988439798142108,0.0011560201857891688,0,5.866867182866326e-05,0.9999413313281713,0,0.9963517420665827,0.0036482579334172283,0,0.9607250129885041,0.039274987011495864,0,0.9390034675598145,0.05731045827269554,0,0.8403636813163757,0.20455190539360046,0,0.9686127639417548,0.03138723605824513,0
1165,接種日周辺に解熱剤の使用はなかった。,接種 日 周辺 解熱 剤 使用 ない た,0,0.9975352255354777,0.0024647744645223653,0,6.122486995468368e-05,0.9999387751300454,0,0.9934220063371529,0.006577993662847089,0,0.9992688568508893,0.0007311431491107557,0,0.950579047203064,0.056632500141859055,0,0.8432843089103699,0.1489526331424713,0,0.972584618273262,0.027415381726737853,0
1166,接種日前後は解熱剤を使用しなかった。,接種 日 前後 解熱 剤 使用 する ない た,0,0.9987355210981618,0.0012644789018382136,0,6.133631646284842e-05,0.9999386636835371,0,0.9927408237456532,0.007259176254346819,0,0.9965795682877324,0.003420431712267532,0,0.9506343007087708,0.055180568248033524,0,0.8260351419448853,0.1451086848974228,0,0.9721483089179672,0.02785169108203273,0
1167,組織検体にウイルスゲノムを検出せず。,組織 検体 ウイルス ゲノム 検出 する ぬ,0,0.9845786692774339,0.015421330722566242,0,7.702579340874618e-05,0.9999229742065913,0,0.6134167641293973,0.38658323587060267,0,0.9735137403868156,0.02648625961318438,0,0.8021810054779053,0.374507874250412,0,0.8134166598320007,0.2160695493221283,0,0.8973566143429628,0.10264338565703728,0
1168,退院後、心筋トロポニンIは10未満。,退院後 心筋 トロポニン I 0 未満,0,0.9824939342873392,0.0175060657126608,0,8.222852112461159e-05,0.9999177714788754,0,0.584809662069532,0.415190337930468,0,0.9991355063035957,0.0008644936964043126,0,0.8617031574249268,0.14628276228904724,0,0.8241051435470581,0.19840289652347565,0,0.9223107495606943,0.07768925043930562,0
1169,退院時、抗原検査は実施されなかった。,退院 時 抗原検査 実施 する れる ない た,0,0.9999914258641879,8.57413581217149e-06,0,2.8346427117929715e-05,0.9999716535728821,0,0.9972645976152695,0.0027354023847304485,0,0.9980477609037026,0.0019522390962974096,0,0.9561728835105896,0.056790873408317566,0,0.8320401310920715,0.14125500619411469,0,0.9729022099427257,0.027097790057274262,0
1170,潰瘍は境界明瞭で腫瘤は認めなかった。,潰瘍 境界明瞭 だ 腫瘤 認める ない た,0,0.9845713457537343,0.01542865424626573,0,0.00010241625452763354,0.9998975837454723,0,0.8955751090722042,0.10442489092779585,0,0.9901390955577014,0.009860904442298592,0,0.9246340990066528,0.11006596684455872,0,0.816864013671875,0.19562938809394836,0,0.959943316196352,0.040056683803647984,0
1171,電子生理学的試験は実施されなかった。,電子 生理 学的 試験 実施 する れる ない た,0,0.9992979952037053,0.0007020047962947813,0,7.165024093499156e-05,0.999928349759065,0,0.964275714265811,0.03572428573418895,0,0.9897648339879134,0.010235166012086596,0,0.9533307552337646,0.056320805102586746,0,0.8372295498847961,0.1445808857679367,0,0.9705874199941319,0.029412580005868008,0
1172,頭部CTで異常なく、高血圧を認めず。,頭部 CT 異常 ない 高血圧 認める ぬ,0,0.9934838422050881,0.006516157794911923,0,0.00010162324813576764,0.9998983767518642,0,0.9877113890457385,0.012288610954261509,0,0.9999472875032206,5.27124967794374e-05,1,0.20266391336917877,0.8752531409263611,1,0.30525118112564087,0.8258280158042908,1,0.6833742584601733,0.3166257415398267,0
1173,日付不明プレドニン40 mgに漸減。,日付 不明 プレドニン 0 mg 漸減,0,0.9845704308420518,0.015429569157948216,0,5.6325338382984e-05,0.999943674661617,0,0.9452384943900434,0.054761505609956615,0,1.0,1.032622013703436e-17,0,0.9216436743736267,0.08065026998519897,0,0.8082416653633118,0.2433484047651291,0,0.9632302564674333,0.036769743532566616,0
1174,日付不明プロテインS:陰性(陰性)。,日付 不明 プロテイン S 陰性 陰性,0,0.9925068259580175,0.007493174041982439,0,5.061325653291282e-05,0.9999493867434671,0,0.9720335494676087,0.027966450532391385,0,1.0,1.7125281633886206e-26,0,0.9161559343338013,0.06670940667390823,0,0.8343369960784912,0.19006715714931488,0,0.9684125515068792,0.03158744849312077,0
1175,日付不明心電図:特記すべき所見なし。,日付 不明 心電図 特記 する べし 所見 ない,0,0.99600584183898,0.003994158161019952,0,5.896578321050185e-05,0.9999410342167895,0,0.9778904485329063,0.022109551467093667,0,0.9842587310796801,0.015741268920319924,0,0.9533803462982178,0.07400882244110107,0,0.8519634008407593,0.15782205760478973,0,0.9704001966216007,0.029599803378399306,0
1176,日付不明接種前の体温:36.5°C。,日付 不明 接種 前 体温 0 0 C,0,0.9246779944362277,0.07532200556377235,0,0.00010545090831643467,0.9998945490916835,0,0.7929026762956063,0.20709732370439374,0,0.5195482961797382,0.48045170382026176,0,0.8434452414512634,0.1743800938129425,0,0.7866699695587158,0.24880623817443848,0,0.8430895228802672,0.15691047711973286,0
1177,日付不明免疫学的検査:陰性(陰性)。,日付 不明 免疫学 的 検査 陰性 陰性,0,0.9919833293403941,0.008016670659605927,0,6.249059733358993e-05,0.9999375094026665,0,0.9806722448607696,0.019327755139230365,0,1.0,1.4940545656725664e-26,0,0.9343594312667847,0.06093030795454979,0,0.8358274102210999,0.17282402515411377,0,0.9701674509202636,0.029832549079736443,0
1178,併用薬及び治療薬は報告されていない。,併用 薬 治療薬 報告 する れる いる ない,0,0.9995371152442926,0.00046288475570745196,0,6.27282229386468e-05,0.9999372717770614,0,0.9920613214333351,0.007938678566664848,0,0.9529189399787974,0.0470810600212026,0,0.9486979246139526,0.05688553676009178,0,0.8208908438682556,0.162461057305336,0,0.968913520629195,0.031086479370805,0
1179,併用薬及び治療薬は報告されなかった。,併用 薬 治療薬 報告 する れる ない た,0,0.9999369677594389,6.30322405611758e-05,0,6.52867916522974e-05,0.9999347132083477,0,0.9934993196465719,0.006500680353428091,0,0.9976874790461997,0.0023125209538003423,0,0.9526671767234802,0.051339372992515564,0,0.8343419432640076,0.14269323647022247,0,0.9727574482963512,0.027242551703648612,0
1180,補中益気湯エキス顆粒、鎮痛薬を投与。,補中益気湯 エキス 顆粒 鎮痛 薬 投与,0,0.9845478639083033,0.015452136091696725,0,8.449470086286412e-05,0.9999155052991371,0,0.9312852565336434,0.06871474346635666,0,0.9902312122049253,0.009768787795074752,0,0.8807852864265442,0.15253303945064545,0,0.8094425201416016,0.2848968207836151,0,0.9554297907894647,0.04457020921053532,0
1181,直近の冠動脈検査は実施されなかった。,直近 冠動脈 検査 実施 する れる ない た,0,0.9999466134315369,5.338656846315325e-05,0,5.0926568599954176e-05,0.9999490734314,0,0.9860224267302892,0.013977573269710813,0,0.9976814597675561,0.0023185402324439742,0,0.9549008011817932,0.0602075420320034,0,0.8370323777198792,0.15392734110355377,0,0.97194687595726,0.028053124042739883,0
1182,(不明日)冠状動脈狭窄は示さなかった,明日 冠状動脈狭窄 示す ない た,0,0.9964336338471587,0.0035663661528413017,0,7.789865449351443e-05,0.9999221013455065,0,0.9595231726546418,0.040476827345358214,0,0.9954620664059826,0.004537933594017465,0,0.9455255270004272,0.05512629449367523,0,0.8328112363815308,0.19589905440807343,0,0.9686383331123894,0.03136166688761065,0
1183,原疾患/合併症の有無は不明であった。,原 疾患 合併症 有無 不明 だ ある た,0,0.9892189701485753,0.01078102985142472,0,6.864352767801896e-05,0.999931356472322,0,0.9892166679492965,0.010783332050703495,0,0.9043608767635958,0.09563912323640421,0,0.9386180639266968,0.059828706085681915,0,0.8386351466178894,0.17269207537174225,0,0.9647860054895654,0.035213994510434596,0
1184,併発疾患(問診票上)は無しであった。,併発疾患 問診 票 上 無い だ ある た,0,0.9845634931078572,0.015436506892142886,0,8.221134996298027e-05,0.999917788650037,0,0.625503468642863,0.374496531357137,0,0.8619527574483268,0.1380472425516732,0,0.9518320560455322,0.07350336760282516,0,0.8495051860809326,0.15863120555877686,0,0.925076339633883,0.074923660366117,0
1185,血圧測定:正常、注記:通常は問題なし,血圧 測定 正常 注記 通常 問題なし,0,0.9840199271936082,0.01598007280639174,0,7.017825048493937e-05,0.9999298217495151,0,0.9923758882265481,0.0076241117734518575,0,0.8699620041857946,0.1300379958142054,0,0.94327712059021,0.06443069875240326,0,0.8171140551567078,0.19782428443431854,0,0.9604938866169408,0.03950611338305913,0
1186,被験者は家族歴を含む病歴はなかった。,被験者 家族 歴 含む 病歴 ない た,0,0.9924591884126361,0.007540811587363886,0,8.04690077324278e-05,0.9999195309922676,0,0.976663929981537,0.023336070018463075,0,0.9948786568879673,0.005121343112032732,0,0.95035719871521,0.05687855929136276,0,0.8426684737205505,0.15579994022846222,0,0.9709289839133926,0.02907101608660745,0
1187,患者の原疾患、合併症は不明であった。,患者 疾患 合併症 不明 だ ある た,0,0.9971844624844823,0.0028155375155175964,0,6.280454523371461e-05,0.9999371954547663,0,0.9973354349899403,0.002664565010059792,0,0.9321564555331179,0.06784354446688207,0,0.938454270362854,0.06204677000641823,0,0.8233698606491089,0.17173853516578674,0,0.9671218801613771,0.03287811983862288,0
1188,主治医の詳細については不明であった。,主治医 詳細 不明 だ ある た,0,0.9947540789460245,0.005245921053975484,0,6.424505914178006e-05,0.9999357549408582,0,0.982782860520663,0.01721713947933702,0,0.9500720860238043,0.049927913976195636,0,0.9442940950393677,0.06511638313531876,0,0.8363959193229675,0.21041376888751984,0,0.9664472017462815,0.033552798253718596,0
1189,患者は、関連した検査を受けなかった。,患者 関連 する た 検査 受ける ない た,0,0.999912829566243,8.717043375692557e-05,0,4.91374461912084e-05,0.9999508625538088,0,0.9965045983778748,0.003495401622125254,0,0.9999996889992093,3.11000790727286e-07,0,0.9526720643043518,0.054279644042253494,0,0.8334437608718872,0.1391020119190216,0,0.9730293938140177,0.026970606185982456,0
1190,ワクチン接種時の体温は不明であった。,ワクチン接種 時 体温 不明 だ ある た,0,0.9993744981248218,0.0006255018751780811,0,5.250755067285554e-05,0.9999474924493271,0,0.9925282571303968,0.007471742869603139,0,0.9671901864647398,0.03280981353526027,0,0.9282877445220947,0.05501655489206314,0,0.847356915473938,0.20145989954471588,0,0.9688549354530915,0.031145064546908376,0
1191,禁煙、アレルギーはないと報告された。,禁煙 アレルギー ない 報告 する れる た,0,0.9986964389057227,0.0013035610942772856,0,7.952628495422636e-05,0.9999204737150458,0,0.9720066735941413,0.02799332640585876,1,0.3497916069166055,0.6502083930833945,0,0.9440357089042664,0.053316764533519745,0,0.8444864153862,0.19855830073356628,1,0.8982377474726728,0.10176225252732718,0
1192,直近の冠状動脈検査は未実施であった。,直近 冠状 動脈 検査 実施 だ ある た,0,0.9845447359019628,0.015455264098037132,0,8.255397989826912e-05,0.9999174460201017,0,0.9570390323584387,0.042960967641561335,0,0.8982735184261282,0.10172648157387172,0,0.944182813167572,0.06794946640729904,0,0.8391199111938477,0.19675417244434357,0,0.9607769903594173,0.03922300964058263,0
1193,COVID-19検査は陰性であった。,COVID 0 検査 陰性 だ ある た,0,0.9980023576072655,0.001997642392734624,0,5.384811654152806e-05,0.9999461518834585,0,0.9871417483372779,0.012858251662722123,0,0.9998420175794512,0.00015798242054876493,0,0.9398707747459412,0.056998759508132935,0,0.8542130589485168,0.17767022550106049,0,0.9715154349195559,0.028484565080444016,0
1194,09/21、症状は改善傾向であった。,0 0 症状 改善 傾向 だ ある た,0,0.999883727858507,0.00011627214149306965,0,4.9710247384853444e-05,0.9999502897526151,0,0.9976142110057766,0.0023857889942233926,0,0.9896151531962395,0.010384846803760481,0,0.9421907663345337,0.060534462332725525,0,0.8348773717880249,0.21000269055366516,0,0.9701381457066527,0.029861854293347243,0
1195,ワクチン接種前の体温は不明であった。,ワクチン接種 前 体温 不明 だ ある た,0,0.9974273840251452,0.002572615974854728,0,6.0553985390693746e-05,0.9999394460146093,0,0.9865641045560012,0.013435895443998772,0,0.9520202820414728,0.0479797179585272,0,0.9273160696029663,0.05597691237926483,0,0.8489368557929993,0.2008209377527237,0,0.967440972012565,0.03255902798743504,0
1196,それ以来、血液検査はしていなかった。,それ 以来 血液検査 する いる ない た,0,0.996618448376753,0.003381551623247071,0,7.367278344795965e-05,0.9999263272165521,0,0.9713008629522449,0.028699137047755084,0,0.9960120321299174,0.0039879678700826485,0,0.9501084089279175,0.05615910515189171,0,0.8303117156028748,0.17936979234218597,0,0.9699068148192906,0.030093185180709317,0
1197,被験者は人工呼吸器を使用しなかった。,被験者 人工呼吸器 使用 する ない た,0,0.9995365048562922,0.00046349514370787906,0,5.906307709617188e-05,0.9999409369229039,0,0.982763423464673,0.017236576535326953,0,0.9988151985942085,0.0011848014057914452,0,0.9544875025749207,0.0568668432533741,0,0.8356069326400757,0.15181554853916168,0,0.9719075662072866,0.028092433792713395,0
1198,患者は1か月内服し経過観察中である。,患者 0 か月 内服 する 経過 観察 中 だ ある,0,0.9845888792989088,0.015411120701091277,0,6.550419697851502e-05,0.9999344958030215,0,0.9957556849573651,0.004244315042634872,0,0.9432720979484628,0.05672790205153717,0,0.9456066489219666,0.08383689075708389,0,0.833199143409729,0.18433234095573425,0,0.9663658605330174,0.03363413946698265,0
1199,ワクチン接種後15分異常はなかった。,ワクチン接種 後 0分 異常 ない た,0,0.9877028543166337,0.012297145683366388,0,8.77215346205724e-05,0.9999122784653794,0,0.9837495366257796,0.016250463374220408,0,0.9947739068560382,0.005226093143961858,0,0.9379193186759949,0.05110054835677147,0,0.8480397462844849,0.1522669792175293,0,0.9711177238579307,0.02888227614206922,0
1200,有害事象後の本剤の投与は中止された。,有害事象 後 本 剤 投与 中止 する れる た,0,0.9845473351578927,0.015452664842107172,0,8.368524564614844e-05,0.9999163147543538,0,0.9448188981723339,0.05518110182766608,1,0.4352183724122669,0.5647816275877331,0,0.9366449117660522,0.08231597393751144,0,0.7830802798271179,0.20690174400806427,1,0.8965850902318891,0.10341490976811073,0
1201,明らかな抗体価の上昇は認めていない。,明らか だ 抗体価 上昇 認める いる ない,0,0.9915321318825604,0.008467868117439662,0,8.817064175763924e-05,0.9999118293582424,0,0.879789432623272,0.12021056737672801,0,0.8706227345802047,0.12937726541979527,0,0.94437175989151,0.09908535331487656,0,0.8006684184074402,0.2862499952316284,0,0.9449957392951382,0.055004260704861675,0
1202,しびれは軽快し、筋力低下も改善した。,しびれ 軽快 する 筋力低下 改善 する た,0,0.9994056232918284,0.0005943767081718102,0,6.015456822512318e-05,0.9999398454317748,0,0.993247418646251,0.006752581353749018,0,0.9978444717013008,0.0021555282986993004,0,0.9362173676490784,0.06525761634111404,0,0.8216986656188965,0.1912945955991745,0,0.9701851158589762,0.029814884141023772,0
1203,患者は、事象のための入院はなかった。,患者 事象 ため 入院 ない た,0,0.9845736357978594,0.015426364202140587,0,9.996855611230836e-05,0.9999000314438877,0,0.9860489546706941,0.013951045329305946,0,0.9906299329199327,0.00937006708006726,0,0.9560543298721313,0.05756714567542076,0,0.818202793598175,0.16620172560214996,0,0.9699153357409348,0.030084664259065252,0
1204,酸素飽和度: (日付不明)低下なし。,酸素飽和度 日付 不明 低下 ない,0,0.9845659974515598,0.015434002548440195,0,7.712224987177523e-05,0.9999228777501282,0,0.9551578558682619,0.044842144131738114,0,0.998329169550275,0.001670830449725069,0,0.9451130628585815,0.06654077768325806,0,0.8349499702453613,0.18782848119735718,0,0.9677655488567737,0.03223445114322629,0
1205,2022/03/18、症状消失した。,0 0 0 症状消失 する た,0,0.9845493099592909,0.015450690040708948,0,0.00011158561797151124,0.9998884143820285,1,0.46666987475520516,0.5333301252447948,1,0.2648534004367099,0.7351465995632901,0,0.9373234510421753,0.0749267190694809,0,0.8294359445571899,0.18970844149589539,1,0.7179858423509214,0.2820141576490786,0
1206,25日目、脳梁膨大部病変は消失した。,0 日 目 脳梁膨大部病変 消失 する た,0,0.9850397862509954,0.014960213749004572,0,7.713452939498713e-05,0.999922865470605,0,0.8870722394269765,0.11292776057302342,0,0.5343200494641593,0.4656799505358407,0,0.9405304193496704,0.08246828615665436,0,0.8153815865516663,0.17782725393772125,0,0.9095896560362569,0.09041034396374302,0
1207,ESR(1時間値)は上昇しなかった。,ESR 0時 間 値 上昇 する ない た,0,0.9722978302910915,0.027702169708908507,0,0.00015217203463897434,0.999847827965361,0,0.9213607284506047,0.0786392715493953,0,0.9976861221750541,0.0023138778249458757,0,0.940790057182312,0.0777219831943512,0,0.8354074954986572,0.1573508083820343,0,0.9652470113748737,0.03475298862512637,0
1208,その後、症状は少し改善してきていた。,その後 症状 改善 する くる いる た,0,0.9983205904194022,0.001679409580597709,0,6.622975551353875e-05,0.9999337702444865,0,0.9891676506293476,0.010832349370652335,0,0.6348548823053024,0.3651451176946976,0,0.9402906894683838,0.07381781190633774,0,0.8131587505340576,0.22375747561454773,0,0.9370675155725348,0.06293248442746532,0
1209,患者が治療を受けたかは不明であった。,患者 治療 受ける た 不明 だ ある た,0,0.9993418827996676,0.0006581172003323362,0,6.101469200179887e-05,0.9999389853079982,0,0.9921284687338373,0.007871531266162645,0,0.9996081823444302,0.00039181765556980697,0,0.9385459423065186,0.06581112742424011,0,0.8390178680419922,0.1696092039346695,0,0.9713747343015929,0.02862526569840695,0
1210,患者の家族歴は特になしと報告された。,患者 家族 歴 ない 報告 する れる た,0,0.9992346174892888,0.0007653825107112892,0,6.490120228715095e-05,0.9999350987977128,0,0.9936791490638955,0.006320850936104498,1,0.3433285781763853,0.6566714218236147,0,0.9446525573730469,0.06871639937162399,0,0.848893940448761,0.18207165598869324,1,0.9016215363349878,0.09837846366501217,0
1211,集中治療室(ICU)受診はなかった。,集中治療室 ICU 受診 ない た,0,0.993558426955031,0.006441573044968987,0,7.74222438516353e-05,0.9999225777561483,0,0.9842262069234109,0.015773793076589087,0,0.9964105078963821,0.003589492103617969,0,0.941774845123291,0.05565657094120979,0,0.836592972278595,0.14302793145179749,0,0.971480370066772,0.028519629933227954,0
1212,心不全は治療され、洞調律に復帰した。,心不全 治療 する れる 洞調律 復帰 する た,0,0.9845491657036496,0.015450834296350349,0,0.0001295130452268108,0.9998704869547732,0,0.5614520153547657,0.43854798464523426,0,0.9630503845263857,0.03694961547361426,0,0.9420604109764099,0.06499990820884705,0,0.7852453589439392,0.21532048285007477,0,0.9216765669547494,0.07832343304525051,0
1213,翌日、症状遷延なく、患者は退院した。,翌日 症状遷延 ない 患者 退院 する た,0,0.999509940538102,0.0004900594618979279,0,6.909061051914725e-05,0.9999309093894808,0,0.9873570812134745,0.01264291878652542,0,0.7908203399746999,0.20917966002530006,0,0.930809497833252,0.08255475759506226,0,0.8103794455528259,0.181121826171875,0,0.9540439951467198,0.04595600485328007,0
1214,(2022/06/24)異常所見なし,0 0 0 異常所見なし,0,0.9890472300880613,0.010952769911938835,0,6.969008117482307e-05,0.9999303099188251,1,0.3741492743921715,0.6258507256078285,0,0.9999996495486204,3.5045137955964286e-07,0,0.9174383878707886,0.07000721991062164,0,0.7778618931770325,0.226139098405838,1,0.8933747362567993,0.10662526374320076,0
1215,「高血圧」(継続中かどうかは不明)。,高血圧 継続 中 不明,0,0.988989038004434,0.01101096199556584,0,7.06939458392616e-05,0.9999293060541607,0,0.9411720588499102,0.05882794115008984,0,0.9999999936937622,6.30623772580771e-09,0,0.9285876154899597,0.08863767981529236,1,0.5212267637252808,0.6429318189620972,1,0.9294786573884637,0.07052134261153635,0
1216,Pain assessment:正常,Pain assessment 正常,0,0.9933513892246802,0.006648610775319758,0,7.34538003554714e-05,0.9999265461996445,0,0.9923758882265481,0.0076241117734518575,0,0.9999999999999992,8.209456352684957e-16,0,0.9236880540847778,0.09868297725915909,0,0.8257831335067749,0.20522263646125793,0,0.9682367611845473,0.03176323881545271,0
1217,経口ウイルス剤内服を希望しなかった。,経口 ウイルス 剤 内服 希望 する ない た,0,0.999485136717297,0.0005148632827030802,0,5.337693896636343e-05,0.9999466230610337,0,0.9875991831984443,0.012400816801555742,0,0.9942822190688774,0.005717780931122616,0,0.9441627860069275,0.054080765694379807,0,0.8430290818214417,0.15678605437278748,0,0.9717818204508781,0.028218179549121952,0
1218,試験観察期間中は授乳していなかった。,試験 観察 期間中 授乳 する いる ない た,0,0.9988294776332028,0.0011705223667972298,0,6.03272307460777e-05,0.9999396727692539,0,0.9806166199844922,0.019383380015507778,0,0.9948738989280564,0.005126101071943513,0,0.9492437243461609,0.06238112226128578,0,0.8395814895629883,0.1478259563446045,0,0.9714568197272873,0.028543180272712774,0
1219,少し嘔気はあるも食欲はやや改善した。,嘔気 ある 食欲 改善 する た,0,0.9845605305729698,0.01543946942703018,0,0.0001013927020021363,0.9998986072979978,0,0.903405449463113,0.09659455053688708,0,0.8513704620448191,0.14862953795518088,0,0.9222788214683533,0.08407539874315262,0,0.800849974155426,0.23685477674007416,0,0.9469029024594245,0.05309709754057537,0
1220,接種当日には疼痛は生じていなかった。,接種 当日 疼痛 生じる いる ない た,0,0.982396942996535,0.017603057003464963,0,0.00012277066171125252,0.9998772293382887,0,0.9608103961431174,0.03918960385688259,0,0.9884814489318567,0.011518551068143229,0,0.9520647525787354,0.06687901169061661,0,0.8403111696243286,0.15159370005130768,0,0.968856963871468,0.031143036128531944,0
1221,55日目、患者は血液科に転科された。,0 日 目 患者 血液 科 科す れる た,0,0.984557892421943,0.015442107578056946,0,0.0001176432687396058,0.9998823567312604,0,0.5055763253498301,0.4944236746501699,1,0.2880509228770768,0.7119490771229232,0,0.869222104549408,0.19432540237903595,0,0.8141857385635376,0.20157207548618317,1,0.6993313703240303,0.30066862967596975,0
1222,"Nitrite urine, (-)",Nitrite urine,0,0.9717857773393365,0.028214222660663694,0,7.852612662116665e-05,0.9999214738733788,1,0.4563792597309324,0.5436207402690676,0,0.999999999998984,1.0159840098517063e-12,0,0.867196798324585,0.1377710998058319,0,0.7354044914245605,0.33487778902053833,1,0.8793659472048116,0.12063405279518838,0
1223,桃核承気湯(漢方薬)を服用していた。,桃 核 承る 気 湯 漢方薬 服用 する いる た,0,0.9845592587604552,0.015440741239544729,0,9.785669209219167e-05,0.9999021433079078,1,0.4231953283818918,0.5768046716181082,1,0.45172544097938716,0.5482745590206128,0,0.858530580997467,0.11347223073244095,0,0.8024125099182129,0.26683127880096436,1,0.7310183402938651,0.26898165970613486,0
1224,15分の待機時間中体調の変化なし。,0分 待機時間 中 体調 変化 ない,0,0.9551161766291922,0.04488382337080786,0,0.00011579686391314175,0.9998842031360868,0,0.9551610920418674,0.04483890795813261,0,0.9229983695563498,0.0770016304436502,0,0.9318954944610596,0.07987030595541,0,0.8267969489097595,0.22329753637313843,0,0.95780358521006,0.04219641478993984,0
1225,1ヵ月後心電図所見は正常となった。,0 ヵ月 後 心電図 所見 正常 なる た,0,0.9845557045692476,0.015444295430752281,0,8.74607218205662e-05,0.9999125392781795,0,0.9924691670702555,0.007530832929744498,0,0.9689928074851095,0.031007192514890505,0,0.9357424378395081,0.06555301696062088,0,0.832025945186615,0.16663788259029388,0,0.9685617752246298,0.03143822477537025,0
1226,2021/10/07洞調律に回復。,0 0 0 洞調律 回復,0,0.9992602688362628,0.0007397311637372359,0,6.577321398340433e-05,0.9999342267860166,0,0.9758996728966532,0.024100327103346794,0,0.9999850883466715,1.4911653328467962e-05,0,0.9262328147888184,0.0776030421257019,0,0.8141136765480042,0.21654386818408966,0,0.9675987720411706,0.03240122795882953,0
1227,2022/02/24脳波検査実施。,0 0 0 脳波 検査 実施,0,0.986674201087206,0.013325798912793944,0,9.849067881539058e-05,0.9999015093211846,0,0.9223939329866618,0.07760606701333819,0,0.999233222987512,0.0007667770124879034,0,0.9164771437644958,0.10374576598405838,0,0.794467568397522,0.23103922605514526,0,0.9605684662208648,0.039431533779135115,0
1228,2022/03/21対麻痺は軽快。,0 0 0 対麻痺 軽快,0,0.9932255353576241,0.006774464642375865,0,8.046064310904127e-05,0.9999195393568909,0,0.9631729633849101,0.036827036615089924,0,0.9999990300121762,9.699878238307367e-07,0,0.936147928237915,0.08398274332284927,0,0.7990207672119141,0.23551903665065765,0,0.9653977971189504,0.034602202881049655,0
1229,2022/04/06改善し、退院。,0 0 0 改善 する 退院,0,0.9999478471448399,5.215285516007723e-05,0,3.9378886227652077e-05,0.9999606211137724,0,0.9952833034019816,0.004716696598018469,0,1.0,2.2488678482660383e-23,0,0.9369111657142639,0.07278241217136383,0,0.80836421251297,0.19407211244106293,0,0.969791621703172,0.03020837829682795,0
1230,2022/04/13症状は未回復。,0 0 0 症状 回復,0,0.9994928066201733,0.0005071933798266493,0,7.24439070514183e-05,0.9999275560929486,0,0.9901809175747592,0.009819082425240775,0,0.9999999999985455,1.4544496460520397e-12,0,0.9248979687690735,0.07373463362455368,0,0.8246062994003296,0.21906885504722595,0,0.9688167115071104,0.031183288492889608,0
1231,2022/04/20下痢改善あり。,0 0 0 下痢改善 ある,0,0.984565783441625,0.015434216558375066,0,0.00013848109674652751,0.9998615189032535,1,0.17134802056202647,0.8286519794379735,0,0.9888201252135203,0.011179874786479777,1,0.106552854180336,0.9272893071174622,0,0.8080458045005798,0.19900992512702942,1,0.5195011644598838,0.4804988355401161,0
1232,2022/04/27経過観察実施。,0 0 0 経過 観察 実施,0,0.9975245711775037,0.0024754288224963124,0,8.454641823979174e-05,0.9999154535817603,0,0.9652886919701484,0.0347113080298516,0,0.9999998611725084,1.388274916521711e-07,0,0.9290890097618103,0.07116426527500153,0,0.7928906083106995,0.2020438015460968,0,0.9669001631458856,0.0330998368541145,0
1233,2022/04/28 ST正常化。,0 0 0 ST 正常化,0,0.9845726590953696,0.015427340904630394,0,8.382571686381419e-05,0.9999161742831362,1,0.35873972300322543,0.6412602769967746,0,1.0,6.190597193661559e-20,0,0.9242200255393982,0.07084143161773682,0,0.7011924386024475,0.311433881521225,1,0.8732416237648879,0.12675837623511207,0
1234,2022/05/23処方薬を中止。,0 0 0 処方 薬 中止,0,0.9982444208587362,0.001755579141263875,0,6.272781280246662e-05,0.9999372721871975,0,0.9003383442922928,0.09966165570770728,0,1.0,1.401865015489077e-22,0,0.9347466230392456,0.08828485757112503,0,0.8111478686332703,0.24854610860347748,0,0.9610727096865772,0.038927290313422895,0
1235,MRI撮影し、異常なしと言われた。,MRI 撮影 する 異常 ない 言う れる た,0,0.998356421222339,0.0016435787776610743,0,7.979121354273312e-05,0.9999202087864573,0,0.9704171274384936,0.029582872561506372,1,0.35238830019231693,0.6476116998076831,0,0.940277099609375,0.0683184266090393,0,0.8295141458511353,0.1780528575181961,1,0.897145551063787,0.10285444893621286,0
1236,ウイルスゲノムは検出されなかった。,ウイルス ゲノム 検出 する れる ない た,0,0.9993690726295349,0.0006309273704651786,0,5.500995888525991e-05,0.9999449900411147,0,0.9704171274384936,0.029582872561506372,0,0.9970617266601779,0.002938273339822136,0,0.9420934319496155,0.06008104607462883,0,0.8286429643630981,0.14109861850738525,0,0.9707832942510168,0.029216705748983107,0
1237,エコーウイルス検査:陰性(陰性)。,エコー ウイルス検査 陰性 陰性,0,0.990039313869821,0.009960686130179006,0,5.402122687831266e-05,0.9999459787731216,0,0.9748863304620521,0.02511366953794793,0,1.0,8.182966018286932e-43,0,0.9316108822822571,0.059814080595970154,0,0.8352975249290466,0.18441227078437805,0,0.9693098148891213,0.030690185110878725,0
1238,オラデオカプセルの内服を中止した。,オラデオカプセル 内服 中止 する た,0,0.9845865145064004,0.015413485493599622,0,8.11434563479689e-05,0.999918856543652,0,0.907952143386692,0.09204785661330803,0,0.8528290684089902,0.14717093159100977,0,0.939590573310852,0.06278104335069656,0,0.8126567006111145,0.2638615667819977,0,0.9486562065988853,0.05134379340111464,0
1239,これまでのところ、胸の痛みはなし。,これ ところ 胸 痛み ない,0,0.9845732031918201,0.015426796808179807,0,0.00010265469410338504,0.9998973453058966,0,0.8770390331101399,0.12296096688986019,0,0.9198454339534179,0.08015456604658211,0,0.9383383393287659,0.08328241854906082,0,0.8076191544532776,0.3133166432380676,0,0.948459886124617,0.05154011387538311,0
1240,ステロイド投与量は漸減中であった。,ステロイド 投与 量 漸減 中 だ ある た,0,0.9974264649555128,0.002573535044487271,0,6.0930459079519484e-05,0.9999390695409205,0,0.9959980534999218,0.004001946500078243,0,0.9281581871834828,0.0718418128165173,0,0.9449111223220825,0.05959064140915871,0,0.8333104252815247,0.21648378670215607,0,0.9659550105677858,0.03404498943221423,0
1241,その後、徐々に症状は軽快し、帰宅。,その後 症状 軽快 する 帰宅,0,0.9976755264542753,0.00232447354572482,0,6.108379056698248e-05,0.999938916209433,0,0.9953665353096659,0.004633464690334062,0,0.999997920820311,2.0791796889965715e-06,0,0.9360360503196716,0.08098694682121277,0,0.7800568342208862,0.29738515615463257,0,0.9652404509202253,0.03475954907977475,0
1242,その他の特記すべき検査はなかった。,その他 特記 する べし 検査 ない た,0,0.9997563166598978,0.00024368334010215438,0,5.1904065456695724e-05,0.9999480959345433,0,0.9924052948796422,0.007594705120357766,0,0.999629925431445,0.00037007456855493,0,0.9488670229911804,0.06554945558309555,0,0.8403177261352539,0.14722023904323578,0,0.9723503183919179,0.027649681608082226,0
1243,マイコプラズマ検査:陰性(陰性)。,マイコプラズマ 検査 陰性 陰性,0,0.9950571668208634,0.004942833179136432,0,5.856944401713178e-05,0.9999414305559828,0,0.9830269590625047,0.016973040937495267,0,1.0,1.0475268218544991e-31,0,0.932883083820343,0.056545108556747437,0,0.8263548016548157,0.22711315751075745,0,0.968685689929633,0.03131431007036703,0
1244,マクロファージはほぼ消失していた。,マクロファージ 消失 する いる た,0,0.9921502521711184,0.007849747828881579,0,7.092684200787643e-05,0.9999290731579922,0,0.9223914315831059,0.07760856841689408,0,0.7866351165330399,0.2133648834669602,0,0.9467419385910034,0.0634889081120491,0,0.8550928831100464,0.18815401196479797,0,0.9503903468035314,0.049609653196468546,0
1245,冠動脈造影にて狭窄は認めなかった。,冠動脈造影 にる 狭窄 認める ない た,0,0.9845915926184395,0.01540840738156048,0,0.00011050129190562155,0.9998894987080944,0,0.9116101275615521,0.08838987243844784,0,0.9915121982074281,0.008487801792571878,0,0.944826602935791,0.05427403002977371,0,0.8338561654090881,0.17939360439777374,0,0.9651309431996496,0.0348690568003504,0
1246,患者の呼吸数は18回/分であった。,患者 呼吸 数 0回 分 だ ある た,1,0.5,0.5,1,0.00020508418984402954,0.999794915810156,0,0.8072700977827157,0.19272990221728423,0,0.8962745472414284,0.10372545275857153,1,0.5283110737800598,0.6398926973342896,0,0.8325029015541077,0.18232253193855286,1,0.7203298188574871,0.27967018114251285,0
1247,患者の併用薬は、報告されなかった。,患者 併用 薬 報告 する れる ない た,0,0.9999691584964517,3.084150354823304e-05,0,5.1834468120064636e-05,0.9999481655318799,0,0.9974125885044414,0.002587411495558632,0,0.9984648780096508,0.0015351219903492169,0,0.9572455883026123,0.05549032986164093,0,0.8317983150482178,0.14673791825771332,0,0.9728436525985352,0.027156347401464765,0
1248,患者は18日間の入院後、退院した。,患者 0 日間 入院 後 退院 する た,0,0.641959968656245,0.35804003134375495,0,0.00013244671829446778,0.9998675532817055,0,0.7053067703095279,0.2946932296904721,0,0.9776530758928271,0.02234692410717282,0,0.915408730506897,0.13199278712272644,0,0.7680532336235046,0.22644761204719543,0,0.8781606406121654,0.12183935938783459,0
1249,患者はステロイド軟膏を処方された。,患者 ステロイド 軟膏 処方 する れる た,0,0.9845701007657414,0.01542989923425879,0,9.73559232958099e-05,0.9999026440767042,0,0.942594209699376,0.05740579030062397,0,0.5342493852479677,0.4657506147520322,0,0.9164851903915405,0.12667885422706604,0,0.8148123621940613,0.21643096208572388,0,0.9098011875797691,0.09019881242023076,0
1250,関連する併用薬は報告されなかった。,関連 する 併用 薬 報告 する れる ない た,0,0.9999116480592886,8.835194071146232e-05,0,6.12280512603661e-05,0.9999387719487396,0,0.9927675586165481,0.0072324413834518615,0,0.9977795060438381,0.002220493956161845,0,0.9542270302772522,0.05507460609078407,0,0.8246240019798279,0.14465172588825226,0,0.9723520025706155,0.027647997429384504,0
1251,胸部CTでは胸腺腫は認めなかった。,胸部 CT 胸腺腫 認める ない た,0,0.9931406284728339,0.006859371527166179,0,8.28284391566325e-05,0.9999171715608434,0,0.9593478235891332,0.04065217641086679,0,0.9928010906644515,0.007198909335548476,0,0.9384923577308655,0.055224526673555374,0,0.8381606936454773,0.16548125445842743,0,0.9691323361144913,0.030867663885508625,0
1252,胸部X線検査では心拡大の所見なし。,胸部 X線検査 心拡大 所見 ない,0,0.9986589625024795,0.0013410374975205027,0,6.989430062474482e-05,0.9999301056993752,0,0.9942124591048224,0.005787540895177679,0,0.9994674754828051,0.0005325245171948344,0,0.9404458999633789,0.0581175796687603,0,0.8350496292114258,0.16698987782001495,0,0.9716730478868408,0.02832695211315904,0
1253,現在は元気に日常生活を送っている。,現在 元気 日常生活 送る いる,0,0.9845971344209018,0.0154028655790982,0,0.00010868992942478109,0.9998913100705752,1,0.46711378816843285,0.5328862118315671,0,0.9972770902583808,0.0027229097416191814,0,0.8729838132858276,0.17601902782917023,0,0.7855674624443054,0.24817852675914764,1,0.8940265732137251,0.10597342678627496,0
1254,後療法として、プレドニゾロン投与。,後 療法 プレドニゾロン 投与,0,0.9845904376766028,0.015409562323397108,0,8.350826212379771e-05,0.9999164917378762,0,0.9565169647458704,0.04348303525412951,0,0.9999999999943593,5.640740225190205e-12,0,0.916235625743866,0.08654600381851196,0,0.8280887007713318,0.21489502489566803,0,0.9652854555584544,0.03471454444154569,0
1255,抗原検査陰性確認は実施しなかった。,抗原検査 陰性確認 実施 する ない た,0,0.9999675951389635,3.2404861036415646e-05,0,5.562819634502646e-05,0.9999443718036549,0,0.9798100957023542,0.020189904297645826,0,0.9981263601152381,0.0018736398847618342,0,0.9501926898956299,0.05333149433135986,0,0.8355917930603027,0.14877386391162872,0,0.9717937082542315,0.028206291745768424,0
1256,抗好中球細胞質抗体:陰性(陰性)。,抗好中球細胞質抗体 陰性 陰性,0,0.9914928236197131,0.008507176380286873,0,5.604270312951405e-05,0.9999439572968705,0,0.9748863304620521,0.02511366953794793,0,1.0,7.308464232385751e-35,0,0.9229817390441895,0.06375575810670853,0,0.8251249194145203,0.18665827810764313,0,0.968646171485782,0.03135382851421787,0
1257,合併症、既往歴、併用薬は報告なし。,合併症 既往 歴 併用 薬 報告 ない,0,0.9994274682509418,0.0005725317490581544,0,5.415364314884383e-05,0.9999458463568511,0,0.9958183419978167,0.004181658002183287,0,0.9510664146344916,0.04893358536550845,0,0.9537925124168396,0.07613924890756607,0,0.8402629494667053,0.16263756155967712,0,0.9691717812252247,0.030828218774775294,0
1258,死亡時画像診断は実施されなかった。,死亡 時 画像 診断 実施 する れる ない た,0,0.9850329843271353,0.01496701567286472,0,0.000105754778632259,0.9998942452213677,0,0.9834298973116512,0.01657010268834879,0,0.9974415956042015,0.0025584043957984884,0,0.9547755122184753,0.05358824133872986,0,0.8184391260147095,0.14579905569553375,0,0.9708536997957463,0.029146300204253645,0
1259,心臓MRI検査は実施されなかった。,心臓 MRI 検査 実施 する れる ない た,0,0.9999716741026733,2.8325897326638196e-05,0,3.947102002557525e-05,0.9999605289799745,0,0.9984485278993342,0.001551472100665757,0,0.9992915529398994,0.0007084470601006851,0,0.9518615007400513,0.05276889726519585,0,0.8332161903381348,0.14246390759944916,0,0.973021012050606,0.026978987949394018,0
1260,心電図:ST変化なし、洞調律正常。,心電図 ST 変化 ない 洞調律正常,0,0.9984834550229298,0.0015165449770701267,0,5.289784106261139e-05,0.9999471021589373,0,0.9579506482269727,0.04204935177302729,0,0.9999995115443386,4.884556613455407e-07,0,0.9335099458694458,0.0836566612124443,0,0.8484117388725281,0.18765383958816528,0,0.9684335251677674,0.031566474832232565,0
1261,接種日周辺の解熱剤使用はなかった。,接種 日 周辺 解熱 剤 使用 ない た,0,0.9975352255354777,0.0024647744645223653,0,6.122486995468368e-05,0.9999387751300454,0,0.9934220063371529,0.006577993662847089,0,0.9992688568508893,0.0007311431491107557,0,0.950579047203064,0.056632500141859055,0,0.8432843089103699,0.1489526331424713,0,0.972584618273262,0.027415381726737853,0
1262,置換性線維形成は認められなかった。,置換 性 線維形成 認める られる ない た,0,0.984583905709772,0.015416094290228107,0,0.00011761547409790295,0.9998823845259021,0,0.908622598346893,0.09137740165310701,0,0.9875589946551675,0.01244100534483254,0,0.9429265856742859,0.0602552592754364,0,0.8330115675926208,0.16356083750724792,0,0.9649021995342796,0.03509780046572054,0
1263,定期的にバイタル確認し、変動なし。,定期的 バイタル 確認 する 変動 ない,0,0.9967174805149309,0.0032825194850692025,0,7.18920581261487e-05,0.9999281079418738,0,0.8949838094974912,0.10501619050250874,0,0.940282226741549,0.05971777325845092,0,0.9471408724784851,0.06887472420930862,0,0.8235705494880676,0.17971843481063843,0,0.9603127517277993,0.039687248272200736,0
1264,特に心電図の異常は見られなかった。,心電図 異常 見る られる ない た,0,0.9848903238177255,0.015109676182274528,0,8.926181249213394e-05,0.9999107381875079,0,0.9524497189104535,0.04755028108954652,0,0.9917997635273442,0.008200236472655805,0,0.943591833114624,0.053039319813251495,0,0.8414934277534485,0.1744602918624878,0,0.9682021981703629,0.03179780182963712,0
1265,特記すべきその他の検査はなかった。,特記 する べし その他 検査 ない た,0,0.9997563166598978,0.00024368334010215438,0,5.1904065456695724e-05,0.9999480959345433,0,0.9924052948796422,0.007594705120357766,0,0.9997480528340149,0.0002519471659851092,0,0.9474872946739197,0.06282839179039001,0,0.8424233794212341,0.149623304605484,0,0.9723847153994808,0.027615284600519204,0
1266,日付不明血中フィブリノゲン:正常。,日付 不明 血 中 フィブリノゲン 正常,0,0.9845866796094718,0.015413320390528317,0,8.596445833370445e-05,0.9999140355416662,0,0.985977436956699,0.01402256304330099,0,0.9999999999998564,1.4355299376939438e-13,0,0.9148561358451843,0.07519576698541641,0,0.8359816670417786,0.19670651853084564,0,0.9683309997813934,0.03166900021860655,0
1267,日付不明接種前体温:35.8°C。,日付 不明 接種 体温 0 0 C,0,0.9521883819259274,0.04781161807407259,0,0.00011564131646531417,0.9998843586835346,0,0.7929026762956063,0.20709732370439374,0,0.5195482961797382,0.48045170382026176,0,0.854759693145752,0.16370746493339539,0,0.796051561832428,0.22502471506595612,0,0.8571219902223219,0.142878009777678,0
1268,入院同日に解熱し、胸痛も消失した。,入院 同日 解熱 胸痛 消失 する た,0,0.9845663176757633,0.015433682324236819,0,9.920152361555491e-05,0.9999007984763845,0,0.7893784262492003,0.21062157375079965,1,0.3779000147170758,0.6220999852829242,0,0.9412381649017334,0.07189678400754929,0,0.8069526553153992,0.1977197378873825,1,0.8560006338331465,0.14399936616685352,0
1269,被験者の併用薬は報告されなかった。,被験者 併用 薬 報告 する れる ない た,0,0.9999106290394352,8.937096056476784e-05,0,5.9090360668494275e-05,0.9999409096393315,0,0.9948610265231945,0.005138973476805431,0,0.9980100463365706,0.0019899536634293683,0,0.9562488794326782,0.05767742171883583,0,0.8395916819572449,0.14154712855815887,0,0.9729408372902124,0.027059162709787542,0
1270,併用薬及び治療薬の報告はなかった。,併用 薬 治療薬 報告 ない た,0,0.9999361672496033,6.383275039660886e-05,0,5.401976263027813e-05,0.9999459802373697,0,0.993011755724752,0.006988244275247992,0,0.9979245292663708,0.0020754707336291815,0,0.9491808414459229,0.05175274237990379,0,0.8508432507514954,0.15046828985214233,0,0.9728712052485712,0.027128794751428854,0
1271,病理組織学的検査は行われなかった。,病理 組織 学 的 検査 行う れる ない た,0,0.9845801678262336,0.015419832173766548,0,8.869603455378195e-05,0.9999113039654463,0,0.9788347826025334,0.021165217397466587,0,0.9958555389060133,0.004144461093986704,0,0.9476890563964844,0.057335685938596725,0,0.8255583047866821,0.14007487893104553,0,0.9705324496147928,0.029467550385207146,0
1272,その他の画像検査は未実施であった。,その他 画像 検査 実施 だ ある た,0,0.9897838905228216,0.010216109477178372,0,6.642778449401344e-05,0.9999335722155059,0,0.9931361081786788,0.0068638918213211626,0,0.9927522485300365,0.007247751469963525,0,0.9461969137191772,0.06337511539459229,0,0.8410149812698364,0.1732580065727234,0,0.9707462155825084,0.02925378441749166,0
1273,高感度CRPは、実施されなかった。,感度 CRP 実施 する れる ない た,0,0.9999709903373051,2.9009662694938614e-05,0,4.288982147220835e-05,0.9999571101785278,0,0.9962602914064265,0.0037397085935735037,0,0.9990214077501014,0.0009785922498986102,0,0.9533487558364868,0.05786503478884697,0,0.8471101522445679,0.16405412554740906,0,0.9725920313322965,0.027407968667703533,0
1274,開始日と停止日は報告されなかった。,開始 日 停止 日 報告 する れる ない た,0,0.9992844890668646,0.0007155109331353011,0,7.858531610305806e-05,0.999921414683897,0,0.9869639185170181,0.013036081482981809,0,0.9957146452664811,0.004285354733518883,0,0.955944299697876,0.05775095522403717,0,0.8355780839920044,0.14862142503261566,0,0.9720566076682068,0.027943392331793084,0
1275,CSF lactate:データなし,CSF lactate データ ない,0,0.9958428225937039,0.004157177406296019,0,7.374435810107291e-05,0.999926255641899,0,0.9584064201532027,0.04159357984679737,0,0.999999139779873,8.602201269689247e-07,0,0.9516012072563171,0.06387484818696976,0,0.8525751829147339,0.17276766896247864,0,0.9700023115291192,0.029997688470880763,0
1276,原疾患および合併症は不明であった。,原 疾患 合併症 不明 だ ある た,0,0.995427026825124,0.004572973174875902,0,6.62104531557366e-05,0.9999337895468443,0,0.99512452441131,0.004875475588689956,0,0.9037021366370098,0.09629786336299014,0,0.9315105080604553,0.05967353656888008,0,0.8310211300849915,0.18692125380039215,0,0.9645854832559645,0.035414516744035486,0
1277,病理組織学的検査は未実施であった。,病理 組織 学 的 検査 実施 だ ある た,0,0.978697638861769,0.02130236113823104,0,8.386899337293394e-05,0.999916131006627,0,0.9763454935873997,0.023654506412600293,0,0.9358910463896852,0.06410895361031482,0,0.9499832987785339,0.06129767745733261,0,0.8410245776176453,0.1589582860469818,0,0.9661960142095014,0.03380398579049854,0
1278,頭部MRIを含む一般検査異常なし。,頭部 MRI 含む 一般 検査 異常 ない,0,0.9948138103785579,0.005186189621442158,0,6.041861627678254e-05,0.9999395813837232,0,0.9865776785376403,0.013422321462359688,0,0.9984508490524393,0.001549150947560703,0,0.9323665499687195,0.06605024635791779,0,0.8401690125465393,0.1582513004541397,0,0.9709156545855161,0.02908434541448378,0
1279,COVID-19の発症はなかった。,COVID 0 発症 ない た,0,0.9838718374804307,0.016128162519569344,0,0.00010237738010854026,0.9998976226198915,0,0.9421421563026525,0.05785784369734743,0,0.9909949773107558,0.00900502268924421,0,0.9416726231575012,0.05596771836280823,0,0.8477257490158081,0.16173231601715088,0,0.9678890706763202,0.03211092932367968,0
1280,精力的な身体活動は特になしだった。,精力 的 だ 身体活動 ない だ た,0,0.9983316405431447,0.0016683594568553696,0,7.232329696231329e-05,0.9999276767030377,0,0.9719964470471235,0.028003552952876435,0,0.9996992178377063,0.0003007821622937147,0,0.9445586204528809,0.06719627231359482,0,0.7661336064338684,0.32813650369644165,0,0.96287234409704,0.03712765590295992,0
1281,直近の冠動脈検査は未実施であった。,直近 冠動脈 検査 実施 だ ある た,0,0.9899997061771086,0.010000293822891342,0,8.031360828449126e-05,0.9999196863917155,0,0.9696251138923869,0.030374886107613033,0,0.9657807288048564,0.034219271195143605,0,0.9457438588142395,0.07021388411521912,0,0.8409557342529297,0.19349172711372375,0,0.9668809172470516,0.03311908275294835,0
1282,CSF glucose:データなし,CSF glucose データ ない,0,0.9969360646445904,0.0030639353554097245,0,5.722912545359172e-05,0.9999427708745464,0,0.9669426749401969,0.03305732505980306,0,0.999990175091925,9.824908075025103e-06,0,0.9517868757247925,0.0674140602350235,0,0.8525751829147339,0.17276766896247864,0,0.9704602209748255,0.0295397790251745,0
1283,患者にアレルギーの既往はなかった。,患者 アレルギー 既往 ない た,0,0.9990772544746874,0.0009227455253126188,0,5.8534612359417946e-05,0.9999414653876406,0,0.991063892930228,0.00893610706977197,0,0.9990266559962302,0.0009733440037698254,0,0.9494031071662903,0.05776368826627731,0,0.8560025095939636,0.15818318724632263,0,0.9725595049478755,0.027440495052124453,0
1284,Fibrin D dimer:正常,Fibrin D dimer 正常,0,0.9954605848125426,0.0045394151874573775,0,8.441811391251884e-05,0.9999155818860875,0,0.9923758882265481,0.0076241117734518575,0,1.0,9.166662592143007e-29,0,0.9074087142944336,0.07924214750528336,0,0.8071967363357544,0.20873652398586273,0,0.9677815949293791,0.03221840507062089,0
1285,遺族の意思で剖検は行われなかった。,遺族 意思 剖検 行う れる ない た,0,0.9845900899056076,0.015409910094392387,0,8.730373598536423e-05,0.9999126962640147,0,0.9139629226681906,0.08603707733180943,0,0.990830160183998,0.009169839816001933,0,0.9523158073425293,0.058162983506917953,0,0.8137935996055603,0.15293185412883759,0,0.9655754915520138,0.03442450844798611,0
1286,患者は観察期間中に授乳はなかった。,患者 観察 期間中 授乳 ない た,0,0.9992208006332687,0.0007791993667313096,0,5.650513337124841e-05,0.9999434948666287,0,0.986421009433611,0.013578990566389042,0,0.9563031678584942,0.04369683214150576,0,0.9495159387588501,0.07085613906383514,0,0.846487283706665,0.1601024568080902,0,0.9692027251258116,0.03079727487418831,0
1287,事象の重篤性は、提供されなかった。,事象 重篤性 提供 する れる ない た,0,0.9994517013377177,0.0005482986622822179,0,5.5209432397006885e-05,0.999944790567603,0,0.9759326743928145,0.024067325607185445,0,0.9976296828527148,0.0023703171472851474,0,0.9522064924240112,0.05451956018805504,0,0.8228138089179993,0.16037297248840332,0,0.9708655396551077,0.02913446034489232,0
1288,左上葉の腫瘍サイズに変化はなかった,左上 葉 腫瘍 サイズ 変化 ない た,0,0.9845456585541816,0.015454341445818422,0,9.185260514277061e-05,0.9999081473948572,0,0.9266823476495376,0.07331765235046236,0,0.9905206647110655,0.009479335288934559,0,0.9325060248374939,0.055784374475479126,0,0.8416870832443237,0.19424808025360107,0,0.9653716919333722,0.034628308066627846,0
1289,X線:(2022/07)異常なし。,X線 0 0 異常 ない,0,0.9927498463723333,0.007250153627666629,0,5.825668088559956e-05,0.9999417433191145,0,0.9830044285363864,0.01699557146361367,0,0.9999999997195534,2.8044657948204867e-10,0,0.9399189352989197,0.059223003685474396,0,0.8413003087043762,0.15211687982082367,0,0.9712934808378032,0.02870651916219681,0
1290,継続中の経口治療は、何も無かった。,継続 中 経口 治療 何 無い た,0,0.9790581991970204,0.020941800802979596,0,6.992013026702458e-05,0.9999300798697329,0,0.6004944215402628,0.3995055784597372,0,0.9994648717993484,0.0005351282006515728,0,0.9436728358268738,0.0583745576441288,0,0.8162566423416138,0.14551299810409546,0,0.9378603477816263,0.06213965221837365,0
1291,D-ダイマーは、上昇なしであった。,D ダイマー 上昇 ない だ ある た,0,0.9933547541809202,0.006645245819079945,0,7.5740068324903e-05,0.9999242599316751,0,0.9133370175451585,0.08666298245484144,0,0.9925639229931544,0.007436077006845511,0,0.9335501194000244,0.06961311399936676,0,0.8557332754135132,0.1743360012769699,0,0.9659077138457136,0.03409228615428645,0
1292,これ以上の追加情報は期待できない。,これ 以上 追加 情報 期待 できる ない,0,0.9890725273310732,0.01092747266892674,0,6.449891535117835e-05,0.9999355010846488,0,0.9725286460364742,0.027471353963525853,0,0.9318452455531122,0.06815475444688783,0,0.9534518718719482,0.07474253326654434,0,0.8040208220481873,0.17157024145126343,0,0.9643663815278452,0.0356336184721549,0
1293,肺炎の画像検査:(不明日)所見なし,肺炎 画像 検査 明日 所見 ない,0,0.9845915477079091,0.015408452292090744,0,7.75565151171466e-05,0.9999224434848829,0,0.9518244895148257,0.04817551048517435,0,0.9996628941297413,0.00033710587025875534,0,0.941742479801178,0.07337510585784912,0,0.8248478770256042,0.18593178689479828,0,0.967060752516004,0.032939247483995925,0
1294,エコー検査で壁運動は良好であった。,エコー 検査 壁 運動 良好 だ ある た,0,0.9845697331973737,0.015430266802626354,0,7.377271926231943e-05,0.9999262272807377,0,0.9745387373889614,0.025461262611038683,0,0.9591857269916879,0.04081427300831209,0,0.9439082741737366,0.05622412636876106,0,0.8472999930381775,0.19793950021266937,0,0.9668749886046618,0.03312501139533817,0
1295,筋力正常:顕著な異常は認めなかった,筋力正常 顕著 だ 異常 認める ない た,0,0.9980651302233992,0.0019348697766009516,0,5.961884661702723e-05,0.999940381153383,0,0.9011570944863692,0.09884290551363079,0,0.9919712373820923,0.008028762617907756,0,0.9418138861656189,0.08113933354616165,0,0.8241481184959412,0.16538502275943756,0,0.9644954346809865,0.0355045653190134,0
1296,搬送時、意識レベルはやや回復した。,搬送 時 意識レベル 回復 する た,0,0.993331710239571,0.006668289760429132,0,7.468263766383436e-05,0.9999253173623361,0,0.9858199126562964,0.014180087343703528,0,0.9383233993049872,0.061676600695012816,0,0.9391813278198242,0.058014530688524246,0,0.8022720813751221,0.20797820389270782,0,0.9647893123126103,0.035210687687389546,0
1297,被験者に、関連する病歴はなかった。,被験者 関連 する 病歴 ない た,0,0.997893203080578,0.002106796919421951,0,7.167955961729177e-05,0.9999283204403827,0,0.9891858552440079,0.010814144755992076,0,0.9990666573169343,0.0009333426830656249,0,0.9510077238082886,0.05513685196638107,0,0.8434045314788818,0.15239736437797546,0,0.9723290951951206,0.02767090480487944,0
1298,その後、外来で経過観察されていた。,その後 外来 経過 観察 する れる いる た,0,0.9845899202750927,0.015410079724907084,0,7.17675700540381e-05,0.999928232429946,0,0.9668470335638635,0.03315296643613658,0,0.7930591257544082,0.20694087424559177,0,0.9460845589637756,0.06827361136674881,0,0.789469301700592,0.22279183566570282,0,0.9494837863964115,0.050516213603588433,0
1299,培養が実施されたかは不明であった。,培養 実施 する れる た 不明 だ ある た,0,0.9986705763820571,0.001329423617942984,0,5.943042938406926e-05,0.999940569570616,0,0.9864413978177932,0.01355860218220688,0,0.9963724130622331,0.003627586937766906,0,0.9421377778053284,0.05955740436911583,0,0.8405044674873352,0.17317794263362885,0,0.9710552502057612,0.02894474979423873,0
1300,家族歴はなかった(報告のとおり)。,家族 歴 ない た 報告 とおり,0,0.9986081248764456,0.001391875123554428,0,6.241655305475372e-05,0.9999375834469453,0,0.978907174937856,0.02109282506214406,0,0.999999999999152,8.479499508218378e-13,0,0.9480734467506409,0.0565827414393425,0,0.8458529710769653,0.21489860117435455,0,0.970043672072711,0.029956327927288865,0
1301,観察期間中に授乳はしていなかった。,観察 期間中 授乳 する いる ない た,0,0.9991601017262672,0.0008398982737329421,0,5.609187438965489e-05,0.9999439081256103,0,0.9849508096411783,0.015049190358821673,0,0.996936662906982,0.003063337093017981,0,0.948688805103302,0.0591726191341877,0,0.8347696661949158,0.15503430366516113,0,0.9715697372253048,0.02843026277469519,0
1302,直近の冠動脈検査:未実施であった。,直近 冠動脈 検査 実施 だ ある た,0,0.9899997061771086,0.010000293822891342,0,8.031360828449126e-05,0.9999196863917155,0,0.9696251138923869,0.030374886107613033,0,0.9657807288048564,0.034219271195143605,0,0.9457438588142395,0.07021388411521912,0,0.8409557342529297,0.19349172711372375,0,0.9668809172470516,0.03311908275294835,0
1303,COVID-19は発現しなかった。,COVID 0 発現 する ない た,0,0.9574287260626968,0.04257127393730316,0,0.00012061324123246547,0.9998793867587675,0,0.8855054308399327,0.11449456916006727,0,0.9997756811123463,0.00022431888765376916,0,0.9530535936355591,0.06671183556318283,0,0.838862955570221,0.1668928563594818,0,0.9624559272777785,0.037544072722221544,0
1304,患者は病歴がなかった(報告通り)。,患者 病歴 ない た 報告 通り,0,0.9993578083210529,0.0006421916789471428,0,5.3643305792604754e-05,0.9999463566942074,0,0.9875915250739895,0.0124084749260105,0,0.9999999999790719,2.092816519607582e-11,0,0.9511950016021729,0.05803923308849335,0,0.8413420915603638,0.17408530414104462,0,0.9716513740353805,0.028348625964619442,0
1305,出産後も母子ともに問題はなかった。,出産後 母子 とも 問題 ない た,0,0.9919959454661712,0.008004054533828834,0,7.972297246915318e-05,0.9999202770275308,0,0.9266823476495376,0.07331765235046236,0,0.9861102435220401,0.013889756477959888,0,0.9447541236877441,0.052900321781635284,0,0.8136097192764282,0.16961561143398285,0,0.9659599443380831,0.034040055661916854,0
1306,消化器系、肝臓系の症状はなかった。,消化器 系 肝臓 系 症状 ない た,0,0.9976432557440391,0.0023567442559607036,0,7.999981946839046e-05,0.9999200001805316,0,0.8746724809512457,0.12532751904875428,0,0.9505056660627107,0.049494333937289324,0,0.9408354163169861,0.05989871546626091,0,0.8182005882263184,0.1485939621925354,0,0.9606965439224903,0.0393034560775096,0
1307,転帰は、治療なしで未回復であった。,転帰 治療 ない だ 回復 だ ある た,0,0.9999847030854224,1.5296914577525275e-05,0,2.9593179281585243e-05,0.9999704068207184,0,0.9863297362003244,0.013670263799675618,0,0.9995560733134095,0.0004439266865905289,0,0.9417897462844849,0.06305916607379913,0,0.8102896809577942,0.1625838428735733,0,0.9706375543705331,0.029362445629466754,0
1308,被験者はICUに収容されなかった。,被験者 ICU 収容 する れる ない た,0,0.9986235139441257,0.0013764860558741778,0,8.093592008252941e-05,0.9999190640799175,0,0.9809189465165651,0.01908105348343488,0,0.9982506300022045,0.0017493699977955365,0,0.9555562734603882,0.06674071401357651,0,0.84201979637146,0.14555703103542328,0,0.9718328214822125,0.028167178517787442,0
1309,9/28、患者は病院から退院した。,0 0 患者 病院 退院 する た,0,0.9845524803797745,0.01544751962022545,0,8.084436984183068e-05,0.9999191556301582,0,0.987470630216285,0.01252936978371504,0,0.9849314691561653,0.015068530843834771,0,0.9339058995246887,0.08150529861450195,0,0.8145678043365479,0.21693788468837738,0,0.9665635804405364,0.03343641955946366,0
1310,COVID-19は発症しなかった。,COVID 0 発症 する ない た,0,0.9794932758541033,0.020506724145896753,0,0.00011896915340565545,0.9998810308465943,0,0.9650937201815049,0.034906279818495166,0,0.9993068541936108,0.0006931458063891854,0,0.946170449256897,0.06002498418092728,0,0.836218535900116,0.16491419076919556,0,0.9690959220172048,0.030904077982795142,0
1311,これ以上の追加調査は不可能である。,これ 以上 追加 調査 不可能 だ ある,0,0.9845526758250306,0.015447324174969546,0,8.023629278540693e-05,0.9999197637072146,0,0.789977038451392,0.21002296154860806,0,0.967106680462617,0.032893319537382906,0,0.9487968683242798,0.07370348274707794,0,0.8176933526992798,0.18186131119728088,0,0.9523186195805812,0.0476813804194188,0
1312,その後、出血なく経過良好であった。,その後 出血 ない 経過 良好 だ ある た,0,0.9991517255609549,0.0008482744390450256,0,5.080743232552755e-05,0.9999491925676744,0,0.9852345393947917,0.014765460605208376,0,0.9720825403343593,0.027917459665640736,0,0.9444144368171692,0.06804154068231583,0,0.8148467540740967,0.18869008123874664,0,0.9681875715142657,0.03181242848573428,0
1313,感染の一次感染部位は不明であった。,感染 一 次感染 部位 不明 だ ある た,0,0.9845877761655705,0.015412223834429481,0,8.008917688380391e-05,0.9999199108231162,0,0.8607218257868976,0.1392781742131024,0,0.8390003673892692,0.1609996326107308,0,0.9337664842605591,0.07345925271511078,0,0.818191647529602,0.17482014000415802,0,0.9464680659033512,0.053531934096648796,0
1314,検査ー鼻腔・咽頭拭い液採取×1回。,検査 ー 鼻腔 咽頭 拭う 液 採取 0回,0,0.984579299987584,0.01542070001241608,0,0.00011339107569377457,0.9998866089243063,1,0.4871654981210316,0.5128345018789684,0,0.9999999994674865,5.325135286384135e-10,0,0.8962706923484802,0.26597222685813904,0,0.7622995376586914,0.2375120222568512,1,0.8907867198550353,0.1092132801449648,0
1315,入院2日後、正常及び正常(正常)。,入院 0 日 後 正常 正常 正常,0,0.9845895546309749,0.015410445369025114,0,5.914842730503222e-05,0.999940851572695,0,0.9653945928965717,0.03460540710342832,0,1.0,9.461423828180488e-87,0,0.9357208013534546,0.08221964538097382,0,0.8330184817314148,0.18563619256019592,0,0.9677348376029391,0.032265162397060974,0
1316,ひきつけを起こしたことはなかった。,ひきつけ 起こす た こと ない た,0,0.9952943995194102,0.0047056004805898465,0,8.063182561679426e-05,0.9999193681743832,0,0.9438527182899861,0.0561472817100139,0,0.9983557883290053,0.0016442116709946835,0,0.9451881051063538,0.06720072031021118,0,0.8374219536781311,0.17793306708335876,0,0.9680973430619606,0.03190265693803949,0
1317,急性心筋炎は、劇症型に該当しない。,急性心筋炎 劇症型 該当 しない,0,0.9845881473142567,0.01541185268574321,0,0.0001427102176134531,0.9998572897823865,1,0.4563792597309324,0.5436207402690676,0,0.9998952010663109,0.00010479893368912891,0,0.6657285094261169,0.48409169912338257,0,0.7745839357376099,0.2586876153945923,1,0.8291398945975639,0.17086010540243607,0
1318,初回の検査で以下のことが判明した。,初回 検査 以下 こと 判明 する た,0,0.9845566452595637,0.015443354740436331,0,0.00013079484173937218,0.9998692051582606,0,0.7576814525380037,0.24231854746199635,1,0.15376380862452288,0.8462361913754771,0,0.8735548853874207,0.17428629100322723,0,0.8077796101570129,0.2235511839389801,1,0.7456912239451169,0.2543087760548831,0
1319,2022/04/06他院に転院。,0 0 0 他 院 転院,0,0.9845561058697863,0.015443894130213723,0,0.00015714622350774754,0.9998428537764923,0,0.5429223509102911,0.45707764908970894,0,0.9999999995648745,4.35125469877527e-10,0,0.8945726156234741,0.12903469800949097,0,0.7811629176139832,0.22308780252933502,0,0.915202883905069,0.08479711609493096,0
1320,2022/04/10嘔気は改善。,0 0 0 嘔気 改善,0,0.9845828422001043,0.015417157799895742,0,0.00011662961189060654,0.9998833703881094,0,0.9492070156328242,0.05079298436717588,0,0.9999986722120704,1.327787929653393e-06,0,0.8979352116584778,0.11541198939085007,0,0.809025228023529,0.23778171837329865,0,0.9616382345135283,0.03836176548647183,0
1321,3日後、これらの症状は改善した。,0 日 後 これら 症状 改善 する た,0,0.9985633302185524,0.0014366697814476308,0,8.428946956270181e-05,0.9999157105304373,0,0.990717310118435,0.009282689881565052,0,0.9703708291217998,0.029629170878200113,0,0.937492311000824,0.06084158644080162,0,0.8323697447776794,0.1712130904197693,0,0.9694474730618449,0.030552526938155206,0
1322,B型肝炎表面抗原:陰性(陰性)。,B型 肝炎 表面 抗原 陰性 陰性,0,0.9893720000863172,0.010627999913682797,0,6.833781272123138e-05,0.9999316621872788,0,0.9748863304620521,0.02511366953794793,0,1.0,1.6379812398336595e-27,0,0.921552836894989,0.060476887971162796,0,0.828904926776886,0.1926100105047226,0,0.9685080306292946,0.031491969370705454,0
1323,COVID-19症状は消失した。,COVID 0 症状 消失 する た,0,0.99657420993234,0.0034257900676600635,0,6.339613319184628e-05,0.9999366038668082,0,0.9385412725893456,0.061458727410654404,0,0.9864551861741213,0.013544813825878677,0,0.9416107535362244,0.0699525773525238,0,0.8229966163635254,0.17956064641475677,0,0.9663776045228384,0.033622395477161574,0
1324,C型肝炎抗体:陰性(陰性)陰性。,C型 肝炎 抗体 陰性 陰性 陰性,0,0.9984022417237375,0.0015977582762626138,0,3.9938203724248445e-05,0.9999600617962757,0,0.9918597849167566,0.008140215083243404,0,1.0,5.873140420854832e-62,0,0.9224393367767334,0.05994211882352829,0,0.834553599357605,0.1924758106470108,0,0.9702631104850478,0.029736889514952163,0
1325,PSL 20 mg/日投与開始。,PSL 0 mg 日 投与 開始,0,0.9985636711205231,0.0014363288794769613,0,5.706848541772905e-05,0.9999429315145822,0,0.991684162301842,0.00831583769815798,0,0.9999999987119375,1.288062586607995e-09,0,0.9107524156570435,0.09975462406873703,0,0.8178473711013794,0.2049010545015335,0,0.9678465534809612,0.032153446519038835,0
1326,アセトアミノフェンが処方された。,アセトアミノフェン 処方 する れる た,0,0.9114250851449265,0.08857491485507325,0,0.00014316581348607646,0.9998568341865139,0,0.5939692787444038,0.4060307212555963,0,0.6033814646031337,0.3966185353968663,0,0.8788239359855652,0.1941526234149933,0,0.7785120010375977,0.32513126730918884,0,0.7950909086897539,0.20490909131024618,0
1327,アナボリックステロイド使用なし。,アナボリックステロイド 使用 ない,0,0.997066462557216,0.002933537442783938,0,7.044385944079475e-05,0.9999295561405592,0,0.9669426749401969,0.03305732505980306,0,0.999999047304415,9.526955850227821e-07,0,0.9499377608299255,0.0630161389708519,0,0.8315331339836121,0.1997627168893814,0,0.9691370408858249,0.030862959114175248,0
1328,これ以上の情報の入手予定はなし。,これ 以上 情報 入手 予定 ない,0,0.9983441700670754,0.0016558299329245882,0,5.2008482055981484e-05,0.999947991517944,0,0.892143225061961,0.10785677493803905,0,0.9999646783687437,3.532163125626535e-05,0,0.9476893544197083,0.06702443212270737,0,0.8160666823387146,0.19444167613983154,0,0.9638513714099797,0.03614862859002038,0
1329,その後来院時には軽快を確認した。,その後 来院 時 軽快 確認 する た,0,0.9910812041143311,0.008918795885668759,0,7.882984760193691e-05,0.999921170152398,0,0.9735151223055561,0.026484877694443902,0,0.8123669818305124,0.18763301816948766,0,0.94362473487854,0.06957078725099564,0,0.8152176141738892,0.17485326528549194,0,0.9555746473639413,0.04442535263605878,0
1330,トロポニンIは実施されなかった。,トロポニン I 実施 する れる ない た,0,0.9999922894092906,7.710590709378497e-06,0,2.6028702408812198e-05,0.9999739712975911,0,0.9977676774133252,0.0022323225866748646,0,0.9996967694529583,0.0003032305470417731,0,0.9503912329673767,0.05479481443762779,0,0.8511800169944763,0.155229389667511,0,0.9730515839930027,0.026948416006997173,0
1331,バイタルサイン測定:安定、安定。,バイタルサイン 測定 安定 安定,0,0.9845531037108656,0.015446896289134449,0,6.979700449016624e-05,0.9999302029955098,1,0.4563792597309324,0.5436207402690676,0,0.9999932824024745,6.71759752546098e-06,0,0.931773841381073,0.06938191503286362,0,0.7895761132240295,0.2742539644241333,1,0.9054843839072592,0.09451561609274087,0
1332,フィブリンDダイマー:変化なし。,フィブリン D ダイマー 変化 ない,0,0.9933271797238259,0.0066728202761740935,0,7.195114509856157e-05,0.9999280488549014,0,0.9584064201532027,0.04159357984679737,0,0.858781141177261,0.14121885882273894,0,0.9396332502365112,0.06663621217012405,0,0.8323370814323425,0.26038986444473267,0,0.9554732927203734,0.044526707279626675,0
1333,ヘパリンによる抗凝固療法を開始。,ヘパリン 抗凝固 療法 開始,0,0.984566462787984,0.015433537212016016,0,8.044126034344132e-05,0.9999195587396565,0,0.8561003128304077,0.14389968716959234,0,0.9999287830303398,7.121696966018528e-05,0,0.9256631135940552,0.07854501903057098,0,0.7456873059272766,0.39527419209480286,0,0.9467926317786249,0.05320736822137509,0
1334,リウマチ因子:陰性(陰性)陰性。,リウマチ 因子 陰性 陰性 陰性,0,0.9845475676658185,0.015452432334181504,0,5.545060335701358e-05,0.999944549396643,0,0.9748863304620521,0.02511366953794793,0,1.0,8.755769029034654e-50,0,0.927933931350708,0.05471188202500343,0,0.8363187909126282,0.20441550016403198,0,0.968449412467555,0.03155058753244501,0
1335,胃も受け付けず、食事しなかった。,胃 受け付ける ぬ 食事 する ない た,0,0.9947059400261011,0.005294059973898837,0,8.192669104776757e-05,0.9999180733089522,0,0.9468580360359651,0.0531419639640349,0,0.99039551778333,0.009604482216669976,0,0.9507186412811279,0.055188290774822235,0,0.8027912974357605,0.17636744678020477,0,0.9672652970897339,0.03273470291026603,0
1336,外用も塗布していないと発言あり。,外用 塗布 する いる ない 発言 ある,0,0.984571391584365,0.01542860841563504,0,7.84941526593199e-05,0.9999215058473406,0,0.7185178252270153,0.28148217477298465,0,0.890128254252998,0.10987174574700202,0,0.9491912722587585,0.0755389928817749,0,0.770058810710907,0.29578524827957153,0,0.9265264946662328,0.07347350533376718,0
1337,冠動脈CT検査で冠動脈狭窄なし。,冠動脈 CT検査 だ 冠動脈狭窄 ない,0,0.9989133961708822,0.0010866038291178907,0,5.676104885579767e-05,0.9999432389511442,0,0.9690807735003097,0.030919226499690207,0,0.9999964366313452,3.563368654863597e-06,0,0.9460092186927795,0.05981045588850975,0,0.8507066369056702,0.1752263307571411,0,0.9706243608149744,0.029375639185025726,0
1338,患者の心肺状態は徐々に改善した。,患者 心肺 状態 改善 する た,0,0.9981694983640396,0.0018305016359605284,0,7.105098562949201e-05,0.9999289490143705,0,0.9741817336115944,0.02581826638840554,0,0.92833574080657,0.07166425919343002,0,0.936089813709259,0.062403589487075806,0,0.8168601393699646,0.18218576908111572,0,0.9647660877912703,0.03523391220872978,0
1339,患者の併用薬は報告されなかった。,患者 併用 薬 報告 する れる ない た,0,0.9999691584964517,3.084150354823304e-05,0,5.1834468120064636e-05,0.9999481655318799,0,0.9974125885044414,0.002587411495558632,0,0.9984648780096508,0.0015351219903492169,0,0.9572455883026123,0.05549032986164093,0,0.8317983150482178,0.14673791825771332,0,0.9728436525985352,0.027156347401464765,0
1340,既往歴、合併症、危険因子はなし。,既往 歴 合併症 危険因子 ない,0,0.9944506071043255,0.0055493928956745035,0,6.40094174329591e-05,0.999935990582567,0,0.986313572726873,0.01368642727312695,0,0.9977524077060345,0.0022475922939655534,0,0.9466089606285095,0.06471224874258041,0,0.8342927694320679,0.16779550909996033,0,0.9708454179060734,0.029154582093926597,0
1341,胸部X線検査で心拡大の所見なし。,胸部 X線検査 だ 心拡大 所見 ない,0,0.9992636874664311,0.000736312533568917,0,5.721911427095471e-05,0.9999427808857291,0,0.9921341810499114,0.007865818950088588,0,0.9995139274043597,0.00048607259564027125,0,0.9426236748695374,0.06057940796017647,0,0.8552866578102112,0.16815532743930817,0,0.972107637410103,0.027892362589896972,0
1342,胸腹部CT心拡大以前と変わらず。,胸腹部 C，T 心拡大 以前 変わる ぬ,0,0.9186706177018218,0.08132938229817824,0,0.0001227439245786363,0.9998772560754213,0,0.5345888104182468,0.46541118958175315,0,0.9790133437299802,0.020986656270019787,0,0.8930145502090454,0.18814679980278015,1,0.44255346059799194,0.7116299271583557,1,0.7859329694577772,0.21406703054222267,0
1343,近医整形で湿布と痛み止めを処方。,近医 整形 湿布 痛み 止め 処方,1,0.1560578222197347,0.8439421777802655,1,0.00016815085547450172,0.9998318491445255,1,0.11211969652701881,0.8878803034729812,0,0.9995863367060981,0.00041366329390194053,0,0.8559418320655823,0.287785142660141,0,0.7587699294090271,0.32008200883865356,1,0.38762858079156787,0.6123714192084322,0
1344,結核菌群検査:陰性(陰性)陰性。,結核菌群 検査 陰性 陰性 陰性,0,0.9950571668208634,0.004942833179136432,0,5.175233554788462e-05,0.9999482476644521,0,0.9799639453345924,0.02003605466540755,0,1.0,2.842942859883014e-54,0,0.9262429475784302,0.06297551840543747,0,0.8329219818115234,0.20028743147850037,0,0.9691130560265717,0.030886943973428158,0
1345,血液検査、画像検査問題なく帰宅。,血液検査 画像 検査 問題 ない 帰宅,0,0.9981047976647373,0.0018952023352626997,0,5.3933315622807566e-05,0.9999460666843772,0,0.9873973913546406,0.012602608645359482,0,0.9999570802763186,4.29197236813801e-05,0,0.9411205053329468,0.06290736049413681,0,0.82439124584198,0.2471553236246109,0,0.9685217915673133,0.03147820843268665,0
1346,血液検査:自己抗体陰性(陰性)。,血液検査 自己抗体 陰性 陰性,0,0.9845532568342337,0.015446743165766342,0,5.4679701286794806e-05,0.9999453202987132,0,0.9748863304620521,0.02511366953794793,0,1.0,3.678353038872408e-27,0,0.9379463791847229,0.06122523918747902,0,0.8345375061035156,0.2164672613143921,0,0.9681324272627723,0.03186757273722779,0
1347,血管造影検査では冠動脈狭窄なし。,血管造影 検査 冠動脈狭窄 ない,0,0.9988559383558065,0.0011440616441933864,0,5.787481396210452e-05,0.9999421251860379,0,0.9790472164735895,0.020952783526410515,0,0.9999999912802284,8.719771618578044e-09,0,0.9385860562324524,0.0584411695599556,0,0.8465416431427002,0.18895702064037323,0,0.9705065959159649,0.029493404084035234,0
1348,原疾患あるいは合併症はなかった。,原 疾患 合併症 ない た,0,0.9994208009434031,0.0005791990565968976,0,5.4342841902737876e-05,0.9999456571580972,0,0.9918667738537149,0.008133226146285085,0,0.9131219948962579,0.08687800510374205,0,0.9376660585403442,0.0540887676179409,0,0.8373154401779175,0.14971020817756653,0,0.9670771187488646,0.03292288125113554,0
1349,合併症に関して報告されていない。,合併症 報告 する れる いる ない,0,0.9980017150994916,0.001998284900508353,0,5.318720541676368e-05,0.9999468127945832,0,0.9940257794748446,0.00597422052515537,0,0.96426386763644,0.035736132363559985,0,0.9491082429885864,0.06027494743466377,0,0.789421021938324,0.1686962991952896,0,0.9683926246078352,0.0316073753921649,0
1350,塞栓性脳梗塞:塞栓性脳梗塞なし。,塞栓性 脳梗塞 塞栓性 脳梗塞 ない,0,0.9943862293612405,0.005613770638759406,0,9.609723959189979e-05,0.9999039027604081,0,0.8110406712935512,0.18895932870644883,0,0.9995410663765052,0.00045893362349484236,0,0.93223637342453,0.06868577748537064,0,0.8180984258651733,0.19272582232952118,0,0.9568535963040062,0.04314640369599378,0
1351,自己抗体検査は実施されなかった。,自己抗体 検査 実施 する れる ない た,0,0.9999762867159233,2.371328407671907e-05,0,4.378866387395893e-05,0.999956211336126,0,0.9942521686228109,0.0057478313771891516,0,0.9986769157108575,0.0013230842891424938,0,0.9523394703865051,0.05603526160120964,0,0.8408591747283936,0.1451052874326706,0,0.9728263122415501,0.02717368775844976,0
1352,処置、経過等の詳細は不明である。,処置 経過 等 詳細 不明 だ ある,0,0.992869227080708,0.007130772919292016,0,7.692053308675287e-05,0.9999230794669133,0,0.9809901307703176,0.01900986922968239,0,0.9931199061236622,0.00688009387633785,0,0.9414190649986267,0.07482904195785522,0,0.8319153189659119,0.22540631890296936,0,0.9679291505446468,0.03207084945535313,0
1353,心エコー:心機能は正常であった。,心 エコー 心 機能 正常 だ ある た,0,0.9983576757883035,0.0016423242116964587,0,7.614403878510597e-05,0.9999238559612149,0,0.9925493014058789,0.007450698594121027,0,0.9078272344820818,0.09217276551791821,0,0.9339793920516968,0.0566888190805912,0,0.8437742590904236,0.18221595883369446,0,0.9656589598889219,0.03434104011107811,0
1354,心エコーでは心機能正常を示した。,心 エコー 心機能正常 示す た,0,0.9845631917954359,0.01543680820456404,0,0.00013406869721590417,0.9998659313027841,1,0.38519019020434153,0.6148098097956585,0,0.6554638621951722,0.34453613780482784,0,0.9164784550666809,0.07927874475717545,0,0.803477942943573,0.22246620059013367,1,0.8128922751920636,0.1871077248079364,0
1355,頭部CTは特に問題なしであった。,頭部 C，T 問題なし だ ある た,0,0.9703936905181036,0.02960630948189628,0,6.985974354419851e-05,0.9999301402564558,0,0.9126655773896276,0.0873344226103724,0,0.9878969915900955,0.012103008409904543,0,0.9390978217124939,0.05613468214869499,0,0.8370781540870667,0.16374486684799194,0,0.9643721167699311,0.03562788323006898,0
1356,特記すべきその他検査はなかった。,特記 する べし その他 検査 ない た,0,0.9997563166598978,0.00024368334010215438,0,5.1904065456695724e-05,0.9999480959345433,0,0.9924052948796422,0.007594705120357766,0,0.9997480528340149,0.0002519471659851092,0,0.9474872946739197,0.06282839179039001,0,0.8424233794212341,0.149623304605484,0,0.9723847153994808,0.027615284600519204,0
1357,日付不明現在、外来で経過観察中。,日付 不明 現在 外来 経過 観察 中,0,0.9978451598054096,0.0021548401945905822,0,5.725912263837786e-05,0.9999427408773616,0,0.9792257314060834,0.020774268593916612,0,0.9995725885542512,0.0004274114457487699,0,0.944269061088562,0.0640931949019432,0,0.8244888782501221,0.20345425605773926,0,0.969368382083315,0.030631617916685117,0
1358,日付不明心エコー:異常所見なし。,日付 不明 心 エコー 異常所見なし,0,0.9840507853615603,0.015949214638439662,0,5.6725499579016e-05,0.999943274500421,0,0.8723612023376061,0.12763879766239392,0,0.9999976380053166,2.3619946833439922e-06,0,0.926849901676178,0.06164901331067085,0,0.8385865092277527,0.18413913249969482,0,0.9620421148120732,0.037957885187926706,0
1359,日付不明毎日リハビリ施行し改善。,日付 不明 毎日 リハビリ 施行 する 改善,0,0.99859970812636,0.0014002918736399563,0,4.988693033542408e-05,0.9999501130696645,0,0.9850027175956909,0.014997282404309054,0,0.9999005323187465,9.946768125347364e-05,0,0.9384092092514038,0.07327478379011154,0,0.8144306540489197,0.24470628798007965,0,0.9677658738178664,0.03223412618213363,0
1360,入院後プレドニン50 mg内服。,入院 後 プレドニン 0 mg 内服,0,0.9845698752433732,0.01543012475662667,0,0.00010108329311585251,0.9998989167068841,0,0.8832564091669384,0.11674359083306161,0,0.9999999999989957,1.0043482438741244e-12,0,0.900793194770813,0.13210158050060272,0,0.8080613613128662,0.24462032318115234,0,0.955552771734105,0.04444722826589496,0
1361,病的な反射なし、APQ抗体陰性。,病的 反射 ない APQ 抗体 陰性,0,0.99995462842438,4.537157561993014e-05,0,4.4336928890624463e-05,0.9999556630711094,0,0.9939845269611203,0.006015473038879769,0,0.9999999878337845,1.2166215474601893e-08,0,0.9352396726608276,0.0743347704410553,0,0.8397005796432495,0.17736394703388214,0,0.9710050078506888,0.028994992149311276,0
1362,母親の併用薬は報告されなかった。,母親 併用 薬 報告 する れる ない た,0,0.9999021937724036,9.78062275964893e-05,0,6.392051305933851e-05,0.9999360794869406,0,0.9931664993241419,0.006833500675858127,0,0.9967374768658945,0.0032625231341054696,0,0.9550492167472839,0.05548085644841194,0,0.8460524082183838,0.15040771663188934,0,0.9727468094384467,0.027253190561553276,0
1363,尿中一般検査結果は正常であった。,尿 中 一般 検査結果 正常 だ ある た,0,0.9936947032660431,0.006305296733956866,0,6.503710332270103e-05,0.9999349628966773,0,0.9915220291850406,0.008477970814959358,0,0.9094193309303623,0.09058066906963766,0,0.9339159727096558,0.06057159602642059,0,0.8522545695304871,0.1696503758430481,0,0.96595226052788,0.03404773947212003,0
1364,(2021/11/03)変化なし,0 0 0 変化 ない,0,0.9980608552292768,0.0019391447707231215,0,6.747088140797454e-05,0.999932529118592,0,0.9840786066824166,0.01592139331758336,0,0.9999954009059021,4.599094097885836e-06,0,0.9297948479652405,0.06840698421001434,0,0.8414503931999207,0.17254093289375305,0,0.970536648387332,0.02946335161266807,0
1365,明らかな原因は確定できなかった。,明らか だ 原因 確定 できる ない た,0,0.9980894020457755,0.0019105979542245245,0,6.994945705691006e-05,0.999930050542943,0,0.9641370065252456,0.03586299347475442,0,0.9968434978285589,0.003156502171441187,0,0.9484241604804993,0.06013236939907074,0,0.8323988318443298,0.17277966439723969,0,0.9697103300735452,0.030289669926454738,0
1366,事象の転帰は、提供されなかった。,事象 転帰 提供 する れる ない た,0,0.9996193813236371,0.00038061867636278744,0,5.953585360733652e-05,0.9999404641463927,0,0.9848953325054064,0.015104667494593613,0,0.9981651515585035,0.001834848441496548,0,0.9515694379806519,0.05052593722939491,0,0.8184370994567871,0.14311830699443817,0,0.9718551148334802,0.02814488516651982,0
1367,トロポニンIは、未実施であった。,トロポニン I 実施 だ ある た,0,0.998550437874464,0.0014495621255360411,0,5.0499371351330456e-05,0.9999495006286486,0,0.9816878274275909,0.01831217257240911,0,0.9998095418130758,0.00019045818692415127,0,0.9422464370727539,0.06397294998168945,0,0.8477911949157715,0.19576983153820038,0,0.9704160083986478,0.029583991601352083,0
1368,被験者に関連する病歴はなかった。,被験者 関連 する 病歴 ない た,0,0.997893203080578,0.002106796919421951,0,7.167955961729177e-05,0.9999283204403827,0,0.9891858552440079,0.010814144755992076,0,0.9990666573169343,0.0009333426830656249,0,0.9510077238082886,0.05513685196638107,0,0.8434045314788818,0.15239736437797546,0,0.9723290951951206,0.02767090480487944,0
1369,Thyroglobulin:なし,Thyroglobulin ない,0,0.9992696923881825,0.000730307611817539,0,6.998440034050061e-06,0.999993001559966,0,0.9871986233676191,0.012801376632380942,0,0.999999712933789,2.8706621099609566e-07,0,0.9336089491844177,0.07361062616109848,0,0.793753981590271,0.28221336007118225,0,0.9659239067460195,0.03407609325398057,0
1370,事象の重篤性は提供されなかった。,事象 重篤性 提供 する れる ない た,0,0.9994517013377177,0.0005482986622822179,0,5.5209432397006885e-05,0.999944790567603,0,0.9759326743928145,0.024067325607185445,0,0.9976296828527148,0.0023703171472851474,0,0.9522064924240112,0.05451956018805504,0,0.8228138089179993,0.16037297248840332,0,0.9708655396551077,0.02913446034489232,0
1371,救急治療室の受診は必要なかった。,救急 治療 室 受診 必要 ない た,0,0.984583126645451,0.015416873354548935,0,0.00011563258683019431,0.9998843674131698,0,0.9626742761288388,0.037325723871161155,0,0.997222365256674,0.002777634743326077,0,0.9471680521965027,0.05615374818444252,0,0.8435277938842773,0.16482345759868622,0,0.9694957313310156,0.030504268668984393,0
1372,(2022/06/10)異常なし,0 0 0 異常 ない,0,0.9927498463723333,0.007250153627666629,0,7.528733154847039e-05,0.9999247126684515,0,0.9840786066824166,0.01592139331758336,0,0.9999999765315247,2.3468475224907915e-08,0,0.9344602823257446,0.06351044774055481,0,0.8413003087043762,0.15211687982082367,0,0.9710818321314071,0.028918167868592894,0
1373,しかし、異常は認められなかった。,異常 認める られる ない た,0,0.98885208405342,0.011147915946579988,0,0.00011284939967698007,0.9998871506003231,0,0.9827307756754879,0.017269224324512063,0,0.998008818365932,0.0019911816340679785,0,0.9501359462738037,0.05354222282767296,0,0.8405105471611023,0.1679076999425888,0,0.9709316360182195,0.029068363981780383,0
1374,患者は、関連した病歴はなかった。,患者 関連 する た 病歴 ない た,0,0.9992144513528315,0.0007855486471684488,0,5.961518155323003e-05,0.9999403848184467,0,0.9927779797039018,0.007222020296098165,0,0.9999976227638939,2.3772361060218155e-06,0,0.9457430839538574,0.05743848904967308,0,0.8441810011863708,0.14981558918952942,0,0.9725290094201728,0.027470990579827027,0
1375,重篤な有害事象の発現はなかった。,重篤 だ 有害事象 の 発現 ない た,0,0.9845497772882859,0.015450222711714092,0,9.277952716198103e-05,0.999907220472838,0,0.9248465959887388,0.07515340401126122,0,0.984182539408007,0.015817460591992946,0,0.9435674548149109,0.05651296302676201,0,0.8360718488693237,0.1862131953239441,0,0.9652516424225202,0.03474835757747998,0
1376,患者は、関連する病歴はなかった。,患者 関連 する 病歴 ない た,0,0.9992144513528315,0.0007855486471684488,0,6.226538070527803e-05,0.9999377346192947,0,0.996001918762496,0.003998081237504004,0,0.99963570865169,0.00036429134830992776,0,0.9464147686958313,0.05628623813390732,0,0.8423335552215576,0.15012820065021515,0,0.9726727301071697,0.027327269892830307,0
1377,重篤な有害事象は起こらなかった。,重篤 だ 有害事象 起こる ない た,0,0.998771917510262,0.0012280824897380233,0,6.131291812864487e-05,0.9999386870818714,0,0.9703095813016211,0.029690418698378903,0,0.8388752242830604,0.16112477571693964,0,0.9513430595397949,0.053797945380210876,0,0.8361278176307678,0.18131552636623383,0,0.959627389554203,0.04037261044579712,0
1378,患者に血栓の危険因子はなかった。,患者 血栓 の 危険因子 ない た,0,0.9956992322780556,0.004300767721944509,0,8.563018492913553e-05,0.9999143698150709,0,0.970462599093617,0.029537400906383036,0,0.9756828255482445,0.024317174451755512,0,0.942008912563324,0.05589929223060608,0,0.8432518839836121,0.16165730357170105,0,0.9692777713276861,0.03072222867231391,0
1379,備考:腹部エコー検査では特記なし,備考 腹部 エコー 検査 特記 ない,0,0.9986589749336183,0.0013410250663816172,0,6.0006208110682686e-05,0.9999399937918894,0,0.9687551800470068,0.03124481995299318,0,0.9997432430974391,0.00025675690256085474,0,0.9520474076271057,0.06558135151863098,0,0.8338168859481812,0.15112383663654327,0,0.9707898541713987,0.02921014582860132,0
1380,患者はICUに収容されなかった。,患者 ICU 収容 する れる ない た,0,0.9995147409454525,0.0004852590545475788,0,7.293386427014012e-05,0.9999270661357299,0,0.9934205725333155,0.006579427466684466,0,0.998721212775409,0.001278787224590945,0,0.9558225274085999,0.05740063637495041,0,0.8401445150375366,0.14496824145317078,0,0.9728025280732446,0.027197471926755482,0
1381,事象に関連する家族歴はなかった。,事象 関連 する 家族 歴 ない た,0,0.9993723481807333,0.0006276518192666459,0,5.3926344080257984e-05,0.9999460736559197,0,0.9906597563716577,0.009340243628342291,0,0.9972248769614542,0.0027751230385457495,0,0.9486984610557556,0.0555313304066658,0,0.8319272398948669,0.15955650806427002,0,0.9718090869329061,0.028190913067093794,0
1382,血液検査の結果に異常はなかった。,血液検査 結果 異常 ない た,0,0.992918591528581,0.007081408471419017,0,6.06843920342847e-05,0.9999393156079657,0,0.987684290871746,0.012315709128254,0,0.996141652587806,0.0038583474121939966,0,0.9388269186019897,0.05555170029401779,0,0.8502784967422485,0.1770731508731842,0,0.9709735290944521,0.02902647090554781,0
1383,観察期間は授乳をしていなかった。,観察 期間 授乳 する いる ない た,0,0.9993072272808212,0.0006927727191789094,0,5.518506124066273e-05,0.9999448149387593,0,0.9879910455118425,0.01200895448815749,0,0.997506467558845,0.0024935324411549664,0,0.9478987455368042,0.05601771920919418,0,0.8371399641036987,0.14542753994464874,0,0.9721672183051585,0.02783278169484142,0
1384,さらなる追加情報は期待できない。,追加 情報 期待 できる ない,0,0.9948085851783874,0.005191414821612558,0,5.987164402364918e-05,0.9999401283559763,0,0.976834771648069,0.023165228351931022,0,0.9754254843836835,0.024574515616316493,0,0.9545618891716003,0.06260617822408676,0,0.8211621046066284,0.17069852352142334,0,0.9688313182437707,0.031168681756229267,0
1385,嚥下機能、経口摂取は可であった。,嚥下 機能 経口摂取 可 だ ある た,0,0.9845753310546611,0.015424668945339063,0,8.73122049586588e-05,0.9999126877950414,0,0.625503468642863,0.374496531357137,0,0.8117186592289051,0.18828134077109493,0,0.9486268758773804,0.05516921356320381,0,0.8346204161643982,0.18563996255397797,0,0.915769503947096,0.08423049605290393,0
1386,現在もまだ発熱は未回復であった。,現在 発熱 回復 だ ある た,0,0.9845841882100419,0.015415811789958076,0,6.937047215109568e-05,0.999930629527849,0,0.9478287575111644,0.05217124248883561,0,0.995558011497986,0.004441988502014013,0,0.9466710090637207,0.061148159205913544,0,0.8245670199394226,0.1979748010635376,0,0.9666956510813188,0.03330434891868119,0
1387,3回目の接種情報は不明であった。,0回目 接種 情報 不明 だ ある た,0,0.984570127592682,0.015429872407317906,0,8.612143466421219e-05,0.9999138785653358,0,0.9865641045560012,0.013435895443998772,0,0.9828249683241207,0.017175031675879304,0,0.9363634586334229,0.05773058533668518,0,0.85047447681427,0.18039144575595856,0,0.9694334794327154,0.03056652056728471,0
1388,これ以上の追加情報は得られない。,これ 以上 追加 情報 得る られる ない,0,0.9845701760141394,0.015429823985860744,0,7.214403688800103e-05,0.999927855963112,0,0.970966001390799,0.029033998609200976,1,0.46667257332524836,0.5333274266747516,0,0.9541892409324646,0.08011927455663681,0,0.8050200343132019,0.17990343272686005,1,0.9124360292466991,0.08756397075330084,0
1389,AEに関連する家族歴はなかった。,AE 関連 する 家族 歴 ない た,0,0.9985483855680192,0.0014516144319808785,0,6.545215248880581e-05,0.9999345478475112,0,0.9891248276813949,0.010875172318605133,0,0.9977958381654487,0.0022041618345513504,0,0.9486345052719116,0.06236015260219574,0,0.8321424126625061,0.1831406056880951,0,0.9708677702370193,0.029132229762980695,0
1390,被験者にアレルギー歴はなかった。,被験者 アレルギー歴 ない た,0,0.9984324268368573,0.0015675731631425716,0,7.191279479311537e-05,0.9999280872052069,0,0.9837495366257796,0.016250463374220408,0,0.9836175091197485,0.016382490880251496,0,0.951228678226471,0.05504763498902321,0,0.8540435433387756,0.15638241171836853,0,0.9714070372817233,0.028592962718276747,0
1391,F8インヒビターは陰性であった。,F 0 インヒビター 陰性 だ ある た,0,0.9959122925057673,0.004087707494232779,0,7.298244253741086e-05,0.9999270175574626,0,0.984800132466641,0.01519986753335898,0,0.9329734087163616,0.06702659128363844,0,0.9308738708496094,0.055205851793289185,0,0.8448590636253357,0.17454148828983307,0,0.9668661044128389,0.03313389558716097,0
1392,すべては使用理由不明で服用した。,すべて 使用 理由 不明 だ 服用 する た,0,0.9973362585960176,0.002663741403982451,0,5.171375676172907e-05,0.9999482862432383,0,0.9564254698916678,0.043574530108332205,0,0.5423620644195113,0.45763793558048865,0,0.9397850632667542,0.06722529232501984,0,0.845557451248169,0.21044601500034332,0,0.9241433777049339,0.07585662229506598,0
1393,転帰は、治療なしで回復であった。,転帰 治療 ない だ 回復 だ ある た,0,0.9999847030854224,1.5296914577525275e-05,0,2.9593179281585243e-05,0.9999704068207184,0,0.9863297362003244,0.013670263799675618,0,0.9995560733134095,0.0004439266865905289,0,0.9417897462844849,0.06305916607379913,0,0.8102896809577942,0.1625838428735733,0,0.9706375543705331,0.029362445629466754,0
1394,(不明日)、血液検査:特記なし。,明日 血液検査 特記 ない,0,0.9991178094372207,0.0008821905627791748,0,4.322115260026567e-05,0.9999567788473998,0,0.9695259862278947,0.030474013772105343,0,0.9999990454711598,9.5452884016827e-07,0,0.9512690305709839,0.09523943811655045,0,0.8331719040870667,0.20654502511024475,0,0.9683246487301471,0.03167535126985288,0
1395,48時間以内にめまいは消失した。,0時 間 以内 めまい 消失 する た,0,0.9845885921588642,0.01541140784113575,0,0.00011496197393974957,0.9998850380260602,0,0.8430358129163229,0.15696418708367704,1,0.3669549875700232,0.6330450124299768,0,0.9371743202209473,0.08792494982481003,0,0.8297131061553955,0.17480555176734924,1,0.8691592731736406,0.13084072682635928,0
1396,それ以前は血圧の薬しかなかった。,それ 以前 血圧 薬 ない た,0,0.9979145937748196,0.0020854062251803394,0,5.831753162115975e-05,0.9999416824683789,0,0.9921657503393292,0.007834249660670768,0,0.9981295878672587,0.001870412132741284,0,0.9460770487785339,0.05323833227157593,0,0.8534016609191895,0.18087983131408691,0,0.971856645164218,0.028143354835781908,0
1397,ポララミン1A IVで改善した。,ポララミン 0 A IV 改善 する た,0,0.9979529298969932,0.0020470701030067735,0,7.550158393772887e-05,0.9999244984160622,0,0.9728044605247275,0.02719553947527255,0,0.9937006391699528,0.006299360830047213,0,0.9421637654304504,0.06290030479431152,0,0.8320368528366089,0.18042249977588654,0,0.9695263381393676,0.03047366186063239,0
1398,一般身体検査:正常、注記:入院時,一般 身体検査 正常 注記 入院 時,0,0.9845452644033169,0.015454735596683125,0,8.230500936575079e-05,0.9999176949906342,0,0.9812984986997815,0.018701501300218495,0,0.9899965605765672,0.010003439423432799,0,0.9323975443840027,0.09836572408676147,0,0.8172272443771362,0.16998182237148285,0,0.9674889036863387,0.032511096313661364,0
1399,患者の死亡年月日は不明であった。,患者 死亡 年月日 不明 だ ある た,0,0.8480788893738118,0.15192111062618824,0,0.0001415505024346688,0.9998584494975653,0,0.9804062841181834,0.0195937158818166,0,0.9480465580315863,0.05195344196841365,0,0.9235696792602539,0.0881303995847702,0,0.8233965635299683,0.16824202239513397,0,0.9545201935031922,0.045479806496807766,0
1400,既知のアレルギーは不明であった。,既知 アレルギー 不明 だ ある た,0,0.9899798590556524,0.010020140944347486,0,7.726259246209858e-05,0.9999227374075379,0,0.982782860520663,0.01721713947933702,0,0.9338784866183024,0.06612151338169756,0,0.9384528994560242,0.06112808361649513,0,0.8451376557350159,0.2109885960817337,0,0.9652735810005695,0.03472641899943059,0
1401,喫煙者/喫煙経験者ではなかった。,喫煙者 喫煙 経験 者 ない た,0,0.9845629958754333,0.015437004124566825,0,8.644720517619133e-05,0.9999135527948239,0,0.9266823476495376,0.07331765235046236,0,0.9955348460052119,0.004465153994788129,0,0.9491831064224243,0.058573734015226364,0,0.8505280017852783,0.1671837866306305,0,0.9673174952852381,0.03268250471476187,0
1402,重篤な有害事象は発現しなかった。,重篤 だ 有害事象 発現 する ない た,0,0.9946643524361781,0.00533564756382193,0,7.687229214436448e-05,0.9999231277078556,0,0.9557962201239608,0.044203779876039136,0,0.9975764899268805,0.0024235100731195072,0,0.9492042660713196,0.05573194846510887,0,0.829595685005188,0.17731592059135437,0,0.9689910634777658,0.031008936522234295,0
1403,本報告時点でフォロー中であった。,報告 時点 フォロー 中 だ ある た,0,0.9845701537885526,0.01542984621144736,0,7.516623525341017e-05,0.9999248337647466,0,0.8400871208718779,0.1599128791281221,0,0.9368774191071412,0.06312258089285878,0,0.9488453269004822,0.06616628170013428,0,0.8405912518501282,0.1762373000383377,0,0.9556488848260996,0.04435111517390044,0
1404,(2022/05/10)結果不明,0 0 0 結果 不明,0,0.9845520100310428,0.01544798996895721,0,0.00010613588070064483,0.9998938641192994,0,0.853660117838474,0.14633988216152602,0,0.9999999999999798,2.0189417254666554e-14,0,0.9287457466125488,0.08583244681358337,0,0.8099156022071838,0.23109382390975952,0,0.9568255253897145,0.04317447461028549,0
1405,(2022/05/31)、正常化,0 0 0 正常化,0,0.9845726590953696,0.015427340904630394,0,8.382571686381419e-05,0.9999161742831362,1,0.35873972300322543,0.6412602769967746,0,0.9999999999999989,1.1088722473207357e-15,0,0.9302956461906433,0.06655573844909668,0,0.7355355024337769,0.26194122433662415,1,0.8833070347936256,0.11669296520637445,0
1406,2021/12/01自宅へ退院。,0 0 0 自宅 退院,0,0.9922651381970875,0.007734861802912577,0,7.885564118835496e-05,0.9999211443588116,0,0.9707399000591053,0.02926009994089471,0,1.0,1.4210340675831764e-18,0,0.9295122027397156,0.08832564204931259,0,0.7971195578575134,0.20618218183517456,0,0.9663753121000632,0.03362468789993682,0
1407,2022/01/03、退院した。,0 0 0 退院 する た,0,0.9915337534271234,0.008466246572876724,0,8.626103159910355e-05,0.9999137389684009,0,0.9761600746411134,0.02383992535888657,0,0.9998283609124675,0.00017163908753253603,0,0.9376015067100525,0.07241042703390121,0,0.8163226842880249,0.2012239694595337,0,0.9681856587574627,0.031814341242537354,0
1408,3ヵ月後に、症状は一旦改善した。,0 ヵ月 後 症状 改善 する た,0,0.9994231719480868,0.0005768280519131805,0,6.781664983817987e-05,0.9999321833501619,0,0.9898295287454759,0.010170471254524053,0,0.9853481373584868,0.014651862641513157,0,0.9391149878501892,0.06367483735084534,0,0.8375788927078247,0.17626243829727173,0,0.9702894986283656,0.029710501371634567,0
1409,ステロイド外用で皮疹は消退した。,ステロイド 外用 だ 皮疹 消退 する た,0,0.9950283399821803,0.004971660017819683,0,6.331347745691345e-05,0.9999366865225431,0,0.965407640328587,0.034592359671413095,1,0.3184363877365075,0.6815636122634925,0,0.9271553754806519,0.08062750101089478,0,0.8254563808441162,0.19437073171138763,1,0.8844727106362577,0.11552728936374233,0
1410,その他の薬剤は抗生物質であった。,その他 薬剤 抗生物質 だ ある た,0,0.9445731502245993,0.055426849775400605,0,0.00010361323194404047,0.9998963867680559,0,0.9044990336980665,0.09550096630193353,0,0.9435639239592849,0.05643607604071509,0,0.9342811703681946,0.08671966195106506,0,0.8352437019348145,0.19053909182548523,0,0.955965380188109,0.044034619811891065,0
1411,自発呼吸はあり脳死ではなかった。,自発呼吸 ある 脳死 だ ない た,0,0.9982635911515774,0.0017364088484226685,0,7.206636000320621e-05,0.9999279336399968,0,0.9023522733724344,0.09764772662756564,0,0.997672940698127,0.002327059301873058,0,0.9500152468681335,0.05677022412419319,0,0.8388027548789978,0.15738558769226074,0,0.966798143421472,0.033201856578527984,0
1412,朝水分を取ったが排尿はなかった。,朝 水分 取る た 排尿 ない た,0,0.8015390755933416,0.19846092440665844,0,0.00014529255444887588,0.9998547074455512,0,0.9249149170253728,0.0750850829746272,0,0.8401939739176962,0.1598060260823037,0,0.9391728043556213,0.06038397178053856,0,0.7734127640724182,0.3452901840209961,0,0.919863800167072,0.08013619983292798,0
1413,心因的な要因検査を今後受診予定。,心 因 的 だ 要因 検査 今後 受診 予定,0,0.9845460654811099,0.015453934518889986,0,9.43536496532081e-05,0.9999056463503468,0,0.542915163979464,0.4570848360205359,0,0.9999882144307035,1.1785569296470288e-05,0,0.807891309261322,0.3529609143733978,0,0.6891531944274902,0.34241849184036255,0,0.8649179987446216,0.13508200125537842,0
1414,発症時から無症状のまま経過した。,発症 時 無症状 まま 経過 する た,0,0.9845706807489805,0.015429319251019537,0,0.00011912032323632152,0.9998808796767636,0,0.5131532552242214,0.4868467447757786,0,0.6646502951247667,0.3353497048752333,0,0.8089781999588013,0.26480719447135925,0,0.8463726043701172,0.17279894649982452,0,0.8238614347467332,0.1761385652532667,0
1415,2022/03/07、解熱した。,0 0 0 解熱 する た,0,0.984550084427234,0.015449915572765913,0,0.0001230094785677384,0.9998769905214323,0,0.7730153889102566,0.22698461108974347,0,0.9786350638153661,0.021364936184633896,0,0.8680447936058044,0.11870232969522476,0,0.8091030716896057,0.1975821703672409,0,0.9444600317238951,0.05553996827610488,0
1416,15:12自覚症状の訴えなし。,0 0 自覚症状 訴え ない,0,0.9845570028441261,0.015442997155873864,0,0.00012662991393826538,0.9998733700860617,0,0.9564049712076866,0.04359502879231336,0,0.9998029848706054,0.00019701512939458506,0,0.9111535549163818,0.16257350146770477,0,0.8318564891815186,0.19377316534519196,0,0.96333033575911,0.036669664240890076,0
1417,2021/07/24症状軽快。,0 0 0 症状 軽快,0,0.9993522492509349,0.0006477507490651824,0,7.866728488889589e-05,0.9999213327151111,0,0.9857479891131042,0.014252010886895804,0,0.9999999846721608,1.5327839186450333e-08,0,0.9302169680595398,0.08282164484262466,0,0.8321419358253479,0.19757963716983795,0,0.9693001159234177,0.03069988407658244,0
1418,2022/02/20解熱傾向。,0 0 0 解熱 傾向,0,0.9942132483972379,0.0057867516027619486,0,8.875130346033721e-05,0.9999112486965397,0,0.9317575857616459,0.06824241423835407,0,0.999999999994762,5.2380343013095534e-12,1,0.5772300362586975,0.5934404134750366,0,0.7867732048034668,0.2589928209781647,1,0.9140161833665754,0.08598381663342457,0
1419,2022/03/28改善なし。,0 0 0 改善 ない,0,0.9999964369850117,3.5630149883428685e-06,0,2.5565519956730737e-05,0.9999744344800433,0,0.991446770974109,0.008553229025890913,0,0.9999999536783224,4.632167755736665e-08,0,0.9435795545578003,0.05697765573859215,0,0.8277443051338196,0.20023071765899658,0,0.9706038000807901,0.029396199919209894,0
1420,2022/04/04経過良好。,0 0 0 経過 良好,0,0.9845558588930615,0.015444141106938536,0,9.527206307956329e-05,0.9999047279369204,0,0.8868193208642747,0.11318067913572527,0,1.0,6.699965816736496e-18,0,0.9219775199890137,0.06993085891008377,0,0.7846022844314575,0.2039499431848526,0,0.9599072023057649,0.04009279769423505,0
1421,2022/07/03観察完了。,0 0 0 観察 完了,0,0.984684248697994,0.015315751302006035,0,8.75231128419437e-05,0.999912476887158,0,0.5747758385969064,0.4252241614030936,0,1.0,1.823495513342139e-23,0,0.9364893436431885,0.07153858989477158,0,0.8176125288009644,0.20094755291938782,0,0.9309073212045884,0.06909267879541157,0
1422,2週間以内の併用薬はなかった。,0 週間 以内 併用 薬 ない た,0,0.9999119647441637,8.803525583631967e-05,0,6.0765990142333126e-05,0.9999392340098576,0,0.9932809539303382,0.006719046069661742,0,0.9995446663476905,0.000455333652309568,0,0.9468573331832886,0.05155769735574722,0,0.8512796759605408,0.15052124857902527,0,0.9729239083710096,0.027076091628990318,0
1423,COVID-19が除外された。,COVID 0 除外 する れる た,0,0.7180115060606048,0.281988493939395,1,0.00017471542520132915,0.9998252845747987,1,0.4501329713919834,0.5498670286080166,0,0.8086219374403574,0.1913780625596426,0,0.899427056312561,0.12904126942157745,0,0.8378358483314514,0.1772700697183609,1,0.7997662120081733,0.2002337879918266,0
1424,CSF検査は実施されなかった。,CSF 検査 実施 する れる ない た,0,0.999993545890449,6.45410955103848e-06,0,2.88442163406598e-05,0.9999711557836594,0,0.9976227445560576,0.0023772554439423863,0,0.9999443913699988,5.560863000116707e-05,0,0.9542859792709351,0.0552641786634922,0,0.8374667763710022,0.14449675381183624,0,0.973068840676788,0.026931159323212057,0
1425,アルコール綿での知覚異常なし。,アルコール 綿 知覚異常 ない,0,0.9845754648255851,0.015424535174414916,0,8.872340857929043e-05,0.9999112765914208,0,0.9508470662576923,0.04915293374230766,0,0.9349102255647418,0.06508977443525817,0,0.9436899423599243,0.0631386786699295,0,0.8443170189857483,0.1728655993938446,0,0.9641825570557933,0.035817442944206745,0
1426,イノバン投与にて血圧80程度。,イノバン 投与 血圧 0 程度,0,0.9845503871251212,0.015449612874878869,0,0.00011442903443903437,0.999885570965561,0,0.9371363224023153,0.06286367759768478,0,0.9999948807190838,5.1192809161275e-06,0,0.9102646708488464,0.09803532809019089,0,0.7839282155036926,0.30083325505256653,0,0.9584697665941911,0.04153023340580882,0
1427,クラミジア検査:陰性(陰性)。,クラミジア 検査 陰性 陰性,0,0.9950571668208634,0.004942833179136432,0,5.969404004692149e-05,0.9999403059599531,0,0.9830269590625047,0.016973040937495267,0,1.0,2.2215613416659074e-30,0,0.9363113641738892,0.05937008932232857,0,0.8237823843955994,0.232956662774086,0,0.9684479029711324,0.03155209702886766,0
1428,ステロイドパルス5日間を施行。,ステロイド パルス 0 日間 施行,0,0.9506251217966359,0.049374878203363955,0,9.515190590626554e-05,0.9999048480940937,0,0.9340271443265542,0.0659728556734458,0,0.9992482693346241,0.0007517306653759712,0,0.9297782182693481,0.0847146213054657,1,0.5453173518180847,0.6114599704742432,1,0.9273658097224778,0.07263419027752216,0
1429,その他の特記すべき検査はなし。,その他 特記 する べし 検査 ない,0,0.9992094638461977,0.0007905361538022926,0,5.5015863866863095e-05,0.9999449841361331,0,0.9908114753680323,0.009188524631967685,0,0.9999777807388455,2.221926115456425e-05,0,0.9447657465934753,0.08719401061534882,0,0.8295071125030518,0.17321167886257172,0,0.9705158424974251,0.02948415750257488,0
1430,レジオネラ検査:陰性(陰性)。,レジオネラ 検査 陰性 陰性,0,0.9950571668208634,0.004942833179136432,0,5.969404004692149e-05,0.9999403059599531,0,0.9830269590625047,0.016973040937495267,0,1.0,3.2714696693776016e-31,0,0.9344494938850403,0.06365859508514404,0,0.8304981589317322,0.21766330301761627,0,0.968928908630697,0.031071091369302962,0
1431,医師より点滴終了後帰宅の指示。,医師 点滴 終了 後 帰宅 指示,0,0.9929560990141575,0.007043900985842479,0,6.345239416523233e-05,0.9999365476058347,0,0.6351029352554477,0.3648970647445523,0,0.9999999767310298,2.3268970235687886e-08,0,0.9387287497520447,0.09929731488227844,0,0.7972448468208313,0.20654615759849548,0,0.9362178635192033,0.06378213648079661,0
1432,画像検査実施し、異常所見なし。,画像 検査 実施 する 異常所見なし,0,0.9993203633708632,0.0006796366291367283,0,3.624642519606806e-05,0.9999637535748039,0,0.9754299391579339,0.024570060842066144,0,0.9999999998829223,1.1707772527197378e-10,0,0.9267519116401672,0.06252580136060715,0,0.8157153725624084,0.292166143655777,0,0.9656880922269097,0.034311907773090414,0
1433,冠動脈造影で冠動脈は異常なし。,冠動脈造影 冠動脈 異常 ない,0,0.9875490844912087,0.012450915508791323,0,5.912553887580674e-05,0.9999408744611242,0,0.9669426749401969,0.03305732505980306,0,0.9999989303387347,1.0696612653684815e-06,0,0.9424129724502563,0.060543086379766464,0,0.8132911920547485,0.20443479716777802,0,0.9676990941656788,0.03230090583432126,0
1434,患者は解熱剤を使用しなかった。,患者 解熱 剤 使用 する ない た,0,0.9999141595391802,8.584046081982471e-05,0,4.6189761433436466e-05,0.9999538102385666,0,0.9974528519226773,0.002547148077322752,0,0.9990522843770108,0.0009477156229892173,0,0.9528939127922058,0.05160098150372505,0,0.8224273324012756,0.15110298991203308,0,0.9724963672745103,0.027503632725489682,0
1435,患者は併用薬を服用しなかった。,患者 併用 薬 服用 する ない た,0,0.9999963934262441,3.606573755807358e-06,0,4.050278572655865e-05,0.9999594972142735,0,0.9976428302712399,0.002357169728760058,0,0.9988473598746089,0.0011526401253910915,0,0.9528583884239197,0.053643811494112015,0,0.8260962963104248,0.15644867718219757,0,0.9723990579367878,0.027600942063212147,0
1436,肝機能検査:正常(正常)正常。,肝機能検査 正常 正常 正常,0,0.9930318519278302,0.006968148072169902,0,5.145496523429039e-05,0.9999485450347657,0,0.9923758882265481,0.0076241117734518575,0,1.0,1.2724918382159038e-75,0,0.9358817934989929,0.06460803747177124,0,0.8180834650993347,0.20875276625156403,0,0.9692765227006848,0.030723477299315214,0
1437,関連する医学的検査はなかった。,関連 する 医学 的 検査 ない た,0,0.9985091437891341,0.001490856210865975,0,8.378739713714079e-05,0.9999162126028629,0,0.9882187031331893,0.011781296866810785,0,0.9998611490679138,0.000138850932086197,0,0.9425588846206665,0.05248120799660683,0,0.8358778953552246,0.14296695590019226,0,0.9722488411884614,0.02775115881153845,0
1438,胸部X線で急性肺疾患は認めず。,胸部 X線 急性 肺疾患 認める ぬ,0,0.9587141570172464,0.04128584298275351,1,0.00019736961335507485,0.999802630386645,0,0.7273916366609199,0.27260836333908006,0,0.9756528585017936,0.02434714149820641,1,0.1693163961172104,0.888898491859436,1,0.21699458360671997,0.847868800163269,1,0.49336432244126105,0.506635677558739,0
1439,近医の病院にてPCR検査実施。,近医 病院 PCR検査 実施,0,0.9830230993962639,0.016976900603736144,0,0.0001222941877258806,0.9998777058122741,0,0.8489506101870259,0.15104938981297406,0,0.9310229767265562,0.06897702327344381,0,0.9136824607849121,0.14264540374279022,0,0.8061448335647583,0.2070934772491455,0,0.9476645374347746,0.052335462565225296,0
1440,抗生剤を服用するが、効果なし。,抗生剤 服用 する 効果 ない,0,0.9996872356233143,0.0003127643766855494,0,5.0346728611883184e-05,0.9999496532713881,0,0.9611876196980635,0.038812380301936455,0,0.998609036613217,0.0013909633867830475,0,0.9362672567367554,0.06788066774606705,0,0.7951976656913757,0.23343022167682648,0,0.9660793667163692,0.03392063328363068,0
1441,合併症(問診票上)はなかった。,合併症 問診 票 上 ない た,0,0.9982389750028737,0.001761024997126326,0,6.774330754417907e-05,0.9999322566924558,0,0.9838958689408175,0.016104131059182486,0,0.9978808154531614,0.0021191845468386187,0,0.9547549486160278,0.05610144883394241,0,0.8435117602348328,0.15325944125652313,0,0.972052243520089,0.02794775647991096,0
1442,最初より気分はよくなっている。,最初 気分 なる いる,0,0.9845760472255463,0.015423952774453768,0,0.0001233128197741268,0.9998766871802258,1,0.38720891217282616,0.6127910878271738,0,0.9778269345042774,0.02217306549572259,0,0.6338804364204407,0.5338279604911804,0,0.6924304366111755,0.5397156476974487,1,0.7215649704645475,0.27843502953545257,0
1443,細菌叢は正常及び陰性(陰性)。,細菌叢 正常 陰性 陰性,0,0.9998638394705797,0.00013616052942041788,0,4.394686433360772e-05,0.9999560531356664,0,0.9968144040430283,0.003185595956971679,0,1.0,2.091127541790446e-37,0,0.9315235614776611,0.06436322629451752,0,0.838530421257019,0.19209317862987518,0,0.9708874715127427,0.02911252848725736,0
1444,症状の軽快を認め、退院とした。,症状 軽快 認める 退院 する た,0,0.9979931976342507,0.0020068023657492055,0,5.5680736810057366e-05,0.9999443192631899,0,0.9779956662916682,0.02200433370833179,0,0.9954425173853318,0.004557482614668173,0,0.94106125831604,0.06570970267057419,0,0.7865520715713501,0.2155640572309494,0,0.9673688874865161,0.03263111251348386,0
1445,心血管造影:狭窄なし(正常)。,心 血管造影 狭窄 ない 正常,0,0.9999405755510432,5.942444895673964e-05,0,4.374424320455816e-05,0.9999562557567955,0,0.9916240778304536,0.008375922169546437,0,0.9999999999999997,3.3376523850148724e-16,0,0.94287109375,0.06143923103809357,0,0.8393204808235168,0.18785430490970612,0,0.9711428235421407,0.028857176457859405,0
1446,心電図(ECG):正常洞調律。,心電図 ECG 正常洞調律,1,0.24876943191667256,0.7512305680833274,1,0.0001908098676724198,0.9998091901323276,1,0.4063552965847804,0.5936447034152196,0,0.9975387806300884,0.0024612193699116523,0,0.8915964961051941,0.15892793238162994,0,0.7965359091758728,0.2554703652858734,1,0.6409391720302173,0.3590608279697827,0
1447,腎機能検査:正常(正常)正常。,腎 機能 検査 正常 正常 正常,0,0.9957217005180133,0.004278299481986675,0,4.32989991930004e-05,0.999956701000807,0,0.9935167321892526,0.006483267810747379,0,1.0,2.373427545308285e-69,0,0.9378671050071716,0.06851920485496521,0,0.8208437561988831,0.21401391923427582,0,0.9693722192484194,0.030627780751580496,0
1448,全身筋緊張ケイレン様症状軽減。,全身 筋緊張 ケイレン 様 症状 軽減,0,0.9845614160915377,0.0154385839084623,0,0.00010250684155894242,0.999897493158441,1,0.458428225516198,0.541571774483802,0,0.985304889646954,0.014695110353045996,0,0.9020875096321106,0.13742245733737946,0,0.7711377143859863,0.29100707173347473,1,0.8910576001438761,0.1089423998561239,0
1449,他のワクチンの接種はなかった。,他 ワクチン 接種 ない た,0,0.99950929209934,0.0004907079006601201,0,6.136553336924942e-05,0.9999386344666308,0,0.993141600532153,0.006858399467847092,0,0.9997757510203622,0.00022424897963784683,0,0.9470692276954651,0.054716650396585464,0,0.8431209921836853,0.15312033891677856,0,0.9725439640470228,0.027456035952977204,0
1450,他のワクチンは接種しなかった。,他 ワクチン 接種 する ない た,0,0.9994492246741529,0.0005507753258472349,0,6.779383110441907e-05,0.9999322061688956,0,0.9954504929560074,0.004549507043992544,0,0.9990786075958116,0.0009213924041884217,0,0.9488300085067749,0.05422355234622955,0,0.8196284770965576,0.14933829009532928,0,0.9721584387647729,0.02784156123522717,0
1451,体温は摂氏36.1度であった。,体温 摂氏 0 0度 だ ある た,0,0.9845566516576059,0.015443348342394102,0,0.0001411187146113232,0.9998588812853887,0,0.8237416283756049,0.17625837162439512,0,0.7784242091268372,0.22157579087316287,0,0.8483776450157166,0.2215268760919571,0,0.8375278115272522,0.2215665727853775,0,0.918079838444147,0.081920161555853,0
1452,超音波スキャン:正常(正常)。,超音波 スキャン 正常 正常,0,0.988928973998427,0.011071026001572927,0,6.509687251925514e-05,0.9999349031274808,0,0.9923758882265481,0.0076241117734518575,0,1.0,1.1648735469563469e-42,0,0.9325152635574341,0.06360556930303574,0,0.8284766674041748,0.22887256741523743,0,0.9686671416825733,0.03133285831742687,0
1453,超音波検査は実施されなかった。,超音波 検査 実施 する れる ない た,0,0.9999805370412613,1.9462958738622608e-05,0,4.260421688149484e-05,0.9999573957831185,0,0.997969824885183,0.002030175114816986,0,0.9991110120885105,0.0008889879114895118,0,0.9522661566734314,0.054540425539016724,0,0.8325112462043762,0.14363238215446472,0,0.9729017131188613,0.027098286881138727,0
1454,日付不明その後、状態改善傾向。,日付 不明 その後 状態 改善 傾向,0,0.9963394361297584,0.0036605638702414817,0,5.348602351171624e-05,0.9999465139764883,0,0.9964225970685476,0.0035774029314523735,0,0.999999996948552,3.0514479471795147e-09,0,0.9382268190383911,0.0710030123591423,0,0.8205338716506958,0.1961619257926941,0,0.9700328101661603,0.029967189833839773,0
1455,日付不明心電図:異常所見なし。,日付 不明 心電図 異常所見なし,0,0.9845814299501706,0.015418570049829352,0,5.938142192854349e-05,0.9999406185780715,0,0.8523450527893098,0.14765494721069017,0,0.9999999999997615,2.3852610093262106e-13,0,0.9322694540023804,0.06104230880737305,0,0.8460891246795654,0.21236151456832886,0,0.9600334964376939,0.03996650356230622,0
1456,日付不明内科的な採血異常なし。,日付 不明 内科 的 だ 採血異常なし,0,0.9845468044961238,0.01545319550387624,0,0.00010364039727947713,0.9998963596027205,0,0.9268717532831331,0.07312824671686693,0,0.9999999892575606,1.0742439356256054e-08,0,0.9285714030265808,0.06502921134233475,0,0.8362978100776672,0.18314988911151886,0,0.9657670652740759,0.0342329347259242,0
1457,培養検査は、実施されなかった。,培養 検査 実施 する れる ない た,0,0.9999863212351281,1.3678764871816884e-05,0,4.583190767823526e-05,0.9999541680923217,0,0.9972805854856915,0.0027194145143084273,0,0.99898742941495,0.0010125705850500305,0,0.9539384841918945,0.05519622936844826,0,0.839745283126831,0.1472136378288269,0,0.9729823145141527,0.027017685485847365,0
1458,服用中の経口治療薬はなかった。,服用 中 経口 治療薬 ない た,0,0.9998157876092723,0.0001842123907278079,0,5.1015229707551834e-05,0.9999489847702925,0,0.9710864211497415,0.028913578850258487,0,0.9988467350750867,0.0011532649249132746,0,0.9483366012573242,0.050534117966890335,0,0.8350670337677002,0.15357786417007446,0,0.9712205383255409,0.028779461674459095,0
1459,併用薬リストの入手はなかった。,併用 薬 リスト 入手 ない た,0,0.999855058461774,0.00014494153822597192,0,6.762050156873782e-05,0.9999323794984313,0,0.9921657503393292,0.007834249660670768,0,0.9991521395235787,0.0008478604764212447,0,0.9534399509429932,0.04986210912466049,0,0.8501733541488647,0.15567520260810852,0,0.9728949784034927,0.027105021596507163,0
1460,容態が安定し、患者は退院した。,容態 安定 する 患者 退院 する た,0,0.9978341448609341,0.0021658551390659414,0,6.709699745072932e-05,0.9999329030025492,0,0.9544897766363575,0.045510223363642494,0,0.9869589582629376,0.013041041737062416,0,0.9320733547210693,0.0639379620552063,0,0.8063961267471313,0.19246728718280792,0,0.9664555598501613,0.033544440149838706,0
1461,検査実施の有無は不明であった。,検査 実施 有無 不明 だ ある た,0,0.9992543074269185,0.0007456925730815788,0,4.472169519543888e-05,0.9999552783048046,0,0.9952420026970122,0.004757997302987805,0,0.9882746039556559,0.011725396044344041,0,0.9432595372200012,0.05932404473423958,0,0.8543223142623901,0.18652883172035217,0,0.9711777050636284,0.02882229493637163,0
1462,患者の病歴は報告されなかった。,患者 病歴 報告 する れる ない た,0,0.9995485828216852,0.0004514171783146974,0,6.213948946249588e-05,0.9999378605105375,0,0.9958087273752693,0.004191272624730788,0,0.9990103722608348,0.0009896277391652645,0,0.9528942108154297,0.055334288626909256,0,0.8319921493530273,0.14184895157814026,0,0.9727894463851364,0.027210553614863436,0
1463,患者の家族歴に特記はなかった。,患者 家族 歴 特記 ない た,0,0.999594870016118,0.0004051299838820725,0,5.005640755879985e-05,0.9999499435924412,0,0.9919306726456911,0.008069327354308889,0,0.9996430096942587,0.0003569903057413475,0,0.9548941850662231,0.05991359055042267,0,0.845271110534668,0.15886491537094116,0,0.9724502111796959,0.027549788820304223,0
1464,酸素投与は、実施されなかった。,酸素 投与 実施 する れる ない た,0,0.9999902245243169,9.775475683127137e-06,0,4.652934200232521e-05,0.9999534706579977,0,0.9954414917963924,0.004558508203607616,0,0.9984902749005936,0.0015097250994063618,0,0.9543745517730713,0.05294476076960564,0,0.8453553915023804,0.15947243571281433,0,0.9727546701462964,0.02724532985370368,0
1465,酸素投与は、施行されなかった。,酸素 投与 施行 する れる ない た,0,0.9999515634386492,4.843656135081045e-05,0,5.2369912339848674e-05,0.9999476300876602,0,0.9963002952149097,0.003699704785090313,0,0.998293557061093,0.0017064429389070021,0,0.9538414478302002,0.05334930121898651,0,0.843129575252533,0.1622375249862671,0,0.9726306268757607,0.0273693731242393,0
1466,人工呼吸器は使用されなかった。,人工呼吸器 使用 する れる ない た,0,0.9996515320822624,0.00034846791773760215,0,5.8334391450241045e-05,0.9999416656085498,0,0.9880202617187389,0.011979738281261058,0,0.9989823656168124,0.0010176343831876157,0,0.9512211084365845,0.05146784707903862,0,0.8421732187271118,0.15214352309703827,0,0.9724337015662861,0.027566298433714023,0
1467,静脈造影: (2021)正常。,静脈造影 0 正常,0,0.9941563321485394,0.00584366785146052,0,7.734992651111323e-05,0.9999226500734889,0,0.9877452240979341,0.012254775902065881,0,0.999999999999994,6.029175589738656e-15,0,0.9358142614364624,0.06353504210710526,0,0.8164166808128357,0.22951708734035492,0,0.9684198396392539,0.03158016036074617,0
1468,重篤性評価は提供されなかった。,重篤性 評価 提供 する れる ない た,0,0.9967356870776138,0.003264312922386082,0,6.966383422509935e-05,0.9999303361657749,0,0.9664774410145305,0.033522558985469554,0,0.9963750426885708,0.003624957311429178,0,0.9566018581390381,0.05433761700987816,0,0.8356202840805054,0.15966765582561493,0,0.9706174809134188,0.029382519086581026,0
1469,事象の転帰は提供されなかった。,事象 転帰 提供 する れる ない た,0,0.9996193813236371,0.00038061867636278744,0,5.953585360733652e-05,0.9999404641463927,0,0.9848953325054064,0.015104667494593613,0,0.9981651515585035,0.001834848441496548,0,0.9515694379806519,0.05052593722939491,0,0.8184370994567871,0.14311830699443817,0,0.9718551148334802,0.02814488516651982,0
1470,患者に関連した病歴はなかった。,患者 関連 する た 病歴 ない た,0,0.9992144513528315,0.0007855486471684488,0,5.961518155323003e-05,0.9999403848184467,0,0.9927779797039018,0.007222020296098165,0,0.9999976227638939,2.3772361060218155e-06,0,0.9457430839538574,0.05743848904967308,0,0.8441810011863708,0.14981558918952942,0,0.9725290094201728,0.027470990579827027,0
1471,胸部CT検査は未実施であった。,胸部 CT検査 実施 だ ある た,0,0.9975000369702817,0.0024999630297183237,0,6.480714477578045e-05,0.9999351928552243,0,0.9847395032727853,0.01526049672721479,0,0.9997543261650762,0.0002456738349237661,0,0.9474197626113892,0.063307985663414,0,0.8453919887542725,0.2188807874917984,0,0.9699604463462879,0.030039553653712123,0
1472,患者は関連する病歴はなかった。,患者 関連 する 病歴 ない た,0,0.9992144513528315,0.0007855486471684488,0,6.226538070527803e-05,0.9999377346192947,0,0.996001918762496,0.003998081237504004,0,0.99963570865169,0.00036429134830992776,0,0.9464147686958313,0.05628623813390732,0,0.8423335552215576,0.15012820065021515,0,0.9726727301071697,0.027327269892830307,0
1473,患者に関連する病歴はなかった。,患者 関連 する 病歴 ない た,0,0.9992144513528315,0.0007855486471684488,0,6.226538070527803e-05,0.9999377346192947,0,0.996001918762496,0.003998081237504004,0,0.99963570865169,0.00036429134830992776,0,0.9464147686958313,0.05628623813390732,0,0.8423335552215576,0.15012820065021515,0,0.9726727301071697,0.027327269892830307,0
1474,原疾患と合併症は不明であった。,原 疾患 合併症 不明 だ ある た,0,0.995427026825124,0.004572973174875902,0,6.62104531557366e-05,0.9999337895468443,0,0.99512452441131,0.004875475588689956,0,0.9037021366370098,0.09629786336299014,0,0.9315105080604553,0.05967353656888008,0,0.8310211300849915,0.18692125380039215,0,0.9645854832559645,0.035414516744035486,0
1475,原疾患および合併症は無かった。,原 疾患 合併症 無い た,0,0.9845558904604684,0.01544410953953161,0,6.83957991007342e-05,0.9999316042008992,0,0.7159001275865964,0.28409987241340356,0,0.9793842060063965,0.02061579399360348,0,0.9338304996490479,0.05822735279798508,0,0.8280228972434998,0.14730386435985565,0,0.9486385236433506,0.051361476356649546,0
1476,更なる追加情報は期待できない。,更 なり 追加 情報 期待 できる ない,0,0.9845882502599616,0.015411749740038408,0,7.75623130609165e-05,0.9999224376869391,0,0.9092115503314506,0.09078844966854933,0,0.9178328698150489,0.08216713018495113,0,0.9542165398597717,0.06736024469137192,0,0.8094483613967896,0.19924134016036987,0,0.9577298176361985,0.04227018236380146,0
1477,原疾患、合併症は不明であった。,原 疾患 合併症 不明 だ ある た,0,0.995427026825124,0.004572973174875902,0,6.62104531557366e-05,0.9999337895468443,0,0.99512452441131,0.004875475588689956,0,0.9037021366370098,0.09629786336299014,0,0.9315105080604553,0.05967353656888008,0,0.8310211300849915,0.18692125380039215,0,0.9645854832559645,0.035414516744035486,0
1478,患者はその他の病歴はなかった。,患者 その他 病歴 ない た,0,0.9994142620519053,0.0005857379480945607,0,5.439231195173695e-05,0.9999456076880483,0,0.9966069638465266,0.0033930361534734305,0,0.9999150840041519,8.49159958480993e-05,0,0.9454630017280579,0.05753321573138237,0,0.8411740064620972,0.15194669365882874,0,0.9725922338391632,0.027407766160836698,0
1479,原疾患・合併症は不明であった。,原 疾患 合併症 不明 だ ある た,0,0.995427026825124,0.004572973174875902,0,6.62104531557366e-05,0.9999337895468443,0,0.99512452441131,0.004875475588689956,0,0.9037021366370098,0.09629786336299014,0,0.9315105080604553,0.05967353656888008,0,0.8310211300849915,0.18692125380039215,0,0.9645854832559645,0.035414516744035486,0
1480,循環器系の基礎疾患はなかった。,循環器 系 基礎疾患 ない た,0,0.9963523559394363,0.003647644060563796,0,6.37107378759189e-05,0.9999362892621241,0,0.968253672491632,0.03174632750836802,0,0.9981848849021351,0.0018151150978649353,0,0.9455103874206543,0.05717923864722252,0,0.8369771838188171,0.14653152227401733,0,0.9708151420117578,0.02918485798824208,0
1481,高感度CRPは未実施であった。,感度 CRP 実施 だ ある た,0,0.9916122967709893,0.00838770322901072,0,7.656888639120295e-05,0.9999234311136088,0,0.9681718458359203,0.031828154164079726,0,0.9975812249622287,0.002418775037771347,0,0.9331348538398743,0.09170030802488327,0,0.8525540232658386,0.20783674716949463,0,0.9677368876461496,0.03226311235385038,0
1482,ワクチンと膿瘍は関係なかった。,ワクチン 膿瘍 関係 ない た,0,0.9986498949290858,0.001350105070914221,0,7.94083426650382e-05,0.9999205916573349,0,0.9640365464408378,0.03596345355916219,0,0.9820701063066981,0.01792989369330189,0,0.9470876455307007,0.05390625819563866,0,0.8525792956352234,0.1634516417980194,0,0.9698799416806558,0.03012005831934426,0
1483,アレルギーや既往歴はなかった。,アレルギー 既往 歴 ない た,0,0.9990167236317766,0.0009832763682234348,0,5.9086445583875695e-05,0.9999409135544162,0,0.9833093291399719,0.016690670860028043,0,0.9985530763091682,0.0014469236908317162,0,0.9483116269111633,0.056228965520858765,0,0.860859215259552,0.1688147485256195,0,0.9719687463136417,0.02803125368635823,0
1484,ウイルスマーカーは陰性であった,ウイルス マーカー 陰性 だ ある た,0,0.9984646538106521,0.001535346189347959,0,4.685740583356149e-05,0.9999531425941665,0,0.984800132466641,0.01519986753335898,0,0.9364268014226609,0.06357319857733912,0,0.9350311756134033,0.05041397362947464,0,0.8476877808570862,0.17341694235801697,0,0.9676533962548266,0.03234660374517332,0
1485,事象の転帰は報告されなかった。,事象 転帰 報告 する れる ない た,0,0.9998086370112781,0.00019136298872188,0,5.855851412249692e-05,0.9999414414858775,0,0.9910498111621115,0.00895018883788848,0,0.9983512081381812,0.0016487918618187565,0,0.9555550813674927,0.05457882955670357,0,0.8120980262756348,0.14459696412086487,0,0.971996256177954,0.02800374382204585,0
1486,血液検査:特に問題はなかった。,血液検査 問題 ない た,0,0.9985885366857149,0.001411463314285026,0,5.4559810943703326e-05,0.9999454401890563,0,0.9900480001823301,0.009951999817669975,0,0.9993246085420426,0.000675391457957359,0,0.9516457915306091,0.052179962396621704,0,0.8440947532653809,0.21941012144088745,0,0.9706929435969838,0.02930705640301614,0
1487,処置により症状は改善となった。,処置 症状 改善 なる た,0,0.9941801703403187,0.0058198296596811815,0,9.089247321744395e-05,0.9999091075267825,0,0.9687667715807041,0.03123322841929586,0,0.9998880512434619,0.00011194875653812368,0,0.9366158843040466,0.05937717482447624,0,0.7960903644561768,0.20237310230731964,0,0.9676046202983339,0.032395379701666165,0
1488,これ以上の情報は期待できない。,これ 以上 情報 期待 できる ない,0,0.9858388986877576,0.014161101312242368,0,6.693705448990358e-05,0.9999330629455101,0,0.9532665165218859,0.046733483478114166,0,0.9450971296532611,0.05490287034673887,0,0.9516372084617615,0.07742679864168167,0,0.8115981817245483,0.17750605940818787,0,0.9636257363161433,0.0363742636838566,0
1489,患者の状態はしばらく安定した。,患者 状態 安定 する た,0,0.9845816768478063,0.01541832315219361,0,0.00010242416804984476,0.9998975758319502,0,0.7402592321582544,0.2597407678417456,0,0.9497501293047904,0.05024987069520961,0,0.9235182404518127,0.06181555986404419,0,0.8212634921073914,0.19602447748184204,0,0.9446076741554705,0.05539232584452953,0
1490,原疾患/合併症は不明であった。,原 疾患 合併症 不明 だ ある た,0,0.995427026825124,0.004572973174875902,0,6.62104531557366e-05,0.9999337895468443,0,0.99512452441131,0.004875475588689956,0,0.9037021366370098,0.09629786336299014,0,0.9315105080604553,0.05967353656888008,0,0.8310211300849915,0.18692125380039215,0,0.9645854832559645,0.035414516744035486,0
1491,それ以外に特に症状はなかった。,それ 以外 症状 ない た,0,0.9988380002903804,0.0011619997096195074,0,6.43758754259665e-05,0.999935624124574,0,0.9818945022164225,0.018105497783577486,0,0.9943773755935508,0.00562262440644922,0,0.9453185200691223,0.05329171568155289,0,0.8421319127082825,0.19556495547294617,0,0.9703715005073043,0.02962849949269565,0
1492,関節造影:結果は不明であった。,関節 造影 結果 不明 だ ある た,0,0.9848984198149632,0.015101580185036899,0,0.00011545686824375712,0.9998845431317562,0,0.9807305178189789,0.01926948218102104,0,0.9426159899743414,0.05738401002565868,0,0.9385055899620056,0.06383688002824783,0,0.8433420658111572,0.21295157074928284,0,0.9651684807107159,0.034831519289284005,0
1493,接種前後の異常は特になかった。,接種 前後 異常 ない た,0,0.9943017026433745,0.005698297356625527,0,6.548892497179545e-05,0.9999345110750282,0,0.9762142247222021,0.023785775277797884,0,0.988512257435469,0.011487742564531035,0,0.9345053434371948,0.061245907098054886,0,0.8445469737052917,0.16088750958442688,0,0.9699711064650824,0.03002889353491758,0
1494,D-ダイマーは上昇しなかった。,D ダイマー 上昇 する ない た,0,0.9951747099070478,0.004825290092952027,0,8.590241924556245e-05,0.9999140975807544,0,0.9758827095130123,0.024117290486987714,0,0.9965327220942478,0.0034672779057522115,0,0.944476306438446,0.06089697405695915,0,0.8366958498954773,0.15599267184734344,0,0.9706773706769191,0.02932262932308106,0
1495,詳細情報の入手は期待できない。,詳細情報 入手 期待 できる ない,0,0.9845811418890803,0.015418858110919833,0,7.862850096349628e-05,0.9999213714990365,0,0.9511824180338596,0.04881758196614037,0,0.9202548692348701,0.0797451307651299,0,0.9479875564575195,0.07067295908927917,0,0.835063099861145,0.16808441281318665,0,0.962905529797682,0.037094470202318014,0
1496,被験者にアレルギーはなかった。,被験者 アレルギー ない た,0,0.9985851520413594,0.001414847958640613,0,5.5329423404200486e-05,0.9999446705765958,0,0.9900480001823301,0.009951999817669975,0,0.9988300548102823,0.001169945189717711,0,0.9504773616790771,0.057078082114458084,0,0.8575013279914856,0.15143974125385284,0,0.9727347367995294,0.02726526320047075,0
1497,2022/03/19自宅退院。,0 0 0 自宅 退院,0,0.9922651381970875,0.007734861802912577,0,7.885564118835496e-05,0.9999211443588116,0,0.9707399000591053,0.02926009994089471,0,1.0,1.4210340675831764e-18,0,0.9295122027397156,0.08832564204931259,0,0.7971195578575134,0.20618218183517456,0,0.9663753121000632,0.03362468789993682,0
1498,2022/06時点で改善した。,0 0時 点 改善 する た,0,0.9950898439399389,0.00491015606006104,0,8.300546402095475e-05,0.999916994535979,0,0.97297294553032,0.027027054469679988,0,0.9773387546948075,0.022661245305192496,0,0.9403482675552368,0.06513204425573349,0,0.8365731835365295,0.18543307483196259,0,0.9682416321527968,0.03175836784720323,0
1499,これ以上の再調査は不要である。,これ 以上 再調査 不要 だ ある,0,0.985018193568999,0.014981806431001027,0,8.120216767775841e-05,0.9999187978323223,0,0.7584848015972057,0.2415151984027944,0,0.9992662329072113,0.0007337670927887643,0,0.9456328749656677,0.07249515503644943,0,0.8163884282112122,0.1787605732679367,0,0.9524142366448196,0.04758576335518028,0
1500,その他の症状/徴候はなかった。,その他 症状 徴候 ない た,0,0.9997557539235152,0.0002442460764847187,0,6.211482322560244e-05,0.9999378851767744,0,0.9928156607142065,0.007184339285793511,0,0.9412234516689035,0.05877654833109649,0,0.9398719668388367,0.05560331046581268,0,0.8446592092514038,0.1823127418756485,0,0.9681493658317893,0.031850634168210656,0
1501,患者は、嚥下/摂取可であった。,患者 嚥下 摂取 可 だ ある た,0,0.9845548304550356,0.015445169544964464,0,8.677830514130764e-05,0.9999132216948587,0,0.6747484548653572,0.3252515451346428,0,0.8389507784669827,0.16104922153301726,0,0.94842129945755,0.05506564676761627,0,0.8530917167663574,0.1936418116092682,0,0.9275390595488183,0.07246094045118172,0
1502,腎機能も元のベースに回復した。,腎 機能 元 ベース 回復 する た,0,0.9845714007381963,0.015428599261803752,0,8.287819722760084e-05,0.9999171218027724,0,0.9177418887895721,0.08225811121042792,0,0.6580936196522933,0.3419063803477067,0,0.9331596493721008,0.06152411922812462,0,0.8124501705169678,0.18520258367061615,0,0.9321290201989512,0.06787097980104877,0
1503,追加調査の試みは不可能である。,追加 調査 試み 不可能 だ ある,0,0.9845665997125997,0.01543340028740029,0,8.189438560352655e-05,0.9999181056143964,0,0.8674366322344741,0.13256336776552588,0,0.9887274899880221,0.011272510011977948,0,0.9512723684310913,0.07536578178405762,0,0.8160354495048523,0.19437968730926514,0,0.960043513345644,0.03995648665435607,0
1504,頭部MRI等一般検査異常なし。,頭部 MRI 等 一般 検査 異常 ない,0,0.9954792491211663,0.004520750878833753,0,5.326850979224892e-05,0.9999467314902077,0,0.9865776785376403,0.013422321462359688,0,0.9987618932325634,0.0012381067674366389,0,0.9369213581085205,0.06507610529661179,0,0.8384975790977478,0.16096442937850952,0,0.9710025889116277,0.02899741108837217,0
1505,(2022/05/06)正常。,0 0 0 正常,0,0.9976767675055506,0.002323232494449425,0,8.090069242610998e-05,0.9999190993075739,0,0.9820634835998474,0.017936516400152612,0,1.0,2.2924534661134948e-23,0,0.9238287210464478,0.08453750610351562,0,0.8071967363357544,0.20873652398586273,0,0.9676229835980137,0.032377016401986196,0
1506,これ以上の再調査は不可である。,これ 以上 再調査 不可 だ ある,0,0.9845818919201411,0.015418108079858741,0,9.494549712422582e-05,0.9999050545028758,0,0.6564074201539737,0.3435925798460263,0,0.995907952427786,0.0040920475722140874,0,0.9415420889854431,0.0674150288105011,0,0.8192183375358582,0.18871355056762695,0,0.9415092894530475,0.05849071054695249,0
1507,以後、動悸は軽快傾向を示した。,以後 動悸 軽快 傾向 示す た,0,0.9787036904796482,0.02129630952035166,0,8.883426282854115e-05,0.9999111657371714,0,0.993782558459774,0.006217441540226,0,0.5707142350213312,0.4292857649786688,0,0.9446333646774292,0.09481822699308395,0,0.7792915105819702,0.26729831099510193,0,0.9204434132751771,0.07955658672482298,0
1508,患者のイニシャルは報告された。,患者 イニシャル 報告 する れる た,0,0.984578095787411,0.015421904212588945,0,0.00010776947482968889,0.9998922305251703,0,0.7040817827103216,0.2959182172896783,1,0.2592455911332714,0.7407544088667286,0,0.9307002425193787,0.11747026443481445,0,0.8176738619804382,0.24949409067630768,1,0.7820130496295202,0.2179869503704799,0
1509,患者は、併用薬を投与していた。,患者 併用 薬 投与 する いる た,0,0.9990472161763091,0.0009527838236909373,0,6.987689314130498e-05,0.9999301231068587,0,0.9961413682583626,0.003858631741637349,0,0.9161909576759868,0.08380904232401316,0,0.9422030448913574,0.07314281910657883,0,0.8069543242454529,0.2073315978050232,0,0.9641388848359899,0.03586111516401023,0
1510,総頚動脈は触知可能でなかった。,総頚動脈 触知 可能 だ ない た,0,0.9985504723345849,0.0014495276654149243,0,6.350447530072102e-05,0.9999364955246993,0,0.9643102618249246,0.035689738175075404,0,0.9960648444228527,0.0039351555771473526,0,0.905279815196991,0.11295376718044281,0,0.8058575391769409,0.20755617320537567,0,0.9647228557055773,0.035277144294422726,0
1511,迷走神経反射の既往はなかった。,迷走神経反射 既往 ない た,0,0.9882164488455788,0.011783551154421259,0,0.0001140385378703342,0.9998859614621297,0,0.9741827841769427,0.025817215823057262,0,0.988190993058912,0.01180900694108799,0,0.9444817304611206,0.057048115879297256,0,0.8511533141136169,0.1816098392009735,0,0.9694802361117266,0.030519763888273328,0
1512,嗅覚は徐々に改善傾向であった。,嗅覚 改善 傾向 だ ある た,0,0.9994327639718155,0.0005672360281845631,0,5.98575990548101e-05,0.9999401424009452,0,0.9962374189710628,0.003762581028937214,0,0.9539792796459418,0.0460207203540582,0,0.945087730884552,0.059360504150390625,0,0.8299223780632019,0.225236713886261,0,0.9673852297474557,0.03261477025254423,0
1513,左鼠経からCVCが留置された。,左 鼠 経 CVC 留置 する れる た,0,0.9768560638995274,0.023143936100472495,0,0.00012472594583717012,0.9998752740541629,1,0.49501830486767817,0.5049816951323218,1,0.4250899479417436,0.5749100520582564,0,0.9022604823112488,0.1523238718509674,0,0.7294298410415649,0.4078576862812042,1,0.7038474294432764,0.29615257055672356,0
1514,左側臥位でボスミンを筋注した。,左 側臥 位 ボスミン 筋 注す た,0,0.9845700618322171,0.015429938167782903,0,0.00013768641387487093,0.9998623135861251,1,0.4476211978209057,0.5523788021790943,0,0.534459134628515,0.465540865371485,0,0.9229026436805725,0.1265597641468048,0,0.7798603177070618,0.2645483911037445,1,0.7764732272074297,0.2235267727925703,0
1515,人工呼吸器の使用はなかった。,人工呼吸器 使用 ない た,0,0.9997642848121406,0.00023571518785933383,0,4.464570618369659e-05,0.9999553542938163,0,0.9900480001823301,0.009951999817669975,0,0.9999290445745254,7.09554254746634e-05,0,0.9465224146842957,0.05069570615887642,0,0.8477968573570251,0.16745077073574066,0,0.9722329331379544,0.02776706686204568,0
1516,06/17、事象は軽快した。,0 0 事象 軽快 する た,0,0.9985218349859918,0.0014781650140082208,0,5.0823287861959744e-05,0.999949176712138,0,0.977017082133677,0.022982917866323022,0,0.9893568530724469,0.010643146927553082,0,0.9425947666168213,0.06527646631002426,0,0.8150374889373779,0.15673334896564484,0,0.969690496283474,0.030309503716526055,0
1517,6週間後に腎生検を施行した。,0 週間 後 腎生検 施行 する た,0,0.9845677158350516,0.01543228416494831,0,0.0001066622821093588,0.9998933377178907,0,0.8129132241870984,0.18708677581290162,0,0.7534789211287913,0.2465210788712086,0,0.9195685982704163,0.08856216818094254,0,0.7941749691963196,0.25482138991355896,0,0.9221908422479032,0.07780915775209683,0
1518,C型肝炎抗体:陰性(陰性)。,C型 肝炎 抗体 陰性 陰性,0,0.9984022417237375,0.0015977582762626138,0,4.529413372222025e-05,0.9999547058662778,0,0.9918597849167566,0.008140215083243404,0,1.0,7.138684451439226e-39,0,0.9244482517242432,0.0590759702026844,0,0.832191526889801,0.19940297305583954,0,0.9700777965821503,0.02992220341784967,0
1519,EIA法でウイルス検査実施。,EIA 法 ウイルス検査 実施,0,0.98514501466032,0.01485498533967985,0,8.081619371252941e-05,0.9999191838062875,0,0.8888730914993862,0.11112690850061376,0,0.9999999999955761,4.423864271344646e-12,0,0.9273431301116943,0.09784631431102753,0,0.8043314814567566,0.2485254853963852,0,0.9582536566247588,0.04174634337524125,0
1520,IgGインデックス上昇なし。,IgG インデックス 上昇 ない,0,0.9933666089942109,0.006633391005789072,0,8.854573145120311e-05,0.9999114542685488,0,0.9096770912505455,0.09032290874945446,0,0.9965355586637834,0.0034644413362165524,0,0.9345847964286804,0.07478059828281403,0,0.8484598398208618,0.17103350162506104,0,0.9656621618738481,0.03433783812615197,0
1521,"WBCは6,500であった。",WBC 0 0 だ ある た,0,0.9079434976784461,0.09205650232155399,0,0.00016164313262197053,0.999838356867378,1,0.4742813195348009,0.5257186804651991,0,0.9999982823592588,1.717640741141791e-06,0,0.865975022315979,0.14900469779968262,0,0.8217395544052124,0.2396690845489502,1,0.8873356503152758,0.11266434968472418,0
1522,ウイルスペア血清は異常なし。,ウイルス ペア 血清 異常 ない,0,0.9911352391034295,0.008864760896570444,0,5.737501469889855e-05,0.9999426249853011,0,0.9529447731844362,0.04705522681556387,0,0.9998032597866652,0.0001967402133347769,0,0.9448225498199463,0.061762236058712006,0,0.852562427520752,0.16588088870048523,0,0.9694576677786289,0.030542332221371104,0
1523,ステロイドパルス療法を開始。,ステロイド パルス 療法 開始,0,0.9845517762753101,0.015448223724689802,0,8.79633778627065e-05,0.9999120366221373,0,0.9754851114156604,0.024514888584339582,0,0.9999999770956921,2.2904307863656657e-08,0,0.9252979755401611,0.08920182287693024,0,0.6166558861732483,0.5702138543128967,0,0.9428262879786595,0.05717371202134055,0
1524,その後、症状の回復を認めた。,その後 症状 回復 認める た,0,0.9932674385850906,0.006732561414909449,0,0.00010027050844175705,0.9998997294915583,0,0.9728633023871981,0.027136697612801908,0,0.9964234255262975,0.0035765744737025324,0,0.9385133981704712,0.06801653653383255,0,0.8108314871788025,0.2299993932247162,0,0.9669663778538093,0.033033622146190704,0
1525,その後、症状の軽快を認めた。,その後 症状 軽快 認める た,0,0.9874707930471992,0.012529206952800699,0,0.00010762970569085087,0.9998923702943091,0,0.9393508169796199,0.060649183020380144,0,0.9429941175346148,0.05700588246538513,0,0.9420651793479919,0.06949499994516373,0,0.8124432563781738,0.2165592461824417,0,0.9611454627320137,0.0388545372679863,0
1526,その後、症状は軽快であった。,その後 症状 軽快 だ ある た,0,0.9989998484002813,0.001000151599718714,0,5.578433182793618e-05,0.999944215668172,0,0.9970890830611342,0.002910916938865792,0,0.9943853802303901,0.005614619769609885,0,0.943642258644104,0.06923838704824448,0,0.8267481327056885,0.19530391693115234,0,0.970312965983517,0.02968703401648296,0
1527,その他特記すべき検査:なし。,その他 特記 する べし 検査 ない,0,0.9992094638461977,0.0007905361538022926,0,5.5015863866863095e-05,0.9999449841361331,0,0.9908114753680323,0.009188524631967685,0,0.9999777807388455,2.221926115456425e-05,0,0.9447657465934753,0.08719401061534882,0,0.8295071125030518,0.17321167886257172,0,0.9705158424974251,0.02948415750257488,0
1528,バイスタンダーCPRを開始。,バイスタンダー CPR 開始,0,0.965923251913712,0.03407674808628793,0,0.00010386499538197435,0.999896135004618,0,0.7739001988092524,0.22609980119074752,0,0.9237850127706149,0.07621498722938508,0,0.9228482842445374,0.0997602716088295,0,0.8184887170791626,0.2984614670276642,0,0.9352657278355215,0.0647342721644784,0
1529,ヘパリンの投与歴はなかった。,ヘパリン 投与 歴 ない た,0,0.9999706738893377,2.9326110662367392e-05,0,2.826588948779129e-05,0.9999717341105122,0,0.9931815800835904,0.006818419916409634,0,0.9991464662781497,0.0008535337218502123,0,0.9455460906028748,0.05376914143562317,0,0.8414924144744873,0.19114404916763306,0,0.9714401919202263,0.028559808079773562,0
1530,ミコナゾールを14日間投与。,ミコナゾール 0 日間 投与,0,0.837691886827718,0.16230811317228183,0,0.00013225808254587701,0.9998677419174541,0,0.9371363224023153,0.06286367759768478,1,0.37712463877311064,0.6228753612268894,0,0.9281905293464661,0.07204873859882355,0,0.8028423190116882,0.25542810559272766,1,0.8465411314134711,0.15345886858652893,0
1531,ゆっくり起立し気分不良なし。,起立 する 気分不良 ない,0,0.9878066428551417,0.012193357144858231,0,9.127325085734719e-05,0.9999087267491427,0,0.9764804652875098,0.02351953471249022,0,0.92641216137819,0.07358783862181,0,0.885762631893158,0.17777425050735474,0,0.836796760559082,0.22229637205600739,0,0.9570603107873961,0.04293968921260387,0
1532,下肢挙上にて130台へ回復。,下肢 挙 上 0 台 回復,0,0.9845778060580916,0.01542219394190848,0,0.00011236816054823868,0.9998876318394517,0,0.8964981073950058,0.10350189260499415,0,0.9956288795065553,0.0043711204934446975,0,0.9367998242378235,0.07437393814325333,0,0.79543137550354,0.29860302805900574,0,0.9574212657383222,0.04257873426167769,0
1533,冠動脈造影CTでは狭窄なし。,冠動脈造影 CT 狭窄 ない,0,0.9975510399866789,0.0024489600133209702,0,5.663514990256115e-05,0.9999433648500975,0,0.9791348391162118,0.020865160883788206,0,0.9999999725304237,2.7469576324544357e-08,0,0.9456803202629089,0.05671986937522888,0,0.8433564901351929,0.17768314480781555,0,0.9709178921421545,0.02908210785784546,0
1534,血液検査、XPにて異常なし。,血液検査 XP 異常 ない,0,0.9887129118634918,0.011287088136508312,0,5.532153654541235e-05,0.9999446784634546,0,0.9871986233676191,0.012801376632380942,0,0.9999986775210407,1.3224789593512278e-06,0,0.9379563331604004,0.06586894392967224,0,0.8416606783866882,0.18901944160461426,0,0.9700163209345628,0.02998367906543708,0
1535,血液検査を実施し、異常なし。,血液検査 実施 する 異常 ない,0,0.9995235417399346,0.0004764582600654232,0,4.080037489678756e-05,0.9999591996251033,0,0.9956528591256267,0.004347140874373258,0,0.9999834274390186,1.6572560981388394e-05,0,0.9442774653434753,0.0619841106235981,0,0.8471564054489136,0.1573564112186432,0,0.9724145730906729,0.027585426909327127,0
1536,血液培養:陰性(陰性)陰性。,血液 培養 陰性 陰性 陰性,0,0.9972409922911355,0.0027590077088645764,0,4.573848878754878e-05,0.9999542615112125,0,0.9748863304620521,0.02511366953794793,0,1.0,1.4640854952000843e-58,0,0.927128255367279,0.057968445122241974,0,0.8356555700302124,0.19847750663757324,0,0.9692515323231086,0.030748467676891426,0
1537,血管心臓造影:正常(正常)。,血管 心臓 造影 正常 正常,0,0.9845593433884022,0.015440656611597752,0,7.296216043755049e-05,0.9999270378395625,0,0.9936388630502189,0.0063611369497811815,0,1.0,3.3646135292266996e-40,0,0.9340916275978088,0.06059897691011429,0,0.8221501111984253,0.20637774467468262,0,0.9691058607109417,0.03089413928905816,0
1538,血栓のリスクとなる因子なし。,血栓 リスク なる 因子 ない,0,0.9845715401898694,0.015428459810130688,0,9.850910711003955e-05,0.9999014908928899,0,0.8924200634648425,0.1075799365351575,0,0.9904040773022229,0.00959592269777709,0,0.9390479922294617,0.06391163915395737,0,0.8317501544952393,0.17659331858158112,0,0.9632183685353326,0.036781631464667376,0
1539,抗体検査は実施されなかった。,抗体検査 実施 する れる ない た,0,0.9999422339340881,5.776606591173163e-05,0,5.377262853045226e-05,0.9999462273714695,0,0.9949935811931101,0.005006418806889883,0,0.9988884707602989,0.0011115292397011756,0,0.9533092975616455,0.059038255363702774,0,0.8423438668251038,0.14663438498973846,0,0.9728205018391984,0.02717949816080154,0
1540,合併症(問診票)はなかった。,合併症 問診 票 ない た,0,0.9992621518780654,0.0007378481219345495,0,5.4052869033410626e-05,0.9999459471309666,0,0.9885060696158745,0.011493930384125453,0,0.9938708968751044,0.006129103124895577,0,0.9504912495613098,0.05432431027293205,0,0.8480141758918762,0.14812873303890228,0,0.9723324822344448,0.027667517765555198,0
1541,骨髄生検で多発骨髄腫認めず。,骨髄生検 だ 多発骨髄腫 認める ぬ,0,0.9845842990608277,0.015415700939172258,0,0.00011319428609082345,0.9998868057139092,0,0.7401159576837206,0.25988404231627943,0,0.9715848194842828,0.028415180515717276,1,0.1351490616798401,0.9027544856071472,1,0.2551504671573639,0.8126559257507324,1,0.5169149573443085,0.48308504265569147,0
1542,左上肢下肢の可動に異常なし。,左 上肢 下肢 可動 異常 ない,0,0.9845742889609258,0.015425711039074074,0,0.00010653941890911569,0.9998934605810909,0,0.9475587853518761,0.05244121464812389,0,0.9520001203903904,0.04799987960960963,0,0.9337401986122131,0.08966070413589478,0,0.8402813076972961,0.2082342952489853,0,0.9624788015092677,0.03752119849073226,0
1543,症状の消失及び回復を認めた。,症状 消失 及ぶ 回復 認める た,0,0.9993752957312186,0.0006247042687813836,0,5.561045480656841e-05,0.9999443895451934,0,0.9877683528639893,0.012231647136010626,0,0.9173349463497305,0.08266505365026952,0,0.9416182637214661,0.06225091218948364,0,0.8195465207099915,0.1914893537759781,0,0.9649903015452831,0.035009698454716874,0
1544,心血管造影:冠動脈疾患なし。,心 血管造影 冠動脈疾患 ない,0,0.9986759111229604,0.0013240888770395158,0,6.153306194228393e-05,0.9999384669380578,0,0.9699920064502837,0.030007993549716328,0,0.9999998766627091,1.2333729089482192e-07,0,0.9484736323356628,0.058614183217287064,0,0.8319636583328247,0.18008427321910858,0,0.9700900438355895,0.0299099561644104,0
1545,心血管造影:顕著な狭窄なし。,心 血管造影 顕著 だ 狭窄 ない,0,0.9989057427742348,0.0010942572257651372,0,5.739502895059712e-05,0.9999426049710494,0,0.9599686112729274,0.040031388727072535,0,0.9999628974017792,3.710259822078125e-05,0,0.9320993423461914,0.07560678571462631,0,0.8448081016540527,0.1955675333738327,0,0.9684316361496835,0.031568363850316375,0
1546,心臓MRIでは異常所見なし。,心臓 MRI 異常所見なし,0,0.9758509629506317,0.02414903704936837,0,5.345672087765238e-05,0.9999465432791224,0,0.5235998838011352,0.4764001161988648,0,0.9999999960275757,3.972424280790988e-09,0,0.9235085844993591,0.05852726474404335,0,0.8012869358062744,0.2044593244791031,0,0.9213489256253596,0.07865107437464032,0
1547,人工呼吸器は使用しなかった。,人工呼吸器 使用 する ない た,0,0.9998232726863061,0.000176727313693852,0,5.0203342670162665e-05,0.9999497966573299,0,0.9933914285537546,0.006608571446245387,0,0.9995751761511338,0.0004248238488662133,0,0.948675811290741,0.05061548203229904,0,0.8307325839996338,0.15627174079418182,0,0.9722991744549523,0.02770082554504768,0
1548,髄液検査は実施されなかった。,髄液 検査 実施 する れる ない た,0,0.9999793624349999,2.0637565000263408e-05,0,4.831001389354357e-05,0.9999516899861065,0,0.9937514103518349,0.00624858964816513,0,0.9984205418407183,0.0015794581592817791,0,0.9507598280906677,0.05659756064414978,0,0.8426021337509155,0.1486181616783142,0,0.9726829063435436,0.02731709365645643,0
1549,造影MRIは得られなかった。,造影 MRI 得る られる ない た,0,0.9966866987258034,0.0033133012741966093,0,8.724536400210347e-05,0.9999127546359979,0,0.9772807076988836,0.022719292301116398,0,0.9941456171897977,0.0058543828102022915,0,0.9472686648368835,0.05210740119218826,0,0.8502881526947021,0.15888871252536774,0,0.9713340726412264,0.028665927358773553,0
1550,他のワクチン接種はなかった。,他 ワクチン接種 ない た,0,0.999625996303483,0.0003740036965171563,0,4.74428243432426e-05,0.9999525571756568,0,0.9958153098940895,0.004184690105910448,0,0.9998553693610887,0.000144630638911338,0,0.944705605506897,0.0544578954577446,0,0.8505964875221252,0.15498781204223633,0,0.9727889661713202,0.02721103382867992,0
1551,退院後も定期受診を継続した。,退院後 定期 受診 継続 する た,0,0.9845450544626352,0.01545494553736474,0,0.00011007720163678366,0.9998899227983632,1,0.29316302826282925,0.7068369717371707,0,0.8314095945371263,0.16859040546287377,0,0.9420220255851746,0.07143574208021164,0,0.8141005039215088,0.20754779875278473,1,0.8449584747025829,0.1550415252974172,0
1552,中枢性めまいとしては否定的。,中枢性めまい 否定的,0,0.984562569320794,0.015437430679206006,0,0.00010477259724178046,0.9998952274027583,1,0.4563792597309324,0.5436207402690676,0,0.999999999998162,1.837973103144557e-12,0,0.9200278520584106,0.10594026744365692,0,0.7707968354225159,0.2510714530944824,1,0.9016688243075822,0.09833117569241771,0
1553,洞調律:正常(正常)、正常。,洞調律 正常 正常 正常,0,0.9989867544470424,0.0010132455529575513,0,3.6062786869823336e-05,0.9999639372131301,0,0.9923758882265481,0.0076241117734518575,0,1.0,1.852121002106057e-80,0,0.9420446753501892,0.07135897874832153,0,0.8190937638282776,0.23058092594146729,0,0.9689915440469237,0.03100845595307647,0
1554,瞳孔や対光反射には異常なし。,瞳孔 対光反射 異常 ない,0,0.9845581086377536,0.01544189136224649,0,7.928939149763647e-05,0.9999207106085024,0,0.9529447731844362,0.04705522681556387,0,0.9910523516534531,0.008947648346546915,0,0.9313650727272034,0.08777394890785217,0,0.8371394872665405,0.18357431888580322,0,0.9662494506758988,0.03375054932410101,0
1555,日付不明症状の回復を認めた。,日付 不明症状 の 回復 認める た,0,0.9845715471716663,0.015428452828333645,0,0.00012076458429724505,0.9998792354157028,0,0.667584087329335,0.3324159126706649,0,0.8719137515959288,0.12808624840407118,0,0.9275383949279785,0.06852242350578308,0,0.8114086389541626,0.20701685547828674,0,0.9249640858406288,0.07503591415937126,0
1556,日付不明症状の軽快を認めた。,日付 不明症状 軽快 認める た,0,0.9845492397921621,0.01545076020783793,0,0.00010137549471251012,0.9998986245052874,0,0.5056635977266556,0.4943364022733444,0,0.8719979358448088,0.1280020641551912,0,0.9400020241737366,0.06454023718833923,0,0.8253907561302185,0.18637916445732117,0,0.9037059653380137,0.09629403466198633,0
1557,日付不明動悸、息切れは消失。,日付 不明 動悸 息切れ 消失,0,0.9845755130514937,0.015424486948506361,0,8.873864546247245e-05,0.9999112613545376,0,0.9086294322481364,0.09137056775186363,0,0.9942070269367733,0.005792973063226652,0,0.9239248037338257,0.10106366872787476,0,0.8065341114997864,0.22095584869384766,0,0.9602063485525117,0.039793651447488226,0
1558,培養検査は実施されなかった。,培養 検査 実施 する れる ない た,0,0.9999863212351281,1.3678764871816884e-05,0,4.583190767823526e-05,0.9999541680923217,0,0.9972805854856915,0.0027194145143084273,0,0.99898742941495,0.0010125705850500305,0,0.9539384841918945,0.05519622936844826,0,0.839745283126831,0.1472136378288269,0,0.9729823145141527,0.027017685485847365,0
1559,培養試験は実施されなかった。,培養 試験 実施 する れる ない た,0,0.9999625274208009,3.747257919901402e-05,0,5.659399168792484e-05,0.9999434060083121,0,0.9919923886840052,0.008007611315994801,0,0.998220091580039,0.00177990841996101,0,0.9543048739433289,0.0544903501868248,0,0.8441901803016663,0.14555110037326813,0,0.9728516889336039,0.027148311066396116,0
1560,服薬中の治療薬は、なかった。,服薬 中 治療薬 ない た,0,0.9989379639171634,0.0010620360828366834,0,8.538081892658712e-05,0.9999146191810734,0,0.9703551732730118,0.029644826726988163,0,0.9990921903250063,0.0009078096749936807,0,0.9445860385894775,0.05115809291601181,0,0.8328436613082886,0.14725752174854279,0,0.9711383580176226,0.028861641982377336,0
1561,併用薬の有無は不明であった。,併用 薬 有無 不明 だ ある た,0,0.9994646974080579,0.0005353025919421046,0,6.46828432819981e-05,0.999935317156718,0,0.9961221645856557,0.0038778354143442287,0,0.9754716160988118,0.024528383901188146,0,0.9454332590103149,0.056874386966228485,0,0.8536621928215027,0.1690158247947693,0,0.9711242299080245,0.028875770091975454,0
1562,併用薬は、報告されなかった。,併用 薬 報告 する れる ない た,0,0.9999747135821347,2.5286417865353357e-05,0,5.1265831842122634e-05,0.9999487341681579,0,0.9967905536114221,0.00320944638857785,0,0.9987734927453671,0.0012265072546328655,0,0.9545119404792786,0.05400380864739418,0,0.843975305557251,0.14661283791065216,0,0.9731180580587265,0.026881941941273545,0
1563,名前の声かけに返事があった。,名前 声掛け 返事 ある た,0,0.9845671929890252,0.015432807010974941,0,0.00012292500550163703,0.9998770749944984,1,0.2305386521634395,0.7694613478365605,0,0.9319495525966421,0.06805044740335785,0,0.9249991178512573,0.13339947164058685,0,0.7953640222549438,0.24946993589401245,1,0.8364229643705889,0.16357703562941103,0
1564,嘔吐・失禁なし、麻痺はなし。,嘔吐 失禁 ない 麻痺 ない,0,0.9845474799266654,0.015452520073334648,0,7.004793490831301e-05,0.9999299520650917,0,0.9591170194278525,0.040882980572147426,0,0.985942753337287,0.01405724666271307,0,0.9116011261940002,0.15133652091026306,0,0.8273836374282837,0.18658262491226196,0,0.9630457486359923,0.036954251364007734,0
1565,その他の画像検査はなかった。,その他 画像 検査 ない た,0,0.9997354170538458,0.00026458294615409043,0,4.447847601510052e-05,0.9999555215239849,0,0.9979719937024103,0.00202800629758973,0,0.9999851690546345,1.4830945365421022e-05,0,0.9390316009521484,0.055093321949243546,0,0.840696394443512,0.15439537167549133,0,0.9725007848519793,0.027499215148020704,0
1566,処置内容は提供されなかった。,処置 内容 提供 する れる ない た,0,0.9952967130967733,0.00470328690322679,0,7.313729124857566e-05,0.9999268627087514,0,0.952990279339334,0.047009720660666034,0,0.997963229542892,0.002036770457108063,0,0.9527096152305603,0.05335254222154617,0,0.8356801271438599,0.15247842669487,0,0.9699739970285536,0.030026002971446326,0
1567,その他の予防接種はなかった。,その他 予防接種 ない た,0,0.9993119113618804,0.000688088638119531,0,5.631393843741653e-05,0.9999436860615626,0,0.9918378594406407,0.008162140559359245,0,0.9999086402332279,9.135976677213032e-05,0,0.9444136619567871,0.0563063770532608,0,0.8451480269432068,0.1523534059524536,0,0.97243164842315,0.027568351576849927,0
1568,酸素投与は実施されなかった。,酸素 投与 実施 する れる ない た,0,0.9999902245243169,9.775475683127137e-06,0,4.652934200232521e-05,0.9999534706579977,0,0.9954414917963924,0.004558508203607616,0,0.9984902749005936,0.0015097250994063618,0,0.9543745517730713,0.05294476076960564,0,0.8453553915023804,0.15947243571281433,0,0.9727546701462964,0.02724532985370368,0
1569,こちらは自然経過で軽快した。,こちら 自然経過 軽快 する た,0,0.9858256578839598,0.014174342116040083,0,7.978421207773078e-05,0.9999202157879222,0,0.9761439710789798,0.023856028921020272,0,0.7836207011727413,0.2163792988272587,0,0.9446704983711243,0.06131221726536751,0,0.8168503642082214,0.18616393208503723,0,0.9528168084890494,0.04718319151095069,0
1570,集中治療室に入室はなかった。,集中治療室 入室 ない た,0,0.998396339063708,0.0016036609362921198,0,6.497005578474601e-05,0.9999350299442152,0,0.9762142247222021,0.023785775277797884,0,0.986029408150588,0.013970591849411974,0,0.9509637355804443,0.05614611506462097,0,0.8459858894348145,0.15855923295021057,0,0.9707915625416808,0.029208437458319168,0
1571,陰性確認は実施されなかった。,陰性確認 実施 する れる ない た,0,0.9999916258373609,8.374162639049045e-06,0,4.441981856948151e-05,0.9999555801814305,0,0.9926330688851366,0.007366931114863472,0,0.998534129571486,0.0014658704285139372,0,0.953040599822998,0.05710924416780472,0,0.8495358228683472,0.15509183704853058,0,0.9726891854253423,0.02731081457465777,0
1572,家族歴は、提供されなかった。,家族 歴 提供 する れる ない た,0,0.9980549736935215,0.0019450263064783712,0,6.534160961904444e-05,0.999934658390381,0,0.9869103890661016,0.01308961093389843,0,0.9981374502811576,0.0018625497188423446,0,0.95345538854599,0.0553889125585556,0,0.8354696035385132,0.1516687422990799,0,0.9720286265968637,0.027971373403136143,0
1573,家族歴に特記事項はなかった。,家族 歴 特記 事項 ない た,0,0.9987117160190749,0.001288283980925083,0,6.17757904475801e-05,0.9999382242095525,0,0.9794319423223689,0.020568057677631122,0,0.9996679612814727,0.00033203871852724855,0,0.9525988101959229,0.06570801138877869,0,0.8482758402824402,0.1846894472837448,0,0.9708643425244264,0.029135657475573524,0
1574,頭部には異常所見はなかった。,頭部 異常所見 ない た,0,0.9904421027624307,0.009557897237569314,0,7.636265289900018e-05,0.999923637347101,0,0.9955247098695854,0.004475290130414574,0,0.9408917053828733,0.05910829461712674,0,0.9447727799415588,0.0691952034831047,0,0.843085527420044,0.1665695607662201,0,0.9678903843851072,0.03210961561489283,0
1575,患者は、他の病歴はなかった。,患者 他 病歴 ない た,0,0.9995545354591985,0.0004454645408014265,0,5.0596349606494024e-05,0.9999494036503935,0,0.9966605999667334,0.0033394000332665993,0,0.9997322197315202,0.0002677802684798265,0,0.9513171315193176,0.05537097528576851,0,0.843718409538269,0.15556201338768005,0,0.9727771533771491,0.02722284662285098,0
1576,患者はアレルギーはなかった。,患者 アレルギー ない た,0,0.9996303686044087,0.0003696313955912304,0,4.363276078588422e-05,0.9999563672392141,0,0.9939711821886024,0.006028817811397642,0,0.9999886277232566,1.1372276743369678e-05,0,0.9485813975334167,0.05385732278227806,0,0.8558496832847595,0.1571117788553238,0,0.9728995261440699,0.02710047385593,0
1577,肺機能検査:通常は問題なし。,肺 機能 検査 通常 問題なし,0,0.8726522053019934,0.12734779469800678,0,0.00011184339374755207,0.9998881566062524,0,0.7195435031040391,0.28045649689596086,0,0.9999935493106914,6.450689308629573e-06,0,0.9350247383117676,0.06455298513174057,0,0.8232815861701965,0.25234663486480713,0,0.9325168262588791,0.06748317374112094,0
1578,医療機関への入院はなかった。,医療機関 入院 ない た,0,0.9845480009849659,0.015451999015034095,0,9.30659045274895e-05,0.9999069340954725,0,0.9764851831547976,0.023514816845202402,0,0.9971901614458386,0.002809838554161384,0,0.9500811100006104,0.05430092290043831,0,0.8443323969841003,0.15652912855148315,0,0.9706939223999275,0.02930607760007252,0
1579,家族歴の有無は不明であった。,家族 歴 有無 不明 だ ある た,0,0.9877604325826087,0.012239567417391413,0,7.712882593024501e-05,0.9999228711740697,0,0.9889038537625233,0.011096146237476637,0,0.9604332702318085,0.03956672976819157,0,0.9386672973632812,0.06445645540952682,0,0.8468031287193298,0.20163001120090485,0,0.9675081113427778,0.03249188865722216,0
1580,ウイルス性肝炎は否定された。,ウイルス性 肝炎 否定 する れる た,0,0.9845908048120763,0.015409195187923691,0,7.500848863936288e-05,0.9999249915113606,0,0.702843706411177,0.29715629358882295,1,0.3119842655762406,0.6880157344237594,0,0.9213038682937622,0.0695108026266098,0,0.8166106343269348,0.1747613400220871,1,0.8164726826723033,0.18352731732769675,0
1581,2日経っても変わらなかった。,0 日 経つ 変わる ない た,0,0.9982402839342701,0.001759716065729743,0,7.127502950366353e-05,0.9999287249704963,0,0.9744274560871035,0.025572543912896505,0,0.997265118409332,0.0027348815906680798,0,0.9517706632614136,0.05518851801753044,0,0.8534056544303894,0.16291047632694244,0,0.9714486888223758,0.02855131117762426,0
1582,ADL自立度は自立していた。,ADL 自立度 自立 する いる た,0,0.9645078356865189,0.03549216431348102,0,0.00010829768660392356,0.9998917023133961,0,0.5312779612882157,0.46872203871178425,0,0.7566560049397073,0.24334399506029275,0,0.8928369879722595,0.09775953739881516,0,0.8262354135513306,0.20347581803798676,0,0.8724656168075916,0.12753438319240842,0
1583,妊娠の疑い/授乳はなかった。,妊娠 疑い 授乳 ない た,0,0.9839493526915862,0.016050647308413834,0,8.932516517421315e-05,0.9999106748348258,0,0.8751194885426148,0.1248805114573852,0,0.8699712177521048,0.1300287822478952,0,0.9378746747970581,0.05920136347413063,0,0.8471663594245911,0.17613287270069122,0,0.9529326899835661,0.047067310016433904,0
1584,一次感染部位は不明であった。,一 次感染 部位 不明 だ ある た,0,0.9922973542403433,0.007702645759656816,0,7.320559059192256e-05,0.9999267944094081,0,0.9740552301890428,0.025944769810957134,0,0.8968590752335384,0.1031409247664617,0,0.9338916540145874,0.06691817939281464,0,0.8387541174888611,0.16633039712905884,0,0.963242642143028,0.03675735785697209,0
1585,取られた処置は不明であった。,取る れる た 処置 不明 だ ある た,0,0.9845545426793125,0.015445457320687627,0,0.00010140667527144119,0.9998985933247285,0,0.9386835508152764,0.06131644918472351,0,0.9922834503591542,0.007716549640845754,0,0.9411634802818298,0.06844218075275421,0,0.8395960330963135,0.18858136236667633,0,0.9662675953276254,0.033732404672374636,0
1586,妊婦の疑いや授乳はなかった。,妊婦 疑い 授乳 ない た,0,0.9845577178475448,0.01544228215245525,0,8.605823790959492e-05,0.9999139417620904,0,0.8779043248838758,0.12209567511612418,0,0.8886925463997767,0.11130745360022329,0,0.9424314498901367,0.05551168695092201,0,0.8435882925987244,0.16071107983589172,0,0.9557346568803818,0.04426534311961816,0
1587,合併症はなかった(問診票)。,合併症 ない た 問診 票,0,0.9992621518780654,0.0007378481219345495,0,5.4052869033410626e-05,0.9999459471309666,0,0.9885060696158745,0.011493930384125453,0,0.9999999999621356,3.7864369117679154e-11,0,0.9333309531211853,0.08390330523252487,0,0.8322952389717102,0.17848192155361176,0,0.9700809904476421,0.029919009552357927,0
1588,直近の冠状動脈検査:未実施。,直近 冠状 動脈 検査 実施,0,0.9845713754516398,0.015428624548360262,0,9.031232129917485e-05,0.9999096876787008,0,0.9206036804361565,0.07939631956384353,0,0.9635629027526675,0.03643709724733247,0,0.8832813501358032,0.18908265233039856,0,0.7947443723678589,0.27337026596069336,0,0.9504158946132064,0.0495841053867936,0
1589,皮膚/粘膜に異常はなかった。,皮膚 粘膜 異常 ない た,0,0.9965122833718059,0.0034877166281941257,0,6.961240631399793e-05,0.999930387593686,0,0.968253672491632,0.03174632750836802,0,0.9390678516725656,0.06093214832743444,0,0.9369339942932129,0.059428777545690536,0,0.842192530632019,0.16476942598819733,0,0.9665193986088717,0.03348060139112819,0
1590,2022年6月6日退院した。,0 年 0 月 0 日 退院 する た,0,0.984567270862008,0.015432729137991957,0,0.00012106111083385365,0.9998789388891661,0,0.9809611153521468,0.01903888464785318,0,0.897426391192183,0.102573608807817,0,0.9333605766296387,0.0816611796617508,0,0.8147127032279968,0.21214357018470764,0,0.9600907700166454,0.03990922998335452,0
1591,アレルギー歴は特になかった。,アレルギー歴 ない た,0,0.9994263555332552,0.0005736444667446799,0,6.166342237841651e-05,0.9999383365776215,0,0.9900480001823301,0.009951999817669975,0,0.9965861402198983,0.0034138597801016755,0,0.9488571882247925,0.054936207830905914,0,0.8627346754074097,0.17506328225135803,0,0.9721813767800372,0.0278186232199629,0
1592,異常な心嚢液貯留はなかった。,異常 だ 心嚢液 貯留 ない た,0,0.9991642227291243,0.0008357772708756895,0,5.867717861702844e-05,0.9999413228213829,0,0.9760944221071713,0.02390557789282861,0,0.8393293436637246,0.1606706563362754,0,0.9391272068023682,0.05497778579592705,0,0.8476982116699219,0.16319581866264343,0,0.9607568761210796,0.039243123878920504,0
1593,患者は併用薬を使用していた。,患者 併用 薬 使用 する いる た,0,0.9938219453412087,0.006178054658791323,0,9.791346490263938e-05,0.9999020865350974,0,0.9853185321221744,0.014681467877825628,0,0.9597755840915517,0.04022441590844825,0,0.943385124206543,0.06741730123758316,0,0.7729883790016174,0.23653222620487213,0,0.9640997991725038,0.0359002008274963,0
1594,再調査の実施は不可能である。,再調査 実施 不可能 だ ある,0,0.9984907056752829,0.0015092943247173227,0,5.347706238397589e-05,0.999946522937616,0,0.9276275695636557,0.07237243043634436,0,0.9999451035675814,5.489643241859511e-05,0,0.9461581707000732,0.07072382420301437,0,0.8302267789840698,0.20275388658046722,0,0.9662727800586971,0.03372721994130297,0
1595,事象の転帰は、回復とされた。,事象 転帰 回復 する れる た,0,0.9968193535309777,0.0031806464690223484,0,6.38488857178289e-05,0.9999361511142821,0,0.9887496365469863,0.011250363453013702,0,0.769671693466022,0.23032830653397796,0,0.9362322092056274,0.06594071537256241,0,0.8091115355491638,0.15591111779212952,0,0.954091135695851,0.04590886430414908,0
1596,術後5年間再発を認めなかった,術後 0 年間 再発 認める ない た,0,0.9845936419364881,0.01540635806351185,0,9.074818248018731e-05,0.9999092518175198,0,0.8800154076340496,0.11998459236595034,0,0.9911655841226137,0.00883441587738631,0,0.948150098323822,0.05637247860431671,0,0.8156801462173462,0.1717006266117096,0,0.962582739000966,0.037417260999034044,0
1597,病院の主治医は不明であった。,病院 主治医 不明 だ ある た,0,0.9914854466172498,0.008514553382750279,0,7.42339259069183e-05,0.9999257660740931,0,0.9865641045560012,0.013435895443998772,0,0.9592097946275259,0.040790205372474145,0,0.9376742243766785,0.06553582102060318,0,0.840986967086792,0.17559947073459625,0,0.9680834330357168,0.03191656696428313,0
1598,HbA1cは6.15と良好。,HbA 0 c 0 0 良好,0,0.98543473659548,0.014565263404519887,0,0.00010606742847885739,0.9998939325715211,0,0.7030286907342638,0.29697130926573617,0,0.9999999999999976,2.4524366914917974e-15,0,0.919987678527832,0.089510977268219,0,0.774029552936554,0.20312359929084778,0,0.9415040784050228,0.058495921594977254,0
1599,患者には病歴は何もなかった。,患者 病歴 何 ない た,0,0.9969658804164786,0.003034119583521381,0,6.99973572585905e-05,0.9999300026427415,0,0.9868749845946331,0.013125015405366898,0,0.9991494668524991,0.0008505331475009691,0,0.9441739916801453,0.0696745291352272,0,0.832497775554657,0.15454477071762085,0,0.9712116360631544,0.028788363936845588,0
1600,患者は独歩にて帰宅となった。,患者 独歩 帰宅 なる た,0,0.9845459900166195,0.01545400998338046,0,8.846775783571601e-05,0.9999115322421643,0,0.7213498965734011,0.27865010342659885,0,0.666670742607073,0.333329257392927,0,0.900615394115448,0.10828818380832672,0,0.8066049218177795,0.24240143597126007,0,0.8910819748567986,0.10891802514320137,0
1601,患者は併用薬を服用していた。,患者 併用 薬 服用 する いる た,0,0.9994408877169825,0.0005591122830174213,0,7.522988638560746e-05,0.9999247701136144,0,0.9853185321221744,0.014681467877825628,0,0.9388489509429261,0.06115104905707391,0,0.9312152862548828,0.07147550582885742,0,0.7847667932510376,0.23325802385807037,0,0.9629814764019211,0.037018523598078924,0
1602,関節炎を疑う所見はなかった。,関節炎 疑う 所見 ない た,0,0.984547075905566,0.015452924094433999,0,0.0001451280402203419,0.9998548719597796,0,0.9759104819134505,0.02408951808654948,0,0.9913224070256023,0.008677592974397737,0,0.9339166283607483,0.06503641605377197,0,0.8455548882484436,0.17812854051589966,0,0.968936234049207,0.031063765950792934,0
1603,事象のため入院はしなかった。,事象 ため 入院 する ない た,0,0.9845609118984237,0.015439088101576267,0,0.00011414728145033932,0.9998858527185497,0,0.9802298673547724,0.019770132645227617,0,0.9989281111779869,0.001071888822013113,0,0.9582054615020752,0.058213602751493454,0,0.8172581195831299,0.17345356941223145,0,0.9698647920420863,0.03013520795791369,0
1604,接種直後も、症状はなかった。,接種 直後 症状 ない た,0,0.9985288940450499,0.0014711059549501993,0,8.02998720827044e-05,0.9999197001279173,0,0.9910270796894673,0.008972920310532696,0,0.9972537910929155,0.002746208907084546,0,0.947282075881958,0.05853073298931122,0,0.8524113297462463,0.1584254652261734,0,0.9722537824438562,0.027746217556143808,0
1605,病院到着日時は不明であった。,病院 到着 日時 不明 だ ある た,0,0.9845632348939689,0.015436765106031066,0,8.537557320053359e-05,0.9999146244267995,0,0.9695361571627071,0.03046384283729289,0,0.9238414665162306,0.07615853348376943,0,0.9343814849853516,0.0771668329834938,0,0.8356122970581055,0.19792507588863373,0,0.9627073904336387,0.03729260956636129,0
1606,"U-Protein, (-)",U Protein,0,0.5547603559024763,0.44523964409752376,1,0.0001843188090939102,0.9998156811909061,1,0.4563792597309324,0.5436207402690676,0,0.5195482961797382,0.48045170382026176,0,0.8851457834243774,0.12217658013105392,0,0.7354044914245605,0.33487778902053833,1,0.5560732273161628,0.4439267726838372,0
1607,今年になってアトピーは消えた,今年 なる アトピー 消える た,0,0.9845640145874845,0.01543598541251551,0,0.00013590225280426602,0.9998640977471958,1,0.30001755754886017,0.6999824424511398,0,0.9676803668372765,0.03231963316272342,0,0.9304302334785461,0.11640805006027222,0,0.775097131729126,0.3043883442878723,1,0.856869233028803,0.14313076697119687,0
1608,併用薬は報告されなかった。,併用 薬 報告 する れる ない た,0,0.9999747135821347,2.5286417865353357e-05,0,5.1265831842122634e-05,0.9999487341681579,0,0.9967905536114221,0.00320944638857785,0,0.9987734927453671,0.0012265072546328655,0,0.9545119404792786,0.05400380864739418,0,0.843975305557251,0.14661283791065216,0,0.9731180580587265,0.026881941941273545,0
1609,既往歴は報告されなかった。,既往 歴 報告 する れる ない た,0,0.999509408929123,0.0004905910708770676,0,6.293394720349369e-05,0.9999370660527965,0,0.9869103890661016,0.01308961093389843,0,0.9981029986232594,0.0018970013767406256,0,0.9544199705123901,0.057797014713287354,0,0.8487445712089539,0.15013286471366882,0,0.9724658022493947,0.02753419775060517,0
1610,併用薬は報告されていない。,併用 薬 報告 する れる いる ない,0,0.9997880061327074,0.0002119938672927059,0,5.0457072164047126e-05,0.999949542927836,0,0.9945069503256507,0.005493049674349296,0,0.9639899456968838,0.036010054303116226,0,0.9493795037269592,0.06087593361735344,0,0.8254104256629944,0.17044158279895782,0,0.9695321950528918,0.030467804947108258,0
1611,10:30頃自発呼吸再開。,0 0 頃 自発呼吸 再開,0,0.9845660299703322,0.015433970029668015,0,0.0001505236448352639,0.9998494763551647,1,0.24931105935462838,0.7506889406453716,0,0.9999998211154382,1.788845617776449e-07,0,0.9225499033927917,0.09711970388889313,0,0.7717968225479126,0.3148301839828491,1,0.8520097662691899,0.14799023373081016,0
1612,10日程で症状は改善した。,0 日程 症状 改善 する た,0,0.9982239997874225,0.0017760002125774145,0,8.190351320016095e-05,0.9999180964867999,0,0.9898936338218349,0.010106366178165084,0,0.9714642164038764,0.028535783596123604,0,0.9367413520812988,0.05915281921625137,0,0.8314582705497742,0.17484605312347412,0,0.9693361867954603,0.030663813204539647,0
1613,1週間後、疼痛は寛解した。,0 週間 後 疼痛 寛解 する た,0,0.9845784882244983,0.015421511775501561,0,0.0001155385571666463,0.9998844614428334,0,0.5185307795273668,0.48146922047263324,0,0.8378978848510386,0.1621021151489615,0,0.9238393306732178,0.08398501574993134,0,0.8305834531784058,0.1757674664258957,0,0.8981572936034037,0.10184270639659633,0
1614,1週間後に胸痛は回復した。,0 週間 後 胸痛 回復 する た,0,0.9853832167559783,0.014616783244021745,0,8.544732541182185e-05,0.9999145526745882,0,0.9464212772640189,0.053578722735981056,0,0.9184380068174745,0.08156199318252554,0,0.9417592883110046,0.06497979164123535,0,0.8281047940254211,0.17018580436706543,0,0.9621432621679855,0.037856737832014445,0
1615,2021/07/17退院。,0 0 0 退院,0,0.9920722534888652,0.007927746511134771,0,8.29972326643408e-05,0.9999170027673356,0,0.9725676061335892,0.027432393866410804,0,0.9999999999999972,2.784734295245917e-15,0,0.9306920170783997,0.07791268080472946,0,0.8066193461418152,0.18465852737426758,0,0.9678350982291429,0.032164901770857075,0
1616,2021/08/20外来。,0 0 0 外来,0,0.9845702275010918,0.015429772498908319,0,0.00011860168931091302,0.9998813983106891,0,0.6532220146696002,0.34677798533039983,0,0.9999999999999998,2.693955610011628e-16,0,0.9112617373466492,0.11284419149160385,0,0.7164995670318604,0.28987398743629456,0,0.9242024243624607,0.07579757563753929,0
1617,2022/07/06解熱。,0 0 0 解熱,0,0.9845811445956029,0.015418855404397152,0,0.00012108966789042891,0.9998789103321095,0,0.6970640681170186,0.30293593188298135,0,0.9999999999999994,5.727606424602591e-16,0,0.8861036896705627,0.10732787847518921,0,0.76530522108078,0.2525051236152649,0,0.9343251537449964,0.06567484625500365,0
1618,COVID-19陰性確認。,COVID 0 陰性確認,0,0.9440914666689125,0.05590853333108754,0,0.00014860687365632873,0.9998513931263436,1,0.3607204586964663,0.6392795413035337,0,0.999999998952261,1.0477390375210255e-09,0,0.8971143960952759,0.12269450724124908,0,0.7740274667739868,0.26369979977607727,1,0.8692869276114148,0.13071307238858515,0
1619,ECG所見にて洞調律正常。,ECG 所見 洞調律正常,0,0.9600204042756035,0.039979595724396286,0,8.476834114602048e-05,0.999915231658854,0,0.6686913221198284,0.3313086778801716,0,0.9999727914244194,2.7208575580603854e-05,0,0.9410635232925415,0.08640113472938538,0,0.8294364809989929,0.23510795831680298,0,0.9374108361521751,0.06258916384782474,0
1620,アレルギーは無しであった。,アレルギー 無い だ ある た,0,0.9849772249234682,0.015022775076531773,0,6.64290084816252e-05,0.9999335709915184,0,0.8237416283756049,0.17625837162439512,0,0.9961367899508615,0.0038632100491384964,0,0.9435470700263977,0.05996750667691231,0,0.8517993092536926,0.176452174782753,0,0.9596420071392083,0.040357992860791614,0
1621,カロナール服用で改善せず。,カロナール 服用 改善 する ぬ,0,0.9996943150340778,0.00030568496592220314,0,5.107906715652605e-05,0.9999489209328435,0,0.9608471126355905,0.03915288736440944,0,0.9786557653808483,0.021344234619151674,0,0.924513578414917,0.09603900462388992,0,0.7860705852508545,0.30381160974502563,0,0.9604269689797967,0.03957303102020321,0
1622,ステロイドパルス療法開始。,ステロイド パルス 療法 開始,0,0.9845517762753101,0.015448223724689802,0,8.79633778627065e-05,0.9999120366221373,0,0.9754851114156604,0.024514888584339582,0,0.9999999770956921,2.2904307863656657e-08,0,0.9252979755401611,0.08920182287693024,0,0.6166558861732483,0.5702138543128967,0,0.9428262879786595,0.05717371202134055,0
1623,その間、解熱した日もあり。,その間 解熱 した 日 ある,0,0.9845722126347982,0.015427787365201652,0,0.00010089720845776332,0.9998991027915423,0,0.6591782218685601,0.3408217781314399,0,0.982756021627085,0.017243978372914998,0,0.9140993356704712,0.1253020465373993,0,0.8049765825271606,0.26584309339523315,0,0.9296382332945814,0.07036176670541865,0
1624,その他異常は認めなかった。,その他 異常 認める ない た,0,0.9886874357255271,0.01131256427447282,0,0.00010082587845613682,0.9998991741215438,0,0.9770249333920512,0.022975066607948742,0,0.998208551680941,0.0017914483190589563,0,0.9351198673248291,0.05914738029241562,0,0.8343759179115295,0.17049787938594818,0,0.9697603211722834,0.030239678827716606,0
1625,バイタル確認し、問題なし。,バイタル 確認 する 問題なし,0,0.9845820486100526,0.015417951389947318,0,7.775531637288266e-05,0.9999222446836271,0,0.512985964211322,0.48701403578867797,0,0.9985375906865895,0.0014624093134104684,0,0.9345125555992126,0.06236231327056885,0,0.7838696241378784,0.3542809784412384,0,0.9083876898444119,0.09161231015558806,0
1626,バイタル観察にて経過観察。,バイタル 観察 経過 観察,0,0.9845506007120498,0.015449399287950177,0,8.301065647112128e-05,0.9999169893435289,0,0.8703625244082095,0.1296374755917905,0,0.9999999999999993,6.957688564224753e-16,0,0.9171138405799866,0.08345700055360794,0,0.6941466331481934,0.379112184047699,0,0.945765815221157,0.05423418477884298,0
1627,ヘパリンNa持続投与開始。,ヘパリン Na 持続 投与 開始,0,0.9928959642751832,0.007104035724816705,0,7.889647062009118e-05,0.9999211035293799,0,0.9722922847214339,0.02770771527856604,0,0.9996809716277701,0.00031902837222980244,0,0.9203919768333435,0.08701825141906738,0,0.7628278136253357,0.3932822048664093,0,0.9582262420344911,0.04177375796550873,0
1628,医師より、独歩で帰宅指示。,医師 独歩 帰宅 指示,0,0.9845693509680008,0.015430649031999205,0,7.580504662631347e-05,0.9999241949533737,0,0.6351029352554477,0.3648970647445523,0,0.9999980792074296,1.9207925704770094e-06,0,0.9372954964637756,0.10009866207838058,0,0.7842364311218262,0.2577398121356964,0,0.9310663307390757,0.06893366926092413,0
1629,冠動脈造影は正常であった。,冠動脈造影 正常 だ ある た,0,0.9961595066290477,0.0038404933709523257,0,4.39249912536998e-05,0.9999560750087463,0,0.9944001532970996,0.005599846702900391,0,0.9923364615556929,0.007663538444307126,0,0.9405808448791504,0.053100258111953735,0,0.8520310521125793,0.19169238209724426,0,0.9710750538605084,0.02892494613949159,0
1630,胸部CTでは異常所見なし。,胸部 CT 異常所見なし,0,0.9934225465584059,0.0065774534415940205,0,4.58019801663478e-05,0.9999541980198337,0,0.6469021024391098,0.35309789756089016,0,0.9999999966239244,3.376075655356257e-09,0,0.9218586087226868,0.06006048247218132,0,0.8332562446594238,0.22086313366889954,0,0.9401912945214591,0.05980870547854088,0
1631,原因ははっきりしなかった。,原因 する ない た,0,0.9998594217035575,0.00014057829644253193,0,4.646973830797076e-05,0.999953530261692,0,0.9914253619683489,0.008574638031651162,0,0.999340829173922,0.0006591708260780169,0,0.9517931342124939,0.05714557319879532,0,0.8303366303443909,0.14867420494556427,0,0.9722844331153905,0.027715566884609577,0
1632,原疾患/合併症はなかった。,原 疾患 合併症 ない た,0,0.9994208009434031,0.0005791990565968976,0,5.4342841902737876e-05,0.9999456571580972,0,0.9918667738537149,0.008133226146285085,0,0.9131219948962579,0.08687800510374205,0,0.9376660585403442,0.0540887676179409,0,0.8373154401779175,0.14971020817756653,0,0.9670771187488646,0.03292288125113554,0
1633,現在、月経は正常となった。,現在 月経 正常 なる た,0,0.9845837231111791,0.015416276888820907,0,8.09621515883883e-05,0.9999190378484116,0,0.9889815522251642,0.011018447774835804,0,0.9608011526834578,0.039198847316542204,0,0.9339376091957092,0.056565385311841965,0,0.8352996706962585,0.1900782585144043,0,0.9674374657441298,0.03256253425587021,0
1634,抗ウイルス薬点滴治療開始。,抗ウイルス薬 点滴 治療 開始,0,0.9845615720694769,0.015438427930523139,0,9.54040999631712e-05,0.9999045959000368,0,0.8298022349786924,0.17019776502130754,0,0.9995778535041622,0.00042214649583787454,0,0.9179170727729797,0.10792035609483719,0,0.773503303527832,0.3080863654613495,0,0.9480185814719572,0.0519814185280429,0
1635,腰にステロイドを打たれた。,腰 ステロイド 打つ れる た,0,0.9845615469877385,0.015438453012261467,0,9.357931748336178e-05,0.9999064206825167,0,0.853632844322244,0.14636715567775607,0,0.7599242144240559,0.24007578557594408,0,0.9340291023254395,0.09863355755805969,0,0.6503884792327881,0.48068273067474365,0,0.900386432321101,0.09961356767889883,0
1636,左眼眼底に異常はなかった。,左 眼 眼底 異常 ない た,0,0.9845734291798748,0.015426570820125163,0,0.00010089790858340672,0.9998991020914166,0,0.9705499830965472,0.029450016903452825,0,0.9825236765953614,0.01747632340463852,0,0.9283342957496643,0.06163356453180313,0,0.8394280672073364,0.16718627512454987,0,0.9681527394707851,0.03184726052921494,0
1637,酸素投与は実施しなかった。,酸素 投与 実施 する ない た,0,0.9999928937799685,7.106220031463747e-06,0,4.0184252636222984e-05,0.9999598157473638,0,0.99720851812949,0.002791481870510081,0,0.9988567852907144,0.0011432147092855856,0,0.9515557289123535,0.05306171998381615,0,0.8345698714256287,0.1606375277042389,0,0.9724716118492884,0.027528388150711562,0
1638,心エコー像:正常(正常)。,心 エコー 像 正常 正常,0,0.9882604292721637,0.011739570727836348,0,6.03725323217646e-05,0.9999396274676783,0,0.9923758882265481,0.0076241117734518575,0,1.0,8.913505523699819e-36,0,0.9307926893234253,0.06420260667800903,0,0.8342182636260986,0.20653843879699707,0,0.9693995839078632,0.03060041609213674,0
1639,心血管造影:正常(正常)。,心 血管造影 正常 正常,0,0.9978019738396751,0.002198026160324949,0,4.6949668666971837e-05,0.9999530503313331,0,0.9923758882265481,0.0076241117734518575,0,1.0,3.722827311345364e-46,0,0.9344287514686584,0.0597827211022377,0,0.8223447203636169,0.219047412276268,0,0.9694804533835583,0.030519546616441632,0
1640,心電図検査は異常所見なし。,心電図 検査 異常所見なし,0,0.984545375126764,0.0154546248732359,0,5.966932182260698e-05,0.9999403306781774,0,0.8073761053157638,0.19262389468423624,0,0.9999999999999997,3.314163584388692e-16,0,0.9268708229064941,0.06030026450753212,0,0.8231139779090881,0.25600385665893555,0,0.9533648434990077,0.04663515650099227,0
1641,生理食塩水で静脈点滴開始。,生理 食塩水 静脈 点滴 開始,0,0.9845849351113137,0.015415064888686231,0,9.479742996702742e-05,0.999905202570033,0,0.703179037954393,0.29682096204560704,0,0.9999641983730071,3.580162699292683e-05,0,0.9180322885513306,0.11121008545160294,0,0.7846802473068237,0.3151243329048157,0,0.9341356325248364,0.06586436747516362,0
1642,生理前は発作が起きやすい。,生理 前 発作 起きる やすい,1,0.03513130306817022,0.9648686969318298,1,0.00022996598491544068,0.9997700340150846,1,0.4121831585886937,0.5878168414113063,1,0.0,1.0,1,0.1427018791437149,0.9249803423881531,1,0.2643711566925049,0.8206827640533447,1,0.011618142709637548,0.9883818572903624,0
1643,他院にて検査し、異常なし。,院 検査 する 異常 ない,0,0.9845534249807167,0.0154465750192832,0,7.403670741722236e-05,0.9999259632925828,0,0.9950580895806044,0.00494191041939564,0,0.9999962985614751,3.701438524923232e-06,0,0.9385644197463989,0.06190628558397293,0,0.8150306940078735,0.16059811413288116,0,0.9704149447272026,0.0295850552727975,0
1644,直ちに胸部レントゲン実施。,胸部 レントゲン 実施,0,0.9965370196030016,0.0034629803969984593,0,6.830528853022531e-05,0.9999316947114698,0,0.9458158208218808,0.05418417917811919,0,0.9999548497380417,4.5150261958288204e-05,0,0.9438362717628479,0.07944921404123306,0,0.7824332118034363,0.40444517135620117,0,0.9579979450746403,0.042002054925359654,0
1645,頭部CTにて出血病変なし。,頭部 C，T 出血 病変なし,0,0.9221363303504584,0.07786366964954161,0,0.00013908991691987164,0.9998609100830801,0,0.6524421138533576,0.34755788614664235,0,0.9994347129261036,0.0005652870738963614,0,0.9090235233306885,0.08981061726808548,0,0.8190963268280029,0.22203628718852997,0,0.9285467566307266,0.0714532433692734,0
1646,頭部MR実施し、異常なし。,頭部 MR 実施 する 異常 ない,0,0.9995745151098471,0.0004254848901529488,0,3.7651746177029544e-05,0.999962348253823,0,0.9974508264666462,0.0025491735333538082,0,0.9998877341709238,0.00011226582907616144,0,0.9452522397041321,0.060557227581739426,0,0.8446259498596191,0.15941143035888672,0,0.9724498623453808,0.027550137654619302,0
1647,内服薬にて心拍数の調整中。,内服薬 心拍数 の 調整 中,0,0.9845807315508099,0.015419268449190244,0,0.00010559097690532822,0.9998944090230947,1,0.3489252254672479,0.6510747745327521,0,0.9999990752406098,9.247593902031675e-07,0,0.879794180393219,0.17093239724636078,0,0.7216874361038208,0.366842120885849,1,0.8495311272197449,0.15046887278025511,0
1648,日付不明術後リハビリ実施。,日付 不明 術後 リハビリ 実施,0,0.994343265178723,0.005656734821277039,0,6.175488739448464e-05,0.9999382451126055,0,0.9051385312728907,0.0948614687271093,0,0.9999999999980476,1.9524729478095172e-12,0,0.9468305110931396,0.07486795634031296,0,0.8183844089508057,0.22058260440826416,0,0.9633446364162062,0.03665536358379376,0
1649,日付不明退院後の経過良好。,日付 不明 退院後 経過 良好,0,0.9923316133567501,0.007668386643249832,0,5.2625508663634845e-05,0.9999473744913364,0,0.9697212173422967,0.030278782657703354,0,0.9999999999999998,1.8984236016480519e-16,0,0.935025155544281,0.06296636164188385,0,0.8221722841262817,0.2026994526386261,0,0.968192922444537,0.03180707755546299,0
1650,培養の実施は不明であった。,培養 実施 不明 だ ある た,0,0.9997818924774127,0.0002181075225872936,0,4.9306028888595175e-05,0.9999506939711114,0,0.9947595974559422,0.00524040254405777,0,0.9955968327777831,0.004403167222216877,0,0.9437050223350525,0.05245136469602585,0,0.854131281375885,0.19232460856437683,0,0.9716242869294704,0.028375713070529468,0
1651,服用中の治療薬はなかった。,服用 中 治療薬 ない た,0,0.9999292139871617,7.07860128382998e-05,0,4.5216947769580525e-05,0.9999547830522304,0,0.9764993146469042,0.023500685353095827,0,0.9991542698153906,0.0008457301846094271,0,0.9453550577163696,0.05068850517272949,0,0.831704318523407,0.15139944851398468,0,0.9714248777902218,0.02857512220977834,0
1652,併用薬は提供されなかった。,併用 薬 提供 する れる ない た,0,0.9999412348583638,5.8765141636094275e-05,0,5.310048733283518e-05,0.9999468995126671,0,0.9945619595865411,0.005438040413458887,0,0.9985496472207745,0.0014503527792254116,0,0.954570472240448,0.05735648423433304,0,0.8394854664802551,0.1456618309020996,0,0.9728076186944005,0.027192381305599596,0
1653,補液、抗血小板薬治療実施。,補液 抗血小板 薬 治療 実施,0,0.9970839087733281,0.0029160912266719464,0,8.3997720506642e-05,0.9999160022794934,0,0.9785540420642955,0.021445957935704495,0,0.9985121644950956,0.0014878355049043855,0,0.9478957056999207,0.07696559280157089,0,0.785197377204895,0.279595285654068,0,0.9652765848978796,0.03472341510212047,0
1654,その他の画像検査:未実施。,その他 画像 検査 実施,0,0.9898444573816123,0.01015554261838769,0,7.210270834861073e-05,0.9999278972916514,0,0.9866337102689655,0.013366289731034516,0,0.9999998547231173,1.4527688278425013e-07,0,0.9121081829071045,0.12531620264053345,0,0.7923007607460022,0.24414390325546265,0,0.9640165408400281,0.0359834591599719,0
1655,胸部CTは未実施であった。,胸部 C，T 実施 だ ある た,0,0.9975000369702817,0.0024999630297183237,0,6.480714477578045e-05,0.9999351928552243,0,0.9847395032727853,0.01526049672721479,0,0.9997543261650762,0.0002456738349237661,0,0.9440693855285645,0.07089006900787354,0,0.8387520909309387,0.18173836171627045,0,0.9705254484584676,0.02947455154153239,0
1656,腎生検は施行されなかった。,腎生検 施行 する れる ない た,0,0.9998536531999411,0.00014634680005885925,0,5.057050341046499e-05,0.9999494294965895,0,0.9917110605426046,0.008288939457395375,0,0.998685018158632,0.0013149818413679757,0,0.9493325352668762,0.05115435644984245,0,0.8386836647987366,0.1486722230911255,0,0.9725829484131824,0.027417051586817724,0
1657,ECMOは使用しなかった。,ECMO 使用 する ない た,0,0.9997735448491731,0.0002264551508269202,0,4.328935054576784e-05,0.9999567106494542,0,0.9896940812805453,0.010305918719454781,0,0.9999900475215254,9.952478474545094e-06,0,0.9541414976119995,0.056623391807079315,0,0.842157244682312,0.15346859395503998,0,0.9724872834784137,0.027512716521586197,0
1658,疾患の経過は不明であった。,疾患 経過 不明 だ ある た,0,0.9976440077865554,0.0023559922134446178,0,6.129130427814373e-05,0.9999387086957219,0,0.9957717133203254,0.004228286679674564,0,0.9950135389207863,0.004986461079213776,0,0.9328947067260742,0.05866120010614395,0,0.8287158012390137,0.20444178581237793,0,0.9699822420136603,0.030017757986339644,0
1659,素因の有無は不明であった。,素因 有無 不明 だ ある た,0,0.9896529358489213,0.010347064151078816,0,7.53854558098756e-05,0.9999246145441901,0,0.9865641045560012,0.013435895443998772,0,0.9549477493644545,0.04505225063554551,0,0.9463273286819458,0.06206166371703148,0,0.8473174571990967,0.20119260251522064,0,0.9674809879669205,0.032519012033079456,0
1660,PCR検査は陰性であった。,PCR検査 陰性 だ ある た,0,0.998411092877678,0.0015889071223219185,0,4.697954060693269e-05,0.999953020459393,0,0.9837058874473645,0.016294112552635503,0,0.9999949869927383,5.013007261787034e-06,0,0.9402440190315247,0.05555092915892601,0,0.8590700626373291,0.18343886733055115,0,0.9713808399133005,0.028619160086699545,0
1661,重篤性は提供されなかった。,重篤性 提供 する れる ない た,0,0.9987451732826729,0.0012548267173271765,0,6.671578926230318e-05,0.9999332842107377,0,0.9809189465165651,0.01908105348343488,0,0.9982439959998974,0.0017560040001025946,0,0.9541540145874023,0.05699997395277023,0,0.8326365947723389,0.1686370074748993,0,0.9711705116056961,0.028829488394303937,0
1662,現在、症状は回復している。,現在 症状 回復 する いる,0,0.9950414154622068,0.004958584537793227,0,5.334272970184594e-05,0.9999466572702982,0,0.9928424294347801,0.007157570565219918,0,0.9950698431514661,0.00493015684853389,0,0.9416331052780151,0.05848828703165054,0,0.8194351196289062,0.21021054685115814,0,0.9694801720188698,0.030519827981130163,0
1663,上記以外の症状はなかった。,上記 以外 症状 ない た,0,0.9995602382507939,0.0004397617492061199,0,5.340208230994511e-05,0.99994659791769,0,0.9818945022164225,0.018105497783577486,0,0.9951102105312476,0.004889789468752388,0,0.9438928365707397,0.05365154519677162,0,0.85145503282547,0.1762831062078476,0,0.9712137832355651,0.02878621676443494,0
1664,患者には家族歴はなかった。,患者 家族 歴 ない た,0,0.9993167900353065,0.0006832099646935401,0,5.648036235625058e-05,0.9999435196376437,0,0.9961301943925636,0.003869805607436436,0,0.9991724177766433,0.0008275822233566786,0,0.9485586881637573,0.054381538182497025,0,0.8455233573913574,0.16683895885944366,0,0.9724070265609925,0.027592973439007577,0
1665,有害事象は発生しなかった。,有害事象 発生 する ない た,0,0.9995610968636257,0.00043890313637442676,0,6.219774288913615e-05,0.9999378022571108,0,0.982763423464673,0.017236576535326953,0,0.9969366054635956,0.0030633945364044123,0,0.9535272121429443,0.05533985793590546,0,0.835545539855957,0.16463321447372437,0,0.9714670093877474,0.02853299061225259,0
1666,家族歴は特記無しであった。,家族 歴 特記 無し だ ある た,0,0.9845809080098155,0.01541909199018457,0,9.616803350653728e-05,0.9999038319664935,0,0.8755708619439511,0.12442913805604891,0,0.9667824577413736,0.03321754225862642,0,0.9535803198814392,0.0638841763138771,0,0.8536790609359741,0.18672707676887512,0,0.961235289930988,0.0387647100690121,0
1667,その後、しびれは軽快した。,その後 しびれ 軽快 する た,0,0.9845613224782712,0.015438677521728785,0,8.55539795483793e-05,0.9999144460204517,0,0.9813913097127226,0.018608690287277452,0,0.8571344147605873,0.14286558523941273,0,0.9427034258842468,0.08375924825668335,0,0.8180408477783203,0.21265369653701782,0,0.9573309995023116,0.04266900049768838,0
1668,SPO2低下なしであった。,SPO 0 低下 ない だ ある た,0,0.9949962721721114,0.005003727827888531,0,7.509840338780423e-05,0.9999249015966122,0,0.9575773728727072,0.04242262712729285,0,0.999871870323691,0.00012812967630900242,0,0.9354457855224609,0.06153259053826332,0,0.8400190472602844,0.18099500238895416,0,0.9688706034507378,0.031129396549262087,0
1669,追加調査の試みは完了した。,追加 調査 試み 完了 する た,0,0.9737630549775421,0.026236945022457922,0,7.490299267039163e-05,0.9999250970073296,0,0.6161699373989168,0.3838300626010832,0,0.9760851529010222,0.02391484709897789,0,0.9492215514183044,0.07084044069051743,0,0.8366814255714417,0.18646694719791412,0,0.9346724124372647,0.06532758756273525,0
1670,入院は必要とされなかった。,入院 必要 する れる ない た,0,0.9845639438289147,0.015436056171085252,0,9.26591929000234e-05,0.9999073408071,0,0.9775880515098896,0.022411948490110432,0,0.9993614394921273,0.0006385605078727212,0,0.9551059007644653,0.054720424115657806,0,0.8302767276763916,0.14067243039608002,0,0.9710610798133555,0.028938920186644564,0
1671,他の症状や徴候はなかった。,他 症状 徴候 ない た,0,0.9997669849902585,0.00023301500974141898,0,5.844496033164258e-05,0.9999415550396683,0,0.9946453076239012,0.005354692376098712,0,0.909585664559085,0.09041433544091498,0,0.9442102313041687,0.05200529098510742,0,0.8488211035728455,0.18117357790470123,0,0.9666882307821902,0.033311769217809775,0
1672,腹部症状は、ほぼ消失した。,腹部症状 消失 する た,0,0.9881595145628294,0.01184048543717059,0,7.34649876872076e-05,0.9999265350123128,0,0.9079409287489064,0.09205907125109361,0,0.6127058919278876,0.3872941080721124,0,0.939105749130249,0.06160123646259308,0,0.8193536400794983,0.1982090324163437,0,0.9252841564259261,0.07471584357407382,0
1673,酸素投与を実施しなかった。,酸素 投与 実施 する ない た,0,0.9999928937799685,7.106220031463747e-06,0,4.0184252636222984e-05,0.9999598157473638,0,0.99720851812949,0.002791481870510081,0,0.9988567852907144,0.0011432147092855856,0,0.9515557289123535,0.05306171998381615,0,0.8345698714256287,0.1606375277042389,0,0.9724716118492884,0.027528388150711562,0
1674,頭部レントゲン:問題なし。,頭部 レントゲン 問題なし,0,0.9845755996390315,0.015424400360968319,0,7.087967920221363e-05,0.9999291203207978,0,0.6524421138533576,0.34755788614664235,0,0.9999910902460086,8.909753991324773e-06,0,0.9362344145774841,0.05999334901571274,0,0.8028798699378967,0.2837444841861725,0,0.9352049091924425,0.06479509080755756,0
1675,皮膚、粘膜症状はなかった。,皮膚 粘膜症状 ない た,0,0.9986934190325555,0.001306580967444691,0,7.767494378502321e-05,0.9999223250562149,0,0.9674531832640656,0.03254681673593442,0,0.938135397327687,0.06186460267231294,0,0.9401067495346069,0.05674046277999878,0,0.8386238813400269,0.17750252783298492,0,0.9662096959859222,0.03379030401407778,0
1676,Blood test:正常,BLOOD test 正常,0,0.9961152367964122,0.0038847632035877134,0,6.837849074290507e-05,0.9999316215092571,0,0.9923758882265481,0.0076241117734518575,0,1.0,2.5889938675206188e-24,0,0.9312140345573425,0.0837179645895958,0,0.8257831335067749,0.20522263646125793,0,0.9690869397946372,0.03091306020536268,0
1677,以降ステロイドを漸減した。,以降 ステロイド 漸減 する た,0,0.9845730030887874,0.015426996911212652,0,8.800490718125769e-05,0.9999119950928187,0,0.9343684190619447,0.06563158093805536,0,0.9953856764747613,0.004614323525238772,0,0.928976833820343,0.06867901235818863,0,0.7979918718338013,0.22243230044841766,0,0.9631973191621587,0.03680268083784123,0
1678,1週後に、患者は退院した。,0 週 後 患者 退院 する た,0,0.9912303747453398,0.008769625254660202,0,7.510868464168972e-05,0.9999248913153583,0,0.9848344427608267,0.01516555723917329,0,0.9739941748744849,0.02600582512551511,0,0.9387099742889404,0.07131081074476242,0,0.8258526921272278,0.1967122107744217,0,0.967604623562188,0.032395376437812026,0
1679,循環器系の症状はなかった。,循環器 系 症状 ない た,0,0.9991484984329634,0.0008515015670365462,0,6.47191834247491e-05,0.9999352808165752,0,0.9856823086061192,0.014317691393880843,0,0.9950099908216974,0.004990009178302648,0,0.9432048201560974,0.05483666807413101,0,0.8399980068206787,0.16099396347999573,0,0.9714513968328361,0.028548603167163955,0
1680,接種当日には問題なかった。,接種 当日 問題 ない た,0,0.9963989360559281,0.003601063944071858,0,7.22390389170523e-05,0.9999277609610829,0,0.9674531832640656,0.03254681673593442,0,0.9972815434451924,0.0027184565548076384,0,0.9461086392402649,0.056942254304885864,0,0.8418422937393188,0.1683807224035263,0,0.9702590946181541,0.029740905381845872,0
1681,2022/06肝生検実施。,0 0 肝生検 実施,0,0.9845722968164896,0.015427703183510449,0,0.00010118961205283514,0.9998988103879471,0,0.8625299684886198,0.13747003151138013,0,0.9998798818234461,0.00012011817655385405,0,0.9154167175292969,0.07884439080953598,0,0.790319561958313,0.23719722032546997,0,0.9562221107761807,0.04377788922381921,0
1682,3回目までは何もなかった。,0回目 何 ない た,0,0.9920395586313924,0.00796044136860767,0,8.392849387468588e-05,0.9999160715061253,0,0.9837495366257796,0.016250463374220408,0,0.9964346369658474,0.0035653630341525157,0,0.9426401853561401,0.06931956857442856,0,0.8459879159927368,0.17605945467948914,0,0.9703404953246407,0.029659504675359348,0
1683,意識消失はすぐに改善した。,意識消失 改善 する た,0,0.9969236009333883,0.003076399066611825,0,7.502894802639171e-05,0.9999249710519736,0,0.97297294553032,0.027027054469679988,0,0.9993838052349336,0.0006161947650664007,0,0.9406634569168091,0.06679576635360718,0,0.8307933807373047,0.20430320501327515,0,0.9689034662703412,0.031096533729658732,0
1684,患者に先行感染はなかった。,患者 先行感染 ない た,0,0.9995463477105412,0.0004536522894589053,0,6.146894378895683e-05,0.999938531056211,0,0.9939711821886024,0.006028817811397642,0,0.9994055171292877,0.0005944828707122657,0,0.9437119364738464,0.05356656014919281,0,0.8483802080154419,0.1608743965625763,0,0.9724447510246822,0.02755524897531782,0
1685,患者の病歴は不明であった。,患者 病歴 不明 だ ある た,0,0.9954008963528728,0.004599103647127368,0,7.060275300359722e-05,0.9999293972469964,0,0.99416386856422,0.005836131435780004,0,0.998366603977613,0.0016333960223870378,0,0.9335402846336365,0.07292667031288147,0,0.8461540341377258,0.17447063326835632,0,0.9709230360427986,0.029076963957201243,0
1686,経過等の詳細は不明である。,経過 等 詳細 不明 だ ある,0,0.9958834913378937,0.004116508662106409,0,6.187564110732417e-05,0.9999381243588926,0,0.9912213892982937,0.008778610701706224,0,0.9985617633460047,0.001438236653995308,0,0.9410556554794312,0.06677133589982986,0,0.8181918859481812,0.23841701447963715,0,0.9684925336926027,0.03150746630739732,0
1687,血圧低下はみられなかった。,血圧低下 みる られる ない た,0,0.958102212667434,0.04189778733256588,0,0.00013556167292542515,0.9998644383270746,0,0.951875525619999,0.048124474380001045,0,0.9940464227193502,0.005953577280649865,0,0.9539527297019958,0.06177256628870964,0,0.8408408164978027,0.19527265429496765,0,0.965975833687358,0.03402416631264207,0
1688,幸いにも、患者は回復した。,幸い 患者 回復 する た,0,0.9963883382651982,0.003611661734801696,0,6.996363707808323e-05,0.9999300363629219,0,0.9938022577126966,0.006197742287303398,0,0.9682545717652458,0.03174542823475421,0,0.9362531304359436,0.06364823132753372,0,0.8247126936912537,0.20205433666706085,0,0.9680865368844668,0.031913463115533156,0
1689,心電図:(不明日)異常なし,心電図 明日 異常 ない,0,0.9901617691803731,0.0098382308196269,0,6.0831540255137665e-05,0.9999391684597448,0,0.973367898209392,0.026632101790608036,0,0.999996841359263,3.158640736943736e-06,0,0.942603588104248,0.06386518478393555,0,0.8461270928382874,0.20474791526794434,0,0.9691502874152803,0.030849712584719677,0
1690,素因的要素は不明であった。,素因 的 要素 不明 だ ある た,0,0.9857277985222156,0.01427220147778443,0,9.03755790471199e-05,0.9999096244209529,0,0.9740552301890428,0.025944769810957134,0,0.9165241451318075,0.08347585486819249,0,0.9398036003112793,0.07103932648897171,0,0.8271427750587463,0.21854443848133087,0,0.961953525340765,0.03804647465923501,0
1691,Spirometry:正常,SPIRO Metry 正常,0,0.997320509506452,0.002679490493547942,0,3.707312330342132e-05,0.9999629268766966,0,0.9923758882265481,0.0076241117734518575,0,1.0,3.63659618749856e-32,0,0.9188171029090881,0.080425925552845,0,0.8257831335067749,0.20522263646125793,0,0.9688838757539568,0.03111612424604309,0
1692,抗アクアポリン4抗体:陰性,アクアポリン 0 抗体 陰性,0,0.9974399183367069,0.0025600816632931596,0,7.491442471375912e-05,0.9999250855752863,0,0.9918597849167566,0.008140215083243404,0,0.9999999999971766,2.823418210131995e-12,0,0.9215332865715027,0.07723047584295273,0,0.8200932145118713,0.22314096987247467,0,0.968323903229227,0.03167609677077292,0
1693,抗ガングリオシド抗体:陰性,ガングリオシド 抗体 陰性,0,0.9969721147981789,0.003027885201821077,0,7.016243883001348e-05,0.9999298375611699,0,0.9918597849167566,0.008140215083243404,0,1.0,3.870513380325631e-17,0,0.9347193837165833,0.06331534683704376,0,0.8264488577842712,0.23348167538642883,0,0.9689969339581274,0.031003066041872633,0
1694,治療せず症状から回復した。,治療 する ぬ 症状 回復 する た,0,0.9984705058353283,0.0015294941646717387,0,5.6473965751447386e-05,0.9999435260342485,0,0.9939837540077503,0.006016245992249724,0,0.9982795168386334,0.001720483161366626,0,0.9402814507484436,0.061263419687747955,0,0.8164386749267578,0.1548476368188858,0,0.9713125782604426,0.028687421739557267,0
1695,弁膜症、壁運動異常も認めず,弁膜症 壁運動異常 認める ぬ,0,0.9845667089373025,0.01543329106269748,0,0.000149156831663048,0.999850843168337,0,0.5335922068555313,0.4664077931444687,0,0.9808153397322654,0.019184660267734587,1,0.11433757096529007,0.9247102737426758,1,0.29792484641075134,0.8148568272590637,1,0.418469878240156,0.581530121759844,0
1696,高い熱は2日ぐらいだった。,高い 熱 0 日 だ た,0,0.5407912259090512,0.459208774090949,1,0.00018309327351076574,0.9998169067264893,0,0.787212630753007,0.21278736924699307,0,0.9960592260346558,0.003940773965344231,1,0.3614242672920227,0.6985222101211548,1,0.20672059059143066,0.8495369553565979,1,0.4178946797204073,0.5821053202795928,0
1697,ST上昇の改善を認めた。,ST 上昇 改善 認める た,0,0.7250728683077492,0.27492713169225097,1,0.00019266670920963346,0.9998073332907904,1,0.34782503695848976,0.6521749630415102,0,0.9999659436263504,3.405637364965517e-05,0,0.9279336333274841,0.06967057287693024,0,0.796663761138916,0.26047855615615845,1,0.8235463064197962,0.1764536935802038,0
1698,アセトアミノフェン投与。,アセトアミノフェン 投与,0,0.9447194206329361,0.05528057936706387,0,0.00010914672552766979,0.9998908532744724,0,0.9371363224023153,0.06286367759768478,0,0.9999999341708398,6.582916026247902e-08,0,0.8733083605766296,0.14162975549697876,0,0.7713261246681213,0.31988006830215454,0,0.9501240820790178,0.049875917920982185,0
1699,その後、血行動態は改善。,その後 血行動態 改善,0,0.9978550500537832,0.002144949946216873,0,6.246063586783469e-05,0.9999375393641322,0,0.9589488521092018,0.0410511478907982,0,0.9999999999999407,5.93204385503255e-14,0,0.9264525175094604,0.09401507675647736,0,0.6775190830230713,0.3676633834838867,0,0.9550419685672069,0.044958031432793026,0
1700,プラバスタチン投与中止。,プラバスタチン 投与 中止,0,0.9845685781810122,0.015431421818987797,0,7.131004848452014e-05,0.9999286899515155,0,0.9420541313809493,0.057945868619050676,0,1.0,1.8188558523441176e-18,0,0.9028410911560059,0.08826223760843277,0,0.7842655181884766,0.3211542069911957,0,0.9581566421855829,0.041843357814417115,0
1701,レミエール症候群は陰性。,レミエール症候群 陰性,0,0.9926872470247423,0.007312752975257615,0,6.691989178608871e-05,0.9999330801082139,0,0.9748863304620521,0.02511366953794793,0,0.9999999987993364,1.2006635615973464e-09,0,0.9365615844726562,0.0642128512263298,0,0.7716602087020874,0.29629597067832947,0,0.9638407734871429,0.03615922651285711,0
1702,安静後、腹痛は改善した。,安静 後 腹痛 改善 する た,0,0.9983120933481378,0.0016879066518622097,0,7.92277028207528e-05,0.9999207722971792,0,0.97297294553032,0.027027054469679988,0,0.9094055576240782,0.0905944423759218,0,0.9362913966178894,0.057983361184597015,0,0.8276830315589905,0.21618367731571198,0,0.9627214864156306,0.03727851358436943,0
1703,一時症状が改善していた。,一時症状 改善 する いる た,0,0.9987997585336466,0.0012002414663534562,0,7.266104182385902e-05,0.9999273389581761,0,0.978805906877325,0.02119409312267499,0,0.9497468673638118,0.05025313263618825,0,0.9397626519203186,0.05599459260702133,0,0.8258993029594421,0.2067069560289383,0,0.9663596812017079,0.033640318798292115,0
1704,関連した検査はなかった。,関連 する た 検査 ない た,0,0.9998159671258572,0.0001840328741428438,0,4.383200915199345e-05,0.999956167990848,0,0.9947231164575291,0.0052768835424708985,0,0.9999999995582244,4.417756098593538e-10,0,0.9456703662872314,0.054195307195186615,0,0.8360019326210022,0.13971185684204102,0,0.9727991910287828,0.02720080897121721,0
1705,関連する検査はなかった。,関連 する 検査 ない た,0,0.9998159671258572,0.0001840328741428438,0,4.497365799808144e-05,0.999955026342002,0,0.9962087788013319,0.003791221198668101,0,0.9999985088645101,1.4911354899018797e-06,0,0.9464279413223267,0.05448225885629654,0,0.8358504176139832,0.14241313934326172,0,0.972814757693862,0.027185242306137877,0
1706,胸部X線は無傷であった。,胸部 X線 無傷 だ ある た,0,0.9710947548564606,0.028905245143539267,0,0.0001045431319338871,0.9998954568680661,0,0.9083753389348065,0.09162466106519356,0,0.9920223444921579,0.00797765550784209,0,0.9125756621360779,0.10813212394714355,0,0.8313003182411194,0.19503363966941833,0,0.9602240498178549,0.03977595018214504,0
1707,血小板数:正常(正常)。,血小板 数 正常 正常,0,0.9845918118800601,0.015408188119939933,0,6.76034675747796e-05,0.9999323965324253,0,0.9923758882265481,0.0076241117734518575,0,1.0,6.052324845629276e-44,0,0.9319176077842712,0.06871122866868973,0,0.8267539739608765,0.22263440489768982,0,0.9683665799406219,0.03163342005937797,0
1708,原因は不明と報告された。,原因 不明 報告 する れる た,0,0.9834696939274747,0.016530306072525393,0,7.114140444379982e-05,0.9999288585955562,0,0.9461043003046159,0.053895699695384124,1,0.3401284678931107,0.6598715321068893,0,0.8437472581863403,0.2121753990650177,0,0.6704994440078735,0.39960312843322754,1,0.8087665508484038,0.19123344915159624,0
1709,抗核抗体:陰性(陰性)。,抗核抗体 陰性 陰性,0,0.9935245254692933,0.006475474530706709,0,4.9364394994205194e-05,0.9999506356050057,0,0.9748863304620521,0.02511366953794793,0,1.0,3.2454859272902625e-37,0,0.9276400208473206,0.05704956501722336,0,0.8230906128883362,0.23432067036628723,0,0.9675880999414069,0.03241190005859294,0
1710,市販の解熱鎮痛薬を内服。,市販 解熱 鎮痛 薬 内服,0,0.9987272655340471,0.001272734465952809,0,6.847869684025996e-05,0.9999315213031598,0,0.9926532017376573,0.007346798262342769,0,0.9999999999074994,9.250052810614749e-11,0,0.8740761280059814,0.1798984855413437,0,0.7312514185905457,0.42519959807395935,0,0.9518060300090728,0.04819396999092719,0
1711,症状の回復が認められた。,症状 回復 認める られる た,0,0.9894924862523947,0.010507513747605281,0,0.00010370013112329534,0.9998962998688767,0,0.9733894681665379,0.026610531833462063,0,0.9736793823297185,0.026320617670281436,0,0.9396935105323792,0.06039116904139519,0,0.8148912787437439,0.21639402210712433,0,0.9661418089230696,0.03385819107693056,0
1712,症状の回復を認め、退院。,症状 回復 認める 退院,0,0.999647910845733,0.0003520891542670651,0,4.8602504731830603e-05,0.9999513974952682,0,0.9910996976942531,0.00890030230574691,0,1.0,1.4608434501023285e-23,0,0.9403046369552612,0.06652862578630447,0,0.7982306480407715,0.22590762376785278,0,0.9685588425988708,0.03144115740112929,0
1713,生前の検査でも全て陰性。,生前 検査 全て 陰性,0,0.989118662113663,0.010881337886336983,0,9.390534396646316e-05,0.9999060946560335,0,0.9830269590625047,0.016973040937495267,0,0.9999999999999999,1.0934272455960898e-16,0,0.9404510259628296,0.06737054884433746,0,0.8284529447555542,0.19744734466075897,0,0.969188320938655,0.030811679061345104,0
1714,接種時には特に問題なし。,接種 時 問題なし,0,0.9845543926081484,0.015445607391851638,0,7.345890093847153e-05,0.9999265410990615,0,0.6181619265999716,0.38183807340002834,0,0.999999999999853,1.4704261410443932e-13,0,0.9279892444610596,0.06605479121208191,0,0.8330875635147095,0.21901749074459076,0,0.9359311771354479,0.06406882286455216,0
1715,先行感染はなしであった。,先行感染 ない だ ある た,0,0.9989052595910293,0.0010947404089707792,0,6.141462656611463e-05,0.9999385853734338,0,0.9783120759805788,0.02168792401942122,0,0.9969377831484463,0.003062216851553718,0,0.9389188289642334,0.06263335049152374,0,0.8439615964889526,0.17636267840862274,0,0.9704683856180586,0.029531614381941414,0
1716,内服薬は希望せず、帰宅。,内服薬 希望 する ぬ 帰宅,0,0.9845628249569153,0.015437175043084615,0,7.934665393035307e-05,0.9999206533460696,0,0.7104446615669933,0.2895553384330067,0,0.9999482123914208,5.178760857919178e-05,0,0.9411942958831787,0.0798003226518631,0,0.8253815770149231,0.24090486764907837,0,0.9445873769725635,0.055412623027436554,0
1717,肉眼的血尿は徐々に回復。,肉眼的血尿 回復,0,0.9901540701385809,0.009845929861419066,0,7.054581734813347e-05,0.9999294541826519,0,0.9793474487283149,0.020652551271685124,0,0.9999999999992768,7.231868706757975e-13,0,0.9366016387939453,0.08504515886306763,0,0.7943739295005798,0.3677055537700653,0,0.96148269644093,0.038517303559070064,0
1718,日付不明血圧測定:正常。,日付 不明 血圧 測定 正常,0,0.9891163793229322,0.010883620677067874,0,5.5650302101011874e-05,0.999944349697899,0,0.9956964720857285,0.004303527914271427,0,1.0,1.0405583338429749e-18,0,0.9404904842376709,0.06032403185963631,0,0.8242353796958923,0.23938563466072083,0,0.9687731810180862,0.03122681898191377,0
1719,日付不明症状は軽快傾向。,日付 不明症状 軽快 傾向,0,0.9968467743246755,0.0031532256753243875,0,5.2390600997914594e-05,0.9999476093990021,0,0.9955053189085007,0.004494681091499344,0,0.9999984615862996,1.5384137004122445e-06,0,0.9391565322875977,0.0713915079832077,0,0.8218827843666077,0.2472430318593979,0,0.9685441979928786,0.031455802007121364,0
1720,年明け、体重変わりなし。,年明け 体重変わりなし,0,0.9845693215526096,0.015430678447390447,0,0.00010477259724178046,0.9998952274027583,1,0.4563792597309324,0.5436207402690676,0,0.9999952928598059,4.707140194123209e-06,0,0.921789824962616,0.06849896162748337,0,0.7209096550941467,0.4518343210220337,1,0.8812649199293353,0.11873508007066472,0
1721,培養は実施されなかった。,培養 実施 する れる ない た,0,0.9999829802986211,1.7019701378917877e-05,0,4.6563215715313255e-05,0.9999534367842847,0,0.9962602914064265,0.0037397085935735037,0,0.9993153772886839,0.0006846227113161066,0,0.954511284828186,0.053742650896310806,0,0.8449388742446899,0.15163230895996094,0,0.9730193919283829,0.026980608071617094,0
1722,白血球数:陰性(陰性)。,白血球 数 陰性 陰性,0,0.9845616763070416,0.015438323692958342,0,7.36039307667435e-05,0.9999263960692333,0,0.9748863304620521,0.02511366953794793,0,1.0,8.240713279371266e-33,0,0.9264364838600159,0.06146927550435066,0,0.8271121382713318,0.23952363431453705,0,0.9668050441397478,0.033194955860252104,0
1723,発症後9 kg減少した。,発症 後 0 kg 減少 する た,0,0.625995302134495,0.374004697865505,1,0.0003129505281447843,0.9996870494718552,1,0.1287915014375417,0.8712084985624583,1,0.3414815044399472,0.6585184955600528,0,0.8988234996795654,0.11873120069503784,0,0.6682998538017273,0.4142268896102905,1,0.31590133515823043,0.6840986648417695,0
1724,搬送中に状態は回復した。,搬送 中 状態 回復 する た,0,0.9845668882943533,0.015433111705646792,0,8.183662004105539e-05,0.999918163379959,0,0.9648581122377538,0.03514188776224626,0,0.9663845643106214,0.03361543568937865,0,0.9405128359794617,0.060730867087841034,0,0.8093511462211609,0.18492615222930908,0,0.9656430447086751,0.034356955291324896,0
1725,病院に搬送し、経過観察。,病院 搬送 する 経過 観察,0,0.9845668509081454,0.015433149091854448,0,0.00014821677437750833,0.9998517832256225,0,0.8730913939128957,0.12690860608710433,0,0.9979984863398053,0.0020015136601947707,0,0.9114592671394348,0.11304306983947754,0,0.7947479486465454,0.21270287036895752,0,0.9565645012709786,0.043435498729021395,0
1726,服薬中の薬剤はなかった。,服薬 中 薬剤 ない た,0,0.9996502566674562,0.0003497433325438178,0,5.887289589797849e-05,0.999941127104102,0,0.9764993146469042,0.023500685353095827,0,0.9992986081859082,0.0007013918140917674,0,0.940160870552063,0.053819041699171066,0,0.8451942801475525,0.16314493119716644,0,0.9712348937074988,0.02876510629250127,0
1727,併用薬の使用はなかった。,併用 薬 使用 ない た,0,0.999965326341036,3.467365896408222e-05,0,4.58531428238648e-05,0.9999541468571761,0,0.9965479362544781,0.003452063745521866,0,0.9999578417508322,4.215824916775337e-05,0,0.9501212239265442,0.050771281123161316,0,0.8529998660087585,0.1517484039068222,0,0.9732377300125101,0.02676226998748983,0
1728,病歴は報告されなかった。,病歴 報告 する れる ない た,0,0.9994933376315859,0.0005066623684141935,0,6.148775612507862e-05,0.9999385122438749,0,0.9930778493590375,0.006922150640962501,0,0.9994299241544526,0.0005700758455473576,0,0.9513115286827087,0.052953366190195084,0,0.8375837206840515,0.14642399549484253,0,0.9727120553164957,0.027287944683504324,0
1729,剖検は実施されなかった。,剖検 実施 する れる ない た,0,0.999974502940993,2.5497059006971513e-05,0,4.1857173761734726e-05,0.9999581428262383,0,0.9949935811931101,0.005006418806889883,0,0.9988553523753654,0.00114464762463463,0,0.9522438049316406,0.05411447584629059,0,0.8137117624282837,0.1481003761291504,0,0.9721173339189015,0.02788266608109849,0
1730,酸素投与はされなかった。,酸素 投与 する れる ない た,0,0.9999083858407454,9.161415925456736e-05,0,6.981419676706973e-05,0.9999301858032329,0,0.9964422315635798,0.0035577684364202383,0,0.9986058513571057,0.0013941486428943816,0,0.9515689015388489,0.05459429323673248,0,0.8499397039413452,0.17417672276496887,0,0.9724224999317759,0.027577500068224157,0
1731,心電図で変化はなかった。,心電図 変化 ない た,0,0.9987219262880501,0.0012780737119497845,0,5.503282882666304e-05,0.9999449671711733,0,0.9872581054821963,0.012741894517803708,0,0.9996380522760913,0.00036194772390875347,0,0.9399083852767944,0.0547441728413105,0,0.8509656190872192,0.16635337471961975,0,0.9718354578142309,0.028164542185769106,0
1732,酸素投与は行わなかった。,酸素 投与 行う ない た,0,0.99970030127763,0.0002996987223699711,0,7.723119688456526e-05,0.9999227688031155,0,0.9927855226694998,0.00721447733050015,0,0.9891532458535067,0.010846754146493257,0,0.923140287399292,0.08160612732172012,0,0.8326306343078613,0.20776408910751343,0,0.9686240020980696,0.031375997901930366,0
1733,磁気共鳴画像:異常なし。,磁気 共鳴 画像 異常 ない,0,0.9845705428727125,0.015429457127287495,0,6.519518996403046e-05,0.9999348048100359,0,0.9705115313197026,0.02948846868029738,0,0.9997623577886079,0.000237642211392088,0,0.9298757314682007,0.05902506411075592,0,0.8343235850334167,0.1553134024143219,0,0.969518514481336,0.03048148551866409,0
1734,その他画像検査:未実施。,その他 画像 検査 実施,0,0.9898444573816123,0.01015554261838769,0,7.210270834861073e-05,0.9999278972916514,0,0.9866337102689655,0.013366289731034516,0,0.9999998547231173,1.4527688278425013e-07,0,0.9121081829071045,0.12531620264053345,0,0.7923007607460022,0.24414390325546265,0,0.9640165408400281,0.0359834591599719,0
1735,患者に原疾患はなかった。,患者 疾患 ない た,0,0.9998725376428764,0.0001274623571234406,0,3.8584601387662104e-05,0.9999614153986124,0,0.9953010537523439,0.004698946247656133,0,0.9999957665176166,4.233482383486541e-06,0,0.9481402039527893,0.05610983073711395,0,0.8437426686286926,0.15796053409576416,0,0.9725679629691271,0.027432037030872946,0
1736,関連した病歴はなかった。,関連 する た 病歴 ない た,0,0.9991019334900147,0.0008980665099851432,0,5.8974113942508574e-05,0.9999410258860575,0,0.9880876408703667,0.01191235912963329,0,0.9999995640509338,4.3594906620423233e-07,0,0.9465047121047974,0.056852880865335464,0,0.8427711129188538,0.1546379029750824,0,0.9721392797664921,0.027860720233508048,0
1737,副作用歴は特になかった。,副作用 歴 ない た,0,0.9997883724786851,0.00021162752131501428,0,4.6689898315103015e-05,0.9999533101016849,0,0.9936029219869664,0.006397078013033564,0,0.9995530103549461,0.00044698964505382227,0,0.9511820673942566,0.053066834807395935,0,0.8571485877037048,0.17011474072933197,0,0.9726452988417069,0.027354701158293113,0
1738,救急要請はされなかった。,救急 要請 する れる ない た,0,0.9990698984381502,0.0009301015618498311,0,8.5939818700693e-05,0.9999140601812994,0,0.9824299083819966,0.01757009161800334,0,0.9983126873834678,0.001687312616532251,0,0.9487211108207703,0.06345934420824051,0,0.8244840502738953,0.1628933697938919,0,0.970876371398306,0.029123628601694034,0
1739,また胸痛も軽快していた。,胸痛 軽快 する いる た,0,0.9845685002867862,0.015431499713213797,0,6.758508403833782e-05,0.9999324149159616,0,0.9425211334218276,0.05747886657817241,0,0.9720401780462423,0.02795982195375773,0,0.9442743062973022,0.05493932217359543,0,0.8413102030754089,0.2358262836933136,0,0.9641952654578262,0.03580473454217376,0
1740,外皮系の症状はなかった。,外皮系 症状 ない た,0,0.9996799233944828,0.0003200766055171697,0,6.85815399218559e-05,0.9999314184600782,0,0.9868211441752747,0.013178855824725312,0,0.9938511799855164,0.0061488200144835334,0,0.941679060459137,0.05430243909358978,0,0.8487884998321533,0.1573268622159958,0,0.9717959403353644,0.028204059664635652,0
1741,抗好中球細胞質抗体:正常,抗好中球細胞質抗体 正常,0,0.9933513892246802,0.006648610775319758,0,7.668000414159625e-05,0.9999233199958584,0,0.9923758882265481,0.0076241117734518575,0,1.0,1.739150641734208e-20,0,0.9102652668952942,0.06935146450996399,0,0.8124023079872131,0.20049917697906494,0,0.9684592134150157,0.0315407865849843,0
1742,患者の家族歴はなかった。,患者 家族 歴 ない た,0,0.9993167900353065,0.0006832099646935401,0,5.648036235625058e-05,0.9999435196376437,0,0.9961301943925636,0.003869805607436436,0,0.9991724177766433,0.0008275822233566786,0,0.9485586881637573,0.054381538182497025,0,0.8455233573913574,0.16683895885944366,0,0.9724070265609925,0.027592973439007577,0
1743,ICUは入室しなかった。,ICU 入室 する ない た,0,0.9996490078270955,0.0003509921729044296,0,6.447946878603023e-05,0.9999355205312139,0,0.9914253619683489,0.008574638031651162,0,0.9994405269611505,0.0005594730388494856,0,0.9554541110992432,0.05959521234035492,0,0.8370916247367859,0.14994226396083832,0,0.972459399062412,0.027540600937587985,0
1744,転帰は報告されなかった。,転帰 報告 する れる ない た,0,0.999600683386184,0.0003993166138159736,0,7.270168794569377e-05,0.9999272983120543,0,0.9930778493590375,0.006922150640962501,0,0.9991416432012327,0.0008583567987673617,0,0.9531260132789612,0.05367426201701164,0,0.8077479004859924,0.13826251029968262,0,0.972151238613792,0.027848761386208065,0
1745,その他の症状はなかった。,その他 症状 ない た,0,0.9998658727891382,0.00013412721086186424,0,4.409380366362762e-05,0.9999559061963363,0,0.9965766140459623,0.0034233859540377023,0,0.9996692580409954,0.00033074195900466475,0,0.9398744702339172,0.05668474733829498,0,0.8455562591552734,0.17997591197490692,0,0.9718343371261873,0.028165662873812638,0
1746,患者に家族歴はなかった。,患者 家族 歴 ない た,0,0.9993167900353065,0.0006832099646935401,0,5.648036235625058e-05,0.9999435196376437,0,0.9961301943925636,0.003869805607436436,0,0.9991724177766433,0.0008275822233566786,0,0.9485586881637573,0.054381538182497025,0,0.8455233573913574,0.16683895885944366,0,0.9724070265609925,0.027592973439007577,0
1747,その他の病歴はなかった。,その他 病歴 ない た,0,0.9993537351144511,0.0006462648855487199,0,5.30930685582246e-05,0.9999469069314417,0,0.9943893037748959,0.005610696225104087,0,0.9999591009833972,4.0899016602767686e-05,0,0.9431632161140442,0.06026674434542656,0,0.8512288331985474,0.16380491852760315,0,0.9722891943461125,0.02771080565388738,0
1748,血液系の症状はなかった。,血液 系 症状 ない た,0,0.9997015124799938,0.0002984875200062108,0,5.1835184905765376e-05,0.9999481648150942,0,0.9856823086061192,0.014317691393880843,0,0.99676937202639,0.003230627973609911,0,0.94016033411026,0.056074272841215134,0,0.84063720703125,0.16307079792022705,0,0.971420299311586,0.02857970068841394,0
1749,少量の利尿薬で安定した。,少量 利尿 薬 安定 する た,0,0.9893695889989934,0.010630411001006545,0,7.837442677676962e-05,0.9999216255732233,0,0.9397906911021675,0.0602093088978325,0,0.7323477844530846,0.2676522155469154,0,0.9371764063835144,0.05548929050564766,0,0.8202798366546631,0.19416393339633942,0,0.9443269307270866,0.055673069272913336,0
1750,家族歴と病歴はなかった。,家族 歴 病歴 ない た,0,0.9979177734529765,0.00208222654702363,0,6.749396092891398e-05,0.9999325060390711,0,0.9895305207410784,0.010469479258921567,0,0.99925184745097,0.0007481525490300767,0,0.9479284882545471,0.057360753417015076,0,0.8460128307342529,0.17058052122592926,0,0.9717919767385056,0.028208023261494405,0
1751,被験者に症状はなかった。,被験者 症状 ない た,0,0.9996911833831115,0.00030881661688857777,0,5.174377666896306e-05,0.9999482562233311,0,0.9939173999201447,0.006082600079855246,0,0.9971556509529725,0.0028443490470275016,0,0.9502301216125488,0.0545346774160862,0,0.8556331992149353,0.15151070058345795,0,0.9729185110588434,0.027081488941156577,0
1752,レートは70に回復した。,レート 0 回復 する た,0,0.9930240919563114,0.006975908043688568,0,8.31155580292013e-05,0.9999168844419708,0,0.985513011982611,0.014486988017388984,0,0.9680777135220969,0.031922286477903045,0,0.9359676241874695,0.06386015564203262,0,0.8269075751304626,0.2196154147386551,0,0.9668434239990452,0.033156576000954646,0
1753,既往歴や内服はなかった。,既往 歴 内服 ない た,0,0.9997411293084594,0.0002588706915406926,0,5.043353608778536e-05,0.9999495664639122,0,0.9929037604554432,0.007096239544556795,0,0.9994509244437839,0.0005490755562160283,0,0.9500731229782104,0.05522901192307472,0,0.8558423519134521,0.1782316267490387,0,0.9722599861962398,0.027740013803760157,0
1754,アレルギー歴はなかった。,アレルギー歴 ない た,0,0.9994263555332552,0.0005736444667446799,0,6.166342237841651e-05,0.9999383365776215,0,0.9900480001823301,0.009951999817669975,0,0.9965861402198983,0.0034138597801016755,0,0.9488571882247925,0.054936207830905914,0,0.8627346754074097,0.17506328225135803,0,0.9721813767800372,0.0278186232199629,0
1755,患者は肥満ではなかった。,患者 肥満 だ ない た,0,0.9997098871128338,0.00029011288716627906,0,5.9845987330632217e-05,0.9999401540126693,0,0.9878585403485579,0.012141459651442109,0,0.9991229166435994,0.0008770833564006083,0,0.9471166133880615,0.053929317742586136,0,0.8387334942817688,0.15494708716869354,0,0.9720903455855404,0.02790965441445963,0
1756,副反応歴は特になかった。,副反応 歴 ない た,0,0.999374261578989,0.0006257384210110031,0,6.548016898179849e-05,0.9999345198310182,0,0.9936029219869664,0.006397078013033564,0,0.9052473726674465,0.09475262733255356,0,0.9498193860054016,0.05368455871939659,0,0.8572804927825928,0.17612303793430328,0,0.9668779277838366,0.033122072216163444,0
1757,副反応歴は不明であった。,副反応 歴 不明 だ ある た,0,0.9962187920867046,0.0037812079132954913,0,8.195074105443499e-05,0.9999180492589456,0,0.9913526279184829,0.008647372081517113,0,0.9556283664063527,0.044371633593647236,0,0.9419465065002441,0.06479313224554062,0,0.8492663502693176,0.1817668378353119,0,0.968666008004918,0.0313339919950821,0
1758,アデホス内服を継続した。,アデホス 内服 継続 する た,0,0.9845869931239606,0.015413006876039382,0,8.663950931453706e-05,0.9999133604906855,0,0.9434730116127187,0.05652698838728128,0,0.9421758734585287,0.05782412654147127,0,0.937195360660553,0.061016663908958435,0,0.7820863127708435,0.24516813457012177,0,0.9590559105656029,0.04094408943439714,0
1759,腎臓系の症状はなかった。,腎臓 系 症状 ない た,0,0.9991484984329634,0.0008515015670365462,0,6.677650993366804e-05,0.9999332234900663,0,0.9818945022164225,0.018105497783577486,0,0.995136310975043,0.004863689024957047,0,0.9396312832832336,0.05799625441431999,0,0.8404029607772827,0.16509942710399628,0,0.970954914465443,0.02904508553455698,0
1760,神経系の症状はなかった。,神経系 症状 ない た,0,0.9996799233944828,0.0003200766055171697,0,7.489248825014482e-05,0.9999251075117499,0,0.9868211441752747,0.013178855824725312,0,0.9955859091263598,0.004414090873640215,0,0.9414855241775513,0.05308264121413231,0,0.8442053198814392,0.16705721616744995,0,0.9715259469983152,0.02847405300168472,0
1761,血管系の症状はなかった。,血管系 症状 ない た,0,0.9997219605089954,0.0002780394910045295,0,6.499749110837131e-05,0.9999350025088917,0,0.9910270796894673,0.008972920310532696,0,0.97198752883419,0.028012471165809957,0,0.9437434673309326,0.05633823946118355,0,0.8482006192207336,0.17877687513828278,0,0.970183754783247,0.02981624521675283,0
1762,心血管疾患歴はなかった。,心血管疾患 歴 ない た,0,0.9995031792460415,0.0004968207539586227,0,7.150562442868451e-05,0.9999284943755713,0,0.9833093291399719,0.016690670860028043,0,0.9907786846544699,0.009221315345530064,0,0.9440217018127441,0.055414389818906784,0,0.8434773087501526,0.16593675315380096,0,0.9710687028476418,0.028931297152358235,0
1763,追加調査は不可能である。,追加 調査 不可能 だ ある,0,0.9838293034650113,0.01617069653498879,0,7.812938533835633e-05,0.9999218706146616,0,0.8853097310823747,0.11469026891762533,0,0.999616105874927,0.00038389412507303653,0,0.9516646862030029,0.070258729159832,0,0.8373613953590393,0.17850929498672485,0,0.963663681224806,0.036336318775194096,0
1764,リンパ節腫大はなかった。,リンパ節腫大 ない た,0,0.9993831417621258,0.0006168582378741913,0,6.392390050534842e-05,0.9999360760994946,0,0.9900480001823301,0.009951999817669975,0,0.8298927164646103,0.1701072835353897,0,0.9364039301872253,0.0609707236289978,0,0.8474025130271912,0.16552816331386566,0,0.9606866117614906,0.03931338823850943,0
1765,患者は、外来フォロー中。,患者 外来 フォロー 中,0,0.9945796250948103,0.005420374905189621,0,6.882413216536062e-05,0.9999311758678346,0,0.8497615893665884,0.15023841063341153,0,0.9999999999455069,5.449306151487837e-11,0,0.9426411390304565,0.06964758783578873,0,0.7756439447402954,0.24663561582565308,0,0.9565125682342382,0.04348743176576172,0
1766,患者は併用薬を使用した。,患者 併用 薬 使用 する た,0,0.9921490249404248,0.0078509750595752,0,0.00011277576216270757,0.9998872242378373,0,0.9825565358149349,0.017443464185065198,0,0.9934621593901654,0.006537840609834637,0,0.942843496799469,0.06816017627716064,0,0.7759516835212708,0.21498803794384003,0,0.9668245840287024,0.03317541597129768,0
1767,鑑別診断は不明であった。,鑑別 診断 不明 だ ある た,0,0.9845469636964559,0.0154530363035443,0,0.00012595175217369577,0.9998740482478263,0,0.9128160051120996,0.08718399488790037,0,0.9676654093838675,0.032334590616132565,0,0.928366482257843,0.0698176845908165,0,0.8180341124534607,0.21592237055301666,0,0.9604930142883231,0.03950698571167688,0
1768,呼吸音に異常はなかった。,呼吸 音 異常 ない た,0,0.9845680331232689,0.01543196687673096,0,9.903776695601148e-05,0.999900962233044,0,0.9710458774792066,0.028954122520793407,0,0.9529139466333735,0.04708605336662652,0,0.9360764622688293,0.05974610894918442,0,0.8500975370407104,0.17120973765850067,0,0.9668330502467848,0.03316694975321513,0
1769,追跡調査は不可能である。,追跡調査 不可能 だ ある,0,0.9848829755256505,0.015117024474349428,0,7.532250860681656e-05,0.9999246774913931,0,0.8127301975226132,0.18726980247738675,0,0.9999824298844364,1.7570115563551512e-05,0,0.9488831162452698,0.06756789982318878,0,0.8388398289680481,0.18803717195987701,0,0.9580113275734264,0.041988672426573635,0
1770,"LYMPHO, 22.1",LYMPHO 0 0,0,0.648277032595875,0.35172296740412506,1,0.0002450053660009475,0.9997549946339991,1,0.3741492743921715,0.6258507256078285,1,0.0009023603904207977,0.9990976396095792,0,0.903905987739563,0.16948169469833374,0,0.6659526824951172,0.409397155046463,1,0.2765033790368995,0.7234966209631005,0
1771,"U-Sugar, (-)",U Sugar,0,0.5547603559024763,0.44523964409752376,1,0.0001843188090939102,0.9998156811909061,1,0.4563792597309324,0.5436207402690676,0,0.5195482961797382,0.48045170382026176,0,0.7950349450111389,0.27442237734794617,0,0.7354044914245605,0.33487778902053833,1,0.4957210372935296,0.5042789627064704,0
1772,COVIDは治癒した。,COVID 治癒 する た,0,0.9686644287803071,0.031335571219692875,0,0.00010826565562675186,0.9998917343443733,0,0.6186777153108296,0.38132228468917034,0,0.9877095272564633,0.012290472743536672,0,0.940068244934082,0.06882662326097488,0,0.8308016657829285,0.17420035600662231,0,0.9357257174337812,0.06427428256621882,0
1773,C-反応性蛋白:陰性。,C 反応 性 蛋白 陰性,0,0.9496374240330554,0.050362575966944635,0,0.00012981654093706998,0.999870183459063,0,0.8773407281562431,0.1226592718437569,0,0.9999999629665458,3.703345423080358e-08,0,0.9199870824813843,0.08105303347110748,0,0.8156112432479858,0.22480881214141846,0,0.9562259200743051,0.043774079925695014,0
1774,PCR検査を実施した。,PCR検査 実施 する た,0,0.9931327652208095,0.006867234779190542,0,6.552931278084162e-05,0.9999344706872192,0,0.7906233309018819,0.20937666909811814,0,0.9999719914934674,2.80085065326414e-05,0,0.9366884231567383,0.08398300409317017,0,0.807460367679596,0.2894454002380371,0,0.9497079555886694,0.05029204441133054,0
1775,アシクロビル投与開始。,アシクロビル 投与 開始,0,0.9845665148417833,0.015433485158216612,0,7.462151878875161e-05,0.9999253784812112,0,0.9722922847214339,0.02770771527856604,0,0.9999151757154475,8.482428455242058e-05,0,0.9023635387420654,0.10554329305887222,0,0.6670913100242615,0.4580910801887512,0,0.9488028744586942,0.05119712554130586,0
1776,カテーテル治療を施行。,カテーテル 治療 施行,0,0.9845658396480725,0.015434160351927472,0,8.595052092186633e-05,0.9999140494790781,0,0.789227446834306,0.21077255316569402,0,0.9999974296777397,2.5703222602123567e-06,0,0.9086055159568787,0.11403995752334595,0,0.7402288317680359,0.4200858175754547,0,0.9347749316147664,0.06522506838523363,0
1777,プレドニン25 mg。,プレドニン 0 mg,0,0.9906207320303747,0.00937926796962529,0,6.931560455007703e-05,0.99993068439545,0,0.7698538536553231,0.2301461463446769,0,0.9999999999998216,1.7838731412612182e-13,0,0.8729352951049805,0.09691204130649567,0,0.8169783353805542,0.28814926743507385,0,0.9440615889819413,0.05593841101805866,0
1778,解熱剤使用はなかった。,解熱 剤 使用 ない た,0,0.9998022926214394,0.00019770737856061765,0,4.11290885105661e-05,0.9999588709114894,0,0.995353694897457,0.004646305102542993,0,0.9999087497033912,9.125029660882308e-05,0,0.9479886889457703,0.05218600481748581,0,0.852943480014801,0.16919244825839996,0,0.9726089411056908,0.02739105889430916,0
1779,感染症は否定的と判断。,感染症 否定 的 判断,0,0.9845517138884251,0.01544828611157477,0,9.904558352188408e-05,0.9999009544164781,0,0.6828328946511164,0.3171671053488836,0,0.9999999995161276,4.838723994613611e-10,0,0.9019753336906433,0.14572353661060333,0,0.8125123977661133,0.20712493360042572,0,0.9368261081079295,0.06317389189207055,0
1780,駆出率:52(正常)。,駆け出し 率 0 正常,0,0.9937701827698123,0.0062298172301877884,0,6.951167301404885e-05,0.999930488326986,0,0.9877452240979341,0.012254775902065881,0,0.9999999999999993,6.959084880994159e-16,0,0.9382311105728149,0.09039001166820526,0,0.7926012873649597,0.27199023962020874,0,0.9654978416596167,0.034502158340383324,0
1781,血算、凝固系検査実施。,血算 凝固 系 検査 実施,0,0.9845608176134347,0.015439182386565274,0,8.486402883033743e-05,0.9999151359711697,0,0.9206036804361565,0.07939631956384353,0,0.9671692864999446,0.03283071350005538,0,0.8771989345550537,0.21475595235824585,0,0.8006897568702698,0.3735611140727997,0,0.9445071420708794,0.05549285792912076,0
1782,再び仰臥位で経過観察。,仰臥位 経過 観察,0,0.9845664315282665,0.015433568471733463,0,8.837597242445883e-05,0.9999116240275755,0,0.8703625244082095,0.1296374755917905,0,0.9582777243638472,0.041722275636152786,0,0.9335941076278687,0.07516676932573318,0,0.7471433877944946,0.4104061424732208,0,0.9438401481852219,0.05615985181477818,0
1783,自覚的呼吸困難感改善。,自覚的 呼吸 困難感 改善,0,0.9711777709618852,0.028822229038114943,0,0.00012775504029786727,0.9998722449597022,0,0.9589488521092018,0.0410511478907982,0,0.9998240945841743,0.00017590541582572844,0,0.8426835536956787,0.21565675735473633,0,0.7660714387893677,0.3313155174255371,0,0.948920397385022,0.05107960261497812,0
1784,腫瘍の兆候はなかった。,腫瘍 兆候 ない た,0,0.9973129910145384,0.0026870089854615967,0,7.520521112579605e-05,0.9999247947888742,0,0.9674531832640656,0.03254681673593442,0,0.9983695682469523,0.0016304317530477087,0,0.9414688348770142,0.052642226219177246,0,0.8464572429656982,0.16644121706485748,0,0.9705527300683319,0.02944726993166816,0
1785,授乳の疑いはなかった。,授乳 疑い ない た,0,0.9901046367238643,0.009895363276135829,0,8.115281147492066e-05,0.9999188471885251,0,0.9722960059574054,0.027703994042594614,0,0.9121122907227746,0.08788770927722545,0,0.9472165107727051,0.05380457267165184,0,0.8466857671737671,0.16780748963356018,0,0.9651583404884292,0.0348416595115708,0
1786,症状の改善はなかった。,症状 改善 ない た,0,0.99999912600766,8.73992339858926e-07,0,1.3799635695913574e-05,0.9999862003643041,0,0.996955645604588,0.003044354395411929,0,0.999997890431614,2.1095683859849474e-06,0,0.941579282283783,0.051172610372304916,0,0.8231319785118103,0.219986230134964,0,0.9703295842200321,0.029670415779967978,0
1787,心筋梗塞は否定された。,心筋梗塞 否定 する れる た,0,0.9845825062649117,0.01541749373508819,0,8.096962293350907e-05,0.9999190303770665,0,0.7789568696412008,0.22104313035879924,1,0.35918674393054373,0.6408132560694563,0,0.9231395721435547,0.07484540343284607,0,0.8070544600486755,0.18978378176689148,1,0.8469891467820404,0.15301085321795949,0
1788,心臓超音波検査を実施。,心臓 超音波 検査 実施,0,0.984542188691245,0.015457811308755093,0,9.103727068465052e-05,0.9999089627293154,0,0.9761168908614765,0.02388310913852358,0,0.9989274016177729,0.001072598382227076,0,0.9245609641075134,0.1328888088464737,0,0.778242826461792,0.32913738489151,0,0.959306124483501,0.04069387551649898,0
1789,心電図:陰性(陰性)。,心電図 陰性 陰性,0,0.984577614082842,0.015422385917157947,0,5.291496258048528e-05,0.9999470850374195,0,0.9673635389978847,0.032636461002115286,0,1.0,5.309980871111098e-56,0,0.9155378341674805,0.0755353644490242,0,0.8396462202072144,0.20950427651405334,0,0.9668862595025599,0.03311374049744005,0
1790,神経学的異常は認めず。,神経学的異常 認める ぬ,0,0.9845434235924525,0.015456576407547459,0,0.00013468369876832765,0.9998653163012317,1,0.4863422138281219,0.5136577861718781,0,0.9999926618391833,7.338160816628716e-06,1,0.1527373045682907,0.9126588702201843,1,0.3280528783798218,0.7926868200302124,1,0.42983373469809366,0.5701662653019064,0
1791,接種前体温36度1分。,接種 体温 0度 0分,0,0.5959407517416451,0.4040592482583549,0,0.00016033680160896046,0.999839663198391,1,0.4329502801674282,0.5670497198325718,0,0.9999997157454488,2.842545512439526e-07,0,0.780589759349823,0.3664015531539917,0,0.8205956816673279,0.20094607770442963,1,0.7487468562589179,0.2512531437410821,0
1792,体はそんなに強くない。,体 強い ない,0,0.9939825480331275,0.006017451966872554,0,9.932678062233558e-05,0.9999006732193777,0,0.9791348391162118,0.020865160883788206,0,0.9878668826755994,0.012133117324400554,0,0.9440591931343079,0.09376180171966553,0,0.716563880443573,0.3833920359611511,0,0.9571246444218953,0.042875355578104755,0
1793,日付不明リハビリ開始。,日付 不明 リハビリ 開始,0,0.9845784670444699,0.015421532955530124,0,8.068248661410606e-05,0.9999193175133859,0,0.9461904138311444,0.053809586168855575,0,0.9999999999999797,2.0314419056120723e-14,0,0.9335000514984131,0.08047740906476974,0,0.8228940963745117,0.23909145593643188,0,0.9643781545945891,0.035621845405410996,0
1794,日付不明現在、通院中。,日付 不明 現在 通院 中,0,0.9553138724001589,0.044686127599841204,0,7.318521768135688e-05,0.9999268147823186,0,0.7831197885910234,0.21688021140897665,0,0.9999999232337397,7.676626032494646e-08,0,0.9318856596946716,0.08359498530626297,0,0.8272548317909241,0.2324746996164322,0,0.9488303943171646,0.05116960568283533,0
1795,日付不明心拍数:正常。,日付 不明 心拍数 正常,0,0.9972410596211642,0.0027589403788358326,0,6.260347709892007e-05,0.999937396522901,0,0.9956964720857285,0.004303527914271427,0,1.0,1.0098345313725241e-19,0,0.9233827590942383,0.0773858055472374,0,0.8267015814781189,0.21309500932693481,0,0.9690997656549512,0.030900234345048894,0
1796,波形の異常はなかった。,波形 異常 ない た,0,0.9978005304688893,0.0021994695311107018,0,6.44627432424285e-05,0.9999355372567575,0,0.9762142247222021,0.023785775277797884,0,0.9896001450166789,0.010399854983321034,0,0.9453891515731812,0.0520259365439415,0,0.8569743037223816,0.1775933802127838,0,0.970690695911333,0.02930930408866699,0
1797,培養の実施はなかった。,培養 実施 ない た,0,0.9999858740920925,1.412590790746877e-05,0,3.3799373591689796e-05,0.9999662006264083,0,0.995425324580732,0.0045746754192680875,0,0.9999383849131614,6.161508683857008e-05,0,0.9500291347503662,0.05035942420363426,0,0.8475923538208008,0.17134161293506622,0,0.972526815187761,0.027473184812238993,0
1798,培養は行われなかった。,培養 行う れる ない た,0,0.9982251106912347,0.001774889308765371,0,9.440630231836132e-05,0.9999055936976816,0,0.988181288112784,0.011818711887215902,0,0.9985988117492988,0.0014011882507012207,0,0.9524572491645813,0.05510416626930237,0,0.848753809928894,0.15467388927936554,0,0.9723914310703797,0.02760856892962023,0
1799,病的神経反射は認めず。,病的 神経反射 認める ぬ,0,0.9845658506704447,0.015434149329555226,0,0.0001226335771447532,0.9998773664228553,0,0.5335922068555313,0.4664077931444687,0,0.9920923233632097,0.00790767663679022,1,0.29349029064178467,0.8418595790863037,1,0.31811395287513733,0.8144031167030334,1,0.494022179007505,0.5059778209924951,0
1800,腹痛はよくなっていた。,腹痛 なる いる た,0,0.9845555162862503,0.015444483713749837,1,0.00018736815184193018,0.999812631848158,1,0.46758898809652194,0.5324110119034781,1,0.48745913795742335,0.5125408620425767,1,0.08638651669025421,0.9418600797653198,1,0.32899096608161926,0.7947940230369568,1,0.1912830673514489,0.808716932648551,0
1801,併用薬は不明であった。,併用 薬 不明 だ ある た,0,0.9998345139539518,0.00016548604604805183,0,5.7579837017105094e-05,0.9999424201629828,0,0.9969322308559265,0.003067769144073435,0,0.9983831930943691,0.0016168069056308849,0,0.943071186542511,0.05809297040104866,0,0.8540509343147278,0.17394736409187317,0,0.9722262393879417,0.02777376061205834,0
1802,明らかに後遺症はなし。,明らか 後遺症 ない,0,0.9915204497350721,0.008479550264927893,0,7.941154168320243e-05,0.9999205884583168,0,0.9791348391162118,0.020865160883788206,0,0.999992446841228,7.553158771984029e-06,0,0.9536628127098083,0.06514183431863785,0,0.8448989391326904,0.17538684606552124,0,0.9706731797391236,0.029326820260876484,0
1803,翌日、事象は軽快した。,翌日 事象 軽快 する た,0,0.9845838960411025,0.01541610395889732,0,8.502306914472509e-05,0.9999149769308553,0,0.9650856099292264,0.034914390070773536,0,0.9572341991658605,0.04276580083413954,0,0.9453269243240356,0.06605012714862823,0,0.7985644936561584,0.15931443870067596,0,0.9655272213826771,0.03447277861732284,0
1804,患者の病歴はなかった。,患者 病歴 ない た,0,0.9995747394458512,0.00042526055414872913,0,4.767971666071472e-05,0.9999523202833392,0,0.9939711821886024,0.006028817811397642,0,0.99999853123801,1.468761990051849e-06,0,0.9519762396812439,0.057917624711990356,0,0.8445573449134827,0.15863949060440063,0,0.9725394639810082,0.027460536018991837,0
1805,抗PF4抗体は未測定。,PF 0 抗体 測定,0,0.9493451538239713,0.05065484617602849,0,9.459652356644144e-05,0.9999054034764335,0,0.6391364478276458,0.3608635521723542,0,1.0,8.825307068537387e-30,0,0.7309626936912537,0.302781879901886,0,0.7515257596969604,0.39969897270202637,0,0.8762252701725479,0.12377472982745205,0
1806,新生児は正常であった。,新生児 正常 だ ある た,0,0.9944738289481211,0.005526171051878899,0,6.427312637382224e-05,0.9999357268736262,0,0.9936768187834663,0.006323181216533722,0,0.9736789821538557,0.026321017846144247,0,0.9425702095031738,0.053634338080883026,0,0.8388611078262329,0.16410717368125916,0,0.9703293616126789,0.029670638387321,0
1807,患者に病歴はなかった。,患者 病歴 ない た,0,0.9995747394458512,0.00042526055414872913,0,4.767971666071472e-05,0.9999523202833392,0,0.9939711821886024,0.006028817811397642,0,0.99999853123801,1.468761990051849e-06,0,0.9519762396812439,0.057917624711990356,0,0.8445573449134827,0.15863949060440063,0,0.9725394639810082,0.027460536018991837,0
1808,追加調査は完了である。,追加 調査 完了 だ ある,0,0.9882924115549063,0.011707588445093552,0,6.576855831549428e-05,0.9999342314416845,0,0.8853097310823747,0.11469026891762533,0,0.9999969174554723,3.08254452773223e-06,0,0.9478638172149658,0.06465335935354233,0,0.840713620185852,0.18371416628360748,0,0.9639988621395659,0.036001137860434185,0
1809,過去の病歴はなかった。,過去 病歴 ない た,0,0.9986455163540433,0.0013544836459566023,0,6.538930719530361e-05,0.9999346106928046,0,0.9837495366257796,0.016250463374220408,0,0.9996153138463596,0.00038468615364035166,0,0.9486373066902161,0.058005038648843765,0,0.8502287268638611,0.17064198851585388,0,0.9716500521042659,0.028349947895734133,0
1810,原因は認められていない,原因 認める られる いる ない,0,0.9882202030892868,0.011779796910713292,0,9.552188485672325e-05,0.9999044781151433,0,0.97803686848454,0.021963131515459994,0,0.799602582089303,0.200397417910697,0,0.9457975029945374,0.06352373957633972,0,0.8058491945266724,0.18666362762451172,0,0.9540590934272439,0.04594090657275615,0
1811,X線:異常はなかった。,X線 異常 ない た,0,0.9992110764688065,0.0007889235311934786,0,3.345326979729496e-05,0.9999665467302027,0,0.9821092300738593,0.017890769926140644,0,0.9998576801044599,0.0001423198955401585,0,0.9427300691604614,0.05114393308758736,0,0.848533034324646,0.16350066661834717,0,0.9717784337570123,0.028221566242987724,0
1812,胸部X線撮影異常なし。,胸部 X線撮影 異常 ない,0,0.996870683553269,0.00312931644673105,0,4.742915498109197e-05,0.9999525708450189,0,0.9937749560675448,0.006225043932455151,0,0.9999974877656925,2.512234307507387e-06,0,0.9422934055328369,0.058742113411426544,0,0.83323073387146,0.15959012508392334,0,0.9717655858301655,0.02823441416983446,0
1813,転帰は未回復であった。,転帰 回復 だ ある た,0,0.9991019596678239,0.0008980403321761371,0,6.169512955472918e-05,0.9999383048704452,0,0.9937736733283236,0.006226326671676467,0,0.9990848963779229,0.0009151036220771452,0,0.9416406154632568,0.06039853021502495,0,0.8280476331710815,0.15882375836372375,0,0.9716539053031151,0.028346094696884802,0
1814,造影効果は認めなかった,造影効果 認める ない た,0,0.9845500799372531,0.015449920062747018,0,9.812341456775966e-05,0.9999018765854323,0,0.9628931979854813,0.03710680201451862,0,0.9984591661665183,0.0015408338334816502,0,0.9473780393600464,0.05394083634018898,0,0.8332160711288452,0.1991906315088272,0,0.9683073200248514,0.03169267997514863,0
1815,腹部エコー:異常なし。,腹部 エコー 異常 ない,0,0.984576535842951,0.015423464157049038,0,8.033997774226042e-05,0.9999196600222577,0,0.9695259862278947,0.030474013772105343,0,0.9998915629288216,0.00010843707117837147,0,0.9374108910560608,0.058693062514066696,0,0.8424761891365051,0.16964998841285706,0,0.969518892007631,0.03048110799236893,0
1816,腱反射は正常であった。,腱反射 正常 だ ある た,0,0.9902550648183204,0.009744935181679577,0,8.19928818812754e-05,0.9999180071181187,0,0.9936768187834663,0.006323181216533722,0,0.9924742385570369,0.007525761442963096,0,0.9424231052398682,0.0592602901160717,0,0.8476740717887878,0.2124723643064499,0,0.9698612339779774,0.03013876602202249,0
1817,追跡調査は完了である。,追跡調査 完了 だ ある,0,0.9920427901758012,0.007957209824198754,0,6.180849942292974e-05,0.9999381915005771,0,0.8127301975226132,0.18726980247738675,0,0.9999999155300204,8.446997959785279e-08,0,0.9446983933448792,0.06489147990942001,0,0.8352944850921631,0.19699136912822723,0,0.9580241869702589,0.0419758130297411,0
1818,冠動脈狭窄はなかった。,冠動脈狭窄 ない た,0,0.9995563966397615,0.0004436033602384801,0,4.740465276476376e-05,0.9999525953472352,0,0.9900480001823301,0.009951999817669975,0,0.989553229745652,0.010446770254348014,0,0.9390810132026672,0.051841773092746735,0,0.8559226989746094,0.17444685101509094,0,0.9714497860500968,0.02855021394990321,0
1819,家族歴は特になかった。,家族 歴 ない た,0,0.9991097415598864,0.0008902584401136864,0,5.5577170502946614e-05,0.999944422829497,0,0.9936029219869664,0.006397078013033564,0,0.9992843356903338,0.0007156643096662292,0,0.9469336867332458,0.053922008723020554,0,0.8463638424873352,0.17449627816677094,0,0.972049846530678,0.02795015346932196,0
1820,胸部CT検査:未実施。,胸部 CT検査 実施,0,0.9954176613296238,0.0045823386703760394,0,6.868911563072967e-05,0.9999313108843693,0,0.9458158208218808,0.05418417917811919,0,0.9954956672691304,0.00450433273086958,0,0.932346522808075,0.11384308338165283,0,0.7925840616226196,0.364191472530365,0,0.9577301384153798,0.04226986158462035,0
1821,MRAに異常はなかった,MRA 異常 ない た,0,0.9992110764688065,0.0007889235311934786,0,3.345326979729496e-05,0.9999665467302027,0,0.9821092300738593,0.017890769926140644,0,0.9998576801044599,0.0001423198955401585,0,0.9420238137245178,0.050386134535074234,0,0.848533034324646,0.16350066661834717,0,0.9717798472982518,0.028220152701748134,0
1822,冠動脈疾患:異常なし。,冠動脈疾患 異常 ない,0,0.9885747296289047,0.0114252703710954,0,5.625259107401967e-05,0.999943747408926,0,0.9791348391162118,0.020865160883788206,0,0.9999995243221729,4.7567782715055877e-07,0,0.93643718957901,0.07134269177913666,0,0.8319579362869263,0.18673937022686005,0,0.969106950520068,0.030893049479931916,0
1823,酵素濃度測定:改善した,酵素 濃度 測定 改善 する た,0,0.9953586983539412,0.004641301646058713,0,7.109521462001655e-05,0.99992890478538,0,0.9638106101144815,0.03618938988551845,0,0.8670460567188073,0.13295394328119273,0,0.9306744337081909,0.056828342378139496,0,0.8364201188087463,0.1829359084367752,0,0.9600709562746846,0.03992904372531526,0
1824,追跡調査は不要である。,追跡調査 不要 だ ある,0,0.9845497152459204,0.015450284754079642,0,7.698244281014236e-05,0.9999230175571898,0,0.8127301975226132,0.18726980247738675,0,0.999997200192868,2.799807131994189e-06,0,0.9438398480415344,0.06755820661783218,0,0.8347029685974121,0.17007270455360413,0,0.9583383595155209,0.041661640484479054,0
1825,心臓弁膜疾患:異常なし,心臓弁膜疾患 異常 ない,0,0.9858197413137091,0.014180258686291022,0,8.217821151645378e-05,0.9999178217884835,0,0.9695259862278947,0.030474013772105343,0,0.9998405192157023,0.00015948078429775758,0,0.9328377842903137,0.07218655943870544,0,0.807558536529541,0.17296510934829712,0,0.9678847337401308,0.03211526625986918,0
1826,処置は、中止であった。,処置 中止 だ ある た,0,0.9845746157484391,0.015425384251560838,0,9.906812486026256e-05,0.9999009318751397,0,0.8127026749387403,0.1872973250612597,0,0.9993592568442704,0.0006407431557296106,0,0.9430897831916809,0.07070564478635788,0,0.8316314816474915,0.20009751617908478,0,0.9567849291541662,0.04321507084583364,0
1827,アレルギーはなかった。,アレルギー ない た,0,0.9994959678975982,0.0005040321024017776,0,4.0373879181260184e-05,0.9999596261208188,0,0.9900480001823301,0.009951999817669975,0,0.9999922356006663,7.764399333659148e-06,0,0.9474626779556274,0.05679560825228691,0,0.8591051697731018,0.16619855165481567,0,0.9724208020320882,0.027579197967911737,0
1828,患者は、熱はなかった。,患者 熱 ない た,0,0.9991264798512153,0.0008735201487848429,0,5.33152561817219e-05,0.9999466847438183,0,0.9939711821886024,0.006028817811397642,1,0.44649280874499364,0.5535071912550064,0,0.9474597573280334,0.061793260276317596,0,0.8245645761489868,0.17663022875785828,1,0.9178048445752273,0.08219515542477279,0
1829,患者は経口可であった。,患者 経口 可 だ ある た,0,0.9845476741247593,0.015452325875240779,0,8.772354660649017e-05,0.9999122764533935,0,0.8893268546379658,0.11067314536203417,0,0.9574464678600967,0.042553532139903365,0,0.9526176452636719,0.06195729970932007,0,0.852691113948822,0.1785891205072403,0,0.9618590633967135,0.0381409366032866,0
1830,伝染性の精密検査:陰性,伝染性 精密検査 陰性,0,0.9845864828232639,0.015413517176736048,0,8.453928051051333e-05,0.9999154607194894,0,0.9748863304620521,0.02511366953794793,0,0.9999999325269904,6.747300962331178e-08,0,0.9265964031219482,0.06585194170475006,0,0.8228387832641602,0.19681401550769806,0,0.967887913387281,0.032112086612719005,0
1831,特記すべき家族歴なし。,特記 する べし 家族 歴 ない,0,0.9964954824981914,0.0035045175018085335,0,6.644412347377831e-05,0.9999335558765262,0,0.9747891507688793,0.025210849231120762,0,0.9441234521270069,0.05587654787299311,0,0.9525619149208069,0.09694316238164902,0,0.835647463798523,0.20894378423690796,0,0.9648813052414058,0.035118694758594256,0
1832,熱は2日間で完治した。,熱 0 日間 完 治す た,0,0.5779978613208703,0.4220021386791295,0,0.00011254301094171975,0.9998874569890582,1,0.42919369837831944,0.5708063016216806,0,0.9963045469082785,0.003695453091721451,0,0.9318684339523315,0.06948903203010559,0,0.8253546953201294,0.1730489730834961,1,0.8208184512961287,0.17918154870387126,0
1833,その後は特に何もない。,その後 何 ない,0,0.9914726519203464,0.008527348079653638,0,6.901005862419518e-05,0.9999309899413759,0,0.9791348391162118,0.020865160883788206,0,0.9999935911208514,6.408879148639562e-06,0,0.941865861415863,0.07442409545183182,0,0.8067573308944702,0.21399672329425812,0,0.9677527092802233,0.032247290719776785,0
1834,家族歴は不明であった。,家族 歴 不明 だ ある た,0,0.9947378495013376,0.005262150498662298,0,7.322875389781674e-05,0.9999267712461022,0,0.9913526279184829,0.008647372081517113,0,0.9899491258441738,0.01005087415582615,0,0.9313476085662842,0.06850329786539078,0,0.8457204103469849,0.2080649882555008,0,0.9693123139414973,0.03068768605850266,0
1835,患者は今治療中である。,患者 治療 中 だ ある,0,0.9868431692500214,0.013156830749978502,0,0.00011488726927626864,0.9998851127307238,0,0.9485130457071738,0.05148695429282619,0,0.9999999014432462,9.855675373157091e-08,0,0.9411452412605286,0.09580982476472855,0,0.7686448693275452,0.23985129594802856,0,0.9624955914057765,0.03750440859422356,0
1836,患者は来院しなかった。,患者 来院 する ない た,0,0.9991186170955585,0.0008813829044415227,0,8.595731790309376e-05,0.9999140426820969,0,0.9895687472098788,0.010431252790121203,0,0.9993149758210272,0.0006850241789727332,0,0.9505940079689026,0.06021011248230934,0,0.83819979429245,0.16895908117294312,0,0.971689435493587,0.028310564506413075,0
1837,血圧もすぐに回復した。,血圧 回復 する た,0,0.995704226710667,0.004295773289332842,0,5.5851977051432366e-05,0.9999441480229486,0,0.9871546381140808,0.01284536188591925,0,0.9985418204357216,0.0014581795642783647,0,0.9367886781692505,0.056224897503852844,0,0.8398094773292542,0.23100900650024414,0,0.9692989828441401,0.030701017155859895,0
1838,再調査は不可能である。,再調査 不可能 だ ある,0,0.9845529323343905,0.015447067665609474,0,7.68657083418209e-05,0.9999231342916581,0,0.8127301975226132,0.18726980247738675,0,0.9999885401764934,1.1459823506616924e-05,0,0.9497683644294739,0.07340170443058014,0,0.833212673664093,0.2030995637178421,0,0.9569412625210056,0.043058737478994295,0
1839,多臓器障害はなかった。,多臓器障害 ない た,0,0.999472032550332,0.000527967449667901,0,6.162898981054875e-05,0.9999383710101895,0,0.9900480001823301,0.009951999817669975,0,0.9976730313763407,0.002326968623659327,0,0.9356949329376221,0.05824418365955353,0,0.8339160680770874,0.16497406363487244,0,0.9712766829360898,0.028723317063910063,0
1840,カロナールを服用した。,カロナール 服用 する た,0,0.9845887929792765,0.015411207020723456,0,0.00011586992558333837,0.9998841300744167,0,0.6186777153108296,0.38132228468917034,0,0.9578047346856964,0.04219526531430367,0,0.9247968196868896,0.0787021592259407,0,0.7365925312042236,0.41819754242897034,0,0.9077832517355371,0.09221674826446284,0
1841,自己心拍が再開された。,自己 心拍 再開 する れる た,0,0.9845792455751915,0.015420754424808577,0,0.00010585086716395417,0.999894149132836,1,0.4692617135814625,0.5307382864185375,0,0.5172165333944116,0.48278346660558835,0,0.9386599659919739,0.09060800820589066,0,0.8238801956176758,0.2245074063539505,1,0.8005525580223152,0.19944744197768474,0
1842,15:07意識清明。,0 0 意識清明,0,0.9845480563665189,0.015451943633481019,0,0.00011783215672845636,0.9998821678432716,1,0.35873972300322543,0.6412602769967746,0,0.9999637036529275,3.6296347072514025e-05,1,0.49730056524276733,0.6664600968360901,0,0.7683768272399902,0.2957252264022827,1,0.7291334874321773,0.2708665125678226,0
1843,2022/06退院。,0 0 退院,0,0.9920722534888652,0.007927746511134771,0,6.37961018609544e-05,0.9999362038981391,0,0.9707399000591053,0.02926009994089471,0,1.0,1.0934769268558602e-24,0,0.9323870539665222,0.07325685769319534,0,0.81625896692276,0.19100336730480194,0,0.9680198654710475,0.03198013452895247,0
1844,ステロイド点滴実施。,ステロイド 点滴 実施,0,0.9985609723619616,0.0014390276380384052,0,5.9735747748826606e-05,0.9999402642522511,0,0.9700155506120149,0.02998444938798504,0,0.9999999999999968,3.165367547369262e-15,0,0.9421204924583435,0.07311820238828659,0,0.768883228302002,0.37225404381752014,0,0.9609434134299092,0.039056586570090736,0
1845,そのまま転院となる。,転院 なる,0,0.9845713790687551,0.015428620931244886,0,0.00016125764305718375,0.9998387423569428,1,0.3167849524176023,0.6832150475823977,0,0.9999981174411775,1.8825588224898941e-06,0,0.8337562084197998,0.25369787216186523,0,0.7719595432281494,0.2619032859802246,1,0.8446374424563392,0.15536255754366082,0
1846,フィラジルを打った。,フィラジル 打つ た,0,0.9845468079820454,0.015453192017954448,0,9.253105669060639e-05,0.9999074689433094,1,0.42919369837831944,0.5708063016216806,0,0.9746191438812997,0.025380856118700328,0,0.9359262585639954,0.09913916140794754,0,0.7591994404792786,0.356548935174942,1,0.8825022304169835,0.11749776958301644,0
1847,プレドニン漸減開始。,プレドニン 漸減 開始,0,0.9887829362152538,0.011217063784746201,0,6.949250875000437e-05,0.99993050749125,0,0.7739001988092524,0.22609980119074752,0,0.9999999999834489,1.6551141821476456e-11,0,0.9213317036628723,0.07983951270580292,0,0.7864611148834229,0.27211591601371765,0,0.9469163931470418,0.0530836068529582,0
1848,ペースメーカー留置。,ペースメーカー 留置,0,0.9845686294642948,0.015431370535705124,0,0.0001385625133541977,0.9998614374866458,1,0.4563792597309324,0.5436207402690676,0,0.9999998641638854,1.3583611452974448e-07,0,0.9169116020202637,0.09785457700490952,0,0.6849175095558167,0.45461514592170715,1,0.873418894413863,0.12658110558613705,0
1849,異常所見はなかった。,異常所見 ない た,0,0.9932373327040351,0.006762667295964837,0,7.459514252265476e-05,0.9999254048574774,0,0.9900480001823301,0.009951999817669975,0,0.9992614891889148,0.000738510811085231,0,0.9465288519859314,0.06179995462298393,0,0.8452945947647095,0.17142613232135773,0,0.9713585362262015,0.028641463773798555,0
1850,運動機能に障害なし。,運動 機能 障害 ない,0,0.9947645116381982,0.005235488361801719,0,7.91088445345835e-05,0.9999208911554655,0,0.9669426749401969,0.03305732505980306,0,0.9999954191866766,4.58081332345502e-06,0,0.9324741959571838,0.07139047235250473,0,0.8417837023735046,0.17072761058807373,0,0.9694007691734619,0.030599230826538062,0
1851,外来フォローとした。,外来 フォロー する た,0,0.9845430086478938,0.015456991352106299,0,7.800693070778128e-05,0.9999219930692922,0,0.8363926612224009,0.16360733877759912,0,0.9619191815151809,0.03808081848481918,0,0.9409066438674927,0.06393169611692429,0,0.7763031721115112,0.2605854272842407,0,0.9506664275459255,0.049333572454074465,0
1852,関連病歴なしを削除。,関連 病歴 ない 削除,0,0.9905461747857128,0.009453825214287202,0,8.66423389971148e-05,0.9999133576610029,0,0.9584064201532027,0.04159357984679737,0,1.0,1.7304639605111503e-25,0,0.9568613171577454,0.07404542714357376,0,0.8453468084335327,0.17966264486312866,0,0.9691289410637539,0.030871058936245987,0
1853,基礎疾患はなかった。,基礎疾患 ない た,0,0.9994457906994244,0.0005542093005754311,0,4.065977164997584e-05,0.99995934022835,0,0.9900480001823301,0.009951999817669975,0,0.9999583370412338,4.1662958766210374e-05,0,0.944445788860321,0.05621518939733505,0,0.85179603099823,0.16368022561073303,0,0.9722217879259166,0.02777821207408341,0
1854,胸部X線は異常なし。,胸部 X線 異常 ない,0,0.996870683553269,0.00312931644673105,0,4.742915498109197e-05,0.9999525708450189,0,0.9937749560675448,0.006225043932455151,0,0.9999974877656925,2.512234307507387e-06,0,0.9402969479560852,0.05855021998286247,0,0.83323073387146,0.15959012508392334,0,0.9717160314111468,0.028283968588853143,0
1855,局所壁運動異常なし。,局所壁運動 異常 ない,0,0.9906844413053989,0.009315558694601015,0,6.567957349663536e-05,0.9999343204265033,0,0.9791348391162118,0.020865160883788206,0,0.9998747131921946,0.0001252868078054758,0,0.939922571182251,0.06971998512744904,0,0.8343244791030884,0.1604401022195816,0,0.9702177025232245,0.029782297476775556,0
1856,筋力は5/5へ回復。,筋力 0 0 回復,0,0.9961036902784183,0.0038963097215816383,0,7.298468853769429e-05,0.9999270153114623,0,0.9758996728966532,0.024100327103346794,0,0.9999990279002854,9.720997146603609e-07,0,0.933106005191803,0.07666508108377457,0,0.7902522087097168,0.2421356588602066,0,0.9660625095494028,0.03393749045059719,0
1857,抗血小板薬投与開始。,抗血小板 薬 投与 開始,0,0.9988728381148714,0.0011271618851285894,0,5.672162123210172e-05,0.999943278378768,0,0.9919135217049047,0.008086478295095343,0,0.9999745272173398,2.5472782660235757e-05,0,0.9206184148788452,0.08436569571495056,0,0.8056036829948425,0.292118102312088,0,0.9654895638437225,0.034510436156277524,0
1858,今は胸の痛みもない。,今 胸 痛みもない,0,0.9845590268383817,0.015440973161618344,0,0.0001344657855089741,0.999865534214491,1,0.4563792597309324,0.5436207402690676,0,0.9974756242949377,0.002524375705062268,0,0.7726089358329773,0.374289870262146,0,0.7245368361473083,0.4248545169830322,1,0.8285091740951405,0.17149082590485948,0
1859,初めての事象である。,事象 だ ある,0,0.9845848721071025,0.015415127892897404,0,9.369732876448105e-05,0.9999063026712355,0,0.8744318597954036,0.12556814020459636,0,0.9999138514449264,8.614855507355337e-05,0,0.7942284345626831,0.3826088309288025,0,0.767818808555603,0.27600109577178955,0,0.9322316382658248,0.06776836173417526,0
1860,症状が改善なかった。,症状 改善 ない た,0,0.99999912600766,8.73992339858926e-07,0,1.3799635695913574e-05,0.9999862003643041,0,0.996955645604588,0.003044354395411929,0,0.999997890431614,2.1095683859849474e-06,0,0.941579282283783,0.051172610372304916,0,0.8231319785118103,0.219986230134964,0,0.9703295842200321,0.029670415779967978,0
1861,症状の回復を認めた。,症状 回復 認める た,0,0.9960949795654915,0.0039050204345085996,0,9.619294245094452e-05,0.9999038070575491,0,0.9728633023871981,0.027136697612801908,0,0.9999675985122402,3.240148775983137e-05,0,0.9366035461425781,0.06024497002363205,0,0.8287188410758972,0.21713289618492126,0,0.9685069468133962,0.031493053186603656,0
1862,症状の改善を認めた。,症状 改善 認める た,0,0.9932493377662712,0.006750662233728758,0,0.00010199498544256842,0.9998980050145574,0,0.9756116216232078,0.024388378376792145,0,0.9999801012392486,1.9898760751391734e-05,0,0.9369819164276123,0.06122835725545883,0,0.8271404504776001,0.21718600392341614,0,0.9684338280463782,0.03156617195362174,0
1863,症状の軽快を認めた。,症状 軽快 認める た,0,0.9914588439991899,0.008541156000810127,0,0.00010546265633354311,0.9998945373436665,0,0.9393508169796199,0.060649183020380144,0,0.9957796865342542,0.004220313465745812,0,0.9393424391746521,0.0608702227473259,0,0.8320248126983643,0.1976965218782425,0,0.9666310200884097,0.033368979911590164,0
1864,症状は30分で消失。,症状 0分 消失,0,0.9905629985487874,0.009437001451212642,0,7.517718421091562e-05,0.9999248228157891,0,0.9397322837609796,0.06026771623902039,0,0.9999999999999957,4.347056720259113e-15,0,0.9371477365493774,0.09296126663684845,0,0.8317859768867493,0.22364962100982666,0,0.9648742649988564,0.03512573500114357,0
1865,心筋炎は軽快と判断。,心筋炎 軽快 判断,0,0.9845850663510864,0.015414933648913571,0,8.845357244555968e-05,0.9999115464275544,0,0.9323371835617679,0.06766281643823215,0,0.9999990664732907,9.335267093175286e-07,0,0.9345718026161194,0.09942969679832458,0,0.8105729222297668,0.2391258031129837,0,0.9623341816661629,0.037665818333837045,0
1866,心膜の炎症所見なし。,心膜 炎症所見 ない,0,0.9936729066503905,0.006327093349609533,0,9.970753409169958e-05,0.9999002924659083,0,0.9695259862278947,0.030474013772105343,0,0.9999930272622826,6.9727377173904395e-06,0,0.94571453332901,0.07994447648525238,0,0.817715585231781,0.1765168011188507,0,0.968736825092827,0.03126317490717305,0
1867,精査するも原因不明。,精査 する 原因 不明,0,0.9845754380636665,0.015424561936333516,0,7.813098358636402e-05,0.9999218690164137,0,0.9442816166300856,0.05571838336991439,0,0.9985313616059831,0.0014686383940168688,0,0.856865406036377,0.13782331347465515,0,0.7635213136672974,0.21930941939353943,0,0.9576367415542556,0.042363258445744394,0
1868,他に誘因はなかった。,他 誘因 ない た,0,0.9993926838347558,0.000607316165244238,0,6.513717821479224e-05,0.9999348628217852,0,0.9913247886493441,0.00867521135065589,0,0.9879519908078166,0.012048009192183391,0,0.9507647752761841,0.04991549625992775,0,0.8398533463478088,0.16561150550842285,0,0.9716001453849225,0.028399854615077467,0
1869,他の病歴はなかった。,他 病歴 ない た,0,0.9995101348924502,0.0004898651075497503,0,4.913322827517847e-05,0.9999508667717248,0,0.9958153098940895,0.004184690105910448,0,0.9998104728226396,0.00018952717736038367,0,0.9487660527229309,0.0556509792804718,0,0.8516113758087158,0.16583329439163208,0,0.9725955591396386,0.02740444086036134,0
1870,他の病歴は無かった。,他 病歴 無い た,0,0.9845807214282485,0.015419278571751545,0,7.043457640924902e-05,0.9999295654235908,0,0.7203058008401695,0.27969419915983057,0,0.9999214296051339,7.857039486618386e-05,0,0.944341242313385,0.060506440699100494,0,0.8476536870002747,0.1703016459941864,0,0.9512440593949516,0.04875594060504849,0
1871,追跡調査は完了した。,追跡調査 完了 する た,0,0.9860637011744176,0.01393629882558251,0,6.416264943076252e-05,0.9999358373505692,0,0.6186777153108296,0.38132228468917034,0,0.9998963039301025,0.00010369606989741657,0,0.9442402720451355,0.0638127326965332,0,0.8325656652450562,0.1924452781677246,0,0.9387710605291402,0.0612289394708598,0
1872,洞性徐脈輸液後帰宅。,洞性徐脈 輸液 後 帰宅,0,0.9845656820814608,0.015434317918539147,0,0.00011073557068892779,0.999889264429311,0,0.6351029352554477,0.3648970647445523,0,0.9999997382009546,2.6179904540505084e-07,1,0.20377898216247559,0.872955858707428,0,0.788234531879425,0.3054500222206116,1,0.7413823590777904,0.2586176409222096,0
1873,洞調律:洞調律正常。,洞調律 洞調律正常,0,0.9845665354603348,0.015433464539665197,0,8.528936509654653e-05,0.9999147106349034,1,0.4563792597309324,0.5436207402690676,0,0.993167660230693,0.006832339769307013,0,0.9329134225845337,0.08102663606405258,0,0.819912314414978,0.26375308632850647,1,0.9069072185502408,0.09309278144975923,0
1874,特記すべき所見なし。,特記 する べし 所見 ない,0,0.9991627383528552,0.0008372616471448112,0,5.143988089270651e-05,0.9999485601191073,0,0.9914217494578458,0.008578250542154225,0,0.9996033107222646,0.0003966892777353404,0,0.9506773948669434,0.08027810603380203,0,0.8332085013389587,0.1979038119316101,0,0.9702920509561404,0.02970794904385959,0
1875,内服処方され、帰宅。,内服 処方 する れる 帰宅,0,0.9845840661204452,0.015415933879554701,0,9.646236262847864e-05,0.9999035376373715,0,0.9560649810419237,0.04393501895807626,0,0.9999877823471134,1.2217652886646654e-05,0,0.9364994764328003,0.09400661289691925,0,0.7679049372673035,0.2874559462070465,0,0.9609998379217305,0.039000162078269375,0
1876,入院は必要なかった。,入院 必要 ない た,0,0.9845676023129272,0.015432397687072797,0,7.080460625369522e-05,0.9999291953937463,0,0.9764851831547976,0.023514816845202402,0,0.9974165319317516,0.0025834680682483703,0,0.9500983357429504,0.05481324344873428,0,0.8389068841934204,0.19271600246429443,0,0.9694852834521249,0.030514716547875097,0
1877,脳波:異常所見なし。,脳波 異常所見なし,0,0.9845804462904625,0.015419553709537485,0,5.677927473190026e-05,0.9999432207252681,1,0.4563792597309324,0.5436207402690676,0,0.9999996830951617,3.1690483826338496e-07,0,0.9275162220001221,0.0585583820939064,0,0.8180517554283142,0.24697676301002502,1,0.9106880543849849,0.0893119456150151,0
1878,発熱は認めなかった。,発熱 認める ない た,0,0.9833257024082837,0.016674297591716437,1,0.00017747380839729836,0.9998225261916027,0,0.9086505191413893,0.09134948085861068,0,0.9119705710855515,0.08802942891444858,0,0.9387876987457275,0.0773390531539917,0,0.842602550983429,0.17886437475681305,1,0.9582510442382625,0.04174895576173769,0
1879,併用薬は、なかった。,併用 薬 ない た,0,0.9999873974519395,1.2602548060481583e-05,0,3.9407977964328975e-05,0.9999605920220357,0,0.9965479362544781,0.003452063745521866,0,0.9999949683721641,5.03162783589716e-06,0,0.9490517973899841,0.05044703930616379,0,0.8576825857162476,0.1549859344959259,0,0.973258702359076,0.02674129764092401,0
1880,平熱は摂氏35度代。,平熱 摂氏 0度 代,0,0.9845760161260735,0.015423983873926527,0,0.00010814553915273136,0.9998918544608473,1,0.4563792597309324,0.5436207402690676,0,0.999999933011397,6.698860303142416e-08,0,0.801848292350769,0.294162392616272,0,0.8211514353752136,0.2653971016407013,1,0.8749624569278807,0.12503754307211942,0
1881,明らかな肺雑音なし。,明らか だ 肺雑音なし,0,0.9845759939829747,0.015424006017025241,0,9.46570605297327e-05,0.9999053429394703,0,0.7333202657056541,0.2666797342943459,0,0.9999999754453318,2.455466819337566e-08,0,0.9277613162994385,0.06813333183526993,0,0.7497221827507019,0.3148099482059479,0,0.938803833769591,0.06119616623040911,0
1882,利尿剤を経静脈投与。,利尿剤 経 静脈 投与,0,0.9845636804878307,0.015436319512169264,0,7.245044240691907e-05,0.9999275495575931,0,0.9371363224023153,0.06286367759768478,0,0.998792759630838,0.0012072403691620246,0,0.8383648991584778,0.18224161863327026,0,0.769884467124939,0.29196441173553467,0,0.9514398744310328,0.04856012556896722,0
1883,心エコー像:結果なし,心 エコー 像 結果 ない,0,0.9952614188201173,0.004738581179882836,0,8.870938083355324e-05,0.9999112906191664,0,0.9619434021833504,0.038056597816649586,0,0.9999011234758856,9.887652411440668e-05,0,0.9473927021026611,0.05496024712920189,0,0.849324643611908,0.19093729555606842,0,0.969681486210008,0.030318513789992074,0
1884,治療は行わなかった。,治療 行う ない た,0,0.9995980259567152,0.0004019740432848001,0,6.687387399182886e-05,0.9999331261260082,0,0.9926143181085526,0.007385681891447365,0,0.9998087454559179,0.0001912545440821194,0,0.9237037301063538,0.08213993161916733,0,0.8191183805465698,0.17408020794391632,0,0.9698447771433065,0.03015522285669341,0
1885,産後腰痛は消失した。,産後腰痛 消失 する た,0,0.9881595145628294,0.01184048543717059,0,7.473760121631107e-05,0.9999252623987837,0,0.9079409287489064,0.09205907125109361,0,0.8268746483062527,0.1731253516937473,0,0.9371913075447083,0.0605163648724556,0,0.8104516267776489,0.18039828538894653,0,0.9503969748369264,0.04960302516307362,0
1886,ウイルス検査:なし。,ウイルス検査 ない,0,0.9986612765981171,0.0013387234018828484,0,5.371878595376698e-05,0.9999462812140463,0,0.9871986233676191,0.012801376632380942,0,0.9999999999997602,2.398568910785255e-13,0,0.9434753060340881,0.0638699159026146,0,0.8372676372528076,0.1995801031589508,0,0.9703766145946869,0.029623385405313094,0
1887,副作用歴はなかった。,副作用 歴 ない た,0,0.9997883724786851,0.00021162752131501428,0,4.6689898315103015e-05,0.9999533101016849,0,0.9936029219869664,0.006397078013033564,0,0.9995530103549461,0.00044698964505382227,0,0.9511820673942566,0.053066834807395935,0,0.8571485877037048,0.17011474072933197,0,0.9726452988417069,0.027354701158293113,0
1888,再検査はしなかった。,再検査 する ない た,0,0.9996209609502162,0.00037903904978369183,0,8.146874499355842e-05,0.9999185312550064,0,0.9933914285537546,0.006608571446245387,0,0.9996321095984201,0.00036789040157993587,0,0.948936402797699,0.054158005863428116,0,0.823672354221344,0.15671339631080627,0,0.9720010340875125,0.027998965912487503,0
1889,現在は軽快している。,現在 軽快 する いる,0,0.9907392621328928,0.009260737867107243,0,5.392310027265818e-05,0.9999460768997274,0,0.9857995391766963,0.014200460823303673,0,0.9999202754674874,7.972453251262682e-05,0,0.9476160407066345,0.06952212750911713,0,0.7970269918441772,0.22341878712177277,0,0.967851974330515,0.03214802566948499,0
1890,救急要請は無かった。,救急 要請 無い た,0,0.9845471989440719,0.015452801055928117,0,8.837138124316189e-05,0.9999116286187568,1,0.45957936436605773,0.5404206356339423,0,0.9991439007613953,0.000856099238604788,0,0.9375866055488586,0.05790656432509422,0,0.8085272908210754,0.24600352346897125,1,0.9112441465714402,0.08875585342855985,0
1891,患者は、経過観察中。,患者 経過 観察 中,0,0.9918524976918494,0.00814750230815068,0,8.68913440871149e-05,0.9999131086559129,0,0.9256130195557871,0.07438698044421291,0,0.9999999993424731,6.575268727977299e-10,0,0.9316093921661377,0.07042662054300308,0,0.8054514527320862,0.23153720796108246,0,0.9633922905277805,0.03660770947221956,0
1892,追加調査は完了した。,追加 調査 完了 する た,0,0.9801064767482093,0.019893523251790637,0,6.863444307967925e-05,0.9999313655569203,0,0.7136746208577696,0.2863253791422304,0,0.9976891821832516,0.0023108178167483484,0,0.94759601354599,0.06764773279428482,0,0.8396059274673462,0.1788564920425415,0,0.9490093101351688,0.05099068986483135,0
1893,有害事象はなかった。,有害事象 ない た,0,0.9998465738790178,0.0001534261209823342,0,2.890032497718242e-05,0.9999710996750228,0,0.9900480001823301,0.009951999817669975,0,0.9999660421863746,3.395781362540948e-05,0,0.9426366090774536,0.05297518149018288,0,0.845206618309021,0.18590639531612396,0,0.9714945589134663,0.028505441086533814,0
1894,救急要請はなかった。,救急 要請 ない た,0,0.9993271465000024,0.0006728534999975414,0,6.960032516962912e-05,0.9999303996748303,0,0.9837495366257796,0.016250463374220408,0,0.9948714153209419,0.005128584679058079,0,0.9453179836273193,0.05870125815272331,0,0.8423575162887573,0.15906184911727905,0,0.9714171137132337,0.028582886286766324,0
1895,腹部症状はなかった。,腹部症状 ない た,0,0.9993831417621258,0.0006168582378741913,0,5.9340305024558526e-05,0.9999406596949755,0,0.9900480001823301,0.009951999817669975,0,0.9702285140610835,0.02977148593891657,0,0.9466437697410583,0.054373517632484436,0,0.8470191955566406,0.21303872764110565,0,0.9691023084154246,0.030897691584575334,0
1896,素因は不明であった。,素因 不明 だ ある た,0,0.9956301999112713,0.004369800088728738,0,7.057539750556992e-05,0.9999294246024945,0,0.9893494680544311,0.010650531945568914,0,0.974248202236968,0.0257517977630321,0,0.9410921931266785,0.06700687110424042,0,0.8203870058059692,0.24195212125778198,0,0.9667895770758201,0.03321042292418002,0
1897,身体的診察:著変なし,身体的 診察 著変 ない,0,0.9845541890886242,0.015445810911375712,0,9.608674748003852e-05,0.9999039132525199,0,0.9584064201532027,0.04159357984679737,0,0.9695478718513723,0.030452128148627727,0,0.9534127712249756,0.06835652887821198,0,0.8320360779762268,0.22682036459445953,0,0.9649561015074487,0.03504389849255137,0
1898,先行感染はなかった。,先行感染 ない た,0,0.9993831417621258,0.0006168582378741913,0,6.0679362139674286e-05,0.9999393206378603,0,0.9900480001823301,0.009951999817669975,0,0.9994559348836477,0.0005440651163522769,0,0.9396547675132751,0.054098062217235565,0,0.8488635420799255,0.1702677458524704,0,0.9718607740630598,0.02813922593694027,0
1899,自由壁は、他より良好,自由 壁 他 良好,0,0.9845924080086828,0.01540759199131719,0,8.427860198299811e-05,0.999915721398017,0,0.906702191385073,0.09329780861492697,0,0.9999999999989789,1.021087609754334e-12,0,0.9418341517448425,0.07526633888483047,0,0.8212562799453735,0.2570658028125763,0,0.961339753787251,0.03866024621274899,0
1900,喫煙経験はなかった。,喫煙 経験 ない た,0,0.9936478547466749,0.006352145253325124,0,8.723009183454056e-05,0.9999127699081655,0,0.9741827841769427,0.025817215823057262,0,0.9982357250220208,0.001764274977979159,0,0.9482947587966919,0.06099150702357292,0,0.857090175151825,0.1919993758201599,0,0.9702493245796543,0.02975067542034575,0
1901,再調査は不要である。,再調査 不要 だ ある,0,0.984569810190038,0.015430189809961949,0,7.850091597071738e-05,0.9999214990840293,0,0.8127301975226132,0.18726980247738675,0,0.9999983712730321,1.628726967899801e-06,0,0.9450701475143433,0.07227768003940582,0,0.8287626504898071,0.18120427429676056,0,0.9575115131457343,0.042488486854265574,0
1902,市販薬の詳細は不明。,市販薬 詳細 不明,0,0.9845825393112333,0.015417460688766588,0,7.503521946185799e-05,0.9999249647805382,0,0.9099484829632907,0.09005151703670927,0,0.9999999998726415,1.2735845963001039e-10,0,0.9355542659759521,0.07742501050233841,0,0.7594949007034302,0.33431991934776306,0,0.9557447280291084,0.04425527197089171,0
1903,沈査:不明日、正常。,沈 査 明日 正常,0,0.9895123387355473,0.0104876612644526,0,7.568508945549042e-05,0.9999243149105446,0,0.9923758882265481,0.0076241117734518575,0,0.9999999999985054,1.4945417478871352e-12,0,0.9448252320289612,0.08193040639162064,0,0.7888891100883484,0.31354984641075134,0,0.9645029026478338,0.035497097352166204,0
1904,追跡調査が完了した。,追跡調査 完了 する た,0,0.9860637011744176,0.01393629882558251,0,6.416264943076252e-05,0.9999358373505692,0,0.6186777153108296,0.38132228468917034,0,0.9998963039301025,0.00010369606989741657,0,0.9442402720451355,0.0638127326965332,0,0.8325656652450562,0.1924452781677246,0,0.9387710605291402,0.0612289394708598,0
1905,予後は不明であった。,予後 不明 だ ある た,0,0.9952525563133633,0.004747443686636703,0,7.812739088412717e-05,0.9999218726091159,0,0.9865641045560012,0.013435895443998772,0,0.9841611882512953,0.01583881174870472,0,0.9389697909355164,0.07330116629600525,0,0.8091422319412231,0.2718684673309326,0,0.9656119970570916,0.034388002942908454,0
1906,冠動脈狭窄:未実施。,冠動脈狭窄 実施,0,0.9845549491976824,0.015445050802317723,0,7.874719364944453e-05,0.9999212528063506,0,0.8888730914993862,0.11112690850061376,0,0.9999993787692747,6.212307252901294e-07,0,0.6800767183303833,0.5281996130943298,0,0.7084757685661316,0.5012259483337402,0,0.8914984518109833,0.10850154818901682,0
1907,1ヶ月くらい続いた。,0 ヶ月 続く た,0,0.9845433920225077,0.015456607977492227,1,0.00018088870786966767,0.9998191112921303,1,0.42904098669920143,0.5709590133007986,0,0.9722996917766273,0.02770030822337262,0,0.8748888373374939,0.20254123210906982,1,0.2871994972229004,0.8158150315284729,1,0.7141982077702087,0.2858017922297912,0
1908,"U-BIL, (-)",U BIL,0,0.5547603559024763,0.44523964409752376,1,0.0001843188090939102,0.9998156811909061,1,0.4563792597309324,0.5436207402690676,0,0.5195482961797382,0.48045170382026176,0,0.7877399921417236,0.2560465335845947,0,0.7354044914245605,0.33487778902053833,1,0.4984911601314618,0.5015088398685381,0
1909,円柱(尿円柱):陰性,円柱 尿円柱 陰性,0,0.984567041231253,0.015432958768746915,0,8.859864699042583e-05,0.9999114013530096,0,0.9748863304620521,0.02511366953794793,0,0.9999999399880836,6.0011916413192e-08,0,0.8509877324104309,0.15381672978401184,0,0.7879897356033325,0.28807786107063293,0,0.9575547015684704,0.04244529843152946,0
1910,追跡調査予定あり。,追跡調査 予定 ある,0,0.9845834992057684,0.015416500794231614,0,8.585031612793217e-05,0.999914149683872,1,0.21948019000176067,0.7805198099982393,0,0.9999999997696413,2.3035868009879986e-10,0,0.9396780133247375,0.07527550309896469,0,0.8108766078948975,0.2534053921699524,1,0.8617823114778267,0.1382176885221734,0
1911,IVIG投与開始。,IVIG 投与 開始,0,0.9912958562803063,0.008704143719693717,0,6.448647078342363e-05,0.9999355135292166,0,0.9722922847214339,0.02770771527856604,0,0.9999999999967627,3.237338762993528e-12,0,0.9195449948310852,0.08497653901576996,0,0.6992616653442383,0.49861907958984375,0,0.9508517208071265,0.049148279192873345,0
1912,解熱剤を1回服用。,解熱 剤 0回 服用,0,0.9979678108884403,0.0020321891115597057,0,6.792286204022417e-05,0.9999320771379597,0,0.7636661631068319,0.23633383689316814,0,1.0,6.836586267237119e-20,0,0.9218887686729431,0.0831756740808487,0,0.8165464401245117,0.26664307713508606,0,0.9484374521575359,0.05156254784246402,0
1913,回復を認め、退院。,回復 認める 退院,0,0.9990692304123298,0.0009307695876701618,0,4.2025593228901e-05,0.9999579744067711,0,0.9219233148240346,0.07807668517596546,0,1.0,1.0203666154987963e-28,0,0.9468390941619873,0.07129325717687607,0,0.787436306476593,0.2687738239765167,0,0.9621768696753573,0.03782313032464262,0
1914,改善傾向を認めた。,改善 傾向 認める た,0,0.9922637512531765,0.007736248746823444,0,7.331837625457777e-05,0.9999266816237454,0,0.9604047491616685,0.039595250838331514,0,0.9996622228865389,0.00033777711346105434,0,0.9356679916381836,0.058094847947359085,0,0.8011460304260254,0.24795956909656525,0,0.9656290388810649,0.03437096111893516,0
1915,眼底には異常なし。,眼底 異常 ない,0,0.9851310187118788,0.01486898128812124,0,7.353778562485553e-05,0.9999264622143751,0,0.9871986233676191,0.012801376632380942,0,0.9999999982853004,1.714699551305833e-09,0,0.9374130964279175,0.07219186425209045,0,0.8539420366287231,0.1731247752904892,0,0.9704261520035914,0.02957384799640857,0
1916,経過観察中である。,経過 観察 中 だ ある,0,0.9849665476908982,0.015033452309101808,0,8.540026492826031e-05,0.9999145997350717,0,0.9784179617425002,0.021582038257499797,0,0.9999424184340103,5.7581565989617366e-05,0,0.944794774055481,0.06837654113769531,0,0.743712842464447,0.29622867703437805,0,0.9626992295522475,0.03730077044775239,0
1917,口のみ歪みが残存。,口 歪み 残存,0,0.9845723500065788,0.015427649993421088,0,9.664703582084102e-05,0.9999033529641792,1,0.4563792597309324,0.5436207402690676,0,0.9999999894091236,1.0590876453556266e-08,0,0.9177327752113342,0.16076189279556274,1,0.2502408027648926,0.8388774991035461,1,0.7408575926879426,0.2591424073120575,0
1918,抗生剤治療を実施。,抗生剤 治療 実施,0,0.9920597655777798,0.007940234422220289,0,7.6548654845005e-05,0.999923451345155,0,0.9275607335412543,0.07243926645874564,0,0.9999999958845232,4.115476863823346e-09,0,0.9408215880393982,0.07549042254686356,0,0.7725967168807983,0.2967416048049927,0,0.9600969062496656,0.03990309375033449,0
1919,再調査は完了した。,再調査 完了 する た,0,0.984544534761643,0.015455465238356956,0,6.565141687343341e-05,0.9999343485831266,0,0.6186777153108296,0.38132228468917034,0,0.9998337894409882,0.00016621055901176323,0,0.9439285397529602,0.06370498239994049,0,0.8351010680198669,0.19305744767189026,0,0.9386881718689979,0.06131182813100201,0
1920,塞栓性脳梗塞なし。,塞栓性 脳梗塞 ない,0,0.9943862293612405,0.005613770638759406,0,6.816946731721516e-05,0.9999318305326828,0,0.9669426749401969,0.03305732505980306,0,0.9999879891867155,1.201081328446533e-05,0,0.9399792551994324,0.06190989166498184,0,0.8340901136398315,0.18955577909946442,0,0.9690928783037703,0.03090712169622975,0
1921,市販の解熱剤内服。,市販 解熱 剤 内服,0,0.9879382324028674,0.012061767597132582,0,8.163270281892531e-05,0.9999183672971811,0,0.9660330581361294,0.03396694186387066,0,0.999999998137202,1.8627979817252195e-09,0,0.9018756747245789,0.15043480694293976,0,0.7368585467338562,0.42488783597946167,0,0.9512706649279125,0.04872933507208751,0
1922,徐々に症状は軽快。,症状 軽快,0,0.9990316469109497,0.000968353089050193,0,4.843822000979763e-05,0.9999515617799902,0,0.9904575180594709,0.009542481940529111,0,0.9999992170788211,7.829211789433152e-07,0,0.9364979267120361,0.07806198298931122,0,0.82552170753479,0.2341294139623642,0,0.9685956821593416,0.03140431784065855,0
1923,心エコー図:正常。,心 エコー 図 正常,0,0.9950731432331504,0.0049268567668494245,0,6.86911382426613e-05,0.9999313088617573,0,0.9923758882265481,0.0076241117734518575,0,0.9999999999998417,1.5829394730767378e-13,0,0.9238927364349365,0.0638810321688652,0,0.823308527469635,0.2175542414188385,0,0.9689556325758567,0.031044367424143217,0
1924,増悪ないため終診。,増悪 ない ため 終 診る,0,0.984555406631508,0.015444593368491976,0,8.949069637855608e-05,0.9999105093036215,0,0.8721458879746742,0.12785411202532576,0,0.9999999999949336,5.066360850050253e-12,0,0.9467275142669678,0.08675764501094818,0,0.7627271413803101,0.2297309935092926,0,0.9571620201220579,0.04283797987794209,0
1925,体温36.4°C。,体温 0 0 C,0,0.9142749744884058,0.08572502551159443,0,0.00013050095323003123,0.9998694990467699,1,0.35873972300322543,0.6412602769967746,0,0.5195482961797382,0.48045170382026176,0,0.8117720484733582,0.19576629996299744,0,0.7351342439651489,0.29938948154449463,1,0.6541061022847584,0.3458938977152415,0
1926,追跡調査予定なし。,追跡調査 予定 ない,0,0.9999667742535374,3.32257464626541e-05,0,3.433389465511185e-05,0.9999656661053449,0,0.9669426749401969,0.03305732505980306,0,0.9999999981528952,1.8471048461384962e-09,0,0.9433723092079163,0.05533330515027046,0,0.8341589570045471,0.18005527555942535,0,0.9699980082780985,0.030001991721901416,0
1927,点滴静脈注射施行。,点滴 静脈 注射 施行,0,0.9687951442256245,0.031204855774375487,0,0.00010048758500342017,0.9998995124149965,0,0.700514021771081,0.299485978228919,0,0.9999996530335714,3.469664285525072e-07,0,0.9246501922607422,0.08999241143465042,0,0.8069692254066467,0.2696138918399811,0,0.9376627818724774,0.06233721812752266,0
1928,破砕赤血球認めず。,破砕赤血球 認める ぬ,0,0.7373924582353499,0.26260754176464995,1,0.00022702575448040039,0.9997729742455196,1,0.4863422138281219,0.5136577861718781,0,0.9999832420178555,1.6757982144455982e-05,1,0.17061513662338257,0.8878087401390076,1,0.28857171535491943,0.8150776624679565,1,0.31092258368712333,0.6890774163128767,0
1929,併用薬はなかった。,併用 薬 ない た,0,0.9999873974519395,1.2602548060481583e-05,0,3.9407977964328975e-05,0.9999605920220357,0,0.9965479362544781,0.003452063745521866,0,0.9999949683721641,5.03162783589716e-06,0,0.9490517973899841,0.05044703930616379,0,0.8576825857162476,0.1549859344959259,0,0.973258702359076,0.02674129764092401,0
1930,併用薬は無かった。,併用 薬 無い た,0,0.9994627048622247,0.0005372951377753787,0,6.097885126011069e-05,0.9999390211487399,0,0.9339929822292574,0.06600701777074258,0,0.9999982034242136,1.7965757863533766e-06,0,0.9418591260910034,0.056885696947574615,0,0.8520054817199707,0.1561468094587326,0,0.9691673121330185,0.03083268786698143,0
1931,併用薬もなかった。,併用 薬 ない た,0,0.9999873974519395,1.2602548060481583e-05,0,3.9407977964328975e-05,0.9999605920220357,0,0.9965479362544781,0.003452063745521866,0,0.9999949683721641,5.03162783589716e-06,0,0.9490517973899841,0.05044703930616379,0,0.8576825857162476,0.1549859344959259,0,0.973258702359076,0.02674129764092401,0
1932,本事象は回復した。,事象 回復 する た,0,0.9993217291954253,0.0006782708045748075,0,3.341758123370995e-05,0.9999665824187662,0,0.9868378329354868,0.01316216706451327,0,0.9994864478119213,0.0005135521880787075,0,0.9435834884643555,0.0618947334587574,0,0.8193776607513428,0.16616219282150269,0,0.9708654483853075,0.029134551614692375,0
1933,夜のみ感冒薬服用。,夜 感冒 薬 服用,0,0.9845578362280037,0.015442163771996396,0,0.00010841012157498596,0.999891589878425,0,0.9364549791102488,0.06354502088975122,0,0.9999999988590532,1.140946786833166e-09,0,0.8917291164398193,0.11775925755500793,1,0.6121108531951904,0.6345822811126709,1,0.9304576653504069,0.06954233464959304,0
1934,血液検査:結果なし,血液検査 結果 ない,0,0.9967596477891106,0.0032403522108893695,0,5.667156000741002e-05,0.9999433284399926,0,0.9847711996584556,0.015228800341544344,0,0.9999999999999963,3.6408374024615946e-15,0,0.9520105123519897,0.055102553218603134,0,0.8504689931869507,0.19207130372524261,0,0.9712090513876902,0.028790948612309686,0
1935,心電図:結果なし。,心電図 結果 ない,0,0.9960453102838578,0.003954689716142217,0,6.727930359936436e-05,0.9999327206964006,0,0.9805311219114832,0.019468878088516793,0,0.9999999999999113,8.865317167681674e-14,0,0.9511469006538391,0.060093000531196594,0,0.8389484882354736,0.22053852677345276,0,0.9696091443627707,0.030390855637229205,0
1936,心膜の炎症所見なし,心膜 炎症所見 ない,0,0.9936729066503905,0.006327093349609533,0,9.970753409169958e-05,0.9999002924659083,0,0.9695259862278947,0.030474013772105343,0,0.9999930272622826,6.9727377173904395e-06,0,0.94571453332901,0.07994447648525238,0,0.817715585231781,0.1765168011188507,0,0.968736825092827,0.03126317490717305,0
1937,既往歴はなかった。,既往 歴 ない た,0,0.9995950475796209,0.00040495242037900015,0,5.405089974582075e-05,0.9999459491002541,0,0.9936029219869664,0.006397078013033564,0,0.9996871767440787,0.0003128232559213348,0,0.9521502256393433,0.055697597563266754,0,0.8570742011070251,0.18436697125434875,0,0.9722138542388858,0.02778614576111414,0
1938,産科歴は無かった。,産科 歴 無い た,0,0.9845729721889792,0.015427027811020767,0,7.771765809146896e-05,0.9999222823419085,0,0.5703992515778513,0.4296007484221487,0,0.99951557058122,0.0004844294187799705,0,0.9258168339729309,0.06294570118188858,0,0.8467639088630676,0.1677698940038681,0,0.9340723624721756,0.06592763752782443,0
1939,治療なく軽快した。,治療 ない 軽快 する た,0,0.9999978271769107,2.172823089216629e-06,0,1.8922853636263204e-05,0.9999810771463638,0,0.9973014077216612,0.0026985922783387523,0,0.9999434001069057,5.659989309423945e-05,0,0.942562997341156,0.06460036337375641,0,0.811976432800293,0.16763678193092346,0,0.9711627301101758,0.028837269889824085,0
1940,自己抗体検査:陰性,自己抗体 検査 陰性,0,0.9949718188583254,0.005028181141674526,0,6.80400236935411e-05,0.9999319599763065,0,0.9887667408779999,0.011233259122000114,0,0.9999999999321575,6.78424689067761e-11,0,0.9366188049316406,0.06037817895412445,0,0.8449128270149231,0.22371263802051544,0,0.9696769261522028,0.030323073847797265,0
1941,家族歴はなかった。,家族 歴 ない た,0,0.9991097415598864,0.0008902584401136864,0,5.5577170502946614e-05,0.999944422829497,0,0.9936029219869664,0.006397078013033564,0,0.9992843356903338,0.0007156643096662292,0,0.9469336867332458,0.053922008723020554,0,0.8463638424873352,0.17449627816677094,0,0.972049846530678,0.02795015346932196,0
1942,母趾探し試験:正常,母 趾探 する 試験 正常,0,0.9845738669457748,0.015426133054225159,0,8.234160063316201e-05,0.9999176583993669,0,0.9925985819614662,0.007401418038533813,0,0.9999999999982072,1.7928275270318867e-12,0,0.9349934458732605,0.09227339178323746,0,0.8145611882209778,0.2581735849380493,0,0.9662230874464632,0.03377691255353675,0
1943,血液検査:異常なし,血液検査 異常 ない,0,0.9887129118634918,0.011287088136508312,0,5.532153654541235e-05,0.9999446784634546,0,0.9871986233676191,0.012801376632380942,0,0.999999999999907,9.299915591480239e-14,0,0.9410409331321716,0.062053922563791275,0,0.8406468629837036,0.2090686559677124,0,0.9696017073184998,0.030398292681500277,0
1944,経過良好であった。,経過 良好 だ ある た,0,0.9858660426179986,0.014133957382001421,0,6.284193945615347e-05,0.9999371580605438,0,0.9874433661528849,0.012556633847115192,0,0.9998432284218742,0.0001567715781257546,0,0.9448676705360413,0.06180580332875252,0,0.8126815557479858,0.21083073318004608,0,0.9686698712128785,0.031330128787121485,0
1945,入院はしなかった。,入院 する ない た,0,0.9845771199452559,0.015422880054744192,0,7.683862677500143e-05,0.999923161373225,0,0.9590621561319187,0.040937843868081344,0,0.9999157602651285,8.423973487144677e-05,0,0.9535055160522461,0.055316656827926636,0,0.8306800723075867,0.16346731781959534,0,0.9693105281471633,0.030689471852836724,0
1946,喫煙歴はなかった。,喫煙 歴 ない た,0,0.9995555137853267,0.00044448621467325607,0,5.3625879988465996e-05,0.9999463741200115,0,0.9895305207410784,0.010469479258921567,0,0.9993692773072717,0.0006307226927283546,0,0.9482241272926331,0.055584270507097244,0,0.8589222431182861,0.1855185478925705,0,0.9718884750496811,0.028111524950318895,0
1947,発疹等はなかった。,発疹等 ない た,0,0.9983043985107728,0.0016956014892271333,0,8.341754738664224e-05,0.9999165824526134,0,0.9900480001823301,0.009951999817669975,0,0.9790074333863904,0.020992566613609584,0,0.9346592426300049,0.0574660487473011,0,0.8528765439987183,0.1919136643409729,0,0.9699109391386274,0.030089060861372613,0
1948,後遺症はなかった。,後遺症 ない た,0,0.9951252633510764,0.00487473664892364,0,7.092029841157444e-05,0.9999290797015884,0,0.9900480001823301,0.009951999817669975,0,0.9967549334765801,0.003245066523419985,0,0.9505371451377869,0.05902150273323059,0,0.8459883332252502,0.16232459247112274,0,0.9717821697537004,0.028217830246299563,0
1949,入院はしていない。,入院 する いる ない,0,0.9300129310444979,0.06998706895550207,0,7.680186290403913e-05,0.999923198137096,0,0.9728796784602949,0.027120321539705106,0,0.962192722911695,0.037807277088305016,0,0.9461904168128967,0.07468534260988235,0,0.8068886399269104,0.20092500746250153,0,0.9611264897533723,0.03887351024662763,0
1950,把握痛はなかった。,把握痛 ない た,0,0.9993831417621258,0.0006168582378741913,0,7.265455767781177e-05,0.9999273454423222,0,0.9837495366257796,0.016250463374220408,0,0.9993183259148835,0.0006816740851164945,0,0.9474758505821228,0.056539662182331085,0,0.8526203036308289,0.17514903843402863,0,0.9716248158208685,0.02837518417913155,0
1951,倦怠感は継続した。,倦怠感 継続 する た,1,0.39353171991698804,0.6064682800830118,0,0.00015929286500348592,0.9998407071349965,1,0.4020311704991173,0.5979688295008827,0,0.9907860579239192,0.009213942076080853,1,0.13485829532146454,0.9062873125076294,1,0.37412458658218384,0.7794022560119629,1,0.16746648965728056,0.8325335103427194,0
1952,レントゲン実施。,レントゲン 実施,0,0.9928706915140842,0.007129308485915871,0,6.91927219765046e-05,0.9999308072780235,0,0.8888730914993862,0.11112690850061376,0,0.9999999996152626,3.847373223873447e-10,0,0.9381381273269653,0.06650170683860779,0,0.7534630298614502,0.46388038992881775,0,0.9490610374576157,0.0509389625423842,0
1953,2-3日で回復。,0 0 日 だ 回復,0,0.9992024675864583,0.0007975324135417888,0,4.872352394646691e-05,0.9999512764760535,0,0.9843636310133235,0.01563636898667652,0,1.0,3.050460976168857e-18,0,0.9297358989715576,0.07765555381774902,0,0.8325409889221191,0.23060232400894165,0,0.9683620490124918,0.031637950987508136,0
1954,PCR検査実施。,PCR検査 実施,0,0.9888717244079571,0.01112827559204281,0,5.6056353351804996e-05,0.9999439436466482,0,0.8888730914993862,0.11112690850061376,0,0.9999938230861555,6.1769138445360845e-06,0,0.9260071516036987,0.11203727126121521,0,0.7829126715660095,0.3388153910636902,0,0.9531872849883264,0.04681271501167359,0
1955,アスピリン終了。,アスピリン 終了,0,0.984567642994755,0.015432357005245052,0,7.883057549730425e-05,0.9999211694245027,1,0.4563792597309324,0.5436207402690676,0,1.0,4.0693431765577967e-17,0,0.9418719410896301,0.06822340190410614,0,0.7823710441589355,0.31497058272361755,1,0.9023048455167262,0.0976951544832737,0
1956,コロナ検査陰性。,コロナ 検査 陰性,0,0.9925490048621947,0.007450995137805396,0,7.581316159620998e-05,0.9999241868384038,0,0.9887667408779999,0.011233259122000114,0,0.9999999999999969,3.0776273691322644e-15,0,0.9394398331642151,0.06877928972244263,0,0.8479828834533691,0.20491057634353638,0,0.9700121404237622,0.029987859576237754,0
1957,プレドニン開始。,プレドニン 開始,0,0.9845544871883851,0.015445512811614789,0,8.23266793388665e-05,0.9999176733206612,0,0.7739001988092524,0.22609980119074752,0,0.9999972127376991,2.7872623008824178e-06,0,0.9107482433319092,0.07886256277561188,0,0.7213196158409119,0.46417510509490967,0,0.9312530480282668,0.06874695197173328,0
1958,プレドニン継続。,プレドニン 継続,0,0.9358800353363299,0.06411996466367002,0,8.573835279264461e-05,0.9999142616472073,0,0.5650878490397497,0.4349121509602503,0,0.9999995572518844,4.427481156032403e-07,0,0.9208579659461975,0.06794444471597672,0,0.7693544030189514,0.3811909258365631,0,0.9040609215242122,0.09593907847578774,0
1959,ロキソニン服用。,ロキソニン 服用,0,0.9845728092995347,0.015427190700465268,0,8.633141498186748e-05,0.9999136685850182,1,0.4563792597309324,0.5436207402690676,0,0.9999999999999856,1.4385871262699224e-14,0,0.8811070919036865,0.0922122374176979,0,0.7237333059310913,0.4246312081813812,1,0.8776190347683869,0.12238096523161317,0
1960,以後、経過観察。,以後 経過 観察,0,0.9845547924989732,0.015445207501026962,0,0.00011363396935057991,0.9998863660306494,0,0.8703625244082095,0.1296374755917905,0,0.9999998736497361,1.2635026390414683e-07,0,0.923008143901825,0.07838484644889832,0,0.785033106803894,0.27820563316345215,0,0.9552769564244522,0.04472304357554785,0
1961,拡張機能は正常。,拡張機能 正常,0,0.9940878222918922,0.005912177708107813,0,7.2091067803547e-05,0.9999279089321964,0,0.9923758882265481,0.0076241117734518575,0,1.0,8.141864822113964e-28,0,0.9222069978713989,0.06842383742332458,0,0.8259412050247192,0.24099375307559967,0,0.968071354580039,0.03192864541996104,0
1962,帰宅後問題なし。,帰宅 後 問題なし,0,0.9845637411021603,0.015436258897839764,0,7.789953757790616e-05,0.9999221004624221,0,0.6351029352554477,0.3648970647445523,0,0.9999999978704881,2.129511886275494e-09,0,0.9329937100410461,0.0631483942270279,0,0.8198146820068359,0.24318841099739075,0,0.9361931185603894,0.06380688143961061,0
1963,血液検査を実施。,血液検査 実施,0,0.984577209534783,0.015422790465217015,0,8.191738645474293e-05,0.9999180826135453,0,0.8888730914993862,0.11112690850061376,0,0.9998896165265053,0.00011038347349468013,0,0.9277148246765137,0.13254119455814362,0,0.8043538331985474,0.3555625081062317,0,0.9521571596507702,0.04784284034922985,0
1964,検尿異常歴なし。,検尿異常 歴 ない,0,0.9983380096754326,0.001661990324567477,0,6.939008653737167e-05,0.9999306099134626,0,0.978572347321287,0.021427652678713084,0,0.9956672290589836,0.004332770941016383,0,0.9458310008049011,0.07009714096784592,0,0.8453494310379028,0.17957700788974762,0,0.9703098535365335,0.02969014646346638,0
1965,自宅で経過観察。,自宅 経過 観察,0,0.9845504661397796,0.015449533860220488,0,9.03706030296492e-05,0.9999096293969704,0,0.8703625244082095,0.1296374755917905,0,0.996855723305239,0.0031442766947610023,0,0.9299196600914001,0.07452501356601715,0,0.7974622845649719,0.24579393863677979,0,0.9573352732873228,0.042664726712677264,0
1966,症状は改善した。,症状 改善 する た,0,0.9995442806601026,0.0004557193398973576,0,4.793655474472652e-05,0.9999520634452552,0,0.9822984212258866,0.01770157877411339,0,0.9999840780959942,1.592190400579754e-05,0,0.9341338872909546,0.05554091930389404,0,0.8293545842170715,0.1926736980676651,0,0.9700849889006162,0.029915011099383763,0
1967,摂氏36.4度。,摂氏 0 0度,0,0.8522425772460633,0.14775742275393658,1,0.00025415485620564385,0.9997458451437944,1,0.3607204586964663,0.6392795413035337,0,0.9281044333147285,0.07189556668527156,0,0.8743793964385986,0.17791663110256195,0,0.8030205368995667,0.29605141282081604,1,0.815488441260614,0.184511558739386,0
1968,素因はなかった。,素因 ない た,0,0.9994164874963968,0.0005835125036032216,0,5.195060780141572e-05,0.9999480493921986,0,0.9900480001823301,0.009951999817669975,0,0.9946576391340068,0.00534236086599317,0,0.9509499073028564,0.055470362305641174,0,0.8545048832893372,0.1729775071144104,0,0.9719510726553257,0.02804892734467436,0
1969,病歴はなかった。,病歴 ない た,0,0.9994671061560182,0.0005328938439818273,0,4.353285229279322e-05,0.9999564671477073,0,0.9821092300738593,0.017890769926140644,0,0.9999994035572005,5.964427994898819e-07,0,0.9514968991279602,0.05807627737522125,0,0.8523594737052917,0.16216003894805908,0,0.971992032980421,0.028007967019579055,0
1970,貧血・黄疸なし。,貧血 黄疸 ない,0,0.9909552919527946,0.009044708047205315,0,9.698524756210312e-05,0.9999030147524379,0,0.9695259862278947,0.030474013772105343,0,0.9999931748845367,6.825115463333642e-06,0,0.9185743927955627,0.09494728595018387,0,0.8261783719062805,0.19212917983531952,0,0.9670359843526952,0.03296401564730489,0
1971,薬物療法を実施。,薬物 療法 実施,0,0.9853505603328273,0.014649439667172689,0,7.398520275729654e-05,0.9999260147972427,0,0.9328982677224309,0.06710173227756906,0,0.9999999999982226,1.7773379412610232e-12,0,0.9465802907943726,0.0691872388124466,0,0.7069717049598694,0.3109055459499359,0,0.9573076406667476,0.0426923593332525,0
1972,身体的検査:正常,身体的 検査 正常,0,0.9954324001163094,0.004567599883690517,0,8.683757176320893e-05,0.9999131624282368,0,0.9962058217242491,0.003794178275750918,0,1.0,7.38642836375584e-21,0,0.9417415261268616,0.06818832457065582,0,0.8266902565956116,0.20550143718719482,0,0.9700608594904747,0.029939140509525196,0
1973,再発はなかった。,再発 ない た,0,0.9990763586190767,0.0009236413809232423,0,4.830386455182327e-05,0.9999516961354482,0,0.9900480001823301,0.009951999817669975,0,0.9997039675366474,0.00029603246335261176,0,0.9409192800521851,0.05457630008459091,0,0.8412226438522339,0.16686369478702545,0,0.9717623528708395,0.028237647129160562,0
1974,左目は改善した。,左目 改善 する た,0,0.9980939316956121,0.0019060683043879637,0,8.248606521937979e-05,0.9999175139347806,0,0.97297294553032,0.027027054469679988,0,0.8588449099725053,0.14115509002749477,0,0.9415282607078552,0.07502450793981552,0,0.8290948271751404,0.20649096369743347,0,0.958873093320044,0.04112690667995606,0
1975,心電図:異常なし,心電図 異常 ない,0,0.9845506511953752,0.015449348804624771,0,6.542210565949339e-05,0.9999345778943405,0,0.9836231613716921,0.016376838628307813,0,0.9999999999977901,2.2098583647608994e-12,0,0.9394018054008484,0.05989222973585129,0,0.8409827947616577,0.19489488005638123,0,0.9695892380826343,0.03041076191736574,0
1976,症状は寛解した。,症状 寛解 する た,0,0.9845565159751444,0.015443484024855547,0,8.360581755825289e-05,0.9999163941824417,0,0.8054825898898723,0.19451741011012774,0,0.9929180363456742,0.0070819636543258116,0,0.9123294949531555,0.0772404819726944,0,0.8371813893318176,0.18073709309101105,0,0.9551101432438345,0.04488985675616556,0
1977,アレルギー歴なし,アレルギー歴 ない,0,0.9980793824389252,0.001920617561074669,0,6.663080659581688e-05,0.9999333691934041,0,0.9871986233676191,0.012801376632380942,0,0.9999999999800612,1.9938850961809718e-11,0,0.9459457397460938,0.06368425488471985,0,0.8401039242744446,0.2055644392967224,0,0.970329725273204,0.029670274726795964,0
1978,器質的疾患なし。,器質的疾患 ない,0,0.9979489286551899,0.002051071344810152,0,6.74310248201189e-05,0.9999325689751799,0,0.9871986233676191,0.012801376632380942,0,0.9999976133275613,2.386672438633149e-06,0,0.9427382946014404,0.06081996113061905,0,0.8443236351013184,0.19156904518604279,0,0.970832478508026,0.029167521491973884,0
1979,すべて正常範囲内,すべて 正常範囲 内,0,0.9845741227515735,0.015425877248426461,0,0.00010617529372319416,0.9998938247062769,0,0.5281300130113602,0.4718699869886398,0,0.9999999992280942,7.719057155073401e-10,0,0.9374121427536011,0.0746208056807518,0,0.7925293445587158,0.2597552239894867,0,0.918428646625206,0.08157135337479403,0
1980,皮疹も消退した。,皮疹 消退 する た,0,0.9845544248175667,0.015445575182433124,0,0.00010863293930491251,0.999891367060695,0,0.6393415670650866,0.3606584329349134,1,0.1560489667550229,0.8439510332449771,0,0.9159829020500183,0.08764772862195969,0,0.8287265300750732,0.2063906043767929,1,0.7331724327090603,0.2668275672909396,0
1981,入院しなかった。,入院 する ない た,0,0.9845771199452559,0.015422880054744192,0,7.683862677500143e-05,0.999923161373225,0,0.9590621561319187,0.040937843868081344,0,0.9999157602651285,8.423973487144677e-05,0,0.9535055160522461,0.055316656827926636,0,0.8306800723075867,0.16346731781959534,0,0.9693105281471633,0.030689471852836724,0
1982,ヘパリン開始。,ヘパリン 開始,0,0.9845427454742182,0.015457254525781733,0,8.016111038910542e-05,0.9999198388896109,0,0.7739001988092524,0.22609980119074752,0,0.9999999999998419,1.5804787054389095e-13,0,0.9215360283851624,0.08247347921133041,0,0.731005847454071,0.4448941946029663,0,0.9335298778375242,0.0664701221624758,0
1983,下腿浮腫なし。,下腿浮腫 ない,0,0.9979408388020129,0.002059161197987049,0,6.904679207705282e-05,0.9999309532079229,0,0.9871986233676191,0.012801376632380942,0,0.9982677246958747,0.001732275304125375,0,0.9218376278877258,0.09712723642587662,0,0.7623541355133057,0.2987668216228485,0,0.9628613126208468,0.037138687379153094,0
1984,回復を認めた。,回復 認める た,0,0.9845464834632386,0.015453516536761504,0,9.004418636676003e-05,0.9999099558136333,0,0.6037284070743381,0.39627159292566194,0,0.9999999907308333,9.269166617423559e-09,0,0.9371131658554077,0.06109451875090599,0,0.8028702735900879,0.2672715485095978,0,0.9301078510122869,0.0698921489877132,0
1985,基礎疾患なし。,基礎疾患 ない,0,0.9981383551924103,0.0018616448075896286,0,4.402788070970007e-05,0.9999559721192903,0,0.9871986233676191,0.012801376632380942,0,0.9999988853561366,1.1146438634291512e-06,0,0.9473768472671509,0.06280523538589478,0,0.8480425477027893,0.17162416875362396,0,0.971577771181996,0.028422228818004085,0
1986,気分不良なし。,気分不良 ない,0,0.9943084608907184,0.005691539109281557,0,7.691261476839414e-05,0.9999230873852316,0,0.9871986233676191,0.012801376632380942,0,0.9979340382274725,0.0020659617725274407,0,0.936471164226532,0.0865349993109703,0,0.8457763195037842,0.2296718955039978,0,0.9684791175271521,0.03152088247284785,0
1987,血圧低下なし。,血圧低下 ない,0,0.9886195725863781,0.011380427413621838,0,6.992661961204148e-05,0.999930073380388,0,0.9871986233676191,0.012801376632380942,0,0.9999944737725218,5.526227478190642e-06,0,0.9338573217391968,0.07123492658138275,0,0.841731607913971,0.25063616037368774,0,0.9678754549462879,0.03212454505371203,0
1988,口唇腫脹なし。,口唇腫脹 ない,0,0.9979489286551899,0.002051071344810152,0,6.74310248201189e-05,0.9999325689751799,0,0.9871986233676191,0.012801376632380942,0,0.9504971790295269,0.04950282097047311,0,0.915033221244812,0.12047310918569565,0,0.8174967765808105,0.2743760943412781,0,0.9611754848693589,0.038824515130641134,0
1989,処方薬を漸減。,処方 薬 漸減,0,0.9957642409421721,0.004235759057827879,0,5.7543598263685304e-05,0.9999424564017363,0,0.9364549791102488,0.06354502088975122,0,1.0,2.893894403903413e-25,0,0.9133709669113159,0.1370161920785904,0,0.8131436705589294,0.26444584131240845,0,0.960441258578406,0.039558741421594,0
1990,症状は未回復。,症状 回復,0,0.9993760220158536,0.0006239779841462697,0,4.227839431681807e-05,0.9999577216056832,0,0.9916032074424309,0.008396792557569034,0,1.0,5.38347411522007e-19,0,0.9366031289100647,0.07190973311662674,0,0.819918692111969,0.2549952566623688,0,0.9680669537855897,0.03193304621441021,0
1991,上肢筋力正常。,上肢 筋力正常,0,0.9845715661202217,0.015428433879778174,0,0.00012448681049250686,0.9998755131895075,1,0.4563792597309324,0.5436207402690676,0,0.9999999460701063,5.3929893694630064e-08,0,0.9262799620628357,0.09480137377977371,0,0.7976803183555603,0.28733766078948975,1,0.9023816240560883,0.09761837594391165,0
1992,心室壁厚正常。,心室 壁 厚い 正常,0,0.9924814920255348,0.007518507974465168,0,7.905678546768258e-05,0.9999209432145323,0,0.9923758882265481,0.0076241117734518575,0,0.9999998640530026,1.359469974627073e-07,0,0.9272682070732117,0.0904395580291748,1,0.42980337142944336,0.7283066511154175,1,0.9247145336600562,0.07528546633994379,0
1993,神経麻痺なし。,神経麻痺なし,0,0.9845575302392945,0.015442469760705414,0,0.00010477259724178046,0.9998952274027583,1,0.4563792597309324,0.5436207402690676,0,0.999903508391881,9.649160811902574e-05,0,0.9323557615280151,0.06241060793399811,0,0.8133533596992493,0.274760365486145,1,0.9080812055453228,0.09191879445467721,0
1994,特記異常なし。,特記異常なし,1,0.46350564751376766,0.5364943524862322,1,0.0001843188090939102,0.9998156811909061,1,0.4563792597309324,0.5436207402690676,0,0.9999999910898802,8.910119753361253e-09,0,0.9388830065727234,0.07265813648700714,0,0.8194699883460999,0.25320547819137573,1,0.7811922545476601,0.2188077454523399,0
1995,内服処方なし。,内服 処方 ない,0,0.9997943636637094,0.00020563633629056376,0,3.6453760799406884e-05,0.9999635462392006,0,0.9945567196909797,0.005443280309020298,0,0.9999999999997696,2.303170251052881e-13,0,0.9469972848892212,0.07029172778129578,0,0.8161178231239319,0.22837327420711517,0,0.9693271769888173,0.03067282301118264,0
1996,日付不明退院。,日付 不明 退院,0,0.9854343081792029,0.014565691820797144,0,5.044740041202246e-05,0.999949552599588,0,0.9825585808962412,0.01744141910375889,0,1.0,2.6823685139226395e-29,0,0.9465838670730591,0.07279299199581146,0,0.8305879831314087,0.2633019983768463,0,0.9669831659544277,0.03301683404557224,0
1997,皮疹軽快あり。,皮疹軽快 ある,0,0.9845444066158188,0.015455593384181128,0,0.00011716341023165215,0.9998828365897684,1,0.21948019000176067,0.7805198099982393,0,0.9854704719041939,0.01452952809580606,1,0.515689492225647,0.7144518494606018,0,0.7997196912765503,0.2880842089653015,1,0.6664333832972288,0.3335666167027712,0
1998,問題なく帰宅。,問題 ない 帰宅,0,0.9993253874565936,0.0006746125434062793,0,4.8731104767101954e-05,0.9999512688952329,0,0.9877967886281708,0.012203211371829278,0,0.9999986487394297,1.3512605703651078e-06,0,0.9346678853034973,0.06993994861841202,0,0.7735620737075806,0.3000052571296692,0,0.964859353584747,0.03514064641525296,0
1999,画像検査:正常,画像 検査 正常,0,0.9978010352491524,0.0021989647508475416,0,5.2523378475005695e-05,0.9999474766215249,0,0.9966264619580367,0.003373538041963278,0,1.0,6.349738602552968e-26,0,0.9334407448768616,0.063230000436306,0,0.8358146548271179,0.18078908324241638,0,0.9710890106842343,0.02891098931576572,0
2000,正常(正常)。,正常 正常,0,0.997320509506452,0.002679490493547942,0,3.707312330342132e-05,0.9999629268766966,0,0.9923758882265481,0.0076241117734518575,0,1.0,2.151272776802705e-65,0,0.9380344748497009,0.0719396248459816,0,0.8343602418899536,0.2177494615316391,0,0.9695920866604681,0.030407913339531713,0
2001,頭部CT:正常,頭部 C，T 正常,0,0.9975950796325189,0.0024049203674809316,0,5.308054992245509e-05,0.9999469194500775,0,0.9953354106047237,0.004664589395276235,0,1.0,2.380806692037766e-20,0,0.9306503534317017,0.08297353982925415,0,0.8100870251655579,0.20975950360298157,0,0.9687495238635605,0.03125047613643947,0
2002,凝固検査:正常,凝固 検査 正常,0,0.9974337616587594,0.002566238341240618,0,6.944233478762287e-05,0.9999305576652123,0,0.9962058217242491,0.003794178275750918,0,1.0,1.2262553113171238e-18,0,0.931522011756897,0.06223181635141373,0,0.8286546468734741,0.2629649341106415,0,0.968397241320777,0.03160275867922294,0
2003,抗核抗体:正常,抗核抗体 正常,0,0.9949395148200029,0.00506048517999719,0,6.515029877915181e-05,0.9999348497012208,0,0.9923758882265481,0.0076241117734518575,0,1.0,7.451468479839163e-21,0,0.9312741160392761,0.06530588865280151,0,0.8285784125328064,0.22936202585697174,0,0.9689298818178969,0.03107011818210311,0
2004,血液検査:正常,血液検査 正常,0,0.9937255027044598,0.006274497295540105,0,5.8774470008439425e-05,0.9999412255299915,0,0.9923758882265481,0.0076241117734518575,0,1.0,5.3394148698313746e-27,0,0.9405030608177185,0.06471113860607147,0,0.8210620880126953,0.3005567789077759,0,0.9667092295538067,0.03329077044619337,0
2005,波形の異常なし,波形 異常 ない,0,0.9858197413137091,0.014180258686291022,0,6.885576774285408e-05,0.9999311442322572,0,0.9791348391162118,0.020865160883788206,0,0.9999868537728408,1.3146227159221957e-05,0,0.94286048412323,0.06222505122423172,0,0.8513957262039185,0.17464862763881683,0,0.970327216655448,0.02967278334455202,0
2006,抗核抗体:陰性,抗核抗体 陰性,0,0.9935245254692933,0.006475474530706709,0,6.958646779635727e-05,0.9999304135322037,0,0.9748863304620521,0.02511366953794793,0,0.9999999999999593,4.069226638329463e-14,0,0.9291180968284607,0.06079120188951492,0,0.8229106664657593,0.2521473467350006,0,0.9669476311481933,0.033052368851806804,0
2007,全血球数:正常,全血 球数 正常,0,0.9845546961817706,0.015445303818229325,0,8.680755475277984e-05,0.9999131924452472,0,0.9923758882265481,0.0076241117734518575,0,0.999999999812724,1.8727593211087315e-10,0,0.9276546835899353,0.09012927860021591,0,0.8260554671287537,0.21774989366531372,0,0.9677003397695396,0.03229966023046036,0
2008,バレー徴候なし,バレー 徴候なし,0,0.9845731797032952,0.015426820296704901,0,0.00011878447351563713,0.9998812155264843,1,0.4563792597309324,0.5436207402690676,0,0.9999999793468314,2.065316865665943e-08,0,0.9291470646858215,0.06965118646621704,0,0.8232448101043701,0.2895268201828003,1,0.9068153869320167,0.09318461306798331,0
2009,上肢は正常。,上肢 正常,0,0.9969319498549917,0.003068050145008322,0,7.814329429944705e-05,0.9999218567057006,0,0.9923758882265481,0.0076241117734518575,0,1.0,4.7492259093341386e-29,0,0.9264978766441345,0.08134707063436508,0,0.8102847337722778,0.2662491500377655,0,0.9666880080151562,0.03331199198484381,0
2010,CCT陰性。,CCT 陰性,0,0.9964809894096348,0.0035190105903651976,0,3.958220113836266e-05,0.9999604177988617,0,0.9748863304620521,0.02511366953794793,0,1.0,3.2325501740900062e-24,0,0.9369999170303345,0.06360754370689392,0,0.8338351249694824,0.23036128282546997,0,0.9683139554412401,0.03168604455876001,0
2011,ベッド臥床。,ベッド 臥床,1,0.1804862652492032,0.8195137347507968,1,0.0002499580708610304,0.999750041929139,1,0.4563792597309324,0.5436207402690676,1,0.0010146338101840735,0.9989853661898159,0,0.8880780935287476,0.21074610948562622,0,0.6854678392410278,0.4517965614795685,1,0.1403077195475704,0.8596922804524296,0
2012,既往歴なし。,既往歴なし,0,0.984570194977866,0.015429805022133989,0,0.00010477259724178046,0.9998952274027583,1,0.4563792597309324,0.5436207402690676,0,0.9999315432543252,6.845674567475793e-05,0,0.9334196448326111,0.06739643961191177,0,0.8383834362030029,0.2730068266391754,1,0.9099784110158574,0.09002158898414259,0
2013,結果は陰性。,結果 陰性,0,0.9942270012359565,0.005772998764043497,0,6.0866878989737356e-05,0.9999391331210102,0,0.958305817871119,0.04169418212888093,0,1.0,4.77002715117192e-28,0,0.9363717436790466,0.06846519559621811,0,0.8066537976264954,0.26444563269615173,0,0.9649500477539203,0.03504995224607968,0
2014,自然に解熱。,解熱,0,0.98455226788422,0.015447732115779975,0,7.754855063987558e-05,0.9999224514493601,0,0.7636661631068319,0.23633383689316814,0,1.0,3.1352623841468213e-18,0,0.8978692889213562,0.13667286932468414,0,0.7700880169868469,0.4005679786205292,0,0.9325985574491324,0.06740144255086764,0
2015,入院後改善。,入院 後 改善,0,0.9845643994862394,0.01543560051376058,0,9.855672857436147e-05,0.9999014432714256,0,0.8333415781248761,0.16665842187512395,0,1.0,1.2222540822626565e-20,0,0.9264863729476929,0.1027633473277092,0,0.7478674650192261,0.27063408493995667,0,0.949643812293694,0.050356187706306066,0
2016,皮疹が軽快。,皮疹 軽快,0,0.9941553694030942,0.00584463059690565,0,5.416456908447013e-05,0.9999458354309155,0,0.9772122176147663,0.022787782385233674,0,0.9958245851596763,0.00417541484032371,0,0.9357285499572754,0.07759630680084229,0,0.7873607873916626,0.3044135868549347,0,0.9635812169017124,0.036418783098287735,0
2017,皮疹は改善。,皮疹 改善,0,0.9988417872470193,0.0011582127529806614,0,5.07402550165863e-05,0.9999492597449834,0,0.9622971234301322,0.03770287656986779,0,0.9999999133635278,8.663647223286692e-08,0,0.9184812903404236,0.08664530515670776,0,0.7510673403739929,0.3299497067928314,0,0.9598953795244145,0.04010462047558549,0
2018,新生児は正常,新生児 正常,0,0.9933513892246802,0.006648610775319758,0,6.947430922415973e-05,0.9999305256907759,0,0.9923758882265481,0.0076241117734518575,0,0.9999999999930768,6.9232025087429235e-12,0,0.9280885457992554,0.07246740162372589,0,0.8180195689201355,0.18581397831439972,0,0.9695108338885946,0.0304891661114054,0
2019,特記異常なし,特記異常なし,1,0.46350564751376766,0.5364943524862322,1,0.0001843188090939102,0.9998156811909061,1,0.4563792597309324,0.5436207402690676,0,0.9999999910898802,8.910119753361253e-09,0,0.9388830065727234,0.07265813648700714,0,0.8194699883460999,0.25320547819137573,1,0.7811922545476601,0.2188077454523399,0
2020,心電図:正常,心電図 正常,0,0.9877495300802686,0.012250469919731465,0,7.006311553979062e-05,0.9999299368844602,0,0.990665508852259,0.009334491147740962,0,1.0,1.2407700153900817e-27,0,0.9355672001838684,0.06880928575992584,0,0.8348127007484436,0.2594705820083618,0,0.9676754652824654,0.03232453471753455,0
2021,筋力低下なし,筋力低下 ない,0,0.996105597722088,0.0038944022779121013,0,6.621594112903719e-05,0.999933784058871,0,0.9871986233676191,0.012801376632380942,0,0.9998727312488543,0.0001272687511456555,0,0.9164986610412598,0.0881296694278717,0,0.8435440063476562,0.19474154710769653,0,0.9690414384013063,0.03095856159869374,0
2022,呼吸音清。,呼吸音清,0,0.9845669628385391,0.015433037161461015,0,0.00010477259724178046,0.9998952274027583,1,0.4563792597309324,0.5436207402690676,0,0.9946608536812038,0.005339146318796151,0,0.9137841463088989,0.1068389043211937,0,0.7100488543510437,0.4349312484264374,1,0.8758263167315847,0.12417368326841526,0
2023,意識清明。,意識清明,0,0.9845666469809364,0.015433353019063616,0,9.778831615682372e-05,0.9999022116838432,1,0.4563792597309324,0.5436207402690676,0,0.9999996946187594,3.0538124063945783e-07,0,0.8542823791503906,0.22222895920276642,0,0.6898073554039001,0.4877975583076477,1,0.8476322666276731,0.1523677333723269,0
2024,異常なし。,異常 ない,0,0.9938070284775011,0.006192971522498838,0,3.640016638020007e-05,0.9999635998336198,0,0.9871986233676191,0.012801376632380942,0,0.9999999999983983,1.601764275027872e-12,0,0.9392883777618408,0.06325583904981613,0,0.8281461000442505,0.18610183894634247,0,0.9701179850032382,0.0298820149967619,0
2025,観察完了。,観察 完了,0,0.9845642778519186,0.01543572214808146,0,6.210942713383019e-05,0.9999378905728662,0,0.669798598473822,0.3302014015261781,0,1.0,2.1112386590215444e-26,0,0.9376221299171448,0.0776529312133789,0,0.7214574813842773,0.3871617019176483,0,0.9243599012268939,0.07564009877310615,0
2026,顔色回復。,顔色 回復,0,0.9951942533782442,0.004805746621755794,0,6.913039731288153e-05,0.9999308696026871,0,0.9793474487283149,0.020652551271685124,0,1.0,4.6434387650401024e-17,0,0.936896026134491,0.0925297811627388,0,0.736637532711029,0.4371328055858612,0,0.9566069222133102,0.04339307778668984,0
2027,検診実施。,検診 実施,0,0.9771499606978072,0.022850039302192725,0,9.174831810384466e-05,0.9999082516818961,0,0.8888730914993862,0.11112690850061376,1,0.476759766636655,0.523240233363345,0,0.8837860226631165,0.2221660017967224,0,0.7634248733520508,0.3423714339733124,1,0.8542613955991188,0.14573860440088118,0
2028,症状なし。,症状なし,0,0.9845542414936113,0.01544575850638875,0,0.00010477259724178046,0.9998952274027583,1,0.4563792597309324,0.5436207402690676,0,0.9999686242694171,3.137573058286028e-05,0,0.929811418056488,0.0597061850130558,0,0.8148344159126282,0.33134642243385315,1,0.9034017750868173,0.09659822491318265,0
2029,剖検実施。,剖検 実施,0,0.984556326784337,0.015443673215662816,0,8.084769395501173e-05,0.999919152306045,0,0.8888730914993862,0.11112690850061376,0,0.999999996057519,3.942480963235224e-09,0,0.9262361526489258,0.11433174461126328,0,0.7844498753547668,0.20981045067310333,0,0.9582562047880437,0.04174379521195639,0
2030,麻痺なし。,麻痺なし,0,0.9845707013988988,0.01542929860110116,0,0.00010477259724178046,0.9998952274027583,1,0.4563792597309324,0.5436207402690676,0,0.9998236121835391,0.0001763878164608877,0,0.9339690208435059,0.0654454231262207,0,0.7794925570487976,0.3553920388221741,1,0.8979251923931553,0.10207480760684477,0
2031,聴診:正常,聴診 正常,0,0.9891560562136684,0.010843943786331462,0,8.159399232064211e-05,0.9999184060076793,0,0.9923758882265481,0.0076241117734518575,0,0.9999999999999998,2.127241597907893e-16,0,0.9411794543266296,0.07061894237995148,0,0.8275190591812134,0.263914555311203,0,0.967622932275014,0.03237706772498611,0
2032,特になし。,ない,0,0.9992696923881825,0.000730307611817539,0,6.998440034050061e-06,0.999993001559966,0,0.9871986233676191,0.012801376632380942,0,0.999999712933789,2.8706621099609566e-07,0,0.9459919333457947,0.06487087160348892,0,0.775280773639679,0.25687599182128906,0,0.9668331770747597,0.0331668229252403,0
2033,培養:陰性,培養 陰性,0,0.9967949560533749,0.003205043946625168,0,7.660037568912357e-05,0.9999233996243109,0,0.9748863304620521,0.02511366953794793,0,1.0,1.7669772703744478e-18,0,0.9390373826026917,0.0573987253010273,0,0.8389608860015869,0.23273788392543793,0,0.9686708965261204,0.03132910347387964,0
2034,心音整。,心音整,0,0.9845551007833455,0.015444899216654519,0,0.00010477259724178046,0.9998952274027583,1,0.4563792597309324,0.5436207402690676,0,0.992356884469162,0.007643115530837909,0,0.839857280254364,0.2965052127838135,0,0.6699427962303162,0.4889681339263916,1,0.8307734472374477,0.16922655276255233,0
2035,透析中。,透析 中,0,0.9845639284142825,0.015436071585717501,0,9.17920081068576e-05,0.9999082079918932,1,0.48037493785636487,0.5196250621436351,0,0.9999999999981354,1.864640376301305e-12,0,0.8474373817443848,0.2668153941631317,0,0.7114884257316589,0.44589242339134216,1,0.85523682733971,0.14476317266029012,0
2036,結果不明,結果 不明,0,0.9845790872654353,0.015420912734564602,0,6.612771057409067e-05,0.9999338722894259,0,0.8833087917580037,0.11669120824199632,0,1.0,1.8073838645808363e-23,0,0.9339479207992554,0.09202031046152115,0,0.8043532371520996,0.2655336260795593,0,0.9575745530820156,0.04242544691798456,0
2037,正常。,正常,0,0.997320509506452,0.002679490493547942,0,3.707312330342132e-05,0.9999629268766966,0,0.9923758882265481,0.0076241117734518575,0,1.0,3.63659618749856e-32,0,0.939212441444397,0.06929641962051392,0,0.8350900411605835,0.2495536208152771,0,0.9687782079469418,0.03122179205305824,0
2038,陰性。,陰性,0,0.9964809894096348,0.0035190105903651976,0,3.958220113836266e-05,0.9999604177988617,0,0.9748863304620521,0.02511366953794793,0,1.0,3.2325501740900062e-24,0,0.9333758354187012,0.06339075416326523,0,0.8305656313896179,0.27132880687713623,0,0.9668190587628973,0.03318094123710273,0
2039,終診。,終 診る,0,0.9069372321204947,0.09306276787950535,0,8.136483328098336e-05,0.999918635166719,1,0.4563792597309324,0.5436207402690676,0,0.9999999999999792,2.0767111139619096e-14,0,0.937518835067749,0.09348972141742706,0,0.7678747773170471,0.26255181431770325,1,0.8885631631541532,0.11143683684584672,0
2040,退院。,退院,0,0.9845811179670515,0.01541888203294859,0,3.785112697165443e-05,0.9999621488730284,0,0.9495255125024696,0.050474487497530356,0,1.0,1.0549935672107504e-38,0,0.9313185811042786,0.07753776758909225,0,0.791079580783844,0.33012890815734863,0,0.9601902830487775,0.039809716951222575,0
2041,なし,ない,0,0.9992696923881825,0.000730307611817539,0,6.998440034050061e-06,0.999993001559966,0,0.9871986233676191,0.012801376632380942,0,0.999999712933789,2.8706621099609566e-07,0,0.9459919333457947,0.06487087160348892,0,0.775280773639679,0.25687599182128906,0,0.9668331770747597,0.0331668229252403,0
2042,"血液検査では、正球性貧血(red cell count 2.40 x 10^6/uL, reference range 3.86-4.92 x 10^6/uL; hemoglobin 7.8 g/dL, 11.6-14.8 g/dL; hematocrit 22.8%, 35.1%-44.4%)と、正常の血小板数(159 x 10^3/uL, 158-348 x 10^3/uL), prothrombin time (10.9 s, 9.5-13.5 s), activated partial thromboplastin time (25.9 s, 25.0-38.0 s)と判明した。",血液検査 正球性 貧血 red cell count 0 0 x 0 0 uL reference range 0 0 0 0 x 0 0 uL hemoglobin 0 0 g dL 0 0 0 0 g dL hematocrit 0 0% 0 0% 0 0% 正常 血小板 数 0 x 0 0 uL 0 0 x 0 0 uL prothrombin time 0 0 s 0 0 0 0 s activated partial thromboplastin time 0 0 s 0 0 0 0 s 判明 する た,1,0.02532528677737142,0.9746747132226287,1,0.00028239496091127394,0.9997176050390887,1,0.25940092281192517,0.7405990771880748,1,0.41831984243745357,0.5816801575625464,1,0.12045043706893921,0.8975120186805725,1,0.19978904724121094,0.8641045093536377,1,0.017383111943592777,0.9826168880564072,1
2043,"2021/09/15: Troponin I:上昇(450 ng/L), CRP:上昇(8.6mg/dl). 2021/09/16: Creatine kinase (CK):上昇(361U/L); Fibrin D dimer(D-dimer):上昇(2.8ug/ml). 2021/09/21: Eosinophils: 307.トロポニンT、CK-MB、高感度CRP、ESR (1時間値)検査は未実施であった。",0 0 0 Troponin I 上昇 0 NG L CRP 上昇 0 0m g dl 0 0 0 Creatine kinase CK 上昇 0 U L Fibrin D dimer D dimer 上昇 0 0 ug ml 0 0 0 Eosinophils 0 トロポニン T CK MB 感度 CRP ESR 0時 間 値 検査 実施 だ ある た,1,0.16257179806436414,0.8374282019356359,1,0.00031892314095220925,0.9996810768590478,1,0.032030803186889334,0.9679691968131107,1,0.33832156146188763,0.6616784385381124,1,0.11139927804470062,0.9276642203330994,1,0.19471804797649384,0.8638498783111572,1,0.011903938601140569,0.9880960613988595,1
2044,血栓形成傾向及び血小板減少の原因病態として、特発性血小板減少性紫斑病や抗リン脂質抗体症候群、血栓性微小血管症などを考えたが、各種自己抗体や骨髄像検査の結果がいずれの疾患としても典型的ではないため、経過からVaccine-Induced Immune Thrombocytopenia and Thrombosis(VITT)の可能性を考え、免疫グロブリン静注療法(1g/kg/day 2日間)を実施した。,血栓形成傾向 血小板減少 の 原因 病態 特発性 血小板減少 性 紫斑病 抗リン脂質抗体症候群 血栓性 微小血管症 考える た 各種 自己抗体 骨髄像 検査 結果 いずれ 疾患 典型 的 だ ない ため 経過 Vaccine Induced Immune Thrombocytopenia AND Thrombosis VITT 可能性 考える 免疫グロブリン 静 療法 0g kg day 0 日間 実施 する た,1,0.03485919118522547,0.9651408088147747,1,0.00027045848945212857,0.9997295415105478,1,0.08172618418320499,0.918273815816795,1,0.19784956418572675,0.8021504358142733,1,0.18256020545959473,0.824560284614563,1,0.22970636188983917,0.8548479676246643,1,0.009586839771278307,0.9904131602287217,1
2045,"CMRは、患者2において、T2強調画像上の局所的T2高信号、T2マッピング上のT2緩和時間の軽度延長、T1強調画像上(+ガドリニウム)の早期ガドリニウム増強(EGE)の上昇、T1マッピング上の天然T1値高値(1,323 ms)、細胞外容積の増加(33.7%)及びLVの基底から中央下外側区域における心内膜心筋領域を伴う非虚血性EGE陽性を認めた。",CMR 患者 0 T 0 強調 画像 上 局所的 T 0 高信号 T 0 マッピング 上 T 0 緩和時間 軽度延長 T 0 強調 画像 上 ガドリニウム 早期 ガドリニウム 増強 EGE 上昇 T 0 マッピング 上 天然 T 0 値 高値 0 0 ms 細胞 外 容積 増加 0 0% LV 基底 中央 下 外側区域 心内膜 心筋 領域 伴う 非虚血性 EGE 陽性 認める た,1,0.013999524968940465,0.9860004750310595,1,0.00043045117809475123,0.9995695488219053,1,0.0017739328986495773,0.9982260671013504,1,0.28370169435637993,0.7162983056436201,1,0.08754962682723999,0.9424840807914734,1,0.19554898142814636,0.8700812458992004,1,0.007177109878351807,0.9928228901216483,1
2046,実施した臨床検査と処置は以下の通り:アラニンアミノトランスフェラーゼ:(2022/04)上昇;アスパラギン酸アミノトランスフェラーゼ:(2022/04)上昇;血中ブドウ糖:(2022/04)上昇;血液検査:(2022/04)結果不明;γーグルタミルトランスフェラーゼ:(2022/04)上昇;肝機能検査値(2022/04)高い。,実施 する た 臨床検査 処置 以下 通り アラニンアミノトランスフェラーゼ 0 0 上昇 アスパラギン酸 アミノトランスフェラーゼ 0 0 上昇 血 中 ブドウ糖 0 0 上昇 血液検査 0 0 結果 不明 ーグルタミルトランスフェラーゼ 0 0 上昇 肝機能検査 値 0 0 高位,1,0.01668000963978224,0.9833199903602178,1,0.000248679988463639,0.9997513200115363,1,0.014631089931351537,0.9853689100686485,1,0.0031107460338378745,0.9968892539661621,1,0.19151760637760162,0.8831800818443298,1,0.2359720915555954,0.8406998515129089,1,0.005340669995322022,0.9946593300046781,1
2047,右下肢のしびれと疼痛のため、ロキソプロフェン60mg(開始日: 2021/08/04、中止日:2021/08/10)、レバミピド100mg(開始日:2021/08/04、中止日:2021/08/10)、ビタミンB-12(メコバラミン5000 mcg、開始日:2021/08/04、中止日:2021/08/10)。,右 下肢のしびれ 疼痛 ため ロキソプロフェン 0m g 開始 日 0 0 0 中止 日 0 0 0 レバミピド 0m g 開始 日 0 0 0 中止 日 0 0 0 ビタミンB 0 メコバラミン 0 mcg 開始 日 0 0 0 中止 日 0 0 0,1,0.02726623535734374,0.9727337646426562,1,0.00017289799492151123,0.9998271020050785,1,0.29389964110429156,0.7061003588957084,1,0.0051699457075540245,0.994830054292446,1,0.13697943091392517,0.9160463213920593,1,0.26612985134124756,0.8297415971755981,1,0.009106115794360232,0.9908938842056397,1
2048,腎生検結果:光顕では軽度のメサンギウム細胞と基質の増加、尿細管間質はびまん性に高度の炎症細胞浸潤を認め、IFではC3優位で、IgG、IgMが軽度に糸球体係蹄に沈着、EMでは高度な管内増殖性変化と糸球体基底膜に連続的な肥厚・濃染がありdense deposit disease(DDD)と診断した。,腎生検 結果 光顕 だ 軽度 メサンギウム 細胞 基質 増加 尿 細管 間質 びまん性 高度 炎症 細胞浸潤 認める IF C 0 優位 だ IgG IgM 軽度 糸球体 係 蹄 沈着 EM 高度 だ 管内 増殖性変化 糸球体 基底膜 連続 的 だ 肥厚 濃染 ある dense deposit disease DDD 診断 する た,1,0.01735792788683379,0.9826420721131663,1,0.00033410679912935717,0.9996658932008706,1,0.035374088384445446,0.9646259116155546,1,0.3226732725536309,0.6773267274463691,1,0.11167619377374649,0.9219081401824951,1,0.18363407254219055,0.8687906265258789,1,0.008629432022918632,0.9913705679770815,1
2049,当院到着時は体温36.4°C、胸部違和感のみ残存していたが、採血でCRP 6.63 mg/dL、CK-MB 55.6 ng/mL、心筋トロポニンI 21.17 ng/mL、CK 815 U/L、D-ダイマー1.4 mcg/mLの上昇を認めたため、急性心筋炎の疑いで当院入院。,院 到着 時 体温 0 0 C 胸部違和感 残存 する いる た 採血 CRP 0 0 mg dL CK MB 0 0 NG mL 心筋 トロポニン I 0 0 NG mL CK 0 U L D ダイマー 0 0 mcg mL 上昇 認める た ため 急性心筋炎 疑い 院 入院,1,0.02009130359577225,0.9799086964042277,1,0.0002339292856403782,0.9997660707143596,1,0.005548599499895168,0.9944514005001048,1,2.477787343857507e-06,0.9999975222126561,1,0.07932882755994797,0.9397045373916626,1,0.1816539615392685,0.8722212314605713,1,0.004073420970180746,0.9959265790298193,1
2050,アスパラギン酸アミノトランスフェラーゼ(AST):(2022/07/28) 6914;血中クレアチニン(Cre):(2022/07/28)1.95;血液ガス:(2022/07/27)88で著明な上昇、注記:Lac88と著明な上昇を認め、全身にリベドを認めた。,アスパラギン酸 アミノトランスフェラーゼ AST 0 0 0 0 血 中 クレアチニン Cre 0 0 0 0 0 血液ガス 0 0 0 0 著 明 だ 上昇 注記 Lac 0 著 明 だ 上昇 認める 全身 リベド 認める た,1,0.015535399044629616,0.9844646009553705,1,0.0004008561311686324,0.9995991438688314,1,0.004688691396994571,0.9953113086030054,1,0.08750191799776497,0.912498082002235,1,0.08073882758617401,0.943433940410614,1,0.18725436925888062,0.8722180128097534,1,0.004813982215371444,0.9951860177846286,1
2051,入院時の臨床検査では、重度のインスリン分泌能不良を認め、空腹時C-ペプチド免疫反応性(CPR)は0.33ng/mL、24時間蓄尿CPRは5.74mcg/day及び3.82mcg/day、グルカゴン負荷テスト中のデルタCPRは0.03ng/mLであった。,入院 時 臨床検査 重度 インスリン分泌 能 不良 認める 空腹 時 C ペプチド 免疫反応 性 CPR 0 0 NG mL 0時 間 蓄尿 CPR 0 0m CG day 0 0m CG day グルカゴン 負荷 テスト 中 デルタ CPR 0 0 NG mL だ ある た,1,0.022308794414561666,0.9776912055854382,1,0.0002836291546812247,0.9997163708453187,1,0.10249206997380667,0.8975079300261933,1,0.3358937964094362,0.6641062035905638,1,0.11066934466362,0.9058709740638733,1,0.20220065116882324,0.8588510155677795,1,0.010666796337053216,0.9893332036629467,1
2052,甲状腺ホルモン検査: (2021/09/16)甲状腺クリーゼ、注記:FT4 5.14ng/dL、FT3 10.95pg/ml、TSH 0.06uIU/ml、TSAb 4104%、TRAb 134.8IU/L、バセドウ病に伴う甲状腺クリーゼと診断された。,甲状腺ホルモン 検査 0 0 0 甲状腺クリーゼ 注記 FT 0 0 0 NG dL FT 0 0 0 PG ml TSH 0 0 uIU ml TSAb 0% TRAb 0 0 IU L バセドウ病 伴う 甲状腺クリーゼ 診断 する れる た,1,0.011403753160670488,0.9885962468393297,1,0.00041340457085906523,0.999586595429141,1,0.03600638766431874,0.9639936123356813,1,0.26602577809753614,0.7339742219024639,1,0.08913503587245941,0.9348141551017761,1,0.18737895786762238,0.8742091059684753,1,0.0073563297833859585,0.992643670216614,1
2053,血液検査でTSH 0.01μIU/mL、FT3 13.79pg/mL、FT4 4.47ng/dLであり、TRAb 6.9IU/Lと高値であり、確からしいバセドウ病と診断したが、前医の甲状腺超音波検査で血流の増加なく、β遮断薬による対症療法を開始した。,血液検査 TSH 0 0 μ IU mL FT 0 0 0 PG mL FT 0 0 0 NG dL だ ある TRAb 0 0 IU L 高値 だ ある 確か らしい バセドウ病 診断 する た 医 甲状腺 超音波 検査 だ 血流 増加 ない 遮断 薬 対症療法 開始 する た,1,0.1155741463401258,0.8844258536598743,1,0.00020504127876939796,0.9997949587212306,1,0.17779719054960308,0.8222028094503969,1,0.34816824784864375,0.6518317521513562,1,0.1719861626625061,0.8732637166976929,1,0.21023228764533997,0.8700140118598938,1,0.016666132687221853,0.9833338673127782,1
2054,中枢神経系に帰することのできる限局性または多発性所見として、2022/03/29に脳神経の単一または複数の異常、深部腱反射の変化(反射減弱または亢進、反射の非対称性)、小脳の機能障害(運動失調症、測定障害、小脳性眼振など)のいずれかが発現。,中枢神経 系 帰 する こと できる 限局 性 多発性 所見 0 0 0 脳神経 単一 複数 異常 深部腱反射 変化 反射 減 弱 亢進 反射 非対称性 小脳 機 能障害 運動失調症 測定障害 小脳性 眼振 いずれ 発現,1,0.016687769629248946,0.983312230370751,1,0.0003537443024841828,0.9996462556975159,1,0.010702218318928258,0.9892977816810717,1,1.1142263213304027e-05,0.9999888577367867,1,0.0971401110291481,0.9396840929985046,1,0.2126503437757492,0.8518858551979065,1,0.004380205791389256,0.9956197942086108,1
2055,36歳、女性、遺伝性血管浮腫3型のため、イカチバント酢酸塩(Icatibant)(シリンジ型注射用液剤)を投与され、遺伝性血管浮腫(呼吸困難、咽頭浮腫)、呼吸不全及び遺伝性血管浮腫(悪天候時、症状が出現すると、家族で入院する)が発現した。,0歳 女性 遺伝性 血管浮腫 0 型 ため イカチバント 酢酸塩 Icatibant シリンジ 型 注射 用 液剤 投与 する れる 遺伝性 血管浮腫 呼吸困難 咽頭浮腫 呼吸不全 遺伝性 血管浮腫 悪天候 時 症状 出現 する 家族 入院 する 発現 する た,1,0.015390476698136936,0.9846095233018629,1,0.00030717103365699436,0.999692828966343,1,0.006584209616233405,0.9934157903837666,1,0.30467356578191296,0.695326434218087,1,0.07738064229488373,0.935390055179596,1,0.1800539642572403,0.8695756196975708,1,0.007438496586738286,0.9925615034132617,1
2056,顔色不良、高血圧(172/139)、SpO2の低下(室内気79%)、胸部CTで肺水腫を認め、腎機能はCre 13mg/dL、BUN 96mg/dL、eGFR 4mL/min/1.73m^2、尿潜血(3+)、尿蛋白217mg/dLだった。,顔色不良 高血圧 0 0 SpO 0 低下 室内 気 0% 胸部 CT だ 肺水腫 認める 腎 機能 Cre 0m g dL BUN 0m g dL eGFR 0m L mi n/ 0 0m 0 尿潜血 0 尿蛋白 0m g dL だ た,1,0.00799416243453702,0.9920058375654629,1,0.0002352197235406896,0.9997647802764593,1,0.0381256338950271,0.9618743661049729,1,0.47791510293724737,0.5220848970627526,1,0.07979422807693481,0.9428234696388245,1,0.18407291173934937,0.8706561326980591,1,0.010975297699352288,0.9890247023006478,1
2057,心室壁厚の変化;心電図:(2022/06/02)異常所見あり、注記:ST上昇又は陰性T波; (2022/06/05)ST上昇;フィブリンDダイマー: (2022/06/20)、上昇なし;トロポニンT:(2022/06/20)、上昇なし。,心室 壁 厚 変化 心電図 0 0 0 異常所見 ある 注記 ST 上昇 陰性 T 波 0 0 0 ST 上昇 フィブリン D ダイマー 0 0 0 上昇 ない トロポニン T 0 0 0 上昇 ない,1,0.06729964882374122,0.932700351176259,1,0.00020114433963967418,0.9997988556603603,1,0.3025704840176541,0.6974295159823459,1,0.13033660499472222,0.8696633950052778,1,0.1603987067937851,0.8974617123603821,1,0.21802940964698792,0.8571765422821045,1,0.012426810014932557,0.9875731899850675,1
2058,2ヶ月以上進行する対称性の運動感覚障害と腱反射が消失する臨床像、脳脊髄液の蛋白細胞解離所見、腰髄神経腫大と造影効果、電気生理学的検査での感覚神経伝導速度低下、複数の神経で伝導ブロックを確認し、慢性炎症性脱髄性多発神経根炎と診断した。,0 ヶ月 以上 進行 する 対称性 運動感覚障害 腱反射 消失 する 臨床 像 脳脊髄液 蛋白細胞解離 所見 腰髄 神経腫大 造影効果 電気 生理 学的 検査 感覚神経 伝導 速度低下 複数 神経 だ 伝導ブロック 確認 する 慢性炎症性 脱髄性 多発神経根炎 診断 する た,1,0.039970405224369544,0.9600295947756304,1,0.00017192874263084694,0.9998280712573692,1,0.16604910692642494,0.8339508930735751,1,0.29722976516780986,0.7027702348321901,1,0.11046557128429413,0.9381808638572693,1,0.19453482329845428,0.8639110326766968,1,0.01109340506418288,0.9889065949358172,1
2059,"搬送時に胸痛は消失しており,有意な心電図変化はなく,経胸壁心エコー検査で壁運動異常はなかったが,血液検査でトロポニンI 1.55ng/mLと心筋逸脱酵素が上昇しており,ワクチン接種後の心筋炎や冠攣縮性狭心症の疑いで入院した。",搬送 時 胸痛 消失 する おる 有意 だ 心電図変化 ない 経 胸壁 心 エコー 検査 だ 壁運動異常 ない た 血液検査 トロポニン I 0 0 NG mL 心筋逸脱酵素 上昇 する おる ワクチン接種 後 心筋炎 冠 攣縮性 狭心症 疑い 入院 する た,1,0.04315540986971762,0.9568445901302823,0,0.00013531253942686093,0.9998646874605731,1,0.1805725497156616,0.8194274502843384,1,0.20836630821858304,0.791633691781417,1,0.09768304228782654,0.9282557368278503,1,0.18633127212524414,0.8644205927848816,1,0.009525583532445196,0.9904744164675549,1
2060,メチルプレドニゾロンパルス(mPSL pulse)、後療法PSL 60 mg/日を開始したが、Cr 9.1 mg/dLまで上昇したため、PE(血漿交換療法)を先行後にリツキシマブを追加したところ、腎機能の改善が得られた。,メチルプレドニゾロン パルス mPSL PULSE 後 療法 PSL 0 mg 日 開始 する た Cr 0 0 mg dL 上昇 する た ため PE 血漿交換 療法 先行 後 リツキシマブ 追加 する た ところ 腎 機能 改善 得る られる た,1,0.16016576567175378,0.8398342343282463,0,0.00013492582804626192,0.9998650741719537,1,0.4013656893655334,0.5986343106344666,1,0.011785807364174228,0.9882141926358258,0,0.7944393157958984,0.23767435550689697,0,0.6397901177406311,0.31640321016311646,1,0.1220730497867488,0.8779269502132512,1
2061,血液ガスpH 6.885、HCO3- 15.7、B.E- 19.0、PaCO2 87.7、PaO2 177.3、Lac 121と著明な代謝性アシドーシス、Lac上昇を認め、心肺停止時間がある程度あった事が予想された。,血液ガス 0 0 HCO 0 0 0 B E 0 0 PaCO 0 0 0 PaO 0 0 0 Lac 0 著 明 だ 代謝性アシドーシス Lac 上昇 認める 心肺停止 時間 ある た 事 予想 する れる た,1,0.0039048885128245172,0.9960951114871756,1,0.0003940182288727858,0.9996059817711272,1,0.01698711948408449,0.9830128805159155,1,0.1925329303681882,0.8074670696318118,1,0.07362953573465347,0.9466831684112549,1,0.18133603036403656,0.8679580688476562,1,0.005869857561952076,0.9941301424380479,1
2062,心電図検査にて発作性又は持続性の心房性又は心室性不整脈、持続モニターで検出された頻回に出現する心房性期外収縮又は心室性期外収縮、広範な誘導における上に凹型のST上昇又は陰性T波、aVR誘導におけるST低下を認めた。,心電図 検査 発作性 持続 性 心房性 心室性不整脈 持続 モニター 検出 する れる た 頻る 回 出現 する 心房性 期外収縮 心室性期外収縮 広範 だ 誘導 上 凹型 ST 上昇 陰性 T 波 aVR 誘導 ST 低下 認める た,1,0.012269041191451785,0.9877309588085481,1,0.0004126419617484571,0.9995873580382515,1,0.01422967713037937,0.9857703228696206,1,0.04909444708549693,0.9509055529145031,1,0.07787514477968216,0.9432110786437988,1,0.19437450170516968,0.8715463280677795,1,0.004539013905301871,0.9954609860946982,1
2063,"心電図前胸部誘導、I,II,aVFでST上昇、胸写、年齢に比し心肥大あり、エコー瀰漫性壁運動低下、採血TnI 15615、CK 1048、AST 118、ALT 61、LDH 325と心筋逸脱酵素の上昇があった。",心電図 前胸部誘導 I II aVF ST 上昇 胸 写 年齢 比す 心肥大 ある エコー 瀰漫性 壁運動低下 採血 TnI 0 CK 0 AST 0 ALT 0 LDH 0 心筋逸脱酵素 上昇 ある た,1,0.01907168572694217,0.9809283142730578,1,0.00033657061838790226,0.9996634293816121,1,0.025352673946053783,0.9746473260539462,1,0.2662182118663122,0.7337817881336878,1,0.07919123023748398,0.9410184025764465,1,0.18321028351783752,0.8706397414207458,1,0.007193925622353108,0.9928060743776469,1
2064,頸部屈筋と四肢近位筋の筋力低下、MRIで近位筋T2高信号、針筋電図で筋原性変化、上腕二頭筋生検で壊死再生線維と非壊死筋線維のMHCclass1発現、血管周囲と筋内鞘に集簇する形質細胞とリンパ球浸潤を認めた。,頸部屈筋 四肢近位筋 の 筋力低下 MRI 位 筋 T 0 高信号 針 筋電図 だ 筋原性変化 上腕 二 頭 筋生検 だ 壊死 再生線維 非壊死筋線維 MHCclass 0 発現 血管 周囲 筋 内 鞘 集簇 する 形質細胞 リンパ球浸潤 認める た,1,0.013772446270122012,0.9862275537298781,1,0.00044040803380085327,0.9995595919661991,1,0.024174478926998755,0.9758255210730012,1,0.15956248002296614,0.8404375199770339,1,0.08879214525222778,0.9328938722610474,1,0.1991497129201889,0.8711174130439758,1,0.005939519570304524,0.9940604804296954,1
2065,2022/06/22、正午過ぎにワクチンを接種し直後に気分不快を訴え、血圧低下(収縮期血圧80台、拡張期血圧50台)、SpO2 80%台、脈拍40台、血糖38mg/dLを認め、点滴、酸素吸入を開始した。,0 0 0 正午 過ぎ ワクチン 接種 する 直後 気分不快 訴える 血圧低下 収縮期 血圧 0 台 拡張期血圧 0 台 SpO 0 0% 台 脈拍 0 台 血糖 0m g dL 認める 点滴 酸素吸入 開始 する た,1,0.011297572999634386,0.9887024270003656,1,0.0003630875578832578,0.9996369124421167,1,0.01406773135783268,0.9859322686421673,1,0.3188351215928289,0.6811648784071711,1,0.08700963109731674,0.9422417879104614,1,0.18335817754268646,0.8684349060058594,1,0.007758466515795399,0.9922415334842046,1
2066,"2022/02/22入院後の血液検査ではCPK 2,613 U/L、CK-MB 79 U/L、トロポニンI 19,409 pg/mLと上昇あるが、心エコー再検では左室駆出率60%台と壁運動低下が改善。",0 0 0 入院 後 血液検査 CPK 0 0 U L CK MB 0 U L トロポニン I 0 0 PG mL 上昇 ある 心 エコー 再検 左 室 駆け出し 率 0% 台 壁運動低下 改善,1,0.09574631603459333,0.9042536839654068,1,0.00023851700777004008,0.99976148299223,1,0.027392480214424086,0.9726075197855759,1,0.37576018791830523,0.6242398120816948,1,0.4199630320072174,0.6894826292991638,1,0.21306326985359192,0.8608635067939758,1,0.019473314279341715,0.9805266857206583,1
2067,SIADに加え、Sjogren症候群の既往、難治性吃逆、MRIで脳室周囲白質病変と胸髄正中に1椎体の信号異常、抗AQPー4抗体陽性を認めたことから視神経脊髄炎スペクトラム障害(NMOSD)と診断した。,SIAD 加える Sjogren 症候群 既往 難治性 吃逆 MRI だ 脳室周囲白質病変 胸 髄 正中 0 椎 体 信号異常 AQP ー 0 抗体陽性 認める た こと 視神経脊髄炎 スペクトラム 障害 NMOSD 診断 する た,1,0.016654215821137748,0.9833457841788623,1,0.0003043699884307372,0.9996956300115692,1,0.04024829132827079,0.9597517086717292,1,0.17868871921028062,0.8213112807897194,1,0.09074894338846207,0.9423902630805969,1,0.1819855272769928,0.8741627931594849,1,0.006230631940772563,0.9937693680592274,1
2068,2022/04/08、血清反応陰性関節炎(入院、医学的に重要)発現、転帰「軽快」、「炎症反応高値、MMP-3抗体高値、リウマチ因子陰性、手指MSIで滑膜炎を認め、RS3PE症候群の診断」と記載された。,0 0 0 血清 反応 陰性関節炎 入院 医学 的 重要 発現 転帰 軽快 炎症反応高値 MMP 0 抗体 高値 リウマチ 因子 陰性 手 指 MSI だ 滑膜炎 認める RS 0 PE 症候群 の 診断 記載 する れる た,1,0.01189671445133565,0.9881032855486641,1,0.00048117506027980743,0.9995188249397202,1,0.003109171807340272,0.9968908281926597,1,0.22362890441470884,0.7763710955852912,1,0.09305565059185028,0.9465395212173462,1,0.18960483372211456,0.8751160502433777,1,0.006300767317286284,0.9936992326827137,1
2069,T・bil 0.95、AST 182、ALT 171、ALP 168、γGTP 104、LDH 289、CRP 6.61、WBC 3700と、肝障害を認め、CTで急性肝炎を示唆する高度脂肪肝を認めた。,T bil 0 0 AST 0 ALT 0 ALP 0 γGTP 0 LDH 0 CRP 0 0 WBC 0 肝障害 認める CT だ 急性肝炎 示唆 する 高度脂肪肝 認める た,1,0.01115255390246672,0.9888474460975333,1,0.0003781125236491034,0.999621887476351,1,0.029511991299064455,0.9704880087009355,1,0.006615611084837769,0.9933843889151622,1,0.07221417874097824,0.944464921951294,1,0.18455635011196136,0.8784880042076111,1,0.0041899577864069545,0.995810042213593,1
2070,Activated partial thromboplastin time: (日付不明) 38.0 seconds; Coagulation test: (日付不明) 1.03;診断病名:脳卒中。,Activated partial thromboplastin time 日付 不明 0 0 seconds Coagulation test 日付 不明 0 0 診断 病名 脳卒中,1,0.06780794636164625,0.9321920536383538,1,0.00020962067736618757,0.9997903793226338,1,0.25344784386736585,0.7465521561326341,1,0.0007158787942972422,0.9992841212057028,1,0.32176563143730164,0.7860784530639648,1,0.20504973828792572,0.8604952692985535,1,0.011257539929349051,0.9887424600706509,1
2071,脊髄炎、対麻痺、視神経脊髄炎スペクトラム障害、発熱、下痢、四肢不快感、筋骨格不快感、異常感覚、感覚鈍麻、筋力低下、感覚障害、膀胱障害、肛門直腸障害のため、入院した(開始日: 2022/05/30)。,脊髄炎 対麻痺 視神経脊髄炎 スペクトラム 障害 発熱 下痢 四肢不快感 筋骨格 不快感 異常感覚 感覚鈍麻 筋力低下 感覚障害 膀胱障害 肛門直腸障害 ため 入院 する た 開始 日 0 0 0,1,0.006432652557903095,0.9935673474420968,1,0.00039221295645645307,0.9996077870435436,1,0.019452311238637554,0.9805476887613624,1,0.014349225335235416,0.9856507746647646,1,0.0938427671790123,0.9426610469818115,1,0.18806608021259308,0.8665129542350769,1,0.004294944934981703,0.9957050550650184,1
2072,年齢が非典型的であり、診断のため右下腿より皮膚生検を施行し、真皮から皮下組織にかけての浮腫、膠原繊維間や葉間の好酸球浸潤、血管周囲の好酸球主体のリンパ球浸潤を認め、NEAEに矛盾しない所見であった。,年齢 非典型 的 だ ある 診断 ため 右 下腿 皮膚生検 施行 する 真皮 皮下 組織 浮腫 膠 繊維 間 葉 間 好酸球浸潤 血管 周囲 好酸球 主体 リンパ球浸潤 認める NEAE 矛盾 する ない 所見 だ ある た,1,0.018000318038429212,0.9819996819615708,1,0.00039202306248713637,0.9996079769375129,1,0.05230279231159496,0.947697207688405,1,0.39768833343317944,0.6023116665668206,1,0.1016201376914978,0.9257404208183289,1,0.20301532745361328,0.853509247303009,1,0.010583205981006788,0.9894167940189933,1
2073,"採血検査ではWBC 11,700、Hb 13.5、RP 0.70、CK 44、Cr 0.82、NTproBNP 64、軽度脱水と炎症反応を認めるが、心筋障害および心不全を認める所見は得なかった。",採血 検査 WBC 0 0 Hb 0 0 RP 0 0 CK 0 Cr 0 0 NTproBNP 0 軽度脱水 炎症反応 認める 心筋障害 心不全 認める 所見 得る ない た,1,0.35885461157444204,0.6411453884255579,1,0.00025582093162573974,0.9997441790683742,1,0.06540485739453217,0.9345951426054678,0,0.7335723530039617,0.2664276469960382,1,0.1675427109003067,0.8799289464950562,1,0.19568274915218353,0.8641278147697449,1,0.044588932143490044,0.95541106785651,1
2074,アナフィラキシー反応の時間的経過を記入してください: 2022/06/22、PM0:00過ぎにワクチン接種し、直後に(0:08)、気分不快を訴え、同時に血圧低下、SpO2低下、低血糖を認めた。,アナフィラキシー反応 時間的 経過 記入 する くださる 0 0 0 PM 0 0 過ぎ ワクチン接種 直後 0 0 気分不快 訴える 血圧低下 SpO 0 低下 低血糖 認める た,1,1.803405726992594e-05,0.99998196594273,1,0.0004407639375344617,0.9995592360624656,1,0.013679049237867669,0.9863209507621323,1,0.03840921568953548,0.9615907843104645,1,0.07441885769367218,0.9488672614097595,1,0.17850945889949799,0.870933473110199,1,0.004228046124796317,0.9957719538752038,1
2075,患者は、腎不全、心不全、肺水腫、急性呼吸窮迫症候群、糖尿病性腎症、状態悪化、血中クレアチニン増加で入院した(開始日: 2021/06/30、退院日:2021/07/06、入院期間:6日)。,患者 腎不全 心不全 肺水腫 急性 呼吸窮迫 症候群 糖尿病 性腎症 状態悪化 血 中 クレアチニン 増加 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.0207734000038671,0.9792265999961327,1,0.0003569578211153378,0.9996430421788847,1,0.029016447395656342,0.9709835526043437,1,0.0003285513211378488,0.9996714486788622,1,0.0887800082564354,0.9451369047164917,1,0.18852494657039642,0.856768012046814,1,0.004391648678768231,0.9956083513212317,1
2076,10日目に実施された心臓MRIは、左心室壁の外側セグメントにおける心外膜下後期ガドリニウム増強及びT2強調画像上の限局性心筋浮腫を伴うLVEFの正常を明らかにし、心筋炎の基準を満たした。,0 日 目 実施 する れる た 心臓 MRI 左心室 壁 外側 セグメント 心外 膜 下 後期 ガドリニウム 増強 T 0 強調 画像 上 限局 性 心筋浮腫 伴う LVEF 正常 明らか する 心筋炎 基準 満たす た,1,0.027218487910787785,0.972781512089212,1,0.0003053805101963975,0.9996946194898036,1,0.10168077416571064,0.8983192258342894,1,0.010083836015665648,0.9899161639843344,1,0.19121979176998138,0.8763555884361267,1,0.19195671379566193,0.8690903782844543,1,0.006158818228089492,0.9938411817719106,1
2077,3回目ワクチン接種15分後に、気分不快がみられ、ワクチン接種30分後に、意識消失、呼吸困難、皮膚掻痒感、全身紅斑が見られたことが認められた;そのためアナフィラキシーショックと診断された。,0回目 ワクチン接種 0分 後 気分不快 みる られる ワクチン接種 0分 後 意識消失 呼吸困難 皮膚掻痒感 全身紅斑 見る られる た こと 認める られる た そのため アナフィラキシー ショック 診断 する れる た,1,0.005350780510849148,0.9946492194891507,1,0.00043115288799799,0.999568847112002,1,0.02047038827471337,0.9795296117252866,1,0.06860913910552524,0.9313908608944748,1,0.0750286802649498,0.9472707509994507,1,0.17691360414028168,0.8705126643180847,1,0.004604444313647739,0.9953955556863522,1
2078,MPO-ANCA 183 U/mLと高値から顕微鏡的多発血管炎(MPA)による急速進行性糸球体腎炎(RPGN)が疑われ、腎生検でpauci-immune型半月体形成性糸球体腎炎と判明。,MPO ANCA 0 U mL 高値 顕微鏡的多発血管炎 MPA 急速進行性 糸球体腎炎 RPGN 疑う れる 腎生検 pauci immune 型 半月体形成性糸球体 腎炎 判明,1,0.01176757602724601,0.988232423972754,1,0.00040798175014892775,0.9995920182498511,1,0.05744034994508462,0.9425596500549154,1,2.2222224060897133e-12,0.9999999999977778,1,0.089567169547081,0.9328652620315552,1,0.18233300745487213,0.8714820146560669,1,0.0045267442557371,0.9954732557442628,1
2079,心筋炎、うっ血性心不全、心房細動、心室壁運動低下、心筋壊死マーカー上昇、小脳梗塞、発熱のために入院した(開始日:2021/07/21、退院日:2021/08/07、入院期間:18日)。,心筋炎 うっ血性 心不全 心房細動 心室壁運動低下 心筋壊死 マーカー 上昇 小脳梗塞 発熱 ため 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.004330372372771599,0.9956696276272283,1,0.00036856271207957305,0.9996314372879205,1,0.005476750752478221,0.9945232492475218,1,0.00023803759874030384,0.9997619624012597,1,0.08452344685792923,0.9473873376846313,1,0.17953374981880188,0.8684267401695251,1,0.00394666677902263,0.9960533332209773,1
2080,10:32顔面紅潮、頭痛、嘔気11:28咳嗽出現、呼吸困難11:33 O26L開始11:38生食500ml点滴11:42アドレナリン筋注射(右大腿外側)アナフィラキシーの転帰は不明。,0 0 顔面紅潮 頭痛 嘔気 0 0 咳嗽 出現 呼吸困難 0 0 O 0 L 開始 0 0 生食 0ml 点滴 0 0 アドレナリン 筋 注射 右 大腿 外側 アナフィラキシー 転帰 不明,1,0.0148788998956531,0.9851211001043468,1,0.0003518506076512038,0.9996481493923488,1,0.0027309408276118274,0.9972690591723882,1,0.030953173062867823,0.9690468269371322,1,0.09403470903635025,0.9418081641197205,1,0.19419580698013306,0.8650380373001099,1,0.0044041858117522615,0.9955958141882478,1
2081,自己免疫性脳炎、意識変容状態、痙攣発作、CSF細胞数増加、幻覚、発熱のため入院が必要となった(入院日: 2022/05/03、退院日: 2022/06/17、入院期間: 45日間)。,自己免疫性 脳炎 意識変容状態 痙攣 発作 CSF 細胞 数 増加 幻覚 発熱 ため 入院 必要 なる た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日間,1,0.005390566403721202,0.9946094335962786,1,0.0004887158934904673,0.9995112841065096,1,0.00584445164830627,0.9941555483516937,1,0.0022092555707526884,0.9977907444292473,1,0.08166013658046722,0.948653519153595,1,0.18940697610378265,0.8655577301979065,1,0.00400867351194138,0.9959913264880585,1
2082,Anti-melanoma differentiation-associated protein 5 antibody positive: (2022/03/02) positive,Anti melanoma differentiation associated protein 0 antibody positive 0 0 0 positive,1,0.03662994486242602,0.963370055137574,1,0.0002573980963886389,0.9997426019036114,1,0.35873972300322543,0.6412602769967746,1,4.176865420013609e-05,0.9999582313457999,1,0.3020193576812744,0.744526207447052,1,0.2933885455131531,0.807846188545227,1,0.015282794834509816,0.9847172051654901,1
2083,入院時、呼吸状態及び循環動態が不安定であり気管支鏡検査は施行できなかったが、血液検査で血中好酸球数の上昇を認めており、ステロイドに速やかに反応した経過から、急性好酸球性肺炎と判断。,入院 時 呼吸 状態 循環動態 不安 定 だ ある 気管支鏡 検査 施行 できる ない た 血液検査 血 中 好酸球 数 上昇 認める おる ステロイド 速やか 反応 する た 経過 急性 好酸球性 肺炎 判断,1,0.016692867605580846,0.9833071323944192,1,0.00027764707706718413,0.9997223529229328,1,0.0038473440642796675,0.9961526559357203,1,2.9301005538551195e-06,0.9999970698994461,1,0.09899059683084488,0.9321296811103821,1,0.21577884256839752,0.8429814577102661,1,0.004413341218454223,0.9955866587815457,1
2084,脊髄炎、対麻痺、視神経脊髄炎スペクトラム障害、発熱、下痢、四肢不快感、筋骨格不快感、異常感覚、感覚鈍麻、筋力低下、感覚障害、膀胱障害、肛門直腸障害の結果として治療的処置がとられた。,脊髄炎 対麻痺 視神経脊髄炎 スペクトラム 障害 発熱 下痢 四肢不快感 筋骨格 不快感 異常感覚 感覚鈍麻 筋力低下 感覚障害 膀胱障害 肛門直腸障害 結果 治療 的 処置 とる れる た,1,0.008472246340621816,0.9915277536593784,1,0.00043065938574214576,0.9995693406142578,1,0.009812026725819933,0.9901879732741801,1,0.17622501688847503,0.823774983111525,1,0.09742757678031921,0.940412163734436,1,0.18070942163467407,0.8686298727989197,1,0.0058176448001606,0.9941823551998394,1
2085,剖検により「多数臓器に及ぶ悪性リンパ腫浸潤/多臓器血管に浸潤する異常リンパ球系細胞が観察され、血管内大細胞型リンパ腫(IVL)が背景疾患として診断された」(リンパ腫)が見つかった。,剖検 多数 臓器 及ぶ 悪性リンパ 腫浸潤 臓器 血管 浸潤 する 異常リンパ球 系 細胞 観察 する れる 血管内大細胞型リンパ腫 IVL 背景 疾患 診断 する れる た リンパ腫 見つかる た,1,0.05530828002962473,0.9446917199703752,0,0.00016164365511594288,0.999838356344884,1,0.09356075438537104,0.906439245614629,1,0.011410517727726832,0.9885894822722732,1,0.09019134938716888,0.9364541172981262,1,0.18567581474781036,0.8660768270492554,1,0.0054548445051775946,0.9945451554948225,1
2086,筋炎特異抗体陰性で病理所見が特発性炎症性筋疾患に特徴的ではなく、口唇生検で小唾液腺導管周囲に50個以上のリンパ球浸潤を認めたことからシェーグレン症候群に関連する筋炎と考えた。,筋炎 特異抗体 陰性 病理 所見 特発性 炎症性 筋疾患 特徴 的 だ ない 口唇 生検 唾液腺 導管 周囲 0 個 以上 リンパ球浸潤 認める た こと シェーグレン 症候群 関連 する 筋炎 考える た,1,0.016682282501399127,0.9833177174986008,1,0.00029348150660490256,0.9997065184933951,1,0.06436521426516573,0.9356347857348343,1,0.0032432874035844828,0.9967567125964155,1,0.10190272331237793,0.9294019341468811,1,0.1984017789363861,0.8527886867523193,1,0.004904343701968357,0.9950956562980316,1
2087,血液検査では高感度トロポニンT 0.183 ng/mL、CK 216 U/Lと心筋逸脱酵素上昇を認め、心臓超音波検査で壁運動のびまん性に低下を認め、臨床経過から心筋炎と判断。,血液検査 感度 トロポニン T 0 0 NG mL CK 0 U L 心筋逸脱酵素上昇 認める 心臓 超音波 検査 壁 運動 びまん性 低下 認める 臨床 経過 心筋炎 判断,1,0.04621416654869365,0.9537858334513064,1,0.0002674360885797155,0.9997325639114203,1,0.04268516559740376,0.9573148344025962,1,2.3074493632257997e-05,0.9999769255063677,1,0.08936046063899994,0.939361572265625,1,0.1826782524585724,0.8703013062477112,1,0.004682430774393658,0.9953175692256062,1
2088,沈査赤血球50-99/HPF、尿蛋白0.88 g/gCre、血清Cre 1.56 mg/dL、尿中NAG上昇、尿中β2MG上昇、溶連菌陽性を認め、精査加療のため入院となった。,沈 査 赤血球 0 0 HPF 尿蛋白 0 0 g gCre 血清 Cre 0 0 mg dL 尿 中 NAG 上昇 尿 中 0 MG 上昇 溶連菌 陽性 認める 精査 加療 ため 入院 なる た,1,0.003435820766658024,0.9965641792333418,1,0.0004165291358697007,0.9995834708641304,1,0.004877720516430761,0.9951222794835692,1,0.22086991400086708,0.7791300859991329,1,0.08469336479902267,0.9473704099655151,1,0.18421706557273865,0.8772470355033875,1,0.006080876171384789,0.9939191238286151,1
2089,検査は入院69日目に行われ、T2画像にて非虚血性心筋損傷及び心筋浮腫を示す、左心室(LV)側壁における早期ガドリニウム増強(EGE)画像の非虚血性分布パターン陽性を認めた。,検査 入院 0 日 目 行う れる T 0 画像 非虚血性 心筋損傷 心筋浮腫 示す 左心室 LV 側壁 早期 ガドリニウム 増強 EGE 画像 非虚血性 分布 パターン 陽性 認める た,1,0.008372361897755429,0.9916276381022445,1,0.0003883995039956147,0.9996116004960044,1,0.006500079557049454,0.9934999204429505,1,0.08599891685183003,0.91400108314817,1,0.07991567999124527,0.9449360370635986,1,0.18834228813648224,0.8748812079429626,1,0.004730231118900911,0.9952697688810991,1
2090,磁気共鳴画像:短いT1時間を用いた反転回復法(STIR)にて高信号及び後期ガドリニウム増強(LGE)、STIRにて高信号領域及びLGEを認め、これらは心筋炎の特徴であった。,磁気 共鳴 画像 短い T 0時 間 用いる た 反転 回復 法 STIR にる 高信号 後期 ガドリニウム 増強 LGE STIR 高信号領域 LGE 認める これら 心筋炎 特徴 だ ある た,1,0.038641502144877216,0.961358497855123,1,0.00020201295669272691,0.9997979870433072,1,0.09839248993666083,0.9016075100633392,1,0.39215744161478694,0.6078425583852131,1,0.10528916120529175,0.9310010671615601,1,0.195011168718338,0.8672846555709839,1,0.01166765545827846,0.9883323445417216,1
2091,トロンボスポンジン1型モチーフ13によるジスインテグリン様およびメタロプロテイナーゼ(ADAMTS13)活性低下も証明でき(2021/06/20)、診断はTTPと確定した。,トロンボスポンジン 0 型 モチーフ 0 ジスインテグリン 様 メタロプロテイナーゼ ADAMTS 0 活性低下 証明 できる 0 0 0 診断 TTP 確定 する た,1,0.04732246821460004,0.9526775317853999,1,0.00023342582122688757,0.9997665741787731,1,0.08294617045849018,0.9170538295415098,1,0.22926579283380377,0.7707342071661962,1,0.15111586451530457,0.8986238837242126,0,0.7249979972839355,0.2985162138938904,1,0.026558431806835658,0.9734415681931643,1
2092,2022年7月15日18時40分Dr指示にて車椅子で救護室へ移動、BP:125/73、P22、SPO2 98 %意識レベル安定、V/S:V.Pも気分不快あり、臥静の指示。,0 年 0 月 0 日 0時 0分 Dr 指示 車椅子 救護 室 移動 BP 0 0 P 0 SPO 0 0 % 意識レベル安定 V S V P 気分不快 ある 臥 静 指示,1,0.04155047079322449,0.9584495292067755,1,0.00021766016566619474,0.9997823398343338,1,0.35873972300322543,0.6412602769967746,1,0.00048120268446738557,0.9995187973155326,1,0.15459519624710083,0.8942016959190369,1,0.19977374374866486,0.8559032678604126,1,0.010013492204419152,0.989986507795581,1
2093,検査データより、クレアチンキナーゼの著明な上昇(482 U/L)、血漿トロポニンT(0.7 mcg/L)、B型ナトリウム利尿ペプチド(43.1 pg/mL)が認められた。,検査 データ クレアチンキナーゼ 著い 明 だ 上昇 0 U L 血漿 トロポニン T 0 0 mcg L B型 ナトリウム利尿 ペプチド 0 0 PG mL 認める られる た,1,0.06143079703432558,0.9385692029656745,1,0.0001957485167178765,0.9998042514832821,1,0.023121150540722835,0.9768788494592772,1,0.06155642453901056,0.9384435754609894,1,0.08393692225217819,0.9438137412071228,1,0.1830933839082718,0.8718323707580566,1,0.005189021703668128,0.9948109782963319,1
2094,低アルブミン血症、浮腫、高度蛋白尿(5.93 g/g・Cr)を認め、ネフローゼ状態であり尿潜血陽性、腎機能障害を呈していることからRPEN(急速進行性腎炎)疑いにて精査。,低アルブミン血症 浮腫 高度蛋白尿 0 0 g g Cr 認める ネフローゼ状態 だ ある 尿潜血陽性 腎機能障害 呈す いる こと RPEN 急速進行性 腎炎 疑い 精査,1,0.01801226451601008,0.9819877354839898,1,0.0003110400788953658,0.9996889599211046,1,0.009065629014058052,0.990934370985942,1,1.8671288729565916e-06,0.999998132871127,1,0.08436308056116104,0.9431998133659363,1,0.18270190060138702,0.8693928122520447,1,0.004107821970074136,0.9958921780299258,1
2095,(2022/07/28)胸部誘導での陰性T波、注記:心電図では胸部誘導での陰性T波を認めたが、病歴と併せ、たこつぼ型心筋症よりも劇症型心筋炎の診断が妥当であると考えられた,0 0 0 胸部誘導 陰性 T 波 注記 心電図 胸部誘導 陰性 T 波 認める た 病歴 併せる たこつぼ 型 心筋症 劇症型 心筋炎 の 診断 妥当 だ ある 考える られる た,1,0.012990511988789005,0.9870094880112111,1,0.00032807321148189283,0.9996719267885181,1,0.011573554250855267,0.9884264457491447,1,0.0804933355127384,0.9195066644872616,1,0.0785503014922142,0.9399915933609009,1,0.2061140537261963,0.8620399236679077,1,0.004934308515798693,0.9950656914842012,1
2096,"2021/08/18血液検査でトロポニンI 21.56 ng/mL、CK 1,268 U/L、CK-MB 89.5 U/L、CRP 4.93 mg/dLの上昇を認めた。",0 0 0 血液検査 トロポニン I 0 0 NG mL CK 0 0 U L CK MB 0 0 U L CRP 0 0 mg dL 上昇 認める た,1,0.038542611092657816,0.9614573889073423,1,0.00023680064543404688,0.9997631993545659,1,0.033997362267607634,0.9660026377323924,1,0.015219356948763085,0.9847806430512369,1,0.07843552529811859,0.9461706280708313,1,0.18912149965763092,0.8737278580665588,1,0.004603385751763892,0.9953966142482361,1
2097,"2022/06/25 Cr 0.7 mg/dL、eGFR 88.4 mL/分、1.03 g/g・Cr、Alb 3,4 g/dL、尿蛋白(3+)、尿潜血(3+)を認める。",0 0 0 Cr 0 0 mg dL eGFR 0 0 mL 分 0 0 g g Cr Alb 0 0 g dL 尿蛋白 0 尿潜血 0 認める,1,0.007220778125620047,0.99277922187438,1,0.00028595527834655767,0.9997140447216535,1,0.09315331308714625,0.9068466869128537,1,1.6335673238998538e-05,0.999983664326761,1,0.08745160698890686,0.9434075355529785,1,0.1913144290447235,0.8699457049369812,1,0.004805225784719287,0.9951947742152806,1
2098,患者は急性肝炎、薬物性肝障害、肝障害、脂肪肝、食欲減退、倦怠感、発熱のために入院した(入院日:2022/07/11、退院日: 2022/07/19、入院期間:8日間)。,患者 急性肝炎 薬物性 肝障害 肝障害 脂肪肝 食欲減退 倦怠感 発熱 ため 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日間,1,0.005410248187996153,0.994589751812004,1,0.0004562172211025331,0.9995437827788974,1,0.005184343242595757,0.9948156567574042,1,0.002249872880375592,0.9977501271196244,1,0.0784953162074089,0.9482340812683105,1,0.19689665734767914,0.863122820854187,1,0.004032357546549374,0.9959676424534506,1
2099,まだら脂肪肝疑い; Cー反応性蛋白:(2022/07/24)2.7;フィブリンDダイマー:(2022/07/24)2.0;白血球数:(2022/07/24)4500。,まだら脂肪肝 疑い C ー 反応 性 蛋白 0 0 0 0 0 フィブリン D ダイマー 0 0 0 0 0 白血球 数 0 0 0 0,1,0.008900890870461555,0.9910991091295385,1,0.00029400051794008166,0.99970599948206,1,0.052429481833379254,0.9475705181666207,1,0.0002779256515194062,0.9997220743484806,1,0.09680546075105667,0.9270010590553284,1,0.20125837624073029,0.8556952476501465,1,0.004675057151586935,0.9953249428484131,1
2100,患者は心原性ショック(心原性ショック)(重篤区分:入院、その他医学的重要及び生命を脅かすもの)及び心筋炎(急性心筋炎)(重篤区分:入院及びその他医学的重要)を呈した。,患者 心原性ショック 心原性ショック 重篤 区分 入院 その他 医学 的 重要 生命 脅かす もの 及ぶ 心筋炎 急性心筋炎 重篤 区分 入院 その他 医学 的 重要 呈す た,1,0.007861966512377272,0.9921380334876228,1,0.000345195737921443,0.9996548042620785,1,0.024491987545825267,0.9755080124541747,1,0.051363071466253074,0.9486369285337469,1,0.09268394112586975,0.9337679743766785,1,0.24289201200008392,0.8292495608329773,1,0.005171965307882351,0.9948280346921178,1
2101,骨髄検査で骨髄巨核球の著明な増加と大型巨核球増加を認め、腎生検所見では、血管内皮細胞の腫大、内皮傷害を伴うTMA病変を認め、TAFRO症候群に矛盾しないと考えられた。,骨髄 検査 骨髄 巨核球 著い 明 だ 増加 大型 巨核球 増加 認める 腎生検 所見 血管 内 皮細胞 の 腫大 内皮傷害 伴う TMA 病変 認める TAFRO 症候群 矛盾 する ない 考える られる た,1,0.04112547459833813,0.958874525401662,1,0.00044374042840421225,0.9995562595715958,1,0.0071003625002636905,0.9928996374997363,1,0.19064153101827308,0.8093584689817269,1,0.10605686902999878,0.9306910634040833,1,0.19193506240844727,0.866335391998291,1,0.006558506205182365,0.9934414937948177,1
2102,収縮期血圧も100程度であり血液ガス検査ではLac88と著明な上昇を認め、全身にリベドを認め低拍出症候群を合併しているものと判断し心原性ショック状態であると診断した。,収縮期 血圧 0 程度 だ ある 血液ガス 検査 Lac 0 著 明 だ 上昇 認める 全身 リベド 認める 低拍出症候群 合併 する いる もの 判断 する 心原性ショック状態 だ ある 診断 する た,1,0.013714703548107571,0.9862852964518924,1,0.0004159558038634815,0.9995840441961366,1,0.04349556983102343,0.9565044301689766,1,0.2440601476056018,0.7559398523943982,1,0.08432692289352417,0.9442562460899353,1,0.19291836023330688,0.8687108159065247,1,0.007157942435110804,0.9928420575648891,1
2103,2021/10/22(ワクチン接種の2日後)、患者は心筋炎(入院期間は7日間)を発現し、治療は以下を含んだ:尿量、レントゲン、採血での慎重なし、経過観察と臥位安静。,0 0 0 ワクチン接種 0 日 後 患者 心筋炎 入院 期間 0 日間 発現 治療 以下 含む だ 尿 量 レントゲン 採血 慎重 ない 経過 観察 臥 位 安静,1,0.016691845824569177,0.9833081541754309,1,0.0001955917179702186,0.9998044082820298,1,0.04387248624833495,0.956127513751665,1,0.00010899689939247725,0.9998910031006075,1,0.25571346282958984,0.8616491556167603,0,0.6811169981956482,0.2784518301486969,1,0.016601315413486247,0.9833986845865137,1
2104,心臓生検:ワクチン接種から25日後に右室中隔から心内膜心筋検体を採取したところ、軽度の好酸球浸潤に加え、主にリンパ球の著明な炎症を伴う重症リンパ球性心筋炎を認めた。,心臓 生検 ワクチン接種 0 日 後 右 室 中隔 心内膜 心筋 検体 採取 する た ところ 軽度 好酸球浸潤 加える 主 リンパ球 著い 明 だ 炎症 伴う 重症 リンパ球 性心筋炎 認める た,1,0.016675420376326296,0.9833245796236737,1,0.00045404428704733053,0.9995459557129527,1,0.008934086542291553,0.9910659134577084,1,0.017399618004490636,0.9826003819955094,1,0.0838790237903595,0.94342440366745,1,0.184639573097229,0.8613613843917847,1,0.004280734057286409,0.9957192659427135,1
2105,中枢神経系に帰することのできる限局性または多発性所見として、2022/03/06に脳症、限局性皮質徴候、原始反射の存在、運動麻痺、感覚異常、深部腱反射の変化が発現。,中枢神経 系 帰 する こと できる 限局 性 多発性 所見 0 0 0 脳症 限局 性 皮質 徴候 原始 反射 存在 運動麻痺 感覚異常 深部腱反射 変化 発現,1,0.016686517909142638,0.9833134820908572,1,0.00038247491325766513,0.9996175250867423,1,0.009155646401143858,0.9908443535988561,1,2.5338139528763293e-06,0.9999974661860471,1,0.0937349870800972,0.9363281726837158,1,0.2091512382030487,0.8622231483459473,1,0.004306942626908807,0.9956930573730911,1
2106,心筋炎、発熱、頭痛、呼吸困難、胸痛、胸部不快感、心電図ST部分上昇のために入院した(入院日:2022/06/07、退院日: 2022/06/14、入院期間:7日)。,心筋炎 発熱 頭痛 呼吸困難 胸痛 胸部不快感 心電図 ST 部分 上昇 ため 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,2.0706079236903265e-06,0.9999979293920763,1,0.0005372222500482311,0.9994627777499517,1,0.0015214280320490214,0.998478571967951,1,0.0001349637105446666,0.9998650362894553,1,0.08268294483423233,0.9455705285072327,1,0.18695469200611115,0.8687261939048767,1,0.003910126675913166,0.9960898733240868,1
2107,造影剤増強コンピューター断層撮影(CT)により胸水(図1a、図1b)、腹水、門脈周囲浮腫、軽度肝脾腫、軽度リンパ節症(縦隔および後腹膜、短軸径約6mm)が判明した。,造影剤 増強 コンピューター 断層 撮影 C，T 胸水 図 0 a 図 0 b 腹水 門脈周囲浮腫 軽度肝脾腫 軽度 リンパ節症 縦 隔 後腹膜 軸 径 0mm 判明 する た,1,0.015510225764914088,0.9844897742350858,1,0.0002840830622732663,0.9997159169377268,1,0.18305336524836435,0.8169466347516356,1,0.26597824954553884,0.7340217504544612,1,0.08435768634080887,0.9361191987991333,1,0.19737493991851807,0.8687812685966492,1,0.010015890661677825,0.9899841093383221,1
2108,偽水晶体性水疱性角膜症に対してDescemet stripping automated endothelial keratoplastyを施行し経過良好であった。,水晶体 性 水疱性 角膜症 Descemet stripping automated endothelial keratoplasty 施行 する 経過 良好 だ ある た,1,0.036811694973804855,0.9631883050261951,1,0.00020872153187573053,0.9997912784681243,1,0.18713742388801446,0.8128625761119855,1,0.33238493344289777,0.6676150665571022,1,0.4403165876865387,0.6654852628707886,0,0.6544651985168457,0.38644906878471375,1,0.05498881316608516,0.9450111868339147,1
2109,心室細動の原因として、本剤接種後の発熱、一過性の心機能低下、トロポニンT陽性より、急性心筋炎を疑い心筋生検を施行後、救命救急センターに入室し人工呼吸器管理とした。,心室細動 の 原因 本 剤 接種 後 発熱 一過性 心機能低下 トロポニン T 陽性 急性心筋炎 疑う 心筋生検 施行 後 救命救急センター 入室 する 人工呼吸器 管理 する た,1,0.019133331773487854,0.9808666682265123,1,0.00031209027514354917,0.9996879097248564,1,0.008116066888954387,0.9918839331110456,1,0.32589426045896996,0.67410573954103,1,0.10796399414539337,0.9300390481948853,1,0.18283820152282715,0.8580787777900696,1,0.00824062655489036,0.9917593734451096,1
2110,"心電図でI、aVL、V2、V3誘導でST上昇、トロポニンI高値(64,203pg/mL)を認め、緊急で冠動脈造影を施行するも狭窄なく、心筋炎の診断で入院となった。",心電図 I aVL V 0 V 0 誘導 ST 上昇 トロポニン I 高値 0 0 PG mL 認める 緊急 だ 冠動脈造影 施行 する 狭窄 ない 心筋炎 の 診断 入院 なる た,1,0.008671292512444294,0.9913287074875559,1,0.00032958495292937024,0.9996704150470707,1,0.04559965204224736,0.9544003479577526,1,0.10379521818211668,0.8962047818178833,1,0.07842402160167694,0.9470394849777222,1,0.17715045809745789,0.8749139308929443,1,0.005222268499732239,0.9947777315002678,1
2111,抗アセチルコリン受容体抗体:(2021/08)陽性テンシロン試験:(2021/08)陽性眼瞼下垂、複視、乳癌、重症筋無力症、胸腺腫の結果として治療措置がとられた。,アセチルコリン受容体 抗体 0 0 陽性 テンシロン 試験 0 0 陽性 眼瞼下垂 複視 乳癌 重症 筋無力症 胸腺腫 結果 治療 措置 とる れる た,1,0.014723038851448864,0.985276961148551,1,0.00043229421891858395,0.9995677057810815,1,0.02031589857924687,0.9796841014207531,1,0.1514464123777044,0.8485535876222956,1,0.08110922574996948,0.9371141195297241,1,0.1901741474866867,0.8760595321655273,1,0.005663379570395717,0.9943366204296042,1
2112,急性散在性脳脊髄炎、視神経脊髄炎スペクトラム障害、尿閉、感覚鈍麻、排尿困難、歩行障害、四肢不快感、筋力低下、反射亢進、感覚障害の結果として、治療的処置がとられた。,急性散在性脳脊 髄炎 視神経脊髄炎 スペクトラム 障害 尿閉 感覚鈍麻 排尿困難 歩行障害 四肢不快感 筋力低下 反射亢進 感覚障害 結果 治療 的 処置 とる れる た,1,0.004548938273144753,0.9954510617268554,1,0.0005144091827140879,0.9994855908172859,1,0.049587664882827065,0.9504123351171729,1,0.14444316146562552,0.8555568385343745,1,0.09013686329126358,0.9439574480056763,1,0.18407708406448364,0.8748306035995483,1,0.005786722055586919,0.994213277944413,1
2113,全血球数は、白血球数正常、やや血小板増加症(36.6 9 104/ microliter[標準、15.8-34.8 9 104/microliter])を示した。,全血 球数 白血球 数 正常 血小板増加症 0 0 0 0 microliter 標準 0 0 0 0 0 0 microliter 示す た,1,0.016711254555980447,0.9832887454440195,1,0.000246947962826705,0.9997530520371732,1,0.2763347634556945,0.7236652365443055,1,0.15562624886900756,0.8443737511309924,1,0.09750845283269882,0.9299814105033875,1,0.19277453422546387,0.8639859557151794,1,0.009894367809754934,0.990105632190245,1
2114,Blood thyroid stimulating hormone (0.50-5.00):(2022/02/04) 0.44 uIU/mL、注釈:コメント:低値,BLOOD thyroid stimulating hormone 0 0 0 0 0 0 0 0 0 uIU mL 注釈 コメント 値,1,0.01022347058804776,0.9897765294119524,1,0.00033097012707762564,0.9996690298729224,1,0.2912285955160354,0.7087714044839646,1,0.0008142816297174171,0.9991857183702826,1,0.19744788110256195,0.8712723851203918,1,0.20628800988197327,0.8470726609230042,1,0.008929595139407963,0.9910704048605921,1
2115,患者は以下の検査と処置を受けた:体温:(2022/06/24)摂氏36.6度、注記:3回目のワクチン接種前;尿蛋白: (2022/06/30)尿蛋白が出現した。,患者 以下 検査 処置 受ける た 体温 0 0 0 摂氏 0 0度 注記 0回目 ワクチン接種 前 尿蛋白 0 0 0 尿蛋白 出現 する た,1,0.016694627154053215,0.9833053728459468,1,0.00033738671302382386,0.9996626132869761,1,0.030141587977987494,0.9698584120220125,1,0.098366055814056,0.901633944185944,1,0.08178356289863586,0.9527771472930908,1,0.19198504090309143,0.8734154105186462,1,0.005161543845778059,0.9948384561542218,1
2116,入院18病日の肝生検では、主に急性肝炎の所見であったが、門脈域に軽度の線維化を認め、典型的な所見は乏しいものの、背景にAIHが存在した可能性は否定できなかった。,入院 0 病 日 肝生検 主 急性肝炎 所見 だ ある た 門脈 域 軽度 線維化 認める 典型 的 だ 所見 乏しい 背景 AIH 存在 する た 可能性 否定 できる ない た,1,0.021008022044668572,0.9789919779553315,1,0.00020858831142056496,0.9997914116885794,1,0.21935177797481742,0.7806482220251826,0,0.8466987958978586,0.15330120410214143,1,0.2980961501598358,0.7578925490379333,1,0.22685733437538147,0.838975727558136,1,0.05228321011241513,0.947716789887585,1
2117,2022/05/24 14:00発症の痙攣発作(医学的に重要)、転帰「回復」(2022/06/09)、「けいれん/倒れて1分ほどの全身痙攣が生じた」と記載された,0 0 0 0 0 発症 の 痙攣 発作 医学 的 重要 転帰 回復 0 0 0 けいれん 倒れる 0分 全身痙攣 生じる た 記載 する れる た,1,0.01667594969341728,0.9833240503065829,1,0.0003735319794769529,0.999626468020523,1,0.11215636523789418,0.8878436347621058,1,0.1795370262619611,0.8204629737380389,1,0.0920727550983429,0.9407710433006287,1,0.1842704862356186,0.8742310404777527,1,0.007237805533601849,0.9927621944663982,1
2118,2022/06/25、来院し、ぴりぴりする痛み、両ふとももにぴりぴりする/胸(表面)にぴりぴりする感覚、注射部位に腫れ、注射部位の下方5cmにしこりを発現した。,0 0 0 来院 する ぴりぴり する 痛み もも ぴりぴり する 胸 表面 ぴりぴり する 感覚 注射 部位 腫れ 注射 部位 下方 0cm する こり 発現 する た,1,0.004904668902104836,0.9950953310978953,1,0.0003881843913693989,0.9996118156086305,1,0.011555180055328074,0.9884448199446719,1,0.25467168931254924,0.7453283106874508,1,0.0842483639717102,0.9429963827133179,1,0.18968352675437927,0.8746988773345947,1,0.0066880399548019005,0.9933119600451982,1
2119,2022/07/07、患者は当院を予約外受診し、血液検査を施行したところ、炎症反応高値と急性腎不全(クレアチニン2.34mg/dL)を発症していたため入院した。,0 0 0 患者 院 予約 外 受診 する 血液検査 施行 する た ところ 炎症反応高値 急性腎不全 クレアチニン 0 0m g dL 発症 する いる た ため 入院 する た,1,0.004963025776382131,0.9950369742236179,1,0.0003942281082680118,0.9996057718917319,1,0.019065135550835555,0.9809348644491644,1,0.06685382791947492,0.9331461720805251,1,0.07338006049394608,0.94632488489151,1,0.17401963472366333,0.8740929365158081,1,0.004539151511114315,0.9954608484888857,1
2120,グリア線維性星細胞性蛋白質抗体関連脳脊髄炎(GFAP)、AQP4-IgG陽性、視神経脊髄炎スペクトラム障害(AQP4)と自己免疫脳炎(AIE)などが挙げられた。,グリア 線維性 星 細胞性 蛋白質 抗体 関連 脳脊髄炎 GFAP AQP 0 IgG 陽性 視神経脊髄炎 スペクトラム 障害 AQP 0 自己免疫 脳炎 AIE 挙げる られる た,1,0.013865709866005379,0.9861342901339948,1,0.0003513859798347971,0.9996486140201652,1,0.030725517971019856,0.9692744820289801,1,0.10099811496370714,0.8990018850362929,1,0.0969674363732338,0.934817910194397,1,0.18399082124233246,0.8737940192222595,1,0.005294531353063595,0.9947054686469364,1
2121,事象「収縮性心膜炎」、「心膜肥厚」、「収縮性心膜炎による右心不全と診断」、「体重増加/1週間で体重が約10kg増加」、「息切れ/呼吸困難感」は来院を必要とした。,事象 収縮 性 心膜炎 心膜肥厚 収縮 性 心膜炎 右心不全 診断 体重増加 0 週間 体重 0kg 増加 息切れ 呼吸 困難感 来院 必要 する た,1,0.014014549524721788,0.9859854504752781,1,0.00040273646797939477,0.9995972635320206,1,0.00829773828606617,0.9917022617139338,1,0.2737721085574967,0.7262278914425033,1,0.07900048047304153,0.9489719271659851,1,0.18607325851917267,0.87343430519104,1,0.006934014130872619,0.9930659858691275,1
2122,事象の経過は、以下の通り:2021/12/20(ワクチン接種の192日後)、患者は不全片麻痺(左)、左半身の感覚鈍麻、構音障害、左半盲(報告の通り)が発現した。,事象 経過 以下 通り 0 0 0 ワクチン接種 0 日 後 患者 不全片麻痺 左 左半身 の 感覚鈍麻 構音障害 左半盲 報告 通り 発現 する た,1,0.015372977954200357,0.9846270220457998,1,0.0003102271090531987,0.9996897728909468,1,0.014337884375839494,0.9856621156241605,1,0.1671286891154391,0.8328713108845609,1,0.08875122666358948,0.9440204501152039,1,0.19182996451854706,0.8686389327049255,1,0.00583645209187867,0.9941635479081213,1
2123,コンピュータ断層撮影:COVID-19ワクチン接種より19日後に施行し、左上肢及び左腋窩のリンパ節に18F-フルオロデオキシグルコース(FDG)集積を認めた。,コンピュータ断層撮影 COVID 0 ワクチン接種 0 日 後 施行 する 左 上肢 左 腋窩 リンパ節 0 F フルオロデオキシグルコース FDG 集積 認める た,1,0.020737879324152844,0.9792621206758472,1,0.0003752249338987454,0.9996247750661013,1,0.09692722930874897,0.903072770691251,1,0.01884871485531192,0.9811512851446881,1,0.0921119675040245,0.9274035692214966,1,0.1875857412815094,0.8608111143112183,1,0.005299976201055793,0.9947000237989443,1
2124,患者は腎性症候群(ネフローゼ症候群、下腿浮腫)(重篤度基準は医学的に重要)、血栓性微小血管症(血栓性微小血管症、発熱)(重篤度基準は医学的に重要)を発現した。,患者 腎 性症候群 ネフローゼ 症候群 下腿浮腫 重篤 度 基準 医学 的 重要 血栓性 微小血管症 血栓性 微小血管症 発熱 重篤 度 基準 医学 的 重要 発現 する た,1,0.006402237591770045,0.99359776240823,1,0.00040103945489552653,0.9995989605451044,1,0.011784290344346027,0.988215709655654,1,0.29164681922485447,0.7083531807751455,1,0.09410298615694046,0.9401839375495911,1,0.2335904836654663,0.8165395259857178,1,0.008093551041650736,0.9919064489583492,1
2125,2022/06/15現在、2022/04/02 11:50、摂氏36.7度、P(脈拍) 59、BP(血圧)116/71、SpO2 93%、患者は頭痛を訴えた。,0 0 0 現在 0 0 0 0 0 摂氏 0 0度 P 脈拍 0 BP 血圧 0 0 SpO 0 0% 患者 頭痛 訴える た,1,0.02186322650229818,0.9781367734977018,1,0.00034482548168098453,0.999655174518319,1,0.04393067554297503,0.956069324457025,1,0.01733785933384402,0.982662140666156,1,0.07432916015386581,0.9479604363441467,1,0.1880781650543213,0.8677180409431458,1,0.004557931717302567,0.9954420682826973,1
2126,患者は、くも膜下出血(開始日:2022/03/13、退院日: 2022/03/28、入院期間:15日)、頭痛(開始日:2022/03/13)のために入院した。,患者 くも膜下出血 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日 頭痛 開始 日 0 0 0 ため 入院 する た,1,0.008970460539267446,0.9910295394607326,1,0.0002954911647840423,0.999704508835216,1,0.02796782332769554,0.9720321766723045,1,0.17217614236979117,0.8278238576302088,1,0.08373063802719116,0.9380635619163513,1,0.18907618522644043,0.8633679151535034,1,0.006001031373528382,0.9939989686264715,1
2127,"2022/03/16未明、ST上昇、CK-MB 21.5 ng/mL、トロポニン6,111.7 pg/mLを認め、副反応疑いによる急性心筋炎の診断にて入院。",0 0 0 未明 ST 上昇 CK MB 0 0 NG mL トロポニン 0 0 0 PG mL 認める 副反応 疑い 急性心筋炎 の 診断 入院,1,8.990127399682845e-08,0.999999910098726,1,0.0005645105810162916,0.9994354894189837,1,0.003133417965612284,0.9968665820343877,1,9.493735464438657e-09,0.9999999905062645,1,0.08510569483041763,0.9429908394813538,1,0.17944586277008057,0.8766546249389648,1,0.0038812939191491835,0.9961187060808507,1
2128,臨床検査では、高血糖、アニオンギャップ(25.6mEq/L)上昇とケトン血症を伴う代謝性アシドーシス(糖尿病性ケトアシドーシスと一致していた)が認められた。,臨床検査 高血糖 アニオンギャップ 0 0m Eq L 上昇 ケトン 血 症 伴う 代謝性アシドーシス 糖尿病 性 ケトアシドーシス 一致 する いる た 認める られる た,1,0.00397997790405521,0.996020022095945,1,0.0004914727422649194,0.9995085272577351,1,0.0030941503217691846,0.9969058496782308,1,0.07412162671253442,0.9258783732874656,1,0.08513079583644867,0.9444147348403931,1,0.18467721343040466,0.8711946606636047,1,0.004575620087648511,0.9954243799123516,1
2129,Computerised tomogram:胸水、腹水、門脈周囲性を認めた、notes:浮腫、軽度肝脾腫大、軽度リンパ節腫脹(縦隔、後腹膜、短軸径約6mm),Computer ised tomogram 胸水 腹水 門脈 周囲 性 認める た notes 浮腫 軽度肝脾腫大 軽度リンパ節腫脹 縦 隔 後腹膜 軸 径 0mm,1,0.01175286267189565,0.9882471373281042,1,0.00045594863027882606,0.9995440513697211,1,0.0176577969611037,0.9823422030388963,1,7.44326717150301e-07,0.9999992556732828,1,0.08399398624897003,0.9414496421813965,1,0.19729286432266235,0.8556753993034363,1,0.004252005365695471,0.9957479946343045,1
2130,患者は広範なST上昇(ワクチン接種から3日後)を伴う重度の胸痛を感じ、ST上昇(高値)は洞調律を示し、相反する変化を伴わない広範で著名なST上昇を認めた。,患者 広範 だ ST 上昇 ワクチン接種 0 日 後 伴う 重度 胸痛 感じる ST 上昇 高値 洞調律 示す 相反 する 変化 伴う ない 広範 だ 著名 だ ST 上昇 認める た,1,0.019429099638306822,0.9805709003616933,1,0.00040594196030256576,0.9995940580396975,1,0.008358048746606506,0.9916419512533935,1,0.07972218935658337,0.9202778106434166,1,0.07393105328083038,0.9472180008888245,1,0.18000291287899017,0.8742890954017639,1,0.00471752369917462,0.9952824763008253,1
2131,"高感度トロポニンI 7,968 pg/mLと上昇、心電図検査にて2、3、aVF、V4-6のST上昇、心臓超音波検査で壁運動異常を認め、心筋炎と考えられた。",感度 トロポニン I 0 0 PG mL 上昇 心電図 検査 0 0 aVF V 0 0 ST 上昇 心臓 超音波 検査 だ 壁運動異常 認める 心筋炎 考える られる た,1,0.010348874057843804,0.989651125942156,1,0.0003385582715155007,0.9996614417284845,1,0.010294685278587679,0.9897053147214123,1,0.032196949919066964,0.967803050080933,1,0.08559989929199219,0.9471349716186523,1,0.1829717755317688,0.8733745813369751,1,0.004296795373071795,0.9957032046269282,1
2132,代謝性アシドーシス、低血圧を認め、胸部から骨盤の造影CT施行により左肺動脈本幹や両肺動脈末梢に塞栓の所見、両側血栓症を確認したため、広範型肺塞栓症と診断。,代謝性アシドーシス 低血圧 認める 胸部 骨盤 造影 C，T 施行 左肺動脈 幹 両肺 動脈 末梢 塞栓 所見 両側 血栓症 確認 する た ため 広範 型 肺塞栓症 診断,1,0.013846320321625595,0.9861536796783742,1,0.0003699164200337533,0.9996300835799663,1,0.03097490236010958,0.9690250976398904,1,0.0002018813544280018,0.999798118645572,1,0.07944514602422714,0.9404893517494202,1,0.19325847923755646,0.8745301961898804,1,0.0042714136372181966,0.9957285863627819,1
2133,ヘノッホ・シェーンライン紫斑病性腎炎、点状出血、尿中蛋白陽性のため入院した(開始日:2022/04/29、退院日:2022/05/06、入院期間:7日間),ヘノッホ・シェーンライン紫斑病 性 腎炎 点状 出血 尿中蛋白 陽性 ため 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日間,1,0.007346001764599725,0.9926539982354001,1,0.0004492032349757215,0.9995507967650242,1,0.004876382407493329,0.9951236175925067,1,0.0015794265723662049,0.9984205734276338,1,0.09262429922819138,0.9391624927520752,1,0.18943385779857635,0.8678460717201233,1,0.004084559851616382,0.9959154401483836,1
2134,"再度診察を行ったところ甲状腺左築に圧痛があり,追加検査にてTSH0.006μU/mL,Free-T4 3.45ng/dLと甲状腺中毒症の所見がみられた。",診察 行う た ところ 甲状腺 左 築 圧痛 ある 追加 検査 TSH 0 0 μ U mL Free T 0 0 0 NG dL 甲状腺中毒症 所見 みる られる た,1,0.05669910842360271,0.9433008915763973,1,0.00031099680741566256,0.9996890031925844,1,0.1397319316441077,0.8602680683558923,1,0.09932010766079069,0.9006798923392093,1,0.07770131528377533,0.9430850148200989,1,0.18221727013587952,0.8656114935874939,1,0.006987269498814227,0.9930127305011858,1
2135,心筋炎、運動不能、心不全、低心拍出量症候群、心原性ショックのため入院(入院日:2022/07/27、退院日:2022/07/28、入院期間:1日)した。,心筋炎 運動 不能 心不全 低心拍出量 症候群 心原性ショック ため 入院 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日 する た,1,0.012845862324730239,0.9871541376752697,1,0.00035924607459258766,0.9996407539254074,1,0.03493518881244728,0.9650648111875527,1,0.23823425607690873,0.7617657439230913,1,0.082071952521801,0.9470463395118713,1,0.1850188970565796,0.8645395040512085,1,0.006883328056580435,0.9931166719434196,1
2136,患者は意識レベルの低下、意識変容状態、呼吸抑制、振戦、悪寒のため入院した(開始日:2022/05/01、退院日:2022/05/04、入院期間:3日)。,患者 意識レベルの低下 意識変容状態 呼吸抑制 振戦 悪寒 ため 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.01671531097920785,0.9832846890207921,1,0.00029207302370451573,0.9997079269762955,1,0.02768323713575993,0.9723167628642401,1,0.00015665569888545505,0.9998433443011145,1,0.08290861546993256,0.9482367038726807,1,0.19583600759506226,0.8584392070770264,1,0.004328325837396593,0.9956716741626034,1
2137,責任病変への経皮的冠動脈形成術後に左右冠動脈を光干渉断層撮影で観察したところ、両側の冠動脈に血栓の付着に加え3層構造の不明瞭化と内膜肥厚が認められた。,責任病変 経皮的冠動脈形成 術後 左右 冠動脈 光 干渉 断層 撮影 だ 観察 する た ところ 両側 冠動脈 血栓 付着 加える 0 層 構造 不明瞭化 内膜肥厚 認める られる た,1,0.016675029306409968,0.9833249706935899,1,0.00026779339392121287,0.9997322066060788,1,0.054961936250683574,0.9450380637493164,1,0.10756666807678805,0.892433331923212,1,0.08607213199138641,0.9350799918174744,1,0.18660925328731537,0.8625622987747192,1,0.005674861755251908,0.9943251382447481,1
2138,乳癌の臨床病期を評価するために、COVID-19ワクチン接種より38日後に超音波検査を実施し、びまん性皮質肥厚及び肺門維持を伴うリンパ節2つを認めた。,乳癌 の 臨床病期 評価 する ため COVID 0 ワクチン接種 0 日 後 超音波 検査 実施 する びまん性 皮質肥厚 肺門 維持 伴う リンパ節 0 つ 認める た,1,0.015148869987135622,0.9848511300128645,1,0.0003899067814849607,0.999610093218515,1,0.04673998991406947,0.9532600100859305,1,0.045981278517556845,0.9540187214824432,1,0.08415211737155914,0.945364236831665,1,0.18491369485855103,0.8620833158493042,1,0.004859919440184284,0.9951400805598157,1
2139,2021/08/24、PRESが発現し、本事象は重篤(重篤性基準:入院/入院期間の延長、入院期間:20日)と評価され、救急治療室への来院を必要とした。,0 0 0 PRES 発現 事象 重篤 重篤性 基準 入院 入院 期間 延長 入院 期間 0 日 評価 する れる 救急 治療 室 来院 必要 する た,1,0.008827401164054656,0.9911725988359451,1,0.0004034744417643404,0.9995965255582356,1,0.004483583579116046,0.995516416420884,1,0.2588672725920066,0.7411327274079934,1,0.08924772590398788,0.9395207762718201,1,0.2468242347240448,0.8229188919067383,1,0.0075307286786290275,0.992469271321371,1
2140,2021/10/17の2回目ワクチン接種後、患者は2021/10/18に摂氏38度台の発熱、2021/10/19に摂氏37度台を呈し、その後解熱した。,0 0 0 0回目 ワクチン接種 後 患者 0 0 0 摂氏 0度 台 発熱 0 0 0 摂氏 0度 台 呈す その後 解熱 する た,1,0.0161289182070783,0.9838710817929216,1,0.0003686289713050765,0.9996313710286949,1,0.008081059641330435,0.9919189403586696,1,0.22572172413326796,0.774278275866732,1,0.09540806710720062,0.9401547908782959,1,0.25732889771461487,0.820062518119812,1,0.007341236440195934,0.9926587635598041,1
2141,"19歳女性(158 cm, 63 kg)が、2回目の本剤接種26日後に、微熱(摂氏37.6度)を伴い持続する胸痛のため、当クリニック外来を受診した。",0歳 女性 0 cm 0 kg 0回目 本 剤 接種 0 日 後 微熱 摂氏 0 0度 伴う 持続 する 胸痛 ため クリニック 外来 受診 する た,1,0.016680007036040428,0.9833199929639596,1,0.0004283006588234324,0.9995716993411766,1,0.03633517614811199,0.963664823851888,1,0.16834829735938184,0.8316517026406182,1,0.07691112905740738,0.9485937356948853,1,0.18023931980133057,0.8744966387748718,1,0.00592662351305375,0.9940733764869463,1
2142,患者は喉のむず痒さ、呼吸困難、頻脈、頚部血管浮腫、持続性悪心、結膜充血、顔面腫脹、非そう痒性頚部血管浮腫及び徐々に発現した悪心といった症状を呈した。,患者 喉 むず痒い さ 呼吸困難 頻脈 頚部血管 浮腫 持続 性 悪心 結膜充血 顔面腫脹 そう痒 性 頚部血管 浮腫 発現 する た 悪心 症状 呈す た,1,0.01090656460141206,0.9890934353985882,1,0.00043736871918077954,0.9995626312808192,1,0.002182835892926005,0.997817164107074,1,0.0017405124973224328,0.9982594875026776,1,0.07450772076845169,0.9483082890510559,1,0.18827176094055176,0.8704442381858826,1,0.003968311110157319,0.9960316888898427,1
2143,来院時の心電図は、軽度びまん性STセグメント、心臓トロポニンT(0.515 ng/mL)及びクレアチンキナーゼ(412 IU/L)値の上昇を示した。,来院 時 心電図 軽度びまん性 ST セグメント 心臓 トロポニン T 0 0 NG mL クレアチンキナーゼ 0 IU L 値 上昇 示す た,1,0.024959979481473504,0.9750400205185267,1,0.00021717045184533432,0.9997828295481547,1,0.0468097646366189,0.9531902353633811,1,0.03218211070233723,0.9678178892976628,1,0.07844999432563782,0.9474449157714844,1,0.18141144514083862,0.8707665801048279,1,0.0047256561345816635,0.9952743438654182,1
2144,顔色不良、胸苦、四肢冷感、血圧測定(血圧):136/94、心拍数(脈):60、酸素飽和度(SpO2):99%であり、心電図にてST-T異常を認めた。,顔色不良 胸苦 四肢冷感 血圧 測定 血圧 0 0 心拍数 脈 0 酸素飽和度 SpO 0 0% だ ある 心電図 ST T 異常 認める た,1,0.005653789359796242,0.994346210640204,1,0.00029047192013563564,0.9997095280798644,1,0.01105762695870982,0.9889423730412902,1,0.024569594455534305,0.9754304055444657,1,0.07861322164535522,0.9490646719932556,1,0.18545441329479218,0.8767655491828918,1,0.00415773003511015,0.9958422699648898,1
2145,2022/01/27(3回目ワクチン接種の1ヵ月3日後)、被験者は発熱がありPCR検査を受け、陽性結果を示し、被験者はCOVID-19と診断された。,0 0 0 0回目 ワクチン接種 0 ヵ月 0 日 後 被験者 発熱 ある PCR検査 受ける 陽性 結果 示す 被験者 COVID 0 診断 する れる た,1,6.363111957315252e-06,0.9999936368880427,1,0.0005267251335335658,0.9994732748664664,1,0.007429850722937781,0.9925701492770622,1,0.14898007651131118,0.8510199234886888,1,0.09019789099693298,0.9444811940193176,1,0.17666573822498322,0.8725165724754333,1,0.00529202565775068,0.9947079743422493,1
2146,2022/07/16 09:55発現、失神寸前の状態(非重篤)、転帰「回復」(2022/07/16)、「血管迷走神経反射/迷走神経反射」と記載された,0 0 0 0 0 発現 失神 寸前 状態 重篤 転帰 回復 0 0 0 血管迷走神経反射 迷走神経反射 記載 する れる た,1,0.016692888218135575,0.9833071117818645,1,0.00034697004735334574,0.9996530299526466,1,0.03582724223268274,0.9641727577673173,1,0.1507655117514829,0.8492344882485171,1,0.10634134709835052,0.930532693862915,1,0.1816425621509552,0.8731371760368347,1,0.006009293101610226,0.9939907068983896,1
2147,画像検査(2022/01/07):びまん性または多発性の白質病変が、T2強調画像・拡散強調画像(DWI)、もしくはFLAIR画像において認められる。,画像 検査 0 0 0 びまん性 多発性 の 白質病変 T 0 強調 画像 拡散強調画像 DWI FLAIR 画像 認める られる,1,0.013452681034729198,0.9865473189652708,1,0.000296220652743932,0.9997037793472561,1,0.04253193090119323,0.9574680690988068,1,0.00040967143598680256,0.9995903285640132,1,0.09373903274536133,0.9340745806694031,1,0.19184403121471405,0.8695163130760193,1,0.004475610652443767,0.9955243893475562,1
2148,心筋炎、右室不全、左室不全、心室性頻脈、ウイルス感染により入院した(入院日:2022/04/02、退院日:2022/05/17、入院期間:45日)。,心筋炎 右室不全 左室不全 心室性頻脈 ウイルス感染 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.08661899485877451,0.9133810051412254,1,0.00026922731512003296,0.99973077268488,1,0.06628734049094487,0.9337126595090551,1,0.00012922859314645763,0.9998707714068535,1,0.08764837682247162,0.9429535269737244,1,0.1889270842075348,0.8630143404006958,1,0.005363381425628618,0.9946366185743715,1
2149,心筋炎、心機能障害、心室壁運動低下、心筋壊死マーカー上昇、心電図ST部分上昇、血行動態不安定、心拡大のため入院した(入院日:2022/06/13)。,心筋炎 心機能障害 心室壁運動低下 心筋壊死 マーカー 上昇 心電図 ST 部分 上昇 血行動態不安定 心拡大 ため 入院 する た 入院 日 0 0 0,1,1.7653335791356352e-05,0.9999823466642087,1,0.00046645925621643307,0.9995335407437835,1,0.0066078382284243675,0.9933921617715756,1,0.026032012597112963,0.973967987402887,1,0.08826854079961777,0.9469311237335205,1,0.179573655128479,0.8734315037727356,1,0.004126163639777969,0.9958738363602221,1
2150,血中コレステロール:高値、注記:2021/05/19より、患者はコレステロールが高値のため、ピタバスタチンCa口腔内破壊錠1mgを経口投与、継続中。,血 中 コレステロール 高値 注記 0 0 0 患者 コレステロール 高値 ため ピタバスタチン Ca 口腔内 破壊 錠 0m g 経口 投与 継続 中,1,0.02598394622449172,0.9740160537755083,1,0.000308210707745426,0.9996917892922546,1,0.19306822034124893,0.8069317796587511,1,0.18891223581222827,0.8110877641877717,1,0.14026476442813873,0.9045155048370361,1,0.35261064767837524,0.7910177707672119,1,0.012295956450687599,0.9877040435493123,1
2151,2022/03/22頚椎MRIにて頚椎全長が腫脹し、頚髄のT2延長信号をびまん性に認め、脳MRIにて多発T2延長信号あり、深部灰白質病変を認めた。,0 0 0 頚椎 MRI 頚椎 全長 腫脹 頚髄 T 0 延長 信号 びまん性 認める 脳 MRI 多発 T 0 延長 信号 ある 深部 灰 白質病変 認める た,1,0.005039043023160039,0.9949609569768398,1,0.00034665977652532953,0.9996533402234746,1,0.026492411684823858,0.9735075883151761,1,0.06959646267429576,0.9304035373257042,1,0.07959698140621185,0.94205641746521,1,0.18212008476257324,0.8733509182929993,1,0.004722228134620378,0.9952777718653796,1
2152,血圧70 mmHg/-の低血圧、発熱なし、心電図では190/分の上室性頻脈を認め、点滴輸液を行いながらATP 10 mg静脈投与し、洞調律へ回復。,血圧 0 mmHg 低血圧 発熱 ない 心電図 0 分 上室性 頻脈 認める 点滴 輸液 行う Association of Tennis Professionals 0 mg 静脈 投与 する 洞調律 回復,1,0.1771733102465163,0.8228266897534837,0,0.00011316699740918058,0.9998868330025908,1,0.24607521907377528,0.7539247809262247,1,0.3951546244434031,0.6048453755565969,1,0.18135736882686615,0.8761864304542542,1,0.24386237561702728,0.8474454879760742,1,0.025053244187279826,0.9749467558127203,1
2153,髄液検査で髄液細胞数、蛋白増加、IL-6著明高値、頭部MRで右大脳半球の広範な腫脹とFLAIRで脳溝の高信号を認め、片側性大脳皮質脳炎が疑われた。,髄液 検査 髄液 細胞 数 蛋白 増加 IL 0 著 明 高値 頭部 MR 右 大脳 半球 広範 だ 腫脹 FLAIR 脳溝 高信号 認める 片側 性 大 脳皮質 脳炎 疑う れる た,1,0.007991792120407135,0.9920082078795929,1,0.0005632121837634789,0.9994367878162366,1,0.0030177266457096508,0.9969822733542903,1,0.22199742406523637,0.7780025759347636,1,0.08059415966272354,0.9417116045951843,1,0.1951477825641632,0.8704218864440918,1,0.006247844946892147,0.9937521550531079,1
2154,入院後は安静·補液などにて経過をみたが肝障害の遷延と黄疸の悪化を認めたため、入院第4病日よりメチルプレドニゾロンを開始したところ改善傾向を示した。,入院 後 安静 補液 経過 みる た 肝障害 遷延 黄疸 の 悪化 認める た ため 入院 0 病 日 メチルプレドニゾロン 開始 する た ところ 改善 傾向 示す た,1,0.016702516812102063,0.9832974831878978,1,0.0003441795276351135,0.9996558204723649,1,0.010479563285470395,0.9895204367145296,1,0.019323485021695674,0.9806765149783043,1,0.12345018237829208,0.9202358722686768,0,0.6525510549545288,0.30369192361831665,1,0.012689282388705779,0.9873107176112942,1
2155,発熱と頭痛の症状に関しては、脳脊髄液中の単核球優位な増加、発症6日でVZV遺伝子を検出、VZV IgGも高値で帯状疱疹ウイルスによる髄膜炎と診断。,発熱 頭痛 症状 脳脊髄液 中 単核球優位 増加 発症 0 日 VZV 遺伝子 検出 VZV IgG 高値 だ 帯状疱疹ウイルス 髄膜炎 診断,1,0.0036518866785708883,0.9963481133214291,1,0.00042944076157732823,0.9995705592384226,1,0.0014368304144265487,0.9985631695855735,1,1.3508004532813978e-05,0.9999864919954672,1,0.09545192867517471,0.9408723711967468,1,0.1815524399280548,0.8736047744750977,1,0.003964475163967497,0.9960355248360325,1
2156,2021/07/21の1回目ワクチン接種の後、患者は2021/07/22に左耳周囲疼痛と顎下部痛み、2021/07/23に左顔面違和感を発現した。,0 0 0 0回目 ワクチン接種 後 患者 0 0 0 左耳周囲疼痛 顎下部痛 みる 0 0 0 左顔面違和感 発現 する た,1,0.005826688919324871,0.9941733110806752,1,0.0004196413520063526,0.9995803586479937,1,0.009127391430938547,0.9908726085690615,1,0.13205020142655777,0.8679497985734422,1,0.08007223159074783,0.9496396780014038,1,0.18389147520065308,0.8730629682540894,1,0.005148484513513611,0.9948515154864863,1
2157,2021/09/14、患者は、ワクチン接種後のギラン・バレー症候群/右末梢性顔面神経麻痺/両側上肢腱反射亢進/両側下肢腱反射高度減弱と診断された。,0 0 0 患者 ワクチン接種 後 ギラン・バレー症候群 右末梢性顔面神経麻痺 両側上肢腱反射亢進 両側 下肢 腱反射 高度 減 弱 診断 する れる た,1,0.016672430817566426,0.9833275691824336,1,0.0004364288024362903,0.9995635711975637,1,0.04215222495857529,0.9578477750414247,1,0.1446088395694497,0.8553911604305503,1,0.08704690635204315,0.9440914988517761,1,0.18299737572669983,0.8784948587417603,1,0.005795839607414767,0.9942041603925852,1
2158,意識消失、アナフィラキシーショック、倦怠感、嘔吐(入院日: 2022/06/04、退院日:2022/06/05(入院期間):1日)のため入院した。,意識消失 アナフィラキシー ショック 倦怠感 嘔吐 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日 ため 入院 する た,1,0.0036902945364001584,0.9963097054635999,1,0.00043157335197293694,0.999568426648027,1,0.008132184871450399,0.9918678151285496,1,0.11171977135796962,0.8882802286420304,1,0.07424671947956085,0.9487466216087341,1,0.1778499335050583,0.8669832944869995,1,0.004889880127574426,0.9951101198724256,1
2159,中心静脈栄養および利尿剤にて心不全の治療を行うも、クレアチニン値は2021/07/03 5.34、2021/07/05 7.37と急速に増悪した。,中心静脈栄養 利尿剤 にる 心不全 治療 行う クレアチニン 値 0 0 0 0 0 0 0 0 0 0 急速 増悪 する た,1,0.01667689089397714,0.9833231091060226,1,0.0003354212955190179,0.999664578704481,1,0.27306714769638907,0.7269328523036109,1,0.16835362691142008,0.8316463730885799,1,0.07512685656547546,0.9483540654182434,1,0.18248286843299866,0.8758271932601929,1,0.009473808099556101,0.9905261919004439,1
2160,2021/**/**、患者はヘモグロビン尿(肉眼的ヘモグロビン尿) (重篤区分:医学的に重要)及びワクチン接種部位疼痛(注射部位疼痛)を呈した。,0 患者 ヘモグロビン尿 肉眼 的 ヘモグロビン尿 重篤 区分 医学 的 重要 及ぶ ワクチン接種 部位疼痛 注射部位疼痛 呈す た,1,0.01667026923973139,0.9833297307602687,1,0.00033604572072862027,0.9996639542792713,1,0.07501057903447628,0.9249894209655237,1,0.00806866755993163,0.9919313324400684,1,0.08073928952217102,0.9483239054679871,1,0.20626966655254364,0.8623962998390198,1,0.004851808568004461,0.9951481914319955,1
2161,2021年11月1日午前12:00症状名:小脳炎疑い、小脳失調(歩行障害、巧緻運動障害) 2021年11月階段昇降時のふらつきがあり前医を受診。,0 年 0 月 0 日 午前 0 0 症状 名 小脳炎 疑い 小脳失調 歩行障害 巧緻運動障害 0 年 0 月 階段 昇降 時 ふらつき ある 医 受診,1,0.01668685529004383,0.9833131447099562,1,0.00032926984238527024,0.9996707301576148,1,0.09169938466661631,0.9083006153333837,1,8.321080221862509e-06,0.9999916789197781,1,0.08556586503982544,0.940507173538208,1,0.18744736909866333,0.8683405518531799,1,0.00487675366373391,0.9951232463362661,1
2162,2022/04/09に強直性脊椎炎を伴った第6頚椎椎体骨折に対し当院入院中の頸椎骨折術後、貧血、両側胸水、発作性心房細動を発症し抗凝固療法開始。,0 0 0 強直性 脊椎炎 伴う た 0 頚椎椎体骨折 院 入院 中 頸椎骨折 術後 貧血 両側胸水 発作性心房 細動 発症 する 抗凝固 療法 開始,1,0.015219570020789813,0.9847804299792102,1,0.00028515461293478835,0.9997148453870652,1,0.026811933173971347,0.9731880668260287,1,0.10297646455638487,0.8970235354436151,1,0.08514208346605301,0.9415948987007141,1,0.1813981980085373,0.8721333742141724,1,0.005185955380028071,0.9948140446199719,1
2163,抗MDA5-ILDで診断された後に、患者は、高用量ステロイド、タクロリムス、シクロホスファミドのパルス療法にて治療され、入院82日後に退院した。,MDA 0 ILD だ 診断 する れる た 後 患者 用量 ステロイド タクロリムス シクロホスファミド パルス 療法 治療 する れる 入院 0 日 後 退院 する た,1,0.05767807475930713,0.9423219252406929,1,0.0001905304685376449,0.9998094695314623,1,0.1289448680324875,0.8710551319675125,0,0.8637271764523116,0.1362728235476885,1,0.3923547863960266,0.7662651538848877,1,0.3989329934120178,0.6947359442710876,1,0.071184698446753,0.928815301553247,1
2164,2022/07/26 01:15、患者は多量の水溶性吐物にまみれている状態で発見され、呼吸停止、脈が触れないことを確認し、関連病院に搬送された。,0 0 0 0 0 患者 多量 水溶性吐物 まみれる いる 状態 だ 発見 する れる 呼吸停止 脈 触れる ない こと 確認 する 関連病院 搬送 する れる た,1,0.27439687646563027,0.7256031235343698,1,0.00020873162433491393,0.9997912683756651,1,0.442109766996571,0.557890233003429,1,0.18428047279363524,0.8157195272063648,1,0.07822653651237488,0.9458622336387634,1,0.19015048444271088,0.8582688570022583,1,0.023344732455466987,0.976655267544533,1
2165,血小板減少、LDHおよびフェリチン高値を認め、さらに脳脊髄液検査および骨髄検査で血球貧食像を認めたことから、血球貧食症候群(HPS)と診断した。,血小板減少 LDH お呼び フェリチン 高値 認める 脳脊髄液 検査 骨髄 検査 血球 貧 食 像 認める た こと 血球貧食症候群 HPS 診断 する た,1,0.00664814881077538,0.9933518511892246,1,0.00041984675275912855,0.9995801532472409,1,0.009869559161815644,0.9901304408381844,1,0.1577481666165551,0.8422518333834449,1,0.08148651570081711,0.9393519163131714,1,0.17665104568004608,0.8714954257011414,1,0.005468114298859192,0.9945318857011408,1
2166,事象「後天性血友病」および「右上腕は筋肉内出血によりコンパートメント症候群を起こして/右上腕筋肉内出血」のため救急治療室への入室が必要であった。,事象 後天性血友病 お呼び 右 上腕 筋肉内出血 コンパートメント 症候群 起こす 右 上腕 筋肉内出血 ため 救急 治療 室 入室 必要 だ ある た,1,0.016693020472168127,0.9833069795278319,1,0.00035956004870886174,0.9996404399512911,1,0.09156865418779003,0.90843134581221,1,0.3308722235445418,0.6691277764554582,1,0.07766059786081314,0.9411519765853882,1,0.207157164812088,0.8560776114463806,1,0.009627811215751814,0.9903721887842482,1
2167,凝固時間:異常なし、CRP:上昇なし、組織培養:陰性、組織学的検査:好中球主体の細胞浸潤で血管炎所見なし、注釈:潰瘍周囲の微小血管に血栓像あり。,凝固 時間 異常 ない CRP 上昇 ない 組織培養 陰性 組織 学 的 検査 好中球主体 の 細胞浸潤 だ 血管炎所見 ない 注釈 潰瘍 周囲 小血管 血栓像 ある,1,0.02021364322912231,0.9797863567708777,1,0.00019296611140545098,0.9998070338885946,0,0.61886414196809,0.38113585803191,1,0.00393241856052462,0.9960675814394754,1,0.15477244555950165,0.901170551776886,1,0.27903857827186584,0.814795732498169,1,0.01806144958537282,0.9819385504146271,1
2168,血液検査では、血小板4.8万/μL、D-dimer 108.5 μg/mL、CRP 10.08 mg/dLと血液凝固障害及び炎症反応上昇あり。,血液検査 血小板 0 0 万 μ L D dimer 0 0 μ g mL CRP 0 0 mg dL 血液凝固障害 炎症反応 上昇 ある,1,0.09800617638051333,0.9019938236194867,1,0.0002237702120642629,0.9997762297879358,1,0.07591295957523392,0.9240870404247661,1,0.0014467370090308629,0.9985532629909691,1,0.08118151128292084,0.9401917457580566,1,0.18678182363510132,0.8661392331123352,1,0.005556646502654724,0.9944433534973453,1
2169,心電図でV4-6、1、2、aVLで軽度ST上昇、血液検査にてトロポニンT 0.124 ng/mL、CRP 1.95 mg/dLと上昇を認めた。,心電図 V 0 0 0 0 aVL 軽度 ST 上昇 血液検査 トロポニン T 0 0 NG mL CRP 0 0 mg dL 上昇 認める た,1,0.006734089195530071,0.9932659108044699,1,0.0003439485300790789,0.9996560514699209,1,0.03560283867419567,0.9643971613258043,1,0.012170273419833455,0.9878297265801665,1,0.08276330679655075,0.9461854696273804,1,0.1829061657190323,0.8774863481521606,1,0.00428517269304396,0.995714827306956,1
2170,精査の結果、抗菌薬不応の肺炎であり、濃厚な浸潤影を呈している点から本剤による二次性器質化肺炎を疑い、短期間のステロイド投与を含めた治療を開始。,精査 結果 抗菌薬 不応 の 肺炎 だ ある 濃厚 だ 浸潤影 呈す いる 点 本 剤 二次 性 器質化 肺炎 疑う 短期間 ステロイド 投与 含める た 治療 開始,1,0.016669555581279912,0.9833304444187202,1,0.00030701306630339,0.9996929869336966,1,0.0062019671487015815,0.9937980328512984,1,0.12734180741402368,0.8726581925859763,1,0.11789984256029129,0.920647919178009,1,0.2486240714788437,0.8297384977340698,1,0.006164149900221153,0.9938358500997788,1
2171,接種から7日後、炎症性細胞浸潤は些少ではあるが(少数の細胞傷害性T細胞)、心筋細胞損傷、間質性浮腫並びに血管周囲及び間質性線維症が認められた。,接種 0 日 後 炎症性 細胞浸潤 些少 だ ある 少数 細胞傷害性 T細胞 心筋細胞 損傷 間質性 浮腫 血管 周囲 間質性 線維 症 認める られる た,1,0.013430863504154076,0.9865691364958459,1,0.00046897242579550303,0.9995310275742045,1,0.04833616644610761,0.9516638335538924,1,0.11278195647394484,0.8872180435260552,1,0.07996761053800583,0.9428533911705017,1,0.17682306468486786,0.8684628009796143,1,0.005461857056793653,0.9945381429432062,1
2172,免疫学的検査:免疫染色にてCD8+Tリンパ球及びマクロファージの著明な浸潤を認め、少数のCD4+Tリンパ球及びわずかなBリンパ球を伴っていた。,免疫学 的 検査 免疫 染色 CD 0 T リンパ球 マクロファージ 著い 明 だ 浸潤 認める 少数 CD 0 T リンパ球 だ Bリンパ球 伴う いる た,1,0.030398462842213207,0.9696015371577869,1,0.0002853005163943612,0.9997146994836056,1,0.09298582596619975,0.9070141740338002,1,0.25458359951279663,0.7454164004872034,1,0.09504048526287079,0.9364156723022461,1,0.18869222700595856,0.863747239112854,1,0.008493504354802157,0.9915064956451978,1
2173,左優位に両側眼瞼下垂/両側眼瞼下垂、嚥下障害、上肢の筋力低下/筋力低下(上肢近位筋優位)を認め、重症筋無力症クリーゼの診断で、病院に入院した。,左 優位 両側眼瞼下垂 両側眼瞼下垂 嚥下障害 上肢 筋力低下 筋力低下 上肢近位筋優位 認める 重症 筋無力症 クリーゼ の 診断 だ 病院 入院 する た,1,0.0029871467225091887,0.9970128532774908,1,0.0003926923788835558,0.9996073076211165,1,0.017717425861712766,0.9822825741382872,1,0.22356565040447085,0.7764343495955291,1,0.08188658952713013,0.9387016892433167,1,0.19492410123348236,0.8702336549758911,1,0.00641424661471346,0.9935857533852867,1
2174,その後も甲状腺機能亢進が持続し、超音波検査を再検したところ甲状腺腫大・実質血流亢進を認めたため、チアマゾール10mg/日による治療を開始した。,その後 甲状腺機能亢進 持続 する 超音波 検査 再検 する た ところ 甲状腺腫大 実質 血流亢進 認める た ため チアマゾール 0m g 日 治療 開始 する た,1,0.016701442086499686,0.9832985579135002,1,0.000275524603954962,0.999724475396045,1,0.08670702690826848,0.9132929730917315,1,0.33153455014587496,0.668465449854125,1,0.3431398570537567,0.7211450338363647,1,0.25175344944000244,0.8386622667312622,1,0.016391308746693863,0.9836086912533061,1
2175,ヘノッホ・シェーンライン紫斑病性腎炎、状態悪化、肺水腫、高血圧、酸素飽和度低下、発熱、過小食、呼吸困難、蒼白の結果として治療的処置がとられた。,ヘノッホ・シェーンライン紫斑病 性 腎炎 状態悪化 肺水腫 高血圧 酸素飽和度 低下 発熱 小食 呼吸困難 蒼白 結果 治療 的 処置 とる れる た,1,0.006362269468930529,0.9936377305310694,1,0.00042944812822813603,0.9995705518717719,1,0.0018691712182132836,0.9981308287817867,1,0.10854606374817244,0.8914539362518276,1,0.07911763340234756,0.9486533999443054,1,0.18163980543613434,0.8748319745063782,1,0.004828813275562562,0.9951711867244374,1
2176,患者は、発熱、着色尿、倦怠感、黄疸、肝機能異常のために入院した(開始日:2022/03/30、退院日:2022/04/02、入院期間:3日)。,患者 発熱 着色尿 倦怠感 黄疸 肝機能異常 ため 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.00828743411976475,0.9917125658802354,1,0.00030542266898694377,0.9996945773310131,1,0.004550705112174258,0.9954492948878257,1,0.0001318161048202704,0.9998681838951797,1,0.0833984762430191,0.9496550559997559,1,0.18309390544891357,0.8655360341072083,1,0.0039813383896035014,0.9960186616103965,1
2177,事象「急性脳症/ COVID-19ワクチン接種を契機とした免疫学的機序による脳症と診断」および「意識障害」は、緊急治療室への来院を必要とした。,事象 急性脳症 COVID 0 ワクチン接種 契機 する た 免疫学的機序 脳症 診断 お呼び 意識障害 緊急 治療 室 来院 必要 する た,1,0.010544913672318175,0.9894550863276816,1,0.00038957230988894537,0.9996104276901111,1,0.029180882107302186,0.9708191178926978,1,0.36411792399711573,0.6358820760028843,1,0.08052751421928406,0.946983814239502,1,0.17834582924842834,0.8691038489341736,1,0.008588141116770755,0.9914118588832292,1
2178,事象の経過は下記の通り:患者は病院に入院時、左室機能はびまん性壁運動障害、発熱、心筋逸脱酵素の軽度上昇があり、総合的に急性心筋炎疑いがあった。,事象 経過 下記 通り 患者 病院 入院 時 左 室 機能 びまん性 壁運動障害 発熱 心筋逸脱酵素 軽度 上昇 ある 総合的 急性心筋炎 疑い ある た,1,0.011134926449092239,0.9888650735509076,1,0.0003800284109638351,0.9996199715890361,1,0.0022353336732414686,0.9977646663267585,1,0.21235620062854155,0.7876437993714585,1,0.08375097066164017,0.9447852969169617,1,0.19426888227462769,0.856672465801239,1,0.006235602599616077,0.993764397400384,1
2179,開放腎生検を施行し、尿細管間質に形質細胞やリンパ球の高度浸潤と、尿細管上皮細胞の核腫大や胞体の平坦化を認め、急性尿細管間質性腎炎と診断した。,開放 腎生検 施行 する 尿 細管 間質 形質細胞 リンパ球 の 高度浸潤 尿細管上皮 細胞 核腫大 胞体 平坦化 認める 急性尿細管間質性腎炎 診断 する た,1,0.014677429960316632,0.9853225700396836,1,0.0003288999076022926,0.9996711000923977,1,0.029973702461598473,0.9700262975384015,1,0.23981305012564436,0.7601869498743556,1,0.09713621437549591,0.9379404187202454,1,0.1853410303592682,0.8702753186225891,1,0.006990748645523144,0.9930092513544768,1
2180,"2022/03/16けいれん重積、ミオクローヌスに対して最終的にイーケプラ2,000 mg、ランドセン6 mg、ビムパット300 mg処方。",0 0 0 けいれん 重積 ミオクローヌス 最終的 イーケプラ 0 0 mg ランドセン 0 mg ビムパット 0 mg 処方,0,0.6419212772696621,0.35807872273033803,0,0.00010865815528933967,0.9998913418447106,0,0.7683266187544705,0.23167338124552952,0,0.9997306509837424,0.00026934901625759276,1,0.17695273458957672,0.8561023473739624,1,0.2185651957988739,0.8487194180488586,1,0.38009867438141715,0.6199013256185829,1
2181,2022年4月8日血液検査で好酸球増多と炎症反応あり、血管炎由来の末梢神経障害として入院、入院後も正中神経障害、腓骨神経障害は進行していた。,0 年 0 月 0 日 血液検査 だ 好酸球増多 炎症反応 ある 血管炎由来 の 末梢神経障害 入院 入院 後 正中神経障害 腓骨神経障害 進行 する いる た,1,0.016681280758318293,0.9833187192416815,1,0.000332097177210058,0.9996679028227899,1,0.029995513427179765,0.9700044865728202,1,0.29029060822958297,0.709709391770417,1,0.07407426834106445,0.9442003965377808,1,0.18546868860721588,0.8673996329307556,1,0.007558779338226502,0.9924412206617734,1
2182,CDCガイドラインのワクチン後心筋炎の定義を満たし、他に胸痛の代替診断がないことから本剤接種後の心筋炎と診断し、同日当科に緊急入院となった。,CDC ガイドライン ワクチン 後 心筋炎 定義 満たす 他 胸痛 代替 診断 ない こと 本 剤 接種 後 心筋炎 診断 日当 科 緊急入院 なる た,1,0.02110604664628548,0.9788939533537147,1,0.0003339120090761135,0.9996660879909239,1,0.026778175737193433,0.9732218242628066,1,0.15053371567959906,0.8494662843204009,1,0.12139204889535904,0.9162260293960571,1,0.20652708411216736,0.8519503474235535,1,0.006414535189296064,0.9935854648107039,1
2183,患者はワクチン接種部位リンパ節腫脹(腋窩リンパ節症/リンパ節はワクチン関連リンパ節症と診断された)(重篤区分:その他医学的に重要)を呈した。,患者 ワクチン接種 部位 リンパ節腫脹 腋窩 リンパ節症 リンパ節 ワクチン 関連 リンパ節症 診断 する れる た 重篤 区分 その他 医学 的 重要 呈す た,1,0.015688092022245297,0.9843119079777546,1,0.00040836157496402104,0.999591638425036,1,0.02309041540294099,0.976909584597059,1,0.0005840706808335483,0.9994159293191665,1,0.08523877710103989,0.9392261505126953,1,0.213931143283844,0.8556495904922485,1,0.004424498867630225,0.9955755011323698,1
2184,個々の筋線維の活動電位の合計(CMPA)や神経線維の活動電位の合計(SNAP)共に低下していたため、慢性炎症性脱髄性多発神経炎の再燃と診断。,個々 筋 線維 活動電位 合計 CMPA 神経線維 活動電位 合計 SNAP 低下 する いる た ため 慢性炎症性 脱髄性 多発神経炎 再燃 診断,1,0.016684386667783175,0.9833156133322168,1,0.00033006802294417026,0.9996699319770558,1,0.051097489811712915,0.9489025101882871,1,0.00017461971612109384,0.9998253802838789,1,0.10446775704622269,0.9335389137268066,1,0.19458994269371033,0.8624407052993774,1,0.004677286941408694,0.9953227130585914,1
2185,神経局在診断としては、腕神経叢レベルであり、高度の疼痛が先行しながらPatchyな筋力低下、感覚障害が出現しており、腕神経叢炎と診断された。,神経 局在 診断 腕神経叢 レベル だ ある 高度 疼痛 先行 する Patchy だ 筋力低下 感覚障害 出現 する おる 腕神経叢炎 診断 する れる た,1,0.012069611009210213,0.9879303889907897,1,0.0004342140016410553,0.999565785998359,1,0.059579050232285824,0.9404209497677142,1,0.17481423660257933,0.8251857633974207,1,0.07884775102138519,0.9473878741264343,1,0.18662384152412415,0.8704288005828857,1,0.006314633799205073,0.9936853662007948,1
2186,2021/06/30 16:00(ワクチン接種の1日後)、患者は腎不全を発症、肺水腫及び心不全の増悪も発症して、同日報告病院に入院となった。,0 0 0 0 0 ワクチン接種 0 日 後 患者 腎不全 発症 肺水腫 心不全 の 増悪 発症 する 同日 報告 病院 入院 なる た,1,1.6612819573275243e-05,0.9999833871804267,1,0.0005395798814123636,0.9994604201185876,1,0.01707403329686108,0.9829259667031389,1,0.10466216137138895,0.895337838628611,1,0.07793765515089035,0.946999728679657,1,0.1791701316833496,0.8732739090919495,1,0.004875811080779006,0.9951241889192209,1
2187,3回目ワクチン接種翌日から摂氏39度台の発熱、倦怠感、消化器系障害あり、それらの症状が落ち着いてきたころに患者は腕の内出血が気になり始めた。,0回目 ワクチン接種 翌日 摂氏 0度 台 発熱 倦怠感 消化器 系 障害 ある それら 症状 落ち着く くる た ころ 患者 腕 内出血 気 なる 始める た,1,0.011760023662939168,0.9882399763370607,1,0.0003952280369397298,0.9996047719630603,1,0.008902987163278642,0.9910970128367214,1,0.04562480146534831,0.9543751985346517,1,0.07776488363742828,0.9501984119415283,1,0.18551082909107208,0.8584490418434143,1,0.004442853571146139,0.9955571464288537,1
2188,"血液検査にてトロポニンI 3,445.3 ng/mL、CK 267 U/L、CK-MB 21 U/L、CRP 3.80 mg/dLと上昇。",血液検査 トロポニン I 0 0 0 NG mL CK 0 U L CK MB 0 U L CRP 0 0 mg dL 上昇,0,0.6424932433411243,0.35750675665887566,1,0.00017085604828851185,0.9998291439517115,1,0.26737687254754416,0.7326231274524558,1,6.917003936290911e-08,0.9999999308299606,1,0.09128522872924805,0.9418507814407349,1,0.19180408120155334,0.8709027767181396,1,0.02390243600205542,0.9760975639979445,1
2189,採血ではトロポニンT 0.568 ng/mL、CK 486 U/L、CK-MB 34 U/L、CRP 2.65 mg/dLの上昇を認めた。,採血 トロポニン T 0 0 NG mL CK 0 U L CK MB 0 U L CRP 0 0 mg dL 上昇 認める た,1,0.07499597688759306,0.9250040231124069,1,0.0002212492887525724,0.9997787507112474,1,0.07047573291824483,0.9295242670817552,1,0.021020807960034915,0.9789791920399651,1,0.07766221463680267,0.946420431137085,1,0.18436618149280548,0.8749356865882874,1,0.005346777105616334,0.9946532228943837,1
2190,接種から101?日後の免疫抑制療法中止後、心筋炎をモニターするために2回目の心内膜心筋標本採取を行い、残存する軽度のリンパ球浸潤を認めた。,接種 0 日後 免疫抑制 療法 中止 後 心筋炎 モニター する ため 0回目 心内膜 心筋 標本 採取 行う 残存 する 軽度 リンパ球浸潤 認める た,1,0.016680000214485326,0.9833199997855145,1,0.00026446252652471156,0.9997355374734753,1,0.015221724523364233,0.9847782754766358,1,0.027867573986735783,0.9721324260132642,1,0.09771174192428589,0.9342362284660339,1,0.23957468569278717,0.831603467464447,1,0.0049250396509400805,0.9950749603490598,1
2191,ヘノッホ・シェーンライン紫斑病性腎炎、ヘノッホ・シェーンライン紫斑病、点状出血、尿中蛋白陽性、尿潜血、の結果として、治療的処置がとられた。,ヘノッホ・シェーンライン紫斑病 性 腎炎 ヘノッホ・シェーンライン紫斑病 点状 出血 尿中蛋白 陽性 尿潜血 結果 治療 的 処置 とる れる た,1,2.830774594021435e-06,0.9999971692254059,1,0.0005492630722143576,0.9994507369277856,1,0.002581244253709758,0.9974187557462902,1,0.11267748756939933,0.8873225124306007,1,0.08560378104448318,0.9377270340919495,1,0.18758419156074524,0.8732839226722717,1,0.004936247735720757,0.9950637522642793,1
2192,2022/05/09、患者は自己免疫性溶血性貧血を発現し、重篤(重篤性基準:入院/入院期間の延長)と評価され、救急治療室への来院を要した。,0 0 0 患者 自己免疫性 溶血性 貧血 発現 重篤 重篤性 基準 入院 入院 期間 延長 評価 する れる 救急 治療 室 来院 要す た,1,0.004007004538854459,0.9959929954611455,1,0.0005618620671926982,0.9994381379328073,1,0.0044422089832169,0.9955577910167831,1,0.024614500661364835,0.9753854993386352,1,0.0850130245089531,0.945862352848053,1,0.1993761658668518,0.8567031621932983,1,0.00427398634028806,0.995726013659712,1
2193,2021/04/07の2回目のワクチン接種後、アトピー性皮膚炎のような発疹が発現し、長期にステロイド外用や抗ヒスタミン内服が必要となった。,0 0 0 0回目 ワクチン接種 後 アトピー性 皮膚炎 の よう 発疹 発現 長期 ステロイド 外用 ヒスタミン 内服 必要 なる た,1,0.07083627084308781,0.9291637291569124,1,0.00021777121776139698,0.9997822287822387,1,0.012917040511001177,0.9870829594889988,1,0.26899093174794875,0.7310090682520513,1,0.09732452780008316,0.9295166730880737,1,0.18303227424621582,0.8691561222076416,1,0.008062855532753588,0.9919371444672465,1
2194,2022/02/27、頭痛を発現した(夜間救急医療サービス受診)、頭部CT、上顎洞にのう胞(疑い)、(前頭部に始まり、右こめかみに疼痛)。,0 0 0 頭痛 発現 した 夜間 救急医療 サービス 受診 頭部 C，T 上顎 洞 のう胞 疑い 頭部 始まる 右 こめかみ 疼痛,1,0.004005589003511321,0.9959944109964884,1,0.00038651483690421766,0.9996134851630958,1,0.004162237001081093,0.9958377629989189,1,0.0011361262606313094,0.9988638737393687,1,0.07968918979167938,0.9471863508224487,1,0.18315355479717255,0.8807843923568726,1,0.0038888434117813598,0.9961111565882187,1
2195,新型コロナワクチン接種後、15分観察中に胸部不快感訴え検脈にて脈不整を認めたため心電図検査すると、以前認めていない心室性期外収縮を認めた。,新型コロナ ワクチン接種 後 0分 観察 中 胸部不快感 訴える 検 脈 脈不整 認める た ため 心電図 検査 する 以前 認める いる ない 心室性期外収縮 認める た,1,0.016659518281263816,0.9833404817187359,1,0.0003736681428540857,0.9996263318571459,1,0.01920655865303289,0.9807934413469671,1,0.004401353445556477,0.9955986465544435,1,0.07683409005403519,0.9479800462722778,1,0.17613248527050018,0.8665817379951477,1,0.004150724529337461,0.9958492754706626,1
2196,リンパ球浸潤はわずかであり、心筋炎の組織学的基準を満たさなかったが、心筋細胞損傷、間質性浮腫並びに血管周囲及び間質性線維症が認められた。,リンパ球浸潤 だ ある 心筋炎 組織 学 的 基準 満たす ない た 心筋細胞 損傷 間質性 浮腫 血管 周囲 間質性 線維 症 認める られる た,1,0.03817969723433135,0.9618203027656687,1,0.0004399304889247199,0.9995600695110752,1,0.2600740753937918,0.7399259246062082,1,0.06922625148114181,0.9307737485188582,1,0.07816851884126663,0.9435052275657654,1,0.1832180768251419,0.8623183369636536,1,0.008093263328112416,0.9919067366718876,1
2197,診察時、左棘下筋及び橈骨神経支配筋の軽度の筋力低下、左肩から上腕の疼痛、左橈骨神経及び正中神経支配領域のしびれ、温痛覚低下が認められた。,診察 時 左 棘下筋 橈骨 神経 支配 筋 軽度 筋力低下 左肩 上腕 疼痛 左 橈骨 神経 正中神経支配領域 の しびれ 温痛覚 低下 認める られる た,1,0.01060623722690631,0.9893937627730935,1,0.0003840887607969424,0.999615911239203,1,0.011686438912747232,0.9883135610872528,1,0.17575314370975725,0.8242468562902427,1,0.08078361302614212,0.9488590955734253,1,0.19129225611686707,0.8584907054901123,1,0.0058327659470989975,0.994167234052901,1
2198,被害妄想、嫉妬妄想が出現し、家族を刃物で追いかけたり、ガラスを割ったりなどしたため、クエチアピン25 mgを処方されたが効果は得られず。,被害 妄想 嫉妬妄想 出現 家族 刃物 追いかける ガラス 割る する た ため クエチアピン 0 mg 処方 する れる た 効果 得る られる ぬ,1,0.035002423140193875,0.964997576859806,1,0.00018098167958242452,0.9998190183204175,1,0.033452863210578276,0.9665471367894217,1,0.22280155688149605,0.777198443118504,1,0.11338641494512558,0.9140146374702454,1,0.2781294584274292,0.7738673686981201,1,0.008893595548270586,0.9911064044517294,1
2199,"IL-6濃度47.5 pg/mLを認めた、血管内、notes:内皮増殖因子5520 pg/mL,血小板関連IgG(PAIgG)の陽性結果",IL 0 濃度 0 0 PG mL 認める た 血管 内 notes 内皮 増殖 因子 0 PG mL 血小板 関連 IgG PAIgG 陽性 結果,1,0.007763866460120529,0.9922361335398794,1,0.00039789116797324186,0.9996021088320267,1,0.011207872316340461,0.9887921276836595,1,0.12091973570417236,0.8790802642958276,1,0.09072022140026093,0.9366469383239746,1,0.18628615140914917,0.8704289197921753,1,0.00522277081124994,0.99477722918875,1
2200,トロポニンIの軽度上昇、胸部X線での肺うっ血像、心エコーでの心嚢液貯留およびLVEFの軽度低下から心筋炎を疑われ報告病院に転院となった。,トロポニン I 軽度 上昇 胸部 X線 肺うっ血像 心 エコー 心嚢液 貯留 LVEF 軽度低下 心筋炎 疑う れる 報告 病院 転院 なる た,1,0.0281071003508866,0.9718928996491136,1,0.00028863055998623165,0.9997113694400138,1,0.031230832584810075,0.9687691674151899,1,0.11290294221530095,0.887097057784699,1,0.09246030449867249,0.9374828934669495,1,0.18541772663593292,0.8715987205505371,1,0.005562417202666159,0.994437582797334,1
2201,筋力異常:頸部、注記:屈筋、上肢の遠位から近位筋、下肢の近位筋肉にMMT4レベルの筋力低下があり、握力は右9 kg左9.5 kgだった。,筋力異常 頸部 注記 屈筋 上肢 遠い 位 位 筋 下肢 位 筋肉 MMT 0 レベル 筋力低下 ある 握力 右 0 kg 左 0 0 kg だ た,1,0.020244448704134527,0.9797555512958657,1,0.0003752016572148335,0.9996247983427852,1,0.13767265278939456,0.8623273472106054,1,0.32137653728104143,0.6786234627189586,1,0.08214055746793747,0.9342772364616394,1,0.1945953518152237,0.8684701323509216,1,0.010285577392778267,0.9897144226072218,1
2202,陽電子放出断層撮影:(不明日)左上葉腫瘤、メモ:最大20.44の標準化取込値(SUV)の集積の亢進と、左肺門リンパ節の集積が認められた。,陽電子放出 断層 撮影 明日 左上葉腫瘤 メモ 最大 0 0 標準化 取り込み 値 SUV 集積 亢進 左 肺門 リンパ節 集積 認める られる た,1,0.016649465653048152,0.9833505343469516,1,0.00032697352541440533,0.9996730264745856,1,0.046659029801515595,0.9533409701984844,1,0.13838830653066503,0.861611693469335,1,0.08526232838630676,0.9361302852630615,1,0.20250625908374786,0.8592466115951538,1,0.006038392434926133,0.9939616075650739,1
2203,患者はさらに呼吸に関連した胸痛を呈し、心膜炎が疑われたため、心膜炎の再発リスクを減らすためにcolchicineによる治療が行われた。,患者 呼吸 関連 する た 胸痛 呈す 心膜炎 疑う れる た ため 心膜炎 再発 リスク 減らす ため colchicine 治療 行う れる た,1,0.0038133526474553826,0.9961866473525446,1,0.000414278966740453,0.9995857210332596,1,0.007115621108844561,0.9928843788911554,1,0.09179900595011659,0.9082009940498834,1,0.08875241875648499,0.9378911256790161,1,0.2232706993818283,0.8505097031593323,1,0.005116814794999006,0.994883185205001,1
2204,血液検査にてトロポニンT 0.609 ng/mL、CK 823 U/L、CK-MB 47 U/L、CRP 1.96 mg/dLと上昇。,血液検査 トロポニン T 0 0 NG mL CK 0 U L CK MB 0 U L CRP 0 0 mg dL 上昇,0,0.6424932433411243,0.35750675665887566,1,0.00016371422831144833,0.9998362857716886,1,0.26737687254754416,0.7326231274524558,1,2.280362043638462e-08,0.9999999771963796,1,0.09079766273498535,0.9420053958892822,1,0.19076557457447052,0.8710251450538635,1,0.023860069972045605,0.9761399300279545,1
2205,女性患者が、新型コロナウイルスmRNAワクチン(商品名不明)接種後にHyper-inflammatory syndromeを発症した。,女性患者 新型コロナウイルス mRNA ワクチン 商品名 不明 接種 後 Hyper inflammatory Syndrome 発症 する た,1,0.06785212891326173,0.9321478710867381,1,0.0002760974298463747,0.9997239025701536,1,0.14901040566253598,0.850989594337464,1,0.11145929141407385,0.8885407085859262,1,0.09389873594045639,0.9395055174827576,1,0.18087202310562134,0.8627263903617859,1,0.007612928513708353,0.9923870714862916,1
2206,心電図(ECG)によると、今年の健康診断の結果に出たECG所見と比較したところ、洞徐脈及び新しいST-T区域の異常な変化が認められた。,心電図 ECG よる 今年 健康 診断 結果 出る た ECG 所見 比較 する た ところ 洞徐脈 新しい ST T 区域 異常 だ 変化 認める られる た,1,0.013171461164785306,0.9868285388352146,1,0.00033099287015482884,0.9996690071298452,1,0.010471433697106791,0.9895285663028932,1,0.017383240321796944,0.9826167596782031,1,0.08887651562690735,0.9398249983787537,1,0.1885032057762146,0.8654796481132507,1,0.004298374683849233,0.9957016253161508,1
2207,男性患者が、新型コロナウイルスmRNAワクチン(商品名不明)接種後にHyper-inflammatory syndromeを発症した。,男性 患者 新型コロナウイルス mRNA ワクチン 商品名 不明 接種 後 Hyper inflammatory Syndrome 発症 する た,1,0.05935076675013644,0.9406492332498635,1,0.0002885780989890076,0.999711421901011,1,0.1585020390305113,0.8414979609694887,1,0.10660806907161158,0.8933919309283884,1,0.08978088200092316,0.9418826103210449,1,0.18567509949207306,0.8630173206329346,1,0.007540145802342777,0.9924598541976573,1
2208,2021/11/02 20:00頃より、胸痛が出現し、翌日も持続しており、2021/11/03 07:00頃、患者は本病院を受診した。,0 0 0 0 0 頃 胸痛 出現 翌日 持続 する おる 0 0 0 0 0 頃 患者 病院 受診 する た,1,9.756285265658524e-06,0.9999902437147342,1,0.0004877834180320549,0.999512216581968,1,0.0034439075454548718,0.9965560924545451,1,0.14537637884579857,0.8546236211542014,1,0.07360269129276276,0.9506039023399353,1,0.18294085562229156,0.8725512027740479,1,0.005127604429280108,0.9948723955707199,1
2209,皮膚生検:フィブリン血栓、注記:毛細管から細静脈レベルでは発熱と高sIL-2R(1340IU/L)精査目的の皮膚生検によって指摘された,皮膚生検 フィブリン血栓 注記 毛細管 細静脈 レベル 発熱 sIL 0 R 0 IU L 精査 目的 皮膚生検 指摘 する れる た,1,0.007589636208721456,0.9924103637912787,1,0.00044479695791229827,0.9995552030420877,1,0.017804502720247917,0.9821954972797521,1,0.16869645004497036,0.8313035499550296,1,0.0911598950624466,0.9322456121444702,1,0.18556492030620575,0.8751243948936462,1,0.005814468734674745,0.9941855312653253,1
2210,8月31日にCr 1.47 mg/dLまで上昇、発熱、倦怠感、体重減少、CRP 11 mg/dL、咳嗽、両下肢・右手のしびれも出現。,0 月 0 日 Cr 0 0 mg dL 上昇 発熱 倦怠感 体重減少 CRP 0 mg dL 咳嗽 下肢 右手のしびれ 出現,1,9.073491439408522e-07,0.9999990926508561,1,0.00033234893845606643,0.999667651061544,1,0.008047747027668306,0.9919522529723317,1,0.002503002319591441,0.9974969976804086,1,0.08410204201936722,0.9459492564201355,1,0.183174267411232,0.8712669610977173,1,0.003957521750201859,0.9960424782497982,1
2211,その6日後より複視が出現、その後日内変動を伴う眼瞼下垂、首下がり、両上肢拳上困難も出現したため8月上旬に当院脳神経内科初診となった。,0 日 後 複視 出現 その後 日内変動 伴う 眼瞼下垂 首 下がる 上肢 拳上困難 出現 する た ため 0 月 上旬 院 脳神経 内科 初診 なる た,1,0.009406449299457708,0.9905935507005422,1,0.0004541091031166916,0.9995458908968833,1,0.011013977294467625,0.9889860227055324,1,0.06568124312143275,0.9343187568785672,1,0.07855923473834991,0.9461009502410889,1,0.18551868200302124,0.8737724423408508,1,0.004574449740645536,0.9954255502593545,1
2212,患者は頚静脈血栓症(左内頚静脈血栓)(重篤区分:医学的に重要)及び肺塞栓症(末梢性肺血栓塞栓症)(重篤区分:医学的に重要)を呈した。,患者 頚静脈血栓症 左内頚静脈血栓 重篤 区分 医学 的 重要 及ぶ 肺塞栓症 末梢 性 肺血栓 塞栓症 重篤 区分 医学 的 重要 呈す た,1,0.010183063671259962,0.9898169363287402,1,0.00041423430716128857,0.9995857656928387,1,0.023572846234151235,0.9764271537658488,1,0.030132485272017284,0.9698675147279827,1,0.07547374814748764,0.9420778751373291,1,0.2513105273246765,0.8414523601531982,1,0.004829646281899649,0.9951703537181003,1
2213,2022/02/08、当院で採血したところTSHの低下、FT4、FT3の上昇を認め、バセドウ病の増悪と考え、従来の主治医に相談した。,0 0 0 院 採血 する た ところ TSH 低下 FT 0 FT 0 上昇 認める バセドウ病 の 増悪 考える 従来 主治医 相談 する た,1,5.120128835858293e-07,0.9999994879871165,1,0.000563045633162038,0.999436954366838,1,0.0009776676573483023,0.9990223323426517,1,0.30422942124565056,0.6957705787543494,1,0.09474872797727585,0.9261795282363892,1,0.185663104057312,0.8641380667686462,1,0.007403550748854045,0.9925964492511459,1
2214,心筋炎、発熱、胸痛、血中クレアチンホスホキナーゼ増加、トロポニンT増加、炎症により、患者は入院が必要となった(入院期間: 5日間)。,心筋炎 発熱 胸痛 血 中 クレアチンホスホキナーゼ 増加 トロポニン T 増加 炎症 患者 入院 必要 なる た 入院 期間 0 日間,1,1.248450315180573e-05,0.9999875154968482,1,0.0004750902253923407,0.9995249097746076,1,0.004404720114577931,0.9955952798854221,1,0.003706377700180119,0.9962936222998199,1,0.08326061069965363,0.9469194412231445,1,0.18719948828220367,0.8661812543869019,1,0.0039682922587053505,0.9960317077412947,1
2215,2015/04、患者はプライバシー病院にて頸髄脊椎症性脊髄症で外科手術を受けた後、両手の痺れと痛み、足踵のしびれ、頚椎症が出現した。,0 0 患者 プライバシー 病院 頸髄 脊椎症 性 脊髄症 外科 手術 受ける た 後 両手 痺れ 痛み 足 踵 しびれ 頚椎症 出現 する た,1,0.012797158187477752,0.9872028418125224,1,0.0003775173951025774,0.9996224826048974,1,0.008989549424752052,0.991010450575248,1,0.14703158183162568,0.8529684181683743,1,0.0763477012515068,0.9461290240287781,1,0.18005192279815674,0.8702594041824341,1,0.0053697100344444115,0.9946302899655556,1
2216,2022/02/01から2022/02/03までの発熱(最高値摂氏38.5度)を含む、安静時の重度の全身疾患を示す臨床徴候があった。,0 0 0 0 0 0 発熱 最高値 摂氏 0 0度 含む 安静 時 重度 全身 疾患 示す 臨床徴候 ある た,1,0.01671942689222863,0.9832805731077714,1,0.00025807319389269877,0.9997419268061073,1,0.019026183207239256,0.9809738167927607,1,0.21982788462574676,0.7801721153742532,1,0.08267606049776077,0.9497936367988586,1,0.17702588438987732,0.8707584142684937,1,0.006373662389305699,0.9936263376106942,1
2217,2022/03/13 15:30(ワクチン接種の16日15時30分後)、頭痛が増強し、病院に救急搬送され、くも膜下出血と診断された。,0 0 0 0 0 ワクチン接種 0 日 0時 0分 後 頭痛 増強 病院 救急搬送 する れる くも膜下出血 診断 する れる た,1,0.00303703111712878,0.9969629688828712,1,0.0005078765957897749,0.9994921234042102,1,0.03482861371704238,0.9651713862829576,1,0.2230988788120808,0.7769011211879192,1,0.07361321151256561,0.9471649527549744,1,0.1758575737476349,0.876766562461853,1,0.006358929944327319,0.9936410700556726,1
2218,感覚鈍麻、歩行障害、感覚障害、発熱のため入院した(開始日: 2022/05/16、退院日:2022/05/28、入院期間:12日)。,感覚鈍麻 歩行障害 感覚障害 発熱 ため 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.0030111472268539306,0.9969888527731459,1,0.0003664320603312653,0.9996335679396687,1,0.007815457073714893,0.9921845429262851,1,8.676047677591558e-05,0.9999132395232241,1,0.08364757895469666,0.9461666941642761,1,0.18426643311977386,0.866403341293335,1,0.0039815427074224715,0.9960184572925774,1
2219,腹部コンピュータ断層撮影:小腸部分全体で炎症性の変化が認められた、注記:小腸壁の肥厚、体液貯留および小腸周辺の腸間膜の脂肪密度の増加,腹部 コンピュータ断層撮影 小腸 部分 全体 だ 炎症性 変化 認める られる た 注記 小腸 壁 肥厚 体液貯留 小腸 周辺 腸間膜 脂肪 密度 増加,1,0.020556312228084857,0.9794436877719153,1,0.00023685560301002931,0.99976314439699,1,0.04702997664772601,0.952970023352274,1,7.79063285615278e-05,0.9999220936714385,1,0.09941254556179047,0.9287722706794739,1,0.20330113172531128,0.8633608818054199,1,0.004708729164866742,0.9952912708351332,1
2220,アナフィラキシー反応、不快感、意識レベルの低下、呼吸困難、末梢冷感、冷汗、血圧低下、心拍数減少の結果として、治療的な処置がとられた。,アナフィラキシー反応 不快感 意識レベルの低下 呼吸困難 末梢冷感 冷汗 血圧低下 心拍数 減少 結果 治療 的 だ 処置 とる れる た,1,0.012299793902052223,0.9877002060979478,1,0.00037211891697696696,0.999627881083023,1,0.024067649152557102,0.9759323508474429,1,0.09331868176282532,0.9066813182371747,1,0.08227277547121048,0.9442972540855408,1,0.19520379602909088,0.8690266013145447,1,0.005088195748375647,0.9949118042516244,1
2221,03:25当院搬送時、BP 143/102、HR 129、BT 36.0、リバーザー8 LでSp02 95%と酸素化低下を認めた。,0 0 院 搬送 時 BP 0 0 HR 0 BT 0 0 リバーザー 0 L Sp 0 0% 酸素化低下 認める た,1,0.006182811536825663,0.9938171884631744,1,0.00033728811406559593,0.9996627118859344,1,0.010483340875527047,0.989516659124473,1,0.01578118319153632,0.9842188168084637,1,0.07426907867193222,0.9493348002433777,1,0.18669237196445465,0.874340295791626,1,0.004081729511659148,0.9959182704883409,1
2222,2022/02/21 13:00頃運動性メインの失語症を発症し、頭部MRI検査で左中大脳動脈遠位の塞栓を認め、心原性脳梗塞と診断。,0 0 0 0 0 頃 運動性 メイン 失語症 発症 頭部 MRI 検査 だ 左中大脳動脈 遠い 位 塞栓 認める 心原性脳梗塞 診断,1,0.0072588586196164545,0.9927411413803833,1,0.0003941218144000841,0.9996058781855999,1,0.008255673017565579,0.9917443269824344,1,1.1678577289342407e-05,0.9999883214227107,1,0.08539685606956482,0.9398979544639587,1,0.18640683591365814,0.8716438412666321,1,0.004038249934568415,0.9959617500654316,1
2223,21歳男性が、SARSコロナウイルス2に対し2回目mRNAワクチン(商品名不明)接種31時間後に胸痛と発熱(38.8度)を訴えた。,0歳 男性 SARS コロナウイルス 0 0回目 mRNA ワクチン 商品名 不明 接種 0時 間 後 胸痛 発熱 0 0度 訴える た,1,0.013329736811710373,0.9866702631882897,1,0.00037790578428527474,0.9996220942157147,1,0.0021116968701078154,0.9978883031298922,1,0.003334327892621003,0.996665672107379,1,0.07954155653715134,0.9505268931388855,1,0.1841932088136673,0.873016893863678,1,0.003983901968827388,0.9960160980311726,1
2224,CT所見は両肺にびまん性のすりガラスがあり、特発性肺腺維症の急性増悪と考え、ステロイドバルス両方を開始するも病状は悪化をたどった。,C，T 所見 両肺 びまん性 すりガラス ある 特発性 肺 腺 維 症 急性増悪 考える ステロイドバルス 両方 開始 する 病状 悪化 たどる た,1,0.01097983790604045,0.9890201620939594,1,0.0003936861795978337,0.9996063138204022,1,0.10014128465983707,0.8998587153401629,1,0.04991960689487562,0.9500803931051244,1,0.0961122214794159,0.9320412278175354,1,0.19108907878398895,0.8650232553482056,1,0.005557718637939086,0.994442281362061,1
2225,"以下の臨床検査および処置が実施された: SARS-CoV-2 test: (2022/07/06)陽性,注記:鼻咽頭ぬぐい液より。",以下 臨床検査 お呼び 処置 実施 する れる た SARS CoV 0 test 0 0 0 陽性 注記 鼻 咽頭 ぬぐ 胃液,1,0.026445390745236337,0.9735546092547638,1,0.0002917374617341077,0.999708262538266,1,0.04502078465966708,0.9549792153403329,1,2.338906375731753e-05,0.9999766109362427,1,0.17924907803535461,0.8976860046386719,1,0.318763792514801,0.7740963101387024,1,0.00649499744599471,0.9935050025540052,1
2226,循環器内科医診察し、CPK 766 U/L、CK-MB 51 U/L、CRP 2.5 mg/dLの上昇、心電図でST上昇を認めた。,循環器 内科医 診察 CPK 0 U L CK MB 0 U L CRP 0 0 mg dL 上昇 心電図 ST 上昇 認める た,1,0.0081400531148991,0.991859946885101,1,0.00033505096442601473,0.999664949035574,1,0.02224860718770827,0.9777513928122917,1,0.014461183958665247,0.9855388160413348,1,0.07850835472345352,0.9479008913040161,1,0.18878412246704102,0.8774625062942505,1,0.0042031830519763695,0.9957968169480236,1
2227,心筋逸脱酵素の上昇を認めず心エコーで異常はなかったが、心電図で広範な誘導にST上昇を認めたため急性心膜炎を疑われ緊急入院となった。,心筋逸脱酵素 上昇 認める ぬ 心 エコー 異常 ない た 心電図 広範 だ 誘導 ST 上昇 認める た ため 急性心膜炎 疑う れる 緊急入院 なる た,1,0.03070922694103355,0.9692907730589665,1,0.0005031909256700162,0.99949680907433,1,0.05440901966507383,0.9455909803349262,1,0.01150546735525515,0.9884945326447448,1,0.07584382593631744,0.947808563709259,1,0.1912451982498169,0.8643324971199036,1,0.004721959721778486,0.9952780402782215,1
2228,2022/01/03、患者は免疫性血管自律神経障害、起立性低血圧、四肢筋力低下と嚥下障害、神経痛性筋萎縮症スペクトラムを発症した。,0 0 0 患者 免疫性 血管 自律神経障害 起立性 低血圧 四肢筋力低下 嚥下障害 神経痛 性 筋萎縮症 スペクトラム 発症 する た,1,0.01655732906541798,0.9834426709345819,1,0.0003784552360312456,0.9996215447639688,1,0.020965234477677064,0.9790347655223229,1,0.12613949710538264,0.8738605028946174,1,0.08192839473485947,0.94564288854599,1,0.17962121963500977,0.8734888434410095,1,0.005327660917603793,0.9946723390823962,1
2229,事象「発熱(摂氏38-40/40.7度)」、「高熱(摂氏40.4度)」、「咳嗽/咳嗽増悪」及び「下痢/水様便」は来院を必要とした。,事象 発熱 摂氏 0 0 0 0度 高熱 摂氏 0 0度 咳嗽 咳嗽 増悪 下痢 水様便 来院 必要 する た,1,1.5724341142158492e-06,0.9999984275658858,1,0.0004355712944572099,0.9995644287055427,1,0.009057678481409481,0.9909423215185905,1,0.21362312508516346,0.7863768749148365,1,0.0729939192533493,0.9504825472831726,1,0.1797482669353485,0.874988853931427,1,0.005902300385335633,0.9940976996146643,1
2230,2021/08/22核酸検出検査(PCR法、LAMP法)にて、COVID-19病原体(SARS-CoV-2)検査を実施し、陽性。,0 0 0 核酸 検出 検査 PCR法 LAMP法 COVID 0 病原体 SARS CoV 0 検査 実施 する 陽性,1,0.05042658640331253,0.9495734135966876,1,0.00023484317975639023,0.9997651568202436,1,0.221303843769471,0.778696156230529,1,2.1438400388262835e-08,0.9999999785615996,1,0.24975454807281494,0.8473027944564819,1,0.5224524736404419,0.5958908796310425,1,0.015874239396271292,0.9841257606037287,1
2231,2022/05/13再診にてCPK、CK-MBの低下、トロポニンT陽性、心電図でのSTの緩和が認められ、本剤による副反応と診断。,0 0 0 再診 CPK CK MB 低下 トロポニン T 陽性 心電図 ST 緩和 認める られる 本 剤 副反応 診断,1,2.4287607876136848e-06,0.9999975712392123,1,0.00047739260842676994,0.9995226073915733,1,0.0060493304378193,0.9939506695621807,1,2.794049436261048e-10,0.9999999997205951,1,0.11270836740732193,0.9347977042198181,1,0.18243847787380219,0.8722398281097412,1,0.004074873477356211,0.9959251265226438,1
2232,2022/05/23定期受診の際、胸部レントゲンで著明な心拡大を認め、心臓超音波で僧帽弁閉鎖不全症の増悪、三尖弁の逆流を認めた。,0 0 0 定期 受診 際 胸部 レントゲン 著 明 だ 心拡大 認める 心臓 超音波 だ 僧帽弁閉鎖不全症 の 増悪 三 尖る 弁 逆流 認める た,1,0.01670310985536372,0.9832968901446364,1,0.0003127439199136945,0.9996872560800864,1,0.0134990532630197,0.9865009467369803,1,0.026035605751123958,0.973964394248876,1,0.07840217649936676,0.948081910610199,1,0.18473049998283386,0.8736220598220825,1,0.004297263767731118,0.9957027362322688,1
2233,しかしその後も前日の疼痛がのこったようで、食欲もなく、つよい痛みでもなかったようで家人により鎮痛剤の投薬が行われ経過観察された。,その後 前日 疼痛 のこる た よう だ 食欲 ない つよい 痛み だ ない た よう 家人 よる 鎮痛 剤 投薬 行う れる 経過 観察 する れる た,1,0.016691019805603176,0.9833089801943969,0,0.00015643164455465545,0.9998435683554453,0,0.6156695566596443,0.3843304433403557,1,0.13528719107720566,0.8647128089227943,1,0.2253797948360443,0.8690412044525146,1,0.3907225430011749,0.6400166153907776,1,0.03365539665170576,0.9663446033482943,1
2234,症例1患者は無症候性血尿のフォロー中、COVID-19ワクチン接種後(製品名不明)に免疫グロブリンA腎症(IgAN)を発症した。,症例 0 患者 無症候性 血尿 フォロー 中 COVID 0 ワクチン接種 後 製品 名 不明 免疫グロブリン A 腎症 IgAN 発症 する た,1,0.028794864690489565,0.9712051353095102,1,0.0002687950491162943,0.9997312049508837,1,0.09256279127552347,0.9074372087244765,1,0.10820255801989054,0.8917974419801095,1,0.08842550963163376,0.9417909383773804,1,0.19325681030750275,0.8626689314842224,1,0.00628603103680133,0.9937139689631987,1
2235,血小板減少の原因としてPAIgGが70.8ng/10M個と陽性であり、ADAMTS13活性は正常で免疫性血小板減少症と診断した。,血小板減少 の 原因 PAIgG 0 0 NG 0 M 個 陽性 だ ある ADAMTS 0 活性 正常 だ 免疫性 血小板減少症 診断 する た,1,0.019304747102971042,0.980695252897029,1,0.00028703453015403686,0.999712965469846,1,0.060486202692863866,0.9395137973071361,1,0.15126633789573463,0.8487336621042654,1,0.10175527632236481,0.9267503023147583,1,0.19614924490451813,0.8757879734039307,1,0.00641968970770709,0.9935803102922929,1
2236,2022/01/30(ワクチン接種の314日後)、被験者の配偶者が発熱し、PCR検査が実施され、COVID-19感染が判明した。,0 0 0 ワクチン接種 0 日 後 被験者 配偶者 発熱 PCR検査 実施 する れる COVID 0 感染 判明 する た,1,0.039563180061536876,0.960436819938463,1,0.0002639876840166383,0.9997360123159834,1,0.08904655257480953,0.9109534474251905,1,0.0939769413455741,0.9060230586544259,1,0.12200313806533813,0.934315025806427,1,0.18549662828445435,0.8646963834762573,1,0.006395082532338997,0.9936049174676611,1
2237,4回目ワクチン接種後7-8時間後から、発熱症状に加え、食思不振、左耳の一過性難聴、めまい、倦怠感、声が出なくなる症状が発現した。,0回目 ワクチン接種 後 0 0時 間 後 発熱症状 加える 食思不振 左 耳 一過性難聴 めまい 倦怠感 声 出る ない なる 症状 発現 する た,1,0.016664692382943585,0.9833353076170565,1,0.0003513432248556845,0.9996486567751444,1,0.02734432475540327,0.9726556752445967,1,0.17240911600865927,0.8275908839913407,1,0.07434307038784027,0.9522872567176819,1,0.17954351007938385,0.8747169971466064,1,0.005826016579489157,0.9941739834205109,1
2238,さらに、本症例では、入院時にケトアシドーシスの急速な進行、比較的低いヘモグロビンAlc値、非常に低い血清C-ペプチド値を認めた。,本 症例 だ 入院 時 ケトアシドーシス 急速 だ 進行 低い ヘモグロビン Alc 値 非常 低い 血清 C ペプチド 値 認める た,1,0.012723565202576377,0.9872764347974238,1,0.00032364907580456474,0.9996763509241955,1,0.04415891997949295,0.955841080020507,1,0.06539167116961508,0.9346083288303849,1,0.07217543572187424,0.9450328946113586,1,0.20231348276138306,0.8535059094429016,1,0.005072408163488284,0.9949275918365117,1
2239,患者は、急性腎障害、炎症(入院日:2022/07/07、退院日: 2022/07/22(入院期間):15日))のために入院した。,患者 急性腎障害 炎症 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日 ため 入院 する た,1,0.04530379967325078,0.9546962003267493,1,0.00033009985766006557,0.9996699001423399,1,0.022958243751349916,0.9770417562486501,1,0.09367250308517272,0.9063274969148273,1,0.07800961285829544,0.9507366418838501,1,0.23145119845867157,0.8462982177734375,1,0.005691663727594575,0.9943083362724053,1
2240,患者は心筋炎、胸痛、発熱、不眠症のために入院した(開始日:2021/12/27、退院日:2021/12/29、入院期間:2日)。,患者 心筋炎 胸痛 発熱 不眠症 ため 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.0032427814823288406,0.9967572185176711,1,0.00033809942777065003,0.9996619005722294,1,0.004652259363374656,0.9953477406366253,1,8.192670240547706e-05,0.9999180732975945,1,0.08102571964263916,0.9480918049812317,1,0.20272593200206757,0.8512263298034668,1,0.004074451575857965,0.9959255484241422,1
2241,心室壁運動低下、QT延長症候群のため(入院日: 2022/04/24、退院日:2022/05/19、入院期間:25日)入院した。,心室壁運動低下 QT 延長症候群 ため 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日 入院 する た,1,0.022576990810268427,0.9774230091897316,1,0.0003442086267732139,0.9996557913732268,1,0.022958243751349916,0.9770417562486501,1,0.10303400485401415,0.8969659951459859,1,0.0801072046160698,0.9496792554855347,1,0.18541719019412994,0.8725669980049133,1,0.00517413795342901,0.994825862046571,1
2242,水溶性ハイドロコートン注射100mg、ポララミン20mg、ファモチジン20mgを点滴し、生理的食塩水注投与し患者は1泊入院した。,水溶性 ハイドロコートン 注射 0m g ポララミン 0m g ファモチジン 0m g 点滴 生理 的 食塩水 投与 する 患者 0 泊 入院 する た,1,0.016680416002165938,0.983319583997834,1,0.00020025677969607797,0.999799743220304,1,0.40263948475129696,0.597360515248703,1,0.24912522157905115,0.7508747784209489,1,0.17502561211585999,0.9004290103912354,1,0.24606269598007202,0.8397059440612793,1,0.018311300148038393,0.9816886998519615,1
2243,右下腿紅斑のためベタメタゾン吉草酸塩(リンデロンーVG、開始日:2021/08/04、中止日:2021/08/10)も投与した。,右下腿紅斑 ため ベタメタゾン 吉草酸 塩 リンデロンー VG 開始 日 0 0 0 中止 日 0 0 0 投与 する た,1,0.043753245208781794,0.9562467547912183,1,0.00021156308146532044,0.9997884369185347,1,0.3372522253640686,0.6627477746359314,1,0.1569525960423741,0.8430474039576259,1,0.24330879747867584,0.8272926211357117,0,0.7330491542816162,0.269670307636261,1,0.04546568543666645,0.9545343145633335,1
2244,2回目のCOVID-19 messenger RNAワクチン(商品名不明)接種後4日目に発熱、呼吸困難感を認め、前医受診した。,0回目 COVID 0 messenger RNA ワクチン 商品名 不明 接種 後 0 日 目 発熱 呼吸 困難感 認める 医 受診 する た,1,0.010827054739436166,0.9891729452605638,1,0.0003841426377848483,0.9996158573622151,1,0.009956546396888477,0.9900434536031115,1,0.1478491930975454,0.8521508069024546,1,0.08257659524679184,0.9491913914680481,1,0.1796121746301651,0.8753353953361511,1,0.005355271875717512,0.9946447281242825,1
2245,カラードップラー超音波検査にて甲状腺右葉優位の腫脹を認め、両葉は血管分布の減少を伴う不均一な低エコー病変が大部分を占めていた。,カラー ドップラー 超音波 検査 甲状腺右葉 優位 腫脹 認める 葉 血管 分布 減少 伴う 均一 だ エコー 病変 大部分 占める いる た,1,0.01668893010010735,0.9833110698998926,1,0.00032842395301144146,0.9996715760469885,1,0.02925497805572963,0.9707450219442704,1,0.30103272276835336,0.6989672772316466,1,0.0884493812918663,0.9349287748336792,1,0.18789073824882507,0.8651804327964783,1,0.00792985568166943,0.9920701443183306,1
2246,クレアチニンホスホキナーゼ(CK)は5692 U/l、トロポニンIは2808.9、CK-MBは151.6 ng/mlであった。,クレアチニンホスホキナーゼ CK 0 U l トロポニン I 0 0 CK MB 0 0 NG ml だ ある た,0,0.6048187270616509,0.395181272938349,1,0.00024131642619870314,0.9997586835738013,0,0.566998608881322,0.43300139111867797,0,0.7310676592745293,0.26893234072547073,0,0.6294825673103333,0.44014522433280945,1,0.22596687078475952,0.8511049747467041,1,0.34761300327112793,0.6523869967288721,1
2247,外来精査の方針となったが、13日目に意識障害及び左片麻痺を呈し緊急搬送、右前頭葉皮質下出血の診断で入院、保存的治療を行なった。,外来 精査 方針 なる た 0 日 目 意識障害 左片麻痺 呈す 緊急 搬送 右前頭葉皮質下出血 の 診断 入院 保存 的 治療 行なう た,1,0.016619893321509368,0.9833801066784906,1,0.0003619478655491702,0.9996380521344508,1,0.030159128996967488,0.9698408710030325,1,0.40492779122799627,0.5950722087720037,1,0.07947340607643127,0.9370545744895935,1,0.19137611985206604,0.8579893112182617,1,0.00975611651113709,0.9902438834888629,1
2248,二次性下肢リンパ浮腫を有する患者で、COVID-19 mRNAワクチンを接種後、リンパ浮腫病変部に蜂巣炎を生じたと報告された。,二次性下肢リンパ浮腫 有する 患者 COVID 0 mRNA ワクチン 接種 後 リンパ浮腫 病変 部 蜂巣炎 生じる た 報告 する れる た,1,0.031299064911200714,0.9687009350887992,1,0.0002773035850279506,0.999722696414972,1,0.2415791850171567,0.7584208149828433,1,0.11272475705761431,0.8872752429423857,1,0.10045625269412994,0.9331648349761963,1,0.18304598331451416,0.8685036897659302,1,0.008608105352911026,0.991391894647089,1
2249,両側大脳の皮質、左頭頂葉の皮質下白質、脳梁膨大部、両側尾状核、両側小脳半球などがDWIにて高信号を認め、低酸素脳症を示す所見。,両側 大脳 皮質 左 頭頂葉 皮質下白質 脳梁 膨大 部 両側尾状核 両側 小脳 半球 DWI 高信号 認める 低酸素 脳症 示す 所見,1,0.01646584966436209,0.983534150335638,1,0.0004145230925128329,0.9995854769074871,1,0.02905633916696615,0.9709436608330339,1,5.804893840055669e-05,0.9999419510615994,1,0.08706777542829514,0.9250960350036621,1,0.20570853352546692,0.8513001799583435,1,0.004533891826969336,0.9954661081730307,1
2250,患者は、円形脱毛症、状態悪化のために入院した(入院日: 2021/12/23、退院日:2021/12/25、入院期間:2日)。,患者 円形脱毛症 状態悪化 ため 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.01670006754200108,0.9832999324579988,1,0.00036797439213532207,0.9996320256078647,1,0.022958243751349916,0.9770417562486501,1,7.832076077296524e-05,0.999921679239227,1,0.09415999054908752,0.9478018879890442,1,0.1999586522579193,0.8565860390663147,1,0.0043637071146540975,0.9956362928853458,1
2251,患者は、甲状腺中毒クリーゼ、バセドウ病、循環虚脱、心室性頻脈、心原性ショックのために入院した(開始日:2021/09/15)。,患者 甲状腺中毒 クリーゼ バセドウ病 循環虚脱 心室性頻脈 心原性ショック ため 入院 する た 開始 日 0 0 0,1,0.01666899934361971,0.9833310006563801,1,0.0003151783755697417,0.9996848216244303,1,0.0487434728361581,0.9512565271638419,1,0.04436259644908791,0.9556374035509121,1,0.0859299972653389,0.9417811036109924,1,0.1846591681241989,0.864589512348175,1,0.004890292089593833,0.9951097079104062,1
2252,心筋炎、心膜炎、胸痛、発熱、頭痛のため入院した(開始日:2022/06/05、退院日:2022/06/11、入院期間:6日)。,心筋炎 心膜炎 胸痛 発熱 頭痛 ため 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,3.6442273464180794e-06,0.9999963557726537,1,0.0004014097159599121,0.9995985902840401,1,0.005722872315014227,0.9942771276849858,1,6.67038207834425e-05,0.9999332961792166,1,0.08194667100906372,0.9457666873931885,1,0.18111540377140045,0.8675660490989685,1,0.003919431996023191,0.9960805680039767,1
2253,切迫早産、妊娠前の母体の曝露のために入院した(入院日:2021/10/27、退院日:2022/01/10、入院期間:75日)。,切迫早産 妊娠前 母体 曝露 ため 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.016693248413545695,0.9833067515864543,1,0.000354849840278796,0.9996451501597212,1,0.022958243751349916,0.9770417562486501,1,0.00013702892092248842,0.9998629710790775,1,0.0927315354347229,0.9377219080924988,1,0.21147854626178741,0.8537246584892273,1,0.004465272596204071,0.995534727403796,1
2254,脳梁膨大部に限局したDWI high領域を認めたことから、MERS(可逆性脳梁膨大部病変を有する軽症脳炎・脳症)と診断された。,脳梁 膨大 部 限局 する た DWI high 領域 認める た こと MERS 可逆性 脳梁膨大部病変 有する 軽症 脳炎 脳症 診断 する れる た,1,0.0036825505759835986,0.9963174494240166,1,0.0004607864376236568,0.9995392135623763,1,0.01480836457937662,0.9851916354206234,1,0.03558977687795073,0.9644102231220493,1,0.08728138357400894,0.9441378116607666,1,0.18525199592113495,0.8722171783447266,1,0.004343427304786331,0.9956565726952137,1
2255,2022年3月15日両下肢遠位にジーンとした錯感覚が出現、3月下旬に筋肉痛、関節痛は落ち着いたが、両下肢痺れは残存していた。,0 年 0 月 0 日 下肢 遠い 位 する た 錯感覚 出現 0 月 下旬 筋肉痛 関節痛 落ち着く た 両下肢痺れ 残存 する いる た,1,0.016723358974465686,0.9832766410255345,1,0.00031212311929590674,0.999687876880704,1,0.02536971944000066,0.9746302805599993,1,0.11676117536898167,0.8832388246310183,1,0.07844831794500351,0.9473258256912231,1,0.19094479084014893,0.8774614930152893,1,0.00528774589031252,0.9947122541096876,1
2256,心筋生検ではリンパ球主体の高度炎症細胞浸潤があり、心臓遅延造影MRIでは心中部下壁・右室下壁に心筋炎、心膜炎併発が疑われた。,心筋生検 リンパ球主体 の 高度炎症 細胞浸潤 ある 心臓 遅延 造影 MRI 心中 部下 壁 右 室 下 壁 心筋炎 心膜炎 併発 疑う れる た,1,0.009803686484797304,0.9901963135152024,1,0.00042893726813625073,0.9995710627318638,1,0.055584809633682175,0.9444151903663178,1,0.1659709647046561,0.8340290352953439,1,0.08665723353624344,0.9423720836639404,1,0.19072623550891876,0.8694376945495605,1,0.006237929394006651,0.9937620706059932,1
2257,心電図から急性心筋梗塞を疑い、心臓カテーテル検査を行ったところ冠動脈の狭窄部位が複数確認されたため、ステント内挿術を行った。,心電図 急性心筋梗塞 疑う 心臓カテーテル検査 行う た ところ 冠動脈 狭窄 部位 複数 確認 する れる た ため ステント 内挿 術 行う た,1,0.016660964157051088,0.9833390358429487,1,0.00039507026231322385,0.9996049297376868,1,0.14357885769382406,0.8564211423061759,1,0.0535938425685456,0.9464061574314544,1,0.10147665441036224,0.9227371215820312,1,0.1973918378353119,0.864909827709198,1,0.00630353636546222,0.9936964636345377,1
2258,成人女性患者は、ワクチン接種のためにメッセンジャーRNAワクチン(商品名不明)を接種し、脳梗塞及び頭蓋内脳血管解離を認めた。,成人女性 患者 ワクチン接種 ため メッセンジャーRNA ワクチン 商品名 不明 接種 する 脳梗塞 頭蓋 内 脳血管 解離 認める た,1,0.024512859678942595,0.9754871403210574,1,0.00029278635837617635,0.9997072136416238,1,0.022027572610729518,0.9779724273892705,1,0.005261540359343453,0.9947384596406565,1,0.08439093083143234,0.9427003860473633,1,0.1814306229352951,0.8653016686439514,1,0.00432938505411272,0.9956706149458872,1
2259,成人男性患者は、ワクチン接種のためにメッセンジャーRNAワクチン(商品名不明)を接種し、脳梗塞及び頭蓋内脳血管解離を認めた。,成人男性 患者 ワクチン接種 ため メッセンジャーRNA ワクチン 商品名 不明 接種 する 脳梗塞 頭蓋 内 脳血管 解離 認める た,1,0.02456795759614705,0.9754320424038528,1,0.00029278635837617635,0.9997072136416238,1,0.022027572610729518,0.9779724273892705,1,0.005261540359343453,0.9947384596406565,1,0.08020322024822235,0.9440449476242065,1,0.1784316897392273,0.8650907874107361,1,0.0042941377720492465,0.9957058622279508,1
2260,"入院第2日に再度胸痛を訴え,血液検査でトロポニンI 9.15ng/mL,有症時の心電図検査でV4-6誘導のST上昇があった。",入院 0 日 再度胸痛 訴える 血液検査 トロポニン I 0 0 NG mL 有症 時 心電図 検査 V 0 0 誘導 ST 上昇 ある た,1,0.015688389628092783,0.9843116103719072,1,0.00030638441926289446,0.9996936155807371,1,0.009269908439481944,0.9907300915605181,1,0.3159419440583525,0.6840580559416475,1,0.08023784309625626,0.9459640979766846,1,0.17893752455711365,0.8715940117835999,1,0.007569954357816123,0.9924300456421838,1
2261,不全対麻痺、Th8以遠の痛覚鈍麻、両下肢振動覚鈍麻を呈しており、脊髄MRIでTh5椎体レベルでの髄内T2高信号変化を認めた。,不全対麻痺 Th 0 以遠 痛覚 鈍麻 下肢 振動 覚る 鈍麻 呈す おる 脊髄 MRI Th 0 椎 体 レベル 髄 内 T 0 高信号 変化 認める た,1,0.017044701549497922,0.9829552984505022,1,0.0003442039508731323,0.9996557960491269,1,0.01748658573475992,0.9825134142652401,1,0.12504020334527466,0.8749597966547253,1,0.08355943113565445,0.9435137510299683,1,0.18795384466648102,0.8755865097045898,1,0.005336918744206651,0.9946630812557933,1
2262,2021/07/21(ワクチン接種の2日後)、患者は事象頻拍性心房細動と心不全増悪/うっ血性心不全を発現し、病院に入院した。,0 0 0 ワクチン接種 0 日 後 患者 事象 頻拍性 心房細動 心不全 増悪 うっ血性 心不全 発現 病院 入院 する た,1,0.002539742438424678,0.9974602575615753,1,0.0003988109644600473,0.99960118903554,1,0.011509233775311767,0.9884907662246882,1,0.12977939966836582,0.8702206003316342,1,0.08382536470890045,0.9461603760719299,1,0.17845240235328674,0.872019350528717,1,0.005130300260094143,0.9948696997399059,1
2263,2021/10/24、朝から胸痛が再燃し、トロポニンT上昇、トロポニンI上昇、CK-MB上昇があり、報告者の病院へ転院した。,0 0 0 朝 胸痛 再燃 する トロポニン T 上昇 トロポニン I 上昇 CK MB 上昇 ある 報告 者 病院 転院 する た,1,0.049632164878290565,0.9503678351217095,1,0.00023809786685741663,0.9997619021331425,1,0.03359716442484584,0.9664028355751542,1,0.15014423760472517,0.8498557623952748,1,0.0962585061788559,0.93100506067276,1,0.17853736877441406,0.8764815926551819,1,0.006271381722073595,0.9937286182779264,1
2264,患者は、ウイルス性心筋炎、心筋炎、心筋収縮性低下、トロポニン増加、リンパ球数増加のため入院した(2022/06/03入院)。,患者 ウイルス性 心筋炎 心筋炎 心筋 収縮 性 低下 トロポニン 増加 リンパ球 数 増加 ため 入院 する た 0 0 0 入院,1,0.0025360732472887826,0.9974639267527111,1,0.0005282791338106004,0.9994717208661894,1,0.006191117462843176,0.9938088825371568,1,9.18221054746482e-12,0.9999999999908178,1,0.09020937234163284,0.946248471736908,1,0.18019352853298187,0.8722737431526184,1,0.003951863390225688,0.9960481366097742,1
2265,患者は、肺炎、食欲減退、倦怠感(入院日:2022/04/28、退院日:2022/05/07、入院期間:9日)のため入院した。,患者 肺炎 食欲減退 倦怠感 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日 ため 入院 する た,1,0.005032823571420674,0.9949671764285792,1,0.00042135578919733725,0.9995786442108027,1,0.0018878619585074308,0.9981121380414926,1,0.09277384736625616,0.9072261526337438,1,0.07718327641487122,0.9506316184997559,1,0.1844383329153061,0.8675692081451416,1,0.00469595183831463,0.9953040481616854,1
2266,Blood creatinine (0.47-0.79):(2022/02/04)0.41 mg/dl、注釈:コメント:低値,BLOOD creatinine 0 0 0 0 0 0 0 0 0 mg dl 注釈 コメント 値,1,0.017792439866457947,0.9822075601335422,1,0.0003798033498261515,0.9996201966501739,1,0.35141485383112747,0.6485851461688725,1,0.0018189450880289337,0.9981810549119711,1,0.12120214849710464,0.9160734415054321,1,0.20842906832695007,0.8450812697410583,1,0.009114689893592388,0.9908853101064076,1
2267,mRNA新型コロナウイルスワクチン(商品名不明)接種後、3週間後より四肢に紫斑、下腿に点状出血、鼻出血あり、当科外来受診。,mRNA 新型コロナウイルス ワクチン 商品名 不明 接種 後 0 週間 後 四肢 紫斑 下腿 点状 出血 鼻出血 ある 科 外来 受診,1,0.02537600580842277,0.974623994191577,1,0.00032256474454958617,0.9996774352554504,1,0.48925022609350655,0.5107497739064935,1,1.5629401263206333e-06,0.9999984370598737,1,0.08013208955526352,0.9451547861099243,1,0.1828499138355255,0.8664897084236145,1,0.01078493222729382,0.9892150677727061,1
2268,右冠動脈又は左冠動脈に顕著な狭窄はなかったが、左心室造影にて、心尖の前外側壁領域の運動低下を伴う駆出率の軽度低下を認めた。,右 冠動脈 左 冠動脈 顕著 だ 狭窄 ない た 左心室 造影 心尖 前 外側壁 領域 運動低下 伴う 駆け出し 率 軽度低下 認める た,1,0.016672646082358973,0.9833273539176411,1,0.0002515497337602987,0.9997484502662397,1,0.09549485801697821,0.9045051419830218,1,0.03771531378635529,0.9622846862136447,1,0.09375599026679993,0.9384753704071045,1,0.2099785953760147,0.8677123188972473,1,0.005474393414761188,0.9945256065852388,1
2269,症状時12誘導心電図では洞調律と単発の上室性期外収縮のみを認め、ホルター心電図再検査では回帰性上室性頻拍の再燃は見られず。,症状 時 0 誘導 心電図 洞調律 単発 上室性 期外収縮 認める ホルター心電図 再検査 回帰 性 上室性 頻拍 再燃 見る られる ぬ,1,0.016689850879350748,0.983310149120649,1,0.00030894770890131814,0.9996910522910987,1,0.08198719679861144,0.9180128032013886,1,0.22554924216918704,0.774450757830813,1,0.10538137704133987,0.9280275702476501,1,0.21455572545528412,0.8507407903671265,1,0.008083926579438032,0.991916073420562,1
2270,発熱のため新型コロナウイルス感染が疑われたが、ポリメラーゼ連鎖反応(PCR)検査の陰性以外には、精密検査は施行しなかった。,発熱 ため 新型コロナ ウイルス感染 疑う れる た ポリメラーゼ連鎖反応 PCR 検査 陰性 以外 精密検査 施行 する ない た,0,0.9105959646028077,0.08940403539719258,0,9.138828236555683e-05,0.9999086117176345,1,0.39731306398112987,0.6026869360188701,0,0.9729610632293001,0.027038936770699934,0,0.9383019208908081,0.07851168513298035,0,0.722568929195404,0.25199058651924133,1,0.8690165896121972,0.13098341038780278,1
2271,13:00、おやつ摂取時に(報告の通り)、気分不良を訴え黄色液を少量嘔吐し、嘔気は消失したが、倦怠感を訴えたため臥床した。,0 0 おやつ 摂取 時 報告 通り 気分不良 訴える 黄色液 少量嘔吐 嘔気 消失 する た 倦怠感 訴える た ため 臥床 する た,1,0.01669348084875708,0.983306519151243,1,0.0002946524106698744,0.9997053475893302,1,0.024651096776641457,0.9753489032233585,1,0.033757187763752805,0.9662428122362472,1,0.08147528767585754,0.945852518081665,1,0.22101424634456635,0.8323081135749817,1,0.004845351967442411,0.9951546480325576,1
2272,皮膚潰瘍および周辺域からの組織生検の組織病理学的分析では、潰瘍形成と表面性皮膚浮腫で中心壊死性化膿性炎症が明らかとなった。,皮膚潰瘍 周辺 域 組織 生検 組織 病理学 的 分析 潰瘍形成 表面 性 皮膚浮腫 中心 壊死性 化膿性 炎症 明らか なる た,1,0.016693312519180405,0.9833066874808196,1,0.0002650482270143223,0.9997349517729857,1,0.11414370154617481,0.8858562984538252,1,0.21343201598839623,0.7865679840116038,1,0.101055808365345,0.9314990043640137,1,0.18033528327941895,0.8606388568878174,1,0.007988920648676881,0.9920110793513232,1
2273,2022/02/25、ワクチン接種を受け、2日後に、頭痛がして、2022/03/13にくも膜下出血のために救急搬送された。,0 0 0 ワクチン接種 受ける 0 日 後 頭痛 する 0 0 0 くも膜下出血 ため 救急搬送 する れる た,1,0.016675942813952845,0.9833240571860472,1,0.00045456535347148324,0.9995454346465286,1,0.15541445413427768,0.8445855458657223,1,0.18678526555539043,0.8132147344446096,1,0.07350463420152664,0.9464028477668762,1,0.17206403613090515,0.8730669617652893,1,0.007727282917531979,0.992272717082468,1
2274,"Glomerular filtration rate (90-0000): (2022/06/15) 71.3,注記:低値",Glomerular filtration rate 0 0 0 0 0 0 0 注記 値,1,0.017699795075074,0.982300204924926,1,0.0002934886996836393,0.9997065113003164,1,0.2912285955160354,0.7087714044839646,1,4.455938431258133e-05,0.9999554406156874,1,0.24105705320835114,0.8412624597549438,1,0.22094327211380005,0.8518857955932617,1,0.009828274021586004,0.990171725978414,1
2275,Cr 0.75 mg/dL、CRP 15 mg/dL、胸水、縦隔リンパ節腫大、リンパ路病変などから原発性肺癌が疑われた。,Cr 0 0 mg dL CRP 0 mg dL 胸水 縦隔リンパ節腫大 リンパ路病変 原発性肺 癌 疑う れる た,1,0.12633794188436848,0.8736620581156316,1,0.00018987165035531784,0.9998101283496447,1,0.2322196409824444,0.7677803590175556,1,0.06945642681207509,0.9305435731879249,1,0.08151128888130188,0.9453550577163696,1,0.18104638159275055,0.8635575175285339,1,0.009103536008984288,0.9908964639910157,1
2276,ステロイドパルス、免疫グロブリンも投与したが、転院翌日には循環不全が進行し、気管内挿管、V-A ECMOの導入を要した。,ステロイド パルス 免疫グロブリン 投与 する た 転院 翌日 循環不全 進行 する 気管 内挿 管 V A ECMO 導入 要す た,1,0.07098839801139739,0.9290116019886028,1,0.00028641312869520793,0.9997135868713047,0,0.7157988506355764,0.2842011493644236,1,0.14600106624269793,0.8539989337573021,1,0.116820327937603,0.9199264645576477,1,0.20185938477516174,0.856425940990448,1,0.02681733643041044,0.9731826635695896,1
2277,その他後頭下筋群の筋緊張、硬直感、不眠など自律神経失調様な訴えが多い(不定愁訴)疼痛が増悪、仕事と日常生活に支障がある。,その他 後頭下筋 群 筋緊張 硬直感 不眠 自律神経失調 様 だ 訴え 多い 不定愁訴 疼痛 増悪 仕事 日常生活 支障 ある,1,0.016658377874558865,0.9833416221254412,1,0.00031396630225457987,0.9996860336977454,1,0.24028942483056748,0.7597105751694325,1,0.025620175283022406,0.9743798247169776,1,0.0890355184674263,0.9423608779907227,1,0.197515606880188,0.8479352593421936,1,0.007118027666325983,0.9928819723336741,1
2278,回転性のめまいの時は自分で注射や車の運転ができなくなるため、夫に運転してもらい病院へ受診し、ベリナートを投与してもらう。,回転性 の めまい 時 自分 注射 車 運転 できる ない なる ため 夫 運転 する もらう 病院 受診 する ベリナート 投与 する もらう,1,0.09782916201345687,0.9021708379865432,1,0.00024201869673202024,0.999757981303268,1,0.20984120346639623,0.7901587965336038,1,2.7207389674543947e-09,0.999999997279261,1,0.46437662839889526,0.7536223530769348,1,0.4069889187812805,0.5887376070022583,1,0.02073113340599415,0.9792688665940058,1
2279,腎生検にてメサンギウム細胞のわずかな増殖を伴うIgANと診断された(Oxford Score: M0E0S0T0C0)。,腎生検 メサンギウム 細胞 だ 増殖 伴う IgAN 診断 する れる た Oxford Score M 0 E 0 S 0 T 0 C 0,1,0.030776181433853855,0.9692238185661461,1,0.0002951802263059697,0.9997048197736941,1,0.04386888934900335,0.9561311106509967,1,0.11397116979069188,0.8860288302093081,1,0.09837537258863449,0.9331833124160767,1,0.19303616881370544,0.8640984296798706,1,0.005893189118533489,0.9941068108814666,1
2280,生検:基底膜の重複を含む膜性増殖の変化、及び内皮細胞内皮細胞の内皮拡大を伴う血栓性微小血管症(TMA)病変が認められた。,生検 基底膜 重複 含む 膜 性 増殖 変化 皮細胞 内 皮細胞 内皮 拡大 伴う 血栓性 微小血管症 TMA 病変 認める られる た,1,0.01925908794269395,0.980740912057306,1,0.00032622003671038094,0.9996737799632897,1,0.016611920062161945,0.983388079937838,1,0.1290144550356005,0.8709855449643995,1,0.08570767194032669,0.9372971653938293,1,0.176325723528862,0.8670621514320374,1,0.005421736956908055,0.9945782630430919,1
2281,大脳白質にはFLAIR像で点状高信号を数個所認めたが、そのほかに脊髄を含めて脱髄病変を示唆するような信号異常はなかった。,大脳白質 FLAIR 像 だ 点状 高信号 数個 所 認める た そのほか 脊髄 含める 脱髄病変 示唆 する よう 信号異常 ない た,1,0.024738932606062865,0.9752610673939371,1,0.0003020243052093626,0.9996979756947907,1,0.2737823655852787,0.7262176344147213,0,0.908231840841544,0.09176815915845604,1,0.26515141129493713,0.7907781600952148,1,0.3451242744922638,0.7756983041763306,1,0.07295965620315352,0.9270403437968465,1
2282,典型的な胸痛、新たな心嚢液貯留、心膜摩擦音、およびECGの変化(広範にてST部分の上昇)を示し、急性心膜炎と診断された。,典型 的 だ 胸痛 新た だ 心嚢液 貯留 心膜摩擦音 ECG 変化 広範 ST 部分 上昇 示す 急性心膜炎 診断 する れる た,1,0.012255759096806313,0.9877442409031939,1,0.00036862697958390595,0.999631373020416,1,0.019901635757021197,0.9800983642429788,1,0.1416117121182382,0.8583882878817618,1,0.08130105584859848,0.9490476250648499,1,0.183661550283432,0.8736872673034668,1,0.005434724959396817,0.9945652750406033,1
2283,頭痛は右半分で右眼の奥に限局しており、右眼の流涙を認め、右眼瞼は完全に下垂、右眼球は外転以外動かず、瞳孔は散瞳していた。,頭痛 右半分 右 眼 奥 限局 する おる 右 眼 流涙 認める 右 眼瞼 完全 下垂 右 眼球 外 転 以外 動く ぬ 瞳孔 散瞳 する いる た,1,0.016688655157949345,0.9833113448420507,1,0.00040194471965791166,0.9995980552803421,1,0.055720502003394956,0.944279497996605,1,0.32899665278810397,0.671003347211896,1,0.07464268058538437,0.9450265765190125,1,0.19431424140930176,0.8730071783065796,1,0.008616168131875483,0.9913838318681245,1
2284,入院5日目に心臓MRIを実施し、STIRマッピングでのMRIにて、主に心外膜側に分布する高信号領域の広い広がりを示した。,入院 0 日 目 心臓 MRI 実施 する STIR マッピング MRI 主 心外 膜 側 分布 する 高信号領域 広い 広がり 示す た,1,0.019955934262126045,0.9800440657378741,1,0.00031863497149847925,0.9996813650285015,1,0.24438450073235984,0.7556154992676402,1,0.10129901710412292,0.8987009828958771,1,0.09966545552015305,0.9386129975318909,1,0.19297528266906738,0.8624125123023987,1,0.00835530175864046,0.9916446982413596,1
2285,病理組織学的所見では、真皮における血管周囲のリンパ球浸潤、並びに表皮における軽度の空胞変性及びリンパ球浸潤などを認めた。,病理 組織 学 的 所見 真皮 血管 周囲 リンパ球浸潤 表皮 軽度 空胞変性 リンパ球浸潤 認める た,1,0.015510408643877021,0.984489591356123,1,0.0003549667812573638,0.9996450332187427,1,0.018032330593525492,0.9819676694064745,1,0.017171272972376084,0.9828287270276239,1,0.1121646836400032,0.9268879294395447,1,0.19844432175159454,0.8569718599319458,1,0.004627442182438425,0.9953725578175616,1
2286,トロポニン:上昇ウイルス性心筋炎、心筋炎、心筋収縮性低下、トロポニン増加、リンパ球数増加の結果として治療処置がとられた。,トロポニン 上昇 ウイルス性 心筋炎 心筋炎 心筋 収縮 性 低下 トロポニン 増加 リンパ球 数 増加 結果 治療 処置 とる れる た,1,0.0042633259449836435,0.9957366740550162,1,0.00044172145846193585,0.9995582785415381,1,0.0031228071046556227,0.9968771928953444,1,0.11322753230882066,0.8867724676911793,1,0.10085690766572952,0.9395221471786499,1,0.18652676045894623,0.8689531683921814,1,0.005071769298538488,0.9949282307014614,1
2287,2022/05/01 11:00発現、振戦(入院)、転帰「回復」(2022/05/04)、「全身のふるえ」と記載された。,0 0 0 0 0 発現 振戦 入院 転帰 回復 0 0 0 全身 ふるえ 記載 する れる た,1,0.016701671305726095,0.983298328694274,1,0.0003037999794930058,0.999696200020507,1,0.020676643376521975,0.979323356623478,1,0.14804519084884504,0.851954809151155,1,0.11124273389577866,0.9291090369224548,1,0.18697814643383026,0.87350994348526,1,0.005864574621402645,0.9941354253785972,1
2288,2021/09/20、鼓動が強い動悸、呼吸困難、安静時呼吸困難、胸が詰まった感じ、心臓がチクチクする感じ/胸痛があった。,0 0 0 鼓動 強いる 動悸 呼吸困難 安静時呼吸困難 胸 詰まる た 感じ 心臓 チクチクする感じ 胸痛 ある た,1,0.016713843366875206,0.9832861566331247,1,0.00030380744816984944,0.9996961925518302,1,0.12219659151582851,0.8778034084841715,1,0.07288110023713334,0.9271188997628667,1,0.08534527570009232,0.9418222308158875,1,0.181958869099617,0.8745378255844116,1,0.005911860855543422,0.9940881391444566,1
2289,患者は、胸痛、発熱、悪心のため入院した(入院日: 2022/06/07、退院日:2022/06/09、入院期間:2日)。,患者 胸痛 発熱 悪心 ため 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.0031336551940447815,0.9968663448059554,1,0.0004118780659177275,0.9995881219340823,1,0.004652259363374656,0.9953477406366253,1,6.41562635119719e-05,0.999935843736488,1,0.07925202697515488,0.9486814737319946,1,0.20678077638149261,0.8522287607192993,1,0.004076817239158388,0.9959231827608416,1
2290,自己免疫性脳炎、意識変容状態、痙攣発作、CSF細胞数増加、幻覚、発熱、上咽頭炎、湿性咳嗽の結果として治療処置が行われた。,自己免疫性 脳炎 意識変容状態 痙攣 発作 CSF 細胞 数 増加 幻覚 発熱 上咽頭炎 湿性咳嗽 結果 治療 処置 行う れる た,1,0.003023138540218391,0.9969768614597816,1,0.00043186760260835173,0.9995681323973916,1,0.008512347802492437,0.9914876521975076,1,0.1558602228089614,0.8441397771910386,1,0.0828888937830925,0.951678991317749,1,0.17865188419818878,0.8730353116989136,1,0.005338178181722008,0.9946618218182779,1
2291,しかし、入院9日目、咳嗽、呼吸不快感、高熱(38度)、新しい皮膚発疹の形成、血中好酸球数上昇と酸素飽和度低下があった。,入院 0 日 目 咳嗽 呼吸 不快感 高熱 0度 新しい 皮膚発疹 形成 血 中 好酸球 数 上昇 酸素飽和度 低下 ある た,1,0.0038549585411280776,0.9961450414588718,1,0.000438164453296213,0.9995618355467037,1,0.01138546939461671,0.9886145306053833,1,0.2729766969008699,0.7270233030991301,1,0.07325375825166702,0.9511948227882385,1,0.18299226462841034,0.8723999261856079,1,0.006759404394363474,0.9932405956056365,1
2292,光干渉断層撮影(OCT):ワクチン接種8日後、網膜内層の高反射、網膜内の高度肥厚及び網膜の組織化層構造の消失を認めた。,光 干渉 断層 撮影 OCT ワクチン接種 0 日 後 網膜 内層 高い 反射 網膜 内 高度肥厚 網膜 組織化 層 構造 消失 認める た,1,0.022267024345912895,0.9777329756540871,1,0.00033318266458768486,0.9996668173354123,1,0.08671087081298912,0.9132891291870109,1,0.1363971826498478,0.8636028173501522,1,0.09296862035989761,0.9368016123771667,1,0.2029169499874115,0.8706990480422974,1,0.006559898958696251,0.9934401010413036,1
2293,心血管磁気共鳴にて、左心室の心外膜下心筋におけるT2強調高強度及びガドリニウム遅延高増強を認め、急性心筋炎が示された。,心血 管 磁気 共鳴 左心室 心外 膜 下 心筋 T 0 強調 高 強度 ガドリニウム 遅延 高い 増強 認める 急性心筋炎 示す れる た,1,0.016723407100400677,0.9832765928995992,1,0.00041041305942740846,0.9995895869405725,1,0.04783949492626527,0.9521605050737347,1,0.1765993100862483,0.8234006899137517,1,0.08650213479995728,0.9460102915763855,1,0.18359529972076416,0.8687425255775452,1,0.006296092170531212,0.9937039078294688,1
2294,2022/01/08、患者は発熱(摂氏38度)、両下肢の痛み、筋肉痛、筋力低下を発現し、立ち上がることができなかった。,0 0 0 患者 発熱 摂氏 0度 下肢 痛み 筋肉痛 筋力低下 発現 立ち上がる こと できる ない た,1,0.016659371365033145,0.9833406286349669,1,0.0003538291043480671,0.9996461708956519,1,0.045921354128525604,0.9540786458714744,0,0.9582431274585614,0.041756872541438554,1,0.08156026899814606,0.9476345777511597,1,0.18939286470413208,0.8680638670921326,1,0.02924430597368821,0.9707556940263117,1
2295,2022/05/09(3回目のワクチン接種3日後)、倦怠感を自覚し、近医受診し、大球性貧血を指摘され、当科紹介された。,0 0 0 0回目 ワクチン接種 0 日 後 倦怠感 自覚 近医 受診 する 大球性貧血 指摘 する れる 科 紹介 する れる た,1,6.095924739791521e-06,0.9999939040752601,1,0.0005911212947245542,0.9994088787052754,1,0.00379889537759337,0.9962011046224066,1,0.24441357191794277,0.7555864280820572,1,0.0777193158864975,0.9457412958145142,1,0.17928721010684967,0.8755346536636353,1,0.006264015964516754,0.9937359840354834,1
2296,18日目、脳MRIにて拡散係数(ADC)値が低い脳梁膨大部における拡散強調画像(DWI)で楕円形の拡散制限がみられた。,0 日 目 脳 MRI 拡散 係数 ADC 値 低い 脳梁 膨大 部 拡散強調画像 DWI 楕円形 拡散 制限 みる られる た,1,0.01691449185533147,0.9830855081446686,1,0.00034599681456535977,0.9996540031854346,1,0.08068177389246023,0.9193182261075398,1,0.1484348787494616,0.8515651212505384,1,0.08528968691825867,0.9383719563484192,1,0.1878543496131897,0.8700116276741028,1,0.006416245260866547,0.9935837547391334,1
2297,2021/09/20(初回ワクチン接種から4日後)より、筋痛性脳脊髄炎/慢性疲労症候群に類似した多数の症状が出現した。,0 0 0 初回 ワクチン接種 0 日 後 筋痛性 脳脊髄炎 慢性疲労 症候群 類似 する た 多数 症状 出現 する た,1,0.016709006237493534,0.9832909937625064,1,0.00034006636716273536,0.9996599336328372,1,0.01546929977121414,0.9845307002287859,1,0.10379108219062294,0.8962089178093771,1,0.08153782039880753,0.9480772018432617,1,0.18022257089614868,0.8749181032180786,1,0.005023381103862842,0.9949766188961371,1
2298,2022/05/29 22:30(ワクチン接種の2日後)、患者は急性心膜炎と急性心筋炎および急性心膜心筋炎を発現した。,0 0 0 0 0 ワクチン接種 0 日 後 患者 急性心膜炎 急性心筋炎 急性心膜心筋炎 発現 する た,1,0.009828985174963532,0.9901710148250363,1,0.000378672195967194,0.9996213278040328,1,0.018951109761968343,0.9810488902380317,1,0.10533846472106179,0.8946615352789382,1,0.08880104124546051,0.948324978351593,1,0.18204224109649658,0.8700396418571472,1,0.005074060716716222,0.9949259392832838,1
2299,これらの特徴は、急速なB細胞破壊とインスリン不足が起きている重度の免疫反応(劇症1型糖尿病と一致している)を示唆する。,これら 特徴 急速 だ B 細胞破壊 インスリン不足 起きる いる 重度 免疫反応 劇症 0 型 糖尿病 一致 する いる 示唆 する,1,0.04603381434846733,0.9539661856515328,1,0.00023546953109910993,0.9997645304689009,1,0.4930105585869311,0.5069894414130689,1,0.0034225015412289173,0.9965774984587711,1,0.09529666602611542,0.9362427592277527,1,0.21391578018665314,0.8466867208480835,1,0.012269270145644186,0.9877307298543558,1
2300,意識障害が解熱後も持続するため2022/05/10に頭MRIを施行し、脳梁部に限局したDWI high(+)を認めた。,意識障害 解熱 後 持続 する ため 0 0 0 頭 MRI 施行 する 脳梁 部 限局 する た DWI high 認める た,1,0.0034909626774118074,0.9965090373225881,1,0.0005097524939741733,0.9994902475060258,1,0.05053310693386659,0.9494668930661334,1,0.0050877022770210445,0.994912297722979,1,0.07642888277769089,0.9466271996498108,1,0.1887354701757431,0.8735275268554688,1,0.004339067423731278,0.9956609325762688,1
2301,患者は、脳梁の細胞傷害性病変、脳炎、脳症、意識変容状態、敗血症、髄膜炎、嘔吐、発熱のため入院した(入院期間:11日)。,患者 脳梁 の 細胞傷害 性病変 脳炎 脳症 意識変容状態 敗血症 髄膜炎 嘔吐 発熱 ため 入院 する た 入院 期間 0 日,1,5.560644384342796e-06,0.9999944393556157,1,0.0005189388855554568,0.9994810611144446,1,0.0068507591954990454,0.993149240804501,1,0.02325191843437313,0.9767480815656269,1,0.08363688737154007,0.9493348002433777,1,0.18800203502178192,0.8616268038749695,1,0.0041600132584300445,0.99583998674157,1
2302,多系統炎症性症候群、心房細動、リンパ球数減少、発熱、四肢痛、筋肉痛、筋力低下、起立障害の結果として治療処置が行われた。,系統 炎症性 症候群 心房細動 リンパ球 数 減少 発熱 四肢痛 筋肉痛 筋力低下 起立障害 結果 治療 処置 行う れる た,1,0.0027694488461629816,0.997230551153837,1,0.00048097245520491334,0.999519027544795,1,0.007781144641951565,0.9922188553580484,1,0.15715633194496104,0.842843668055039,1,0.08886715024709702,0.9477736353874207,1,0.18310706317424774,0.8718712329864502,1,0.005425014846626903,0.9945749851533731,1
2303,ワクチン接種の8日後に、高血糖(随時血糖469mg/dL、ヘモグロビンAlc 7.2%)のため、総合病院に紹介された。,ワクチン接種 0 日 後 高血糖 随時血糖 0m g dL ヘモグロビン Alc 0 0% ため 総合病院 紹介 する れる た,1,0.02427241854465461,0.9757275814553454,1,0.0003313207590980587,0.999668679240902,1,0.140429192774429,0.859570807225571,1,0.1593113858202032,0.8406886141797968,1,0.08893647789955139,0.9397939443588257,1,0.18104951083660126,0.8730748295783997,1,0.007434260383959058,0.992565739616041,1
2304,"両まぶたの浮腫が確認された,注記:両耳介に掻痒を伴う紅斑および後頸部から後頭部にかけて掻痒を伴う鱗状紅斑が認められた。",まぶた 浮腫 確認 する れる た 注記 耳介 掻痒 伴う 紅斑 お呼び 後 頸部 後頭部 かける 掻痒 伴う 鱗状紅斑 認める られる た,1,0.007439157818676296,0.9925608421813238,1,0.0004481601332368326,0.9995518398667632,1,0.031134170389524263,0.9688658296104757,1,0.09096210447730457,0.9090378955226954,1,0.07874974608421326,0.9484598636627197,1,0.18137268722057343,0.8687346577644348,1,0.004981130130800009,0.9950188698692,1
2305,2022/01/31から2022/02/02まで、被験者はCOVID-19感染のためカロナール500mgを内服した。,0 0 0 0 0 0 被験者 COVID 0 感染 ため カロナール 0m g 内服 する た,1,0.03375660450560879,0.9662433954943911,1,0.0002170800379475381,0.9997829199620525,1,0.2777197649198758,0.7222802350801242,1,0.2779159095460999,0.7220840904539001,1,0.3786875605583191,0.7552919983863831,1,0.20060011744499207,0.862906277179718,1,0.020639524510567293,0.9793604754894327,1
2306,血中クレアチンホスホキナーゼ:ピーク時に324 U/L(高値)、ピーク時のクレアチンホスホキナーゼは324 U/L。,血 中 クレアチンホスホキナーゼ ピーク時 0 U L 高値 ピーク時 クレアチンホスホキナーゼ 0 U L,1,0.00594817495613939,0.9940518250438608,1,0.00034691562353440157,0.9996530843764656,1,0.09044142679626188,0.9095585732037381,0,0.5195482961797382,0.48045170382026176,1,0.1353800892829895,0.9204638004302979,1,0.2715216875076294,0.8298910856246948,1,0.01612887963214564,0.9838711203678544,1
2307,超音波画像でもLHBの水腫、血流増加、MRIでも肩峰下滑液包、肩関節包炎がみられ、SIRVAとしても矛盾のない所見。,超音波 画像 LHB 水腫 血流 増加 MRI 肩 峰下 滑液 包 肩 関節包炎 みる られる SIRVA 矛盾 ない 所見,1,0.03513784965052789,0.9648621503494723,1,0.0002872689632610495,0.999712731036739,1,0.25595222442957,0.74404777557043,1,0.0019985078263999867,0.9980014921736,1,0.11534735560417175,0.9227750301361084,1,0.20337672531604767,0.8549579381942749,1,0.007597894638234002,0.9924021053617661,1
2308,2022/03/29(ワクチン接種2日後)、発熱(摂氏37.5度)を発現し、29、30日のみ、カロナールを服用した。,0 0 0 ワクチン接種 0 日 後 発熱 摂氏 0 0度 発現 0 0 日 カロナール 服用 する た,1,0.012126106250565207,0.9878738937494346,1,0.0003230760880007389,0.9996769239119992,1,0.009481959073737167,0.9905180409262628,1,0.27740091136692024,0.7225990886330798,1,0.0810973197221756,0.946707010269165,1,0.19393712282180786,0.8725370764732361,1,0.0070647660431507895,0.9929352339568494,1
2309,自己免疫性溶血性貧血、倦怠感、大球性貧血のため、患者は入院/入院期間の延長となった(入院日:2022/05/12)。,自己免疫性 溶血性 貧血 倦怠感 大球性貧血 ため 患者 入院 入院 期間 延長 なる た 入院 日 0 0 0,1,0.004519213889807073,0.9954807861101931,1,0.00044556337665628977,0.9995544366233438,1,0.005372803308576035,0.994627196691424,1,0.0371510730985829,0.9628489269014171,1,0.08034957200288773,0.9483717679977417,1,0.20351889729499817,0.858011782169342,1,0.004374679365271652,0.9956253206347284,1
2310,事象「著明な低酸素症/低酸素血症」、「CTで両肺広範な浸潤影、すりガラス影を認め」により、医療機関への来院を要した。,事象 著 明 だ 低酸素症 低酸素血症 CT だ 両肺 広範 だ 浸潤影 すりガラス影 認める 医療機関 来院 要す た,1,0.018280883094748162,0.9817191169052517,1,0.00034192515971970516,0.9996580748402802,1,0.06517611112754274,0.9348238888724573,1,0.02311323579033453,0.9768867642096655,1,0.0768669918179512,0.9486080408096313,1,0.18600590527057648,0.8724620938301086,1,0.0047522527613156965,0.9952477472386844,1
2311,心電図にて頻脈性心房細動、心エコーにて左室駆出率30%を示し、患者はびまん性の壁運動低下とうっ血性心不全を併発した。,心電図 頻脈性 心房細動 心 エコー 左 室 駆け出し 率 0% 示す 患者 びまん性 壁運動低下 うっ血性 心不全 併発 する た,1,0.01667627439135271,0.9833237256086472,1,0.00037065385899737126,0.9996293461410026,1,0.21128600445980328,0.7887139955401967,1,0.07454477249129376,0.9254552275087062,1,0.08230991661548615,0.9462937116622925,1,0.1856602132320404,0.8693168759346008,1,0.007090490246904151,0.9929095097530959,1
2312,著名な貧血、血小板減少が認められ、末梢血の破砕赤血球を認めたため急性血栓性血小板減少性紫斑病(TTP)と診断された。,著名 だ 貧血 血小板減少 認める られる 末梢血 破砕赤血球 認める た ため 急性 血栓性 血小板減少 性 紫斑病 TTP 診断 する れる た,1,0.00259517566638844,0.9974048243336114,1,0.0005900031138743576,0.9994099968861256,1,0.006555863613413648,0.9934441363865864,1,0.16222921795613632,0.8377707820438637,1,0.07957542687654495,0.9411441683769226,1,0.17970573902130127,0.8725568652153015,1,0.005429416786351889,0.9945705832136482,1
2313,2022/07/14発現、失神(医学的に重要)、転帰「回復」(2022/07/15)、「神経調節性失神」と記載された,0 0 0 発現 失神 医学 的 重要 転帰 回復 0 0 0 神経調節性 失神 記載 する れる た,1,0.016699355968099013,0.983300644031901,1,0.00036058930037163634,0.9996394106996284,1,0.03582724223268274,0.9641727577673173,1,0.14606884531424824,0.8539311546857518,1,0.11233550310134888,0.9228404760360718,1,0.19560912251472473,0.8625898957252502,1,0.006184080430412648,0.9938159195695873,1
2314,Laboratory examinations:高血糖、代謝性アシドーシス(以下を伴う)、注記:アニオンギャップ上昇,Laboratory examinations 高血糖 代謝性アシドーシス 以下 伴う 注記 アニオンギャップ 上昇,1,0.018479407105043054,0.981520592894957,1,0.00035450032261849236,0.9996454996773815,1,0.02767608620177009,0.9723239137982299,1,2.3630855172651621e-07,0.9999997636914483,1,0.09133436530828476,0.9388418197631836,1,0.2001500278711319,0.8582305312156677,1,0.004440369191150539,0.9955596308088495,1
2315,好酸球性心筋炎、発熱、食欲減退、心電図ST部分上昇、心嚢液貯留、トロポニンT増加の結果として、治療措置が講じられた。,好酸球性 心筋炎 発熱 食欲減退 心電図 ST 部分 上昇 心嚢液 貯留 トロポニン T 増加 結果 治療 措置 講じる られる た,1,0.009047145608996693,0.9909528543910034,1,0.0003370224311936994,0.9996629775688063,1,0.01091155325841675,0.9890884467415832,1,0.08268062322087277,0.9173193767791272,1,0.08249576389789581,0.9475486278533936,1,0.18411241471767426,0.87340247631073,1,0.004733289971798674,0.9952667100282013,1
2316,事象「胸部正中の刺される痛み」と「トロポニンI値高値(12.00ng/mL)」は来院し、緊急治療室受診を必要とした。,事象 胸部 正中 刺す れる 痛み トロポニン I 値 高値 0 0 NG mL 来院 する 緊急 治療 室 受診 必要 する た,1,0.020126783138038767,0.9798732168619615,1,0.00029580818399938333,0.9997041918160006,1,0.026532623178329384,0.9734673768216706,1,0.3210119222759077,0.6789880777240923,1,0.07965096831321716,0.9501565098762512,1,0.17601223289966583,0.8694944977760315,1,0.007938556923454161,0.992061443076546,1
2317,振戦、低ナトリウム血症のため入院した(入院日:2022/03/28、退院日:2022/03/29、入院期間:1日)。,振戦 低ナトリウム血症 ため 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.016683643270212763,0.983316356729787,1,0.0003515251861127612,0.9996484748138872,1,0.022958243751349916,0.9770417562486501,1,7.748999778256493e-05,0.9999225100022174,1,0.08146068453788757,0.9471378922462463,1,0.20056191086769104,0.8585790395736694,1,0.004305477178282174,0.9956945228217179,1
2318,2022年3月15日午前8時00分症状名:末梢神経障害接種1週間後に、左顔面のしびれ感がみられ現在も持続している。,0 年 0 月 0 日 午前0時 0分 症状 名 末梢神経障害 接種 0 週間 後 左 顔面のしびれ 感 みる られる 現在 持続 する いる,1,0.016686628161493713,0.9833133718385063,1,0.000308578988541906,0.9996914210114581,1,0.16972006821916308,0.8302799317808369,1,0.27173657001739693,0.7282634299826031,1,0.09254460781812668,0.9459555745124817,1,0.19543491303920746,0.8716614842414856,1,0.009827118019463874,0.9901728819805362,1
2319,その後、次第に痺れや違和感の範囲は縮小したが、右手第1・第3・第4指の先端や第1関節の真ん中くらいまで症状が残る。,その後 痺れ 違和感 範囲 縮小 する た 右手 0 0 0 指 先端 0 関節 真ん中 症状 残る,1,0.016702047444496694,0.9832979525555032,1,0.00034554604949975885,0.9996544539505002,1,0.33618236329937823,0.6638176367006218,1,3.4782613991257705e-06,0.9999965217386009,1,0.16929005086421967,0.8983785510063171,1,0.28708139061927795,0.8163629174232483,1,0.010437031912344798,0.9895629680876553,1
2320,胸写上、CTR 53%と心拡大、心エコー上、左室の壁運動低下(びまん性)を認め、左室駆出率は43%と低下していた。,胸 写 上 CTR 0% 心拡大 心 エコー 上 左 室 壁運動低下 びまん性 認める 左 室 駆け出し 率 0% 低下 する いる た,1,0.00928398447022283,0.9907160155297772,1,0.00041986214332298235,0.999580137856677,1,0.03629341271525843,0.9637065872847416,1,0.30943161305904443,0.6905683869409556,1,0.0938461497426033,0.9416617155075073,1,0.19073352217674255,0.8654851317405701,1,0.008068316168228786,0.9919316838317711,1
2321,結果、右椎骨動脈の閉塞、左椎骨動脈解離性脳動脈瘤、Wallenberg症候群が認められ、同日他医療機関に緊急入院。,結果 右 椎骨動脈 閉塞 左椎骨動脈 解離性 脳動脈瘤 Wallenberg 症候群 認める られる 同日 医療機関 緊急入院,1,0.007120972321258846,0.9928790276787413,1,0.00040897970405431806,0.9995910202959457,1,0.018969786592253568,0.9810302134077464,1,0.0043189724775224425,0.9956810275224776,1,0.0809960663318634,0.9362412095069885,1,0.18599404394626617,0.8731312155723572,1,0.0041489397343664495,0.9958510602656335,1
2322,新型コロナウイルスワクチンによる薬物性肝障害が疑われたが、自己抗体陽性であり背景にAIHやPBCの存在も疑われた。,新型コロナウイルス ワクチン 薬物性 肝障害 疑う れる た 自己抗体 陽性 だ ある 背景 AIH PBC 存在 疑う れる た,1,0.00808363578198484,0.9919163642180153,1,0.0005577940306718315,0.9994422059693282,1,0.010232273268154346,0.9897677267318457,1,0.11277623772445078,0.8872237622755492,1,0.07939885556697845,0.942095935344696,1,0.18819180130958557,0.8675083518028259,1,0.005073117402685923,0.9949268825973141,1
2323,当院転院時、収縮期血圧72mmHg、末梢冷感著明で、経胸壁心エコーでは左室駆出率(LVEF)25%と低下を認めた。,院 転院 時 収縮期 血圧 0m mHg 末梢冷感著明 だ 経 胸壁 心 エコー 左 室 駆け出し 率 LVEF 0% 低下 認める た,1,0.03299696330684098,0.9670030366931589,1,0.0002149361614223501,0.9997850638385777,1,0.01665602788523657,0.9833439721147634,1,0.028283889721036126,0.9717161102789639,1,0.07706207036972046,0.947603166103363,1,0.18416430056095123,0.8695065379142761,1,0.004498154844174488,0.9955018451558254,1
2324,本剤の副反応により、肺毛細管レベルの血管炎を発症、抗凝固剤の内服中であったため、び漫性肺胞出血を発症と想定された。,本 剤 副反応 肺 毛細管 レベル 血管炎 発症 抗凝固剤 内服 中 だ ある た ため び漫性肺胞出血 発症 想定 する れる た,1,0.016678310877069495,0.9833216891229305,1,0.0003682920915530946,0.9996317079084469,1,0.08311994662646027,0.9168800533735397,1,0.16323423991062358,0.8367657600893764,1,0.07788402587175369,0.9393959045410156,1,0.1955869346857071,0.8560368418693542,1,0.006725103082697824,0.9932748969173022,1
2325,夜、軽度の頭痛、倦怠感、36.9̶37.5°Cの発熱(普段36°C前半)、両下肢筋力低下、食欲低下が発現し、継続。,夜 軽度 頭痛 倦怠感 0 0 0 0 C 発熱 普段 0 C 前半 両下肢筋力低下 食欲低下 発現 継続,1,1.5746007912942106e-08,0.9999999842539921,1,0.00048150656711902495,0.999518493432881,1,0.0011893259173787474,0.9988106740826213,1,0.015389893746682093,0.9846101062533179,1,0.08285161852836609,0.9468136429786682,1,0.18633496761322021,0.8761045932769775,1,0.003991414627263131,0.996008585372737,1
2326,来院時、心筋トロポニンTの上昇と不完全右脚ブロックを認め、経胸壁心臓超音波検査で側壁から下壁の壁運動低下を認めた。,来院 時 心筋 トロポニン T 上昇 不完全右脚 ブロック 認める 経 胸壁 心臓 超音波 検査 側壁 壁 壁運動低下 認める た,1,0.025895145113258387,0.9741048548867417,1,0.0003550109472890429,0.9996449890527109,1,0.00892374089198944,0.9910762591080106,1,0.00807782970158999,0.99192217029841,1,0.08098947256803513,0.945309042930603,1,0.19250436127185822,0.8740727305412292,1,0.004238136423554873,0.9957618635764451,1
2327,2021/07/24には、両大腿の感覚障害と歩行障害(バランスがとれず、スムーズに一歩ずつ足が出ない)が出現した。,0 0 0 大腿 感覚障害 歩行障害 バランス とれる ぬ スムーズ 一 歩 足 出る ない 出現 する た,1,0.016684860463982817,0.9833151395360173,1,0.0003116420537924297,0.9996883579462076,1,0.05453409620377514,0.9454659037962249,1,0.16637393287046098,0.833626067129539,1,0.07677149027585983,0.9447648525238037,1,0.19256554543972015,0.8696801066398621,1,0.0062475492811406835,0.9937524507188592,1
2328,キャッスルマン病、クレブシエラ感染、腹水、胸水、肝腫大、脾腫、骨髄線維症、菌血症の結果として治療的処置が取られた。,キャッスルマン病 クレブシエラ 感染 腹水 胸水 肝腫大 脾腫 骨髄線維症 菌血症 結果 治療 的 処置 取る れる た,1,0.016703651992240002,0.9832963480077599,1,0.0003371564650243981,0.9996628435349756,1,0.16475317911538068,0.8352468208846193,1,0.12060367181774845,0.8793963281822516,1,0.08573666960000992,0.9400790929794312,1,0.18620747327804565,0.8631907105445862,1,0.007199412916812427,0.9928005870831876,1
2329,2021/11/19 CTを撮影し、肺炎、肺膿瘍の診断となり、メロペネム、バンコマイシン、ミカファンギンを投与。,0 0 0 C，T 撮影 する 肺炎 肺膿瘍 の 診断 なる メロペネム バンコマイシン ミカファンギン 投与,1,0.007553837436728713,0.9924461625632713,1,0.00033448741006340355,0.9996655125899366,1,0.027079400480439775,0.9729205995195602,1,0.0001497212230692213,0.9998502787769308,1,0.14308854937553406,0.8936382532119751,1,0.19437916576862335,0.8648311495780945,1,0.004722107445400963,0.9952778925545991,1
2330,2022/03/20頃両側側頭部と右後頭部に10分程持続する殴られたような頭痛を1日3回ほど認めるようになった。,0 0 0 頃 両側 側 頭部 右 後頭部 0分 持続 する 殴る れる た よう 頭痛 0 日 0回 認める よう なる た,1,0.00720661360099933,0.9927933863990006,1,0.00048455392401885447,0.9995154460759812,1,0.003719881682515802,0.9962801183174842,1,0.3547882343000619,0.6452117656999381,1,0.0831787958741188,0.9465177059173584,1,0.18608704209327698,0.874675989151001,1,0.008005972268692672,0.9919940277313074,1
2331,2022/04/08プレドニゾロン30 mgに減量後発熱、炎症反応の増悪を認め、プレドニゾロン50 mgに増量。,0 0 0 プレドニゾロン 0 mg 減量 後発熱 炎症反応 の 増悪 認める プレドニゾロン 0 mg 増量,1,0.016685080438101452,0.9833149195618985,1,0.0001955929077860996,0.9998044070922139,1,0.07818663706465423,0.9218133629353458,1,0.0009106729352686971,0.9990893270647313,1,0.14240679144859314,0.9151178598403931,1,0.19041922688484192,0.86699378490448,1,0.005182201384524864,0.9948177986154751,1
2332,2022/06/21血液検査実施したところ、AST、CK、LDH値の増悪を認め、エコー上も心嚢液の増加を認めた。,0 0 0 血液検査 実施 する た ところ AST CK LDH 値 増悪 認める エコー 上 心嚢液 増加 認める た,1,0.007408069993844377,0.9925919300061556,1,0.00047141443099729224,0.9995285855690027,1,0.012686638959851115,0.9873133610401489,1,0.00886144403966116,0.9911385559603388,1,0.07914102077484131,0.9469327330589294,1,0.18478819727897644,0.8714500665664673,1,0.004088018730587674,0.9959119812694123,1
2333,"2022/07/11血液検査でGOT 3,111、GPT 3,450、T-Bil 5.1と著明な肝障害を認めた。",0 0 0 血液検査 GOT 0 0 GPT 0 0 T Bil 0 0 著 明 だ 肝障害 認める た,1,0.018036667651992393,0.9819633323480076,1,0.0003378197432321862,0.9996621802567678,1,0.03448493330296498,0.965515066697035,1,0.014917439067713922,0.9850825609322861,1,0.0744311735033989,0.9481121301651001,1,0.18365545570850372,0.8751472234725952,1,0.004365623819727725,0.9956343761802723,1
2334,患者は脳脊髄炎(RIBS処置から14ヶ月後、脳脊髄炎疑いのため死亡)(重篤度基準死亡、医学的に重要)を発現した。,患者 脳脊髄炎 RIBS 処置 0 ヶ月 後 脳脊髄炎 疑い ため 死亡 重篤 度 基準 死亡 医学 的 重要 発現 する た,1,2.757824440061251e-06,0.99999724217556,1,0.0006723488828169227,0.999327651117183,1,0.006467256521841325,0.9935327434781587,1,0.18546342073248379,0.8145365792675162,1,0.09544383734464645,0.9362649321556091,1,0.23241576552391052,0.8251296281814575,1,0.006379133812061524,0.9936208661879384,1
2335,近医にて血液検査が行われ、血糖値539mg/dL、HbAc(報告の通り)11.4%と急激な血糖上昇が認められた。,近医 血液検査 行う れる 血糖 値 0m g dL HbAc 報告 通り 0 0% 急激 だ 血糖上昇 認める られる た,1,0.0186747260309058,0.9813252739690941,1,0.0002723284553486829,0.9997276715446514,1,0.030031807641440755,0.9699681923585592,1,0.05724779517407386,0.9427522048259261,1,0.07791154831647873,0.9474273324012756,1,0.17975082993507385,0.867794930934906,1,0.004748784131999912,0.995251215868,1
2336,高感度トロポニンIの上昇あり、緊急冠動脈造影にて両側冠動脈末梢部位の瘤状変化と右冠動脈房室枝の血栓閉塞を認めた。,感度 トロポニン I 上昇 ある 緊急 冠動脈造影 両側 冠動脈 末梢 部位 瘤状変化 右 冠動脈 房 室 枝 血栓 閉塞 認める た,1,0.013541029944764084,0.9864589700552358,1,0.00033930890006850727,0.9996606910999315,1,0.00980930396598989,0.9901906960340101,1,0.04564531807801775,0.9543546819219823,1,0.07407717406749725,0.9459138512611389,1,0.19080379605293274,0.8753707408905029,1,0.0044175895770247236,0.9955824104229752,1
2337,接種から45日後(2回目)、LV基底下部中壁に遅延ガドリニウム増強を認めた、基底中壁にT2WBB高信号を認めた。,接種 0 日 後 0回目 LV 基底 下部 中 壁 遅延 ガドリニウム 増強 認める た 基底 中 壁 T 0W B・B 高信号 認める た,1,0.020070053463601953,0.979929946536398,1,0.00034520357119121215,0.9996547964288088,1,0.025829695450967805,0.9741703045490322,1,0.020928673285485866,0.9790713267145141,1,0.08128479868173599,0.942733108997345,1,0.18790991604328156,0.8784970045089722,1,0.004417789927099169,0.9955822100729008,1
2338,"接種後38日時点でsCr 7.25mg/dL、尿中β2MG 17,647ng/mLと腎機能の増悪を認め入院した。",接種 後 0 日 時点 sCr 0 0m g dL 尿 中 0 MG 0 0 NG mL 腎 機能 増悪 認める 入院 する た,1,0.009283962015419839,0.9907160379845803,1,0.000290863000382872,0.9997091369996172,1,0.01056986241550062,0.9894301375844994,1,0.1393424610920463,0.8606575389079537,1,0.07537905871868134,0.9492965340614319,1,0.17631648480892181,0.8718404173851013,1,0.005217700605252755,0.9947822993947472,1
2339,炎症反応高値、MMP-3抗体高値、リウマチ因子陰性、手指MSIで滑膜炎を認め、RS3 PE症候群の診断であった。,炎症反応高値 MMP 0 抗体 高値 リウマチ 因子 陰性 手 指 MSI だ 滑膜炎 認める RS 0 PE 症候群 の 診断 だ ある た,1,0.011273781107843913,0.988726218892156,1,0.0003997569937862932,0.9996002430062138,1,0.011532313134626437,0.9884676868653736,1,0.40910640774024787,0.5908935922597521,1,0.09088251739740372,0.9421877264976501,1,0.18500548601150513,0.8724502325057983,1,0.009247372402311696,0.9907526275976883,1
2340,解剖検査の結果、C反応性蛋白(CRP)上昇、病理検査にて心筋内に広範に炎症細胞の浸潤を認め、心筋炎と診断された。,解剖 検査 結果 C 反応 性 蛋白 CRP 上昇 病理検査 心筋 内 広範 炎症細胞 浸潤 認める 心筋炎 診断 する れる た,1,0.005721476586935497,0.9942785234130648,1,0.00045712494644976795,0.9995428750535502,1,0.0037997106474079168,0.9962002893525921,1,0.1415594117392882,0.8584405882607118,1,0.0905139148235321,0.9515252709388733,1,0.18168386816978455,0.8727087378501892,1,0.0052255250205253175,0.9947744749794747,1
2341,2022/03/06の朝から、呼吸困難、摂氏38.0度(1日のみ)の発熱、SpO2 93%を発現して、入院した。,0 0 0 朝 呼吸困難 摂氏 0 0度 0 日 発熱 SpO 0 0% 発現 する 入院 する た,1,3.507485468866786e-08,0.9999999649251453,1,0.0006713989064796128,0.9993286010935204,1,0.0029767139330161285,0.9970232860669839,1,0.17728350966997952,0.8227164903300205,1,0.07142411172389984,0.9509070515632629,1,0.17453180253505707,0.8728266954421997,1,0.005400145955250726,0.9945998540447493,1
2342,しかし、2021/08/26から、左上腕に異常感覚(上腕部の熱さ)と疼痛、左前腕橈骨神経領域のしびれが発現した。,0 0 0 左上 腕 異常感覚 上腕 部 熱 さ 疼痛 左前腕 橈骨 神経 領域 しびれ 発現 する た,1,0.004429064572829534,0.9955709354271705,1,0.00044821194456797923,0.999551788055432,1,0.008703189029049652,0.9912968109709503,1,0.14681344509375238,0.8531865549062476,1,0.07672733068466187,0.9466181397438049,1,0.18956877291202545,0.8764382600784302,1,0.0052934767846814015,0.9947065232153186,1
2343,ラテックスアレルギーを含む、他の物質に対するアレルギーがあり、アナフィラキシー歴もあることから、入院加療とした。,ラテックスアレルギー 含む 他 物質 アレルギー ある アナフィラキシー 歴 ある こと 入院 加療 する た,1,0.01668923860733623,0.9833107613926638,1,0.00024912526985356267,0.9997508747301465,1,0.07042236510718147,0.9295776348928185,1,0.09991602615839279,0.9000839738416072,1,0.11322725564241409,0.9283548593521118,1,0.219855397939682,0.8444297909736633,1,0.0062733698250409965,0.993726630174959,1
2344,事象「発熱」、「労作時呼吸困難感が出現、増悪/労作時、安静時、又は臥位での息切れ」、「嘔気」のため受診を要した。,事象 発熱 労作時呼吸 困難感 出現 増悪 労作 時 安静 時 臥 位 息切れ 嘔気 ため 受診 要す た,1,1.5361102533705146e-05,0.9999846388974662,1,0.0004219474802048328,0.9995780525197951,1,0.002864350868033383,0.9971356491319666,1,0.026488129850801623,0.9735118701491984,1,0.08176200836896896,0.9482678771018982,1,0.18605172634124756,0.8738327026367188,1,0.004091648602994139,0.995908351397006,1
2345,Protein total (6.5- 8.2):(2022/02/04)6.4 g/dl、注釈:コメント:低値,Protein total 0 0 0 0 0 0 0 0 0 g dl 注釈 コメント 値,1,0.007830471484683497,0.9921695285153165,1,0.0004457492536328193,0.9995542507463672,1,0.21609434582327636,0.7839056541767236,1,0.0015861495886501098,0.9984138504113499,1,0.151227667927742,0.8886737823486328,1,0.20842906832695007,0.8450812697410583,1,0.007230539039705319,0.9927694609602947,1
2346,"2021/07/05帯状疱疹後神経痛でメチコバール1,000 mcg、セレコキシブ200 mgを経口投与開始。",0 0 0 帯状疱疹後 神経痛 メチコバール 0 0 mcg セレコキシブ 0 mg 経口 投与 開始,0,0.8886710798100689,0.11132892018993136,0,0.00013935290763064824,0.9998606470923693,0,0.875724574173768,0.12427542582623191,1,0.06364297540302755,0.9363570245969725,0,0.7703051567077637,0.29836323857307434,0,0.6151186227798462,0.381859689950943,1,0.5894172428942935,0.41058275710570646,1
2347,2021/07/24、両大腿の感覚障害と歩行障害(バランスがとれず、スムーズに一歩ずつ足が出ない)が出現した。,0 0 0 大腿 感覚障害 歩行障害 バランス とれる ぬ スムーズ 一 歩 足 出る ない 出現 する た,1,0.016684860463982817,0.9833151395360173,1,0.0003116420537924297,0.9996883579462076,1,0.05453409620377514,0.9454659037962249,1,0.16637393287046098,0.833626067129539,1,0.07677149027585983,0.9447648525238037,1,0.19256554543972015,0.8696801066398621,1,0.0062475492811406835,0.9937524507188592,1
2348,MRIでは大脳皮質、白質や視床、脳幹、右三叉神経などの多数の部位に病変を認めたが、自覚症状は複視のみであった。,MRI 脳皮質 白質 視床 脳幹 右 三叉神経 多数 部位 病変 認める た 自覚症状 複視 だ ある た,1,0.012163769272543774,0.9878362307274562,1,0.0003215751986237813,0.9996784248013763,1,0.019638232532174227,0.9803617674678258,1,0.40004161215512535,0.5999583878448747,1,0.07923950999975204,0.9459006190299988,1,0.181550070643425,0.8748785853385925,1,0.009052153277416784,0.9909478467225833,1
2349,以前は健全であった22歳の日本人男性が2日間発熱し、その後本剤接種3日後に鈍い胸痛の為、当救急科に移送された。,以前 健全 だ ある た 0歳 日本人男性 0 日間 発熱 その後 本 剤 接種 0 日 後 鈍い 胸痛 為 救急科 移送 する れる た,1,0.016661484010817875,0.9833385159891821,1,0.0002874822168529332,0.9997125177831471,1,0.009962099907818711,0.9900379000921813,1,0.17305200630038153,0.8269479936996185,1,0.07647240161895752,0.9494858980178833,1,0.18582606315612793,0.8636588454246521,1,0.005760693088335891,0.9942393069116641,1
2350,右第3指と第4指の中手指節関節(MCP)及び近位指節間(PIP)関節に腫脹を認め軽度の発赤と温感を伴っていた。,右 0 指 0 指 中手 指 節 関節 MCP 位 指 節 間 PIP 関節 腫脹 認める 軽度 発赤 温 感 伴う いる た,1,0.004277920674958054,0.995722079325042,1,0.0004214934682564097,0.9995785065317436,1,0.01092194810750502,0.989078051892495,1,0.31583166399372364,0.6841683360062764,1,0.07783323526382446,0.9442874789237976,1,0.1908290684223175,0.8650715351104736,1,0.007556284816038209,0.9924437151839619,1
2351,蛍光抗体法不能であり、免疫染色したところIgA沈着を認め、IgA腎症による半月体形成性糸球体腎炎を呈していた。,蛍光 抗体 法 不能 だ ある 免疫 染色 する た ところ IgA 沈着 認める IgA 腎症 半月体形成性糸球体 腎炎 呈す いる た,1,0.026658772461231245,0.9733412275387686,1,0.00028410252503307984,0.9997158974749669,1,0.009824121053390478,0.9901758789466095,1,0.0810506338779059,0.9189493661220941,1,0.09262756258249283,0.9321674108505249,1,0.19170963764190674,0.8638113141059875,1,0.005086801432803306,0.9949131985671967,1
2352,血液検査で心筋トロポニンI 2.240 ng/mL、CK 255 U/L、CRP 2.11 mg/dLと上昇。,血液検査 心筋 トロポニン I 0 0 NG mL CK 0 U L CRP 0 0 mg dL 上昇,0,0.7660913313025449,0.2339086686974551,0,0.00015524923128723472,0.9998447507687128,1,0.25457604837771164,0.7454239516222884,1,2.1973703523414656e-08,0.9999999780262965,1,0.09664129465818405,0.9400186538696289,1,0.1903751790523529,0.8721796274185181,1,0.029784314537075408,0.9702156854629246,1
2353,新しいST区域の異常な沈降がII、III、及びaVFに、逆向きT波がIII、aVF、及びV2-3に認められた。,新しい ST 区域 異常 だ 沈降 II III aVF 向き T 波 III aVF V 0 0 認める られる た,1,0.010699229709021455,0.9893007702909784,1,0.0003003343875598259,0.9996996656124402,1,0.02547769314974435,0.9745223068502556,1,0.0676882713443655,0.9323117286556345,1,0.07633442431688309,0.946008026599884,1,0.18669603765010834,0.8707321882247925,1,0.004747498178189201,0.9952525018218109,1
2354,日付不明両側膝関節や両側足関節の疼痛のため歩行困難となり、近医総合病院救急外来を受診後に同院内科で精査された。,日付 不明 両側 膝関節 両側 足関節 疼痛 ため 歩行困難 なる 近医 総合病院 救急外来 受診 後 同院 内科 精査 する れる た,1,0.016672267763464043,0.9833277322365361,1,0.0003767674205354402,0.9996232325794645,1,0.0609208863568359,0.9390791136431641,1,0.1844253080624052,0.8155746919375948,1,0.0831160843372345,0.9438742399215698,1,0.18348950147628784,0.8666625618934631,1,0.006566796180109833,0.9934332038198902,1
2355,本剤第1回目を接種し、翌日から下肢の浮腫と乏尿を生じ、尿蛋白3+が3日間持続し、体重は67.0kgに増加した。,本 剤 0回目 接種 する 翌日 下肢 浮腫 乏尿 生じる 尿蛋白 0 0 日間 持続 する 体重 0 0kg 増加 する た,1,0.0025278005917060684,0.9974721994082939,1,0.0007629129433736507,0.9992370870566264,1,0.1767083671594788,0.8232916328405212,1,0.23733536634789554,0.7626646336521045,1,0.07474508881568909,0.9529243111610413,1,0.1906115859746933,0.8727139234542847,1,0.008787378216623233,0.9912126217833769,1
2356,2021/10/29朝05:00、被験者は右腰痛を主訴とし、外来患者として報告病院の救急科と診療所を受診した。,0 0 0 朝 0 0 被験者 右腰痛 主訴 する 外来患者 報告 病院 救急 科 診療所 受診 する た,1,0.016664932504461778,0.9833350674955383,1,0.0003329869807385129,0.9996670130192615,1,0.2383662988479207,0.7616337011520793,1,0.13212019771235195,0.867879802287648,1,0.07867611199617386,0.9503689408302307,1,0.18137021362781525,0.8747069835662842,1,0.008243433253022903,0.9917565667469771,1
2357,2022/04/05、ワクチン接種後より、食欲低下、倦怠感が出現し、2022/04/28に両側肺炎像を認めた。,0 0 0 ワクチン接種 後 食欲低下 倦怠感 出現 0 0 0 両側肺炎像 認める た,1,1.2146283209298795e-07,0.9999998785371679,1,0.000532877978143148,0.9994671220218568,1,0.0035738514199440408,0.996426148580056,1,0.00740018293814626,0.9925998170618537,1,0.07834094017744064,0.9507577419281006,1,0.18015916645526886,0.878376841545105,1,0.0038815933380135473,0.9961184066619866,1
2358,2022/04/09 23:00ごろ(ワクチン接種から1日と23時間後)、患者は意識消失、転倒、骨折を呈した。,0 0 0 0 0 ごろ ワクチン接種 0 日 0時 間 後 患者 意識消失 転倒 骨折 呈す た,1,0.01358492841775248,0.9864150715822473,1,0.00038717490884111695,0.9996128250911589,1,0.07679747702953599,0.923202522970464,1,0.0003845714497330288,0.999615428550267,1,0.07949409633874893,0.945599377155304,1,0.1777215600013733,0.8724578619003296,1,0.004593388693623295,0.9954066113063766,1
2359,2022/04/22(3回目接種翌日)から、強い口渇感を自覚するようになり、多飲多尿症状を認めるようになった。,0 0 0 0回目 接種 翌日 強い 口渇感 自覚 する よう なる 多飲 多尿症状 認める よう なる た,1,2.021199588846636e-06,0.9999979788004111,1,0.0004746041579897087,0.9995253958420103,1,0.004930014035382291,0.9950699859646177,1,0.3428345009594307,0.6571654990405693,1,0.07725781947374344,0.9498870372772217,1,0.18401779234409332,0.8737120628356934,1,0.007646425335783816,0.992353574664216,1
2360,その後意識レベルが低下し(JCS III-200位)、呼吸抑制(一時的)を認め、右上肢のシバリングが出現した。,その後 意識レベル 低下 する JCS III 0 位 呼吸抑制 一時的 認める 右 上肢 シバリング 出現 する た,1,7.012837214528814e-07,0.9999992987162786,1,0.0005142654113315221,0.9994857345886685,1,0.003138030847336548,0.9968619691526635,1,0.17128819862392686,0.8287118013760731,1,0.0755542740225792,0.9480326175689697,1,0.17957375943660736,0.8737888336181641,1,0.005395332960232695,0.9946046670397674,1
2361,ただし、患者によると背部や上肢に痛みが出現しており、ワクチンの副反応だけでは説明ができない症状をきたしていた。,患者 よる 背部 上肢 痛み 出現 する おる ワクチン 副反応 だ 説明 できる ない 症状 きたす いる た,1,0.21255730171317233,0.7874426982868276,1,0.00021483493241703546,0.999785165067583,1,0.04567508126335862,0.9543249187366414,1,0.17485147747141772,0.8251485225285823,1,0.0843830332159996,0.9430791735649109,1,0.2177066057920456,0.8426244854927063,1,0.009785531577712394,0.9902144684222877,1
2362,過去の病歴および検査所見は、COVID-19ワクチン接種を契機とした免疫学的機序による脳症の診断につながった。,過去 病歴 お呼び 検査 所見 COVID 0 ワクチン接種 契機 する た 免疫学的機序 脳症 の 診断 つながる た,1,0.04082965630700218,0.9591703436929977,1,0.0002678474624164273,0.9997321525375835,1,0.05382166394645149,0.9461783360535485,1,0.06776339826352118,0.9322366017364788,1,0.08693140000104904,0.9407066702842712,1,0.23185570538043976,0.8549224138259888,1,0.0057575053877747554,0.9942424946122251,1
2363,抗MDA抗体は6300(高値)であり、抗MDA5抗体陽性間質性肺炎(anti-MDA5-ILD)と診断された。,MDA 抗体 0 高値 だ ある MDA 0 抗体陽性 間質性 肺炎 ANTI MDA 0 ILD 診断 する れる た,1,0.004991323880309072,0.9950086761196912,1,0.0005458699199137561,0.9994541300800862,1,0.008388214816649864,0.9916117851833501,1,0.26599823841945436,0.7340017615805456,1,0.07969341427087784,0.94366055727005,1,0.182702898979187,0.8772745728492737,1,0.006701555372200673,0.9932984446277993,1
2364,振戦、血圧上昇のため入院した(入院日:2022/06/16、退院日:2022/06/19、入院期間:3日間)。,振戦 血圧 上昇 ため 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日間,1,0.00663472371370031,0.9933652762862997,1,0.00039511454040986775,0.9996048854595901,1,0.010019628512399792,0.9899803714876002,1,0.0007392402685324484,0.9992607597314676,1,0.07844837009906769,0.9476892948150635,1,0.19636526703834534,0.8599206805229187,1,0.004081426568841706,0.9959185734311582,1
2365,頭部磁気共鳴画像:DWI画像にて脳梁膨大部に限局した高信号域を認め、同部位はADC画像では低信号を呈していた。,頭部 磁気 共鳴 画像 DWI 画像 脳梁 膨大 部 限局 する た 高信号域 認める 部位 ADC 画像 低信号 呈す いる た,1,0.03178273875721916,0.968217261242781,1,0.0002554689189690415,0.999744531081031,1,0.013374204857326655,0.9866257951426733,1,0.13907650040390107,0.8609234995960989,1,0.08381349593400955,0.9387908577919006,1,0.204444020986557,0.8673164248466492,1,0.005772436017806054,0.9942275639821939,1
2366,特異的所見:(2022/01)ovoid lesionやisolated U-fiber lesionを認めた,特異的 所見 0 0 ovoid lesion isolated U fiber lesion 認める た,1,0.006708403758427194,0.9932915962415726,1,0.0003066110041077495,0.9996933889958922,1,0.03954730932014172,0.9604526906798583,1,0.009410723578643254,0.9905892764213567,1,0.08642962574958801,0.9318832755088806,1,0.18987129628658295,0.869250476360321,1,0.004438958180429258,0.9955610418195708,1
2367,発熱、排尿困難のため入院した(入院日:2022/06/16、退院日: 2022/06/19、入院期間:3日間),発熱 排尿困難 ため 入院 する た 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日間,1,0.004698069394359367,0.9953019306056405,1,0.00037824905792526657,0.9996217509420747,1,0.01213759009899451,0.9878624099010055,1,0.0006044755943721558,0.9993955244056278,1,0.08176329731941223,0.9489659070968628,1,0.20022156834602356,0.860531747341156,1,0.004103201880480529,0.9958967981195195,1
2368,C1 esterase inhibitor test:わずかに上昇、注記:2回目投与の4週間後に検査が行われた,C 0 esterase inhibitor test 上昇 注記 0回目 投与 0 週間 後 検査 行う れる た,1,0.02064862655216357,0.9793513734478365,1,0.0002573638996985633,0.9997426361003015,1,0.11655484232087443,0.8834451576791256,1,0.24695197370112698,0.753048026298873,1,0.1509251445531845,0.9032142758369446,1,0.21253573894500732,0.8587550520896912,1,0.009663557913177025,0.990336442086823,1
2369,2022年2月18日ワクチン接種後より接種した左上肢から肩の痛みが持続し、次第に左肩の可動域制限をきたした。,0 年 0 月 0 日 ワクチン接種 後 接種 する た 左上 肢 肩 痛み 持続 する 左肩 可動域 制限 きたす た,1,0.016699478981513104,0.983300521018487,1,0.0003974376483535907,0.9996025623516465,1,0.17087248204676864,0.8291275179532314,1,0.054621150887121495,0.9453788491128785,1,0.08170200884342194,0.9479089975357056,1,0.1877826452255249,0.8723230361938477,1,0.006270765827834752,0.9937292341721653,1
2370,MRIではSTIR像で両側の視神経周囲に水平断でtram- track状、冠伏断でリング状の高信号を認めた。,MRI STIR 像 両側 視神経 周囲 水平 断 tram track 状 冠 伏 断 リング 状 高信号 認める た,1,0.012543802321788353,0.9874561976782117,1,0.0003632227064557748,0.9996367772935443,1,0.05154861421279733,0.9484513857872027,1,0.12429119601324734,0.8757088039867527,1,0.09345127642154694,0.9356123805046082,1,0.21060112118721008,0.8671539425849915,1,0.0059333206517002725,0.9940666793482996,1
2371,解剖時に採血した血液及び尿中3-ヒドロキシ酪酸濃度の著増を認め、ケトアシドーシスにより死亡したと考えられた。,解剖 時 採血 する た 血液 尿 中 0 ヒドロキシ酪酸 濃度 著 増 認める ケトアシドーシス 死亡 する た 考える られる た,1,0.00785910192621038,0.9921408980737895,1,0.0003540391809369694,0.999645960819063,1,0.015249297626654612,0.9847507023733454,1,0.007940663666172743,0.9920593363338273,1,0.07722845673561096,0.942323625087738,1,0.20800089836120605,0.8476828932762146,1,0.004312262607416331,0.9956877373925836,1
2372,頚部膿瘍の除外目的に実施した頚部造影CTにて甲状腺左葉に辺縁に造影効果を伴う濃度不均一な腫瘤性病変を認めた。,頚部膿瘍 除外 目的 実施 する た 頚部 造影 C，T 甲状腺左葉 辺縁 造影効果 伴う 濃度不均一 腫瘤 性病変 認める た,1,0.07837314231685931,0.9216268576831407,1,0.00021158962141039676,0.9997884103785896,1,0.03745303518518195,0.962546964814818,1,0.01924580852361324,0.9807541914763868,1,0.09583736211061478,0.9295443296432495,1,0.1957351714372635,0.8598671555519104,1,0.005339487555950172,0.99466051244405,1
2373,血液検査上、AST、LDH、トロポニンIと心筋逸脱酵素の上昇を認めたため急性心膜炎と診断し、入院対応とした。,血液検査 上 AST LDH トロポニン I 心筋逸脱酵素 上昇 認める た ため 急性心膜炎 診断 入院 対応 する た,1,2.0130769685559552e-07,0.9999997986923032,1,0.0005320508212000199,0.9994679491788,1,0.005093776661185934,0.9949062233388141,1,0.1321180993916281,0.8678819006083719,1,0.08013135194778442,0.9479694366455078,1,0.1814572811126709,0.8743950724601746,1,0.0050400442970518315,0.9949599557029483,1
2374,頭部の3次元コンピュータ断層撮影(CT)血管造影術では、右VAの紡錘状拡張を認め、解離性動脈瘤が示唆された。,頭部 0 次元 コンピュータ断層撮影 C，T 血管造影 術 右 VA 紡錘状拡張 認める 解離性 動脈瘤 示唆 する れる た,1,0.007854868663441384,0.9921451313365586,1,0.00036911895523698997,0.999630881044763,1,0.016883509804651253,0.9831164901953487,1,0.13308884103882235,0.8669111589611777,1,0.08234791457653046,0.9384749531745911,1,0.1896943598985672,0.873899519443512,1,0.005357214418835182,0.9946427855811647,1
2375,同時にAlb 2.1g/dL、Cr 1.75mg/dL、尿蛋白11.4g/gCrのネフローゼ症候群を認めた。,Alb 0 0g dL Cr 0 0m g dL 尿蛋白 0 0g gCr ネフローゼ 症候群 認める た,1,0.007679160556442469,0.9923208394435578,1,0.0002854576201886999,0.9997145423798113,1,0.025789004138087934,0.9742109958619121,1,0.005382233434486183,0.9946177665655138,1,0.07570717483758926,0.9462912678718567,1,0.1830776035785675,0.8753211498260498,1,0.004133223299591212,0.9958667767004088,1
2376,心電図では胸部誘導での陰性T波を認めたが、病歴と併せたこつぼ型心筋症よりも劇症型心筋炎の診断が妥当と考えた。,心電図 胸部誘導 陰性 T 波 認める た 病歴 併せる たこつぼ 型 心筋症 劇症型 心筋炎 の 診断 妥当 考える た,1,0.010896094893847972,0.989103905106152,1,0.000403404340536449,0.9995965956594636,1,0.004087859167701047,0.995912140832299,1,0.03354101964687295,0.966458980353127,1,0.08183268457651138,0.9400916695594788,1,0.20116114616394043,0.8603562116622925,1,0.0044094009163682365,0.9955905990836318,1
2377,2022/07/27 18:00ごろ(ワクチン接種の4時間30分後)、患者は体調不良と全身筋痛症を発現した。,0 0 0 0 0 ごろ ワクチン接種 0時 間 0分 後 患者 体調不良 全身筋痛 症 発現 する た,1,0.0045078410692677056,0.9954921589307322,1,0.00039926360837448584,0.9996007363916255,1,0.01871572649241715,0.9812842735075828,1,0.11345801233623676,0.8865419876637632,1,0.08151202648878098,0.9502556324005127,1,0.17735640704631805,0.8727990388870239,1,0.005016345889820118,0.99498365411018,1
2378,2022/04/06 13:00(ワクチン接種1日後)、微熱、左上腕の腫脹、左上腕の疼痛、左胸痛を発症した。,0 0 0 0 0 ワクチン接種 0 日 後 微熱 左上 腕 腫脹 左上 腕 疼痛 左胸痛 発症 する た,1,0.004829686576532066,0.995170313423468,1,0.0004422828335829577,0.9995577171664171,1,0.05643433464600689,0.9435656653539931,1,0.12432971632779899,0.875670283672201,1,0.07502888143062592,0.9489408731460571,1,0.1766597479581833,0.8739011883735657,1,0.005491313288873267,0.9945086867111268,1
2379,ギラン・バレー症候群、ミラー・フィッシャー症候群、複視、眼運動障害、眼瞼下垂の結果として治療処置が行われた。,ギラン・バレー症候群 ミラー フィッシャー症候群 複視 眼運動障害 眼瞼下垂 結果 治療 処置 行う れる た,1,0.015718314188971766,0.9842816858110282,1,0.0002340983044481309,0.9997659016955519,1,0.12533456421671574,0.8746654357832843,1,0.1778634556475981,0.8221365443524019,1,0.08383719623088837,0.9397185444831848,1,0.18577231466770172,0.8760684132575989,1,0.0073339752561142535,0.9926660247438857,1
2380,ただし、心筋の信号強度が骨格筋よりも高く、典型的には少なくとも1カ所の非虚血領域において遅延造影像を認めた。,心筋 信号 強度 骨格筋 高い 典型的 0 カ所 虚血領域 遅延 造影 像 認める た,1,0.014185264134667457,0.9858147358653327,1,0.0003529229100209544,0.999647077089979,1,0.04109752215137652,0.9589024778486235,1,0.016343343182664394,0.9836566568173356,1,0.08282111585140228,0.9389642477035522,1,0.18329590559005737,0.8676926493644714,1,0.004511599291944741,0.9954884007080553,1
2381,事象「左手小指の変形」、「左手小指を動かしにくい感じ/左手小指の可動性低下」により、診療所への来院を要した。,事象 左手 小指 変形 左手 小指 動かす にくい 感じ 左手 小指 可動性低下 診療所 来院 要す た,1,0.016697123331482513,0.9833028766685175,1,0.0003507272266004698,0.9996492727733995,1,0.3840022050546271,0.6159977949453729,1,0.15917127028906497,0.840828729710935,1,0.07724106311798096,0.9449430108070374,1,0.1866254359483719,0.8661540746688843,1,0.011811638912244956,0.988188361087755,1
2382,多発関節痛、筋痛があり、2022/05/18の再診時に抗好中球細胞質抗体(HPO-ANCA)陽性が判明した。,多発関節痛 筋痛 ある 0 0 0 再診 抗好中球細胞質抗体 HPO ANCA 陽性 判明 する た,1,0.006621318462270297,0.9933786815377298,1,0.0003676941694801348,0.9996323058305199,1,0.020352679490613146,0.9796473205093869,1,0.1451247737298209,0.8548752262701791,1,0.08900925517082214,0.9461336135864258,1,0.18288686871528625,0.8764379024505615,1,0.0054550556980382916,0.9945449443019617,1
2383,頭痛、頚部痛、浮動性めまい、フィブリン分解産物増加、フィブリンDダイマー増加の結果として治療処置がとられた。,頭痛 頚部痛 浮動性 めまい フィブリン 分解 産物 増加 フィブリン D ダイマー 増加 結果 治療 処置 とる れる た,1,0.0072405484956525965,0.9927594515043475,1,0.0004079266140697729,0.9995920733859303,1,0.01132856099609103,0.988671439003909,1,0.14550051837173694,0.8544994816282631,1,0.08066882938146591,0.9396629333496094,1,0.18785354495048523,0.8667950630187988,1,0.005437516399443924,0.994562483600556,1
2384,肺炎、発熱のため入院した(開始日:2022/03/23、退院日: 2022/03/29、入院期間:6日間)。,肺炎 発熱 ため 入院 する た 開始 日 0 0 0 退院 日 0 0 0 入院 期間 0 日間,1,1.3579729211050957e-05,0.999986420270789,1,0.0003816382162032412,0.9996183617837967,1,0.0019648825351457067,0.9980351174648543,1,0.00038950739459298056,0.999610492605407,1,0.07898011058568954,0.9474509954452515,1,0.190708190202713,0.8585811257362366,1,0.003947000266144492,0.9960529997338555,1
2385,発熱の結果として、アセトアミノフェン(カロナール、2022/05/16、経口)を含む治療的な処置がとられた。,発熱 結果 アセトアミノフェン カロナール 0 0 0 経口 含む 治療 的 だ 処置 とる れる た,1,0.016682923313434156,0.9833170766865659,1,0.0003198304397444614,0.9996801695602555,1,0.01673231972713274,0.9832676802728673,1,0.09255427038068709,0.9074457296193129,1,0.09158121049404144,0.9351675510406494,1,0.22118236124515533,0.8470166325569153,1,0.0053951671532211695,0.9946048328467788,1
2386,有意な心筋逸脱酵素上昇と軽度な心電図異常が認められた(2021/10/15)、患者は急性心筋炎と診断された。,有意 だ 心筋逸脱酵素上昇 軽度 だ 心電図異常 認める られる た 0 0 0 患者 急性心筋炎 診断 する れる た,1,0.004947810303395586,0.9950521896966041,1,0.0003060498047223667,0.9996939501952776,1,0.02547358936018851,0.9745264106398115,1,0.07307579819386223,0.9269242018061378,1,0.07991679012775421,0.9528705477714539,1,0.17452268302440643,0.8751510381698608,1,0.004651164631200052,0.9953488353687999,1
2387,臨床概要: 2022/01/25(ワクチン接種の同日)、アナフィラキシー症状(発疹、咽頭不快感)を発現した。,臨床 概要 0 0 0 ワクチン接種 同日 アナフィラキシー症状 発疹 咽頭不快感 発現 する た,1,0.010320131835933135,0.9896798681640671,1,0.00035292194878004077,0.99964707805122,1,0.019272235273748217,0.9807277647262518,1,0.13016405040436685,0.8698359495956332,1,0.0821520984172821,0.9456884264945984,1,0.18428802490234375,0.876904308795929,1,0.005293679729224695,0.9947063202707752,1
2388,入院時のCT血管造影では、完全に血栓化した弓部大動脈瘤が認められ、EL又はSG関連の合併症の徴候はなかった。,入院 時 CT 血管造影 だ 完全 血栓化 する た 弓部大動脈瘤 認める られる EL SG 関連 合併症 の 徴候 ない た,1,0.12192591202656215,0.8780740879734378,0,0.00016152171412349347,0.9998384782858765,0,0.6767841234522163,0.32321587654778366,0,0.818569233887413,0.18143076611258702,1,0.3753344714641571,0.7722707986831665,0,0.7520260810852051,0.26710057258605957,1,0.336902328128627,0.663097671871373,1
2389,11歳時に紫斑病性腎炎を発症し、加療を行うも腎機能障害が進行し、慢性腎臓病(CKD)stage5に至った。,0歳 時 紫斑病 性 腎炎 発症 加療 行う 腎機能障害 進行 する 慢性腎臓病 CKD stage 0 至る た,1,0.014120206627935467,0.9858797933720644,1,0.000413727856623215,0.9995862721433768,1,0.021543218409183384,0.9784567815908166,1,0.032705730448655324,0.9672942695513447,1,0.07935436069965363,0.943114161491394,1,0.18049786984920502,0.8761849403381348,1,0.0043993864243313885,0.9956006135756686,1
2390,2021/08発症6日目、眼の発赤、疼痛を伴わない右眼にお血突発性及び重症の視力喪失のため、当院紹介受診。,0 0 発症 0 日 目 眼 発赤 疼痛 伴う ない 右 眼 お血 突発性 重症 の 視力喪失 ため 院 紹介 受診,1,0.005612143407920016,0.9943878565920798,1,0.00045556328382636267,0.9995444367161737,1,0.014977298722964272,0.9850227012770357,1,3.4269810811338175e-07,0.9999996573018919,1,0.07743702083826065,0.9465407729148865,1,0.19375503063201904,0.8732100129127502,1,0.004044002982924132,0.9959559970170758,1
2391,2022/04/30から2022/05/02まで、感冒症状のためセフジトレンピボキシル(経口)を投与した。,0 0 0 0 0 0 感冒症状 ため セフジトレンピボキシル 経口 投与 する た,1,0.016715884733009768,0.9832841152669903,1,0.0002621311867423336,0.9997378688132577,1,0.2982591795862496,0.7017408204137504,1,0.21851636178530331,0.7814836382146967,1,0.12415965646505356,0.9186659455299377,1,0.28756341338157654,0.8148085474967957,1,0.014004897349259257,0.9859951026507408,1
2392,X年10月にはCr 2.0 mg/dLまで上昇、異常円柱の出現から急速進行性糸球体腎炎(RPGN)と判断。,X 年 0 月 Cr 0 0 mg dL 上昇 異常 円柱 出現 急速進行性 糸球体腎炎 RPGN 判断,1,0.014219092397922383,0.9857809076020777,1,0.0002724138406000453,0.9997275861593999,1,0.00854181408902177,0.9914581859109782,1,0.0053113953709871264,0.9946886046290129,1,0.09139184653759003,0.9430813789367676,1,0.18157751858234406,0.8713931441307068,1,0.004132154069305184,0.9958678459306948,1
2393,Y月Z日に臥位で増悪する胸部圧迫感を自覚し近医を受診したところ心電図変化を認めたため当院へ救急搬送された。,Y 月 Z 日 臥 位 だ 増悪 する 胸部圧迫感 自覚 する 近医 受診 する た ところ 心電図変化 認める た ため 院 救急搬送 する れる た,1,1.3927816381125376e-05,0.9999860721836189,1,0.0006983920171432751,0.9993016079828567,1,0.002490232491898059,0.9975097675081019,1,0.015623111275721802,0.9843768887242782,1,0.07834655046463013,0.9467806220054626,1,0.18749673664569855,0.8720935583114624,1,0.004008268648838383,0.9959917313511615,1
2394,画像診断では軽度の肝変形と、急性肝障害を示唆する門脈周囲の浮腫性変化を認め、慢性肝炎の急性増悪も疑われた。,画像 診断 軽度 肝変形 急性肝障害 示唆 する 門脈 周囲 浮腫性 変化 認める 慢性肝炎 の 急性増悪 疑う れる た,1,0.002680863323976488,0.9973191366760236,1,0.0005215522807566101,0.9994784477192434,1,0.0050123718961770924,0.9949876281038229,1,0.10634897896378737,0.8936510210362126,1,0.07794173061847687,0.9453399181365967,1,0.1881139725446701,0.87001633644104,1,0.004868093002123647,0.9951319069978762,1
2395,患者がmRNAワクチン(商品名、投与目的不明)接種直後に、紫斑、口腔内出血、免疫性血小板減少症を発症した。,患者 mRNA ワクチン 商品名 投与 目的 不明 接種 直後 紫斑 口腔内 出血 免疫性 血小板減少症 発症 する た,1,0.027968588574470172,0.9720314114255298,1,0.0002767637973831144,0.9997232362026169,1,0.2485125521375562,0.7514874478624438,1,0.09434739231859579,0.9056526076814042,1,0.08985303342342377,0.9425469040870667,1,0.18632622063159943,0.870958149433136,1,0.008202213333843862,0.9917977866661561,1
2396,血液検査でTSH低値、FT3・FT4高値であり甲状腺機能亢進を認めたため、4月27日に当院を紹介受診した。,血液検査 TSH 値 FT 0 FT 0 高値 だ ある 甲状腺機能亢進 認める た ため 0 月 0 日 院 紹介 受診 する た,1,2.3452433342766887e-06,0.9999976547566658,1,0.0006651190153368528,0.9993348809846632,1,0.0017382880206409101,0.9982617119793591,1,0.032683949239104226,0.9673160507608958,1,0.08738958090543747,0.9396075010299683,1,0.18254034221172333,0.8743175864219666,1,0.0041776675953360065,0.9958223324046641,1
2397,血中免疫グロブリンG:指数8.00で陽性、抗パルボウイルスB19 IgG抗体は指数8.00で陽性であった。,血 中 免疫グロブリン G 指数 0 0 陽性 パルボウイルス B 0 IgG 抗体 指数 0 0 陽性 だ ある た,1,0.046227783447800035,0.9537722165522001,1,0.00036435519950100785,0.999635644800499,1,0.02168070314187942,0.9783192968581206,1,0.2996524227576476,0.7003475772423524,1,0.10278455913066864,0.9321810603141785,1,0.25129714608192444,0.8462992906570435,1,0.009116164815281902,0.9908838351847181,1
2398,当初は2回目の本剤接種の1週間後、胸痛を伴う微熱(摂氏37.6度)を主訴として、他のクリニックを受診した。,当初 0回目 本 剤 接種 0 週間 後 胸痛 伴う 微熱 摂氏 0 0度 主訴 他 クリニック 受診 する た,1,0.016660409836438326,0.9833395901635616,1,0.00038029083379924713,0.9996197091662008,1,0.040730776355139775,0.9592692236448602,1,0.1357307302716042,0.8642692697283958,1,0.07843760401010513,0.9487316012382507,1,0.17777109146118164,0.8703190088272095,1,0.005619722058365405,0.9943802779416345,1
2399,日付不明右眼眼底検査:全4象限に広範な火炎状出血、黄斑の白色化、視神経乳頭浮腫及び網膜動脈の減弱を認めた。,日付 不明 右 眼 眼底 検査 0 象限 広範 だ 火炎 状出血 黄斑 の 白色化 視神経乳頭浮腫 網膜 動脈 減 弱 認める た,1,0.01669608147076715,0.9833039185292327,1,0.0003596624222506758,0.9996403375777493,1,0.018765582913179535,0.9812344170868205,1,0.06902573889953034,0.9309742611004697,1,0.07628355920314789,0.9473913908004761,1,0.1886204034090042,0.8697237372398376,1,0.004761038594307636,0.9952389614056925,1
2400,翌日の採血ではAST 6914、ALT 2341、Cre 1.95と循環不全の影響と思われる上昇を認めた。,翌日 採血 AST 0 ALT 0 Cre 0 0 循環不全 影響 思う れる 上昇 認める た,1,1.5709041175741575e-06,0.9999984290958824,1,0.0005686227325398236,0.9994313772674602,1,0.003813732476392162,0.9961862675236078,1,0.01745759158886273,0.9825424084111373,1,0.08546789735555649,0.943172037601471,1,0.1824178844690323,0.8704366683959961,1,0.004061877240027945,0.9959381227599722,1
2401,心筋炎、発熱、胸痛、血中クレアチンホスホキナーゼ増加、トロポニンT増加、炎症の結果、治療的処置が行われた。,心筋炎 発熱 胸痛 血 中 クレアチンホスホキナーゼ 増加 トロポニン T 増加 炎症 結果 治療 的 処置 行う れる た,1,0.0027438483996216683,0.9972561516003785,1,0.00046005558833638234,0.9995399444116636,1,0.003681100444703267,0.9963188995552967,1,0.18493818454718125,0.8150618154528187,1,0.08208481967449188,0.9459176659584045,1,0.184255912899971,0.8709961175918579,1,0.005669737015844818,0.9943302629841553,1
2402,2022/06/04(初回ワクチン接種の翌日)、患者は、筋緊張やや亢進、その後SaO2やや低下を発現した。,0 0 0 初回 ワクチン接種 翌日 患者 筋緊張 亢進 その後 SaO 0 低下 発現 する た,1,0.010794776108824577,0.9892052238911754,1,0.000337247114217008,0.999662752885783,1,0.004719138730104877,0.9952808612698951,1,0.1567242771404984,0.8432757228595016,1,0.0796830952167511,0.9483601450920105,1,0.18115271627902985,0.8778908848762512,1,0.0053768333175108094,0.9946231666824892,1
2403,2022/01/04、歩行困難、下肢筋力低下あり、脊髄MRIでTh5-8付近の中心優位の異常信号を認めた。,0 0 0 歩行困難 下肢筋力低下 ある 脊髄 MRI Th 0 0 付近 中心 優位 異常信号 認める た,1,0.0036701876965283806,0.9963298123034717,1,0.00041598523180026394,0.9995840147681997,1,0.026473766395164633,0.9735262336048354,1,0.012484940373501896,0.9875150596264981,1,0.07609881460666656,0.9473190903663635,1,0.18091757595539093,0.8751952052116394,1,0.004154466469149712,0.9958455335308501,1
2404,脳梁の細胞傷害性病変、脳炎、脳症、意識変容状態、敗血症、髄膜炎、嘔吐、発熱の結果として治療処置が行われた。,脳梁 の 細胞傷害 性病変 脳炎 脳症 意識変容状態 敗血症 髄膜炎 嘔吐 発熱 結果 治療 処置 行う れる た,1,0.004061336229764195,0.9959386637702359,1,0.000364504118003728,0.9996354958819963,1,0.013638072929546885,0.9863619270704531,1,0.15079470838585418,0.8492052916141458,1,0.08384127169847488,0.9484073519706726,1,0.1795528680086136,0.8673023581504822,1,0.005407219797775561,0.9945927802022243,1
2405,2022/06/13(3回目のワクチン接種3日後)、前胸部痛、発汗が持続するため、救急要請され搬送された。,0 0 0 0回目 ワクチン接種 0 日 後 前胸部痛 発汗 持続 する ため 救急 要請 する れる 搬送 する れる た,1,0.006936273256724931,0.9930637267432751,1,0.00045575308543262906,0.9995442469145673,1,0.09553364580947354,0.9044663541905265,1,0.22041747639937304,0.779582523600627,1,0.07869940251111984,0.9502156972885132,1,0.18003588914871216,0.8780567049980164,1,0.0072257603904863675,0.9927742396095136,1
2406,2021/08/27(ワクチン接種日)のワクチン接種後しばらくしてから発現、患者は橈骨神経損傷を発症した。,0 0 0 ワクチン接種 日 ワクチン接種 後 する 発現 患者 橈骨神経損傷 発症 する た,1,6.2463796275172355e-06,0.9999937536203725,1,0.00044375267229177846,0.9995562473277082,1,0.011124627885655936,0.9888753721143441,1,0.029841466125534066,0.9701585338744659,1,0.0895940363407135,0.9408277869224548,1,0.1841060370206833,0.870337963104248,1,0.0042582337540962014,0.9957417662459039,1
2407,2021/09/05、昼より、再度腰痛が出現、Short leg rising test 45度であった。,0 0 0 昼 腰痛 出現 Short leg rising test 0度 だ ある た,1,0.026058696223967073,0.973941303776033,1,0.0003125969065025771,0.9996874030934975,1,0.015394467690847735,0.9846055323091523,1,0.4896845075010505,0.5103154924989495,1,0.08566022664308548,0.9439702033996582,1,0.1831892877817154,0.8683471083641052,1,0.011200122349167464,0.9887998776508324,1
2408,眼科検査:後極部の漿液性網膜剥離(SRD)、注釈:両眼の極、網膜静脈拡大および視神経乳頭充血、正常に戻った,眼科 検査 後極 部 漿液性 網膜剥離 SRD 注釈 眼 極 網膜 静脈拡大 視神経 乳頭 充血 正常 戻る た,1,0.024138136764105173,0.975861863235895,1,0.0003449635866073509,0.9996550364133926,1,0.26545537871402947,0.7345446212859705,0,0.5098579548095977,0.4901420451904023,1,0.2150297462940216,0.8541568517684937,1,0.2187124639749527,0.8574644923210144,1,0.024643586652778295,0.9753564133472217,1
2409,2021/10/29から2021/12/06まで、患者は心エコーを受け、結果は心嚢水がやや多めであった。,0 0 0 0 0 0 患者 心 エコー 受ける 結果 心嚢水 多め だ ある た,0,0.8947818753413767,0.1052181246586233,1,0.00017085249912163295,0.9998291475008784,1,0.4040575401990891,0.5959424598009109,0,0.5923959214705804,0.4076040785294196,1,0.1584251970052719,0.8892516493797302,1,0.20208117365837097,0.8550401926040649,1,0.16784565573337373,0.8321543442666263,1
2410,2022/05/27、午後18時頃、顔面浮腫、血管性浮腫(全身性)、リンパ球数減少(相対的)を発現した。,0 0 0 午後0時 頃 顔面浮腫 血管性 浮腫 全身 性 リンパ球 数 減少 相対的 発現 する た,1,7.590100908255788e-06,0.9999924098990917,1,0.00048580870883719056,0.9995141912911628,1,0.0034561408493000156,0.9965438591507,1,0.13730489579566185,0.8626951042043381,1,0.0785495936870575,0.9460325837135315,1,0.1862683743238449,0.8797737956047058,1,0.005074299678031843,0.9949257003219681,1
2411,患者が呼吸時の胸痛を呈したため心膜炎を疑い、これらの症状の緩和のため非ステロイド性抗炎症薬が投与された。,患者 呼吸 時 胸痛 呈す た ため 心膜炎 疑う これら 症状 緩和 ため ステロイド性 抗炎症 薬 投与 する れる た,1,0.016692861455788677,0.9833071385442113,1,0.00023767181795151618,0.9997623281820485,1,0.018099690297364357,0.9819003097026356,1,0.12619952735277862,0.8738004726472214,1,0.08953604847192764,0.9406993985176086,1,0.22123654186725616,0.8474589586257935,1,0.005737793313946292,0.9942622066860537,1
2412,"抗MDA5抗体1,400と高値であり、抗MDA5抗体陽性間質性肺炎(anti-MDA5-ILD)と診断。",MDA 0 抗体 0 0 高値 だ ある MDA 0 抗体陽性 間質性 肺炎 ANTI MDA 0 ILD 診断,1,0.0071625257801212145,0.9928374742198787,1,0.000519069383592751,0.9994809306164073,1,0.00852657050967931,0.9914734294903207,1,1.582137142608353e-05,0.9999841786285739,1,0.08573759347200394,0.9397293925285339,1,0.1846713274717331,0.8747946619987488,1,0.004023116650047343,0.9959768833499526,1
2413,採血にて、トロポニンI、CK/CK-MBが高値であったため、心筋炎の診断となり、安静経過観察目的で入院。,採血 トロポニン I CK CK MB 高値 だ ある た ため 心筋炎 の 診断 なる 安静 経過 観察 目的 入院,1,0.005753812332343007,0.9942461876676569,1,0.00038983377081784496,0.9996101662291822,1,0.011142584463074368,0.9888574155369256,1,1.4666760250747757e-07,0.9999998533323975,1,0.13480275869369507,0.9154462814331055,1,0.19749192893505096,0.8669257164001465,1,0.004427404359203615,0.9955725956407965,1
2414,脳外科医師にも画像を見てもらったが異常なしのため、本剤接種による一時的な全身状態悪化の可能性ありと診断。,脳外科 医師 画像 見る もらう た 異常 ない ため 本 剤 接種 一時 的 だ 全身状態悪化 の 可能性 あり 診断,1,0.016676898203053927,0.983323101796946,1,0.0003269617671615404,0.9996730382328385,1,0.06775119997493628,0.9322488000250637,1,0.0009048514025498111,0.9990951485974502,1,0.3478698432445526,0.8342500925064087,0,0.5877392888069153,0.5258834958076477,1,0.014019261228881919,0.9859807387711181,1
2415,眼底検査:びまん性視神経乳頭の腫れが見られ、ゴールドマン、メモ:視野検査により、下方視野欠損が確認された,眼底 検査 びまん性 視神経 乳頭 腫れ 見る られる ゴールドマン メモ 視野 検査 下方 視野 欠損 確認 する れる た,1,0.016693144476252607,0.9833068555237473,1,0.0003423223998149266,0.9996576776001851,1,0.49416040989007937,0.5058395901099206,1,0.20368292288235434,0.7963170771176457,1,0.07843727618455887,0.9448745846748352,1,0.19041818380355835,0.8597856760025024,1,0.016205805174999418,0.9837941948250005,1
2416,2022/06/05、患者は咳嗽増悪、水様便、発熱(摂氏40.7度)にて、報告者の病院に時間外受診した。,0 0 0 患者 咳嗽 増悪 水様便 発熱 摂氏 0 0度 報告 者 病院 時間 外 受診 する た,1,0.005803158905067758,0.9941968410949322,1,0.0003795136438957546,0.9996204863561042,1,0.015862609479712853,0.9841373905202871,1,0.15191378892784746,0.8480862110721525,1,0.07501542568206787,0.9495304822921753,1,0.17976579070091248,0.8762110471725464,1,0.005361998084736941,0.9946380019152631,1
2417,2021/06/22(ワクチン接種2日後)、摂氏37.1度の発熱が出現し、その後摂氏35度台に解熱した。,0 0 0 ワクチン接種 0 日 後 摂氏 0 0度 発熱 出現 その後 摂氏 0度 台 解熱 する た,1,0.0112344901189998,0.988765509881,1,0.0003375863559649356,0.9996624136440351,1,0.006886698164503602,0.9931133018354964,1,0.19572037977724055,0.8042796202227595,1,0.08762256801128387,0.9461513161659241,1,0.20064955949783325,0.8729510307312012,1,0.006044931139740131,0.9939550688602599,1
2418,2022/01/08、患者は多系統炎症性症候群、心房細動(発作性)および相対的リンパ球数減少を発現した。,0 0 0 患者 系統 炎症性 症候群 心房細動 発作性 相対的 リンパ球 数 減少 発現 する た,1,1.2263626428363267e-05,0.9999877363735716,1,0.00045731937650445037,0.9995426806234955,1,0.00820194899736959,0.9917980510026304,1,0.12992054492341387,0.8700794550765861,1,0.08100429177284241,0.9486143589019775,1,0.18607984483242035,0.8770516514778137,1,0.005059588357118915,0.9949404116428812,1
2419,2022/05/11 17:10(ワクチン接種10分後)、患者は嘔気、顔面蒼白および結膜発赤を発現した。,0 0 0 0 0 ワクチン接種 0分 後 患者 嘔気 顔面蒼白 結膜発赤 発現 する た,1,0.004395175231615639,0.9956048247683844,1,0.000369538474323455,0.9996304615256766,1,0.011516859636183652,0.9884831403638163,1,0.11820141471665546,0.8817985852833445,1,0.08361025154590607,0.9497962594032288,1,0.18198224902153015,0.8756574392318726,1,0.005012002083520972,0.9949879979164791,1
2420,COVIDー19ワクチン2回目接種後2ヵ月半程度で円形脱毛症が急性増悪し、ステロイドパルス入院を要した。,COVID ー 0 ワクチン 0回目 接種 後 0 ヵ月 半 程度 だ 円形脱毛症 急性増悪 ステロイド パルス 入院 要す た,1,0.018343118171144077,0.981656881828856,1,0.0003147840159065154,0.9996852159840934,1,0.1618508385637707,0.8381491614362293,1,0.013429582935964302,0.9865704170640357,1,0.099369116127491,0.9331543445587158,1,0.18456467986106873,0.8659575581550598,1,0.005897560552827726,0.9941024394471722,1
2421,磁気共鳴画像:(2022/05/23)左横静脈洞血栓症、注:脳静脈還流障害による一過性全健忘と診断した。,磁気 共鳴 画像 0 0 0 左横静脈洞 血栓症 注 脳静脈 還流障害 一過性全健忘 診断 する た,1,0.016699492600243466,0.9833005073997564,1,0.0003389986151104872,0.9996610013848896,1,0.06227836827852906,0.9377216317214709,1,0.13705866255724208,0.8629413374427579,1,0.08336706459522247,0.9397784471511841,1,0.1798301339149475,0.8767063021659851,1,0.005937354841203067,0.994062645158797,1
2422,心電図(ECG)洞性頻脈、胸部心エコー検査(TTE)前壁中隔から前壁中部から心尖部で壁運動低下を示した。,心電図 ECG 洞性頻脈 胸部 心 エコー 検査 TTE 壁 中隔 壁 中部 心尖 部 だ 壁運動低下 示す た,1,0.04380181747354717,0.9561981825264528,1,0.00026223527289678426,0.9997377647271032,1,0.2695421631981896,0.7304578368018104,1,0.06900832331276141,0.9309916766872386,1,0.08533882349729538,0.9427340626716614,1,0.19495521485805511,0.8667160272598267,1,0.008459858600633356,0.9915401413993666,1
2423,Fibrin degradation products (0-5): (2022/06/15)2.5未満,Fibrin degradation products 0 0 0 0 0 0 0 未満,1,0.055170743883598855,0.9448292561164011,1,0.000245730179218477,0.9997542698207815,1,0.35873972300322543,0.6412602769967746,1,0.0024030323566371914,0.9975969676433628,1,0.2535170316696167,0.8648165464401245,1,0.22922450304031372,0.830337405204773,1,0.012379043698307935,0.9876209563016921,1
2424,2022/02/21 02:45頃睡眠中に呼吸促迫、家人が呼びかけても反応がないなど意識障害を認めた。,0 0 0 0 0 頃 睡眠中 呼吸 促迫 家人 呼びかける 反応 ない 意識障害 認める た,1,0.016684897618312027,0.9833151023816882,1,0.00034338671249060384,0.9996566132875094,1,0.06312197622131055,0.9368780237786895,1,0.0075300152335394666,0.9924699847664605,1,0.07894603163003922,0.9455302357673645,1,0.18873384594917297,0.875758171081543,1,0.004594693358628854,0.9954053066413711,1
2425,2022年7月16日患者は接種した箇所が内出血して黒くなっている、腕が上がらない、発熱及び頭痛が出現。,0 年 0 月 0 日 患者 接種 する た 箇所 内出血 する 黒い なる いる 腕 上がる ない 発熱 頭痛 出現,1,0.042935636176243165,0.9570643638237568,1,0.0003128098264096807,0.9996871901735903,1,0.01161960577867438,0.9883803942213256,1,0.005361706338112282,0.9946382936618877,1,0.08034960925579071,0.9475573897361755,1,0.1854507327079773,0.8692812323570251,1,0.004361454148511488,0.9956385458514885,1
2426,右顔面神経麻痺、右耳痛も認め、後日、帯状疱疹ウイルス感染症も明らかになり、ラムゼイハント症候群と診断。,右 顔面神経 麻痺 右耳痛 認める 後日 帯状疱疹ウイルス 感染症 明らか なる ラムゼイハント症候群 診断,1,0.003572868631494218,0.9964271313685059,1,0.0004297038304180995,0.9995702961695819,1,0.01399543498156508,0.9860045650184349,1,2.924402863535569e-06,0.9999970755971365,1,0.08982956409454346,0.936958909034729,1,0.18326333165168762,0.8688612580299377,1,0.004083433090240551,0.9959165669097595,1
2427,眼底検査で多発性火焔状網膜出血、網膜動脈狭細化、視神経乳頭浮腫を認め、黄斑部網膜は白濁浮腫状であった。,眼底 検査 だ 多発性 火焔状 網膜出血 網膜 動脈狭細化 視神経乳頭浮腫 認める 黄斑部 網膜 白濁 浮腫状 だ ある た,1,0.01667659414740586,0.9833234058525943,1,0.0003263504808731737,0.9996736495191269,1,0.09431511174096796,0.905684888259032,1,0.32602121639074166,0.6739787836092583,1,0.08214821666479111,0.9400997757911682,1,0.1988270878791809,0.8709157109260559,1,0.00942087629197496,0.990579123708025,1
2428,後遺症として低酸素脳症、覚醒度は自発開眼があるものの、随意運動や追視などは認めず、意思疎通困難が残る。,後遺症 する 低酸素 脳症 覚醒度 自発開眼 ある 随意運動 追視 認める ぬ 意思疎通困難 残る,1,0.007126010640843617,0.9928739893591563,1,0.00037872542078844077,0.9996212745792116,1,0.30169230556838544,0.6983076944316146,1,0.00022698750258387523,0.9997730124974161,1,0.09453527629375458,0.9357413649559021,1,0.24576905369758606,0.8397001028060913,1,0.008031746687635163,0.9919682533123648,1
2429,2021/07/27の電気生理学的検査:結果はM波振幅の低下とF波出現頻度の低下で、GBSと一致した。,0 0 0 電気 生理 学的 検査 結果 M 波 振幅 低下 F 波 出現 頻度 低下 GBS 一致 する た,1,0.00654253133148037,0.9934574686685195,1,0.00045511828878018663,0.9995448817112198,1,0.0055372556526286365,0.9944627443473714,1,0.21436785312415918,0.7856321468758408,1,0.11092755943536758,0.9384903907775879,1,0.19376051425933838,0.8675230741500854,1,0.006384228865311866,0.9936157711346882,1
2430,2022/06/02、ヘモグロビンA1Cの上昇は当院での採血で判明し、精密検査のために当院に来院した。,0 0 0 ヘモグロビン A 0 C 上昇 院 採血 判明 する 精密検査 ため 院 来院 する た,1,0.005228533371615489,0.9947714666283843,1,0.0003816767412820786,0.9996183232587179,1,0.011957347786011985,0.988042652213988,1,0.13649992452792148,0.8635000754720785,1,0.08004338294267654,0.95001620054245,1,0.1929570585489273,0.877525269985199,1,0.005238821781937565,0.9947611782180623,1
2431,第3病日にワクチン後の血小板減少症を伴う血栓症(TTS)を疑われIVIgを開始され当院へ転院となった。,0 病 日 ワクチン 後 血小板減少症 伴う 血栓症 TTS 疑う れる IVIg 開始 する れる 院 転院 なる た,1,0.033808368201060396,0.9661916317989397,1,0.00030719554876452846,0.9996928044512354,1,0.035262483848329085,0.9647375161516709,1,0.1792740336797305,0.8207259663202695,1,0.08396659791469574,0.9411560893058777,1,0.1819734126329422,0.8734188675880432,1,0.006360099893124617,0.9936399001068755,1
2432,以上のことから、肝機能異常をきたす2022/03/30以前の、ワクチン接種による肝機能障害が疑われた。,以上 こと 肝機能異常 きたす 0 0 0 以前 ワクチン接種 肝機能障害 疑う れる た,1,0.016674518422070857,0.9833254815779289,1,0.00033255895629376704,0.9996674410437062,1,0.04533726394973314,0.9546627360502669,1,0.0898128459215537,0.9101871540784463,1,0.07770141214132309,0.942594051361084,1,0.1831621378660202,0.8710377216339111,1,0.0052281608119088925,0.9947718391880911,1
2433,意識障害(JCSIII-300)、40度の発熱、右共同偏視、右上下肢間代性痙攣、左上下肢麻痺を認めた。,意識障害 JCSIII 0 0度 発熱 右共同偏視 右上 下肢 間代性 痙攣 左上下肢麻痺 認める た,1,5.558887440543089e-06,0.9999944411125594,1,0.0004038217969992156,0.9995961782030007,1,0.010994863777020192,0.9890051362229798,1,0.006959695147401024,0.993040304852599,1,0.07460323721170425,0.9480667114257812,1,0.19068679213523865,0.8760045170783997,1,0.003981713671056223,0.9960182863289437,1
2434,2021/09/20(初回ワクチン接種から4日後)より、筋痛性脳脊髄炎/慢性疲労症候群疑いが出現した。,0 0 0 初回 ワクチン接種 0 日 後 筋痛性 脳脊髄炎 慢性疲労 症候群 疑い 出現 する た,1,0.003576725593206466,0.9964232744067937,1,0.00041735264999527495,0.9995826473500047,1,0.004298254436886251,0.9957017455631137,1,0.1586330751520869,0.8413669248479131,1,0.08066537976264954,0.9480685591697693,1,0.17961624264717102,0.8758413791656494,1,0.005326196321346763,0.9946738036786533,1
2435,2022/02/24、COVID-19を発症し、COVID-19 PCR、LAMP検査で陽性であった。,0 0 0 COVID 0 発症 COVID 0 PCR LAMP 検査 陽性 だ ある た,1,0.007145074410030672,0.9928549255899695,1,0.0005165597132241248,0.9994834402867758,1,0.1807959035459462,0.8192040964540538,0,0.8950737997639351,0.10492620023606486,1,0.10660509020090103,0.9301086664199829,1,0.18795306980609894,0.8747857809066772,1,0.034116120251507266,0.9658838797484927,1
2436,2022/04/03(ワクチン接種後18日)、右心不全・左心不全の悪化があり、血行動態の悪化があった。,0 0 0 ワクチン接種 後 0 日 右心不全 左心不全 の 悪化 ある 血行動態 の 悪化 ある た,1,0.016684019134671838,0.9833159808653281,1,0.000329724775850539,0.9996702752241494,1,0.10421202453114486,0.8957879754688551,1,0.30397369273576547,0.6960263072642345,1,0.07854402810335159,0.9502667188644409,1,0.1824273020029068,0.867293655872345,1,0.008958175823892895,0.9910418241761072,1
2437,神経精神全身性エリテマトーデス(NPSLE)を疑い、入院第1病日目よりステロイドパルス療法を実施した。,神経 精神 全身性エリテマトーデス NPSLE 疑う 入院 0 病 日目 ステロイド パルス 療法 実施 する た,1,0.029373103400295888,0.970626896599704,1,0.00022349352460465432,0.9997765064753954,1,0.06488459491361342,0.9351154050863866,1,0.22518516232114516,0.7748148376788548,1,0.09567400813102722,0.9334220290184021,1,0.20137153565883636,0.8652702569961548,1,0.007673235911749102,0.9923267640882509,1
2438,2021/10/15 01:00(ワクチン接種4日後としても報告された)、患者は急性心筋炎を経験した。,0 0 0 0 0 ワクチン接種 0 日 後 報告 する れる た 患者 急性心筋炎 経験 する た,1,0.01669731010075941,0.9833026898992409,1,0.0002772955054713889,0.9997227044945286,1,0.45507319337434626,0.5449268066256537,1,0.027780657879713955,0.972219342120286,1,0.10434325039386749,0.9429478049278259,1,0.1976051777601242,0.8563941121101379,1,0.01101156476718651,0.9889884352328134,1
2439,2022/07/11 20:00、患者はCOVID-19陽性で、頭痛と喉の痛みもあるとのことであった。,0 0 0 0 0 患者 COVID 0 陽性 頭痛 喉 痛み ある こと だ ある た,1,0.009950977197306806,0.990049022802693,1,0.00042037542700353015,0.9995796245729964,1,0.006811139908411867,0.9931888600915881,0,0.8841760179848372,0.11582398201516274,1,0.07973649352788925,0.9443545341491699,1,0.18407703936100006,0.8644550442695618,1,0.02315134114341948,0.9768486588565806,1
2440,異常発見時の状況:タクシー運転手として空車で運転中、蛇行運転となり自損事故を起こし、緊急通報となった。,異常 発見 時 状況 タクシー運転手 空車 運転 中 蛇行 運転 なる 損 事故 起こす 緊急通報 なる た,1,0.01669672595927607,0.9833032740407239,1,0.0003100092403270263,0.999689990759673,1,0.14415099553875144,0.8558490044612486,1,0.2786229349168181,0.7213770650831819,1,0.08725091814994812,0.9404026865959167,1,0.18945716321468353,0.8644529581069946,1,0.00948431582610763,0.9905156841738924,1
2441,"Lymphocyte count (20-53): (2022/06/15) 11.4 %,注記:低値",Lymphocyte count 0 0 0 0 0 0 0 % 注記 値,1,0.023649697633403313,0.9763503023665968,1,0.00026154054876671034,0.9997384594512333,1,0.30511803822789274,0.6948819617721073,1,0.000242443279291904,0.9997575567207081,1,0.22480611503124237,0.8446735739707947,1,0.22094327211380005,0.8518857955932617,1,0.010028287270053497,0.9899717127299466,1
2442,2021/**/**、患者は免疫性心筋炎(免疫性心筋炎)(重篤区分:入院及び医学的に重要)を呈した。,0 患者 免疫性 心筋炎 免疫性 心筋炎 重篤 区分 入院 医学 的 重要 呈す た,1,8.933795621209005e-06,0.9999910662043787,1,0.0004392519495391744,0.9995607480504608,1,0.011106142893589688,0.9888938571064103,1,0.0015357929873601739,0.9984642070126398,1,0.08159875869750977,0.9428359866142273,1,0.21980206668376923,0.8405459523200989,1,0.004253286809220625,0.9957467131907795,1
2443,2021/08、COVID-19ワクチンの2回目の接種後に左の第1、2指のしびれ及び痛みが発現した。,0 0 COVID 0 ワクチン 0回目 接種 後 左 0 0 指 しびれ 痛み 発現 する た,1,1.5305441398430868e-05,0.9999846945586015,1,0.00047618975658576454,0.9995238102434142,1,0.007712513709152047,0.992287486290848,1,0.12818548974453003,0.87181451025547,1,0.08064401894807816,0.9461593627929688,1,0.18410082161426544,0.8746592998504639,1,0.005050047313776305,0.9949499526862238,1
2444,2021/09/18- 2022/01/11、患者は好酸球増加及び全身症状を伴う薬疹のため入院した。,0 0 0 0 0 0 患者 好酸球 増加 及ぶ 全身症状 伴う 薬疹 ため 入院 する た,1,0.0030400345001585596,0.9969599654998416,1,0.00039214262247810725,0.9996078573775219,1,0.010547824994677879,0.9894521750053221,1,0.14838678412331507,0.8516132158766849,1,0.07494872808456421,0.9466868042945862,1,0.17612376809120178,0.8748343586921692,1,0.0052424239173103244,0.9947575760826897,1
2445,2022/01/25 COVID-19病原体(SARS-CoV-2)検査を抗原検査にて実施し、陽性。,0 0 0 COVID 0 病原体 SARS CoV 0 検査 抗原検査 実施 する 陽性,1,0.034895681358882595,0.9651043186411175,1,0.0002835843987615434,0.9997164156012385,1,0.27173255046507483,0.7282674495349252,1,6.847661770947866e-09,0.9999999931523382,1,0.2681298553943634,0.8457005023956299,1,0.3423393964767456,0.7867783308029175,1,0.012030747223572448,0.9879692527764277,1
2446,2022/02/11 03:00(3回目ワクチン接種から1ヵ月と21日後)、被験者は腹痛を発現した。,0 0 0 0 0 0回目 ワクチン接種 0 ヵ月 0 日 後 被験者 腹痛 発現 する た,1,0.01048996129894911,0.989510038701051,1,0.0003331243169626517,0.9996668756830374,1,0.018951109761968343,0.9810488902380317,1,0.13051769440642114,0.8694823055935789,1,0.07822958379983902,0.9484940767288208,1,0.1875261515378952,0.8744403719902039,1,0.005290200264031563,0.9947097997359684,1
2447,2022/03/12 09:05(ワクチン接種の358日後)、被験者はCOVID- 19を発現した。,0 0 0 0 0 ワクチン接種 0 日 後 被験者 COVID 0 発現 する た,1,0.014826036832357115,0.9851739631676428,1,0.00035023658506529816,0.9996497634149347,1,0.017869635704999443,0.9821303642950006,1,0.09699970218127851,0.9030002978187215,1,0.09317031502723694,0.9429191946983337,1,0.1887671798467636,0.8680946826934814,1,0.005122458480733511,0.9948775415192666,1
2448,2022/03/27抗原検査にて、COVID-19病原体(SARS-CoV-2)検査を実施し、陽性。,0 0 0 抗原検査 COVID 0 病原体 SARS CoV 0 検査 実施 する 陽性,1,0.034895681358882595,0.9651043186411175,1,0.0002835843987615434,0.9997164156012385,1,0.27173255046507483,0.7282674495349252,1,7.403312851650412e-09,0.9999999925966871,1,0.27089861035346985,0.8279187679290771,1,0.5221880078315735,0.620595395565033,1,0.017265920852706007,0.982734079147294,1
2449,2022/05/11 17:35(ワクチン接種35分後)、患者に摂氏37.6-38度の発熱があった。,0 0 0 0 0 ワクチン接種 0分 後 患者 摂氏 0 0 0度 発熱 ある た,1,0.016708601416992777,0.9832913985830071,1,0.00033465175327007586,0.9996653482467299,1,0.035496227901813615,0.9645037720981864,1,0.10622265118894103,0.893777348811059,1,0.07796669006347656,0.951641321182251,1,0.18153277039527893,0.8679683804512024,1,0.005258767369950095,0.99474123263005,1
2450,3日前に2回目のSARS-CoV-2mRNAワクチン(商品名不明)の注射を受け、翌日38度発熱した。,0 日 前 0回目 SARS CoV 0m RNA ワクチン 商品名 不明 注射 受ける 翌日 0度 発熱 する た,1,0.02985236857577956,0.9701476314242202,1,0.0002737274127731042,0.9997262725872269,1,0.07470269310493383,0.9252973068950662,1,0.09340277438270383,0.9065972256172962,1,0.11068432033061981,0.9378894567489624,1,0.1836177557706833,0.8770210146903992,1,0.005916093490383381,0.9940839065096166,1
2451,CMRではT2強調画像で、ガドリニウム遅延増強及び心尖部前壁での輝度上昇を認め、心筋浮腫が示された。,CMR T 0 強調 画像 ガドリニウム 遅延 増強 心尖 部 壁 輝度 上昇 認める 心筋浮腫 示す れる た,1,0.004714776351495949,0.9952852236485038,1,0.0005186964373127781,0.9994813035626873,1,0.002882714704083189,0.9971172852959168,1,0.10417556189303212,0.8958244381069679,1,0.0861532986164093,0.9427865147590637,1,0.18572160601615906,0.8721072673797607,1,0.004876518061346373,0.9951234819386537,1
2452,患者はmRNA COVID-19ワクチンの2回目投与から19?日後に、胸痛、筋肉痛及び発熱を呈した。,患者 mRNA COVID 0 ワクチン 0回目 投与 0 日後 胸痛 筋肉痛 発熱 呈す た,1,0.016016696470030078,0.9839833035299699,1,0.0003513099906937023,0.9996486900093063,1,0.01680488368635291,0.9831951163136471,1,2.6866172629924634e-05,0.9999731338273701,1,0.07883308827877045,0.9492648839950562,1,0.18716022372245789,0.869981050491333,1,0.00412377853980124,0.9958762214601987,1
2453,患者は四肢の圧痕浮腫、急性発症、年齢50歳以上、リウマチ因子陰性によりRS3PEと診断され入院した。,患者 四肢 圧痕 浮腫 急性発症 年齢 0歳 以上 リウマチ 因子 陰性 RS 0 PE 診断 する れる 入院 する た,1,0.01288440384823993,0.98711559615176,1,0.00041831793421534807,0.9995816820657847,1,0.08550861765195117,0.9144913823480488,1,0.14577402988138155,0.8542259701186184,1,0.07912257313728333,0.9502786993980408,1,0.18287961184978485,0.8735635280609131,1,0.006226658608818418,0.9937733413911816,1
2454,血液検査施行し、血清Cr 1.20 mg/dL、尿蛋白(++)、尿潜血(++)と腎機能障害を呈した。,血液検査 施行 する 血清 Cr 0 0 mg dL 尿蛋白 尿潜血 腎機能障害 呈す た,1,0.05207765617410905,0.9479223438258909,1,0.0002050951899143024,0.9997949048100857,1,0.33104430987145406,0.6689556901285459,1,0.00012747922973865844,0.9998725207702613,1,0.07907798886299133,0.9472630023956299,1,0.1833217442035675,0.8689390420913696,1,0.00826936975731736,0.9917306302426826,1
2455,血中クレアチンホスホキナーゼ(59 U/L-248 U/L):337 U/L(異常)337 U/L。,血 中 クレアチンホスホキナーゼ 0 U L 0 U L 0 U L 異常 0 U L,1,0.005169719226783172,0.9948302807732168,1,0.00026865127802222136,0.9997313487219778,1,0.11572163469261998,0.88427836530738,0,0.5195482961797382,0.48045170382026176,1,0.16605131328105927,0.9098563194274902,1,0.21406932175159454,0.8496079444885254,1,0.016335776444070995,0.983664223555929,1
2456,広範囲の虚血であったため、ステント留置後も左室駆出率30%と心拍出量は低下し、薬物療法を行っている。,広範囲 虚血 だ ある た ため ステント 留置 後 左 室 駆け出し 率 0% 心拍 出る 量 低下 する 薬物 療法 行う いる,1,0.01669286491283135,0.9833071350871686,1,0.00029501656589729175,0.9997049834341027,1,0.10833773535361935,0.8916622646463807,1,0.2829394797234315,0.7170605202765685,1,0.21596714854240417,0.8641069531440735,1,0.28992441296577454,0.8114150166511536,1,0.012703407669829043,0.9872965923301709,1
2457,心電図変化は見られなかったが、トロポニンT陽性を認めたため、本剤接種後心筋炎と診断し、入院となった。,心電図変化 見る られる ない た トロポニン T 陽性 認める た ため 本 剤 接種 後 心筋炎 診断 入院 なる た,1,0.013584018740913466,0.9864159812590864,1,0.0004678933392389063,0.9995321066607611,1,0.122195231894767,0.877804768105233,1,0.002150703758257211,0.9978492962417428,1,0.08958356082439423,0.9383225440979004,1,0.18851380050182343,0.8710838556289673,1,0.005196740724373759,0.9948032592756262,1
2458,診察時、水疱は認めなかったが、右耳介の発赤と腫脹が認められ、柳原法で18点の右顔面麻痺が認められた。,診察 時 水疱 認める ない た 右 耳介 発赤 腫脹 認める られる 柳原 法 0点 右顔面麻痺 認める られる た,1,0.01668653153786165,0.9833134684621382,1,0.00037863264605552944,0.9996213673539445,1,0.09450374783065518,0.9054962521693448,1,0.08891384050367135,0.9110861594963287,1,0.07882950454950333,0.9509400129318237,1,0.1833142340183258,0.86965411901474,1,0.00572321514144532,0.9942767848585548,1
2459,第2病日に施行した心臓造影MRIでは、左室に限局する炎症像を認め、心筋炎として矛盾ない結果であった。,0 病 日 施行 する た 心臓 造影 MRI 左 室 限局 する 炎症像 認める 心筋炎 矛盾 ない 結果 だ ある た,1,0.020653661424312065,0.9793463385756881,1,0.0002457139512591104,0.9997542860487408,0,0.6013853739602718,0.3986146260397282,1,0.4472049149820989,0.5527950850179011,1,0.1356121450662613,0.9086018204689026,1,0.21176649630069733,0.8579485416412354,1,0.03625699312831161,0.9637430068716885,1
2460,2021/09/06、夕方より、患者は両手足先のぴりぴりとした異常感覚、上下肢の筋力低下を自覚した。,0 0 0 夕方 患者 手足 先 ぴりぴり する た 異常感覚 上下 肢 筋力低下 自覚 する た,1,0.022900292869144783,0.9770997071308549,1,0.0003279421730152003,0.9996720578269848,1,0.05989299572762952,0.9401070042723705,1,0.09404480956264394,0.9059551904373561,1,0.0816851407289505,0.9466342329978943,1,0.1897483468055725,0.8795298337936401,1,0.005484125040077595,0.9945158749599224,1
2461,2021/11/08に施行された胸椎MRIで脊椎炎を疑う初見が認められたことから、即日入院となった。,0 0 0 施行 する れる た 胸椎 MRI だ 脊椎炎 疑う 初見 認める られる た こと 即日 入院 なる た,1,0.005541673095595819,0.9944583269044042,1,0.0003518108110739079,0.9996481891889261,1,0.025672140457659975,0.97432785954234,1,0.00786794685913339,0.9921320531408666,1,0.08220237493515015,0.9430275559425354,1,0.1825532466173172,0.8673194646835327,1,0.004207273752151296,0.9957927262478486,1
2462,2021/11/20 12:49(ワクチン接種の1日後)、広域肺梗塞症および左下肢血栓症を発現した。,0 0 0 0 0 ワクチン接種 0 日 後 広域 肺梗塞症 左下肢血栓症 発現 する た,1,0.016700293892948352,0.9832997061070516,1,0.0003447144446388428,0.9996552855553612,1,0.019272235273748217,0.9807277647262518,1,0.13197913485294221,0.8680208651470578,1,0.0768684446811676,0.9446589350700378,1,0.18330536782741547,0.8768788576126099,1,0.0053527845050837086,0.9946472154949162,1
2463,2022/03/15、微熱、胸の鎖骨に痛み、頭が痛く、首が痛く、足に重りを付けたような怠さがあった。,0 0 0 微熱 胸 鎖骨 痛み 頭 痛く 首 痛く 足 重り 付ける た よう 怠さ ある た,1,0.010390162734627813,0.9896098372653722,1,0.0003763534462142278,0.9996236465537858,1,0.13343359632125706,0.8665664036787429,1,0.369820218792567,0.630179781207433,1,0.07436773926019669,0.9473993182182312,1,0.18024666607379913,0.8710534572601318,1,0.010604688897118731,0.9893953111028813,1
2464,2022/06/15、来院し、ピリピリした痛み、両手首と両肘の痛み、両ひざから下のだるさを発現した。,0 0 0 来院 する ピリピリ する た 痛み 手首 肘 痛み ひざ 下 だるさ 発現 する た,1,0.0030320967528229734,0.996967903247177,1,0.0004017023279543819,0.9995982976720457,1,0.006985701044548875,0.9930142989554511,1,0.09612818264683443,0.9038718173531656,1,0.07740091532468796,0.9461681842803955,1,0.18373918533325195,0.8757767081260681,1,0.00473649827315241,0.9952635017268476,1
2465,2022/06/28、酸素飽和度低下(入院)発現、転帰「不明」、「6/28SpO2=80%台に低下。,0 0 0 酸素飽和度 低下 入院 発現 転帰 不明 0 0 SpO 0 0% 台 低下,1,4.419619571405727e-06,0.9999955803804286,1,0.00041528915242083263,0.9995847108475792,1,0.003093671032540657,0.9969063289674593,1,2.6582138890063334e-07,0.9999997341786111,1,0.08509784936904907,0.9479297995567322,1,0.19894921779632568,0.8666217923164368,1,0.003976070616498963,0.9960239293835009,1
2466,2022/07/28夕方17:00(ワクチン接種後)、患者より呼吸苦の訴えがあり、救急が要請された。,0 0 0 夕方 0 0 ワクチン接種 後 患者 呼吸苦 訴え ある 救急 要請 する れる た,1,0.02650397173130373,0.9734960282686963,1,0.000338231829023768,0.9996617681709762,1,0.25230499925964733,0.7476950007403527,1,0.23205402053137403,0.767945979468626,1,0.07590124756097794,0.9466807246208191,1,0.17662818729877472,0.8730126023292542,1,0.010511050702924796,0.9894889492970752,1
2467,誤嚥性肺炎、嘔吐、意識レベルの低下、悪寒、発熱、酸素飽和度低下、ラ音、炎症のため治療処置が施された。,誤嚥性 肺炎 嘔吐 意識レベルの低下 悪寒 発熱 酸素飽和度 低下 ラ音 炎症 ため 治療 処置 施す れる た,1,0.002905011588018484,0.9970949884119813,1,0.0004262669433664365,0.9995737330566336,1,0.001515436376668844,0.9984845636233312,1,0.11480322838142598,0.885196771618574,1,0.07790727913379669,0.9462850689888,1,0.17955724895000458,0.8725054860115051,1,0.004859123980494485,0.9951408760195056,1
2468,事象「心筋炎/劇症型心筋炎」および「自宅内で動けなくなっているところを」のため救急外来受診を要した。,事象 心筋炎 劇症型 心筋炎 お呼び 自宅 内 動ける ない なる いる ところ ため 救急外来 受診 要す た,1,0.01672199559195324,0.9832780044080466,1,0.0002187867878486333,0.9997812132121514,1,0.10257214348805077,0.8974278565119492,1,0.017589376945769786,0.9824106230542302,1,0.07576592266559601,0.9456872344017029,1,0.182501420378685,0.859096109867096,1,0.005105535128344626,0.9948944648716553,1
2469,事象「心膜炎が疑われた/心膜炎/心膜輝度上昇/急性心膜炎」は、医師の診察と救急外来受診を必要とした。,事象 心膜炎 疑う れる た 心膜炎 心膜 輝度 上昇 急性心膜炎 医師 診察 救急外来 受診 必要 する た,1,0.010011856740839606,0.9899881432591604,1,0.0003831224229088728,0.9996168775770912,1,0.017797441874122688,0.9822025581258773,1,0.16578246541558916,0.8342175345844108,1,0.0825943723320961,0.9479002356529236,1,0.18025973439216614,0.8704141974449158,1,0.0056664462865105006,0.9943335537134895,1
2470,心筋炎疑いにて、CK-MBなど採血で上昇しており、夕方には息苦しく立っていられないとして病院へ紹介。,心筋炎 疑い CK MB 採血 上昇 する おる 夕方 息苦しく 立つ いる られる ない 病院 紹介,1,0.02813952201644159,0.9718604779835582,1,0.000256606388968228,0.9997433936110318,1,0.043592598254326265,0.9564074017456737,1,5.727126546339889e-07,0.9999994272873454,1,0.1053299531340599,0.9340035319328308,1,0.18084284663200378,0.8641564846038818,1,0.004641762263313132,0.995358237736687,1
2471,心膜炎、心筋炎のため(入院日:2022/05/29、退院日:2022/05/31、入院期間:2日)。,心膜炎 心筋炎 ため 入院 日 0 0 0 退院 日 0 0 0 入院 期間 0 日,1,0.01670212011208593,0.983297879887914,1,0.0003389065650698294,0.9996610934349301,1,0.03639197208861933,0.9636080279113807,1,3.1396284968732147e-05,0.9999686037150313,1,0.1004539504647255,0.9382110834121704,1,0.19506175816059113,0.8594440817832947,1,0.004517761442796245,0.9954822385572037,1
2472,冠攣縮性狭心症の可能性を考え、後日心臓カテーテル検査を再検し、冠攣縮誘発試験を施行する方針とした。,冠 攣縮性 狭心症 の 可能性 考える 後日 心臓カテーテル検査 再検 する 冠攣縮 誘発 試験 施行 する 方針 する た,1,0.016698065335867564,0.9833019346641324,1,0.0003264083282784187,0.9996735916717215,1,0.13090272394463676,0.8690972760553632,1,0.3507875797704635,0.6492124202295365,1,0.37531396746635437,0.7223268151283264,1,0.4115501642227173,0.7410557866096497,1,0.024624301310437555,0.9753756986895625,1
2473,腫瘤における関心領域から得た時間強度曲線にて、初期相に急速な増加を認め、遅延相に洗い出しを認めた。,腫瘤 関心領域 得る た 時間 強度 曲線 初期 相 急速 だ 増加 認める 遅延相 洗い出し 認める た,1,0.016674848017601614,0.9833251519823984,1,0.0003702461262175209,0.9996297538737825,1,0.02248870376730261,0.9775112962326974,1,0.048413865910130194,0.9515861340898698,1,0.08883851021528244,0.9392284154891968,1,0.20502860844135284,0.8726360201835632,1,0.004763005634141531,0.9952369943658584,1
2474,9月に意識レベル低下を認め、両下肢脱力が増悪したため、患者は報告者の病院の救急治療科に搬送された。,0 月 意識レベル低下 認める 両下肢脱力 増悪 する た ため 患者 報告 者 病院 救急 治療 科 搬送 する れる た,1,0.008401843542919514,0.9915981564570806,1,0.0003600634487404914,0.9996399365512595,1,0.014620380475761308,0.9853796195242387,1,0.10210496849110229,0.8978950315088977,1,0.07556615024805069,0.9509062767028809,1,0.18045754730701447,0.876454770565033,1,0.004867173528886095,0.9951328264711139,1
2475,2022/06/17 22:00(ワクチン接種2日と7時間後)、患者は嘔吐、誤嚥性肺炎を発症した。,0 0 0 0 0 ワクチン接種 0 日 0時 間 後 患者 嘔吐 誤嚥性 肺炎 発症 する た,1,1.131392864798243e-05,0.999988686071352,1,0.0004547200168243241,0.9995452799831757,1,0.012368439018998867,0.9876315609810011,1,0.08834767458930737,0.9116523254106926,1,0.0773916020989418,0.9467629194259644,1,0.18043220043182373,0.8721243143081665,1,0.004684973039181111,0.9953150269608189,1
2476,胸水、麻痺性イレウス、感染、随伴疾患悪化、炎症、脱水、酸素飽和度低下の結果、治療的処置がとられた。,胸水 麻痺性 イレウス 感染 随伴 疾患 悪化 炎症 脱水 酸素飽和度 低下 結果 治療 的 処置 とる れる た,1,0.004493344739811536,0.9955066552601888,1,0.00039494282766633853,0.9996050571723336,1,0.02701556271394767,0.9729844372860523,1,0.10350118889761284,0.8964988111023872,1,0.0877973884344101,0.9434347748756409,1,0.18722893297672272,0.8586228489875793,1,0.005187918889202169,0.9948120811107978,1
2477,上肢近位筋の筋力低下、嚥下障害、構音障害を認め、クリーゼとして、免疫グロブリン大量療法を開始した。,上肢 位 筋 筋力低下 嚥下障害 構音障害 認める クリーゼ 免疫グロブリン 大量 療法 開始 する た,1,0.01668816163322663,0.9833118383667734,1,0.0003757665504291206,0.9996242334495709,1,0.04474684172373011,0.9552531582762699,1,0.21916720098438525,0.7808327990156148,1,0.08528183400630951,0.9398541450500488,1,0.20270873606204987,0.8707283139228821,1,0.006959692606474661,0.9930403073935253,1
2478,心嚢液貯留、トロポニンT上昇のため、入院した(2021/09/15から2021/09/28まで)。,心嚢液 貯留 トロポニン T 上昇 ため 入院 する た 0 0 0 0 0 0,1,0.0030853528281389784,0.996914647171861,1,0.00033332654585544055,0.9996666734541445,1,0.0165313627666418,0.9834686372333582,1,0.002120030569499609,0.9978799694305004,1,0.08333954215049744,0.9448140263557434,1,0.1794426590204239,0.8640412092208862,1,0.004062310117611032,0.9959376898823888,1
2479,不明日、発熱を伴ったためアセトアミノフェンを屯用し経過観察をしていたが、胸痛も伴う為当院受診した。,明日 発熱 伴う た ため アセトアミノフェン 屯 用 する 経過 観察 する いる た 胸痛 伴う 為当 院 受診 する た,1,0.016676660898807944,0.9833233391011921,1,0.00029223878503752273,0.9997077612149625,1,0.00769824041506284,0.9923017595849372,1,0.06819061725759068,0.9318093827424093,1,0.08200641721487045,0.9503118395805359,1,0.19333267211914062,0.8482487201690674,1,0.004784841965569279,0.9952151580344307,1
2480,2022/02/28、頭痛(前頭部に始まり右側こめかみまでの疼痛)のため、整形外科病院を受診した。,0 0 0 頭痛 頭部 始まる 右側 こめかみ 疼痛 ため 整形外科 病院 受診 する た,1,0.008442965160448205,0.9915570348395518,1,0.00038354260220430005,0.9996164573977957,1,0.03117089190056388,0.9688291080994361,1,0.1493834469209585,0.8506165530790415,1,0.07791497558355331,0.9441863894462585,1,0.1755845844745636,0.875677227973938,1,0.005554359265593077,0.9944456407344069,1
2481,画像検査:心臓超音波検査:2021/11/26実施、異常な心嚢液貯留:なし、心膜の炎症所見:あり。,画像 検査 心臓 超音波 検査 0 0 0 実施 異常 だ 心嚢液 貯留 ない 心膜 炎症所見 ある,1,0.016684319337817395,0.9833156806621824,0,8.343638595053163e-05,0.9999165636140495,0,0.8077591911749291,0.19224080882507094,1,9.179667921377366e-05,0.9999082033207862,1,0.15838292241096497,0.8983959555625916,1,0.23218974471092224,0.8500739336013794,1,0.023923966797848608,0.9760760332021514,1
2482,01:25当院に到着直前から不穏状態となり、来院後、直ぐに血圧低下、徐脈、瞳孔散大と状態が悪化。,0 0 院 到着 直前 不穏状態 なる 来院 後 血圧低下 徐脈 瞳孔散大 状態 悪化,1,0.01194908873191815,0.9880509112680821,1,0.0003688873677140693,0.9996311126322859,1,0.136495122836224,0.863504877163776,1,4.4656323749947546e-07,0.9999995534367625,1,0.08518411219120026,0.9464634656906128,1,0.18534395098686218,0.8671907782554626,1,0.005243550488718439,0.9947564495112815,1
2483,2022/02/21、採血をした結果、GOT、GPT、およびγGTPは全てハイのマークがついた。,0 0 0 採血 する た 結果 GOT GPT γGTP 全て ハイ マーク つく た,1,0.25040247102405505,0.7495975289759448,1,0.0001778034673772619,0.9998221965326227,1,0.3266441637092161,0.6733558362907839,1,0.003344937765139999,0.99665506223486,1,0.5381307601928711,0.6111756563186646,0,0.73448646068573,0.2559208869934082,1,0.08066538829084549,0.9193346117091545,1
2484,"2022/03/22 WBC 15,140、CRP 19.0と炎症反応高値を認め、前病院に入院。",0 0 0 WBC 0 0 CRP 0 0 炎症反応 高値 認める 病院 入院,1,6.668928089649837e-07,0.999999333107191,1,0.000540651839188694,0.9994593481608113,1,0.004524336336112156,0.9954756636638878,1,1.559952167440315e-11,0.9999999999844005,1,0.08121053874492645,0.9444520473480225,1,0.18582427501678467,0.8724721074104309,1,0.003912112320343029,0.9960878876796571,1
2485,2022/06/14 20:00頃(ワクチン接種後)、後頭部の痛み、摂氏38度の発熱が出現した。,0 0 0 0 0 頃 ワクチン接種 後 後頭部 痛み 摂氏 0度 発熱 出現 する た,1,2.556649364913371e-07,0.9999997443350634,1,0.0006127962013891539,0.9993872037986109,1,0.0030966580714874015,0.9969033419285126,1,0.13171940723316355,0.8682805927668364,1,0.08234386891126633,0.9501029253005981,1,0.17725922167301178,0.8763604164123535,1,0.00498659936893187,0.9950134006310682,1
2486,2022/06/27、患者はPCR検査を受け、検査方法は上咽頭スワブであり、結果は陽性であった。,0 0 0 患者 PCR検査 受ける 検査方法 上 咽頭 スワブ だ ある 結果 陽性 だ ある た,1,0.086691438795247,0.9133085612047532,1,0.0003049365211597605,0.9996950634788402,1,0.34845191584977253,0.6515480841502275,0,0.865868977808206,0.13413102219179399,1,0.14758260548114777,0.910762369632721,1,0.32030734419822693,0.7944479584693909,1,0.06693918623855745,0.9330608137614426,1
2487,2022/07入院時の血液検査で抗AQP4抗体が陽性であり、視神経脊椎炎スペクトラム障害と診断。,0 0 入院 時 血液検査 AQP 0 抗体 陽性 だ ある 視神経 脊椎炎 スペクトラム 障害 診断,1,0.00884520383190365,0.9911547961680965,1,0.0004860357825846846,0.9995139642174153,1,0.022420038450458146,0.9775799615495419,1,5.836072816123306e-07,0.9999994163927184,1,0.09283304959535599,0.9442266821861267,1,0.18825466930866241,0.8676888942718506,1,0.00420476126879253,0.9957952387312075,1
2488,50日後、血尿、尿蛋白0.8 g/gCr、Cr 1.38 mg/dLの進行性腎機能障害を認めた。,0 日 後 血尿 尿蛋白 0 0 g gCr Cr 0 0 mg dL 進行性腎機能障害 認める た,1,0.08485565353851933,0.9151443464614807,1,0.00029515813292728697,0.9997048418670728,1,0.05720022341952613,0.9427997765804739,1,0.005754436532055762,0.9942455634679442,1,0.07577662169933319,0.9494384527206421,1,0.18003152310848236,0.8747389316558838,1,0.005106312850233668,0.9948936871497663,1
2489,血液検査にてAST1200U/l・ALT1203U/lと肝障害を認めたため当院紹介入院となった。,血液検査 AST 0 U l ALT 0 U l 肝障害 認める た ため 院 紹介 入院 なる た,1,5.937818773760597e-07,0.9999994062181227,1,0.0006570571988755299,0.9993429428011245,1,0.008762871238788494,0.9912371287612115,1,0.012187273002198906,0.9878127269978011,1,0.07938965409994125,0.943588137626648,1,0.18606188893318176,0.8739122748374939,1,0.004034487789187734,0.9959655122108123,1
2490,心筋生検では炎症細胞浸潤があり、心臓遅延造影MRIでは心基部中隔に心筋炎、心膜炎併発が疑われた。,心筋生検 炎症 細胞浸潤 ある 心臓 遅延 造影 MRI 心 基部 中隔 心筋炎 心膜炎 併発 疑う れる た,1,0.012141683064454295,0.9878583169355456,1,0.0004061236586988327,0.9995938763413011,1,0.08397766281604802,0.916022337183952,1,0.06387116891010702,0.936128831089893,1,0.08202433586120605,0.9420344829559326,1,0.1862194687128067,0.8706456422805786,1,0.005358794435001733,0.9946412055649982,1
2491,心臓超音波検査にて、左室駆出率62%であり、異常な心嚢液貯留を疑う所見、心膜の炎症所見を認めた。,心臓 超音波 検査 左 室 駆け出し 率 0% だ ある 異常 だ 心嚢液 貯留 疑う 所見 心膜 炎症所見 認める た,1,0.005038603007667683,0.9949613969923323,1,0.00024397782059307376,0.999756022179407,1,0.011068812640320447,0.9889311873596796,1,0.00931739474760429,0.9906826052523957,1,0.07940983772277832,0.9464420080184937,1,0.18850255012512207,0.8634697794914246,1,0.004108166523062621,0.9958918334769374,1
2492,尿沈渣:14/HF、高倍率視野当たりの赤血球、ガラス円柱及び上皮円柱において14/HFを認めた。,尿沈渣 0 HF 倍率 視野 当たり 赤血球 ガラス円柱 上皮円柱 0 HF 認める た,1,0.011864883448879319,0.9881351165511206,1,0.0003646200400904828,0.9996353799599095,1,0.03421949850397754,0.9657805014960225,1,0.01690459803290545,0.9830954019670946,1,0.08577106893062592,0.941493034362793,1,0.19056309759616852,0.8673040270805359,1,0.004470583680945472,0.9955294163190546,1
2493,2022/05/01 11:00頃(ワクチン接種約15分後)、全身のふるえと意識障害が出現した。,0 0 0 0 0 頃 ワクチン接種 0分 後 全身 ふるえ 意識障害 出現 する た,1,9.674779688788558e-06,0.9999903252203112,1,0.0004970832631118879,0.9995029167368881,1,0.012413083958139781,0.9875869160418602,1,0.11953893598194831,0.8804610640180517,1,0.07998310029506683,0.9485518932342529,1,0.18346402049064636,0.8791971206665039,1,0.004969845264977147,0.9950301547350228,1
2494,2022/05/28、咳嗽と喀血、呼吸困難が出現し、肺胞出血あるいは間質性肺炎急性増悪を認めた。,0 0 0 咳嗽 喀血 呼吸困難 出現 肺胞出血 間質性 肺炎 急性増悪 認める た,1,1.2756357275135846e-07,0.9999998724364273,1,0.0005274455692055654,0.9994725544307944,1,0.002005202920145277,0.9979947970798547,1,0.005159975222903013,0.994840024777097,1,0.07367013394832611,0.9454714059829712,1,0.1808774769306183,0.876803994178772,1,0.003863378776699797,0.9961366212233002,1
2495,顔面麻痺、ベル麻痺、耳帯状疱疹、眼部不快感、兎眼、錯感覚、ジスキネジアのため治療処置が施された。,顔面麻痺 ベル麻痺 耳帯状疱疹 眼 部 不快感 兎眼 錯感覚 ジスキネジア ため 治療 処置 施す れる た,1,0.016685400940498165,0.9833145990595018,1,0.0003266151023230972,0.9996733848976769,1,0.053786871091496935,0.9462131289085031,1,0.12835631234011602,0.871643687659884,1,0.09126464277505875,0.9446174502372742,1,0.18499648571014404,0.8741056323051453,1,0.0057995901472938675,0.9942004098527061,1
2496,症例は38歳、女性、検診で貧血を指摘され、近医で下腿のうっ滞性皮膚炎として軟膏処方を受けていた。,症例 0歳 女性 検診 だ 貧血 指摘 する れる 近医 下腿 うっ滞性 皮膚炎 する 軟膏 処方 受ける いる た,1,0.016693748667853798,0.9833062513321462,1,0.00026630055880101823,0.9997336994411989,1,0.3114785387625941,0.6885214612374059,1,0.38874040855120073,0.6112595914487993,1,0.08712144941091537,0.9371269941329956,1,0.18822209537029266,0.8671432733535767,1,0.016389828383192667,0.9836101716168073,1
2497,備考:尿検査(尿沈渣、RBC)は、20-29/HPF (尿タンパク/Cre 0.05)を認めた。,備考 尿検査 尿沈渣 RBC 0 0 HPF 尿タンパク Cre 0 0 認める た,1,0.022611523175958357,0.9773884768240417,1,0.00027172611269491093,0.9997282738873051,1,0.026271519280135158,0.9737284807198648,1,0.015525514447784383,0.9844744855522156,1,0.09283537417650223,0.9368844032287598,1,0.1884356141090393,0.8715952038764954,1,0.00450591567673227,0.9954940843232677,1
2498,恐らくMPAに伴う間質性肺炎が元々存在し、ワクチン接種後に全身症状が顕在化した病態が考えられた。,MPA 伴う 間質性 肺炎 存在 する ワクチン接種 後 全身症状 顕在 化 する た 病態 考える られる た,1,0.010003538900007743,0.9899964610999924,1,0.000391945298332414,0.9996080547016676,1,0.01751273267437481,0.9824872673256252,1,0.02375861100710308,0.9762413889928969,1,0.08832581341266632,0.9381183385848999,1,0.19305108487606049,0.8637881875038147,1,0.004419955176104228,0.9955800448238956,1
2499,12日目に車の運転中に接触事故を起こし、周辺視野が見えにくくなっていることに気が付き受診した。,0 日 目 車 運転中 接触事故 起こす 周辺 視野 見える にくい なる いる こと 気が付く 受診 する た,1,0.016679722276225786,0.9833202777237742,1,0.0003210031221504217,0.9996789968778496,1,0.22173785611687324,0.7782621438831268,1,0.1593692084914804,0.8406307915085196,1,0.08636334538459778,0.9422468543052673,1,0.18585830926895142,0.8699225187301636,1,0.008630951267233334,0.9913690487327667,1
2500,2021/07/13息苦しさが増悪したため当院へ救急搬送され、急性呼吸窮迫症候群の診断で入院。,0 0 0 息苦しさ 増悪 したためる 院 救急搬送 する れる 急性 呼吸窮迫 症候群 の 診断 入院,1,1.6186242917109363e-07,0.9999998381375708,1,0.0006555326226112277,0.9993444673773888,1,0.0057037634046873675,0.9942962365953126,1,6.0145206592920886e-09,0.9999999939854793,1,0.07951349020004272,0.9440283179283142,1,0.18089522421360016,0.8671412467956543,1,0.003918805360897675,0.9960811946391024,1
2501,2022年7月8日当院外来受診、採血でアミラーゼとリパーゼの上昇を認め急性膵炎(軽症)の診断。,0 年 0 月 0 日当 院 外来 受診 採血 アミラーゼ リパーゼ 上昇 認める 急性膵炎 軽症 診断,1,0.004122100352758539,0.9958778996472416,1,0.00038600181082201654,0.999613998189178,1,0.014239093606945308,0.9857609063930547,1,2.6416957618069503e-06,0.9999973583042382,1,0.0832032561302185,0.9410497546195984,1,0.18296676874160767,0.8732604384422302,1,0.004027232526458222,0.9959727674735418,1
2502,21歳、男性【主訴】胸痛【現病歴】2021年X月末に本剤の2回目を接種し、同日悪寒が出現した。,0歳 男性 主訴 胸痛 病歴 0 年 X 月末 本 剤 0回目 接種 する 同日 悪寒 出現 する た,1,0.007723692749456933,0.9922763072505429,1,0.00045943097995026203,0.9995405690200497,1,0.008688262449108919,0.9913117375508911,1,0.13486905273324257,0.8651309472667574,1,0.08592567592859268,0.9498249292373657,1,0.18388131260871887,0.8754155039787292,1,0.0052099960454118,0.9947900039545883,1
2503,V/S. KT36.1、BP140/78、P61、SPO2 98 %約2分焦点合わず発語なし。,V S KT 0 0 BP 0 0 P 0 SPO 0 0 % 0分 焦点 合う ぬ 発語なし,1,0.3197561665178362,0.6802438334821638,1,0.000247235032404332,0.9997527649675957,1,0.3395276738276354,0.6604723261723646,1,0.27317365454952935,0.7268263454504706,1,0.2574266195297241,0.8591950535774231,1,0.20364424586296082,0.8514485955238342,1,0.03279408269271222,0.9672059173072879,1
2504,その後、患者は2回目の投与を受け、発熱及び頭痛が持続したため、12日目に当院外来部を受診した。,その後 患者 0回目 投与 受ける 発熱 頭痛 持続 する た ため 0 日 目 院 外来 部 受診 する た,1,0.01668011408310569,0.9833198859168941,1,0.0002691649805614964,0.9997308350194385,1,0.08215212327656285,0.9178478767234372,1,0.0819679488460584,0.9180320511539416,1,0.08383535593748093,0.9475916624069214,1,0.18583019077777863,0.8686308860778809,1,0.005571974191235314,0.9944280258087647,1
2505,"冠動脈造影検査で有意狭窄やプラーク形成,血栓像はなく,冠動脈攣縮による急性心筋梗塞と診断した。",冠動脈造影 検査 だ 有意狭窄 プラーク形成 血栓像 ない 冠動脈攣縮 急性心筋梗塞 診断 する た,1,0.016702344380825577,0.9832976556191745,1,0.00021437187886870962,0.9997856281211313,1,0.4757904368101069,0.5242095631898931,1,0.14711891177100145,0.8528810882289986,1,0.11696332693099976,0.9211174249649048,1,0.20003636181354523,0.8657833933830261,1,0.014916638512504146,0.9850833614874959,1
2506,患者はcMRIにおける心筋炎の診断基準と考えられているレイクルイーズ基準(LLC)を満たした。,患者 cMRI 心筋炎 の 診断 基準 考える られる いる レイク・ルイーズ 基準 LLC 満たす た,1,1.657972330967066e-05,0.9999834202766904,1,0.0005393985291793886,0.9994606014708206,1,0.007312638570671326,0.9926873614293287,1,0.0034066544674160593,0.9965933455325839,1,0.10573041439056396,0.9390637874603271,1,0.2598074674606323,0.8297981023788452,1,0.004583157272511997,0.995416842727488,1
2507,急激な血小板減少は、ステロイドにて止まったが、患者は、血漿交換の治療目的で別の病院へ転院した。,急激 だ 血小板減少 ステロイド 止まる た 患者 血漿交換 治療 目的 別 病院 転院 する た,1,0.01668006489006791,0.9833199351099322,1,0.00023891434653023992,0.9997610856534698,1,0.42660272425660084,0.5733972757433992,1,0.08622352599218219,0.9137764740078178,1,0.13898475468158722,0.8932070136070251,1,0.20880892872810364,0.8477497696876526,1,0.012949389885110373,0.9870506101148896,1
2508,経胸壁心エコー検査では心機能の低下を認め、心臓磁気共鳴画像では両側心室に浮腫及び炎症を認めた。,経 胸壁 心 エコー 検査 心 機能 低下 認める 心臓 磁気 共鳴 画像 両側 心室 浮腫 炎症 認める た,1,0.016670586498903295,0.9833294135010966,1,0.00028624315085564616,0.9997137568491443,1,0.023648541200991136,0.9763514587990089,1,0.0037455266248138663,0.9962544733751861,1,0.08480602502822876,0.9455989599227905,1,0.18160225450992584,0.8649778366088867,1,0.004254702227163534,0.9957452977728365,1
2509,蛍光眼底造影検査で両眼視神経乳頭から蛍光漏出を認めたが、頭部造影MRIでは異常は認めなかった。,蛍光 眼底 造影 検査 両眼視 神経 乳頭 蛍光漏出 認める た 頭部 造影 MRI 異常 認める ない た,1,0.025626425565773197,0.9743735744342268,1,0.0002526241584479098,0.999747375841552,1,0.11515647687263653,0.8848435231273635,0,0.8993565157068423,0.10064348429315777,1,0.45240697264671326,0.681443989276886,0,0.684302031993866,0.3503258228302002,1,0.14012203905648093,0.8598779609435191,1
2510,心筋ダメージがどの程度まで進行するか、ピークアウトして状態が落ち着くまでは入院して経過を観た。,心筋ダメージ 程度 進行 する ピークアウト する 状態 落ち着く 入院 する 経過 観る た,1,0.03950355829034795,0.9604964417096521,1,0.00032129750896566704,0.9996787024910343,1,0.14812014293125475,0.8518798570687452,0,0.5976733752277237,0.40232662477227626,1,0.27614107728004456,0.8583290576934814,1,0.22623765468597412,0.8259215950965881,1,0.0263230351602926,0.9736769648397073,1
2511,心筋生検では、リンパ球を主体とする著明な炎症細胞浸潤、心筋壊死を認め、劇症型心筋炎と診断した。,心筋生検 だ リンパ球 主体 する 著 明 だ 炎症 細胞浸潤 心筋壊死 認める 劇症型 心筋炎 診断 する た,1,0.0036306418484152296,0.9963693581515849,1,0.00041263912441403123,0.999587360875586,1,0.04119859218718769,0.9588014078128123,1,0.15506090677527296,0.844939093224727,1,0.09087797999382019,0.9411707520484924,1,0.192594975233078,0.866850733757019,1,0.005917283340829599,0.9940827166591704,1
2512,"身体診察上,左前頸部に圧痛を認めるが発赤はなく,甲状腺腿大や頸部リンパ節腫脹はみられなかった。",身体 診察上 左前 頸部 圧痛 認める 発赤 ない 甲状腺 腿 大 頸部リンパ節腫脹 みる られる ない た,1,0.016711384911003442,0.9832886150889963,1,0.00027325895634828194,0.9997267410436517,0,0.9028401988186175,0.09715980118138247,0,0.8963595075918538,0.10364049240814624,1,0.2836489975452423,0.8401573300361633,0,0.7183055877685547,0.32748955488204956,1,0.36974204548759587,0.6302579545124042,1
2513,入院3日目に、完全房室ブロック、心原性ショックとなり、一時的ペースメーカー挿入し当院転院した。,入院 0 日 目 完全房室ブロック 心原性ショック なる 一時的 ペースメーカー 挿入 する 院 転院 する た,1,0.01670919768400601,0.983290802315994,1,0.0002939552225528116,0.9997060447774472,1,0.12642763854597705,0.873572361454023,1,0.21745596135608702,0.782544038643913,1,0.08674611151218414,0.9420576691627502,1,0.20054326951503754,0.843521237373352,1,0.00835490885005697,0.991645091149943,1
2514,エドロフォニウム・テスト陽性(抗アセチルコリン受容体抗体陽性)による重症筋無力症と診断された。,エドロフォニウム・テスト 陽性 アセチルコリン受容体 抗体陽性 重症 筋無力症 診断 する れる た,1,9.694011339876624e-06,0.9999903059886601,1,0.00046431396080656446,0.9995356860391934,1,0.013863198120276476,0.9861368018797235,1,0.2241226662739263,0.7758773337260737,1,0.0912940502166748,0.9423069953918457,1,0.1972862035036087,0.8727759122848511,1,0.006371155383012201,0.9936288446169877,1
2515,」は、「2021/08/24、動悸の訴えがあったため心筋炎を疑い、他院の循環器科を紹介された。,0 0 0 動悸 訴え ある た ため 心筋炎 疑う 他 院 循環器 科 紹介 する れる た,1,1.9020957595887115e-05,0.9999809790424041,1,0.00047515750573712295,0.9995248424942629,1,0.03974161337240212,0.9602583866275979,1,0.077537528082401,0.922462471917599,1,0.07751648128032684,0.9456869959831238,1,0.1751067191362381,0.8708000779151917,1,0.004828797882813168,0.9951712021171869,1
2516,2021/08/23 19:00、脳炎/脳症、けいれん、血小板減少性紫斑病、血管炎を発現した。,0 0 0 0 0 脳炎 脳症 けいれん 血小板減少 性 紫斑病 血管炎 発現 する た,1,4.976647862170566e-06,0.9999950233521377,1,0.0005720916827418269,0.9994279083172581,1,0.008629214167112487,0.9913707858328875,1,0.14620854570080755,0.8537914542991925,1,0.07665514200925827,0.9452499151229858,1,0.17970620095729828,0.8762738108634949,1,0.005197674546222771,0.9948023254537772,1
2517,2022/05/14(ワクチン接種の1日後)、患者はベラパミル感受性心室細動と発熱を発現した。,0 0 0 ワクチン接種 0 日 後 患者 ベラパミル 感受性 心室細動 発熱 発現 する た,1,0.003312399001031232,0.9966876009989687,1,0.0003790491342883713,0.9996209508657117,1,0.009059919955341722,0.9909400800446583,1,0.12444488426128775,0.8755551157387123,1,0.0848219245672226,0.9502467513084412,1,0.18601930141448975,0.8704814910888672,1,0.0050893920338187775,0.9949106079661811,1
2518,23:00ごろ、トイレで排便した後に意識消失を起こして転倒、左手を打撲、病院へ救急搬送された。,0 0 ごろ トイレ 排便 する た 後 意識消失 起こす 転倒 左手 打撲 病院 救急搬送 する れる た,1,0.010380812351819872,0.9896191876481805,1,0.00037509692823042276,0.9996249030717695,0,0.5359318525206658,0.4640681474793342,1,0.10971707060305957,0.8902829293969404,1,0.07783358544111252,0.9442009329795837,1,0.17907081544399261,0.8716100454330444,1,0.014117849404706348,0.9858821505952936,1
2519,筋力低下、疲労、四肢不快感、異常感、錯感覚、感覚鈍麻、起立障害の結果として治療処置がとられた。,筋力低下 疲労 四肢不快感 異常感 錯感覚 感覚鈍麻 起立障害 結果 治療 処置 とる れる た,1,0.004302355428318637,0.9956976445716814,1,0.0003521432110301299,0.9996478567889698,1,0.025462054269746792,0.9745379457302532,1,0.08224094304867602,0.917759056951324,1,0.08249785006046295,0.9472934007644653,1,0.18817947804927826,0.8706098794937134,1,0.004856780190321404,0.9951432198096786,1
2520,事象「腕がしびれて肩までしびれた」と「腕の違和感(多分左腕)」により、診療所への来院を要した。,事象 腕 しびれ 肩 しびれ た 腕 違和感 左腕 診療所 来院 要す た,1,0.00674804185005761,0.9932519581499423,1,0.00044247636659470644,0.9995575236334053,1,0.20496753646113208,0.7950324635388679,1,0.005755143015388708,0.9942448569846113,1,0.07316097617149353,0.94901442527771,1,0.18331480026245117,0.8668919205665588,1,0.005919276567729289,0.9940807234322708,1
2521,受診時、口腔内は吐物で満たされ、呼吸停止、Asystole、瞳孔散瞳、対光反射消失を確認した。,受診 時 口腔内 吐物 満たす れる 呼吸停止 Asystole 瞳孔散瞳 対光反射消失 確認 する た,1,0.027598572428598946,0.9724014275714012,1,0.00032823669686137,0.9996717633031387,1,0.2640486247230803,0.7359513752769197,1,0.22234769012158506,0.7776523098784149,1,0.08067859709262848,0.9456276297569275,1,0.20996135473251343,0.8489861488342285,1,0.011258299013516201,0.9887417009864838,1
2522,重症筋無力症、複視、眼瞼下垂、眼運動障害、疲労、筋力低下の結果として、治療的な処置がとられた。,重症 筋無力症 複視 眼瞼下垂 眼運動障害 疲労 筋力低下 結果 治療 的 だ 処置 とる れる た,1,0.012558730014953588,0.9874412699850464,1,0.00030882291162878065,0.9996911770883712,1,0.025462054269746792,0.9745379457302532,1,0.08567500211654888,0.9143249978834511,1,0.07746805250644684,0.9434611201286316,1,0.19422869384288788,0.8740417957305908,1,0.0049777012933120805,0.9950222987066879,1
2523,身体的検査:全身性鱗屑性紅斑が認められた、注:及びほぼ全身に引っかき傷の痕を伴った斑が見られた,身体的 検査 身性 鱗屑 性紅斑 認める られる た 注 全身 引っかく 傷 痕 伴う た 斑 見る られる た,1,0.016694281960750318,0.9833057180392497,1,0.00031098026345402447,0.999689019736546,1,0.04227856658621687,0.9577214334137831,1,0.10250926117605907,0.8974907388239409,1,0.08200929313898087,0.9469287395477295,1,0.17930738627910614,0.8681480288505554,1,0.005324096627773766,0.9946759033722262,1
2524,他の病歴は高血圧、肺疾患、胸髄麻痺(下肢)が含まれ、両側上肺野に小粒状影多発、珪肺が疑われる。,他 病歴 高血圧 肺疾患 胸髄麻痺 下肢 含む れる 両側 上 肺 野 小粒状影多発 珪肺 疑う れる,1,0.016722804504728923,0.9832771954952712,1,0.0003140876546048777,0.9996859123453952,1,0.15436636381047808,0.8456336361895219,1,0.015104060603985281,0.9848959393960147,1,0.08158347010612488,0.9402291774749756,1,0.18596114218235016,0.8684269785881042,1,0.005663143509696451,0.9943368564903036,1
2525,再度PCR検査が実施され、陽性を示し、トファシチニブクエン酸塩はオルミエントに切り替えられた。,PCR検査 実施 する れる 陽性 示す トファシチニブ クエン酸 塩 オルミエント 切り替える られる た,1,0.025257534268181718,0.9747424657318182,1,0.00029900494835165834,0.9997009950516483,1,0.037905830666948415,0.9620941693330516,1,0.19451115061352586,0.8054888493864741,1,0.2633429765701294,0.8529534935951233,1,0.23740804195404053,0.8497121334075928,1,0.009139504624524617,0.9908604953754754,1
2526,"2021/05/06(同年)、当院を受診、左第1,2背側のしびれと疼痛あり、左に下垂手あり。",0 0 0 同年 院 受診 左 0 0 背 側 しびれ 疼痛 ある 左 下垂手 ある,1,0.004244608464990125,0.9957553915350099,1,0.00037585059722393405,0.9996241494027761,1,0.07026992146262767,0.9297300785373723,1,4.661779575587666e-06,0.9999953382204244,1,0.07688424736261368,0.9450715184211731,1,0.1877533495426178,0.8641968965530396,1,0.004519425466472142,0.9954805745335279,1
2527,2021/08中旬、接種2日後に朝起きるとぼやけてきて、急激な右眼視力低下を自覚し近医受診。,0 0 中旬 接種 0 日 後 朝 起きる ぼやける くる 急激 だ 右眼視力低下 自覚 する 近医 受診,1,0.006686024492064192,0.9933139755079355,1,0.0004259004113348597,0.9995740995886652,1,0.023037645392560813,0.9769623546074392,1,3.0823113505995536e-07,0.9999996917688649,1,0.08741120249032974,0.9478480815887451,1,0.18654046952724457,0.8740478754043579,1,0.004120529640609458,0.9958794703593906,1
2528,2回目接種翌日、患者は一過性の軽度の疲労及び注射部位の局所疼痛を呈し、症状は翌日に回復した。,0回目 接種 翌日 患者 一過性 軽度 疲労 注射 部位 局所疼痛 呈す 症状 翌日 回復 する た,1,0.016668055305648004,0.9833319446943517,1,0.0003459789568516899,0.9996540210431483,1,0.032190435389574446,0.9678095646104256,1,0.22876137139772512,0.7712386286022749,1,0.14941620826721191,0.921815812587738,1,0.24341990053653717,0.8460110425949097,1,0.00800970760815345,0.9919902923918467,1
2529,C-反応性蛋白:8.78(高値)、45日後(2回目)のC-反応性蛋白は8.78 mg/dL。,C 反応 性 蛋白 0 0 高値 0 日 後 0回目 C 反応 性 蛋白 0 0 mg dL,1,0.04177379547204123,0.9582262045279587,1,0.0003073712533428399,0.9996926287466572,1,0.07170124913688813,0.9282987508631119,0,0.5195482961797382,0.48045170382026176,1,0.10022677481174469,0.9396387338638306,1,0.20420683920383453,0.8538482189178467,1,0.014451616916955255,0.9855483830830448,1
2530,フェキソフェナジン、キンダベート軟膏を処方されたが改善せず、発熱、手掌・足底に湿疹を認めた。,フェキソフェナジン キンダベート 軟膏 処方 する れる た 改善 する ぬ 発熱 手 掌 足 底 湿疹 認める た,1,0.0166937321915516,0.9833062678084483,1,0.0002441494001808461,0.9997558505998192,1,0.10300727594797399,0.896992724052026,1,0.0115375944521936,0.9884624055478064,1,0.08691715449094772,0.9450992345809937,1,0.188879132270813,0.8515023589134216,1,0.005179572084377868,0.9948204279156221,1
2531,各種心筋炎スクリーニングで特記所見なく、本剤関連心筋炎疑いと判断し、当科外来加療継続の方針。,各種 心筋炎 スクリーニング 特記 所 見る ない 本 剤 関連 心筋炎 疑い 判断 する 科 外来 加療 継続 方針,1,0.24108276649325674,0.7589172335067433,0,0.0001387553612783657,0.9998612446387216,1,0.3605373926098365,0.6394626073901635,0,0.9997317401616261,0.0002682598383739183,0,0.785591721534729,0.3994161784648895,0,0.6437305808067322,0.39034950733184814,1,0.4607156170073107,0.5392843829926893,1
2532,心筋炎調査票:2021/10/15、急性発症の胸痛又は胸部圧迫感の臨床症状/所見が出現した。,心筋炎 調査 票 0 0 0 急性発症 の 胸痛 胸部圧迫感 の 臨床症状 所見 出現 する た,1,0.007803406605160163,0.9921965933948397,1,0.0003124118113452975,0.9996875881886547,1,0.0045242528693215656,0.9954757471306784,1,0.16374188550565416,0.8362581144943458,1,0.07762032002210617,0.9471184015274048,1,0.1781686544418335,0.8759379386901855,1,0.005407730057293266,0.9945922699427068,1
2533,接種部位は数日間6x6 cm大に発赤し、腋窩リンパが腫脹したが、発熱や全身倦怠感はなかった。,接種 部位 数 日間 0 x 0 cm 大 発赤 腋窩 リンパ 腫脹 する た 発熱 全身倦怠感 ない た,1,0.01667843700215473,0.9833215629978453,1,0.000326225622622281,0.9996737743773777,1,0.1535581405000228,0.8464418594999772,0,0.8825778140215941,0.11742218597840597,1,0.1259748637676239,0.9338029623031616,1,0.19275395572185516,0.8656787276268005,1,0.03310288560394725,0.9668971143960527,1
2534,頭部MRIで脳幹部に高信号を認め、本剤接種後の脳炎・脳症が疑われたため当院へ搬送され、入院。,頭部 MRI 脳幹 部 高信号 認める 本 剤 接種 後 脳炎 脳症 疑う れる た ため 院 搬送 する れる 入院,1,2.033894579483836e-06,0.9999979661054206,1,0.0007404361265504679,0.9992595638734495,1,0.0010757382332016174,0.9989242617667984,1,1.0119697768651292e-07,0.9999998988030223,1,0.08783721923828125,0.9370641112327576,1,0.18423253297805786,0.8718147277832031,1,0.003937859014531763,0.9960621409854683,1
2535,入院時の血糖値が500 mg/dL以上あり、脱力感やふらつきは高血糖状態によるものであった。,入院 時 血糖 値 0 mg dL 以上 ある 脱力感 ふらつき 高血糖状態 もの だ ある た,1,0.2279691455593148,0.7720308544406853,1,0.00018734752515361854,0.9998126524748464,1,0.20071024426333495,0.799289755736665,0,0.7142543537430173,0.28574564625698273,1,0.08175976574420929,0.9466316103935242,1,0.19508257508277893,0.8542482256889343,1,0.03776793056997169,0.9622320694300283,1
2536,肺膿瘍による呼吸不全、脳多発小梗塞や感染に伴う免疫能の低下での単純ヘルペス感染が認められた。,肺膿瘍 呼吸不全 脳 多発小梗塞 感染 伴う 免疫 能 低下 単純ヘルペス感染 認める られる た,1,0.006711368591116326,0.9932886314088839,1,0.0003901814621126213,0.9996098185378873,1,0.012570041436558599,0.9874299585634414,1,0.05094897458504022,0.9490510254149598,1,0.07886570692062378,0.9465091824531555,1,0.1776593029499054,0.8690851330757141,1,0.004417174096065084,0.995582825903935,1
2537,不全片麻痺(左)、左半身の分節性感覚鈍麻、構音障害を認め、脳梗塞として抗血栓療法を開始した。,不全片麻痺 左 左半身 分節 性 感覚鈍麻 構音障害 認める 脳梗塞 する 抗血栓 療法 開始 する た,1,0.011133280811130674,0.9888667191888694,1,0.0003482444970334716,0.9996517555029665,1,0.018985679337008454,0.9810143206629915,1,0.32726210331451433,0.6727378966854857,1,0.08437635749578476,0.9376461505889893,1,0.19434405863285065,0.873087465763092,1,0.008029631624067238,0.9919703683759328,1
2538,負荷試験の結果からは、典型的ではないもののLQT2、Brugata症候群などが鑑別に上がる。,負荷 試験 結果 典型的 ない もの LQT 0 Brugata 症候群 鑑別 上がる,1,0.1469568619704218,0.8530431380295782,1,0.0002094469910249908,0.999790553008975,0,0.6454301502169093,0.35456984978309064,1,2.19824158875781e-14,0.999999999999978,1,0.15547126531600952,0.8770300149917603,1,0.2743433713912964,0.8169083595275879,1,0.024628098732912485,0.9753719012670876,1
2539,断定できないが、急な発症様式からは心血管イベントが疑われ、死因は急性心筋梗塞の疑いとなった。,断定 できる ない 急 だ 発症 様式 心血 管 イベント 疑う れる 死因 急性心筋梗塞 疑い なる た,1,0.050793699937477135,0.9492063000625227,1,0.00034033966461108567,0.9996596603353889,1,0.08571371893608892,0.9142862810639111,1,0.08964153539402331,0.9103584646059767,1,0.07970361411571503,0.9432919025421143,1,0.20562279224395752,0.8567826151847839,1,0.0062944695098179505,0.993705530490182,1
2540,2021/10/23 08:00頃(ワクチン接種の2日後)、患者は心筋炎と心膜炎を発現した。,0 0 0 0 0 頃 ワクチン接種 0 日 後 患者 心筋炎 心膜炎 発現 する た,1,0.0041882890404612615,0.9958117109595387,1,0.0004337572217747617,0.9995662427782253,1,0.004253539290504427,0.9957464607094956,1,0.07567052368210325,0.9243294763178967,1,0.08139411360025406,0.9465739130973816,1,0.17928193509578705,0.8705080151557922,1,0.004553416376263608,0.9954465836237364,1
2541,2/24、手指の腫脹のため、指輪が食い込んで疼痛があるとのことで当院夜間救急外来を受診した。,0 0 手 指 腫脹 ため 指輪 食い込む 疼痛 ある こと 院 夜間 救急外来 受診 する た,1,0.006773594716089232,0.9932264052839107,1,0.00040857700282354535,0.9995914229971764,1,0.041839117541281334,0.9581608824587187,1,0.13038328290787204,0.869616717092128,1,0.08077716082334518,0.9453428983688354,1,0.18323862552642822,0.8765374422073364,1,0.005491455179643728,0.9945085448203563,1
2542,2021/06/10、全身倦怠感、嘔吐、悪心、めまい、発熱は入院を必要とし、転帰不明であった,0 0 0 全身倦怠感 嘔吐 悪心 めまい 発熱 入院 必要 する 転帰 不明 だ ある た,1,0.01042324214956127,0.9895767578504389,1,0.00031513634779899467,0.999684863652201,1,0.008474093575076891,0.9915259064249231,0,0.6719089752736296,0.3280910247263705,1,0.07738549262285233,0.949855387210846,1,0.18433833122253418,0.8710579872131348,1,0.015113371483921325,0.9848866285160786,1
2543,2021/09/21(ワクチン接種11日後)、心筋生検を施行し、心筋に炎症細胞浸潤を認めた。,0 0 0 ワクチン接種 0 日 後 心筋生検 施行 する 心筋 炎症 細胞浸潤 認める た,1,0.01670574120998404,0.9832942587900159,1,0.00031356917242350086,0.9996864308275765,1,0.07684913261699211,0.9231508673830079,1,0.005738936369512615,0.9942610636304874,1,0.08474000543355942,0.9436846375465393,1,0.1846596598625183,0.8661256432533264,1,0.004767302920245751,0.9952326970797541,1
2544,2021/10/03(2回目接種1日後)、リンパ節腫脹、発熱、倦怠感、線維筋痛症を発現した。,0 0 0 0回目 接種 0 日 後 リンパ節腫脹 発熱 倦怠感 線維筋痛症 発現 する た,1,6.263351316085478e-07,0.9999993736648684,1,0.0004483207308141901,0.9995516792691858,1,0.003137957424287796,0.9968620425757122,1,0.10602502135350145,0.8939749786464986,1,0.07770063728094101,0.9476078748703003,1,0.181010901927948,0.8774611949920654,1,0.00473921315646364,0.9952607868435362,1
2545,2022/02/26 4:00頃(ワクチン接種の13時間後)、患者は急性心筋梗塞を発現した。,0 0 0 0 0 頃 ワクチン接種 0時 間 後 患者 急性心筋梗塞 発現 する た,1,0.0058339778371086625,0.9941660221628913,1,0.00042426805499796684,0.999575731945002,1,0.012377604694964406,0.9876223953050356,1,0.09236315600913025,0.9076368439908697,1,0.08720187097787857,0.9504104852676392,1,0.18004262447357178,0.8704261183738708,1,0.004813076512855237,0.9951869234871449,1
2546,2022/05/15から2022/05/19 2022/05/20、5日以上の発熱があった。,0 0 0 0 0 0 0 0 0 0 日 以上 発熱 ある た,1,0.016054722859132165,0.9839452771408678,1,0.0003109780959898871,0.9996890219040101,1,0.026848325200379386,0.9731516747996206,1,0.18688996650984258,0.8131100334901574,1,0.07699605077505112,0.9502364993095398,1,0.18798086047172546,0.8772184252738953,1,0.006046144249784108,0.9939538557502159,1
2547,2022/06/10、報告病院を受診し、慢性糸球体腎炎の疑いとして、経過観察の方針となった。,0 0 0 報告 病院 受診 する 慢性糸球体腎炎 疑い 経過 観察 方針 なる た,1,0.01669562221994201,0.983304377780058,1,0.0002440781268697649,0.9997559218731302,1,0.041110098366696324,0.9588899016333037,0,0.6233005174436604,0.37669948255633956,1,0.08730357140302658,0.9389939904212952,1,0.2317437380552292,0.8381987810134888,1,0.016375710580079764,0.9836242894199203,1
2548,2022/07/04(ワクチン接種の9日後)、患者は両側足関節以遠の脱力・しびれを発現した。,0 0 0 ワクチン接種 0 日 後 患者 両側 足関節 以遠 脱力 しびれ 発現 する た,1,0.010516344662226292,0.9894836553377736,1,0.00044874499228269747,0.9995512550077174,1,0.013951057137388534,0.9860489428626115,1,0.14081200126981697,0.859187998730183,1,0.0795373022556305,0.9470918774604797,1,0.1910443902015686,0.878548800945282,1,0.005359009528926474,0.9946409904710736,1
2549,急性心筋炎に伴う心機能低下から、血行動態破綻する可能性も考えられ集中治療室へ入院管理とした。,急性心筋炎 伴う 心機能低下 血行動態破綻 する 可能性 考える られる 集中治療室 入院 管理 する た,1,0.0037943113092209213,0.9962056886907793,1,0.0004031929301895988,0.9995968070698104,1,0.01709811670070982,0.9829018832992902,0,0.6079249909694195,0.39207500903058046,1,0.08625197410583496,0.9391218423843384,1,0.20067591965198517,0.857011079788208,1,0.014053040179772453,0.9859469598202275,1
2550,事象「腰を痛めた/腰痛増悪/強い腰痛/再度腰痛が出現」は、医師受診と緊急治療室受診を要した。,事象 腰 痛める た 腰痛 増悪 強いる 腰痛 再度腰痛 出現 医師 受診 緊急 治療 室 受診 要す た,1,0.008606152293398174,0.9913938477066017,1,0.0003922223665404414,0.9996077776334595,1,0.007919332667445822,0.9920806673325542,1,0.018759838756520097,0.9812401612434799,1,0.0772843211889267,0.9480453729629517,1,0.18078070878982544,0.8743475675582886,1,0.004098722400114544,0.9959012775998854,1
2551,発熱、末梢腫脹、下痢、頭痛、食欲減退、倦怠感、リンパ節症の結果として、治療的処置がとられた。,発熱 末梢腫脹 下痢 頭痛 食欲減退 倦怠感 リンパ節症 結果 治療 的 処置 とる れる た,1,1.2226233499931326e-05,0.9999877737665,1,0.0005277442178862834,0.9994722557821137,1,0.0011260902819201224,0.9988739097180799,1,0.0962823830549796,0.9037176169450204,1,0.08625595271587372,0.9467546939849854,1,0.18834207952022552,0.8676221370697021,1,0.004754575669055705,0.9952454243309444,1
2552,脳脊髄液細胞数は細胞数増加を示し、MRI(磁気共鳴画像)は脳梁膨大部(DWI信号)を示した。,脳脊髄液 細胞 数 細胞 数 増加 示す MRI 磁気 共鳴 画像 脳梁 膨大 部 DWI 信号 示す た,1,0.03438181561724113,0.9656181843827588,1,0.0002676604138303692,0.9997323395861696,1,0.1489404337422413,0.8510595662577587,1,0.02876714116561685,0.9712328588343832,1,0.09692828357219696,0.9305940866470337,1,0.19141413271427155,0.863873302936554,1,0.006172799591044184,0.9938272004089558,1
2553,12誘導心電図は非特異的ST上昇を認め、心エコーでは心嚢液なく心室の壁浮腫を認めなかった。,0 誘導 心電図 非特異的 ST 上昇 認める 心 エコー 心嚢液 ない 心室 壁浮腫 認める ない た,1,0.046246580664686954,0.953753419335313,1,0.00025629822925101733,0.999743701770749,0,0.5626954637262342,0.43730453627376575,0,0.9714374176982318,0.028562582301768256,1,0.1638774424791336,0.9057215452194214,1,0.2728559672832489,0.8260977268218994,1,0.10585342689908053,0.8941465731009194,1
2554,2021/09/08、右末梢性顔面神経麻痺、嚥下障害、構音障害、呼吸筋障害も軽度出現した。,0 0 0 右末梢性顔面神経麻痺 嚥下障害 構音障害 呼吸 筋障害 軽度 出現 する た,1,0.0074979415850032005,0.9925020584149967,1,0.0003653675538363205,0.9996346324461637,1,0.00935574097978853,0.9906442590202115,1,0.18989112910437533,0.8101088708956247,1,0.07738050073385239,0.9495156407356262,1,0.18293403089046478,0.8813396692276001,1,0.005729845317898839,0.9942701546821011,1
2555,2021/10/29、トロポニンIの結果は31.1 pg/ml、胸痛でアスピリン開始した。,0 0 0 トロポニン I 結果 0 0 PG ml 胸痛 アスピリン 開始 する た,1,0.10982456682288322,0.8901754331771169,1,0.00020128966430781116,0.9997987103356922,1,0.28130362265301767,0.7186963773469823,1,0.35708939895134406,0.6429106010486559,1,0.14998139441013336,0.9013420939445496,1,0.18502110242843628,0.8712939620018005,1,0.0190623109480174,0.9809376890519826,1
2556,2022/02/28 00:55頃就寝中、急に胸苦を訴えたため、当院の救急外来に救急搬送。,0 0 0 0 0 頃 就寝 中 急 胸苦 訴える た ため 院 救急外来 救急搬送,1,0.006418688315193971,0.9935813116848061,1,0.0004490812505359118,0.9995509187494641,1,0.015540978966542718,0.9844590210334573,1,6.22224494151169e-11,0.9999999999377776,1,0.08079657703638077,0.9459654688835144,1,0.18944649398326874,0.8715859055519104,1,0.004060053516152358,0.9959399464838476,1
2557,2022/04/11歩行時左脇胸部の違和感・軽い痛み、倦怠感を自覚したが、様子を見ていた。,0 0 0 歩行 時 左脇 胸部 違和感 軽い 痛み 倦怠感 自覚 する た 様子 見る いる た,1,0.01669593634715039,0.9833040636528498,1,0.00025457276810236703,0.9997454272318976,1,0.018624343234902696,0.9813756567650973,1,0.33855089320937315,0.6614491067906269,1,0.0806523784995079,0.9464164972305298,1,0.1861942857503891,0.8672007322311401,1,0.008174569382774478,0.9918254306172255,1
2558,2022年4月歩行時に杖が必要になり、指先が使いずらくなった(タイピングが遅くなるなど)。,0 年 0 月 歩行 時 杖 必要 なる 指先 使う ぬ らく なる た タイピング 遅い なる,1,0.016694807952531435,0.9833051920474687,1,0.0002231834691856859,0.9997768165308143,1,0.2765752104800805,0.7234247895199195,1,5.80569877234316e-05,0.9999419430122766,1,0.20773671567440033,0.8519790768623352,1,0.20555774867534637,0.8577616810798645,1,0.008930221231259779,0.9910697787687401,1
2559,CMR画像にて同病変に非虚血性領域の分布とともに限局性の遅延増強を認め、心筋炎が示された。,CMR 画像 病変 非虚血性 領域 分布 限局 性 遅延 増強 認める 心筋炎 示す れる た,1,0.00830070547461521,0.9916992945253846,1,0.0004508593199533414,0.9995491406800466,1,0.007726297178346386,0.9922737028216536,1,0.11250624948301946,0.8874937505169805,1,0.08849027007818222,0.9427738785743713,1,0.18836702406406403,0.8716209530830383,1,0.005068800863571995,0.9949311991364279,1
2560,mRNA COVID-19ワクチンの2回目の投与から3?日後、患者は熱及び胸痛を発現した。,mRNA COVID 0 ワクチン 0回目 投与 0 日後 患者 熱 胸痛 発現 する た,1,0.01998668354328263,0.9800133164567174,1,0.0002679192013562705,0.9997320807986437,1,0.023874826523671233,0.9761251734763288,1,0.051582491436730105,0.9484175085632699,1,0.083455890417099,0.9464842081069946,1,0.18962383270263672,0.8734825253486633,1,0.004700086643220241,0.9952999133567798,1
2561,患者は甲状腺中毒性周期性四肢麻痺(甲状腺中毒性周期性四肢麻痺)(重篤区分:入院)を呈した。,患者 甲状腺 中毒性 周期性四肢麻痺 甲状腺 中毒性 周期性四肢麻痺 重篤 区分 入院 呈す た,1,0.0058429332183513585,0.9941570667816487,1,0.00036366307912256545,0.9996363369208774,1,0.03339634076885756,0.9666036592311424,1,0.007353838433376669,0.9926461615666233,1,0.08229931443929672,0.9353349804878235,1,0.2016938328742981,0.8513678908348083,1,0.004457072103902795,0.9955429278960972,1
2562,採血でCK上昇、心電図ではV2-6、2、aVFで広範囲ST上昇見られ、緊急カテーテル施行。,採血 CK 上昇 心電図 V 0 0 0 aVF 広範囲 ST 上昇 見る られる 緊急 カテーテル 施行,1,0.045313590388136066,0.9546864096118639,1,0.00023162533991290496,0.9997683746600871,1,0.055762996710366663,0.9442370032896333,1,0.0015784705746639816,0.998421529425336,1,0.08944470435380936,0.9394411444664001,1,0.18010297417640686,0.8701720237731934,1,0.004800170446797147,0.9951998295532029,1
2563,心膜炎調査票: 2021/10/15、急性の胸痛又は胸部圧迫感の臨床症状/所見が出現した。,心膜炎 調査 票 0 0 0 急性 胸痛 胸部圧迫感 の 臨床症状 所見 出現 する た,1,0.011129907768625083,0.988870092231375,1,0.0002835502574843758,0.9997164497425156,1,0.004818000677307865,0.9951819993226921,1,0.1823413682734769,0.8176586317265231,1,0.07477466017007828,0.9473696947097778,1,0.1789897084236145,0.8769499659538269,1,0.005633305589838121,0.994366694410162,1
2564,新型コロナウイルスは検出されなかったが、COVID IgG Quantの異常高値を認めた。,新型コロナウイルス 検出 する れる ない た COVID IgG Quant 異常高値 認める た,1,0.2788264344991125,0.7211735655008875,1,0.00024686375341012015,0.9997531362465899,0,0.8821566149605108,0.1178433850394892,1,5.364310200883793e-05,0.9999463568979912,1,0.10172394663095474,0.9380666017532349,1,0.19209136068820953,0.8677499294281006,1,0.03956527764655344,0.9604347223534466,1
2565,接種5日後、左室基部-中央下-外側の心外膜下の壁にLGE及びT2WBBでの高信号を認めた。,接種 0 日 後 左 室 基部 中央 下 外側 心外 膜 下 壁 LGE T 0W B・B 高信号 認める た,1,0.023052245828513257,0.9769477541714867,1,0.0003425582974126694,0.9996574417025873,1,0.03751643165620333,0.9624835683437967,1,0.03423657400110036,0.9657634259988996,1,0.08746518194675446,0.9355799555778503,1,0.18233053386211395,0.8686614632606506,1,0.004753306854756551,0.9952466931452435,1
2566,接種後、発熱が2週間持続し、患者は両側の末梢浮腫、多関節痛、起立困難及び歩行困難を呈した。,接種 後 発熱 0 週間 持続 する 患者 両側 末梢浮腫 多関節痛 起立困難 歩行困難 呈す た,1,0.005372566780010235,0.9946274332199899,1,0.0004145099680891051,0.9995854900319109,1,0.0055899959135891075,0.9944100040864109,1,0.0008707285250603158,0.9991292714749397,1,0.07695429772138596,0.9497907757759094,1,0.19024105370044708,0.8722314834594727,1,0.003949018775558781,0.9960509812244411,1
2567,低酸素血症、酸素飽和度(SpO2)92%を伴う呼吸器症状を示し、再検査は99%迄上昇した。,低酸素血症 酸素飽和度 SpO 0 0% 伴う 呼吸器症状 示す 再検査 0% 上昇 する た,1,0.004739184212990055,0.9952608157870099,1,0.0004534578780794086,0.9995465421219206,1,0.01121050463974882,0.9887894953602512,1,0.204883699685123,0.795116300314877,1,0.08238434791564941,0.9480441212654114,1,0.18216483294963837,0.8760725855827332,1,0.005958300703896197,0.9940416992961038,1
2568,頭皮・顔面には痒みを伴う点状発赤疹、体幹・四肢に紫斑、肛門付近の皮下結節から出血を認めた。,頭皮 顔面 痒み 伴う 点状 発赤疹 体幹 四肢 紫斑 肛門付近 の 皮下結節 出血 認める た,1,0.004924249964334621,0.9950757500356653,1,0.00045633414416068493,0.9995436658558393,1,0.03047542326560193,0.9695245767343981,1,0.021865531076586397,0.9781344689234136,1,0.08567449450492859,0.943051278591156,1,0.1876673847436905,0.8710612058639526,1,0.004384316733505144,0.995615683266495,1
2569,頭部CTにて出血疑いで脳神経外科へコンサルトのため転院搬送されたが、明らかな異常なく帰宅。,頭部 C，T 出血 疑い 脳神経外科 コンサルト ため 転院 搬送 する れる た 明らか だ 異常 ない 帰宅,1,0.027472943932880984,0.972527056067119,1,0.00018039861971436467,0.9998196013802856,1,0.21641694550905688,0.7835830544909431,1,0.3126701952991655,0.6873298047008345,1,0.28190404176712036,0.7937182188034058,1,0.2786375880241394,0.8063259720802307,1,0.019340544899259758,0.9806594551007403,1
2570,頭部MRI検査ではDWIで橋下部右腹側にHIA、大脳白質、両側放線冠に虚血性変化を認めた。,頭部 MRI 検査 DWI 橋 下部 右 腹 側 HIA 大脳白質 両側 放線 冠 虚血性 変化 認める た,1,0.010966343567689064,0.9890336564323109,1,0.00040288706307488325,0.9995971129369251,1,0.01611303927239993,0.9838869607276001,1,0.026883849458207765,0.9731161505417922,1,0.0796608105301857,0.9406682848930359,1,0.1894589513540268,0.8719446659088135,1,0.0043433308827098725,0.99565666911729,1
2571,日付不明その後、蛍光眼底造影にて右眼に腕網膜時間、網膜循環時間の延長、充填欠損が見られた。,日付 不明 その後 蛍光 眼底 造影 右 眼 腕 網膜 時間 網膜 循環 時間 延長 充填 欠損 見る られる た,1,0.01669257492127398,0.9833074250787259,1,0.000346264823052755,0.9996537351769472,1,0.09185938409962258,0.9081406159003774,1,0.14738557529071872,0.8526144247092813,1,0.10807725042104721,0.9167710542678833,1,0.1880703866481781,0.8658185005187988,1,0.006868793466633013,0.993131206533367,1
2572,急性肝炎、薬物性肝障害、肝障害、脂肪肝、食欲減退、倦怠感、発熱のため治療処置が施行された。,急性肝炎 薬物性 肝障害 肝障害 脂肪肝 食欲減退 倦怠感 発熱 ため 治療 処置 施行 する れる た,1,0.02650937172645595,0.973490628273544,1,0.00037402717954995203,0.9996259728204501,1,0.018273497220283264,0.9817265027797167,1,0.14555510951149042,0.8544448904885096,1,0.0783698558807373,0.9443656206130981,1,0.18114425241947174,0.8746001124382019,1,0.005607496637883365,0.9943925033621166,1
2573,トロポニンI値高値(12.00 ng/mL)、心電図ST上昇があり、急性心筋炎と診断した。,トロポニン I 値 高値 0 0 NG mL 心電図 ST 上昇 ある 急性心筋炎 診断 する た,1,2.2977866767653487e-06,0.9999977022133232,1,0.000634245030582928,0.999365754969417,1,0.008437381346781403,0.9915626186532186,1,0.10665167256265584,0.8933483274373442,1,0.08139713108539581,0.9474558234214783,1,0.17916110157966614,0.8760320544242859,1,0.0048136304655271795,0.9951863695344728,1
2574,(2022/05/30) V1-6、I、aVLにてST上昇あり、注記:ST上昇が指摘された,0 0 0 V 0 0 I aVL ST 上昇 ある 注記 ST 上昇 指摘 する れる た,1,7.720534433030435e-06,0.999992279465567,1,0.0005777261557178957,0.9994222738442821,1,0.025341856800449647,0.9746581431995504,1,0.2896344898118557,0.7103655101881443,1,0.07518571615219116,0.9457410573959351,1,0.18327683210372925,0.8797464966773987,1,0.007132740763687066,0.992867259236313,1
2575,2021/10/29(2回目ワクチン接種07ヵ月と10日後)、被験者は尿路結石を発現した。,0 0 0 0回目 ワクチン接種 0 ヵ月 0 日 後 被験者 尿路結石 発現 する た,1,0.013574168092895364,0.9864258319071045,1,0.0003144842795908625,0.9996855157204091,1,0.018951109761968343,0.9810488902380317,1,0.09902456860358178,0.9009754313964182,1,0.09721637517213821,0.9419823288917542,1,0.19395053386688232,0.8626090288162231,1,0.005221705670741085,0.994778294329259,1
2576,2022/01/27、SARS-CoV-2検査(PCR)で、COVID-19陽性を示した。,0 0 0 SARS CoV 0 検査 PCR だ COVID 0 陽性 示す た,1,0.02406107508073818,0.9759389249192615,1,0.00039951641056510295,0.9996004835894349,1,0.1314439811028303,0.8685560188971697,1,0.06761858288502243,0.9323814171149776,1,0.09461283683776855,0.9399192333221436,1,0.18784084916114807,0.8724149465560913,1,0.0061640741418026845,0.9938359258581974,1
2577,2022/04/06 13:00時頃、微熱、左上腕の腫脹、左上腕の疼痛、左胸痛を発症した。,0 0 0 0 0時 頃 微熱 左上 腕 腫脹 左上 腕 疼痛 左胸痛 発症 する た,1,9.997030696472781e-06,0.9999900029693035,1,0.0004452108321229426,0.9995547891678771,1,0.028890878195194536,0.9711091218048055,1,0.11265909913274763,0.8873409008672524,1,0.07650485634803772,0.9502589702606201,1,0.17772841453552246,0.875637948513031,1,0.005028195249009559,0.9949718047509903,1
2578,2022/06/20の朝から、左眼がゴロゴロして瞬目しづらい症状が発現し、徐々に悪化した。,0 0 0 朝 左 眼 ゴロゴロ する 瞬目 する づらい 症状 発現 悪化 する た,1,0.007181047607474914,0.9928189523925252,1,0.000391911118879827,0.9996080888811202,1,0.0178029781336857,0.9821970218663143,1,0.31872457585294445,0.6812754241470556,1,0.0901792049407959,0.9471665620803833,1,0.1847943514585495,0.8751267790794373,1,0.007697604187672249,0.9923023958123277,1
2579,2月にコロナ陽性になった12歳の女児が、昨夜から摂氏39度から摂氏40度の発熱で来院した。,0 月 コロナ 陽性 なる た 0歳 女児 昨夜 摂氏 0度 摂氏 0度 発熱 来院 する た,1,5.774067381098822e-06,0.9999942259326189,1,0.00046154310264159913,0.9995384568973584,1,0.004459169288803411,0.9955408307111966,1,0.06374870050134684,0.9362512994986532,1,0.07932043075561523,0.9510217308998108,1,0.17951928079128265,0.8694180846214294,1,0.004389023938733186,0.9956109760612669,1
2580,血小板90000/μlと急な減少を認め、D-dimer 11.2μg/mlと高値であった。,血小板 0 μ l 急 だ 減少 認める D dimer 0 0 μ g ml 高値 だ ある た,1,0.010315024379274503,0.9896849756207253,1,0.00040925544349398207,0.999590744556506,1,0.01825743596167939,0.9817425640383206,1,0.3306962877289439,0.6693037122710561,1,0.08000203222036362,0.9475162625312805,1,0.18014909327030182,0.8709424138069153,1,0.007853187879073978,0.9921468121209261,1
2581,心筋炎、心膜炎(2021/10/232021/10/28、入院期間: 5日日)で入院した。,心筋炎 心膜炎 0 0 0 0 0 入院 期間 0 日 日 入院 する た,1,0.00582033175937878,0.9941796682406213,1,0.0004372950969482736,0.9995627049030518,1,0.038426882069531265,0.9615731179304687,1,0.1195751058266058,0.8804248941733942,1,0.071925587952137,0.9485073089599609,1,0.1820755898952484,0.8701438903808594,1,0.0052926432385587184,0.9947073567614412,1
2582,新型コロナワクチン1回目接種翌日より、腹部膨満、胆汁性胃残が出現し、絶食、輸液を開始した。,新型コロナ ワクチン 0回目 接種 翌日 腹部膨満 胆汁性胃残 出現 絶食 輸液 開始 する た,1,0.01666049701401685,0.9833395029859832,1,0.00031507273817136367,0.9996849272618287,1,0.013442066030469269,0.9865579339695307,1,0.2492658592525524,0.7507341407474476,1,0.08984534442424774,0.9392687082290649,1,0.18358513712882996,0.8683350682258606,1,0.006862438743927024,0.993137561256073,1
2583,身体診察では、身長160cm、体重47kg、体温摂氏38.0度、酸素飽和度98%を認めた。,身体 診察 だ 身長 0cm 体重 0kg 体温 摂氏 0 0度 酸素飽和度 0% 認める た,1,0.01670202377109274,0.9832979762289071,1,0.00032749976918539016,0.9996725002308147,1,0.02115073498712683,0.9788492650128732,1,0.019418181838960824,0.9805818181610392,1,0.07765044271945953,0.944500207901001,1,0.18522579967975616,0.8699964284896851,1,0.004336147106190634,0.9956638528938094,1
2584,体位性頻脈症候群、起立不耐性、浮動性めまい、頭痛、傾眠の結果として治療的な処置がとられた。,体位性頻脈 症候群 起立 不耐性 浮動性 めまい 頭痛 傾眠 結果 治療 的 だ 処置 とる れる た,1,0.009647052917278841,0.9903529470827211,1,0.0003792088808589498,0.999620791119141,1,0.006594013239968888,0.9934059867600311,1,0.08650176266608167,0.9134982373339183,1,0.07961928844451904,0.9412261843681335,1,0.20062631368637085,0.8663514256477356,1,0.004863662804859423,0.9951363371951405,1
2585,発熱、食欲不振、全身倦怠感が2週間続き、その後腹部膨満、体重増加したため、当院を受診した。,発熱 食欲不振 全身倦怠感 0 週間 続く その後 腹部膨満 体重増加 する た ため 院 受診 する た,1,4.403283569047924e-06,0.9999955967164309,1,0.0004414562820010714,0.9995585437179989,1,0.028498799930342544,0.9715012000696575,1,0.0835196688521257,0.9164803311478743,1,0.08046534657478333,0.9439343810081482,1,0.1880565732717514,0.8699432015419006,1,0.004866862741044454,0.9951331372589556,1
2586,皮膚筋炎、間質性肺疾患、発熱、紅斑、末梢腫脹、四肢痛、発疹の結果として治療処置が行われた。,皮膚筋炎 間質性 肺疾患 発熱 紅斑 末梢腫脹 四肢痛 発疹 結果 治療 処置 行う れる た,1,0.009383152659191638,0.9906168473408082,1,0.00033354760794109087,0.9996664523920589,1,0.013079197853881674,0.9869208021461183,1,0.16002133867434143,0.8399786613256586,1,0.07669956982135773,0.945015013217926,1,0.1766415685415268,0.8669771552085876,1,0.0055245338454989025,0.994475466154501,1
2587,備考:尿検査(尿沈渣、RBC)は、>100/HPF(尿タンパク/Cre 1.12)を認めた,備考 尿検査 尿沈渣 RBC 0 HPF 尿タンパク Cre 0 0 認める た,1,0.022611523175958357,0.9773884768240417,1,0.0002676262012578702,0.9997323737987421,1,0.025039656570858604,0.9749603434291414,1,0.017035817650525864,0.9829641823494741,1,0.09226003289222717,0.9372999668121338,1,0.18883290886878967,0.8718038201332092,1,0.0045047785141045255,0.9954952214858954,1
2588,"日付不明、血中クレアチン・ホスホキナーゼ:1,200 U/L(高値)、1,200 U/L。",日付 不明 血 中 クレアチン・ホスホキナーゼ 0 0 U L 高値 0 0 U L,1,0.012468047577815434,0.9875319524221846,1,0.0003219819625996932,0.9996780180374003,1,0.10926134988168801,0.890738650118312,0,0.5195482961797382,0.48045170382026176,1,0.10183236747980118,0.9374572038650513,1,0.23216870427131653,0.8265358209609985,1,0.01556883830062441,0.9844311616993757,1
2589,MCHC(平均赤血球ヘモグロビン濃度)(31.3-36.1):28.5 g/dl、注記:低,MCHC 平均 赤血球 ヘモグロビン 濃度 0 0 0 0 0 0 g dl 注記 低い,1,0.026490788678797346,0.9735092113212028,1,0.00037657321279811485,0.9996234267872018,1,0.27289429690483746,0.7271057030951625,1,0.0014076612312690084,0.998592338768731,1,0.13920269906520844,0.8930521607398987,1,0.2211756855249405,0.8537041544914246,1,0.008292807758444504,0.9917071922415553,1
2590,2022/03/07かかりつけ医を受診し、腹部エコーで腰背部痛の原因を指摘できなかった。,0 0 0 かかりつけ医 受診 する 腹部 エコー だ 腰背部痛 の 原因 指摘 できる ない た,1,0.0166839796661324,0.9833160203338674,1,0.00024077223305465784,0.9997592277669454,1,0.20942526237582249,0.7905747376241775,0,0.9557196302482851,0.044280369751714906,1,0.3047713041305542,0.8117241263389587,0,0.7323525547981262,0.2866341173648834,1,0.1548450432092268,0.8451549567907732,1
2591,COVID-19ワクチン2回目接種3日後に四肢に皮疹が生じ、全身に拡大し紅皮症に至った。,COVID 0 ワクチン 0回目 接種 0 日 後 四肢 皮疹 生じる 全身 拡大 する 紅皮症 至る た,1,0.037724739823713695,0.9622752601762865,1,0.00043772246030637053,0.9995622775396936,1,0.40603202213487977,0.5939679778651202,1,0.0029338634976522338,0.9970661365023478,1,0.0827166810631752,0.9471843838691711,1,0.18168550729751587,0.8711218237876892,1,0.009380965705726376,0.9906190342942736,1
2592,Tolosa-Hunt症候群、視神経炎、視神経周囲炎として、ステロイドパルス療法を実施。,Tolosa Hunt 症候群 視神経炎 視神経周囲炎 ステロイド パルス 療法 実施,1,0.3330092735251386,0.6669907264748615,1,0.00016995287642409626,0.9998300471235759,0,0.8042653177391503,0.1957346822608496,0,0.9726576132557091,0.02734238674429095,1,0.20659618079662323,0.8656857013702393,1,0.21071487665176392,0.8666322827339172,1,0.25071499451070883,0.7492850054892911,1
2593,VZV IgG/IgM結果:3.3/0.33、コメント:IgG:陽性およびIgM:陰性。,VZV IgG IgM 結果 0 0 0 0 コメント IgG 陽性 IgM 陰性,1,0.1975958548189737,0.8024041451810267,1,0.00036129184978876867,0.9996387081502113,0,0.5511900890944539,0.44880991090554617,0,0.9999502182667347,4.978173326529092e-05,1,0.27485522627830505,0.8363680839538574,1,0.2481669932603836,0.849920392036438,1,0.15908240283732183,0.8409175971626781,1
2594,コメント:GM1-IgG /+、Ga/NaC-6Dia-IgM /+、同IgG /+)。,コメント GM 0 IgG Ga NaC 0 Dia IgM IgG,1,0.22682724847165614,0.7731727515283437,1,0.00036831804062321385,0.9996316819593768,1,0.35873972300322543,0.6412602769967746,0,0.5195482961797382,0.48045170382026176,1,0.1864604651927948,0.8348242044448853,1,0.26933759450912476,0.8235491514205933,1,0.047806433182030095,0.95219356681797,1
2595,患者は重度のCOVID-19(covid 19)(重篤度基準は医学的に重要)を発現した。,患者 重度 COVID 0 covid 0 重篤 度 基準 医学 的 重要 発現 する た,1,0.009882771659020817,0.9901172283409789,1,0.00034778273059478653,0.9996522172694052,1,0.027635060215504437,0.9723649397844956,1,0.1694265399997622,0.8305734600002378,1,0.08933533728122711,0.9477644562721252,1,0.2219906449317932,0.8348107933998108,1,0.006326478393275721,0.9936735216067244,1
2596,急性発症の両側性・左右対称性の多関節炎で手背に圧痕性浮腫を伴い、RS3PE症候群と診断。,急性発症 の 両側性 左右対称 性 多関節炎 手 背 圧痕性 浮腫 伴う RS 0 PE 症候群 診断,1,0.005040455113695251,0.9949595448863047,1,0.00044164490208096574,0.999558355097919,1,0.010996046731954201,0.9890039532680458,1,4.7293447429375135e-06,0.9999952706552571,1,0.08872134983539581,0.9455188512802124,1,0.18794693052768707,0.871320366859436,1,0.004041035096849493,0.9959589649031506,1
2597,血圧測定不能時間が継続し軽快みられず、軽いショック状態の長時間継続のため救急搬送を実施。,血圧 測定不能 時間 継続 する 軽快 みる られる ぬ 軽い ショック状態 長時間 継続 ため 救急搬送 実施,1,0.27852482065450734,0.7214751793454925,1,0.0001621995268278125,0.9998378004731722,1,0.13495360989493255,0.8650463901050675,1,0.008332054952626344,0.9916679450473737,0,0.6623609662055969,0.5528979301452637,1,0.1997317522764206,0.8515165448188782,1,0.024165278800894287,0.9758347211991057,1
2598,血液検査で炎症反応高値、リウマトイド因子陰性、関節エコーで両手関節での滑膜炎の所見あり。,血液検査 だ 炎症反応高値 リウマトイド 因子 陰性 関節 エコー 両手 関節 滑膜炎 所見 ある,1,0.016682023279124634,0.9833179767208754,1,0.00021650030084420258,0.9997834996991558,0,0.587341298539223,0.41265870146077693,1,0.0003918623883560901,0.9996081376116439,1,0.1062866747379303,0.923657238483429,1,0.2239333838224411,0.8516445159912109,1,0.014261629064587689,0.9857383709354123,1
2599,検査所見: 2022/06/04、トロポニンTは、1.9ng/ml(上昇あり)であった。,検査 所見 0 0 0 トロポニン T 0 0 NG ml 上昇 あり だ ある た,1,0.14036250873000541,0.8596374912699944,1,0.0002473760237604767,0.9997526239762395,1,0.2252559930517123,0.7747440069482877,0,0.7637636597899938,0.23623634021000617,1,0.11351431161165237,0.9281297922134399,1,0.19371609389781952,0.867344319820404,1,0.03808943134141746,0.9619105686585826,1
2600,好中球優位の白血球増加・軽度肝障害・フェリチン著増を認め成人スチル病(AOSD)と診断。,好中球優位 白血球 増加 軽度肝障害 フェリチン 著 増 認める 成人スチル病 AOSD 診断,1,0.0035775885636203904,0.9964224114363793,1,0.000403772404909677,0.9995962275950904,1,0.01655480136438603,0.983445198635614,1,7.193053553933293e-05,0.9999280694644607,1,0.09990327060222626,0.9368371963500977,1,0.19734786450862885,0.8654832243919373,1,0.004219319810999914,0.9957806801890001,1
2601,頭痛も軽かったが咳がきっかけで猛烈な頭痛出現のため、レルパックスを内服し、暫くして軽快。,頭痛 軽い た 咳 きっかけ 猛烈 だ 頭痛 出現 ため レルパックス 内服 する する 軽快,1,0.01668721724610999,0.9833127827538901,1,0.0003098148564882543,0.9996901851435117,1,0.006327564413873166,0.9936724355861268,1,0.2856828956328099,0.7143171043671901,1,0.11481829732656479,0.9228665828704834,1,0.2604704201221466,0.8227689862251282,1,0.008557678125401499,0.9914423218745986,1
2602,頭部MRIでは拡散強調画像で左前頭葉、頭頂葉病変、点状高信号を認め、急性期脳梗塞と診断。,頭部 MRI 拡散強調画像 だ 左前頭葉 頭頂葉病変 点状 高信号 認める 急性期 脳梗塞 診断,1,0.01361218257971568,0.9863878174202844,1,0.0003194777679331231,0.9996805222320668,1,0.025138872321638916,0.9748611276783611,1,2.198800282959823e-07,0.9999997801199717,1,0.09422492235898972,0.9344314336776733,1,0.20450736582279205,0.8645841479301453,1,0.004398244768794115,0.9956017552312058,1
2603,臨床検査では、皮膚筋炎特異的皮疹(ゴットロン丘疹、ゴットロン徴候及び爪郭異常)を認めた。,臨床検査 皮膚筋炎 特異的 皮疹 ゴットロン丘疹 ゴットロン徴候 爪 郭 異常 認める た,1,0.01667548302371397,0.9833245169762862,1,0.00029580437890197126,0.999704195621098,1,0.023506047138307284,0.9764939528616927,1,0.01052565831368546,0.9894743416863145,1,0.08228319883346558,0.9428613185882568,1,0.18812014162540436,0.8698484301567078,1,0.004319441274966394,0.9956805587250337,1
2604,心肺停止、心停止、意識レベルの低下、転倒、いびき呼吸の結果として、治療的処置がとられた。,心肺停止 心停止 意識レベルの低下 転倒 いびき 呼吸 結果 治療 的 処置 とる れる た,1,0.002705330237343026,0.997294669762657,1,0.0005346804355473463,0.9994653195644526,1,0.022694638163449188,0.9773053618365508,1,0.09678989975064156,0.9032101002493584,1,0.07658571004867554,0.9469479918479919,1,0.18876145780086517,0.8641475439071655,1,0.004965322833534494,0.9950346771664657,1
2605,事象「肝機能障害」、「発熱」、「胸苦しいような気がして」により、診療所への来院を要した。,事象 肝機能障害 発熱 胸 苦しい よう だ 気 する 診療所 来院 要す た,1,0.01669145189234922,0.9833085481076508,1,0.00031906607646361946,0.9996809339235364,1,0.01974498534434932,0.9802550146556507,1,0.008798702531166547,0.9912012974688335,1,0.07557642459869385,0.9491596817970276,1,0.18660391867160797,0.8677545189857483,1,0.004220276411445495,0.9957797235885546,1
2606,brain stemの血管運動中枢の機能停止、呼吸中枢の障害による呼吸停止が考えられた。,brain stem 血管 運動 中枢 機能 停止 呼吸 中枢 障害 呼吸停止 考える られる た,1,0.01665715194656723,0.9833428480534325,1,0.000310721133598792,0.9996892788664012,1,0.06853728791100044,0.9314627120889996,1,0.07644227468774023,0.9235577253122598,1,0.0813591480255127,0.936016321182251,1,0.19348642230033875,0.8689459562301636,1,0.005452455560718139,0.9945475444392818,1
2607,病院到着時、患者は完全房室ブロックによる高度徐脈があり、体外式ペースメーカーを留置した。,病院 到着 時 患者 完全房室ブロック 高度徐脈 ある 体外 式 ペースメーカー 留置 する た,1,0.016693369510614283,0.9833066304893858,1,0.000177555734449632,0.9998224442655503,1,0.4057601229575317,0.5942398770424683,1,0.24911841630795095,0.750881583692049,1,0.10390999168157578,0.9346964359283447,1,0.24538129568099976,0.8248839378356934,1,0.01684372075852743,0.9831562792414725,1
2608,2022/07/24 00:00頃より、呼吸が荒くなり、痙攣と熱発(38度)が発現した。,0 0 0 0 0 頃 呼吸 荒い なる 痙攣 熱発 0度 発現 する た,1,8.885685304623547e-06,0.9999911143146955,1,0.0004799894544478424,0.9995200105455522,1,0.008158650692201674,0.9918413493077983,1,0.1376466054123875,0.8623533945876125,1,0.07579963654279709,0.9503525495529175,1,0.18131127953529358,0.8788936138153076,1,0.005068913476421584,0.9949310865235783,1
2609,15:20、患者は呼吸が不安定になり、心拍数は60/minから40/min台に低下した。,0 0 患者 呼吸 不安 定 なる 心拍数 0 min 0 min 台 低下 する た,1,0.016715284168368663,0.9832847158316314,1,0.0003340807913935654,0.9996659192086065,1,0.2429454706700125,0.7570545293299875,1,0.17936437721904452,0.8206356227809555,1,0.08032519370317459,0.9482041001319885,1,0.19382964074611664,0.8685752749443054,1,0.009341471494047038,0.9906585285059529,1
2610,2020/03/04に年初からの10-30分の頻脈発作のため、他院より紹介にて当院初診。,0 0 0 年初 0 0分 頻脈 発作 ため 院 紹介 院 初診,1,0.006782937130310288,0.9932170628696896,1,0.0003748654749007881,0.9996251345250992,1,0.10145915173057574,0.8985408482694243,1,2.220446049250313e-15,0.9999999999999978,1,0.0781746655702591,0.94427490234375,1,0.18426395952701569,0.8712948560714722,1,0.004792508764242888,0.995207491235757,1
2611,2021/07/17(ワクチン接種8日後)、全身痛、皮フピリピリ感および胸痛が発現した。,0 0 0 ワクチン接種 0 日 後 全身痛 皮ふ ピリピリ感 胸痛 発現 する た,1,0.006353080056989064,0.993646919943011,1,0.0003828160289835281,0.9996171839710165,1,0.00891260612286715,0.9910873938771328,1,0.12281373016381347,0.8771862698361865,1,0.07716585695743561,0.9497716426849365,1,0.18330135941505432,0.8786361217498779,1,0.005011399398212008,0.9949886006017881,1
2612,2021/07/22(ワクチン接種の1日後)、患者は左耳周囲疼痛と顎下部痛みを発現した。,0 0 0 ワクチン接種 0 日 後 患者 左耳周囲疼痛 顎下部痛 み 発現 する た,1,0.016690913103839394,0.9833090868961606,1,0.0003436952234263401,0.9996563047765736,1,0.018951109761968343,0.9810488902380317,1,0.129079445127663,0.870920554872337,1,0.08570744842290878,0.9503200650215149,1,0.18114598095417023,0.875118613243103,1,0.005333207697159515,0.9946667923028405,1
2613,2021/08/26(ワクチン接種185日後)、被験者はCOVID-19陽性を発現した。,0 0 0 ワクチン接種 0 日 後 被験者 COVID 0 陽性 発現 する た,1,1.9944820467904524e-06,0.9999980055179531,1,0.000659971370375104,0.9993400286296249,1,0.003257396103064525,0.9967426038969355,1,0.06164865200905534,0.9383513479909447,1,0.08938971906900406,0.9484511017799377,1,0.19565385580062866,0.8638613820075989,1,0.004513615814749674,0.9954863841852503,1
2614,2022/03/23、入浴の際脱衣時に、ファスナー接触にて右下肢にU字の剥離を受傷した。,0 0 0 入浴 際 脱衣 時 ファスナー 接触 右 下肢 U 字 剥離 受傷 する た,1,0.012265139270705026,0.9877348607292951,1,0.00035926471100794125,0.9996407352889921,1,0.13767265278939456,0.8623273472106054,1,0.11834031912026288,0.8816596808797371,1,0.08120138943195343,0.9390649199485779,1,0.1845436543226242,0.8763808608055115,1,0.006610746612072284,0.9933892533879276,1
2615,2022/05/11(3回目のワクチン接種の1日後)、患者は頭痛、起立不耐症を発現した。,0 0 0 0回目 ワクチン接種 0 日 後 患者 頭痛 起立 不耐症 発現 する た,1,0.004223468324628017,0.9957765316753718,1,0.00034704252889842873,0.9996529574711016,1,0.004825818654231928,0.9951741813457681,1,0.12248023109298078,0.8775197689070192,1,0.07986655831336975,0.9497730135917664,1,0.1856965571641922,0.8740429282188416,1,0.004994058984589095,0.995005941015411,1
2616,2022/06/07、朝から発熱し、午後より摂氏339度台の発熱と嘔気、胸痛が出現した。,0 0 0 朝 発熱 午後 摂氏 0度 台 発熱 嘔気 胸痛 出現 する た,1,8.330746113988603e-08,0.9999999166925388,1,0.0006436335701550185,0.9993563664298449,1,0.0013814014249282636,0.9986185985750717,1,0.12882531895847127,0.8711746810415287,1,0.07465982437133789,0.9502103328704834,1,0.18009021878242493,0.8750172257423401,1,0.00492361424215789,0.9950763857578422,1
2617,2022/07/21 13:00(4回目のワクチン接種と同日)、心室性期外収縮を認めた。,0 0 0 0 0 0回目 ワクチン接種 同日 心室性期外収縮 認める た,1,0.012795317275611957,0.9872046827243879,1,0.00037346481641028204,0.9996265351835897,1,0.025039656570858604,0.9749603434291414,1,0.014633482732880787,0.9853665172671192,1,0.07971709966659546,0.9446302056312561,1,0.1818472445011139,0.874305248260498,1,0.004270744303779231,0.9957292556962208,1
2618,事象「体感失調」、「歩行障害」、「頭痛」、「両大腿の感覚障害」は診療所受診を必要とした。,事象 体感 失調 歩行障害 頭痛 大腿 感覚障害 診療所 受診 必要 する た,1,0.016700574141461047,0.9832994258585389,1,0.0003487782215175046,0.9996512217784825,1,0.10101954326453644,0.8989804567354636,1,0.2644024276794482,0.7355975723205518,1,0.08075720071792603,0.9453935027122498,1,0.1834040731191635,0.8694619536399841,1,0.008278738038512513,0.9917212619614876,1
2619,心エコーで、左室壁運動の低下、心膜輝度の上昇があり、急性心筋炎と急性心膜炎と診断された。,心 エコー だ 左 室 壁 運動 低下 心膜 輝度 上昇 ある 急性心筋炎 急性心膜炎 診断 する れる た,1,0.007068282729206985,0.992931717270793,1,0.00042310736131614474,0.9995768926386839,1,0.0058283490019493955,0.9941716509980506,1,0.16333943847117627,0.8366605615288237,1,0.08401256799697876,0.9490499496459961,1,0.19112776219844818,0.867432713508606,1,0.005552030964542438,0.9944479690354575,1
2620,心筋炎、発熱、高体温症、気管支炎、マイコプラズマ感染の結果として治療的な処置がとられた。,心筋炎 発熱 高体温症 気管支炎 マイコプラズマ感染 結果 治療 的 だ 処置 とる れる た,1,0.004986726789313399,0.9950132732106868,1,0.0003802077265421969,0.9996197922734578,1,0.004678208695954922,0.9953217913040451,1,0.09516393631572906,0.9048360636842709,1,0.08445077389478683,0.943522572517395,1,0.18603047728538513,0.8679393529891968,1,0.004818020212660965,0.995181979787339,1
2621,組織学的検査:(不明日)心筋炎、注記:心筋内に広範に炎症細胞の浸潤を認めた(解剖検査)。,組織 学 的 検査 明日 心筋炎 注記 心筋 内 広範 炎症細胞 浸潤 認める た 解剖 検査,1,0.016693906580732693,0.9833060934192673,1,0.00026109015211406387,0.9997389098478859,1,0.07932131298461798,0.920678687015382,1,0.002893511811675409,0.9971064881883246,1,0.09348193556070328,0.9361248016357422,1,0.2585263252258301,0.8272369503974915,1,0.005415747777767349,0.9945842522222326,1
2622,聴力検査:高音部の感音難聴、注記:右側18.8dB、左側20.0dBと両側で認められた。,聴力 検査 高音 部 感音難聴 注記 右側 0 0 dB 左側 0 0 dB 両側 認める られる た,1,0.016019649875086323,0.9839803501249137,1,0.00039792074380306744,0.9996020792561969,1,0.02708641209536733,0.9729135879046327,1,0.050472553122109076,0.9495274468778909,1,0.08502618968486786,0.9430552124977112,1,0.19860287010669708,0.8658226728439331,1,0.004785843039776838,0.9952141569602233,1
2623,頭皮全体と顔、首、手足に皮膚炎が認められ、TARCが789pg/mlと軽度上昇していた。,頭皮 全体 顔 首 手足 皮膚炎 認める られる TARC 0 PG ml 軽度 上昇 する いる た,1,1.9183213994224033e-05,0.9999808167860057,1,0.000503798678526044,0.999496201321474,1,0.015234475939921777,0.9847655240600782,1,0.4347663109241444,0.5652336890758556,1,0.08415402472019196,0.9466037154197693,1,0.1850929707288742,0.8709163665771484,1,0.009497107112258386,0.9905028928877417,1
2624,陽電子放出断層撮影:胸大動脈、鎖骨下動脈、腋窩動脈、上腕動脈、側頭動脈で過蓄積が見られた,陽電子放出 断層 撮影 胸 大動脈 鎖骨 下 動脈 腋窩動脈 上腕 動脈 側 頭 動脈 蓄積 見る られる た,1,0.016687349182229062,0.983312650817771,1,0.0002923160667380854,0.9997076839332619,1,0.23162025766721406,0.7683797423327859,1,0.17328220576167008,0.8267177942383299,1,0.0899612084031105,0.9177751541137695,1,0.20026692748069763,0.8634985089302063,1,0.009496582966202293,0.9905034170337977,1
2625,2021/08/02の自己抗体検査:結果は抗GM1抗体陽性、抗GQ1b抗体陰性であった。,0 0 0 自己抗体 検査 結果 GM 0 抗体陽性 GQ 0 b 抗体 陰性 だ ある た,1,0.49337252480715427,0.5066274751928458,0,0.0001202790487519306,0.9998797209512481,0,0.8782075229646888,0.12179247703531115,0,0.6682192071800737,0.3317807928199263,1,0.3211299180984497,0.7642461061477661,0,0.7426959276199341,0.2918725311756134,1,0.5218726009432507,0.4781273990567492,1
2626,現在はCLDに伴う酸素化の低下がみられるため、在宅酸素療法HOTが導入され退院となった。,現在 CLD 伴う 酸素化 低下 みる られる ため 在宅 酸素 療法 HOT 導入 する れる 退院 なる た,1,0.034308614210202454,0.9656913857897974,1,0.0002631717993020452,0.999736828200698,1,0.08792344116083362,0.9120765588391664,1,0.35081911938543564,0.6491808806145644,1,0.23652854561805725,0.8546749949455261,1,0.2657215893268585,0.8043325543403625,1,0.014627322748607154,0.9853726772513929,1
2627,Fibrin D dimer:(2022/05/29)0.84ug/ml、注記:上昇あり,Fibrin D dimer 0 0 0 0 0 ug ml 注記 上昇 ある,1,0.015251013231782993,0.9847489867682169,1,0.0004215145738681067,0.9995784854261319,1,0.033170415928877706,0.9668295840711223,1,0.00010833181664526847,0.9998916681833547,1,0.08838928490877151,0.9390088319778442,1,0.1964859813451767,0.8650191426277161,1,0.004402150858129361,0.9955978491418707,1
2628,2021/07/09、患者は丘疹性皮疹(丘疹小水疱性皮疹)(重篤区分:入院)を呈した。,0 0 0 患者 丘疹性 皮疹 丘疹 水疱性 皮疹 重篤 区分 入院 呈す た,1,0.01229187047158128,0.9877081295284187,1,0.0002916932163812095,0.9997083067836188,1,0.026807897868161845,0.9731921021318382,1,0.0008885589742554378,0.9991114410257446,1,0.07298941165208817,0.9496620297431946,1,0.18465593457221985,0.8672528266906738,1,0.004157358039885045,0.995842641960115,1
2629,2021/09/08時々ふらつき、左目の視力が落ちた感覚を認めたため、他院に受診指示。,0 0 0時 ふらつき 左目 視力 落ちる た 感覚 認める た ため 院 受診 指示,1,0.003585350837615878,0.996414649162384,1,0.00037383109562855,0.9996261689043715,1,0.012506655447153237,0.9874933445528468,1,0.0002489694764418182,0.9997510305235582,1,0.08597791939973831,0.9454417824745178,1,0.18839359283447266,0.8733144402503967,1,0.004025970844237086,0.9959740291557628,1
2630,2022/02/26(ワクチン接種37日後)、右顔面神経麻痺と顔面神経麻痺が出現した。,0 0 0 ワクチン接種 0 日 後 右 顔面神経 麻痺 顔面神経 麻痺 出現 する た,1,0.0034976824620510426,0.9965023175379488,1,0.00041115472862426737,0.9995888452713757,1,0.010457947288063596,0.9895420527119364,1,0.10074238595083296,0.899257614049167,1,0.07438275218009949,0.9505075216293335,1,0.1816219538450241,0.8760556578636169,1,0.004771364689384341,0.9952286353106156,1
2631,2022/03/16胸部・腹部・下肢の造影CT検査を実施し、両側肺動脈血栓塞栓の所見。,0 0 0 胸部 腹部 下肢 造影 CT検査 実施 する 両側肺 動脈血栓 塞栓 所見,0,0.704918920187238,0.29508107981276227,0,0.00015525872835460072,0.9998447412716454,0,0.7102371729474906,0.2897628270525094,1,0.0001481991054316234,0.9998518008945684,1,0.15410278737545013,0.8934857249259949,1,0.21467909216880798,0.8535380959510803,1,0.07260654539656822,0.9273934546034318,1
2632,"2022/03/21心不全を認め、輸液を1,500 mL/日に減量し、フロセミド開始。",0 0 0 心不全 認める 輸液 0 0 mL 日 減量 する フロセミド 開始,1,0.03566116637979359,0.9643388336202062,1,0.0003004842119229908,0.999699515788077,1,0.04550556590681998,0.95449443409318,1,0.08940872276827816,0.9105912772317218,0,0.5591263771057129,0.5104634761810303,1,0.21061620116233826,0.8612171411514282,1,0.013923084234104289,0.9860769157658957,1
2633,2022/05/23、痛みの強さは軽減したが、頭痛は週3回あり、血圧は落ち着いてきた。,0 0 0 痛み 強い さ 軽減 する た 頭痛 週 0回 ある 血圧 落ち着く くる た,1,0.0166783055481799,0.98332169445182,1,0.00021787865714475017,0.9997821213428553,1,0.06634502749041415,0.9336549725095858,1,0.0037262949724060634,0.9962737050275939,1,0.08361470699310303,0.9422414302825928,0,0.709277868270874,0.2918336093425751,1,0.013826470151865148,0.9861735298481349,1
2634,2022年5月18日左上下肢軽度麻痺、頭部MRIで右大脳皮質FLAIR高信号を認めた。,0 年 0 月 0 日 左上 下肢軽度 麻痺 頭部 MRI 右 大 脳皮質 FLAIR 高信号 認める た,1,0.012478354658200677,0.9875216453417992,1,0.0004068131196815713,0.9995931868803184,1,0.0182144994334672,0.9817855005665328,1,0.015367438657157395,0.9846325613428426,1,0.0791231021285057,0.946132242679596,1,0.18544895946979523,0.8753371238708496,1,0.004218857697376486,0.9957811423026236,1
2635,irAEの症状は、関節炎、下垂体炎で、プレドニゾロン25mgの内服を開始して改善した。,irAE 症状 関節炎 下垂体炎 だ プレドニゾロン 0m g 内服 開始 する 改善 する た,1,0.1275730419250076,0.8724269580749923,0,9.589410353620037e-05,0.9999041058964638,0,0.9735284483055932,0.02647155169440689,0,0.8591500516774109,0.14084994832258918,1,0.43166232109069824,0.6491347551345825,0,0.6370779275894165,0.44361308217048645,1,0.47419476948223965,0.5258052305177604,1
2636,MPO-ANCA 90.9 U/mLと高値から顕微鏡的多発血管炎(MPA)が疑われた。,MPO ANCA 0 0 U mL 高値 顕微鏡的多発血管炎 MPA 疑う れる た,1,0.005426654080375195,0.9945733459196248,1,0.000562395799574823,0.9994376042004252,1,0.015686820658373457,0.9843131793416265,1,0.07826145184329703,0.921738548156703,1,0.08184147626161575,0.9411407709121704,1,0.17855913937091827,0.8729915618896484,1,0.004707605936017502,0.9952923940639826,1
2637,X-1日、辻褄の合わない会話や裸で徘徊するなどの異常行動が出現し救急病院に搬送された。,X 0 日 辻褄 合う ない 会話 裸 徘徊 する 異常行動 出現 救急病院 搬送 する れる た,1,0.031878533482816766,0.9681214665171833,1,0.0002867811392319006,0.9997132188607681,1,0.06273286834759573,0.9372671316524043,1,0.13845076646551446,0.8615492335344855,1,0.07802702486515045,0.9459567070007324,1,0.1805674135684967,0.8725215196609497,1,0.0061009818712023205,0.9938990181287976,1
2638,胸部X線検査では、血栓・塞栓症を示唆する所見があり、肺血管陰性の消失、心拡大を認めた。,胸部 X線検査 血栓 塞栓症 示唆 する 所見 ある 肺血 管 陰性 消失 心拡大 認める た,1,0.031470732224002,0.9685292677759979,1,0.000199929062218095,0.9998000709377819,1,0.1640884060369442,0.8359115939630558,1,0.02017948777440448,0.9798205122255955,1,0.08960028737783432,0.9363020062446594,1,0.1939663290977478,0.867476224899292,1,0.006130470103028757,0.9938695298969712,1
2639,血液検査では、嘔吐による電解質異常は認めるが、その他の明らかな異常所見は認めなかった。,血液検査 嘔吐 電解質異常 認める その他 明らか だ 異常所見 認める ない た,1,0.01668282647684854,0.9833171735231515,1,0.00024065708449675068,0.9997593429155033,1,0.24915256992229362,0.7508474300777064,0,0.963756826614345,0.03624317338565492,1,0.2721088230609894,0.8473252654075623,0,0.6394412517547607,0.48391610383987427,1,0.12346428420184133,0.8765357157981587,1
2640,検査所見:2022/06/04、トロポニンTは、1.9ng/ml(上昇あり)であった。,検査 所見 0 0 0 トロポニン T 0 0 NG ml 上昇 あり だ ある た,1,0.14036250873000541,0.8596374912699944,1,0.0002473760237604767,0.9997526239762395,1,0.2252559930517123,0.7747440069482877,0,0.7637636597899938,0.23623634021000617,1,0.11351431161165237,0.9281297922134399,1,0.19371609389781952,0.867344319820404,1,0.03808943134141746,0.9619105686585826,1
2641,好酸球増加と全身症状を伴う薬物反応および間質性肺疾患の結果として治療的処置がとられた。,好酸球 増加 全身症状 伴う 薬物 反応 間質性 肺疾患 結果 治療 的 処置 とる れる た,1,0.008009168435618472,0.9919908315643815,1,0.00037617371283285757,0.9996238262871672,1,0.007853443529732607,0.9921465564702674,1,0.09100679175179582,0.9089932082482042,1,0.08112137764692307,0.9436647891998291,1,0.18492428958415985,0.868911862373352,1,0.004810941955609668,0.9951890580443903,1
2642,心電図では広範な誘導における上に凹型のST上昇及びaVR誘導におけるST低下を認めた。,心電図 広範 だ 誘導 上 凹型 ST 上昇 aVR 誘導 ST 低下 認める た,1,0.0030562694884470176,0.9969437305115528,1,0.0004202292002469067,0.9995797707997531,1,0.004278241200399546,0.9957217587996005,1,0.017784082050023242,0.9822159179499768,1,0.08130872994661331,0.9456450343132019,1,0.18642312288284302,0.866188108921051,1,0.004098514928748197,0.9959014850712518,1
2643,日中の心エコーでは、左室駆出率39%(diffuse hypo)と壁運動低下を認めた。,日中 心 エコー だ 左 室 駆け出し 率 0% diffuse hypo 壁運動低下 認める た,1,0.01669449415638914,0.9833055058436108,1,0.0002991326048917356,0.9997008673951082,1,0.022660617472778144,0.9773393825272219,1,0.015273479154045866,0.9847265208459541,1,0.08134807646274567,0.945321798324585,1,0.1946524679660797,0.8661291599273682,1,0.00438314949284518,0.9956168505071548,1
2644,2022/04/18、心電図が実施され、徐脈と右心負荷の所見を示し、変化が認められた。,0 0 0 心電図 実施 する れる 徐脈 右心負荷 所見 示す 変化 認める られる た,1,0.07270718974223382,0.9272928102577662,1,0.0002372007388229215,0.9997627992611771,1,0.05358269074546973,0.9464173092545303,1,0.09809569847483557,0.9019043015251644,1,0.07879971712827682,0.9509022831916809,1,0.18496757745742798,0.8636177182197571,1,0.006050730576110891,0.9939492694238891,1
2645,2022/03/30(ワクチン接種3日後)、倦怠感強く、黄疸を発現し、内科を受診した。,0 0 0 ワクチン接種 0 日 後 倦怠感強く 黄疸 発現 内科 受診 する た,1,0.007609350263454932,0.992390649736545,1,0.00039272934794543145,0.9996072706520546,1,0.01489533448578928,0.9851046655142107,1,0.14854364407464016,0.8514563559253598,1,0.07346118241548538,0.9498986601829529,1,0.18489494919776917,0.876285195350647,1,0.005351856139932319,0.9946481438600676,1
2646,2021/08/23、動悸の訴えがあったので心筋炎を疑い、病院の循環器科を紹介された。,0 0 0 動悸 訴え ある た 心筋炎 疑う 病院 循環器 科 紹介 する れる た,1,0.004103027139107487,0.9958969728608925,1,0.00041940529081012286,0.9995805947091899,1,0.027149218610678538,0.9728507813893215,1,0.06283457873258147,0.9371654212674185,1,0.07633312791585922,0.9462053179740906,1,0.17663508653640747,0.8740853667259216,1,0.004594409654312265,0.9954055903456877,1
2647,2021/10/26(ワクチン接種の2日後)、患者は急性の胸痛、胸部圧迫感を発現した。,0 0 0 ワクチン接種 0 日 後 患者 急性 胸痛 胸部圧迫感 発現 する た,1,0.004376041658664821,0.995623958341335,1,0.0004269110378427386,0.9995730889621572,1,0.006084660983809997,0.99391533901619,1,0.05928950611677519,0.9407104938832248,1,0.07752210646867752,0.9500173926353455,1,0.1848529726266861,0.8775837421417236,1,0.004386306409750013,0.99561369359025,1
2648,2021/10/28、熱は下がったが、左上肢痛が続いたため、当院来院したと報告された。,0 0 0 熱 下がる た 左上肢痛 続く た ため 院 来院 する た 報告 する れる た,1,0.01670346511550536,0.9832965348844946,1,0.0003182757067617741,0.9996817242932382,1,0.03155869812087364,0.9684413018791264,1,0.001935857001690855,0.9980641429983091,1,0.0762861967086792,0.9500053524971008,1,0.18083925545215607,0.8710039854049683,1,0.004223531007519,0.995776468992481,1
2649,2022/06/20 9:00(ワクチン接種10日後)、患者は顔面神経麻痺を発症した。,0 0 0 0 0 ワクチン接種 0 日 後 患者 顔面神経 麻痺 発症 する た,1,0.016710169960708073,0.9832898300392918,1,0.00034983795268042693,0.9996501620473196,1,0.06416583234720818,0.9358341676527918,1,0.05311195481652886,0.9468880451834711,1,0.07663629949092865,0.9473071098327637,1,0.18325813114643097,0.871713399887085,1,0.005014220402885092,0.9949857795971149,1
2650,TSHの上昇と遊離T3、T4が正常であることから無症候性甲状腺機能低下症が示唆された。,TSH 上昇 遊離 T 0 T 0 正常 だ ある こと 無症候性 甲状腺機能低下症 示唆 する れる た,1,0.09041621099709486,0.909583789002905,1,0.00022550089470628777,0.9997744991052937,1,0.15906675851477914,0.8409332414852209,1,0.20341653459628528,0.7965834654037147,1,0.11299890279769897,0.9225717186927795,1,0.19882875680923462,0.8692680597305298,1,0.010213669632357425,0.9897863303676426,1
2651,患者は、低心拍出量症候群を合併していると判断され、心原性ショック状態であると診断された,患者 低心拍出量 症候群 合併 する いる 判断 する れる 心原性ショック状態 だ ある 診断 する れる た,1,0.016683839819947786,0.9833161601800524,1,0.0003520355179953125,0.9996479644820047,1,0.035611929268549614,0.9643880707314504,1,0.3528521373361919,0.6471478626638081,1,0.08613260835409164,0.9464973211288452,1,0.19713094830513,0.8653172850608826,1,0.008857873948925458,0.9911421260510745,1
2652,徐脈、血圧低下、失神寸前の状態、蒼白、異常感、冷汗の結果として治療的な処置がとられた。,徐脈 血圧低下 失神 寸前 状態 蒼白 異常感 冷汗 結果 治療 的 だ 処置 とる れる た,1,0.006409299551103541,0.9935907004488964,1,0.0004341508657452935,0.9995658491342547,1,0.02431164451033274,0.9756883554896673,1,0.08386812854136416,0.9161318714586358,1,0.07764866203069687,0.9481313228607178,1,0.18511991202831268,0.8700263500213623,1,0.004843113252675829,0.995156886747324,1
2653,消化管浮腫、悪心、腹痛、食欲減退、おくび、脂肪肝の結果として、治療的な処置がとられた。,消化 管浮腫 悪心 腹痛 食欲減退 おくび 脂肪肝 結果 治療 的 だ 処置 とる れる た,1,0.016706290234431695,0.9832937097655684,1,0.00035222881612421975,0.9996477711838758,1,0.028746951943891985,0.971253048056108,1,0.08313872041451176,0.9168612795854882,1,0.08078446239233017,0.9410034418106079,1,0.1923900842666626,0.8685550689697266,1,0.00507421869534268,0.9949257813046573,1
2654,エコーにて明らかな壁運動を認めず、心筋炎は否定的と考え、脱水に伴う横紋筋融解症の診断。,エコー 明らか だ 壁 運動 認める ぬ 心筋炎 否定 的 考える 脱水 伴う 横紋筋融解症 の 診断,1,0.016686513804746225,0.9833134861952538,1,0.0003528197454587435,0.9996471802545412,1,0.030760398037800507,0.9692396019621995,1,9.387388124060259e-06,0.9999906126118759,1,0.09465012699365616,0.9350630640983582,1,0.2230232208967209,0.8451732993125916,1,0.00464668002745257,0.9953533199725474,1
2655,患者が高齢者であり、BNP増加が観察されたため、血漿輸血のみが血漿交換なしで行われた。,患者 高齢者 だ ある BNP 増加 観察 する れる た ため 血漿 輸血 血漿交換 ない 行う れる た,1,0.04466299060199542,0.9553370093980046,1,0.00022134395433493333,0.9997786560456651,0,0.5638434009110639,0.4361565990889361,1,0.3131421804241956,0.6868578195758044,1,0.25543227791786194,0.836027979850769,1,0.3480779230594635,0.7418936491012573,1,0.04185966277026212,0.9581403372297379,1
2656,2021/11/12転院後、再度自己免疫疾患の関与を疑い、メチルプレドニゾロン投与。,0 0 0 転院 後 自己免疫疾患 関与 疑う メチルプレドニゾロン 投与,1,0.016664862549027024,0.983335137450973,1,0.0002603588218204194,0.9997396411781796,1,0.15882808196022036,0.8411719180397796,1,6.120279863763844e-05,0.9999387972013624,1,0.10243743658065796,0.9230618476867676,1,0.2448602318763733,0.8341193199157715,1,0.006316493731663599,0.9936835062683363,1
2657,2022/03/28近医で採血にて脱水、低Na血症、高K血症を認め、当院へ紹介受診。,0 0 0 近医 採血 脱水 Na 血 症 K 血 症 認める 院 紹介 受診,1,1.1329048669999023e-08,0.9999999886709513,1,0.0006869133137351911,0.9993130866862648,1,0.010959428936111237,0.9890405710638888,1,5.1517882182494645e-08,0.9999999484821178,1,0.08248580247163773,0.9424252510070801,1,0.18184298276901245,0.8748431205749512,1,0.0039517122340129275,0.996048287765987,1
2658,allopurinolによる典型的な薬剤性過敏症症候群(DiHS)の診断が下された。,allopurinol 典型 的 だ 薬剤性 過敏症 症候群 DiHS 診断 下す れる た,1,0.0208204676548645,0.9791795323451354,1,0.00031729679948704867,0.999682703200513,1,0.03731151115503517,0.9626884888449648,1,0.07012474459532614,0.9298752554046739,1,0.08411532640457153,0.9448573589324951,1,0.18631017208099365,0.8717464804649353,1,0.005021310816889718,0.9949786891831103,1
2659,X-10日に発熱、咽頭痛が出現、腎機能障害を認め当科紹介となり、X-2日に受診した。,X 0 日 発熱 咽頭痛 出現 腎機能障害 認める 科 紹介 なる X 0 日 受診 する た,1,2.31055120745645e-07,0.9999997689448792,1,0.0006567921803575601,0.9993432078196425,1,0.002262997984281978,0.997737002015718,1,0.19971574156042393,0.8002842584395761,1,0.07229027897119522,0.9523212313652039,1,0.18705952167510986,0.8743338584899902,1,0.005697388062925717,0.9943026119370744,1
2660,しかし、前回採血から6ヵ月以上経過したため、採血検査したところ、顆粒球減少を認めた。,前回 採血 0 ヵ月 以上 経過 する た ため 採血 検査 する た ところ 顆粒球減少 認める た,1,0.016687409701924526,0.9833125902980755,1,0.00027176630975115615,0.9997282336902489,1,0.046308285098665136,0.9536917149013349,1,0.0007265808914863614,0.9992734191085136,1,0.07756148278713226,0.9458189010620117,1,0.20608460903167725,0.8521355986595154,1,0.004557921075224707,0.9954420789247753,1
2661,最大強度投影(MIP)画像より、左腋窩の増強腫瘤及びリンパ節(LN)腫脹が示された。,最大 強度 投影 MIP 画像 左 腋窩 増強 腫瘤 リンパ節 LN 腫脹 示す れる た,1,0.024565866769430615,0.9754341332305694,1,0.00036226153765629,0.9996377384623437,1,0.26728653046648376,0.7327134695335162,1,0.08721710701277519,0.9127828929872248,1,0.07984647899866104,0.946209192276001,1,0.18106889724731445,0.8722321391105652,1,0.008173407223606998,0.991826592776393,1
2662,心エコー:心筋の浮腫状変化あり、心膜の輝度上昇あり、心のう液なし、左室収縮低下なし。,心 エコー 心筋 浮腫状変化 ある 心膜 輝度 上昇 ある 心 液 ない 左 室 収縮低下 ない,1,0.01668579424457636,0.9833142057554236,1,0.00019667334962498483,0.999803326650375,1,0.4145401906077103,0.5854598093922897,1,0.27119540685872634,0.7288045931412737,1,0.20111988484859467,0.8878089189529419,1,0.27972957491874695,0.8064460754394531,1,0.02170710665690226,0.9782928933430977,1
2663,心電図検査では、2、3、aVF、V4-6で2相性から陰性T波を認め、異常所見を指摘。,心電図 検査 0 0 aVF V 0 0 0 相性 陰性 T 波 認める 異常所見 指摘,1,0.006121925742400407,0.9938780742575997,1,0.00034966629428522455,0.9996503337057148,1,0.026771663187638683,0.9732283368123613,1,1.1995071602655116e-09,0.9999999988004928,1,0.09399338066577911,0.9390860795974731,1,0.18542203307151794,0.8714934587478638,1,0.004215857025956223,0.9957841429740437,1
2664,診断病名は血栓性血小板減少性紫斑病であり、除外した疾患は免疫性血小板減少症であった。,診断 病名 血栓性 血小板減少 性 紫斑病 だ ある 除外 する た 疾患 免疫性 血小板減少症 だ ある た,1,0.01668362393848487,0.983316376061515,1,0.00027398143475162214,0.9997260185652483,1,0.12503334765673235,0.8749666523432676,0,0.9126263454156269,0.08737365458437309,1,0.15318208932876587,0.8817816972732544,0,0.564261257648468,0.4995843172073364,1,0.0721121672321185,0.9278878327678814,1
2665,06/06、心エコーにてEF18%と左室内血栓、著明な心機能低下(心筋症)を認めた。,0 0 心 エコー EF 0% 左室内血栓 著 明 だ 心機能低下 心筋症 認める た,1,0.016983168347607356,0.9830168316523928,1,0.00038108296527583375,0.9996189170347242,1,0.016913627584474566,0.9830863724155254,1,0.003654598754833094,0.9963454012451669,1,0.0739845409989357,0.9474309086799622,1,0.18205121159553528,0.8734910488128662,1,0.004114884048253513,0.9958851159517466,1
2666,」を「2021/07/27(ワクチン接種1日後)、患者は心肺停止(CPA)を呈した。,0 0 0 ワクチン接種 0 日 後 患者 心肺停止 CPA 呈す た,1,0.02167589652005648,0.9783241034799436,1,0.0004692297641212627,0.9995307702358788,1,0.07763082912012864,0.9223691708798714,1,1.055157982310373e-05,0.9999894484201769,1,0.07373882830142975,0.9512127041816711,1,0.23843184113502502,0.8338737487792969,1,0.005100298969775314,0.9948997010302247,1
2667,2022/05/24 14:00頃(ワクチン接種のおよそ1日後)、痙攣発作が生じた。,0 0 0 0 0 頃 ワクチン接種 凡そ 0 日 後 痙攣 発作 生じる た,1,0.01670484042807488,0.983295159571925,1,0.0003951844909254206,0.9996048155090745,1,0.1738335038505714,0.8261664961494286,1,0.0001788934670621245,0.9998211065329379,1,0.08295173197984695,0.9469769597053528,1,0.18170547485351562,0.8733996748924255,1,0.0056328297833515405,0.9943671702166486,1
2668,ギラン・バレー症候群、複視、感覚鈍麻のため入院した(入院日:2021/06/17)。,ギラン・バレー症候群 複視 感覚鈍麻 ため 入院 する た 入院 日 0 0 0,1,6.154560670032498e-07,0.999999384543933,1,0.0005906224570032465,0.9994093775429967,1,0.01604865347463702,0.983951346525363,1,0.10704832299466338,0.8929516770053366,1,0.08064809441566467,0.9463785886764526,1,0.18760187923908234,0.8709498047828674,1,0.004958397267845184,0.9950416027321549,1
2669,ワクチン接種からの倦怠感やその後の両下肢血栓により、最終的には下肢切断に至っていた。,ワクチン接種 倦怠感 その後 両下肢血栓 最終的 下肢切断 至る いる た,1,0.016719134207816455,0.9832808657921837,1,0.00025211317028804944,0.9997478868297119,1,0.18258989961435723,0.8174101003856428,1,0.2701276198053365,0.7298723801946635,1,0.0925394743680954,0.9268718361854553,1,0.1884135603904724,0.8671956658363342,1,0.010213924139842406,0.9897860758601575,1
2670,冠動脈CTで冠動脈に有意狭窄を認めず、患者はワクチン接種後の心筋炎の診断で入院した。,冠動脈 CT 冠動脈 有意狭窄 認める ぬ 患者 ワクチン接種 後 心筋炎 の 診断 入院 する た,1,1.067493789291546e-05,0.9999893250621071,1,0.0004631900382727501,0.9995368099617272,1,0.05423908504839903,0.945760914951601,1,0.16879636211430105,0.831203637885699,1,0.08918255567550659,0.9404581189155579,1,0.18401873111724854,0.8703563213348389,1,0.0061167153851647135,0.9938832846148352,1
2671,呼吸停止、心停止、窒息、脈拍欠損、散瞳、瞳孔反射障害の結果として治療処置が行われた。,呼吸停止 心停止 窒息 脈拍 欠損 散瞳 瞳孔反射 障害 結果 治療 処置 行う れる た,1,0.016693312367206153,0.983306687632794,1,0.0003441105091031704,0.9996558894908968,1,0.153283782767884,0.846716217232116,1,0.15088435098055952,0.8491156490194405,1,0.08386843651533127,0.9407459497451782,1,0.19033434987068176,0.865848958492279,1,0.007465413721738857,0.9925345862782613,1
2672,事象の経過は次のとおり: 6月下旬より関節痛、浮腫が出現し、1ヶ月間症状が持続した。,事象 経過 次 とおり 0 月 下旬 関節痛 浮腫 出現 0 ヶ月 間 症状 持続 する た,1,0.07322621317787725,0.9267737868221226,1,0.0002539239944036271,0.9997460760055964,1,0.03603733883734239,0.9639626611626576,1,0.2352952983556944,0.7647047016443056,1,0.07583287358283997,0.9491441249847412,1,0.190768301486969,0.8739362955093384,1,0.007638746440088589,0.9923612535599113,1
2673,心筋炎、右室不全、左室不全、心室性頻脈、ウイルス感染の結果として治療処置が行われた。,心筋炎 右室不全 左室不全 心室性頻脈 ウイルス感染 結果 治療 処置 行う れる た,1,0.015538906723797796,0.9844610932762022,1,0.00022798601955178698,0.9997720139804482,1,0.09147834370525254,0.9085216562947475,1,0.24786279827503532,0.7521372017249647,1,0.09229449927806854,0.9384416341781616,1,0.18413668870925903,0.8703253269195557,1,0.00798542572092689,0.992014574279073,1
2674,心筋炎、心膜炎、胸痛、トロポニンI増加、倦怠感、頭痛の結果として治療処置が行われた。,心筋炎 心膜炎 胸痛 トロポニン I 増加 倦怠感 頭痛 結果 治療 処置 行う れる た,1,9.531484614387098e-06,0.9999904685153856,1,0.00038112953414389244,0.9996188704658561,1,0.003756689420855497,0.9962433105791445,1,0.3173244485867749,0.6826755514132251,1,0.0781325176358223,0.9487985372543335,1,0.1821538507938385,0.8724158406257629,1,0.007260753609510949,0.992739246390489,1
2675,身体的診察は、多数の引っかき傷を伴う全身の広汎性発赤、顔面と下腿の腫脹が認められた。,身体的 診察 多数 引っかく 傷 伴う 全身 広汎 性 発赤 顔面 下腿 腫脹 認める られる た,1,0.005147840564302038,0.9948521594356979,1,0.0005614823684289948,0.999438517631571,1,0.01074081689195061,0.9892591831080494,1,0.051064874572071095,0.9489351254279289,1,0.0817297026515007,0.9478865265846252,1,0.1824701577425003,0.8709032535552979,1,0.0044095651189068235,0.9955904348810931,1
2676,膠原病内科に治療の相談を行ったところ、直ちに専門病院への転院が望ましいと助言された。,膠原病内科 治療 相談 行う た ところ 専門 病院 転院 望ましい 助言 する れる た,1,0.01666569549086176,0.9833343045091384,1,0.0002620963328492732,0.9997379036671508,1,0.38472905997945317,0.6152709400205468,1,0.1367092934236761,0.8632907065763239,1,0.5212997794151306,0.6746830344200134,1,0.21574798226356506,0.8352826833724976,1,0.024216992771152596,0.9757830072288474,1
2677,Troponin T:(2022/05/29)0.573ng/ml、注記:上昇あり。,Troponin T 0 0 0 0 0 NG ml 注記 上昇 ある,1,0.011978847305291456,0.9880211526947082,1,0.0004778257928408016,0.9995221742071592,1,0.02977364058693277,0.9702263594130672,1,8.81493144067047e-06,0.9999911850685593,1,0.10160645097494125,0.932572603225708,1,0.194827601313591,0.8662880659103394,1,0.004416645589593812,0.9955833544104062,1
2678,HbA1c(NGSP) (グリコヘモグロビン)(4.6-6.2):8.4%、注記:高,HbA 0 c NGSP グリコヘモグロビン 0 0 0 0 0 0% 注記 高,1,0.035494830681622104,0.964505169318378,1,0.0003436310177340276,0.999656368982266,1,0.24685328856898958,0.7531467114310104,1,1.904698765486934e-06,0.9999980953012345,1,0.15520164370536804,0.8681513667106628,1,0.19643950462341309,0.8622471690177917,1,0.008055036499775702,0.9919449635002243,1
2679,2022/03/14 02:00慢性心不全増悪が発現し、呼吸苦、胸部違和感を自覚。,0 0 0 0 0 慢性心不全 増悪 発現 呼吸苦 胸部違和感 自覚,1,4.884507648424917e-08,0.9999999511549236,1,0.0005040099375528056,0.9994959900624472,1,0.004227155955593753,0.9957728440444062,1,2.697908563220608e-10,0.9999999997302091,1,0.08455031365156174,0.9441903233528137,1,0.18516290187835693,0.8703763484954834,1,0.003929166616831529,0.9960708333831685,1
2680,2022/03/16発熱、下痢、嘔吐、しびれ、以前からあった胃部不快感のため入院。,0 0 0 発 熱 下痢 嘔吐 しびれ 以前 ある た 胃部不快感 ため 入院,1,4.612433471920753e-08,0.9999999538756653,1,0.0004916676237261503,0.9995083323762739,1,0.005443916283849326,0.9945560837161507,1,8.129875550544341e-09,0.9999999918701244,1,0.08212665468454361,0.9506489634513855,1,0.17501284182071686,0.8705859780311584,1,0.0038638333752190044,0.9961361666247811,1
2681,2022/04/04眼科を受診し、MRIにて脳内に多発のT2高信号な病変を認めた。,0 0 0 眼科 受診 する MRI 脳内 多発 T 0 高信号 病変 認める た,1,0.005690240803412944,0.994309759196587,1,0.0003751707530536894,0.9996248292469463,1,0.015961135926019776,0.9840388640739802,1,0.0052038085330328165,0.9947961914669672,1,0.07686184346675873,0.9472920894622803,1,0.1820347011089325,0.873103141784668,1,0.004041708127436459,0.9959582918725637,1
2682,2022/04/15 22:00右大腿から下肢の張り、つり感、疼痛、痺れ感が出現。,0 0 0 0 0 右 大腿 下肢 張り つり感 疼痛 痺れ感 出現,1,0.003952778681757907,0.996047221318242,1,0.0004664927165891338,0.9995335072834108,1,0.009408166254711414,0.9905918337452886,1,0.009146727868963533,0.9908532721310365,1,0.0840749740600586,0.9439980983734131,1,0.1856280416250229,0.8738252520561218,1,0.004061342820155619,0.9959386571798444,1
2683,2022/04/22午前頃(ワクチン接種1日後)、患者は急性心機能不全を発症した。,0 0 0 午前 頃 ワクチン接種 0 日 後 患者 急性 心機能不全 発症 する た,1,0.005441746038101395,0.9945582539618986,1,0.00043951615772066843,0.9995604838422794,1,0.034526079374707086,0.9654739206252929,1,0.05640798237375355,0.9435920176262464,1,0.07911129295825958,0.9500820636749268,1,0.18005459010601044,0.8691002726554871,1,0.004649266039213666,0.9953507339607863,1
2684,2022/07/22 14:15(ワクチン接種後15分)、肩と首に痛みを発症した。,0 0 0 0 0 ワクチン接種 後 0分 肩 首に 痛み 発症 する た,1,0.004281221118764566,0.9957187788812353,1,0.0004163256093190368,0.999583674390681,1,0.028641080435215516,0.9713589195647845,1,0.07698982042314273,0.9230101795768573,1,0.0827140137553215,0.946101725101471,1,0.18039239943027496,0.8763026595115662,1,0.0047794396187704705,0.9952205603812295,1
2685,6月29日(3回目ワクチン接種122日後)、左肩MRI評価から、腱板損傷を認めた。,0 月 0 日 0回目 ワクチン接種 0 日 後 左肩 MRI 評価 腱板損傷 認める た,1,0.010013476825745053,0.989986523174255,1,0.00033970619221096346,0.9996602938077891,1,0.02701909092674004,0.97298090907326,1,0.022405263164971267,0.9775947368350287,1,0.09051957726478577,0.9387718439102173,1,0.18204770982265472,0.8732450008392334,1,0.004408096460985414,0.9955919035390146,1
2686,近医にて右視神経乳頭浮腫を指摘され、頭蓋内病変精査目的に当院脳神経外科を受診した。,近医 にる 右視神経乳頭浮腫 指摘 する れる 頭蓋内病変 精査 目的 院 脳神経外科 受診 する た,1,0.009780435322800905,0.9902195646771991,1,0.00039892125427822613,0.9996010787457218,1,0.0802111560824662,0.9197888439175338,1,0.12316919080790356,0.8768308091920964,1,0.0788065642118454,0.9455695748329163,1,0.19014841318130493,0.863248348236084,1,0.005983527278249601,0.9940164727217504,1
2687,治療的な処置は、下垂体卒中、内出血、尿崩症、下垂体機能低下症の結果としてとられた。,治療 的 だ 処置 下垂体卒中 内出血 尿崩症 下垂 体 機能低下症 結果 とる れる た,1,0.015469681421516725,0.9845303185784832,1,0.00035680770601667015,0.9996431922939834,1,0.028746951943891985,0.971253048056108,1,0.08131811926515964,0.9186818807348404,1,0.11664790660142899,0.9159812927246094,1,0.1932467669248581,0.8676806092262268,1,0.005367643952633513,0.9946323560473666,1
2688,自発呼吸なく、頸動脈触知できず、心肺停止と判断し、胸骨圧迫開始とBVM換気を継続。,自発呼吸 ない 頸動脈 触知 できる ぬ 心肺停止 判断 する 胸骨圧迫 開始 BVM 換気 継続,1,0.05973134241249615,0.9402686575875038,0,0.0001532656288777653,0.9998467343711223,0,0.6609838519623575,0.33901614803764246,1,0.0007652972403116021,0.9992347027596884,1,0.26555171608924866,0.8366270661354065,1,0.3257628083229065,0.7476874589920044,1,0.027929835801692636,0.9720701641983074,1
2689,心筋壊死マーカーは上昇した、トロポニンI 4534.8 ng/mlの上昇を認めた。,心筋壊死 マーカー 上昇 する た トロポニン I 0 0 NG ml 上昇 認める た,1,0.004152122103972255,0.9958478778960278,1,0.00036143290113780074,0.9996385670988622,1,0.02004632913412796,0.979953670865872,1,0.0019182879613773851,0.9980817120386226,1,0.08037859946489334,0.9451984763145447,1,0.18230028450489044,0.8775914311408997,1,0.00404123837493513,0.9959587616250649,1
2690,新生児呼吸窮迫症候群、動脈管開存症、新生児貧血の結果として、治療的処置がとられた。,新生児 呼吸窮迫 症候群 動脈管開存症 新生児貧血 結果 治療 的 処置 とる れる た,1,0.008797316873281879,0.9912026831267181,1,0.0003668827798554382,0.9996331172201446,1,0.01611597294842826,0.9838840270515717,1,0.0967320712011156,0.9032679287988844,1,0.0954178124666214,0.9277694821357727,1,0.21703216433525085,0.8460875749588013,1,0.005392266669411865,0.9946077333305883,1
2691,身体的診察にて多数の掻破痕を伴う全身のびまん性発赤及び顔面及び下肢の腫脹を認めた。,身体的 診察 多数 掻破痕 伴う 全身 びまん性発赤 顔面 下肢 腫脹 認める た,1,0.005044590785146434,0.9949554092148535,1,0.0004471197537003325,0.9995528802462996,1,0.014468129034872823,0.9855318709651272,1,0.004118312387929812,0.9958816876120702,1,0.08496271073818207,0.9461588859558105,1,0.18798911571502686,0.868080198764801,1,0.004098076951900904,0.9959019230480992,1
2692,脱水も否定できず補液ラクテックG 500、カロナール200 6錠分3で3日分処方。,脱水 否定 できる ぬ 補液 ラクテック G 0 カロナール 0 0 錠 分 0 0 日 分 処方,1,0.025952303753184473,0.9740476962468152,1,0.00016946772464526745,0.9998305322753547,0,0.5686509745928294,0.43134902540717057,1,0.0012982439200002194,0.9987017560799998,0,0.8807426691055298,0.20545470714569092,0,0.7278054356575012,0.26131749153137207,1,0.15894723407207212,0.8410527659279278,1
2693,本剤に伴う血管炎を疑い、入院翌日よりステロイド加療を開始したところ下熱が得られた。,本 剤 伴う 血管炎 疑う 入院 翌日 ステロイド 加療 開始 する た ところ 下熱 得る られる た,1,0.004020858622710297,0.9959791413772896,1,0.0004001065576830689,0.9995998934423169,1,0.01496326772179446,0.9850367322782055,1,0.07335328775484995,0.92664671224515,1,0.07842470705509186,0.9463830590248108,1,0.36903685331344604,0.7067036628723145,1,0.006560214701338318,0.9934397852986617,1
2694,造影眼窩MRIで右視神経高信号と造影効果を認めたことにより右眼視神経炎と診断した。,造影 眼窩 MRI 右 視神経 高信号 造影効果 認める た こと 右眼視神経炎 診断 する た,1,0.004734227104285722,0.9952657728957143,1,0.00036093331401381416,0.9996390666859862,1,0.012871544000792934,0.9871284559992071,1,0.0405217775697676,0.9594782224302324,1,0.08629831671714783,0.9455034732818604,1,0.18980741500854492,0.8692684173583984,1,0.004400227074697296,0.9955997729253027,1
2695,2022/05/08 20:00、患者は、MERSを発現し、救急治療室に来院した。,0 0 0 0 0 患者 MERS 発現 救急 治療 室 来院 する た,1,0.014389469225744755,0.9856105307742553,1,0.00041605121365632713,0.9995839487863437,1,0.007898630753428781,0.9921013692465712,1,0.08201423109662875,0.9179857689033712,1,0.07836508750915527,0.9472386240959167,1,0.1985814869403839,0.8569862246513367,1,0.0048794007994187065,0.9951205992005813,1
2696,2021/12/24、急性散在性脳脊髄炎の疑いを認め、ステロイドパルスで治療した。,0 0 0 急性散在性脳脊 髄炎 疑い 認める ステロイド パルス 治療 する た,1,0.016702582522390718,0.9832974174776093,1,0.00034819500938217335,0.9996518049906178,1,0.017479561676929545,0.9825204383230705,1,0.23963234094639008,0.7603676590536099,1,0.1087164431810379,0.9235203862190247,1,0.18650470674037933,0.8779211640357971,1,0.00697866133718485,0.9930213386628153,1
2697,患者は、食欲減退、倦怠感、低血糖(開始日:2022/07/19)のために入院した。,患者 食欲減退 倦怠感 低血糖 開始 日 0 0 0 ため 入院 する た,1,0.006621879357631474,0.9933781206423685,1,0.00033894374146248334,0.9996610562585375,1,0.006900550522533133,0.9930994494774669,1,0.12745420228656912,0.8725457977134309,1,0.07585037499666214,0.9484018683433533,1,0.1784123033285141,0.8740382194519043,1,0.0050387474861694785,0.9949612525138306,1
2698,15日目、低酸素血症のため再入院となった:呼吸時のSpO2は90-94%であった。,0 日 目 低酸素血症 ため 入院 なる た 呼吸 時 SpO 0 0 0% だ ある た,1,0.021994317844541388,0.9780056821554588,1,0.0003467525557069264,0.9996532474442931,1,0.04380942103499652,0.9561905789650035,0,0.5895829999727107,0.41041700002728937,1,0.09281453490257263,0.9386140704154968,1,0.19113251566886902,0.8587196469306946,1,0.014746115247103687,0.9852538847528964,1
2699,2021/07/25午前、微熱が6週間続き、呼吸苦、関節炎悪化、関節炎が発現した。,0 0 0 午前 微熱 0 週間 続く 呼吸苦 関節炎 悪化 関節炎 発現 する た,1,0.002890569483467324,0.9971094305165329,1,0.0003921360709086773,0.9996078639290913,1,0.01871572649241715,0.9812842735075828,1,0.10102670893213228,0.8989732910678677,1,0.07501309365034103,0.9490330219268799,1,0.1850007027387619,0.8785479068756104,1,0.004861587279403464,0.9951384127205966,1
2700,2021/08/26(ワクチン接種の1日後)、末梢性神経障害と知覚異常を発症した。,0 0 0 ワクチン接種 0 日 後 末梢性神経障害 知覚異常 発症 する た,1,0.01668860821218357,0.9833113917878166,1,0.0003600310789988167,0.9996399689210012,1,0.06416583234720818,0.9358341676527918,1,0.041175175659016294,0.9588248243409837,1,0.07777176052331924,0.9472651481628418,1,0.1818484365940094,0.8773238062858582,1,0.00486801334032808,0.9951319866596718,1
2701,2021/10/23、朝から胸痛があり、同日夕方に、前医の医療センターを受診した。,0 0 0 朝 胸痛 ある 同日 夕方 医 医療センター 受診 する た,1,0.012884360096895496,0.9871156399031042,1,0.0003701708185285785,0.9996298291814715,1,0.06017966287892074,0.9398203371210793,1,0.15163880201819346,0.8483611979818065,1,0.0709749385714531,0.9472354054450989,1,0.18371540307998657,0.8664292693138123,1,0.00600685889115693,0.9939931411088431,1
2702,2021/12/20、夕食後、左手の力が低下したことを自覚し、翌日、救急受診した。,0 0 0 夕食 後 左手 力 低下 する た こと 自覚 翌日 救急 受診 する た,1,1.140697934275188e-05,0.9999885930206572,1,0.0004959116747101983,0.9995040883252898,1,0.0063360227520723456,0.9936639772479277,1,0.08197057390036067,0.9180294260996393,1,0.08440771698951721,0.9491249322891235,1,0.18490324914455414,0.871371865272522,1,0.004616193267522909,0.9953838067324771,1
2703,2022/02/02(ワクチン接種と同日)、患者は摂氏40.1度の発熱を発症した。,0 0 0 ワクチン接種 同日 患者 摂氏 0 0度 発熱 発症 する た,1,0.0034193709344835705,0.9965806290655164,1,0.0004264658110162719,0.9995735341889838,1,0.01398541680523524,0.9860145831947648,1,0.017932108347935904,0.9820678916520641,1,0.08142408728599548,0.9481984376907349,1,0.18285004794597626,0.8726051449775696,1,0.004131384632792504,0.9958686153672074,1
2704,2022/03/30 12:00、事象(倦怠感強く、黄疸、急性肝障害)が出現した。,0 0 0 0 0 事象 倦怠感強く 黄疸 急性肝障害 出現 する た,1,0.016693972944398366,0.9833060270556016,1,0.00030281063980471803,0.9996971893601952,1,0.027901234287424637,0.9720987657125754,1,0.1329240801004895,0.8670759198995105,1,0.07586032152175903,0.9509758949279785,1,0.17979824542999268,0.879857063293457,1,0.00538076089423769,0.9946192391057624,1
2705,2022/07/07(ワクチン接種後、午前)、患者は嘔吐、肝障害、微熱を発症した。,0 0 0 ワクチン接種 後 午前 患者 嘔吐 肝障害 微熱 発症 する た,1,1.5366647010405866e-05,0.9999846333529896,1,0.0005078253236117971,0.9994921746763882,1,0.0236072481156524,0.9763927518843476,1,0.033209562580535645,0.9667904374194644,1,0.07622932642698288,0.9499890208244324,1,0.18332135677337646,0.8781363368034363,1,0.004261367579459021,0.995738632420541,1
2706,2回目のワクチン接種後、患者は脊柱管狭窄症、下肢のしびれと多少腕の重さを発現した。,0回目 ワクチン接種 後 患者 脊柱管狭窄症 下肢のしびれ 腕 重い さ 発現 する た,1,0.006343708244401072,0.9936562917555991,1,0.0004069482984335687,0.9995930517015664,1,0.0299837697456683,0.9700162302543317,1,0.16196276553565003,0.83803723446435,1,0.07976265251636505,0.9474630951881409,1,0.18396253883838654,0.8718007206916809,1,0.0057194643447852495,0.9942805356552149,1
2707,Autopsy:剖検で、腹水、胸水、notes:肝腫大、脾腫、骨髄線維症を認めた。,Autopsy 剖検 腹水 胸水 notes 肝腫大 脾腫 骨髄線維症 認める た,1,0.016580210107710477,0.9834197898922896,1,0.00035336363606388574,0.9996466363639361,1,0.03806770060034348,0.9619322993996565,1,0.004162650033848858,0.9958373499661511,1,0.07789052277803421,0.9425228834152222,1,0.1872275471687317,0.8758029341697693,1,0.004342816523438756,0.9956571834765613,1
2708,事象「胸痛」、「発熱/摂氏39度台の発熱」、「嘔気」は、診療所に来院を必要とした。,事象 胸痛 発熱 摂氏 0度 台 発熱 嘔気 診療所 来院 必要 する た,1,0.0036510099782856575,0.9963489900217144,1,0.00039807516565716215,0.9996019248343428,1,0.005492453058969726,0.9945075469410303,1,0.3128089074945829,0.6871910925054171,1,0.07692111283540726,0.9490327835083008,1,0.18442876636981964,0.8729705810546875,1,0.007275413692820167,0.99272458630718,1
2709,日付不明(2022年01月07日以降)、瞼、目が腫れて開かなくなった(眼瞼腫脹)。,日付 不明 0 年 0 月 0 日 以降 瞼 目 腫れ 開く ない なる た 眼瞼腫脹,1,0.01669432773394388,0.983305672266056,1,0.00020385658222856634,0.9997961434177715,1,0.4656930820797126,0.5343069179202874,1,1.1606696897925595e-05,0.9999883933031021,1,0.08549018949270248,0.9435527920722961,1,0.20542755722999573,0.8584328889846802,1,0.010499608518639961,0.98950039148136,1
2710,鼻スワブによる逆転写ポリメラーゼ連鎖反応(RT-PCR)検査にて新規感染を認めた。,鼻 スワブ 逆転 写 ポリメラーゼ連鎖反応 ReTweet PCR 検査 新規感染 認める た,1,0.0394237965493148,0.9605762034506851,1,0.00024836852180108097,0.9997516314781989,1,0.03690481442095772,0.9630951855790423,1,0.015268871545841112,0.9847311284541589,1,0.09856369346380234,0.936725914478302,1,0.1844242811203003,0.8601062893867493,1,0.00481998642541772,0.9951800135745822,1
2711,翌2022/02/27には右顔面神経麻痺も出現しため報告病院の救急外来を受診した。,0 0 0 右 顔面神経 麻痺 出現 下目 報告 病院 救急外来 受診 する た,1,9.963104975122996e-06,0.999990036895025,1,0.0004328233622879841,0.999567176637712,1,0.007975587048037358,0.9920244129519626,1,0.17514069228127704,0.824859307718723,1,0.0731772631406784,0.9473133087158203,1,0.18313777446746826,0.8795624375343323,1,0.0054675474535490565,0.994532452546451,1
2712,2022/07/11 00:30(ワクチン接種の15時間後)、心肺停止が発現した。,0 0 0 0 0 ワクチン接種 0時 間 後 心肺停止 発現 する た,1,0.0045869592160031405,0.9954130407839967,1,0.0004344931070736383,0.9995655068929263,1,0.012014960095098615,0.9879850399049014,1,0.06961764314322927,0.9303823568567707,1,0.07865174114704132,0.9462509155273438,1,0.18970857560634613,0.874225378036499,1,0.004592133375047629,0.9954078666249523,1
2713,耳内は清明、聴力検査で左右の差なし、耳小骨筋反射検査は疼痛のため実施できなかった。,耳 内 清明 聴力 検査 左右 差 ない 耳小骨 筋 反射 検査 疼痛 ため 実施 できる ない た,1,0.01669530271293341,0.9833046972870667,1,0.00017143420592088474,0.9998285657940791,0,0.9051629253717693,0.09483707462823066,0,0.9420748523161502,0.0579251476838498,0,0.9113937020301819,0.10054025799036026,0,0.8071159720420837,0.16878201067447662,1,0.7644793529028293,0.2355206470971707,1
2714,交差混合試験は阻害パターンを明らかにし、抗F13Aサブユニット抗体は陽性であった。,交差 混合 試験 阻害 パターン 明らか する F 0 A サブユニット 抗体 陽性 だ ある た,1,0.029142172350387106,0.9708578276496129,1,0.0002558915594199406,0.99974410844058,1,0.034546069593586304,0.9654539304064137,1,0.35272692441143283,0.6472730755885672,1,0.251504510641098,0.8269201517105103,1,0.24417418241500854,0.8496617078781128,1,0.012773067892806552,0.9872269321071934,1
2715,"トロンポニンI 14482.7 pg/ml,正常高値16.7,翌日よりピークアウト",トロンポニン I 0 0 PG ml 正常高値 0 0 翌日 ピークアウト,1,0.023398186892490767,0.9766018131075092,1,0.00040844215483291826,0.9995915578451671,1,0.19528032181325072,0.8047196781867493,1,7.339963914443359e-08,0.9999999266003609,1,0.18653066456317902,0.8960579037666321,1,0.24773739278316498,0.8457860946655273,1,0.0076194543212795545,0.9923805456787205,1
2716,メニエール病、(または突発性難聴)に準じ、ステロイド点滴および内服治療を開始した。,メニエール病 突発性 難聴 準じる ステロイド 点滴 内服 治療 開始 する た,1,0.016679500201085072,0.9833204997989149,1,0.0001778753146573122,0.9998221246853427,0,0.7409016459118856,0.2590983540881144,1,0.3505011560323006,0.6494988439676994,1,0.1634151041507721,0.8859243988990784,1,0.22861409187316895,0.8578073382377625,1,0.04167912796941431,0.9583208720305857,1
2717,接種から体重が6kg減少し、ボディ・マス・インデックスは20.6kg/mであった。,接種 体重 0kg 減少 する ボディ マス インデックス 0 0kg m だ ある た,1,0.016689729511681142,0.983310270488319,1,0.00030005191251009165,0.9996999480874899,1,0.24970128728300622,0.7502987127169938,1,0.32303894208400863,0.6769610579159914,0,0.7921016216278076,0.2377968728542328,1,0.20025917887687683,0.8528621792793274,1,0.05123014002573518,0.9487698599742648,1
2718,06/03、、造影CT検査にて両側膝窩動脈血栓閉塞+上腸間膜動脈血栓症を認めた。,0 0 造影 CT検査 両側 膝窩動脈血栓 閉塞 上腸間膜動脈 血栓症 認める た,1,0.005002750447903309,0.9949972495520967,1,0.00042371878971263254,0.9995762812102874,1,0.02455727041750211,0.9754427295824979,1,0.0027459696237800424,0.99725403037622,1,0.07335884869098663,0.9389709830284119,1,0.19195587933063507,0.8768994808197021,1,0.004130999576867594,0.9958690004231323,1
2719,2021/08/29偏頭痛、判別不能な強い頭痛のためイブプロフェン内服し、軽快。,0 0 0 偏頭痛 判別 不能 だ 強い 頭痛 ため イブプロフェン 内服 する 軽快,1,0.25737549592314757,0.7426245040768521,1,0.00018565266798873403,0.9998143473320112,1,0.3021182345160214,0.6978817654839786,1,0.12373492798482266,0.8762650720151773,1,0.1296277791261673,0.9139586091041565,1,0.21638496220111847,0.8584091663360596,1,0.016964431561343855,0.983035568438656,1
2720,2021/08/30 37.8°Cの発熱、頭痛のためイブプロフェン内服し、軽快。,0 0 0 0 0 C 発熱 頭痛 ため イブプロフェン 内服 する 軽快,1,0.017331691592395438,0.9826683084076046,1,0.00024728625113165317,0.9997527137488683,1,0.043218006145798626,0.9567819938542014,0,0.6538707187839126,0.3461292812160875,1,0.10002411156892776,0.9376614093780518,1,0.185201957821846,0.8691897988319397,1,0.01642660906528367,0.9835733909347163,1
2721,2021/11/04所見から自己免疫疾患の関与を疑い、メチルプレドニゾロン投与。,0 0 0 所見 自己免疫疾患 関与 疑う メチルプレドニゾロン 投与,1,0.016699241616888284,0.9833007583831118,1,0.0002614437021208055,0.9997385562978792,1,0.15882808196022036,0.8411719180397796,1,5.8641363260503176e-05,0.9999413586367395,1,0.08792655915021896,0.9308748841285706,1,0.20729918777942657,0.8628138303756714,1,0.005784522470430862,0.9942154775295693,1
2722,2022/03/31朝から歩行出来ず、呼吸苦、全身脱力、嘔吐を認め、当院に搬送。,0 0 0 朝 歩行出来 ぬ 呼吸苦 全身脱力 嘔吐 認める 院 搬送,1,0.0160285356205847,0.9839714643794154,1,0.000376129949042472,0.9996238700509575,1,0.026591035132900953,0.973408964867099,1,2.4424906541753444e-15,0.9999999999999976,1,0.08045036345720291,0.9463809132575989,1,0.18946389853954315,0.873711884021759,1,0.004217916593886484,0.9957820834061134,1
2723,2022/05/13症状の軽快を認めたが、後遺症として左視野障害、左麻痺が残る。,0 0 0 症状 軽快 認める た 後遺症 する 左視野障害 左麻痺 残る,1,0.016691462978412227,0.9833085370215877,1,0.00030843095283106063,0.9996915690471689,1,0.17511170417000044,0.8248882958299996,1,1.305514210070413e-07,0.999999869448579,1,0.2723754644393921,0.8520814180374146,1,0.3506944477558136,0.7674300670623779,1,0.009832137637501624,0.9901678623624984,1
2724,2022/06/11午後(夕方)(報告のとおり)、患者は、全身倦怠感を発現した。,0 0 0 午後 夕方 報告 とおり 患者 全身倦怠感 発現 する た,1,0.01668573471023748,0.9833142652897625,1,0.0003332001154883425,0.9996667998845117,1,0.018368453688523134,0.9816315463114769,1,0.11030695200780127,0.8896930479921987,1,0.08382294327020645,0.9485902190208435,1,0.19525545835494995,0.8590080738067627,1,0.005287379011662472,0.9947126209883376,1
2725,MRIで頚髄内に高信号病変を認め、頭部MRIでも側脳室周囲に高信号病変を認めた。,MRI 頚髄 内 高信号病変 認める 頭部 MRI 側脳室 周囲 高信号病変 認める た,1,0.013633892584610398,0.9863661074153894,1,0.0003697213084606369,0.9996302786915393,1,0.04534619632010395,0.954653803679896,1,0.0042378201844048835,0.9957621798155951,1,0.0876779705286026,0.9345697164535522,1,0.19638818502426147,0.8716792464256287,1,0.004518675036449067,0.9954813249635509,1
2726,トロポニンT(不明-0.014 ng/mL未満):0.49 ng/mL(高値)。,トロポニン T 不明 0 0 NG mL 未満 0 0 NG mL 高値,0,0.5436393989487049,0.4563606010512949,0,0.0001482454835409192,0.9998517545164591,1,0.4881095312872443,0.5118904687127557,1,0.0,1.0,1,0.1108352467417717,0.9305011034011841,1,0.18863268196582794,0.8643427491188049,1,0.03132290893325527,0.9686770910667447,1
2727,冠動脈に有意狭窄を認めず、経過から本剤の副反応による心筋炎の疑いで入院となった。,冠動脈 有意狭窄 認める ぬ 経過 本 剤 副反応 心筋炎 疑い 入院 なる た,1,0.0066284773572323,0.9933715226427678,1,0.00042649611631337023,0.9995735038836866,1,0.02418080623319907,0.9758191937668009,1,0.06380617753055629,0.9361938224694437,1,0.08762942999601364,0.9390001893043518,1,0.199831023812294,0.8595505356788635,1,0.004864057648183729,0.9951359423518161,1
2728,血液検査で、CK上昇、トロポニンT陽性、心電図でST上昇を指摘され、当院へ転送。,血液検査 CK 上昇 トロポニン T 陽性 心電図 ST 上昇 指摘 する れる 院 転送,1,1.931813263998861e-06,0.9999980681867359,1,0.0005322486163478457,0.9994677513836522,1,0.006499971144713235,0.9935000288552868,1,4.404150134384999e-05,0.9999559584986562,1,0.09064502269029617,0.9365807175636292,1,0.18528562784194946,0.8580459952354431,1,0.004051777181013933,0.9959482228189861,1
2729,採血で心筋逸脱酵素の上昇を認め、急性冠症候群疑いで緊急心臓カテーテル検査を実施。,採血 だ 心筋逸脱酵素 上昇 認める 急性冠症候群 疑い 緊急 心臓カテーテル検査 実施,1,0.01671058180317085,0.983289418196829,1,0.00031417532851928467,0.9996858246714807,1,0.006362573141737937,0.9936374268582621,1,0.033315717764707764,0.9666842822352922,1,0.09442108124494553,0.9341089725494385,1,0.19416876137256622,0.8677535057067871,1,0.004496870576931693,0.9955031294230682,1
2730,初回接種から26日後、患者は顔面及び末梢性浮腫様症状を呈し、1週間後に入院した。,初回 接種 0 日 後 患者 顔面 末梢性浮腫 様 症状 呈す 0 週間 後 入院 する た,1,0.07872956702331096,0.9212704329766889,1,0.00023754800701026435,0.9997624519929897,1,0.022683798689740686,0.9773162013102593,1,0.17715731700659043,0.8228426829934096,1,0.0828612819314003,0.9474960565567017,1,0.18104423582553864,0.8602707982063293,1,0.006784919047859819,0.9932150809521402,1
2731,心エコー検査:心エコー検査にて軽度の左室機能障害(左室駆出率約46%)を認めた。,心 エコー 検査 心 エコー 検査 軽度 左室機能障害 左 室 駆け出し 率 0% 認める た,1,0.016682504582487555,0.9833174954175126,1,0.00027111730505454,0.9997288826949454,1,0.01417247605727101,0.985827523942729,1,0.023372662259728783,0.9766273377402712,1,0.0904342383146286,0.9422091841697693,1,0.19933712482452393,0.8599928021430969,1,0.004480932509631559,0.9955190674903684,1
2732,心臓・下肢静脈エコーにおいて左膝下静脈に可動性血栓、両側ヒラメ静脈に血栓を確認。,心臓 下肢 静脈 エコー 左膝 静脈 可動性 血栓 両側 ヒラメ 静脈 血栓 確認,1,0.016662072792340787,0.9833379272076593,1,0.0001705120129807064,0.9998294879870193,1,0.3552747656803007,0.6447252343196993,1,0.001355640134788283,0.9986443598652117,1,0.09505258500576019,0.9185165762901306,1,0.22673384845256805,0.8384458422660828,1,0.009118858080377275,0.9908811419196227,1
2733,心臓超音波検査では心膜の炎症所見、胸部造影CTでは心膜の炎症を疑う所見を認めた。,心臓 超音波 検査 心膜 炎症所見 胸部 造影 CT 心膜 炎症 疑う 所見 認める た,1,0.020684318021002537,0.9793156819789974,1,0.00031633158378917823,0.9996836684162108,1,0.022984563364742305,0.9770154366352577,1,0.009287890869216553,0.9907121091307834,1,0.10582960397005081,0.9324005246162415,1,0.19107788801193237,0.8657870292663574,1,0.004519906341652377,0.9954800936583477,1
2734,心電図:ST上昇、ST上昇及びST上昇を伴う洞調律:I、II、aVF、V2-6。,心電図 ST 上昇 ST 上昇 ST 上昇 伴う 洞調律 I II aVF V 0 0,1,0.027773226235856298,0.9722267737641437,1,0.00044906362012345756,0.9995509363798766,1,0.02628306377638312,0.9737169362236169,1,0.025574035429926645,0.9744259645700734,1,0.0902741402387619,0.9415585994720459,1,0.1892150491476059,0.8595319390296936,1,0.004672197704202364,0.9953278022957976,1
2735,接種後1日目、患者は発熱を呈し、接種後2日目、患者は胸部圧迫感及び悪心を呈した。,接種 後 0 日 目 患者 発熱 呈す 接種 後 0 日 目 患者 胸部圧迫感 悪心 呈す た,1,0.015309493115351534,0.9846905068846484,1,0.0003660547639368078,0.9996339452360632,1,0.009933452876150772,0.9900665471238492,1,4.90608756289479e-05,0.999950939124371,1,0.07913566380739212,0.9502107501029968,1,0.20285195112228394,0.8628178238868713,1,0.004153156462095695,0.9958468435379043,1
2736,超音波スキャン:びまん性の皮質厚及び脂肪肺門を伴うリンパ節腫脹2つが確認された。,超音波 スキャン びまん性 皮質厚 脂肪 肺門 伴う リンパ節腫脹 0 つ 確認 する れる た,1,0.016673387793412153,0.9833266122065879,1,0.0003421784955245331,0.9996578215044755,1,0.2102064553133881,0.7897935446866119,1,0.14549459047242497,0.854505409527575,1,0.07849770039319992,0.9463282227516174,1,0.18560998141765594,0.8642215728759766,1,0.008154407291010166,0.9918455927089899,1
2737,肺高分解能コンピュータ断層撮影では、両側のすりガラス陰影及び肺葉の硬化を認めた。,肺 高 分解能 コンピュータ断層撮影 両側 すりガラス陰影 肺葉 硬化 認める た,1,0.0056112709000463645,0.9943887290999535,1,0.0004312714873144575,0.9995687285126855,1,0.034365236480359385,0.9656347635196406,1,0.0073642458203543315,0.9926357541796457,1,0.09016238152980804,0.9356822967529297,1,0.18731537461280823,0.8704099655151367,1,0.004350647493624071,0.9956493525063759,1
2738,発熱、胸腹水、血小板減少、リンパ節腫大、腎障害を認めTAFRO症候群が疑われた。,発熱 胸腹水 血小板減少 リンパ節腫大 腎障害 認める TAFRO 症候群 疑う れる た,1,2.3668013563110083e-06,0.9999976331986438,1,0.0005186190275804669,0.9994813809724196,1,0.0032426380955860035,0.996757361904414,1,0.0667668987565917,0.9332331012434083,1,0.07777349650859833,0.9443517923355103,1,0.18426239490509033,0.8702262043952942,1,0.0044451745423722796,0.9955548254576276,1
2739,本ワクチンの4回目接種後、10日後のゴルフプレー後に心臓痛(胸痛)症状を訴えた。,ワクチン 0回目 接種 後 0 日 後 ゴルフ プレー 後 心臓痛 胸痛 症状 訴える た,1,0.016682625721580708,0.9833173742784191,1,0.0003420491296768365,0.9996579508703232,1,0.028098977369145905,0.9719010226308541,1,0.003650346069601129,0.9963496539303989,1,0.07917511463165283,0.9490117430686951,1,0.17922234535217285,0.8612873554229736,1,0.004259420505161796,0.9957405794948382,1
2740,本剤接種の副反応として輸液で経過観察を行うも帰宅できるほどの回復はみられず入院。,本 剤 接種 副反応 輸液 経過 観察 行う 帰宅 できる 回復 みる られる ぬ 入院,1,0.016659523902825282,0.9833404760971747,0,0.00014229473819124238,0.9998577052618087,1,0.16236451392023044,0.8376354860797696,1,3.931667757584023e-06,0.9999960683322424,0,0.9046069979667664,0.15597519278526306,0,0.7793570160865784,0.17537087202072144,1,0.09203461308207829,0.9079653869179217,1
2741,2021/11、病院受診時、ODテストが施行され、体位性頻脈症候群と診断された。,0 0 病院 受診 時 OD テスト 施行 する れる 体位性頻脈 症候群 診断 する れる た,1,0.08874778297878325,0.9112522170212166,1,0.00028501599687799406,0.999714984003122,1,0.1659045442370919,0.8340954557629081,1,0.414282759375321,0.585717240624679,1,0.08448769897222519,0.9464930295944214,1,0.19204619526863098,0.8709625601768494,1,0.014737955173682926,0.9852620448263171,1
2742,全例で胸痛(転帰不明)、発熱を認め、3例(42%)に心筋逸脱酵素の上昇を認めた。,例 だ 胸痛 転帰 不明 発熱 認める 0 例 0% 心筋逸脱酵素 上昇 認める た,1,1.6235654302618602e-05,0.9999837643456974,1,0.00047004690509135647,0.9995299530949087,1,0.0017798068842297399,0.9982201931157703,1,0.0051224706118615515,0.9948775293881384,1,0.07809998095035553,0.9483378529548645,1,0.18369942903518677,0.8721831440925598,1,0.0038958324183720255,0.996104167581628,1
2743,91日目、発熱が発現し、血液培養により多剤耐性肺炎桿菌による菌血症が認められた。,0 日 目 発熱 発現 血液 培養 多剤耐性 肺炎桿菌 菌血症 認める られる た,1,0.0055533521172864385,0.9944466478827135,1,0.00037391989701454533,0.9996260801029855,1,0.012001359008302126,0.9879986409916979,1,0.05147709230811959,0.9485229076918804,1,0.07826187461614609,0.9526664018630981,1,0.17558985948562622,0.8675106167793274,1,0.004374783619194827,0.9956252163808051,1
2744,11:15頃、患者は、両手に力が入りにくい感じがあり、力に左右差ありを発現した。,0 0 頃 患者 両手 力 入る にくい 感じ ある 力 左右 差 ある 発現 する た,1,1.213235854143301e-05,0.9999878676414586,1,0.0004631893560249021,0.9995368106439751,1,0.007152898477733816,0.9928471015222662,1,0.16242683866632468,0.8375731613336753,1,0.08324425667524338,0.9482207298278809,1,0.1895732432603836,0.8724337220191956,1,0.005444300437317489,0.9945556995626825,1
2745,2021/07/24(ワクチン接種の3日後)、患者はBell麻痺疑いを発現した。,0 0 0 ワクチン接種 0 日 後 患者 Bell 麻痺 疑い 発現 する た,1,0.0059370778385821775,0.994062922161418,1,0.00046782353631345526,0.9995321764636865,1,0.0031222548791881577,0.9968777451208118,1,0.04800830973758918,0.9519916902624108,1,0.08752508461475372,0.9481756091117859,1,0.18835121393203735,0.8694661855697632,1,0.004378353533992676,0.9956216464660073,1
2746,2022/01/05、電気生理学的検査が実施され、上下肢で節性脱髄所見を認めた。,0 0 0 電気 生理 学的 検査 実施 する れる 上下 肢 節 性 脱髄所見 認める た,1,0.016688517721877006,0.9833114822781229,1,0.00029588262794225307,0.9997041173720578,1,0.01912981952053694,0.9808701804794631,1,0.008256864350419169,0.9917431356495808,1,0.0936613529920578,0.9364842176437378,1,0.19286370277404785,0.8738671541213989,1,0.0043419334504615935,0.9956580665495385,1
2747,2022/01/31、患者は報告の通り、事象「IgA血管炎の腎病変」を発症した。,0 0 0 患者 報告 通り 事象 IgA 血管炎 の 腎病変 発症 する た,1,0.035962008565299214,0.9640379914347007,1,0.00025713169126368867,0.9997428683087363,1,0.053016735433589646,0.9469832645664104,1,0.05632271944288458,0.9436772805571154,1,0.08877444267272949,0.9361454248428345,1,0.18510977923870087,0.8642311096191406,1,0.005296623048438157,0.9947033769515619,1
2748,2022/02/03より右耳痛、2022/02/05より頭痛、右耳痛が悪化した。,0 0 0 右耳痛 0 0 0 頭痛 右耳痛 悪化 する た,1,0.016681496902471685,0.9833185030975286,1,0.00032007722779773244,0.9996799227722023,1,0.1533774970224282,0.8466225029775718,1,0.170512668812704,0.829487331187296,1,0.07519225031137466,0.9504005908966064,1,0.18589510023593903,0.8783078789710999,1,0.007496177504451605,0.9925038224955485,1
2749,また、両肺胸膜直下に510mm大のすりガラス陰影小結節(GGNs)を複数認めた。,両肺 胸膜 直下 0mm 大 すりガラス陰影 小結節 GGNs 複数 認める た,1,0.01108546740906755,0.9889145325909325,1,0.0004180386247619749,0.999581961375238,1,0.03806770060034348,0.9619322993996565,1,0.020389811206744657,0.9796101887932553,1,0.07780008018016815,0.9440144896507263,1,0.1885557919740677,0.8689470291137695,1,0.004466455798311306,0.9955335442016887,1
2750,患者が前の医療機関から病院に搬送された際、GC:E4V1M2で不穏状態であった。,患者 前 医療機関 病院 搬送 する れる た 際 GC E 0V 0 M 0 だ 不穏状態 だ ある た,1,0.08661274911358008,0.9133872508864199,1,0.00017523343938864738,0.9998247665606114,0,0.5987191227178905,0.40128087728210954,0,0.6610999351421192,0.33890006485788077,1,0.08331930637359619,0.9434192776679993,1,0.21200892329216003,0.8424943089485168,1,0.05746639259306131,0.9425336074069387,1
2751,事象「心室細動」、「心肺停止」、「植物状態」により、救急治療室への来院を要した。,事象 心室細動 心肺停止 植物状態 救急 治療 室 来院 要す た,1,0.013800348129683483,0.9861996518703168,1,0.0004059495839415942,0.9995940504160584,1,0.208307056387805,0.791692943612195,1,0.006459931020297405,0.9935400689797026,1,0.082469642162323,0.9465620517730713,1,0.19249916076660156,0.8593201041221619,1,0.006224818113368458,0.9937751818866316,1
2752,診断は、蘇生後脳症、心肺停止状態、虚血性心疾患による重症心機能低下と報告された。,診断 蘇生後脳症 心肺停止状態 虚血性 心疾患 重症 心機能低下 報告 する れる た,1,0.016688477361902834,0.9833115226380974,1,0.00034342328590161844,0.9996565767140984,1,0.06288430629520281,0.9371156937047972,1,0.1848340709924421,0.8151659290075579,1,0.09048715978860855,0.9455276727676392,1,0.1964428573846817,0.8714556097984314,1,0.006689177481738944,0.9933108225182611,1
2753,接種2日後から出現しているリンパ節腫脹は、エコー所見では反応性の腫大が疑われた。,接種 0 日 後 出現 する いる リンパ節腫脹 エコー 所見 反応 性 腫大 疑う れる た,1,0.0083438058088934,0.9916561941911066,1,0.0004260702094484531,0.9995739297905516,1,0.004215766458268377,0.9957842335417316,1,0.09679307312468932,0.9032069268753107,1,0.07910740375518799,0.9455665946006775,1,0.18231289088726044,0.8657081127166748,1,0.004819293563373431,0.9951807064366266,1
2754,組織学的検査:中心壊死を認めた、備考:潰瘍形成を伴う化膿性炎症と表面性皮膚浮腫。,組織 学 的 検査 中心壊死 認める た 備考 潰瘍形成 伴う 化膿性 炎症 表面 性 皮膚浮腫,1,0.01401474841234132,0.9859852515876587,1,0.0003713324466133084,0.9996286675533866,1,0.007638958372236382,0.9923610416277636,1,5.843926087489848e-07,0.9999994156073913,1,0.0901377871632576,0.9427471160888672,1,0.203278049826622,0.8575754761695862,1,0.004223513284054142,0.9957764867159458,1
2755,低酸素症、低血糖、失神寸前の状態、蒼白、不快気分の結果として治療処置が行われた。,低酸素症 低血糖 失神 寸前 状態 蒼白 不快気分 結果 治療 処置 行う れる た,1,0.011321142399397879,0.9886788576006023,1,0.00031129793067662603,0.9996887020693234,1,0.10764864876707403,0.892351351232926,1,0.16044111250996496,0.839558887490035,1,0.0762801468372345,0.9484103322029114,1,0.18263354897499084,0.8670951724052429,1,0.00671184184488118,0.9932881581551188,1
2756,脳神経内科の診察依頼がされたが、小声痛みが強く筋力低下に関して評価不能であった。,脳神経 内科 診察 依頼 する れる た 小声 痛み 強い 筋力低下 評価不能 だ ある た,1,0.04592263238587201,0.9540773676141278,1,0.00022644204996009407,0.9997735579500399,1,0.11723503832398474,0.8827649616760153,1,0.44442163081976327,0.5555783691802367,1,0.07540915906429291,0.9487625360488892,1,0.35583484172821045,0.7421101927757263,1,0.017225019383343036,0.9827749806166569,1
2757,左上腕(接種部)の神経障害、挙上困難が認められ、就業、運転に支障ありであった。,左上 腕 接種 部 神経障害 挙 上 困難 認める られる 就業 運転 支障 ある だ ある た,1,0.016342543395293528,0.9836574566047065,1,0.00039789941065869884,0.9996021005893413,1,0.012107525820001075,0.9878924741799989,0,0.5139299997900595,0.48607000020994046,1,0.0799991711974144,0.9453402161598206,1,0.19522108137607574,0.8647512197494507,1,0.011551568473687723,0.9884484315263122,1
2758,2021/10/06(1回目のワクチン接種日)、患者は四肢のしびれを発症した。,0 0 0 0回目 ワクチン接種 日 患者 四肢のしびれ 発症 する た,1,0.00817045490436413,0.9918295450956359,1,0.0004258881941640469,0.999574111805836,1,0.07288467250477026,0.9271153274952297,1,0.021686715002137258,0.9783132849978627,1,0.07696777582168579,0.9466782808303833,1,0.18460018932819366,0.8770309686660767,1,0.00469848398026996,0.99530151601973,1
2759,2022/01/20(ワクチン接種23日後)、IgA血管炎の腎病変を発現した。,0 0 0 ワクチン接種 0 日 後 IgA 血管炎 の 腎病変 発現 する た,1,0.0037311284042653723,0.9962688715957347,1,0.0005004969970565769,0.9994995030029434,1,0.010060360126714851,0.9899396398732851,1,0.0800792936917274,0.9199207063082726,1,0.07604195177555084,0.9467528462409973,1,0.1817491352558136,0.8716635704040527,1,0.004623897144944474,0.9953761028550554,1
2760,2022/02/06(ワクチン接種45日後)、COVID-19陽性を発現した。,0 0 0 ワクチン接種 0 日 後 COVID 0 陽性 発現 する た,1,1.1088331103397391e-06,0.9999988911668896,1,0.0007570382070780367,0.9992429617929219,1,0.0033974436074601932,0.9966025563925398,1,0.041260082400690345,0.9587399175993097,1,0.082801453769207,0.9504658579826355,1,0.19345374405384064,0.8710092306137085,1,0.004259272475468078,0.995740727524532,1
2761,2022/03/01ホルター心電図で持続する上室性頻拍を認め継続内服治療開始。,0 0 0 ホルター心電図 持続 する 上室性 頻拍 認める 継続 内服 治療 開始,1,0.016676931605572723,0.9833230683944273,1,0.00024327969577046373,0.9997567203042296,1,0.08647073310636755,0.9135292668936325,0,0.5113849012796962,0.48861509872030384,1,0.15529979765415192,0.887790322303772,1,0.19659742712974548,0.8730957508087158,1,0.0150763452138716,0.9849236547861285,1
2762,2022/03/29 06:00頃、急に呼吸困難が出現し、医療機関に救急搬送。,0 0 0 0 0 頃 急 呼吸困難 出現 医療機関 救急搬送,1,0.01478045938331516,0.9852195406166848,1,0.00038970013780549454,0.9996102998621945,1,0.0128662269921489,0.9871337730078511,1,5.6621374255882984e-14,0.9999999999999434,1,0.08434897661209106,0.9419910311698914,1,0.18264742195606232,0.8691197037696838,1,0.004118900706278583,0.9958810992937215,1
2763,2022/04/04右眼瞼下垂、複視を認め、精査加療のため当院に紹介され入院。,0 0 0 右眼瞼下垂 複視 認める 精査 加療 ため 院 紹介 する れる 入院,1,9.45830576384671e-08,0.9999999054169423,1,0.0005864851971983015,0.9994135148028017,1,0.005701320783456865,0.9942986792165431,1,6.386456696816367e-09,0.9999999936135433,1,0.08926896750926971,0.9393275380134583,1,0.19327589869499207,0.8771374821662903,1,0.00398452637469406,0.996015473625306,1
2764,2022/04/18または2022/04/19に、横紋筋融解症が発現し、入院。,0 0 0 0 0 0 横紋筋融解症 発現 入院,1,1.7259541827734006e-09,0.9999999982740457,1,0.0005296248743444747,0.9994703751256555,1,0.0035850669754408093,0.9964149330245592,1,6.439293542825908e-13,0.9999999999993561,1,0.08213747292757034,0.9459949135780334,1,0.18116454780101776,0.8699114322662354,1,0.0038941622656275296,0.9961058377343726,1
2765,2022/05/27 06:00下肢筋力低下を認め、横紋筋融解が発現した疑い。,0 0 0 0 0 下肢筋力低下 認める 横紋筋融解 発現 する た 疑い,1,2.3862209451148054e-08,0.9999999761377905,1,0.00048669541953691876,0.9995133045804631,1,0.0020473344217327716,0.9979526655782672,1,2.3314683517128287e-14,0.9999999999999767,1,0.08045828342437744,0.943213164806366,1,0.17829224467277527,0.8764488101005554,1,0.0038499285166049965,0.9961500714833951,1
2766,2022年7月16日接種後15分後より、咽頭違和感、呼吸困難と喘鳴が発現した。,0 年 0 月 0 日 接種 後 0分 後 咽頭違和感 呼吸困難 喘鳴 発現 する た,1,0.009923401004641655,0.9900765989953582,1,0.0004067515592710722,0.9995932484407289,1,0.017068447523997277,0.9829315524760027,1,0.11554556114314629,0.8844544388568537,1,0.07738928496837616,0.9451735615730286,1,0.18771107494831085,0.8780133724212646,1,0.00510610987183357,0.9948938901281665,1
2767,安静時重度の全身疾患を示す臨床徴候を示しており、摂氏37.3度の発熱があった。,安静 時 重度 全身 疾患 示す 臨床徴候 示す おる 摂氏 0 0度 発熱 ある た,1,0.016679745317531785,0.9833202546824682,1,0.00025526450552994945,0.9997447354944701,1,0.02967849153084512,0.9703215084691549,1,0.15886032949005047,0.8411396705099495,1,0.07773350924253464,0.9504214525222778,1,0.1769324690103531,0.8732088208198547,1,0.005720190062633492,0.9942798099373665,1
2768,患者は、1日3Lの水を飲み始め、体重は、次の12日間にわたって5kg減少した。,患者 0 日 0 L 水 飲む 始める 体重 次 0 日間 0kg 減少 する た,1,0.020896502128133775,0.9791034978718665,1,0.0003287820617220327,0.999671217938278,1,0.27613106684937816,0.7238689331506218,1,0.21262708983335799,0.787372910166642,1,0.13822980225086212,0.9128980040550232,1,0.20044364035129547,0.8628938794136047,1,0.011924646638017393,0.9880753533619826,1
2769,眼科受診で両眼の視力低下(右眼0.06、左眼1.2)、周辺視野の欠損を認めた。,眼科 受診 眼 視力低下 右 眼 0 0 左 眼 0 0 周辺 視野 の 欠損 認める た,1,8.306307050324048e-06,0.9999916936929496,1,0.0004935305658166214,0.9995064694341834,1,0.010970883906011308,0.9890291160939887,1,0.026919536765624863,0.9730804632343751,1,0.07348840683698654,0.9482715129852295,1,0.1887642741203308,0.8738185167312622,1,0.0041394148586570475,0.995860585141343,1
2770,"血小板2,000/μLと低下、免疫性血小板減少性紫斑病(ITP)と診断された。",血小板 0 0 μ L 低下 免疫性 血小板減少 性 紫斑病 ITP 診断 する れる た,1,0.005306953898459272,0.9946930461015406,1,0.00046850606145344974,0.9995314939385466,1,0.006861914951298509,0.9931380850487015,1,0.24586648137060918,0.7541335186293908,1,0.08826058357954025,0.9425835609436035,1,0.18113848567008972,0.8759359121322632,1,0.006482710907381562,0.9935172890926185,1
2771,現在はFT4、FT3はほぼ正常化するが、TRAb 21.5と高値が続いている。,現在 FT 0 FT 0 正常 化 する TRAb 0 0 高値 続く いる,1,0.2673973303354381,0.7326026696645616,0,0.0001609319349649167,0.9998390680650351,0,0.6637844826120587,0.3362155173879413,1,0.07208478171847899,0.927915218281521,1,0.14805668592453003,0.9014278054237366,1,0.25824907422065735,0.8382279276847839,1,0.03467335807845532,0.9653266419215447,1
2772,骨髄検査では血小板付着のない巨核球の増加を認め、免疫性血小板減少症と診断した。,骨髄 検査 血小板付着 ない 巨核球 増加 認める 免疫性 血小板減少症 診断 する た,1,0.016676256653474646,0.9833237433465254,1,0.0002984157751862708,0.9997015842248137,1,0.18127705946170103,0.818722940538299,1,0.20003429147529583,0.7999657085247042,1,0.08681391179561615,0.9421356320381165,1,0.19658507406711578,0.8710814118385315,1,0.008721139245075404,0.9912788607549247,1
2773,左手のひらと手指のしびれ・違和感、左大腿外側から下肢にしびれ・違和感を認めた。,左 手のひら 手指のしびれ 違和感 左 大腿 外側 下肢 しびれ 違和感 認める た,1,0.010310733848546494,0.9896892661514535,1,0.00039160085525266733,0.9996083991447473,1,0.036319577121847635,0.9636804228781524,1,0.012662964398649112,0.9873370356013509,1,0.07815854996442795,0.9449034333229065,1,0.19853080809116364,0.8677311539649963,1,0.004422686455122366,0.9955773135448776,1
2774,酸素15 L/分でもSpO2 70-80%となったため、挿管し、人工呼吸開始。,酸素 0 L 分 SpO 0 0 0% なる た ため 挿管 する 人工呼吸 開始,1,0.07026665351056283,0.9297333464894374,1,0.0002810273330739528,0.999718972666926,1,0.054588304817512756,0.9454116951824872,1,0.0002828860728911753,0.9997171139271088,1,0.33555102348327637,0.7888908982276917,1,0.23025596141815186,0.8430926203727722,1,0.008039321408904211,0.9919606785910958,1
2775,点滴管理し、頭部CT上左側頭部位に高吸収認め、脳出血疑いで他院救急外来へ搬送。,点滴 管理 する 頭部 CT 上 左側 頭部 位 吸収 認める 脳出血 疑い 他 院 救急外来 搬送,1,0.015766513253431504,0.9842334867465686,1,0.0003151725511291012,0.9996848274488709,1,0.011153471428937078,0.9888465285710629,1,1.5094814287408553e-11,0.9999999999849052,1,0.08943013846874237,0.9335800409317017,1,0.19390195608139038,0.8595420718193054,1,0.004255325130416836,0.9957446748695832,1
2776,入院後、モニターで5秒以上の心静止と失神再発を認め、ペースメーカー留置となる。,入院 後 モニター 0秒 以上 心静止 失神再発 認める ペースメーカー 留置 なる,1,0.016686549919395458,0.9833134500806044,1,0.0003400365143608802,0.9996599634856391,1,0.036247154115309654,0.9637528458846903,1,0.007221337228935143,0.9927786627710649,1,0.10372740030288696,0.9288821220397949,1,0.19937804341316223,0.8539579510688782,1,0.004684761632952037,0.9953152383670479,1
2777,針筋電図記録法による神経伝導速度研究の結果、比較的初期の末梢神経障害を示した。,針 筋電図 記録 法 神経伝導速度 研究 結果 初期 末梢神経障害 示す た,1,0.016671935151984542,0.9833280648480154,1,0.0002756796603811106,0.9997243203396189,1,0.23241737382932415,0.7675826261706759,1,0.009030767290942321,0.9909692327090577,1,0.2838957607746124,0.817186713218689,1,0.21239818632602692,0.847699761390686,1,0.009454162554710684,0.9905458374452893,1
2778,2021/08に患者は、別の病院を受診し、両眼眼瞼下垂、両眼複視が認められた。,0 0 患者 別 病院 受診 する 両眼眼瞼下垂 両眼複視 認める られる た,1,0.013009147060653436,0.9869908529393465,1,0.0003677561777634855,0.9996322438222365,1,0.03117157748292254,0.9688284225170775,1,0.0701742099903453,0.9298257900096547,1,0.0787893608212471,0.947242796421051,1,0.18463532626628876,0.87496018409729,1,0.004823919514075394,0.9951760804859245,1
2779,2022/06/04、胸痛が継続し、広範囲に増悪したため、救急搬送を依頼した。,0 0 0 胸痛 継続 する 広範囲 増悪 する た ため 救急搬送 依頼 する た,1,0.006603400165455657,0.9933965998345442,1,0.00034210514322174495,0.9996578948567783,1,0.037008666053303774,0.9629913339466962,1,0.10604021985642531,0.8939597801435747,1,0.07638201117515564,0.9477565288543701,1,0.18315134942531586,0.8722553849220276,1,0.005165935366644134,0.9948340646333559,1
2780,患者は未診断のIgA腎症があり、発熱(感染)を契機に顕在化した可能性があった。,患者 診断 IgA 腎症 ある 発熱 感染 契機 顕在 化 する た 可能性 ある た,1,0.005449253834862959,0.9945507461651368,1,0.00037331925016501364,0.999626680749835,1,0.009716287670667456,0.9902837123293325,0,0.6157872131110654,0.38421278688893457,1,0.08523795753717422,0.9483595490455627,1,0.22629360854625702,0.8426505923271179,1,0.014531099438663927,0.985468900561336,1
2781,2022/05/30より発熱を認め、以降労作時呼吸困難感が出現、増悪を認めた。,0 0 0 発熱 認める 以降 労作時呼吸 困難感 出現 増悪 認める た,1,1.1066405241136256e-08,0.9999999889335947,1,0.000766032673364756,0.9992339673266353,1,0.0022920615094902397,0.9977079384905098,1,0.0009707308759038247,0.9990292691240962,1,0.08151177316904068,0.9504624009132385,1,0.19086310267448425,0.8708412051200867,1,0.003907777461712512,0.9960922225382876,1
2782,壁運動異常と心筋臓逸脱酵素上昇により、ワクチン接種による急性心筋炎が疑われた。,壁運動異常 心筋 臓 逸脱 酵素 上昇 ワクチン接種 急性心筋炎 疑う れる た,1,0.016674019464204496,0.9833259805357956,1,0.0003344201211538953,0.9996655798788461,1,0.014632214973706037,0.985367785026294,1,0.07276945064245988,0.9272305493575401,1,0.08203588426113129,0.9474897384643555,1,0.18898947536945343,0.8707139492034912,1,0.004780785727392143,0.9952192142726078,1
2783,2021/11/09 01:20頃、下腹部痛を自覚し、病院へ救急搬送となった。,0 0 0 0 0 頃 下腹部痛 自覚 病院 救急搬送 なる た,1,0.012192310801637185,0.9878076891983628,1,0.0003815393733887345,0.9996184606266113,1,0.016975373159440754,0.9830246268405592,1,0.011873153141172987,0.988126846858827,1,0.07840140908956528,0.9491294026374817,1,0.18933038413524628,0.8723698258399963,1,0.004189720706289668,0.9958102792937104,1
2784,2022/03/16、被験者の発熱は下がったが咳、咽頭痛と鼻水の症状があった。,0 0 0 被験者 発熱 下がる た 咳 咽頭痛 鼻水 症状 ある た,1,0.01517580012447285,0.9848241998755269,1,0.0003383343114853186,0.9996616656885147,1,0.027767664940652637,0.9722323350593474,1,0.03111948992709268,0.9688805100729073,1,0.07137195020914078,0.9497967958450317,1,0.18101991713047028,0.8724637627601624,1,0.004402957557174749,0.9955970424428253,1
2785,2022/06/22 12:08、迷走神経反射疑い(報告のとおり)を発現した。,0 0 0 0 0 迷走神経反射 疑い 報告 とおり 発現 する た,1,1.2580493582671539e-05,0.9999874195064173,1,0.0004226309940125958,0.9995773690059874,1,0.004392013939509387,0.9956079860604906,1,0.13202485550054777,0.8679751444994522,1,0.09019571542739868,0.9441862106323242,1,0.18176458775997162,0.8718569278717041,1,0.005115361725840336,0.9948846382741597,1
2786,2022/06/23から、四肢脱力および握力低下を呈したが、歩行可能であった。,0 0 0 四肢脱力 握力低下 呈す た 歩行可能 だ ある た,1,0.016700382487087932,0.9832996175129122,1,0.0002977169635339882,0.999702283036466,1,0.10785086130411892,0.8921491386958811,1,0.4802787273090734,0.5197212726909266,1,0.0967993438243866,0.9372844696044922,1,0.1896492838859558,0.8748779296875,1,0.013184276208081557,0.9868157237919184,1
2787,2022/07/13から、食欲不振、吐き気が出現し、食事を摂取できなくなった。,0 0 0 食欲不振 吐き気 出現 食事 摂取 できる ない なる た,1,0.01668862061387696,0.983311379386123,1,0.00029091974198758216,0.9997090802580124,1,0.25189119000374394,0.7481088099962561,0,0.5670476379215932,0.43295236207840687,1,0.0756196677684784,0.9475142359733582,1,0.18710094690322876,0.8698453903198242,1,0.02017752047292907,0.9798224795270709,1
2788,2022/07/26発現、散瞳(死亡)、転帰「死亡」、「瞳孔散瞳」と記述された,0 0 0 発現 散瞳 死亡 転帰 死亡 瞳孔散瞳 記述 する れる た,1,4.777161995414955e-06,0.9999952228380047,1,0.00047602164858196545,0.999523978351418,1,0.01732392421733464,0.9826760757826654,1,0.1782164569794904,0.8217835430205096,1,0.07725401222705841,0.942543089389801,1,0.2567428946495056,0.8233469724655151,1,0.006433062067204746,0.9935669379327952,1
2789,5月30日(ワクチン接種2日後)、明け方就寝中、前胸部の痛みにて途中覚醒した。,0 月 0 日 ワクチン接種 0 日 後 明け方 就寝 中 胸部 痛み にる 途中覚醒 する た,1,0.016707355072621284,0.9832926449273788,1,0.0002799305384094797,0.9997200694615905,1,0.24636578578610713,0.7536342142138929,1,0.14997334959658914,0.8500266504034109,1,0.08448408544063568,0.944223165512085,1,0.20166811347007751,0.8704363107681274,1,0.008996749798943304,0.9910032502010567,1
2790,"Laboratory examination:筋偏差の高値を示した,注記:酵素",Laboratory examination 筋 偏差 高値 示す た 注記 酵素,1,0.020248924210099273,0.9797510757899007,1,0.0003392735221070482,0.999660726477893,1,0.10044312007786693,0.8995568799221331,1,1.9914421223177214e-09,0.9999999980085579,1,0.10646721720695496,0.9354314804077148,1,0.19214777648448944,0.8642265200614929,1,0.0051736983633574795,0.9948263016366424,1
2791,しかし、顕微鏡的血尿(高倍率視野で100を超える)と軽度の蛋白尿が認められた。,顕微鏡的血尿 倍率 視野 0 超える 軽度 蛋白尿 認める られる た,1,0.004727922607768866,0.9952720773922309,1,0.0003837136187072322,0.9996162863812927,1,0.019146961441570687,0.9808530385584293,1,0.06424784682514928,0.9357521531748507,1,0.08355097472667694,0.9505134224891663,1,0.18758036196231842,0.8719669580459595,1,0.004612619117891295,0.9953873808821088,1
2792,ホルダーECGは、上室性期外収縮11551拍(11.5%)と動悸ありを示した。,ホルダー ECG 上室性 期外収縮 0 拍 0 0% 動悸 ある 示す た,1,0.012224766797509747,0.9877752332024903,1,0.0003937183130351209,0.9996062816869649,1,0.16259106233429577,0.8374089376657042,1,0.039855547449340945,0.960144452550659,1,0.08237835764884949,0.9412212371826172,1,0.1875869333744049,0.8687531352043152,1,0.006000589545455445,0.9939994104545444,1
2793,ワクチン接種後2日後に心症状のため他院受診し胸部誘導にてST上昇が指摘された。,ワクチン接種 後 0 日 後 心症状 ため 他 院 受診 する 胸部誘導 ST 上昇 指摘 する れる た,1,2.338762845935442e-06,0.9999976612371541,1,0.0004641044667512699,0.9995358955332487,1,0.02361862698126793,0.9763813730187321,1,0.22913752648983032,0.7708624735101697,1,0.07983379811048508,0.9483810663223267,1,0.17672179639339447,0.8679136037826538,1,0.006347705814813644,0.9936522941851863,1
2794,患者は妊娠前の母体の曝露、切迫流産のために入院した(開始日:2021/07)。,患者 妊娠前 母体 曝露 切迫流産 ため 入院 する た 開始 日 0 0,1,0.011644339776638798,0.9883556602233613,1,0.00035324395059536706,0.9996467560494047,1,0.04745216300216881,0.9525478369978312,1,0.018313060227452715,0.9816869397725473,1,0.0939665287733078,0.9436421394348145,1,0.19558292627334595,0.8601738214492798,1,0.004684778334777548,0.9953152216652225,1
2795,事象「瓦せんべいで発疹が出た/全身に発疹」により、救急治療室への来院を要した。,事象 瓦せんべい だ 発疹 出る た 全身 発疹 救急 治療 室 来院 要す た,1,0.016719483242187305,0.9832805167578125,1,0.00036447927527616825,0.9996355207247238,1,0.22123053757629196,0.778769462423708,1,0.004216776559627378,0.9957832234403726,1,0.08186358958482742,0.9433578848838806,1,0.18083743751049042,0.8691000938415527,1,0.006276201251872725,0.9937237987481273,1
2796,症状は、発熱、ceph.、傾眠、尿閉、外転神経麻痺、顔面神経麻痺などであった。,症状 発熱 ceph 傾眠 尿閉 外転神経 麻痺 顔面神経 麻痺 だ ある た,1,0.01666235167438627,0.9833376483256135,1,0.00029676052798010253,0.9997032394720199,1,0.029552333861500468,0.9704476661384995,1,0.31226034127895064,0.6877396587210494,1,0.07548988610506058,0.948225736618042,1,0.20241886377334595,0.860622763633728,1,0.008054827973666887,0.9919451720263331,1
2797,心電図:(2021/11/26)ST上昇、メモ: VF V2から6でST上昇。,心電図 0 0 0 ST 上昇 メモ VF V 0 0 ST 上昇,1,0.023281706548925772,0.9767182934510743,1,0.00039838315398953844,0.9996016168460105,1,0.049036920773075754,0.9509630792269242,1,2.204902926905561e-13,0.9999999999997795,1,0.08494959771633148,0.9396970868110657,1,0.19217421114444733,0.867902934551239,1,0.004563723822599265,0.9954362761774007,1
2798,動悸、上室性期外収縮、疾患進行、脈拍異常の結果として、治療的な処置がとられた。,動悸 上室性 期外収縮 疾患進行 脈拍異常 結果 治療 的 だ 処置 とる れる た,1,0.01668632203644344,0.9833136779635566,1,0.0003661581987586062,0.9996338418012414,1,0.025462054269746792,0.9745379457302532,1,0.0962031988957377,0.9037968011042623,1,0.07953572273254395,0.944748044013977,1,0.20181922614574432,0.8641097545623779,1,0.005219775794198274,0.9947802242058017,1
2799,発熱、咽頭腫脹、体重減少、嚥下障害のため入院した(入院日: 2022/03)。,発熱 咽頭腫脹 体重減少 嚥下障害 ため 入院 する た 入院 日 0 0,1,7.600567285017023e-08,0.9999999239943272,1,0.0004760032926646933,0.9995239967073353,1,0.006535900857384536,0.9934640991426155,1,0.021936900532414372,0.9780630994675856,1,0.07899867743253708,0.9476385116577148,1,0.17875586450099945,0.8707370758056641,1,0.004059113583876276,0.9959408864161238,1
2800,臨床症状/所見:2021/11/26、急性発症の胸痛または胸部圧迫感を呈した。,臨床症状 所見 0 0 0 急性発症 の 胸痛 胸部圧迫感 呈す た,1,0.016687356337748174,0.9833126436622517,1,0.000396675681975801,0.9996033243180242,1,0.016708654885313146,0.9832913451146869,1,2.8830333979157352e-05,0.9999711696660208,1,0.07458634674549103,0.9488672614097595,1,0.18842880427837372,0.8758304119110107,1,0.004094370640041983,0.9959056293599581,1
2801,自覚症状は倦怠感や易疲労感は続いているものの、日常生活はほぼ通常にできている。,自覚症状 倦怠感 易疲労感 続く いる 日常生活 通常 できる いる,1,0.016700822507951258,0.9832991774920489,1,0.00022729543740747485,0.9997727045625925,1,0.21645404932743673,0.7835459506725633,1,0.024172059318537498,0.9758279406814625,1,0.11076632887125015,0.9258785843849182,1,0.2934042811393738,0.8184490203857422,1,0.007962257868744495,0.9920377421312555,1
2802,2021/08/16-2021/09/02、患者は丘疹性皮疹のため入院した。,0 0 0 0 0 0 患者 丘疹性 皮疹 ため 入院 する た,1,0.009792952064323636,0.9902070479356763,1,0.0003201182048317011,0.9996798817951683,1,0.02664215123637348,0.9733578487636265,1,0.13831317336295956,0.8616868266370404,1,0.07930955290794373,0.948258638381958,1,0.1800258457660675,0.8721314072608948,1,0.005427049371632033,0.9945729506283679,1
2803,2021/10/08-2021/11/01、患者は麻疹様発疹のため入院した。,0 0 0 0 0 0 患者 麻疹 様 発疹 ため 入院 する た,1,0.005536808628444881,0.9944631913715551,1,0.0002770634306469667,0.9997229365693531,1,0.02097825368472017,0.9790217463152798,1,0.15392848205283982,0.8460715179471602,1,0.07778584957122803,0.9494286179542542,1,0.18174925446510315,0.8658899068832397,1,0.00551725548565991,0.99448274451434,1
2804,2021/12/17(ワクチン接種15日後)、症状の増悪があり入院となった。,0 0 0 ワクチン接種 0 日 後 症状 増悪 ある 入院 なる た,1,0.014591049778586582,0.9854089502214135,1,0.0004488623748633538,0.9995511376251367,1,0.03282747400852093,0.9671725259914791,1,0.03433087685544234,0.9656691231445577,1,0.07062923163175583,0.952350378036499,1,0.18930697441101074,0.8687365651130676,1,0.0045108248869552645,0.9954891751130447,1
2805,2022/04/18フォークト・小柳・原田病、両側軽度難聴と診断され、入院。,0 0 0 フォークト・小柳・原田病 両側軽度難聴 診断 する れる 入院,1,2.790005411801425e-06,0.9999972099945882,1,0.00041877995204670567,0.9995812200479532,1,0.012865198475357054,0.987134801524643,1,3.989737429321849e-10,0.9999999996010263,1,0.08844581991434097,0.9418964385986328,1,0.18499283492565155,0.8777762055397034,1,0.003991214723185956,0.9960087852768139,1
2806,2022/04/22 12:00発熱、倦怠感、けいれん、末梢神経障害が発現。,0 0 0 0 0 発 熱 倦怠感 けいれん 末梢神経障害 発現,1,3.8113682973927577e-07,0.9999996188631702,1,0.0003894632812773908,0.9996105367187226,1,0.005970226846494064,0.9940297731535059,1,1.192379528447418e-13,0.9999999999998808,1,0.08276444673538208,0.944883406162262,1,0.18339793384075165,0.8741570115089417,1,0.003910554437311632,0.9960894455626883,1
2807,2022/07/10 06:00頃体温38°C台となりアンヒバ坐薬にて対処。,0 0 0 0 0 頃 体温 0 C 台 なる アン ヒバ 坐薬 対処,1,0.009657117699167014,0.9903428823008331,1,0.00029075190440134733,0.9997092480955987,1,0.19695010280517244,0.8030498971948276,1,6.249113415623953e-08,0.9999999375088658,1,0.32905104756355286,0.7914665937423706,1,0.21592219173908234,0.8410333395004272,1,0.009250990328692268,0.9907490096713079,1
2808,2022年5月12日業務中14:30頃、意識消失と左上肢けいれん、救急要請。,0 年 0 月 0 日 業務 中 0 0 頃 意識消失 左上肢けいれん 救急 要請,1,0.016689549104215037,0.983310450895785,1,0.00026102363283762425,0.9997389763671624,1,0.2176927302160241,0.7823072697839759,1,3.247713209475478e-11,0.9999999999675229,1,0.08495303243398666,0.9391055107116699,1,0.19079862534999847,0.8648377656936646,1,0.006312411955511603,0.9936875880444884,1
2809,2022年7月4日腹痛出現(心窝部主体) 2022年7月5日頃腹痛のピーク。,0 年 0 月 0 日 腹痛 出現 心 窝部 主体 0 年 0 月 0 日 頃 腹痛 ピーク,1,0.01669670276655913,0.9833032972334408,1,0.0003293598594027794,0.9996706401405973,1,0.013871019153977926,0.9861289808460221,1,0.0,1.0,1,0.09632599353790283,0.9437763690948486,1,0.19149699807167053,0.8728652000427246,1,0.0042060164083000725,0.9957939835916999,1
2810,フォークト・小柳・原田病および漿液性網膜剥離の結果として治療処置が行われた。,フォークト・小柳・原田病 漿液性 網膜剥離 結果 治療 処置 行う れる た,1,0.016687060750757723,0.9833129392492422,1,0.00030634400859997035,0.9996936559914,1,0.11023159353021328,0.8897684064697867,1,0.30431003495617037,0.6956899650438296,1,0.11731433123350143,0.9156152606010437,1,0.22306841611862183,0.8529893159866333,1,0.01030108274051497,0.989698917259485,1
2811,画像上でアテローム性A to A及び脱水による血行力学性の脳梗塞を疑い入院。,画像 上 だ アテローム性 A TO A 脱水 血行 力学 性 脳梗塞 疑い 入院,1,0.003567394091053435,0.9964326059089466,1,0.00035681292013607657,0.9996431870798639,1,0.01768766922721765,0.9823123307727823,1,2.2148149980694143e-10,0.9999999997785185,1,0.10500005632638931,0.9296178221702576,1,0.19006142020225525,0.8697309494018555,1,0.004231056410027117,0.9957689435899728,1
2812,原因究明のため病理解剖を勧めたが希望されず、直接の死因は急性心臓死となった。,原因 究明 ため 病理解剖 勧める た 希望 する れる ぬ 直接 死因 急性 心臓 死 なる た,1,0.01668180280532961,0.9833181971946704,1,0.0002595893924729253,0.999740410607527,1,0.1653823827600337,0.8346176172399663,1,0.035024706611353706,0.9649752933886463,1,0.1022946760058403,0.9206574559211731,1,0.2779904901981354,0.7859902381896973,1,0.007452942048103401,0.9925470579518966,1
2813,現在は、頭頂部と前頭部の脱毛は回復したが、後頭部には円形脱毛症が残っている。,現在 頭頂 部 頭部 脱毛 回復 する た 後頭部 円形脱毛症 残る いる,1,0.01666993097444442,0.9833300690255554,1,0.0002388316425528494,0.9997611683574471,0,0.6220371168494052,0.3779628831505948,1,0.01479272946390675,0.9852072705360932,1,0.21996499598026276,0.8580348491668701,1,0.3359456956386566,0.7877307534217834,1,0.022261626889990938,0.9777383731100091,1
2814,心電図にてII、III、aVF、V2-6誘導でST上昇を伴う洞調律を認めた。,心電図 II III aVF V 0 0 誘導 ST 上昇 伴う 洞調律 認める た,1,3.4400450120760397e-06,0.9999965599549879,1,0.0004953454092927247,0.9995046545907073,1,0.005390328348442108,0.9946096716515579,1,0.006824040299920231,0.9931759597000798,1,0.08038631081581116,0.9456908702850342,1,0.18772944808006287,0.8744717240333557,1,0.003963641740002147,0.9960363582599978,1
2815,"生来健康な21歳男性が本剤の2回目接種2日後に胸痛を発症し,救急搬送された。",健康 だ 0歳 男性 本 剤 0回目 接種 0 日 後 胸痛 発症 救急搬送 する れる た,1,0.015135629243250662,0.9848643707567493,1,0.0003742015545967927,0.9996257984454032,1,0.031900613786522314,0.9680993862134777,1,0.18554336750849032,0.8144566324915097,1,0.08246579766273499,0.9446945786476135,1,0.1827964037656784,0.8658896088600159,1,0.006185059653817836,0.9938149403461822,1
2816,大動脈や冠状動脈で一部プラークが観察されたが、硬化狭窄等は観察されなかった。,大動脈 冠状 動脈 一部 プラーク 観察 する れる た 硬化 狭窄等 観察 する れる ない た,1,0.01667729592430339,0.9833227040756968,1,0.00016233014519931546,0.9998376698548007,0,0.8229208652097714,0.17707913479022863,0,0.9357695918911674,0.06423040810883263,0,0.9386588335037231,0.09660724550485611,0,0.8125882744789124,0.20192191004753113,1,0.7318007530891575,0.26819924691084257,1
2817,転倒時に受傷したと思われる左上瞼の直径10 mm切創及び左肩の打撲を認めた。,転倒 受傷 する た 思う れる 左上 瞼 直径 0 mm 切創 左肩 打撲 認める た,1,0.0048881759556164035,0.9951118240443836,1,0.000390983245513674,0.9996090167544863,1,0.04039109524996032,0.9596089047500397,1,0.009290429815627999,0.990709570184372,1,0.07947219908237457,0.9450162649154663,1,0.18446587026119232,0.8727594614028931,1,0.004303918057387443,0.9956960819426126,1
2818,日付不明(2022年01月07日以降)、耳鳴り、閉塞感を伴うめまいが起きた。,日付 不明 0 年 0 月 0 日 以降 耳鳴り 閉塞感 伴う めまい 起きる た,1,0.01670418902355419,0.9832958109764458,1,0.0003074391739069799,0.999692560826093,1,0.18889101477225478,0.8111089852277452,1,0.0003644340278697866,0.9996355659721302,1,0.07697536796331406,0.9474173188209534,1,0.18446460366249084,0.8709041476249695,1,0.00579846136490325,0.9942015386350967,1
2819,日付不明(2022年01月07日以降)、生理2週間前、HAE発作が頻発した。,日付 不明 0 年 0 月 0 日 以降 生理 0 週間 前 HAE 発作 頻発 する た,1,0.0351640097248554,0.9648359902751448,1,0.00021808780177716848,0.9997819121982229,1,0.32201239011440563,0.6779876098855944,1,0.09247057573737505,0.907529424262625,1,0.08234592527151108,0.9450523853302002,1,0.1941557228565216,0.8765138983726501,1,0.009514912471540673,0.9904850875284593,1
2820,日付不明網膜血管造影:網膜周辺の無灌流領域並びに血管の漏出及び破壊を示した。,日付 不明 網膜 血管造影 網膜 周辺 灌流 領域 血管 漏出 破壊 示す た,1,0.016681160135943607,0.9833188398640564,1,0.00032416612834866,0.9996758338716514,1,0.31272538682028195,0.687274613179718,1,0.061521551411252595,0.9384784485887474,1,0.11136897653341293,0.9285030364990234,1,0.19238251447677612,0.8727567791938782,1,0.008880266362818221,0.9911197336371818,1
2821,入院精査するも原因不明のまま退院したが退院2日後に胸痛あり救急受診となった。,入院 精査 する 原因 不明 まま 退院 する た 退院 0 日 後 胸痛 ある 救急 受診 なる た,1,0.016691945791166538,0.9833080542088337,0,9.980488465380233e-05,0.9999001951153462,1,0.20007190522610052,0.7999280947738995,1,0.04212448244882072,0.9578755175511793,1,0.07977885752916336,0.9441457986831665,1,0.18485458195209503,0.8538778424263,1,0.006591153577579598,0.9934088464224203,1
2822,腹痛発作時は内部からナイフでつつかれ内臓を引き上げられる感じがするほど痛む。,腹痛 発作 時 内部 ナイフ だ つ つかれ 内臓 引き上げる られる 感じ する 痛む,1,0.01667383422246678,0.9833261657775332,1,0.0002873214541289276,0.9997126785458711,1,0.30590242660428535,0.6940975733957147,1,5.258823353337938e-06,0.9999947411766467,1,0.10750563442707062,0.9390823841094971,1,0.2259119600057602,0.8552349805831909,1,0.008040730676640562,0.9919592693233595,1
2823,薬剤性肺炎を疑い、ステロイド治療が開始され、2022/05/07に退院した。,薬剤性 肺炎 疑う ステロイド 治療 開始 する れる 0 0 0 退院 する た,1,0.016716980933039992,0.9832830190669599,1,0.00021181090268547175,0.9997881890973145,1,0.1879232304770928,0.8120767695229072,0,0.8212886721045337,0.17871132789546632,1,0.15650305151939392,0.8828959465026855,1,0.35485947132110596,0.7510727047920227,1,0.0443480626613724,0.9556519373386276,1
2824,2021/12/24、運動麻痺、感覚異常、深部腱反射の変化、尿閉が発現した。,0 0 0 運動麻痺 感覚異常 深部腱反射 変化 尿閉 発現 する た,1,0.00346016479940064,0.9965398352005994,1,0.00031306223248194555,0.999686937767518,1,0.018951109761968343,0.9810488902380317,1,0.12982331317021512,0.8701766868297849,1,0.07685267925262451,0.9482936859130859,1,0.1865832507610321,0.87724369764328,1,0.005183869437488224,0.9948161305625117,1
2825,脳脊髄液検査にて蛋白細胞解離を認めたため、ギラン・バレー症候群と診断された。,脳脊髄液 検査 蛋白細胞解離 認める た ため ギラン・バレー症候群 診断 する れる た,1,0.003501803774344257,0.9964981962256557,1,0.0004238705711128968,0.9995761294288871,1,0.01578013364199149,0.9842198663580085,1,0.037329278858160064,0.9626707211418399,1,0.09699977189302444,0.9377442598342896,1,0.18562735617160797,0.8691889643669128,1,0.004450688193938869,0.9955493118060611,1
2826,2021/09、時刻不明、患者は起立性調節障害と体位性頻脈症候群を発現した。,0 0 時刻 不明 患者 起立性 調節障害 体位性頻脈 症候群 発現 する た,1,0.022841461596470214,0.97715853840353,1,0.00025655774374591834,0.9997434422562541,1,0.017356809568040976,0.982643190431959,1,0.11493199323160963,0.8850680067683904,1,0.09784231334924698,0.9422329068183899,1,0.18961742520332336,0.870354413986206,1,0.005408534276862222,0.9945914657231378,1
2827,2022/06/07から2021/06/08まで、患者は脱水のため入院した。,0 0 0 0 0 0 患者 脱水 ため 入院 する た,1,2.760902162427499e-07,0.9999997239097838,1,0.0004526622889489401,0.9995473377110511,1,0.018866138766235552,0.9811338612337644,1,0.08878047988065707,0.9112195201193429,1,0.07886995375156403,0.947616457939148,1,0.18147216737270355,0.8706148266792297,1,0.004764958759421131,0.9952350412405789,1
2828,胸椎MRIでは7椎体程に及ぶT2高信号域が認められ、横断性脊椎炎が疑われた。,胸椎 MRI 0 椎 体 及ぶ T 0 高信号域 認める られる 横断性脊椎炎 疑う れる た,1,0.0050870854774539885,0.994912914522546,1,0.00036079121505953594,0.9996392087849405,1,0.015069189609527411,0.9849308103904726,1,0.08975002725875425,0.9102499727412457,1,0.08520399779081345,0.9465198516845703,1,0.19133491814136505,0.865344762802124,1,0.004894232733908006,0.9951057672660919,1
2829,ST変化の対側性変化(ST低下)を認めない誘導全般におけるPR低下がみられた,ST 変化 対 側 性 変化 ST 低下 認める ない 誘導 全般 PR 低下 みる られる た,1,0.06726508061423962,0.9327349193857604,1,0.00031502301040387486,0.9996849769895961,1,0.02328725205306037,0.9767127479469396,1,0.07525198151137802,0.924748018488622,1,0.09120099246501923,0.9451557397842407,1,0.1964435577392578,0.8609833121299744,1,0.005561801827258681,0.9944381981727414,1
2830,2021/06/21(ワクチン接種1日後)、摂氏38.4度の発熱が出現した。,0 0 0 ワクチン接種 0 日 後 摂氏 0 0度 発熱 出現 する た,1,4.417242369543437e-06,0.9999955827576303,1,0.0004968871607299748,0.9995031128392701,1,0.00648540273750331,0.9935145972624967,1,0.07257926521925362,0.9274207347807464,1,0.07638564705848694,0.9520339369773865,1,0.18194328248500824,0.8754370212554932,1,0.004451688969023142,0.9955483110309769,1
2831,2021/07/23(ワクチン接種の2日後)、患者は左顔面違和感を発現した。,0 0 0 ワクチン接種 0 日 後 患者 左顔面違和感 発現 する た,1,0.01670278426663972,0.9832972157333603,1,0.00036470568764193227,0.9996352943123581,1,0.009700427435965553,0.9902995725640344,1,0.05284020662135891,0.9471597933786411,1,0.0833149403333664,0.9488080143928528,1,0.19277772307395935,0.873147189617157,1,0.0045564423464155976,0.9954435576535845,1
2832,2021/09/12(ワクチン接種2日後)、患者は好酸球性心筋炎を発症した。,0 0 0 ワクチン接種 0 日 後 患者 好酸球性 心筋炎 発症 する た,1,0.007992098887108199,0.9920079011128919,1,0.00042497932702000377,0.99957502067298,1,0.02199127286027469,0.9780087271397253,1,0.01692286056349035,0.9830771394365097,1,0.08037099987268448,0.9452595710754395,1,0.1888502538204193,0.8636497855186462,1,0.004299166492152074,0.995700833507848,1
2833,2021/09/25(ワクチン接種から6ヵ月9日後)、事象のために入院した。,0 0 0 ワクチン接種 0 ヵ月 0 日 後 事象 ため 入院 する た,1,0.016699277621900235,0.9833007223780996,1,0.00027881092587156534,0.9997211890741284,1,0.02328717942756231,0.9767128205724377,1,0.11939010614930645,0.8806098938506935,1,0.11373142898082733,0.9318931698799133,1,0.1897483915090561,0.8642377853393555,1,0.005633693521106805,0.9943663064788932,1
2834,2022/02/25に再診時、右耳介に痂皮があり、水疱の治癒過程と思われた。,0 0 0 再診 時 右 耳介 痂皮 ある 水疱 の 治癒過程 思う れる た,1,0.016694342014499427,0.9833056579855005,1,0.00035113913627900483,0.999648860863721,1,0.10815727595609914,0.8918427240439009,1,0.16462172338359782,0.8353782766164022,1,0.08681568503379822,0.943559467792511,1,0.24404622614383698,0.8400774598121643,1,0.00759134601747284,0.9924086539825272,1
2835,2022/05/27、午前10時接種、同日夕から全身の発赤と発熱を発現した。,0 0 0 午前0時 接種 同日 夕 全身 発赤 発熱 発現 する た,1,8.94916282300383e-06,0.999991050837177,1,0.0004021654635157029,0.9995978345364843,1,0.008151714521387299,0.9918482854786127,1,0.11900295568689367,0.8809970443131063,1,0.08272223174571991,0.9486771821975708,1,0.18352164328098297,0.8772082924842834,1,0.004944562174020655,0.9950554378259794,1
2836,2022/07/19 09:00、ワクチン接種翌日に顔面神経麻痺を発現した。,0 0 0 0 0 ワクチン接種 翌日 顔面神経 麻痺 発現 する た,1,0.002521368406091069,0.997478631593909,1,0.0004827041500225123,0.9995172958499775,1,0.00719758523505698,0.992802414764943,1,0.06630428705932712,0.9336957129406729,1,0.08063548803329468,0.9503347873687744,1,0.18479274213314056,0.8765739798545837,1,0.004458525638799124,0.995541474361201,1
2837,20分ほど後症状改善したため、座位にて一口水分摂取数回するが、嘔気を訴えた。,0分 後症状 改善 する た ため 座位 一 口 水分摂取 数回 する 嘔気 訴える た,1,0.18498252447771313,0.8150174755222869,1,0.00018231274445084118,0.9998176872555492,1,0.21646987407202423,0.7835301259279758,1,0.0005644729312392904,0.9994355270687607,1,0.09702584147453308,0.9411682486534119,1,0.5034742951393127,0.6496738195419312,1,0.014980035477147368,0.9850199645228526,1
2838,7/1に、SpO2 =60%台となり」、「発熱」は救急治療室の受診を要した。,0 0 SpO 0 0% 台 なる 発熱 救急 治療 室 受診 要す た,1,0.0031263791545134458,0.9968736208454866,1,0.0006981715563262038,0.9993018284436738,1,0.01549017889589277,0.9845098211041072,1,0.0076715097004519395,0.9923284902995481,1,0.07417786121368408,0.9532403945922852,1,0.17679205536842346,0.8760939240455627,1,0.003972449848009035,0.9960275501519908,1
2839,ワクチン接種後7日目、尿蛋白/クレアチニン比が1.99 g/gまで上昇した。,ワクチン接種 後 0 日 目 尿蛋白 クレアチニン 比 0 0 g g 上昇 する た,1,0.016680403171576517,0.9833195968284236,1,0.0003167483219501701,0.9996832516780498,1,0.04216139544845299,0.957838604551547,1,0.1963353771596018,0.8036646228403982,1,0.10614031553268433,0.934395432472229,1,0.1852066069841385,0.8746781945228577,1,0.00664819923163093,0.993351800768369,1
2840,夕方頃に、徐々に胸部正中部に押さえられるような疼痛を自覚し、近医を受診した。,夕方 頃 胸部 中部 押さえる られる よう 疼痛 自覚 近医 受診 する た,1,0.011089105825256901,0.9889108941747431,1,0.00041269534696924053,0.9995873046530308,1,0.010496979268789786,0.9895030207312102,1,0.16138148919701634,0.8386185108029837,1,0.08135107904672623,0.9476562738418579,1,0.18968595564365387,0.8594589233398438,1,0.005656273735207797,0.9943437262647922,1
2841,2021/06/14(ワクチン接種11日後)、ギラン・バレ症候群を発症した。,0 0 0 ワクチン接種 0 日 後 ギラン バレる 症候群 発症 する た,1,0.01668559208226486,0.9833144079177352,1,0.00039779699016656166,0.9996022030098335,1,0.04121398054675929,0.9587860194532407,1,0.04872526496074503,0.951274735039255,1,0.0809980034828186,0.9472426176071167,1,0.18310557305812836,0.8724043965339661,1,0.004765868794329554,0.9952341312056704,1
2842,SARS-CoV-2検査:(2022/02/24)陽性、メモ:正常値:陰性。,SARS CoV 0 検査 0 0 0 陽性 メモ 正常 値 陰性,0,0.6659619490872392,0.33403805091276084,0,0.0001537416898628019,0.9998462583101372,0,0.8619694006446434,0.1380305993553566,0,0.9999999864782844,1.3521715595241366e-08,0,0.8428168892860413,0.19847451150417328,1,0.5547513365745544,0.6165174841880798,1,0.8373642857629551,0.16263571423704498,1
2843,11:00には意識レベルがJCS III-200くらいにレベルダウンした。,0 0 意識レベル JCS III 0 レベル ダウン する た,1,0.25507744503810875,0.7449225549618913,1,0.0002106284886826179,0.9997893715113174,1,0.3533345469092234,0.6466654530907766,0,0.6317933550007804,0.3682066449992197,0,0.8697951436042786,0.15202659368515015,1,0.19246581196784973,0.8647043108940125,1,0.18639028583288836,0.8136097141671116,1
2844,2021/10/15低酸素血症、KL-6 489 U/mLの上昇を認めた。,0 0 0 低酸素血症 KL 0 0 U mL 上昇 認める た,1,5.4011651213374385e-06,0.9999945988348786,1,0.0004668348658558788,0.9995331651341441,1,0.01207196036759961,0.9879280396324004,1,0.01538032983406945,0.9846196701659305,1,0.08031404763460159,0.9468042254447937,1,0.1825886070728302,0.8761322498321533,1,0.00405320961482283,0.9959467903851772,1
2845,2022/03/09(ワクチン接種1日後)ごろ、急性心不全の疑いを認めた。,0 0 0 ワクチン接種 0 日 後 ごろ 急性心不全 疑い 認める た,1,0.004304570237607686,0.9956954297623922,1,0.00048519711970836717,0.9995148028802916,1,0.006820175762229708,0.9931798242377703,1,0.006391186877509614,0.9936088131224904,1,0.0757281556725502,0.9489332437515259,1,0.18164008855819702,0.8749580979347229,1,0.003948273335838947,0.9960517266641611,1
2846,2022/03/25-2022/03/26近医にて食欲不振のため点滴施行。,0 0 0 0 0 0 近医 にる 食欲不振 ため 点滴 施行,1,0.016688162483213337,0.9833118375167864,1,0.00026929747785094257,0.999730702522149,1,0.21174670815126018,0.7882532918487398,1,0.0257188104271725,0.9742811895728275,1,0.15448786318302155,0.9156903028488159,1,0.18665899336338043,0.8671185374259949,1,0.007154624357369432,0.9928453756426305,1
2847,2022/07/04、足趾先端の痺れ出現し、足関節以遠の筋力低下も認めた。,0 0 0 足 趾先 端 痺れ 出現 足関節 以遠 筋力低下 認める た,1,2.2034412758476054e-06,0.9999977965587241,1,0.0004211347398128505,0.9995788652601871,1,0.010326206764158408,0.9896737932358416,1,0.01332198026095599,0.986678019739044,1,0.07622746378183365,0.9450740814208984,1,0.1938260942697525,0.8764469623565674,1,0.004056684072242657,0.9959433159277574,1
2848,2022/07/10 18:30(ワクチン接種の9時間後)、発熱があった。,0 0 0 0 0 ワクチン接種 0時 間 後 発熱 ある た,1,0.015347729684196402,0.9846522703158035,1,0.00032916383553139374,0.9996708361644686,1,0.015754201952768443,0.9842457980472316,1,0.07905312981195756,0.9209468701880424,1,0.07794970273971558,0.9493541121482849,1,0.18607546389102936,0.8643598556518555,1,0.00482686109874022,0.9951731389012598,1
2849,2022年4月30日A院で左穿刺後肩関節周囲炎(SIRVA)と診断された。,0 年 0 月 0 日 A 院 左 穿刺 後 肩関節周囲炎 SIRVA 診断 する れる た,1,0.020900164776030714,0.9790998352239692,1,0.000354830277520411,0.9996451697224796,1,0.06509575130990175,0.9349042486900982,1,0.2405279855521325,0.7594720144478675,1,0.11475005000829697,0.9318749904632568,1,0.18013271689414978,0.8769534826278687,1,0.007689439400483812,0.9923105605995161,1
2850,CMR画像所見は、臨床背景及びCMR基準による急性心筋炎の診断を裏付けた。,CMR 画像所見 臨床 背景 CMR 基準 急性心筋炎 の 診断 裏付ける た,1,0.0092976039774283,0.9907023960225715,1,0.000344725384847029,0.999655274615153,1,0.04004376121409703,0.959956238785903,1,0.12614840061535815,0.8738515993846419,1,0.13214527070522308,0.9194245338439941,1,0.20404501259326935,0.8564856648445129,1,0.006132198114047947,0.9938678018859521,1
2851,X-15日に近医を受診し血尿2+蛋白尿1.05 g/gCreを指摘された。,X 0 日 近医 受診 する 血尿 0 蛋白尿 0 0 g gCre 指摘 する れる た,1,0.018366497711870187,0.9816335022881296,1,0.00044193328087562277,0.9995580667191244,1,0.08723029235397561,0.9127697076460244,1,0.2763373701549715,0.7236626298450285,1,0.07435078173875809,0.9490410685539246,1,0.1816420704126358,0.8772176504135132,1,0.008118053549584916,0.991881946450415,1
2852,しかし物体の動きが速いと残像を認めて、焦点が合うのが遅れるとのことだった。,物体 動き 速い 残像 認める 焦点 合う の 遅れる こと だ た,1,0.01668964713895908,0.9833103528610411,1,0.0003150055574650644,0.9996849944425349,1,0.03291937279628632,0.9670806272037137,0,0.558317397229565,0.44168260277043503,1,0.12461767345666885,0.9070820808410645,1,0.22331765294075012,0.8397642374038696,1,0.015031996221804202,0.9849680037781958,1
2853,患者は亜急性甲状腺炎及び甲状腺中毒性周期性四肢麻痺のため、7日間入院した。,患者 亜急性 甲状腺炎 甲状腺 中毒性 周期性四肢麻痺 ため 0 日間 入院 する た,1,0.0040390999749328575,0.9959609000250672,1,0.0003494712635736311,0.9996505287364263,1,0.05692368798469061,0.9430763120153094,1,0.17495636826715066,0.8250436317328493,1,0.07957902550697327,0.9427313208580017,1,0.19405212998390198,0.8652325868606567,1,0.006294307050048671,0.9937056929499514,1
2854,患者は蜂巣炎(リンパ浮腫部位の蜂巣炎)(重篤区分:医学的に重要)を呈した。,患者 蜂巣炎 リンパ 浮腫部位 の 蜂巣炎 重篤 区分 医学 的 重要 呈す た,1,0.011300516672914103,0.9886994833270857,1,0.000465766072586207,0.9995342339274138,1,0.05508806652013121,0.9449119334798688,1,0.00238447041853429,0.9976155295814657,1,0.0974036380648613,0.9392199516296387,1,0.23438067734241486,0.8417940139770508,1,0.004913945628337717,0.9950860543716623,1
2855,血圧140/70、脈120/分、体温40.2°Cの発熱、SpO2 80%。,血圧 0 0 脈 0 分 体温 0 0 C 発熱 SpO 0 0%,1,0.007831181414050334,0.9921688185859496,1,0.000320892678591981,0.999679107321408,1,0.022491204791569408,0.9775087952084306,1,0.0005328535530504386,0.9994671464469496,1,0.09021075069904327,0.9445472359657288,1,0.2021198719739914,0.8543075919151306,1,0.004302822627040051,0.99569717737296,1
2856,"採血検査でCRP3.5lmg/dL,赤沈89mmと炎症反応は高値であった。",採血 検査 CRP 0 0 lmg dL 赤沈 0mm 炎症反応 高値 だ ある た,1,0.25850857698757423,0.7414914230124258,1,0.00024013848991089393,0.9997598615100891,1,0.2061200532564189,0.7938799467435811,0,0.5500357675807814,0.4499642324192186,1,0.0949636921286583,0.9342856407165527,1,0.19653654098510742,0.863269031047821,1,0.029995732017221482,0.9700042679827786,1
2857,市販の痛み止めを飲んでいて、ある程度は効いたが、効果が切れると痛くなった。,市販 痛み 止め 飲む いる 効く た 効果 切れる 痛く なる た,1,0.016690396810799882,0.9833096031892001,1,0.00020917108847553166,0.9997908289115245,1,0.15249732502771618,0.8475026749722838,1,0.17640275056323262,0.8235972494367674,1,0.2637655735015869,0.8257653117179871,1,0.30818837881088257,0.8079306483268738,1,0.012491425624508034,0.9875085743754921,1
2858,主に末梢肺野における多巣性の拡張した気管支、両側のすりガラス陰影及び硬化。,主 末梢 肺 野 多巣性 拡張 する た 気管支 両側 すりガラス陰影 硬化,1,0.016688758788369444,0.9833112412116307,1,0.00038133654869698837,0.999618663451303,1,0.36432345500221197,0.635676544997788,1,1.01661710727452e-06,0.9999989833828927,1,0.09703201800584793,0.9271197319030762,1,0.21812482178211212,0.8577503561973572,1,0.008951661843529971,0.9910483381564701,1
2859,水痘・帯状疱疹ウイルス抗原キットにて検査を行い、陽性であり帯状疱疹と診断。,水痘 帯状疱疹ウイルス 抗原 キット 検査 行う 陽性 だ ある 帯状疱疹 診断,1,0.012877296392254215,0.9871227036077458,1,0.000359032157614594,0.9996409678423854,1,0.01039089974232621,0.9896091002576738,1,8.808320057895891e-06,0.9999911916799421,1,0.13019604980945587,0.9280980825424194,1,0.21396851539611816,0.86533522605896,1,0.00448734478838467,0.9955126552116152,1
2860,造影コンピュータ断層撮影にて左内頚静脈血栓及び末梢性肺血栓塞栓症を認めた。,造影 コンピュータ断層撮影 左内頚静脈血栓 末梢 性 肺血栓 塞栓症 認める た,1,0.003834292274499068,0.996165707725501,1,0.0004933358845453478,0.9995066641154546,1,0.011845086555826945,0.988154913444173,1,0.009760887747495062,0.9902391122525049,1,0.0766233503818512,0.9372429847717285,1,0.19410203397274017,0.8682477474212646,1,0.004140052586200377,0.9958599474137997,1
2861,日付不明2回目接種後に症状が出て、病院を受診し、急性甲状腺炎と診断された。,日付 不明 0回目 接種 後 症状 出し手 病院 受診 する 急性甲状腺炎 診断 する れる た,1,0.01668936723700156,0.9833106327629983,1,0.0003202166269802208,0.9996797833730198,1,0.0546890270088366,0.9453109729911634,1,0.22549582571033655,0.7745041742896634,1,0.08679033815860748,0.946758508682251,1,0.17858503758907318,0.870660662651062,1,0.006980325539490088,0.9930196744605098,1
2862,入院後に延髄梗塞併発あり、C-ANCA・P-ANCA陽性、血清M蛋白検出。,入院 後 延髄梗塞 併発 ある C ANCA P-A NCA 陽性 血清 M 蛋白検出,1,1.1623645083814984e-05,0.9999883763549162,1,0.00043417856575168553,0.9995658214342483,1,0.012615825915180956,0.987384174084819,1,0.16818479301006395,0.831815206989936,1,0.09066537022590637,0.9278475046157837,1,0.1861942708492279,0.8674077987670898,1,0.005732224881336292,0.9942677751186637,1
2863,本剤契機の自己免疫異常を疑い、メチルプレドニゾロン500 mgを投与開始。,本 剤 契機 自己免疫 異常 疑う メチルプレドニゾロン 0 mg 投与 開始,1,0.016662549100126,0.9833374508998739,1,0.00022648144022233946,0.9997735185597777,1,0.17932425839895105,0.820675741601049,1,0.06738154351765901,0.932618456482341,1,0.12450072914361954,0.9271935820579529,1,0.2558397352695465,0.8376944065093994,1,0.007711066227505292,0.9922889337724948,1
2864,2021/10/31、患者はしびれ、不眠、四肢の痛み、知覚異常を発症した。,0 0 0 患者 しびれ 不眠 四肢 痛み 知覚異常 発症 する た,1,4.92321906105088e-07,0.9999995076780939,1,0.0006388993568189355,0.9993611006431811,1,0.027570876506343267,0.9724291234936567,1,0.061865646114893647,0.9381343538851064,1,0.0751258134841919,0.9471521377563477,1,0.17991147935390472,0.8773698806762695,1,0.00454427297083212,0.995455727029168,1
2865,2022/03/10より、両指先のしびれあり(左>右)、悪化傾向であった。,0 0 0 指先 しびれあり 左 右 悪化傾向 だ ある た,1,0.01670785517417956,0.9832921448258205,1,0.00037293067489633657,0.9996270693251037,1,0.16666186231937052,0.8333381376806295,0,0.7057716586624542,0.29422834133754583,1,0.09799176454544067,0.9418193697929382,1,0.19562514126300812,0.869680643081665,1,0.023228914735583674,0.9767710852644164,1
2866,23:00ごろ、トイレで排便した後に意識消失あり、転倒し、左手を打撲した。,0 0 ごろ トイレ 排便 する た 後 意識消失 ある 転倒 左手 打撲 する た,1,0.007796209902247373,0.9922037900977527,1,0.000373289300690291,0.9996267106993098,1,0.47748510181968895,0.522514898180311,1,0.023100121884717217,0.9768998781152828,1,0.08263212442398071,0.9435247778892517,1,0.1798369139432907,0.8713130950927734,1,0.010614538475102572,0.9893854615248975,1
2867,9/15、呼吸苦が悪化し、患者は搬送され、病院に入院し、治療が開始された。,0 0 呼吸苦 悪化 患者 搬送 する れる 病院 入院 する 治療 開始 する れる た,1,0.016681558722755133,0.9833184412772449,1,0.00030029109785444157,0.9996997089021455,1,0.07524589714850605,0.924754102851494,0,0.7293191775632302,0.27068082243676983,1,0.07832004129886627,0.9464896321296692,1,0.1801333874464035,0.8694527745246887,1,0.019562294843688707,0.9804377051563113,1
2868,mRNA-1273ワクチン接種後、患者は5か月に4回蜂巣炎を発症している。,mRNA 0 ワクチン接種 後 患者 0 か月 0回 蜂巣炎 発症 する いる,1,0.036904454131985655,0.9630955458680143,1,0.00022006889922831135,0.9997799311007717,1,0.08467424956896197,0.915325750431038,1,0.04675042139516161,0.9532495786048384,1,0.09440620988607407,0.9432987570762634,1,0.19017016887664795,0.8599764704704285,1,0.005587609402985652,0.9944123905970144,1
2869,関節痛、頚部痛、発疹、そう痒症、咽喉絞扼感の結果として治療処置がとられた。,関節痛 頚部痛 発疹 痒症 咽喉 絞扼感 結果 治療 処置 とる れる た,1,0.016722014843566398,0.9832779851564338,1,0.00034696728438527667,0.9996530327156147,1,0.025462054269746792,0.9745379457302532,1,0.0863601384101208,0.9136398615898792,1,0.07910700142383575,0.9463608860969543,1,0.18766586482524872,0.8610395193099976,1,0.005052307028806787,0.9949476929711933,1
2870,血栓性血小板減少性紫斑病(TTP)が疑われたので、患者は病院へ移送された。,血栓性 血小板減少 性 紫斑病 TTP 疑う れる た 患者 病院 移送 する れる た,1,0.017979906107049363,0.9820200938929504,1,0.00043776069706031305,0.9995622393029396,1,0.024755140964679234,0.9752448590353208,1,0.21675544023700433,0.7832445597629957,1,0.07923668622970581,0.9426566362380981,1,0.18467262387275696,0.8697791695594788,1,0.006504921915840719,0.9934950780841593,1
2871,循環不全を呈しており、ImpellaCPを挿入、同時に心筋生検を施行した。,循環不全 呈す おる ImpellaCP 挿入 心筋生検 施行 する た,1,0.04517415913025178,0.9548258408697481,1,0.00026022739009355715,0.9997397726099064,1,0.16551187964683778,0.8344881203531622,1,0.3727294434707835,0.6272705565292165,1,0.15019558370113373,0.8928064703941345,1,0.321609228849411,0.8062690496444702,1,0.016957880948368323,0.9830421190516317,1
2872,食欲不振と倦怠感が発現し、改善しなかったため、07/11に当院を受診した。,食欲不振 倦怠感 発現 改善 する ない た ため 0 0 院 受診 する た,1,0.016698195159503857,0.9833018048404961,1,0.00022602193561538478,0.9997739780643846,1,0.28832053243009903,0.711679467569901,1,0.09651502159949987,0.9034849784005001,1,0.17140741646289825,0.8776437044143677,1,0.1964881420135498,0.8640012741088867,1,0.01024944004100948,0.9897505599589905,1
2873,経過中、インデラルを使用したが、症状は悪化し、メトリジン内服が継続された。,経過 中 インデラル 使用 する た 症状 悪化 メトリジン 内服 継続 する れる た,1,0.016684450026778288,0.9833155499732219,1,0.00016530620810120396,0.9998346937918988,0,0.6981869060522177,0.3018130939477823,1,0.14065449655686668,0.8593455034431333,1,0.15864339470863342,0.8840986490249634,1,0.3175920248031616,0.7143980860710144,1,0.03195719368073709,0.968042806319263,1
2874,アルブミン(血中アルブミン)(60.8- 71.8):57.7%、注記:低,アルブミン 血 中 アルブミン 0 0 0 0 0 0% 注記 低い,1,0.01667562781570041,0.9833243721842996,1,0.00032309771231539027,0.9996769022876846,1,0.15049866019381009,0.8495013398061899,1,0.0007612957548532862,0.9992387042451467,1,0.2566465437412262,0.8389354944229126,0,0.6667916178703308,0.44777998328208923,1,0.017519603220447388,0.9824803967795526,1
2875,Hepatitis B surface antigen: negative,Hepatitis B surface antigen negative,0,0.9122334571805835,0.08776654281941661,0,0.00011415300791128175,0.9998858469920887,1,0.4563792597309324,0.5436207402690676,0,1.0,4.371550875712133e-31,1,0.46655285358428955,0.6240311861038208,1,0.39771580696105957,0.7395210862159729,1,0.5592626569407508,0.4407373430592491,1
2876,2021/08/22右目奥にかつて経験したことの無い強さの頭痛を認めた。,0 0 0 右目 奥 経験 する た こと 無い 強い さ 頭痛 認める た,1,0.015904502198438607,0.9840954978015614,1,0.00030084237538372487,0.9996991576246163,1,0.015143201568462494,0.9848567984315375,1,0.005941207805761239,0.9940587921942388,1,0.07716391980648041,0.9495185613632202,1,0.19421203434467316,0.877727746963501,1,0.004146684613925023,0.995853315386075,1
2877,2022/04/16多発脳神経麻痺、顔面神経麻痺、三叉神経の障害が発現。,0 0 0 多発脳神経麻痺 顔面神経 麻痺 三叉神経 障害 発現,1,0.015720843506335114,0.984279156493665,1,0.0003813842408403261,0.9996186157591597,1,0.01927370609511725,0.9807262939048828,1,7.848943717192469e-11,0.9999999999215106,1,0.08502504229545593,0.9449107646942139,1,0.18513034284114838,0.8684170246124268,1,0.004183476047998784,0.9958165239520013,1
2878,2022/04接種1週間後、IgA血管炎、ネフローゼ症候群、血尿が発現。,0 0 接種 0 週間 後 IgA 血管炎 ネフローゼ 症候群 血尿 発現,1,0.005200914725544204,0.9947990852744558,1,0.0004517914859138422,0.9995482085140862,1,0.014783927250451856,0.9852160727495481,1,5.573985717433061e-12,0.999999999994426,1,0.0938703641295433,0.9425349235534668,1,0.18279020488262177,0.8636010885238647,1,0.0041166017480333,0.9958833982519668,1
2879,2022/07/03急性発症の胸痛又は胸部圧迫感、倦怠感、嘔吐を認めた。,0 0 0 急性発症 の 胸痛 胸部圧迫感 倦怠感 嘔吐 認める た,1,9.181057453567862e-08,0.9999999081894255,1,0.0005438783887055281,0.9994561216112945,1,0.001132894547269836,0.9988671054527302,1,0.0028610074499704208,0.9971389925500296,1,0.08015225827693939,0.9469529390335083,1,0.1825583428144455,0.8804377913475037,1,0.003850845041257177,0.9961491549587428,1
2880,患者は心筋炎(心筋炎)(重篤区分:入院及びその他医学的に重要)を呈した。,患者 心筋炎 心筋炎 重篤 区分 入院 その他 医学 的 重要 呈す た,1,0.002637265421812426,0.9973627345781876,1,0.00045247891617152913,0.9995475210838285,1,0.010645250676641016,0.989354749323359,1,0.0005520141409995905,0.9994479858590004,1,0.0827246755361557,0.9421930909156799,1,0.2268201857805252,0.8333348035812378,1,0.00433189443348494,0.9956681055665151,1
2881,胸部レントゲンで心拡大の増悪、血漿BNPの上昇を認めたため利尿薬を増量。,胸部 レントゲン だ 心拡大 の 増悪 血漿 BNP 上昇 認める た ため 利尿 薬 増量,1,0.01944786544581399,0.980552134554186,1,0.0002849850079834357,0.9997150149920165,1,0.018293746929998522,0.9817062530700015,1,0.004278875957865358,0.9957211240421346,1,0.10091441869735718,0.9302743077278137,1,0.2290334850549698,0.8333833813667297,1,0.004729952999138376,0.9952700470008616,1
2882,経胸壁心エコー像にて駆出率の低下を伴わない心尖部の軽度運動低下を認めた。,経 胸壁 心 エコー 像 駆け出し 率 低下 伴う ない 心尖 部 軽度 運動低下 認める た,1,0.016707820471292774,0.9832921795287072,1,0.00034307765945965605,0.9996569223405404,1,0.008767815649542099,0.9912321843504579,1,0.01898924763813714,0.9810107523618629,1,0.08497084677219391,0.9481663703918457,1,0.2060207575559616,0.8536006212234497,1,0.004402548361849041,0.995597451638151,1
2883,心筋炎調査票: 2022/06/02、急性発症の胸痛又は圧迫感があった。,心筋炎 調査 票 0 0 0 急性発症 の 胸痛 圧迫感 ある た,1,0.016680093873841787,0.983319906126158,1,0.0002571888989578865,0.9997428111010421,1,0.04518017076166414,0.9548198292383359,1,0.1612302799944697,0.8387697200055303,1,0.07793796807527542,0.9448198080062866,1,0.18398810923099518,0.8721123337745667,1,0.006009951016055702,0.9939900489839444,1
2884,心電図(ECG)ST部:V3-6誘導のST上昇、V3-6誘導のST上昇。,心電図 ECG ST 部 V 0 0 誘導 ST 上昇 V 0 0 誘導 ST 上昇,1,0.012267322467158101,0.9877326775328419,1,0.0004394854968286166,0.9995605145031714,1,0.026052505183718933,0.9739474948162811,1,2.107114482896577e-11,0.9999999999789289,1,0.09459356218576431,0.9364972710609436,1,0.2004241794347763,0.8641862273216248,1,0.0043720260873723,0.9956279739126278,1
2885,心嚢液から白血球が検出され、心嚢脂肪織内血管周囲にも単核球浸潤を認めた。,心嚢液 白血球 検出 する れる 心嚢 脂肪織 血管 周囲 単核球浸潤 認める た,1,0.016703297369977037,0.9832967026300228,1,0.00034978202138667767,0.9996502179786133,1,0.03449258875587913,0.9655074112441209,1,0.010207474250988668,0.9897925257490113,1,0.08836746215820312,0.9408395290374756,1,0.18889154493808746,0.8634674549102783,1,0.0044804481347517746,0.9955195518652482,1
2886,接種後から急に夜間徘徊、見当識低下などBPSDが出現し、せん妄となった。,接種 後 急 夜間徘徊 見当識低下 BPSD 出現 せん妄 なる た,1,0.010840338097785857,0.9891596619022142,1,0.0003418464457273385,0.9996581535542727,1,0.020795934742019906,0.9792040652579801,1,0.011412809004127111,0.9885871909958729,1,0.08678395301103592,0.9465264678001404,1,0.1744815558195114,0.8726634383201599,1,0.004188803520286857,0.9958111964797131,1
2887,日付不明、遊離サイロキシン(0.9 -1.7):7.77 ng/dL超。,日付 不明 遊離 サイロキシン 0 0 0 0 0 0 NG dL 超,1,0.22106126673912946,0.7789387332608707,1,0.0002162522678511248,0.9997837477321488,1,0.37867821805460133,0.6213217819453987,1,0.0,1.0,1,0.19239091873168945,0.8849133849143982,1,0.3084321618080139,0.7910451292991638,1,0.018429088257482625,0.9815709117425174,1
2888,日付不明当科受診時は両下腿や上腕に紅色から褐色の浸潤触れる色素斑が多発。,日付 不明 科 受診 時 下腿 上腕 紅色 褐色 浸潤触 れる 色素斑 多発,1,0.01669361783453456,0.9833063821654654,1,0.0003083849140223538,0.9996916150859776,1,0.20093466423723672,0.7990653357627633,1,0.0,1.0,1,0.0993012860417366,0.9381282925605774,1,0.19221508502960205,0.8570089340209961,1,0.006257188175866276,0.9937428118241337,1
2889,日付不明頭痛が継続し、倦怠感が強く食欲低下を認め、体重-5 kgとなる。,日付 不明 頭痛 継続 する 倦怠感 強い 食欲低下 認める 体重 0 kg なる,1,8.325194253561903e-06,0.9999916748057465,1,0.0004510787044255129,0.9995489212955745,1,0.004600387884194923,0.9953996121158051,1,8.026882966083448e-07,0.9999991973117034,1,0.08110211789608002,0.9472680687904358,1,0.18231505155563354,0.8687450289726257,1,0.003901540084575145,0.9960984599154249,1
2890,入院直後、トイレで体動困難、呼吸困難となり挿管・人工呼吸器管理となった。,入院 直後 トイレ だ 体動困難 呼吸困難 なる 挿管 人工呼吸器 管理 なる た,1,0.04569612460043686,0.9543038753995633,1,0.00020484108605960593,0.9997951589139404,1,0.0942854649068231,0.9057145350931769,0,0.6476188378975689,0.35238116210243114,1,0.07442652434110641,0.9444483518600464,1,0.18979568779468536,0.8584653735160828,1,0.018650037563127934,0.981349962436872,1
2891,来院時、ショック、PEAを認め、心肺停止状態となり、緊急ECMOを挿入。,来院 時 ショック PEA 認める 心肺停止状態 なる 緊急 ECMO 挿入,1,0.01850946444672169,0.9814905355532783,1,0.0003775299819704307,0.9996224700180296,1,0.016525369613628826,0.9834746303863712,1,6.517866690813889e-09,0.9999999934821333,1,0.08657529205083847,0.9405432939529419,1,0.19255495071411133,0.8600010871887207,1,0.004275415541952055,0.9957245844580479,1
2892,"来院時は39.4度の発熱と毎分108回の頻脈を認め,やや倦怠様であった。",来院 時 0 0度 発熱 0回 頻脈 認める 倦怠 様 だ ある た,1,0.03527190482533134,0.9647280951746686,1,0.00022602809769100207,0.999773971902309,1,0.010447501520310265,0.9895524984796897,0,0.63845043940692,0.36154956059307997,1,0.07756533473730087,0.9479681253433228,1,0.18048706650733948,0.8686723113059998,1,0.014923292186826633,0.9850767078131732,1
2893,両肺野に胸水貯留、下肺野に浸潤影を認めたため、他病院内科に紹介し、入院。,両肺 野 胸水 貯留 肺 野 浸潤影 認める た ため 病院 内科 紹介 する 入院,1,7.82219632862686e-06,0.9999921778036713,1,0.0005032353392675366,0.9994967646607325,1,0.016437234602424855,0.9835627653975751,1,1.406329972475362e-07,0.9999998593670028,1,0.08046112954616547,0.9421722292900085,1,0.18776465952396393,0.867964506149292,1,0.004037780837761046,0.9959622191622389,1
2894,血液検査:抗TIF1-c抗体と高値を示した、注記:炭水化物抗原19- 9,血液検査 TIF 0 c 抗体 高値 示す た 注記 炭水化物 抗原 0 0,1,0.028632385878326897,0.9713676141216732,1,0.00029201602637931164,0.9997079839736207,1,0.08822424550731289,0.9117757544926871,1,0.0665215704798533,0.9334784295201467,1,0.09810330718755722,0.9385124444961548,1,0.1859407126903534,0.8606665730476379,1,0.005778622507343987,0.994221377492656,1
2895,患者は、起立性低血圧、血圧低下(発現日:2021/10)のため入院した。,患者 起立性 低血圧 血圧低下 発現 日 0 0 ため 入院 する た,1,1.86926345269302e-07,0.9999998130736547,1,0.0005804331618929908,0.999419566838107,1,0.003119313632372278,0.9968806863676277,1,0.12123837849832797,0.878761621501672,1,0.07816045731306076,0.9458248019218445,1,0.18742559850215912,0.8706740736961365,1,0.004961683261176461,0.9950383167388236,1
2896,2021/07/10(ワクチン接種20日後)00:00、乾癬を発現した。,0 0 0 ワクチン接種 0 日 後 0 0 乾癬 発現 する た,1,0.013290610101765847,0.986709389898234,1,0.00037887906307402066,0.999621120936926,1,0.012362003212852524,0.9876379967871475,1,0.06768591914801025,0.9323140808519897,1,0.08115261048078537,0.9514198303222656,1,0.1863434761762619,0.869288444519043,1,0.004652082536714954,0.995347917463285,1
2897,:2022/06/05発現、発熱(入院)、転帰「回復」(2022/06),0 0 0 発現 発熱 入院 転帰 回復 0 0,1,0.002958959706804274,0.9970410402931957,1,0.00030024200301242824,0.9996997579969876,1,0.01405974556025369,0.9859402544397463,1,0.03398771574138071,0.9660122842586193,1,0.1255493015050888,0.9235442876815796,1,0.19460712373256683,0.8637305498123169,1,0.004657977462977634,0.9953420225370225,1
2898,2021/06/06から2021/06/07頃より、左耳鳴りが発生した。,0 0 0 0 0 0 頃 左耳鳴り 発生 する た,1,0.1758768583410914,0.8241231416589087,1,0.0002475365086251599,0.9997524634913748,1,0.24492492026123835,0.7550750797387616,1,0.045968026345559077,0.9540319736544409,1,0.08143770694732666,0.9413027763366699,1,0.18730595707893372,0.8765169978141785,1,0.00980468938507302,0.990195310614927,1
2899,2021/09/11(ワクチン接種25日後)、血球貪食症候群が発現した。,0 0 0 ワクチン接種 0 日 後 血球貪食 症候群 発現 する た,1,0.008316887919655964,0.9916831120803438,1,0.0004365211402747008,0.9995634788597253,1,0.006103561825856807,0.9938964381741432,1,0.04772402698732314,0.9522759730126769,1,0.08214925974607468,0.9468684792518616,1,0.1873290091753006,0.8711571097373962,1,0.0043928028033426375,0.9956071971966574,1
2900,2022/07/29 06:00頃、患者は、血圧低下、心肺停止となった。,0 0 0 0 0 頃 患者 血圧低下 心肺停止 なる た,1,0.016708677868614224,0.9832913221313858,1,0.00033581456600311117,0.9996641854339969,1,0.144178656050431,0.855821343949569,1,0.005482742160162202,0.9945172578398378,1,0.07625783979892731,0.94935142993927,1,0.1909637153148651,0.875901460647583,1,0.005353592071809823,0.9946464079281903,1
2901,CTミエロ、RI脳槽シンチを施行、腰椎より髄液漏出像を疑う所見を認めた。,C，T ミエ ロ RI 脳 槽 シンチ 施行 腰椎 髄液漏出 像 疑う 所見 認める た,1,0.014472106385096287,0.9855278936149039,1,0.00029292274816919135,0.9997070772518308,1,0.10903732568616975,0.8909626743138302,1,0.01852095477273963,0.9814790452272604,1,0.08647295087575912,0.9405187368392944,1,0.19238677620887756,0.8720310926437378,1,0.005225095118078971,0.9947749048819211,1
2902,アナフィラキシーショック、嘔吐、蒼白の結果として治療的な処置がとられた。,アナフィラキシー ショック 嘔吐 蒼白 結果 治療 的 だ 処置 とる れる た,1,0.006077925603323802,0.9939220743966762,1,0.00040893362893986915,0.9995910663710601,1,0.012949512033381572,0.9870504879666184,1,0.09385113372438147,0.9061488662756185,1,0.08052219450473785,0.9455133080482483,1,0.1990985870361328,0.8495150208473206,1,0.005022298957433957,0.9949777010425661,1
2903,患者は、摂氏40.4度の体温および意識レベルJCS II-30を示した。,患者 摂氏 0 0度 体温 意識レベル JCS II 0 示す た,1,0.1902326054082892,0.8097673945917108,1,0.00018643277771316727,0.9998135672222869,1,0.27355504524334795,0.726444954756652,1,0.05757874606507607,0.9424212539349239,1,0.08598087728023529,0.9388057589530945,1,0.2111717313528061,0.8584176301956177,1,0.011464546795109323,0.9885354532048908,1
2904,患者は2021年から免疫チェックポイント阻害剤によるirAEを発症した。,患者 0 年 免疫チェックポイント阻害剤 irAE 発症 する た,1,0.034210024055751694,0.9657899759442482,1,0.0002796534786712022,0.9997203465213288,1,0.12646574882146278,0.8735342511785372,1,0.01312117613903796,0.986878823860962,1,0.0971272885799408,0.9397059082984924,1,0.20140311121940613,0.8593538999557495,1,0.005752359437137489,0.9942476405628626,1
2905,患者は筋力低下、筋炎のために入院した(開始日: 2021/07/27)。,患者 筋力低下 筋炎 ため 入院 する た 開始 日 0 0 0,1,0.013545190726553443,0.9864548092734466,1,0.0003675806613301576,0.9996324193386699,1,0.020023439651736585,0.9799765603482634,1,0.1001854128959001,0.8998145871040999,1,0.08545692265033722,0.9452461004257202,1,0.19315385818481445,0.854603111743927,1,0.005204595104559278,0.9947954048954407,1
2906,入院時の診断は、急性心筋炎(COVID-19ワクチン接種関連)であった。,入院 時 診断 急性心筋炎 COVID 0 ワクチン接種 関連 だ ある た,1,0.10247181940150651,0.8975281805984935,1,0.0002822644069613142,0.9997177355930387,1,0.2044757087139072,0.7955242912860928,0,0.9257771938815005,0.07422280611849955,1,0.09214357286691666,0.9398909211158752,1,0.2791298031806946,0.8192480206489563,1,0.05108387158768437,0.9489161284123157,1
2907,2022/03/18の朝(ワクチン接種1日後)、肉眼的血尿を発現した。,0 0 0 朝 ワクチン接種 0 日 後 肉眼的血尿 発現 する た,1,0.0055236665769943846,0.9944763334230056,1,0.00041095674430567273,0.9995890432556943,1,0.009700427435965553,0.9902995725640344,1,0.0746245275231121,0.9253754724768879,1,0.07710790634155273,0.9511712789535522,1,0.18666663765907288,0.8751538395881653,1,0.0045774218768532705,0.9954225781231467,1
2908,2021/08/31体温37.9°C、倦怠感を認め、寝て過ごしていた。,0 0 0 体温 0 0 C 倦怠感 認める 寝る 過ごす いる た,1,0.006736748587691943,0.993263251412308,1,0.0002766042324441622,0.9997233957675559,1,0.010066739974850414,0.9899332600251496,1,0.40236028321028927,0.5976397167897107,1,0.07675013691186905,0.9487415552139282,1,0.18504363298416138,0.8729858994483948,1,0.008827183307801993,0.991172816692198,1
2909,2021/09/28頃(ワクチン接種15日後)、ぶどう膜炎を発現した。,0 0 0 頃 ワクチン接種 0 日 後 ぶどう膜炎 発現 する た,1,0.0092877872179178,0.9907122127820822,1,0.00043670195594836534,0.9995632980440516,1,0.006315019386617271,0.9936849806133827,1,0.09689830368020891,0.9031016963197911,1,0.08234871178865433,0.9501928091049194,1,0.18346020579338074,0.8730083703994751,1,0.004813447541874095,0.9951865524581258,1
2910,2022/02/15左足が動きにくく、歩行も困難となり、救急車で搬送。,0 0 0 左足 動く にくい 歩行 困難 なる 救急車 搬送,1,0.016717665202611857,0.983282334797388,1,0.00037610705737971695,0.9996238929426203,1,0.20117746978674256,0.7988225302132574,1,2.220446049250313e-16,0.9999999999999998,1,0.08634236454963684,0.9396834969520569,1,0.18984664976596832,0.8693726658821106,1,0.006081978568083353,0.9939180214319167,1
2911,2022/05/16 16:00、接種部位の遷延性神経障害が発現した。,0 0 0 0 0 接種 部位 遷延性 神経障害 発現 する た,1,0.0084747574611943,0.9915252425388058,1,0.0003328150010767414,0.9996671849989233,1,0.017068447523997277,0.9829315524760027,1,0.07359908604778809,0.9264009139522119,1,0.09227047860622406,0.9430006146430969,1,0.18688108026981354,0.8744301795959473,1,0.004776168446804068,0.9952238315531959,1
2912,2022/05/16近医を受診し、感冒として処方を受け経過観察となる。,0 0 0 近医 受診 する 感冒 処方 受ける 経過 観察 なる,1,0.016679725457183197,0.9833202745428168,1,0.00018527879649875815,0.9998147212035012,1,0.1190384723513277,0.8809615276486723,1,0.0005312866382685133,0.9994687133617315,1,0.10112164169549942,0.9347825646400452,1,0.20472170412540436,0.8485903739929199,1,0.0054609311532826795,0.9945390688467173,1
2913,2022/06/02時刻不詳(ワクチン接種日同日)、心筋炎を発現した。,0 0 0時 刻 不詳 ワクチン接種 日 同日 心筋炎 発現 する た,1,0.013708969057448674,0.9862910309425513,1,0.0003409607231436057,0.9996590392768564,1,0.01583670160902384,0.9841632983909762,1,0.11120843493203003,0.88879156506797,1,0.0855184942483902,0.9450289607048035,1,0.18398062884807587,0.8750333786010742,1,0.0051255787007935495,0.9948744212992066,1
2914,"SARS- CoV-2抗体検査は陽性で40,600 U/mLであった。",SARS CoV 0 抗体検査 陽性 0 0 U mL だ ある た,1,0.02159636579280002,0.9784036342072,1,0.000405669992116757,0.9995943300078832,1,0.1174343215714666,0.8825656784285334,0,0.9428088333113039,0.05719116668869607,1,0.15460798144340515,0.9095438122749329,1,0.21216922998428345,0.8599923849105835,1,0.037750734208180786,0.9622492657918192,1
2915,SpO2 96%、P 41、BP 95/42と徐脈、血圧低下を認めた。,SpO 0 0% P 0 BP 0 0 徐脈 血圧低下 認める た,1,1.2769618870468133e-06,0.9999987230381129,1,0.0005019254815007086,0.9994980745184993,1,0.016398818834608586,0.9836011811653914,1,0.004849896925117503,0.9951501030748825,1,0.07429181784391403,0.9475359916687012,1,0.18316695094108582,0.8785799145698547,1,0.003969438465901904,0.9960305615340981,1
2916,エピネフリン負荷試験、サンリズム負荷試験と加算平均心電図が陽性だった。,エピネフリン 負荷 試験 サンリズム 負荷 試験 加算 平均 心電図 陽性 だ た,1,0.016681578740053382,0.9833184212599465,1,0.00031458747968296594,0.9996854125203171,1,0.039316657974476144,0.9606833420255239,1,0.36523489087386696,0.634765109126133,1,0.22818812727928162,0.8189696669578552,1,0.2838226556777954,0.8359764218330383,1,0.013389032867531642,0.9866109671324683,1
2917,その他所見には軽度の心嚢液貯留及び左室(LV)心尖部血栓などがあった。,その他 所見 軽度 心嚢液 貯留 左 室 LV 心尖部血栓 ある た,1,0.11841140395516093,0.881588596044839,1,0.00019916810923980988,0.9998008318907602,1,0.2755890597118391,0.7244109402881609,1,0.4676092538315536,0.5323907461684464,1,0.0880608931183815,0.9305710792541504,1,0.20456624031066895,0.8575459718704224,1,0.02249144241832343,0.9775085575816764,1
2918,意識障害、記憶障害、血清Na124mEq/Lの低値を認め入院となった。,意識障害 記憶障害 血清 Na 0m Eq L 値 認める 入院 なる た,1,1.1103401584159905e-07,0.9999998889659842,1,0.00040071653308667633,0.9995992834669133,1,0.0058773266728675555,0.9941226733271324,1,0.05497664985422335,0.9450233501457767,1,0.07763490080833435,0.9455013275146484,1,0.18226249516010284,0.8760969638824463,1,0.004324214049617033,0.995675785950383,1
2919,患者がmRNAワクチン(商品名)接種直後に、心筋炎、心膜炎を発症した。,患者 mRNA ワクチン 商品名 接種 直後 心筋炎 心膜炎 発症 する た,1,0.012621756711904145,0.9873782432880958,1,0.00039626798311386707,0.9996037320168861,1,0.03014639901534444,0.9698536009846556,1,0.024922379077734313,0.9750776209222657,1,0.08823266625404358,0.940575897693634,1,0.18454711139202118,0.8657456636428833,1,0.004508068720411909,0.995491931279588,1
2920,患者に特筆すべき病歴はなく、胸痛及び首へ放散する背部痛のため受診した。,患者 特筆 する べし 病歴 ない 胸痛 首 放散 する 背部痛 ため 受診 する た,1,0.016687318164220356,0.9833126818357796,1,0.00027140747416975764,0.9997285925258302,1,0.22980984526010229,0.7701901547398977,1,0.2161842893734237,0.7838157106265763,1,0.08328264206647873,0.946108341217041,1,0.20518918335437775,0.8572806715965271,1,0.010060654350943823,0.9899393456490563,1
2921,近医整形外科で薬物療法を受けたが改善せず、握力が10 kg程度に低下。,近医 整形外科 だ 薬物 療法 受ける た 改善 する ぬ 握力 0 kg 程度 低下,1,0.01667384746053852,0.9833261525394614,0,0.00012895338261581808,0.9998710466173841,1,0.47847489829258116,0.5215251017074188,1,0.00017169760860002992,0.9998283023914,1,0.16300222277641296,0.9127929210662842,1,0.2751618027687073,0.8132172226905823,1,0.01342729662233195,0.986572703377668,1
2922,死因はケトアシドーシスと考えられ、その原因はアルコール性であると推定。,死因 ケトアシドーシス 考える られる 原因 アルコール性 だ ある 推定,1,0.016669040950493173,0.9833309590495066,1,0.0003385594547107496,0.9996614405452893,1,0.09678735938720628,0.9032126406127937,1,1.8621659769735288e-10,0.9999999998137834,1,0.10161954164505005,0.915494441986084,1,0.29535144567489624,0.7889497876167297,1,0.00618217771308554,0.9938178222869144,1
2923,治療的な処置は、心筋炎、うっ血性心不全、心房細動の結果としてとられた。,治療 的 だ 処置 心筋炎 うっ血性 心不全 心房細動 結果 とる れる た,1,0.007668820878153183,0.9923311791218467,1,0.00042159052389954013,0.9995784094761004,1,0.018409719208610786,0.9815902807913892,1,0.07006855769427844,0.9299314423057216,1,0.0878850519657135,0.9414944052696228,1,0.190318763256073,0.8658033013343811,1,0.004792225985881222,0.9952077740141188,1
2924,上下肢、顔面及び腹部の圧痕浮腫、呼吸音は清明で、肺雑音は認めなかった。,上下 肢 顔面 腹部 圧痕 浮腫 呼吸 音 清明 だ 肺 雑音 認める ない た,1,0.016702476399531166,0.983297523600469,1,0.00027976877460760664,0.9997202312253924,1,0.21825873868084344,0.7817412613191566,0,0.7891960253818567,0.21080397461814326,1,0.1851077526807785,0.8805208802223206,1,0.5442698001861572,0.5727793574333191,1,0.06446183088009597,0.9355381691199041,1
2925,心筋トロポニンT及びクレアチンキナーゼ値は軽度に上昇したままであった。,心筋 トロポニン T クレアチンキナーゼ 値 軽度 上昇 する た まま だ ある た,0,0.9778580287391213,0.022141971260878687,0,0.00016138494958578767,0.9998386150504142,1,0.25606064211040225,0.7439393578895978,0,0.6226123872093321,0.3773876127906679,0,0.8540319800376892,0.16653411090373993,1,0.3327302932739258,0.8010954260826111,1,0.4831358048810308,0.5168641951189691,0
2926,心電図ではST上昇又は陰性T波、心房期外収縮又は心室期外収縮を認めた。,心電図 ST 上昇 陰性 T 波 心房期外収縮 心室期外収縮 認める た,1,0.013976507037297145,0.9860234929627029,1,0.0003458062915318151,0.9996541937084682,1,0.012243361943482856,0.9877566380565171,1,0.00229108919522103,0.997708910804779,1,0.0829392597079277,0.9438806176185608,1,0.18963542580604553,0.8666425943374634,1,0.004151047013984316,0.9958489529860156,1
2927,神経痛性筋萎縮症、血管自律神経障害による洞性頻脈・起立性低血圧が発現。,神経痛 性 筋萎縮症 血管 自律神経障害 洞性頻脈 起立性 低血圧 発現,1,0.012042242477728048,0.987957757522272,1,0.00041973054480048494,0.9995802694551995,1,0.009155646401143858,0.9908443535988561,1,7.677436464348375e-11,0.9999999999232256,1,0.09755873680114746,0.9397585391998291,1,0.2020713984966278,0.8658065795898438,1,0.004224168425463499,0.9957758315745364,1
2928,脊髄MRIでC5-Th5に連続性の異常信号がみられ、脊髄炎が疑われた。,脊髄 MRI C 0 Th 0 連続性 の 異常信号 みる られる 脊髄炎 疑う れる た,1,0.0065219709711653385,0.9934780290288346,1,0.0004621808570427016,0.9995378191429573,1,0.015006159125535157,0.9849938408744648,1,0.08725630905873771,0.9127436909412623,1,0.08270172029733658,0.9469833970069885,1,0.18797333538532257,0.8643546104431152,1,0.004858429788464566,0.9951415702115354,1
2929,接種1日後、患者は突然激しい頭痛及び呼吸困難を呈し、病院へ紹介された。,接種 0 日 後 患者 激しい頭痛 呼吸 困難 呈す 病院 紹介 する れる た,1,0.012513380605521164,0.9874866193944789,1,0.00040437077256116915,0.9995956292274388,1,0.06537933330317836,0.9346206666968216,1,0.23932031013221733,0.7606796898677827,1,0.07883051037788391,0.9476572275161743,1,0.17699967324733734,0.8668769598007202,1,0.007221325615607103,0.9927786743843928,1
2930,接種の2、3分後、患者は(接種した方の)左上肢のしびれと疼痛を訴えた。,接種 0 0分 後 患者 接種 する た 方 左上肢のしびれ 疼痛 訴える た,1,0.01665948226155748,0.9833405177384427,1,0.0003458136725990857,0.9996541863274009,1,0.09930300629483935,0.9006969937051607,1,7.14611673300336e-05,0.99992853883267,1,0.07640647143125534,0.9495773315429688,1,0.18271952867507935,0.8597550988197327,1,0.004881317220892725,0.9951186827791072,1
2931,吐き気などの消化管症状が強く、状態観察の看護師から報告、診察依頼あり。,吐き気 消化管症状 強い 状態 観察 看護師 報告 診察 依頼 ある,1,0.016684944358015864,0.9833150556419842,1,0.00026926669084641284,0.9997307333091536,1,0.37262499876709054,0.6273750012329095,1,0.0073216736878913835,0.9926783263121086,1,0.10271722078323364,0.9408162832260132,1,0.2245893031358719,0.8179616332054138,1,0.009587421479620025,0.99041257852038,1
2932,同時に、胸が締め付けられるような感じ、息苦しい感じを自覚し、当院受診。,胸 締め付けられるような感じ 息苦しい感じ 自覚 院 受診,1,1.7260995900899966e-05,0.9999827390040991,1,0.0003886473367859073,0.9996113526632141,1,0.015261765404805172,0.9847382345951948,1,2.3243429403407845e-10,0.9999999997675657,1,0.0854954794049263,0.9491974115371704,1,0.19369767606258392,0.8666718006134033,1,0.004048546009585421,0.9959514539904146,1
2933,皮膚炎、脱毛症、アトピー性皮膚炎の結果として、治療的な処置がとられた。,皮膚炎 脱毛症 アトピー性 皮膚炎 結果 治療 的 だ 処置 とる れる た,1,0.011240844272312025,0.9887591557276881,1,0.00036290067751289495,0.9996370993224871,1,0.025462054269746792,0.9745379457302532,1,0.08339890820112605,0.916601091798874,1,0.09128297120332718,0.9367784261703491,1,0.20734131336212158,0.8606920838356018,1,0.005179175297750266,0.9948208247022496,1
2934,臨床経過:不明日(4回目のワクチン接種1日後)顔面神経麻痺を発症した。,臨床 経過 明日 0回目 ワクチン接種 0 日 後 顔面神経 麻痺 発症 する た,1,0.016696881950536754,0.9833031180494632,1,0.0002538533346834249,0.9997461466653166,1,0.10504810570713163,0.8949518942928684,1,0.05302624944586731,0.9469737505541327,1,0.07981925457715988,0.943481981754303,1,0.20440831780433655,0.8596971035003662,1,0.005658615555599924,0.9943413844444,1
2935,臨床経過より本剤接種に伴うIgA腎症および急速進行性糸球体腎炎と診断。,臨床 経過 本 剤 接種 伴う IgA 腎症 急速進行性 糸球体腎炎 診断,1,0.03186647265249201,0.9681335273475078,1,0.0003640374640198057,0.9996359625359802,1,0.03134714822781859,0.9686528517721814,1,2.0845385417800344e-09,0.9999999979154615,1,0.10512001812458038,0.9348253011703491,1,0.194478377699852,0.8632099628448486,1,0.004626665112031404,0.9953733348879686,1
2936,19:00頃も肉眼的に血尿が出現し、21:00頃応急診療所を受診した。,0 0 頃 肉眼 的 血尿 出現 0 0 頃 応急 診療 所 受診 する た,1,0.004861994934126884,0.9951380050658731,1,0.0004123776085934305,0.9995876223914065,1,0.012083482836436343,0.9879165171635637,1,0.12905260258081497,0.870947397419185,1,0.07934533804655075,0.9462524056434631,1,0.18643887341022491,0.873124361038208,1,0.005164486976074481,0.9948355130239255,1
2937,2022/06/05 12:00、患者は左上肢へじんましんを発現した。,0 0 0 0 0 患者 左上 肢 じんましん 発現 する た,1,0.01584790404041094,0.9841520959595892,1,0.0003658352544407497,0.9996341647455592,1,0.017370694206666926,0.9826293057933331,1,0.07051767864710778,0.9294823213528922,1,0.0825323611497879,0.9474793672561646,1,0.18397113680839539,0.8734539151191711,1,0.004743498455812216,0.9952565015441878,1
2938,2022/06/06深夜、胸痛と息苦しさを訴え、同センターを受診した。,0 0 0 深夜 胸痛 息苦しさ 訴える センター 受診 する た,1,0.004418809237446361,0.9955811907625535,1,0.0004157971503051734,0.9995842028496948,1,0.01292868408624126,0.9870713159137587,1,0.16530687888169937,0.8346931211183006,1,0.07485014200210571,0.9472419619560242,1,0.18154512345790863,0.8759649991989136,1,0.005482637057715145,0.9945173629422848,1
2939,2022/07/03(ワクチン接種翌日)、摂氏38度台の発熱を認めた。,0 0 0 ワクチン接種 翌日 摂氏 0度 台 発熱 認める た,1,2.1718640848009345e-06,0.9999978281359152,1,0.0007060294859275311,0.9992939705140724,1,0.004799460145889278,0.9952005398541107,1,0.0007035334622660372,0.999296466537734,1,0.07564342021942139,0.9499490857124329,1,0.18502742052078247,0.8756900429725647,1,0.0038625952673273533,0.9961374047326726,1
2940,右側18.8dB、左側20.0dBと両側高音部の感音難聴が認められた。,右側 0 0 dB 左側 0 0 dB 両側 高音 部 感音難聴 認める られる た,1,0.011118033725080908,0.9888819662749192,1,0.0004121058331070635,0.999587894166893,1,0.028937825878605716,0.9710621741213943,1,0.06320593972738853,0.9367940602726115,1,0.08456079661846161,0.9471665620803833,1,0.18987955152988434,0.868487536907196,1,0.004802206808443134,0.995197793191557,1
2941,昼寝中の頭痛、頭部CTで右内頚動脈破裂によるくも膜下出血が認められた。,昼寝 中 頭痛 頭部 CT 右内 頚動脈破裂 くも膜下出血 認める られる た,1,0.004267137458660309,0.9957328625413394,1,0.00033157001194028177,0.9996684299880597,1,0.057702263156571565,0.9422977368434284,1,0.04238954928736749,0.9576104507126325,1,0.07429434359073639,0.9457857608795166,1,0.17642061412334442,0.872814953327179,1,0.00468587970898127,0.9953141202910187,1
2942,頭痛が発現し、小児科(かかりつけ医)を受診し、カロナールが処方された。,頭痛 発現 小児科 かかりつけ医 受診 する カロナール 処方 する れる た,1,0.015878645698342766,0.9841213543016571,1,0.0003748855738949108,0.9996251144261051,1,0.007470143644396243,0.9925298563556038,1,0.361936708652317,0.638063291347683,1,0.1168343722820282,0.9273266792297363,1,0.19645150005817413,0.8598137497901917,1,0.008990694827452395,0.9910093051725475,1
2943,2021/10/22(ワクチン接種の2日後)、患者は心筋炎を発現した。,0 0 0 ワクチン接種 0 日 後 患者 心筋炎 発現 する た,1,0.006499899006929246,0.9935001009930708,1,0.0004385006767982348,0.9995614993232018,1,0.004702308418405354,0.9952976915815946,1,0.017071130622961395,0.9829288693770386,1,0.0850362554192543,0.9470800161361694,1,0.19225122034549713,0.8614904284477234,1,0.00417748650480372,0.9958225134951961,1
2944,日付不明、頚部コンピュータ断層撮影:左内頚静脈血栓及び末梢性(異常)。,日付 不明 頚部 コンピュータ断層撮影 左内頚静脈血栓 末梢 性 異常,1,0.016676117623773974,0.983323882376226,1,0.00027962006661220323,0.9997203799333878,1,0.048831552254724575,0.9511684477452754,1,2.6001423236721166e-13,0.99999999999974,1,0.12765555083751678,0.9051020741462708,1,0.2088385820388794,0.8484489321708679,1,0.005039068171305738,0.9949609318286944,1
2945,17:45頃帰宅途中に右)耳介後部の後頭部痛を訴えクリニックに戻る。,0 0 頃 帰宅 途中 右 耳介 後部 後頭部痛 訴える クリニック 戻る,1,0.016721738551007632,0.9832782614489924,1,0.0003519727242877127,0.9996480272757123,1,0.04947895135056046,0.9505210486494395,1,0.0018665250629690266,0.998133474937031,1,0.15421253442764282,0.9239708781242371,1,0.18233241140842438,0.8629588484764099,1,0.004900300487749021,0.9950996995122511,1
2946,2021/07/01発熱、倦怠感、29.9以上のCRP上昇を認めた。,0 0 0 発 熱 倦怠感 0 0 以上 CRP 上昇 認める た,1,5.4707984416360866e-09,0.9999999945292015,1,0.0005267787160912244,0.9994732212839088,1,0.0044568605595483035,0.9955431394404517,1,0.020649091096091032,0.979350908903909,1,0.08030173927545547,0.9506139159202576,1,0.18159855902194977,0.8796001076698303,1,0.004001612420738067,0.9959983875792618,1
2947,2021/07/09 12:50(ワクチン接種後)、充血が発現した。,0 0 0 0 0 ワクチン接種 後 充血 発現 する た,1,0.006969659838656447,0.9930303401613436,1,0.00043673024062662163,0.9995632697593734,1,0.009427390499791577,0.9905726095002084,1,0.05363906039800481,0.9463609396019952,1,0.08429908752441406,0.951357901096344,1,0.18717029690742493,0.8747281432151794,1,0.004435493756305752,0.9955645062436942,1
2948,2021/09/06倦怠感、遷延する発熱、頭痛、便秘、関節痛が発現。,0 0 0 倦怠感 遷延 する 発熱 頭痛 便秘 関節痛 発現,1,3.179385532825505e-08,0.9999999682061447,1,0.00044979231950039356,0.9995502076804996,1,0.001279762211558344,0.9987202377884417,1,3.178768359646256e-11,0.9999999999682123,1,0.08094871789216995,0.9470468759536743,1,0.18588756024837494,0.8792585730552673,1,0.0038492894153771906,0.9961507105846227,1
2949,2021/09/29接種後に発熱が発現し、その後から見づらさを自覚。,0 0 0 接種 後 発熱 発現 その後 見づらい さ 自覚,1,5.091358574734009e-07,0.9999994908641426,1,0.0005130026312706844,0.9994869973687294,1,0.0027528770871704245,0.9972471229128296,1,5.992395480269863e-06,0.9999940076045197,1,0.08919966965913773,0.947196900844574,1,0.18571257591247559,0.8661475777626038,1,0.003942902441042098,0.996057097558958,1
2950,2021/12/14(ワクチン接種12日後)、咽頭痛のため受診した。,0 0 0 ワクチン接種 0 日 後 咽頭痛 ため 受診 する た,1,0.014648119489608964,0.9853518805103911,1,0.000481220696215957,0.9995187793037841,1,0.06379684683418374,0.9362031531658163,1,0.09654276195043876,0.9034572380495612,1,0.08487999439239502,0.9477444887161255,1,0.18485450744628906,0.8689556121826172,1,0.005508015184279157,0.9944919848157209,1
2951,2022/03/14 23:00末梢神経障害、食欲不振、下痢が発現。,0 0 0 0 0 末梢神経障害 食欲不振 下痢 発現,1,1.5992247551024922e-06,0.9999984007752449,1,0.00046402673697799006,0.999535973263022,1,0.01258682133196587,0.9874131786680341,1,2.8954616482224083e-13,0.9999999999997105,1,0.08321266621351242,0.9427585601806641,1,0.1866006851196289,0.8729909658432007,1,0.0039905356888897524,0.9960094643111103,1
2952,2022/03/31髄液検査で細胞数増多、蛋白増多、糖低下を認めた。,0 0 0 髄液 検査 だ 細胞数増多 蛋白増多 糖低下 認める た,1,0.016700764922133536,0.9832992350778664,1,0.000277805348863833,0.9997221946511362,1,0.04388315921407582,0.9561168407859242,1,0.014076628766847121,0.9859233712331529,1,0.09326742589473724,0.9417997002601624,1,0.18510670959949493,0.8750423192977905,1,0.00454762950818574,0.9954523704918143,1
2953,2022/04/14 00:00頃ショック状態となり、搬送され入院。,0 0 0 0 0 頃 ショック状態 なる 搬送 する れる 入院,1,0.003749261616077103,0.996250738383923,1,0.0004027153221595162,0.9995972846778405,1,0.01316514178714312,0.9868348582128569,1,1.1465077776051658e-09,0.9999999988534922,1,0.07978547364473343,0.9463016986846924,1,0.1772473305463791,0.8701422214508057,1,0.0039709270079721845,0.9960290729920277,1
2954,2022/05/30-2022/06/09新型コロナに感染を認めた。,0 0 0 0 0 0 新型コロナ 感染 認める た,1,0.00913776103729832,0.9908622389627018,1,0.0003330136742810664,0.9996669863257189,1,0.026712323073502686,0.9732876769264973,1,0.0029064613947847873,0.9970935386052152,1,0.0787624940276146,0.9483376741409302,1,0.18119218945503235,0.872283399105072,1,0.004141746918676434,0.9958582530813236,1
2955,2022/06/04(ワクチン接種1日後)、両上肢に皮疹が出現した。,0 0 0 ワクチン接種 0 日 後 上肢 皮疹 出現 する た,1,0.016685787402855253,0.9833142125971445,1,0.0003478863435865066,0.9996521136564135,1,0.02619673683649626,0.9738032631635037,1,0.09999119509050292,0.9000088049094971,1,0.07713040709495544,0.9514904618263245,1,0.18453502655029297,0.8753379583358765,1,0.0050730869846871245,0.994926913015313,1
2956,2022/07/16 09:55、患者は血管迷走神経反射を経験した。,0 0 0 0 0 患者 血管迷走神経反射 経験 する た,1,0.0166853913006349,0.9833146086993649,1,0.0002926677027742889,0.9997073322972257,1,0.3533345469092234,0.6466654530907766,1,0.09917879832669307,0.9008212016733069,1,0.09787232428789139,0.9476885199546814,1,0.18675243854522705,0.8722640872001648,1,0.009987877940371707,0.9900121220596283,1
2957,2回目投与直後から羞明が出現し、視力は0.7から0.02に低下した。,0回目 投与 直後 羞明 出現 視力 0 0 0 0 低下 する た,1,0.016695448341059838,0.9833045516589405,1,0.00032260969009289446,0.9996773903099071,1,0.023468298547319022,0.976531701452681,1,0.25441580141838505,0.745584198581615,1,0.08608098328113556,0.9482272267341614,1,0.19082225859165192,0.8789583444595337,1,0.006960784212240626,0.9930392157877593,1
2958,6月上旬、陰のう腫大認め、精査の結果、陰のう癌、肺転移と診断された。,0 月 上旬 陰のう腫大 認める 精査 結果 陰のう癌 肺転移 診断 する れる た,1,0.005564488065391836,0.9944355119346082,1,0.0003838256804437068,0.9996161743195563,1,0.010079872372988907,0.9899201276270111,1,0.2072247925564077,0.7927752074435923,1,0.08882793039083481,0.9425049424171448,1,0.18009942770004272,0.8731155395507812,1,0.00605867427677875,0.9939413257232212,1
2959,C-反応性蛋白:1.16 mg/dL(高値)、1.16 mg/dL。,C 反応 性 蛋白 0 0 mg dL 高値 0 0 mg dL,1,0.037440065779016214,0.9625599342209837,1,0.00020929951983587376,0.9997907004801642,1,0.08069641984244014,0.9193035801575599,0,0.5195482961797382,0.48045170382026176,1,0.09821277856826782,0.941803514957428,1,0.1994689553976059,0.8582621812820435,1,0.014391864015241057,0.985608135984759,1
2960,mRNA-1273の2回目の接種日、患者は摂氏38度の発熱を呈した。,mRNA 0 0回目 接種 日 患者 摂氏 0度 発熱 呈す た,1,0.0053449937289166026,0.9946550062710835,1,0.0005079101518955163,0.9994920898481044,1,0.006890860649305441,0.9931091393506946,1,2.6152408438839814e-07,0.9999997384759156,1,0.08032780140638351,0.9518970251083374,1,0.18789777159690857,0.8705942034721375,1,0.003955134856749787,0.9960448651432502,1
2961,サイログロブリン(2-31):667 ng/mL、667ng/mL。,サイログロブリン 0 0 0 NG mL 0 NG mL,1,0.3083740201820965,0.6916259798179035,1,0.0002243564477518618,0.9997756435522481,1,0.35873972300322543,0.6412602769967746,0,0.5195482961797382,0.48045170382026176,1,0.22093738615512848,0.8732358813285828,1,0.3363305926322937,0.7846722602844238,1,0.061406466236210454,0.9385935337637895,1
2962,しかし、患者が10/04に2回目を接種してから、左上肢痛が持続した。,患者 0 0 0回目 接種 する 左上肢痛 持続 する た,1,0.016701224821600337,0.9832987751783996,1,0.0003272991117521204,0.9996727008882479,1,0.3391047989812217,0.6608952010187783,0,0.8380276986021552,0.16197230139784483,1,0.08055832237005234,0.9524415731430054,1,0.19346244633197784,0.8684751987457275,1,0.040754766414135814,0.9592452335858641,1
2963,一度非持続性心室頻拍を認めたものの、時間とともに電気的には安定した。,非持続性心室頻拍 認める た 時間 電気 的 安定 する た,1,0.01668561501743106,0.983314384982569,1,0.00030702521800554325,0.9996929747819945,1,0.03562789945297007,0.9643721005470299,1,0.21551415003187668,0.7844858499681233,1,0.12652669847011566,0.9147090315818787,1,0.3635251820087433,0.7587627172470093,1,0.009497813222252844,0.9905021867777472,1
2964,核磁気共鳴画像:左下腹部に最大径29 mmの腫瘤の輪状濃染を認めた。,核磁気共鳴 画像 左 下腹部 最大 径 0 mm 腫瘤 の 輪状濃染 認める た,1,0.019128592090223107,0.9808714079097769,1,0.00026241722751490956,0.9997375827724851,1,0.02733828744287803,0.972661712557122,1,0.012903194255735162,0.9870968057442648,1,0.08039408922195435,0.9398501515388489,1,0.1860804557800293,0.8711523413658142,1,0.004384598563653666,0.9956154014363463,1
2965,左顔神経知覚障害・しびれ、左上肢不全麻痺、左上下肢のしびれを認めた。,左 顔 神経知覚障害 しびれ 左上肢不全 麻痺 左上 下肢のしびれ 認める た,1,0.01667098520080247,0.9833290147991975,1,0.0003480295035246547,0.9996519704964754,1,0.03431737296261861,0.9656826270373814,1,0.009525443622694363,0.9904745563773056,1,0.07620804011821747,0.9439760446548462,1,0.18985508382320404,0.8656987547874451,1,0.004399356165748513,0.9956006438342515,1
2966,症状は軽快しているが、左上腕から左肘まで中程度の痛みは持続していた。,症状 軽快 する いる 左上 腕 左肘 中程度 の 痛み 持続 する いる た,1,0.016692461603304315,0.9833075383966958,1,0.00021189108899722031,0.9997881089110028,1,0.22272982547970033,0.7772701745202997,0,0.8238757712899456,0.1761242287100544,1,0.10999336838722229,0.9333909153938293,1,0.3356758952140808,0.7889609336853027,1,0.04110457134727795,0.958895428652722,1
2967,心臓MRI検査ではT1強調像におけるガドリニウム遅延造影像を認めた。,心臓 MRI 検査 T 0 強調像 ガドリニウム 遅延 造影 像 認める た,1,0.010544311060268454,0.9894556889397317,1,0.00034058880797421267,0.9996594111920258,1,0.04918949589054522,0.9508105041094548,1,0.004800732599340107,0.9951992674006599,1,0.0966436117887497,0.9316427111625671,1,0.196627676486969,0.8669836521148682,1,0.004606797908419994,0.9953932020915799,1
2968,心内膜/間質の病巣においてテネイシン-C(TN-C)は陽性であった。,心内膜 間質 病巣 テネイシン C TN C 陽性 だ ある た,1,0.012570493765841937,0.987429506234158,1,0.00034287267451707894,0.999657127325483,1,0.0943875837972028,0.9056124162027972,0,0.6975715663913744,0.30242843360862554,1,0.12019594758749008,0.9219706654548645,1,0.24070262908935547,0.8338897228240967,1,0.022199914971521746,0.9778000850284783,1
2969,診断は急性心筋心膜炎であり、たこつぼ心筋症は主要な鑑別疾患であった。,診断 急性心筋心膜炎 だ ある たこつぼ 心筋症 主要 だ 鑑別疾患 だ ある た,1,0.016694739179253137,0.9833052608207468,1,0.00024237589750807434,0.9997576241024919,1,0.33136623902246964,0.6686337609775304,0,0.83408694929162,0.16591305070838003,1,0.10155907273292542,0.9281816482543945,1,0.22208662331104279,0.8508807420730591,1,0.04349516390839356,0.9565048360916063,1
2970,中等度の心内膜心筋線維性肥厚及び軽度の心筋間質性線維症も認められた。,中等度 心内膜 心筋線維 性肥厚 軽度 心筋 間質性 線維 症 認める られる た,1,0.012767534720284066,0.987232465279716,1,0.0003655091491310669,0.999634490850869,1,0.021280255955841376,0.9787197440441586,1,0.04110886772288935,0.9588911322771106,1,0.0865013524889946,0.9467373490333557,1,0.1867913156747818,0.8669393062591553,1,0.00454424241369283,0.9954557575863072,1
2971,著しい血小板減少(0.8万/μL)を認め、脳出血の原因と示唆された。,著しい 血小板減少 0 0 万 μ L 認める 脳出血 の 原因 示唆 する れる た,1,0.0062097150394384215,0.9937902849605617,1,0.00043354138843985733,0.9995664586115601,1,0.026237172333055225,0.9737628276669448,1,0.1838385538077486,0.8161614461922514,1,0.0788547620177269,0.9478135704994202,1,0.1832474023103714,0.876854658126831,1,0.005886861026509404,0.9941131389734905,1
2972,頭頚部MRIでは左視神経に造影効果を認め、視神経炎の診断で同日入院。,頭 頚部 MRI 左視神経 造影効果 認める 視神経炎 の 診断 だ 同日 入院,1,9.695267698712703e-06,0.9999903047323013,1,0.00048200270546647727,0.9995179972945335,1,0.011163870992247471,0.9888361290077525,1,6.456771125540328e-07,0.9999993543228874,1,0.09321539849042892,0.9401165246963501,1,0.21185341477394104,0.8599829077720642,1,0.004186403024439517,0.9958135969755605,1
2973,日付不明1週間程度経過した時期より、悪寒、発熱、肝障害、黄疸が発現。,日付 不明 0 週間 程度 経過 する た 時期 悪寒 発熱 肝障害 黄疸 発現,1,0.011337055358241763,0.9886629446417583,1,0.0003538975707872073,0.9996461024292128,1,0.01973960910471595,0.980260390895284,1,2.4811486198927923e-11,0.9999999999751885,1,0.08711948245763779,0.9496374130249023,1,0.18744021654129028,0.8721821904182434,1,0.004133870190891906,0.9958661298091082,1
2974,尿閉と髄液異常を認め、頭部MRIでは異常なく、当初髄膜炎が疑われた。,尿閉 髄液異常 認める 頭部 MRI 異常 ない 当初髄膜炎 疑う れる た,1,0.01702058315996261,0.9829794168400375,1,0.000308186897357384,0.9996918131026427,1,0.2885140091022992,0.7114859908977008,1,0.08693783647136621,0.9130621635286338,1,0.09832001477479935,0.9377991557121277,1,0.18631640076637268,0.8647668957710266,1,0.008728729497266089,0.9912712705027339,1
2975,剖検で、「肝線維症」(肝線維症);「脂肪肝」(脂肪肝)が認められた。,剖検 肝線維症 肝線維症 脂肪肝 脂肪肝 認める られる た,1,0.002892322209676598,0.9971076777903236,1,0.00034094081649552204,0.9996590591835045,1,0.07342039785894638,0.9265796021410536,1,0.03329928722468245,0.9667007127753175,1,0.07737551629543304,0.9372191429138184,1,0.18701916933059692,0.869953453540802,1,0.004855035457175108,0.9951449645428249,1
2976,薬物性肝障害、自己免疫性肝炎、肝炎の結果として治療的処置がとられた。,薬物性 肝障害 自己免疫性 肝炎 肝炎 結果 治療 的 処置 とる れる た,1,0.007952463380383804,0.9920475366196162,1,0.0003413896820544133,0.9996586103179456,1,0.025462054269746792,0.9745379457302532,1,0.09300143373322001,0.90699856626678,1,0.0857873484492302,0.9313502907752991,1,0.19647403061389923,0.8647363185882568,1,0.005166856517651929,0.9948331434823482,1
2977,柳原法にて、安静時非対称・部分強閉眼・不全頬膨らましを認め、20点。,柳原 法 安静時非対称 部分 強閉眼 不全 頬 膨らます 認める 0点,1,0.01669012214349973,0.9833098778565004,1,0.0002922981929472475,0.9997077018070527,1,0.06905306549518919,0.9309469345048108,1,4.6558223942838595e-10,0.9999999995344178,1,0.09636595845222473,0.9463722705841064,1,0.2138759046792984,0.8626891374588013,1,0.004836341912708582,0.9951636580872916,1
2978,(2022/06/07)I、II、III、のVFでST上昇、注:夜間,0 0 0 I II III VF ST 上昇 注 夜間,1,0.06670786908269392,0.933292130917306,1,0.00033022726097427604,0.9996697727390257,1,0.05235443617527091,0.9476455638247291,1,1.7571699650886785e-10,0.999999999824283,1,0.08682718127965927,0.9400622844696045,1,0.18676209449768066,0.8692042231559753,1,0.004982184629338939,0.995017815370661,1
2979,2021/06/22(ワクチン接種2日後)、患者は心筋炎を発現した。,0 0 0 ワクチン接種 0 日 後 患者 心筋炎 発現 する た,1,0.006499899006929246,0.9935001009930708,1,0.0004385006767982348,0.9995614993232018,1,0.004702308418405354,0.9952976915815946,1,0.017071130622961395,0.9829288693770386,1,0.0850362554192543,0.9470800161361694,1,0.19225122034549713,0.8614904284477234,1,0.00417748650480372,0.9958225134951961,1
2980,2021/10/31(ワクチン接種日)、摂氏37度台の発熱があった。,0 0 0 ワクチン接種 日 摂氏 0度 台 発熱 ある た,1,0.016699484206814316,0.9833005157931857,1,0.0004076274771999485,0.9995923725228001,1,0.018538840384484945,0.981461159615515,1,0.008082945771309302,0.9919170542286907,1,0.07522743940353394,0.9515855312347412,1,0.1834266036748886,0.8732827305793762,1,0.004157163651740618,0.9958428363482593,1
2981,2022/01/31、被験者は摂氏39.9度の発熱と関節痛があった。,0 0 0 被験者 摂氏 0 0度 発熱 関節痛 ある た,1,0.016665650275228393,0.9833343497247717,1,0.00029345265789393387,0.9997065473421061,1,0.015754201952768443,0.9842457980472316,1,0.01012233100565485,0.9898776689943452,1,0.07305967807769775,0.9512633085250854,1,0.18069612979888916,0.8722154498100281,1,0.004135299378455153,0.9958647006215449,1
2982,2022/02/01発現、呼吸困難(非重篤)、「息切れ」と記述された,0 0 0 発現 呼吸困難 重篤 息切れ 記述 する れる た,1,0.016690912982269795,0.9833090870177302,1,0.0003535364506956788,0.9996464635493043,1,0.012023380865419653,0.9879766191345803,1,0.2766508012581712,0.7233491987418288,1,0.07790937274694443,0.9496720433235168,1,0.17769137024879456,0.8795981407165527,1,0.006948669325581382,0.9930513306744185,1
2983,2022/04/02頃より、活気がなくなり、食欲低下が著しくなった。,0 0 0 頃 活気 なくなる 食欲低下 著しい なる た,1,0.01669560457843488,0.9833043954215651,1,0.0002757277938913434,0.9997242722061087,1,0.11171783696564475,0.8882821630343553,1,0.30928477607878757,0.6907152239212124,1,0.08851762861013412,0.9466251730918884,1,0.18873324990272522,0.8726865649223328,1,0.009321070907904242,0.9906789290920957,1
2984,2022/06/23早朝から胸痛強く、報告病院の救急外来を受診した。,0 0 0 早朝 胸痛 強い 報告 病院 救急外来 受診 する た,1,0.012466452406614776,0.987533547593385,1,0.0003269391276340802,0.999673060872366,1,0.05789261096064058,0.9421073890393594,1,0.1509567951315538,0.8490432048684462,1,0.07318881154060364,0.9464496970176697,1,0.18264706432819366,0.8753046989440918,1,0.005924994373181515,0.9940750056268184,1
2985,5月上旬から、味覚異常を自覚し烏龍茶が極端に苦くなり飲めなくなった。,0 月 上旬 味覚異常 自覚 き 烏龍茶 極端 苦い 飲める ない なる た,1,0.016661845982780983,0.9833381540172189,1,0.0002943678942921068,0.9997056321057078,1,0.20701391386831958,0.7929860861316804,1,0.31676894183106397,0.683231058168936,1,0.0883922427892685,0.9384060502052307,1,0.19054222106933594,0.8729219436645508,1,0.011533312090711298,0.9884666879092887,1
2986,しかし、血液検査で心筋逸脱酵素の上昇を認め心筋炎疑いとして入院した。,血液検査 だ 心筋逸脱酵素 上昇 認める 心筋炎 疑い 入院 する た,1,7.55535800037948e-09,0.999999992444642,1,0.0006523562055590649,0.999347643794441,1,0.002896294030676594,0.9971037059693234,1,0.04042910812596778,0.9595708918740322,1,0.08092103898525238,0.944610059261322,1,0.19233819842338562,0.8693050146102905,1,0.004266438518568105,0.9957335614814319,1
2987,患者は、背部痛、腹痛のため入院した(入院日:2022/07/20)。,患者 背部痛 腹痛 ため 入院 する た 入院 日 0 0 0,1,0.004187878479502505,0.9958121215204976,1,0.0005225511089255812,0.9994774488910744,1,0.01604865347463702,0.983951346525363,1,0.09352358017769002,0.90647641982231,1,0.08048621565103531,0.9480515122413635,1,0.18991486728191376,0.8583874106407166,1,0.004930007775143317,0.9950699922248567,1
2988,患者は陰嚢癌、新生物進行のため入院した(開始日: 2022/06)。,患者 陰嚢癌 新生物進行 ため 入院 する た 開始 日 0 0,1,0.016675823816358612,0.9833241761836413,1,0.0003329940032097191,0.9996670059967903,1,0.019344256081454625,0.9806557439185454,1,0.04277716804469456,0.9572228319553054,1,0.10870106518268585,0.9424087405204773,1,0.18705996870994568,0.8587148189544678,1,0.0047393623840146825,0.9952606376159854,1
2989,所見:頸部脊柱管狭窄による頸椎症性脊髄症と腰部脊柱管狭窄症を認めた。,所見 頸部脊柱管狭窄 頸椎症性 脊髄症 腰部脊柱管 狭窄症 認める た,1,0.01668729062305372,0.9833127093769461,1,0.0003020091824370542,0.9996979908175629,1,0.03806770060034348,0.9619322993996565,1,0.006933053739360817,0.9930669462606392,1,0.08210497349500656,0.9412029981613159,1,0.2113649845123291,0.8613389134407043,1,0.004563498256290165,0.9954365017437099,1
2990,心室細動、心肺停止、失外套症候群の結果として、治療的処置がとられた。,心室細動 心肺停止 失外套症候群 結果 治療 的 処置 とる れる た,1,0.005845150123164619,0.9941548498768356,1,0.000429280855519392,0.9995707191444806,1,0.021486218659389933,0.9785137813406101,1,0.09546171219215016,0.9045382878078498,1,0.07883594185113907,0.9423671960830688,1,0.1998291015625,0.8397734761238098,1,0.005183741795547946,0.994816258204452,1
2991,洞停止、胸痛、胸部不快感、徐脈の結果として、治療的な処置がとられた。,洞停止 胸痛 胸部不快感 徐脈 結果 治療 的 だ 処置 とる れる た,1,0.014209692123695135,0.985790307876305,1,0.00036424520438743685,0.9996357547956125,1,0.010547825091945628,0.9894521749080544,1,0.09286212862282972,0.9071378713771703,1,0.07807948440313339,0.9452211260795593,1,0.2020328938961029,0.8653791546821594,1,0.004993957539844533,0.9950060424601554,1
2992,不明日、患者は白血球減少(3000)、血小板減少(9万)を発症した。,明日 患者 白血球減少 0 血小板減少 0 万 発症 する た,1,0.01671298872978329,0.9832870112702167,1,0.00029902080392182483,0.9997009791960781,1,0.07235852755850747,0.9276414724414925,1,0.06308201000271818,0.9369179899972818,1,0.07649374008178711,0.9476702213287354,1,0.2160189300775528,0.8556472063064575,1,0.005454202892079577,0.9945457971079203,1
2993,ガンマ(免疫グロブリン)(10.2-20.4):21.4%、注記:高,GANMA 免疫グロブリン 0 0 0 0 0 0% 注記 高,1,0.021282704362200575,0.9787172956377995,1,0.0004248307969162564,0.9995751692030838,1,0.24685328856898958,0.7531467114310104,1,6.166922228434402e-07,0.9999993833077772,0,0.7191444039344788,0.36891254782676697,1,0.21009816229343414,0.8642757534980774,1,0.022602722091300348,0.9773972779086996,1
2994,Myoglobin blood: 401.8 ng/ml、注記:高値,Myoglobin BLOOD 0 0 NG ml 注記 高値,1,0.020889077772218486,0.9791109222277818,1,0.0006195372665347764,0.9993804627334653,1,0.10920007150423816,0.8907999284957618,1,0.0,1.0,1,0.1352185159921646,0.9130030274391174,1,0.20595301687717438,0.8595637083053589,1,0.00565256175998694,0.994347438240013,1
2995,(HLA)-DR抗原は毛細血管/内皮細胞でびまん性に陽性であった。,HLA DR 抗原 毛細血管 内 皮細胞 びまん性 陽性 だ ある た,1,0.02803960945660569,0.9719603905433943,1,0.00031807143305876643,0.9996819285669413,1,0.12199896345759065,0.8780010365424094,0,0.6778352383681505,0.32216476163184954,1,0.2540630102157593,0.8554834127426147,1,0.22534853219985962,0.8556129336357117,1,0.02724397159051662,0.9727560284094834,1
2996,2021/03/27、発現時刻不明、患者は両下肢筋膜炎を発現した。,0 0 0 発現 時刻 不明 患者 下肢筋膜炎 発現 する た,1,0.016687009605776112,0.9833129903942237,1,0.00028491654912049427,0.9997150834508796,1,0.017907397393845614,0.9820926026061544,1,0.026957609171157304,0.9730423908288427,1,0.09503863751888275,0.9439786672592163,1,0.1867419332265854,0.8753854632377625,1,0.004434439752370151,0.9955655602476299,1
2997,2022/02/13 14:00頃血小板減少症を伴う血栓症が発現。,0 0 0 0 0 頃 血小板減少症 伴う 血栓症 発現,1,0.00416554868441443,0.9958344513155858,1,0.0004778060428566963,0.9995221939571433,1,0.006139089523882091,0.9938609104761179,1,6.115108419635362e-13,0.9999999999993885,1,0.08248558640480042,0.9440376162528992,1,0.18269255757331848,0.8770942091941833,1,0.003933091036581394,0.9960669089634187,1
2998,2022/03上旬頃、接種後10日程度経過し、末梢神経障害が発現。,0 0 上旬 頃 接種 後 0 日 程度 経過 する 末梢神経障害 発現,1,0.01671732065201806,0.9832826793479817,1,0.00042909460938846437,0.9995709053906116,1,0.012222291814411035,0.987777708185589,1,2.0266011091507607e-12,0.9999999999979734,1,0.09154890477657318,0.9445899724960327,1,0.19285301864147186,0.8684487342834473,1,0.004193992306268716,0.9958060076937312,1
2999,2022/04/05 06:30微熱、前胸部痛、胸部違和感が発現。,0 0 0 0 0 微熱 前胸部痛 胸部違和感 発現,1,0.0025829812021518055,0.997417018797848,1,0.000392309951606934,0.9996076900483931,1,0.017666872295022507,0.9823331277049775,1,1.3389289676979388e-13,0.9999999999998661,1,0.08371717482805252,0.9443963170051575,1,0.18111664056777954,0.8715308308601379,1,0.004030569010902208,0.9959694309890978,1
3000,2022/04/20、2ヶ月の経過観察後も尿蛋白(2+)であった。,0 0 0 0 ヶ月 経過 観察 後 尿蛋白 0 だ ある た,1,0.016690995517894606,0.9833090044821055,1,0.00018112183540171603,0.9998188781645982,1,0.41511891830174297,0.584881081698257,0,0.7330647866371558,0.26693521336284415,0,0.705574095249176,0.34533002972602844,1,0.19732040166854858,0.8640312552452087,1,0.1217079182957152,0.8782920817042847,1
3001,2022/05/12、高度蛋白尿、血尿、高血圧を認め頭痛も伴った。,0 0 0 高度蛋白尿 血尿 高血圧 認める 頭痛 伴う た,1,2.699747375328243e-06,0.9999973002526247,1,0.0005031265133273048,0.9994968734866727,1,0.002599291312452734,0.9974007086875473,1,0.0017665265555121268,0.9982334734444879,1,0.07881013303995132,0.9488115310668945,1,0.18184894323349,0.8802497982978821,1,0.0038391453639177835,0.9961608546360822,1
3002,aVR誘導を除く全ての誘導にてST上昇を認めた(救急治療室にて)。,aVR 誘導 除く 全て 誘導 ST 上昇 認める た 救急 治療 室,1,0.014365459095399331,0.9856345409046006,1,0.0003531631850661663,0.9996468368149338,1,0.009822505232801704,0.9901774947671983,1,3.4811967353221007e-07,0.9999996518803265,1,0.08830999583005905,0.9446225166320801,1,0.20134520530700684,0.8535049557685852,1,0.004238116024655262,0.9957618839753446,1
3003,SARS-CoV-2ポリメラーゼ連鎖反応(PCR)は陽性であった。,SARS CoV 0 ポリメラーゼ連鎖反応 PCR 陽性 だ ある た,1,0.054442106393479295,0.9455578936065208,1,0.0003053152839742823,0.9996946847160257,1,0.16949921630866482,0.8305007836913352,0,0.9541910786563282,0.04580892134367171,1,0.1921014040708542,0.892237663269043,1,0.23317396640777588,0.8429107069969177,1,0.049595029263364426,0.9504049707366357,1
3004,さらに超音波検査でも圧痛部位に一致した不均ーな低エコー域がみられ。,超音波 検査 圧痛部位 一致 する た 均 ー だ 低エコー域 みる られる,1,0.016719243225834336,0.9832807567741657,1,0.0002775096762606394,0.9997224903237394,1,0.19404217069172036,0.8059578293082796,1,0.00022077929360153625,0.9997792207063985,1,0.1322760432958603,0.9305639863014221,1,0.23643134534358978,0.8381191492080688,1,0.006844401413053689,0.9931555985869462,1
3005,また、周辺部網膜血管から蛍光漏出を認め、血管炎の関与が示唆された。,周辺部 網膜 血管 蛍光漏出 認める 血管炎 関与 示唆 する れる た,1,0.004475726825136937,0.9955242731748629,1,0.0005139693165167471,0.9994860306834833,1,0.03914864816601782,0.9608513518339822,1,0.19456591855801475,0.8054340814419853,1,0.0909920334815979,0.9385451674461365,1,0.19650664925575256,0.869337797164917,1,0.006413119098095081,0.993586880901905,1
3006,運転中、左手小指・肘の痺れを認め、その後左足も痺れるとの訴えあり。,運転中 左手 小指 肘 痺れ 認める その後 左足 痺れ る 訴え ある,1,0.004182798090146198,0.9958172019098539,1,0.00038972330182428206,0.9996102766981757,1,0.06468256102366099,0.935317438976339,1,0.00042659088412522195,0.9995734091158748,1,0.08203370869159698,0.942202627658844,1,0.18323221802711487,0.8548350930213928,1,0.004530381520552711,0.9954696184794473,1
3007,患者は、以下の検査と処置を受けた:SARS-CoV-2検査:陽性。,患者 以下 検査 処置 受ける た SARS CoV 0 検査 陽性,1,0.22355239575552566,0.7764476042444743,1,0.00032321385309124726,0.9996767861469088,1,0.3491274910576352,0.6508725089423648,1,6.177930860218339e-07,0.999999382206914,1,0.26994627714157104,0.8517268896102905,0,0.744735062122345,0.31920871138572693,1,0.04696509671811106,0.9530349032818889,1
3008,"初回ワクチン接種後14日目、LDHは2,039 U/Lへ上昇した。",初回 ワクチン接種 後 0 日 目 LDH 0 0 U L 上昇 する た,1,0.0838002455967205,0.9161997544032795,1,0.00020147863741097215,0.9997985213625891,1,0.06641764167635267,0.9335823583236473,1,0.1887147195976545,0.8112852804023455,1,0.09206410497426987,0.9415136575698853,1,0.1847565770149231,0.8687304258346558,1,0.00772793816278986,0.9922720618372101,1
3009,診察では易疲労性が明らかであり重症筋無力症疑いで同日入院となった。,診察 易疲労性 明らか だ ある 重症 筋無力症 疑い 同日 入院 なる た,1,0.03425193488297854,0.9657480651170215,1,0.00027458107975026534,0.9997254189202497,1,0.054266822608048604,0.9457331773919514,1,0.11060226234524151,0.8893977376547585,1,0.07945387065410614,0.9471478462219238,1,0.21311673521995544,0.8685823082923889,1,0.005914781689952323,0.9940852183100477,1
3010,接種後、患者は1日目に発熱、2日目に胸痛を呈し入院したと報告した。,接種 後 患者 0 日 目 発熱 0 日 目 胸痛 呈す 入院 する た 報告 する た,1,6.302383654201972e-06,0.9999936976163458,1,0.00033598299599565636,0.9996640170040043,1,0.0015692140897979323,0.9984307859102021,1,0.0839899358175551,0.9160100641824449,1,0.08406948298215866,0.9459280371665955,1,0.1918773353099823,0.8542668223381042,1,0.004714225951527408,0.9952857740484727,1
3011,昼頃から息切れ、倦怠感、悪寒、嘔気が発現し、食事摂取困難となった。,昼 頃 息切れ 倦怠感 悪寒 嘔気 発現 食事摂取困難 なる た,1,9.501437260443864e-07,0.999999049856274,1,0.0004164352754744559,0.9995835647245256,1,0.002365792894866936,0.9976342071051331,1,0.16570274571505306,0.8342972542849469,1,0.0807451456785202,0.9499356150627136,1,0.1894172579050064,0.8712035417556763,1,0.00541041214686427,0.9945895878531358,1
3012,日付不明(2022年01月07日以降)、下腹部が腫れ、膨満感あり。,日付 不明 0 年 0 月 0 日 以降 下腹部 腫れ 膨満感 ある,1,0.03969023430990855,0.9603097656900914,1,0.0002252601384437752,0.9997747398615562,1,0.2720628859073908,0.7279371140926092,1,4.704203268257601e-06,0.9999952957967317,1,0.08797609061002731,0.9434131383895874,1,0.2026417851448059,0.866260826587677,1,0.007427653414597126,0.9925723465854028,1
3013,本剤接種後のADEMもしくはMOG抗体関連疾患の増悪が考えられた。,本 剤 接種 後 ADEM MOG 抗体 関連 疾患 増悪 考える られる た,1,0.026442505403706823,0.9735574945962933,1,0.000257520592390314,0.9997424794076097,1,0.07489124232818334,0.9251087576718167,1,0.024478291567837762,0.9755217084321622,1,0.10262394696474075,0.9362693428993225,1,0.18958692252635956,0.8637761473655701,1,0.005190632854383001,0.9948093671456171,1
3014,翌日、患者は、微熱(体温37°C)を発症したが、すぐに落ち着いた。,翌日 患者 微熱 体温 0 C 発症 する た 落ち着く た,1,0.005095306898569518,0.9949046931014304,1,0.0003284557107541328,0.9996715442892459,1,0.05301755302978772,0.9469824469702123,1,0.0013300088406352772,0.9986699911593647,1,0.08137252926826477,0.9513923525810242,1,0.18280376493930817,0.8707906007766724,1,0.004327346481108717,0.9956726535188913,1
3015,20:00頃、下顎呼吸、ときにtachycardiaが認められた。,0 0 頃 顎 呼吸 とき tachycardia 認める られる た,1,0.005002805419423449,0.9949971945805764,1,0.0003174774917996954,0.9996825225082003,1,0.022126987168417545,0.9778730128315825,1,0.06865401421987938,0.9313459857801206,1,0.0831460952758789,0.9475117921829224,1,0.18634794652462006,0.8724560141563416,1,0.004686968957462815,0.9953130310425372,1
3016,Biopsy bone marrow:レチクリン骨髄線維症を認めた,Biopsy bone marrow レチクリン 骨髄線維症 認める た,1,0.018196052752490477,0.9818039472475097,1,0.00033221457430861,0.9996677854256913,1,0.03431092931605395,0.965689070683946,1,0.00357941845604981,0.9964205815439502,1,0.07921317219734192,0.9394294619560242,1,0.1831388920545578,0.8739203810691833,1,0.004328654178751605,0.9956713458212485,1
3017,2021/09/03、腰痛増悪し、患者は地元の整形外科を受診した。,0 0 0 腰痛 増悪 患者 地元 整形外科 受診 する た,1,0.01667364948896588,0.9833263505110342,1,0.0003757226643999991,0.9996242773356,1,0.09917161065244795,0.900828389347552,1,0.15359185596754876,0.8464081440324512,1,0.07814604789018631,0.9494511485099792,1,0.17918194830417633,0.8724592924118042,1,0.006528963108520607,0.9934710368914794,1
3018,頭頂部が脱毛したので皮膚科を受診し、AGAの疑いで治療が始まった。,頭頂 部 脱毛 する た 皮膚科 受診 する AGA 疑い 治療 始まる た,1,0.014167856747032822,0.9858321432529674,1,0.00042528815535155287,0.9995747118446484,1,0.06927860468265057,0.9307213953173494,1,0.28256150681658,0.71743849318342,1,0.08024653047323227,0.9466813802719116,1,0.18719832599163055,0.8595554828643799,1,0.008114738232336655,0.9918852617676633,1
3019,2021/07/17、腋窩の腫脹感、シビレ、両足関節痛が発現した。,0 0 0 腋窩 腫脹感 シビレ 両足関節痛 発現 する た,1,0.010227366979546714,0.9897726330204534,1,0.00036085432481994706,0.9996391456751801,1,0.018951109761968343,0.9810488902380317,1,0.09545451688727558,0.9045454831127244,1,0.07501176744699478,0.9502227306365967,1,0.1855314075946808,0.8759160041809082,1,0.004890258476143815,0.9951097415238561,1
3020,2021/09/02朝、患者はめまい、頭痛と朝起床困難を発現した。,0 0 0 朝 患者 めまい 頭痛 朝起床困難 発現 する た,1,0.0038957618789637895,0.996104238121036,1,0.00040572960328704035,0.999594270396713,1,0.003518861315256472,0.9964811386847435,1,0.09182871918020619,0.9081712808197938,1,0.07807300239801407,0.9486786127090454,1,0.18576061725616455,0.8769221901893616,1,0.004667426674789188,0.9953325733252109,1
3021,2021/10/26、患者は急性心筋炎および急性心膜炎を発現した。,0 0 0 患者 急性心筋炎 急性心膜炎 発現 する た,1,0.009172682047776081,0.9908273179522239,1,0.0004108982820986831,0.9995891017179013,1,0.013782634949524253,0.9862173650504757,1,0.00849606537260239,0.9915039346273976,1,0.08750863373279572,0.949802815914154,1,0.17762868106365204,0.873982310295105,1,0.004090768583827568,0.9959092314161725,1
3022,2021/11/21、患者は起立性調節障害、胃食道逆流を発現した。,0 0 0 患者 起立性 調節障害 胃食道逆流 発現 する た,1,0.01670141601306991,0.9832985839869299,1,0.0003335886337865427,0.9996664113662135,1,0.017370694206666926,0.9826293057933331,1,0.10645910008655535,0.8935408999134447,1,0.09650716185569763,0.9416924118995667,1,0.1832132786512375,0.8728171586990356,1,0.005204261949054451,0.9947957380509456,1
3023,2022/03/03、被験者は咳と発熱(摂氏38.2度)があった。,0 0 0 被験者 咳 発熱 摂氏 0 0度 ある た,1,0.004965561731325009,0.995034438268675,1,0.00038272839058918874,0.9996172716094108,1,0.019419679917371258,0.9805803200826287,1,0.08518454193073377,0.9148154580692662,1,0.07270482927560806,0.9498934745788574,1,0.1818327009677887,0.8724880814552307,1,0.004735416161936242,0.9952645838380638,1
3024,2022/03/28、胸痛発生しプライバシー病院へ緊急搬送された。,0 0 0 胸痛発生 き プライバシー 病院 緊急 搬送 する れる た,1,0.016692992357181198,0.9833070076428189,1,0.0003065030950695087,0.9996934969049305,1,0.21685073832211266,0.7831492616778873,1,0.21656264274172388,0.7834373572582761,1,0.07177634537220001,0.9482918977737427,1,0.17546160519123077,0.8693485856056213,1,0.009289139725749329,0.9907108602742506,1
3025,2022/04/27発現、発熱(入院)、転帰「回復」(2022年),0 0 0 発現 発熱 入院 転帰 回復 0 年,1,0.004794740903553996,0.9952052590964462,1,0.0002782143116512833,0.9997217856883487,1,0.01405974556025369,0.9859402544397463,1,2.4116385599626255e-07,0.999999758836144,1,0.10450176894664764,0.9335927367210388,1,0.21910633146762848,0.8505890369415283,1,0.004397517926594303,0.9956024820734058,1
3026,2022/05/17(ワクチン接種3日後)、患者は発熱を発現した。,0 0 0 ワクチン接種 0 日 後 患者 発熱 発現 する た,1,7.419385969418123e-06,0.9999925806140305,1,0.0004846176994947896,0.9995153823005052,1,0.005633956424104025,0.994366043575896,1,0.011203747902965189,0.9887962520970348,1,0.08227280527353287,0.9520092010498047,1,0.18930073082447052,0.8713717460632324,1,0.004001215177410065,0.99599878482259,1
3027,2022/06/01当院受診時に左側胸部誘導の陰性T波が出現した。,0 0 0 院 受診 時 左側胸部 誘導 陰性 T 波 出現 する た,1,0.03908153362370543,0.9609184663762947,1,0.00029698403036686704,0.9997030159696332,1,0.06568206453668868,0.9343179354633113,1,0.17116262243157265,0.8288373775684273,1,0.08031970262527466,0.950292706489563,1,0.18632353842258453,0.8754763603210449,1,0.006648591783337967,0.993351408216662,1
3028,2022/07/11 00:30ころ、心肺停止となり救急要請した。,0 0 0 0 0 ころ 心肺停止 なる 救急 要請 する た,1,0.01669284003457929,0.9833071599654207,1,0.0003031363144431661,0.9996968636855569,1,0.20666937799209006,0.7933306220079099,1,0.21491015014785253,0.7850898498521475,1,0.08081155270338058,0.940439760684967,1,0.19619180262088776,0.8735255002975464,1,0.009379445747823156,0.9906205542521769,1
3029,2022/07/19 15:00発現、喘鳴(入院)、転帰「不明」。,0 0 0 0 0 発現 喘鳴 入院 転帰 不明,1,0.006145226601508367,0.9938547733984918,1,0.00035771774273787117,0.9996422822572621,1,0.007078286380437615,0.9929217136195624,1,4.390620031446968e-05,0.9999560937996855,1,0.08616960793733597,0.9407064914703369,1,0.19166918098926544,0.8627853989601135,1,0.004076617099358357,0.9959233829006416,1
3030,ワクチン接種後、15分ほどで両眼の瘙痒感と下半身の熱感を自覚した。,ワクチン接種 後 0分 だ 眼 瘙痒感 下半身 熱感 自覚 する た,1,0.016696265509727456,0.9833037344902723,1,0.00031954633752311084,0.9996804536624769,1,0.07738214401916443,0.9226178559808356,1,0.16409188438157973,0.8359081156184203,1,0.08251161128282547,0.953671395778656,1,0.18977124989032745,0.8740131855010986,1,0.006442200653901718,0.9935577993460983,1
3031,圧迫骨折、背部痛、ストレス骨折の結果として、治療的処置がとられた。,圧迫 骨折 背部痛 ストレス 骨折 結果 治療 的 処置 とる れる た,1,0.0026771306102917197,0.9973228693897085,1,0.00041230611993568544,0.9995876938800643,1,0.028746951943891985,0.971253048056108,1,0.08315504294076559,0.9168449570592344,1,0.0780702531337738,0.9418830275535583,1,0.19908323884010315,0.8575184941291809,1,0.005005174962499989,0.9949948250374999,1
3032,咳嗽、発熱、湿性咳嗽、変色痰の結果として、治療的な処置がとられた。,咳嗽 発熱 湿性咳嗽 変色 痰 結果 治療 的 だ 処置 とる れる た,1,0.005655275640676126,0.9943447243593239,1,0.00039015712253722453,0.9996098428774628,1,0.004937697058215007,0.995062302941785,1,0.09553455583771908,0.9044654441622809,1,0.07428332418203354,0.9474923014640808,1,0.19327403604984283,0.866015613079071,1,0.004806752757018095,0.9951932472429819,1
3033,肝機能に関しては、GOT、GPT、γGTPがすべて急激に上昇した。,機能 GOT GPT γGTP すべて 急激 上昇 する た,1,0.09062560769868315,0.9093743923013168,1,0.00026570665454940106,0.9997342933454506,1,0.08442379332723715,0.9155762066727628,1,0.24824596729436665,0.7517540327056333,1,0.09013066440820694,0.9428549408912659,1,0.19393391907215118,0.8700737357139587,1,0.009177851249946536,0.9908221487500536,1
3034,駆出率減少、心電図ST上昇、心電図T波逆転(陰性T波)が発現した。,駆け出し 率 減少 心電図 ST 上昇 心電図 T 波 逆転 陰性 T 波 発現 する た,1,0.013328551472075631,0.9866714485279243,1,0.00033832284909556556,0.9996616771509045,1,0.010068915086083208,0.9899310849139168,1,0.12535197923709995,0.8746480207629,1,0.08174978196620941,0.950528621673584,1,0.18918807804584503,0.870046854019165,1,0.005212538791563133,0.994787461208437,1
3035,心筋生検:リンパ球の増加、注記:リンパ球の増加と心筋の脱落を認めた,心筋生検 リンパ球 増加 注記 リンパ球 増加 心筋 脱落 認める た,1,0.006739846997781534,0.9932601530022185,1,0.00043570015150428586,0.9995642998484957,1,0.023719323434761796,0.9762806765652382,1,0.008217909689732128,0.9917820903102679,1,0.09934695065021515,0.9361554384231567,1,0.18270303308963776,0.863139271736145,1,0.004324955184017792,0.9956750448159823,1
3036,心電図異常、心筋逸脱酵素の上昇がみられ、心膜心筋炎として入院した。,心電図異常 心筋逸脱酵素 上昇 みる られる 心膜心筋炎 入院 する た,1,4.304468413130475e-06,0.9999956955315867,1,0.0003677311089019559,0.999632268891098,1,0.007510172596624454,0.9924898274033755,1,0.08282079024727906,0.9171792097527209,1,0.08044200390577316,0.9468268752098083,1,0.18592296540737152,0.8686373233795166,1,0.004643219640640983,0.995356780359359,1
3037,典型的な画像診断の特徴に基づき、脳梁の細胞傷害性病変と診断された。,典型 的 だ 画像 診断 特徴 基づく 脳梁 の 細胞傷害 性病変 診断 する れる た,1,0.01671069725672637,0.9832893027432738,1,0.00036271411188788815,0.9996372858881121,1,0.03433570263186425,0.9656642973681357,1,0.1386245161019456,0.8613754838980544,1,0.09109126031398773,0.9414500594139099,1,0.19506710767745972,0.8679099082946777,1,0.005805458316017249,0.9941945416839828,1
3038,翌日の2022/07/05、しびれの範囲がくるぶしにまで拡大した。,翌日 0 0 0 しびれ 範囲 くるぶし 拡大 する た,1,0.016687938817379927,0.9833120611826199,1,0.00033633545044031585,0.9996636645495597,1,0.17548540389110734,0.8245145961088927,1,0.2975340947567824,0.7024659052432176,1,0.12427514046430588,0.934005081653595,1,0.19467785954475403,0.8733552098274231,1,0.010896905196665493,0.9891030948033346,1
3039,2022/07/21、患者はPCR検査を受け、結果は陽性であった。,0 0 0 患者 PCR検査 受ける 結果 陽性 だ ある た,1,0.16265616758607826,0.8373438324139217,1,0.0003343545632741683,0.9996656454367259,0,0.5066120620990113,0.4933879379009887,0,0.9226535718478337,0.07734642815216625,1,0.16947436332702637,0.8918328881263733,1,0.2890154719352722,0.8203178644180298,1,0.11213177394793426,0.8878682260520656,1
3040,翌日には症状は軽快したものの、心筋逸脱酵素はいずれも上昇していた。,翌日 症状 軽快 する た 心筋逸脱酵素 いずれ 上昇 する いる た,1,0.01668230200347926,0.9833176979965209,1,0.00017174272806914795,0.9998282572719308,1,0.16042263050634842,0.8395773694936516,1,0.3614025777482236,0.6385974222517764,1,0.19697314500808716,0.8759436011314392,1,0.37389206886291504,0.7367714047431946,1,0.0186242432871215,0.9813757567128785,1
3041,18:30頃41.2°Cの発熱及びけいれん発作を主訴に救急要請。,0 0 頃 0 0 C 発熱 けいれん 発作 主訴 救急 要請,1,0.004144938298930756,0.9958550617010692,1,0.0003907510697917036,0.9996092489302083,1,0.01810342918665886,0.9818965708133411,1,5.218048215738236e-14,0.9999999999999478,1,0.08397476375102997,0.9428050518035889,1,0.18884438276290894,0.8655176162719727,1,0.004109952916263978,0.9958900470837361,1
3042,20:50自宅浴室の浴槽内で入浴中に溺水して死亡した状態で発見。,0 0 自宅 浴室 浴槽 内 入浴 中 溺水 する 死亡 する た 状態 だ 発見,1,0.016699175919724925,0.9833008240802751,1,0.0003003403742063094,0.9996996596257937,0,0.5752266759791855,0.4247733240208144,1,2.39479557295752e-08,0.9999999760520443,1,0.0910988450050354,0.9309874176979065,1,0.19040556252002716,0.8645077347755432,1,0.013002340190449461,0.9869976598095505,1
3043,2021/08/10、好酸球数高値、紫斑、末梢神経障害を認めた。,0 0 0 好酸球 数 高値 紫斑 末梢神経障害 認める た,1,5.335457055559434e-06,0.9999946645429445,1,0.000557084191661257,0.9994429158083388,1,0.006714766583622356,0.9932852334163776,1,0.0005460096860803176,0.9994539903139197,1,0.07858307659626007,0.9456601738929749,1,0.1854708343744278,0.8786605000495911,1,0.0038932103468123863,0.9961067896531877,1
3044,2022/03/06 JCS 2桁の意識障害が出現し、前医受診。,0 0 0 JCS 0 桁 意識障害 出現 医 受診,1,2.8776611288319545e-07,0.9999997122338871,1,0.00045176901733580757,0.9995482309826642,1,0.01251713096566287,0.9874828690343371,1,3.116358282539977e-10,0.9999999996883642,1,0.08298005163669586,0.9445546865463257,1,0.1799919456243515,0.868933379650116,1,0.003971714887726834,0.9960282851122733,1
3045,2022/03/18(ワクチン接種の1日後)朝、血尿を発現した。,0 0 0 ワクチン接種 0 日 後 朝 血尿 発現 する た,1,0.005314713366510353,0.9946852866334898,1,0.0004711352852646428,0.9995288647147353,1,0.009700427435965553,0.9902995725640344,1,0.0408924720158953,0.9591075279841047,1,0.07465465366840363,0.9513898491859436,1,0.19018560647964478,0.8743929862976074,1,0.00428566326119653,0.9957143367388034,1
3046,2022/03/26出勤するも体調が悪く、休憩を長くとっていた。,0 0 0 出勤 する 体調 悪い 休憩 長い とる いる た,1,0.01671968764772749,0.9832803123522724,1,0.00037202562038423997,0.9996279743796158,1,0.12689944653591045,0.8731005534640895,1,0.2784579439555106,0.7215420560444894,1,0.09413652122020721,0.9367252588272095,1,0.19969062507152557,0.8653402328491211,1,0.009346710618520571,0.9906532893814796,1
3047,2022/03/29 12:00血小板減少症を伴う血栓症が発現。,0 0 0 0 0 血小板減少症 伴う 血栓症 発現,1,0.004662627605110766,0.9953373723948893,1,0.00044909367982462803,0.9995509063201754,1,0.0065070965396504254,0.9934929034603496,1,1.5076828674409626e-13,0.9999999999998492,1,0.08493077754974365,0.9425786733627319,1,0.1871589869260788,0.8770562410354614,1,0.003972783841174478,0.9960272161588256,1
3048,2022/04/20右上肢の浮腫、両手関節痛も出現し、当院初診。,0 0 0 右 上肢 浮腫 両手関節痛 出現 院 初診,1,7.5963815120614375e-06,0.999992403618488,1,0.00046026170905249267,0.9995397382909476,1,0.00658589493923345,0.9934141050607666,1,0.0,1.0,1,0.07654357701539993,0.9455624222755432,1,0.18996277451515198,0.8714582324028015,1,0.003925193168534082,0.9960748068314659,1
3049,2022年4月18日胸痛自覚し、急性の胸痛又は胸部圧迫感あった。,0 年 0 月 0 日 胸痛 自覚 急性 胸痛 胸部圧迫感 ある た,1,0.004376527731057512,0.9956234722689427,1,0.00044560701239459836,0.9995543929876054,1,0.016959799040347723,0.9830402009596523,1,0.027699530755895818,0.9723004692441042,1,0.07545497268438339,0.9441651701927185,1,0.18419714272022247,0.8777634501457214,1,0.004221587236955582,0.9957784127630445,1
3050,5月30日のECGを取り寄せたところV2-5のST上昇を認めた。,0 月 0 日 ECG 取り寄せる た ところ V 0 0 ST 上昇 認める た,1,0.0053341719570608615,0.994665828042939,1,0.00042634244714424293,0.9995736575528558,1,0.012025388722879393,0.9879746112771206,1,0.001226044036333529,0.9987739559636665,1,0.07357793301343918,0.9468234777450562,1,0.19421638548374176,0.8721805214881897,1,0.004017036197494622,0.9959829638025054,1
3051,CAGでは重要な狭窄は示されず、LVGは前壁の運動低下を示した。,CAG 重要 だ 狭窄 示す れる ぬ LVG 壁 運動低下 示す た,1,0.06462640779734168,0.9353735922026581,1,0.00028035597451838226,0.9997196440254816,1,0.40114758956456664,0.5988524104354334,1,0.03699452489781341,0.9630054751021866,1,0.08783531934022903,0.9426147937774658,1,0.1893080621957779,0.8608225584030151,1,0.010769639446461251,0.9892303605535387,1
3052,アナフィラキシー反応、感覚鈍麻の結果として、治療処置がとられた。,アナフィラキシー反応 感覚鈍麻 結果 治療 処置 とる れる た,1,1.7538452776449048e-05,0.9999824615472236,1,0.00042887641035039995,0.9995711235896496,1,0.021486218659389933,0.9785137813406101,1,0.05614685021663157,0.9438531497833684,1,0.0866255909204483,0.9428118467330933,1,0.20270587503910065,0.8547433018684387,1,0.004716011385801296,0.9952839886141988,1
3053,"トロポニンT:1,660 ng/L(高値)1,660 ng/L。",トロポニン T 0 0 NG L 高値 0 0 NG L,1,0.18023528217219023,0.8197647178278099,1,0.0003066565701657298,0.9996933434298343,1,0.16357797755856263,0.8364220224414374,0,0.5195482961797382,0.48045170382026176,1,0.09650001674890518,0.938788652420044,1,0.19656147062778473,0.8542435169219971,1,0.022474693074517164,0.9775253069254829,1
3054,下壁誘導のST上昇様もあったため、心筋炎の可能性あり当院へ紹介。,壁 誘導 ST 上昇 様 ある た ため 心筋炎 の 可能性 ある 院 紹介,1,0.0030181756443929657,0.9969818243556069,1,0.0004491669816177816,0.9995508330183822,1,0.009390849568198134,0.9906091504318019,1,8.811977898481871e-07,0.9999991188022102,1,0.09076491743326187,0.9353978633880615,1,0.2058325856924057,0.8462353944778442,1,0.004238418671302034,0.995761581328698,1
3055,元々視力に左右差はないが、入院後の右眼視力は左より低下していた。,視力 左右 差 ない 入院 後 右 眼 視力 左 低下 する いる た,1,0.01667635235178808,0.9833236476482118,1,0.00023653993735786986,0.9997634600626422,1,0.1543908722934676,0.8456091277065324,1,0.46892650966012317,0.5310734903398768,1,0.08829855918884277,0.9431450963020325,1,0.33953288197517395,0.7936516404151917,1,0.017489595932683354,0.9825104040673166,1
3056,限界フリッカ値は両眼とも正常であったが、右眼に中心暗点を認めた。,限界 FLICKA 値 眼 正常 だ ある た 右 眼 中心暗点 認める た,1,0.022683657833790644,0.9773163421662092,1,0.00024901878714620655,0.9997509812128538,1,0.018622620415453373,0.9813773795845466,1,0.0044429029303569845,0.995557097069643,1,0.09097528457641602,0.9380866289138794,1,0.2055799961090088,0.8672502636909485,1,0.0044217630605186764,0.9955782369394813,1
3057,心臓超音波検査にて、左室駆出率52%であり、心嚢液貯留を認めた。,心臓 超音波 検査 左 室 駆け出し 率 0% だ ある 心嚢液 貯留 認める た,1,0.016670332304948274,0.9833296676950517,1,0.00022880594458254684,0.9997711940554175,1,0.07847547447059133,0.9215245255294087,1,0.004057993041290842,0.9959420069587092,1,0.08090037852525711,0.9470024108886719,1,0.20316281914710999,0.8624419569969177,1,0.0048374615998227136,0.9951625384001772,1
3058,心電図にてびまん性ST上昇及び左心室に軽微な壁運動異常を認めた。,心電図 びまん性 ST 上昇 左心室 軽微 だ 壁運動異常 認める た,1,0.008084618886123489,0.9919153811138767,1,0.00037144079984099894,0.999628559200159,1,0.015667033094166727,0.9843329669058333,1,0.031226140868165775,0.9687738591318342,1,0.07917289435863495,0.9461973309516907,1,0.18908807635307312,0.8691787123680115,1,0.0043361769302841975,0.9956638230697158,1
3059,心電図上、1、2、aVF、V3-6にて広範囲にST上昇を認めた。,心電図 上 0 0 aVF V 0 0 広範囲 ST 上昇 認める た,1,2.613478011133827e-06,0.9999973865219889,1,0.0005033408167368391,0.9994966591832631,1,0.009237247680439986,0.99076275231956,1,0.019272362400003074,0.9807276375999969,1,0.07976879924535751,0.946525514125824,1,0.1814139187335968,0.8764505386352539,1,0.004054915762942589,0.9959450842370574,1
3060,夜、これまでに経験したことのない痛みのため、当院救急外来を受診。,夜 これ 経験 する た こと ない 痛み ため 院 救急外来 受診,1,0.016074429722145248,0.9839255702778547,1,0.0002383720414262241,0.9997616279585738,1,0.16286521823514644,0.8371347817648536,1,8.168330789537492e-09,0.9999999918316692,1,0.09891525655984879,0.9424809217453003,1,0.22291478514671326,0.8482764363288879,1,0.005996461268844172,0.9940035387311559,1
3061,心エコー図:心膜肥厚と吸気時のseptal bounceを認めた,心 エコー 図 心膜肥厚 吸気時 septal bounce 認める た,1,0.016689841253637948,0.9833101587463621,1,0.000276049203014706,0.9997239507969853,1,0.03806770060034348,0.9619322993996565,1,0.01364245587470414,0.9863575441252959,1,0.082215815782547,0.945275068283081,1,0.19298097491264343,0.8643363118171692,1,0.004509440753967597,0.9954905592460324,1
3062,2022/05/08、意識障害のため当院に来院し、入院加療した。,0 0 0 意識障害 ため 院 来院 する 入院 加療 する た,1,1.8267208676316603e-09,0.9999999981732791,1,0.0006375617514992015,0.9993624382485008,1,0.006175595811523826,0.9938244041884762,1,0.026868864854125984,0.973131135145874,1,0.07299533486366272,0.9477615356445312,1,0.18455299735069275,0.8696539402008057,1,0.0041006402208126624,0.9958993597791873,1
3063,食欲低下、息切れを自覚し、CT結果説明と合わせて病院を受診した。,食欲低下 息切れ 自覚 CT 結果 説明 合わせる 病院 受診 する た,1,0.004810892994930025,0.9951891070050699,1,0.0004428836015377981,0.9995571163984622,1,0.013555595783089847,0.9864444042169102,1,0.15523294647702046,0.8447670535229795,1,0.08276115357875824,0.9464688301086426,1,0.1870562732219696,0.8685061931610107,1,0.005502292558996244,0.9944977074410037,1
3064,2021/07/24、患者は体感失調、頭痛、歩行障害を発現した。,0 0 0 患者 体感 失調 頭痛 歩行障害 発現 する た,1,0.003249667910382159,0.9967503320896178,1,0.0004444152531482881,0.9995555847468517,1,0.0044180677426872705,0.9955819322573127,1,0.06191325581013729,0.9380867441898627,1,0.0789613202214241,0.949367880821228,1,0.18116198480129242,0.8793042302131653,1,0.00437049908103141,0.9956295009189686,1
3065,2022/03/08(報告の通り)、視力低下と左半盲が発現した。,0 0 0 報告 通り 視力低下 左半盲 発現 する た,1,0.016690776737099587,0.9833092232629006,1,0.0003111172098890573,0.9996888827901109,1,0.009973523585646626,0.9900264764143534,1,0.06407988665452413,0.9359201133454759,1,0.08023218810558319,0.9462868571281433,1,0.19220568239688873,0.8715859651565552,1,0.004663454921134409,0.9953365450788657,1
3066,2022/03/15、左手掌に直径5-6mmの水疱が形成された。,0 0 0 左手 掌 直径 0 0mm 水疱 形成 する れる た,1,0.06690032613072522,0.9330996738692747,1,0.00030842167667042333,0.9996915783233296,1,0.3169884258361091,0.6830115741638909,1,0.1718474698615109,0.8281525301384891,1,0.09212493151426315,0.9396032691001892,1,0.1827288717031479,0.8719236254692078,1,0.01183739349651394,0.9881626065034861,1
3067,2022/05/07より発熱、咳嗽、鼻汁、頭痛あり近医受診した。,0 0 0 発熱 咳嗽 鼻汁 頭痛 ある 近医 受診 する た,1,4.5074049226840977e-07,0.9999995492595077,1,0.0004752485357606415,0.9995247514642394,1,0.003978723513590854,0.9960212764864091,1,0.1537218834285391,0.8462781165714609,1,0.07585109770298004,0.9474678039550781,1,0.1786971390247345,0.8726773858070374,1,0.005224051206622894,0.9947759487933772,1
3068,40.1度の高熱(2022/02/03午前2時頃、搬送先病院)。,0 0度 高熱 0 0 0 午前0時 頃 搬送先 病院,1,0.016681594005174265,0.9833184059948256,1,0.0003520018999346456,0.9996479981000653,1,0.2176927302160241,0.7823072697839759,1,0.0,1.0,1,0.0840686559677124,0.9483123421669006,1,0.22905239462852478,0.8475382924079895,1,0.006605160753838344,0.9933948392461617,1
3069,Tnl(トロポニンI)も3.8から13まで経時的な上昇を認めた。,Tnl トロポニン I 0 0 0 経時 的 だ 上昇 認める た,1,0.027438867811112058,0.972561132188888,1,0.0002797921976022125,0.9997202078023978,1,0.05579352813379457,0.9442064718662054,1,0.02651577965385299,0.973484220346147,1,0.08646735548973083,0.9425034523010254,1,0.18463431298732758,0.8732372522354126,1,0.004846775407525506,0.9951532245924745,1
3070,意識消失、心肺停止、転倒、嘔吐の結果として治療的処置がとられた。,意識消失 心肺停止 転倒 嘔吐 結果 治療 的 処置 とる れる た,1,3.843074510176986e-06,0.9999961569254898,1,0.0005764500134456662,0.9994235499865544,1,0.00872261862756507,0.9912773813724349,1,0.09455884272003012,0.9054411572799699,1,0.07883724570274353,0.9457369446754456,1,0.18791398406028748,0.8658300042152405,1,0.00478681260330126,0.9952131873966987,1
3071,患者は2021/06/28から2021/07/16まで入院した。,患者 0 0 0 0 0 0 入院 する た,1,0.024250064555591366,0.9757499354444089,1,0.0002993600571584468,0.9997006399428415,1,0.06789795766116524,0.9321020423388348,1,0.03332478492863944,0.9666752150713606,1,0.08469255268573761,0.9436013102531433,1,0.28402113914489746,0.8161814212799072,1,0.00582632944878573,0.9941736705512143,1
3072,甲状腺エコー:(2021/10/21)反応性腫脹の疑いを示した。,甲状腺 エコー 0 0 0 反応性腫脹 疑い 示す た,1,0.04256187612522275,0.9574381238747773,1,0.00035396997968972554,0.9996460300203103,1,0.0875982238440618,0.9124017761559382,1,0.004098458197676735,0.9959015418023233,1,0.07734928280115128,0.9451451897621155,1,0.2064611315727234,0.8515813946723938,1,0.0052529894328298896,0.9947470105671702,1
3073,左上腕から左肩への痛み、左前腕しびれ、左手先のしびれが持続した。,左上 腕 左肩 痛み 左前腕 しびれ 左 手先のしびれ 持続 する た,1,0.007085571317046851,0.992914428682953,1,0.0003202730550556023,0.9996797269449444,1,0.1282098689930522,0.8717901310069478,1,0.34730077280686833,0.6526992271931317,1,0.07548470050096512,0.94461989402771,1,0.19796614348888397,0.8659964799880981,1,0.010238260066041461,0.9897617399339586,1
3074,頭痛、副鼻腔嚢胞、悪心、食欲減退の結果として治療処置がとられた。,頭痛 副鼻腔嚢胞 悪心 食欲減退 結果 治療 処置 とる れる た,1,0.006679421507638323,0.9933205784923618,1,0.00041572020681732624,0.9995842797931827,1,0.0038362607409025973,0.9961637392590974,1,0.09053593974799068,0.9094640602520093,1,0.08129367977380753,0.94649338722229,1,0.18927037715911865,0.8706330060958862,1,0.0047557789676948535,0.9952442210323053,1
3075,発熱し強直間代性痙攣を繰り返し意識障害が遷延し前医入院となった。,発熱 する 強直 間代性 痙攣 繰り返す 意識障害 遷延 する 医 入院 なる た,1,3.0866810388560346e-07,0.999999691331896,1,0.00048310203575845155,0.9995168979642416,1,0.028150092108134128,0.9718499078918659,1,0.11059291186852971,0.8894070881314703,1,0.0766616240143776,0.948647141456604,1,0.18582700192928314,0.8646350502967834,1,0.005105386094574152,0.9948946139054258,1
3076,痙攣発作、呼吸音異常、発熱の結果として、治療的な処置がとられた。,痙攣 発作 呼吸音異常 発熱 結果 治療 的 だ 処置 とる れる た,1,0.0035412810916543324,0.9964587189083455,1,0.00044886881616834526,0.9995511311838317,1,0.004114311962177042,0.995885688037823,1,0.09403094842450788,0.9059690515754921,1,0.07514133304357529,0.9513788819313049,1,0.18918220698833466,0.8558237552642822,1,0.00477959563614973,0.9952204043638504,1
3077,正常低値:0正常高値:0.2コメント:有害事象発生前16-18。,正常 値 0 正常高値 0 0 コメント 有害事象発生 0 0,1,0.016659745178431842,0.9833402548215681,1,0.0002579204820460481,0.9997420795179539,1,0.46304951591817556,0.5369504840818244,1,0.06261273302280113,0.9373872669771989,1,0.15776704251766205,0.9111676216125488,1,0.21687832474708557,0.8401329517364502,1,0.013499710516953334,0.9865002894830466,1
3078,心電図: (2022/04/08)ST上昇、注記:心内膜炎なし。,心電図 0 0 0 ST 上昇 注記 心内膜炎 ない,1,0.0889987999242567,0.9110012000757433,1,0.00020925740541855855,0.9997907425945814,0,0.7523476253993967,0.24765237460060333,1,0.05151305517413507,0.9484869448258649,1,0.1652148962020874,0.8905011415481567,1,0.33911776542663574,0.7538713812828064,1,0.03376760772342863,0.9662323922765713,1
3079,頭痛、倦怠感、発熱、両下肢筋力低下、食欲低下、歩行時の疲れやすさ,頭痛 倦怠感 発熱 両下肢筋力低下 食欲低下 歩行 時 疲れ 安さ,1,2.474296005454997e-06,0.9999975257039947,1,0.00037692408113185536,0.9996230759188681,1,0.013835794364718823,0.9861642056352812,1,4.4047981154982097e-05,0.999955952018845,1,0.08699271827936172,0.9424689412117004,1,0.20043858885765076,0.8669741749763489,1,0.004096598269911665,0.9959034017300883,1
3080,05/29 AM4時、顔面浮腫、上半身両上肢発赤、右眼瞼浮腫。,0 0 AM 0時 顔面浮腫 上半身 両上肢発赤 右眼瞼浮腫,1,0.042209711091822866,0.9577902889081771,1,0.00026678641202185216,0.9997332135879782,1,0.4068323482018076,0.5931676517981924,1,1.5551340215580467e-09,0.999999998444866,1,0.08087355643510818,0.9451900720596313,1,0.19460906088352203,0.8737636208534241,1,0.009519447871919464,0.9904805521280805,1
3081,18:40接種後座位にて10分待機後、血管迷走神経反射が発現。,0 0 接種 後 座位 0分 待機 後 血管迷走神経反射 発現,1,0.0059930961078468094,0.9940069038921534,1,0.0003614028069163782,0.9996385971930836,1,0.019436934980843867,0.9805630650191561,1,1.7177417266367456e-09,0.9999999982822583,1,0.09776556491851807,0.9426361918449402,1,0.20773926377296448,0.8410289883613586,1,0.00437886395366273,0.9956211360463373,1
3082,2021/06/16 10:50、アナフィラキシーを発現した。,0 0 0 0 0 アナフィラキシー 発現 する た,1,0.005388145411737946,0.9946118545882621,1,0.0004120984298385544,0.9995879015701614,1,0.009830092720909511,0.9901699072790905,1,0.013590496338567792,0.9864095036614322,1,0.08757621794939041,0.9449957013130188,1,0.18129630386829376,0.8759285807609558,1,0.0040961219102185345,0.9959038780897814,1
3083,2021/09/07目の奥・頭全体の痛み、両足の痺れを認めた。,0 0 0 目 奥 ・ 頭 全体 痛み 両足 痺れ 認める た,1,1.8320898856633036e-05,0.9999816791011433,1,0.00036009015563883074,0.9996399098443611,1,0.015788701730375387,0.9842112982696246,1,0.00937881315961342,0.9906211868403866,1,0.07501636445522308,0.9470911622047424,1,0.18515388667583466,0.8742551207542419,1,0.004029464522711547,0.9959705354772885,1
3084,2021/10/22 10:00デスクワーク中に失神を認めた。,0 0 0 0 0 デスクワーク 中 失神 認める た,1,0.0025738223063197212,0.9974261776936802,1,0.00037570459308132904,0.9996242954069187,1,0.025039656570858604,0.9749603434291414,1,0.004482603320062228,0.9955173966799378,1,0.07359376549720764,0.9485293626785278,1,0.18246835470199585,0.8743700385093689,1,0.004062468641821006,0.995937531358179,1
3085,2022/03/28午後、突然左胸部に圧迫感を伴う痛みが出現。,0 0 0 午後 左 胸部 圧迫感 伴う 痛み 出現,1,0.00371958225379119,0.9962804177462088,1,0.00048340749190689986,0.9995165925080931,1,0.009008794503889583,0.9909912054961104,1,0.0007133877703328073,0.9992866122296672,1,0.0818406194448471,0.9442744851112366,1,0.1848566234111786,0.8688945770263672,1,0.003995347079584616,0.9960046529204154,1
3086,2022/03/31 Hb低下を認め、当院血液内科へ紹介受診。,0 0 0 Hb 低下 認める 院 血液 内科 紹介 受診,1,3.062741449580465e-06,0.9999969372585504,1,0.00039501694740774984,0.9996049830525923,1,0.005082326143497462,0.9949176738565025,1,4.037947753943172e-11,0.9999999999596205,1,0.08769730478525162,0.9431310892105103,1,0.1923472136259079,0.8705389499664307,1,0.003979289722946528,0.9960207102770535,1
3087,2022/03接種後、新型コロナウイルス感染症に罹患を認めた。,0 0 接種 後 新型コロナウイルス 感染症 罹患 認める た,1,0.005370070273205096,0.9946299297267949,1,0.0003553403994978751,0.9996446596005021,1,0.025957101473613298,0.9740428985263867,1,0.001888325385070555,0.9981116746149294,1,0.09036210179328918,0.9435635209083557,1,0.1822100281715393,0.869367241859436,1,0.004180159486461131,0.9958198405135389,1
3088,2022/04/01-2022/04/18発熱が発現し、持続。,0 0 0 0 0 0 発 熱 発現 持続,1,5.258179405013156e-07,0.9999994741820595,1,0.00042143782570331446,0.9995785621742966,1,0.01258682133196587,0.9874131786680341,1,1.2123464454560917e-09,0.9999999987876536,1,0.08761972188949585,0.9450835585594177,1,0.18711140751838684,0.872672975063324,1,0.004001773528949912,0.9959982264710501,1
3089,2022/05/23、MRIで左横静脈洞血栓症の所見を認めた。,0 0 0 MRI だ 左横静脈洞 血栓症 所見 認める た,1,0.011610757851841326,0.9883892421481586,1,0.0003036495469047776,0.9996963504530952,1,0.09200332018715363,0.9079966798128464,1,0.004326503328360931,0.9956734966716391,1,0.0776670053601265,0.9426072835922241,1,0.18587231636047363,0.8755704164505005,1,0.004781776435950248,0.9952182235640498,1
3090,2022/05/30 38°Cの発熱、嘔吐を認め、内科を受診。,0 0 0 0 C 発熱 嘔吐 認める 内科 受診,1,2.502682506399567e-08,0.9999999749731749,1,0.0005724983562418472,0.9994275016437582,1,0.002537867231537261,0.9974621327684627,1,8.152514219261775e-10,0.9999999991847486,1,0.07950299233198166,0.9457418322563171,1,0.18210303783416748,0.8709298372268677,1,0.0038768618551507377,0.9961231381448492,1
3091,2022/06/06、急性発症の胸痛又は胸部圧迫感が発現した。,0 0 0 急性発症 の 胸痛 胸部圧迫感 発現 する た,1,6.454134710948408e-06,0.999993545865289,1,0.00046536371120252655,0.9995346362887975,1,0.0040185659277278685,0.9959814340722721,1,0.03289993399524571,0.9671000660047543,1,0.0769495889544487,0.9479244351387024,1,0.1812908947467804,0.8794786334037781,1,0.004092974453900152,0.9959070255460998,1
3092,2022/06/10、心拍数は一時40-50/分まで低下した。,0 0 0 心拍数 一時 0 0 分 低下 する た,1,0.01670687673115337,0.9832931232688465,1,0.000374343794564804,0.9996256562054352,1,0.12054287899291916,0.8794571210070808,1,0.26574284156186556,0.7342571584381344,1,0.08874861896038055,0.94749915599823,1,0.2021261751651764,0.868624746799469,1,0.008849414067704415,0.9911505859322957,1
3093,2022/06/18(ワクチン接種後1日目)、発熱が発現した。,0 0 0 ワクチン接種 後 0 日 目 発熱 発現 する た,1,1.2347101431240721e-05,0.9999876528985687,1,0.00041283231710023216,0.9995871676828998,1,0.004639119209198794,0.9953608807908012,1,0.016577846105318428,0.9834221538946816,1,0.08010555058717728,0.9526136517524719,1,0.18685844540596008,0.875311017036438,1,0.003999109727019976,0.9960008902729801,1
3094,2022/06/27の追加報告、もともと血尿は指摘されていた。,0 0 0 追加 報告 血尿 指摘 する れる いる た,1,0.016677601210140145,0.9833223987898599,1,0.00023349474862994858,0.99976650525137,1,0.29782497711645106,0.7021750228835489,0,0.6910779609258799,0.30892203907412014,1,0.08437298983335495,0.9417905211448669,1,0.19155143201351166,0.8608449101448059,1,0.028886108728693738,0.9711138912713063,1
3095,2022年4月17日ー2022年4月18日発熱し、自覚に軽快。,0 年 0 月 0 日 ー 0 年 0 月 0 日 発熱 自覚 軽快,1,0.016699386955296557,0.9833006130447034,1,0.00023895946925890142,0.9997610405307411,1,0.009721146497740474,0.9902788535022595,1,0.007031985299245314,0.9929680147007547,0,0.8059310913085938,0.322192907333374,1,0.21109610795974731,0.8647341728210449,1,0.016262185239957604,0.9837378147600425,1
3096,2回目接種後より38°C台の発熱に加え、経口摂取不良になった。,0回目 接種 後 0 C 台 発熱 加える 経口摂取不良 なる た,1,0.00987335068940085,0.9901266493105991,1,0.0003533352192110425,0.999646664780789,1,0.024138322983077387,0.9758616770169226,1,0.1556085889180968,0.8443914110819032,1,0.0805644541978836,0.949110209941864,1,0.18230308592319489,0.8770058155059814,1,0.005578166880173882,0.9944218331198262,1
3097,3日程度症状(倦怠感、声の出にくさ、きこえにくさ)は継続した。,0 日 程度 症状 倦怠感 声 出る にくい さ きこえる にくい さ 継続 する た,1,0.016698724937925565,0.9833012750620745,1,0.0003596971941125443,0.9996403028058874,1,0.17678354697999188,0.8232164530200081,1,0.2593878674598974,0.7406121325401026,1,0.13602468371391296,0.9145803451538086,1,0.21539466083049774,0.8490669131278992,1,0.010924440080267864,0.9890755599197322,1
3098,52歳女性は発熱、一過性意識消失、低血圧を呈し当院に来院した。,0歳 女性 発熱 一過性意識消失 低血圧 呈す 院 来院 する た,1,5.2410300837063554e-06,0.9999947589699163,1,0.0005052566903419151,0.999494743309658,1,0.003998888268191281,0.9960011117318087,1,0.12957237705065838,0.8704276229493416,1,0.07307122647762299,0.95086270570755,1,0.1794915497303009,0.8751670122146606,1,0.004940660159389469,0.9950593398406106,1
3099,OCT血管造影像にて、中心窩及び中心窩周辺の血流欠損を認めた。,OCT 血管造影 像 中心窩 中心窩 周辺 血流 欠損 認める た,1,0.018345878523201953,0.981654121476798,1,0.00030391763276648375,0.9996960823672335,1,0.04396738163270386,0.9560326183672961,1,0.009545665701491846,0.9904543342985082,1,0.08331746608018875,0.9356163740158081,1,0.20271340012550354,0.8728881478309631,1,0.004595150780841006,0.9954048492191591,1
3100,しかしTCZによる薬疹を発症し、ステロイド再増量などを要した。,TCZ 薬疹 発症 ステロイド 増量 要す た,1,0.038328831485712846,0.9616711685142874,1,0.00028899686429067876,0.9997110031357094,1,0.4847256670666852,0.5152743329333148,1,0.04546285413176243,0.9545371458682376,1,0.11428060382604599,0.9105772972106934,1,0.18721650540828705,0.8737430572509766,1,0.012802741528952586,0.9871972584710474,1
3101,ヒトヘルペスウイルス(HHV)-6血清学的検査:陽性(陽性)。,ヒト ヘルペスウイルス HHV 0 血清 学的 検査 陽性 陽性,1,0.03382045942467802,0.9661795405753221,1,0.00035471082444280715,0.9996452891755572,1,0.06035713484990268,0.9396428651500973,1,0.0,1.0,1,0.207658052444458,0.8792046904563904,1,0.21289832890033722,0.8682786822319031,1,0.0058359661816321596,0.9941640338183679,1
3102,悪寒、発熱、関節痛が出現し、39°Cの発熱がその後3日間継続。,悪寒 発熱 関節痛 出現 0 C 発熱 その後 0 日間 継続,1,0.0042080913275628065,0.9957919086724374,1,0.0003393735540196782,0.9996606264459803,1,0.009804977246380076,0.9901950227536199,1,0.34599063308481004,0.65400936691519,1,0.08781807124614716,0.9475813508033752,1,0.18605086207389832,0.8710486888885498,1,0.007969951770737836,0.9920300482292622,1
3103,右の肩甲骨付近に電気の走るような激痛、額と目の周りの痺れ出現。,右 肩甲骨 付近 電気 走る よう 激痛 額 目 周り 痺れ 出現,1,0.005999076758268292,0.9940009232417318,1,0.0003764114562817449,0.9996235885437182,1,0.014911085487269604,0.9850889145127304,1,0.004450037835368681,0.9955499621646313,1,0.08207762986421585,0.9448241591453552,1,0.19144469499588013,0.8695633411407471,1,0.004113365205449008,0.995886634794551,1
3104,患者は2回目の投与を受けた3日後に発熱及び胸痛のため来院した。,患者 0回目 投与 受ける た 0 日 後 発熱 胸痛 ため 来院 する た,1,0.016717282018894747,0.9832827179811052,1,0.0003192555045623264,0.9996807444954376,1,0.13833058186877312,0.8616694181312269,1,0.003425774886027133,0.9965742251139729,1,0.0802936926484108,0.9492295384407043,1,0.1928502768278122,0.8651256561279297,1,0.005358888283713341,0.9946411117162867,1
3105,患者は蜂巣炎(蜂巣炎)(重篤区分:その他医学的重要)を呈した。,患者 蜂巣炎 蜂巣炎 重篤 区分 その他 医学 的 重要 呈す た,1,0.01669191541395877,0.9833080845860415,1,0.00042881911777528203,0.9995711808822247,1,0.09515055050354781,0.9048494494964522,1,0.0012152965632206136,0.9987847034367794,1,0.096445232629776,0.9352847337722778,1,0.2546508014202118,0.8264443278312683,1,0.005576178200918656,0.9944238217990814,1
3106,休憩中に気分が悪くなり、立ち上がろうとして崩れるように倒れた。,休憩 中 気分 悪い なる 立ち上がる う 崩れる よう 倒れる た,1,0.01668624459743985,0.98331375540256,1,0.000258032392795825,0.9997419676072041,1,0.38244910582284064,0.6175508941771594,1,0.016179506354930373,0.9838204936450696,1,0.08490092307329178,0.9378980398178101,1,0.19746018946170807,0.8585038781166077,1,0.009167371477487314,0.9908326285225126,1
3107,血液検査にて、CPK、心筋トロポニンTの高度上昇が認められた。,血液検査 CPK 心筋 トロポニン T 高度 上昇 認める られる た,1,0.02787176996951457,0.9721282300304854,1,0.0002925142147427648,0.9997074857852573,1,0.041414712139874243,0.9585852878601258,1,0.13526640588333882,0.8647335941166612,1,0.08661264181137085,0.9471902847290039,1,0.18391309678554535,0.870269238948822,1,0.005839560986233704,0.9941604390137663,1
3108,口渇、多飲症、及び多尿が、2回目のワクチン接種の2日後に発現。,口渇 多飲症 多尿 0回目 ワクチン接種 0 日 後 発現,1,0.014010212375559411,0.9859897876244405,1,0.0003589312902041704,0.9996410687097959,1,0.029499750744329978,0.97050024925567,1,1.3428755885058763e-09,0.9999999986571244,1,0.08777997642755508,0.9437455534934998,1,0.20689962804317474,0.8644585609436035,1,0.004382312781181973,0.995617687218818,1
3109,循環動態は安定していたが呼吸音で右後ろにグレード2の喘鳴あり。,循環動態 安定 する いる た 呼吸 音 右 後ろ グレード 0 喘鳴 ある,1,0.016697567038843966,0.9833024329611563,1,0.0002853861172188856,0.9997146138827812,1,0.13432556825793496,0.865674431742065,1,4.428182929117064e-06,0.9999955718170709,1,0.0790666788816452,0.9412554502487183,1,0.3448474705219269,0.7746084928512573,1,0.006764201375175916,0.9932357986248241,1
3110,症状進行していると考えアドレナリン0.5 mgを右大腿に筋注。,症状進行 する いる 考える アドレナリン 0 0 mg 右 大腿 筋 注,1,0.016675293009556093,0.9833247069904439,1,0.00033202609583745377,0.9996679739041625,1,0.0929929487336566,0.9070070512663434,1,3.143124205351455e-09,0.9999999968568758,1,0.19541028141975403,0.8856909871101379,1,0.211283877491951,0.8455601930618286,1,0.006032419125812994,0.993967580874187,1
3111,心エコー上、左室側壁周辺に軽度ではあったが心嚢液貯留を認めた。,心 エコー 上 左 室 側壁 周辺 軽度 だ ある た 心嚢液 貯留 認める た,1,0.04959461413553968,0.9504053858644602,1,0.000282009099161911,0.9997179909008381,1,0.008934919436475841,0.9910650805635242,1,0.0007654632385358795,0.9992345367614641,1,0.09318936616182327,0.9418684244155884,1,0.20017807185649872,0.8580658435821533,1,0.004552966950788106,0.995447033049212,1
3112,心臓超音波検査では左室駆出率59%、局所の壁運動異常を認めた。,心臓 超音波 検査 左 室 駆け出し 率 0% 局所 壁運動異常 認める た,1,0.016702393990725522,0.9832976060092746,1,0.00027540430235067356,0.9997245956976494,1,0.029566648669798634,0.9704333513302014,1,0.01903149800525694,0.9809685019947431,1,0.08483412116765976,0.9434679746627808,1,0.19782470166683197,0.8667183518409729,1,0.004512525288688663,0.9954874747113115,1
3113,心電図検査:投与時、軽度のびまん性ST上昇とT波上昇を認めた。,心電図 検査 投与 時 軽度 びまん性 ST 上昇 T 波 上昇 認める た,1,0.011488544913800998,0.9885114550861989,1,0.0005064885924247834,0.9994935114075753,1,0.020895662457797504,0.9791043375422025,1,0.016560051945652576,0.9834399480543474,1,0.08898331224918365,0.9409887790679932,1,0.18572469055652618,0.8658354878425598,1,0.00435002242126009,0.99564997757874,1
3114,心電図検査では、発症時期は不明だが不完全右脚ブロックを認めた。,心電図 検査 発症 時期 不明 だ 不完全右脚 ブロック 認める た,1,0.016664433431201768,0.9833355665687981,1,0.000285159471092569,0.9997148405289075,1,0.05130793111366316,0.9486920688863368,1,0.054079732514318524,0.9459202674856815,1,0.07714276015758514,0.9445114135742188,1,0.19537685811519623,0.8677273392677307,1,0.004991351960866559,0.9950086480391336,1
3115,接種後より冷汗、脱力感を訴え、ベッドで横になると起き上がれず。,接種 後 冷汗 脱力感 訴える ベッド 横 なる 起き上がれる ぬ,1,0.01668896706809802,0.9833110329319017,1,0.0003465220569931985,0.9996534779430069,1,0.09719943075072779,0.9028005692492722,1,0.0006751816962190516,0.999324818303781,1,0.10905662924051285,0.9345927238464355,1,0.2164061814546585,0.8371966481208801,1,0.005396968119223102,0.9946030318807769,1
3116,摂氏39度の高熱であった(ワクチン接種から1日以内の入院前)。,摂氏 0度 高熱 だ ある た ワクチン接種 0 日 以内 入院 前,1,0.01666653483943648,0.9833334651605635,1,0.00030241231295293153,0.9996975876870471,1,0.23444540922960355,0.7655545907703964,1,4.048779500553934e-08,0.999999959512205,1,0.11223037540912628,0.9356147050857544,1,0.24818475544452667,0.8338873982429504,1,0.007345766936479071,0.9926542330635209,1
3117,全身痛を認め、起き上がれなくなっているところを発見され、入院。,全身痛 認める 起き上がれる ない なる いる ところ 発見 する れる 入院,1,0.016676568490135713,0.9833234315098641,1,0.0003995354833524063,0.9996004645166476,1,0.18077090157581177,0.8192290984241882,1,3.025693917635408e-09,0.9999999969743061,1,0.08093424141407013,0.9449368715286255,1,0.18880949914455414,0.849969208240509,1,0.005884870306726717,0.9941151296932732,1
3118,発疹等のアナフィラキシー症状はなく、迷走神経反射が考えられた。,発疹等 の アナフィラキシー症状 ない 迷走神経反射 考える られる た,1,0.016707959371777156,0.9832920406282227,1,0.0002956898482367677,0.9997043101517632,1,0.4543386503062945,0.5456613496937055,1,0.03538198579014784,0.9646180142098522,1,0.13110531866550446,0.9177767634391785,0,0.7849411368370056,0.2914559841156006,1,0.03627288377435247,0.9637271162256474,1
3119,報告者によると、ワクチン接種45分後に上気道性喘鳴がみられた。,報告 者 よる ワクチン接種 0分 後 上気道 性 喘鳴 みる られる た,1,0.016687932356680306,0.9833120676433197,1,0.0003473316114094383,0.9996526683885906,1,0.04624196364453004,0.95375803635547,1,0.05646964490617479,0.9435303550938252,1,0.08385283499956131,0.9502613544464111,1,0.18536628782749176,0.8592631220817566,1,0.004962792183594552,0.9950372078164055,1
3120,翌日から肉眼的血尿が出現、3日間かけて徐々に改善し、軽快した。,翌日 肉眼的血尿 出現 0 日間 かける 改善 する 軽快 する た,1,0.016687462008238816,0.9833125379917613,1,0.00018219808324725358,0.9998178019167527,1,0.27283774468813693,0.7271622553118631,0,0.8882895716614982,0.11171042833850181,0,0.9345842003822327,0.11273782700300217,0,0.665956437587738,0.4098697006702423,1,0.3621434670782043,0.6378565329217958,1
3121,膀胱ポリープ、尿管結石症の結果として、治療的な処置がとられた。,膀胱ポリープ 尿管結石症 結果 治療 的 だ 処置 とる れる た,1,0.016686223690861594,0.9833137763091383,1,0.0003338455436110096,0.999666154456389,1,0.029090311785350487,0.9709096882146495,1,0.09099552338814854,0.9090044766118515,1,0.09353547543287277,0.932609498500824,1,0.2105674296617508,0.8637922406196594,1,0.005388489979881758,0.9946115100201183,1
3122,2022/02/26、摂氏37.8度の発熱を発症し、受診した。,0 0 0 摂氏 0 0度 発熱 発症 受診 する た,1,1.9232538705936177e-06,0.9999980767461294,1,0.0005650541620134475,0.9994349458379865,1,0.011474802043245469,0.9885251979567545,1,0.03252167718428334,0.9674783228157167,1,0.07533950358629227,0.9496570229530334,1,0.1798085868358612,0.8726556897163391,1,0.004160140103619029,0.9958398598963809,1
3123,1時間後、依然脱力と意識混濁があったため、患者を救急搬送した。,0時 間 後 脱力 意識混濁 ある た ため 患者 救急搬送 する た,1,0.01669479029572559,0.9833052097042746,1,0.00032349544263720194,0.9996765045573628,1,0.19502448372960124,0.8049755162703988,1,0.004102515921015626,0.9958974840789844,1,0.0826716274023056,0.9459995031356812,1,0.18336309492588043,0.8674520254135132,1,0.005969372322644193,0.994030627677356,1
3124,2021/08/23頃、患者は左上腕から左肘の痛みを発現した。,0 0 0 頃 患者 左上 腕 左肘 痛み 発現 する た,1,1.405756132335872e-06,0.9999985942438677,1,0.0005006782160884371,0.9994993217839115,1,0.0056842565655829125,0.9943157434344171,1,0.09587978142503806,0.9041202185749619,1,0.08305825293064117,0.9481341242790222,1,0.18162646889686584,0.8719457387924194,1,0.004719776429849695,0.9952802235701502,1
3125,2021/10/21より、頭痛、視覚異常などの症状が発現した。,0 0 0 頭痛 視覚異常 症状 発現 する た,1,0.009198979352164275,0.9908010206478358,1,0.0003893939926053046,0.9996106060073947,1,0.01277326811553825,0.9872267318844618,1,0.03415958249652584,0.9658404175034742,1,0.07937148213386536,0.948728084564209,1,0.1767089068889618,0.8744107484817505,1,0.004260852794619509,0.9957391472053804,1
3126,2022/02/17、摂氏37.8度の発熱と咽頭痛が発現した。,0 0 0 摂氏 0 0度 発熱 咽頭痛 発現 する た,1,9.582408777516297e-07,0.9999990417591222,1,0.0005232827600797734,0.9994767172399203,1,0.004023634721230351,0.9959763652787696,1,0.022425725719550593,0.9775742742804494,1,0.07627543807029724,0.9511552453041077,1,0.1823452264070511,0.8763056993484497,1,0.004010211278966929,0.9959897887210329,1
3127,2022/03/06、被験者は発熱(摂氏37.0度)があった。,0 0 0 被験者 発熱 摂氏 0 0度 ある た,1,0.011168812306188065,0.988831187693812,1,0.00032407360956265087,0.9996759263904373,1,0.015754201952768443,0.9842457980472316,1,0.019635906206237008,0.980364093793763,1,0.08112554252147675,0.9469230771064758,1,0.18558037281036377,0.8646618127822876,1,0.004273187129985915,0.9957268128700142,1
3128,2022/03/31 0:40、巡回時に心肺停止で発見された。,0 0 0 0 0 巡回 時 心肺停止 だ 発見 する れる た,1,0.01668373267383043,0.9833162673261697,1,0.00031939421748602536,0.9996806057825139,1,0.48265190159938576,0.5173480984006142,1,0.24446551101658887,0.7555344889834111,1,0.07957228273153305,0.9451009035110474,1,0.1913735568523407,0.8741581439971924,1,0.01695533323446981,0.9830446667655302,1
3129,2022/04/08午後、肝機能障害、倦怠感、鼻水を発現した。,0 0 0 午後 肝機能障害 倦怠感 鼻水 発現 する た,1,0.0033122154252599044,0.9966877845747402,1,0.00039132453428100347,0.999608675465719,1,0.005373552462950348,0.9946264475370497,1,0.07091631116530439,0.9290836888346956,1,0.07672584801912308,0.9468843936920166,1,0.18603350222110748,0.878489077091217,1,0.004484528453897135,0.9955154715461028,1
3130,2022/05/14、患者は、呼吸困難感、胸苦しさを自覚した。,0 0 0 患者 呼吸 困難感 胸苦しさ 自覚 する た,1,0.0167100528975536,0.9832899471024465,1,0.0003848828497263203,0.9996151171502736,1,0.04232046603523709,0.9576795339647629,1,0.13334831615052778,0.8666516838494722,1,0.08122969418764114,0.9492169618606567,1,0.18410448729991913,0.8767522573471069,1,0.005623802304126876,0.9943761976958732,1
3131,2022/06/01、発熱、咳嗽、右頸部リンパ節痛を発現した。,0 0 0 発熱 咳嗽 右 頸部リンパ節痛 発現 する た,1,3.497702569289824e-08,0.9999999650229743,1,0.0005418884640214752,0.9994581115359785,1,0.002184778719394709,0.9978152212806053,1,0.024915441455251264,0.9750845585447487,1,0.0749436616897583,0.9526057243347168,1,0.18043380975723267,0.8769620656967163,1,0.003994214881275501,0.9960057851187245,1
3132,2022/06/03、朝に摂氏37度台の微熱と頭痛が発現した。,0 0 0 朝 摂氏 0度 台 微熱 頭痛 発現 する た,1,3.0971137950991153e-06,0.9999969028862049,1,0.0005764850207362906,0.9994235149792637,1,0.003518861315256472,0.9964811386847435,1,0.0602735589603538,0.9397264410396462,1,0.07668405771255493,0.9509487748146057,1,0.18442612886428833,0.8763302564620972,1,0.004331826178706275,0.9956681738212938,1
3133,2022/07/20、患者は病院に入院し、血栓症と診断された。,0 0 0 患者 病院 入院 する 血栓症 診断 する れる た,1,1.2205084711005213e-05,0.999987794915289,1,0.0004503739467056702,0.9995496260532943,1,0.0162685438347977,0.9837314561652023,1,0.23997245731024253,0.7600275426897575,1,0.07380072772502899,0.9491995573043823,1,0.18668070435523987,0.8699552416801453,1,0.006398540856303856,0.9936014591436961,1
3134,Lymphocyte count:両方の皮膚サンプルで上昇した,Lymphocyte count 両方 皮膚 サンプル 上昇 する た,1,0.027876728766625846,0.9721232712333743,1,0.00026949905116223084,0.9997305009488378,1,0.07245212633725984,0.9275478736627402,1,0.19187129405351366,0.8081287059464863,1,0.09966639429330826,0.9376435279846191,1,0.5479002594947815,0.6389017105102539,1,0.012817553309662376,0.9871824466903376,1
3135,カルバマゼピンによって誘発される典型的なDiHSと診断された。,カルバマゼピン 誘発 する れる 典型 的 だ DiHS 診断 する れる た,1,0.023958616829855534,0.9760413831701444,1,0.0003152752318395696,0.9996847247681604,1,0.14162576057271525,0.8583742394272847,0,0.5507970595715426,0.4492029404284575,1,0.0849456936120987,0.9478030800819397,1,0.2106369435787201,0.8664315938949585,1,0.016540596402245273,0.9834594035977547,1
3136,症状は体感失調と両大腿の感覚障害による歩行困難が遷延していた。,症状 体感 失調 大腿 感覚障害 歩行困難 遷延 する いる た,1,0.016709617900345437,0.9832903820996547,1,0.0003179927674074897,0.9996820072325925,1,0.4519571797219716,0.5480428202780284,1,0.486944692951945,0.513055307048055,1,0.08081161975860596,0.9431742429733276,1,0.1983073353767395,0.8657621741294861,1,0.026135987118801347,0.9738640128811986,1
3137,被験者は安静時、重度の全身疾患を示す臨床徴候(発熱)を示した。,被験者 安静 時 重度 全身 疾患 示す 臨床徴候 発熱 示す た,1,0.01669661410304614,0.9833033858969538,1,0.00021019006140279644,0.9997898099385972,1,0.05266028477982221,0.9473397152201778,1,0.001247044448296597,0.9987529555517034,1,0.09248731285333633,0.9504801630973816,1,0.18699748814105988,0.8618867993354797,1,0.004535591368049585,0.9954644086319503,1
3138,臨床概要:2022/03/13、肺炎および発熱持続を発症した。,臨床 概要 0 0 0 肺炎 発熱持続 発症 する た,1,0.0026034889826527657,0.9973965110173473,1,0.0003805507699739457,0.9996194492300261,1,0.012160922265608165,0.9878390777343918,1,0.05038390737427689,0.9496160926257231,1,0.07597245275974274,0.9476110935211182,1,0.1796095371246338,0.8724218010902405,1,0.004349249831535599,0.9956507501684645,1
3139,臨床経過は以下のとおり:咽頭痛、発熱(T38.6)が発現した。,臨床 経過 以下 とおり 咽頭痛 発熱 T 0 0 発現 する た,1,0.004279433008035573,0.9957205669919644,1,0.0003386459009764992,0.9996613540990235,1,0.005936843564307237,0.9940631564356928,1,0.09941128337892091,0.9005887166210791,1,0.07697921246290207,0.950096070766449,1,0.18501080572605133,0.8744757771492004,1,0.004760411350885128,0.9952395886491148,1
3140,2021/08/30、再診するも息苦しさの原因不詳、経過観察。,0 0 0 再診 する 息苦しさ の 原因不詳 経過 観察,1,0.016678133059488582,0.9833218669405116,1,0.00028567513798809593,0.999714324862012,1,0.2448881041353289,0.7551118958646711,1,0.20559761786753517,0.7944023821324648,0,0.7669496536254883,0.3324130177497864,1,0.4543726444244385,0.6500014066696167,1,0.05592505484580748,0.9440749451541925,1
3141,2021/10/15、心電図検査は実施され、異常所見があった。,0 0 0 心電図 検査 実施 する れる 異常所見 ある た,1,0.09059773716598057,0.9094022628340196,1,0.0001998759535958427,0.9998001240464042,0,0.7525618026170922,0.24743819738290787,1,0.3402014441964806,0.6597985558035194,1,0.21868163347244263,0.8581393361091614,1,0.21142567694187164,0.8476265072822571,1,0.05173316773971647,0.9482668322602835,1
3142,RDW-CV(赤血球分布幅)(8-16):16.1%、注記:高,RDW CV 赤血球 分布 幅 0 0 0 0% 注記 高,1,0.020291638151306225,0.9797083618486937,1,0.00037351545483322863,0.9996264845451668,1,0.24685328856898958,0.7531467114310104,1,1.4041354280402985e-06,0.999998595864572,1,0.13494747877120972,0.9024674296379089,1,0.20164388418197632,0.8587082028388977,1,0.0074686482367820675,0.9925313517632179,1
3143,SP-D(血液検査)結果: 42.6ng/ml、正常高値109,SP-D 血液検査 結果 0 0 NG ml 正常高値 0,1,0.12373212914732439,0.8762678708526759,1,0.0003252785783175987,0.9996747214216825,1,0.3149967692637238,0.6850032307362762,1,0.013934524551883598,0.9860654754481164,1,0.1387709081172943,0.9064210057258606,1,0.19390514492988586,0.8655425310134888,1,0.01063082145102275,0.9893691785489771,1
3144,PO2:(2022/06/22)69.8 Torr、注記:低値,PO 0 0 0 0 0 0 Torr 注記 値,1,0.01964672245572956,0.9803532775442706,1,0.0002840812978150327,0.999715918702185,1,0.30511803822789274,0.6948819617721073,1,0.0003255022165066235,0.9996744977834934,1,0.2606145739555359,0.8149700164794922,1,0.22660580277442932,0.8528316617012024,1,0.010667459095669886,0.9893325409043301,1
3145,20:00前看護師が自発呼吸なく、瞳孔散大している所を発見。,0 0 看護師 自発呼吸 ない 瞳孔散大 する いる 所 発見,1,0.0167172369027435,0.9832827630972566,1,0.000258112930518836,0.9997418870694812,0,0.7673364759918788,0.23266352400812118,1,2.461586490198897e-12,0.9999999999975384,1,0.11494720727205276,0.934607207775116,1,0.20524851977825165,0.8275392651557922,1,0.020365702620022623,0.9796342973799773,1
3146,2021/**/**、組織学的検査:リンパ球性炎症細胞亜型。,0 組織 学 的 検査 リンパ球 性 炎症細胞 亜 型,1,0.016696098569188453,0.9833039014308116,1,0.0003670125287600966,0.9996329874712399,1,0.2157206695878211,0.7842793304121789,1,5.10702591327572e-13,0.9999999999994893,1,0.16935649514198303,0.9072263836860657,1,0.2943689525127411,0.8051995635032654,1,0.008300264957265784,0.9916997350427341,1
3147,2021/07/10右上肢、前胸部に皮疹が拡大し、当院受診。,0 0 0 右 上肢 胸部 皮疹 拡大 する 院 受診,1,0.012110679837792513,0.9878893201622074,1,0.00037363380616350315,0.9996263661938365,1,0.10782043446420575,0.8921795655357943,1,6.668752217109386e-10,0.9999999993331248,1,0.07649902999401093,0.9470247626304626,1,0.18433496356010437,0.8721202611923218,1,0.004880080517762786,0.9951199194822371,1
3148,2021/07/28、右優位の両側の感覚障害と疼痛を認めた。,0 0 0 右優位 両側 感覚障害 疼痛 認める た,1,0.009071895615649942,0.9909281043843502,1,0.0004298479364758138,0.9995701520635242,1,0.018442947392753095,0.9815570526072469,1,0.00860911325215541,0.9913908867478446,1,0.0771680548787117,0.949533998966217,1,0.18779461085796356,0.8729234337806702,1,0.004133918035210075,0.99586608196479,1
3149,2021/07/31 00:00頃嘔気が増悪し、何度か嘔吐。,0 0 0 0 0 頃 嘔気 増悪 何度 嘔吐,1,5.071716981948936e-07,0.9999994928283018,1,0.00041442852233577934,0.9995855714776642,1,0.030761532092307697,0.9692384679076923,1,3.774758283725532e-15,0.9999999999999962,1,0.09237053245306015,0.9502116441726685,1,0.18431517481803894,0.8777636289596558,1,0.004115230828637856,0.9958847691713621,1
3150,2021/07/31上肢脱力、しびれ、肛門部しびれを認めた。,0 0 0 上肢脱力 しびれ 肛門 部 しびれ 認める た,1,0.003705059355149164,0.9962949406448509,1,0.00039022938014800077,0.999609770619852,1,0.013253985338213647,0.9867460146617864,1,0.007862983581368388,0.9921370164186316,1,0.07892987132072449,0.9472768306732178,1,0.18345534801483154,0.8760876059532166,1,0.004027576651104443,0.9959724233488956,1
3151,2022/02/17ストレス下におけるたこつぼ型心筋症発症。,0 0 0 ストレス下 たこつぼ 型 心筋症 発症,1,0.01669718356727807,0.983302816432722,1,0.00034260251303858873,0.9996573974869614,1,0.0704933642542338,0.9295066357457662,1,0.0,1.0,1,0.08306508511304855,0.9401572942733765,1,0.1844482719898224,0.869339108467102,1,0.00464680968250493,0.995353190317495,1
3152,2022/03/14 18:00横紋筋融解症、腎不全が発現。,0 0 0 0 0 横紋筋融解症 腎不全 発現,1,2.022639532567228e-06,0.9999979773604675,1,0.00041181943453462574,0.9995881805654654,1,0.00987732563689947,0.9901226743631005,1,8.881784197001252e-16,0.9999999999999991,1,0.08711999654769897,0.943838894367218,1,0.1800244152545929,0.8733256459236145,1,0.00395253489680463,0.9960474651031953,1
3153,2022/03/21-2022/03/22肩の痛みを認めた。,0 0 0 0 0 0 肩 痛み 認める た,1,1.2898128775570706e-06,0.9999987101871225,1,0.00046046070466216916,0.9995395392953378,1,0.013681814030086503,0.9863181859699135,1,0.004850717342618216,0.9951492826573818,1,0.07667198032140732,0.9516851902008057,1,0.1818041205406189,0.8742541074752808,1,0.003952389863733575,0.9960476101362663,1
3154,2022/04/03右眼視力低下し、両眼視神経炎が発症した。,0 0 0 右眼視力低下 両眼視神経炎 発症 する た,1,0.016679155528099895,0.9833208444718999,1,0.00034172512436430626,0.9996582748756357,1,0.06707087023669567,0.9329291297633043,1,0.014627310943160055,0.98537268905684,1,0.07502270489931107,0.9477754831314087,1,0.18447591364383698,0.8770879507064819,1,0.004642140796344532,0.9953578592036554,1
3155,2022/05/01夜中、眠れないほどの左後頚部痛を認めた。,0 0 0 夜中 眠れる ない 左後頚部痛 認める た,1,0.01667219177932593,0.9833278082206739,1,0.00032344037646611184,0.9996765596235339,0,0.523212649566047,0.476787350433953,1,0.02455740965546216,0.9754425903445378,1,0.07963486015796661,0.950506329536438,1,0.18709127604961395,0.8748168349266052,1,0.01178508272870107,0.9882149172712988,1
3156,2022/05/08朝より腹痛、頻回嘔吐が出現し、寝込んだ。,0 0 0 朝 腹痛 頻回嘔吐 出現 寝込む だ,1,0.016698476828842367,0.9833015231711575,1,0.0003310753042691291,0.9996689246957309,1,0.02478126032867889,0.9752187396713211,1,0.001984727969889355,0.9980152720301106,1,0.07654060423374176,0.9502149820327759,1,0.1853988915681839,0.8751962184906006,1,0.004169086112596651,0.9958309138874033,1
3157,2022/05/29、解熱したが前胸部の鋭い痛みを自覚した。,0 0 0 解熱 した 胸部 鋭い 痛み 自覚 する た,1,0.016664538965358886,0.9833354610346413,1,0.00024862457675782105,0.9997513754232422,1,0.043741762104341664,0.9562582378956583,1,0.1270585651632139,0.8729414348367861,1,0.07990332692861557,0.9522080421447754,1,0.19007818400859833,0.8772706985473633,1,0.005573903049880212,0.9944260969501199,1
3158,2022/06/06、下腿浮腫と皮疹(点状紫斑)が出現した。,0 0 0 下腿浮腫 皮疹 点状 紫斑 出現 する た,1,0.016692631383714383,0.9833073686162859,1,0.0003445210742726918,0.9996554789257273,1,0.024321112058362737,0.9756788879416373,1,0.09162224618318515,0.9083777538168148,1,0.07419008016586304,0.9497169852256775,1,0.1856890469789505,0.8780831098556519,1,0.004957124726536883,0.9950428752734631,1
3159,2022/07/05現在、腕がピクピクする症状を認めている。,0 0 0 現在 腕 ピクピク する 症状 認める いる,1,0.016709124478831976,0.9832908755211681,1,0.0003161782526576477,0.9996838217473424,1,0.1426141565906366,0.8573858434093634,1,0.03338999203145798,0.966610007968542,1,0.08132103830575943,0.9466302990913391,1,0.1976792812347412,0.8620112538337708,1,0.005802873193159354,0.9941971268068406,1
3160,2022/07/11から、体幹部左側に有痛性皮疹が出現した。,0 0 0 体 幹部 左側に 有痛性 皮疹 出現 する た,1,0.04124280564656759,0.9587571943534324,1,0.00023523265376772562,0.9997647673462323,1,0.026577041188269646,0.9734229588117304,1,0.20167743034116248,0.7983225696588375,1,0.07815621793270111,0.9485104084014893,1,0.1886284500360489,0.8773545622825623,1,0.006563701250506825,0.993436298749493,1
3161,2022年1月21日SARS-CoV-2検査:(陽性)陽性。,0 年 0 月 0 日 SARS CoV 0 検査 陽性 陽性,1,0.015928473104398825,0.9840715268956014,1,0.0006540117078454342,0.9993459882921546,1,0.08835606525631301,0.911643934743687,1,0.0,1.0,1,0.15240652859210968,0.893829345703125,1,0.2155066579580307,0.8639352321624756,1,0.005596652300842078,0.9944033476991581,1
3162,2回接種後はちょっと頭が痛かっただけで、薬局の薬を使用した。,0回 接種 後 頭 痛い た だ 薬局 薬 使用 する た,1,0.016688748533368308,0.9833112514666313,1,0.00018167803692145708,0.9998183219630785,0,0.846995599220088,0.15300440077991198,1,0.21201139652858747,0.7879886034714125,1,0.2629046142101288,0.8488835692405701,1,0.24723802506923676,0.8256654143333435,1,0.046857582150019395,0.9531424178499805,1
3163,2回目のワクチン接種後、患者は、嘔吐と眩暈で1週間入院した。,0回目 ワクチン接種 後 患者 嘔吐 眩暈 0 週間 入院 する た,1,0.016689662579381637,0.9833103374206184,1,0.00034480409114227996,0.9996551959088578,1,0.03160161207134471,0.9683983879286553,1,0.13197756599202337,0.8680224340079766,1,0.0857718288898468,0.9464656114578247,1,0.17861603200435638,0.8674337863922119,1,0.0055505941470887065,0.9944494058529113,1
3164,意識清明も強い頭痛、高熱、視機能のさらなる低下が認められた。,意識清明 強いる 頭痛 高熱 視る 機能 さら なり 低下 認める られる た,1,0.007651784250355645,0.9923482157496443,1,0.0003170420582626237,0.9996829579417373,1,0.01543253446373094,0.9845674655362691,1,0.05686266149975572,0.9431373385002443,1,0.0799863263964653,0.9515448212623596,1,0.19614513218402863,0.8675549030303955,1,0.004575559554968866,0.9954244404450311,1
3165,患者はワクチン接種部位腫脹(ワクチン接種部位腫脹)を呈した。,患者 ワクチン接種 部位腫脹 ワクチン接種 部位腫脹 呈す た,1,0.016661023468918745,0.9833389765310813,1,0.0003227223634862461,0.9996772776365137,1,0.07501057903447628,0.9249894209655237,1,0.0001507326707049783,0.999849267329295,1,0.08639289438724518,0.9432912468910217,1,0.20174354314804077,0.8624617457389832,1,0.00480478584880472,0.9951952141511953,1
3166,血液検査で末梢血好酸球12%(960/uL)と上昇を認めた。,血液検査 末梢血 好酸球 0% 0 uL 上昇 認める た,1,2.2573924998974058e-06,0.9999977426075002,1,0.0004056308156150589,0.9995943691843849,1,0.006047603829562931,0.9939523961704371,1,0.019703631748464345,0.9802963682515357,1,0.08416159451007843,0.942814826965332,1,0.18714581429958344,0.8727470636367798,1,0.0041029558324754255,0.9958970441675247,1
3167,後頭部皮下出血、非致死的外傷性くも膜下出血、脂肪肝を認めた。,後頭部皮下出血 致死的 外傷性 くも膜下出血 脂肪肝 認める た,1,0.002982787126080264,0.9970172128739198,1,0.0003231461363032261,0.9996768538636968,1,0.033384662606492976,0.966615337393507,1,0.0023475178958087817,0.9976524821041912,1,0.07647049427032471,0.9418864250183105,1,0.1905665546655655,0.871155321598053,1,0.004202231623128702,0.9957977683768713,1
3168,更に、左上葉S3縦隔側に37mm大の辺縁不整な結節を認めた。,左上 葉 S 0 縦 隔側 0mm 大 辺縁 不整 だ 結節 認める た,1,0.018437782568313524,0.9815622174316863,1,0.000322565093881951,0.999677434906118,1,0.04109752215137652,0.9589024778486235,1,0.009340623843134499,0.9906593761568655,1,0.08536124974489212,0.9418954849243164,1,0.18276110291481018,0.863288164138794,1,0.004502255747797601,0.9954977442522023,1
3169,再度心拍再開したが、その後再び心停止となり心拍再開に至らず。,心拍 再開 する た その後 心停止 なる 心拍 再開 至る ぬ,1,0.01666281565508824,0.9833371843449116,1,0.00016348951539654188,0.9998365104846034,1,0.37872675974517955,0.6212732402548204,1,0.02431762203865151,0.9756823779613485,1,0.2072543054819107,0.8842946290969849,1,0.30281901359558105,0.7750658988952637,1,0.0132614231157949,0.9867385768842051,1
3170,視神経脊髄炎再燃による左上下肢脱力が出現し、歩行困難となる。,視神経脊髄炎再燃 左上下肢脱力 出現 歩行困難 なる,1,0.0033975657914081772,0.9966024342085917,1,0.0003979810938169984,0.999602018906183,1,0.015002964258101215,0.9849970357418988,1,2.1056025609755835e-06,0.999997894397439,1,0.08637493848800659,0.943494439125061,1,0.1927804946899414,0.8715471029281616,1,0.004077096013388231,0.9959229039866118,1
3171,身体所見、検査所見からは心筋炎として矛盾しない経過であった。,身体所見 検査 所見 心筋炎 矛盾 しない 経過 だ ある た,1,0.016673980168305097,0.9833260198316948,1,0.00022302009977703726,0.999776979900223,1,0.46330495291598695,0.536695047084013,0,0.7896044108962015,0.2103955891037985,1,0.18319085240364075,0.8696673512458801,0,0.8196083903312683,0.22091105580329895,1,0.17535124953495362,0.8246487504650463,1
3172,身体診察:左頚部で炎症を認めた(異常)左頚部で炎症を認めた。,身体 診察 左 頚部 だ 炎症 認める た 異常 左 頚部 だ 炎症 認める た,1,0.010066470662701435,0.9899335293372983,1,0.00033050783384382733,0.9996694921661562,1,0.058397219647140175,0.9416027803528598,1,0.0011721230542244276,0.9988278769457756,1,0.08276993036270142,0.9398379325866699,1,0.18105548620224,0.8614027500152588,1,0.004507555147075775,0.9954924448529243,1
3173,人工呼吸開始したが酸素100%でもSp02 44 torr。,人工呼吸 開始 する た 酸素 0% Sp 0 0 torr,1,0.2948239004841895,0.7051760995158103,1,0.00022566803020203163,0.9997743319697979,1,0.34774602648863273,0.6522539735113673,0,0.9999981109925162,1.8890074837320668e-06,0,0.8690551519393921,0.22872339189052582,1,0.46589815616607666,0.5941848754882812,1,0.4495800649036655,0.5504199350963346,1
3174,接種14日後に右眼、21日後に左眼の急激な視力低下を来した。,接種 0 日 後 右 眼 0 日 後 左 眼 急激 だ 視力低下 来す た,1,0.016703348007008016,0.9832966519929919,1,0.00030609196291094275,0.999693908037089,1,0.1776880382178374,0.8223119617821626,1,0.00907053847583661,0.9909294615241634,1,0.07872143387794495,0.9506544470787048,1,0.18934370577335358,0.8664776086807251,1,0.005814720412857478,0.9941852795871426,1
3175,瞳孔散大、下顎硬直が始まっており、口腔内には嘔吐物を認めた。,瞳孔散大 下顎硬直 始まる おる 口腔内 嘔吐 物 認める た,1,0.004630003908783769,0.9953699960912163,1,0.0004083413890440453,0.999591658610956,1,0.033384662606492976,0.966615337393507,1,0.010306484718525466,0.9896935152814745,1,0.08215212821960449,0.9453579187393188,1,0.19195795059204102,0.8655269145965576,1,0.00432367812337515,0.9956763218766248,1
3176,日付不明(2022年01月07日以降)、下痢、腹痛が生じた。,日付 不明 0 年 0 月 0 日 以降 下痢 腹痛 生じる た,1,0.016689303786771477,0.9833106962132286,1,0.00025513230451086356,0.9997448676954891,1,0.35850433952828775,0.6414956604717122,1,6.706301401337988e-05,0.9999329369859866,1,0.07961779087781906,0.9464401006698608,1,0.18612492084503174,0.8720131516456604,1,0.00814899038759497,0.991851009612405,1
3177,日付不明接種2週間程度後、健康診断にて心電図の異常を認めた。,日付 不明 接種 0 週間 程度 後 健康診断 心電図 異常 認める た,1,0.051232820300581905,0.9487671796994182,1,0.00024293393842729938,0.9997570660615727,1,0.023023927507595965,0.976976072492404,1,0.010834771168591995,0.989165228831408,1,0.10578440129756927,0.9327399730682373,1,0.18347656726837158,0.8647721409797668,1,0.004784478719150063,0.9952155212808498,1
3178,発熱、倦怠感、接種部位の痛み、腕の痛み、末梢のしびれが発現。,発熱 倦怠感 接種 部位 痛み 腕 痛み 末梢 しびれ 発現,1,8.447151181155244e-09,0.9999999915528488,1,0.0005906267859382265,0.9994093732140618,1,0.001569908748482396,0.9984300912515176,1,2.844519508826693e-09,0.9999999971554805,1,0.08271007239818573,0.9470047950744629,1,0.19508525729179382,0.8644347786903381,1,0.003952986260514927,0.996047013739485,1
3179,病理組織学的検査にて乾酪壊死を伴わない非特異的潰瘍を認めた。,病理 組織 学 的 検査 乾酪壊死 伴う ない 非特異的 潰瘍 認める た,1,0.01668536968719101,0.9833146303128091,1,0.00024641987101470974,0.9997535801289853,1,0.36978949999018373,0.6302105000098163,1,0.006948183067417402,0.9930518169325826,1,0.08600810915231705,0.9444901347160339,1,0.19890712201595306,0.8552529215812683,1,0.008771051142890047,0.99122894885711,1
3180,本剤接種後に冠動脈瘤を伴うNSTEMIを発症した一例である。,本 剤 接種 後 冠動脈瘤 伴う NSTEMI 発症 した 一 例 だ ある,1,0.02453639207820408,0.9754636079217961,1,0.000301946228182299,0.9996980537718178,1,0.03464251593042844,0.9653574840695716,1,0.08213838582507382,0.9178616141749262,1,0.14748448133468628,0.9139711260795593,1,0.25463029742240906,0.8278892040252686,1,0.006327471020174865,0.993672528979825,1
3181,冷汗が出て気分不良となり、呂律が回らなくなり、一度回復する。,冷汗 出る 気分不良 なる 呂律が回らなくなり 回復 する,1,0.016675671687432357,0.9833243283125678,1,0.0002676676253454814,0.9997323323746545,0,0.7949588823905682,0.20504111760943175,1,0.1498888699898122,0.8501111300101878,1,0.3715600073337555,0.8512738943099976,1,0.22022654116153717,0.8503870368003845,1,0.03968484275303181,0.9603151572469681,1
3182,05/17、一過性脳虚血発作症状、左下肢虚血症状を発現した。,0 0 一過性脳虚血 発作症状 左下肢虚血 症状 発現 する た,1,0.01671670509669828,0.9832832949033017,1,0.00032620206427379494,0.9996737979357262,1,0.01980963906746025,0.9801903609325398,1,0.10043292002047355,0.8995670799795265,1,0.07506585866212845,0.9464003443717957,1,0.1814882457256317,0.8782772421836853,1,0.004998767719509831,0.9950012322804902,1
3183,2022/04/22午前頃、患者は急性心機能不全を発現した。,0 0 0 午前 頃 患者 急性 心機能不全 発現 する た,1,1.5922338278095617e-05,0.9999840776617219,1,0.0004422755221857114,0.9995577244778143,1,0.007828175203085097,0.9921718247969149,1,0.053426151053809545,0.9465738489461905,1,0.08465529978275299,0.9520660042762756,1,0.1791621893644333,0.8692717552185059,1,0.00434621075157651,0.9956537892484234,1
3184,2021/10/03、摂氏37.1度の発熱と倦怠感があった。,0 0 0 摂氏 0 0度 発熱 倦怠感 ある た,1,0.004007964489648179,0.9959920355103518,1,0.00037076287146528086,0.9996292371285347,1,0.006789084779605936,0.9932109152203941,1,0.08815043335329287,0.9118495666467071,1,0.0783253088593483,0.9500815272331238,1,0.1835334748029709,0.8723828792572021,1,0.004669749640896582,0.9953302503591033,1
3185,2022/04/09の朝より、最高摂氏39度の発熱があった。,0 0 0 朝 最高 摂氏 0度 発熱 ある た,1,0.006792309329617088,0.9932076906703828,1,0.00036973422950386115,0.9996302657704962,1,0.015754201952768443,0.9842457980472316,1,0.030023897451783244,0.9699761025482168,1,0.07914172857999802,0.9527854323387146,1,0.18354812264442444,0.8754832148551941,1,0.00423681139491981,0.9957631886050803,1
3186,2022/05/04、患者は自己免疫抗体性の脳炎を発現した。,0 0 0 患者 自己免疫 抗体 性 脳炎 発現 する た,1,0.013226428229362389,0.9867735717706374,1,0.0004011333309734471,0.9995988666690265,1,0.013677939863627198,0.9863220601363728,1,0.03618602715704233,0.9638139728429577,1,0.09010419249534607,0.9449847340583801,1,0.1814601868391037,0.8733102679252625,1,0.004408741281645199,0.9955912587183549,1
3187,2022/06/23から、四肢脱力および握力低下が出現した。,0 0 0 四肢脱力 握力低下 出現 する た,1,0.0037137390538268195,0.9962862609461731,1,0.0004324858216292026,0.9995675141783708,1,0.020242080509046634,0.9797579194909534,1,0.07963261583990044,0.9203673841600996,1,0.07751710712909698,0.9496467709541321,1,0.1859135627746582,0.87908536195755,1,0.004691690323128582,0.9953083096768714,1
3188,2022/07/17、他病院を受診し、帯状疱疹と診断された。,0 0 0 病院 受診 する 帯状疱疹 診断 する れる た,1,0.011892837182430744,0.9881071628175693,1,0.0004558322044280485,0.999544167795572,1,0.037985218745275495,0.9620147812547245,1,0.28158029967831044,0.7184197003216896,1,0.08401055634021759,0.9511664509773254,1,0.18496759235858917,0.8690858483314514,1,0.007484222471108581,0.9925157775288914,1
3189,その後、抗AQP4抗体が陽性のため、視神経脊髄炎と診断した。,その後 AQP 0 抗体 陽性 ため 視神経脊髄炎 診断 する た,1,0.0031729139178537794,0.9968270860821464,1,0.0005300400741055271,0.9994699599258945,1,0.033802329042675994,0.966197670957324,1,0.08136758846084469,0.9186324115391553,1,0.13251696527004242,0.9240738153457642,1,0.18511852622032166,0.8724457621574402,1,0.005266345530858789,0.9947336544691411,1
3190,解熱後も頭痛、全身倦怠感が続き、06/20、当院を受診した。,解熱 後 頭痛 全身倦怠感 続く 0 0 院 受診 する た,1,0.016712529420132852,0.9832874705798672,1,0.00031856303797462063,0.9996814369620254,1,0.03257448885587522,0.9674255111441248,1,0.142834103197524,0.857165896802476,1,0.07850135862827301,0.9498711228370667,1,0.1938132345676422,0.8657894730567932,1,0.005717631268993208,0.9942823687310068,1
3191,患者は「呼吸困難、胸痛、呼吸不全、微熱、倦怠感」を発現した。,患者 呼吸困難 胸痛 呼吸不全 微熱 倦怠感 発現 する た,1,9.089728872472723e-06,0.9999909102711276,1,0.00043389033579396,0.999566109664206,1,0.002831532885049559,0.9971684671149504,1,0.045259612710233155,0.9547403872897668,1,0.07630763947963715,0.9475646615028381,1,0.189745232462883,0.8749569654464722,1,0.004238068828021902,0.9957619311719782,1
3192,血液検査:(2022/07/07)炎症反応高値と急性腎不全。,血液検査 0 0 0 炎症反応高値 急性腎不全,1,0.01670937977945231,0.9832906202205475,1,0.00032939361718950776,0.9996706063828105,1,0.35873972300322543,0.6412602769967746,1,0.0,1.0,1,0.08175122737884521,0.9423420429229736,1,0.18559198081493378,0.8725318312644958,1,0.008195232703323653,0.9918047672966762,1
3193,好酸球性心筋炎、胸痛、呼吸困難のために救急治療室を来院した。,好酸球性 心筋炎 胸痛 呼吸困難 ため 救急 治療 室 来院 する た,1,0.011199594207476982,0.9888004057925232,1,0.000488629122313812,0.9995113708776862,1,0.015304638506470791,0.9846953614935292,1,0.10544775354848446,0.8945522464515155,1,0.07695670425891876,0.945836067199707,1,0.18955223262310028,0.8708382248878479,1,0.0050400618244892245,0.9949599381755108,1
3194,自己免疫性肝炎、発熱、脾腫の結果として治療的処置がとられた。,自己免疫性 肝炎 発熱 脾腫 結果 治療 的 処置 とる れる た,1,0.003640453646981201,0.9963595463530189,1,0.00044493276174207864,0.9995550672382579,1,0.004153030614471809,0.9958469693855282,1,0.09499473842326367,0.9050052615767363,1,0.0781983807682991,0.9465822577476501,1,0.1857297271490097,0.8692305684089661,1,0.004747310545849022,0.995252689454151,1
3195,心肺停止、発熱、血圧低下の結果として治療的な処置がとられた。,心肺停止 発熱 血圧低下 結果 治療 的 だ 処置 とる れる た,1,6.550098473061808e-06,0.9999934499015268,1,0.0005025136233738374,0.9994974863766262,1,0.006477070168233068,0.9935229298317669,1,0.07291848905488285,0.9270815109451171,1,0.07685983926057816,0.9489923119544983,1,0.18950092792510986,0.8607959747314453,1,0.004570197099608171,0.9954298029003918,1
3196,副腎クリーゼと診断され、緊急にヒドロコルチゾンが投与された。,副腎クリーゼ 診断 する れる 緊急 ヒドロコルチゾン 投与 する れる た,1,0.18498244367233355,0.8150175563276666,1,0.0002100821446698058,0.9997899178553302,1,0.3499884316094408,0.6500115683905592,0,0.5329487340972251,0.4670512659027749,1,0.09691819548606873,0.9310811161994934,1,0.2011406570672989,0.860897421836853,1,0.03364521141491904,0.966354788585081,1
3197,V3-V6のST低下、Q波なし、心筋梗塞を思わせる所見なし。,V 0 V 0 ST 低下 Q 波 ない 心筋梗塞 思う せる 所見 ない,1,0.31218376576860696,0.6878162342313932,0,0.0001256780877228425,0.9998743219122772,0,0.9553020094426738,0.0446979905573262,0,0.9874699945759642,0.012530005424035777,1,0.2650085687637329,0.8449854254722595,1,0.30583131313323975,0.7826546430587769,1,0.36664493453357005,0.6333550654664298,1
3198,"日付不明、トロポニンI:1,801.7 pm/mL(高値)。",日付 不明 トロポニン I 0 0 0 pm mL 高値,1,0.07277767127097193,0.9272223287290281,1,0.00023890946938003594,0.99976109053062,1,0.40679270933097333,0.5932072906690267,1,0.0,1.0,1,0.11331509798765182,0.9254917502403259,1,0.19423453509807587,0.8562633395195007,1,0.010829563681101585,0.9891704363188984,1
3199,13:20血圧測定するも、測定不能状態が継続、意識は明瞭。,0 0 血圧 測定 する 測定不能 状態 継続 意識 明瞭,1,0.016720055389711694,0.9832799446102881,1,0.00023442801228102267,0.999765571987719,1,0.3730066244273972,0.6269933755726028,1,0.00013627184127840142,0.9998637281587216,1,0.21987159550189972,0.8768234848976135,1,0.2607809901237488,0.8091059923171997,1,0.011831565838430024,0.98816843416157,1
3200,18:00頃帰宅後、ふらつき、嘔気を認め、病院に救急搬送。,0 0 頃 帰宅 後 ふらつき 嘔気 認める 病院 救急搬送,1,0.013598156199943248,0.9864018438000568,1,0.00037309644931891075,0.9996269035506811,1,0.023164097310650722,0.9768359026893493,1,0.0,1.0,1,0.09105432778596878,0.9428892135620117,1,0.18729819357395172,0.8673837780952454,1,0.004245463527285224,0.9957545364727147,1
3201,2021/06/17、患者はギラン・バレ症候群を発現した。,0 0 0 患者 ギラン バレる 症候群 発現 する た,1,0.009060707371735663,0.9909392926282644,1,0.0003746716513024198,0.9996253283486976,1,0.005931159141052467,0.9940688408589475,1,0.05055456590498919,0.9494454340950108,1,0.09480349719524384,0.9471269845962524,1,0.18332451581954956,0.8721613883972168,1,0.00445475657497698,0.995545243425023,1
3202,2021/07/06接種8日後、C6部位に帯状疱疹が発現。,0 0 0 接種 0 日 後 C 0部 位 帯状疱疹 発現,1,0.009447803155888574,0.9905521968441116,1,0.0004254425793690558,0.999574557420631,1,0.018174163624599338,0.9818258363754007,1,3.955724636739433e-12,0.9999999999960443,1,0.0959492027759552,0.9475150108337402,1,0.1841576099395752,0.8707184791564941,1,0.0041436257355312225,0.9958563742644688,1
3203,2021/07/30 11:00急性心筋炎、心膜炎が発現。,0 0 0 0 0 急性心筋炎 心膜炎 発現,1,0.007989134405783655,0.9920108655942165,1,0.00041420581923576506,0.9995857941807642,1,0.00987732563689947,0.9901226743631005,1,8.881784197001252e-16,0.9999999999999991,1,0.08731876313686371,0.9464625120162964,1,0.17715926468372345,0.8716394305229187,1,0.004001555309945389,0.9959984446900547,1
3204,2021/09/12、急性発症の胸痛又は胸部圧迫感が発現。,0 0 0 急性発症 の 胸痛 胸部圧迫感 発現,1,0.002586983219250608,0.9974130167807492,1,0.00047287205562048103,0.9995271279443795,1,0.004211455002965048,0.995788544997035,1,1.1102230246251565e-15,0.9999999999999989,1,0.08210396766662598,0.9451456665992737,1,0.18230563402175903,0.8755409121513367,1,0.0039044185049922717,0.9960955814950077,1
3205,2021/12/17動悸、徐脈、3度房室ブロックを認めた。,0 0 0 動悸 徐脈 0度 房室ブロック 認める た,1,0.012709455643530293,0.9872905443564699,1,0.0003889967606648116,0.9996110032393352,1,0.025039656570858604,0.9749603434291414,1,0.00044055464500003527,0.999559445355,1,0.07581673562526703,0.9458210468292236,1,0.17880131304264069,0.8787766695022583,1,0.004099336685343905,0.995900663314656,1
3206,2022/03/04右外陰部・殿部・大腿に帯状疱疹が発現。,0 0 0 右 外 陰部 殿部 大腿 帯状疱疹 発現,1,0.0037222494926885874,0.9962777505073115,1,0.0004051443838657193,0.9995948556161343,1,0.010525487190776173,0.9894745128092238,1,7.20192794290142e-11,0.9999999999279807,1,0.08508975803852081,0.9423580169677734,1,0.1834440529346466,0.8729812502861023,1,0.003999813562938924,0.996000186437061,1
3207,2022/03/05-2022/03/06腰背部痛を自覚。,0 0 0 0 0 0 腰背部痛 自覚,1,0.016704246948652114,0.9832957530513481,1,0.000409282904316387,0.9995907170956836,1,0.053074651828207364,0.9469253481717926,1,1.492620693710478e-09,0.9999999985073793,1,0.08846820145845413,0.9475957155227661,1,0.190265953540802,0.8652980923652649,1,0.004524185413939727,0.9954758145860604,1
3208,2022/03/06幻覚、妄想が発現し、次第にひどくなる。,0 0 0 幻覚 妄想 発現 ひどい なる,1,0.002862845327341808,0.9971371546726582,1,0.00040366686566410876,0.9995963331343359,1,0.006844972041654462,0.9931550279583455,1,1.238495772826198e-06,0.9999987615042272,1,0.08910065144300461,0.9470245242118835,1,0.18203125894069672,0.8703972697257996,1,0.003965837747342833,0.9960341622526571,1
3209,2022/03/29急性散在性脳脊髄炎(ADEM)が発現。,0 0 0 急性散在性脳脊 髄炎 ADEM 発現,1,0.011154040303241202,0.9888459596967588,1,0.00040916866012028727,0.9995908313398797,1,0.00987732563689947,0.9901226743631005,1,1.680877659282487e-13,0.9999999999998319,1,0.08468227833509445,0.9417096972465515,1,0.18331265449523926,0.8722763061523438,1,0.0040575505262845065,0.9959424494737155,1
3210,2022/03接種後数週間から1ヶ月、腸炎の症状を認めた。,0 0 接種 後 数 週間 0 ヶ月 腸炎 症状 認める た,1,0.016693981778947754,0.9833060182210522,1,0.0002752132920137559,0.9997247867079863,1,0.09915963327811372,0.9008403667218863,1,0.005426081031925212,0.9945739189680748,1,0.08193117380142212,0.9491540193557739,1,0.18019671738147736,0.8715601563453674,1,0.004890897946140349,0.9951091020538596,1
3211,2022/04/01 PET-CTで右肺野にすりガラス影。,0 0 0 PET CT 右 肺 野 すりガラス影,1,0.0234205981786765,0.9765794018213235,1,0.00037696829519300127,0.999623031704807,1,0.13617054063529066,0.8638294593647093,1,3.3874036908798644e-10,0.9999999996612596,1,0.11077602952718735,0.9165400266647339,1,0.2004154473543167,0.860064685344696,1,0.005791952579238822,0.9942080474207612,1
3212,2022/04/19アブレーション治療の承諾を得て、入院。,0 0 0 アブレーション 治療 承諾 得る 入院,1,0.016692850525234768,0.9833071494747652,1,0.00027143461854343953,0.9997285653814566,1,0.08700807301074842,0.9129919269892516,1,7.435629889585016e-11,0.9999999999256437,1,0.1933087557554245,0.864936113357544,0,0.7505538463592529,0.3062896132469177,1,0.017646419422241905,0.9823535805777582,1
3213,2022/04/23左脇胸部の違和感・軽い痛みを再度自覚。,0 0 0 左脇 胸部 違和感 軽い 痛み 自覚,1,0.016668933171191447,0.9833310668288084,1,0.0003901960965221383,0.9996098039034779,1,0.037755357005347046,0.962244642994653,1,4.247446838689939e-11,0.9999999999575255,1,0.08908192813396454,0.9472376704216003,1,0.18525488674640656,0.8646783828735352,1,0.004372883105344087,0.9956271168946559,1
3214,2022/05/24、アナフィラキシーショックを発現した。,0 0 0 アナフィラキシー ショック 発現 する た,1,0.005999106626166914,0.994000893373833,1,0.0004177975970805937,0.9995822024029194,1,0.009830092720909511,0.9901699072790905,1,0.019996556666194154,0.9800034433338058,1,0.08642363548278809,0.9463992714881897,1,0.17946378886699677,0.8751296997070312,1,0.004138996031554036,0.995861003968446,1
3215,2022/06、CTスキャンで悪性リンパ腫再燃がみられた。,0 0 CTスキャン だ 悪性リンパ腫再燃 みる られる た,1,0.07923097308166627,0.9207690269183336,1,0.000265547045759761,0.9997344529542402,1,0.3199206298480599,0.6800793701519401,1,0.054912512277621284,0.9450874877223787,1,0.10280273109674454,0.9311357140541077,1,0.1855732500553131,0.8625912070274353,1,0.009984451501752051,0.9900155484982479,1
3216,2022/06/16、震えが来て摂氏39.7度の熱が出た。,0 0 0 震え 来る 摂氏 0 0度 熱 出る た,1,0.01666466881198417,0.9833353311880159,1,0.0003450977918505966,0.9996549022081495,1,0.33237027757282755,0.6676297224271724,1,0.00435047109929021,0.9956495289007098,1,0.08623028546571732,0.9457316994667053,1,0.184647336602211,0.8699142932891846,1,0.00786600908917262,0.9921339909108273,1
3217,EGE結果と一致し、CMRはT2画像にて心筋浮腫も認めた。,EGE 結果 一致 する CMR T 0 画像 心筋浮腫 認める た,1,0.009212996035259716,0.9907870039647401,1,0.0003441022988612913,0.9996558977011387,1,0.022058932677069154,0.9779410673229308,1,0.004771265455085993,0.995228734544914,1,0.07526986300945282,0.9474520683288574,1,0.18400563299655914,0.8715963959693909,1,0.004123182010283461,0.9958768179897166,1
3218,しかし、左心室の心尖壁における軽度の運動低下が認められた。,左心室 心尖 壁 軽度 運動低下 認める られる た,1,0.005177768936216025,0.9948222310637842,1,0.00048716550262163134,0.9995128344973784,1,0.02024804925663115,0.9797519507433688,1,0.13411173353105688,0.8658882664689431,1,0.0921311303973198,0.9479601979255676,1,0.19373555481433868,0.8592261075973511,1,0.005479372863445451,0.9945206271365545,1
3219,しかし2回目接種10日後、患者は重症の口蓋粘膜痛を呈した。,0回目 接種 0 日 後 患者 重症 口蓋 粘膜痛 呈す た,1,0.016668226702702647,0.9833317732972975,1,0.0003779610195844018,0.9996220389804156,1,0.06451285700775056,0.9354871429922494,1,7.886934902223697e-05,0.9999211306509778,1,0.08761505782604218,0.9517683386802673,1,0.1873169094324112,0.866664707660675,1,0.0045856589896681585,0.9954143410103319,1
3220,下肢筋力は2/5と著明低下、食欲低下を認め、即入院となる。,下肢 筋力 0 0 著い 明 低下 食欲低下 認める 入院 なる,1,2.6064643384711028e-06,0.9999973935356615,1,0.00048378353479309696,0.9995162164652069,1,0.003184652745466532,0.9968153472545335,1,6.8450512343831704e-06,0.9999931549487656,1,0.09029407799243927,0.949533998966217,1,0.1913723200559616,0.8703472018241882,1,0.003946943565594488,0.9960530564344057,1
3221,胸痛または胸部圧迫感、息切れ、動悸、間欠的な発熱を認めた。,胸痛 胸部圧迫感 息切れ 動悸 間欠的 発熱 認める た,1,9.297428360927217e-06,0.9999907025716391,1,0.00046155055405192394,0.999538449445948,1,0.004976878496317894,0.9950231215036821,1,0.0019095052450306405,0.9980904947549694,1,0.0780034065246582,0.9477410912513733,1,0.18861009180545807,0.872603714466095,1,0.003915001645374058,0.9960849983546259,1
3222,好酸球性心筋炎の可能性もあり、ステロイドパルスを施行した。,好酸球性 心筋炎 の 可能性 ある ステロイド パルス 施行 する た,1,0.01669395189161768,0.9833060481083824,1,0.0001915371695147688,0.9998084628304852,1,0.2090523273198993,0.7909476726801007,1,0.4033097717769083,0.5966902282230917,1,0.24333332479000092,0.8038249611854553,1,0.30834105610847473,0.8161928653717041,1,0.021671483051073574,0.9783285169489264,1
3223,考えられる遺伝子検査すべて受け、5か所に異常が見つかった。,考える られる 遺伝子検査 すべて 受ける 0 か所 異常 見つかる た,1,0.01666496380935153,0.9833350361906485,1,0.0002357087805483635,0.9997642912194517,1,0.07207189199182462,0.9279281080081754,1,0.0021986511818430365,0.997801348818157,1,0.10620427876710892,0.9208861589431763,1,0.19316749274730682,0.8641812205314636,1,0.004950257285772229,0.9950497427142276,1
3224,自己免疫性溶血性貧血の結果として、治療的な処置がとられた。,自己免疫性 溶血性 貧血 結果 治療 的 だ 処置 とる れる た,1,0.008660501869428098,0.9913394981305718,1,0.00037389233780047213,0.9996261076621995,1,0.029090311785350487,0.9709096882146495,1,0.08697382612609939,0.9130261738739006,1,0.094845712184906,0.9336873888969421,1,0.20024874806404114,0.8600180149078369,1,0.005228368688763461,0.9947716313112365,1
3225,初診時矯正視力は両眼1.2、右眼に視神経乳頭浮腫を認めた。,初診 時 矯正 視力 眼 0 0 右 眼 視神経乳頭浮腫 認める た,1,0.02253372993180217,0.9774662700681979,1,0.00024384341239051078,0.9997561565876095,1,0.02434232829616434,0.9756576717038357,1,0.005132809467870536,0.9948671905321295,1,0.07139663398265839,0.9491651654243469,1,0.19420012831687927,0.8717919588088989,1,0.004274285240280481,0.9957257147597196,1
3226,診察の結果、上肢バレー正常、下肢は両側で筋力低下を認めた。,診察 結果 上肢 バレー 正常 下肢 両側 だ 筋力低下 認める た,1,0.016686922208608537,0.9833130777913913,1,0.00020244789513479606,0.9997975521048652,1,0.07506205050240067,0.9249379494975993,1,0.022409786037365098,0.9775902139626349,1,0.08119368553161621,0.9460200071334839,1,0.19843851029872894,0.8630053400993347,1,0.004963487873819166,0.9950365121261809,1
3227,接種5時間後、接種側上腕の痛み、37.3°Cの発熱が発現。,接種 0時 間 後 接種 側 上腕 痛み 0 0 C 発熱 発現,1,2.336985325378096e-07,0.9999997663014674,1,0.0005947949547315077,0.9994052050452685,1,0.004672313769675807,0.9953276862303242,1,6.87894186057747e-13,0.9999999999993121,1,0.09198852628469467,0.9452794194221497,1,0.18294496834278107,0.8665634393692017,1,0.0039646124489925005,0.9960353875510074,1
3228,接種から3日後、患者は発熱及び胸痛を訴えに病院を受診した。,接種 0 日 後 患者 発熱 胸痛 訴える 病院 受診 する た,1,4.449303128757293e-06,0.9999955506968713,1,0.0005419833197146663,0.9994580166802853,1,0.0015646010976213542,0.9984353989023786,1,0.05268352426410017,0.9473164757358998,1,0.08093642443418503,0.9498310685157776,1,0.18061506748199463,0.8650436997413635,1,0.004304698618453991,0.995695301381546,1
3229,日付不明現在は生理関係なく、全身脱毛、左手指振戦を認める。,日付 不明 現在 生理 関係 ない 全身 脱毛 左手指振戦 認める,0,0.8098780169800269,0.19012198301997327,0,0.00014156070835074744,0.9998584392916493,1,0.48694627097320986,0.5130537290267901,1,8.407805541787994e-07,0.9999991592194458,1,0.09173393249511719,0.9392744898796082,1,0.22104957699775696,0.8615543246269226,1,0.05244540030186743,0.9475545996981325,1
3230,入院時のCTで両肺上肺野を中心にびまん性に浸潤影を認めた。,入院 時 CT だ 両肺 上 肺 野 中心 びまん性 浸潤影 認める た,1,0.007230205133983011,0.992769794866017,1,0.0004233357618105806,0.9995766642381895,1,0.040873437291248926,0.9591265627087511,1,0.007548881367606675,0.9924511186323933,1,0.07894983887672424,0.9476824998855591,1,0.18938954174518585,0.8596929907798767,1,0.004377526122050129,0.9956224738779499,1
3231,白血球数は正常、CRP 6.06と上昇、トロポニンT陽性。,白血球 数 正常 CRP 0 0 上昇 トロポニン T 陽性,1,0.0839670066566337,0.9160329933433662,1,0.00025836777507814616,0.9997416322249219,1,0.23851076415464367,0.7614892358453563,1,8.109823923518888e-11,0.9999999999189018,1,0.1752641350030899,0.8909460306167603,1,0.20235323905944824,0.8659040331840515,1,0.008716693329377505,0.9912833066706225,1
3232,嘔気が強く摂食できない状態のため、家族がゼリー飲料を用意。,嘔気 強い 摂食 できる ない 状態 ため 家族 ゼリー飲料 用意,1,0.016667322655110433,0.9833326773448897,1,0.0002819067981501351,0.9997180932018499,1,0.3746173774375473,0.6253826225624527,1,8.690844377490237e-09,0.9999999913091556,1,0.13218583166599274,0.927512526512146,1,0.4504846930503845,0.6889486908912659,1,0.014054513697906655,0.9859454863020933,1
3233,日齢1に増悪を認め、界面活性剤(S-Ta)が再投与された。,日齢 0 増悪 認める 界面活性剤 S Ta 投与 する れる た,1,0.011376901475641885,0.9886230985243583,1,0.00027073448598319527,0.9997292655140168,1,0.0775487037451762,0.9224512962548238,1,0.2989165140446366,0.7010834859553634,1,0.09649551659822464,0.9355660676956177,1,0.21427404880523682,0.8648421168327332,1,0.008894279326946463,0.9911057206730536,1
3234,体動により両上肢の肩の痛み、左上肢に筋力低下を強く認めた。,体 動 上肢 肩 痛み 左上 肢 筋力低下 強い 認める た,1,0.0030100664871240885,0.996989933512876,1,0.0004383434049239946,0.999561656595076,1,0.009354557602294755,0.9906454423977052,1,0.013692556887413776,0.9863074431125862,1,0.07671167701482773,0.9487974643707275,1,0.19427809119224548,0.8607509136199951,1,0.004129061363926733,0.9958709386360732,1
3235,2021/10/04、左頚部の腫脹と全身の痛みが発現した。,0 0 0 左 頚部 腫脹 全身 痛み 発現 する た,1,8.065229034186676e-06,0.9999919347709658,1,0.0005897158115116907,0.9994102841884883,1,0.005358193000201794,0.9946418069997982,1,0.05088691476034457,0.9491130852396554,1,0.07388222217559814,0.9485333561897278,1,0.17746363580226898,0.8744657039642334,1,0.004244120874817033,0.9957558791251829,1
3236,(2022/05/30)異常あり、注記:V2-5のST上昇,0 0 0 異常 ある 注記 V 0 0 ST 上昇,1,1.046401535819827e-05,0.9999895359846419,1,0.0003719237446393207,0.9996280762553607,1,0.014110110357735461,0.9858898896422645,1,3.2028610874590413e-09,0.9999999967971389,1,0.08188821375370026,0.9426457285881042,1,0.18903496861457825,0.8726415634155273,1,0.004008270481300211,0.9959917295186997,1
3237,2020/05、検診で血尿を指摘され、報告病院を受診した。,0 0 検診 だ 血尿 指摘 する れる 報告 病院 受診 する た,1,0.010866546271770462,0.9891334537282295,1,0.0002684146687609796,0.9997315853312391,1,0.14940701610786555,0.8505929838921344,1,0.14800679407635553,0.8519932059236445,1,0.0776442363858223,0.9449945688247681,1,0.1906043440103531,0.8698909282684326,1,0.007177937472714645,0.9928220625272853,1
3238,2021/08/26の夜中、患者は末梢神経障害を発症した。,0 0 0 夜中 患者 末梢神経障害 発症 する た,1,0.016681201592025068,0.9833187984079748,1,0.00035803708499598363,0.9996419629150041,1,0.06707087023669567,0.9329291297633043,1,0.008330222038703705,0.9916697779612963,1,0.08001746982336044,0.9477542638778687,1,0.18250057101249695,0.8750519156455994,1,0.004607702921217229,0.9953922970787827,1
3239,2021/09/15から、頭痛、めまい、頚部痛を発症した。,0 0 0 頭痛 めまい 頚部痛 発症 する た,1,0.004557355225073972,0.9954426447749262,1,0.0004607655993656083,0.9995392344006344,1,0.014624590377488644,0.9853754096225114,1,0.010592088662884747,0.9894079113371153,1,0.07662168890237808,0.9428934454917908,1,0.18038460612297058,0.8776153922080994,1,0.004057861937961358,0.9959421380620386,1
3240,2021/10/22、朝から摂氏38.2度の発熱があった。,0 0 0 朝 摂氏 0 0度 発熱 ある た,1,0.0058952311135389455,0.9941047688864612,1,0.0003719327608147869,0.9996280672391852,1,0.015754201952768443,0.9842457980472316,1,0.006213491520301484,0.9937865084796985,1,0.07519552856683731,0.9519666433334351,1,0.18252608180046082,0.8725945353507996,1,0.004028318211528878,0.9959716817884712,1
3241,2021/10/26、患者は心筋炎および心膜炎を発現した。,0 0 0 患者 心筋炎 心膜炎 発現 する た,1,0.004041216142333667,0.9959587838576663,1,0.00042975978696647077,0.9995702402130335,1,0.007075280189786204,0.9929247198102138,1,0.002721702607589971,0.99727829739241,1,0.08263304084539413,0.9435850381851196,1,0.17889714241027832,0.8742552995681763,1,0.003959089578508046,0.996040910421492,1
3242,2021/11/19、血小板減少症を伴う血栓症を発現した。,0 0 0 血小板減少症 伴う 血栓症 発現 する た,1,0.004591952114799623,0.9954080478852005,1,0.000466643028032852,0.9995333569719671,1,0.0064758744957243985,0.9935241255042756,1,0.015676371224577768,0.9843236287754222,1,0.08264664560556412,0.9432984590530396,1,0.1863768994808197,0.8771479725837708,1,0.004082311642984452,0.9959176883570154,1
3243,2022/04/09朝から、最高摂氏39度の発熱があった。,0 0 0 朝 最高 摂氏 0度 発熱 ある た,1,0.006792309329617088,0.9932076906703828,1,0.00036973422950386115,0.9996302657704962,1,0.015754201952768443,0.9842457980472316,1,0.030023897451783244,0.9699761025482168,1,0.07914172857999802,0.9527854323387146,1,0.18354812264442444,0.8754832148551941,1,0.00423681139491981,0.9957631886050803,1
3244,2022/04/15現在、2022/01/27、発症した。,0 0 0 現在 0 0 0 発症 する た,1,0.016666483337523588,0.9833335166624763,1,0.0002905520077678095,0.9997094479922322,1,0.07134578776953437,0.9286542122304656,1,0.029626497502031057,0.9703735024979689,1,0.07875228673219681,0.946186900138855,1,0.1841728687286377,0.8715948462486267,1,0.004873788812367436,0.9951262111876326,1
3245,2022/05/18、溶血性貧血で診断された後に入院した。,0 0 0 溶血性 貧血 だ 診断 する れる た 後 入院 する た,1,0.0036977408340024636,0.9963022591659975,1,0.00038082110021183405,0.9996191788997881,1,0.027903692939435176,0.9720963070605648,1,0.022996893884872027,0.977003106115128,1,0.08825039118528366,0.9369637370109558,1,0.1821824312210083,0.8682284355163574,1,0.004386615449442705,0.9956133845505573,1
3246,2022/05/20、患者は来院時に甲状腺の腫れを訴えた。,0 0 0 患者 来院 時 甲状腺 腫れ 訴える た,1,0.016659588719124478,0.9833404112808756,1,0.00041920716183746823,0.9995807928381625,1,0.05313661562863414,0.9468633843713659,1,7.801071836199824e-05,0.999921989281638,1,0.07665617763996124,0.9451767206192017,1,0.1813071072101593,0.8636738657951355,1,0.004450402257763719,0.9955495977422362,1
3247,2022/06/06、朝より肉眼的血尿、蛋白尿が出現した。,0 0 0 朝 肉眼的血尿 蛋白尿 出現 する た,1,1.7249734150248725e-05,0.9999827502658498,1,0.00038711743274658637,0.9996128825672534,1,0.020242080509046634,0.9797579194909534,1,0.1082280295093162,0.8917719704906838,1,0.07210894674062729,0.95071941614151,1,0.18614418804645538,0.8771865963935852,1,0.004908316218840204,0.9950916837811599,1
3248,2022/06/20 22:00から、食欲不振が発現した。,0 0 0 0 0 食欲不振 発現 する た,1,7.064170703809082e-07,0.9999992935829296,1,0.0004683082062812857,0.9995316917937187,1,0.009830092720909511,0.9901699072790905,1,0.02902750424229794,0.9709724957577021,1,0.08369612693786621,0.9468171000480652,1,0.1815980076789856,0.8771013617515564,1,0.0041521380438554545,0.9958478619561446,1
3249,2022/06/22、のどがしめつけられる痛みが発症した。,0 0 0 のど しめつける られる 痛み 発症 する た,1,4.355093673862926e-06,0.9999956449063261,1,0.0004246508901024487,0.9995753491098975,1,0.023927821066288324,0.9760721789337117,1,0.04002370361207708,0.9599762963879229,1,0.0862819254398346,0.9427176713943481,1,0.1804906725883484,0.87537682056427,1,0.0043964101967422595,0.9956035898032576,1
3250,2022/06/22、のどがしめつけられる痛みを発症した。,0 0 0 のど しめつける られる 痛み 発症 する た,1,4.355093673862926e-06,0.9999956449063261,1,0.0004246508901024487,0.9995753491098975,1,0.023927821066288324,0.9760721789337117,1,0.04002370361207708,0.9599762963879229,1,0.0862819254398346,0.9427176713943481,1,0.1804906725883484,0.87537682056427,1,0.0043964101967422595,0.9956035898032576,1
3251,2022/07/06(接種1日後)に急性腎不全を発症した。,0 0 0 接種 0 日 後 急性腎不全 発症 する た,1,0.016672676313810683,0.9833273236861894,1,0.00038171454480887836,0.9996182854551912,1,0.058057216084424934,0.9419427839155751,1,0.009416168791866797,0.9905838312081332,1,0.07664535939693451,0.9461831450462341,1,0.1831202507019043,0.8752947449684143,1,0.004529261946058533,0.9954707380539415,1
3252,ODテスト:(2021/11)体位性頻脈症候群と診断された,OD テスト 0 0 体位性頻脈 症候群 診断 する れる た,1,0.0170221651341543,0.9829778348658458,1,0.0004013015963352137,0.9995986984036648,1,0.05258129801033906,0.9474187019896609,1,0.269542300871615,0.730457699128385,1,0.09324289113283157,0.9419946074485779,1,0.2021149843931198,0.8723067045211792,1,0.007846196047060725,0.9921538039529392,1
3253,左腋窩上肢にかけて紅色の丘疹、紅斑/体幹の紅斑が増加した。,左 腋窩 上肢 紅色 丘疹 紅斑 体幹 紅斑 増加 する た,1,0.016701590648888116,0.983298409351112,1,0.000377387167943322,0.9996226128320567,1,0.30137797651717,0.69862202348283,1,0.16790825555743027,0.8320917444425697,1,0.08221838623285294,0.9522420763969421,1,0.1941467672586441,0.8670707941055298,1,0.010249567663984455,0.9897504323360157,1
3254,事象「前胸部痛」、「発汗」は救急治療室の受診を必要とした。,事象 前胸部痛 発汗 救急 治療 室 受診 必要 する た,1,0.01667908240887733,0.9833209175911227,1,0.00023627419705103548,0.9997637258029489,1,0.1986106693924734,0.8013893306075266,1,0.38656731558292956,0.6134326844170704,1,0.08056369423866272,0.9497502446174622,1,0.18437114357948303,0.8665247559547424,1,0.012778208351261864,0.9872217916487381,1
3255,事象急性心筋炎と急性心膜炎のために治療的な処置がとられた。,事象 急性心筋炎 急性心膜炎 ため 治療 的 だ 処置 とる れる た,1,0.016699741533272323,0.9833002584667276,1,0.00039686160972296345,0.999603138390277,1,0.07044379813183888,0.9295562018681611,1,0.07491300687079738,0.9250869931292026,1,0.08219199627637863,0.9457622766494751,1,0.18933168053627014,0.8653091192245483,1,0.005406990831353305,0.9945930091686468,1
3256,数日前、患者は嚥下障害/嚥下困難/経口摂取困難を発現した。,数 日 前 患者 嚥下障害 嚥下困難 経口摂取 困難 発現 する た,1,0.01665945100887302,0.9833405489911271,1,0.0002902034586611013,0.9997097965413388,1,0.0299837697456683,0.9700162302543317,1,0.16396908783592357,0.8360309121640764,1,0.08049129694700241,0.9486603736877441,1,0.18845120072364807,0.8679879307746887,1,0.0059057780968261205,0.994094221903174,1
3257,同日14:00頃、突然吐き気があり、視野が真っ白になった。,同日 0 0 頃 吐き 気 ある 視野 真っ白 なる た,1,0.016669242048219967,0.98333075795178,1,0.00033391773254428243,0.9996660822674557,1,0.11875766834282175,0.8812423316571782,1,0.21232493045768963,0.7876750695423104,1,0.08349450677633286,0.9471120238304138,1,0.18545694649219513,0.8732578754425049,1,0.007727235030960077,0.9922727649690399,1
3258,本症例では、肉眼的血尿がIgA腎症診断のきっかけとなった。,症例 だ 肉眼的血尿 IgA 腎症 診断 きっかけ なる た,1,0.04228046854976752,0.9577195314502326,1,0.00030474094675106433,0.999695259053249,1,0.06663957492019246,0.9333604250798075,1,0.006135618887728289,0.9938643811122717,1,0.0860036164522171,0.9426165819168091,1,0.20529170334339142,0.8639832139015198,1,0.005043575586059134,0.9949564244139409,1
3259,左右の肺動脈主幹部に内腔を完全に閉塞する血栓が認められた。,左右 肺動脈主幹 部 腔 完全 閉塞 する 血栓 認める られる た,1,0.02125223440732507,0.9787477655926747,1,0.00028109248046566474,0.9997189075195343,1,0.04013886417598389,0.9598611358240161,1,0.05476095234777534,0.9452390476522247,1,0.07783839106559753,0.9412146806716919,1,0.1924383044242859,0.8679182529449463,1,0.004937286125272343,0.9950627138747278,1
3260,2022/07/11 02:13、患者の死亡が確認された。,0 0 0 0 0 患者 死亡 確認 する れる た,1,0.016675732661702976,0.9833242673382969,1,0.0002946203521924678,0.9997053796478075,1,0.36881045775043975,0.6311895422495603,1,0.3420930620121181,0.6579069379878819,1,0.1030990481376648,0.9258944392204285,1,0.37924066185951233,0.7433515191078186,1,0.023404173824084953,0.976595826175915,1
3261,不明日、患者は鼻咽頭スワブ検査を受け、結果は陽性であった。,明日 患者 鼻 咽頭 スワブ 検査 受ける 結果 陽性 だ ある た,1,0.26183468366363033,0.7381653163363694,1,0.00019863346371193542,0.999801366536288,1,0.25034444737079387,0.7496555526292061,0,0.7014725915780315,0.2985274084219684,1,0.22127731144428253,0.8734739422798157,0,0.6335905194282532,0.49591267108917236,1,0.11038465232030546,0.8896153476796945,1
3262,酸素飽和度:(2022/07/19)、80代まで低下あり。,酸素飽和度 0 0 0 0 代 低下 ある,1,0.08633391318500644,0.9136660868149936,1,0.0002431584651902365,0.9997568415348098,1,0.06233892861538959,0.9376610713846104,1,0.0012660443414107547,0.9987339556585892,1,0.09237761050462723,0.9379248023033142,1,0.18459898233413696,0.8679428696632385,1,0.005332825409877616,0.9946671745901223,1
3263,血中亜鉛:(2021/09/07) 75、コメント:低値。,血 中 亜鉛 0 0 0 0 コメント 値,1,0.005548228805543655,0.9944517711944564,1,0.00035314286769219964,0.9996468571323078,1,0.181732418439582,0.818267581560418,1,5.434752307598156e-05,0.999945652476924,1,0.1408081203699112,0.9021479487419128,1,0.31619858741760254,0.7861576676368713,1,0.007722055773051493,0.9922779442269485,1
3264,磁気共鳴画像: (2021/06/07)左視床に再発病変。,磁気 共鳴 画像 0 0 0 左視床 再発病変,1,0.016690268329694297,0.9833097316703056,1,0.00023189695310320456,0.9997681030468968,1,0.33139811744680214,0.6686018825531979,1,6.293413187252739e-07,0.9999993706586813,1,0.13082855939865112,0.8946089148521423,1,0.21189038455486298,0.856993556022644,1,0.008904609674017842,0.9910953903259822,1
3265,その頃から何かにつかまらないと床から立ち上がれなくなった。,頃 何 つかまる ない 床 立ち上がれる ない なる た,1,0.01667332797840677,0.9833266720215933,1,0.0001664314688784823,0.9998335685311215,0,0.9359819229557514,0.0640180770442486,0,0.7262949550471021,0.27370504495289794,1,0.22385424375534058,0.834033191204071,1,0.22111430764198303,0.8457027673721313,1,0.13278747770638977,0.8672125222936103,1
3266,05:45頃看護師訪室時、左半身痙攣、意識消失を認めた。,0 0 頃 看護師 訪室時 左半身 痙攣 意識消失 認める た,1,4.6061869108063095e-06,0.9999953938130891,1,0.0004342676025435101,0.9995657323974565,1,0.013355625360694123,0.9866443746393059,1,0.012145173245893037,0.987854826754107,1,0.08001592755317688,0.9500485062599182,1,0.18693038821220398,0.8767684102058411,1,0.004037872628690018,0.9959621273713101,1
3267,15:15眼球偏位を示すけいれん発作を15分程度認めた。,0 0 眼球偏位 示す けいれん 発作 0分 程度 認める た,1,0.003449485686070844,0.9965505143139292,1,0.00044920654533620063,0.9995507934546638,1,0.01644165906827444,0.9835583409317256,1,0.0487927168773844,0.9512072831226156,1,0.07734455168247223,0.947607696056366,1,0.18858832120895386,0.8730834722518921,1,0.004423053328719148,0.9955769466712808,1
3268,2021/09/01頭痛、めまい、倦怠感、高血圧が発現。,0 0 0 頭痛 めまい 倦怠感 高血圧 発現,1,2.169621433927243e-06,0.999997830378566,1,0.00045292037218987,0.9995470796278101,1,0.0010616462165553564,0.9989383537834446,1,1.7258061646430178e-10,0.9999999998274194,1,0.08266237378120422,0.945320725440979,1,0.17843280732631683,0.8731639981269836,1,0.003855636565396716,0.9961443634346033,1
3269,2021/09/05朝方、頭痛と肩こりの強い症状が出現。,0 0 0 朝方 頭痛 肩こり の 強い症状 出現,1,0.006695944289010421,0.9933040557109896,1,0.0003857641873409809,0.9996142358126591,1,0.0032697754371262544,0.9967302245628737,1,0.0023103029059412528,0.9976896970940587,1,0.08536363393068314,0.9488727450370789,1,0.18772703409194946,0.8729463815689087,1,0.003976357145804288,0.9960236428541958,1
3270,2021/11/24右こめかみにヘルペス感染症を認めた。,0 0 0 右 こめかみ ヘルペス 感染症 認める た,1,1.2617102541370258e-05,0.9999873828974586,1,0.00039059334362652795,0.9996094066563734,1,0.009328004042247207,0.9906719959577528,1,0.001823496575335648,0.9981765034246644,1,0.07430974394083023,0.9485716223716736,1,0.17755071818828583,0.8728358745574951,1,0.003886169337074496,0.9961138306629255,1
3271,2022/01/29 COVID-19を発症したと診断。,0 0 0 COVID 0 発症 する た 診断,1,5.86527632664412e-06,0.9999941347236734,1,0.0005649232093683763,0.9994350767906316,1,0.057214235172653005,0.942785764827347,1,1.192491017043551e-07,0.9999998807508983,1,0.08411190658807755,0.946264922618866,1,0.1848318874835968,0.8694552183151245,1,0.0043587310000985265,0.9956412689999015,1
3272,2022/02/16 06:00頃突然、頻脈発作が出現。,0 0 0 0 0 頃 頻脈 発作 出現,1,0.004109371737052694,0.9958906282629474,1,0.000494711576466087,0.9995052884235339,1,0.012806945354905563,0.9871930546450944,1,1.7539529820753685e-06,0.9999982460470179,1,0.08374527096748352,0.9451936483383179,1,0.18336772918701172,0.8688072562217712,1,0.004021533502626919,0.995978466497373,1
3273,2022/03/07午前、顔面神経麻痺、知覚異常が発現。,0 0 0 午前 顔面神経 麻痺 知覚異常 発現,1,0.01190334726123294,0.9880966527387671,1,0.0003731178442201324,0.9996268821557799,1,0.00987732563689947,0.9901226743631005,1,5.029843208603779e-11,0.9999999999497016,1,0.0861448347568512,0.946107029914856,1,0.18647335469722748,0.8741719126701355,1,0.004056567972985188,0.9959434320270149,1
3274,2022/03/20両下肢の完全麻痺(対麻痺)を認めた。,0 0 0 両 下肢 完全麻痺 対麻痺 認める た,1,0.013333816451190613,0.9866661835488093,1,0.00031087089507445865,0.9996891291049256,1,0.022181345542693243,0.9778186544573068,1,0.0024967560178054127,0.9975032439821946,1,0.07715905457735062,0.9489737153053284,1,0.18927043676376343,0.8754655122756958,1,0.004146381883180333,0.9958536181168196,1
3275,2022/03/30 00:33急性心筋炎として、入院。,0 0 0 0 0 急性心筋炎 入院,1,0.015132039944585594,0.9848679600554143,1,0.00036031583999069755,0.9996396841600093,1,0.05532740434206673,0.9446725956579333,1,2.220446049250313e-15,0.9999999999999978,1,0.08544737100601196,0.9461666941642761,1,0.18131965398788452,0.8689137697219849,1,0.0044664988953465835,0.9955335011046533,1
3276,2022/03/30行政解剖の結果、無菌性髄膜炎と診断。,0 0 0 行政解剖 結果 無菌性髄膜炎 診断,1,0.016712103483069236,0.9832878965169306,1,0.0003273312202878872,0.9996726687797121,1,0.055688215093414595,0.9443117849065854,1,3.152218719382205e-08,0.9999999684778128,1,0.10537705570459366,0.9378291368484497,1,0.19210949540138245,0.8678861856460571,1,0.004666012896451774,0.9953339871035481,1
3277,2022/04/09 38°C-39°Cの発熱を認めた。,0 0 0 0 C 0 C 発熱 認める た,1,3.491441511167926e-06,0.9999965085584889,1,0.0004963970825137579,0.9995036029174862,1,0.010152221619393553,0.9898477783806064,1,2.8987241870614966e-05,0.9999710127581294,1,0.07597965747117996,0.950557291507721,1,0.18300531804561615,0.8769845366477966,1,0.0038832398647742914,0.9961167601352258,1
3278,2022/04/09興奮、徘徊を認め、当院救急科を受診。,0 0 0 興奮 徘徊 認める 院 救急科 受診,1,3.348888488598087e-06,0.9999966511115115,1,0.0004648510493332736,0.9995351489506668,1,0.011732799045241382,0.9882672009547586,1,1.0405010186786967e-12,0.9999999999989595,1,0.08228182792663574,0.9442212581634521,1,0.1848704218864441,0.8707333207130432,1,0.003976375181573465,0.9960236248184264,1
3279,2022/04/14両側の下肢のしびれ、筋力低下も出現。,0 0 0 両 側 下肢のしびれ 筋力低下 出現,1,0.007847487683496057,0.9921525123165038,1,0.0004675010492553019,0.9995324989507447,1,0.02097495322731857,0.9790250467726814,1,0.0035755625729967377,0.9964244374270033,1,0.08999629318714142,0.9432047009468079,1,0.19437184929847717,0.871549665927887,1,0.004215951049116381,0.9957840489508837,1
3280,2022/05/23、背中と両上肢の重だるさを自覚した。,0 0 0 背中 上肢 重だるさ 自覚 する た,1,0.0167033103770013,0.9832966896229988,1,0.0003574931236926509,0.9996425068763074,1,0.047365096732634115,0.9526349032673659,1,0.0869722999256568,0.9130277000743432,1,0.07602827996015549,0.9492037296295166,1,0.19078309834003448,0.8773217797279358,1,0.0051843254539368855,0.994815674546063,1
3281,2022/05/28無菌性髄膜炎、右顔面神経麻痺が発現。,0 0 0 無菌性髄膜炎 右 顔面神経 麻痺 発現,1,1.2026873639574746e-05,0.9999879731263605,1,0.0004795570244726857,0.9995204429755273,1,0.0049934209175019895,0.995006579082498,1,3.542672821765791e-10,0.9999999996457327,1,0.08213523775339127,0.9444908499717712,1,0.1821344941854477,0.8724976181983948,1,0.0039043626203517576,0.9960956373796482,1
3282,2022/06/05未明、発熱、頭痛、息苦しさを訴えた。,0 0 0 未明 発熱 頭痛 息苦しさ 訴える た,1,1.6703906539026157e-06,0.9999983296093461,1,0.00045118229550246907,0.9995488177044975,1,0.002275320868359465,0.9977246791316405,1,0.00016619959275121499,0.9998338004072488,1,0.07577745616436005,0.9492048025131226,1,0.18076454102993011,0.8757571578025818,1,0.0038239837598413144,0.9961760162401587,1
3283,2022/06/23心筋逸脱酵素のピークアウトを認めた。,0 0 0 心筋逸脱酵素 ピークアウト 認める た,1,0.0063814628100496,0.9936185371899505,1,0.00037416372121869534,0.9996258362787813,1,0.023008821655429723,0.9769911783445703,1,0.006243966535555701,0.9937560334644443,1,0.07970621436834335,0.9473085999488831,0,0.8033496141433716,0.2067032903432846,1,0.014789479922408812,0.9852105200775912,1
3284,2022/07/07、両手のしびれと足の脱力が出現した。,0 0 0 両手のしびれ 足 脱力 出現 する た,1,0.004640360595873917,0.995359639404126,1,0.0003811563092198433,0.9996188436907801,1,0.020242080509046634,0.9797579194909534,1,0.06853132888148905,0.931468671118511,1,0.0760175883769989,0.9491851329803467,1,0.1856471449136734,0.8770459890365601,1,0.004600512065366776,0.9953994879346333,1
3285,2022/07/09 09:40 38°Cの発熱が発現。,0 0 0 0 0 0 C 発熱 発現,1,1.1728167537143671e-07,0.9999998827183246,1,0.0004639204673750092,0.999536079532625,1,0.004216766065844202,0.9957832339341558,1,0.0,1.0,1,0.08471152931451797,0.9479225277900696,1,0.18412740528583527,0.8713104724884033,1,0.003907149261002403,0.9960928507389976,1
3286,2回目ワクチン接種の翌日、発熱及び肉眼的血尿を発症した。,0回目 ワクチン接種 翌日 発熱 肉眼的血尿 発症 する た,1,3.375229793773995e-07,0.9999996624770207,1,0.0006099461389042677,0.9993900538610957,1,0.009216040588569618,0.9907839594114304,1,0.012868861804105847,0.9871311381958942,1,0.07773934304714203,0.9477584362030029,1,0.18309429287910461,0.875363826751709,1,0.004002210299918437,0.9959977897000816,1
3287,C-反応性蛋白(CRP):5.63 mg/dL(高値)。,C 反応 性 蛋白 CRP 0 0 mg dL 高値,1,0.037440065779016214,0.9625599342209837,1,0.00028424685606544275,0.9997157531439346,1,0.08069641984244014,0.9193035801575599,1,0.0,1.0,1,0.10959187150001526,0.9286535978317261,1,0.19700291752815247,0.8615996837615967,1,0.00523668053218409,0.9947633194678158,1
3288,ST上昇後に陰性T波が出現し、時間経過とともに改善した。,ST 上昇 後 陰性 T 波 出現 時間 経過 改善 する た,1,0.17557477710177447,0.8244252228982256,1,0.00019469063769180395,0.9998053093623082,0,0.6768209629236699,0.32317903707633017,0,0.8759779229576835,0.1240220770423165,0,0.9268873929977417,0.08185914158821106,0,0.8163064122200012,0.17655904591083527,1,0.7194857762496667,0.28051422375033336,1
3289,その後、落ち着き帰宅したが、途中で再度手のしびれが出現。,その後 落ち着き 帰宅 する た 途中 手のしびれ 出現,1,0.01667766160984423,0.9833223383901557,1,0.00030178947500016686,0.9996982105249999,1,0.0653538181272515,0.9346461818727485,1,0.000997304645423025,0.999002695354577,1,0.09037387371063232,0.9388102889060974,1,0.19692032039165497,0.8411282896995544,1,0.00484002683192997,0.99515997316807,1
3290,その後、両下肢の痺れの増悪、左下肢の筋力低下がみられた。,その後 下肢 痺れ の 増悪 左下 肢 筋力低下 みる られる た,1,0.0031247277026097814,0.99687527229739,1,0.0004311907305566462,0.9995688092694434,1,0.0569702112180015,0.9430297887819985,1,0.1095740628981915,0.8904259371018085,1,0.08162356913089752,0.946003794670105,1,0.1962558776140213,0.8662665486335754,1,0.005518087863683137,0.994481912136317,1
3291,リンパ球形態異常:6%、異型リンパ球分画は6%であった。,リンパ球 形態異常 0% 異型 リンパ球分画 0% だ ある た,1,0.016705844358873737,0.9832941556411262,1,0.0003133297950012988,0.9996866702049987,1,0.21542956939169555,0.7845704306083044,0,0.5587769928559592,0.44122300714404084,1,0.23418651521205902,0.8126435875892639,1,0.2054557502269745,0.8538675308227539,1,0.025470909326748066,0.974529090673252,1
3292,陰のう癌、新生物進行の結果として治療的な処置がとられた。,陰のう癌 新生物進行 結果 治療 的 だ 処置 とる れる た,1,0.016690632515671933,0.9833093674843281,1,0.0003599610437823676,0.9996400389562177,1,0.029090311785350487,0.9709096882146495,1,0.08575233061848042,0.9142476693815196,1,0.10005953162908554,0.9340739250183105,1,0.19693711400032043,0.8529701232910156,1,0.005344858947016315,0.9946551410529837,1
3293,下痢・発疹を呈したため、症例定義に則りMISと診断した。,下痢 発疹 呈す た ため 症例 定義 則る MIS 診断 する た,1,1.2316536253557575e-05,0.9999876834637464,1,0.0005180730996154968,0.9994819269003845,1,0.018786830445249425,0.9812131695547506,1,0.03537801991423872,0.9646219800857613,1,0.09783393889665604,0.9398111701011658,1,0.22627350687980652,0.8449338674545288,1,0.004719850582957582,0.9952801494170423,1
3294,冠状断からの3Dレンダリングにて、LN腫脹を5つ認めた。,冠状 断 0 D レンダリング LN 腫脹 0 つ 認める た,1,0.006635039510170474,0.9933649604898297,1,0.00032511703765082965,0.9996748829623492,1,0.02723283850974978,0.9727671614902502,1,0.016281740936227806,0.9837182590637722,1,0.07118796557188034,0.947440505027771,1,0.18192647397518158,0.8724759221076965,1,0.004210927553419294,0.9957890724465807,1
3295,顔面神経麻痺と診断し、プレドニンとバラシクロビルで加療。,顔面神経 麻痺 診断 プレドニン バラシクロビル 加療,1,0.016718922397982606,0.9832810776020173,1,0.000293331864610549,0.9997066681353894,1,0.06260030355645518,0.9373996964435448,1,0.0,1.0,1,0.15376456081867218,0.8829002976417542,1,0.2165766954421997,0.8557882308959961,1,0.00543675045185091,0.9945632495481491,1
3296,血液・骨髄検査の結果、自己免疫性溶血性貧血と診断された。,血液 骨髄 検査 結果 自己免疫性 溶血性 貧血 診断 する れる た,1,0.016689222731483364,0.9833107772685167,1,0.0002988065551549958,0.999701193444845,1,0.07912491576297198,0.920875084237028,1,0.24211620681182,0.75788379318818,1,0.08811160176992416,0.9434390068054199,1,0.1939491182565689,0.8678155541419983,1,0.0077465150143580476,0.992253484985642,1
3297,左眼視力は0.01で直接対光反射は消失、RAPDも陽性。,左 眼 視力 0 0 だ 直接対光反射 消失 RAPD 陽性,1,0.3051529025278332,0.6948470974721667,1,0.00020088993130605313,0.9997991100686939,1,0.2156428173184467,0.7843571826815533,1,8.996097200508757e-10,0.9999999991003903,1,0.13831374049186707,0.9119895696640015,1,0.2199857234954834,0.8575486540794373,1,0.012502497560565016,0.9874975024394351,1
3298,左前胸部圧迫感、呼吸困難感を自覚し、当院救急外来を受診。,左前胸部圧迫感 呼吸 困難感 自覚 院 救急外来 受診,1,6.43165651492588e-07,0.9999993568343486,1,0.00046329458356841354,0.9995367054164316,1,0.013587539464690268,0.9864124605353097,1,3.995548558677342e-09,0.9999999960044514,1,0.08876913040876389,0.9426555633544922,1,0.2042054980993271,0.8650414347648621,1,0.004124738414779234,0.9958752615852207,1
3299,最大強度投影画像にてFDG集積を伴うLNの分布を認めた。,最大 強度 投影 画像 FDG 集積 伴う LN 分布 認める た,1,0.012690806715991026,0.9873091932840091,1,0.000410519778391689,0.9995894802216083,1,0.014086180239212265,0.9859138197607877,1,0.015461675589769297,0.9845383244102307,1,0.08567658811807632,0.941835343837738,1,0.19375845789909363,0.8700542449951172,1,0.004290056126659976,0.9957099438733399,1
3300,受診時、37°C台の発熱、咳嗽、関節痛、嘔気などが継続。,受診 時 0 C 台 発熱 咳嗽 関節痛 嘔気 継続,1,9.929876189940073e-06,0.99999007012381,1,0.00030964900577441236,0.9996903509942255,1,0.04418611590798405,0.955813884092016,1,0.0003518012042064145,0.9996481987957936,1,0.08487648516893387,0.9473525881767273,1,0.1857977956533432,0.8728029727935791,1,0.0042365254580829514,0.9957634745419169,1
3301,脊柱管狭窄症、背部痛の結果として治療的な処置がとられた。,脊柱管狭窄症 背部痛 結果 治療 的 だ 処置 とる れる た,1,0.01666661174424222,0.983333388255758,1,0.00036430532504391376,0.999635694674956,1,0.0303308374168737,0.9696691625831263,1,0.08327168569751198,0.916728314302488,1,0.09019540250301361,0.9362149834632874,1,0.20739808678627014,0.8541204333305359,1,0.005317210557844707,0.9946827894421553,1
3302,接種後翌日より腹部膨満、胸水増加、感染兆候が認められた。,接種 後 翌日 腹部膨満 胸水増加 感染兆候 認める られる た,1,0.005621886488860017,0.99437811351114,1,0.00034421232637288216,0.9996557876736272,1,0.028681670904567746,0.9713183290954323,1,0.08000772136604084,0.9199922786339592,1,0.07858576625585556,0.9476351737976074,1,0.18206718564033508,0.8645906448364258,1,0.004857984169288743,0.9951420158307113,1
3303,同年06/04頃、両下肢浮腫および皮膚発赤が認められた。,同年 0 0 頃 両下肢浮腫 皮膚発赤 認める られる た,1,0.009200108227636465,0.9907998917723637,1,0.00034241795978407716,0.9996575820402159,1,0.028110431711985795,0.9718895682880142,1,0.0739812573110954,0.9260187426889046,1,0.07641711831092834,0.9507442116737366,1,0.18806783854961395,0.8716797232627869,1,0.004798363005466996,0.9952016369945331,1
3304,無疱疹性帯状疱疹も鑑み、バラシクロビルの投与を開始した。,無疱疹性帯状疱疹 鑑みる バラシクロビル 投与 開始 する た,1,0.01669760098888445,0.9833023990111155,1,0.0002325380204382229,0.9997674619795618,0,0.8508637905388365,0.14913620946116352,1,0.42066459279935386,0.5793354072006461,1,0.28221333026885986,0.8223748207092285,1,0.5439215302467346,0.6061303019523621,1,0.11655629283092588,0.883443707169074,1
3305,翌日も熱発は継続(摂氏37.4度)、解熱剤が使用された。,翌日 熱発 継続 摂氏 0 0度 解熱 剤 使用 する れる た,1,0.016686969011166296,0.9833130309888336,1,0.00022374676200083297,0.9997762532379991,1,0.3084860671495109,0.6915139328504891,1,0.3184873476032305,0.6815126523967695,1,0.3961081802845001,0.7729542255401611,1,0.18737266957759857,0.863598108291626,1,0.02263631790845716,0.9773636820915429,1
3306,2022/02/25、患者はCOVID-19を発症した。,0 0 0 患者 COVID 0 発症 する た,1,0.025606707644711263,0.9743932923552886,1,0.00035246045253815156,0.9996475395474619,1,0.10643188518716684,0.8935681148128332,1,0.0016171061362035832,0.9983828938637964,1,0.08088261634111404,0.9469184875488281,1,0.18230368196964264,0.8690149188041687,1,0.0050428373724312175,0.9949571626275688,1
3307,2022/03/19、患者は体調の不調のため、来院した。,0 0 0 患者 体調 不調 ため 来院 する た,1,0.01516424763210336,0.9848357523678968,1,0.00039861443410000186,0.9996013855659,1,0.05919210977666178,0.9408078902233382,1,0.10240374425827914,0.8975962557417209,1,0.0807122141122818,0.9499387741088867,1,0.19153548777103424,0.8638589978218079,1,0.0055564018255465,0.9944435981744535,1
3308,2022/04/08、患者はRS3PE症候群を発現した。,0 0 0 患者 RS 0 PE 症候群 発現 する た,1,0.007384688889137376,0.9926153111108627,1,0.0004941033739810722,0.999505896626019,1,0.014795956301607238,0.9852040436983928,1,0.003024100292594256,0.9969758997074057,1,0.08885364979505539,0.9464446902275085,1,0.18572860956192017,0.8703677654266357,1,0.004107468299881893,0.9958925317001182,1
3309,2022/04/29、IgA血管炎の腎病変と診断された。,0 0 0 IgA 血管炎 の 腎病変 診断 する れる た,1,0.005480056840983408,0.9945199431590164,1,0.00047628188435022993,0.9995237181156498,1,0.04319584262165388,0.9568041573783461,1,0.2879307419318372,0.7120692580681628,1,0.08129927515983582,0.9433406591415405,1,0.18287703394889832,0.8731807470321655,1,0.007553371244535126,0.9924466287554649,1
3310,2022/05/08午前朝、腹痛、嘔吐、脱水が発現した。,0 0 0 午前 朝 腹痛 嘔吐 脱水 発現 する た,1,3.295672901210625e-07,0.9999996704327099,1,0.000538961854632241,0.9994610381453678,1,0.005526050620892287,0.9944739493791077,1,0.04266031117970115,0.9573396888202989,1,0.07658831030130386,0.9493887424468994,1,0.18006984889507294,0.8773331642150879,1,0.0041826766539948355,0.9958173233460053,1
3311,2022/05/27の夜、患者は発熱と両肩痛を発症した。,0 0 0 夜 患者 発熱 両肩痛 発症 する た,1,8.052607960123624e-08,0.9999999194739204,1,0.00040502951189140123,0.9995949704881086,1,0.01398541680523524,0.9860145831947648,1,0.02216044781193871,0.9778395521880613,1,0.0755147635936737,0.9512789249420166,1,0.18132951855659485,0.8781675100326538,1,0.0040721641790295955,0.9959278358209703,1
3312,2022/06/20 22:00から、めまいが発現した。,0 0 0 0 0 めまい 発現 する た,1,0.01084341447052207,0.9891565855294778,1,0.0003893880372918197,0.9996106119627082,1,0.010189603299610828,0.9898103967003892,1,0.014642534407776409,0.9853574655922236,1,0.07944369316101074,0.9504552483558655,1,0.18082819879055023,0.8766722083091736,1,0.00409157355262158,0.9959084264473784,1
3313,2022/06/20 22:00から、失声症が発現した。,0 0 0 0 0 失声症 発現 する た,1,0.010536876545779068,0.989463123454221,1,0.0003580141782926961,0.9996419858217073,1,0.009427390499791577,0.9905726095002084,1,0.05054440879622679,0.9494555912037732,1,0.08296613395214081,0.9496705532073975,1,0.18526336550712585,0.8746355175971985,1,0.004432526371540004,0.9955674736284601,1
3314,6週間が過ぎ、微熱がおさまった頃より、呼吸苦が出現した。,0 週間 過ぎる 微熱 おさまる た 頃 呼吸苦 出現 する た,1,0.009436664679674439,0.9905633353203256,1,0.00034864246123193267,0.9996513575387681,1,0.028718990037405967,0.971281009962594,1,0.016639666047585044,0.983360333952415,1,0.08083400875329971,0.9521057605743408,1,0.18616801500320435,0.8715190887451172,1,0.004293565773252865,0.9957064342267472,1
3315,近隣の救急外来でECGが施行され、ST上昇が指摘された。,近隣 救急外来 ECG 施行 する れる ST 上昇 指摘 する れる た,1,0.014612976039513654,0.9853870239604862,1,0.0002933663186697047,0.9997066336813303,1,0.08089541867757366,0.9191045813224263,0,0.5807647183015117,0.4192352816984883,1,0.08070796728134155,0.9475786685943604,1,0.18335255980491638,0.869579017162323,1,0.014774552798581598,0.9852254472014185,1
3316,頚部痛、発熱、リンパ節炎の結果、治療的な処置がとられた。,頚部痛 発熱 リンパ節炎 結果 治療 的 だ 処置 とる れる た,1,0.006431133962835199,0.9935688660371648,1,0.00039694723607869406,0.9996030527639213,1,0.004921829783213982,0.995078170216786,1,0.08896987438278148,0.9110301256172185,1,0.07869162410497665,0.9475513696670532,1,0.1866430640220642,0.8608368635177612,1,0.00476531954052174,0.9952346804594783,1
3317,四肢筋力低下、嚥下障害と誤嚥性肺炎のために救急入院した。,四肢筋力低下 嚥下障害 誤嚥性 肺炎 ため 救急 入院 する た,1,4.713345764256898e-06,0.9999952866542358,1,0.00043055730237533514,0.9995694426976247,1,0.0064729713018846224,0.9935270286981154,1,0.13552429033276514,0.8644757096672349,1,0.07922948896884918,0.9409864544868469,1,0.1907588094472885,0.8682239651679993,1,0.005197548745350603,0.9948024512546493,1
3318,自宅待機中に咽頭痛が増強し、摂氏38度台の発熱があった。,自宅待機 中 咽頭痛 増強 摂氏 0度 台 発熱 ある た,1,0.01670591315556978,0.9832940868444302,1,0.00034680425534974925,0.9996531957446503,1,0.03941766619733633,0.9605823338026637,1,0.10638424950530045,0.8936157504946995,1,0.07755909115076065,0.9524813294410706,1,0.17999455332756042,0.8681349158287048,1,0.005286210893900476,0.9947137891060995,1
3319,頭部MRIで両側大脳、視床に広範な血管原性浮腫を認めた。,頭部 MRI 両側 大脳 視床 広範 だ 血管原性 浮腫 認める た,1,0.0037403206991995994,0.9962596793008005,1,0.00038147162928750284,0.9996185283707125,1,0.07355448281290433,0.9264455171870957,1,0.0037492974243769073,0.9962507025756231,1,0.07880347222089767,0.9411707520484924,1,0.1952166110277176,0.8701695799827576,1,0.004612008744607759,0.9953879912553922,1
3320,発熱、倦怠感、黄疸の結果として、治療的な処置がとられた。,発熱 倦怠感 黄疸 結果 治療 的 だ 処置 とる れる た,1,0.0032839090945056934,0.996716090905494,1,0.0004283451917602472,0.9995716548082397,1,0.004770727518114581,0.9952292724818854,1,0.06790693221394883,0.9320930677860512,1,0.07765159755945206,0.9495142698287964,1,0.1908598691225052,0.8638279438018799,1,0.0045319942084555915,0.9954680057915445,1
3321,発熱、頭痛、倦怠感の結果として、治療的な処置がとられた。,発熱 頭痛 倦怠感 結果 治療 的 だ 処置 とる れる た,1,5.753728002901429e-06,0.9999942462719971,1,0.0005338008447423601,0.9994661991552577,1,0.0025017080944508274,0.9974982919055492,1,0.05419390742554453,0.9458060925744555,1,0.08050940185785294,0.9489076137542725,1,0.19502170383930206,0.861329972743988,1,0.004406597295915417,0.9955934027040847,1
3322,1ヵ月にわたって、複数の新規発症の皮膚小潰瘍が出現した。,0 ヵ月 複数 の 新規発症 皮膚 小潰瘍 出現 する た,1,0.014252846680521807,0.9857471533194782,1,0.0002526803819804558,0.9997473196180195,1,0.024276850068938427,0.9757231499310616,1,0.16062547388814763,0.8393745261118524,1,0.07893001288175583,0.9489572048187256,1,0.18530112504959106,0.8744470477104187,1,0.005706892344128061,0.9942931076558719,1
3323,2022/04/21腕のしびれが継続するため、外来受診。,0 0 0 腕のしびれ 継続 する ため 外来 受診,1,0.016680682106423338,0.9833193178935766,1,0.0002525767271372951,0.9997474232728627,1,0.30213227710622603,0.697867722893774,1,4.257941332852511e-09,0.9999999957420587,1,0.09295789897441864,0.9373417496681213,1,0.19554202258586884,0.8656721115112305,1,0.0075668494841280255,0.9924331505158719,1
3324,気道狭窄音あり、シムビコートと抗アレルギー剤を処方した。,気道狭窄音 ある シムビコート 抗アレルギー 剤 処方 する た,1,0.3741585257654766,0.6258414742345235,0,0.00015663714865407727,0.9998433628513459,1,0.3505987784797122,0.6494012215202878,1,0.47429417791626993,0.5257058220837301,0,0.7941873073577881,0.34108859300613403,0,0.6209020018577576,0.4939846396446228,1,0.2647221470423825,0.7352778529576176,1
3325,"White blood cells urine, (-)",White BLOOD cells urine,0,0.9446175433278697,0.055382456672130195,0,0.00010661488284464612,0.9998933851171553,1,0.4563792597309324,0.5436207402690676,0,0.9999999999981483,1.851720125426946e-12,1,0.5135196447372437,0.6331620812416077,1,0.5098938345909119,0.6303535103797913,1,0.6369393927059808,0.36306060729401923,1
3326,(心筋損傷)T1強調像におけるガドリニウム遅延造影像。,心筋損傷 T 0 強調像 ガドリニウム 遅延 造影 像,1,0.05098880663177039,0.9490111933682296,1,0.0002776822349807318,0.9997223177650193,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.15478698909282684,0.8593347072601318,1,0.2355152666568756,0.8438099026679993,1,0.013419303975253889,0.9865806960247462,1
3327,10:20頃接種後20分程度でアナフィラキシーが発現。,0 0 頃 接種 後 0分 程度 だ アナフィラキシー 発現,1,0.01670386540324016,0.9832961345967597,1,0.0003913099044841271,0.9996086900955159,1,0.016618920270703552,0.9833810797292964,1,2.708944180085382e-14,0.9999999999999729,1,0.10822395235300064,0.9378265142440796,1,0.18790683150291443,0.868635356426239,1,0.004308263027352353,0.9956917369726476,1
3328,16:40前胸部絞扼感が発現したため、当院に救急搬送。,0 0 前胸部絞扼感 発現 する た ため 院 救急搬送,1,2.512280605103601e-06,0.9999974877193949,1,0.0004479533871293255,0.9995520466128707,1,0.005630104173840578,0.9943698958261594,1,0.0,1.0,1,0.08051323890686035,0.9467124342918396,1,0.19221162796020508,0.8684666752815247,1,0.003949169044710926,0.9960508309552891,1
3329,2021/06/26 C5部位に汎発性帯状疱疹が発現。,0 0 0 C 0部 位 汎発性 帯状疱疹 発現,1,0.007205223240962486,0.9927947767590374,1,0.00039169827451098225,0.999608301725489,1,0.017666872295022507,0.9823331277049775,1,2.2304380564719395e-12,0.9999999999977696,1,0.09053312242031097,0.9479411244392395,1,0.1843479573726654,0.8751755356788635,1,0.004079439100391218,0.9959205608996089,1
3330,2021/07/03帯状疱疹が発現し、体幹に皮疹あり。,0 0 0 帯状疱疹 発現 体幹 皮疹 ある,1,0.008795118977129143,0.991204881022871,1,0.000372368297032555,0.9996276317029674,1,0.006324958861622654,0.9936750411383773,1,3.387311422720085e-05,0.9999661268857728,1,0.08016590774059296,0.9480034708976746,1,0.18157802522182465,0.8708770275115967,1,0.003965760764973459,0.9960342392350265,1
3331,2021/11/03肺炎、呼吸困難、多臓器不全が発現。,0 0 0 肺炎 呼吸困難 多臓器不全 発現,1,2.339335071150605e-06,0.9999976606649289,1,0.00046269442592141336,0.9995373055740786,1,0.0023857226430131773,0.9976142773569868,1,0.0,1.0,1,0.0795881599187851,0.9416611194610596,1,0.18158230185508728,0.8774088025093079,1,0.003863934299668955,0.9961360657003311,1
3332,2021/12/24、両下肢しびれ発症、排尿障害あり。,0 0 0 両下肢しびれ 発症 排尿障害 ある,1,0.0038619765326600225,0.9961380234673397,1,0.000406770648195179,0.9995932293518048,1,0.033212164548064194,0.9667878354519358,1,2.9102253840118664e-07,0.9999997089774616,1,0.08018852025270462,0.94597989320755,1,0.18607856333255768,0.8696403503417969,1,0.004175276182176901,0.9958247238178232,1
3333,2022/01中旬、両下腿に点状出血斑(+)を認めた。,0 0 中旬 下腿 点状 出血斑 認める た,1,6.026604826459673e-06,0.9999939733951735,1,0.00045506200551696026,0.9995449379944831,1,0.025957101473613298,0.9740428985263867,1,0.004019733139274617,0.9959802668607254,1,0.07375463843345642,0.9495984315872192,1,0.19035488367080688,0.8747415542602539,1,0.004072754658454116,0.9959272453415459,1
3334,2022/02/06意味不明言動、四肢けいれんが発現。,0 0 0 意味不明言動 四肢けいれん 発現,1,2.021454195214444e-06,0.9999979785458049,1,0.0003976645092034571,0.9996023354907966,1,0.00987732563689947,0.9901226743631005,1,3.469002862743764e-12,0.999999999996531,1,0.08705554902553558,0.9416075944900513,1,0.19180232286453247,0.8686251044273376,1,0.004026509362955679,0.9959734906370443,1
3335,2022/03/01びまん性肺胞出血、呼吸不全が発現。,0 0 0 びまん性肺胞出血 呼吸不全 発現,1,0.010736499947276558,0.9892635000527235,1,0.00040200943169252525,0.9995979905683074,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.07994461804628372,0.9429097771644592,1,0.18288999795913696,0.8724770545959473,1,0.004027713666310807,0.9959722863336892,1
3336,2022/03/27発熱、倦怠感、関節痛、頭痛が発現。,0 0 0 発 熱 倦怠感 関節痛 頭痛 発現,1,2.6718541420283627e-07,0.9999997328145859,1,0.00045244012565723524,0.9995475598743427,1,0.0010616462165553564,0.9989383537834446,1,3.0049296384504487e-12,0.9999999999969951,1,0.08213584870100021,0.9469940662384033,1,0.18279559910297394,0.8765265345573425,1,0.00385101359551006,0.9961489864044899,1
3337,2022/04/02動眼神経麻痺、視神経周囲炎が発現。,0 0 0 動眼神経麻痺 視神経周囲炎 発現,1,0.00887421687536377,0.9911257831246361,1,0.00038845232604435424,0.9996115476739557,1,0.00987732563689947,0.9901226743631005,1,8.770761894538737e-14,0.9999999999999123,1,0.09036366641521454,0.9430274367332458,1,0.18396763503551483,0.8750969767570496,1,0.004047850870540342,0.9959521491294596,1
3338,2022/04/12 00:00頃眼瞼周囲の腫脹あり。,0 0 0 0 0 頃 眼瞼 周囲 腫脹 ある,1,0.016691471905687875,0.983308528094312,1,0.00041938937244816567,0.9995806106275519,1,0.18201680164884804,0.817983198351152,1,6.298441812546685e-08,0.9999999370155819,1,0.07965724915266037,0.9476354122161865,1,0.18304359912872314,0.8682494759559631,1,0.005737780060909927,0.99426221993909,1
3339,2022/04接種1週間後、肺水腫を起こし、緊急入院。,0 0 接種 0 週間 後 肺水腫 起こす 緊急入院,1,0.016698055562264606,0.9833019444377354,1,0.0002755210998145092,0.9997244789001855,1,0.4052386445496693,0.5947613554503307,1,0.0,1.0,1,0.08296819776296616,0.9427445530891418,1,0.18240784108638763,0.8539084792137146,1,0.009131493716964608,0.9908685062830354,1
3340,2022/05/17 12:00心筋炎、心膜炎が発現。,0 0 0 0 0 心筋炎 心膜炎 発現,1,0.0032748400549357333,0.996725159945064,1,0.00043922012724618065,0.9995607798727538,1,0.0033982837012268563,0.9966017162987731,1,4.440892098500626e-16,0.9999999999999996,1,0.08377553522586823,0.9455881118774414,1,0.17982029914855957,0.871701180934906,1,0.0039132396733197366,0.9960867603266803,1
3341,2022/06/24左半身に力が入らない症状を認めた。,0 0 0 左半身 力 入る ない 症状 認める た,1,0.016681340196649068,0.9833186598033508,1,0.00024846673064694673,0.9997515332693531,0,0.5022755776371759,0.49772442236282416,1,0.022229160187817842,0.9777708398121822,1,0.07949240505695343,0.947405219078064,1,0.1847134530544281,0.8747707605361938,1,0.011260821110032343,0.9887391788899675,1
3342,2022/06/30症状がひどくなり歩行困難となった。,0 0 0 症状 ひどい なる 歩行困難 なる た,1,0.016707314885575947,0.983292685114424,1,0.00035441044268203425,0.999645589557318,1,0.287588121316664,0.712411878683336,1,0.06759742596562379,0.9324025740343762,1,0.0742054358124733,0.9466695189476013,1,0.18524226546287537,0.8753736019134521,1,0.008017324546325866,0.9919826754536742,1
3343,22日目に患者は四肢脱力を発症し、歩行困難を報告した。,0 日 目 患者 四肢脱力 発症 歩行困難 報告 する た,1,0.016684799493012267,0.9833152005069875,1,0.00030848357760332316,0.9996915164223967,1,0.13133563915833135,0.8686643608416686,1,0.15466898210985414,0.8453310178901459,1,0.09011273831129074,0.9440693259239197,1,0.18883644044399261,0.8641470670700073,1,0.007222743878235773,0.9927772561217644,1
3344,37.5°Cの発熱、頭痛のためカロナール内服にて軽快。,0 0 C 発熱 頭痛 ため カロナール 内服 軽快,1,0.02378461790063746,0.9762153820993625,1,0.00018544711689351734,0.9998145528831065,1,0.13797625536151625,0.8620237446384837,1,0.0010822837996408152,0.9989177162003592,1,0.1545163094997406,0.9134954810142517,1,0.19453446567058563,0.8661901354789734,1,0.006032292289120944,0.9939677077108791,1
3345,37.6°Cの発熱、頭痛のためカロナール内服して軽快。,0 0 C 発熱 頭痛 ため カロナール 内服 する 軽快,1,0.010760612003104299,0.9892393879968958,1,0.00019613030092613862,0.9998038696990739,1,0.13797625536151625,0.8620237446384837,0,0.96752495387864,0.032475046121360034,1,0.15201067924499512,0.9120538234710693,1,0.21235790848731995,0.8571068644523621,1,0.04023789639290949,0.9597621036070905,1
3346,PR68、SpO2 83%だが口唇チアノーゼは認めず。,PR 0 SpO 0 0% だ 口唇チアノーゼ 認める ぬ,1,0.09133285175828346,0.9086671482417165,1,0.0003168083259493106,0.9996831916740507,1,0.34223674352334654,0.6577632564766535,1,0.47077666330062273,0.5292233366993773,1,0.10882344096899033,0.9362431764602661,1,0.18390415608882904,0.8712368607521057,1,0.023999588905839486,0.9760004110941605,1
3347,ミオグロビン尿著明などから横紋筋融解症、腎不全の診断。,ミオグロビン尿 著い 明 横紋筋融解症 腎不全 の 診断,1,0.0030520912400573215,0.9969479087599425,1,0.00033800894735298165,0.999661991052647,1,0.03727066011862723,0.9627293398813728,1,1.718227624625257e-07,0.9999998281772375,1,0.09497474133968353,0.9383751153945923,1,0.19511011242866516,0.8680052757263184,1,0.0043424110666712154,0.9956575889333288,1
3348,核酸検出検査(PCR法、LAMP法)にて実施し、陽性。,核酸 検出 検査 PCR法 LAMP法 実施 する 陽性,1,0.07152757591271294,0.9284724240872871,1,0.00024119857557890241,0.9997588014244211,1,0.30081250401369053,0.6991874959863095,1,3.4413771832220164e-09,0.9999999965586228,1,0.23628896474838257,0.8645070791244507,0,0.807738721370697,0.22546440362930298,1,0.03554439811783211,0.9644556018821678,1
3349,患者は心原性ショック及び心筋炎のため79日間入院した。,患者 心原性ショック 心筋炎 ため 0 日間 入院 する た,1,3.0850147760387678e-06,0.999996914985224,1,0.0003887017084007433,0.9996112982915992,1,0.014161651768677008,0.985838348231323,1,0.054862500887626786,0.9451374991123732,1,0.07864078879356384,0.9460320472717285,1,0.19532938301563263,0.8705880641937256,1,0.004479215595230177,0.9955207844047698,1
3350,気分不良の訴えと同時に座位から転倒、意識消失を認めた。,気分不良 訴え 座位 転倒 意識消失 認める た,1,6.924425786834475e-06,0.9999930755742131,1,0.00042418670733146245,0.9995758132926685,1,0.03271476643218074,0.9672852335678193,1,0.012840847781441456,0.9871591522185585,1,0.08150072395801544,0.9468702077865601,1,0.18501225113868713,0.8740119934082031,1,0.004225447210882026,0.9957745527891179,1
3351,血栓・塞栓症の所見があり、右心拡大、左室圧排を認めた。,血栓 塞栓症 所見 ある 右心拡大 左室圧排 認める た,1,0.0075397460198368665,0.9924602539801632,1,0.00033295934297640224,0.9996670406570236,1,0.02463640744460116,0.9753635925553988,1,0.019756662255258628,0.9802433377447414,1,0.07928586006164551,0.9464343190193176,1,0.19695934653282166,0.8700658082962036,1,0.004339170912814717,0.9956608290871852,1
3352,血中クレアチンホスホキナーゼ:415 U/L(高値)。,血 中 クレアチンホスホキナーゼ 0 U L 高値,1,0.005292999760522546,0.9947070002394776,1,0.0004513308813112901,0.9995486691186887,1,0.09868961983634261,0.9013103801636574,1,0.0,1.0,1,0.11014965176582336,0.9278503656387329,1,0.2581358551979065,0.8371849060058594,1,0.005552815660930633,0.9944471843390694,1
3353,限界フリッカ値は両眼とも低下、右眼に中心暗点を認めた。,限界 FLICKA 値 眼 低下 右 眼 中心暗点 認める た,1,8.647196038199993e-08,0.9999999135280396,1,0.00046190373613406137,0.9995380962638659,1,0.0047431488105760256,0.995256851189424,1,0.013851151250166893,0.9861488487498331,1,0.07928039133548737,0.9497759342193604,1,0.19783896207809448,0.8747533559799194,1,0.004032623458114877,0.995967376541885,1
3354,左頚部にも汎発疹があり、汎発性帯状疱疹と診断し、入院。,左 頚部 汎発疹 ある 汎発性 帯状疱疹 診断 入院,1,5.481910410241631e-06,0.9999945180895897,1,0.0004414623273363268,0.9995585376726637,1,0.01593108303904911,0.9840689169609509,1,4.6308956669349755e-11,0.999999999953691,1,0.08076813817024231,0.9454994201660156,1,0.1858220398426056,0.8615598082542419,1,0.004038991825301786,0.9959610081746982,1
3355,細隙灯試験:浅前眼房であるが、角膜又は虹彩の異常なし。,細 隙 灯 試験 浅い 眼 房 だ ある 角膜 虹彩 異常 ない,1,0.016681259834420804,0.9833187401655793,1,0.0002266863894454208,0.9997733136105545,0,0.5442989271060736,0.4557010728939263,0,0.8201043910177896,0.17989560898221038,0,0.6945365071296692,0.5210991501808167,0,0.8356037735939026,0.1882169097661972,1,0.39734182048107414,0.6026581795189259,1
3356,事象の臨床経過: 2021/08/25、咳嗽が現れた。,事象 臨床 経過 0 0 0 咳嗽 現れる た,1,0.016718392258245243,0.983281607741755,1,0.000203978009637356,0.9997960219903627,1,0.3870459740658463,0.6129540259341537,1,3.5264174846894036e-07,0.9999996473582515,1,0.07952787727117538,0.9452846050262451,1,0.18614280223846436,0.8712379336357117,1,0.008637950465044777,0.9913620495349552,1
3357,軸位像にて左上肢及び左腋窩におけるFDG集積を認めた。,軸 位 像 左 上肢 左 腋窩 FDG 集積 認める た,1,0.017846958088826397,0.9821530419111735,1,0.0004361827037521117,0.9995638172962479,1,0.03687948615314629,0.9631205138468537,1,0.0175362629911876,0.9824637370088124,1,0.0903424620628357,0.9296401739120483,1,0.1939699798822403,0.8548692464828491,1,0.00470319371543871,0.9952968062845612,1
3358,心エコー像:心エコーにて重症の左心室機能不全を認めた。,心 エコー 像 心 エコー にる 重症 の 左心室機能不全 認める た,1,0.016683378476522712,0.9833166215234774,1,0.00029090643208047894,0.9997090935679195,1,0.03135493894771113,0.9686450610522889,1,0.005886444333796814,0.9941135556662032,1,0.08311423659324646,0.9449480175971985,1,0.19491781294345856,0.8609750270843506,1,0.004410005172183628,0.9955899948278163,1
3359,心臓磁気共鳴画像(CMR):心筋障害が明らかになった。,心臓 磁気 共鳴 画像 CMR 心筋障害 明らか なる た,1,0.06335542674935576,0.9366445732506442,0,0.00015295837665865337,0.9998470416233414,1,0.3136924983826076,0.6863075016173924,1,0.08259675621367357,0.9174032437863264,1,0.27774491906166077,0.8119984269142151,1,0.21270494163036346,0.8439679741859436,1,0.014120294428621604,0.9858797055713784,1
3360,数分後意識が戻ると両腕にしびれを認め、動けず救急要請。,数 分 後 意識 戻る 腕 しびれ 認める 動ける ぬ 救急 要請,1,0.04212337951402741,0.9578766204859724,1,0.0004246050516284781,0.9995753949483716,1,0.312393902243427,0.687606097756573,1,3.874780496460062e-10,0.999999999612522,1,0.08595439791679382,0.9428625106811523,1,0.20336943864822388,0.8560861945152283,1,0.008164667506537993,0.9918353324934621,1
3361,接種後、頭痛、39.7°Cの発熱、倦怠感、悪寒が発現。,接種 後 頭痛 0 0 C 発熱 倦怠感 悪寒 発現,1,5.0563694503122176e-08,0.9999999494363055,1,0.0006108971617889223,0.999389102838211,1,0.000875900724629064,0.9991240992753709,1,0.0,1.0,1,0.09165700525045395,0.9463865160942078,1,0.18342983722686768,0.8735645413398743,1,0.003903811212597789,0.9960961887874022,1
3362,接種後24日目に、患者は呼吸困難のため病院を受診した。,接種 後 0 日 目 患者 呼吸困難 ため 病院 受診 する た,1,0.016684486968595827,0.9833155130314043,1,0.0003099901506092575,0.9996900098493907,1,0.07119129538463187,0.9288087046153681,1,0.07227802832083485,0.9277219716791651,1,0.08620844781398773,0.9445242285728455,1,0.20187009871006012,0.8583366274833679,1,0.005519930938368455,0.9944800690616317,1
3363,日付不明洞調律だがやや心拍数増加し動悸症状で当院受診。,日付 不明 洞調律 だ 心拍数 増加 する 動悸症状 院 受診,1,0.13500045118334966,0.8649995488166504,1,0.00017314522752698308,0.999826854772473,1,0.28205690130965555,0.7179430986903445,1,1.2594487674988386e-09,0.9999999987405512,1,0.08317197859287262,0.9472724199295044,1,0.2111271768808365,0.8666713237762451,1,0.009146607034649831,0.9908533929653502,1
3364,入院時、両手及び手首に発性関節炎及び圧痕浮腫を認めた。,入院 時 両手 手首 発性関節炎 圧痕 浮腫 認める た,1,0.005366413561837228,0.9946335864381627,1,0.00040310504577603776,0.999596894954224,1,0.03189861765342994,0.9681013823465701,1,0.002854347670260271,0.9971456523297397,1,0.0741899311542511,0.9478157162666321,1,0.19454699754714966,0.8613473773002625,1,0.004238150305085669,0.9957618496949143,1
3365,2022/02/01、症状を発現した(発熱と咽頭痛)。,0 0 0 症状 発現 した 発熱 咽頭痛,1,0.00521592726871632,0.9947840727312838,1,0.00037199769119337396,0.9996280023088067,1,0.011292979832965733,0.9887070201670343,1,0.0,1.0,1,0.0794467031955719,0.950813353061676,1,0.1831151396036148,0.8767063617706299,1,0.003945618778256153,0.9960543812217438,1
3366,身体的診察で、右下肢に境界明瞭な皮膚潰瘍を複数認めた。,身体的 診察 だ 右 下肢 境界明瞭 皮膚潰瘍 複数 認める た,1,0.008302381744768406,0.9916976182552318,1,0.0003620794296575554,0.9996379205703424,1,0.01399070693073512,0.9860092930692649,1,0.016869094783047323,0.9831309052169527,1,0.07600931078195572,0.947567880153656,1,0.19212590157985687,0.8651101589202881,1,0.004212429884388351,0.9957875701156117,1
3367,2022/04/03、左の耳の聞こえにくさを自覚した。,0 0 0 左 耳 聞こえにくさ 自覚 する た,1,0.016693074181612373,0.9833069258183875,1,0.00039453398005837286,0.9996054660199416,1,0.052244339689922925,0.9477556603100771,1,0.11520992857782497,0.884790071422175,1,0.07593792676925659,0.9492890238761902,1,0.18886853754520416,0.8723756670951843,1,0.005553408697649432,0.9944465913023507,1
3368,05/12から下肢しびれが出現し、歩行困難が出現した。,0 0 下肢しびれ 出現 歩行困難 出現 する た,1,0.0025814520214339286,0.9974185479785659,1,0.0004906018721562423,0.9995093981278438,1,0.020987527750757407,0.9790124722492426,1,0.04041098266680587,0.9595890173331941,1,0.077191561460495,0.9493044018745422,1,0.1863545924425125,0.8768208026885986,1,0.004348190084493813,0.9956518099155061,1
3369,2021/07/22、患者は左顔面周囲疼痛を発現した。,0 0 0 患者 左 顔面 周囲疼痛 発現 する た,1,0.01667028951124045,0.9833297104887597,1,0.00036799522504157064,0.9996320047749584,1,0.01044137345424656,0.9895586265457534,1,0.046284907281171184,0.9537150927188288,1,0.08461806178092957,0.9482669234275818,1,0.18378174304962158,0.8753655552864075,1,0.004461922955259311,0.9955380770447407,1
3370,2021/08/05、患者は痛みのため不眠を経験した。,0 0 0 患者 痛み ため 不眠 経験 する た,1,2.4611453443319588e-06,0.9999975388546557,1,0.0005437923433701068,0.9994562076566299,1,0.05723065302717867,0.9427693469728213,1,0.14389398652171137,0.8561060134782886,1,0.07947036623954773,0.9497806429862976,1,0.1829516887664795,0.872559130191803,1,0.005728389845069589,0.9942716101549304,1
3371,2021/08/06(推定)、患者は心筋炎を発症した。,0 0 0 推定 患者 心筋炎 発症 する た,1,0.00604060831741755,0.9939593916825824,1,0.00036444954756393075,0.999635550452436,1,0.022918239443608268,0.9770817605563917,1,0.008753450276162034,0.991246549723838,1,0.0816052109003067,0.9447847008705139,1,0.17909705638885498,0.8711997270584106,1,0.004155622896604452,0.9958443771033955,1
3372,2021/08/23頃、患者は接種部位鈍痛を発現した。,0 0 0 頃 患者 接種 部位 鈍痛 発現 する た,1,0.007531158721947836,0.9924688412780521,1,0.00034088631366587007,0.9996591136863341,1,0.005519881046188613,0.9944801189538114,1,0.03202951169620949,0.9679704883037905,1,0.08849754184484482,0.9506375193595886,1,0.18788523972034454,0.8715400695800781,1,0.004256883743975901,0.9957431162560241,1
3373,2022/02/02頃から、右耳鳴、耳閉感が出現した。,0 0 0 頃 右耳鳴 耳閉感 出現 する た,1,0.008011747100613014,0.9919882528993869,1,0.00036438518934936085,0.9996356148106507,1,0.013510863773264936,0.9864891362267351,1,0.10955965145936042,0.8904403485406396,1,0.07725662738084793,0.9483473300933838,1,0.1905306726694107,0.8770177364349365,1,0.004993140942936091,0.995006859057064,1
3374,2022/02/24、患者は左肩拳上困難症を発現した。,0 0 0 患者 左肩 拳上困難 症 発現 する た,1,0.006640666179104456,0.9933593338208957,1,0.0003999028051700007,0.99960009719483,1,0.009427390499791577,0.9905726095002084,1,0.03417735514046505,0.965822644859535,1,0.08272437006235123,0.9481584429740906,1,0.18600589036941528,0.8767411112785339,1,0.004257194317727485,0.9957428056822725,1
3375,2022/03/14、患者は発熱してコロナに感染した。,0 0 0 患者 発熱 する コロナ 感染 する た,1,0.020176603751879237,0.9798233962481206,1,0.00025046408356706326,0.9997495359164329,1,0.03303292489220011,0.9669670751077999,1,0.020313204213866842,0.9796867957861332,1,0.08671827614307404,0.9442868232727051,1,0.17919877171516418,0.8662306666374207,1,0.004509478675275679,0.9954905213247243,1
3376,2022/05/11、嘔吐が続き再受診し入院となった。,0 0 0 嘔吐 続く 受診 する 入院 なる た,1,4.477548007755206e-06,0.9999955224519922,1,0.0005109894234712831,0.9994890105765287,1,0.008582461174587608,0.9914175388254124,1,0.027719897196624266,0.9722801028033757,1,0.0729752853512764,0.9495270252227783,1,0.18152301013469696,0.8715632557868958,1,0.00409878968518867,0.9959012103148114,1
3377,2022/06/20 22:00から、難聴が発現した。,0 0 0 0 0 難聴 発現 する た,1,0.005481774419796879,0.9945182255802032,1,0.0003920432396977816,0.9996079567603022,1,0.009830092720909511,0.9901699072790905,1,0.01904229220932685,0.9809577077906732,1,0.08015918731689453,0.9478259086608887,1,0.18271958827972412,0.8748486638069153,1,0.004109633230928682,0.9958903667690713,1
3378,血尿、発熱、体調不良の結果として治療的処置がとられた。,血尿 発熱 体調不良 結果 治療 的 処置 とる れる た,1,2.9843342733948093e-06,0.9999970156657265,1,0.0005733873265705779,0.9994266126734295,1,0.004153030614471809,0.9958469693855282,1,0.0755295204759232,0.9244704795240768,1,0.07594307512044907,0.9508097171783447,1,0.1866891235113144,0.8621406555175781,1,0.00454215897647473,0.9954578410235253,1
3379,心肺停止、呼吸停止および発熱のため治療処置が施された。,心肺停止 呼吸停止 発熱 ため 治療 処置 施す れる た,1,0.008580140679435558,0.9914198593205645,1,0.0004159073777025459,0.9995840926222974,1,0.01544001719914323,0.9845599828008568,1,0.1859526554204155,0.8140473445795845,1,0.07605072855949402,0.9479016065597534,1,0.1859818398952484,0.8679307699203491,1,0.00586411476852329,0.9941358852314768,1
3380,身体所見で両下腿の非圧痕性浮腫と紅斑、掻痒感を認めた。,身体所見 下腿 非圧痕性 浮腫 紅斑 掻痒感 認める た,1,0.002991117937173916,0.997008882062826,1,0.0004321273882136185,0.9995678726117864,1,0.033384662606492976,0.966615337393507,1,0.0067988952402147085,0.9932011047597853,1,0.08601681888103485,0.9455233216285706,1,0.1994882971048355,0.8660991787910461,1,0.004325452101069858,0.9956745478989302,1
3381,身体的診察:全身の広汎性発赤を認めた、注釈:顔面腫脹。,身体的 診察 全身 広汎 性 発赤 認める た 注釈 顔面腫脹,1,0.014145307905883753,0.9858546920941165,1,0.00043043938060368,0.9995695606193963,1,0.011845086555826945,0.988154913444173,1,2.4927176767164383e-07,0.9999997507282323,1,0.08663652092218399,0.9437240958213806,1,0.18870635330677032,0.865593433380127,1,0.004147338601073597,0.9958526613989264,1
3382,同日の夜から、数秒から1分の間代性けいれんが出現した。,同日 夜 数 秒 0分 間代性 けいれん 出現 する た,1,0.0026546044854439837,0.9973453955145563,1,0.0003326969417065954,0.9996673030582934,1,0.0325218988705025,0.9674781011294975,1,0.129252013070701,0.870747986929299,1,0.08044496923685074,0.9462962746620178,1,0.18757294118404388,0.8685545921325684,1,0.005392653171028135,0.9946073468289718,1
3383,比較するとST上昇の正常化と、新規の陰性T波を認めた。,比較 する ST 上昇 正常 化 新規 陰性 T 波 認める た,1,0.12137472035606743,0.8786252796439324,1,0.00021359415416310638,0.9997864058458369,1,0.03669465457920218,0.9633053454207978,1,0.017969809632002343,0.9820301903679977,1,0.0986260324716568,0.9358887076377869,1,0.23083701729774475,0.8589733839035034,1,0.0059826355092348574,0.9940173644907652,1
3384,来院時、摂氏37.7度の発熱あり、胸痛は持続していた。,来院 時 摂氏 0 0度 発熱 ある 胸痛 持続 する いる た,1,0.00773465801618018,0.9922653419838199,1,0.00033443505846838986,0.9996655649415316,1,0.007283397352072618,0.9927166026479274,0,0.6960398066190279,0.3039601933809722,1,0.07450341433286667,0.9496057033538818,1,0.18506254255771637,0.8693789839744568,1,0.015725300125479413,0.9842746998745205,1
3385,血圧測定:(2022/07/20)110/88mmHg,血圧 測定 0 0 0 0 0m mHg,1,0.21218638675801735,0.7878136132419826,0,0.0001496056341861435,0.9998503943658139,1,0.4120070811255634,0.5879929188744366,0,0.5195482961797382,0.48045170382026176,1,0.1904222071170807,0.8977020978927612,1,0.49855655431747437,0.5954927802085876,1,0.07471413900555238,0.9252858609944477,1
3386,今年になってアトピーは消えたのだが、尋天疱瘡になった。,今年 なる アトピー 消える た の だ 尋 天疱瘡 なる た,1,0.01671245535535015,0.9832875446446497,1,0.00019830601198520318,0.9998016939880148,1,0.2992852170198438,0.7007147829801562,1,0.0009873968655738086,0.9990126031344262,1,0.3226276934146881,0.7783949971199036,1,0.290936142206192,0.796484649181366,1,0.01303561072311691,0.9869643892768831,1
3387,心電図検査:2021/11/26実施、異常所見:あり。,心電図 検査 0 0 0 実施 異常所見 ある,1,0.01669682988758737,0.9833031701124127,1,0.00018865110957708693,0.9998113488904229,0,0.6965742675298192,0.30342573247018084,1,0.002679707068418802,0.9973202929315812,1,0.11116805672645569,0.9269741177558899,1,0.21869786083698273,0.8534615635871887,1,0.01766597625663283,0.9823340237433671,1
3388,日付不明コンピュータ断層撮影:すりガラス陰影(異常)。,日付 不明 コンピュータ断層撮影 すりガラス陰影 異常,1,0.016683549755323462,0.9833164502446764,1,0.00021153684004198055,0.9997884631599581,1,0.4681789921850199,0.5318210078149801,1,3.424386552097758e-09,0.9999999965756134,1,0.26701438426971436,0.8308236598968506,1,0.23023968935012817,0.8526529669761658,1,0.014541872525506783,0.9854581274744932,1
3389,2021/09/07 10:30急性期脳梗塞が発現。,0 0 0 0 0 急性期 脳梗塞 発現,1,0.013929348011122977,0.986070651988877,1,0.00035190470735759974,0.9996480952926424,1,0.00987732563689947,0.9901226743631005,1,5.3290705182007514e-14,0.9999999999999467,1,0.08079148828983307,0.9438117146492004,1,0.18675217032432556,0.8679184317588806,1,0.004086916025379408,0.9959130839746206,1
3390,2021/09/10、両上肢腱反射減弱が認められた。,0 0 0 上肢 腱反射 減 弱 認める られる た,1,0.010191212504357755,0.9898087874956424,1,0.0003628914257959579,0.9996371085742041,1,0.04484868196944369,0.9551513180305563,1,0.13222454980527598,0.867775450194724,1,0.08971408009529114,0.9459605813026428,1,0.19186143577098846,0.8703110814094543,1,0.005712092021617932,0.994287907978382,1
3391,2021/10/10、患者は、左眼瞼下垂を発現した。,0 0 0 患者 左眼瞼 下垂 発現 する た,1,0.010101872573193909,0.9898981274268059,1,0.00041080902003122575,0.9995891909799688,1,0.009427390499791577,0.9905726095002084,1,0.02293758227320386,0.9770624177267961,1,0.0881614238023758,0.9475324153900146,1,0.1882464438676834,0.8781231045722961,1,0.004220835806054996,0.995779164193945,1
3392,2022/02/04、腹腔鏡下子宮全摘手術を受けた。,0 0 0 腹腔鏡 下る 子宮全摘 手術 受ける た,0,0.7520906829299212,0.24790931707007893,1,0.00018319794508377666,0.9998168020549162,0,0.5319610433231199,0.4680389566768801,0,0.8363916182968415,0.1636083817031585,0,0.850947380065918,0.19450688362121582,0,0.7803356051445007,0.2915877401828766,1,0.8000235326057866,0.19997646739421343,1
3393,2022/03/02胸痛増悪を認め、救急外来を受診。,0 0 0 胸痛 増悪 認める 救急外来 受診,1,1.4536023379504937e-08,0.9999999854639765,1,0.0007290574649197241,0.9992709425350803,1,0.004632385039903264,0.9953676149600967,1,5.3870241600861846e-12,0.999999999994613,1,0.0810379609465599,0.943457841873169,1,0.18891049921512604,0.8723534941673279,1,0.0039301493375131,0.9960698506624868,1
3394,2022/03/15 06:21急性肺塞栓症が発現。,0 0 0 0 0 急性肺塞栓症 発現,1,0.014016702217813681,0.9859832977821862,1,0.00033223771896640533,0.9996677622810336,1,0.00987732563689947,0.9901226743631005,1,3.3222313788883184e-12,0.9999999999966778,1,0.08726411312818527,0.943202793598175,1,0.1814059466123581,0.8698193430900574,1,0.004086793046909801,0.9959132069530903,1
3395,2022/03/15 11:00頃胸痛増悪を認めた。,0 0 0 0 0 頃 胸痛 増悪 認める た,1,5.716492846021309e-08,0.9999999428350715,1,0.000545701347803122,0.9994542986521969,1,0.005746523691206429,0.9942534763087936,1,0.0004934253024133639,0.9995065746975866,1,0.07596157491207123,0.9511989951133728,1,0.18510249257087708,0.8728329539299011,1,0.0038747322126301852,0.9961252677873698,1
3396,2022/04/01再び頭痛が酷くなり、近医を受診。,0 0 0 頭痛 酷い なる 近医 受診,1,0.005979415849932715,0.9940205841500673,1,0.000394795918806438,0.9996052040811936,1,0.016766735195524518,0.9832332648044755,1,1.4807777226621965e-10,0.9999999998519222,1,0.08474449813365936,0.944648802280426,1,0.17968963086605072,0.8682528138160706,1,0.004061287854387825,0.9959387121456122,1
3397,2022/04/16意識消失、四肢のけいれんが発現。,0 0 0 意識消失 四肢 けいれん 発現,1,0.0033861530425200763,0.9966138469574799,1,0.0004697503663531861,0.9995302496336468,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08403974771499634,0.942031979560852,1,0.18260473012924194,0.8730126023292542,1,0.003986156607958514,0.9960138433920415,1
3398,2022/04/28現在、後遺症として倦怠感が残る。,0 0 0 現在 後遺症 する 倦怠感 残る,1,0.003719071661021156,0.9962809283389786,1,0.00038799509952496686,0.9996120049004751,1,0.1497707388456596,0.8502292611543404,1,2.9178938376617225e-08,0.9999999708210616,1,0.12356336414813995,0.9178417325019836,1,0.21501246094703674,0.871732771396637,1,0.005804831134698539,0.9941951688653015,1
3399,2022/05/29昼、食欲がなく、味覚も変わった。,0 0 0 昼 食欲 ない 味覚 変わる た,0,0.9948561217797796,0.005143878220220466,0,9.738235742593523e-05,0.999902617642574,0,0.8399625662106882,0.1600374337893118,1,0.39485523383418697,0.605144766165813,1,0.20405785739421844,0.8662964105606079,1,0.1942075937986374,0.8611260056495667,1,0.29533455269618325,0.7046654473038167,1
3400,2022/05/31 16:00頃急性心筋炎が発現。,0 0 0 0 0 頃 急性心筋炎 発現,1,0.007605339555623612,0.9923946604443764,1,0.0004509618753280446,0.999549038124672,1,0.006430581757262188,0.9935694182427378,1,0.0,1.0,1,0.08653222769498825,0.9485458135604858,1,0.1760038286447525,0.8722312450408936,1,0.003953206422293374,0.9960467935777066,1
3401,3回目の接種時同日、患者は左肩拳上困難症を発現した。,0回目 接種 時 同日 患者 左肩 拳上困難 症 発現 する た,1,0.016692922322727892,0.9833070776772721,1,0.0003307480861324774,0.9996692519138676,1,0.04114073045933908,0.9588592695406609,1,0.07658615114099288,0.9234138488590071,1,0.08553970605134964,0.9476921558380127,1,0.18535977602005005,0.8732553720474243,1,0.005063872968733346,0.9949361270312667,1
3402,CT検査の結果、心臓が大きいということで検査を実施。,CT検査 結果 心臓 大きい こと 検査 実施,1,0.15531009776167107,0.8446899022383288,0,0.0001258380184640682,0.9998741619815359,0,0.874068001960107,0.12593199803989294,0,0.9816356257471084,0.018364374252891655,1,0.563752293586731,0.5793523788452148,1,0.23772673308849335,0.8157034516334534,1,0.36093744664618477,0.6390625533538152,1
3403,CT検査より肺炎像を認め、肺炎の診断で人工呼吸管理。,CT検査 肺炎像 認める 肺炎 の 診断 だ 人工呼吸 管理,1,0.0029510766541194964,0.9970489233458805,1,0.0003821354043510843,0.9996178645956489,1,0.004850246341836617,0.9951497536581634,1,4.184810420126972e-05,0.9999581518957987,1,0.08731476962566376,0.9374014735221863,1,0.19522684812545776,0.8680498600006104,1,0.004044038971614083,0.995955961028386,1
3404,患者は重症炎症性細胞浸潤及び重症心機能障害を呈した。,患者 重症 炎症性 細胞浸潤 重症 心機能障害 呈す た,1,0.016685967473005783,0.9833140325269941,1,0.0003835282692667706,0.9996164717307332,1,0.07779012494166748,0.9222098750583325,1,0.00014686401035290952,0.9998531359896471,1,0.08440353721380234,0.9431926012039185,1,0.1965465247631073,0.8531634211540222,1,0.00484287064147079,0.9951571293585291,1
3405,気分不良、顔面蒼白、嘔吐、口唇腫脹、手の紅斑が出現。,気分不良 顔面蒼白 嘔吐 口唇腫脹 手 紅斑 出現,1,1.210261987714334e-05,0.9999878973801228,1,0.0003891387436972226,0.9996108612563028,1,0.011978823886524603,0.9880211761134754,1,0.010250391673824577,0.9897496083261754,1,0.08682268112897873,0.9472144842147827,1,0.19172286987304688,0.8676812052726746,1,0.004106418270733664,0.9958935817292665,1
3406,胸部CTでは、神経因性心筋症による両側肺水を認めた。,胸部 CT 神経因性 心筋症 両側肺 水 認める た,1,0.02062313558162924,0.9793768644183709,1,0.00033822377547877117,0.9996617762245212,1,0.06296692446373875,0.9370330755362613,1,0.019946264196715746,0.9800537358032843,1,0.07780785113573074,0.9433191418647766,1,0.18121406435966492,0.8715381622314453,1,0.00473472203261169,0.9952652779673883,1
3407,"胸部レントゲン,胸部CT:両側肺門部リンパ節が腫大。",胸部 レントゲン 胸部 C，T 両側肺 門部 リンパ節が腫大,0,0.6405802751627239,0.3594197248372762,0,0.0001487134405135765,0.9998512865594864,0,0.6469021024391098,0.35309789756089016,1,1.5736393521592618e-08,0.9999999842636065,1,0.12181273847818375,0.9225760102272034,1,0.20008333027362823,0.848915696144104,1,0.0534370361889655,0.9465629638110346,1
3408,血液検査にてCKとTrop-Tレベルの上昇を示した。,血液検査 CK Trop T レベル 上昇 示す た,1,0.014070999975689023,0.985929000024311,1,0.0003486723335706718,0.9996513276664293,1,0.06028344616827919,0.9397165538317208,1,0.08793805903743923,0.9120619409625608,1,0.09033822268247604,0.9431487321853638,1,0.18345481157302856,0.8703957796096802,1,0.005407914702047612,0.9945920852979524,1
3409,検査したが陰性であった、今も多少違和感が残っていた。,検査 する た 陰性 だ ある た 今 多少違和感 残る いる た,1,0.016693153838593315,0.9833068461614067,1,0.00017801592854834602,0.9998219840714516,0,0.8554700757827636,0.14452992421723637,1,0.12782800131902416,0.8721719986809758,1,0.4216437041759491,0.6760848760604858,0,0.6920089721679688,0.4648878872394562,1,0.11639900677431879,0.8836009932256811,1
3410,口腔内検査では大臼歯部の両側口蓋粘膜に潰瘍を認めた。,口腔内 検査 大臼歯 部 両側 口蓋 粘膜 潰瘍 認める た,1,0.016667165621917664,0.983332834378082,1,0.0003706176727753812,0.9996293823272246,1,0.023565000399168867,0.9764349996008311,1,0.005397108633564018,0.994602891366436,1,0.08854907006025314,0.9456163644790649,1,0.19125810265541077,0.8656266927719116,1,0.004323160132963665,0.9956768398670364,1
3411,左手足が動きにくく、呂律が回りにくいことに気づいた。,左 手足 動く にくい 呂律 回りにくい こと 気づく た,1,0.016675169054497355,0.9833248309455027,1,0.0002877094299140872,0.9997122905700859,1,0.41268845079626704,0.587311549203733,1,0.018885205831987606,0.9811147941680124,1,0.10039051622152328,0.9427376985549927,1,0.20397819578647614,0.8521077632904053,1,0.010017004383386027,0.9899829956166141,1
3412,左片麻痺・感覚障害を認め、CTで右被殻出血を認めた。,左片麻痺 感覚障害 認める CT だ 右被殻出血 認める た,1,0.022775687571620424,0.9772243124283795,1,0.00038782677254852284,0.9996121732274514,1,0.04622703170268361,0.9537729682973164,1,0.0013773815901101383,0.9986226184098899,1,0.07278334349393845,0.9446818828582764,1,0.18609748780727386,0.8659031391143799,1,0.004450987674038502,0.9955490123259615,1
3413,心電図の異常所見は2022/04/22まで継続した。,心電図 異常所見 0 0 0 継続 する た,1,0.01667125470225554,0.9833287452977446,1,0.00022976021362985225,0.9997702397863701,1,0.45340064552770853,0.5465993544722915,0,0.873652462661002,0.126347537338998,1,0.2062535285949707,0.8627336621284485,1,0.2532185912132263,0.8228565454483032,1,0.07322256262456192,0.926777437375438,1
3414,水痘帯状ヘルペスIG陽性、水痘帯状ヘルペスIM陰性。,水痘 帯状 ヘルペス IG 陽性 水痘 帯状 ヘルペス IM 陰性,1,0.25341665352239795,0.7465833464776023,1,0.00019768093617526076,0.9998023190638248,1,0.10160946938576565,0.8983905306142344,1,0.026982350718121162,0.9730176492818788,1,0.5501462817192078,0.587623119354248,1,0.330710768699646,0.775931179523468,1,0.0237002297357345,0.9762997702642654,1
3415,接種前、患者は2年半の間に5回蜂巣炎を発症していた。,接種 前 患者 0 年 半 間 0回 蜂巣炎 発症 する いる た,1,0.016699659611186576,0.9833003403888133,1,0.000260828824787323,0.9997391711752127,1,0.1000048109540832,0.8999951890459168,1,0.4859970584220866,0.5140029415779134,1,0.08254992216825485,0.9485282301902771,1,0.20248115062713623,0.8581592440605164,1,0.01318072105001043,0.9868192789499896,1
3416,朝、両手首以遠及び両膝以遠のしびれ感、脱力感が出現。,朝 手首 以遠 膝 以遠 しびれ感 脱力感 出現,1,0.01330845524568454,0.9866915447543154,1,0.0003432019274346473,0.9996567980725654,1,0.03401654200974713,0.9659834579902529,1,0.004850963647912487,0.9951490363520875,1,0.08923237770795822,0.9418616890907288,1,0.1975298523902893,0.865085244178772,1,0.004428983418342007,0.9955710165816579,1
3417,吐気・めまいはないが、気分不快、左胸部痛の訴えあり。,吐気 めまい ない 気分不快 左胸部痛 訴え ある,1,0.016703536032743327,0.9832964639672565,1,0.0002885169841347435,0.9997114830158652,0,0.7110288453487497,0.28897115465125034,1,2.861269972287417e-05,0.9999713873002771,1,0.08677664399147034,0.9453441500663757,1,0.21130961179733276,0.836765468120575,1,0.017499572268418147,0.9825004277315817,1
3418,入院時の検査でCS1の心不全と診断され、ICU入室。,入院 時 検査 CS 0 心不全 診断 する れる ICU 入室,1,0.019805683468319627,0.9801943165316804,1,0.0003342502074199761,0.99966574979258,1,0.07638509497789614,0.9236149050221039,1,9.640125031573632e-09,0.999999990359875,1,0.1118711605668068,0.9338346719741821,1,0.184425488114357,0.8655145764350891,1,0.00491761183253578,0.9950823881674643,1
3419,発熱、頭痛、構音障害、手指失認、体幹失調が順次出現。,発熱 頭痛 構音障害 手指失認 体幹失調 出現,1,4.335252666048972e-07,0.9999995664747334,1,0.00040906399645749636,0.9995909360035425,1,0.0026100338923684685,0.9973899661076315,1,0.002035516774190893,0.9979644832258091,1,0.09219525009393692,0.9388327598571777,1,0.19931265711784363,0.8688566088676453,1,0.0040456009568780125,0.9959543990431219,1
3420,発熱により説明できない脳症(意識の変容や行動変化)。,発熱 説明 できる ない 脳症 意識 変容 行動 変化,1,0.016687754920840434,0.9833122450791595,1,0.000248056532009817,0.9997519434679902,1,0.2705254622050026,0.7294745377949974,1,0.0011854640295341223,0.9988145359704659,1,0.10605090856552124,0.9418696761131287,1,0.24408887326717377,0.7838707566261292,1,0.008176287581500744,0.9918237124184993,1
3421,本剤によるサイトカインストームが起こったと思われる。,本 剤 サイトカインストーム 起こる た 思う れる,1,0.016692488859846748,0.9833075111401532,1,0.00030583268162743003,0.9996941673183726,1,0.3872374663002206,0.6127625336997794,1,0.022627409737745907,0.9773725902622541,1,0.15414434671401978,0.9165844321250916,1,0.2629641890525818,0.7835931777954102,1,0.011781856779066579,0.9882181432209334,1
3422,溶血性貧血、呼吸困難の結果として治療処置がとられた。,溶血性 貧血 呼吸困難 結果 治療 処置 とる れる た,1,0.01282626917220932,0.9871737308277907,1,0.00040538292039870856,0.9995946170796013,1,0.021486218659389933,0.9785137813406101,1,0.06452906647200274,0.9354709335279973,1,0.08123105019330978,0.9420667290687561,1,0.18714724481105804,0.8654202818870544,1,0.004770060384515702,0.9952299396154843,1
3423,翌日、発熱、呼吸困難、膨隆疹を認め鎮痛薬を内服した。,翌日 発熱 呼吸困難 膨隆疹 認める 鎮痛 薬 内服 する た,1,0.016690698026186584,0.9833093019738136,1,0.00031695759926438083,0.9996830424007356,1,0.040996744884368774,0.9590032551156312,1,0.397489549213373,0.602510450786627,1,0.07770324498414993,0.9463326930999756,1,0.18714530766010284,0.8620159029960632,1,0.00963651843157271,0.9903634815684272,1
3424,心電図にてI、aVL、V4-6でのST低下を認めた。,心電図 I aVL V 0 0 ST 低下 認める た,1,2.8268408594406137e-06,0.9999971731591406,1,0.0005537073489605598,0.9994462926510395,1,0.009258184429988159,0.9907418155700118,1,0.0457793383087719,0.9542206616912281,1,0.08071596920490265,0.945025622844696,1,0.18583182990550995,0.8751610517501831,1,0.004310202982307279,0.9956897970176927,1
3425,神経伝導検査にて橈骨神経障害を示唆する所見を認めた。,神経 伝導 検査 橈骨神経障害 示唆 する 所見 認める た,1,0.01667979871422605,0.983320201285774,1,0.00029076207834126156,0.9997092379216588,1,0.042966896473941474,0.9570331035260585,1,0.015095865015985699,0.9849041349840143,1,0.08709824830293655,0.943149745464325,1,0.19443096220493317,0.8552269339561462,1,0.004647438387178808,0.9953525616128213,1
3426,下肢の亀裂部に一致、不一致の紅斑、赤色丘疹を認めた。,下肢 亀裂 部 一致 不一致 紅斑 赤色丘疹 認める た,1,0.006406263994873222,0.9935937360051268,1,0.000408600368444411,0.9995913996315556,1,0.017590079605015907,0.9824099203949841,1,0.017888009557100126,0.9821119904428999,1,0.08715205639600754,0.9493676424026489,1,0.19014862179756165,0.8653137683868408,1,0.004266036990217707,0.9957339630097823,1
3427,2021/09中旬、患者は労作性呼吸困難を発現した。,0 0 中旬 患者 労作性呼吸困難 発現 する た,1,0.01667565879274614,0.9833243412072538,1,0.00034398080761350637,0.9996560191923864,1,0.009427390499791577,0.9905726095002084,1,0.028600892413277457,0.9713991075867225,1,0.08279339224100113,0.9479908347129822,1,0.18494948744773865,0.8752092719078064,1,0.004297729695995327,0.9957022703040046,1
3428,2022/05/30、患者は劇症型心筋炎を発現した。,0 0 0 患者 劇症型 心筋炎 発現 する た,1,0.011271807414706599,0.9887281925852933,1,0.00033237039306334583,0.9996676296069367,1,0.004567958101016734,0.9954320418989833,1,0.012671117514311936,0.9873288824856881,1,0.0829399824142456,0.9454994201660156,1,0.1805863380432129,0.8708406686782837,1,0.0040899375183605854,0.9959100624816395,1
3429,(不明日)、尿中赤血球:尿中に変形赤血球が認められた,明日 尿中赤血球 尿 中 変形赤血球 認める られる た,1,0.016718148302960187,0.9832818516970399,1,0.0002748468502802199,0.9997251531497198,1,0.0608646310211608,0.9391353689788392,1,0.07653049419470936,0.9234695058052906,1,0.09040229767560959,0.933243989944458,1,0.40102270245552063,0.7381512522697449,1,0.007605915423453957,0.992394084576546,1
3430,2021/07/17 03:40、異常が発見された。,0 0 0 0 0 異常 発見 する れる た,1,0.016705921238018333,0.9832940787619815,1,0.0003801532707207321,0.9996198467292793,1,0.19898063703052327,0.8010193629694767,1,0.21937808858312025,0.7806219114168798,1,0.09159114956855774,0.9392316937446594,1,0.18293049931526184,0.8763986825942993,1,0.009283230160639479,0.9907167698393604,1
3431,2022/04/10頃、再度しびれと痛みが発現した。,0 0 0 頃 しびれ 痛み 発現 する た,1,3.2198881246397094e-07,0.9999996780111876,1,0.0005773160616419207,0.9994226839383581,1,0.003383366304078761,0.9966166336959212,1,0.01902171695020871,0.9809782830497913,1,0.08461687713861465,0.9457065463066101,1,0.18524710834026337,0.8740057945251465,1,0.004054428321276579,0.9959455716787233,1
3432,2022/06/13、患者は体調不良と発熱であった。,0 0 0 患者 体調不良 発熱 だ ある た,1,0.01668352440465937,0.9833164755953406,1,0.00025702280199026953,0.9997429771980098,1,0.23541291292584965,0.7645870870741504,0,0.6284126518264275,0.37158734817357253,1,0.07743703573942184,0.9482324123382568,1,0.18177148699760437,0.8684051632881165,1,0.02196926147241281,0.9780307385275872,1
3433,2022/06/27、発熱(入院)発現、転帰「不明」,0 0 0 発熱 入院 発現 転帰 不明,1,2.895435044997646e-07,0.9999997104564956,1,0.0003954809899748825,0.9996045190100251,1,0.006302276443875154,0.9936977235561248,1,4.304159341161906e-07,0.9999995695840659,1,0.09387989342212677,0.9363083839416504,1,0.20694895088672638,0.8548735976219177,1,0.004164623091254659,0.9958353769087454,1
3434,9月中旬から息切れが出現し、被験者は病院を受診した。,0 月 中旬 息切れ 出現 被験者 病院 受診 する た,1,0.0055713517356120274,0.994428648264388,1,0.0003990143846027232,0.9996009856153972,1,0.014035532185261768,0.9859644678147382,1,0.10008848121017033,0.8999115187898297,1,0.07404152303934097,0.9484198093414307,1,0.18541286885738373,0.8727785348892212,1,0.004861401782061836,0.995138598217938,1
3435,ストレス骨折、背部痛の結果として治療処置がとられた。,ストレス 骨折 背部痛 結果 治療 処置 とる れる た,1,0.006837435005834441,0.9931625649941657,1,0.0003914754133695077,0.9996085245866305,1,0.021486218659389933,0.9785137813406101,1,0.08551838662787958,0.9144816133721204,1,0.08017882704734802,0.9423396587371826,1,0.1924465000629425,0.8595677018165588,1,0.004962775426623863,0.9950372245733763,1
3436,角膜後面に沈着物が認められ、ぶどう膜炎と診断された。,角膜 後 面 沈着 物 認める られる ぶどう膜炎 診断 する れる た,1,0.005678028365472249,0.9943219716345277,1,0.00038879770721663115,0.9996112022927833,1,0.02911667573962695,0.970883324260373,1,0.21932545418706262,0.7806745458129374,1,0.09742233902215958,0.943799614906311,1,0.18581116199493408,0.8708112835884094,1,0.006545831560204054,0.9934541684397958,1
3437,患者は、痙攣発作のために入院した(入院期間:1日)。,患者 痙攣 発作 ため 入院 する た 入院 期間 0 日,1,8.771930088703186e-06,0.9999912280699114,1,0.0006241121071405817,0.9993758878928595,1,0.027818196030389042,0.972181803969611,1,0.0007592831376169729,0.999240716862383,1,0.08957833051681519,0.9480394721031189,1,0.2379145473241806,0.8395296335220337,1,0.004488869118224327,0.9955111308817758,1
3438,患者は高齢発症としては珍しいが、陰のう癌を経験した。,患者 高齢発症 珍しい 陰のう癌 経験 する た,1,0.15306221850665686,0.8469377814933431,1,0.00022054215969864307,0.9997794578403013,1,0.48021634188129947,0.5197836581187005,1,0.20875287726644176,0.7912471227335582,1,0.09078215062618256,0.9438615441322327,1,0.20944039523601532,0.8503217101097107,1,0.021679785558791194,0.9783202144412089,1
3439,関節に熱感や圧痛を認めず、線維筋痛症の疑いがあった。,関節 熱感 圧痛 認める ぬ 線維筋痛症 疑い ある た,1,0.013869510656008865,0.986130489343991,1,0.0004012603192257317,0.9995987396807743,1,0.08741034517488355,0.9125896548251164,1,0.23517068439683841,0.7648293156031616,1,0.08589828014373779,0.9402151703834534,1,0.20810839533805847,0.8540542721748352,1,0.00795033452227692,0.9920496654777231,1
3440,"心電図: I, II, V2-6誘導でST上昇あり、",心電図 I II V 0 0 誘導 ST 上昇 ある,1,0.005979122560802359,0.9940208774391976,1,0.0004281175438254496,0.9995718824561746,1,0.022878516616085642,0.9771214833839144,1,2.1016100415494066e-07,0.9999997898389958,1,0.07905649393796921,0.9408811926841736,1,0.19574712216854095,0.863292932510376,1,0.004190238533179099,0.995809761466821,1
3441,心電図I、II、IIIのVFでST上昇が観察された。,心電図 I II III VF ST 上昇 観察 する れる た,1,0.09760319928084582,0.9023968007191541,1,0.0002395996642990091,0.999760400335701,1,0.19651724524189185,0.8034827547581082,1,0.3546526234312979,0.6453473765687021,1,0.07802104204893112,0.9488596320152283,1,0.1907828152179718,0.860609233379364,1,0.014166050040757522,0.9858339499592425,1
3442,尿中赤血球形態は異形であり、糸球体性血尿が示された。,尿中赤血球 形態 異形 だ ある 糸球体性 血尿 示す れる た,1,0.016714075362381498,0.9832859246376187,1,0.00035962852540766244,0.9996403714745924,1,0.31070202041704487,0.6892979795829551,1,0.10520386961746353,0.8947961303825365,1,0.08305659145116806,0.9350605607032776,1,0.19269104301929474,0.8524965047836304,1,0.00951005322487466,0.9904899467751253,1
3443,発熱、振戦、排尿困難の結果として治療処置がとられた。,発熱 振戦 排尿困難 結果 治療 処置 とる れる た,1,0.004426689002770806,0.9955733109972291,1,0.00044561262064933636,0.9995543873793507,1,0.004153030614471809,0.9958469693855282,1,0.07025116813405152,0.9297488318659485,1,0.07932053506374359,0.9462507963180542,1,0.1878143846988678,0.8570084571838379,1,0.004597789086376665,0.9954022109136234,1
3444,味覚消失、口腔知覚不全のために治療的処置がとられた。,味覚消失 口腔 知覚不全 ため 治療 的 処置 とる れる た,1,0.011373759269647137,0.9886262407303529,1,0.00040584665989282676,0.9995941533401071,1,0.027386430059893163,0.9726135699401068,1,0.09506187889852702,0.904938121101473,1,0.0900416448712349,0.9359459280967712,1,0.19876286387443542,0.856859564781189,1,0.005295727298112176,0.9947042727018879,1
3445,unsleeping the whole night,unsleeping The Who LE night,1,0.17469628426263073,0.8253037157373694,1,0.00024273069197982595,0.9997572693080202,1,0.4563792597309324,0.5436207402690676,1,2.7848452821555014e-07,0.9999997215154718,1,0.4988492429256439,0.6585657596588135,1,0.39771580696105957,0.7395210862159729,1,0.03772836090497466,0.9622716390950252,1
3446,心エコーで左室高緻密化障害を否定できない所見があった,心 エコー 左 室 高 緻密 化 障害 否定 できる ない 所見 ある た,0,0.8123651806960211,0.18763481930397885,0,0.00010221332722446277,0.9998977866727755,0,0.8693145237824182,0.13068547621758175,1,0.30180875922520445,0.6981912407747956,0,0.9287702441215515,0.08967183530330658,1,0.23077668249607086,0.8320403099060059,1,0.5510752610858282,0.44892473891417184,1
3447,抗MOG抗体陽性であり、MOGADの診断となった。,MOG 抗体陽性 だ ある MOGAD 診断 なる た,1,0.06908000302625956,0.9309199969737404,1,0.000337725115975832,0.9996622748840241,1,0.31242737445102264,0.6875726255489774,1,0.20507021056039343,0.7949297894396066,1,0.09190063923597336,0.9385064244270325,1,0.20400381088256836,0.8681014180183411,1,0.012908550523869375,0.9870914494761305,1
3448,2021/09抗MDA5抗体陽性間質性肺炎が発現。,0 0 MDA 0 抗体陽性 間質性 肺炎 発現,1,1.2572311366128369e-06,0.9999987427688635,1,0.0006014142964809021,0.9993985857035191,1,0.0023857226430131773,0.9976142773569868,1,0.0,1.0,1,0.0891428142786026,0.9377520084381104,1,0.18768525123596191,0.8758314847946167,1,0.003947259611892336,0.9960527403881075,1
3449,2021/10/15、患者は右眼瞼下垂を発現した。,0 0 0 患者 右眼瞼下垂 発現 する た,1,0.016683884456347248,0.9833161155436526,1,0.00035296973316863606,0.9996470302668313,1,0.023394727173343233,0.9766052728266568,1,0.0076455972833070485,0.992354402716693,1,0.08056814223527908,0.9501777291297913,1,0.18910135328769684,0.8763819336891174,1,0.004232437420480561,0.9957675625795196,1
3450,2021/12/27、選択的帝王切開にて出産した。,0 0 0 選択的帝王切開 出産 する た,1,0.016685726201807614,0.9833142737981924,1,0.00028910373785397635,0.999710896262146,1,0.3533345469092234,0.6466654530907766,1,0.164998119004774,0.835001880995226,1,0.49665626883506775,0.5335327386856079,0,0.7505040168762207,0.2963835895061493,1,0.07501141806455053,0.9249885819354495,1
3451,2022/02その後、DICを合併し利尿得られず。,0 0 その後 DIC 合併 する 利尿 得る られる ぬ,1,0.036932161728943105,0.9630678382710568,1,0.00020796797697488842,0.9997920320230251,1,0.3848699852644518,0.6151300147355482,1,0.00541207931902854,0.9945879206809715,1,0.17756183445453644,0.8954513669013977,1,0.21141546964645386,0.8533335328102112,1,0.010933141971397345,0.9890668580286026,1
3452,2022/03/09 38°Cの発熱、全身痛あり。,0 0 0 0 C 発熱 全身痛 ある,1,0.0036794088336969026,0.996320591166303,1,0.00037331662073341313,0.9996266833792666,1,0.016501062830204583,0.9834989371697954,1,7.562321879817091e-10,0.9999999992437678,1,0.07560509443283081,0.9467059373855591,1,0.17485444247722626,0.8702741265296936,1,0.0039684120329648576,0.9960315879670351,1
3453,2022/03/14 09:00急性心筋炎が発現。,0 0 0 0 0 急性心筋炎 発現,1,0.009695940044074534,0.9903040599559254,1,0.00042190106356989135,0.9995780989364301,1,0.00987732563689947,0.9901226743631005,1,2.220446049250313e-16,0.9999999999999998,1,0.09029113501310349,0.9473108649253845,1,0.17852072417736053,0.8705592751502991,1,0.00403354495181672,0.9959664550481834,1
3454,2022/03/29 13:00急性心不全が発現。,0 0 0 0 0 急性心不全 発現,1,0.00607234086801124,0.9939276591319886,1,0.00038837601810336983,0.9996116239818966,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08725649863481522,0.9448462724685669,1,0.1809549629688263,0.8714793920516968,1,0.004008034904723722,0.9959919650952763,1
3455,2022/03/29朝、頭痛、嘔気、発熱を認めた。,0 0 0 朝 頭痛 嘔気 発熱 認める た,1,2.3170203167821898e-09,0.9999999976829796,1,0.0007042214136981015,0.9992957785863019,1,0.001743257311639601,0.9982567426883604,1,0.0001489645337016121,0.9998510354662984,1,0.07925469428300858,0.9490233063697815,1,0.1795320361852646,0.8734357357025146,1,0.003839832075761052,0.9961601679242389,1
3456,2022/04/09心房細動、洞休止症候群が発現。,0 0 0 心房細動 洞 休止 症候群 発現,1,0.004308258000141675,0.9956917419998583,1,0.00041165156671900584,0.999588348433281,1,0.011149349189002677,0.9888506508109973,1,1.0312450893223968e-09,0.9999999989687549,1,0.09969504922628403,0.9390370845794678,1,0.18667322397232056,0.8749172687530518,1,0.004087004637006379,0.9959129953629937,1
3457,2022/04/17発熱、下痢、気分不良を認めた。,0 0 0 発 熱 下痢 気分不良 認める た,1,4.586659461304137e-07,0.9999995413340539,1,0.00042935957913099753,0.999570640420869,1,0.025039656570858604,0.9749603434291414,1,0.005957395377615637,0.9940426046223844,1,0.07589087635278702,0.9502406120300293,1,0.18136915564537048,0.8775756359100342,1,0.004039034144929319,0.9959609658550705,1
3458,2022/04/22、患者は1型糖尿病を発症した。,0 0 0 患者 0 型 糖尿病 発症 する た,1,0.01667134582989599,0.983328654170104,1,0.0003000813837245565,0.9996999186162755,1,0.06707087023669567,0.9329291297633043,1,0.020100963953199824,0.9798990360468002,1,0.07879282534122467,0.946942150592804,1,0.1832103431224823,0.8729867935180664,1,0.00472740963664851,0.9952725903633516,1
3459,2022/05/01午後、持続する発熱が発現した。,0 0 0 午後 持続 する 発熱 発現 する た,1,5.279982608159312e-07,0.9999994720017392,1,0.000502142058852328,0.9994978579411476,1,0.003995724553512159,0.9960042754464878,1,0.01529281024792184,0.9847071897520782,1,0.08005298674106598,0.9497132301330566,1,0.1847653090953827,0.8770162463188171,1,0.0039806214204590636,0.9960193785795408,1
3460,2022/05/09、報告病院の皮膚科を受診した。,0 0 0 報告 病院 皮膚科 受診 する た,1,0.0166753662604092,0.9833246337395909,1,0.00024679008434629,0.9997532099156538,1,0.18151334429254085,0.8184866557074592,1,0.06817161314183717,0.9318283868581628,1,0.0864478126168251,0.9390721917152405,1,0.2274753898382187,0.8412895202636719,1,0.0071517249254041335,0.9928482750745959,1
3461,2022/05/22 38.5°Cの発熱を認めた。,0 0 0 0 0 C 発熱 認める た,1,3.491441511167926e-06,0.9999965085584889,1,0.0004963970825137579,0.9995036029174862,1,0.010152221619393553,0.9898477783806064,1,2.8987241870614966e-05,0.9999710127581294,1,0.07592342048883438,0.9499355554580688,1,0.18185433745384216,0.8759438991546631,1,0.003885000878653507,0.9961149991213464,1
3462,2022/06/20 12:00左眼の眼痛が出現。,0 0 0 0 0 左 眼 眼痛 出現,1,0.0026614606551416233,0.9973385393448584,1,0.00045567575574435913,0.9995443242442557,1,0.025318861126218728,0.9746811388737813,1,0.020691396749926705,0.9793086032500733,1,0.0826944038271904,0.9497631192207336,1,0.18688811361789703,0.8672555088996887,1,0.004281414096002205,0.9957185859039978,1
3463,2022/06/20症状改善なく、入院加療とした。,0 0 0 症状改善 ない 入院 加療 する た,1,0.01669305701244755,0.9833069429875525,0,0.00016179673366669762,0.9998382032663333,0,0.7943127871271487,0.2056872128728513,1,0.015480539410967942,0.9845194605890321,0,0.735776960849762,0.27855184674263,1,0.26746195554733276,0.8319724202156067,1,0.0791473309984456,0.9208526690015545,1
3464,2022/07/06 06:00右視神経炎が発現。,0 0 0 0 0 右視神経炎 発現,1,0.014016702217813681,0.9859832977821862,1,0.00036142419347650034,0.9996385758065235,1,0.00987732563689947,0.9901226743631005,1,2.220446049250313e-16,0.9999999999999998,1,0.08210697025060654,0.9474784135818481,1,0.18667146563529968,0.871497392654419,1,0.004063307218459717,0.9959366927815404,1
3465,3回目の接種時も、30分後に全身の痺れ感を訴えた。,0回目 接種 時 0分 後 全身 痺れ感 訴える た,1,0.01669142251509734,0.9833085774849026,1,0.00030282264446442254,0.9996971773555355,1,0.1318102059274816,0.8681897940725184,1,0.0003756730029814692,0.9996243269970185,1,0.08243565261363983,0.9465821385383606,1,0.18415655195713043,0.8675820827484131,1,0.0052242204785542465,0.9947757795214458,1
3466,Cr 7.0 mg/dL、蛋白尿・血尿・異常円柱。,Cr 0 0 mg dL 蛋白尿 血尿 異常 円柱,1,0.08322762064642175,0.9167723793535784,1,0.00017380647445732245,0.9998261935255427,0,0.5699879718855327,0.43001202811446726,1,2.2437607327674414e-12,0.9999999999977562,1,0.08676233887672424,0.9433568120002747,1,0.1921260952949524,0.8647753596305847,1,0.014450576879143353,0.9855494231208567,1
3467,その後、咳込みや呼吸困難感の増悪、吐き気を認めた。,その後 咳込み 呼吸 困難感 の 増悪 吐き 気 認める た,1,1.328173383111724e-05,0.9999867182661689,1,0.00043342806790260473,0.9995665719320974,1,0.013844531984842035,0.986155468015158,1,0.011902015147500444,0.9880979848524996,1,0.08256863057613373,0.9486989974975586,1,0.18758313357830048,0.8669136166572571,1,0.004098308033318531,0.9959016919666814,1
3468,意識消失、徐脈の結果として、治療的処置がとられた。,意識消失 徐脈 結果 治療 的 処置 とる れる た,1,0.009156523497043751,0.9908434765029563,1,0.000449456915142113,0.9995505430848579,1,0.021486218659389933,0.9785137813406101,1,0.06666525466612516,0.9333347453338748,1,0.08447276800870895,0.9401823878288269,1,0.19126947224140167,0.8553743362426758,1,0.004848143116930804,0.9951518568830692,1
3469,咽頭の違和感、咳込み、接種側上肢のかゆみを認めた。,咽頭 違和感 咳込み 接種 側 上肢 かゆみ 認める た,1,0.016699627986805205,0.9833003720131946,1,0.00037273002962487405,0.9996272699703751,1,0.03045429833464508,0.9695457016653549,1,0.008452623268650594,0.9915473767313494,1,0.07822136580944061,0.9473908543586731,1,0.1859169751405716,0.865411102771759,1,0.0043349317546119105,0.995665068245388,1
3470,横静脈洞血栓症、頭痛の結果、治療的処置がとられた。,横静脈洞 血栓症 頭痛 結果 治療 的 処置 とる れる た,1,0.004041201631538682,0.9959587983684614,1,0.00045226329946496693,0.999547736700535,1,0.0038362607409025973,0.9961637392590974,1,0.08924146495650598,0.910758535043494,1,0.07756265997886658,0.9420233964920044,1,0.19279387593269348,0.8699967861175537,1,0.0047421026361049905,0.9952578973638949,1
3471,壊疽性膿皮症の結果として、治療的な処置がとられた。,壊疽性 膿皮症 結果 治療 的 だ 処置 とる れる た,1,0.016662257319296787,0.9833377426807032,1,0.0003598759221941451,0.9996401240778059,1,0.029090311785350487,0.9709096882146495,1,0.08709937049058158,0.9129006295094184,1,0.08475851267576218,0.9410078525543213,1,0.20946598052978516,0.8490583300590515,1,0.005328100921260019,0.9946718990787399,1
3472,角膜浮腫を認め視力は0.7から0.02に低下した。,角膜浮腫 認める 視力 0 0 0 0 低下 する た,1,0.0034089216894445137,0.9965910783105553,1,0.000388295206054976,0.999611704793945,1,0.009929350110261081,0.9900706498897389,1,0.24313743335997495,0.756862566640025,1,0.07854943722486496,0.9494701027870178,1,0.19275446236133575,0.8773028254508972,1,0.006420991572060414,0.9935790084279396,1
3473,患者は軽い意識障害があったが頭痛の訴えはなかった。,患者 軽い 意識障害 ある た 頭痛 訴え ない た,1,0.01667493923818289,0.9833250607618171,1,0.00023728410066377724,0.9997627158993362,1,0.34047781111766207,0.6595221888823379,0,0.8877637422245187,0.11223625777548128,1,0.1689886599779129,0.8957462310791016,0,0.7556753754615784,0.24168804287910461,1,0.1515542261415608,0.8484457738584391,1
3474,筋力低下、体重減少の結果として治療処置が行われた。,筋力低下 体重減少 結果 治療 処置 行う れる た,1,0.00533714044826181,0.994662859551738,1,0.00028750957238081546,0.9997124904276192,1,0.11023159353021328,0.8897684064697867,1,0.3289336043160478,0.6710663956839522,1,0.08382140100002289,0.9405076503753662,1,0.21275219321250916,0.8544639348983765,1,0.009865291693291199,0.9901347083067088,1
3475,経過中に両上肢静脈血栓症、肺血栓塞栓症も合併した。,経過 中 上肢静脈血栓症 肺血栓 塞栓症 合併 する た,1,0.016711149723131178,0.9832888502768689,1,0.00030322766476279726,0.9996967723352372,1,0.46908510374761503,0.530914896252385,1,0.1712289565250006,0.8287710434749994,1,0.07817427068948746,0.9385862350463867,1,0.1860525906085968,0.8658736348152161,1,0.014406334880202596,0.9855936651197973,1
3476,血液検査で、急激な血小板減少と貧血の進行を示した。,血液検査 急激 だ 血小板減少 貧血 進行 示す た,1,0.030097017641572812,0.9699029823584272,1,0.00035677594986346787,0.9996432240501365,1,0.4974585703814468,0.5025414296185532,1,0.0022547706932812828,0.9977452293067187,1,0.07976163923740387,0.9457115530967712,1,0.1879487931728363,0.8654627799987793,1,0.011171780428462676,0.9888282195715374,1
3477,治療的処置は、異常高熱、発熱の結果としてとられた。,治療 的 処置 異常高熱 発熱 結果 とる れる た,1,0.0034512150225072718,0.9965487849774928,1,0.00044576214754444557,0.9995542378524556,1,0.004153030614471809,0.9958469693855282,1,0.03662240625818869,0.9633775937418113,1,0.0865170806646347,0.9493466019630432,1,0.1996864676475525,0.8563023209571838,1,0.004363531267134227,0.9956364687328657,1
3478,心電図では5例にST変化、1例に心房細動を認めた。,心電図 0 例 ST 変化 0 例 心房細動 認める た,1,0.0057508334277690774,0.9942491665722307,1,0.0003131093066428173,0.9996868906933571,1,0.026677171260525823,0.9733228287394742,1,0.007956426202453959,0.992043573797546,1,0.08126219362020493,0.9449900984764099,1,0.1855824589729309,0.8706110119819641,1,0.004204605331112262,0.9957953946688878,1
3479,神経学的には、JSC 1の軽度の意識障害を認めた。,神経学 的 JSC 0 軽度 意識障害 認める た,1,1.8204420353289533e-07,0.9999998179557965,1,0.0006394777601213062,0.9993605222398787,1,0.010195649934864437,0.9898043500651356,1,0.000649676194063975,0.999350323805936,1,0.0787072405219078,0.9482895135879517,1,0.1915299892425537,0.8750564455986023,1,0.0039497762203776635,0.9960502237796224,1
3480,身体検査:両手に多発性関節炎及び圧痕浮腫を認めた。,身体検査 両手 多発性 関節炎 圧痕 浮腫 認める た,1,2.8890676678567037e-06,0.9999971109323322,1,0.0004136570490630936,0.999586342950937,1,0.03431092931605395,0.965689070683946,1,0.0026307109127234884,0.9973692890872765,1,0.07653548568487167,0.9446297883987427,1,0.18619298934936523,0.8715748190879822,1,0.004157149838198067,0.9958428501618019,1
3481,身体検査により両下腿の非圧痕性浮腫と紅斑を認めた。,身体検査 下腿 非圧痕性 浮腫 紅斑 認める た,1,0.003686254758002053,0.996313745241998,1,0.000353130590879168,0.9996468694091208,1,0.03271476643218074,0.9672852335678193,1,0.007127234486540179,0.9928727655134598,1,0.07996883243322372,0.9464977383613586,1,0.19146613776683807,0.8667370676994324,1,0.004260763413719063,0.995739236586281,1
3482,体位にて変動する痛みと合わせて、心膜炎が疑われた。,体位 変動 する 痛み 合わせる 心膜炎 疑う れる た,1,0.007564351710451728,0.9924356482895481,1,0.00032250103115169656,0.9996774989688483,1,0.02218555889265983,0.9778144411073402,1,0.06543738435300483,0.9345626156469952,1,0.07838404923677444,0.944603681564331,1,0.1914224773645401,0.8573981523513794,1,0.0047673984837206885,0.9952326015162793,1
3483,長椅子に腰掛けていたところ、AM8時頃、意識消失。,長椅子 腰掛ける いる た ところ AM 0時 頃 意識消失,1,0.04257952019704903,0.9574204798029511,1,0.00025328215701644376,0.9997467178429835,1,0.2722045333749973,0.7277954666250027,1,0.0006347843875724735,0.9993652156124275,1,0.11416138708591461,0.9323323369026184,1,0.19304616749286652,0.8699496984481812,1,0.0076624599235561915,0.9923375400764438,1
3484,日付不明右肩から胸部、上肢にかけてびらんを認めた。,日付 不明 右肩 胸部 上肢 かける びらん 認める た,1,0.01667512622087099,0.9833248737791291,1,0.0003179814306607636,0.9996820185693392,1,0.09008895665229366,0.9099110433477063,1,0.001507697899417515,0.9984923021005825,1,0.07977452129125595,0.9469587206840515,1,0.18915767967700958,0.8645815849304199,1,0.004842699125061246,0.9951573008749387,1
3485,熱はないが、目も開けられないほどぐったりしていた。,熱 ない 目 開ける られる ない する いる た,0,0.9902398584476643,0.009760141552335686,0,4.720676910829082e-05,0.9999527932308917,0,0.9916278598229009,0.008372140177099127,0,0.791151404444677,0.20884859555532298,0,0.9346303343772888,0.09143636375665665,0,0.7952092289924622,0.22838926315307617,0,0.9505531910071138,0.04944680899288619,1
3486,翌日から発熱と胸痛を認め、当院救急外来を受診した。,翌日 発熱 胸痛 認める 院 救急外来 受診 する た,1,9.472646452157172e-09,0.9999999905273534,1,0.0008835234743676955,0.9991164765256323,1,0.0014584675162987448,0.9985415324837013,1,0.10569316552503949,0.8943068344749605,1,0.07746049016714096,0.9484736323356628,1,0.18389324843883514,0.8693227171897888,1,0.0047712120417720124,0.995228787958228,1
3487,両側肺野の浸潤影と皮膚筋炎特異的皮疹が認められた。,両側肺 野 浸潤影 皮膚筋炎 特異的 皮疹 認める られる た,1,0.016718223043597918,0.9832817769564021,1,0.0003614574176377101,0.9996385425823623,1,0.06759006285691438,0.9324099371430856,1,0.0768818430572562,0.9231181569427438,1,0.07870044559240341,0.9484233260154724,1,0.1881723254919052,0.8655437231063843,1,0.005356939559385079,0.9946430604406148,1
3488,2022/02/23、COVID-19を発症した。,0 0 0 COVID 0 発症 する た,1,0.02042316592108113,0.9795768340789189,1,0.00039129537512080746,0.9996087046248792,1,0.09937846729482758,0.9006215327051724,1,0.0009385797091012726,0.9990614202908987,1,0.078647680580616,0.9463766813278198,1,0.18177784979343414,0.8737402558326721,1,0.004881407149776845,0.9951185928502233,1
3489,2022/05/03、発熱と痙攣のため搬送された。,0 0 0 発熱 痙攣 ため 搬送 する れる た,1,0.002936065720272455,0.9970639342797277,1,0.0004693502440845263,0.9995306497559154,1,0.011220125732065989,0.988779874267934,1,0.17973743661393293,0.8202625633860671,1,0.07323137670755386,0.9479847550392151,1,0.1759186089038849,0.8746291995048523,1,0.005570202965220036,0.9944297970347801,1
3490,2022/02/02、倦怠感と易疲労感を発現した。,0 0 0 倦怠感 易疲労感 発現 する た,1,9.003272044218194e-06,0.9999909967279559,1,0.00043343052848755456,0.9995665694715125,1,0.003024866725863773,0.9969751332741362,1,0.0252965451463093,0.9747034548536907,1,0.08120914548635483,0.9461029767990112,1,0.18520604074001312,0.8795678019523621,1,0.00406313954318288,0.9959368604568171,1
3491,21:00以降、BP低下、DOA upも反応なし。,0 0 以降 BP 低下 DOA up 反応 ない,1,0.2608043677025443,0.7391956322974559,1,0.0001773971190907972,0.9998226028809092,0,0.760007627790692,0.23999237220930797,1,0.029854309819883684,0.9701456901801163,0,0.8724130392074585,0.1943565011024475,1,0.2095191776752472,0.8540870547294617,1,0.1341417733247327,0.8658582266752672,1
3492,19:00、腹痛増強し、管理のため病院に入院した。,0 0 腹痛 増強 管理 ため 病院 入院 する た,1,0.004014369714805621,0.9959856302851943,1,0.0003659744181169275,0.9996340255818831,1,0.01677981023167674,0.9832201897683233,1,0.0868822689300982,0.9131177310699018,1,0.0877000242471695,0.9426097869873047,1,0.18157055974006653,0.8727447390556335,1,0.004820722455668005,0.9951792775443319,1
3493,2021/07/21、患者は急性心筋炎を発現した。,0 0 0 患者 急性心筋炎 発現 する た,1,0.011670178010987502,0.9883298219890126,1,0.00041401887274090417,0.999585981127259,1,0.023394727173343233,0.9766052728266568,1,0.0014919928202310473,0.998508007179769,1,0.0919918641448021,0.9482925534248352,1,0.18155866861343384,0.869742214679718,1,0.004191307600082111,0.995808692399918,1
3494,2021/10発現、血圧低下(入院)、転帰「不明」,0 0 発現 血圧低下 入院 転帰 不明,1,9.642896461485974e-06,0.9999903571035386,1,0.00031490924093471596,0.9996850907590653,1,0.011036342289325485,0.9889636577106745,1,3.755673397609627e-06,0.9999962443266024,1,0.12526953220367432,0.916251003742218,1,0.1943397969007492,0.8649740815162659,1,0.00432552670368969,0.9956744732963104,1
3495,2022/04/08より右上肢の疼痛にて発症した。,0 0 0 右 上肢 疼痛 にる 発症 する た,1,0.005566349658018792,0.9944336503419812,1,0.000491336255911157,0.9995086637440889,1,0.02197315638602626,0.9780268436139737,1,0.025950703176301437,0.9740492968236986,1,0.08208731561899185,0.9482083916664124,1,0.18376153707504272,0.8744930028915405,1,0.00428265854732776,0.9957173414526722,1
3496,2022/04/29 09:00、複視が発現した。,0 0 0 0 0 複視 発現 する た,1,0.004253054227028983,0.995746945772971,1,0.00041476557472284027,0.9995852344252771,1,0.009830092720909511,0.9901699072790905,1,0.014951839769390518,0.9850481602306095,1,0.0828496515750885,0.9464325904846191,1,0.18647368252277374,0.8778492212295532,1,0.004086144214813507,0.9959138557851864,1
3497,2022/05/30朝から頭痛と倦怠感が発現した。,0 0 0 朝 頭痛 倦怠感 発現 する た,1,2.679293623433546e-07,0.9999997320706375,1,0.0005418764933703816,0.9994581235066297,1,0.0010955191894584937,0.9989044808105415,1,0.022310837788834248,0.9776891622111658,1,0.07929950952529907,0.9490930438041687,1,0.18276885151863098,0.8764440417289734,1,0.0040075015975623105,0.9959924984024378,1
3498,2022/06/05胸部X線:やや心拡大を認めた。,0 0 0 胸部 X線 心拡大 認める た,1,0.01081071320723666,0.9891892867927634,1,0.0003433242122378096,0.9996566757877622,1,0.06480031386080787,0.9351996861391921,1,0.016722387580495046,0.983277612419505,1,0.07770218700170517,0.9426161646842957,1,0.181448832154274,0.8734257221221924,1,0.004625487039905413,0.9953745129600945,1
3499,2022/07/21、全身倦怠感と頭痛は持続した。,0 0 0 全身倦怠感 頭痛 持続 する た,1,0.016702465436743193,0.9832975345632567,1,0.0004229609020801053,0.9995770390979198,1,0.08495552213196877,0.9150444778680312,0,0.5485893023793802,0.4514106976206198,1,0.07805891335010529,0.9488477110862732,1,0.18917767703533173,0.8790543079376221,1,0.013934913261073646,0.9860650867389263,1
3500,34年前、生まぐろを食べてショック症状を発現した。,0 年 前 まぐろ 食べる ショック症状 発現 する た,1,0.011664637030673983,0.988335362969326,1,0.00027487065284381517,0.9997251293471562,1,0.028712271504341857,0.9712877284956581,1,0.1412538647485687,0.8587461352514313,1,0.08132889866828918,0.9486432075500488,1,0.18875758349895477,0.8768405318260193,1,0.005532399072801738,0.9944676009271983,1
3501,呼吸苦、発熱、血圧変動、SpO2減少が認められた。,呼吸苦 発熱 血圧変動 SpO 0 減少 認める られる た,1,3.4451016022652763e-06,0.9999965548983978,1,0.00042560230672348913,0.9995743976932765,1,0.01242510107134498,0.987574898928655,1,0.18798600086648165,0.8120139991335183,1,0.07867415994405746,0.9521012306213379,1,0.18106335401535034,0.8650227189064026,1,0.0057333459597239365,0.9942666540402761,1
3502,手のふるえが出現し、採血にて低Na血症が出現した。,手 ふるえ 出現 採血 Na 血 症 出現 する た,1,0.0028945768281207103,0.9971054231718791,1,0.0006092641207746059,0.9993907358792254,1,0.016779090695973276,0.9832209093040267,1,0.043388591546909994,0.95661140845309,1,0.08003605902194977,0.9448232054710388,1,0.18518619239330292,0.8724907636642456,1,0.004386844223918086,0.9956131557760819,1
3503,心筋炎(開始日:2022/02)のために入院した。,心筋炎 開始 日 0 0 ため 入院 する た,1,0.0040943061098056045,0.9959056938901945,1,0.00041497976372893735,0.999585020236271,1,0.015021049106345163,0.9849789508936548,1,0.018484195154386374,0.9815158048456136,1,0.07569444179534912,0.9462421536445618,1,0.20776809751987457,0.8648365139961243,1,0.004271170421168909,0.9957288295788311,1
3504,低血糖・低酸素血症(SpO2 80%台)を認めた。,低血糖 低酸素血症 SpO 0 0% 台 認める た,1,1.0484173467756278e-05,0.9999895158265322,1,0.0004753134561030822,0.9995246865438969,1,0.018574068134094568,0.9814259318659054,1,0.006574686512407335,0.9934253134875927,1,0.07308497279882431,0.9481956362724304,1,0.1829676330089569,0.8757852911949158,1,0.004003163263659452,0.9959968367363407,1
3505,肺胞虚脱と毛管の増生が見られた(HE染色x 40),肺胞虚脱 毛管 増生 見る られる た HE 染色 x 0,1,0.028793460465508663,0.9712065395344912,1,0.0002622412335320854,0.9997377587664679,1,0.23162025766721406,0.7683797423327859,1,0.015994348385669155,0.9840056516143308,1,0.11090251058340073,0.915307879447937,1,0.18803167343139648,0.8524984121322632,1,0.007278455724880202,0.9927215442751198,1
3506,発熱、体調不良の結果として治療的な処置がとられた。,発熱 体調不良 結果 治療 的 だ 処置 とる れる た,1,1.3372470645561643e-05,0.9999866275293545,1,0.0004429726081161872,0.9995570273918838,1,0.01749649767968764,0.9825035023203124,1,0.05343019036246466,0.9465698096375353,1,0.07997339963912964,0.9484032988548279,1,0.1957458257675171,0.8590934872627258,1,0.004545727106090493,0.9954542728939094,1
3507,微熱、悪寒、頭痛、咽頭痛もひどく、病院に受診した。,微熱 悪寒 頭痛 咽頭痛 ひどい 病院 受診 する た,1,0.003442112980177878,0.9965578870198223,1,0.0004541174194949041,0.9995458825805051,1,0.03468193272886688,0.9653180672711331,1,0.12459498776087996,0.87540501223912,1,0.08196785300970078,0.9465099573135376,1,0.1891845315694809,0.864605188369751,1,0.005412502829850889,0.994587497170149,1
3508,臀部に強い電撃痛があり、患者は整形外科に入院した。,臀部 強いる 電撃痛 ある 患者 整形外科 入院 する た,1,0.014765676224459276,0.9852343237755407,1,0.0003001791425241269,0.9996998208574759,1,0.07529190564195087,0.9247080943580491,1,0.13313909417894232,0.8668609058210577,1,0.08100098371505737,0.9506325721740723,1,0.19603730738162994,0.8628750443458557,1,0.0061235213615289585,0.9938764786384711,1
3509,基礎疾患としてアルコール性肝障害と糖尿病があった。,基礎疾患 する アルコール性 肝障害 糖尿病 ある た,1,0.016678226744613812,0.9833217732553862,1,0.000267492130656364,0.9997325078693436,1,0.2484026291458642,0.7515973708541358,1,0.2801298599909531,0.7198701400090469,1,0.09598592668771744,0.9339366555213928,1,0.23518218100070953,0.8541923761367798,1,0.012542575209914116,0.9874574247900859,1
3510,臨床症状と合わせて軽症の心筋炎であると診断された。,臨床症状 合わせる 軽症 の 心筋炎 だ ある 診断 する れる た,1,0.00989505683655043,0.9901049431634495,1,0.000365512734750519,0.9996344872652495,1,0.02725739299182306,0.9727426070081769,1,0.27287309574968677,0.7271269042503132,1,0.10117089003324509,0.9377892017364502,1,0.216231107711792,0.8583855628967285,1,0.00770622586813293,0.992293774131867,1
3511,何らかの感染症に伴う急性脳症であっても矛盾はない。,感染症 伴う 急性脳症 だ ある 矛盾 ない,1,0.016703868202301506,0.9832961317976987,1,0.0002791962298199184,0.9997208037701801,0,0.6918023311922932,0.30819766880770677,1,0.1494199215048242,0.8505800784951758,1,0.5017345547676086,0.6886489987373352,1,0.28670305013656616,0.8156529664993286,1,0.04745055811106957,0.9525494418889305,1
3512,05/29、リンパ球は実数で660まで低下した。,0 0 リンパ球 実数 0 低下 する た,1,0.01668920615323825,0.9833107938467618,1,0.0003474288301657373,0.9996525711698343,1,0.12054287899291916,0.8794571210070808,1,0.2620817167556935,0.7379182832443065,1,0.35165584087371826,0.7582324147224426,1,0.19629888236522675,0.8684875965118408,1,0.013661164718005022,0.9863388352819951,1
3513,05:26吐き気を認め、痛み増強のため救急要請。,0 0 吐き 気 認める 痛み 増強 ため 救急 要請,1,1.2894358882327248e-05,0.9999871056411177,1,0.0005063489524431018,0.9994936510475569,1,0.008149940754062168,0.9918500592459378,1,2.284838984678572e-13,0.9999999999997715,1,0.08644026517868042,0.9425411820411682,1,0.19033870100975037,0.872298002243042,1,0.0039869975829665,0.9960130024170334,1
3514,12日目に亜急性甲状腺炎(SAT)と診断された。,0 日 目 亜急性 甲状腺炎 SAT 診断 する れる た,1,0.03770966113123908,0.962290338868761,1,0.0002516927848610562,0.999748307215139,1,0.09834206663090383,0.9016579333690962,1,0.30796600161816867,0.6920339983818313,1,0.10992766171693802,0.932913601398468,1,0.18226194381713867,0.8770657777786255,1,0.009667692167364085,0.9903323078326359,1
3515,2021/**/**、体温:摂氏39度(高温)。,0 体温 摂氏 0度 高温,1,0.01670656268697684,0.983293437313023,1,0.0003017640280305471,0.9996982359719695,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.16267071664333344,0.9083889126777649,1,0.2017163336277008,0.8599339127540588,1,0.011462331601724692,0.9885376683982753,1
3516,2021/06/07、右下肢感覚障害が出現した。,0 0 0 右下肢感覚障害 出現 する た,1,0.011817578906552887,0.9881824210934472,1,0.00037096744757586704,0.9996290325524241,1,0.02237017478191028,0.9776298252180897,1,0.049730423879259855,0.9502695761207401,1,0.07617443054914474,0.9520676136016846,1,0.1882178783416748,0.8777335286140442,1,0.0045104821318038835,0.9954895178681961,1
3517,2021/06/15、手足のしびれ感を自覚した。,0 0 0 手足のしびれ 感 自覚 する た,1,0.016693888856644738,0.9833061111433552,1,0.00037547395048660286,0.9996245260495134,1,0.047365096732634115,0.9526349032673659,1,0.06509219932871524,0.9349078006712848,1,0.08317148685455322,0.9483546018600464,1,0.18931950628757477,0.8769741654396057,1,0.004997614398741725,0.9950023856012582,1
3518,2021/07/09、眼球結膜充血が認められた。,0 0 0 眼球結膜 充血 認める られる た,1,0.002887618449111198,0.9971123815508889,1,0.0004257057399290422,0.9995742942600709,1,0.04945260649813854,0.9505473935018615,1,0.08050430231534389,0.9194956976846561,1,0.08421052992343903,0.9484882950782776,1,0.18326115608215332,0.8682577610015869,1,0.005052866467346381,0.9949471335326537,1
3519,2021/07/20、摂氏38度の発熱があった。,0 0 0 摂氏 0度 発熱 ある た,1,0.015206730171738009,0.9847932698282621,1,0.00036159838722439575,0.9996384016127756,1,0.016326799253838953,0.983673200746161,1,0.0002194223337422807,0.9997805776662577,1,0.07531064748764038,0.9505645632743835,1,0.1826445758342743,0.8721225261688232,1,0.004068100226629307,0.9959318997733707,1
3520,2021/08/16朝より、38.0°Cの発熱。,0 0 0 朝 0 0 C 発熱,1,0.005569210125761796,0.9944307898742382,1,0.00033879621207093263,0.9996612037879291,1,0.03627370622288928,0.9637262937771107,1,0.0,1.0,1,0.08868766576051712,0.9498792886734009,1,0.1879826933145523,0.8680498600006104,1,0.0042486539256944705,0.9957513460743055,1
3521,2021/09/01発熱を認めたが、体温は不明。,0 0 0 発 熱 認める た 体温 不明,1,0.016709404152307643,0.9832905958476925,1,0.000181036248946324,0.9998189637510537,1,0.057910043636346775,0.9420899563636532,1,0.0014073920542025942,0.9985926079457974,1,0.08608607947826385,0.9449170827865601,1,0.18598158657550812,0.8705880045890808,1,0.004536639991492654,0.9954633600085074,1
3522,2021/10/05から、左眼瞼下垂が出現した。,0 0 0 左眼瞼 下垂 出現 する た,1,0.0060837954912316495,0.9939162045087684,1,0.0004419640051964532,0.9995580359948035,1,0.02109690637277717,0.9789030936272228,1,0.031391364520359066,0.9686086354796409,1,0.07354743778705597,0.9500541090965271,1,0.18958373367786407,0.877582848072052,1,0.0042929552174092575,0.9957070447825909,1
3523,2022/02/11 03:00背部痛を認めた。,0 0 0 0 0 背部痛 認める た,1,0.007985741906188414,0.9920142580938118,1,0.00040561373275687117,0.9995943862672432,1,0.02454924288366911,0.9754507571163309,1,0.0006280892231896873,0.9993719107768103,1,0.0777789056301117,0.9477518200874329,1,0.1827101856470108,0.8763099908828735,1,0.004084612877885007,0.995915387122115,1
3524,2022/02/26頃より右口角麻痺が出現した。,0 0 0 頃 右口角麻痺 出現 する た,1,0.007076642652147167,0.9929233573478529,1,0.000388850603685318,0.9996111493963147,1,0.014085516096501105,0.9859144839034989,1,0.06271416765349713,0.9372858323465029,1,0.07863899320363998,0.9492194056510925,1,0.19031910598278046,0.8773068189620972,1,0.0045456082027898964,0.9954543917972102,1
3525,2022/03/11敗血性腸炎と肩の痛みで入院。,0 0 0 敗 血 性腸炎 肩 痛み 入院,1,2.0466627356906e-06,0.9999979533372644,1,0.0003983285733282187,0.9996016714266718,1,0.019310907237565678,0.9806890927624343,1,1.2903167423417017e-10,0.9999999998709683,1,0.07933995127677917,0.9427149891853333,1,0.17916445434093475,0.8696737885475159,1,0.004011934197230476,0.9959880658027694,1
3526,2022/03/29 03:30頃心筋炎が発現。,0 0 0 0 0 頃 心筋炎 発現,1,0.003156922876870095,0.99684307712313,1,0.00048147338926359234,0.9995185266107364,1,0.0022287231653089767,0.997771276834691,1,0.0,1.0,1,0.0864098072052002,0.94681715965271,1,0.17896650731563568,0.8712866306304932,1,0.003907301908112416,0.9960926980918877,1
3527,2022/03/31朝、頭痛、熱っぽさを認めた。,0 0 0 朝 頭痛 熱っぽさ 認める た,1,1.0434590653872285e-05,0.9999895654093461,1,0.0004155244109364912,0.9995844755890635,1,0.005087297936319568,0.9949127020636804,1,0.008096699929778683,0.9919033000702213,1,0.0761876031756401,0.9509624242782593,1,0.18035995960235596,0.8712638020515442,1,0.003917178633413074,0.9960828213665869,1
3528,2022/04/05急速進行性糸球体腎炎が発現。,0 0 0 急速進行性 糸球体腎炎 発現,1,0.014870180435581973,0.985129819564418,1,0.0003764097439734369,0.9996235902560265,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08369071036577225,0.9449792504310608,1,0.18000230193138123,0.8712244629859924,1,0.004060975298394102,0.9959390247016058,1
3529,2022/04/12頃視力低下、聴力低下が発現。,0 0 0 頃 視力低下 聴力低下 発現,1,0.008575007061222174,0.9914249929387777,1,0.00040058600069349857,0.9995994139993065,1,0.006430581757262188,0.9935694182427378,1,4.929390229335695e-14,0.9999999999999507,1,0.08776550740003586,0.9466772079467773,1,0.18487536907196045,0.8726994395256042,1,0.004006098053724088,0.9959939019462759,1
3530,2022/04/27 05:30頃心膜炎が発現。,0 0 0 0 0 頃 心膜炎 発現,1,0.007970639777294966,0.9920293602227049,1,0.00042518091441248664,0.9995748190855875,1,0.006430581757262188,0.9935694182427378,1,6.661338147750939e-16,0.9999999999999993,1,0.08394164592027664,0.9478287696838379,1,0.17871318757534027,0.871533989906311,1,0.0039619263626533945,0.9960380736373465,1
3531,2022/05/02昼、胸痛が出現し、近医受診。,0 0 0 昼 胸痛 出現 近医 受診,1,1.4023818264845912e-06,0.9999985976181734,1,0.0005349989321387074,0.9994650010678613,1,0.002567852013671601,0.9974321479863284,1,2.955613531696599e-11,0.9999999999704439,1,0.08016198873519897,0.9452006816864014,1,0.18681666254997253,0.862210214138031,1,0.0039337377131508115,0.9960662622868491,1
3532,2022/05/16、右下肢虚血症状を発現した。,0 0 0 右下肢虚血症状 発現 する た,1,0.010536876545779068,0.989463123454221,1,0.0003699554239676511,0.9996300445760323,1,0.012385251018906751,0.9876147489810932,1,0.014277801454245065,0.9857221985457549,1,0.07220876216888428,0.9479959011077881,1,0.18299613893032074,0.876551628112793,1,0.004093704529614965,0.995906295470385,1
3533,2022年7月20日報告まで2回の発作のみ出現。,0 年 0 月 0 日 報告 0回 発作 出現,1,0.016683207104436576,0.9833167928955634,1,0.00031605851982001,0.99968394148018,1,0.021866695028282646,0.9781333049717174,1,3.3026701861116337e-05,0.9999669732981389,1,0.08663566410541534,0.9458150863647461,1,0.1925906538963318,0.8740594387054443,1,0.004223535471830305,0.9957764645281697,1
3534,2回目接種の1日後、全身疲労感と発熱を自覚した。,0回目 接種 0 日 後 全身疲労感 発熱 自覚 する た,1,4.139291440520346e-06,0.9999958607085595,1,0.00045246635795401214,0.999547533642046,1,0.008791340201244835,0.9912086597987552,1,0.05201015479204307,0.9479898452079569,1,0.08142311125993729,0.9520291686058044,1,0.18759748339653015,0.8744768500328064,1,0.004342430308252898,0.995657569691747,1
3535,2回目接種の翌日、発熱及び肉眼的血尿を発症した。,0回目 接種 翌日 発熱 肉眼的血尿 発症 する た,1,9.356159468194719e-08,0.9999999064384053,1,0.000586055311386798,0.9994139446886132,1,0.007547254604668985,0.992452745395331,1,0.013244318607081862,0.9867556813929181,1,0.07883643358945847,0.9475982785224915,1,0.1837754249572754,0.8753892779350281,1,0.003999333303953443,0.9960006666960466,1
3536,この発見は心筋症ではなく心筋炎の可能性を示した。,発見 心筋症 出端 ない 心筋炎 の 可能性 示す た,1,0.016687433335250874,0.9833125666647489,1,0.0003182766778487491,0.9996817233221512,0,0.628335698259765,0.37166430174023507,1,0.05678806848953655,0.9432119315104635,1,0.10603418946266174,0.9350168108940125,1,0.2113950252532959,0.8543135523796082,1,0.01682961681361381,0.9831703831863862,1
3537,その後、2、3日間、発熱があり、咳嗽を発現した。,その後 0 0 日間 発熱 ある 咳嗽 発現 する た,1,5.222583118947745e-07,0.9999994777416881,1,0.0004884139229797347,0.9995115860770203,1,0.002711098388311961,0.997288901611688,1,0.011320107999781226,0.9886798920002188,1,0.08190607279539108,0.9476632475852966,1,0.18068619072437286,0.876870334148407,1,0.003938923820892383,0.9960610761791076,1
3538,のどがしめつけられる痛みと胸の痛みが確認された。,のど しめつける られる 痛み 胸 痛み 確認 する れる た,1,0.016688104166534386,0.9833118958334657,1,0.0002898180013532363,0.9997101819986468,1,0.09649908566728882,0.9035009143327112,1,0.2525538471174893,0.7474461528825107,1,0.09005172550678253,0.943503737449646,1,0.19491338729858398,0.854538083076477,1,0.008317716676615274,0.9916822833233846,1
3539,壊疽性膿皮症の結果として治療的な処置がとられた。,壊疽性 膿皮症 結果 治療 的 だ 処置 とる れる た,1,0.016662257319296787,0.9833377426807032,1,0.0003598759221941451,0.9996401240778059,1,0.029090311785350487,0.9709096882146495,1,0.08709937049058158,0.9129006295094184,1,0.08475851267576218,0.9410078525543213,1,0.20946598052978516,0.8490583300590515,1,0.005328100921260019,0.9946718990787399,1
3540,患者は血清反応陰性関節炎のため18日間入院した。,患者 血清 反応 陰性関節炎 ため 0 日間 入院 する た,1,0.0026137163418362675,0.9973862836581637,1,0.00032467400079430326,0.9996753259992057,1,0.029921995607162244,0.9700780043928378,1,0.11542266105187027,0.8845773389481297,1,0.10090520232915878,0.9394364953041077,1,0.19985641539096832,0.8690384030342102,1,0.005425811684539487,0.9945741883154604,1
3541,患者は発熱、紅皮症及び肝機能障害のため転院した。,患者 発熱 紅皮症 肝機能障害 ため 転院 する た,1,0.01668034705501999,0.9833196529449798,1,0.00030810460157887473,0.9996918953984211,1,0.030630355159532496,0.9693696448404675,1,0.18131005297029879,0.8186899470297012,1,0.08652085810899734,0.9399081468582153,1,0.22412164509296417,0.8331565260887146,1,0.006662574426296135,0.993337425573704,1
3542,軽度の意識障害以外の神経脱落症候は認めなかった。,軽度 意識障害 以外 神経脱落 症候 認める ない た,1,0.016688311418188197,0.9833116885818118,1,0.0002774534470512114,0.9997225465529488,1,0.3172580338067724,0.6827419661932276,0,0.9639104890550737,0.03608951094492627,0,0.7649860382080078,0.42624494433403015,0,0.8222206234931946,0.18328607082366943,1,0.39506856760777237,0.6049314323922277,1
3543,呼吸状態悪化(SpO2: 71%)が認められた。,呼吸 状態悪化 SpO 0 0% 認める られる た,1,4.3683069695479655e-06,0.9999956316930304,1,0.0004881799770304858,0.9995118200229696,1,0.026327267817210065,0.9736727321827899,1,0.2317074243948628,0.7682925756051372,1,0.08134104311466217,0.9501587748527527,1,0.18170970678329468,0.869053065776825,1,0.006437820406911363,0.9935621795930887,1
3544,呼吸不全、肺障害の結果として治療処置が行われた。,呼吸不全 肺 障害 結果 治療 処置 行う れる た,1,0.016687061074997768,0.9833129389250024,1,0.00030396736289519505,0.9996960326371048,1,0.11023159353021328,0.8897684064697867,1,0.3377368306876507,0.6622631693123493,1,0.10272904485464096,0.921454131603241,1,0.19073638319969177,0.8619240522384644,1,0.010353800542612123,0.989646199457388,1
3545,午後、発熱、倦怠感、右手の痺れ・違和感を認めた。,午後 発熱 倦怠感 右手 痺れ 違和感 認める た,1,4.037580239476102e-06,0.9999959624197606,1,0.0004570086666264478,0.9995429913333735,1,0.004892717002539793,0.9951072829974602,1,0.009228821609030269,0.9907711783909697,1,0.07738799601793289,0.9494689106941223,1,0.18821121752262115,0.8686813116073608,1,0.003976432578676655,0.9960235674213234,1
3546,座位にて経過観察するが寒気、気分不良の訴えあり。,座位 経過 観察 する 寒気 気分不良 訴え ある,1,0.016676037403330693,0.9833239625966692,1,0.00026303713968901235,0.999736962860311,1,0.34433904271528537,0.6556609572847146,1,1.0094815541594748e-05,0.9999899051844584,1,0.08413786441087723,0.9468445181846619,1,0.20356345176696777,0.8393460512161255,1,0.008359907831237889,0.991640092168762,1
3547,受診後から耳が聞こえづらく、顔を押さえると痛む。,受診 後 耳 聞こえる づらい 顔 押さえる 痛む,1,0.016690008317958364,0.9833099916820415,1,0.0003469401903759819,0.999653059809624,1,0.21362969124823594,0.7863703087517641,1,9.627276753576552e-11,0.9999999999037272,1,0.09521535784006119,0.9441784024238586,1,0.20425108075141907,0.8452584743499756,1,0.006505134159123638,0.9934948658408763,1
3548,心電図検査にて2、aVF、V5、V6でST上昇。,心電図 検査 0 aVF V 0 V 0 ST 上昇,1,0.05607129005255121,0.9439287099474487,1,0.0003289083064283923,0.9996710916935716,1,0.1709404215781265,0.8290595784218735,1,1.1844969449725795e-11,0.999999999988155,1,0.09362352639436722,0.9363088011741638,1,0.19425266981124878,0.8644290566444397,1,0.006316958625791462,0.9936830413742085,1
3549,全身倦怠感、呼吸困難感、前胸部発赤を認め、来所。,全身倦怠感 呼吸 困難感 前胸部発赤 認める 来所,1,0.010163467306972153,0.9898365326930278,1,0.00038444166689903596,0.999615558333101,1,0.05336661075544602,0.946633389244554,1,2.1424186347207552e-07,0.9999997857581365,1,0.09882334619760513,0.9472803473472595,1,0.19186219573020935,0.8527184724807739,1,0.004579917712930249,0.9954200822870698,1
3550,帯状疱疹、神経痛の結果として治療処置がとられた。,帯状疱疹 神経痛 結果 治療 処置 とる れる た,1,0.014831572950794668,0.9851684270492055,1,0.00039883766924071225,0.9996011623307592,1,0.021486218659389933,0.9785137813406101,1,0.0552534874305175,0.9447465125694825,1,0.09086231887340546,0.9403839707374573,1,0.20535148680210114,0.8500926494598389,1,0.004916045899793076,0.9950839541002069,1
3551,単純ヘルペスIgG陽性、単純ヘルペスIgM陰性。,単純ヘルペス IgG 陽性 単純ヘルペス IgM 陰性,1,0.19693967675697022,0.8030603232430297,1,0.000270211885101799,0.9997297881148982,1,0.13320120740605623,0.8667987925939438,0,0.857384555707532,0.14261544429246797,0,0.6354833841323853,0.5051428079605103,1,0.384517103433609,0.7610239386558533,1,0.13347520940342483,0.8665247905965752,1
3552,転院後14日目にHHV-6再活性化が検出された。,転院 後 0 日 目 HHV 0 再活性化 検出 する れる た,1,0.09819475719814907,0.9018052428018509,1,0.00019052135685212066,0.9998094786431478,1,0.39897281336128354,0.6010271866387165,1,0.3353410003056492,0.6646589996943508,1,0.1282145231962204,0.924513041973114,1,0.19717596471309662,0.8518276810646057,1,0.02219263835416185,0.977807361645838,1
3553,日付不明2週間で次第に弱って食べない、臥床状態。,日付 不明 0 週間 弱る 食べる ない 臥床 状態,1,0.01669156703446653,0.9833084329655333,1,0.00017502348691753695,0.9998249765130824,0,0.8105781710483217,0.1894218289516782,1,0.00028332288266974537,0.9997166771173303,1,0.17998090386390686,0.8992161750793457,1,0.29751625657081604,0.7847296595573425,1,0.02789564692691378,0.9721043530730862,1
3554,発熱はなく、上腕の痛みを認め、睡眠不足であった。,発熱 ない 上腕 痛み 認める 睡眠不足 だ ある た,1,0.016664724161908968,0.983335275838091,1,0.0002968457511021741,0.9997031542488978,1,0.1920316336396488,0.8079683663603512,0,0.7655019780180745,0.23449802198192554,1,0.08855421841144562,0.9397268295288086,1,0.21923059225082397,0.8488397002220154,1,0.02842108059147527,0.9715789194085247,1
3555,搬送時の採血などで心筋梗塞であろうと診断あった。,搬送 時 採血 だ 心筋梗塞 だ ある う 診断 ある た,1,0.016685964852097234,0.9833140351479026,1,0.00021639797518727182,0.9997836020248128,1,0.299765170373554,0.700234829626446,0,0.7196287959100012,0.28037120408999877,1,0.09533315151929855,0.9273629188537598,1,0.22444824874401093,0.833621084690094,1,0.03329101558305201,0.966708984416948,1
3556,比較的軽症の心筋炎と判断し、経過観察入院となる。,比較的軽症 の 心筋炎 判断 する 経過 観察 入院 なる,1,0.016673420914082842,0.9833265790859171,1,0.00028440752243168784,0.9997155924775684,1,0.017159333002293553,0.9828406669977064,1,4.077384238465598e-06,0.9999959226157615,1,0.09963273257017136,0.9338057041168213,1,0.25671204924583435,0.8366863131523132,1,0.00474501320343566,0.9952549867965642,1
3557,不明日(ワクチン接種後)に、リウマチを発現した。,明日 ワクチン接種 後 リウマチ 発現 する た,1,0.046736215222983615,0.9532637847770163,1,0.0002544357502749729,0.999745564249725,1,0.01638955050992086,0.9836104494900791,1,0.03388911111496451,0.9661108888850355,1,0.12134672701358795,0.937509298324585,1,0.3814292848110199,0.7216449975967407,1,0.006951378382393809,0.9930486216176062,1
3558,不明日、白血球2100、好中球602をきたした。,明日 白血球 0 好中球 0 きたす た,0,0.6399198097321737,0.3600801902678264,1,0.0001774751529271209,0.9998225248470729,1,0.3406142264948072,0.6593857735051928,1,0.0005449864657380843,0.9994550135342619,0,0.870150625705719,0.22528132796287537,0,0.6512941718101501,0.4816851317882538,1,0.22740741458792285,0.7725925854120771,1
3559,本剤による心筋炎または心膜炎を疑い、他院に紹介。,本 剤 心筋炎 心膜炎 疑う 院 紹介,1,0.00420092640500204,0.9957990735949979,1,0.00045174263365375077,0.9995482573663462,1,0.02175054721530001,0.9782494527847,1,2.658341546890597e-09,0.9999999973416585,1,0.09898214787244797,0.9264101982116699,1,0.20168301463127136,0.8542645573616028,1,0.004376137050815741,0.9956238629491843,1
3560,免疫染色では少数のCD 8+Tリンパ球を認めた。,免疫 染色 少数 CD 0 Tリンパ球 認める た,1,0.01631628574063348,0.9836837142593665,1,0.00033795747040112566,0.9996620425295989,1,0.03129164173810284,0.9687083582618972,1,0.01964104798265809,0.9803589520173419,1,0.09453418850898743,0.9329249262809753,1,0.19529244303703308,0.8575220108032227,1,0.004653615118625742,0.9953463848813743,1
3561,目撃者はいないが、状況からは迷走神経反射の疑い。,目撃者 いる ない 状況 迷走神経反射 疑い,1,0.01669899757049806,0.9833010024295019,1,0.00023982763408927105,0.9997601723659107,0,0.6706288725169819,0.3293711274830181,1,8.881784197001252e-16,0.9999999999999991,1,0.11373049020767212,0.9281697869300842,1,0.29322731494903564,0.7809580564498901,1,0.019321340281506432,0.9806786597184937,1
3562,夜間にかけて、さらに増悪のため、近医で救急受診。,夜間 増悪 ため 近医 救急 受診,1,2.745110177829742e-06,0.9999972548898222,1,0.0005052008046126951,0.9994947991953873,1,0.03330399054035882,0.9666960094596412,1,3.468336728928989e-12,0.9999999999965317,1,0.09380336105823517,0.9449531435966492,1,0.2192327082157135,0.850658655166626,1,0.004429841215335077,0.9955701587846649,1
3563,2022/01/24、患者は、味覚消失を訴えた。,0 0 0 患者 味覚消失 訴える た,1,0.01670143336329169,0.9832985666367081,1,0.000350635886469276,0.9996493641135307,1,0.0939419057999753,0.9060580942000247,1,0.004605797860478655,0.9953942021395213,1,0.07984938472509384,0.9488979578018188,1,0.19429148733615875,0.8590653538703918,1,0.004953855777923007,0.995046144222077,1
3564,2021/03/29、患者が筋力低下を発症した。,0 0 0 患者 筋力低下 発症 する た,1,0.01582613648477492,0.9841738635152251,1,0.0003747503576765479,0.9996252496423235,1,0.10028168765679513,0.8997183123432049,1,0.003884902569239679,0.9961150974307603,1,0.08060359954833984,0.9459934234619141,1,0.1824738085269928,0.8740213513374329,1,0.004887366049165278,0.9951126339508346,1
3565,2022/04/20、患者は右肩の疼痛を認めた。,0 0 0 患者 右肩 疼痛 認める た,1,0.01666493048517437,0.9833350695148254,1,0.00041512252870548204,0.9995848774712945,1,0.026415147204447154,0.9735848527955528,1,0.001132476204415589,0.9988675237955844,1,0.07544061541557312,0.9514307379722595,1,0.1808442622423172,0.8730484843254089,1,0.004156407907189037,0.9958435920928108,1
3566,造影MRIにて、右頭頂葉皮質に高信号域を認めた。,造影 MRI 右 頭頂葉 皮質 高信号域 認める た,1,0.007103257878027977,0.992896742121972,1,0.0004065176421860407,0.999593482357814,1,0.01059977350854513,0.9894002264914549,1,0.010161570512936757,0.9898384294870632,1,0.09329672902822495,0.9375427961349487,1,0.20391325652599335,0.8664587140083313,1,0.004276863688199649,0.9957231363118003,1
3567,2021/06/25、患者は呼吸困難を発現した。,0 0 0 患者 呼吸 困難 発現 する た,1,0.007458805231474314,0.9925411947685259,1,0.0004309420592494888,0.9995690579407505,1,0.012268649032559531,0.9877313509674405,1,0.05393201565844141,0.9460679843415586,1,0.08199027180671692,0.9482718110084534,1,0.18511362373828888,0.8762984871864319,1,0.0044549010363715575,0.9955450989636284,1
3568,2021/09/11、発熱と食欲不振が発現した。,0 0 0 発熱 食欲不振 発現 する た,1,2.8951952641246833e-09,0.9999999971048048,1,0.0006475264450435553,0.9993524735549565,1,0.005243546603279081,0.9947564533967209,1,0.00503979290682377,0.9949602070931762,1,0.08185724169015884,0.9498475193977356,1,0.17916840314865112,0.8781161308288574,1,0.003891442755515145,0.9961085572444848,1
3569,2022/03/11、両手のしびれ感を発現した。,0 0 0 両手のしびれ 感 発現 する た,1,0.010323957430555237,0.9896760425694446,1,0.0003418468002895556,0.9996581531997104,1,0.009427390499791577,0.9905726095002084,1,0.03351241440303554,0.9664875855969645,1,0.08159636706113815,0.9476187229156494,1,0.18671457469463348,0.8743263483047485,1,0.0042931895264644755,0.9957068104735355,1
3570,2022/04/16、首の痛みと発熱を発現した。,0 0 0 首 痛み 発熱 発現 する た,1,1.0173958733371906e-08,0.9999999898260412,1,0.0005808186061118681,0.9994191813938881,1,0.002738319771399045,0.997261680228601,1,0.010770852074176829,0.9892291479258232,1,0.07510343194007874,0.9493228793144226,1,0.17702645063400269,0.8746572136878967,1,0.003896896862970776,0.9961031031370291,1
3571,2022/06/03、心筋炎と心膜炎が発現した。,0 0 0 心筋炎 心膜炎 発現 する た,1,1.7294096229766062e-05,0.9999827059037704,1,0.0004744433911050725,0.999525556608895,1,0.0042682244437455275,0.9957317755562545,1,0.0012849477734125925,0.9987150522265874,1,0.08003737777471542,0.9445354342460632,1,0.177400603890419,0.8753008246421814,1,0.0038712137751212845,0.9961287862248787,1
3572,右膝窩静脈と中心にその上下に血栓の充満があった。,右 膝窩静脈 中心 上下 血栓 充満 ある た,1,0.05808607666908361,0.9419139233309164,1,0.0002366996467362126,0.9997633003532638,1,0.12748530209824782,0.8725146979017522,1,0.09398880119343678,0.9060111988065632,1,0.07910851389169693,0.937015950679779,1,0.20851664245128632,0.8650307655334473,1,0.006999949357521877,0.993000050642478,1
3573,急性心筋炎、急性胃腸炎と診断され、入院となった。,急性心筋炎 急性胃腸炎 診断 する れる 入院 なる た,1,4.916790360701572e-06,0.9999950832096393,1,0.00043765555452595853,0.9995623444454741,1,0.011317620253808447,0.9886823797461916,1,0.034602964493621546,0.9653970355063785,1,0.07715132087469101,0.9471216201782227,1,0.19638584554195404,0.8688257932662964,1,0.004279271958162502,0.9957207280418375,1
3574,呼吸不全、発熱の結果として治療的処置がとられた。,呼吸不全 発熱 結果 治療 的 処置 とる れる た,1,0.003244441107713629,0.9967555588922864,1,0.0005306190477851671,0.9994693809522148,1,0.004153030614471809,0.9958469693855282,1,0.055423150924020614,0.9445768490759794,1,0.07889646291732788,0.9474948644638062,1,0.19359669089317322,0.8522965908050537,1,0.0044936070326822,0.9955063929673177,1
3575,座位をとるが水分摂取後しばらくして嘔気を訴えた。,座位 とる 水分摂取 後 する 嘔気 訴える た,1,0.008042845121863427,0.9919571548781365,1,0.00048266438156199695,0.999517335618438,1,0.028484789783880138,0.9715152102161199,1,0.00025166095816220313,0.9997483390418378,1,0.09145247936248779,0.9447166919708252,1,0.20234990119934082,0.8456488847732544,1,0.00439869368420495,0.995601306315795,1
3576,術後、患者は汎下垂体機能低下症と尿崩症を発現した,術後 患者 汎下垂体機能低下症 尿崩症 発現 する た,1,0.016664430141354773,0.9833355698586452,1,0.0002901675058402123,0.9997098324941598,1,0.015000455550220115,0.9849995444497799,1,0.08509725410099045,0.9149027458990096,1,0.09973572939634323,0.9355958104133606,1,0.20751610398292542,0.8454311490058899,1,0.005274040516318884,0.9947259594836811,1
3577,数日前から嚥下障害を自覚し、当科へ外来受診した。,数 日 前 嚥下障害 自覚 科 外来 受診 する た,1,0.016670224277625257,0.9833297757223748,1,0.0002503225364379153,0.9997496774635621,1,0.07883529978882775,0.9211647002111722,1,0.1544643207244858,0.8455356792755142,1,0.08382114768028259,0.9458353519439697,1,0.19602356851100922,0.8590009212493896,1,0.006531594134968421,0.9934684058650316,1
3578,体温:(2022/03/12)発熱、注釈:夜から,体温 0 0 0 発熱 注釈 夜,1,0.004228780640657931,0.9957712193593422,1,0.0003210273356475021,0.9996789726643525,1,0.03402325630758096,0.965976743692419,1,0.003284032107287227,0.9967159678927128,0,0.5987339615821838,0.48311343789100647,1,0.19674140214920044,0.8540685176849365,1,0.01145291038570121,0.9885470896142988,1
3579,典型的な発症の経過から副反応の心筋炎と思われる。,典型 的 だ 発症 経過 副反応 心筋炎 思う れる,1,0.035481856773203306,0.9645181432267966,1,0.0004423304282871802,0.9995576695717128,1,0.05088293956691847,0.9491170604330815,1,0.00021828696209291731,0.9997817130379071,1,0.09346376359462738,0.9366897940635681,1,0.27125120162963867,0.8018866777420044,1,0.00548733196863981,0.9945126680313601,1
3580,患者は発熱及び意識障害の精査加療目的に入院した。,患者 発熱 意識障害 精査 加療 目的 入院 する た,1,7.2752392119817e-07,0.9999992724760788,1,0.00041292256809283767,0.9995870774319071,1,0.013974174435153697,0.9860258255648463,1,0.11872691889483511,0.8812730811051649,1,0.09677327424287796,0.9385841488838196,1,0.19261948764324188,0.8627521991729736,1,0.005242429106195052,0.9947575708938048,1
3581,感冒改善も、喘息に対し吸入薬と点滴加療を行った。,感冒 改善 喘息 吸入 薬 点滴 加療 行う た,0,0.9955695034656458,0.00443049653435417,0,0.0001013268173601712,0.9998986731826398,0,0.9796304865980336,0.02036951340196631,1,0.07316651557733056,0.9268334844226694,0,0.9280717968940735,0.088353730738163,0,0.8096911907196045,0.20136165618896484,1,0.8241879780740824,0.17581202192591763,1
3582,ギラン・バレー症候群の結果、治療措置が取られた。,ギラン・バレー症候群 結果 治療 措置 取る れる た,1,0.016679678314146653,0.9833203216858535,1,0.00025650940416116784,0.9997434905958388,1,0.2489614826224268,0.7510385173775732,1,0.11761187441712184,0.8823881255828782,1,0.17046284675598145,0.8890241384506226,1,0.24279145896434784,0.8447320461273193,1,0.010420729919631031,0.9895792700803688,1
3583,血中カリウム:(2021/12/07)軽度低値。,血 中 カリウム 0 0 0 軽度 値,1,0.004591025486664413,0.9954089745133355,1,0.0003035649061760571,0.9996964350938239,1,0.10222192715997791,0.8977780728400221,1,9.482523200554649e-05,0.9999051747679945,1,0.1381433755159378,0.9161144495010376,1,0.2784242033958435,0.8293308019638062,1,0.005973356656876462,0.9940266433431235,1
3584,(接種してから)最初の2週間は腕がだるかった。,接種 する 最初 0 週間 腕 だるい た,1,0.016679004911137125,0.983320995088863,1,0.00023834350851069982,0.9997616564914893,1,0.46801676478185317,0.5319832352181468,1,0.00026783452572176625,0.9997321654742782,1,0.25462132692337036,0.8349982500076294,1,0.21990124881267548,0.8435671329498291,1,0.014292300251843363,0.9857076997481565,1
3585,2021/11/21 3度房室ブロックが発現。,0 0 0 0度 房室ブロック 発現,1,0.016707778231981888,0.983292221768018,1,0.00039370634185201134,0.999606293658148,1,0.00987732563689947,0.9901226743631005,1,2.220446049250313e-16,0.9999999999999998,1,0.0938652753829956,0.9426997303962708,1,0.18313607573509216,0.8730473518371582,1,0.004132267712303237,0.9958677322876969,1
3586,2022/02/15、軽度の咽喉痛が出現した。,0 0 0 軽度 咽喉痛 出現 する た,1,0.0038032234414809413,0.996196776558519,1,0.0004327418276549852,0.999567258172345,1,0.010018516647652742,0.9899814833523473,1,0.07538274307975601,0.924617256920244,1,0.07804333418607712,0.9554447531700134,1,0.18599870800971985,0.8763895630836487,1,0.0045479615424817025,0.9954520384575183,1
3587,2022/02/20昼食や水分が摂れなかった。,0 0 0 昼食 水分 摂る ない た,1,0.01667867935835912,0.983321320641641,1,0.0002108691992186455,0.9997891308007814,0,0.8399625662106882,0.1600374337893118,0,0.9720953582947177,0.02790464170528229,0,0.9328798651695251,0.05805225297808647,0,0.6345109343528748,0.42654937505722046,1,0.6771454358067803,0.3228545641932197,1
3588,2022/02/24ぼんやり感の増悪を認めた。,0 0 0 ぼんやり感 の 増悪 認める た,1,7.832629228169121e-07,0.9999992167370771,1,0.00045295508301402366,0.999547044916986,1,0.013365255002296794,0.9866347449977032,1,0.002547555681846836,0.9974524443181532,1,0.08534105867147446,0.9487730264663696,1,0.1922161728143692,0.8751158714294434,1,0.004015385036456656,0.9959846149635434,1
3589,2022/02/25頃倦怠感、高体温を認めた。,0 0 0 頃 倦怠感 高体温 認める た,1,6.257756486806528e-06,0.9999937422435131,1,0.00039399535013079096,0.9996060046498693,1,0.007816240670117436,0.9921837593298826,1,0.00679541219576929,0.9932045878042307,1,0.0848870575428009,0.9491194486618042,1,0.18767917156219482,0.8760327100753784,1,0.003979696359768707,0.9960203036402312,1
3590,2022/02/25重症多型滲出性紅斑が発現。,0 0 0 重症 多型 滲出性 紅斑 発現,1,0.008014568437369692,0.9919854315626302,1,0.00038171483404593796,0.9996182851659541,1,0.01927370609511725,0.9807262939048828,1,1.3412826405101441e-11,0.9999999999865872,1,0.08675972372293472,0.9508057236671448,1,0.18708907067775726,0.8736791610717773,1,0.0040892498142966,0.9959107501857034,1
3591,2022/03/01左胸に痛み、息苦しさあり。,0 0 0 左 胸 痛み 息苦しさあり,1,0.01668837065752923,0.9833116293424708,1,0.00030567093802001585,0.99969432906198,1,0.1708799436793479,0.8291200563206521,1,9.019163194068369e-11,0.9999999999098084,1,0.08304467797279358,0.9474309682846069,1,0.18008826673030853,0.8614783883094788,1,0.005652277300306984,0.994347722699693,1
3592,2022/03/03 02:30心筋炎が発現。,0 0 0 0 0 心筋炎 発現,1,0.003673429371144811,0.9963265706288552,1,0.0004537699324060965,0.9995462300675939,1,0.0033982837012268563,0.9966017162987731,1,2.220446049250313e-16,0.9999999999999998,1,0.08529091626405716,0.9453554749488831,1,0.1809566169977188,0.8709576725959778,1,0.0039306399332275765,0.9960693600667725,1
3593,2022/03/08全身に湿疹が拡大し、入院。,0 0 0 全身 湿疹 拡大 する 入院,1,0.007014213521277187,0.9929857864787228,1,0.0003707167831150719,0.9996292832168849,1,0.0544035911667059,0.9455964088332941,1,1.0774314773698279e-10,0.9999999998922569,1,0.08784802258014679,0.9435623288154602,1,0.18315397202968597,0.8697207570075989,1,0.004413323966733126,0.9955866760332669,1
3594,2022/03/13夜、しびれが臍下まで上行。,0 0 0 夜 しびれ 臍 下 上 行,1,0.013917919179808422,0.9860820808201917,1,0.000320414217158772,0.9996795857828412,1,0.33437932271854065,0.6656206772814593,1,1.42691757498703e-06,0.999998573082425,1,0.09382595866918564,0.9397106170654297,1,0.21259845793247223,0.8504043817520142,1,0.008272985653846324,0.9917270143461537,1
3595,2022/03/29胸部不快感が出現し、受診。,0 0 0 胸部不快感 出現 受診,1,0.002736079913543842,0.997263920086456,1,0.00046852007671018876,0.9995314799232898,1,0.01251713096566287,0.9874828690343371,1,1.3988810110276972e-13,0.9999999999998601,1,0.08218838274478912,0.9481458067893982,1,0.18546099960803986,0.8731071949005127,1,0.003981289991038616,0.9960187100089614,1
3596,2022/03/31より、起坐呼吸が出現した。,0 0 0 起坐 呼吸 出現 する た,1,0.00540326223364609,0.9945967377663538,1,0.00040169509685116075,0.9995983049031488,1,0.018794778891286334,0.9812052211087137,1,0.07231816698577598,0.927681833014224,1,0.07517410069704056,0.9514346122741699,1,0.1891845166683197,0.8803231120109558,1,0.004616168916125709,0.9953838310838742,1
3597,2022/04/03、瓦せんべいで発疹が出た。,0 0 0 瓦せんべい だ 発疹 出る た,1,0.016686894521584558,0.9833131054784153,1,0.00033144162239206077,0.9996685583776079,0,0.5330370230486732,0.46696297695132677,1,0.0004619817002528004,0.9995380182997472,1,0.0838555246591568,0.9411380290985107,1,0.18655849993228912,0.8686171174049377,1,0.01167794674238029,0.9883220532576198,1
3598,2022/04/06前胸部痛が続き、前医受診。,0 0 0 前胸部痛 続く 医 受診,1,0.04580414762964066,0.9541958523703594,1,0.00031371252385282153,0.9996862874761472,1,0.1696624431196888,0.8303375568803112,1,1.39265265985955e-10,0.9999999998607347,1,0.08669641613960266,0.9465020298957825,1,0.1901368498802185,0.867550790309906,1,0.006025812293914084,0.993974187706086,1
3599,2022/04/08 17:00躁症状が発現。,0 0 0 0 0 躁症状 発現,1,0.014016702217813681,0.9859832977821862,1,0.00034343814918641176,0.9996565618508136,1,0.00987732563689947,0.9901226743631005,1,9.15134634738024e-12,0.9999999999908487,1,0.08691096305847168,0.9466495513916016,1,0.18373620510101318,0.867041289806366,1,0.0040922131199498685,0.9959077868800502,1
3600,2022/04/23ゴルフの練習中に卒倒した。,0 0 0 ゴルフ 練習中 卒倒 する た,1,0.3414247180836849,0.658575281916315,1,0.00021239109555404583,0.999787608904446,1,0.3533345469092234,0.6466654530907766,1,0.09397709096743057,0.9060229090325694,1,0.4248064160346985,0.7682155966758728,1,0.18394142389297485,0.8678365349769592,1,0.03078655484478668,0.9692134451552133,1
3601,2022/06頃さらに1ヶ月以上しびれが継続。,0 0 頃 0 ヶ月 以上 しびれ 継続,1,0.016706117377131978,0.983293882622868,1,0.00023273223113902514,0.9997672677688609,1,0.26242158564297136,0.7375784143570286,1,0.00014011255579893245,0.9998598874442011,1,0.13953794538974762,0.9163159728050232,1,0.19099153578281403,0.8621444702148438,1,0.007473206385443975,0.9925267936145561,1
3602,2022年3月2日両下肢関節痛、筋肉痛が出現。,0 年 0 月 0 日 両下肢関節痛 筋肉痛 出現,1,0.013815257829284302,0.9861847421707159,1,0.0003629557716568501,0.9996370442283431,1,0.02259850188359802,0.977401498116402,1,4.808607656503483e-08,0.9999999519139234,1,0.08965113759040833,0.9473938345909119,1,0.18958202004432678,0.8756554126739502,1,0.004192475737958009,0.995807524262042,1
3603,CK-MBは120u/L(上昇あり)であった。,CK MB 0 u L 上昇 あり だ ある た,1,0.23142185739475407,0.7685781426052457,1,0.00028113854208925207,0.9997188614579108,0,0.6467626794273417,0.35323732057265833,0,0.9245040255147761,0.07549597448522395,1,0.27348583936691284,0.822114884853363,1,0.19996556639671326,0.8604642152786255,1,0.16753647858681975,0.8324635214131801,1
3604,MRAでは左頚部内頸動脈に狭窄性変化を認めた。,MRA 左 頚部 内 頸動脈 狭窄性 変化 認める た,1,0.024791227850749848,0.9752087721492502,1,0.00034075171941573123,0.9996592482805843,1,0.05071731511451394,0.9492826848854861,1,0.0309240471079264,0.9690759528920736,1,0.07832943648099899,0.9433988332748413,1,0.1912159025669098,0.8675543665885925,1,0.004830989948053269,0.9951690100519467,1
3605,X+2月6日腎生検施行、膜性腎症と診断された。,X+ 0 月 0 日 腎生検 施行 膜性腎症 診断 する れる た,1,0.2872929532928555,0.7127070467071447,1,0.00020793743701916025,0.9997920625629808,1,0.235079594532842,0.764920405467158,1,0.29991165053003654,0.7000883494699635,1,0.11185649782419205,0.9245960116386414,1,0.1943916380405426,0.8757308125495911,1,0.02085482842091847,0.9791451715790815,1
3606,イブプロフェンで軽快するも痛みは繰り返し発生。,イブプロフェン 軽快 する 痛み 繰り返す 発生,1,0.01670804397616678,0.9832919560238332,1,0.00023668863299832282,0.9997633113670017,1,0.322674208101155,0.677325791898845,1,0.0,1.0,1,0.1280696839094162,0.9184128046035767,1,0.274227112531662,0.8111348152160645,1,0.009489703036239597,0.9905102969637604,1
3607,意識障害、血圧低下、頻脈、チアノーゼを認めた。,意識障害 血圧低下 頻脈 チアノーゼ 認める た,1,1.21373485927896e-06,0.9999987862651407,1,0.0003958274057756373,0.9996041725942244,1,0.03271476643218074,0.9672852335678193,1,0.0008314371229797279,0.9991685628770203,1,0.08155863732099533,0.9434154629707336,1,0.18653462827205658,0.8734714984893799,1,0.004148269151919476,0.9958517308480804,1
3608,右口内や舌、右耳後ろから後頭部に痛みを認めた。,右 口内 舌 右 耳 後ろ 後頭部 痛み 認める た,1,1.695383286158468e-06,0.9999983046167139,1,0.0004950925883448616,0.9995049074116551,1,0.005427714191446054,0.994572285808554,1,0.009312515518853037,0.990687484481147,1,0.07991382479667664,0.950206458568573,1,0.19062860310077667,0.8646901249885559,1,0.004014259193763171,0.9959857408062367,1
3609,右腋窩神経の障害による三角筋麻痺と考えられた。,右 腋窩神経 障害 三角 筋麻痺 考える られる た,1,0.009274680854602143,0.9907253191453979,1,0.00038304398239097116,0.999616956017609,1,0.028084732618879116,0.9719152673811209,1,0.052466050878597126,0.9475339491214029,1,0.08471091836690903,0.9344287514686584,1,0.19121970236301422,0.8586832284927368,1,0.004788374785519041,0.995211625214481,1
3610,顔面麻痺、ベル麻痺のための治療処置が施された。,顔面麻痺 ベル麻痺 ため 治療 処置 施す れる た,1,0.06840321324181214,0.931596786758188,1,0.0002668175809894112,0.9997331824190105,1,0.07574287692649184,0.9242571230735082,1,0.20175444113702157,0.7982455588629784,1,0.11113810539245605,0.9196867346763611,1,0.19929218292236328,0.8644025325775146,1,0.008315165930825296,0.9916848340691746,1
3611,帰宅後、不眠、活動性の亢進、性的逸脱を認めた。,帰宅 後 不眠 活動性 亢進 性的逸脱 認める た,1,0.01667598398467626,0.9833240160153237,1,0.0003493379810900245,0.99965066201891,1,0.06860752577251616,0.9313924742274838,1,0.018085564075913996,0.981914435924086,1,0.0811188742518425,0.9446279406547546,1,0.18952764570713043,0.8692441582679749,1,0.004793026140818471,0.9952069738591814,1
3612,胸部レントゲン検査で両側の間質性肺炎を認めた。,胸部 レントゲン 検査 両側 間質性 肺炎 認める た,1,0.016681426089793096,0.9833185739102069,1,0.00034154600921156714,0.9996584539907885,1,0.01702246173145261,0.9829775382685474,1,0.0007498169910933328,0.9992501830089067,1,0.0777406245470047,0.9429393410682678,1,0.1960468888282776,0.8619304299354553,1,0.0042292526617927935,0.9957707473382073,1
3613,後遺症として自制内の頚部・肩の痛みなどが残る。,後遺症 する 自制 内 頚部 肩 痛み 残る,1,0.006096636896879026,0.9939033631031209,1,0.0004305445162171051,0.9995694554837828,1,0.186149194161092,0.813850805838908,1,1.680288352901016e-09,0.9999999983197116,1,0.11036968231201172,0.9379187226295471,1,0.25381526350975037,0.8101018071174622,1,0.0067029447128736765,0.9932970552871264,1
3614,手のしびれもあったことで過換気症候群を疑った。,手のしびれ ある た こと だ 過換気 症候群 疑う た,1,0.016692628609046533,0.9833073713909534,1,0.000321561809854261,0.9996784381901458,1,0.1347451319832853,0.8652548680167147,1,4.039428789237576e-07,0.9999995960571211,1,0.08273760974407196,0.9391616582870483,1,0.2054223269224167,0.8424714803695679,1,0.005541386458882929,0.9944586135411171,1
3615,心エコーで下壁周りの壁運動がやや低下していた。,心 エコー 壁 周り 壁 運動 低下 する いる た,1,0.016690419353746957,0.9833095806462533,1,0.00019110572895429496,0.9998088942710457,1,0.18364624061488943,0.8163537593851106,0,0.5581384205756561,0.44186157942434384,1,0.12938693165779114,0.9148746132850647,1,0.2240535467863083,0.8458644151687622,1,0.020036373125546993,0.979963626874453,1
3616,心電図ではV1-V6において高いT波を示した。,心電図 V 0 V 0 高い T 波 示す た,1,0.021609534581264148,0.978390465418736,1,0.0004205426739087791,0.9995794573260912,1,0.22056915311123537,0.7794308468887646,1,0.04487000090609716,0.9551299990939028,1,0.08429014682769775,0.9423784613609314,1,0.19560649991035461,0.862579345703125,1,0.0070327302713139245,0.9929672697286861,1
3617,心電図のV2-V5でST上昇を認め、当院紹介。,心電図 V 0 V 0 ST 上昇 認める 院 紹介,1,3.2224095746453175e-07,0.9999996777590425,1,0.0006553610304891749,0.9993446389695109,1,0.0086468499271517,0.9913531500728483,1,8.593792344413487e-12,0.9999999999914062,1,0.08858919888734818,0.9417304396629333,1,0.19917836785316467,0.8679619431495667,1,0.004056703003401821,0.9959432969965981,1
3618,接種後の状態観察中に、全身のふるえが出現した。,接種 後 状態 観察 中 全身 ふるえ 出現 する た,1,0.016678444405730276,0.9833215555942697,1,0.00024521839498998604,0.99975478160501,1,0.04141400187313449,0.9585859981268655,1,0.08227623403712536,0.9177237659628746,1,0.09030015021562576,0.9474362134933472,1,0.1855812668800354,0.8593542575836182,1,0.005221781149779989,0.99477821885022,1
3619,遅れて定型的皮疹も出現し、Day8に当科入院。,遅れる 定型的皮疹 出現 Day 0 科 入院,1,8.012063307884165e-06,0.9999919879366922,1,0.0003728584204002487,0.9996271415795998,1,0.010874999274361863,0.9891250007256381,1,2.632116746781321e-12,0.9999999999973679,1,0.08304930478334427,0.9467930197715759,1,0.19021174311637878,0.861711323261261,1,0.00401885393880778,0.9959811460611923,1
3620,頭痛、めまい、高血圧に対する追加治療を行った。,頭痛 めまい 高血圧 追加 治療 行う た,1,0.25202412566351395,0.747975874336486,1,0.00023113653977683313,0.9997688634602232,1,0.23498364417472684,0.7650163558252732,1,0.23447693921440238,0.7655230607855976,1,0.12478472292423248,0.915070116519928,1,0.2079804390668869,0.8589673638343811,1,0.01802439005466258,0.9819756099453375,1
3621,日付不明食欲低下で数口の固形物と水分摂取のみ。,日付 不明 食欲低下 数口 固形物 水分摂取,1,0.01666712206725479,0.9833328779327453,1,0.0002376766990241001,0.9997623233009759,1,0.4960993896082022,0.5039006103917978,1,0.0032701630994189657,0.996729836900581,1,0.19986560940742493,0.8910489082336426,1,0.21496953070163727,0.8528127074241638,1,0.01343351820266381,0.9865664817973363,1
3622,入院中に体重が通常よりも6.6 kg増加した。,入院 中 体重 通常 0 0 kg 増加 する た,1,0.011860455511174277,0.9881395444888257,1,0.00035100909751874086,0.9996489909024813,1,0.033576165049550966,0.966423834950449,1,0.22003923502980127,0.7799607649701987,1,0.09163957834243774,0.9460030198097229,1,0.20966777205467224,0.8598004579544067,1,0.006875836418948866,0.9931241635810512,1
3623,頻呼吸、咽頭の狭窄感を認め、気道狭窄音を聴取。,頻呼吸 咽頭 狭窄感 認める 気道狭窄音 聴取,1,0.016678857998936113,0.9833211420010638,1,0.00031666169073074613,0.9996833383092693,1,0.06247122371881342,0.9375287762811866,1,0.000997248014963481,0.9990027519850365,1,0.08933465927839279,0.938888669013977,1,0.20545952022075653,0.8579859733581543,1,0.004767508728894618,0.9952324912711054,1
3624,両側肺野の湿潤影と皮膚筋炎特異的皮疹を認めた。,両側肺 野 湿潤影 皮膚筋炎 特異的 皮疹 認める た,1,0.01667464375580226,0.9833253562441978,1,0.0003490306260811807,0.9996509693739188,1,0.037163716343586284,0.9628362836564137,1,0.013777134287023873,0.9862228657129761,1,0.07948515564203262,0.9469955563545227,1,0.1887466311454773,0.8688856363296509,1,0.004444115684209852,0.9955558843157901,1
3625,2021/08下旬、患者は乾性咳嗽を発現した。,0 0 下旬 患者 乾性咳嗽 発現 する た,1,0.01540231890265017,0.98459768109735,1,0.00035232338886239035,0.9996476766111376,1,0.01278141127084409,0.9872185887291559,1,0.030145680055786217,0.9698543199442138,1,0.07782851904630661,0.9495424032211304,1,0.18480022251605988,0.8731991648674011,1,0.00430892170272809,0.9956910782972719,1
3626,2021/08/29、夜に息苦しさが出現した。,0 0 0 夜 息苦しさ 出現 する た,1,4.0378992835671114e-07,0.9999995962100716,1,0.0004596190458492123,0.9995403809541508,1,0.02109690637277717,0.9789030936272228,1,0.052347901427827415,0.9476520985721726,1,0.07597897946834564,0.9515368342399597,1,0.18392784893512726,0.8771998882293701,1,0.0044031586794178275,0.9955968413205821,1
3627,2021/09/06頃、患者は発熱を発現した。,0 0 0 頃 患者 発熱 発現 する た,1,8.868988254063601e-07,0.9999991131011746,1,0.0005441695033422139,0.9994558304966578,1,0.0067898644351902515,0.9932101355648097,1,0.0016950968450994974,0.9983049031549005,1,0.08683126419782639,0.950742781162262,1,0.18224450945854187,0.8729245066642761,1,0.003924705719848936,0.9960752942801511,1
3628,2022/02/01、動悸と息切れを発現した。,0 0 0 動悸 息切れ 発現 する た,1,0.009006354899742164,0.990993645100258,1,0.0003876714765727998,0.9996123285234272,1,0.010189603299610828,0.9898103967003892,1,0.004853519456658906,0.9951464805433411,1,0.07756295055150986,0.9485518932342529,1,0.1806674301624298,0.876312255859375,1,0.003998778796285597,0.9960012212037143,1
3629,2022/02/24、患者は左肩痛を発現した。,0 0 0 患者 左肩痛 発現 する た,1,0.016691719795022025,0.9833082802049781,1,0.00035183667622059987,0.9996481633237794,1,0.014284614282912944,0.9857153857170871,1,0.11350105632173302,0.886498943678267,1,0.0822887048125267,0.9503231644630432,1,0.1903245598077774,0.8641976714134216,1,0.00520845929486285,0.9947915407051372,1
3630,2022/03/04、咽頭痛と咳嗽が発現した。,0 0 0 咽頭痛 咳嗽 発現 する た,1,1.6453777335954597e-05,0.999983546222664,1,0.00048503528705966226,0.9995149647129403,1,0.010189603299610828,0.9898103967003892,1,0.0037195980904154435,0.9962804019095846,1,0.07659546285867691,0.9496757984161377,1,0.17989666759967804,0.875906765460968,1,0.003910121471871156,0.9960898785281288,1
3631,2022/06/18、嘔吐:2回のみ発現した。,0 0 0 嘔吐 0回 発現 する た,1,0.005741045750966326,0.9942589542490337,1,0.0003647684764557592,0.9996352315235443,1,0.004742833822349302,0.9952571661776507,1,0.01375968241221126,0.9862403175877887,1,0.0781681016087532,0.9480896592140198,1,0.18221904337406158,0.8792275190353394,1,0.003998962398162472,0.9960010376018374,1
3632,2022/07/06、発熱と倦怠感が出現した。,0 0 0 発熱 倦怠感 出現 する た,1,3.985133891707294e-08,0.999999960148661,1,0.00057513320442458,0.9994248667955754,1,0.0034860046442192205,0.9965139953557808,1,0.008097612862477233,0.9919023871375228,1,0.07839397341012955,0.9518516659736633,1,0.17897929251194,0.8773584365844727,1,0.0038819844712314616,0.9961180155287684,1
3633,3日間継続していた発熱を主訴に前医を受診した。,0 日間 継続 する いる た 発熱 主訴 医 受診 する た,1,0.024410549213682794,0.9755894507863174,1,0.000257862405009517,0.9997421375949905,1,0.07136158288756245,0.9286384171124376,1,0.07810901363885248,0.9218909863611475,1,0.0806388184428215,0.9473502039909363,1,0.18899917602539062,0.8670076131820679,1,0.005505747313674586,0.9944942526863253,1
3634,患者は意識清明で、全方向性に複視が認められた。,患者 意識清明 だ 方向性 複視 認める られる た,1,0.01668738550216082,0.9833126144978391,1,0.00021718451205911921,0.9997828154879409,1,0.09576465970016079,0.9042353402998392,1,0.0951846519263223,0.9048153480736777,1,0.08305931091308594,0.9488571882247925,1,0.20193396508693695,0.8629071116447449,1,0.00599352941035521,0.9940064705896448,1
3635,患者は蘇生したが、患者は低酸素脳症を発現した。,患者 蘇生 する た 患者 低酸素 脳症 発現 する た,1,0.010639037589621396,0.9893609624103783,1,0.0003868870107388316,0.9996131129892611,1,0.08323470144765954,0.9167652985523405,1,0.0014809424036859031,0.9985190575963141,1,0.08724834024906158,0.947306215763092,1,0.1923644244670868,0.8590676188468933,1,0.004795463406983114,0.9952045365930168,1
3636,患者は頭痛、視力障害、視力低下のため入院した。,患者 頭痛 視力障害 視力低下 ため 入院 する た,1,1.3424849358381295e-05,0.9999865751506417,1,0.00042568569386005305,0.99957431430614,1,0.011646039161320343,0.9883539608386797,1,0.08887693767868854,0.9111230623213115,1,0.08087398111820221,0.9448287487030029,1,0.21251988410949707,0.8511242270469666,1,0.004963664699496511,0.9950363353005034,1
3637,造影CT検査では、複数の器官で血栓症を認めた。,造影 CT検査 複数 器官 だ 血栓症 認める た,1,0.025390395753924447,0.9746096042460756,1,0.0003177249620861593,0.9996822750379138,1,0.07196337898955818,0.9280366210104418,1,0.0013566754246761015,0.9986433245753239,1,0.08094216883182526,0.940912127494812,1,0.1951371282339096,0.8717129826545715,1,0.004780160836848266,0.9952198391631517,1
3638,注記:進行したS状結腸癌を示唆する所見を認めた,注記 進行 する た S 状結腸癌 示唆 する 所見 認める た,1,0.016245709620046025,0.983754290379954,1,0.0003903351654225556,0.9996096648345775,1,0.08986954476345299,0.910130455236547,1,0.0013810521216942595,0.9986189478783057,1,0.07969768345355988,0.9478713274002075,1,0.1947961300611496,0.8646148443222046,1,0.004858191132209713,0.9951418088677901,1
3639,両下肢の脱力と両下肢の圧痛、体動困難となった。,下肢 脱力 下肢 圧痛 体動困難 なる た,1,0.016697189691765393,0.9833028103082347,1,0.000324454813656713,0.9996755451863433,1,0.23002115774778586,0.7699788422522141,1,0.02535624449535423,0.9746437555046458,1,0.07827533781528473,0.9446417093276978,1,0.19977478682994843,0.8686671853065491,1,0.006756568246410528,0.9932434317535895,1
3640,失神寸前の状態、喘鳴のため治療処置が施された。,失神 寸前 状態 喘鳴 ため 治療 処置 施す れる た,1,0.016697334664536042,0.9833026653354638,1,0.0003907979150596137,0.9996092020849404,1,0.0645384788976574,0.9354615211023426,1,0.17678582794586362,0.8232141720541364,1,0.0775502473115921,0.9453227519989014,1,0.18547722697257996,0.86112380027771,1,0.006518350752448557,0.9934816492475516,1
3641,3日間良くならないので病院に行き脳梗塞と判明。,0 日間 良い なる ない 病院 行く 脳梗塞 判明,0,0.7764526650889517,0.22354733491104817,0,0.00013715424685963075,0.9998628457531403,0,0.7011945649078982,0.2988054350921018,1,0.0,1.0,1,0.4185861647129059,0.7148796916007996,1,0.1932508945465088,0.8516741394996643,1,0.11929240523109726,0.8807075947689027,1
3642,下肢感覚障害が残存しているが、原因不詳である。,下肢感覚障害 残存 する いる 原因不詳 だ ある,1,0.01668565232878987,0.9833143476712102,1,0.00021781693117409374,0.9997821830688259,0,0.6887524075421143,0.31124759245788575,0,0.5182897563208239,0.48171024367917614,1,0.3971794545650482,0.7792834043502808,1,0.3033532202243805,0.8269003629684448,1,0.07887293679973285,0.9211270632002672,1
3643,血中亜鉛: (2021/12/07)軽度低値。,血 中 亜鉛 0 0 0 軽度 値,1,0.005228503221685093,0.9947714967783147,1,0.00034755778334626586,0.9996524422166537,1,0.10222192715997791,0.8977780728400221,1,0.00011140988420010878,0.9998885901157999,1,0.14800462126731873,0.9118594527244568,1,0.26607203483581543,0.8303619027137756,1,0.005986011771807095,0.994013988228193,1
3644, 2回目の時は、腕がしびれて肩までしびれた。,0回目 時 腕 しびれ 肩 しびれ た,1,0.016703990400237196,0.9832960095997627,1,0.000278777216953181,0.9997212227830469,0,0.5218521227805466,0.4781478772194534,1,5.4078121314304894e-06,0.9999945921878686,1,0.07926184684038162,0.945605993270874,1,0.19376729428768158,0.8626034259796143,1,0.01145849014716789,0.9885415098528321,1
3645,06:43、接触時いびき様呼吸が認められた。,0 0 接触 時 いびき 様 呼吸 認める られる た,1,0.016684240282550132,0.9833157597174497,1,0.0002742942274764375,0.9997257057725235,1,0.06369322342582306,0.9363067765741769,1,0.09840601769126356,0.9015939823087364,1,0.07596433162689209,0.9473415613174438,1,0.18913447856903076,0.8621517419815063,1,0.005561673985372851,0.994438326014627,1
3646,08:55本剤によるアナフィラキシーと診断。,0 0本 剤 アナフィラキシー 診断,1,0.027505810632988875,0.972494189367011,1,0.0002928098897896881,0.9997071901102104,1,0.06260030355645518,0.9373996964435448,1,6.885733506711844e-07,0.9999993114266493,1,0.1398191750049591,0.9234098792076111,1,0.19713108241558075,0.8646038770675659,1,0.005115943962239588,0.9948840560377604,1
3647,13:00救急受診し、頻脈性心房細動の診断。,0 0 救急 受診 する 頻脈性 心房細動 の 診断,1,5.110930214848807e-06,0.9999948890697852,1,0.000505297900230718,0.9994947020997693,1,0.022489305956852723,0.9775106940431473,1,4.081222704233056e-08,0.999999959187773,1,0.09731317311525345,0.9382132887840271,1,0.19241394102573395,0.8745926022529602,1,0.004164112661915493,0.9958358873380845,1
3648,13:19経過観察中に椅子にて嘔気訴えあり。,0 0 経過 観察 中 椅子 嘔気 訴える ある,1,0.016681867136795675,0.9833181328632045,1,0.00028885942067580407,0.9997111405793242,1,0.04327869868011358,0.9567213013198864,1,1.862839563604446e-06,0.9999981371604364,1,0.08819729089736938,0.9460434317588806,1,0.19483840465545654,0.8504372835159302,1,0.004527973910998978,0.995472026089001,1
3649,15分間の待機時間を過ぎても脱力感を訴える。,0分 間 待機時間 過ぎる 脱力感 訴える,1,0.01668388076374357,0.9833161192362564,1,0.0003563775380204396,0.9996436224619796,1,0.12753012654101137,0.8724698734589886,1,8.386380478953015e-11,0.9999999999161362,1,0.10005365312099457,0.9438943266868591,1,0.20364439487457275,0.8463287949562073,1,0.005500589135820263,0.9944994108641798,1
3650,18:59顔面皮疹を認め、ビラノア1錠内服。,0 0 顔面皮疹 認める ビラ ノア 0 錠 内服,1,0.016667259092463145,0.9833327409075368,1,0.0002480589785599496,0.99975194102144,1,0.032176286084571126,0.9678237139154289,1,0.0005158434596129746,0.999484156540387,1,0.08802977949380875,0.9374295473098755,1,0.22284749150276184,0.8541357517242432,1,0.004579966389699323,0.9954200336103006,1
3651,19:00頃脳梗塞、右内頚動脈狭窄症が発現。,0 0 頃 脳梗塞 右内頚動脈狭窄症 発現,1,0.010908772921393979,0.9890912270786059,1,0.00037443292228098,0.999625567077719,1,0.006430581757262188,0.9935694182427378,1,6.483702463810914e-14,0.9999999999999352,1,0.08565809577703476,0.94398432970047,1,0.18169763684272766,0.8723167777061462,1,0.0040157080648268425,0.9959842919351731,1
3652,2021/06/30頃、乾癬の悪化を認めた。,0 0 0 頃 乾癬 の 悪化 認める た,1,1.0699876468526229e-05,0.9999893001235314,1,0.00048228400712047465,0.9995177159928795,1,0.013260904486368963,0.986739095513631,1,0.03698484377684841,0.9630151562231516,1,0.08265119791030884,0.9482263922691345,1,0.18510892987251282,0.8703625202178955,1,0.004280689440068974,0.9957193105599311,1
3653,2021/07/15、両足首に紫斑を認めた。,0 0 0 足首 紫斑 認める た,1,0.009135354373480682,0.9908646456265194,1,0.0003782365876347205,0.9996217634123653,1,0.027668999526336058,0.9723310004736639,1,9.989613410477105e-05,0.9999001038658952,1,0.07600844651460648,0.9479799270629883,1,0.18711933493614197,0.8741717338562012,1,0.004133622673097634,0.9958663773269023,1
3654,2021/08/31微熱、頭の鈍痛を認めた。,0 0 0 微熱 頭 鈍痛 認める た,1,1.0854374733907033e-05,0.9999891456252661,1,0.0004508338592202826,0.9995491661407797,1,0.027668999526336058,0.9723310004736639,1,0.000149418225543263,0.9998505817744567,1,0.08121044188737869,0.9485617876052856,1,0.18294775485992432,0.8764303922653198,1,0.004052850344861299,0.9959471496551386,1
3655,2021/09/30朝、起床後に動悸を自覚。,0 0 0 朝 起床 後 動悸 自覚,1,0.016696199055941132,0.9833038009440589,1,0.00046185731346193445,0.9995381426865381,1,0.04983575894163639,0.9501642410583636,1,5.773159728050814e-15,0.9999999999999942,1,0.09360288828611374,0.938228189945221,1,0.1956029236316681,0.8590212464332581,1,0.0046139056117378875,0.9953860943882622,1
3656,2021/10/15、右眼瞼下垂が出現した。,0 0 0 右眼瞼下垂 出現 する た,1,0.010692222233139053,0.9893077777668611,1,0.00038641085404384135,0.9996135891459561,1,0.025519463631970773,0.9744805363680292,1,0.012062355862181184,0.9879376441378188,1,0.0767885074019432,0.9487861394882202,1,0.19011400640010834,0.8761624693870544,1,0.004232482179352126,0.9957675178206479,1
3657,2021/11/07、排尿がしづらくなった。,0 0 0 排尿 する づらい なる た,1,0.01669341368302966,0.9833065863169701,1,0.000313754046508699,0.9996862459534913,1,0.22623601488086664,0.7737639851191334,0,0.5647986536960505,0.4352013463039494,1,0.16105428338050842,0.848385214805603,1,0.20495952665805817,0.865617573261261,1,0.02338711066445716,0.9766128893355429,1
3658,2022/02/15視神経脊髄炎再燃が発現。,0 0 0 視神経脊髄炎再燃 発現,1,0.014016702217813681,0.9859832977821862,1,0.0003888843088914712,0.9996111156911085,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.09780927002429962,0.942775309085846,1,0.1846015751361847,0.8731443881988525,1,0.0041316302476383,0.9958683697523616,1
3659,2022/02/19 10:00紅斑が発現。,0 0 0 0 0 紅斑 発現,1,0.006823499949137694,0.9931765000508622,1,0.00044222089084905187,0.999557779109151,1,0.00987732563689947,0.9901226743631005,1,8.950395979923087e-12,0.9999999999910496,1,0.09122994542121887,0.9478356242179871,1,0.18689218163490295,0.8728433847427368,1,0.004036748623400507,0.9959632513765996,1
3660,2022/03/12、全身に湿疹が出現した。,0 0 0 全身 湿疹 出現 する た,1,0.013699045406999484,0.9863009545930008,1,0.00037426907708201757,0.999625730922918,1,0.02109690637277717,0.9789030936272228,1,0.019764244178744228,0.9802357558212558,1,0.07691718637943268,0.9502643942832947,1,0.18024781346321106,0.8767522573471069,1,0.004235612514353241,0.9957643874856468,1
3661,2022/03/13 00:00発熱が発現。,0 0 0 0 0 発 熱 発現,1,5.504732483198387e-07,0.9999994495267517,1,0.0004113755714359992,0.999588624428564,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08198396861553192,0.9467246532440186,1,0.18124161660671234,0.8714537620544434,1,0.003933147710294257,0.9960668522897057,1
3662,2022/03/24、朝方より発熱があった。,0 0 0 朝方 発熱 ある た,1,0.013749486541992956,0.9862505134580071,1,0.0003463228552338767,0.9996536771447662,1,0.016326799253838953,0.983673200746161,1,0.00411363147990329,0.9958863685200967,1,0.07529500126838684,0.9493628144264221,1,0.1815756857395172,0.872020959854126,1,0.0040886613947893535,0.9959113386052105,1
3663,2022/03/29発熱、肉眼的血尿を自覚。,0 0 0 発 熱 肉眼的血尿 自覚,1,7.858150441147878e-07,0.9999992141849559,1,0.00042281015259019273,0.9995771898474098,1,0.04983575894163639,0.9501642410583636,1,4.565237077258644e-13,0.9999999999995435,1,0.08425382524728775,0.9458949565887451,1,0.1859368085861206,0.8692141771316528,1,0.004301846558768114,0.9956981534412318,1
3664,2022/04/07午前、ぶどう膜炎が発現。,0 0 0 午前 ぶどう膜炎 発現,1,0.014577496234490029,0.9854225037655101,1,0.00038773871488904726,0.9996122612851109,1,0.00987732563689947,0.9901226743631005,1,3.5340610404777095e-07,0.999999646593896,1,0.08796340972185135,0.9463453888893127,1,0.19299018383026123,0.8650873303413391,1,0.004148739742626139,0.995851260257374,1
3665,2022/04/12、肝機能異常を発現した。,0 0 0 肝機能異常 発現 する た,1,0.01507477986620642,0.9849252201337937,1,0.000349020890366001,0.999650979109634,1,0.01317415815663825,0.9868258418433618,1,0.013077936392171696,0.9869220636078283,1,0.08073513209819794,0.9468990564346313,1,0.18422606587409973,0.8769273161888123,1,0.004170611061581995,0.9958293889384179,1
3666,2022/04/18後遺症として右聾が残る。,0 0 0 後遺症 右 聾 残る,1,0.004523333402256788,0.9954766665977434,1,0.0004636370782640303,0.999536362921736,1,0.13617054063529066,0.8638294593647093,1,2.4202861936828413e-14,0.9999999999999758,1,0.1175282746553421,0.915514349937439,1,0.2140052169561386,0.8629429340362549,1,0.005682819388568821,0.9943171806114312,1
3667,2022/07/06 78日間の入院経過中。,0 0 0 0 日間 入院 経過 中,1,0.016697847993724597,0.9833021520062754,1,0.000228777063164249,0.9997712229368357,1,0.12538617262650187,0.8746138273734981,1,0.0013197105432434242,0.9986802894567566,1,0.2715182602405548,0.8665182590484619,1,0.31282439827919006,0.782313883304596,1,0.008349041332619784,0.9916509586673803,1
3668,2022年4月18日、発熱、頭痛が発現した。,0 年 0 月 0 日 発熱 頭痛 発現 する た,1,2.2579869377499555e-06,0.9999977420130621,1,0.0005523721219127563,0.9994476278780873,1,0.002253139355818501,0.9977468606441815,1,0.01919359991133318,0.9808064000886668,1,0.07766559720039368,0.9498484134674072,1,0.18366187810897827,0.8777221441268921,1,0.003980972030539799,0.9960190279694603,1
3669,これら所見は微小変化群(MCD)と一致した。,これら 所見 微小変化群 MCD 一致 する た,1,0.0706025310831183,0.9293974689168817,1,0.00020785524807703183,0.999792144751923,0,0.6799152128484656,0.32008478715153443,0,0.5732927190884303,0.4267072809115698,1,0.11660733073949814,0.9267092943191528,1,0.2842732071876526,0.8302890062332153,1,0.06249818801356894,0.9375018119864311,1
3670,はじめは腹痛が起こり、徐々に呼吸苦が生じた。,はじめ 腹痛 起る こり 呼吸苦 生じる た,1,0.016702900096660655,0.9832970999033395,1,0.0003130971575266695,0.9996869028424733,1,0.4222685474776221,0.5777314525223779,1,0.00030679662867261204,0.9996932033713274,1,0.08598185330629349,0.9398656487464905,1,0.1869812160730362,0.8707393407821655,1,0.00939201298364379,0.9906079870163563,1
3671,右視神経乳頭浮腫、網膜中心静脈閉塞を認めた。,右視神経乳頭浮腫 網膜中心静脈閉塞 認める た,1,0.025908823682137164,0.9740911763178628,1,0.0002760955436683236,0.9997239044563316,1,0.03612019239178477,0.9638798076082152,1,0.000510610163538816,0.9994893898364612,1,0.07485421001911163,0.9450139403343201,1,0.20168998837471008,0.8713191151618958,1,0.004433346261834216,0.9955666537381659,1
3672,患者は2時間後に嘔吐し、経過観察されていた。,患者 0時 間 後 嘔吐 経過 観察 する れる いる た,1,0.016719026614316082,0.9832809733856838,1,0.00016587543255309586,0.9998341245674469,1,0.35101746907399645,0.6489825309260036,0,0.7006003974767749,0.2993996025232251,1,0.1616986244916916,0.9106236100196838,0,0.7897722721099854,0.2166670709848404,1,0.11518752808052464,0.8848124719194752,1
3673,帰宅後、興奮、脱衣を行うなどの行為を認めた。,帰宅 後 興奮 脱衣 行う 行為 認める た,1,0.016691083452021926,0.983308916547978,1,0.0003206811580828298,0.9996793188419172,1,0.06552412469296454,0.9344758753070355,1,0.043515348749043836,0.9564846512509562,1,0.08643528074026108,0.9430890083312988,1,0.19135454297065735,0.8465659022331238,1,0.005169673767515359,0.9948303262324847,1
3674,蛍光眼底造影検査では両乳頭より漏出を認めた。,蛍光 眼底 造影 検査 乳頭 漏出 認める た,1,0.016687315364765073,0.9833126846352351,1,0.00034356087137311735,0.9996564391286269,1,0.041813508989882786,0.9581864910101172,1,0.0025078415026895673,0.9974921584973104,1,0.08763278275728226,0.9441378116607666,1,0.21506930887699127,0.8543005585670471,1,0.0046186116140512655,0.9953813883859487,1
3675,月経困難症にもなったため、婦人科も受診した。,月経困難症 なる た ため 婦人科 受診 する た,1,0.01668249811509607,0.9833175018849039,1,0.0003538325743586038,0.9996461674256414,1,0.05985697385943034,0.9401430261405697,1,0.008649476990469362,0.9913505230095306,1,0.08777046948671341,0.9384703040122986,1,0.21484041213989258,0.8505299687385559,1,0.004891738241740374,0.9951082617582597,1
3676,呼吸困難、咽頭のかゆみを訴え、救護所に入室。,呼吸困難 咽頭 かゆみ 訴える 救護 所 入室,1,0.01668579726657764,0.9833142027334223,1,0.00036206656081907865,0.999637933439181,1,0.12753012654101137,0.8724698734589886,1,2.460526449254985e-09,0.9999999975394736,1,0.09703376889228821,0.9451082348823547,1,0.18430280685424805,0.8557673692703247,1,0.005322989222203344,0.9946770107777967,1
3677,左肩関節周囲炎に対して血管塞栓治療を行った。,左肩関節 周囲炎 血管塞栓 治療 行う た,1,0.016691750164704262,0.9833082498352957,1,0.0002806340870423913,0.9997193659129576,1,0.4148259742226219,0.5851740257773781,1,0.2025788215161829,0.7974211784838171,1,0.1991237848997116,0.8600755929946899,1,0.23278924822807312,0.8480098247528076,1,0.017855654981991567,0.9821443450180085,1
3678,左方視以外での複視、左眼瞼下垂が確認された。,左方視 以外 複視 左眼瞼 下垂 確認 する れる た,1,0.0166797021749529,0.9833202978250473,1,0.000263230129557088,0.9997367698704429,1,0.462213568166863,0.537786431833137,1,0.24787399401143084,0.7521260059885692,1,0.07993095368146896,0.9448394775390625,1,0.20455898344516754,0.8648402690887451,1,0.016772022863381402,0.9832279771366186,1
3679,持続する胸痛のため、当クリニックを受診した。,持続 する 胸痛 ため クリニック 受診 する た,1,0.016689301093391548,0.9833106989066083,1,0.0003978340596098687,0.9996021659403901,1,0.026651471381605507,0.9733485286183945,1,0.18742821842314983,0.8125717815768502,1,0.08106818050146103,0.9436517357826233,1,0.19910794496536255,0.858192503452301,1,0.006309718765791418,0.9936902812342087,1
3680,上腹部、胃周囲に波打つような腫脹が見られた。,上 腹部 胃 周囲 波打つ よう 腫脹 見る られる た,1,0.01667407458384374,0.9833259254161563,1,0.0002893420600811832,0.9997106579399189,1,0.23162025766721406,0.7683797423327859,1,0.05915450482092954,0.9408454951790705,1,0.07644034177064896,0.9482210278511047,1,0.18497776985168457,0.8578639626502991,1,0.0071804239772523485,0.9928195760227477,1
3681,心電図検査でST上昇または陰性T波を認めた。,心電図 検査 ST 上昇 陰性 T 波 認める た,1,0.05237477132728375,0.9476252286727165,1,0.0003144320490352272,0.9996855679509647,1,0.039785282997333415,0.9602147170026666,1,0.004662872646104099,0.9953371273538959,1,0.08618054538965225,0.9442538022994995,1,0.19139012694358826,0.8573376536369324,1,0.0048219365144565145,0.9951780634855435,1
3682,数時間後より息苦しさ、味覚・嗅覚障害が出現。,数時間 後 息苦しさ 味覚 嗅覚障害 出現,1,0.016706202474930428,0.9832937975250695,1,0.0003448181576379756,0.999655181842362,1,0.03401654200974713,0.9659834579902529,1,0.0017848288392561251,0.9982151711607439,1,0.0878831297159195,0.9432041645050049,1,0.20113617181777954,0.8710323572158813,1,0.004409773451408818,0.9955902265485913,1
3683,切迫早産の結果として治療的な処置がとられた。,切迫早産 結果 治療 的 だ 処置 とる れる た,1,0.02128487108481428,0.9787151289151856,1,0.00032709879390586553,0.9996729012060941,1,0.13287482231623438,0.8671251776837656,1,0.05592085794261281,0.9440791420573872,1,0.0935293436050415,0.9324613809585571,1,0.2530060410499573,0.8185972571372986,1,0.006802036482325314,0.9931979635176746,1
3684,接種後、腹痛、倦怠感、反応性の低下を認めた。,接種 後 腹痛 倦怠感 反応 性 低下 認める た,1,3.5435226981432197e-06,0.9999964564773018,1,0.0005939887908576821,0.9994060112091423,1,0.002265602633428121,0.9977343973665719,1,0.024871726308027364,0.9751282736919726,1,0.0828365609049797,0.9491356611251831,1,0.1841409057378769,0.8668424487113953,1,0.004096444899921248,0.9959035551000788,1
3685,多発性硬化症、脳症のため治療処置が施された。,多発性 硬化症 脳症 ため 治療 処置 施す れる た,1,0.016672801864357472,0.9833271981356425,1,0.00032598946208502335,0.9996740105379149,1,0.07574287692649184,0.9242571230735082,1,0.1870085154045228,0.8129914845954772,1,0.10907267779111862,0.9279765486717224,1,0.20081967115402222,0.8665295839309692,1,0.007209547582234062,0.992790452417766,1
3686,体温:摂氏37.4度(高温)摂氏37.4度。,体温 摂氏 0 0度 高温 摂氏 0 0度,1,0.01670656268697684,0.983293437313023,1,0.00029596741751849244,0.9997040325824815,1,0.3607204586964663,0.6392795413035337,0,0.5460127118007186,0.45398728819928136,1,0.1575293242931366,0.9028555750846863,1,0.3470163643360138,0.799197256565094,1,0.03389399376704865,0.9661060062329514,1
3687,超音波スキャン:右葉の腫脹及び低エコー病変。,超音波 スキャン 右 葉 腫脹 エコー 病変,1,0.016698511000992056,0.983301488999008,1,0.0003005113193586349,0.9996994886806414,1,0.16970356572488454,0.8302964342751155,1,2.1169799246933962e-10,0.999999999788302,1,0.08702374994754791,0.9368999004364014,1,0.24871203303337097,0.8398109674453735,1,0.006258292677653486,0.9937417073223466,1
3688,当院でECGにてV3-6に陰性T波を認めた。,院 ECG V 0 0 陰性 T 波 認める た,1,0.08978323004348837,0.9102167699565116,1,0.0002802552969572828,0.9997197447030427,1,0.0738302190678174,0.9261697809321826,1,0.00269849624052354,0.9973015037594765,1,0.0811961218714714,0.9441981911659241,1,0.19855724275112152,0.8607606291770935,1,0.005530005840217939,0.9944699941597821,1
3689,入院後、左上肢に痙攣、Todd麻痺を認めた。,入院 後 左上 肢 痙攣 Todd 麻痺 認める た,1,0.005286241387426672,0.9947137586125733,1,0.0004817584575111039,0.9995182415424889,1,0.011758096173836718,0.9882419038261633,1,0.0205926195815882,0.9794073804184118,1,0.07255004346370697,0.9482867121696472,1,0.18837016820907593,0.8627959489822388,1,0.004177213087463221,0.9958227869125367,1
3690,微熱、咳嗽が継続したため、近医にて入院加療。,微熱 咳嗽 継続 する た ため 近医 入院 加療,1,2.7689774930747524e-06,0.9999972310225069,1,0.0004118272760482875,0.9995881727239517,1,0.03108212834251456,0.9689178716574854,1,0.0,1.0,1,0.09528277069330215,0.9396557211875916,1,0.20072133839130402,0.857488214969635,1,0.004328715253698882,0.9956712847463011,1
3691,橈骨神経麻痺の結果として治療処置がとられた。,橈骨神経麻痺 結果 治療 処置 とる れる た,1,0.015955431045314068,0.984044568954686,1,0.00037162426109716085,0.9996283757389028,1,0.021486218659389933,0.9785137813406101,1,0.04310287951201741,0.9568971204879826,1,0.09672077000141144,0.9285961389541626,1,0.20366939902305603,0.8530227541923523,1,0.004871856612409267,0.9951281433875907,1
3692,頸部、腋窩、鼠径部にリンパ節症が認められた。,頸部 腋窩 鼠径部 リンパ節症 認める られる た,1,0.016261115996016776,0.9837388840039831,1,0.0003723447709009761,0.999627655229099,1,0.0608646310211608,0.9391353689788392,1,0.03607754983282274,0.9639224501671773,1,0.08359992504119873,0.9456923604011536,1,0.18692471086978912,0.8571836948394775,1,0.0049411679334323754,0.9950588320665676,1
3693,2022/03/21、患者は発熱を発症した。,0 0 0 患者 発熱 発症 する た,1,3.5470293966489043e-06,0.9999964529706035,1,0.00047294805626550587,0.9995270519437345,1,0.02004425869533788,0.9799557413046621,1,6.281632829008288e-05,0.9999371836717099,1,0.07748501002788544,0.9486440420150757,1,0.17911720275878906,0.873053789138794,1,0.00397428396945727,0.9960257160305428,1
3694,2022/06/03、患者は腹痛を発現した。,0 0 0 患者 腹痛 発現 する た,1,0.016679949854453827,0.983320050145546,1,0.0003935991479965196,0.9996064008520035,1,0.023394727173343233,0.9766052728266568,1,0.003086490295411415,0.9969135097045886,1,0.07967501878738403,0.9499621987342834,1,0.18273676931858063,0.875989556312561,1,0.004166804085346758,0.9958331959146531,1
3695,2021/08/12、患者は胸水を発症した。,0 0 0 患者 胸水 発症 する た,1,0.015993077018887532,0.9840069229811123,1,0.00040951501884994217,0.9995904849811501,1,0.10028168765679513,0.8997183123432049,1,0.0007639694003320763,0.9992360305996679,1,0.07800471037626266,0.9475509524345398,1,0.17951267957687378,0.8702667951583862,1,0.004842818262120611,0.9951571817378794,1
3696,2021/06/14、朝より複視が発現した。,0 0 0 朝 複視 発現 する た,1,0.002819370144064827,0.9971806298559351,1,0.00045940239311352766,0.9995405976068865,1,0.012385251018906751,0.9876147489810932,1,0.0134729665247878,0.9865270334752122,1,0.07999680191278458,0.9483993053436279,1,0.18476220965385437,0.8744705319404602,1,0.004070799127648871,0.9959292008723513,1
3697,2021/07下旬、眼瞼下垂症が指摘された。,0 0 下旬 眼瞼下垂症 指摘 する れる た,1,0.016677901186568103,0.9833220988134319,1,0.00033791878702170257,0.9996620812129783,1,0.20730589853996118,0.7926941014600388,1,0.2470180833789798,0.7529819166210202,1,0.07828784734010696,0.9479530453681946,1,0.18617595732212067,0.8770986199378967,1,0.009776895682445405,0.9902231043175544,1
3698,2021/08/07より胸の痛みが出現した。,0 0 0 胸 痛み 出現 する た,1,1.1733834728034672e-05,0.9999882661652719,1,0.000437956813830688,0.9995620431861693,1,0.014178260379355767,0.9858217396206442,1,0.022545529619579674,0.9774544703804203,1,0.07528501003980637,0.9501697421073914,1,0.17991429567337036,0.8740734457969666,1,0.0040916907602793606,0.9959083092397205,1
3699,2022/07/23、全身性皮疹を発症した。,0 0 0 全身性皮疹 発症 する た,1,0.016682617249344164,0.9833173827506559,1,0.0003546048203982812,0.9996453951796017,1,0.07375158136634685,0.9262484186336531,1,0.004973438947883491,0.9950265610521165,1,0.07607748359441757,0.9500194191932678,1,0.18119408190250397,0.8780543208122253,1,0.0045899862876208454,0.9954100137123792,1
3700,ただし、同側の母指の疼痛を少し自覚していた。,側 母 指 疼痛 自覚 する いる た,1,0.01669081766868622,0.9833091823313139,1,0.00030218463170908916,0.9996978153682909,1,0.06392906682286703,0.936070933177133,0,0.5891832880507092,0.4108167119492908,1,0.08678929507732391,0.9461183547973633,1,0.20706744492053986,0.8545485734939575,1,0.015268164093208938,0.984731835906791,1
3701,硬口蓋に発赤が認められ、触ると痛みがあった。,硬口蓋 発赤 認める られる 触る 痛み ある た,1,1.1707873508844516e-05,0.9999882921264911,1,0.00038184206347298817,0.999618157936527,1,0.01240452132921388,0.9875954786707861,1,0.28735429854048566,0.7126457014595143,1,0.08765696734189987,0.9457061290740967,1,0.20247340202331543,0.8494650721549988,1,0.007356874023465734,0.9926431259765344,1
3702,手指の腫脹のため指輪が食い込んで疼痛がある。,手 指 腫脹 ため 指輪 食い込む 疼痛 ある,1,0.016002297569223535,0.9839977024307764,1,0.00036051941711659073,0.9996394805828834,1,0.1502579092794164,0.8497420907205836,1,2.0498424498582857e-05,0.9999795015755014,1,0.08900844305753708,0.9371758103370667,1,0.22824864089488983,0.8573309779167175,1,0.0058006529106581035,0.9941993470893419,1
3703,心筋炎、胃腸炎、胸痛により、患者は入院した。,心筋炎 胃腸炎 胸痛 患者 入院 する た,1,0.004061916184403249,0.9959380838155967,1,0.0003498686227617248,0.9996501313772382,1,0.02593110133613008,0.9740688986638699,1,0.03458238715845896,0.965417612841541,1,0.08027046918869019,0.9464480876922607,1,0.1915530413389206,0.8599405884742737,1,0.004475219481609517,0.9955247805183906,1
3704,脳静脈還流障害による一過性全健忘と診断した。,脳静脈 還流障害 一過性全健忘 診断 する た,1,0.016691612091915334,0.9833083879080845,1,0.00034988475519645215,0.9996501152448035,1,0.07513980272388376,0.9248601972761162,1,0.1405823708497289,0.8594176291502711,1,0.0797068253159523,0.9450748562812805,1,0.18716321885585785,0.8767610788345337,1,0.006123746943797099,0.993876253056203,1
3705,搬送病院により肺塞栓症の可能性が指摘された。,搬送 病院 よる 肺塞栓症 の 可能性 指摘 する れる た,1,0.013460786158934217,0.9865392138410659,1,0.0003852013729363216,0.9996147986270637,1,0.104044149487307,0.895955850512693,1,0.2662319187648483,0.7337680812351517,1,0.07734589278697968,0.9419263005256653,1,0.18851244449615479,0.8635575771331787,1,0.008397557040216781,0.9916024429597832,1
3706,翌日に、左上腕しびれと左肩甲骨痛が出現した。,翌日 左上腕しびれ 左肩甲骨痛 出現 する た,1,0.0029139918095889596,0.997086008190411,1,0.0003899289136587443,0.9996100710863413,1,0.013510434300608387,0.9864895656993916,1,0.05738381091217082,0.9426161890878292,1,0.08084407448768616,0.9475039839744568,1,0.18790322542190552,0.874891996383667,1,0.00447282443155668,0.9955271755684434,1
3707,脳症、意識変容状態のため治療処置が施された。,脳症 意識変容状態 ため 治療 処置 施す れる た,1,0.0413009225472439,0.9586990774527561,1,0.00029061023380152123,0.9997093897661985,1,0.09252207669350276,0.9074779233064972,1,0.17409922138930056,0.8259007786106994,1,0.08082497864961624,0.9470739364624023,1,0.20757611095905304,0.8511226773262024,1,0.0074403452611230434,0.9925596547388769,1
3708,"呼吸数: 18,注記:単位:呼吸/分,入院時",呼吸 数 0 注記 単位 呼吸 分 入院 時,1,0.0166891851372474,0.9833108148627525,1,0.0003547264445730529,0.999645273555427,1,0.23604899762493714,0.7639510023750629,1,0.07941245091477933,0.9205875490852207,1,0.2074514925479889,0.9062834978103638,0,0.76582270860672,0.23293225467205048,1,0.02928575739298265,0.9707142426070173,1
3709,両側膝窩動脈血栓閉塞+上腸間膜動脈血栓症あり,両側 膝窩動脈血栓 閉塞 上腸間膜動脈 血栓症 ある,1,0.01671493109789949,0.9832850689021002,1,0.0003427727329173197,0.9996572272670827,1,0.2936606467898849,0.7063393532101151,1,3.1055167220017665e-06,0.999996894483278,1,0.08235972374677658,0.9161375761032104,1,0.21238191425800323,0.8514778017997742,1,0.007756550116609237,0.9922434498833907,1
3710,10:20接種後、アナフィラキシーが発現。,0 0 接種 後 アナフィラキシー 発現,1,0.011028444465077083,0.9889715555349229,1,0.0004609922678462836,0.9995390077321538,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.10496356338262558,0.9393606185913086,1,0.1873513162136078,0.8650895357131958,1,0.004196071077448471,0.9958039289225517,1
3711,15:47血圧160から90台へ血圧低下。,0 0 血圧 0 0 台 血圧低下,1,0.01667468582611124,0.9833253141738889,1,0.0002667220924650941,0.9997332779075349,1,0.35873972300322543,0.6412602769967746,1,0.00013011438639287665,0.9998698856136071,1,0.09450658410787582,0.9425501823425293,1,0.194925457239151,0.8649817109107971,1,0.008438492003244131,0.9915615079967558,1
3712,2020年12月14日扁桃周囲膿瘍が発現。,0 年 0 月 0 日 扁桃周囲膿瘍 発現,1,0.015277037764182632,0.9847229622358172,1,0.0003040688750352468,0.9996959311249648,1,0.011635475161891895,0.9883645248381081,1,4.765743355505947e-12,0.9999999999952343,1,0.08253529667854309,0.9476116299629211,1,0.19519926607608795,0.8662576675415039,1,0.004144988875261393,0.9958550111247386,1
3713,2021/10/15心房細動を指摘された。,0 0 0 心房細動 指摘 する れる た,1,0.016710285121927904,0.9832897148780722,1,0.00038553269110881374,0.9996144673088911,1,0.24398833652634944,0.7560116634736506,1,0.21018755836372438,0.7898124416362756,1,0.07913120836019516,0.9446117877960205,1,0.18569140136241913,0.8760157823562622,1,0.009821984656106276,0.9901780153438938,1
3714,2021/10の不明日、被験者は妊娠した。,0 0 明日 被験者 妊娠 する た,0,0.6879493175080141,0.31205068249198575,0,0.00013784501923048666,0.9998621549807695,1,0.3885690005175487,0.6114309994824513,1,0.12134367791210121,0.8786563220878988,1,0.4062080979347229,0.6929075717926025,1,0.3315407633781433,0.769683301448822,1,0.08876225510743078,0.9112377448925693,1
3715,2021/11/14休息中に失神を認めた。,0 0 0 休息 中 失神 認める た,1,0.0025738223063197212,0.9974261776936802,1,0.00038277890723930014,0.9996172210927607,1,0.027668999526336058,0.9723310004736639,1,0.0015183261620724808,0.9984816738379275,1,0.07400500774383545,0.9486634731292725,1,0.18542584776878357,0.8783472776412964,1,0.004056814952903455,0.9959431850470966,1
3716,2021/11/20作業中に失神を認めた。,0 0 0 作業 中 失神 認める た,1,0.0025738223063197212,0.9974261776936802,1,0.00038277890723930014,0.9996172210927607,1,0.027668999526336058,0.9723310004736639,1,0.0022094538446876255,0.9977905461553124,1,0.07437910884618759,0.9482223391532898,1,0.1870935559272766,0.8768314719200134,1,0.004078614255089566,0.9959213857449104,1
3717,2022/03/03急激に呼吸状態が悪化。,0 0 0 急激 呼吸 状態 悪化,1,0.016677134125606997,0.983322865874393,1,0.0004003961937618187,0.9995996038062381,1,0.29507391277636486,0.7049260872236351,1,4.253735141901416e-10,0.9999999995746265,1,0.09617099910974503,0.9457917213439941,1,0.1865750104188919,0.8739878535270691,1,0.007298720901283449,0.9927012790987165,1
3718,2022/03/13右肩甲部の疼痛を自覚。,0 0 0 右肩 甲部 疼痛 自覚,1,0.0152302102230721,0.9847697897769279,1,0.00040913321183798596,0.999590866788162,1,0.040923674412921995,0.959076325587078,1,2.430220469307187e-10,0.999999999756978,1,0.08156775683164597,0.9476622939109802,1,0.18993909657001495,0.8647640347480774,1,0.004373565944422978,0.995626434055577,1
3719,2022/04/01左眼視力低下を認めた。,0 0 0 左眼視力低下 認める た,1,0.011158967306005843,0.9888410326939943,1,0.0003685424859246623,0.9996314575140753,1,0.025944857950418232,0.9740551420495818,1,0.001894535436122724,0.9981054645638773,1,0.07667388767004013,0.9478861093521118,1,0.18922372162342072,0.8739444017410278,1,0.00416361578470472,0.9958363842152953,1
3720,2022/04/07朝、急性心不全が発現。,0 0 0 朝 急性心不全 発現,1,0.00495063803144203,0.995049361968558,1,0.0004266090682421697,0.9995733909317578,1,0.00987732563689947,0.9901226743631005,1,7.327471962526033e-15,0.9999999999999927,1,0.0836557149887085,0.9477232098579407,1,0.18793514370918274,0.8708879947662354,1,0.004003753469808119,0.9959962465301918,1
3721,2022/04/15肩痛/上背部痛を自覚。,0 0 0 肩痛 上背部痛 自覚,1,0.016681069207529414,0.9833189307924706,1,0.00028119518105034326,0.9997188048189497,1,0.04983575894163639,0.9501642410583636,1,2.099875828776021e-12,0.9999999999979001,1,0.08652926236391068,0.9483852386474609,1,0.18377844989299774,0.8713532090187073,1,0.004425949436168784,0.9955740505638312,1
3722,2022/04/26間欠的な発熱を認めた。,0 0 0 間欠的 発熱 認める た,1,1.9280408972219743e-06,0.9999980719591027,1,0.0005427463527798307,0.9994572536472202,1,0.009506383729647072,0.9904936162703529,1,5.6233528206939276e-05,0.9999437664717931,1,0.07773271203041077,0.9498808979988098,1,0.18406248092651367,0.8740744590759277,1,0.0039035971029758604,0.9960964028970242,1
3723,2022/05/06倦怠感、頭重感が出現。,0 0 0 倦怠感 頭重感 出現,1,0.003627212245848192,0.9963727877541518,1,0.0004128449658995663,0.9995871550341004,1,0.007464624059542291,0.9925353759404577,1,0.00017394745904220077,0.9998260525409578,1,0.0920494794845581,0.946876049041748,1,0.1847960650920868,0.8663396835327148,1,0.004017727835782015,0.9959822721642179,1
3724,2022/05/21朝、体調不良を認めた。,0 0 0 朝 体調不良 認める た,1,4.809243031741721e-06,0.9999951907569683,1,0.0004330401946011011,0.9995669598053989,1,0.025944857950418232,0.9740551420495818,1,0.0031742105165561973,0.9968257894834438,1,0.07771774381399155,0.9495371580123901,1,0.18264873325824738,0.8739230036735535,1,0.004054036913255051,0.995945963086745,1
3725,2022/05/22朝、38°C台の発熱。,0 0 0 朝 0 C 台 発熱,1,0.0028247915791186884,0.9971752084208813,1,0.00038823118447240383,0.9996117688155276,1,0.03402325630758096,0.965976743692419,1,0.0,1.0,1,0.087470144033432,0.9497223496437073,1,0.1842270940542221,0.8710375428199768,1,0.0041744474322486114,0.9958255525677514,1
3726,2022/07/07心筋炎、心膜炎が発現。,0 0 0 心筋炎 心膜炎 発現,1,0.0032748400549357333,0.996725159945064,1,0.0004887670192195554,0.9995112329807805,1,0.0033982837012268563,0.9966017162987731,1,0.0,1.0,1,0.08374468237161636,0.944767415523529,1,0.17906053364276886,0.8730689287185669,1,0.003908414760662197,0.9960915852393377,1
3727,39度に発熱時、呼吸困難、頻呼吸があった。,0度 発熱 時 呼吸困難 頻呼吸 ある た,1,0.046975461412336196,0.9530245385876639,1,0.0002579613721650414,0.999742038627835,1,0.03180405140051379,0.9681959485994862,1,0.00821401983983261,0.9917859801601674,1,0.07398296147584915,0.9456138014793396,1,0.1820727288722992,0.8705225586891174,1,0.004561291791360526,0.9954387082086394,1
3728,ぶどう膜炎の結果として治療処置がとられた。,ぶどう膜炎 結果 治療 処置 とる れる た,1,0.015955431045314068,0.984044568954686,1,0.00040179293416552596,0.9995982070658345,1,0.021486218659389933,0.9785137813406101,1,0.03482979719417356,0.9651702028058264,1,0.08796507120132446,0.942937970161438,1,0.21438957750797272,0.8515295386314392,1,0.00474094592818633,0.9952590540718137,1
3729,ループスアンチコアグラント弱陽性を認めた。,ループスアンチコアグラント 弱陽性 認める た,1,0.016687196361911915,0.983312803638088,1,0.0003384074012885911,0.9996615925987115,1,0.03612019239178477,0.9638798076082152,1,0.06266814225408235,0.9373318577459177,1,0.08753859251737595,0.9407867789268494,1,0.20266559720039368,0.8663497567176819,1,0.005039959803908855,0.9949600401960911,1
3730,血液検査でIgA 440への上昇を認めた。,血液検査 IgA 0 上昇 認める た,1,3.260923125559887e-06,0.9999967390768745,1,0.0005873248040429327,0.9994126751959571,1,0.010983784617431769,0.9890162153825682,1,0.0004287931948634416,0.9995712068051366,1,0.08711813390254974,0.9437457919120789,1,0.18871623277664185,0.871017575263977,1,0.004010093069941875,0.9959899069300581,1
3731,血清で、炎症性サイトカインの上昇を認めた。,血清 だ 炎症性 サイトカイン 上昇 認める た,1,0.01668448093786358,0.9833155190621363,1,0.00031943160144686563,0.9996805683985531,1,0.0381758221232994,0.9618241778767006,1,0.006589940848304332,0.9934100591516957,1,0.08789245784282684,0.942992091178894,1,0.19240184128284454,0.8546751141548157,1,0.004523959023819215,0.9954760409761808,1
3732,誇大妄想、多弁、感情の起伏の増大を認めた。,誇大妄想 多弁 感情 起伏 の 増大 認める た,1,0.0166989875662478,0.9833010124337526,1,0.00033247842785693617,0.9996675215721431,1,0.02845802024019195,0.971541979759808,1,0.015745004086920256,0.9842549959130797,1,0.09788213670253754,0.9391312599182129,1,0.18738415837287903,0.8673028945922852,1,0.004502100809547595,0.9954978991904524,1
3733,口唇の腫脹、赤黒い変色、表皮剥離を認めた。,口唇 腫脹 赤黒い 変色 表皮剥離 認める た,1,0.012745587667139286,0.9872544123328606,1,0.00035005541740148224,0.9996499445825985,1,0.033384662606492976,0.966615337393507,1,0.01407027061822641,0.9859297293817736,1,0.08304926753044128,0.9462135434150696,1,0.18695297837257385,0.8669952154159546,1,0.004398404286329364,0.9956015957136706,1
3734,心筋心膜炎の結果、治療的な処置がとられた。,心筋心膜炎 結果 治療 的 だ 処置 とる れる た,1,0.016665184406248795,0.9833348155937514,1,0.0003422993527601227,0.9996577006472399,1,0.12598599578187553,0.8740140042181245,1,0.05918993051889898,0.940810069481101,1,0.0899348109960556,0.9399169087409973,1,0.2022249698638916,0.8556542992591858,1,0.00606555861660393,0.9939344413833962,1
3735,心電図:入院時、びまん性ST上昇を認めた。,心電図 入院 時 びまん性 ST 上昇 認める た,1,1.8865867401946037e-06,0.9999981134132597,1,0.0006225982133104863,0.9993774017866895,1,0.010514903129868025,0.989485096870132,1,0.008659189545325519,0.9913408104546745,1,0.0801035538315773,0.9459297060966492,1,0.18841727077960968,0.862737774848938,1,0.004067910879540452,0.9959320891204595,1
3736,心電図変化及び心筋逸脱酵素の上昇を認めた。,心電図変化 心筋逸脱酵素 上昇 認める た,1,0.002937962568824446,0.9970620374311755,1,0.000400954559340283,0.9995990454406597,1,0.012340394525310328,0.9876596054746897,1,0.007089231458736522,0.9929107685412635,1,0.08232587575912476,0.9422019720077515,1,0.19437673687934875,0.8617408871650696,1,0.004144982315470246,0.9958550176845298,1
3737,神経伝達速度検査(NCV)も低下していた。,神経伝達速度 検査 NCV 低下 する いる た,1,0.5,0.5,0,0.00015976588520438955,0.9998402341147956,0,0.7009036975167946,0.29909630248320535,0,0.7957586547269361,0.20424134527306395,1,0.2724590301513672,0.8238602876663208,1,0.26297858357429504,0.8436700701713562,1,0.24260533069199997,0.757394669308,1
3738,接種後5日目から右眼の視力低下を自覚した。,接種 後 0 日 目 右 眼 視力低下 自覚 する た,1,0.005975729565956967,0.9940242704340428,1,0.00046316121841165017,0.9995368387815884,1,0.03411164010915457,0.9658883598908454,1,0.06295412239746911,0.9370458776025309,1,0.08064493536949158,0.9504346251487732,1,0.19885076582431793,0.870746374130249,1,0.004798337009317747,0.9952016629906822,1
3739,接種直後、左上肢全体のしびれ、疼痛を自覚。,接種 直後 左上 肢 全体 しびれ 疼痛 自覚,1,0.004504158062169035,0.9954958419378308,1,0.00046060507281587534,0.9995393949271841,1,0.055031402515035244,0.9449685974849648,1,1.6492931464995308e-09,0.9999999983507069,1,0.09373127669095993,0.9404152035713196,1,0.1908891201019287,0.8606112599372864,1,0.0045123540579508235,0.9954876459420492,1
3740,特発性肺腺維症は慢性の経過で進行していた。,特発性 肺 腺 維 症 慢性 経過 進行 する いる た,1,0.016683961776914214,0.9833160382230857,1,0.0002719377602974648,0.9997280622397026,1,0.4231953283818918,0.5768046716181082,1,0.48698387497012074,0.5130161250298793,1,0.09871143847703934,0.9285847544670105,1,0.22120314836502075,0.8577783107757568,1,0.026283514204326362,0.9737164857956736,1
3741,被験者は無症候症例で、ホテル療養となった。,被験者 無症候 症例 だ ホテル 療養 なる た,1,0.4010484536393152,0.5989515463606848,0,0.00015225625513231035,0.9998477437448677,1,0.3111854130525119,0.6888145869474881,1,0.15552064033272106,0.8444793596672789,1,0.3882023096084595,0.6952010989189148,0,0.803472638130188,0.2389732152223587,1,0.11850273696868326,0.8814972630313168,1
3742,本報告はアナフィラキシーの基準を満たした。,報告 アナフィラキシー 基準 満たす た,1,0.016695081846015224,0.9833049181539848,1,0.00033036809344042,0.9996696319065596,1,0.44317765831659817,0.5568223416834018,1,7.133105057233191e-05,0.9999286689494277,1,0.15631815791130066,0.9195346832275391,1,0.3244367837905884,0.783818244934082,1,0.01335988077775394,0.9866401192222461,1
3743,両下肢の近位筋大殿筋の筋力低下がみられた。,下肢 位 筋 大殿 筋 筋力低下 みる られる た,1,0.01670178959040491,0.9832982104095951,1,0.0003766886487176808,0.9996233113512824,1,0.1465038853193409,0.8534961146806591,1,0.07724505166308149,0.9227549483369185,1,0.0807267278432846,0.9439883232116699,1,0.21509701013565063,0.8519921898841858,1,0.006570964895615769,0.9934290351043843,1
3744,2022/04/08夜、倦怠感を発現した。,0 0 0 夜 倦怠感 発現 する た,1,3.1636768047313903e-08,0.9999999683632319,1,0.00047544890429554725,0.9995245510957045,1,0.0038280652744927535,0.9961719347255072,1,0.01663642927495168,0.9833635707250483,1,0.07882124185562134,0.9498117566108704,1,0.1864037662744522,0.8791628479957581,1,0.003982442161312885,0.9960175578386871,1
3745,2021/08ごろ、体の倦怠感が発現した。,0 0 ごろ 体 倦怠感 発現 する た,1,0.0030710798298048416,0.9969289201701953,1,0.0003427465950670668,0.9996572534049329,1,0.003024866725863773,0.9969751332741362,1,0.03524864186099741,0.9647513581390026,1,0.08451595157384872,0.947637140750885,1,0.1853586733341217,0.8742626905441284,1,0.004199211165895176,0.9958007888341048,1
3746,2021/09/25から、複視が出現した。,0 0 0 複視 出現 する た,1,0.004773764725676023,0.9952262352743239,1,0.00045710882010785767,0.9995428911798921,1,0.025519463631970773,0.9744805363680292,1,0.0061395498351281,0.9938604501648719,1,0.07866048067808151,0.9478552341461182,1,0.18978866934776306,0.8785034418106079,1,0.004134977869830905,0.995865022130169,1
3747,2022/06/21、胸の痛みが発症した。,0 0 0 胸 痛み 発症 する た,1,0.003324914439536515,0.9966750855604635,1,0.0004057901998305457,0.9995942098001694,1,0.042338604067232666,0.9576613959327673,1,0.0032041742792026096,0.9967958257207974,1,0.0747605413198471,0.9455904364585876,1,0.1784331202507019,0.8735436201095581,1,0.004204471135733524,0.9957955288642666,1
3748,2022/06/21、胸の痛みを発症した。,0 0 0 胸 痛み 発症 する た,1,0.003324914439536515,0.9966750855604635,1,0.0004057901998305457,0.9995942098001694,1,0.042338604067232666,0.9576613959327673,1,0.0032041742792026096,0.9967958257207974,1,0.0747605413198471,0.9455904364585876,1,0.1784331202507019,0.8735436201095581,1,0.004204471135733524,0.9957955288642666,1
3749,2022/07/07、朝から嘔吐があった。,0 0 0 朝 嘔吐 ある た,1,0.01667048198519674,0.9833295180148033,1,0.00035789951172739403,0.9996421004882726,1,0.05590876727245342,0.9440912327275466,1,0.02164047958963433,0.9783595204103657,1,0.0816647931933403,0.9453617334365845,1,0.18548175692558289,0.8719659447669983,1,0.004674135910937302,0.9953258640890628,1
3750,心エコー上、心膜輝度高く、肥厚にも見えた。,心 エコー 上 心膜 輝度 高い 肥厚 見える た,1,0.01669699165793239,0.9833030083420677,1,0.00032681542689169744,0.9996731845731083,1,0.4222685474776221,0.5777314525223779,1,0.008611112644388408,0.9913888873556116,1,0.08598747104406357,0.9370536208152771,1,0.2049848884344101,0.8491853475570679,1,0.009957126976349876,0.9900428730236501,1
3751,日付不明、患者は発熱と痙攣発作を発現した。,日付 不明 患者 発熱 痙攣 発作 発現 する た,1,0.004119940701485484,0.9958800592985143,1,0.0003948928839913945,0.9996051071160086,1,0.010098631630035104,0.9899013683699649,1,0.010570306491073156,0.9894296935089268,1,0.08699697256088257,0.9478143453598022,1,0.18214620649814606,0.8639200925827026,1,0.004101781316582052,0.9958982186834179,1
3752,入院10日目にHHV-6再燃が認められた。,入院 0 日 目 HHV 0 再燃 認める られる た,1,0.004652125428598092,0.9953478745714021,1,0.00039187244496758327,0.9996081275550324,1,0.01545939555221476,0.9845406044477852,1,0.12840531817766299,0.871594681822337,1,0.08923579007387161,0.9465801119804382,1,0.18695694208145142,0.8713127374649048,1,0.005251988444783645,0.9947480115552163,1
3753,皮膚筋炎(入院期間:182日)で入院した。,皮膚筋炎 入院 期間 0 日 入院 する た,1,0.016710512869887287,0.9832894871301125,1,0.0004754477631770385,0.999524552236823,1,0.09312848393498518,0.9068715160650148,1,0.034114170540873845,0.9658858294591262,1,0.07864689081907272,0.9475759267807007,1,0.28102001547813416,0.8056122660636902,1,0.006031774125071651,0.9939682258749284,1
3754,Blood fibrinogen:著明減少,BLOOD fibrinogen 著 明 減少,1,0.023996402073420686,0.9760035979265793,1,0.0003145006385535789,0.9996854993614465,1,0.3653415883548712,0.6346584116451288,1,0.0004064497927201982,0.9995935502072798,1,0.2003970891237259,0.9105740785598755,1,0.21667802333831787,0.8551138639450073,1,0.010267054803052234,0.9897329451969478,1
3755,乾癬、疾患再発に対して治療措置がとられた。,乾癬 疾患 再発 治療 措置 とる れる た,1,0.016685447635775518,0.9833145523642246,1,0.00032915274779338893,0.9996708472522066,1,0.11262926617700186,0.8873707338229981,1,0.10015605664656202,0.899843943353438,1,0.2974182665348053,0.8032193183898926,1,0.21378184854984283,0.8485589027404785,1,0.009184798500312149,0.9908152014996877,1
3756, 05/11および05/12、発熱した。,0 0 お呼び 0 0 発熱 する た,1,0.016675090394399277,0.983324909605601,1,0.0002862521548194773,0.9997137478451805,1,0.0468138744197506,0.9531861255802494,1,0.0026316975411084798,0.9973683024588915,1,0.14204701781272888,0.9069188833236694,1,0.20272371172904968,0.8430345058441162,1,0.005105243397312065,0.9948947566026879,1
3757,19:12右手のそう痒感、発疹を認めた。,0 0 右手 そう痒感 発疹 認める た,1,0.004288129556061377,0.9957118704439388,1,0.0003706352926775832,0.9996293647073224,1,0.028679948765369057,0.9713200512346309,1,0.0013626277435416778,0.9986373722564583,1,0.07815390825271606,0.9516777992248535,1,0.18657821416854858,0.8752424120903015,1,0.004099487473346867,0.9959005125266531,1
3758,2021/08/15頃全身にあざが発現。,0 0 0 頃 全身 あざ 発現,1,0.015603583262885643,0.9843964167371144,1,0.00037615733121382986,0.9996238426687861,1,0.006430581757262188,0.9935694182427378,1,7.076561558960748e-13,0.9999999999992923,1,0.09528741240501404,0.9437069296836853,1,0.18088163435459137,0.8651162981987,1,0.004119754107314265,0.9958802458926858,1
3759,2021/09/29、急性頭痛発症した。,0 0 0 急性頭痛 発症 する た,1,0.01669514485640072,0.9833048551435994,1,0.0003546048203982812,0.9996453951796017,1,0.07375158136634685,0.9262484186336531,1,0.0040786485523147675,0.9959213514476852,1,0.07877335697412491,0.9492260813713074,1,0.17798283696174622,0.875157356262207,1,0.004596434818629333,0.9954035651813706,1
3760,2021/12/25から発熱が発現した。,0 0 0 発熱 発現 する た,1,3.374346710885736e-07,0.9999996625653289,1,0.0006197930414186968,0.9993802069585813,1,0.005243546603279081,0.9947564533967209,1,4.652388984738298e-05,0.9999534761101526,1,0.08382882177829742,0.9496541023254395,1,0.18228597939014435,0.8769596219062805,1,0.003877504267238893,0.9961224957327611,1
3761,2021/12/26から胸痛が出現した。,0 0 0 胸痛 出現 する た,1,1.9050182498562536e-05,0.9999809498175014,1,0.000496185082774241,0.9995038149172257,1,0.007512627290926277,0.9924873727090737,1,0.0005662424692323142,0.9994337575307677,1,0.07338380068540573,0.9500768780708313,1,0.1802254468202591,0.8758631348609924,1,0.00385261703270181,0.9961473829672982,1
3762,2022/02/07、咽頭痛が出現した。,0 0 0 咽頭痛 出現 する た,1,0.007055609634360561,0.9929443903656396,1,0.00046007344921989563,0.9995399265507801,1,0.025519463631970773,0.9744805363680292,1,0.005525232333931207,0.9944747676660688,1,0.0766100361943245,0.9510082602500916,1,0.1809447705745697,0.8743593692779541,1,0.004108042798471108,0.9958919572015289,1
3763,2022/02/15横紋筋融解症が発現。,0 0 0 横紋筋融解症 発現,1,9.734348287923443e-07,0.9999990265651713,1,0.000508010115227043,0.999491989884773,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.09107343852519989,0.9415638446807861,1,0.18133355677127838,0.8716539740562439,1,0.003989713326994628,0.9960102866730054,1
3764,2022/03/12末梢神経障害が発現。,0 0 0 末梢神経障害 発現,1,0.013883765739034408,0.9861162342609656,1,0.0004177316751504584,0.9995822683248495,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08770991861820221,0.9429451823234558,1,0.18355423212051392,0.872369110584259,1,0.004087635844709088,0.9959123641552908,1
3765,2022/03/28めまいを認め、受診。,0 0 0 めまい 認める 受診,1,0.0029407611725155098,0.9970592388274845,1,0.0005728882074537432,0.9994271117925463,1,0.017453930983583055,0.982546069016417,1,0.0,1.0,1,0.08333099633455276,0.9456570744514465,1,0.18651506304740906,0.8758847713470459,1,0.004030763228061648,0.9959692367719383,1
3766,2022/04/03体全体の痛みが発現。,0 0 0 体 全体 痛み 発現,1,5.658450062325729e-06,0.9999943415499377,1,0.00042077810753501156,0.999579221892465,1,0.005615020967933315,0.9943849790320667,1,2.0427437519288105e-11,0.9999999999795726,1,0.0830945074558258,0.9450095891952515,1,0.18520225584506989,0.8704142570495605,1,0.00393052436016149,0.9960694756398386,1
3767,2022/04/08右突発性難聴が発現。,0 0 0 右 突発性 難聴 発現,1,2.504533509116e-06,0.999997495466491,1,0.0005388505112578713,0.9994611494887421,1,0.0049934209175019895,0.995006579082498,1,6.661338147750939e-16,0.9999999999999993,1,0.07881759107112885,0.9470053911209106,1,0.18416881561279297,0.8745484948158264,1,0.003882066946367329,0.9961179330536327,1
3768,2022/04/14午前、心膜炎が発現。,0 0 0 午前 心膜炎 発現,1,0.010946452848719208,0.9890535471512807,1,0.0003998965109819392,0.9996001034890181,1,0.00987732563689947,0.9901226743631005,1,1.546940353591708e-11,0.9999999999845306,1,0.08347368985414505,0.9446282982826233,1,0.1930781900882721,0.8661542534828186,1,0.0041035806986024215,0.9958964193013976,1
3769,2022/05/12拍動性の頭痛が出現。,0 0 0 拍 動性 頭痛 出現,1,0.005704732644276347,0.9942952673557237,1,0.0003755354541846492,0.9996244645458153,1,0.0034828816805111407,0.9965171183194889,1,0.00036238435738999986,0.99963761564261,1,0.08150911331176758,0.9458155035972595,1,0.1841893047094345,0.8681378960609436,1,0.0039566072787605416,0.9960433927212393,1
3770,2022/05/18息切れ、動悸を自覚。,0 0 0 息切れ 動悸 自覚,1,0.02201346675804284,0.9779865332419571,1,0.00041293099524918324,0.9995870690047508,1,0.04983575894163639,0.9501642410583636,1,0.0,1.0,1,0.09049573540687561,0.9434413909912109,1,0.19170235097408295,0.85630202293396,1,0.004618661315428129,0.9953813386845719,1
3771,2022/05/23、脊髄炎を発現した。,0 0 0 脊髄炎 発現 する た,1,0.01025378834554521,0.9897462116544549,1,0.0004020388714894772,0.9995979611285105,1,0.01317415815663825,0.9868258418433618,1,0.004904111319690929,0.9950958886803091,1,0.08298317342996597,0.9490898251533508,1,0.18287132680416107,0.8756905794143677,1,0.004064233049723576,0.9959357669502765,1
3772,2022/06/30、尿蛋白が出現した。,0 0 0 尿蛋白 出現 する た,1,0.0027589118730198645,0.9972410881269801,1,0.0005146343665794449,0.9994853656334206,1,0.025519463631970773,0.9744805363680292,1,0.010142124743517611,0.9898578752564824,1,0.07542207837104797,0.9512778520584106,1,0.18485099077224731,0.8780480623245239,1,0.004106036522780334,0.9958939634772197,1
3773,2022年4月1日右手に痺れが出現した。,0 年 0 月 0 日 右手 痺れ 出現 する た,1,0.014942438848023917,0.9850575611519758,1,0.0003920401620206485,0.9996079598379793,1,0.021810165508300172,0.9781898344916998,1,0.10561207567149711,0.8943879243285029,1,0.07935146987438202,0.9412420392036438,1,0.1871805638074875,0.8770001530647278,1,0.005136688617518833,0.9948633113824813,1
3774,2022年4月6日左手に痺れが出現した。,0 年 0 月 0 日 左手 痺れ 出現 する た,1,0.0088325851497912,0.9911674148502088,1,0.0004216252418492098,0.9995783747581508,1,0.021810165508300172,0.9781898344916998,1,0.10899233011032217,0.8910076698896778,1,0.0786033496260643,0.9424049854278564,1,0.18609826266765594,0.8766865730285645,1,0.005095562970227553,0.9949044370297725,1
3775,27歳の男性が胸痛を主訴にEDを訪れた。,0歳 男性 胸痛 主訴 ED 訪れる た,1,0.020650975646684163,0.979349024353316,1,0.0003275123253115828,0.9996724876746884,1,0.17853457951994767,0.8214654204800523,1,0.0019252650390538806,0.9980747349609461,1,0.08326685428619385,0.9469457864761353,1,0.18159788846969604,0.8698058724403381,1,0.005771642287863714,0.9942283577121362,1
3776,2回目接種後、同日、患者は発熱を呈した。,0回目 接種 後 同日 患者 発熱 呈す た,1,0.0033333630531523287,0.9966666369468477,1,0.0004709847174257595,0.9995290152825742,1,0.009448730769810343,0.9905512692301897,1,1.369315308918928e-07,0.9999998630684691,1,0.09094066172838211,0.9475661516189575,1,0.18161682784557343,0.8685217499732971,1,0.00400170916249925,0.9959982908375008,1
3777,6月4日の朝から両上肢に皮疹が出現した。,0 月 0 日 朝 上肢 皮疹 出現 する た,1,0.01671464300492617,0.9832853569950736,1,0.0003596532768019189,0.9996403467231981,1,0.02619673683649626,0.9738032631635037,1,0.09376026871955634,0.9062397312804437,1,0.07814360409975052,0.9492089152336121,1,0.18909470736980438,0.8743022084236145,1,0.005055499942895036,0.9949445000571049,1
3778,ECG上、上室性期外収縮3段脈を認めた。,ECG 上 上室性 期外収縮 0 段 脈 認める た,1,0.009635027663529302,0.9903649723364706,1,0.00043212886026891307,0.9995678711397311,1,0.028328074167349948,0.97167192583265,1,0.005727267608247932,0.9942727323917521,1,0.07742848247289658,0.9483931064605713,1,0.1850401610136032,0.8714737892150879,1,0.004197109530215066,0.9958028904697849,1
3779,これらの検査結果より、急性心筋炎と診断。,これら 検査結果 急性心筋炎 診断,1,0.026346398304723843,0.973653601695276,1,0.00022488423777007529,0.9997751157622299,1,0.06260030355645518,0.9373996964435448,1,8.273168263572828e-06,0.9999917268317364,1,0.11699617654085159,0.9353761076927185,1,0.1939200460910797,0.86053067445755,1,0.004934138491172997,0.995065861508827,1
3780,しびれが出て1ヵ月くらい薬を飲んでいる。,しびれ 出し手 0 ヵ月 薬 飲む いる,0,0.8435390540965458,0.15646094590345394,0,0.0001311953047315748,0.9998688046952684,0,0.9325124790351367,0.06748752096486327,0,0.9999840389872299,1.596101277015993e-05,1,0.2792346775531769,0.8494879007339478,1,0.23483556509017944,0.840391993522644,1,0.5930344330127524,0.4069655669872476,1
3781,その後もJCS 3-300、発熱が継続。,その後 JCS 0 0 発熱 継続,1,0.036178907678425465,0.9638210923215745,1,0.00020148322120502968,0.9997985167787949,1,0.047919395740590565,0.9520806042594094,1,1.2123335335623153e-08,0.9999999878766647,1,0.34811830520629883,0.7878149747848511,1,0.18808698654174805,0.8610497713088989,1,0.007075195521945389,0.9929248044780546,1
3782,トイレでめまいが発現し、意識消失、転倒。,トイレ だ めまい 発現 意識消失 転倒,1,0.005705308668069245,0.9942946913319307,1,0.000352549188100927,0.9996474508118991,1,0.057544246225665674,0.9424557537743343,1,6.661338147750939e-16,0.9999999999999993,1,0.08216723799705505,0.9421435594558716,1,0.19291450083255768,0.8642607927322388,1,0.004477876513589589,0.9955221234864103,1
3783,咽頭腫脹の結果として治療措置がとられた。,咽頭腫脹 結果 治療 措置 とる れる た,1,0.014510193843674484,0.9854898061563255,1,0.0003919038361902834,0.9996080961638097,1,0.0715721786119925,0.9284278213880075,1,0.07530300350746633,0.9246969964925337,1,0.09048058837652206,0.9446884989738464,1,0.19866685569286346,0.8620085716247559,1,0.005519160496281235,0.9944808395037187,1
3784,右上肢の疼痛を認め、モーラステープ貼付。,右 上肢 疼痛 認める モーラステープ 貼付,1,0.007299873739922578,0.9927001262600773,1,0.00041674292964412264,0.9995832570703559,1,0.016082828003912475,0.9839171719960875,1,1.831819058661921e-07,0.9999998168180941,1,0.12083548307418823,0.9057119488716125,1,0.3312503397464752,0.7695236206054688,1,0.005621326132961832,0.9943786738670383,1
3785,患者は免疫性心筋炎のため3日間入院した。,患者 免疫性 心筋炎 ため 0 日間 入院 する た,1,1.7437025261312928e-06,0.999998256297474,1,0.0004095977427480543,0.9995904022572519,1,0.014161651768677008,0.985838348231323,1,0.05003735380543728,0.9499626461945627,1,0.08238992840051651,0.9431167840957642,1,0.20270444452762604,0.8601605892181396,1,0.004545949690889449,0.9954540503091106,1
3786,顔面麻痺の結果として治療処置がとられた。,顔面麻痺 結果 治療 処置 とる れる た,1,0.015314896191270915,0.9846851038087291,1,0.00039365509669927903,0.9996063449033007,1,0.021486218659389933,0.9785137813406101,1,0.03552828515300477,0.9644717148469952,1,0.09001749008893967,0.9385925531387329,1,0.21507449448108673,0.8491048216819763,1,0.004786493100189698,0.9952135068998103,1
3787,急性心筋炎・心膜炎の診断で入院となった。,急性心筋炎 心膜炎 の 診断 入院 なる た,1,3.207657327859923e-06,0.9999967923426721,1,0.0005607477347713697,0.9994392522652287,1,0.00906674127534468,0.9909332587246553,1,0.011013387784485906,0.9889866122155141,1,0.0777990072965622,0.9465532898902893,1,0.19279339909553528,0.8709434866905212,1,0.004047435332637562,0.9959525646673624,1
3788,巨細胞性動脈炎のため治療処置が施された。,巨細胞 性 動脈炎 ため 治療 処置 施す れる た,1,0.016695354134496517,0.9833046458655035,1,0.0003318948234196252,0.9996681051765803,1,0.018494717198555888,0.9815052828014441,1,0.1832913950036903,0.8167086049963097,1,0.0962100476026535,0.9142151474952698,1,0.19282788038253784,0.8661476373672485,1,0.006345156537232871,0.9936548434627672,1
3789,午前に急性心筋心膜炎が発現したと考える。,午前 急性心筋心膜炎 発現 する た 考える,1,0.00408180478918137,0.9959181952108187,1,0.0004955874092603431,0.9995044125907396,1,0.0030461332165095945,0.9969538667834904,1,8.486544800234697e-13,0.9999999999991513,1,0.08559396117925644,0.9459559917449951,1,0.20359158515930176,0.8602577447891235,1,0.00406292411361344,0.9959370758863866,1
3790,後遺症として右末梢性顔面神経麻痺が残る。,後遺症 する 右末梢性顔面神経麻痺 残る,1,0.013084393286638074,0.9869156067133619,1,0.00040812478662052506,0.9995918752133794,1,0.4743167706678745,0.5256832293321255,1,2.4424906541753444e-15,0.9999999999999976,1,0.14299806952476501,0.9157156348228455,1,0.2472907304763794,0.8434277772903442,1,0.01220974433288934,0.9877902556671107,1
3791,四肢の痛み、頚部痛のため首を動かせない。,四肢 痛み 頚部痛 ため 首 動く せる ない,1,0.016703236860009192,0.9832967631399908,1,0.0003359569173836581,0.9996640430826164,1,0.2933310075848692,0.7066689924151308,1,0.023241658652475627,0.9767583413475244,1,0.159281387925148,0.9114341139793396,1,0.4271779954433441,0.6386178135871887,1,0.013434962179188135,0.9865650378208118,1
3792,心膜炎、胸痛のための治療処置が施された。,心膜炎 胸痛 ため 治療 処置 施す れる た,1,0.01666124814033986,0.9833387518596601,1,0.00030160480492708177,0.9996983951950729,1,0.033138078974709106,0.9668619210252909,1,0.16144794175633204,0.838552058243668,1,0.08363158255815506,0.9390010237693787,1,0.1864607334136963,0.8699295520782471,1,0.005965728468749388,0.9940342715312507,1
3793,切迫流産の結果として治療処置が行われた。,切迫流産 結果 治療 処置 行う れる た,1,0.016675768959326088,0.9833242310406736,1,0.000300973535764374,0.9996990264642356,1,0.11023159353021328,0.8897684064697867,1,0.32135313995767456,0.6786468600423254,1,0.09691321849822998,0.9290161728858948,1,0.20455440878868103,0.8593984246253967,1,0.01005256501671225,0.9899474349832877,1
3794,接種の10日後くらいに、発熱を発現した。,接種 0 日 後 発熱 発現 する た,1,1.579027432560548e-06,0.9999984209725674,1,0.0005638334490130842,0.9994361665509869,1,0.005328852970078457,0.9946711470299215,1,0.0004310960537223796,0.9995689039462776,1,0.08445122838020325,0.950642466545105,1,0.18705953657627106,0.8711076974868774,1,0.00392057498276736,0.9960794250172327,1
3795,接種後6日目より呼吸困難が出現し、受診。,接種 後 0 日 目 呼吸困難 出現 受診,1,0.004142932033604842,0.9958570679663953,1,0.00040650921631757273,0.9995934907836824,1,0.016103359785967775,0.9838966402140322,1,2.0650148258027912e-14,0.9999999999999793,1,0.08449660241603851,0.9448536038398743,1,0.19306400418281555,0.8620849251747131,1,0.0041187745449803295,0.9958812254550196,1
3796,造影MRIで右視神経に造影効果を認めた。,造影 MRI 右 視神経 造影効果 認める た,1,0.005805110573980304,0.9941948894260196,1,0.0003862315638444033,0.9996137684361556,1,0.01173107006047669,0.9882689299395233,1,0.0029670824482284086,0.9970329175517716,1,0.1165580227971077,0.9184094071388245,1,0.20681148767471313,0.8681555986404419,1,0.004401421849534346,0.9955985781504657,1
3797,大腸出血の結果として治療処置が行われた。,大腸出血 結果 治療 処置 行う れる た,1,0.01667576895932561,0.9833242310406743,1,0.0002889705768225749,0.9997110294231775,1,0.11023159353021328,0.8897684064697867,1,0.31250993908653646,0.6874900609134635,1,0.08665506541728973,0.9345834255218506,1,0.2165888249874115,0.848004162311554,1,0.009952480221788736,0.9900475197782114,1
3798,締め付けるような胸痛が出現し、救急要請。,締め付ける よう 胸痛 出現 救急 要請,1,0.022796032677684704,0.9772039673223153,1,0.0002795346068845851,0.9997204653931154,1,0.00920752969711447,0.9907924703028855,1,6.661338147750939e-16,0.9999999999999993,1,0.08937017619609833,0.9376562833786011,1,0.20970165729522705,0.8561179041862488,1,0.004363376546959639,0.9956366234530404,1
3799,頭部CTでは大量のくも膜下出血を認めた。,頭部 CT 大量 くも膜下出血 認める た,1,1.6018693019884048e-05,0.9999839813069802,1,0.0003717542378937587,0.9996282457621063,1,0.07731530055675484,0.9226846994432452,1,8.749778346750503e-05,0.9999125022165325,1,0.0799870491027832,0.9427106380462646,1,0.19179902970790863,0.8720719218254089,1,0.004552955527938217,0.9954470444720617,1
3800,日付不明食欲低下し、体重が5 kg減少。,日付 不明 食欲低下 体重 0 kg 減少,1,0.016719577675753022,0.983280422324247,1,0.0002808518654054377,0.9997191481345946,1,0.46473448416522223,0.5352655158347778,1,1.4438827378171482e-07,0.9999998556117262,1,0.11894190311431885,0.9389456510543823,1,0.1962776780128479,0.8591042757034302,1,0.010778549382382843,0.9892214506176171,1
3801,日付不明接種2日後から夜間に微熱が出現。,日付 不明 接種 0 日 後 夜間 微熱 出現,1,0.06009738912885086,0.9399026108711493,1,0.0003090024912111492,0.9996909975087889,1,0.2292128227975685,0.7707871772024315,1,1.0639424241620787e-06,0.9999989360575758,1,0.09150507301092148,0.9461482167243958,1,0.19368548691272736,0.8613849878311157,1,0.007081927157399731,0.9929180728426001,1
3802,不可逆的な状態となり、植物状態であった。,可逆的 状態 なる 植物状態 だ ある た,1,0.09978555578053507,0.900214444219465,1,0.00023201667666314276,0.9997679833233368,0,0.646506045725548,0.35349395427445196,0,0.7882093747970538,0.2117906252029462,1,0.1507343053817749,0.9092394113540649,1,0.38380998373031616,0.7140268087387085,1,0.11719594966837814,0.8828040503316218,1
3803,夜、腰部違和感、上肢脱力、しびれが発現。,夜 腰部違和感 上肢脱力 しびれ 発現,1,6.293083443984701e-07,0.9999993706916556,1,0.00037538755099687625,0.9996246124490031,1,0.015996370134666482,0.9840036298653335,1,2.2344126549000976e-11,0.9999999999776559,1,0.08398327231407166,0.9424492716789246,1,0.1953335702419281,0.8719618916511536,1,0.004060624748713994,0.995939375251286,1
3804,両肺に捻髪音あり、四肢に浮腫の報告なし。,両肺 捻髪音 ある 四肢 浮腫 報告 ない,1,0.01668544178824784,0.9833145582117522,1,0.00025410282364404807,0.999745897176356,0,0.6420678313948279,0.3579321686051721,1,0.3454928264708331,0.6545071735291669,1,0.3615538775920868,0.8171076774597168,0,0.7189016342163086,0.4458511471748352,1,0.10215530011076757,0.8978446998892323,1
3805,2021/09/23、咽頭痛、微熱あり。,0 0 0 咽頭痛 微熱 ある,1,0.016675730961660126,0.9833242690383399,1,0.00035412445081894846,0.999645875549181,1,0.17134802056202647,0.8286519794379735,1,3.5618175076024272e-12,0.9999999999964382,1,0.08198008686304092,0.9436282515525818,1,0.18142807483673096,0.8692499399185181,1,0.005637202039550946,0.994362797960449,1
3806,2022/03/18の朝、微熱があった。,0 0 0 朝 微熱 ある た,1,0.016686727266149348,0.9833132727338508,1,0.00031897723386719543,0.9996810227661328,1,0.1698208245120627,0.8301791754879373,1,0.001626052891530283,0.9983739471084697,1,0.08097445964813232,0.9465950727462769,1,0.186349019408226,0.866277813911438,1,0.005660062270810157,0.9943399377291899,1
3807,CTスキャンで左小脳に低吸収域を認めた。,CTスキャン 左 小脳 吸収 域 認める た,1,0.027129316770498048,0.972870683229502,1,0.00038266161041904177,0.999617338389581,1,0.03614208497430993,0.9638579150256901,1,0.4991295011691129,0.5008704988308871,1,0.0993657261133194,0.933565616607666,1,0.19310781359672546,0.8652397990226746,1,0.012361075014593948,0.987638924985406,1
3808,患者は昨年、起立性低血圧のため入院した。,患者 昨年 起立性 低血圧 ため 入院 する た,1,0.00971470964003773,0.9902852903599623,1,0.0003696074358752013,0.9996303925641248,1,0.029921995607162244,0.9700780043928378,1,0.10032518332388463,0.8996748166761154,1,0.08513408899307251,0.9431747198104858,1,0.21693482995033264,0.8444665670394897,1,0.005459577292681962,0.994540422707318,1
3809,主訴は、心肺停止(CPA)と報告された。,主訴 心肺停止 CPA 報告 する れる た,1,0.22060680196901883,0.7793931980309808,1,0.0002864208150823631,0.9997135791849177,0,0.5925977658941617,0.40740223410583826,1,0.29678830354999086,0.7032116964500091,1,0.07826364785432816,0.9448106288909912,1,0.18610715866088867,0.8701615333557129,1,0.03455480337524843,0.9654451966247516,1
3810,心電図検査は、V2-4ST上昇を示した。,心電図 検査 V 0 0 ST 上昇 示す た,1,0.022563679156896173,0.977436320843104,1,0.00036700750389853057,0.9996329924961015,1,0.1715499304237149,0.8284500695762851,1,0.00794660046074469,0.9920533995392553,1,0.08281852304935455,0.9439672827720642,1,0.18390557169914246,0.8710978031158447,1,0.005803425762286036,0.994196574237714,1
3811,入院同日の午後に胸痛増強の訴えがあった。,入院 同日 午後 胸痛 増強 訴え ある た,1,0.004660038902354807,0.9953399610976449,1,0.00040613949736590125,0.9995938605026341,1,0.01849376154727589,0.9815062384527241,1,0.22598337237844912,0.7740166276215509,1,0.07874617725610733,0.9494979977607727,1,0.18968565762043,0.8539552092552185,1,0.006458140621409082,0.9935418593785909,1
3812,発熱(摂氏37.2度)と咽頭痛があった。,発熱 摂氏 0 0度 咽頭痛 ある た,1,0.009466134542229467,0.9905338654577706,1,0.0003789672113062577,0.9996210327886937,1,0.019393317930214593,0.9806066820697854,1,0.000467601296161968,0.999532398703838,1,0.07325077801942825,0.9482201933860779,1,0.18146905303001404,0.8724364042282104,1,0.004043774676124006,0.9959562253238761,1
3813,起立性低血圧のために坐位になれなかった。,起立性 低血圧 ため 坐る 位 なれる ない た,0,0.9259705507649897,0.07402944923501041,1,0.00018870084834345015,0.9998112991516566,0,0.7682896045890321,0.2317103954109679,0,0.9792843476324026,0.020715652367597464,0,0.8559358716011047,0.1711018830537796,1,0.5376307964324951,0.642667829990387,1,0.8729462059999304,0.12705379400006955,1
3814,「急性心機能不全」に対して受けた処置。,急性 心機能不全 受ける た 処置,1,0.01667367291493711,0.983326327085063,1,0.0002679850354690518,0.9997320149645309,1,0.3908221365458221,0.6091778634541779,1,1.3753667094107414e-09,0.9999999986246333,1,0.2060583382844925,0.8826701641082764,1,0.20553822815418243,0.8421084880828857,1,0.011012458692295606,0.9889875413077044,1
3815,08:50アナフィラキシー反応が発現。,0 0 アナフィラキシー反応 発現,1,0.014016702217813681,0.9859832977821862,1,0.00040336587079795754,0.9995966341292021,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.10114604234695435,0.939187228679657,1,0.18675042688846588,0.8703743815422058,1,0.0041807697980576885,0.9958192302019423,1
3816,12:25ふらつき、四肢脱力感が出現。,0 0 ふらつき 四肢脱力感 出現,1,0.020644009829166556,0.9793559901708333,1,0.0003468283817084465,0.9996531716182916,1,0.02097495322731857,0.9790250467726814,1,6.083997750039316e-10,0.9999999993916002,1,0.09350846707820892,0.9464218020439148,1,0.18760351836681366,0.8700200319290161,1,0.0042719734644492795,0.9957280265355506,1
3817,14:00頃発熱、呼吸苦、下痢が出現。,0 0 頃 発熱 呼吸苦 下痢 出現,1,6.032204667515601e-07,0.9999993967795333,1,0.000559525377368463,0.9994404746226315,1,0.004190100222302151,0.9958098997776978,1,2.298125689748076e-09,0.9999999977018743,1,0.0809682160615921,0.9485962390899658,1,0.18536941707134247,0.8699049353599548,1,0.003900808204936678,0.9960991917950632,1
3818,14:07しびれ、高血圧、胸苦が発現。,0 0 しびれ 高血圧 胸苦 発現,1,0.004879957541827395,0.995120042458173,1,0.00035497451662622865,0.9996450254833738,1,0.00887860420301323,0.9911213957969868,1,2.194755488460487e-11,0.9999999999780524,1,0.0805501863360405,0.9423483610153198,1,0.17932841181755066,0.8668680191040039,1,0.003985453680515728,0.9960145463194842,1
3819,2021/07/29頭痛が出現し持続。,0 0 0 頭痛 出現 する 持続,1,4.146003195065663e-06,0.999995853996805,1,0.0006033518448937826,0.9993966481551062,1,0.004155198403432703,0.9958448015965673,1,3.907274503944791e-11,0.9999999999609273,1,0.08543570339679718,0.9424768090248108,1,0.1845865249633789,0.8742830157279968,1,0.003922045458393899,0.9960779545416062,1
3820,2021/08/03胸痛を主訴に来院。,0 0 0 胸痛 主訴 来院,1,0.01667648734348065,0.9833235126565192,1,0.00039925230845789503,0.9996007476915421,1,0.06886580573290557,0.9311341942670944,1,0.0,1.0,1,0.08333483338356018,0.9406951665878296,1,0.19503168761730194,0.864230215549469,1,0.004703771527303911,0.995296228472696,1
3821,2021/08/17昼から胸痛が増悪。,0 0 0 昼 胸痛 増悪,1,0.006609288189177523,0.9933907118108224,1,0.0003606363287512931,0.9996393636712487,1,0.08141779273500338,0.9185822072649966,1,3.730349362740526e-13,0.999999999999627,1,0.08328988403081894,0.9501286745071411,1,0.18672247231006622,0.8731017708778381,1,0.004602957541380485,0.9953970424586196,1
3822,2021/08/23胸痛を認め、搬送。,0 0 0 胸痛 認める 搬送,1,0.005733521749212932,0.9942664782507872,1,0.000535075125432924,0.9994649248745671,1,0.009165910116216702,0.9908340898837833,1,0.0,1.0,1,0.07981590926647186,0.9443705081939697,1,0.18150436878204346,0.870611846446991,1,0.003978781031656968,0.996021218968343,1
3823,2022/02/13幻覚、興奮が発現。,0 0 0 幻覚 興奮 発現,1,0.01231442697198056,0.9876855730280194,1,0.00036471222710576583,0.9996352877728942,1,0.00987732563689947,0.9901226743631005,1,1.0480505352461478e-13,0.9999999999998952,1,0.08750218152999878,0.9447532892227173,1,0.18399395048618317,0.870159387588501,1,0.0040770199218840555,0.9959229800781159,1
3824,2022/02/25、発熱がみられた。,0 0 0 発熱 みる られる た,1,0.008791840016508741,0.9912081599834912,1,0.00041016227615958646,0.9995898377238405,1,0.018682950179954805,0.9813170498200452,1,0.009740862004143036,0.990259137995857,1,0.09248550981283188,0.9452014565467834,1,0.18121238052845,0.8662073016166687,1,0.0042251801908686605,0.9957748198091314,1
3825,2022/03/07 ARDSが発現。,0 0 0 ARDS 発現,1,0.013138808815979916,0.9868611911840203,1,0.0005183673546548428,0.9994816326453452,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08234687894582748,0.9439010620117188,1,0.19325010478496552,0.8558527231216431,1,0.00416407728142391,0.995835922718576,1
3826,2022/03/20朝、心筋炎が発現。,0 0 0 朝 心筋炎 発現,1,0.003140427743164781,0.9968595722568353,1,0.0005190735576547238,0.9994809264423453,1,0.0033982837012268563,0.9966017162987731,1,1.1102230246251565e-14,0.9999999999999889,1,0.08340124785900116,0.9477787613868713,1,0.19101716578006744,0.8662763833999634,1,0.003967984329404134,0.9960320156705957,1
3827,2022/03/26体調不良を訴えた。,0 0 0 体調不良 訴える た,1,0.010535490859567518,0.9894645091404326,1,0.00040359207485362924,0.9995964079251464,1,0.08928256435383775,0.9107174356461623,1,1.8883812495928964e-06,0.9999981116187504,1,0.07942081242799759,0.9493017196655273,1,0.1834385246038437,0.8717567324638367,1,0.0046893914259184466,0.9953106085740816,1
3828,2022/03末、右下肢に疼痛が拡大。,0 0 末 右 下肢 疼痛 拡大,1,0.016658954419874812,0.9833410455801251,1,0.0003992382146904259,0.9996007617853095,1,0.09428119336674379,0.9057188066332562,1,1.1635839292090111e-08,0.9999999883641607,1,0.1763613373041153,0.8965293169021606,1,0.18798454105854034,0.8671634793281555,1,0.0056150823279194385,0.9943849176720807,1
3829,2022/04、両手の脱力を発現した。,0 0 両手 脱力 発現 する た,1,0.005660281513067848,0.9943397184869324,1,0.00043739542307101267,0.999562604576929,1,0.010189603299610828,0.9898103967003892,1,0.007536817318857025,0.992463182681143,1,0.07555744051933289,0.9446357488632202,1,0.18543614447116852,0.877586841583252,1,0.0040154560559839845,0.995984543944016,1
3830,2022/04/01突発性難聴が発現。,0 0 0 突発性 難聴 発現,1,0.005077928931270148,0.9949220710687299,1,0.00039875270228386615,0.9996012472977162,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08418569713830948,0.9472282528877258,1,0.183540940284729,0.8739944100379944,1,0.003978801051141003,0.996021198948859,1
3831,2022/04/23体調不良を認めた。,0 0 0 体調不良 認める た,1,9.50021468824945e-06,0.9999904997853118,1,0.0004285767399223745,0.9995714232600776,1,0.025944857950418232,0.9740551420495818,1,3.450776350255591e-05,0.9999654922364974,1,0.07883410900831223,0.9489074945449829,1,0.18236000835895538,0.8758044838905334,1,0.004027062132254678,0.9959729378677452,1
3832,2022/04/29急性心不全が発現。,0 0 0 急性心不全 発現,1,0.00607234086801124,0.9939276591319886,1,0.00041928455855952173,0.9995807154414404,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08710035681724548,0.9451735615730286,1,0.18073904514312744,0.8717858195304871,1,0.00400426841134113,0.9959957315886588,1
3833,2022/05/15咳嗽、発熱が発現。,0 0 0 咳嗽 発熱 発現,1,3.093771900847258e-08,0.999999969062281,1,0.0006187357824436019,0.9993812642175564,1,0.004216766065844202,0.9957832339341558,1,0.0,1.0,1,0.07945288717746735,0.9461819529533386,1,0.18129968643188477,0.8725299835205078,1,0.003879011786618241,0.9961209882133817,1
3834,2022/05/24急性心筋炎が発現。,0 0 0 急性心筋炎 発現,1,0.009695940044074534,0.9903040599559254,1,0.0004804007103792815,0.9995195992896208,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.09138355404138565,0.9474540948867798,1,0.17854341864585876,0.8718201518058777,1,0.004032854064173364,0.9959671459358266,1
3835,2022/06/05、発熱が出現した。,0 0 0 発熱 出現 する た,1,4.434939033939268e-07,0.9999995565060966,1,0.0006047153486606862,0.9993952846513393,1,0.007081099675880997,0.992918900324119,1,0.0003576640363949224,0.9996423359636051,1,0.07892598956823349,0.950411856174469,1,0.1819896548986435,0.8763489127159119,1,0.0038733398261265564,0.9961266601738734,1
3836,2022/06/09急性肝障害が発現。,0 0 0 急性肝障害 発現,1,0.011616608110575702,0.9883833918894241,1,0.00040428792270012976,0.9995957120772999,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.0883086696267128,0.9461171627044678,1,0.18537107110023499,0.8749247789382935,1,0.004055709192111272,0.9959442908078887,1
3837,2022/06/18、発熱を発症した。,0 0 0 発熱 発症 する た,1,1.7792082913713686e-06,0.9999982207917085,1,0.0005404052241817818,0.9994595947758182,1,0.018596743844619956,0.98140325615538,1,1.6016700101095793e-05,0.9999839832998989,1,0.0808015987277031,0.9468038082122803,1,0.18151867389678955,0.8758866190910339,1,0.00398168612910898,0.996018313870891,1
3838,2022/06/18、嘔吐を発症した。,0 0 0 嘔吐 発症 する た,1,0.002561135903211669,0.9974388640967883,1,0.0004934767901254298,0.9995065232098745,1,0.03356070393827115,0.9664392960617288,1,0.0002166672019381366,0.9997833327980619,1,0.07837484031915665,0.9468299150466919,1,0.17873546481132507,0.8779062032699585,1,0.0040946872469994405,0.9959053127530004,1
3839,2022/06/21、下痢を発症した。,0 0 0 下痢 発症 する た,1,0.016055653804777446,0.9839443461952224,1,0.0004078151711748432,0.9995921848288252,1,0.09359316286399222,0.9064068371360078,1,0.0006510536949024814,0.9993489463050975,1,0.07436006516218185,0.9476695656776428,1,0.17750220000743866,0.8774318099021912,1,0.004717142606048115,0.995282857393952,1
3840,2022/06/27視力低下を認めた。,0 0 0 視力低下 認める た,1,0.0077812643712011475,0.992218735628799,1,0.0004420497816564405,0.9995579502183436,1,0.025944857950418232,0.9740551420495818,1,3.500957695135032e-05,0.9999649904230486,1,0.07667149603366852,0.9499770402908325,1,0.18764613568782806,0.8755282759666443,1,0.00409950415114781,0.9959004958488522,1
3841,23:30意識消失、痙攣、発熱が発現。,0 0 意識消失 痙攣 発熱 発現,1,2.2438927435043897e-07,0.9999997756107256,1,0.0004893794643321991,0.9995106205356677,1,0.004216766065844202,0.9957832339341558,1,0.0,1.0,1,0.08213911950588226,0.9474707841873169,1,0.17935910820960999,0.8695443272590637,1,0.003887460430659379,0.9961125395693406,1
3842,39.0°Cの発熱を認め、近医を受診。,0 0 C 発熱 認める 近医 受診,1,5.5212102940074975e-08,0.999999944787897,1,0.0007840124349411176,0.9992159875650589,1,0.005751271725617957,0.994248728274382,1,0.0,1.0,1,0.08066467940807343,0.9473870992660522,1,0.18868786096572876,0.8659940361976624,1,0.0039465548151275485,0.9960534451848725,1
3843,SARS-CoV-2 PCR検査陽性。,SARS CoV 0 PCR検査 陽性,1,0.0066355275460701175,0.99336447245393,1,0.0010015206066775976,0.9989984793933224,1,0.03373134057844185,0.9662686594215582,1,0.0,1.0,1,0.20065230131149292,0.8893866539001465,1,0.23569989204406738,0.8406049013137817,1,0.0054271318088602956,0.9945728681911397,1
3844,T2強調の浮腫、注:心筋障害を認めた。,T 0 強調 浮腫 注 心筋障害 認める た,1,0.003068612958584285,0.9969313870414157,1,0.0004044417120221063,0.9995955582879779,1,0.028328074167349948,0.97167192583265,1,0.007114291546069129,0.9928857084539309,1,0.07357809692621231,0.9424142241477966,1,0.18310602009296417,0.8725615739822388,1,0.004150113525835798,0.9958498864741643,1
3845,右眼に視神経乳頭浮腫及び発赤を認めた。,右 眼 視神経乳頭浮腫 発赤 認める た,1,9.975732183211103e-06,0.9999900242678167,1,0.00046826873566550544,0.9995317312643345,1,0.01173107006047669,0.9882689299395233,1,0.0005242672916970781,0.9994757327083029,1,0.0787438154220581,0.9473395943641663,1,0.19709886610507965,0.867196261882782,1,0.004016875265836376,0.9959831247341637,1
3846,炎症細胞亜型はリンパ球性と報告された。,炎症細胞 亜 型 リンパ球 性 報告 する れる た,1,0.016672274184766283,0.9833277258152339,1,0.0003613282942149951,0.999638671705785,1,0.14656374265865713,0.8534362573413429,1,0.27503541200978543,0.7249645879902146,1,0.2823302149772644,0.833113968372345,1,0.29898396134376526,0.7974516749382019,1,0.015187389228947423,0.9848126107710525,1
3847,家族よりいつもと違うようだとの話あり。,家族 違う よう だ 話 ある,1,0.016676663854744943,0.983323336145255,1,0.0002466167666572458,0.9997533832333427,0,0.6702185656181219,0.3297814343818781,1,0.0012390550950825974,0.9987609449049174,1,0.2698497772216797,0.8185946345329285,1,0.2888193428516388,0.7544423341751099,1,0.025640528816595565,0.9743594711834044,1
3848,患者は全身に丘疹小水疱性皮疹を呈した。,患者 全身 丘疹 水疱性 皮疹 呈す た,1,0.1433876894326575,0.8566123105673423,1,0.00025164589246310927,0.9997483541075369,1,0.08438622899509729,0.9156137710049027,1,2.65636373157907e-05,0.9999734363626842,1,0.08410973101854324,0.9496868848800659,1,0.19132888317108154,0.8666602969169617,1,0.006152016713443425,0.9938479832865567,1
3849,眼のかゆみも認めたが、花粉症を疑った。,眼のかゆみ 認める た 花粉症 疑う た,1,0.005330629615053159,0.994669370384947,1,0.0003535979514802467,0.9996464020485197,1,0.010789306065139836,0.9892106939348602,1,7.728000338225183e-05,0.9999227199966177,1,0.08824991434812546,0.9414097666740417,1,0.18955226242542267,0.8609110713005066,1,0.004105077894304203,0.9958949221056957,1
3850,起床時、息苦しい感じと圧迫感を認めた。,起床 時 息苦しい感じ 圧迫感 認める た,1,0.016676073207790493,0.9833239267922093,1,0.00031476544327705666,0.999685234556723,1,0.05573292834250976,0.9442670716574902,1,0.013658895430531448,0.9863411045694686,1,0.0872863382101059,0.9468879103660583,1,0.20169910788536072,0.8675000071525574,1,0.004713325285685862,0.9952866747143141,1
3851,急性散在性脳脊髄炎(ADEM)と診断。,急性散在性脳脊 髄炎 ADEM 診断,1,0.018422901496469746,0.9815770985035301,1,0.00035754434136358074,0.9996424556586364,1,0.06260030355645518,0.9373996964435448,1,3.1649165888048003e-07,0.9999996835083411,1,0.10547477751970291,0.9255734086036682,1,0.19781853258609772,0.868415117263794,1,0.004830644257723262,0.9951693557422768,1
3852,胸部重苦感を認め、当院救急外来を受診。,胸部重苦感 認める 院 救急外来 受診,1,3.2099204321614627e-06,0.9999967900795679,1,0.0004381013887239645,0.9995618986112761,1,0.025567344093833655,0.9744326559061663,1,6.64928112570351e-11,0.9999999999335072,1,0.08450518548488617,0.9454259872436523,1,0.2063310444355011,0.8660433888435364,1,0.004199356273890268,0.9958006437261097,1
3853,軽度の間質性炎症及び心内膜炎を認めた。,軽度 間質性 炎症 心内膜炎 認める た,1,8.891836463772289e-06,0.9999911081635362,1,0.0004823927255906485,0.9995176072744093,1,0.01180860231139469,0.9881913976886053,1,9.492789358389597e-05,0.9999050721064161,1,0.08876901865005493,0.9422454833984375,1,0.19140291213989258,0.8641039729118347,1,0.004064515650575572,0.9959354843494245,1
3854,血管炎の結果として治療処置が取られた。,血管炎 結果 治療 処置 取る れる た,1,0.01668033416264181,0.9833196658373582,1,0.00025475530249462306,0.9997452446975054,1,0.11023159353021328,0.8897684064697867,1,0.0584580458593329,0.9415419541406671,1,0.0860871747136116,0.9403693675994873,1,0.21033704280853271,0.8445424437522888,1,0.005956853921054737,0.9940431460789453,1
3855,呼吸時に左胸部痛あるも左胸部外傷なし。,呼吸 左胸部痛 ある 左 胸部外傷 ない,1,0.016700536762972958,0.983299463237027,1,0.0002500732880065485,0.9997499267119935,0,0.6703818778054471,0.3296181221945529,1,0.08476213211405326,0.9152378678859467,1,0.14446374773979187,0.9116296172142029,0,0.6200077533721924,0.4546295404434204,1,0.04489055942179111,0.955109440578209,1
3856,後遺症として歩行障害、排尿障害が残る。,後遺症 する 歩行障害 排尿障害 残る,1,0.002944512728197772,0.9970554872718023,1,0.00048297768460914714,0.9995170223153909,1,0.4637986912464749,0.5362013087535251,1,7.771561172376096e-14,0.9999999999999223,1,0.11082808673381805,0.9320133924484253,1,0.2328018844127655,0.8545916676521301,1,0.010894717662448839,0.9891052823375512,1
3857,左腋窩リンパ節、左上腕の腫脹を認めた。,左 腋窩リンパ節 左上 腕 腫脹 認める た,1,0.004506263175466789,0.9954937368245333,1,0.00041767644874448115,0.9995823235512555,1,0.03614208497430993,0.9638579150256901,1,0.00043572717047701826,0.999564272829523,1,0.07896854728460312,0.9485751986503601,1,0.19202633202075958,0.8547565340995789,1,0.004280766037601159,0.9957192339623988,1
3858,受診時、興奮、徘徊を認め医療保護入院。,受診 時 興奮 徘徊 認める 医療保護入院,1,0.01669590216070905,0.9833040978392908,1,0.0003542110730728847,0.9996457889269271,1,0.05038080055035754,0.9496191994496425,1,3.7239513916986766e-08,0.9999999627604861,1,0.08518949896097183,0.9372100234031677,1,0.1940816044807434,0.8552764654159546,1,0.004594210845175259,0.9954057891548247,1
3859,心電図でST上昇又は陰性T波を認めた。,心電図 ST 上昇 陰性 T 波 認める た,1,0.0352409723669775,0.9647590276330223,1,0.0003613650112110715,0.9996386349887889,1,0.02739237977876452,0.9726076202212355,1,0.0029167052879259803,0.997083294712074,1,0.08616761863231659,0.9446117877960205,1,0.19201606512069702,0.8563820123672485,1,0.0045367953358076045,0.9954632046641924,1
3860,神経学的に四肢の腱反射は低下から消失。,神経学 的 四肢 腱反射 低下 消失,1,0.01666924955322578,0.9833307504467742,1,0.00023161765631704698,0.9997683823436829,1,0.4585209356955434,0.5414790643044566,1,0.009361291712025488,0.9906387082879745,0,0.6123303174972534,0.574802577495575,0,0.7825443744659424,0.23324266076087952,1,0.0799075099774917,0.9200924900225084,1
3861,接種翌日から嘔気·倦怠感·発熱が出現。,接種 翌日 嘔気 倦怠感 発熱 出現,1,4.2483668556026424e-10,0.9999999995751633,1,0.0007503948647862642,0.9992496051352138,1,0.001151644082275749,0.9988483559177243,1,2.3888158118268166e-10,0.9999999997611184,1,0.09534905850887299,0.9440704584121704,1,0.18658913671970367,0.8652049899101257,1,0.003975849083970631,0.9960241509160294,1
3862,組織学的検査:リンパ球性炎症細胞亜型。,組織 学 的 検査 リンパ球 性 炎症細胞 亜 型,1,0.016701237484407702,0.9832987625155922,1,0.00035784086297729385,0.9996421591370227,1,0.2157206695878211,0.7842793304121789,1,4.247713292215849e-13,0.9999999999995752,1,0.18236814439296722,0.9036729335784912,1,0.3201652765274048,0.7918303608894348,1,0.00877173367692536,0.9912282663230746,1
3863,電子顕微鏡検査にて糸球体4個を認めた。,電子顕微鏡 検査 糸球体 0 個 認める た,1,0.016667963103169058,0.983332036896831,1,0.00033119096034989523,0.99966880903965,1,0.04264382233352082,0.9573561776664792,1,0.020524613434897643,0.9794753865651024,1,0.09807740151882172,0.9344801902770996,1,0.21940523386001587,0.8488878011703491,1,0.00493944716993628,0.9950605528300638,1
3864,日付不明頭痛、めまい、吐き気を認めた。,日付 不明 頭痛 めまい 吐き 気 認める た,1,0.016674098839939522,0.9833259011600606,1,0.00032398815633836835,0.9996760118436616,1,0.01060505360406816,0.9893949463959318,1,0.005501076892001522,0.9944989231079985,1,0.07736129313707352,0.9497847557067871,1,0.1831415593624115,0.8685920238494873,1,0.0041040622663541864,0.9958959377336458,1
3865,入院後、患者は心原性ショックを呈した。,入院 後 患者 心原性ショック 呈す た,1,0.008400829410815637,0.9915991705891841,1,0.0004288324642170415,0.999571167535783,1,0.017230522705713236,0.9827694772942868,1,8.05364006595255e-08,0.9999999194635993,1,0.08151793479919434,0.9474722146987915,1,0.1997029185295105,0.84659343957901,1,0.004232486053367136,0.9957675139466329,1
3866,脳炎が疑われ、X日当院に転院となった。,脳炎 疑う れる X 日当 院 転院 なる た,1,0.030557234035748473,0.9694427659642515,1,0.0003486548721899491,0.9996513451278101,1,0.030336265993507694,0.9696637340064923,1,0.29506696648344033,0.7049330335165597,1,0.07805966585874557,0.9464573860168457,1,0.1932935118675232,0.864316463470459,1,0.007948416105744312,0.9920515838942556,1
3867,発見時、口腔内より吐水、泡沫を認めた。,発見 時 口腔内 吐水 泡沫 認める た,1,0.0150401822937509,0.9849598177062489,1,0.0003961730487903858,0.9996038269512096,1,0.0504509376997645,0.9495490623002355,1,0.031012018243416928,0.9689879817565831,1,0.08335164934396744,0.9442447423934937,1,0.19635023176670074,0.8525630235671997,1,0.004852933026819561,0.9951470669731806,1
3868,発熱、呼吸苦、下痢を主訴に当院に搬送。,発熱 呼吸苦 下痢 主訴 院 搬送,1,0.0026182474318865363,0.9973817525681133,1,0.00040317934458743507,0.9995968206554126,1,0.016661362044204875,0.9833386379557951,1,0.0,1.0,1,0.08075864613056183,0.9426349401473999,1,0.19925659894943237,0.8518752455711365,1,0.004172206288057646,0.9958277937119423,1
3869,発熱を認め、市販薬のバファリンを服用。,発熱 認める 市販薬 バファリン 服用,1,0.0957544072445996,0.9042455927554006,1,0.00022465058490727603,0.9997753494150927,1,0.022248551275047435,0.9777514487249526,0,0.9999999932173882,6.7826118006764375e-09,1,0.1513465940952301,0.9064539670944214,1,0.21050336956977844,0.8510136008262634,1,0.04073176828618455,0.9592682317138154,1
3870,来院時、両手・両足しびれ感の訴えあり。,来院 時 両手 両足しびれ感 訴え ある,1,0.016702903277664993,0.983297096722335,1,0.00032022604404988365,0.9996797739559501,1,0.1379571588356745,0.8620428411643255,1,1.5051557828993367e-06,0.9999984948442171,1,0.08973845839500427,0.9431403279304504,1,0.19324235618114471,0.8521751165390015,1,0.005473377171495942,0.994526622828504,1
3871,2022/05/30、発熱が発現した。,0 0 0 発熱 発現 する た,1,3.374346710885736e-07,0.9999996625653289,1,0.0006197930414186968,0.9993802069585813,1,0.005243546603279081,0.9947564533967209,1,4.652388984738298e-05,0.9999534761101526,1,0.08382882177829742,0.9496541023254395,1,0.18228597939014435,0.8769596219062805,1,0.003877504267238893,0.9961224957327611,1
3872,2022/06/21、下痢が発症した。,0 0 0 下痢 発症 する た,1,0.016055653804777446,0.9839443461952224,1,0.0004078151711748432,0.9995921848288252,1,0.09359316286399222,0.9064068371360078,1,0.0006510536949024814,0.9993489463050975,1,0.07436006516218185,0.9476695656776428,1,0.17750220000743866,0.8774318099021912,1,0.004717142606048115,0.995282857393952,1
3873,atypical DiHSと診断された,atypical DiHS 診断 する れる た,1,0.023649766237092036,0.976350233762908,1,0.0003540011373633362,0.9996459988626366,1,0.10238321195210076,0.8976167880478992,1,0.28574491366054966,0.7142550863394503,1,0.0861668512225151,0.9452718496322632,1,0.19337153434753418,0.8699845671653748,1,0.00891156192497499,0.991088438075025,1
3874,血液検査の結果は、肝機能障害を示した。,血液検査 結果 肝機能障害 示す た,1,0.016682804004093638,0.9833171959959065,1,0.0002540106151904237,0.9997459893848096,1,0.23721691691501012,0.7627830830849899,1,0.00873330062701938,0.9912666993729806,1,0.09565757215023041,0.9364087581634521,1,0.1925048679113388,0.8501017689704895,1,0.006877669277749705,0.9931223307222503,1
3875,高体温症の結果、治療的処置がとられた。,高体温症 結果 治療 的 処置 とる れる た,1,0.011271898745902328,0.9887281012540976,1,0.0004082401163744229,0.9995917598836256,1,0.021486218659389933,0.9785137813406101,1,0.05828312379748768,0.9417168762025123,1,0.08790642768144608,0.9419645667076111,1,0.26124101877212524,0.8195794820785522,1,0.005327679179758462,0.9946723208202416,1
3876,消化管内視鏡検査:憩室症が認められた。,消化 管 内視鏡検査 憩室症 認める られる た,1,0.016688034291223456,0.9833119657087765,1,0.00029689014391215364,0.9997031098560879,1,0.0608646310211608,0.9391353689788392,1,0.09596077686683468,0.9040392231331653,1,0.08911263197660446,0.9434376358985901,1,0.19998623430728912,0.8617402911186218,1,0.005661108322631113,0.9943388916773689,1
3877,聴診上両側肺に断続性ラ音が聴取された。,聴診 上 両側肺 断続性ラ音 聴取 する れる た,1,0.16574487655081666,0.8342551234491832,1,0.00024123606040731558,0.9997587639395927,1,0.4692617135814625,0.5307382864185375,1,0.305547550949277,0.694452449050723,1,0.08448504656553268,0.943742573261261,1,0.19708430767059326,0.8583248853683472,1,0.025608038275855595,0.9743919617241444,1
3878,左不全麻痺を指摘され、当院紹介された。,左不全麻痺 指摘 する れる 院 紹介 する れる た,1,0.011538453815539659,0.9884615461844604,1,0.00034341063945900923,0.999656589360541,1,0.23385727188245164,0.7661427281175484,0,0.5625116659811624,0.4374883340188376,1,0.08926381170749664,0.9392238259315491,1,0.19235679507255554,0.8639059662818909,1,0.019743158759764387,0.9802568412402356,1
3879,しゃがむと手をつかないと立てなかった。,しゃがむ 手 つく ない 立てる ない た,0,0.9028725796767322,0.09712742032326793,0,9.395488724300726e-05,0.999906045112757,0,0.9902983424788883,0.009701657521111722,0,0.9968068495520446,0.0031931504479554133,0,0.9291298389434814,0.10489378869533539,0,0.6924540996551514,0.377741277217865,0,0.9487822090494892,0.051217790950510926,1
3880,検査:イレウスと診断、注記:接種翌日。,検査 イレウス 診断 注記 接種 翌日,1,0.016672810305356393,0.9833271896946434,1,0.00038852087761683944,0.9996114791223831,1,0.07543389025850633,0.9245661097414937,1,4.6952981415104844e-05,0.9999530470185849,1,0.17487218976020813,0.8959721922874451,0,0.6875397562980652,0.444633424282074,1,0.013478233726307118,0.9865217662736928,1
3881,メチコバール経口、腰・膝の疼痛のため。,メチコバール 経口 腰 膝 疼痛 ため,1,0.016679474391487124,0.9833205256085129,1,0.0002900446014042174,0.9997099553985958,1,0.17414383793182486,0.8258561620681751,1,6.392593562276616e-06,0.9999936074064377,1,0.39771801233291626,0.7761658430099487,1,0.42466869950294495,0.6313202977180481,1,0.014732460958143598,0.9852675390418564,1
3882,甲状腺ホルモン検査:(日付不明)陽性。,甲状腺ホルモン 検査 日付 不明 陽性,1,0.01669280989232023,0.9833071901076798,1,0.0003188158178751604,0.9996811841821248,1,0.2384967931424551,0.7615032068575449,1,6.37234620376459e-05,0.9999362765379624,1,0.2168676257133484,0.8528804779052734,0,0.8211902379989624,0.23957616090774536,1,0.028106250704153506,0.9718937492958464,1
3883,意識は清明だが、軽度の頭痛があった。,意識 清明 だ 軽度 頭痛 ある た,1,0.05750637386705633,0.9424936261329437,1,0.0004426637113737027,0.9995573362886263,1,0.22430356622390812,0.7756964337760919,1,0.19184375800346298,0.808156241996537,1,0.09992603212594986,0.9360840916633606,1,0.31235000491142273,0.7990299463272095,1,0.012436006573759999,0.9875639934262399,1
3884,02:50心室細動、けいれんが発現。,0 0 心室細動 けいれん 発現,1,0.01670694277383864,0.9832930572261613,1,0.00035076392942026013,0.9996492360705798,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08646401017904282,0.9384841918945312,1,0.18214534223079681,0.8719091415405273,1,0.004119424339165415,0.9958805756608345,1
3885,13:27嘔気を認めたが、嘔吐なし。,0 0 嘔気 認める た 嘔吐 ない,1,0.016693700109397944,0.9833062998906021,1,0.0002673833032914581,0.9997326166967085,1,0.431639638925998,0.568360361074002,1,0.007669085330917147,0.9923309146690829,1,0.2568127512931824,0.8334057331085205,1,0.23055025935173035,0.8598273396492004,1,0.013475293836911347,0.9865247061630885,1
3886,2021/09/07、尿閉を認めた。,0 0 0 尿閉 認める た,1,8.708651862115338e-07,0.9999991291348138,1,0.0005267447223350208,0.999473255277665,1,0.025944857950418232,0.9740551420495818,1,0.0001210126839860104,0.999878987316014,1,0.07542970776557922,0.9472970366477966,1,0.18513093888759613,0.876797080039978,1,0.004028411919134334,0.9959715880808657,1
3887,2021/10上旬、乾性咳嗽が出現。,0 0 上旬 乾性咳嗽 出現,1,0.01668213124935624,0.9833178687506438,1,0.0004064524184814631,0.9995935475815185,1,0.02097495322731857,0.9790250467726814,1,7.965313169944199e-05,0.9999203468683006,1,0.08406766504049301,0.9460257291793823,1,0.1920168548822403,0.8682451844215393,1,0.004227533687365982,0.9957724663126339,1
3888,2021/11/17精査目的に入院。,0 0 0 精査 目的 入院,1,0.03793815664977353,0.9620618433502264,1,0.0003250452769633776,0.9996749547230366,1,0.047706191085813754,0.9522938089141862,1,4.776650186499865e-10,0.999999999522335,0,0.6849667429924011,0.4719095826148987,1,0.23328015208244324,0.8511927127838135,1,0.014302479584726928,0.985697520415273,1
3889,2022/03/03倦怠感を認めた。,0 0 0 倦怠感 認める た,1,7.3785049421319306e-06,0.999992621495058,1,0.00046850971696060106,0.9995314902830394,1,0.010614461064794578,0.9893855389352054,1,0.000732028461571832,0.9992679715384282,1,0.07929889857769012,0.9499783515930176,1,0.18648399412631989,0.876699686050415,1,0.003921896282825587,0.9960781037171743,1
3890,2022/04/02めまいを認めた。,0 0 0 めまい 認める た,1,0.010316167509590088,0.9896838324904099,1,0.00042578937646206534,0.9995742106235379,1,0.025944857950418232,0.9740551420495818,1,1.0500627851572908e-05,0.9999894993721484,1,0.0770653784275055,0.9485524296760559,1,0.1839951127767563,0.8780960440635681,1,0.004101905353517912,0.995898094646482,1
3891,2022/04左手の筋力低下も出現。,0 0 左手 筋力低下 出現,1,0.003408972658283221,0.9965910273417168,1,0.0004828901312458431,0.9995171098687542,1,0.02097495322731857,0.9790250467726814,1,0.0009875634763663044,0.9990124365236337,1,0.08168748766183853,0.9444026947021484,1,0.18707995116710663,0.8693910241127014,1,0.0040973155910770925,0.9959026844089229,1
3892,2022/05/23夜間、胸痛出現。,0 0 0 夜間 胸痛 出現,1,0.005467005414180094,0.9945329945858199,1,0.0004225771326037452,0.9995774228673963,1,0.0061545250508937555,0.9938454749491062,1,1.5834711319939743e-09,0.9999999984165289,1,0.08082778006792068,0.9480893015861511,1,0.18921464681625366,0.87336665391922,1,0.0039608602774921075,0.9960391397225078,1
3893,2022/06/06息切れが再出現。,0 0 0 息切れ 出現,1,0.016675253829601416,0.9833247461703988,1,0.00042774073451814153,0.9995722592654819,1,0.02097495322731857,0.9790250467726814,1,2.4349411376078933e-12,0.9999999999975651,1,0.0838475152850151,0.9465426206588745,1,0.1895112693309784,0.8697035312652588,1,0.0042072435241004786,0.9957927564758994,1
3894,21:00頃37°C台の発熱が発現。,0 0 頃 0 C 台 発熱 発現,1,7.249413637363712e-08,0.9999999275058636,1,0.0006453917505586661,0.9993546082494413,1,0.0030949076225079697,0.996905092377492,1,0.0,1.0,1,0.08203643560409546,0.9499537348747253,1,0.1807183176279068,0.8731600046157837,1,0.003861316724341178,0.9961386832756587,1
3895,22:00頃アナフィラキシーが発現。,0 0 頃 アナフィラキシー 発現,1,0.005534831252048118,0.9944651687479521,1,0.0005079545936208787,0.9994920454063791,1,0.006430581757262188,0.9935694182427378,1,0.0,1.0,1,0.10438777506351471,0.9411013126373291,1,0.1816682070493698,0.8717877864837646,1,0.004062498281072892,0.9959375017189271,1
3896,5月30日、胸痛や呼吸困難を認めた。,0 月 0 日 胸痛 呼吸 困難 認める た,1,1.7936227107304214e-05,0.9999820637728927,1,0.0005069129884066314,0.9994930870115933,1,0.0108175401972056,0.9891824598027944,1,0.046395297589523876,0.9536047024104761,1,0.07386672496795654,0.9469873309135437,1,0.18503917753696442,0.8737136125564575,1,0.004293630893184648,0.9957063691068153,1
3897,以上から、網膜中心静脈閉塞症と診断。,以上 網膜中心静脈閉塞症 診断,1,0.015462799667149363,0.9845372003328505,1,0.0003479508071351653,0.9996520491928649,1,0.06260030355645518,0.9373996964435448,1,1.785737240622698e-05,0.9999821426275938,1,0.11971442401409149,0.9285423755645752,1,0.2159249484539032,0.8680591583251953,1,0.004946558622539361,0.9950534413774607,1
3898,以前はなかった右脚ブロックを認めた。,以前 ない た 右脚ブロック 認める た,1,0.016671580870414628,0.9833284191295852,1,0.00019453160394860547,0.9998054683960514,0,0.7543609872211063,0.24563901277889363,1,0.0008843369896976983,0.9991156630103023,1,0.07900353521108627,0.9429585337638855,1,0.20981620252132416,0.8478344678878784,1,0.018747849824369375,0.9812521501756306,1
3899,患者は心筋炎のため13日間入院した。,患者 心筋炎 ため 0 日間 入院 する た,1,1.7285021709200157e-06,0.999998271497829,1,0.0004623652293434053,0.9995376347706566,1,0.021222230150269916,0.9787777698497301,1,0.017965338399999586,0.9820346616000004,1,0.08215221017599106,0.9443168044090271,1,0.235010027885437,0.8403211236000061,1,0.004549525797544229,0.9954504742024559,1
3900,顔が黄色になっているとのことで受診。,顔 黄色 なる いる こと 受診,1,0.016673445582349393,0.9833265544176505,1,0.00025590402298318745,0.9997440959770169,1,0.12367960383948395,0.876320396160516,1,2.812316945988158e-08,0.9999999718768305,1,0.14155736565589905,0.9081295728683472,1,0.25517529249191284,0.820408046245575,1,0.006364802085593657,0.9936351979144062,1
3901,急性心不全と診断し、入院加療とした。,急性心不全 診断 入院 加療 する た,1,2.0712112270671772e-07,0.9999997928788773,1,0.0004430009756679512,0.999556999024332,1,0.01599761725525739,0.9840023827447426,1,0.005223461177986222,0.9947765388220138,1,0.08411339670419693,0.9434981346130371,1,0.20083484053611755,0.8684350252151489,1,0.004136927741614562,0.9958630722583853,1
3902,後遺症に右肩関節の外転制限を認めた。,後遺症 右肩 関節 外 転 制限 認める た,1,0.010310186038064165,0.989689813961936,1,0.0003490877153389118,0.9996509122846611,1,0.033384662606492976,0.966615337393507,1,0.08928487436156185,0.9107151256384381,1,0.07734958827495575,0.9488758444786072,1,0.19759032130241394,0.8623177409172058,1,0.005119346169818842,0.9948806538301811,1
3903,構音障害があることに家族が気付いた。,構音障害 ある こと 家族 気付く た,1,0.016680603209604093,0.9833193967903959,1,0.00023914466091119301,0.9997608553390888,1,0.21259679024711953,0.7874032097528805,1,0.0005960795910600059,0.99940392040894,1,0.3895103335380554,0.7557291984558105,1,0.20843160152435303,0.8492869734764099,1,0.010489361104123239,0.9895106388958766,1
3904,左後頭部̃側頭部の知覚異常があった。,左 後頭部 側 頭部 知覚異常 ある た,1,0.01667011312517937,0.9833298868748206,1,0.0002998681867040932,0.9997001318132959,1,0.40117940298781174,0.5988205970121883,1,0.10183808037728426,0.8981619196227157,1,0.08474472910165787,0.9440513253211975,1,0.19353535771369934,0.8592804670333862,1,0.011150290835506055,0.9888497091644939,1
3905,心電図と心痛所見より、心筋炎と診断。,心電図 心痛 所見 心筋炎 診断,1,0.009237741165090777,0.9907622588349092,1,0.00032367140811092026,0.999676328591889,1,0.04059108431532732,0.9594089156846727,1,1.943112337698949e-12,0.9999999999980569,1,0.11489850282669067,0.9321535229682922,1,0.1909572184085846,0.861283540725708,1,0.004553585504706754,0.9954464144952933,1
3906,接種後より頚部痛、左咽頭痛を認めた。,接種 後 頚部痛 左咽頭痛 認める た,1,0.012066893904062008,0.9879331060959381,1,0.0003288047884996637,0.9996711952115004,1,0.03295790184891123,0.9670420981510888,1,0.0004910081197910809,0.9995089918802089,1,0.08084534853696823,0.9475809335708618,1,0.18237559497356415,0.8645625114440918,1,0.004247224561091435,0.9957527754389086,1
3907,直接の死因は消化管出血と考えられた。,直接 死因 消化 管出血 考える られる た,1,0.01670270734379635,0.9832972926562035,1,0.00033550601563212684,0.9996644939843679,1,0.0792860558434838,0.9207139441565162,1,0.03990379895926688,0.9600962010407331,1,0.08424843847751617,0.9347832798957825,1,0.20489275455474854,0.8570050597190857,1,0.0053240060645792205,0.9946759939354207,1
3908,低酸素血症、KL-6の上昇を認めた。,低酸素血症 KL 0 上昇 認める た,1,5.4011651213374385e-06,0.9999945988348786,1,0.0005377839225162758,0.9994622160774838,1,0.010983784617431769,0.9890162153825682,1,0.001807744929938182,0.9981922550700618,1,0.08357444405555725,0.9431634545326233,1,0.18729977309703827,0.8755438327789307,1,0.003985243570785746,0.9960147564292143,1
3909,同日、発熱と嘔吐が発現したと言った。,同日 発熱 嘔吐 発現 する た 言う た,1,3.103983862313893e-06,0.9999968960161376,1,0.0003826746986013892,0.9996173253013986,1,0.0019513024123810618,0.9980486975876189,1,1.9826840877423813e-05,0.9999801731591226,1,0.0821244940161705,0.9496675133705139,1,0.18022805452346802,0.8668208122253418,1,0.0038746338117480066,0.9961253661882521,1
3910,尿細管上皮のうっ血及び腫脹を認めた。,尿細管上皮 の うっ血 腫脹 認める た,1,0.008635809620130521,0.9913641903798693,1,0.0003712248555307985,0.9996287751444692,1,0.026988341209902567,0.9730116587900974,1,0.0001589824353415148,0.9998410175646585,1,0.0862869843840599,0.9413703083992004,1,0.19292616844177246,0.8653268218040466,1,0.004255937208798549,0.9957440627912015,1
3911,肺炎の結果として治療措置が取られた。,肺炎 結果 治療 措置 取る れる た,1,0.003166567098931227,0.9968334329010687,1,0.0003384782165894552,0.9996615217834105,1,0.0650293872666261,0.9349706127333739,1,0.10961902788259714,0.8903809721174029,1,0.0995078980922699,0.9304227828979492,1,0.21313345432281494,0.853909432888031,1,0.0059678433512686015,0.9940321566487313,1
3912,両下肢のジンジンするしびれを訴えた。,下肢 ジンジン する しびれ 訴える た,1,0.016681490778965444,0.9833185092210345,1,0.0003856569822653866,0.9996143430177347,1,0.09739067343823427,0.9026093265617657,1,0.00011280345887454413,0.9998871965411255,1,0.08665889501571655,0.9475345611572266,1,0.2089197188615799,0.8515927791595459,1,0.005094899184944673,0.9949051008150552,1
3913,両側の肺炎と呼吸不全を指摘され入院。,両側 肺炎 呼吸不全 指摘 する れる 入院,1,3.1805368368412324e-07,0.9999996819463163,1,0.0007331477119842752,0.9992668522880157,1,0.01015974195603031,0.9898402580439697,1,5.009415104950676e-11,0.9999999999499058,1,0.08066284656524658,0.9401921629905701,1,0.1867869794368744,0.8688790202140808,1,0.003990521135653486,0.9960094788643465,1
3914,10/09、感冒持続のため受診した。,0 0 感冒 持続 ため 受診 する た,1,0.016699950826771677,0.9833000491732282,1,0.0004245108732434572,0.9995754891267565,1,0.06525872780082076,0.9347412721991792,1,0.10819242506636784,0.8918075749336322,1,0.07928548008203506,0.9507668018341064,1,0.18909317255020142,0.8750112652778625,1,0.005617427556735428,0.9943825724432647,1
3915,水様便と眼球結膜充血が、観察された。,水様便 眼球結膜 充血 観察 する れる た,1,0.01670567996338501,0.9832943200366151,1,0.00026172622478097134,0.9997382737752191,0,0.5434113812552768,0.45658861874472323,1,0.28538035465021105,0.714619645349789,1,0.08224724978208542,0.9490246176719666,1,0.21005813777446747,0.8444915413856506,1,0.021674786161275304,0.9783252138387246,1
3916,2022/04/27頃より発熱した。,0 0 0 頃 発熱 する た,1,0.012693114292332183,0.9873068857076677,1,0.00037349863990702477,0.999626501360093,1,0.02990848759554976,0.9700915124044502,1,0.00011182905930906539,0.9998881709406909,1,0.08355449885129929,0.9497042894363403,1,0.182180717587471,0.8758948445320129,1,0.0041781905791590185,0.995821809420841,1
3917,10/06、感冒症状あり、受診した。,0 0 感冒症状 ある 受診 する た,1,0.016671986598493817,0.9833280134015062,1,0.00038920925134829543,0.9996107907486517,1,0.11896748974069216,0.8810325102593078,1,0.07590021448609496,0.924099785513905,1,0.07711389660835266,0.9499092698097229,1,0.1876901239156723,0.8669989705085754,1,0.005892023045087517,0.9941079769549124,1
3918,日付不明、18点の右顔面麻痺を認めた,日付 不明 0点 右顔面麻痺 認める た,1,0.016686485287826812,0.983313514712173,1,0.00030037926381816895,0.9996996207361818,1,0.06003047830208996,0.93996952169791,1,0.007649904417552644,0.9923500955824474,1,0.07623232156038284,0.9470161199569702,1,0.19039689004421234,0.8721460103988647,1,0.004572107522207916,0.9954278924777922,1
3919,そして、摂氏40度の発熱を発現した。,摂氏 0度 発熱 発現 する た,1,2.623158569307721e-06,0.9999973768414306,1,0.0005387973094848349,0.9994612026905152,1,0.009219843030059072,0.9907801569699409,1,0.00030058732739868255,0.9996994126726013,1,0.08174953609704971,0.9503979086875916,1,0.184794083237648,0.8780558109283447,1,0.0039042161093423805,0.9960957838906577,1
3920,右眼の下転と外転に制限が認められた。,右 眼 転 外 転 制限 認める られる た,1,0.009283410139694297,0.9907165898603059,1,0.0002958531262525233,0.9997041468737474,1,0.03204726819446624,0.9679527318055338,1,0.08234958268053205,0.917650417319468,1,0.08906011283397675,0.9451978206634521,1,0.20848393440246582,0.8541914820671082,1,0.005199948576528202,0.9948000514234718,1
3921,右耳介の発赤、腫脹あり、右耳介に痂皮,右 耳介 発赤 腫脹 ある 右 耳介 痂皮,1,0.006058179467888794,0.9939418205321111,1,0.0004171260597267675,0.9995828739402732,1,0.12659011797892483,0.8734098820210752,1,3.6051432672490336e-07,0.9999996394856733,1,0.07780147343873978,0.9447145462036133,1,0.2279621809720993,0.8235030174255371,1,0.0055064014763515435,0.9944935985236484,1
3922,発熱、微熱、摂氏37度台が発現した。,発熱 微熱 摂氏 0度 台 発現 する た,1,4.885242845281823e-07,0.9999995114757155,1,0.0005711889409350571,0.9994288110590649,1,0.006446190413194497,0.9935538095868055,1,0.01839699174300602,0.981603008256994,1,0.07579311728477478,0.9499716758728027,1,0.18541787564754486,0.8742738962173462,1,0.00402096269594669,0.9959790373040532,1
3923,血中クレアチンホスホキナーゼMB増加,血 中 クレアチンホスホキナーゼ MB 増加,1,0.010631120575213041,0.989368879424787,1,0.0003286282483808867,0.9996713717516191,1,0.2347552482602464,0.7652447517397536,1,2.3565187690088862e-08,0.9999999764348123,1,0.11437901109457016,0.9278953075408936,1,0.342682421207428,0.7949081659317017,1,0.008373189186993656,0.9916268108130064,1
3924,02:50、患者の死亡が確認された。,0 0 患者 死亡 確認 する れる た,1,0.016675732661702976,0.9833242673382969,1,0.0002891827420827378,0.9997108172579172,0,0.6113758614561089,0.38862413854389116,1,0.350085113889425,0.649914886110575,1,0.11755937337875366,0.9192715883255005,1,0.4796358346939087,0.6557945609092712,1,0.04648527999025972,0.9535147200097402,1
3925,日付不明、心エコー像:軽度運動低下。,日付 不明 心 エコー 像 軽度 運動低下,1,0.01668661587565429,0.9833133841243457,1,0.0002711357557118826,0.9997288642442881,1,0.28763384021578486,0.7123661597842151,1,0.0027660904035043954,0.9972339095964956,1,0.1322641521692276,0.9249090552330017,1,0.24735815823078156,0.8373480439186096,1,0.008426434402388817,0.9915735655976112,1
3926,10:30アナフィラキシーが発現。,0 0 アナフィラキシー 発現,1,0.007051432920637645,0.9929485670793623,1,0.0004903491698115179,0.9995096508301885,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.09755188971757889,0.9412099719047546,1,0.18276271224021912,0.8691889047622681,1,0.004089453658838973,0.9959105463411612,1
3927,15:46血管迷走神経反射が発現。,0 0 血管迷走神経反射 発現,1,0.0038229069826913845,0.9961770930173087,1,0.00045949815021254593,0.9995405018497875,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08944956958293915,0.9460943341255188,1,0.18941742181777954,0.8706488609313965,1,0.0040315818047344095,0.9959684181952656,1
3928,18:00び漫性肺胞出血を認めた。,0 0 び漫性肺胞出血 認める た,1,0.010805313171843148,0.9891946868281568,1,0.00038663006420432616,0.9996133699357956,1,0.025944857950418232,0.9740551420495818,1,0.0005102063265793877,0.9994897936734206,1,0.07251795381307602,0.9476134777069092,1,0.18864063918590546,0.8716870546340942,1,0.004140259638243111,0.9958597403617568,1
3929,20:00皮膚粘膜眼症候群が発現。,0 0 皮膚粘膜 眼症 候 群 発現,1,0.01624366269859282,0.9837563373014073,1,0.00033998269966966597,0.9996600173003304,1,0.019436934980843867,0.9805630650191561,1,8.057435274544389e-09,0.9999999919425647,1,0.10347072780132294,0.9444432258605957,1,0.1837262362241745,0.8692229390144348,1,0.004259105041859749,0.9957408949581402,1
3930,2021/09上旬、息切れが出現。,0 0 上旬 息切れ 出現,1,0.014229396484942845,0.9857706035150571,1,0.0004189426036511461,0.9995810573963488,1,0.02097495322731857,0.9790250467726814,1,2.285899691756299e-09,0.9999999977141003,1,0.0819057822227478,0.9459765553474426,1,0.18961764872074127,0.8693540096282959,1,0.004182892816634722,0.9958171071833654,1
3931,2022/02/09関節炎が発現。,0 0 0 関節炎 発現,1,9.750077042684254e-07,0.9999990249922958,1,0.00047044049540178185,0.9995295595045982,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08695629239082336,0.948118269443512,1,0.18390026688575745,0.8724657297134399,1,0.003954140834162554,0.9960458591658373,1
3932,2022/03/01倦怠感が発現。,0 0 0 倦怠感 発現,1,9.858627991273623e-06,0.9999901413720087,1,0.0004822269424294208,0.9995177730575706,1,0.003039501375629805,0.9969604986243702,1,0.0,1.0,1,0.09122152626514435,0.9438077807426453,1,0.18554119765758514,0.8746795654296875,1,0.00393202302032645,0.9960679769796734,1
3933,2022/03/09髄膜炎が発現。,0 0 0 髄膜炎 発現,1,0.014016702217813681,0.9859832977821862,1,0.0003901576794185971,0.9996098423205814,1,0.00987732563689947,0.9901226743631005,1,4.440892098500626e-16,0.9999999999999996,1,0.0868927612900734,0.9480097889900208,1,0.18277078866958618,0.8741104602813721,1,0.00405440645360053,0.9959455935463993,1
3934,2022/03/10脊髄炎が発現。,0 0 0 脊髄炎 発現,1,0.013641454138574744,0.986358545861425,1,0.0004119239907233418,0.9995880760092767,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.0899510458111763,0.9457404613494873,1,0.1838773787021637,0.8683438301086426,1,0.004101083894024291,0.9958989161059757,1
3935,2022/03下旬頃、脱毛が出現。,0 0 下旬 頃 脱毛 出現,1,0.010703333900747075,0.989296666099253,1,0.0004382991808432371,0.9995617008191567,1,0.014003513319513217,0.9859964866804868,1,5.1476918725867904e-05,0.9999485230812741,1,0.09682642668485641,0.9363260865211487,1,0.19541241228580475,0.8647348880767822,1,0.004242171122308906,0.9957578288776912,1
3936,2022/04/08仕事中に失神。,0 0 0 仕事 中 失神,1,0.016666036951280584,0.9833339630487195,1,0.0003154021006089178,0.9996845978993911,1,0.38120158226216483,0.6187984177378352,1,0.0,1.0,1,0.09114721417427063,0.9453738927841187,1,0.19461049139499664,0.8615056276321411,1,0.008794845038922309,0.9912051549610778,1
3937,2022/05/02心筋炎が発現。,0 0 0 心筋炎 発現,1,0.003673429371144811,0.9963265706288552,1,0.0005488113393951493,0.9994511886606049,1,0.0033982837012268563,0.9966017162987731,1,0.0,1.0,1,0.08669333904981613,0.9443697333335876,1,0.18094654381275177,0.8723744750022888,1,0.0039351503475693874,0.9960648496524307,1
3938,2022/05/26倦怠感が増悪。,0 0 0 倦怠感 増悪,1,0.004229344199657656,0.9957706558003423,1,0.00035887481543736896,0.9996411251845626,1,0.1051280301361609,0.8948719698638391,1,1.8207657603852567e-14,0.9999999999999818,1,0.09881915897130966,0.946474552154541,1,0.19294649362564087,0.8706449866294861,1,0.004937622982567816,0.9950623770174323,1
3939,2022/06/19解熱を認めた。,0 0 0 解熱 認める た,1,0.05570048529927948,0.9442995147007206,1,0.00022014134207507888,0.999779858657925,1,0.09309891209554388,0.9069010879044561,1,0.10536513582290474,0.8946348641770953,1,0.22896862030029297,0.8271719217300415,0,0.5724520683288574,0.5047203302383423,1,0.017606873170181007,0.982393126829819,1
3940,2022年4月19日胸痛増悪した。,0 年 0 月 0 日 胸痛 増悪 する た,1,0.01670339771625697,0.983296602283743,1,0.0003428259251971214,0.9996571740748029,1,0.0907601860042817,0.9092398139957183,1,0.008755281384388747,0.9912447186156113,1,0.07929849624633789,0.9489668607711792,1,0.18963849544525146,0.8760666251182556,1,0.004854547032546211,0.9951454529674538,1
3941,2022年7月(約)肝損傷が発見。,0 年 0 月 肝損傷 発見,1,0.01671147509768381,0.9832885249023161,1,0.00035777544659569625,0.9996422245534043,1,0.3607204586964663,0.6392795413035337,1,3.796074565798335e-12,0.9999999999962039,1,0.1835932433605194,0.8791084885597229,1,0.19365525245666504,0.8675245046615601,1,0.009816699820960102,0.99018330017904,1
3942,39.6°Cの高熱、倦怠感を自覚。,0 0 C 高熱 倦怠感 自覚,1,9.372683320294254e-08,0.9999999062731667,1,0.0006040325344640612,0.9993959674655359,1,0.015776481785511165,0.9842235182144888,1,0.0,1.0,1,0.08746366202831268,0.9501909613609314,1,0.1859707534313202,0.8594520092010498,1,0.004056187543632832,0.9959438124563671,1
3943,4日後から両手・口唇の痺れを発症。,0 日 後 両手 口唇 痺れ 発症,1,0.016680146593352364,0.9833198534066475,1,0.0003867878505420282,0.999613212149458,1,0.1057160099271166,0.8942839900728834,1,0.0,1.0,1,0.08741188794374466,0.9367083311080933,1,0.18700505793094635,0.8712847828865051,1,0.0050264095154630185,0.9949735904845369,1
3944,5分以内の痙攣発作を頻回に認めた。,0分 以内 痙攣 発作 頻る 回 認める た,1,0.010603987927918139,0.9893960120720819,1,0.00036214347594279694,0.9996378565240572,1,0.0274731958500406,0.9725268041499594,1,0.018245209979640742,0.9817547900203593,1,0.07862062007188797,0.9510776996612549,1,0.18776154518127441,0.872721791267395,1,0.004303352581882067,0.995696647418118,1
3945,9/12、発熱、呼吸苦が出現した。,0 0 発熱 呼吸苦 出現 する た,1,4.651550752283594e-07,0.9999995348449247,1,0.0005384142135673575,0.9994615857864326,1,0.007081099675880997,0.992918900324119,1,0.006615782191413899,0.9933842178085861,1,0.07472852617502213,0.952034056186676,1,0.17935769259929657,0.8761363625526428,1,0.00388936402372719,0.9961106359762729,1
3946,apnea、尿便失禁が認められた。,apnea 尿便失禁 認める られる た,1,0.01670912241608639,0.9832908775839138,1,0.0003296123695267143,0.9996703876304733,1,0.06699734358191589,0.9330026564180841,1,0.09275611742640555,0.9072438825735945,1,0.08558903634548187,0.9425032734870911,1,0.1997528076171875,0.8586069345474243,1,0.005696537203889803,0.9943034627961101,1
3947,COVID-19の発症を診断した。,COVID 0 発症 診断 する た,1,5.86527632664412e-06,0.9999941347236734,1,0.0007263255779539989,0.999273674422046,1,0.04335899038743152,0.9566410096125685,1,0.0013580840319602494,0.9986419159680398,1,0.08911250531673431,0.9442314505577087,1,0.1898113489151001,0.8740081787109375,1,0.004284672656808393,0.9957153273431915,1
3948,COVID-19を発症したと診断。,COVID 0 発症 する た 診断,1,5.86527632664412e-06,0.9999941347236734,1,0.0007263255779539989,0.999273674422046,1,0.04335899038743152,0.9566410096125685,1,5.836771066469737e-10,0.9999999994163229,1,0.08712621033191681,0.9438736438751221,1,0.19202370941638947,0.8658720254898071,1,0.004310363387607121,0.9956896366123927,1
3949,オムツには赤褐色の浸出液を認めた。,オムツ 赤褐色 浸出液 認める た,1,0.01669429414947103,0.983305705850529,1,0.0003284470834588871,0.9996715529165411,1,0.03271476643218074,0.9672852335678193,1,0.00393794152676008,0.9960620584732399,1,0.08266999572515488,0.9462906122207642,1,0.2151307314634323,0.8488646745681763,1,0.004541239694843394,0.9954587603051566,1
3950,コロナ感染症をPCRより鑑別した。,コロナ 感染症 PCR 鑑別 する た,1,0.08209600631441129,0.9179039936855887,1,0.00017242250178873528,0.9998275774982113,1,0.47961583475769,0.52038416524231,1,0.030278732148038334,0.9697212678519617,1,0.1674293577671051,0.8926127552986145,1,0.5111685395240784,0.6586401462554932,1,0.024403345280704692,0.9755966547192952,1
3951,しかし翌日、心室細動を2回認めた。,翌日 心室細動 0回 認める た,1,0.01666078926256145,0.9833392107374385,1,0.0003595650851280161,0.999640434914872,1,0.01794954489651568,0.9820504551034843,1,0.03228956081422696,0.967710439185773,1,0.08196401596069336,0.943576991558075,1,0.18423889577388763,0.8711419105529785,1,0.004434054023878888,0.9955659459761211,1
3952,その後から右顔面の麻痺が出現した。,その後 右 顔面 麻痺 出現 する た,1,0.005397146719531439,0.9946028532804684,1,0.00046737328557270463,0.9995326267144273,1,0.010166800015328548,0.9898331999846715,1,0.04685255556724699,0.953147444432753,1,0.08381788432598114,0.9438362717628479,1,0.19955366849899292,0.8660916090011597,1,0.00449274482549791,0.9955072551745021,1
3953,また、左鎖骨上窩の圧痛が見られた。,左 鎖骨 上 窩 圧痛 見る られる た,1,0.01669059534123964,0.9833094046587604,1,0.0003098862626099669,0.99969011373739,1,0.2634171108443446,0.7365828891556554,1,0.08116953612568445,0.9188304638743156,1,0.09041804820299149,0.9451087117195129,1,0.19970010221004486,0.8500556349754333,1,0.008310651145941083,0.9916893488540588,1
3954,顔面発赤、強い嘔気、腹痛を認めた。,顔面発赤 強い 嘔気 腹痛 認める た,1,0.002718155557645535,0.9972818444423543,1,0.0004156625849410965,0.9995843374150589,1,0.0228270300578719,0.9771729699421281,1,0.001335854884171983,0.998664145115828,1,0.08312595635652542,0.9478242993354797,1,0.18698367476463318,0.8675376176834106,1,0.004108178565795627,0.9958918214342044,1
3955,頚部から左胸痛が出現し、当院受診。,頚部 左胸痛 出現 院 受診,1,1.6626040957491432e-06,0.9999983373959043,1,0.0004566588125042063,0.9995433411874958,1,0.009482259603795229,0.9905177403962048,1,2.8774760352234807e-12,0.9999999999971225,1,0.08134118467569351,0.9438326358795166,1,0.20443880558013916,0.8568785786628723,1,0.004090251979357107,0.9959097480206429,1
3956,後遺症として左半身不全麻痺が残る。,後遺症 する 左半身不全 麻痺 残る,1,0.016686074883823097,0.9833139251161769,1,0.000377673542458914,0.9996223264575411,1,0.4637986912464749,0.5362013087535251,1,1.6184831252985532e-11,0.9999999999838152,1,0.10154102742671967,0.9359719157218933,1,0.24970149993896484,0.8428267240524292,1,0.011364500167946911,0.9886354998320531,1
3957,今の体調は咳があるくらいであった。,今 体調 咳 ある だ ある た,1,0.016664662455493508,0.9833353375445067,1,0.0003107261207423432,0.9996892738792577,0,0.6413040603704893,0.35869593962951074,0,0.9540110021512245,0.04598899784877558,1,0.24581295251846313,0.8104924559593201,1,0.29537782073020935,0.8211223483085632,1,0.13402344027527666,0.8659765597247234,1
3958,左肩関節痛、左上肢の浮腫を認めた。,左肩関節痛 左上 肢 浮腫 認める た,1,0.006383692845574645,0.9936163071544253,1,0.00039904093918491097,0.9996009590608151,1,0.03271476643218074,0.9672852335678193,1,0.00048773310628669186,0.9995122668937133,1,0.0756886750459671,0.9496986269950867,1,0.1905713528394699,0.8621553778648376,1,0.004211887926366143,0.9957881120736338,1
3959,左上腕熱感、痛み、違和感があった。,左上腕熱感 痛み 違和感 ある た,1,0.01666169272952465,0.9833383072704754,1,0.0003261347360740939,0.9996738652639259,1,0.05355589505563696,0.946444104944363,1,0.0676502480891128,0.9323497519108872,1,0.08153987675905228,0.9471169114112854,1,0.20701952278614044,0.8607136011123657,1,0.005257212937417748,0.9947427870625821,1
3960,耳鳴りは改善されず、不眠もあった。,耳鳴り 改善 する れる ぬ 不眠 ある た,1,0.016696973158310677,0.9833030268416892,1,0.0001968564206976529,0.9998031435793023,0,0.8713560350049323,0.12864396499506775,1,0.26696309078948377,0.7330369092105162,1,0.45376959443092346,0.7171001434326172,1,0.3065289855003357,0.7763143181800842,1,0.08145875641563087,0.9185412435843692,1
3961,足のない子供や大人が見えると話す。,足 ない 子供 大人 見える 話す,1,0.016673929746006504,0.9833260702539934,1,0.0002526180466520515,0.999747381953348,0,0.8454964221087805,0.15450357789121946,1,1.0930794447361336e-07,0.9999998906920555,1,0.20871059596538544,0.8821181058883667,1,0.2249450385570526,0.8143320083618164,1,0.02825155906010905,0.9717484409398909,1
3962,体重減少:発症後9 kg減少した。,体重減少 発症 後 0 kg 減少 する た,1,0.016684030356524875,0.9833159696434751,1,0.0003113857518234772,0.9996886142481766,1,0.09386907046077797,0.906130929539222,1,0.35627374668622513,0.6437262533137749,1,0.13607190549373627,0.9135932922363281,1,0.21466802060604095,0.8736789226531982,1,0.01096245736822279,0.9890375426317772,1
3963,脱毛症に対して治療措置が取られた。,脱毛症 治療 措置 取る れる た,1,0.016708401584870674,0.9832915984151295,1,0.000279601004134155,0.9997203989958658,1,0.4743757479787001,0.5256242520212999,1,0.10242313765971234,0.8975768623402877,1,0.1254473775625229,0.9129274487495422,1,0.21584472060203552,0.8635696768760681,1,0.014096509575633865,0.9859034904243662,1
3964,注射後、WBC数が徐々に減少した。,注射 後 WBC 数 減少 する た,1,0.0293008197819571,0.9706991802180429,1,0.0003509462500059766,0.999649053749994,1,0.44175068109612947,0.5582493189038705,0,0.6527209155960049,0.34727908440399513,1,0.2466941624879837,0.8638364672660828,0,0.7372843623161316,0.3049474060535431,1,0.12602641513027096,0.873973584869729,1
3965,頭部CTにて、腫瘍内出血を認めた。,頭部 C，T 腫瘍 内出血 認める た,1,0.006108884014856074,0.993891115985144,1,0.0002653339047823316,0.9997346660952177,1,0.07731530055675484,0.9226846994432452,1,4.258117866640099e-05,0.9999574188213336,1,0.0764942541718483,0.9430758953094482,1,0.18734709918498993,0.8721672892570496,1,0.004568744469469282,0.9954312555305307,1
3966,日付不明37.5°Cの発熱が発現。,日付 不明 0 0 C 発熱 発現,1,1.6191891193823542e-06,0.9999983808108805,1,0.00037671309532930655,0.9996232869046707,1,0.00819854351141136,0.9918014564885886,1,0.0,1.0,1,0.09185508638620377,0.9471651315689087,1,0.18093274533748627,0.8708099722862244,1,0.003958067247527084,0.996041932752473,1
3967,日付不明接種3週間後、高熱が発現。,日付 不明 接種 0 週間 後 高熱 発現,1,0.016685211691606243,0.9833147883083937,1,0.00031110184080226667,0.9996888981591977,1,0.023291538442668624,0.9767084615573314,1,0.0,1.0,1,0.09577175974845886,0.9442452788352966,1,0.18749387562274933,0.862236738204956,1,0.0043093880103590365,0.9956906119896409,1
3968,本報告は、脊椎炎の基準を満たした。,報告 脊椎炎 基準 満たす た,1,0.016664581293939027,0.983335418706061,1,0.00034291885388037607,0.9996570811461196,1,0.44317765831659817,0.5568223416834018,1,0.00024891018991768377,0.9997510898100823,1,0.2009906768798828,0.8905121088027954,1,0.39990222454071045,0.7288105487823486,1,0.016341649181740827,0.9836583508182591,1
3969,膠原病の方からの心臓弁膜炎と診断。,膠原病 方 心臓 弁膜炎 診断,1,0.01668069643493299,0.9833193035650668,1,0.0003194992864293841,0.9996805007135706,1,0.08039869684093537,0.9196013031590646,1,1.856405618116952e-08,0.9999999814359438,1,0.134078249335289,0.9188426733016968,1,0.1879195272922516,0.8703527450561523,1,0.0051050860016718215,0.9948949139983282,1
3970,発熱を認め、同日、前医に入院した。,発熱 認める 同日 医 入院 する た,1,8.530105922297596e-07,0.9999991469894078,1,0.0005666009241444535,0.9994333990758556,1,0.005668749432803377,0.9943312505671966,1,0.06114601798684949,0.9388539820131505,1,0.07939913123846054,0.9466450214385986,1,0.18565277755260468,0.8644853830337524,1,0.004445913678741508,0.9955540863212585,1
3971,患者はCOVIDー19を発症した。,患者 COVID ー 0 発症 する た,1,0.02464177486039099,0.9753582251396089,1,0.0002978911392576744,0.9997021088607423,1,0.10788480641642617,0.8921151935835738,1,0.0006163059593398135,0.9993836940406602,1,0.08788278698921204,0.9431502819061279,1,0.209445521235466,0.8518661260604858,1,0.005320747404206808,0.9946792525957933,1
3972,患者は結膜充血(眼系)を発現した。,患者 結膜充血 眼 系 発現 する た,1,0.02387791696946883,0.9761220830305312,1,0.00023191583762272397,0.9997680841623773,1,0.015637459802734566,0.9843625401972654,1,0.07267258503371521,0.9273274149662848,1,0.1042957454919815,0.9475385546684265,1,0.21169665455818176,0.8414607644081116,1,0.005229652021242448,0.9947703479787575,1
3973,両側大脳、視床に広範な血管原性浮腫,両側 大脳 視床 広範 だ 血管原性 浮腫,1,0.016702105875777595,0.9832978941242224,1,0.00033173048983698475,0.999668269510163,0,0.5164888610134042,0.4835111389865958,1,9.015010959956271e-12,0.999999999990985,1,0.08712335675954819,0.9320417642593384,1,0.21770723164081573,0.8460145592689514,1,0.012054609085372089,0.987945390914628,1
3974,アイスパックテストは陽性であった。,アイスパックテスト 陽性 だ ある た,1,0.016671001976111294,0.9833289980238885,1,0.00037814672738842867,0.9996218532726115,1,0.23846090304536105,0.761539096954639,0,0.9320036459768856,0.06799635402311446,1,0.12584595382213593,0.9185869693756104,1,0.40438657999038696,0.7574784755706787,1,0.05892233135241533,0.9410776686475847,1
3975,"ALT(GPT), 61 high",ALT GPT 0 high,1,0.024962433313062655,0.9750375666869373,1,0.0003684479624939621,0.9996315520375061,1,0.3607204586964663,0.6392795413035337,1,0.0,1.0,1,0.24027633666992188,0.8424878716468811,1,0.5098938345909119,0.6303535103797913,1,0.01888042761532109,0.981119572384679,1
3976,2021/07/06皮疹は痂皮化。,0 0 0 皮疹 痂皮化,1,0.016711987252315003,0.983288012747685,1,0.00025198113557303384,0.999748018864427,1,0.37935887182533035,0.6206411281746697,1,0.028621803684385272,0.9713781963156147,1,0.15817463397979736,0.9009680151939392,1,0.20653009414672852,0.8576036691665649,1,0.010519205556976177,0.9894807944430238,1
3977,18:16冷感、頭重感を認めた。,0 0 冷感 頭重感 認める た,1,0.012092746430224365,0.9879072535697757,1,0.0003535442417296682,0.9996464557582704,1,0.027668999526336058,0.9723310004736639,1,0.0015516341360755082,0.9984483658639245,1,0.08625223487615585,0.9503065943717957,1,0.18883632123470306,0.8776284456253052,1,0.004195607772892396,0.9958043922271076,1
3978,接種後より四肢のしびれがあった。,接種 後 四肢のしびれ ある た,1,0.016695255586889998,0.98330474441311,1,0.0002838622773054015,0.9997161377226946,1,0.18625885336127357,0.8137411466387264,1,0.07159754277730923,0.9284024572226908,1,0.09953802078962326,0.9386221766471863,1,0.19995680451393127,0.8494006991386414,1,0.007111840042762466,0.9928881599572376,1
3979,2021/07/20頭痛が発現。,0 0 0 頭痛 発現,1,0.0030382602132527498,0.9969617397867474,1,0.0006031558638833095,0.9993968441361167,1,0.0034654486011322927,0.9965345513988677,1,0.0,1.0,1,0.08363623172044754,0.9469341039657593,1,0.18204715847969055,0.8705233931541443,1,0.003920685495782297,0.9960793145042177,1
3980,2022/03/04頭痛が出現。,0 0 0 頭痛 出現,1,0.004437761694079679,0.9955622383059203,1,0.0005905392289197615,0.9994094607710803,1,0.0034828816805111407,0.9965171183194889,1,3.0114583715601384e-08,0.9999999698854163,1,0.08177130669355392,0.9457425475120544,1,0.18483510613441467,0.8716936707496643,1,0.003935369449792583,0.9960646305502074,1
3981,2022/04急性心不全と診断。,0 0 急性心不全 診断,1,0.016683226526490926,0.9833167734735091,1,0.00038223084324710957,0.9996177691567529,1,0.06694048937330044,0.9330595106266996,1,0.0,1.0,1,0.11182087659835815,0.940985381603241,1,0.18474219739437103,0.8713439702987671,1,0.004736286341956069,0.995263713658044,1
3982,2022/04頃肩の痛みが悪化。,0 0 頃 肩 痛み 悪化,1,0.014532654669351363,0.9854673453306487,1,0.0004047774817201553,0.9995952225182798,1,0.10901370305824365,0.8909862969417564,1,2.90878432451791e-14,0.9999999999999709,1,0.09381154924631119,0.9457218647003174,1,0.19712719321250916,0.8673688769340515,1,0.005095698864563693,0.9949043011354364,1
3983,2022/05/01発熱が発現。,0 0 0 発 熱 発現,1,5.504732483198387e-07,0.9999994495267517,1,0.0004394981407648625,0.9995605018592352,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08307867497205734,0.9488121867179871,1,0.18115809559822083,0.872042715549469,1,0.003926848974024886,0.9960731510259752,1
3984,2022/06/21朝から発熱。,0 0 0 朝 発熱,1,0.005569210125761796,0.9944307898742382,1,0.0003612323383477329,0.9996387676616523,1,0.03402325630758096,0.965976743692419,1,0.0,1.0,1,0.09020919352769852,0.9466913342475891,1,0.1938098669052124,0.8619881272315979,1,0.0043003338901582075,0.9956996661098417,1
3985,3.目がまぶしてTV見られない。,0 目 まぶす TV 見る られる ない,1,0.2684964264115871,0.7315035735884129,0,0.00013214286721545656,0.9998678571327846,0,0.9201315473288436,0.07986845267115637,1,0.12389706803066669,0.8761029319693333,0,0.8770332336425781,0.2907441556453705,1,0.24452009797096252,0.8308176398277283,1,0.20186250342096143,0.7981374965790385,1
3986,COVID-19の発症を認めた。,COVID 0 発症 認める た,1,5.96373275920877e-07,0.9999994036267241,1,0.000996595121316068,0.9990034048786839,1,0.010083035660682138,0.9899169643393179,1,4.412514797991207e-11,0.9999999999558749,1,0.07817886024713516,0.9483979344367981,1,0.18610674142837524,0.8740091919898987,1,0.003926936250088203,0.9960730637499117,1
3987,ギラン・バレー症候群が発現した。,ギラン・バレー症候群 発現 する た,1,0.013914473570830865,0.986085526429169,1,0.00040940447991654784,0.9995905955200834,1,0.02288969230989535,0.9771103076901047,1,0.0007972355267878983,0.9992027644732121,1,0.10530117899179459,0.9407232403755188,1,0.1959267556667328,0.8646778464317322,1,0.004372006891294957,0.995627993108705,1
3988,めまいを伴う右突発性難聴の診断。,めまい 伴う 右 突発性 難聴 の 診断,1,1.2339246306061833e-06,0.9999987660753693,1,0.0006464449474687957,0.9993535550525312,1,0.010887247683598056,0.9891127523164019,1,1.702008456394566e-08,0.9999999829799154,1,0.09781192243099213,0.9341984391212463,1,0.19293366372585297,0.865801215171814,1,0.004126526590222569,0.9958734734097774,1
3989,下肢の先端にチアノーゼを認めた。,下肢 先端 チアノーゼ 認める た,1,0.016676399303491404,0.9833236006965085,1,0.0003609869789314303,0.9996390130210686,1,0.02992298022855866,0.9700770197714413,1,8.198993667596355e-05,0.999918010063324,1,0.07810640335083008,0.9463236331939697,1,0.19638469815254211,0.8607978224754333,1,0.004326994777990162,0.9956730052220099,1
3990,下痢、嘔気、腹痛、呼吸不全あり。,下痢 嘔気 腹痛 呼吸不全 ある,1,0.00786931657084591,0.9921306834291542,1,0.0003457761158611407,0.9996542238841388,1,0.15391353655548623,0.8460864634445138,1,3.6615155352137663e-13,0.9999999999996338,1,0.08919483423233032,0.9407800436019897,1,0.2040291577577591,0.8514931201934814,1,0.005625567965251697,0.9943744320347483,1
3991,胸痛は一時回復したが、再発した。,胸痛 一時 回復 する た 再発 する た,1,0.016701167339422805,0.983298832660577,0,0.0001603712189046121,0.9998396287810953,0,0.5863785049046875,0.4136214950953126,1,0.11976259719874305,0.880237402801257,1,0.576662003993988,0.5807588696479797,1,0.24205853044986725,0.8290548920631409,1,0.04128526369967952,0.9587147363003206,1
3992,胸部CTでは肺うっ血像を認めた。,胸部 CT 肺うっ血像 認める た,1,0.024363980015068277,0.9756360199849319,1,0.0003341792250712855,0.9996658207749287,1,0.08083122747376026,0.9191687725262397,1,0.00019712277841055226,0.9998028772215894,1,0.09019012004137039,0.9417778849601746,1,0.19157472252845764,0.864754855632782,1,0.004901429606221933,0.995098570393778,1
3993,胸部X線検査で心拡大を疑う所見。,胸部 X線検査 だ 心拡大 疑う 所見,0,0.5281073378502158,0.47189266214978426,1,0.00020741673462864197,0.9997925832653713,0,0.7459798254552844,0.2540201745447156,1,7.855869288420081e-10,0.9999999992144131,1,0.10626021027565002,0.9183618426322937,1,0.22334645688533783,0.843725323677063,1,0.05295564076718122,0.9470443592328187,1
3994,血液検査にてCRP上昇を認めた。,血液検査 CRP 上昇 認める た,1,1.8054003791762633e-05,0.9999819459962083,1,0.0005668498865298906,0.9994331501134701,1,0.012340394525310328,0.9876596054746897,1,0.00037304381146163745,0.9996269561885384,1,0.09130700677633286,0.9416325688362122,1,0.18938201665878296,0.8665944337844849,1,0.004066323890853204,0.9959336761091468,1
3995,顕微鏡検査:糸球体4個を認めた。,顕微鏡 検査 糸球体 0 個 認める た,1,0.016683736783094975,0.9833162632169049,1,0.0003128022705302925,0.9996871977294697,1,0.04264382233352082,0.9573561776664792,1,0.02010582648998127,0.9798941735100187,1,0.09570282697677612,0.9371788501739502,1,0.19383741915225983,0.8611050248146057,1,0.0047292355500150205,0.9952707644499849,1
3996,午後、38°C台の発熱を認めた。,午後 0 C 台 発熱 認める た,1,3.2392456790287932e-06,0.999996760754321,1,0.0005141972727358164,0.9994858027272642,1,0.010358510224410145,0.9896414897755899,1,1.756174208211725e-05,0.9999824382579179,1,0.07659335434436798,0.950518786907196,1,0.18336234986782074,0.8722100853919983,1,0.0039073294863213245,0.9960926705136787,1
3997,午前、一時的全身状態悪化が発現。,午前 一時的 全身状態悪化 発現,1,0.01230563320051293,0.987694366799487,1,0.0003614268941333226,0.9996385731058667,1,0.0139694990307071,0.9860305009692929,1,1.3937524467877438e-09,0.9999999986062476,1,0.1447606235742569,0.9348244667053223,1,0.19552016258239746,0.8619645237922668,1,0.004481815932172138,0.995518184067828,1
3998,高感度心筋マーカー高値を認めた。,感度 心筋 マーカー 高値 認める た,1,0.016693874378467498,0.9833061256215323,1,0.0003324523103814654,0.9996675476896185,1,0.008480197145708246,0.9915198028542918,1,0.0010474733095787725,0.9989525266904212,1,0.08743572235107422,0.9429408311843872,1,0.1944115310907364,0.8635970950126648,1,0.004186967992980916,0.9958130320070192,1
3999,左肩から手の節の上の痛みが発現。,左肩 手 節 上 痛み 発現,1,1.4594612189471049e-05,0.9999854053878106,1,0.00041458906304003395,0.99958541093696,1,0.004298960604859903,0.9957010393951401,1,2.3172552765515775e-10,0.9999999997682745,1,0.0903061032295227,0.9403810501098633,1,0.20408831536769867,0.8559122085571289,1,0.004100887479731798,0.9958991125202682,1
4000,四肢の遠位部の筋力低下を認めた。,四肢 遠い 位部 筋力低下 認める た,1,0.004154496759830916,0.995845503240169,1,0.0004242072755487971,0.9995757927244512,1,0.03271476643218074,0.9672852335678193,1,0.010907396477324971,0.989092603522675,1,0.08005734533071518,0.9472435712814331,1,0.20536473393440247,0.8580492734909058,1,0.004392436724162337,0.9956075632758378,1
4001,自宅で眼前暗黒から失神を認めた。,自宅 だ 眼前暗黒 失神 認める た,1,0.013896945406090044,0.98610305459391,1,0.0002971039524954662,0.9997028960475045,1,0.10312482310691051,0.8968751768930895,1,0.001303835684810628,0.9986961643151894,1,0.07667142897844315,0.9487883448600769,1,0.19047729671001434,0.8658503890037537,1,0.004916427428339276,0.9950835725716607,1
4002,徐々に胸まで発赤、膨疹を認めた。,胸 発赤 膨疹 認める た,1,0.019236055994842446,0.9807639440051574,1,0.0003208709545517912,0.9996791290454482,1,0.03612019239178477,0.9638798076082152,1,0.00035344217256305654,0.9996465578274369,1,0.07969751209020615,0.9454560279846191,1,0.1889754980802536,0.8594930768013,1,0.004389175827518354,0.9956108241724816,1
4003,心磁気共鳴映像法:異常(異常)。,心 磁気 共鳴 映像 法 異常 異常,1,0.01667420270057661,0.9833257972994234,1,0.0001672678556541807,0.9998327321443459,1,0.23923436640119278,0.7607656335988072,1,0.0,1.0,1,0.1429833620786667,0.8980419635772705,1,0.20049284398555756,0.8620807528495789,1,0.007358636063797714,0.9926413639362023,1
4004,心電図で心房細動の再発を認めた。,心電図 だ 心房細動 再発 認める た,1,0.01859554803039132,0.9814044519696085,1,0.0002678138478905816,0.9997321861521095,1,0.07446549152219584,0.9255345084778042,1,0.0011148030098795392,0.9988851969901205,1,0.08536617457866669,0.937720775604248,1,0.19270044565200806,0.8604403138160706,1,0.004814930269544293,0.9951850697304557,1
4005,心電図にて右脚ブロックを認めた。,心電図 右脚ブロック 認める た,1,8.028544825366024e-07,0.9999991971455174,1,0.0004925463491868598,0.9995074536508132,1,0.02780472192166561,0.9721952780783344,1,0.06571150441385332,0.9342884955861467,1,0.07750364392995834,0.946090817451477,1,0.1973043978214264,0.8530676960945129,1,0.004790438770417146,0.9952095612295829,1
4006,接種2日後に肉眼的血尿を認めた。,接種 0 日 後 肉眼的血尿 認める た,1,0.009668978590437336,0.9903310214095626,1,0.0003778028405071324,0.9996221971594929,1,0.028706039454886034,0.971293960545114,1,0.06412721328601734,0.9358727867139827,1,0.07871558517217636,0.9490708708763123,1,0.1841742992401123,0.8665177226066589,1,0.004740133192533376,0.9952598668074667,1
4007,息切れ、動悸を認め、徐々に増悪。,息切れ 動悸 認める 増悪,1,1.1347452475063707e-05,0.9999886525475249,1,0.00048749887366435457,0.9995125011263356,1,0.033766309795227545,0.9662336902047725,1,0.0,1.0,1,0.0904541015625,0.9467881917953491,1,0.20856894552707672,0.8691627979278564,1,0.0042847563375299986,0.99571524366247,1
4008,直後から接種部位の疼痛を認めた。,直後 接種 部位 疼痛 認める た,1,0.016712808009076978,0.9832871919909232,1,0.00033350186117775876,0.9996664981388222,1,0.02474683862366267,0.9752531613763373,1,0.0017094033148360444,0.998290596685164,1,0.09588013589382172,0.9445576667785645,1,0.19161419570446014,0.8588318824768066,1,0.004368793136130047,0.9956312068638699,1
4009,頭痛と倦怠感で就業できていない。,頭痛 倦怠感 就業 できる いる ない,1,0.01671239176396758,0.9832876082360325,1,0.00019780106540997458,0.99980219893459,1,0.4194655200715758,0.5805344799284242,0,0.6977673068454315,0.3022326931545685,1,0.2702668309211731,0.8126431703567505,1,0.34243711829185486,0.7927802801132202,1,0.06154689617903747,0.9384531038209625,1
4010,特発性血小板減少性紫斑病と診断。,特発性 血小板減少 性 紫斑病 診断,1,0.007774882872344716,0.9922251171276552,1,0.0004522834776487556,0.9995477165223512,1,0.01705790872554258,0.9829420912744574,1,3.726873254450425e-09,0.9999999962731267,1,0.14011511206626892,0.9154471755027771,1,0.21008093655109406,0.8684780597686768,1,0.0045722868210889495,0.995427713178911,1
4011,突然、眼球運動制限、複視が出現。,眼球運動制限 複視 出現,1,0.007708103998086017,0.9922918960019139,1,0.00037522057999636387,0.9996247794200036,1,0.031149335862347582,0.9688506641376524,1,2.259103963031528e-05,0.9999774089603697,1,0.08973132818937302,0.9418339729309082,1,0.20292727649211884,0.8673651814460754,1,0.004329216667226358,0.9956707833327737,1
4012,肺血栓塞栓症と診断し、治療開始。,肺血栓 塞栓症 診断 治療 開始,1,0.01668955846439729,0.9833104415356027,1,0.000324206918168103,0.9996757930818319,1,0.2343282405171806,0.7656717594828194,1,0.04287971775591015,0.9571202822440898,1,0.22404730319976807,0.854256808757782,1,0.2141972780227661,0.8672129511833191,1,0.009060028155963422,0.9909399718440365,1
4013,頻呼吸(38拍/分)及び捻髪音。,頻呼吸 0 拍 分 及ぶ 捻髪音,1,0.18577313422785005,0.8142268657721501,1,0.00025240804734239815,0.9997475919526576,1,0.4563792597309324,0.5436207402690676,1,8.588851385660234e-08,0.9999999141114861,1,0.08667969703674316,0.9385539293289185,1,0.2479778379201889,0.8384350538253784,1,0.015405251552787018,0.984594748447213,1
4014,本報告は心筋炎の基準を満たした。,報告 心筋炎 基準 満たす た,1,0.013609391674928235,0.986390608325072,1,0.0003464183759029042,0.9996535816240971,1,0.2100988562790086,0.7899011437209914,1,3.699753181007903e-05,0.9999630024681899,1,0.12418555468320847,0.9277829527854919,1,0.2925863564014435,0.8032153844833374,1,0.007644893548702527,0.9923551064512974,1
4015,夕方、38.0°Cの発熱が出現。,夕方 0 0 C 発熱 出現,1,3.127845435652967e-07,0.9999996872154564,1,0.0005933224968020373,0.999406677503198,1,0.006233307004365751,0.9937666929956342,1,1.3100631690576847e-14,0.9999999999999869,1,0.08156512677669525,0.9483712315559387,1,0.1850712150335312,0.8754533529281616,1,0.0038974242331308562,0.9961025757668692,1
4016,患者は、発熱と紅皮症で入院した。,患者 発熱 紅皮症 入院 する た,1,1.1115405359878716e-05,0.9999888845946401,1,0.00037072269614525725,0.9996292773038548,1,0.02792922539936038,0.9720707746006396,1,0.000906307666176942,0.9990936923338231,1,0.08292696624994278,0.9452573657035828,1,0.20899741351604462,0.8432561755180359,1,0.004328680596269258,0.9956713194037307,1
4017,感覚系では、偽性アテトーゼがあり,感覚 系 偽 性 アテトーゼ ある,1,0.01669131121020323,0.9833086887897965,1,0.0002956488207601919,0.9997043511792398,1,0.10406299251664797,0.895937007483352,1,1.6005931588569666e-05,0.9999839940684114,1,0.11384275555610657,0.9176824688911438,1,0.22727377712726593,0.8265085220336914,1,0.005703573094430439,0.9942964269055696,1
4018,高熱(摂氏39.2度)があった。,高熱 摂氏 0 0度 ある た,1,0.01667929075574024,0.9833207092442598,1,0.00036746287528709556,0.9996325371247129,1,0.2187338136608028,0.7812661863391972,1,0.005214694233856232,0.9947853057661438,1,0.07858546078205109,0.9482500553131104,1,0.1823316514492035,0.8643141388893127,1,0.006245328894985604,0.9937546711050145,1
4019,翌日に右眼の視力低下を自覚した。,翌日 右 眼 視力低下 自覚 する た,1,9.608751165291556e-07,0.9999990391248835,1,0.0007124860489643297,0.9992875139510357,1,0.016826732111482112,0.9831732678885179,1,0.04729367521779948,0.9527063247822005,1,0.07987062633037567,0.9496555924415588,1,0.19449491798877716,0.8721352219581604,1,0.004417484634401803,0.995582515365598,1
4020,その後、時々脈の乱れを自覚した。,その後 脈 乱れ 自覚 する た,1,0.016682991661088654,0.9833170083389112,1,0.00036419843283752915,0.9996358015671625,1,0.0744162766773111,0.9255837233226889,1,0.10238591664418062,0.8976140833558194,1,0.09625757485628128,0.9401178956031799,1,0.19283856451511383,0.8675675988197327,1,0.00587655555502878,0.9941234444449714,1
4021,抗体検査: (日付不明)異常高値,抗体検査 日付 不明 異常高値,1,0.01669780913196616,0.9833021908680337,1,0.00023543609512805886,0.9997645639048719,0,0.7663032111311,0.23369678886890002,1,6.232436788877749e-11,0.9999999999376756,1,0.1685238629579544,0.9048047661781311,0,0.825036883354187,0.27607813477516174,1,0.06780859279700709,0.932191407202993,1
4022,WBCと好中球数はさらに減少した,WBC 好中球 数 減少 する た,1,0.023744325004379927,0.9762556749956198,1,0.0002897691885499876,0.99971023081145,1,0.44175068109612947,0.5582493189038705,1,0.33662501236403886,0.6633749876359611,1,0.11416071653366089,0.9327629804611206,1,0.2015685886144638,0.8684688210487366,1,0.020219463560987166,0.9797805364390128,1
4023,15:05頃急性胃潰瘍が発現。,0 0 頃 急性胃潰瘍 発現,1,0.010625506499634839,0.9893744935003651,1,0.00038925694055204455,0.999610743059448,1,0.006430581757262188,0.9935694182427378,1,0.0,1.0,1,0.09308785200119019,0.9452906847000122,1,0.17844808101654053,0.8740550875663757,1,0.004018103128681219,0.9959818968713188,1
4024,18:27胃部不快感を認めた。,0 0 胃部不快感 認める た,1,0.011158967306005843,0.9888410326939943,1,0.000323529366513306,0.9996764706334867,1,0.025944857950418232,0.9740551420495818,1,0.00019892743474148045,0.9998010725652585,1,0.08115390688180923,0.9502537250518799,1,0.18526619672775269,0.8729304671287537,1,0.004145773425396345,0.9958542265746037,1
4025,19:07末梢神経障害が発現。,0 0 末梢神経障害 発現,1,0.013883765739034408,0.9861162342609656,1,0.0004303093785437887,0.9995696906214562,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08768843859434128,0.9436864256858826,1,0.18448586761951447,0.8712475299835205,1,0.004092995248215995,0.9959070047517841,1
4026,2022/07/09他院受診。,0 0 0 他 院 受診,1,0.016713625842360504,0.9832863741576394,1,0.00026317210819755253,0.9997368278918024,1,0.20807607457612176,0.7919239254238782,1,4.913847106990943e-12,0.9999999999950862,1,0.19025324285030365,0.8893474340438843,1,0.2113553136587143,0.8492418527603149,1,0.007488463608819744,0.9925115363911802,1
4027,COVID-19発症を認めた。,COVID 0 発症 認める た,1,5.96373275920877e-07,0.9999994036267241,1,0.000996595121316068,0.9990034048786839,1,0.010083035660682138,0.9899169643393179,1,4.412514797991207e-11,0.9999999999558749,1,0.07817886024713516,0.9483979344367981,1,0.18610674142837524,0.8740091919898987,1,0.003926936250088203,0.9960730637499117,1
4028,画像上、両下葉の肺炎を認めた。,画像 上 両下 葉 肺炎 認める た,1,0.0046871819342987646,0.9953128180657012,1,0.000394512298282943,0.9996054877017171,1,0.005972032877506694,0.9940279671224933,1,0.0015063016311569477,0.998493698368843,1,0.07545159012079239,0.9466928243637085,1,0.19079852104187012,0.8631689548492432,1,0.003995863894315895,0.9960041361056842,1
4029,胸部X線にて胸水を少量認めた。,胸部 X線 胸水 少量 認める た,1,0.011500040854930987,0.9884999591450689,1,0.0002997950076157934,0.9997002049923842,1,0.07214403955276483,0.9278559604472352,1,0.019606069117122704,0.9803939308828773,1,0.0997161865234375,0.9326412081718445,1,0.21451637148857117,0.8568963408470154,1,0.005126435361901593,0.9948735646380985,1
4030,血液検査でSCC上昇を認めた。,血液検査 SCC 上昇 認める た,1,1.8054003791762633e-05,0.9999819459962083,1,0.0005668498865298906,0.9994331501134701,1,0.012340394525310328,0.9876596054746897,1,0.00037304381146163745,0.9996269561885384,1,0.09335967153310776,0.9419909119606018,1,0.18938201665878296,0.8665944337844849,1,0.004073191304641386,0.9959268086953587,1
4031,見た目は潰瘍性大腸炎様の腸炎。,見た目 潰瘍性大 腸炎様 の 腸炎,1,0.1660750544949186,0.8339249455050816,1,0.00018512625704219873,0.9998148737429579,1,0.3273590907543167,0.6726409092456833,1,0.0,1.0,1,0.12695267796516418,0.9164326190948486,1,0.2129278928041458,0.8529464602470398,1,0.011632404824993527,0.9883675951750065,1
4032,口腔内白斑、潰瘍多発を認めた。,口腔内 白斑 潰瘍多発 認める た,1,0.016673571684440603,0.9833264283155593,1,0.00036573764895668964,0.9996342623510434,1,0.03271476643218074,0.9672852335678193,1,0.0009825708776102227,0.9990174291223898,1,0.08579179644584656,0.9465155005455017,1,0.18982280790805817,0.864170253276825,1,0.004348363544379909,0.99565163645562,1
4033,高熱が続き、PCR検査を実施。,高熱 続く PCR検査 実施,1,0.06184601729275608,0.9381539827072439,1,0.0001868075896470374,0.9998131924103529,0,0.8888730914993862,0.11112690850061376,0,0.8043253892878506,0.19567461071214945,1,0.2359122335910797,0.8690758943557739,1,0.22925123572349548,0.830687940120697,1,0.15133896222167637,0.8486610377783236,1
4034,春と秋はアレルギー症状が出る。,春 秋 アレルギー症状 出る,1,0.01668586923515261,0.9833141307648471,1,0.00033481968902812436,0.9996651803109718,1,0.4563792597309324,0.5436207402690676,1,1.962388029852491e-10,0.9999999998037612,1,0.12844747304916382,0.913877010345459,1,0.19969840347766876,0.8530393242835999,1,0.011074535829993092,0.988925464170007,1
4035,心筋炎または心膜炎発現の疑い。,心筋炎 心膜炎 発現 疑い,1,4.848166116377116e-07,0.9999995151833884,1,0.000613011056002024,0.999386988943998,1,0.0017330330680960238,0.998266966931904,1,0.0,1.0,1,0.0981663390994072,0.9378572702407837,1,0.20023533701896667,0.8540876507759094,1,0.004115585113913163,0.9958844148860869,1
4036,心電図でST上昇が認められた。,心電図 ST 上昇 認める られる た,1,1.1260034964221079e-05,0.9999887399650358,1,0.0005863800615991866,0.9994136199384008,1,0.019147947757171546,0.9808520522428285,1,0.14243357516945565,0.8575664248305443,1,0.08725972473621368,0.9461081027984619,1,0.18706421554088593,0.855282723903656,1,0.005471540230954859,0.9945284597690451,1
4037,神経痛のような痛みが発現した。,神経痛 の よう 痛み 発現 する た,1,1.4785816950439165e-05,0.9999852141830496,1,0.0004389437628247446,0.9995610562371753,1,0.0036407880963129635,0.996359211903687,1,0.036659612324027036,0.963340387675973,1,0.08658691495656967,0.9470716714859009,1,0.19269460439682007,0.8554044961929321,1,0.004313484629211333,0.9956865153707887,1
4038,身体的診察:上下肢の圧痕浮腫。,身体的 診察 上下 肢 圧痕 浮腫,1,0.016668751217396666,0.9833312487826031,1,0.00030523392891746115,0.9996947660710825,1,0.4563792597309324,0.5436207402690676,1,1.1102230246251565e-15,0.9999999999999989,1,0.08537279814481735,0.9394614100456238,1,0.24329717457294464,0.8317458033561707,1,0.011032339138184853,0.9889676608618152,1
4039,接種直後、接種部に痛みが発現。,接種 直後 接種 部 痛み 発現,1,7.396884340830021e-06,0.9999926031156592,1,0.0004633103613153763,0.9995366896386846,1,0.0027747237439926797,0.9972252762560073,1,7.143130531517272e-11,0.9999999999285687,1,0.10897140949964523,0.94292151927948,1,0.19463838636875153,0.8580292463302612,1,0.004107396269038295,0.9958926037309618,1
4040,蘇生処置中に回復せず死亡した。,蘇生 処置 中 回復 する ぬ 死亡 する た,1,0.016659507752971668,0.9833404922470281,1,0.00017195284905699082,0.999828047150943,0,0.7683461985865774,0.23165380141342262,1,0.13420914506608295,0.865790854933917,1,0.1692119985818863,0.8944189548492432,1,0.27243921160697937,0.7851781845092773,1,0.03232134173601342,0.9676786582639866,1
4041,息苦しい感じがすると訴えあり。,息苦しい感じ する 訴える ある,1,0.009915105369879544,0.9900848946301203,1,0.00046274014617910393,0.9995372598538209,1,0.08199946701965355,0.9180005329803465,1,1.5178254529901736e-06,0.999998482174547,1,0.09596702456474304,0.9436485171318054,1,0.21185925602912903,0.838695228099823,1,0.005017667462626315,0.9949823325373738,1
4042,体温:摂氏39.1度(高温)。,体温 摂氏 0 0度 高温,1,0.01670656268697684,0.983293437313023,1,0.0003017640280305471,0.9996982359719695,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.17784877121448517,0.8943872451782227,1,0.21312853693962097,0.8573083877563477,1,0.01196250879157334,0.9880374912084265,1
4043,帯状疱疹、リンパ球減少が発現。,帯状疱疹 リンパ球減少 発現,1,0.005305462780171695,0.9946945372198284,1,0.00041876169901824755,0.9995812383009818,1,0.0139694990307071,0.9860305009692929,1,7.311928840181281e-13,0.9999999999992688,1,0.1096714660525322,0.9415265321731567,1,0.19590742886066437,0.8599955439567566,1,0.004250091008489809,0.9957499089915103,1
4044,頭痛発作は1週間のうち3日程。,頭痛 発作 0 週間 うち 0 日程,1,0.016683800421734216,0.9833161995782659,1,0.00030405024067593376,0.9996959497593241,1,0.0710478791411483,0.9289521208588517,1,0.0005721907282491001,0.9994278092717509,1,0.10159663110971451,0.936097264289856,1,0.20896916091442108,0.848726212978363,1,0.004981442677595152,0.9950185573224047,1
4045,同日までリンパ球減少を認める。,同日 リンパ球減少 認める,1,0.016668865733800428,0.9833311342661996,1,0.0004021032270480703,0.999597896772952,1,0.06381987226535135,0.9361801277346486,1,4.9333876789292574e-06,0.9999950666123211,1,0.11177133023738861,0.9287344217300415,1,0.20575915277004242,0.8610672354698181,1,0.004915277720041604,0.9950847222799584,1
4046,同日夜から嘔気、頭痛を訴えた。,同日 夜 嘔気 頭痛 訴える た,1,1.9367809239833068e-08,0.9999999806321908,1,0.0005097915731110639,0.999490208426889,1,0.016264814750323264,0.9837351852496767,1,3.82800163396535e-05,0.9999617199836603,1,0.08428023010492325,0.9473706483840942,1,0.1817808896303177,0.8690840601921082,1,0.004002730442000415,0.9959972695579996,1
4047,日付不明副反応が発現し、入院。,日付 不明 副反応 発現 入院,1,1.1847638620990022e-05,0.9999881523613791,1,0.00034238155904361246,0.9996576184409564,1,0.010333532277562174,0.9896664677224378,1,0.0,1.0,1,0.1001027375459671,0.9360538721084595,1,0.2112112045288086,0.829708456993103,1,0.004350637065771399,0.9956493629342286,1
4048,皮疹、腹痛、下腿浮腫を認めた。,皮疹 腹痛 下腿浮腫 認める た,1,0.10029763472078916,0.8997023652792105,1,0.0002713780307998047,0.9997286219692002,1,0.03349865919709716,0.9665013408029028,1,8.997464725013504e-05,0.9999100253527499,1,0.07808418571949005,0.9461869597434998,1,0.18982884287834167,0.8661170601844788,1,0.0050864500483902035,0.9949135499516097,1
4049,夜、38°C台の発熱を認めた。,夜 0 C 台 発熱 認める た,1,8.460568167403034e-09,0.9999999915394318,1,0.0006397167640042389,0.9993602832359958,1,0.010631805650156978,0.989368194349843,1,7.501870557868884e-06,0.9999924981294421,1,0.07709430158138275,0.9512064456939697,1,0.1852198839187622,0.8722233176231384,1,0.00391679329733934,0.9960832067026606,1
4050,両側鼡径部リンパ節症を認めた。,両側 鼡径 部 リンパ節症 認める た,1,0.013647313128051983,0.9863526868719479,1,0.0004255629019527088,0.9995744370980473,1,0.0177501028803424,0.9822498971196576,1,0.00038578180630777226,0.9996142181936922,1,0.08008246123790741,0.9445145726203918,1,0.1971922516822815,0.8601476550102234,1,0.0042230318235771626,0.9957769681764229,1
4051,3日後、内顆に紫斑が発現した。,0 日 後 内顆 紫斑 発現 する た,1,0.01668330090389073,0.9833166990961091,1,0.00038029974719621876,0.9996197002528038,1,0.016284538323529718,0.9837154616764703,1,0.026866785009828087,0.9731332149901719,1,0.08091414719820023,0.9466474056243896,1,0.19210785627365112,0.8785235285758972,1,0.00435650518913588,0.9956434948108641,1
4052,X線で左肩の炎症を指摘された。,X線 左肩 炎症 指摘 する れる た,1,0.015508387588786188,0.9844916124112136,1,0.0003215188933405921,0.9996784811066594,1,0.3378873378388443,0.6621126621611557,1,0.19272436290861983,0.8072756370913802,1,0.09554209560155869,0.937654435634613,1,0.18344050645828247,0.868768036365509,1,0.011721304494665801,0.9882786955053342,1
4053,受診日から多量の下痢を認めた。,受診 日 多量 下痢 認める た,1,0.01666932350589286,0.9833306764941071,1,0.0004153159032137653,0.9995846840967862,1,0.023243979190398445,0.9767560208096016,1,0.0004731600897539545,0.999526839910246,1,0.08090613782405853,0.9487054347991943,1,0.19046151638031006,0.870593786239624,1,0.0042089341846215265,0.9957910658153785,1
4054,肺炎として抗菌薬投与を受ける。,肺炎 抗菌薬 投与 受ける,1,0.016700282426415244,0.9832997175735847,1,0.00019710476573961102,0.9998028952342604,0,0.5920297400753869,0.40797025992461317,1,6.015475614296051e-07,0.9999993984524386,1,0.15700769424438477,0.8975749611854553,1,0.32504063844680786,0.7569965720176697,1,0.018804643555396922,0.9811953564446031,1
4055,日付不明、網状赤血球数:増加。,日付 不明 網状 赤血球数 増加,1,0.016690937969600673,0.9833090620303993,1,0.00027030540933704596,0.999729694590663,1,0.4494644657088246,0.5505355342911754,1,2.847189159871366e-05,0.9999715281084013,1,0.1414327472448349,0.9107980132102966,1,0.22987137734889984,0.8429128527641296,1,0.011549477625302269,0.9884505223746977,1
4056,血中クレアチニン:すごく高い。,血 中 クレアチニン すごい 高い,1,0.016682991174626453,0.9833170088253738,1,0.0003086661029448777,0.9996913338970551,1,0.31213492943884336,0.6878650705611566,1,7.764011655808645e-12,0.999999999992236,1,0.15594078600406647,0.9078393578529358,1,0.34322434663772583,0.7639949321746826,1,0.010831394484184012,0.989168605515816,1
4057,10:00頃脳脊髄炎が発現。,0 0 頃 脳脊髄炎 発現,1,1.909203886631922e-05,0.9999809079611337,1,0.00048578399019636966,0.9995142160098036,1,0.006430581757262188,0.9935694182427378,1,0.0,1.0,1,0.10312711447477341,0.9412718415260315,1,0.17951133847236633,0.8723074197769165,1,0.004001526176576134,0.995998473823424,1
4058,11:20意識消失を認めた。,0 0 意識消失 認める た,1,0.006656908080330505,0.9933430919196695,1,0.0004271971457617245,0.9995728028542383,1,0.025944857950418232,0.9740551420495818,1,0.012063627348653627,0.9879363726513464,1,0.07686719298362732,0.9493135213851929,1,0.18274463713169098,0.877605676651001,1,0.004163934681346872,0.9958360653186531,1
4059,12:30一過性失神が発現。,0 0 一過性失神 発現,1,0.014016702217813681,0.9859832977821862,1,0.00037669682376557186,0.9996233031762344,1,0.00987732563689947,0.9901226743631005,1,4.218847493575595e-15,0.9999999999999958,1,0.08794665336608887,0.9472650289535522,1,0.1813841462135315,0.8734905123710632,1,0.00405846677996668,0.9959415332200333,1
4060,16:00胸痛症状を認めた。,0 0 胸痛症状 認める た,1,0.011158967306005843,0.9888410326939943,1,0.000370859306854289,0.9996291406931457,1,0.025944857950418232,0.9740551420495818,1,8.73237176405306e-05,0.9999126762823595,1,0.07708161324262619,0.9494640827178955,1,0.18158692121505737,0.8736367225646973,1,0.004113708084332467,0.9958862919156676,1
4061,2-3日前に腹痛が再びあり。,0 0 日 前 腹痛 ある,1,0.016709851898381273,0.9832901481016187,1,0.00023305815259856968,0.9997669418474014,1,0.19615371488446476,0.8038462851155352,1,3.943583469778744e-07,0.999999605641653,1,0.08757995814085007,0.9455332159996033,1,0.1908091902732849,0.8616572618484497,1,0.006044117776548446,0.9939558822234515,1
4062,38.3°Cの発熱を認めた。,0 0 C 発熱 認める た,1,3.491441511167926e-06,0.9999965085584889,1,0.0007620297638978478,0.9992379702361022,1,0.007118524082522448,0.9928814759174776,1,4.9253934264470445e-12,0.9999999999950746,1,0.07648036628961563,0.9506639242172241,1,0.18232637643814087,0.8744673728942871,1,0.0038702575252958023,0.9961297424747042,1
4063,50歳代から尿潜血指摘あり。,0歳 代 尿潜血指摘 ある,1,0.016663868810688095,0.9833361311893121,1,0.00027880226656624865,0.9997211977334337,1,0.21948019000176067,0.7805198099982393,1,1.6336058738186665e-05,0.9999836639412618,1,0.12732750177383423,0.9223551750183105,1,0.19066739082336426,0.8542349934577942,1,0.0067884780645330696,0.9932115219354669,1
4064,COVID-19を発現した。,COVID 0 発現 する た,1,0.009581977589738654,0.9904180224102613,1,0.0006262216380434998,0.9993737783619565,1,0.0034250761073815195,0.9965749238926185,1,1.4051269991988136e-06,0.9999985948730008,1,0.09823552519083023,0.9412130117416382,1,0.18957270681858063,0.8718270063400269,1,0.004078405523353813,0.9959215944766461,1
4065,COVID-19を発症した。,COVID 0 発症 する た,1,0.02042316592108113,0.9795768340789189,1,0.00046928428338729924,0.9995307157166127,1,0.029937120878209766,0.9700628791217902,1,1.2757025202869698e-07,0.999999872429748,1,0.08482223004102707,0.9429728388786316,1,0.19009937345981598,0.8707190155982971,1,0.0043331806313113615,0.9956668193686886,1
4066,COVIDー19を発症した。,COVID ー 0 発症 する た,1,0.020024396417531967,0.979975603582468,1,0.00033022572698879036,0.9996697742730112,1,0.09677307075935193,0.9032269292406481,1,0.00025296303820698807,0.999747036961793,1,0.08507246524095535,0.9428565502166748,1,0.19524666666984558,0.8703914284706116,1,0.004975866155636389,0.9950241338443637,1
4067,X-5日、38°C台の発熱。,X 0 日 0 C 台 発熱,1,0.008914047149913912,0.991085952850086,1,0.0003905682409176266,0.9996094317590823,1,0.03990612106666447,0.9600938789333355,1,0.0,1.0,1,0.08519000560045242,0.9483445286750793,1,0.18459856510162354,0.8691419959068298,1,0.004281008444948236,0.9957189915550518,1
4068,X日不穏状態となり救急搬送。,X 日 不穏状態 なる 救急搬送,1,0.32564625054793883,0.6743537494520611,1,0.0002878985521140661,0.9997121014478859,1,0.40027301641803525,0.5997269835819647,1,0.0,1.0,1,0.08216621726751328,0.943198025226593,1,0.19639647006988525,0.8470656275749207,1,0.01696843070748448,0.9830315692925155,1
4069,びまん性肺胞障害の所見あり。,びまん性肺胞障害 所見 ある,1,0.016698602439954552,0.9833013975600453,1,0.0002557033537474864,0.9997442966462525,1,0.2808338466417021,0.7191661533582979,1,5.843427297591575e-07,0.9999994156572702,1,0.09030335396528244,0.9370761513710022,1,0.21822229027748108,0.8544535636901855,1,0.007484364928615675,0.9925156350713843,1
4070,以後、発熱、解熱を繰り返す。,以後 発熱 解熱 繰り返す,1,0.016676227826360388,0.9833237721736394,1,0.00023190873896844033,0.9997680912610316,1,0.1404210350519185,0.8595789649480815,1,1.1102230246251565e-15,0.9999999999999989,1,0.1602618545293808,0.9159590005874634,1,0.3128732144832611,0.7880449891090393,1,0.007273550648550306,0.9927264493514497,1
4071,右VAの紡錘状拡張を認めた。,右 VA 紡錘状拡張 認める た,1,0.003170818949937606,0.9968291810500624,1,0.0005592364821691782,0.9994407635178308,1,0.011935441504990263,0.9880645584950097,1,0.014773112908740504,0.9852268870912595,1,0.08277487754821777,0.9374861121177673,1,0.19443906843662262,0.8627758026123047,1,0.004226394135775087,0.9957736058642249,1
4072,患者は発熱(発熱)を呈した。,患者 発熱 発熱 呈す た,1,0.006893739126055828,0.993106260873944,1,0.0005532429192823222,0.9994467570807177,1,0.018001840581261086,0.9819981594187389,1,6.661338147750939e-16,0.9999999999999993,1,0.0840638279914856,0.947618305683136,1,0.1857908070087433,0.8669238090515137,1,0.004095388754223342,0.9959046112457768,1
4073,間欠的な発熱が継続している。,間欠的 発熱 継続 する いる,1,0.01669326769410124,0.9833067323058987,1,0.0002177472376793952,0.9997822527623206,1,0.13135984967872538,0.8686401503212746,1,0.14084025229799546,0.8591597477020045,1,0.1348785012960434,0.9284585118293762,1,0.27199888229370117,0.8343732357025146,1,0.008344839271661308,0.9916551607283387,1
4074,眼痛にて眼が動かなくなった。,眼痛 眼 動く ない なる た,1,0.01670188956559986,0.9832981104344,1,0.00019708441005415395,0.9998029155899458,0,0.9196908866651906,0.08030911333480935,0,0.5893095118497139,0.4106904881502861,1,0.1581869125366211,0.8823730945587158,1,0.3353517949581146,0.7461239099502563,1,0.11074443081486722,0.8892555691851328,1
4075,眼瞼腫脹(顔面上部の腫脹)。,眼瞼腫脹 顔面 上部 腫脹,1,0.016687963244252868,0.9833120367557472,1,0.00034842091175206355,0.999651579088248,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.09947438538074493,0.9383581876754761,1,0.20400778949260712,0.8627744317054749,1,0.010448233517548613,0.9895517664824514,1
4076,急性心筋梗塞の可能性がある。,急性心筋梗塞 の 可能性 ある,1,0.016679869960771986,0.983320130039228,1,0.000374410201804824,0.9996255897981952,1,0.1401644955046225,0.8598355044953775,1,6.72460065964664e-07,0.999999327539934,1,0.1838456243276596,0.8887773752212524,1,0.24991831183433533,0.8166788220405579,1,0.006983109527333923,0.9930168904726662,1
4077,急性心筋心膜炎の診断で入院。,急性心筋心膜炎 の 診断 入院,1,8.456466870819463e-07,0.9999991543533129,1,0.0004870711208997561,0.9995129288791003,1,0.007240936845219759,0.9927590631547802,1,0.0,1.0,1,0.08640053123235703,0.9449914693832397,1,0.20725180208683014,0.8634277582168579,1,0.004072938935266924,0.995927061064733,1
4078,胸痛を認めたため、救急要請。,胸痛 認める た ため 救急 要請,1,0.0062745115292014205,0.9937254884707987,1,0.0004438569557292341,0.9995561430442708,1,0.010695272403706158,0.9893047275962938,1,0.0,1.0,1,0.0872875526547432,0.9368529915809631,1,0.21476756036281586,0.8464308381080627,1,0.004293281333441362,0.9957067186665587,1
4079,頚椎症性神経根症を発症した。,頚椎症性 神経根症 発症 する た,1,0.016685176773563886,0.9833148232264363,1,0.0003299406094082687,0.9996700593905917,1,0.10414604710808151,0.8958539528919185,1,0.015582981477206825,0.9844170185227932,1,0.08333369344472885,0.9433478713035583,1,0.19731272757053375,0.8631612062454224,1,0.005207810386329391,0.9947921896136707,1
4080,今月は特に自分の体調が悪い。,今月 自分 体調 悪い,1,0.016683674206444895,0.9833163257935551,1,0.0003049232317545698,0.9996950767682454,1,0.4563792597309324,0.5436207402690676,1,2.5915210577820424e-05,0.9999740847894222,1,0.37046998739242554,0.7880967259407043,1,0.22885358333587646,0.8397438526153564,1,0.016598103150257157,0.9834018968497428,1
4081,採血で異常値があり当院紹介。,採血 だ 異常値 ある 院 紹介,1,0.016709310297596976,0.9832906897024029,1,0.0002063025505163394,0.9997936974494837,0,0.7320039915750978,0.26799600842490223,1,3.7348669823522584e-08,0.9999999626513302,0,0.7322261333465576,0.3705766201019287,1,0.22884024679660797,0.8321697115898132,1,0.060435450110575724,0.9395645498894242,1
4082,初診時、幻覚、興奮を認めた。,初診 時 幻覚 興奮 認める た,1,0.0842053143214359,0.9157946856785641,1,0.0002332615408739347,0.9997667384591261,1,0.06848413743445336,0.9315158625655466,1,0.004623005999318197,0.9953769940006818,1,0.0813753604888916,0.9446196556091309,1,0.19205300509929657,0.8668439984321594,1,0.005362522482065407,0.9946374775179345,1
4083,心筋逸脱酵素の上昇を認めた。,心筋逸脱酵素 上昇 認める た,1,6.395656631286796e-06,0.9999936043433687,1,0.0005766845609209014,0.9994233154390791,1,0.012340394525310328,0.9876596054746897,1,0.000426769781047609,0.9995732302189524,1,0.08927512913942337,0.9406394958496094,1,0.2027895748615265,0.856208086013794,1,0.0041599550065300325,0.9958400449934699,1
4084,雪かきの冷気で発作が起きる。,雪かき 冷気 だ 発作 起きる,1,0.016677446565617947,0.9833225534343819,1,0.00027638009576625805,0.9997236199042338,0,0.5224211363358076,0.47757886366419244,1,0.0,1.0,1,0.09094763547182083,0.9468490481376648,1,0.203271746635437,0.8470107316970825,1,0.011880673385949395,0.9881193266140507,1
4085,聴診にて肺野に狭窄音を聴取。,聴診 肺 野 狭窄音 聴取,1,0.016682277448507733,0.9833177225514923,1,0.0002588252787159249,0.9997411747212841,1,0.4563792597309324,0.5436207402690676,1,0.0001360999110239236,0.9998639000889761,1,0.11609291285276413,0.9093672037124634,1,0.24204668402671814,0.8228409886360168,1,0.01180734742103907,0.9881926525789608,1
4086,特有のリンパ球減少を認めた。,特有 リンパ球減少 認める た,1,0.011605918379678065,0.9883940816203219,1,0.0003578958568723231,0.9996421041431277,1,0.03315825702912345,0.9668417429708765,1,0.0009160091827403738,0.9990839908172596,1,0.09042079001665115,0.9433115124702454,1,0.18805243074893951,0.858326256275177,1,0.0043592417034077876,0.9956407582965923,1
4087,入浴中に腰部しびれを認めた。,入浴 中 腰部しびれ 認める た,1,0.01669858854899204,0.9833014114510079,1,0.00032878981793693624,0.9996712101820631,1,0.03612019239178477,0.9638798076082152,1,0.003920760640376386,0.9960792393596236,1,0.08165889233350754,0.9478312730789185,1,0.18748822808265686,0.8623950481414795,1,0.004377272703284561,0.9956227272967154,1
4088,脳・脊髄内に新規病変が出現。,脳 脊髄 内 新規病変 出現,1,0.016689135108172527,0.9833108648918277,1,0.00033876632517364225,0.9996612336748264,1,0.041101094275581174,0.9588989057244188,1,0.0004310446052490091,0.999568955394751,1,0.09294784069061279,0.9380935430526733,1,0.25894156098365784,0.8124816417694092,1,0.005058742804912094,0.9949412571950879,1
4089,歩行時の疲れやすさを認める。,歩行 時 疲れ 安さ 認める,1,0.01666744545761495,0.983332554542385,1,0.00031602935848186106,0.9996839706415181,1,0.09966060355049255,0.9003393964495074,1,5.973149353466489e-06,0.9999940268506465,1,0.10788232833147049,0.9387803673744202,1,0.2735174298286438,0.8305620551109314,1,0.005739412033730874,0.994260587966269,1
4090,薬剤性肝障害の疑いを認めた。,薬剤性 肝障害 疑い 認める た,1,5.733882558607989e-06,0.9999942661174414,1,0.00057993828984643,0.9994200617101535,1,0.008486756656504446,0.9915132433434956,1,0.0038399161457302045,0.9961600838542698,1,0.08247281610965729,0.9403438568115234,1,0.19563652575016022,0.8604707717895508,1,0.004082802021923021,0.995917197978077,1
4091,立位にて気分不良の訴えあり。,立位 気分不良 訴え ある,1,0.01670076267588345,0.9832992373241167,1,0.00032450237407955797,0.9996754976259205,1,0.21948019000176067,0.7805198099982393,1,1.7482733545293172e-06,0.9999982517266455,1,0.09237439185380936,0.9431061744689941,1,0.24463944137096405,0.82735276222229,1,0.006961111287288454,0.9930388887127115,1
4092,両側肺動脈に透亮像を認めた。,両側肺 動脈 透亮像 認める た,1,0.024059970090769368,0.9759400299092306,1,0.0003051694496136449,0.9996948305503863,1,0.03612019239178477,0.9638798076082152,1,0.00350602695932134,0.9964939730406787,1,0.08454272896051407,0.9357615113258362,1,0.1946014016866684,0.8664383888244629,1,0.00451838038686301,0.9954816196131371,1
4093,患者は後頭部の疼痛を訴えた。,患者 後頭部 疼痛 訴える た,1,0.016676219260627796,0.9833237807393723,1,0.0003782340435540284,0.9996217659564459,1,0.11994523068729523,0.8800547693127048,1,1.555485997895012e-06,0.9999984445140021,1,0.0912039577960968,0.9483708739280701,1,0.19425934553146362,0.8497684001922607,1,0.005279273686346239,0.9947207263136538,1
4094,多剤耐性による菌血症を認めた,多剤耐性 菌血症 認める た,1,0.016685004701009302,0.9833149952989908,1,0.0003702251831246956,0.9996297748168753,1,0.030080649445520358,0.9699193505544796,1,0.0009938790644795636,0.9990061209355204,1,0.0855991467833519,0.9433816075325012,1,0.18930205702781677,0.8558260798454285,1,0.004372462112501919,0.995627537887498,1
4095,夜から咽頭痛と発熱があった。,夜 咽頭痛 発熱 ある た,1,6.905479678989812e-07,0.9999993094520321,1,0.00039041670375714976,0.9996095832962428,1,0.019393317930214593,0.9806066820697854,1,0.00017502417379322566,0.9998249758262068,1,0.08394504338502884,0.9472993016242981,1,0.19489550590515137,0.8614420294761658,1,0.0041109492931525006,0.9958890507068475,1
4096,クレアチンホスホキナーゼ増加,クレアチンホスホキナーゼ 増加,1,0.016668587205032247,0.9833314127949677,1,0.00033013540305343086,0.9996698645969466,1,0.34010870494002554,0.6598912950599745,1,8.511826953061519e-05,0.9999148817304694,1,0.12585760653018951,0.9229377508163452,1,0.5568817853927612,0.645880401134491,1,0.015191761466577636,0.9848082385334224,1
4097,"PLT, 46.3 High",PLT 0 0 High,0,0.648277032595875,0.35172296740412506,1,0.0002450053660009475,0.9997549946339991,1,0.3741492743921715,0.6258507256078285,0,0.5195482961797382,0.48045170382026176,1,0.28326013684272766,0.8151814937591553,1,0.5098938345909119,0.6303535103797913,1,0.17251000016311577,0.8274899998368842,1
4098,非動脈炎性前部虚血性視神経症,動脈炎性 前部 虚血性 視神経症,1,0.01668877168086382,0.9833112283191362,1,0.00029393628702969473,0.9997060637129703,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.1275705099105835,0.9096222519874573,1,0.22732433676719666,0.8563433885574341,1,0.011381189735337445,0.9886188102646625,1
4099,10/03、喘息出現した。,0 0 喘息 出現 する た,1,0.011817578906552887,0.9881824210934472,1,0.0003775184880986115,0.9996224815119014,1,0.025519463631970773,0.9744805363680292,1,0.04289697837553874,0.9571030216244613,1,0.07316751778125763,0.9494492411613464,1,0.18174420297145844,0.8725884556770325,1,0.004469928590014913,0.9955300714099852,1
4100,15歳時蛋白尿の指摘あり。,0歳 時 蛋白尿 指摘 ある,1,0.01667016636598708,0.983329833634013,1,0.0003112618810765457,0.9996887381189234,1,0.2092513092956586,0.7907486907043414,1,2.4839433814261014e-06,0.9999975160566186,1,0.11534664779901505,0.9308006167411804,1,0.1998324990272522,0.8525973558425903,1,0.006588964005776778,0.9934110359942232,1
4101,17:40腕の痛みが発現。,0 0 腕 痛み 発現,1,4.6454171767855903e-07,0.9999995354582824,1,0.0006601500943016105,0.9993398499056984,1,0.005615020967933315,0.9943849790320667,1,0.0,1.0,1,0.07961571216583252,0.9480488300323486,1,0.1820794641971588,0.8646892309188843,1,0.00391705040732121,0.9960829495926787,1
4102,2021/11/17入院。,0 0 0 入院,1,0.016670162203852208,0.9833298377961478,1,0.00038941073154605564,0.9996105892684539,1,0.05532740434206673,0.9446725956579333,1,8.43769498715119e-15,0.9999999999999916,1,0.11011479049921036,0.9302526116371155,1,0.5271942019462585,0.5690629482269287,1,0.008860671092646405,0.9911393289073537,1
4103,2022/03/28発熱。,0 0 0 発 熱,1,0.01667756444029325,0.9833224355597067,1,0.000280749893039273,0.9997192501069607,1,0.35873972300322543,0.6412602769967746,1,0.0,1.0,1,0.09883894771337509,0.9397500157356262,1,0.18559446930885315,0.8648009300231934,1,0.008419735740094381,0.9915802642599055,1
4104,2022/04/11死亡。,0 0 0 死亡,1,0.01666163720362797,0.9833383627963722,1,0.00039606553781570123,0.9996039344621843,1,0.35873972300322543,0.6412602769967746,1,0.0,1.0,1,0.10297092795372009,0.9322812557220459,1,0.25510409474372864,0.8356438875198364,1,0.009393910855132954,0.990606089144867,1
4105,2022/04発熱が発現。,0 0 発 熱 発現,1,5.504732483198387e-07,0.9999994495267517,1,0.0004465258465696728,0.9995534741534303,1,0.00987732563689947,0.9901226743631005,1,0.0,1.0,1,0.08485850691795349,0.9498518705368042,1,0.183491513133049,0.8712338209152222,1,0.003942119415689028,0.996057880584311,1
4106,38°C台の発熱を認めた。,0 C 台 発熱 認める た,1,1.8099202930415707e-06,0.9999981900797069,1,0.0006869380405908499,0.9993130619594092,1,0.00986045059697227,0.9901395494030277,1,8.868877077183868e-09,0.9999999911311229,1,0.07605233788490295,0.9514877200126648,1,0.18384632468223572,0.8736872673034668,1,0.003894926611770635,0.9961050733882294,1
4107,けいれん重積発作を認めた。,けいれん 重積 発作 認める た,1,0.015117229783094327,0.9848827702169055,1,0.00033729748356255417,0.9996627025164374,1,0.030350123000993934,0.9696498769990061,1,0.000142557514431485,0.9998574424855685,1,0.08274948596954346,0.9455623030662537,1,0.1920674443244934,0.8593352437019348,1,0.004328543620726635,0.9956714563792733,1
4108,その後、筋力低下を認めた。,その後 筋力低下 認める た,1,0.016712199489218437,0.9832878005107815,1,0.000354428002723254,0.9996455719972768,1,0.0338877844772828,0.9661122155227172,1,0.048596062838771714,0.9514039371612283,1,0.08507613837718964,0.9437891840934753,1,0.19798213243484497,0.8599750995635986,1,0.004861160528857202,0.9951388394711429,1
4109,その後発熱、嘔吐を認めた。,後発熱 嘔吐 認める た,1,1.3992007810645159e-05,0.9999860079921894,1,0.0004626259941681243,0.9995373740058319,1,0.009675880240324841,0.9903241197596752,1,2.523861546910311e-05,0.9999747613845309,1,0.08634164184331894,0.9462042450904846,1,0.1911163181066513,0.8673333525657654,1,0.004006893179024976,0.995993106820975,1
4110,メニエール病と診断された。,メニエール病 診断 する れる た,1,0.01669454774978733,0.9833054522502127,1,0.00042565219599924623,0.9995743478040008,1,0.10238321195210076,0.8976167880478992,1,0.2394571442485398,0.7605428557514602,1,0.1083686500787735,0.9344711303710938,1,0.1912100613117218,0.8645742535591125,1,0.00831334145673868,0.9916866585432612,1
4111,亜急性甲状腺炎と診断した。,亜急性 甲状腺炎 診断 する た,1,0.03435367777525323,0.9656463222247468,1,0.0002723033395718364,0.9997276966604282,1,0.0825531143064473,0.9174468856935527,1,0.03382713777412716,0.9661728622258728,1,0.12390466034412384,0.9252690076828003,1,0.19569097459316254,0.8646939396858215,1,0.005661691241912547,0.9943383087580874,1
4112,角膜後面色素沈着も認めた。,角膜 後 面 色素沈着 認める た,1,0.027497167997979292,0.9725028320020208,1,0.0003091212008764764,0.9996908787991236,1,0.03271476643218074,0.9672852335678193,1,0.02510220826924603,0.974897791730754,1,0.10219965130090714,0.945858895778656,1,0.20189031958580017,0.8623064756393433,1,0.004807165652568577,0.9951928343474314,1
4113,顔面紅潮を認め、発疹なし。,顔面紅潮 認める 発疹 ない,0,0.9240389863784289,0.07596101362157129,1,0.00018011264345179395,0.9998198873565483,0,0.9371957093363782,0.06280429066362177,0,0.9786927142216012,0.021307285778398827,1,0.46797457337379456,0.7242981195449829,0,0.7410888075828552,0.40362513065338135,1,0.8533793051808691,0.14662069481913084,1
4114,帰宅後、体調不良を認めた。,帰宅 後 体調不良 認める た,1,0.01670718499073151,0.9832928150092687,1,0.0002790849539382839,0.9997209150460618,1,0.06779110509891972,0.9322088949010803,1,0.0020875249757805747,0.9979124750242194,1,0.08433675765991211,0.9449944496154785,1,0.18821057677268982,0.8586989641189575,1,0.004690958834128856,0.995309041165871,1
4115,起床時、右視力低下を自覚。,起床 時 右視力低下 自覚,1,0.016676299780457798,0.983323700219542,1,0.00032646460830570024,0.9996735353916943,1,0.13179698075479673,0.8682030192452033,1,8.071099344419963e-12,0.9999999999919289,1,0.08725030720233917,0.9429148435592651,1,0.21087633073329926,0.8687598705291748,1,0.005399962978178859,0.9946000370218211,1
4116,倦怠感、嘔吐、発熱が発現。,倦怠感 嘔吐 発熱 発現,1,1.9475370906404786e-09,0.9999999980524629,1,0.0006998787864266775,0.9993001212135734,1,0.001004139658590919,0.9989958603414091,1,0.0,1.0,1,0.08662460744380951,0.9449859261512756,1,0.1953694373369217,0.864848792552948,1,0.003972288776445471,0.9960277112235546,1
4117,後遺症は排尿障害であった。,後遺症 排尿障害 だ ある た,1,0.016661450698456228,0.9833385493015441,1,0.00024478157432295466,0.999755218425677,0,0.8237416283756049,0.17625837162439512,0,0.6642063136365544,0.3357936863634456,1,0.1309487372636795,0.9167095422744751,1,0.31286799907684326,0.7998145222663879,1,0.09423408230372889,0.905765917696271,1
4118,左の手の甲のかゆみも発現。,左 手の甲 かゆみ 発現,1,0.01673460465121254,0.9832653953487874,1,0.000321883355812831,0.9996781166441872,1,0.015464391274946254,0.9845356087250537,1,5.113687251423471e-13,0.9999999999994886,1,0.08898834139108658,0.945180356502533,1,0.2095082849264145,0.8472422361373901,1,0.004368818826800678,0.9956311811731994,1
4119,四肢体幹の蕁麻疹を認めた。,四肢 体幹 蕁麻疹 認める た,1,0.006402151573418532,0.9935978484265815,1,0.00040903689447168427,0.9995909631055283,1,0.03612019239178477,0.9638798076082152,1,0.00034937011086200176,0.999650629889138,1,0.08013790845870972,0.9467241168022156,1,0.1893034428358078,0.8643800616264343,1,0.004256250547810422,0.9957437494521895,1
4120,出血傾向は治まらなかった。,出血傾向 治まる ない た,1,0.01667785408522017,0.9833221459147798,1,0.00017749152015289832,0.9998225084798471,0,0.968253672491632,0.03174632750836802,0,0.7623212159001932,0.23767878409980678,0,0.9404770135879517,0.04911121353507042,0,0.8368255496025085,0.2291104793548584,1,0.7298657071806293,0.2701342928193706,1
4121,心電図:ST上昇を認めた。,心電図 ST 上昇 認める た,1,8.683046298194341e-06,0.9999913169537019,1,0.0007184309770255894,0.9992815690229744,1,0.010084843704113888,0.9899151562958861,1,0.0003191647783520324,0.999680835221648,1,0.08613764494657516,0.9437441825866699,1,0.18804879486560822,0.8615578413009644,1,0.004034407184376364,0.9959655928156236,1
4122,心電図でST変化を認めた。,心電図 ST 変化 認める た,1,0.0234637575753062,0.9765362424246937,1,0.0003009299861938941,0.9996990700138061,1,0.02780472192166561,0.9721952780783344,1,0.3343689115398347,0.6656310884601653,1,0.10307531803846359,0.9342716932296753,1,0.19413632154464722,0.8538717031478882,1,0.00884467990839469,0.9911553200916052,1
4123,心電図は心房細動を認めた。,心電図 心房細動 認める た,1,0.00875656201335431,0.9912434379866457,1,0.0004420490401954365,0.9995579509598046,1,0.02780472192166561,0.9721952780783344,1,2.5124017709154955e-05,0.9999748759822908,1,0.08140943199396133,0.9413828253746033,1,0.19594824314117432,0.8564922213554382,1,0.0042930290276257145,0.9957069709723743,1
4124,接種後に39度の熱が出た。,接種 後 0度 熱 出る た,1,0.016704555353786302,0.9832954446462139,1,0.00035565646132149656,0.9996443435386785,1,0.41011725418436284,0.5898827458156372,1,4.377928406129605e-06,0.9999956220715939,1,0.12739653885364532,0.9186398983001709,1,0.19195474684238434,0.8598470687866211,1,0.009904894325769315,0.9900951056742305,1
4125,前胸部痛を認め、前医受診。,前胸部痛 認める 医 受診,1,0.0035792834149648697,0.9964207165850351,1,0.00047461794255611626,0.9995253820574439,1,0.03437972961383173,0.9656202703861683,1,1.7763568394002505e-14,0.9999999999999822,1,0.09521583467721939,0.9442360401153564,1,0.19919070601463318,0.8534635901451111,1,0.0043795251618792335,0.9956204748381208,1
4126,体温:摂氏38度(高温)。,体温 摂氏 0度 高温,1,0.012327620627542292,0.9876723793724576,1,0.0002907671989808078,0.9997092328010192,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.23495885729789734,0.8672844171524048,1,0.22345390915870667,0.8542300462722778,1,0.01305933906696534,0.9869406609330347,1
4127,当院救急外来へ搬送された。,院 救急外来 搬送 する れる た,1,0.016678927545634416,0.9833210724543657,1,0.00029948734811443233,0.9997005126518855,1,0.3101432592957528,0.6898567407042472,1,0.19850602810267204,0.801493971897328,1,0.08688598871231079,0.9417581558227539,1,0.21353667974472046,0.8468659520149231,1,0.011693658393932892,0.9883063416060671,1
4128,日付不明急性心筋炎が発現。,日付 不明 急性心筋炎 発現,1,0.016678064853649876,0.98332193514635,1,0.00028714926841357034,0.9997128507315864,1,0.028908994774402896,0.9710910052255971,1,0.0,1.0,1,0.10708989948034286,0.942467987537384,1,0.19265872240066528,0.8597009181976318,1,0.004448756997508883,0.9955512430024911,1
4129,脳硬膜外出血が認められた。,脳硬膜外 出血 認める られる た,1,0.016687099493304824,0.9833129005066951,1,0.0003498011303616652,0.9996501988696384,1,0.06699734358191589,0.9330026564180841,1,0.0246979235327055,0.9753020764672945,1,0.07759097963571548,0.9447072148323059,1,0.18964216113090515,0.8609689474105835,1,0.0048641915872390555,0.9951358084127611,1
4130,夜、突然の右難聴を認めた。,夜 右難聴 認める た,1,1.8304655987036352e-06,0.9999981695344012,1,0.00037398938544273787,0.9996260106145572,1,0.0338877844772828,0.9661122155227172,1,0.0041061625315299555,0.99589383746847,1,0.07535459101200104,0.9495082497596741,1,0.19832272827625275,0.8684221506118774,1,0.0042039682550006775,0.9957960317449993,1
4131,夜間痛、可動域制限が出現。,夜間痛 可動域制限 出現,1,0.01668644611780479,0.9833135538821952,1,0.00034330921110471333,0.9996566907888953,1,0.031149335862347582,0.9688506641376524,1,0.020995801967202188,0.9790041980327978,1,0.09854312241077423,0.9427700638771057,1,0.21234190464019775,0.8625245690345764,1,0.004697296338794571,0.9953027036612054,1
4132,患者は心筋炎と診断された。,患者 心筋炎 診断 する れる た,1,0.016667714873492386,0.9833322851265076,1,0.00041264622684976377,0.9995873537731502,1,0.0589197841145086,0.9410802158854914,1,0.2670639605265981,0.7329360394734019,1,0.09236857295036316,0.9438251852989197,1,0.19395408034324646,0.8656219244003296,1,0.007868437289951367,0.9921315627100487,1
4133,食欲不振と脱水が発現した。,食欲不振 脱水 発現 する た,1,1.9203971729557887e-08,0.9999999807960283,1,0.0005673968580422716,0.9994326031419577,1,0.02288969230989535,0.9771103076901047,1,0.0014777184216112627,0.9985222815783887,1,0.08232008665800095,0.9445159435272217,1,0.18687881529331207,0.8676360249519348,1,0.004098270986383044,0.995901729013617,1
4134,複数の器官に血栓症を認めた,複数 器官 血栓症 認める た,1,0.010183443556180182,0.9898165564438197,1,0.0004009382463758726,0.9995990617536241,1,0.03612019239178477,0.9638798076082152,1,0.00016875953607908833,0.9998312404639209,1,0.07991243898868561,0.9430752396583557,1,0.1900099515914917,0.8706216812133789,1,0.004277806736140272,0.9957221932638598,1
4135,"HGB, 12.2 Low",HGB 0 0 Low,0,0.648277032595875,0.35172296740412506,1,0.0002450053660009475,0.9997549946339991,1,0.3741492743921715,0.6258507256078285,0,0.5195482961797382,0.48045170382026176,1,0.2827756404876709,0.8174087405204773,1,0.5098938345909119,0.6303535103797913,1,0.17212324172479912,0.8278767582752009,1
4136,"HCT, 38.0 Low",HCT 0 0 Low,0,0.648277032595875,0.35172296740412506,1,0.0002450053660009475,0.9997549946339991,1,0.3741492743921715,0.6258507256078285,0,0.5195482961797382,0.48045170382026176,1,0.17367683351039886,0.876073956489563,1,0.5098938345909119,0.6303535103797913,1,0.14951404261923495,0.8504859573807649,1
4137,10:15、死亡確認した。,0 0 死亡 確認 する た,1,0.01670862457919882,0.9832913754208009,1,0.00029754342465156326,0.9997024565753484,1,0.46666987475520516,0.5333301252447948,1,0.2636576624565412,0.7363423375434588,1,0.2047577053308487,0.8554760217666626,1,0.5447058081626892,0.5637133121490479,1,0.040115182765151795,0.9598848172348481,1
4138,"LDH, 219 high",LDH 0 high,1,0.024962433313062655,0.9750375666869373,1,0.0003684479624939621,0.9996315520375061,1,0.3607204586964663,0.6392795413035337,1,0.0,1.0,1,0.2685190737247467,0.8378118872642517,0,0.6659526824951172,0.409397155046463,1,0.02817790476793102,0.971822095232069,1
4139,体重:1週間で約10増加。,体重 0 週間 0 増加,1,0.10784324250518772,0.8921567574948123,1,0.0003529540041653935,0.9996470459958346,1,0.2949284980939013,0.7050715019060987,1,1.4732362896285878e-07,0.999999852676371,1,0.109406478703022,0.9400213956832886,1,0.20672300457954407,0.8606112599372864,1,0.009209628302137682,0.9907903716978623,1
4140,11日後、呼吸困難出現。,0 日 後 呼吸困難 出現,1,0.016681403384195957,0.983318596615804,1,0.00045176655957591234,0.9995482334404241,1,0.02476931578430608,0.9752306842156939,1,0.0,1.0,1,0.08647622913122177,0.9449119567871094,1,0.19439373910427094,0.8604232668876648,1,0.004317893864933385,0.9956821061350666,1
4141,16:03失神を認めた。,0 0 失神 認める た,1,2.0688558629790786e-06,0.999997931144137,1,0.0006607664647202638,0.9993392335352798,1,0.025944857950418232,0.9740551420495818,1,4.2319103299437444e-07,0.999999576808967,1,0.07608348876237869,0.9480611085891724,1,0.18489143252372742,0.8772426843643188,1,0.00402533918774063,0.9959746608122593,1
4142,21:00頃発熱が発現。,0 0 頃 発熱 発現,1,1.5101237455675148e-07,0.9999998489876254,1,0.0007015731357587871,0.9992984268642412,1,0.0030949076225079697,0.996905092377492,1,0.0,1.0,1,0.08790988475084305,0.9493716359138489,1,0.18365448713302612,0.8706464767456055,1,0.003907818647394854,0.9960921813526051,1
4143,21:00頃嘔気が発現。,0 0 頃 嘔気 発現,1,1.0941767082208853e-06,0.9999989058232918,1,0.0005717556031736704,0.9994282443968263,1,0.004495021312519554,0.9955049786874804,1,0.0,1.0,1,0.10166662931442261,0.947054386138916,1,0.1923132687807083,0.8711267113685608,1,0.004013518257963935,0.9959864817420361,1
4144,23:00心筋炎が発現。,0 0 心筋炎 発現,1,0.003673429371144811,0.9963265706288552,1,0.0006083718402544843,0.9993916281597455,1,0.0033982837012268563,0.9966017162987731,1,0.0,1.0,1,0.08721408993005753,0.9439116716384888,1,0.18403393030166626,0.8724693059921265,1,0.003951216271920201,0.9960487837280798,1
4145,HAEの発作も起こった。,HAE 発作 起こる た,1,0.05095436860674196,0.949045631393258,1,0.00029908910118969795,0.9997009108988103,1,0.4153101175182917,0.5846898824817083,1,3.2307490016592055e-13,0.9999999999996769,1,0.08388201147317886,0.9412133097648621,1,0.20339147746562958,0.8511951565742493,1,0.010231419529312282,0.9897685804706877,1
4146,IgA腎症と診断された。,IgA 腎症 診断 する れる た,1,0.03450116017824941,0.9654988398217507,1,0.0004059834000638604,0.9995940165999362,1,0.10238321195210076,0.8976167880478992,1,0.2924784907443462,0.7075215092556538,1,0.10290670394897461,0.9369928240776062,1,0.19188176095485687,0.8710908889770508,1,0.009435857560243737,0.9905641424397563,1
4147,X-16日、頭痛が出現。,X 0 日 頭痛 出現,1,0.0067177078376486074,0.9932822921623514,1,0.0006174874765027558,0.9993825125234972,1,0.00386603842630151,0.9961339615736985,1,5.449297952542231e-06,0.9999945507020475,1,0.08211241662502289,0.9448115825653076,1,0.1893216222524643,0.870265007019043,1,0.003984983412447499,0.9960150165875525,1
4148,X-2日から頭痛が出現。,X 0 日 頭痛 出現,1,0.0067177078376486074,0.9932822921623514,1,0.0006174874765027558,0.9993825125234972,1,0.00386603842630151,0.9961339615736985,1,5.449297952542231e-06,0.9999945507020475,1,0.08211241662502289,0.9448115825653076,1,0.1893216222524643,0.870265007019043,1,0.003984983412447499,0.9960150165875525,1
4149,しんどくて立てなくなる。,しんどい 立てる ない なる,1,0.016699388739586925,0.9833006112604129,1,0.00021242124911428087,0.9997875787508858,0,0.906286837793901,0.09371316220609908,1,0.00019573615312096226,0.999804263846879,0,0.7752425074577332,0.4023689925670624,1,0.41589272022247314,0.7223032116889954,1,0.11039151291173807,0.8896084870882619,1
4150,タコツボ型心筋症と診断。,タコツボ型心筋症 診断,1,0.016679711986682336,0.9833202880133176,1,0.00034607644250386006,0.9996539235574962,1,0.06260030355645518,0.9373996964435448,1,6.377842043381321e-08,0.9999999362215796,1,0.257170706987381,0.8451646566390991,1,0.20094433426856995,0.8665142059326172,1,0.0060941601723811896,0.9939058398276187,1
4151,びまん性肺胞出血と診断。,びまん性肺胞出血 診断,1,0.016686686778200014,0.9833133132217999,1,0.0003600636534436301,0.9996399363465563,1,0.06260030355645518,0.9373996964435448,1,4.440892098500626e-16,0.9999999999999996,1,0.09249772131443024,0.934198260307312,1,0.20582684874534607,0.8644184470176697,1,0.004768241619656156,0.9952317583803437,1
4152,リンパ球性炎症細胞亜型。,リンパ球 性 炎症細胞 亜 型,1,0.01181801186196559,0.9881819881380343,1,0.0004131190140191431,0.9995868809859808,1,0.1402000172138923,0.8597999827861077,1,0.0,1.0,1,0.17549002170562744,0.9016261696815491,1,0.31396883726119995,0.7953939437866211,1,0.007371765643920193,0.9926282343560797,1
4153,咽頭違和感、咳嗽が発現。,咽頭違和感 咳嗽 発現,1,0.005094421928093631,0.9949055780719064,1,0.00039425556683022944,0.9996057444331697,1,0.0139694990307071,0.9860305009692929,1,0.0,1.0,1,0.08729466795921326,0.9386608004570007,1,0.20326267182826996,0.8661492466926575,1,0.004171346369016248,0.9958286536309838,1
4154,右眼瞼下垂が認められた。,右眼瞼下垂 認める られる た,1,0.02191185245948141,0.9780881475405183,1,0.0003358612049073063,0.9996641387950926,1,0.06298126889024747,0.9370187311097525,1,0.0069976160488030015,0.993002383951197,1,0.08659607917070389,0.9425875544548035,1,0.201112762093544,0.8580119609832764,1,0.004828220090268343,0.9951717799097317,1
4155,右手掌に紅斑、水泡形成。,右手 掌 紅斑 水泡形成,1,0.016688621835234906,0.9833113781647649,1,0.00031841308697327665,0.9996815869130268,1,0.4563792597309324,0.5436207402690676,1,0.006671902356791493,0.9933280976432085,1,0.08947441726922989,0.9389893412590027,1,0.21426253020763397,0.832118034362793,1,0.010908397597964983,0.989091602402035,1
4156,急性胃潰瘍の診断で入院。,急性胃潰瘍 の 診断 入院,1,1.4108331933588772e-06,0.9999985891668066,1,0.00046632241954973005,0.9995336775804503,1,0.007240936845219759,0.9927590631547802,1,0.0,1.0,1,0.09896894544363022,0.9399302005767822,1,0.20770585536956787,0.858206033706665,1,0.004168407490837104,0.9958315925091629,1
4157,軽度の間質の炎症性浸潤。,軽度 間質 炎症性浸潤,1,0.016677603043867343,0.9833223969561327,1,0.0003269886408791798,0.9996730113591208,1,0.2111743480837438,0.7888256519162562,1,0.0003062791582834068,0.9996937208417166,1,0.17777520418167114,0.9060570001602173,1,0.298031210899353,0.8045039772987366,1,0.008344409018455215,0.9916555909815449,1
4158,頚部の血管の異常を指摘。,頚部 血管 異常 指摘,1,0.004313134376773404,0.9956868656232265,1,0.0003823234334237827,0.9996176765665762,1,0.11595837982152668,0.8840416201784733,1,0.0,1.0,1,0.11405768990516663,0.9285019040107727,1,0.20477643609046936,0.8455010056495667,1,0.00541118599241958,0.9945888140075804,1
4159,血液検査でCK上昇した。,血液検査 CK 上昇 する た,1,0.05222647327964134,0.9477735267203586,1,0.0002994116856795459,0.9997005883143204,1,0.10070170942571766,0.8992982905742823,1,0.10780487812376571,0.8921951218762343,1,0.09174669533967972,0.9415513873100281,1,0.19333495199680328,0.8686395287513733,1,0.006672642452255095,0.9933273575477449,1
4160,検査で網膜剥離を認めた。,検査 だ 網膜剥離 認める た,1,0.11350903361070691,0.8864909663892931,1,0.00025167553388825026,0.9997483244661117,1,0.15643636482988632,0.8435636351701137,1,0.0004157711227148475,0.9995842288772852,1,0.09471272677183151,0.9372420907020569,1,0.20128262042999268,0.854793131351471,1,0.007000044002278864,0.9929999559977211,1
4161,左下肢脱力となり、転倒。,左下肢脱力 なる 転倒,1,0.01666647198427331,0.9833335280157266,1,0.00029411511615748463,0.9997058848838425,1,0.3167849524176023,0.6832150475823977,1,0.0,1.0,1,0.08907868713140488,0.9371820688247681,1,0.20749664306640625,0.8597376346588135,1,0.007900845367613136,0.9920991546323868,1
4162,左上腕にしびれを認めた。,左上 腕 しびれ 認める た,1,1.4939296234186826e-05,0.9999850607037658,1,0.0004442441956806338,0.9995557558043193,1,0.030536178702377015,0.969463821297623,1,0.0003759403132812533,0.9996240596867187,1,0.08069343119859695,0.9474811553955078,1,0.19306740164756775,0.8539121747016907,1,0.004214965948563632,0.9957850340514365,1
4163,採血にて肝障害を認めた。,採血 肝障害 認める た,1,0.0166900241381491,0.9833099758618508,1,0.00039648885985005126,0.99960351114015,1,0.0338877844772828,0.9661122155227172,1,0.00808490797530581,0.9919150920246942,1,0.08492645621299744,0.9420010447502136,1,0.19631001353263855,0.85109543800354,1,0.0045243731527189876,0.9954756268472809,1
4164,症状改善せず、前医受診。,症状改善 する ぬ 医 受診,1,0.016684044745946564,0.9833159552540534,1,0.00020977619578062444,0.9997902238042193,1,0.2552324109167221,0.7447675890832779,1,2.9701070858312306e-07,0.9999997029892914,1,0.3553939759731293,0.8032186031341553,1,0.3857268989086151,0.7017567157745361,1,0.01449141566353288,0.9855085843364672,1
4165,心筋炎が発現した可能性。,心筋炎 発現 する た 可能性,1,0.0026998303795476887,0.9973001696204522,1,0.00047464367834549156,0.9995253563216545,1,0.007465595458434615,0.9925344045415654,1,2.167706215638887e-07,0.9999997832293784,1,0.12523862719535828,0.9322952628135681,1,0.21231424808502197,0.8351500630378723,1,0.004457889933637547,0.9955421100663625,1
4166,生理前が特にひどくなる。,生理 前 ひどい なる,1,0.016669414698257046,0.9833305853017428,1,0.00025568894045015423,0.9997443110595499,1,0.3167849524176023,0.6832150475823977,1,4.364224622799284e-06,0.9999956357753772,1,0.1647244691848755,0.9216052889823914,1,0.27620506286621094,0.8285719156265259,1,0.009548102740728853,0.9904518972592712,1
4167,接種後より息切れが発現。,接種 後 息切れ 発現,1,0.012336729797826478,0.9876632702021736,1,0.0004025838671767339,0.9995974161328233,1,0.012720888152579768,0.9872791118474202,1,0.0,1.0,1,0.10160885751247406,0.9385230541229248,1,0.19344806671142578,0.8651870489120483,1,0.004245112643955307,0.9957548873560447,1
4168,組織学的検査:異常あり。,組織 学 的 検査 異常 ある,1,0.016698491708869088,0.9833015082911308,1,0.00020125994413947124,0.9997987400558606,1,0.2656265718679084,0.7343734281320916,1,3.7625739738311736e-06,0.9999962374260262,1,0.17687785625457764,0.896458625793457,1,0.2705346941947937,0.788536548614502,1,0.0092620702912988,0.9907379297087013,1
4169,大腿四頭筋萎縮を認める。,大腿四頭筋 萎縮 認める,1,0.04414027459348261,0.9558597254065174,1,0.0002837432678253775,0.9997162567321746,1,0.07610200923430988,0.9238979907656901,1,2.0461410343841635e-12,0.9999999999979539,1,0.09341219812631607,0.9336799383163452,1,0.23919202387332916,0.8476484417915344,1,0.005444596791205432,0.9945554032087947,1
4170,頭位変換で眼振を認めた。,頭位変換 だ 眼振 認める た,1,0.016677946512454293,0.9833220534875456,1,0.0003090185557166974,0.9996909814442833,1,0.10312482310691051,0.8968751768930895,1,0.010492197425591598,0.9895078025744084,1,0.08597680926322937,0.9393962025642395,1,0.21102361381053925,0.850890576839447,1,0.0053140204929244894,0.9946859795070756,1
4171,日付不明急性脳症が発現。,日付 不明 急性脳症 発現,1,0.015153743366922807,0.9848462566330772,1,0.0003401886909448674,0.9996598113090551,1,0.028908994774402896,0.9710910052255971,1,3.774758283725532e-15,0.9999999999999962,1,0.0960562452673912,0.9443520307540894,1,0.19473989307880402,0.8631036281585693,1,0.004373303693924297,0.9956266963060756,1
4172,入院後は時折胸痛が出現。,入院 後 時折胸痛 出現,1,0.0028814133573961892,0.9971185866426038,1,0.0004327126240136343,0.9995672873759863,1,0.009767179512274682,0.9902328204877253,1,1.2959033297121891e-05,0.9999870409667029,1,0.09192941337823868,0.9437974691390991,1,0.20176854729652405,0.8540381789207458,1,0.004160506970225826,0.9958394930297743,1
4173,脳幹梗塞、脳卒中の診断。,脳幹梗塞 脳卒中 の 診断,1,0.013608332581193334,0.9863916674188066,1,0.0003521551304982571,0.9996478448695018,1,0.03727066011862723,0.9627293398813728,1,3.522766522934262e-10,0.9999999996477233,1,0.1223381981253624,0.9155642986297607,1,0.20541416108608246,0.856844961643219,1,0.004762566628065429,0.9952374333719347,1
4174,半月体形成性腎炎と診断。,半月体形成性 腎炎 診断,1,0.016693304887970148,0.9833066951120296,1,0.00034413713418066447,0.9996558628658193,1,0.06260030355645518,0.9373996964435448,1,1.5746708958985778e-06,0.9999984253291041,1,0.11083853244781494,0.9272136688232422,1,0.200143963098526,0.8627325892448425,1,0.004870457136210999,0.995129542863789,1
4175,標準純音聴力検査で右聾。,標準 純音 聴力 検査 右 聾,1,0.01666895977018284,0.9833310402298171,1,0.0002890208855705541,0.9997109791144294,1,0.25637073455841364,0.7436292654415864,1,3.4994229736184934e-12,0.9999999999965006,1,0.22442634403705597,0.8166647553443909,0,0.6017119884490967,0.5471932291984558,1,0.018144757303288708,0.9818552426967112,1
4176,夜、発熱、胸痛を認めた。,夜 発熱 胸痛 認める た,1,1.9073933578999447e-08,0.9999999809260663,1,0.0006373363192365773,0.9993626636807634,1,0.005590138599340211,0.9944098614006598,1,2.5650639623453486e-07,0.9999997434936038,1,0.07845597714185715,0.9482879042625427,1,0.18712234497070312,0.8653193116188049,1,0.003928452948593586,0.9960715470514064,1
4177,腋窩腫脹、陰嚢痛が発現。,腋窩腫脹 陰嚢痛 発現,1,0.014064424959410793,0.985935575040589,1,0.00034241068064249356,0.9996575893193576,1,0.0139694990307071,0.9860305009692929,1,1.9539925233402755e-14,0.9999999999999805,1,0.08843042701482773,0.9416928291320801,1,0.2007761299610138,0.8562727570533752,1,0.004269387574084494,0.9957306124259155,1
4178,徐脈と血圧低下を認めた。,徐脈 血圧低下 認める た,1,0.006198714348997516,0.9938012856510026,1,0.00040180565062743505,0.9995981943493726,1,0.0338877844772828,0.9661122155227172,1,0.00014013088235387272,0.9998598691176461,1,0.08243989199399948,0.9433205127716064,1,0.18867550790309906,0.8588783144950867,1,0.004278664286816638,0.9957213357131833,1
4179,前胸部の痛み/急性の胸痛,胸部 痛み 急性 胸痛,1,0.016689586853993636,0.9833104131460063,1,0.0003004431329025087,0.9996995568670974,1,0.07249107470317306,0.9275089252968269,1,0.0,1.0,1,0.08659040182828903,0.9403457045555115,1,0.20399783551692963,0.856277585029602,1,0.004834781464815287,0.9951652185351848,1
4180,尿路結石のため入院した。,尿路結石 ため 入院 する た,1,0.004160536222600726,0.9958394637773993,1,0.0003994298201788004,0.9996005701798212,1,0.03580153371013628,0.9641984662898637,1,0.01049009166642989,0.9895099083335701,1,0.08624507486820221,0.9379561543464661,1,0.21965175867080688,0.8498775362968445,1,0.004585620540386398,0.9954143794596135,1
4181,両下肢の痺れ(異常感覚),下肢 痺れ 異常感覚,1,0.15048874636166076,0.8495112536383392,1,0.0002513694626980338,0.999748630537302,1,0.40320045074199284,0.5967995492580072,1,0.0,1.0,1,0.10032376646995544,0.9324578642845154,1,0.2568870782852173,0.8360692262649536,1,0.013341623618808968,0.986658376381191,1
4182,両下腿に点状出血斑(+),下腿 点状 出血斑,1,0.016676821102658085,0.9833231788973419,1,0.00031935473371433255,0.9996806452662856,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.09267491102218628,0.9368788599967957,1,0.24135294556617737,0.8421683311462402,1,0.011005773845356262,0.9889942261546437,1
4183,片側性大脳皮質脳炎の疑い,片側 性 大 脳皮質 脳炎 疑い,1,0.00620119021466976,0.9937988097853301,1,0.0004100031232593116,0.9995899968767407,1,0.03701858282661574,0.9629814171733843,1,0.0,1.0,1,0.12688490748405457,0.9253794550895691,1,0.2067623883485794,0.8577457070350647,1,0.004668591599512943,0.9953314084004871,1
4184,"CL, 97.6 low",CL 0 0 low,1,0.03655408677809661,0.9634459132219033,1,0.0004033723407678913,0.9995966276592321,1,0.35873972300322543,0.6412602769967746,1,0.00024046071771599564,0.999759539282284,1,0.16261698305606842,0.8906029462814331,1,0.5098938345909119,0.6303535103797913,1,0.01701379914032748,0.9829862008596725,1
4185,X+1月4日近位受診。,X+ 0 月 0 日 近 位 受診,1,0.02698316426694886,0.9730168357330512,1,0.0003538224716702563,0.9996461775283297,1,0.19259486087002242,0.8074051391299776,1,3.667066650336892e-12,0.9999999999963329,1,0.1690264791250229,0.9017559289932251,0,0.5672781467437744,0.5131264328956604,1,0.014220977645177624,0.9857790223548223,1
4186,右手の筋力低下を自覚。,右手 筋力低下 自覚,1,0.007159184751456669,0.9928408152485433,1,0.00043061264127980414,0.9995693873587201,1,0.07296635357140446,0.9270336464285955,1,4.6629367034256575e-15,0.9999999999999953,1,0.09121096879243851,0.939498245716095,1,0.20294401049613953,0.8438697457313538,1,0.004829838493447783,0.9951701615065521,1
4187,患者は微熱を発症した。,患者 微熱 発症 する た,1,0.015358506426455143,0.9846414935735448,1,0.0003752182087184855,0.9996247817912816,1,0.1777013981121156,0.8222986018878844,1,1.6238109136090806e-05,0.9999837618908639,1,0.08421763777732849,0.9475193023681641,1,0.21157275140285492,0.853042483329773,1,0.005953121431165938,0.9940468785688341,1
4188,眼瞼結膜やや貧血気味。,眼瞼結膜 貧血気味,1,0.3811196105047234,0.6188803894952767,1,0.0001843188090939102,0.9998156811909061,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.10311710834503174,0.9337038397789001,1,0.36075469851493835,0.7881589531898499,1,0.027050554797674167,0.9729494452023257,1
4189,急に腰の痛みを認めた。,急 腰 痛み 認める た,1,0.0031616183907670465,0.9968383816092329,1,0.00040394283398870423,0.9995960571660113,1,0.008120990601519495,0.9918790093984805,1,0.0007241022201209812,0.999275897779879,1,0.08104224503040314,0.9526909589767456,1,0.18630056083202362,0.8653449416160583,1,0.003966598814486917,0.996033401185513,1
4190,継続した末梢神経障害。,継続 する た 末梢神経障害,0,0.8055943695540396,0.1944056304459603,0,0.00015583572795477643,0.9998441642720453,0,0.7002135479426206,0.2997864520573794,1,0.0,1.0,1,0.12771274149417877,0.9164891839027405,0,0.7020159959793091,0.3895573616027832,1,0.18779675826078548,0.8122032417392145,1
4191,高度の蛋白尿を認めた。,高度 蛋白尿 認める た,1,0.016683298151345588,0.9833167018486544,1,0.0003806553207715373,0.9996193446792284,1,0.0338877844772828,0.9661122155227172,1,0.017321568050763014,0.982678431949237,1,0.0821300595998764,0.9475921392440796,1,0.19514517486095428,0.8671289682388306,1,0.004492249810654426,0.9955077501893456,1
4192,左頚部に圧痛を認める。,左 頚部 圧痛 認める,1,0.014838713205358015,0.9851612867946419,1,0.0005470362159481039,0.9994529637840519,1,0.07026914588416033,0.9297308541158397,1,9.525713551283843e-14,0.9999999999999047,1,0.0986938327550888,0.9372817873954773,1,0.21716806292533875,0.8428595662117004,1,0.005001667684767267,0.9949983323152326,1
4193,心筋炎、心膜炎が発現。,心筋炎 心膜炎 発現,1,0.0027545278184486367,0.9972454721815512,1,0.0004924489734217411,0.9995075510265783,1,0.004819256951930306,0.9951807430480697,1,0.0,1.0,1,0.09614133089780807,0.939276397228241,1,0.19652841985225677,0.8576182723045349,1,0.00411869197246283,0.9958813080275372,1
4194,心電図心拍46に低下。,心電図 心拍 0 低下,1,0.0166760113719319,0.9833239886280681,1,0.00029667842934440766,0.9997033215706556,1,0.10615928624148852,0.8938407137585115,1,0.0006986246619528069,0.9993013753380472,1,0.09642329812049866,0.9355723261833191,1,0.24558965861797333,0.820009171962738,1,0.0056754864951837885,0.9943245135048162,1
4195,深部静脈血栓症と診断。,深部静脈血栓症 診断,1,0.0166629314837635,0.9833370685162365,1,0.00034607644250386006,0.9996539235574962,1,0.06260030355645518,0.9373996964435448,1,7.01693370075418e-10,0.9999999992983066,1,0.1095387414097786,0.9214180111885071,1,0.19843654334545135,0.8665591478347778,1,0.0048651376933355785,0.9951348623066645,1
4196,生検:心筋炎(異常)。,生検 心筋炎 異常,1,0.012565411314035439,0.9874345886859645,1,0.0002466785885454442,0.9997533214114546,1,0.08172753742135885,0.9182724625786411,1,0.0,1.0,1,0.10331215709447861,0.9334127306938171,1,0.21491344273090363,0.8484522104263306,1,0.0050941256746650405,0.9949058743253348,1
4197,動悸、息切れも認めた。,動悸 息切れ 認める た,1,0.016678625784438877,0.983321374215561,1,0.0003651272016995272,0.9996348727983004,1,0.0338877844772828,0.9661122155227172,1,7.286903215275586e-07,0.9999992713096785,1,0.0862073302268982,0.9458968639373779,1,0.19627521932125092,0.8665339350700378,1,0.004372302128410395,0.9956276978715896,1
4198,発熱、胸部痛を認めた。,発熱 胸部痛 認める た,1,0.005840109460787604,0.9941598905392125,1,0.0004095723896365065,0.9995904276103635,1,0.012481215295086612,0.9875187847049134,1,2.5761752968644913e-06,0.9999974238247031,1,0.07934334874153137,0.9483731389045715,1,0.18664775788784027,0.8599254488945007,1,0.004050563290059088,0.995949436709941,1
4199,夕方、腹痛が出現した。,夕方 腹痛 出現 する た,1,0.016707140741733083,0.983292859258267,1,0.00042579485647466204,0.9995742051435254,1,0.04060957646262875,0.9593904235373713,1,0.027764944600312202,0.9722350553996878,1,0.07925471663475037,0.949536144733429,1,0.1967352330684662,0.8685823678970337,1,0.004627438388881683,0.9953725616111183,1
4200,両肺に湿性ラ温を聴取。,両肺 湿性 ラ 温 聴取,1,0.0985511445678199,0.9014488554321801,1,0.00023008429622602478,0.9997699157037739,1,0.4563792597309324,0.5436207402690676,1,0.008293650013574072,0.9917063499864259,1,0.14747796952724457,0.8978122472763062,1,0.24655552208423615,0.8257400393486023,1,0.014736081716034714,0.9852639182839653,1
4201,性発症の胸痛又は圧迫感,性 発症 の 胸痛 圧迫感,1,0.003322433067544201,0.9966775669324557,1,0.0005767535194670239,0.9994232464805329,1,0.005873806319476538,0.9941261936805235,1,0.0,1.0,1,0.09216970205307007,0.9360464811325073,1,0.20551879703998566,0.8681912422180176,1,0.004123162041623315,0.9958768379583768,1
4202,"TP, 6.4 low",TP 0 0 low,1,0.03655408677809661,0.9634459132219033,1,0.0004033723407678913,0.9995966276592321,1,0.35873972300322543,0.6412602769967746,1,0.00024046071771599564,0.999759539282284,1,0.1860065907239914,0.8775584697723389,1,0.5098938345909119,0.6303535103797913,1,0.0176339795908869,0.9823660204091131,1
4203,"UA, 2.9 low",UA 0 0 low,1,0.03655408677809661,0.9634459132219033,1,0.0004033723407678913,0.9995966276592321,1,0.35873972300322543,0.6412602769967746,1,0.00024046071771599564,0.999759539282284,1,0.16996347904205322,0.8840437531471252,1,0.5098938345909119,0.6303535103797913,1,0.017247931188952743,0.9827520688110473,1
4204,心筋逸脱酵素の軽度上昇,心筋逸脱酵素 軽度 上昇,1,0.00732104165176418,0.9926789583482359,1,0.00045748772704435703,0.9995425122729557,1,0.049549980390095394,0.9504500196099046,1,2.708944180085382e-12,0.9999999999972911,1,0.11659892648458481,0.9259163737297058,1,0.2845488488674164,0.806106686592102,1,0.005398514775370675,0.9946014852246294,1
4205,"WBC,87 High",WBC 0 High,0,0.648277032595875,0.35172296740412506,1,0.0002450053660009475,0.9997549946339991,1,0.3741492743921715,0.6258507256078285,0,0.5195482961797382,0.48045170382026176,1,0.238369420170784,0.8548372983932495,0,0.6659526824951172,0.409397155046463,1,0.21832178157757237,0.7816782184224277,1
4206,"ALB, 3.1low",ALB 0 0 low,1,0.03655408677809661,0.9634459132219033,1,0.0004033723407678913,0.9995966276592321,1,0.35873972300322543,0.6412602769967746,1,0.00024046071771599564,0.999759539282284,1,0.1712106615304947,0.8854039907455444,1,0.5098938345909119,0.6303535103797913,1,0.017246014959672956,0.9827539850403271,1
4207,IgA血管炎の腎病変,IgA 血管炎 の 腎病変,1,0.045813489551864234,0.9541865104481357,1,0.00032628602614744414,0.9996737139738525,1,0.3273590907543167,0.6726409092456833,1,5.2091664315412345e-12,0.9999999999947908,1,0.1039116382598877,0.9189748167991638,1,0.21582716703414917,0.8514629006385803,1,0.008980299503804185,0.9910197004961958,1
4208,その晩に、死亡した。,晩 死亡 する た,1,0.016686957157767503,0.9833130428422326,1,0.00033581955097548844,0.9996641804490245,0,0.6038157186482433,0.3961842813517567,1,0.007421562287644012,0.992578437712356,1,0.12611430883407593,0.9161802530288696,1,0.21896184980869293,0.8455085158348083,1,0.015366306037328624,0.9846336939626715,1
4209,右突発性難聴と診断。,右 突発性 難聴 診断,1,4.155040274051318e-06,0.9999958449597259,1,0.0004829079209666652,0.9995170920790334,1,0.02272871076238947,0.9772712892376105,1,0.0,1.0,1,0.10289455950260162,0.9292364716529846,1,0.19942890107631683,0.8653449416160583,1,0.004295740199233156,0.9957042598007669,1
4210,過換気症候群が発現。,過換気 症候群 発現,1,0.0032467136947085325,0.9967532863052914,1,0.00045912191102783065,0.9995408780889722,1,0.00880375734925043,0.9911962426507496,1,0.0,1.0,1,0.09572579711675644,0.9455142617225647,1,0.20027554035186768,0.8551173210144043,1,0.00415362705750321,0.9958463729424969,1
4211,帰宅後、嘔気を自覚。,帰宅 後 嘔気 自覚,1,0.0099537181168134,0.9900462818831867,1,0.00034720928712447964,0.9996527907128755,1,0.080430565852467,0.919569434147533,1,1.3322676295501878e-15,0.9999999999999987,1,0.11591096222400665,0.9354181289672852,1,0.20011597871780396,0.8551756739616394,1,0.005000999821968506,0.9949990001780316,1
4212,胸痛、息切れを自覚。,胸痛 息切れ 自覚,1,0.0047696150349387095,0.9952303849650613,1,0.0004657297614104802,0.9995342702385895,1,0.0315819760685736,0.9684180239314264,1,0.0,1.0,1,0.09319174289703369,0.944377064704895,1,0.1975501924753189,0.8575972318649292,1,0.0043310806023087,0.9956689193976912,1
4213,胸痛、発熱を認めた。,胸痛 発熱 認める た,1,6.5396702192809624e-06,0.9999934603297806,1,0.0007226278932892583,0.9992773721067107,1,0.005590138599340211,0.9944098614006598,1,3.2087665857716274e-12,0.9999999999967912,1,0.07982322573661804,0.9470025300979614,1,0.18789154291152954,0.8650915026664734,1,0.0039434790925391245,0.9960565209074609,1
4214,経過観察のため入院。,経過 観察 ため 入院,1,0.016688443923507757,0.9833115560764922,1,0.00026189721731786366,0.9997381027826822,1,0.10534855140099653,0.8946514485990035,1,1.2567724638756772e-13,0.9999999999998743,0,0.7242534756660461,0.5179415941238403,0,0.6821237206459045,0.3470216691493988,1,0.038642699090616205,0.9613573009093838,1
4215,倦怠感と嘔気が持続。,倦怠感 嘔気 持続,1,1.4946853055788523e-05,0.9999850531469442,1,0.00032796807364335426,0.9996720319263567,1,0.13401010437757443,0.8659898956224256,1,5.440092820663267e-12,0.9999999999945599,1,0.09397531300783157,0.9408203363418579,1,0.28490301966667175,0.8318920135498047,1,0.005910316885157019,0.9940896831148429,1
4216,口内炎や白苔が多発。,口内炎 白苔 多発,1,0.016690423850064102,0.9833095761499357,1,0.00029708242911943915,0.9997029175708806,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.10225009173154831,0.9393196105957031,1,0.21035800874233246,0.8385949730873108,1,0.010786946870066313,0.9892130531299338,1
4217,好酸球性肺炎を発症。,好酸球性 肺炎 発症,1,5.088392234716582e-06,0.9999949116077653,1,0.0005736894831848724,0.9994263105168151,1,0.01911583359703284,0.9808841664029672,1,0.0,1.0,1,0.09006307274103165,0.9354817271232605,1,0.19392786920070648,0.8577064275741577,1,0.0041943739607149255,0.9958056260392851,1
4218,重度の血管炎が発現。,重度 血管炎 発現,1,0.0026234406255795035,0.9973765593744204,1,0.00047603075358194707,0.9995239692464181,1,0.0139694990307071,0.9860305009692929,1,0.0,1.0,1,0.10066507756710052,0.9420012831687927,1,0.19126276671886444,0.8596892952919006,1,0.004170148380074375,0.9958298516199255,1
4219,心筋炎の診断で入院。,心筋炎 の 診断 入院,1,6.73875019627831e-08,0.999999932612498,1,0.0007434713155316559,0.9992565286844683,1,0.0030657714146654635,0.9969342285853345,1,0.0,1.0,1,0.09735840559005737,0.9398541450500488,1,0.2083423137664795,0.8597031235694885,1,0.004126305718614522,0.9958736942813855,1
4220,心尖部血栓を認めた。,心尖部血栓 認める た,1,0.025917187222450247,0.9740828127775496,1,0.00028455214687034004,0.9997154478531297,1,0.0338877844772828,0.9661122155227172,1,0.0002272698719011368,0.9997727301280989,1,0.08201645314693451,0.9417047500610352,1,0.20118176937103271,0.8593804240226746,1,0.004508584005734134,0.9954914159942659,1
4221,心膜摩擦音を認めた。,心膜摩擦音 認める た,1,0.016673903056173802,0.983326096943826,1,0.00037812104263396936,0.999621878957366,1,0.0338877844772828,0.9661122155227172,1,3.7212272808839764e-05,0.9999627877271912,1,0.09601838886737823,0.9382981657981873,1,0.19689950346946716,0.8532935976982117,1,0.004510979279427234,0.9954890207205728,1
4222,接種後、痙攣が発現。,接種 後 痙攣 発現,1,0.012264043592623041,0.987735956407377,1,0.0003940247688713773,0.9996059752311286,1,0.012720888152579768,0.9872791118474202,1,0.0,1.0,1,0.1041419506072998,0.9383782744407654,1,0.1911354511976242,0.8546136617660522,1,0.004290908648083114,0.995709091351917,1
4223,胎動を認め、腹部軟。,胎動 認める 腹部 軟,1,0.040263853535442214,0.9597361464645575,1,0.00027098278399143076,0.9997290172160086,1,0.05964594313784888,0.9403540568621511,0,0.9999999450212126,5.497878740531397e-08,1,0.36814984679222107,0.8295702934265137,0,0.7066949009895325,0.4578818380832672,1,0.11792316121818905,0.882076838781811,1
4224,日付不明嘔吐が発現。,日付 不明嘔吐 発現,1,0.004241465217845468,0.9957585347821546,1,0.0004161795507075905,0.9995838204492924,1,0.012988545319868039,0.987011454680132,1,2.6429969324226477e-12,0.999999999997357,1,0.10283074527978897,0.9437782764434814,1,0.20019783079624176,0.8665259480476379,1,0.00418529809076614,0.9958147019092339,1
4225,尿蛋白:3+、3+。,尿蛋白 0 0,1,0.21970137170750667,0.7802986282924933,1,0.0003234256114598833,0.9996765743885401,1,0.35873972300322543,0.6412602769967746,1,0.000368158624253323,0.9996318413757467,1,0.22682519257068634,0.8573768138885498,1,0.25735828280448914,0.8494811058044434,1,0.016883196712601144,0.9831168032873989,1
4226,肺炎を確認し、入院。,肺炎 確認 する 入院,1,6.742314969854502e-06,0.9999932576850302,1,0.0004363635656991567,0.9995636364343008,1,0.01864862877110729,0.9813513712288927,1,3.552713678800501e-15,0.9999999999999964,1,0.09957033395767212,0.9327597618103027,1,0.5900586843490601,0.6310414671897888,1,0.007876306292430248,0.9921236937075698,1
4227,末梢神経障害が発現。,末梢神経障害 発現,1,0.013325972549700178,0.9866740274502998,1,0.00041188048227506536,0.999588119517725,1,0.0139694990307071,0.9860305009692929,1,0.0,1.0,1,0.0944804772734642,0.9398329854011536,1,0.2248290628194809,0.8284780383110046,1,0.00452507051227522,0.9954749294877248,1
4228,夜、39°Cの熱発。,夜 0 C 熱発,1,0.006235294171661379,0.9937647058283384,1,0.0003519612099147879,0.9996480387900852,1,0.4068323482018076,0.5931676517981924,1,0.0,1.0,1,0.10144035518169403,0.93448805809021,1,0.1946502923965454,0.8566627502441406,1,0.009301625498128388,0.9906983745018717,1
4229,脾臓に腫れを認める。,脾臓 腫れ 認める,1,0.01668820668899968,0.9833117933110003,1,0.00039972744310941695,0.9996002725568905,1,0.06381987226535135,0.9361801277346486,1,2.2357227180691552e-11,0.9999999999776428,1,0.0852745920419693,0.937568187713623,1,0.19220180809497833,0.8443010449409485,1,0.00476075342080928,0.9952392465791908,1
4230,"TP, 6.0low",TP 0 0 low,1,0.03655408677809661,0.9634459132219033,1,0.0004033723407678913,0.9995966276592321,1,0.35873972300322543,0.6412602769967746,1,0.00024046071771599564,0.999759539282284,1,0.18600648641586304,0.8775585889816284,1,0.5098938345909119,0.6303535103797913,1,0.01763397571889009,0.98236602428111,1
4231,心電図にて異常指摘。,心電図 異常 指摘,1,0.003224181281514333,0.9967758187184858,1,0.0003201076580289682,0.9996798923419711,1,0.09661644488243082,0.9033835551175692,1,0.0,1.0,1,0.12031295150518417,0.9201024174690247,1,0.20654058456420898,0.8442789316177368,1,0.005286983858499822,0.9947130161415002,1
4232,体重:16kg減少。,体重 0kg 減少,1,0.01669824795344673,0.9833017520465532,1,0.000414357161548876,0.9995856428384511,1,0.3653415883548712,0.6346584116451288,1,1.520100711971395e-09,0.9999999984798993,1,0.1894034892320633,0.9126213192939758,1,0.2957407832145691,0.8182035088539124,1,0.011197853318910685,0.9888021466810893,1
4233,尿中赤血球形態は異形,尿中赤血球 形態 異形,1,0.016673787475179818,0.9833262125248201,1,0.000326764011312336,0.9996732359886876,1,0.4563792597309324,0.5436207402690676,1,4.8290038634490884e-11,0.99999999995171,1,0.22560755908489227,0.8284610509872437,1,0.34913358092308044,0.7589358687400818,1,0.016858531807026525,0.9831414681929734,1
4234,気分不快などあり。,気分不快 ある,1,0.016671136111123676,0.9833288638888763,1,0.00035186514736731804,0.9996481348526327,1,0.21948019000176067,0.7805198099982393,1,0.0052360106367737025,0.9947639893632263,1,0.12633772194385529,0.9268358945846558,1,0.22660842537879944,0.8455814719200134,1,0.007132093537487202,0.9928679064625129,1
4235,急性心膜炎と診断。,急性心膜炎 診断,1,0.016687951142480246,0.9833120488575199,1,0.0003885436351377295,0.9996114563648623,1,0.06260030355645518,0.9373996964435448,1,0.0,1.0,1,0.09698012471199036,0.9430116415023804,1,0.19875770807266235,0.8658173084259033,1,0.004708166123108725,0.9952918338768912,1
4236,欠神発作を認めた。,欠神 発作 認める た,1,0.00630219189158901,0.9936978081084108,1,0.00041856689623822983,0.9995814331037618,1,0.02846380301274365,0.9715361969872564,1,0.00016951927459418759,0.9998304807254058,1,0.08105140924453735,0.9487428665161133,1,0.18911302089691162,0.8635217547416687,1,0.0041877629692638725,0.9958122370307362,1
4237,構音障害を認めた。,構音障害 認める た,1,0.01661101231001894,0.983388987689981,1,0.0003961295101560299,0.999603870489844,1,0.0338877844772828,0.9661122155227172,1,0.0012916516757737195,0.9987083483242263,1,0.08910682052373886,0.9426447749137878,1,0.20783346891403198,0.8609927892684937,1,0.004485882244405774,0.9955141177555942,1
4238,細菌感染を認めた。,細菌感染 認める た,1,0.016674561941275413,0.9833254380587246,1,0.00036111305309048956,0.9996388869469095,1,0.0338877844772828,0.9661122155227172,1,8.032619250586404e-05,0.9999196738074941,1,0.09303269535303116,0.9414964318275452,1,0.187535360455513,0.8548041582107544,1,0.004435255374738695,0.9955647446252613,1
4239,状況失神を認めた。,状況失神 認める た,1,0.025917187222450247,0.9740828127775496,1,0.0003068797925743849,0.9996931202074256,1,0.0338877844772828,0.9661122155227172,1,0.000630491344550288,0.9993695086554497,1,0.09849508106708527,0.9387308955192566,1,0.18687406182289124,0.8643910884857178,1,0.004513008034489699,0.9954869919655103,1
4240,植物状態になった。,植物状態 なる た,1,0.016692885972293233,0.9833071140277068,1,0.00028446523150127255,0.9997155347684987,1,0.39189517227961035,0.6081048277203897,1,0.0012892559178919738,0.998710744082108,1,0.12676237523555756,0.9213300943374634,1,0.2550434172153473,0.7670407891273499,1,0.011137455589718494,0.9888625444102815,1
4241,心室期外収縮散発。,心室期外収縮 散発,1,0.016680578085937734,0.9833194219140624,1,0.0002882899716954454,0.9997117100283045,1,0.4563792597309324,0.5436207402690676,1,1.709743457922741e-14,0.9999999999999829,1,0.13108660280704498,0.8988355994224548,1,0.25040242075920105,0.8398959040641785,1,0.012002725094416996,0.987997274905583,1
4242,身体的診察:異常。,身体的 診察 異常,1,0.016670079571313525,0.9833299204286864,1,0.0002217102060870302,0.9997782897939129,1,0.22152358159337648,0.7784764184066235,1,0.0,1.0,1,0.11433751881122589,0.9220329523086548,1,0.2931487560272217,0.8206692934036255,1,0.007703209180340089,0.9922967908196599,1
4243,摂氏40度の発熱。,摂氏 0度 発熱,1,0.016675846953560513,0.9833241530464396,1,0.0003298500208772057,0.9996701499791228,1,0.04399113296158974,0.9560088670384103,1,0.0,1.0,1,0.09515722841024399,0.9452133774757385,1,0.19100701808929443,0.8692339062690735,1,0.004468209102900782,0.9955317908970991,1
4244,知覚異常を認めた。,知覚異常 認める た,1,0.016776580842038424,0.9832234191579615,1,0.00038850041398192167,0.999611499586018,1,0.0338877844772828,0.9661122155227172,1,0.00015338320025226615,0.9998466167997477,1,0.08824919164180756,0.9471672177314758,1,0.19459488987922668,0.8599340915679932,1,0.004399545749479479,0.9956004542505206,1
4245,昼から胸痛が出現。,昼 胸痛 出現,1,0.004385302840474548,0.9956146971595254,1,0.00043159490215015784,0.9995684050978498,1,0.00920752969711447,0.9907924703028855,1,7.253441625110213e-09,0.9999999927465584,1,0.08498872816562653,0.9453470706939697,1,0.2079136222600937,0.8634716272354126,1,0.0041196148542767905,0.9958803851457231,1
4246,夜、発熱を認めた。,夜 発熱 認める た,1,8.915496485830634e-08,0.9999999108450351,1,0.0006301075990709682,0.999369892400929,1,0.012481215295086612,0.9875187847049134,1,1.7537600427441902e-07,0.9999998246239957,1,0.08333713561296463,0.9492334723472595,1,0.1912621110677719,0.8628026843070984,1,0.004024933898942894,0.9959750661010571,1
4247,夜、眠れなかった。,夜 眠れる ない た,1,0.01670648731915179,0.9832935126808482,1,0.0001901084900758002,0.9998098915099242,0,0.9741827841769427,0.025817215823057262,0,0.6710734861249624,0.3289265138750376,0,0.94200199842453,0.05966318026185036,0,0.6719645857810974,0.5290696024894714,1,0.5865059125816227,0.41349408741837745,1
4248,溶血性貧血の疑い。,溶血性 貧血 疑い,1,0.016689450276247554,0.9833105497237526,1,0.00031995751899197955,0.9996800424810081,1,0.16521699794874212,0.8347830020512579,1,0.0,1.0,1,0.10163027048110962,0.937166154384613,1,0.21683382987976074,0.8554133176803589,1,0.006001880009591948,0.993998119990408,1
4249,立位困難を認める。,立位困難 認める,1,0.016668419447479533,0.9833315805525203,1,0.0003779923916717582,0.9996220076083282,1,0.06381987226535135,0.9361801277346486,1,9.15312270421964e-12,0.9999999999908469,1,0.09353138506412506,0.9372197389602661,1,0.22394023835659027,0.8464577794075012,1,0.004944742761536552,0.9950552572384636,1
4250,嘔気が強いと話す。,嘔気 強い 話す,1,0.004983834019484067,0.9950161659805158,1,0.0003673286203123955,0.9996326713796876,1,0.33614359631703783,0.6638564036829622,1,5.773159728050814e-15,0.9999999999999942,1,0.13342858850955963,0.9289606809616089,1,0.2891652584075928,0.8144912123680115,1,0.009585532979895376,0.9904144670201046,1
4251,右上下肢間代性痙攣,右上 下肢 間代性 痙攣,1,0.23565630754406908,0.7643436924559311,1,0.0002293923991227269,0.9997706076008773,1,0.40320045074199284,0.5967995492580072,1,0.0,1.0,1,0.09554067254066467,0.9384020566940308,1,0.239531010389328,0.8281458616256714,1,0.015469356841862077,0.9845306431581379,1
4252,紫斑病性腎炎の疑い,紫斑病 性 腎炎 疑い,1,0.01668517892847795,0.9833148210715219,1,0.000415683238984965,0.999584316761015,1,0.03701858282661574,0.9629814171733843,1,0.0,1.0,1,0.10353811085224152,0.9327992796897888,1,0.2437429577112198,0.8530799150466919,1,0.004818994994744545,0.9951810050052554,1
4253,非特異的ECG異常,非特異的 ECG 異常,1,0.007837184217494684,0.9921628157825055,1,0.0003336588877990629,0.999666341112201,1,0.22152358159337648,0.7784764184066235,1,0.0,1.0,1,0.14710769057273865,0.891964316368103,1,0.2382229119539261,0.8546350598335266,1,0.007377761281018284,0.9926222387189817,1
4254,びまん性壁運動障害,びまん性 壁運動障害,1,0.01667517477282782,0.9833248252271721,1,0.0003098338525255556,0.9996901661474744,1,0.4563792597309324,0.5436207402690676,1,7.358558207215538e-13,0.9999999999992641,1,0.10146404057741165,0.9261428117752075,1,0.237191841006279,0.8498832583427429,1,0.011089099351538841,0.9889109006484611,1
4255,(くも膜下出血)。,くも膜下出血,1,0.016677589964178098,0.983322410035822,1,0.000324271243080137,0.9996757287569199,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.14281250536441803,0.8935555219650269,1,0.21279899775981903,0.8634307384490967,1,0.011491239808049957,0.9885087601919501,1
4256,03:20死亡。,0 0 死亡,1,0.01666163720362797,0.9833383627963722,1,0.0004112525215650808,0.999588747478435,1,0.35873972300322543,0.6412602769967746,1,0.0,1.0,1,0.105878546833992,0.933870255947113,1,0.25364378094673157,0.8399398922920227,1,0.009352986310822393,0.9906470136891776,1
4257,ふらつきが出現。,ふらつき 出現,1,0.016682760598851987,0.9833172394011478,1,0.0004235511470047015,0.9995764488529953,1,0.031149335862347582,0.9688506641376524,1,6.88338275267597e-14,0.9999999999999312,1,0.1084877997636795,0.9310081601142883,1,0.21189557015895844,0.8619874119758606,1,0.004604523615452705,0.9953954763845473,1
4258,咳嗽も出現した。,咳嗽 出現 する た,1,0.005988560248476987,0.9940114397515228,1,0.00048210179689161603,0.9995178982031084,1,0.04060957646262875,0.9593904235373713,1,3.9531691851224515e-05,0.9999604683081488,1,0.081343874335289,0.94559246301651,1,0.20178861916065216,0.8654593229293823,1,0.0043480089942730124,0.995651991005727,1
4259,倦怠感を認めた。,倦怠感 認める た,1,0.0035463950978912723,0.9964536049021088,1,0.0005017237186316923,0.9994982762813683,1,0.008106504700336137,0.9918934952996639,1,0.00019951528028594456,0.999800484719714,1,0.08643776178359985,0.9452695250511169,1,0.2014542818069458,0.8679527640342712,1,0.0040676173019284535,0.9959323826980715,1
4260,肩の痛みが出現。,肩 痛み 出現,1,2.8035004590928386e-06,0.999997196499541,1,0.0005581060447504982,0.9994418939552495,1,0.01001861839273177,0.9899813816072682,1,1.4512169244085271e-11,0.9999999999854878,1,0.08678553998470306,0.9451295733451843,1,0.1980585753917694,0.8577308058738708,1,0.004082897125212562,0.9959171028747875,1
4261,後遺症が残った。,後遺症 残る た,1,0.01570105162310961,0.9842989483768904,1,0.0004049535273462835,0.9995950464726537,1,0.45957936436605773,0.5404206356339423,1,0.0012075417269844513,0.9987924582730155,1,0.28709059953689575,0.8175670504570007,1,0.327964723110199,0.771693229675293,1,0.01762908016814077,0.9823709198318591,1
4262,息切れを認めた。,息切れ 認める た,1,0.016692529386052635,0.9833074706139475,1,0.00041325687598147044,0.9995867431240185,1,0.0338877844772828,0.9661122155227172,1,8.212195556911439e-08,0.9999999178780444,1,0.08318879455327988,0.9475434422492981,1,0.20301248133182526,0.8688117861747742,1,0.004371941135067569,0.9956280588649326,1
4263,突然死であった。,突然死 だ ある た,1,0.016693760281879032,0.9833062397181211,1,0.0002456698556381204,0.9997543301443619,0,0.8237416283756049,0.17625837162439512,1,0.21008934504774668,0.7899106549522533,1,0.2025909125804901,0.8540586233139038,1,0.48294368386268616,0.5955407023429871,1,0.065221287318276,0.934778712681724,1
4264,皮膚生検:異常。,皮膚生検 異常,1,0.016664405064907743,0.9833355949350923,1,0.00028039638587678975,0.9997196036141233,1,0.22152358159337648,0.7784764184066235,1,0.0,1.0,1,0.13265839219093323,0.9088107943534851,1,0.2354486882686615,0.8433126211166382,1,0.007339779941099924,0.9926602200589,1
4265,夜、痙攣が発現。,夜 痙攣 発現,1,8.446141272868854e-07,0.9999991553858727,1,0.0004276645547417444,0.9995723354452583,1,0.0139694990307071,0.9860305009692929,1,0.0,1.0,1,0.09655103087425232,0.9409471750259399,1,0.1940661519765854,0.8684858679771423,1,0.004110793883284554,0.9958892061167155,1
4266,心不全が疑われた,心不全 疑う れる た,1,0.01669965790241687,0.9833003420975831,1,0.00041696167974539634,0.9995830383202546,1,0.07503641093942781,0.9249635890605722,1,8.232323057866253e-05,0.9999176767694213,1,0.08012466877698898,0.9452261328697205,1,0.199321910738945,0.8490836024284363,1,0.004818835719728845,0.9951811642802711,1
4267,声かけに反応せず,声掛け 反応 する ぬ,1,0.01670391822074503,0.9832960817792548,1,0.0001994322243354161,0.9998005677756646,0,0.5801097963961727,0.41989020360382734,1,0.002548615699902723,0.9974513843000973,1,0.5737451314926147,0.6401548385620117,0,0.7062187790870667,0.48333027958869934,1,0.06633514602079345,0.9336648539792065,1
4268,臀部に強い電撃痛,臀部 強いる 電撃痛,1,0.3018446772211285,0.6981553227788713,1,0.00021078916589028072,0.9997892108341098,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.1030680388212204,0.9425759315490723,1,0.22906483709812164,0.8619472980499268,1,0.018788908362898253,0.9812110916371017,1
4269,トロポニンI増加,トロポニン I 増加,1,0.298334686986904,0.7016653130130963,1,0.0001820379435219668,0.999817962056478,1,0.46373061676998695,0.536269383230013,1,5.685829584933799e-11,0.9999999999431417,1,0.15185219049453735,0.917607307434082,1,0.20344534516334534,0.8567468523979187,1,0.019946334462881396,0.9800536655371187,1
4270,尿潜血:(2+),尿潜血 0,1,0.016671073822493648,0.9833289261775063,1,0.00030299218777339956,0.9996970078122266,1,0.3607204586964663,0.6392795413035337,1,0.017158573878651162,0.9828414261213488,1,0.16442464292049408,0.8846153020858765,1,0.2647538185119629,0.8382189869880676,1,0.010944107826299253,0.9890558921737007,1
4271,トイレで失神。,トイレ だ 失神,1,0.016664825578455035,0.983335174421545,1,0.00030180776732759477,0.9996981922326724,0,0.7333202657056541,0.2666797342943459,1,0.0,1.0,1,0.09183160215616226,0.9335606098175049,0,0.7045918703079224,0.536615252494812,1,0.040187629570614405,0.9598123704293855,1
4272,胸痛を認めた。,胸痛 認める た,1,0.005780973205078104,0.994219026794922,1,0.0005746776258956975,0.9994253223741043,1,0.005394640414290497,0.9946053595857095,1,6.128431095930864e-14,0.9999999999999387,1,0.08649121969938278,0.9449800848960876,1,0.19126416742801666,0.8635105490684509,1,0.004040916455288062,0.9959590835447119,1
4273,血便を認めた。,血便 認める た,1,0.01667600812608471,0.9833239918739154,1,0.00036111305309048956,0.9996388869469095,1,0.0338877844772828,0.9661122155227172,1,1.6597480335667214e-06,0.9999983402519664,1,0.08116183429956436,0.9469133615493774,1,0.1945248395204544,0.8594006299972534,1,0.004369297414092487,0.9956307025859075,1
4274,倦怠感が出現。,倦怠感 出現,1,1.5475286972624507e-05,0.9999845247130273,1,0.0004983146402350013,0.999501685359765,1,0.011160216712827076,0.9888397832871729,1,0.02682520360703111,0.9731747963929689,1,0.0943228006362915,0.9392485022544861,1,0.2092047780752182,0.8594954013824463,1,0.004415460521923927,0.9955845394780761,1
4275,心筋炎と診断。,心筋炎 診断,1,0.005153480566438137,0.9948465194335617,1,0.0005088064515298374,0.9994911935484702,1,0.021971659283963052,0.978028340716037,1,0.0,1.0,1,0.1120460033416748,0.9310587048530579,1,0.20028401911258698,0.8645092248916626,1,0.004372797124182459,0.9956272028758176,1
4276,心電図:異常。,心電図 異常,1,0.01668749658709119,0.9833125034129088,1,0.00020566903928542164,0.9997943309607146,1,0.1883243461082088,0.8116756538917912,1,0.0,1.0,1,0.1286814659833908,0.905992865562439,1,0.26004573702812195,0.828300952911377,1,0.007138194645009778,0.9928618053549901,1
4277,心不全と診断。,心不全 診断,1,0.014788391250974585,0.9852116087490254,1,0.000404249808075362,0.9995957501919246,1,0.06260030355645518,0.9373996964435448,1,0.0,1.0,1,0.10801222920417786,0.9341436624526978,1,0.20449991524219513,0.8603870868682861,1,0.004837862353409984,0.9951621376465901,1
4278,心膜炎と診断。,心膜炎 診断,1,0.01670605696733406,0.9832939430326658,1,0.0003845442801543809,0.9996154557198457,1,0.06260030355645518,0.9373996964435448,1,0.0,1.0,1,0.11190897226333618,0.9295217990875244,1,0.1948644369840622,0.863285481929779,1,0.004836806433622061,0.995163193566378,1
4279,入院となった。,入院 なる た,1,0.016706338587638703,0.9832936614123613,1,0.0003677925852997953,0.9996322074147002,1,0.05233310800348712,0.9476668919965129,1,6.347987125177035e-06,0.9999936520128748,1,0.10093014687299728,0.9331149458885193,1,0.3338180184364319,0.790191650390625,1,0.00576750639377736,0.9942324936062227,1
4280,発熱を認めた。,発熱 認める た,1,0.004988160617976153,0.995011839382024,1,0.000871822029962293,0.9991281779700377,1,0.00628315489639919,0.9937168451036008,1,0.0,1.0,1,0.08595754951238632,0.9464402198791504,1,0.19087612628936768,0.8548588156700134,1,0.004069411847861262,0.9959305881521386,1
4281,左腕全体の痺れ,左腕 全体 痺れ,1,0.01670888238472334,0.9832911176152765,1,0.00028800151491939117,0.9997119984850806,1,0.4563792597309324,0.5436207402690676,1,6.283862319378386e-14,0.9999999999999372,1,0.10685640573501587,0.9180687665939331,1,0.22830484807491302,0.8477600812911987,1,0.011163104426395107,0.988836895573605,1
4282,自己免疫性脳炎,自己免疫性 脳炎,1,0.016677927367675618,0.9833220726323243,1,0.00027530103231497696,0.999724698967685,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.1443689465522766,0.905200183391571,1,0.24962873756885529,0.8493351340293884,1,0.011963342027582783,0.9880366579724172,1
4283,異常所見あり。,異常所見 ある,1,0.013442038184524153,0.9865579618154756,1,0.0003083341942955445,0.9996916658057045,1,0.21948019000176067,0.7805198099982393,1,1.5938675046456297e-08,0.999999984061325,1,0.25023218989372253,0.8469341993331909,1,0.24426302313804626,0.8329970240592957,1,0.00884538354052952,0.9911546164594706,1
4284,MOG脳脊髄炎,MOG 脳脊髄炎,1,0.1087754842843677,0.8912245157156321,1,0.00024299570919250496,0.9997570042908075,1,0.4563792597309324,0.5436207402690676,1,1.0658141036401503e-14,0.9999999999999893,1,0.2155156284570694,0.8846197724342346,1,0.2076946198940277,0.8582254648208618,1,0.01493736391900239,0.9850626360809976,1
4285,血小板数:減少,血小板 数 減少,1,0.016666156968068925,0.9833338430319312,1,0.00027189582737044925,0.9997281041726296,1,0.3653415883548712,0.6346584116451288,1,8.265402473561778e-09,0.9999999917345975,1,0.21324151754379272,0.8859915733337402,1,0.38618895411491394,0.7297502160072327,1,0.014039354498781378,0.9859606455012185,1
4286,声が出なくなる,声 出る ない なる,0,0.7779369606587062,0.22206303934129368,1,0.00019678339452504516,0.999803216605475,0,0.9331913829796381,0.06680861702036191,1,0.0007494479804007748,0.9992505520195992,0,0.6689295768737793,0.4405081868171692,1,0.473918080329895,0.662236750125885,1,0.3691772288138974,0.6308227711861026,1
4287,胸痛を自覚。,胸痛 自覚,1,0.00473696588849368,0.9952630341115064,1,0.000552709235564231,0.9994472907644357,1,0.0315819760685736,0.9684180239314264,1,0.0,1.0,1,0.09513973444700241,0.9418231844902039,1,0.1958867758512497,0.8621176481246948,1,0.0043243013117005985,0.9956756986882994,1
4288,死因は肺炎。,死因 肺炎,1,0.01667874711283753,0.9833212528871625,1,0.00041263984060882513,0.9995873601593912,1,0.11835898155778857,0.8816410184422114,1,0.0,1.0,1,0.12837891280651093,0.902624249458313,1,0.26427724957466125,0.817692220211029,1,0.006325883646959262,0.9936741163530408,1
4289,徐々に増悪。,増悪,1,0.01669503361059606,0.9833049663894038,1,0.00033973937675997265,0.99966026062324,1,0.3151478705399626,0.6848521294600374,1,0.0,1.0,1,0.1581622064113617,0.9185647368431091,1,0.29846012592315674,0.8170508742332458,1,0.00980870406118738,0.9901912959388126,1
4290,痛みも伴う。,痛み 伴う,1,0.011581465872738724,0.9884185341272612,1,0.0005027280803053113,0.9994972719196947,1,0.06980523316416798,0.930194766835832,1,0.0,1.0,1,0.12088942527770996,0.9320341348648071,1,0.23722060024738312,0.8442785143852234,1,0.0051972038158307155,0.9948027961841692,1
4291,微熱が発現。,微熱 発現,1,0.0027168098888205555,0.9972831901111794,1,0.0005105588915687957,0.9994894411084312,1,0.0139694990307071,0.9860305009692929,1,0.0,1.0,1,0.08898790180683136,0.946262776851654,1,0.22836513817310333,0.8520330786705017,1,0.0042926502194316676,0.9957073497805683,1
4292,右上肢の膨疹,右 上肢 膨疹,1,0.01670548326606732,0.9832945167339326,1,0.00034362866577174065,0.9996563713342282,1,0.16970356572488454,0.8302964342751155,1,0.0,1.0,1,0.09593026340007782,0.9264835119247437,1,0.3757149875164032,0.7720195055007935,1,0.007741774847895784,0.9922582251521042,1
4293,四肢けいれん,四肢けいれん,1,0.46350564751376766,0.5364943524862322,1,0.0001843188090939102,0.9998156811909061,1,0.4563792597309324,0.5436207402690676,1,2.3314683517128287e-14,0.9999999999999767,1,0.11874311417341232,0.9048227667808533,1,0.23315714299678802,0.8360868096351624,1,0.02795323807053387,0.9720467619294662,1
4294,意味不明言動,意味不明言動,1,0.016679396069087568,0.9833206039309126,1,0.0002848411752893621,0.9997151588247106,1,0.4563792597309324,0.5436207402690676,1,7.212153704594382e-05,0.9999278784629541,1,0.15488049387931824,0.9140416383743286,1,0.217148557305336,0.8483843207359314,1,0.011617402579113027,0.988382597420887,1
4295,横紋筋融解症,横紋筋融解症,1,0.016685881232943192,0.9833141187670569,1,0.00028640529976422174,0.9997135947002358,1,0.4563792597309324,0.5436207402690676,1,4.218847493575595e-15,0.9999999999999958,1,0.1328856498003006,0.9215807914733887,1,0.2017899751663208,0.8576099276542664,1,0.011010743379821759,0.9889892566201782,1
4296,炎症反応高値,炎症反応高値,1,0.016687703106140157,0.9833122968938597,1,0.0003438017630107428,0.9996561982369893,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.11291050165891647,0.9257981777191162,1,0.21402610838413239,0.8568792343139648,1,0.010890445289970381,0.9891095547100297,1
4297,IgA血管炎,IgA 血管炎,1,0.11577516156421407,0.884224838435786,1,0.0002930549259624332,0.9997069450740376,1,0.4563792597309324,0.5436207402690676,1,1.565649762225174e-05,0.9999843435023777,1,0.13024751842021942,0.8965677618980408,1,0.22598141431808472,0.8452191948890686,1,0.014194118684654287,0.9858058813153457,1
4298,異常あり。,異常 ある,1,0.008133331718503674,0.9918666682814963,1,0.00022504031144954668,0.9997749596885505,1,0.10161352581995553,0.8983864741800445,1,0.0,1.0,1,0.16430670022964478,0.8986821174621582,1,0.25387805700302124,0.8092683553695679,1,0.006244302694833479,0.9937556973051664,1
4299,入院した。,入院 する た,1,0.017972644419089173,0.9820273555809108,1,0.00039284608330031643,0.9996071539166996,1,0.04048963444514164,0.9595103655548584,1,3.6931806614015628e-06,0.9999963068193386,1,0.12230926007032394,0.9238798022270203,1,0.36720678210258484,0.7851473689079285,1,0.0060490087049918,0.9939509912950082,1
4300,軽度心筋炎,軽度 心筋炎,1,0.016695883831681347,0.9833041161683187,1,0.0004150999190721001,0.9995849000809279,1,0.07726117042051694,0.922738829579483,1,6.975899635719429e-09,0.9999999930241004,1,0.13281980156898499,0.9232269525527954,0,0.6755895018577576,0.5496405363082886,1,0.011253999882167867,0.9887460001178322,1
4301,左手を打撲,左手 打撲,1,0.016702276246604794,0.9832977237533951,1,0.0002952580922463492,0.9997047419077536,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.10861103236675262,0.92498779296875,1,0.22063016891479492,0.8252149820327759,1,0.011270768643367462,0.9887292313566325,1
4302,運動性低下,運動性 低下,1,0.016696825278198418,0.9833031747218018,1,0.0003139919118294531,0.9996860080881705,1,0.151316425063592,0.848683574936408,1,0.0009674830166803705,0.9990325169833196,1,0.15164124965667725,0.919074296951294,1,0.2854306399822235,0.8075832724571228,1,0.007026632790606386,0.9929733672093936,1
4303,気管支痙攣,気管支痙攣,1,0.016662310152882224,0.9833376898471178,1,0.0002848411752893621,0.9997151588247106,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.13202935457229614,0.9346413612365723,1,0.23091347515583038,0.8484408855438232,1,0.011278810466941597,0.9887211895330584,1
4304,不整脈疑い,不整脈 疑い,1,0.016679149262553317,0.9833208507374467,1,0.00032718772244609876,0.9996728122775539,1,0.16521699794874212,0.8347830020512579,1,0.0,1.0,1,0.11272918432950974,0.9333981871604919,1,0.23404794931411743,0.8494765162467957,1,0.0062329635476436945,0.9937670364523562,1
4305,悪化傾向。,悪化傾向,1,0.016675103098265608,0.9833248969017343,1,0.0002960556290409448,0.9997039443709591,1,0.4563792597309324,0.5436207402690676,1,5.3897202842767555e-05,0.9999461027971572,1,0.2307542860507965,0.9033329486846924,1,0.2762327790260315,0.8154703974723816,1,0.013857043791394363,0.9861429562086056,1
4306,低Na血症,Na 血 症,1,0.02531116948742821,0.9746888305125716,1,0.0004048750626153856,0.9995951249373846,1,0.31213492943884336,0.6878650705611566,1,0.0,1.0,1,0.13063520193099976,0.9097213745117188,1,0.2454122006893158,0.8436899185180664,1,0.008998466191405152,0.9910015338085949,1
4307,感覚鈍麻,感覚鈍麻,1,0.01669743609483553,0.9833025639051646,1,0.0002723680149602021,0.9997276319850398,1,0.4563792597309324,0.5436207402690676,1,7.41205471443962e-06,0.9999925879452856,1,0.11159822344779968,0.9282528758049011,1,0.3595593571662903,0.7872103452682495,1,0.013418750167382558,0.9865812498326174,1
4308,意識障害,意識障害,1,0.01668221932596864,0.9833177806740313,1,0.00032342593503258566,0.9996765740649675,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.1058865636587143,0.9338690042495728,1,0.2093467116355896,0.861394464969635,1,0.010631344163708537,0.9893686558362915,1
4309,四肢冷感,四肢冷感,1,0.01667017563074115,0.9833298243692586,1,0.0002988891646755668,0.9997011108353244,1,0.4563792597309324,0.5436207402690676,1,5.551115123125783e-15,0.9999999999999944,1,0.10062777251005173,0.941646933555603,1,0.32522156834602356,0.7605840563774109,1,0.013000457843027082,0.986999542156973,1
4310,少し嘔気,嘔気,1,0.01666740655335819,0.9833325934466418,1,0.00028415363047451373,0.9997158463695255,1,0.33614359631703783,0.6638564036829622,1,0.0,1.0,1,0.11313216388225555,0.9368003606796265,1,0.2798532247543335,0.8216291069984436,1,0.009384623726641972,0.9906153762733579,1
4311,顔面蒼白,顔面蒼白,1,0.46350564751376766,0.5364943524862322,1,0.00019808202185382702,0.9998019179781462,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.11388558149337769,0.938709020614624,1,0.22580444812774658,0.8590412139892578,1,0.02613762299666426,0.9738623770033357,1
4312,筋力低下,筋力低下,1,0.30274875288339037,0.6972512471166096,1,0.00023777976518857356,0.9997622202348114,1,0.4563792597309324,0.5436207402690676,1,2.2694807815248907e-06,0.9999977305192185,1,0.11243434995412827,0.9280882477760315,1,0.2503449618816376,0.843134880065918,1,0.020041449090237563,0.9799585509097625,1
4313,肝線維症,肝線維症,1,0.01668245272973653,0.9833175472702635,1,0.0003109597813145433,0.9996890402186854,1,0.4563792597309324,0.5436207402690676,1,0.0001711664691494974,0.9998288335308505,1,0.11867719143629074,0.902743935585022,1,0.2510829567909241,0.8403162360191345,1,0.011818359142583248,0.9881816408574168,1
4314,免疫不全,免疫不全,1,0.01668168941561419,0.9833183105843858,1,0.00027010161493914455,0.9997298983850609,1,0.4563792597309324,0.5436207402690676,1,6.084022174945858e-13,0.9999999999993916,1,0.1977192908525467,0.8950080275535583,1,0.2654534578323364,0.813758373260498,1,0.013401036935047008,0.9865989630649529,1
4315,圧迫骨折,圧迫 骨折,1,0.016689378209993125,0.9833106217900068,1,0.00027477781753394124,0.9997252221824661,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.0995829850435257,0.9155675768852234,1,0.23495543003082275,0.8448586463928223,1,0.011215263616384497,0.9887847363836155,1
4316,高K血症,K 血 症,1,0.02531116948742821,0.9746888305125716,1,0.0004048750626153856,0.9995951249373846,1,0.31213492943884336,0.6878650705611566,1,0.0,1.0,1,0.13457271456718445,0.9195342063903809,1,0.2454122006893158,0.8436899185180664,1,0.008946223926784418,0.9910537760732155,1
4317,食欲不振,食欲不振,1,0.016673790952396746,0.9833262090476033,1,0.0003120265499049155,0.9996879734500951,1,0.4563792597309324,0.5436207402690676,1,4.548218024424955e-09,0.999999995451782,1,0.1312343180179596,0.9208112359046936,1,0.20068524777889252,0.8631559610366821,1,0.010929311800192429,0.9890706881998076,1
4318,肩の痛み,肩 痛み,1,0.023721875880093852,0.9762781241199061,1,0.0003362012585803817,0.9996637987414196,1,0.1427464386641103,0.8572535613358897,1,0.0,1.0,1,0.10660077631473541,0.9315930604934692,1,0.27302420139312744,0.8327569365501404,1,0.006361457472778887,0.9936385425272212,1
4319,異常。,異常,1,0.0259798596884462,0.9740201403115539,1,0.00017028153754069925,0.9998297184624593,1,0.22152358159337648,0.7784764184066235,1,0.0,1.0,1,0.20545035600662231,0.8913198709487915,1,0.30201080441474915,0.787733256816864,1,0.009227977830521233,0.9907720221694788,1
4320,入院。,入院,1,0.015932921992014137,0.984067078007986,1,0.00045271703869459207,0.9995472829613055,1,0.07696334651396064,0.9230366534860394,1,0.0,1.0,1,0.1838856041431427,0.8886529803276062,0,0.652146577835083,0.591809868812561,1,0.01145585104883246,0.9885441489511676,1
4321,関節炎,関節炎,1,0.016702055349890634,0.9832979446501093,1,0.00025854974579144174,0.9997414502542086,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.10612787306308746,0.931495726108551,1,0.24866071343421936,0.8348713517189026,1,0.011374981583368717,0.9886250184166313,1
4322,足骨折,足骨折,1,0.46350564751376766,0.5364943524862322,1,0.0001843188090939102,0.9998156811909061,1,0.4563792597309324,0.5436207402690676,1,6.439293542825908e-15,0.9999999999999936,1,0.11988167464733124,0.9152509570121765,1,0.3129070997238159,0.7755603194236755,1,0.03174119494096786,0.9682588050590321,1
4323,倦怠感,倦怠感,1,0.08320714661788241,0.9167928533821176,1,0.0002350803087268105,0.9997649196912732,1,0.20418208000997073,0.7958179199900293,1,0.0010884181451367159,0.9989115818548633,1,0.13833127915859222,0.9237942695617676,1,0.22984890639781952,0.8582249879837036,1,0.00787298685607132,0.9921270131439286,1
4324,低値,値,1,0.016699709622611303,0.9833002903773886,1,0.0002320939675067476,0.9997679060324932,1,0.3814227122398556,0.6185772877601444,1,6.271865249374287e-10,0.9999999993728135,1,0.5166298747062683,0.6622956395149231,0,0.7715873122215271,0.383565217256546,1,0.049222247187064395,0.9507777528129356,1
4325,尿閉,尿閉,1,0.01670332601667201,0.9832966739833279,1,0.00031078689305512336,0.9996892131069449,1,0.4563792597309324,0.5436207402690676,1,3.9968028886505635e-15,0.999999999999996,1,0.13878203928470612,0.9182007908821106,1,0.21041446924209595,0.8543636798858643,1,0.011244352625151395,0.9887556473748487,1
4326,脱水,脱水,1,0.016691515564757262,0.9833084844352428,1,0.00029510185257802644,0.999704898147422,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.1109258309006691,0.9263046979904175,1,0.20908351242542267,0.851707935333252,1,0.010865136212165605,0.9891348637878344,1
4327,梅毒,梅毒,1,0.016689371220186086,0.9833106287798139,1,0.0002848411752893621,0.9997151588247106,1,0.4563792597309324,0.5436207402690676,1,0.0,1.0,1,0.36494019627571106,0.7736787796020508,0,0.7309935688972473,0.4535086750984192,1,0.03975141539791991,0.9602485846020802,1
